Citrus Sinensis ID: 043720
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1103 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S7I6 | 1151 | LRR receptor-like serine/ | yes | no | 0.980 | 0.940 | 0.575 | 0.0 | |
| Q9ZRF9 | 540 | Probable LRR receptor-lik | no | no | 0.398 | 0.814 | 0.580 | 1e-144 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.907 | 0.908 | 0.306 | 1e-132 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.939 | 0.869 | 0.313 | 1e-131 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.923 | 0.925 | 0.321 | 1e-126 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.903 | 0.887 | 0.322 | 1e-126 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.924 | 0.919 | 0.326 | 1e-123 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.954 | 0.843 | 0.300 | 1e-121 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.860 | 0.831 | 0.314 | 1e-119 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.926 | 0.909 | 0.304 | 1e-119 |
| >sp|Q9S7I6|RPK2_ARATH LRR receptor-like serine/threonine-protein kinase RPK2 OS=Arabidopsis thaliana GN=RPK2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1185 bits (3066), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 640/1113 (57%), Positives = 803/1113 (72%), Gaps = 31/1113 (2%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
+K++LL FK +VSDP IL+SW + +CSWFGVSCDS SRV+ALNI+G SE S+
Sbjct: 46 DKSVLLRFKKTVSDPGSILASWVEESEDYCSWFGVSCDSSSRVMALNISGSGSSE-ISRN 104
Query: 67 FFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPE 126
F+C +FP YGFG+RR C G L G L ++ L+ LRVLSLPFN FSGE P
Sbjct: 105 RFTCGDIGKFPLYGFGVRR-DCTGNHGALAGNLPSVIMSLTGLRVLSLPFNSFSGEIPVG 163
Query: 127 IWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186
IW +EKLEVLD+EGN ++G LP++F GLRNLRV+NL FNR+ G+IP SL+N LE+LNL
Sbjct: 164 IWGMEKLEVLDLEGNLMTGSLPDQFTGLRNLRVMNLGFNRVSGEIPNSLQNLTKLEILNL 223
Query: 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS 246
GN++ G +PGF+G F RVL L N L GS+P ++G C LEHLDLSGN L GRIP
Sbjct: 224 GGNKLNGTVPGFVGRF---RVLHLPLNWLQGSLPKDIGDSCGKLEHLDLSGNFLTGRIPE 280
Query: 247 SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLV 306
SLGKC LR+LLL+ N L + IP E G L+KLEVLDVSRN L+G +P ELGNC LSVLV
Sbjct: 281 SLGKCAGLRSLLLYMNTLEETIPLEFGSLQKLEVLDVSRNTLSGPLPVELGNCSSLSVLV 340
Query: 307 LSNLFDPLLSGRNIRGE--LSVGQSDASNGEK-NSFIGSIPMEITTLSKLRIIWAPRLNL 363
LSNL++ ++RGE L G S E N + G IP EIT L KL+I+W PR L
Sbjct: 341 LSNLYNVYEDINSVRGEADLPPGADLTSMTEDFNFYQGGIPEEITRLPKLKILWVPRATL 400
Query: 364 EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423
EG+ P WG+C++LEM+NL QN +G++ +CK L +DLSSN L+GEL ++ VPC
Sbjct: 401 EGRFPGDWGSCQNLEMVNLGQNFFKGEIPVGLSKCKNLRLLDLSSNRLTGELLKEISVPC 460
Query: 424 MALFDVSGNHMSGSIPRFDYNVCHQMP----LQSSDLCQGYDPSFTYMQYFMSKARLGMP 479
M++FDV GN +SG IP F N P + DPS Y+ +F KA++G
Sbjct: 461 MSVFDVGGNSLSGVIPDFLNNTTSHCPPVVYFDRFSIESYSDPSSVYLSFFTEKAQVGTS 520
Query: 480 L--LVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQ 537
L L S V HNF+ NNFTG + +P+A ERL +R Y F AG N+L G FPG+LF
Sbjct: 521 LIDLGSDGGPAVFHNFADNNFTGTLKSIPLAQERLGKRVSYIFSAGGNRLYGQFPGNLFD 580
Query: 538 ACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
C+E + N+S N + G IP + MC SL++LDAS NQI G +P SL +L SLV L+
Sbjct: 581 NCDELKAVYVNVSFNKLSGRIPQGLNNMCTSLKILDASVNQIFGPIPTSLGDLASLVALN 640
Query: 598 LNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVP 656
L+ N+LQG+IP SL ++ L +LS+A+NNLTG IP S G+L SL+VL+LSSN LSG +P
Sbjct: 641 LSWNQLQGQIPGSLGKKMAALTYLSIANNNLTGQIPQSFGQLHSLDVLDLSSNHLSGGIP 700
Query: 657 EGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVI 716
VNL+NLT LLL+NN LSG +PSG A + ++FN S NNLSGP P CS V
Sbjct: 701 HDFVNLKNLTVLLLNNNNLSGPIPSGFA---TFAVFNVSSNNLSGPVPSTNGLTKCSTVS 757
Query: 717 GNPFLDPCQMY---------KDISSSELTSSNANSQ-HNITAPTGSRTEDHKIQIASIVS 766
GNP+L PC ++ +D + +T A+S N + + + + ++IASI S
Sbjct: 758 GNPYLRPCHVFSLTTPSSDSRDSTGDSITQDYASSPVENAPSQSPGKGGFNSLEIASIAS 817
Query: 767 ASAIVLILLTLVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTS 826
ASAIV +L+ LVILFFY RK P +++ + RE+T+F+DIGVP+T+++++RATG+FN S
Sbjct: 818 ASAIVSVLIALVILFFYTRKWHPKSKIMATTKREVTMFMDIGVPITFDNVVRATGNFNAS 877
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
N IG+GGFG TYKAEIS ++VA+K+L++GRFQ GVQQFHAEIKTLG +RHPNLVTLIGY
Sbjct: 878 NLIGNGGFGATYKAEISQDVVVAIKRLSIGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGY 936
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
AS EMFL+YNYLPGGNLE FI+ R++R DW++LHKIALD+A ALAYLHDQC PRVLH
Sbjct: 937 HASETEMFLVYNYLPGGNLEKFIQERSTR--DWRVLHKIALDIARALAYLHDQCVPRVLH 994
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKAD 1006
RDVKPSNILLDDD NAYLSDFGL+RLLGTSETHATTGVAGTFGYVAPEYA+TCRVSDKAD
Sbjct: 995 RDVKPSNILLDDDCNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKAD 1054
Query: 1007 VYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDD 1066
VYSYGVVLLEL+SDKKALDPSF S+G+GFNI+ WA MLLRQG+ K+ F A LW +GPHDD
Sbjct: 1055 VYSYGVVLLELLSDKKALDPSFVSYGNGFNIVQWACMLLRQGRAKEFFTAGLWDAGPHDD 1114
Query: 1067 LEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
L ++LHLA+ CTV++LSTRPTMKQVV+ LKQ+Q
Sbjct: 1115 LVEVLHLAVVCTVDSLSTRPTMKQVVRRLKQLQ 1147
|
Key regulator of anther development (e.g. lignification pattern), including tapetum degradation during pollen maturation (e.g. germination capacity). Together with RPK1, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9ZRF9|RPK1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RPK1 OS=Arabidopsis thaliana GN=RPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 513 bits (1320), Expect = e-144, Method: Compositional matrix adjust.
Identities = 263/453 (58%), Positives = 343/453 (75%), Gaps = 13/453 (2%)
Query: 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP---WNVTTMNCSG 714
GV++L +L++ +L G + + +++ + + + SFN+L G P W + +
Sbjct: 90 GVLHLPDLSSCSSSKRRLGGVISPVVGDLSEIRVLSLSFNDLRGEIPKEIWGLEKLEILD 149
Query: 715 VIGNPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRTED------HKIQIASIVSAS 768
+ GN F+ ++ ++ +L S + P+ + + + I+IASIVSAS
Sbjct: 150 LKGNNFIGGIRVVDNVVLRKLMSFEDEDE---IGPSSADDDSPGKSGLYPIEIASIVSAS 206
Query: 769 AIVLILLTLVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNC 828
IV +LL LVILF Y RK +++VQV E +E+ +F+DIG+PLTYE I+RATG F+ SNC
Sbjct: 207 VIVFVLLVLVILFIYTRKWKRNSQVQVDEIKEIKVFVDIGIPLTYEIIVRATGYFSNSNC 266
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
IG GGFG+TYKAE+SP + AVK+L+VGRFQ G QQFHAEI L VRHPNLV LIGY A
Sbjct: 267 IGHGGFGSTYKAEVSPTNVFAVKRLSVGRFQ-GDQQFHAEISALEMVRHPNLVMLIGYHA 325
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
S EMFLIYNYL GGNL++FIK R+ A++WK+LHKIALDVA AL+YLH+QC+P+VLHRD
Sbjct: 326 SETEMFLIYNYLSGGNLQDFIKERSKAAIEWKVLHKIALDVARALSYLHEQCSPKVLHRD 385
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+KPSNILLD+++NAYLSDFGLS+LLGTS++H TTGVAGTFGYVAPEYA+TCRVS+KADVY
Sbjct: 386 IKPSNILLDNNYNAYLSDFGLSKLLGTSQSHVTTGVAGTFGYVAPEYAMTCRVSEKADVY 445
Query: 1009 SYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLE 1068
SYG+VLLELISDK+ALDPSFSSH +GFNI+SWA M+L QG+ K+VF LW +GP DDL
Sbjct: 446 SYGIVLLELISDKRALDPSFSSHENGFNIVSWAHMMLSQGKAKEVFTTGLWETGPPDDLV 505
Query: 1069 DMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
++LHLAL+CTV++LS RPTMKQ V+ LK+IQ S
Sbjct: 506 EVLHLALKCTVDSLSIRPTMKQAVRLLKRIQPS 538
|
Involved in the main abscisic acid-mediated (ABA) signaling pathway and in early ABA perception. Together with RPK2, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 474 bits (1219), Expect = e-132, Method: Compositional matrix adjust.
Identities = 352/1149 (30%), Positives = 550/1149 (47%), Gaps = 148/1149 (12%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCD---SESRVVALNITGGDVSEGN 63
E LLE K+ D L +W +N S C W GV C S+ V++LN++ +S
Sbjct: 30 EGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSMVLS--- 86
Query: 64 SKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEF 123
GKLSP +GGL L+ L L +NG SG+
Sbjct: 87 ---------------------------------GKLSPSIGGLVHLKQLDLSYNGLSGKI 113
Query: 124 PPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183
P EI + LE+L + N G +P E L +L L + NRI G +P + N SL
Sbjct: 114 PKEIGNCSSLEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQ 173
Query: 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGR 243
L N + G +P +G+ +L N ++GS+PSE+G C L L L+ N L G
Sbjct: 174 LVTYSNNISGQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGG-CESLVMLGLAQNQLSGE 232
Query: 244 IPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELS 303
+P +G ++L ++L+ N + IPRE+ LE L + +N+L G IP ELG+ L
Sbjct: 233 LPKEIGMLKKLSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLE 292
Query: 304 VLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNL 363
L L + L+G R ++ + + +N+ G IP+E+ + L +++ L
Sbjct: 293 FLYL---YRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQL 349
Query: 364 EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQ-VP 422
G +P ++L L+L+ N L G + F + L + L N LSG + KL
Sbjct: 350 TGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYS 409
Query: 423 CMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLV 482
+ + D+S NH+SG IP + LC + M LG
Sbjct: 410 DLWVLDMSDNHLSGRIPSY--------------LC---------LHSNMIILNLG----- 441
Query: 483 SAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEF 542
+N SGN TG + RL R N L G FP +L C +
Sbjct: 442 -------TNNLSGNIPTGITTCKTLVQLRLAR----------NNLVGRFPSNL---CKQV 481
Query: 543 HGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNK 602
+ L N G IP ++G C +L+ L + N +G +P+ + L+ L L+++ NK
Sbjct: 482 NVTAIELGQNRFRGSIPREVG-NCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNK 540
Query: 603 LQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNL 662
L GE+PS + K L+ L + NN +G +PS +G L LE+L+LS+N+LSG +P + NL
Sbjct: 541 LTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNL 600
Query: 663 RNLTALLLDNNKLSGHLPSGLANVTSLSI-FNASFNNLSGPFPWNVTTM----------- 710
LT L + N +G +P L ++T L I N S+N L+G P ++ +
Sbjct: 601 SRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNN 660
Query: 711 -----------NCSGVIG-----NPFLDPCQMYKDISSSELTSS--------NANSQHNI 746
N S ++G N P + ++IS S + N Q
Sbjct: 661 NLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLLRNISMSSFIGNEGLCGPPLNQCIQTQP 720
Query: 747 TAPTGSRTEDHKIQIASIVSASAIVL---ILLTLVILFFYVRKGFPDTRVQVSESRELTL 803
AP+ S + ++ + I++ +A V+ L+ + ++ + +R+ + + +
Sbjct: 721 FAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEM 780
Query: 804 FIDIGVP----LTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAV---- 855
+DI P T++ ++ AT +F+ S +G G GT YKA + G +AVKKLA
Sbjct: 781 SLDIYFPPKEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEG 840
Query: 856 GRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSR 915
G + F AEI TLGN+RH N+V L G+ L+Y Y+P G+L + S
Sbjct: 841 GNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILH-DPSC 899
Query: 916 AVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975
+DW KIAL A LAYLH C PR+ HRD+K +NILLDD F A++ DFGL++++
Sbjct: 900 NLDWSKRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 959
Query: 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF 1035
+ + + +AG++GY+APEYA T +V++K+D+YSYGVVLLEL++ K + P G
Sbjct: 960 PHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPI----DQGG 1015
Query: 1036 NIISWASMLLRQGQVKD-VFNAELWASGPH--DDLEDMLHLALRCTVETLSTRPTMKQVV 1092
++++W +R+ + V +A L + +L +AL CT + RP+M+QVV
Sbjct: 1016 DVVNWVRSYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVV 1075
Query: 1093 QCLKQIQHS 1101
L + + S
Sbjct: 1076 LMLIESERS 1084
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 471 bits (1213), Expect = e-131, Method: Compositional matrix adjust.
Identities = 383/1223 (31%), Positives = 579/1223 (47%), Gaps = 187/1223 (15%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
E T L+ FK S+ +PS + S ++++SHC W GV
Sbjct: 26 ETTSLISFKRSLENPSLLSSWNVSSSASHCDWVGV------------------------- 60
Query: 67 FFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPE 126
+CL+ R + L G++ + L LR L L N FSG+ PPE
Sbjct: 61 --TCLLG----------RVNSLSLPSLSLRGQIPKEISSLKNLRELCLAGNQFSGKIPPE 108
Query: 127 IWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSL-RNFESLEVLN 185
IW+L+ L+ LD+ GN L+G LP L L L+L+ N G +P S + +L L+
Sbjct: 109 IWNLKHLQTLDLSGNSLTGLLPRLLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLD 168
Query: 186 LAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP 245
++ N + G IP +G L L++ N +G IPSE+G L++ G +P
Sbjct: 169 VSNNSLSGEIPPEIGKLSNLSNLYMGLNSFSGQIPSEIGNI-SLLKNFAAPSCFFNGPLP 227
Query: 246 SSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVL 305
+ K + L L L N L IP+ G L L +L++ L GLIP ELGNC L L
Sbjct: 228 KEISKLKHLAKLDLSYNPLKCSIPKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSL 287
Query: 306 VLSNLFD-------------PLLSGRNIRGELS------VGQSDASNG---EKNSFIGSI 343
+LS F+ PLL+ R +LS +G+ + N F G I
Sbjct: 288 MLS--FNSLSGPLPLELSEIPLLTFSAERNQLSGSLPSWMGKWKVLDSLLLANNRFSGEI 345
Query: 344 PMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHF 403
P EI L+ + L G +P SLE ++L+ N+L G + VFD C L
Sbjct: 346 PHEIEDCPMLKHLSLASNLLSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGE 405
Query: 404 IDLSSNELSGELDVKL-QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSS-DLCQGYD 461
+ L++N+++G + L ++P MAL D+ N+ +G IP+ + + M +S + +GY
Sbjct: 406 LLLTNNQINGSIPEDLWKLPLMAL-DLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYL 464
Query: 462 PS-----FTYMQYFMSKARLG--MPLLVSAARFMVIHNFSGNNFTGPICWLPVA------ 508
P+ + + +S +L +P + + + N + N F G I PV
Sbjct: 465 PAEIGNAASLKRLVLSDNQLTGEIPREIGKLTSLSVLNLNANMFQGKI---PVELGDCTS 521
Query: 509 ---------------PERLRRRTDYAFLA-GANKLTGSFPG---SLFQACN-------EF 542
P+++ L N L+GS P + F +
Sbjct: 522 LTTLDLGSNNLQGQIPDKITALAQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQH 581
Query: 543 HGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNK 602
HG + +LS N + G IP ++G C L + S+N +SG +P SL LT+L LDL+GN
Sbjct: 582 HG-IFDLSYNRLSGPIPEELG-ECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNA 639
Query: 603 LQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNL 662
L G IP + L+ L+LA+N L G IP S G L SL L L+ N L G VP + NL
Sbjct: 640 LTGSIPKEMGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNL 699
Query: 663 RNLT------------------------ALLLDNNKLSGHLPSGLANVTSLSIFNASFNN 698
+ LT L ++ NK +G +PS L N+T L + S N
Sbjct: 700 KELTHMDLSFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENL 759
Query: 699 LSGPFPWNVTTMNCSGVIGNPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRT---- 754
LSG P + + G P L+ + K+ E+ S + +G++
Sbjct: 760 LSGEIP--------TKICGLPNLEFLNLAKNNLRGEVPSDGVCQDPSKALLSGNKELCGR 811
Query: 755 ---EDHKIQIASIVSASAIVLILLTL-VILFFYV-------------------------R 785
D KI+ + SA I ++L +I+F +V
Sbjct: 812 VVGSDCKIEGTKLRSAWGIAGLMLGFTIIVFVFVFSLRRWAMTKRVKQRDDPERMEESRL 871
Query: 786 KGFPDTRVQV---SESRE-----LTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTT 837
KGF D + S SRE + +F + + I+ AT F+ N IG GGFGT
Sbjct: 872 KGFVDQNLYFLSGSRSREPLSINIAMFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTV 931
Query: 838 YKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897
YKA + VAVKKL+ + Q G ++F AE++TLG V+HPNLV+L+GY + E L+Y
Sbjct: 932 YKACLPGEKTVAVKKLSEAKTQ-GNREFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVY 990
Query: 898 NYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955
Y+ G+L+++++ +T +DW KIA+ A LA+LH P ++HRD+K SNIL
Sbjct: 991 EYMVNGSLDHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNIL 1050
Query: 956 LDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLL 1015
LD DF ++DFGL+RL+ E+H +T +AGTFGY+ PEY + R + K DVYS+GV+LL
Sbjct: 1051 LDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILL 1110
Query: 1016 ELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLAL 1075
EL++ K+ P F +G N++ WA + QG+ DV + L + + +L +A+
Sbjct: 1111 ELVTGKEPTGPDF-KESEGGNLVGWAIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAM 1169
Query: 1076 RCTVETLSTRPTMKQVVQCLKQI 1098
C ET + RP M V++ LK+I
Sbjct: 1170 LCLAETPAKRPNMLDVLKALKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-126, Method: Compositional matrix adjust.
Identities = 360/1120 (32%), Positives = 558/1120 (49%), Gaps = 101/1120 (9%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
E +LLEFK ++D +G L+SW S+ C+W G++C V ++++ G ++S G P
Sbjct: 27 EGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLS-GTLSP 85
Query: 67 FFSCL------------MTAQFPFYGFGMRRRTCLH-GRGKLVGKLSPLVGGLSELRVLS 113
L ++ P R L + G + + + L+ L
Sbjct: 86 LICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLY 145
Query: 114 LPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPF 173
L N G P +I +L L+ L + N L+G +P LR LR++ N G IP
Sbjct: 146 LCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPS 205
Query: 174 SLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHL 233
+ ESL+VL LA N ++G +P L L L L N L+G IP +G R LE L
Sbjct: 206 EISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISR-LEVL 264
Query: 234 DLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIP 293
L N G IP +GK +++ L L++N L IPRE+G L +D S N+L G IP
Sbjct: 265 ALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIP 324
Query: 294 TELGNCVELSVLVLSNLFDPLLSGRNIR--GELSVGQS-DASNGEKNSFIGSIPMEITTL 350
E G+ + L +L +LF+ +L G R GEL++ + D S N G+IP E+ L
Sbjct: 325 KEFGHILNLKLL---HLFENILLGPIPRELGELTLLEKLDLS---INRLNGTIPQELQFL 378
Query: 351 SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNE 410
L + LEGK+P G + +L+++ N L G + F R + L + L SN+
Sbjct: 379 PYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNK 438
Query: 411 LSGELDVKLQVPCMALFD--VSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQ 468
LSG + L+ C +L + N ++GS+P +N+ + L+ +
Sbjct: 439 LSGNIPRDLKT-CKSLTKLMLGDNQLTGSLPIELFNLQNLTALE------------LHQN 485
Query: 469 YFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLT 528
+ + L + R + NNFTG I PE + K+
Sbjct: 486 WLSGNISADLGKLKNLERL----RLANNNFTGEI-----PPE----------IGNLTKIV 526
Query: 529 GSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLE 588
G N+S+N + GHIP ++G C +++ LD S N+ SG + Q L
Sbjct: 527 G-----------------FNISSNQLTGHIPKELGS-CVTIQRLDLSGNKFSGYIAQELG 568
Query: 589 NLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEV-LELS 647
L L L L+ N+L GEIP S L L L L N L+ IP +G+L SL++ L +S
Sbjct: 569 QLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNIS 628
Query: 648 SNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV 707
N+LSG +P+ + NL+ L L L++NKLSG +P+ + N+ SL I N S NNL G P
Sbjct: 629 HNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTA 688
Query: 708 T--TMNCSGVIGNPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIV 765
M+ S GN L Q S + +++S+ N R + + I IV
Sbjct: 689 VFQRMDSSNFAGNHGLCNSQR----SHCQPLVPHSDSKLNWLINGSQRQK--ILTITCIV 742
Query: 766 SASAIVLILLTLVILFFYVRKGFPDTRVQVSESRELTLFIDIGVP---LTYESIIRATGD 822
S + L+T + L + +++ P V + + + + P TY+ ++ AT +
Sbjct: 743 IGS---VFLITFLGLCWTIKRREP-AFVALEDQTKPDVMDSYYFPKKGFTYQGLVDATRN 798
Query: 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKL-AVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
F+ +G G GT YKAE+S G ++AVKKL + G F AEI TLG +RH N+V
Sbjct: 799 FSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIV 858
Query: 882 TLIGYRASGNEMFLIYNYLPGGNL-ENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
L G+ N L+Y Y+ G+L E + + +DW ++IAL A L YLH C
Sbjct: 859 KLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIALGAAEGLCYLHHDC 918
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
P+++HRD+K +NILLD+ F A++ DFGL++L+ S + + + VAG++GY+APEYA T +
Sbjct: 919 RPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMK 978
Query: 1001 VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG-QVKDVFNAELW 1059
V++K D+YS+GVVLLELI+ K + P GD +++W +R ++F+A L
Sbjct: 979 VTEKCDIYSFGVVLLELITGKPPVQP-LEQGGD---LVNWVRRSIRNMIPTIEMFDARLD 1034
Query: 1060 ASGPHD--DLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097
+ ++ +L +AL CT + ++RPTM++VV + +
Sbjct: 1035 TNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITE 1074
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 452 bits (1164), Expect = e-126, Method: Compositional matrix adjust.
Identities = 370/1149 (32%), Positives = 531/1149 (46%), Gaps = 152/1149 (13%)
Query: 21 PSGILSSWQTNTS--SHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQFPF 78
P + S+W+ N S + C+WFG++CD V +LN T VS G P L + Q
Sbjct: 47 PPQVTSTWKINASEATPCNWFGITCDDSKNVASLNFTRSRVS-GQLGPEIGELKSLQI-- 103
Query: 79 YGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDV 138
+ T G + +G ++L L L NGFS + P + SL++LEVL +
Sbjct: 104 ----LDLST-----NNFSGTIPSTLGNCTKLATLDLSENGFSDKIPDTLDSLKRLEVLYL 154
Query: 139 EGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGF 198
NFL+G LP + L+VL L +N + G IP S+ + + L L++ NQ G IP
Sbjct: 155 YINFLTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSMYANQFSGNIPES 214
Query: 199 LGSFLKLRVLFLSYNELNGSIPSELGKY-----------------------CRYLEHLDL 235
+G+ L++L+L N+L GS+P L C+ L LDL
Sbjct: 215 IGNSSSLQILYLHRNKLVGSLPESLNLLGNLTTLFVGNNSLQGPVRFGSPNCKNLLTLDL 274
Query: 236 SGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTE 295
S N G +P +LG C L L++ S L+ IP LG L+ L +L++S NRL+G IP E
Sbjct: 275 SYNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAE 334
Query: 296 LGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRI 355
LGNC L++L L++ N +G IP + L KL
Sbjct: 335 LGNCSSLNLLKLND---------------------------NQLVGGIPSALGKLRKLES 367
Query: 356 IWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGEL 415
+ G++P +SL L + QN L G+L KKL L +N G +
Sbjct: 368 LELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAI 427
Query: 416 DVKLQV-PCMALFDVSGNHMSGSIPRFDYNVCHQMPLQ----SSDLCQGYDPSF-----T 465
L V + D GN ++G IP N+CH L+ S+L G P+ T
Sbjct: 428 PPGLGVNSSLEEVDFIGNKLTGEIPP---NLCHGRKLRILNLGSNLLHGTIPASIGHCKT 484
Query: 466 YMQYFMSKARL-GMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLA-G 523
++ + + L G+ S + +F+ NNF GPI P L + + +
Sbjct: 485 IRRFILRENNLSGLLPEFSQDHSLSFLDFNSNNFEGPI------PGSLGSCKNLSSINLS 538
Query: 524 ANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIV 583
N+ TG P L N + NLS N + G +P + C SL D N ++G V
Sbjct: 539 RNRFTGQIPPQLGNLQNLGY---MNLSRNLLEGSLPAQLS-NCVSLERFDVGFNSLNGSV 594
Query: 584 PQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEV 643
P + N L L L+ N+ G IP L LK L L +A N G IPSSIG + L
Sbjct: 595 PSNFSNWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDLIY 654
Query: 644 -LELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
L+LS N L+GE+P + +L LT L + NN L+G L S L +TSL + S N +GP
Sbjct: 655 DLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVSNNQFTGP 713
Query: 703 FPWNVTTM---NCSGVIGNPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRT----- 754
P N+ S GNP N H+ +A SR+
Sbjct: 714 IPDNLEGQLLSEPSSFSGNP-------------------NLCIPHSFSASNNSRSALKYC 754
Query: 755 EDHKIQIASIVSASAIVLI-----------LLTLVILFFYVRKGFPDTRVQVSESRELTL 803
+D S +S IVLI +L LV + RKG P+ V E
Sbjct: 755 KDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPEKDAYVFTQEE--- 811
Query: 804 FIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQ 863
G L ++ AT + N IG G G Y+A + G + AVK+L Q
Sbjct: 812 ----GPSLLLNKVLAATDNLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASHIRANQ 867
Query: 864 QFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSR--AVDWKI 921
EI T+G VRH NL+ L G+ ++ ++Y Y+P G+L + + + + +DW
Sbjct: 868 SMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVLDWSA 927
Query: 922 LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981
+ +AL VA LAYLH C P ++HRD+KP NIL+D D ++ DFGL+RLL S T +T
Sbjct: 928 RYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDS-TVST 986
Query: 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWA 1041
V GT GY+APE A ++DVYSYGVVLLEL++ K+A+D SF D I+SW
Sbjct: 987 ATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTD---IVSWV 1043
Query: 1042 SMLL--RQGQVKDVFNA--------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQV 1091
L V+D+ EL S + + + LAL CT + + RPTM+
Sbjct: 1044 RSALSSSNNNVEDMVTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDA 1103
Query: 1092 VQCLKQIQH 1100
V+ L+ ++H
Sbjct: 1104 VKLLEDVKH 1112
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 443 bits (1139), Expect = e-123, Method: Compositional matrix adjust.
Identities = 364/1116 (32%), Positives = 537/1116 (48%), Gaps = 96/1116 (8%)
Query: 18 VSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCL------ 71
S PS I SW + S+ CSW GV CD V LN++ +S G P S L
Sbjct: 39 TSIPSDITQSWNASDSTPCSWLGVECDRRQFVDTLNLSSYGIS-GEFGPEISHLKHLKKV 97
Query: 72 -MTAQFPFYGFGMRRRTC---LH---GRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFP 124
++ F + C H G + +G L LR LSL FN G FP
Sbjct: 98 VLSGNGFFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLIGPFP 157
Query: 125 PEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184
+ S+ LE + GN L+G +P+ + L L L N+ G +P SL N +L+ L
Sbjct: 158 ESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITTLQEL 217
Query: 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI 244
L N + G +P L + L L + N L G+IP + C+ ++ + LS N G +
Sbjct: 218 YLNDNNLVGTLPVTLNNLENLVYLDVRNNSLVGAIPLDFVS-CKQIDTISLSNNQFTGGL 276
Query: 245 PSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSV 304
P LG C LR FS L+ IP G L KL+ L ++ N +G IP ELG C +
Sbjct: 277 PPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHFSGRIPPELGKCKSMID 336
Query: 305 LVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLE 364
L L ++N G IP E+ LS+L+ + NL
Sbjct: 337 LQL---------------------------QQNQLEGEIPGELGMLSQLQYLHLYTNNLS 369
Query: 365 GKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQV-PC 423
G++P S +SL+ L L QN L G+L K+L + L N +G + L
Sbjct: 370 GEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSS 429
Query: 424 MALFDVSGNHMSGSIPRFDYNVCHQMPLQ----SSDLCQGYDPS-----FTYMQYFMSKA 474
+ + D++ N +G IP N+C Q L+ + +G PS T + + +
Sbjct: 430 LEVLDLTRNMFTGHIPP---NLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEEN 486
Query: 475 RL--GMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFP 532
L G+P V + + SGNNFTGPI P + L+ T A +N+L+GS P
Sbjct: 487 NLRGGLPDFVEKQNLLFF-DLSGNNFTGPI---PPSLGNLKNVT--AIYLSSNQLSGSIP 540
Query: 533 GSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTS 592
L H NLS+N + G +P ++ C L LDASHN ++G +P +L +LT
Sbjct: 541 PELGSLVKLEH---LNLSHNILKGILPSELS-NCHKLSELDASHNLLNGSIPSTLGSLTE 596
Query: 593 LVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS 652
L L L N G IP+SL + L +L L N L G IP +G L++L L LSSN L+
Sbjct: 597 LTKLSLGENSFSGGIPTSLFQSNKLLNLQLGGNLLAGDIP-PVGALQALRSLNLSSNKLN 655
Query: 653 GEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTT-MN 711
G++P + L+ L L + +N LSG L L+ + SL+ N S N SGP P ++T +N
Sbjct: 656 GQLPIDLGKLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVPPSLTKFLN 714
Query: 712 CS--GVIGNPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASA 769
S GN D+ + A + +I P ++ K ++++
Sbjct: 715 SSPTSFSGN---------SDLCINCPADGLACPESSILRPCNMQSNTGKGGLSTL----G 761
Query: 770 IVLILLTLVILFFYVRKGFPDTRVQVSES-RELTLFIDIGVPLTYESIIRATGDFNTSNC 828
I +I+L ++ + + +S +E+ + G ++ AT + N
Sbjct: 762 IAMIVLGALLFIICLFLFSAFLFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYV 821
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
IG G GT YKA +SP + AVKKL ++G EI+T+G VRH NL+ L +
Sbjct: 822 IGKGAHGTIYKATLSPDKVYAVKKLVFTGIKNGSVSMVREIETIGKVRHRNLIKLEEFWL 881
Query: 889 SGNEMFLIYNYLPGGNLENFI-KARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++Y Y+ G+L + + + + +DW H IA+ A LAYLH C P ++HR
Sbjct: 882 RKEYGLILYTYMENGSLHDILHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHR 941
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKAD 1006
D+KP NILLD D ++SDFG+++LL S T + V GT GY+APE A T S ++D
Sbjct: 942 DIKPMNILLDSDLEPHISDFGIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESD 1001
Query: 1007 VYSYGVVLLELISDKKALDPSFSSHGDGFNIISWA-SMLLRQGQVKDVFNA----ELWAS 1061
VYSYGVVLLELI+ KKALDPSF+ D I+ W S+ + G+++ + + EL S
Sbjct: 1002 VYSYGVVLLELITRKKALDPSFNGETD---IVGWVRSVWTQTGEIQKIVDPSLLDELIDS 1058
Query: 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097
+ + + L LALRC + + RPTM+ VV+ L +
Sbjct: 1059 SVMEQVTEALSLALRCAEKEVDKRPTMRDVVKQLTR 1094
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 438 bits (1127), Expect = e-121, Method: Compositional matrix adjust.
Identities = 374/1244 (30%), Positives = 583/1244 (46%), Gaps = 191/1244 (15%)
Query: 11 LLEFKNS-VSDPS--GILSSWQTNTSSHCSWFGVSCDSES--RVVALNITGGDVSEGNSK 65
LLE K S V++P L W ++ ++CSW GV+CD+ RV+ALN+TG ++ G+
Sbjct: 30 LLEVKKSLVTNPQEDDPLRQWNSDNINYCSWTGVTCDNTGLFRVIALNLTGLGLT-GSIS 88
Query: 66 PFFSCLMTAQFPFYGFGMRRRTCLH---GRGKLVGKLSPLVGGLSELRVLSLPFNGFSGE 122
P+F R +H LVG + + L+ L L L N +GE
Sbjct: 89 PWFG--------------RFDNLIHLDLSSNNLVGPIPTALSNLTSLESLFLFSNQLTGE 134
Query: 123 FPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182
P ++ SL + L + N L G +P L NL++L LA R+ G IP L ++
Sbjct: 135 IPSQLGSLVNIRSLRIGDNELVGDIPETLGNLVNLQMLALASCRLTGPIPSQLGRLVRVQ 194
Query: 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG 242
L L N ++G IP LG+ L V + N LNG+IP+ELG+ LE L+L+ NSL G
Sbjct: 195 SLILQDNYLEGPIPAELGNCSDLTVFTAAENMLNGTIPAELGRL-ENLEILNLANNSLTG 253
Query: 243 RIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVEL 302
IPS LG+ QL+ L L +N L +IP+ L L L+ LD+S N L G IP E N +L
Sbjct: 254 EIPSQLGEMSQLQYLSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQL 313
Query: 303 SVLVL-----------------SNLFDPLLSGRNIRGEL--------SVGQSDASNGEKN 337
LVL +NL +LSG + GE+ S+ Q D SN N
Sbjct: 314 LDLVLANNHLSGSLPKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSN---N 370
Query: 338 SFIGSIPM------------------------EITTLSKLRIIWAPRLNLEGKLPSSWGA 373
S GSIP I+ L+ L+ + NLEGKLP A
Sbjct: 371 SLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISA 430
Query: 374 CESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL-QVPCMALFDVSGN 432
LE+L L +N G++ C L ID+ N GE+ + ++ + L + N
Sbjct: 431 LRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQN 490
Query: 433 HMSGSIPRFDYNVCHQM---PLQSSDLCQGYDPSFTYMQ------YFMSKARLGMPLLVS 483
+ G +P N CHQ+ L + L SF +++ + + + +P +
Sbjct: 491 ELVGGLPASLGN-CHQLNILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLI 549
Query: 484 AARFMVIHNFSGNNFTG---PIC--------------WLPVAPERLRRRTDYAFLA-GAN 525
+ R + N S N G P+C + P L + L G N
Sbjct: 550 SLRNLTRINLSHNRLNGTIHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKN 609
Query: 526 KLTGSFPGSLFQ---------ACNEFHGMVA------------NLSNNNIIGHIPLDIGV 564
+LTG P +L + + N G + +L+NN + G IP +G
Sbjct: 610 QLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGK 669
Query: 565 M-----------------------CKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGN 601
+ C L VL N ++G +PQ + NL +L L+L+ N
Sbjct: 670 LSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKN 729
Query: 602 KLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLE-VLELSSNSLSGEVPEGVV 660
+ G +P ++ +L L L L+ N+LTG IP IG+L+ L+ L+LS N+ +G++P +
Sbjct: 730 QFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIG 789
Query: 661 NLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPF 720
L L L L +N+L+G +P + ++ SL N SFNNL G + +GN
Sbjct: 790 TLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTG 849
Query: 721 LDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASAIVLILLTLVIL 780
L S L+ N +N +R+ + I++I + +AI L++L + +
Sbjct: 850 L---------CGSPLSRCNRVRSNNKQQGLSARS---VVIISAISALTAIGLMILVIALF 897
Query: 781 F-----FYVRKGFPDT----RVQVSESRELTLFIDIGVP--LTYESIIRATGDFNTSNCI 829
F F+ + G T S++ LF + + +E I+ AT + + I
Sbjct: 898 FKQRHDFFKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMI 957
Query: 830 GSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS 889
GSGG G YKAE+ G VAVKK+ + F E+KTLG +RH +LV L+GY +S
Sbjct: 958 GSGGSGKVYKAELENGETVAVKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSS 1017
Query: 890 GNE--MFLIYNYLPGGNLENFIKA------RTSRAVDWKILHKIALDVASALAYLHDQCA 941
+E LIY Y+ G++ +++ + + +DW+ +IA+ +A + YLH C
Sbjct: 1018 KSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCV 1077
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT---SETHATTGVAGTFGYVAPEYALT 998
P ++HRD+K SN+LLD + A+L DFGL+++L + T + T A ++GY+APEYA +
Sbjct: 1078 PPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYS 1137
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR-QGQVKD-VFNA 1056
+ ++K+DVYS G+VL+E+++ K D F + D ++ W L G +D + +
Sbjct: 1138 LKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMD---MVRWVETHLEVAGSARDKLIDP 1194
Query: 1057 ELWASGP--HDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
+L P D +L +AL+CT + RP+ +Q L +
Sbjct: 1195 KLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSLLHV 1238
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1107), Expect = e-119, Method: Compositional matrix adjust.
Identities = 326/1036 (31%), Positives = 532/1036 (51%), Gaps = 87/1036 (8%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
G ++++ + S+P P + + L+ L + G L+G LP L+VL+L+
Sbjct: 81 GFITDIDIESVPLQL---SLPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLS 137
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N + GDIP+SL +LE L L NQ+ G IP + KL+ L L N L GSIP+EL
Sbjct: 138 SNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTEL 197
Query: 224 GKYCRYLEHLDLSGNSLV-GRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
GK LE + + GN + G+IPS +G C L L L ++ +P LG L+KLE L
Sbjct: 198 GKLSG-LEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLS 256
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGS 342
+ ++G IP++LGNC EL L L ++ LSG R + + + +NS +G
Sbjct: 257 IYTTMISGEIPSDLGNCSELVDLFL---YENSLSGSIPREIGQLTKLEQLFLWQNSLVGG 313
Query: 343 IPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLH 402
IP EI S L++I L G +PSS G LE ++ N G + C L
Sbjct: 314 IPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLV 373
Query: 403 FIDLSSNELSGELDVKL-QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQ--- 458
+ L N++SG + +L + + LF N + GSIP + LQ+ DL +
Sbjct: 374 QLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPP---GLADCTDLQALDLSRNSL 430
Query: 459 -GYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTD 517
G PS +M ++K LL+S + I GN C V RLR
Sbjct: 431 TGTIPSGLFMLRNLTKL-----LLISNSLSGFIPQEIGN------CSSLV---RLR---- 472
Query: 518 YAFLAGANKLTGSFPGSL--FQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDAS 575
G N++TG P + + N + S+N + G +P +IG C L+++D S
Sbjct: 473 ----LGFNRITGEIPSGIGSLKKIN-----FLDFSSNRLHGKVPDEIGS-CSELQMIDLS 522
Query: 576 HNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI 635
+N + G +P + +L+ L LD++ N+ G+IP+SL RL L L L+ N +G IP+S+
Sbjct: 523 NNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSL 582
Query: 636 GELRSLEVLELSSNSLSGEVPEGVVNLRNLT-ALLLDNNKLSGHLPSGLANVTSLSIFNA 694
G L++L+L SN LSGE+P + ++ NL AL L +N+L+G +PS +A++ LSI +
Sbjct: 583 GMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDL 642
Query: 695 SFNNLSGPFP-----WNVTTMNCSGVIGNPFLDPCQMYKDIS------SSELTSSNANS- 742
S N L G N+ ++N S + +L ++++ +S + +L SS +S
Sbjct: 643 SHNMLEGDLAPLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQDSC 702
Query: 743 -----QHNITAPTGSRTEDHKIQIASIVSASAIVLILLTLVILFFYVRKGFPDTR-VQVS 796
+ N G + K+++ + + V++++ + R+ + R ++
Sbjct: 703 FLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELG 762
Query: 797 ESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVG 856
E+ + + + + IIR N IG G G Y+A++ G ++AVKKL
Sbjct: 763 ETYKWQFTPFQKLNFSVDQIIRC---LVEPNVIGKGCSGVVYRADVDNGEVIAVKKLWPA 819
Query: 857 RFQHGVQQ--------FHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENF 908
G + F AE+KTLG +RH N+V +G + N L+Y+Y+P G+L +
Sbjct: 820 MVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSL 879
Query: 909 IKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFG 968
+ R ++DW + ++I L A LAYLH C P ++HRD+K +NIL+ DF Y++DFG
Sbjct: 880 LHERRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFG 939
Query: 969 LSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPS 1027
L++L+ + + VAG++GY+APEY + ++++K+DVYSYGVV+LE+++ K+ +DP+
Sbjct: 940 LAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPT 999
Query: 1028 FSSHGDGFNIISWASMLLRQGQVK-DVFNAELWA--SGPHDDLEDMLHLALRCTVETLST 1084
+G +++ W +RQ + +V ++ L + D++ +L AL C +
Sbjct: 1000 VP---EGIHLVDW----VRQNRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDE 1052
Query: 1085 RPTMKQVVQCLKQIQH 1100
RPTMK V LK+I+
Sbjct: 1053 RPTMKDVAAMLKEIKQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 429 bits (1102), Expect = e-119, Method: Compositional matrix adjust.
Identities = 342/1123 (30%), Positives = 543/1123 (48%), Gaps = 101/1123 (8%)
Query: 11 LLEFKN-SVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVA---LNITGGDVSEGNSKP 66
LLE KN D L +W + C+W GV+C S+ + L +T D+S N
Sbjct: 40 LLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQGSSSSSNSLVVTSLDLSSMN--- 96
Query: 67 FFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPE 126
L G +SP +GGL L L+L +N +G+ P E
Sbjct: 97 ----------------------------LSGIVSPSIGGLVNLVYLNLAYNALTGDIPRE 128
Query: 127 IWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186
I + KLEV+ + N G +P E L LR N+ N++ G +P + + +LE L
Sbjct: 129 IGNCSKLEVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVA 188
Query: 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS 246
N + G +P LG+ KL N+ +G+IP+E+GK C L+ L L+ N + G +P
Sbjct: 189 YTNNLTGPLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGK-CLNLKLLGLAQNFISGELPK 247
Query: 247 SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLV 306
+G +L+ ++L+ N + IP+++G L LE L + N L G IP+E+GN L L
Sbjct: 248 EIGMLVKLQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLY 307
Query: 307 LSNLFDPLLSGRNIR--GELS-VGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNL 363
L + L+G + G+LS V + D S +N G IP+E++ +S+LR+++ + L
Sbjct: 308 L---YQNQLNGTIPKELGKLSKVMEIDFS---ENLLSGEIPVELSKISELRLLYLFQNKL 361
Query: 364 EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423
G +P+ +L L+L+ N L G + F + + L N LSG + L +
Sbjct: 362 TGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYS 421
Query: 424 -MALFDVSGNHMSGSIPRFDYNVCHQ-----MPLQSSDLCQGYDPSFTYMQYFMSKARLG 477
+ + D S N +SG IP F +C Q + L S+ + P + + +G
Sbjct: 422 PLWVVDFSENQLSGKIPPF---ICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVG 478
Query: 478 ------MPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSF 531
P + + N F+GP+ ++L+R AN+ + +
Sbjct: 479 NRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQR-----LHLAANQFSSNL 533
Query: 532 PGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLT 591
P + + N + N+S+N++ G IP +I CK L+ LD S N G +P L +L
Sbjct: 534 PNEISKLSNL---VTFNVSSNSLTGPIPSEIA-NCKMLQRLDLSRNSFIGSLPPELGSLH 589
Query: 592 SLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEV-LELSSNS 650
L L L+ N+ G IP ++ L +L L + N +G IP +G L SL++ + LS N
Sbjct: 590 QLEILRLSENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYND 649
Query: 651 LSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWN--VT 708
SGE+P + NL L L L+NN LSG +P+ N++SL N S+NNL+G P
Sbjct: 650 FSGEIPPEIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQ 709
Query: 709 TMNCSGVIGNPFLDPCQMYKDISSSELTSSNAN--SQHNITAPTGSRTEDHKIQIASIVS 766
M + +GN K + L S + + S +I++ +I I
Sbjct: 710 NMTLTSFLGN---------KGLCGGHLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSV 760
Query: 767 ASAIVLILLTLVILFFY--VRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFN 824
I L+L+ +V+ F V P + +E ++ T + I+ AT F+
Sbjct: 761 IGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPFFQESDIYFVPKERFTVKDILEATKGFH 820
Query: 825 TSNCIGSGGFGTTYKAEISPGILVAVKKL------AVGRFQHGVQQFHAEIKTLGNVRHP 878
S +G G GT YKA + G +AVKKL + F AEI TLG +RH
Sbjct: 821 DSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHR 880
Query: 879 NLVTLIG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
N+V L Y N L+Y Y+ G+L + S ++DW IAL A LAYL
Sbjct: 881 NIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHSMDWPTRFAIALGAAEGLAYL 940
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H C PR++HRD+K +NIL+D++F A++ DFGL++++ + + + VAG++GY+APEYA
Sbjct: 941 HHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYA 1000
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ----GQVKD 1052
T +V++K D+YS+GVVLLEL++ K + P GD + +W +R ++ D
Sbjct: 1001 YTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGD---LATWTRNHIRDHSLTSEILD 1056
Query: 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095
+ ++ + + + +A+ CT + S RPTM++VV L
Sbjct: 1057 PYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1103 | ||||||
| 224098986 | 1122 | predicted protein [Populus trichocarpa] | 0.984 | 0.967 | 0.662 | 0.0 | |
| 359488527 | 1139 | PREDICTED: LRR receptor-like serine/thre | 0.982 | 0.951 | 0.63 | 0.0 | |
| 255573382 | 1141 | conserved hypothetical protein [Ricinus | 0.985 | 0.952 | 0.615 | 0.0 | |
| 255542014 | 1100 | protein with unknown function [Ricinus c | 0.970 | 0.973 | 0.621 | 0.0 | |
| 356523630 | 1120 | PREDICTED: LRR receptor-like serine/thre | 0.980 | 0.965 | 0.611 | 0.0 | |
| 359472820 | 1098 | PREDICTED: LRR receptor-like serine/thre | 0.963 | 0.968 | 0.618 | 0.0 | |
| 224141079 | 1143 | predicted protein [Populus trichocarpa] | 0.986 | 0.951 | 0.605 | 0.0 | |
| 356567098 | 1136 | PREDICTED: LRR receptor-like serine/thre | 0.980 | 0.951 | 0.602 | 0.0 | |
| 147803536 | 1136 | hypothetical protein VITISV_038106 [Viti | 0.931 | 0.904 | 0.631 | 0.0 | |
| 356573540 | 1131 | PREDICTED: LRR receptor-like serine/thre | 0.972 | 0.948 | 0.594 | 0.0 |
| >gi|224098986|ref|XP_002311344.1| predicted protein [Populus trichocarpa] gi|222851164|gb|EEE88711.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1395 bits (3610), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 731/1104 (66%), Positives = 856/1104 (77%), Gaps = 18/1104 (1%)
Query: 3 KVLPEKTILLEFKNSVSDPSGILSSWQTNTS-----SHCSWFGVSCDSESRVVALNITGG 57
+ P+K++LLEFK++VSDP GILSSW N+S SHCSWFGV+C+S+SRV++LNITGG
Sbjct: 32 EAFPDKSVLLEFKSAVSDPYGILSSWNPNSSNKTKTSHCSWFGVTCNSKSRVISLNITGG 91
Query: 58 DVSEGNSKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFN 117
D GNSK C + +FPF+ G +R TC + GKL GKLSP +G LSEL VLSLP+N
Sbjct: 92 DGYGGNSK-VPPCSRSLKFPFFALGTKR-TCYNHDGKLKGKLSPSIGKLSELTVLSLPYN 149
Query: 118 GFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRN 177
FSGE P EIW L+KL+VLD+EGN +G+LP+EF GL+ LRVLNL FNR+DG+IP SL N
Sbjct: 150 EFSGEIPMEIWGLDKLQVLDLEGNLFAGKLPDEFAGLKKLRVLNLGFNRLDGEIPISLSN 209
Query: 178 FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSG 237
S+EVLNLAGN + G IPGF SFLKLR L L+ NELNG++P G CRYLEHLDLSG
Sbjct: 210 SVSMEVLNLAGNMLTGSIPGFFVSFLKLRELNLANNELNGTVPGGFGSNCRYLEHLDLSG 269
Query: 238 NSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELG 297
N L GRIP +LG CQQLR LLLFSNML VIPR+ G LR+LEVLDVSRN +NG +P ELG
Sbjct: 270 NFLAGRIPLTLGNCQQLRILLLFSNMLTGVIPRKFGQLRRLEVLDVSRNFINGAVPAELG 329
Query: 298 NCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIW 357
NCVELSVL+LSNLF+ RN G++ VG S + E N F+GS+P E+T L KLRI+W
Sbjct: 330 NCVELSVLILSNLFETQPGERNKSGKVLVGLSRVAGVEYNHFVGSLPAEVTALPKLRILW 389
Query: 358 APRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDV 417
APR L+GKLP+SWG CESLEM+NLAQN G + G F+RCKKL+ +DLSSN L GELD
Sbjct: 390 APRATLKGKLPTSWGDCESLEMVNLAQNGFYGQIKGAFERCKKLYHLDLSSNRLRGELDR 449
Query: 418 KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLG 477
L VPCM +FDVS N +SG IPRFDYNVC P +SDL Q DP Y+ +F + R+
Sbjct: 450 NLPVPCMTVFDVSHNLLSGPIPRFDYNVCS--PSLNSDLVQVDDPLSGYVPFFTHETRVA 507
Query: 478 MPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQ 537
L + A VIHNF NNFTG I WLPV PER ++ DYAFLA N LTGSFPGSLF+
Sbjct: 508 SHLPFAPASLAVIHNFGRNNFTGQIRWLPVIPERYGKQIDYAFLAAGNTLTGSFPGSLFR 567
Query: 538 ACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
C E +GM+A++S N ++G IPL+IG MC+SLR LDAS N+ISG +P SL NL SL+ LD
Sbjct: 568 KCGELNGMIADVSKNKLLGPIPLNIGAMCRSLRFLDASDNEISGYIPHSLGNLRSLITLD 627
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPE 657
+GN+L G+IP+SL+RLKYL+H+SL+ NNLTG IPS +G LRSLEVL LSSNSLSGE+P
Sbjct: 628 FSGNRLWGQIPASLYRLKYLKHISLSGNNLTGAIPSGLGRLRSLEVLNLSSNSLSGEIPL 687
Query: 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIG 717
+V L+NLT LLLDNN SG +PSGL+ SLS N NNLSGPFP NC G
Sbjct: 688 DIVLLKNLTVLLLDNNSFSGQIPSGLSKAASLSTVNV--NNLSGPFPLIRKVANCGNAPG 745
Query: 718 NPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASAIVLILLTL 777
NP+ +PC + + S+ T SNA T+ GS+ + I+IASI SASAIV +LL L
Sbjct: 746 NPYPNPCHRFLQSAPSDSTDSNA------TSSPGSKAGFNSIEIASIASASAIVSVLLAL 799
Query: 778 VILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTT 837
V+LFFY RK P RVQVSE +E+T F+DIGVPL YE+I++ATG+FN+ NCIG+GGFG T
Sbjct: 800 VVLFFYTRKRIPMARVQVSEPKEITTFVDIGVPLLYENIVQATGNFNSINCIGNGGFGAT 859
Query: 838 YKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897
YKAEISPG LVA+KKLAVGRFQ GVQQF AEIK LG VRHPNLVTLIGY AS EMFLIY
Sbjct: 860 YKAEISPGSLVAIKKLAVGRFQ-GVQQFDAEIKALGRVRHPNLVTLIGYHASETEMFLIY 918
Query: 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957
NYLPGGNLE+FIK R+ R V WKILHKIALDVA AL+YLHDQCAPRVLHRDVKP+NILLD
Sbjct: 919 NYLPGGNLEDFIKERSKREVSWKILHKIALDVARALSYLHDQCAPRVLHRDVKPNNILLD 978
Query: 958 DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLEL 1017
+DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA+TCRVS+KADVYSYGVVLLEL
Sbjct: 979 NDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAMTCRVSEKADVYSYGVVLLEL 1038
Query: 1018 ISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRC 1077
ISDKK LDPSFSSH +GFNI+SWA MLLR GQ K+VF LW SGPHDDL DMLHLA+ C
Sbjct: 1039 ISDKKPLDPSFSSHENGFNIVSWACMLLRHGQAKEVFTTGLWDSGPHDDLVDMLHLAVTC 1098
Query: 1078 TVETLSTRPTMKQVVQCLKQIQHS 1101
TV++LS RPTMKQVVQ LK+IQ S
Sbjct: 1099 TVDSLSNRPTMKQVVQRLKRIQPS 1122
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359488527|ref|XP_002279979.2| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1341 bits (3471), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 693/1100 (63%), Positives = 854/1100 (77%), Gaps = 16/1100 (1%)
Query: 11 LLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSC 70
LL+FK+SVSDPSG+LSSW+++ S HCSW GV+CDS SRV++LN++GG GNS +
Sbjct: 41 LLQFKDSVSDPSGLLSSWKSSNSDHCSWLGVTCDSGSRVLSLNVSGG-CGGGNSD--LNA 97
Query: 71 LMTAQFP---FYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEI 127
L+ +QFP +G+G+ + C G KL+G LSP++ L+ELR LSLP+N F G+ P EI
Sbjct: 98 LLGSQFPQLPLFGYGIMK-NCTGGNVKLIGTLSPVIAKLTELRALSLPYNEFGGQIPIEI 156
Query: 128 WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187
W +EKLEVLD+EGN +SG LP F GLRN RVLNL FN+I G IP SL N SLE+LNLA
Sbjct: 157 WGMEKLEVLDLEGNSMSGSLPIRFGGLRNSRVLNLGFNKIAGVIPSSLSNLMSLEILNLA 216
Query: 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSS 247
GN V G IPGF+GSF +LR ++LS+N L GSIPSE+G C+ LE LDLSGN LVG IPSS
Sbjct: 217 GNMVNGTIPGFIGSFKELRGVYLSFNRLGGSIPSEIGSNCQKLEDLDLSGNLLVGGIPSS 276
Query: 248 LGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL 307
LG C QLR++LLFSN+L +VIP ELG LR LEVLDVSRN L+G IP LGNC +LS LVL
Sbjct: 277 LGNCSQLRSILLFSNLLEEVIPAELGQLRNLEVLDVSRNSLSGSIPPALGNCSQLSALVL 336
Query: 308 SNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKL 367
SNLFDPLL+ +N++G+ + GQ + N + N F G+IP+EITTL KLRIIWAPR LEG+
Sbjct: 337 SNLFDPLLNIKNMKGDSNSGQLVSGNDDYNYFQGTIPVEITTLPKLRIIWAPRATLEGRF 396
Query: 368 PSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALF 427
PS+WGAC+SLE++NL+QN G++ F RCKKLHF+DLSSN+L+GEL KL VPCM +F
Sbjct: 397 PSNWGACDSLEVINLSQNFFTGEIPEGFSRCKKLHFLDLSSNKLTGELVEKLPVPCMTVF 456
Query: 428 DVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAA-- 485
DVS N +SG IPRF Y C ++P + + + S Y+ +F +K + PLL S
Sbjct: 457 DVSCNLLSGRIPRFYYGSCTRVPSNNRYVLESSSLSSAYVSFFANKGIVEAPLLFSKGDD 516
Query: 486 RFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGM 545
V HNF+ NNF G +P+A +RL ++T Y+FLAG N LTG FP +LF C + +
Sbjct: 517 SLSVFHNFASNNFNGTFESMPIASDRLGKQTVYSFLAGENNLTGPFPRNLFDKCYGLNRV 576
Query: 546 VANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG 605
V N+SNN I G +P +IG +CK+L +LDAS NQI+G +P S+ NL SLV L+L+ N LQG
Sbjct: 577 VVNVSNNRISGQLPTEIGALCKTLTLLDASGNQINGSIPHSIGNLVSLVALNLSSNHLQG 636
Query: 606 EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
EIPSSL +++ L++LSLA N LTG IPSS+G L+SLEVLELSSNSLSGE+P +VNLR+L
Sbjct: 637 EIPSSLGKIEGLKYLSLAGNILTGPIPSSLGNLQSLEVLELSSNSLSGEIPRDLVNLRSL 696
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQ 725
T LLL++NKLSG +PSGLANVT+LS FN SFNNLSGP P N M CS V+GNP L C+
Sbjct: 697 TVLLLNDNKLSGQIPSGLANVTTLSAFNVSFNNLSGPLPLNDNLMKCSSVLGNPLLRSCR 756
Query: 726 MYK-DISSSELTSSNANSQHNITAPTGSRTED-----HKIQIASIVSASAIVLILLTLVI 779
++ + SS+ +SQ +P+GS T + I+IASI SASAIV +LL LV+
Sbjct: 757 LFSLTVPSSDQQGGVGDSQDYSASPSGSPTRSRSSSFNSIEIASITSASAIVSVLLALVV 816
Query: 780 LFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTTYK 839
LF Y RK P +R+ S +E+T+F DIGVPLT+E+++RATG FN SNCIG+GGFG TYK
Sbjct: 817 LFIYTRKCNPKSRILRSARKEVTVFNDIGVPLTFENVVRATGSFNASNCIGNGGFGATYK 876
Query: 840 AEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899
AEISPG+LVA+K+LAVGRFQ GVQQFHAE+KTLG + HPNLVTLIGY AS EMFLIYNY
Sbjct: 877 AEISPGVLVAIKRLAVGRFQ-GVQQFHAEVKTLGRLDHPNLVTLIGYHASETEMFLIYNY 935
Query: 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD 959
LPGGNLE FI+ R++RAVDW++LHKIALD+A ALAYLHDQC PRVLHRDVKPSNILLDDD
Sbjct: 936 LPGGNLEKFIQERSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDD 995
Query: 960 FNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
FNAYLSDFGL+RLLG SETHATTGVAGTFGYVAPEYA+TCRVSDKADVYSYGVVLLEL+S
Sbjct: 996 FNAYLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLS 1055
Query: 1020 DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTV 1079
DKKALDPSFSS+G+GFNI++W MLLRQG+ K+ F A LW +GPHDDL ++LHLA+ CTV
Sbjct: 1056 DKKALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTV 1115
Query: 1080 ETLSTRPTMKQVVQCLKQIQ 1099
++LSTRPTM+QVV+ LKQ+Q
Sbjct: 1116 DSLSTRPTMRQVVRRLKQLQ 1135
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255573382|ref|XP_002527617.1| conserved hypothetical protein [Ricinus communis] gi|223532991|gb|EEF34756.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1310 bits (3391), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 682/1108 (61%), Positives = 832/1108 (75%), Gaps = 21/1108 (1%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQ-TNTSSHCSWFGVSCDSESRVVALNITGGDVSEGN-- 63
+K++LLEFKNS+SD SG+LSSW N+ +CSW GVSCD SRVV+LNITG + G+
Sbjct: 36 DKSVLLEFKNSLSDQSGLLSSWNLINSDYYCSWTGVSCDKNSRVVSLNITGQGNNYGDRG 95
Query: 64 ----SKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGF 119
++ FF C + Q+P YGFG+RR C G G LVG L PL+ L+ELR+LSLPFNGF
Sbjct: 96 KKSKNRSFFFCSGSVQYPLYGFGIRR-DCKSGNGVLVGNLLPLIAKLTELRILSLPFNGF 154
Query: 120 SGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFE 179
SGE P EIW +EKLEVLD+EGN ++G LP F GLRNL+VLNL FN+I+G+IP SL N
Sbjct: 155 SGEIPGEIWGMEKLEVLDLEGNLVTGSLPVSFSGLRNLQVLNLGFNKIEGEIPSSLVNCA 214
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
+LE+LNLAGN++ G IP F+G F R + LS N+L GS+P E+G C LEHLDLSGN
Sbjct: 215 NLEILNLAGNRINGTIPAFVGGF---RGVHLSLNQLAGSVPGEIGYKCEKLEHLDLSGNF 271
Query: 240 LVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNC 299
VG IP+SLG C LRTLLL+SN+ +VIP ELG LRKLEVLDVSRN L+G IP ELGNC
Sbjct: 272 FVGAIPTSLGNCGNLRTLLLYSNLFEEVIPPELGMLRKLEVLDVSRNSLSGSIPFELGNC 331
Query: 300 VELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAP 359
LSVLVLSN+ DP + RG+ + Q +++N + N F G IPMEI L LR++WAP
Sbjct: 332 SALSVLVLSNIIDPYQGVNSSRGDYLLDQLNSANEDFNFFQGGIPMEIMNLPNLRMLWAP 391
Query: 360 RLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL 419
LEG L S+ GAC+ LEM+NLA N G + F RC KL ++DLS N L GEL L
Sbjct: 392 SATLEGSLQSNHGACDKLEMINLAHNFFSGGIPRNFRRCAKLWYLDLSYNRLKGELAEGL 451
Query: 420 QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLG-- 477
VPCM +FDVSGN +SG IP F N C +P + +DPS Y+ +F KA+ G
Sbjct: 452 LVPCMTVFDVSGNSLSGPIPNFYRNSCQWVPSINGHPSSIFDPSSAYLSFFARKAQAGSL 511
Query: 478 MPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQ 537
+ L + +++HNF NNFTG + +P+A RL ++T YAFLAG NKLTG F G LF+
Sbjct: 512 VQSLAGDSESIILHNFGSNNFTGTLQSMPIANVRLGKQTAYAFLAGENKLTGPFLGVLFE 571
Query: 538 ACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
C+E M+ N+SNN I G IP DIG +C+SL++LDAS NQI G +P + L +LV L+
Sbjct: 572 KCDELSKMILNVSNNRISGQIPADIGKLCRSLKLLDASSNQIIGPIPPGVGKLVTLVSLN 631
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPE 657
L+ N LQG+IP+SL ++K LR+LSLA N + G IP+S+G L SLEVL+LSSN LSGE+P
Sbjct: 632 LSWNILQGQIPTSLSQIKGLRYLSLAGNEVNGSIPNSLGNLWSLEVLDLSSNMLSGEIPN 691
Query: 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIG 717
+VNLRNLTALLL++NKLSG +P GLANVT LS+FN SFNNLSGP P + M CS V+G
Sbjct: 692 NLVNLRNLTALLLNDNKLSGQIPFGLANVTMLSVFNVSFNNLSGPLPLSNNLMKCSSVLG 751
Query: 718 NPFLDPCQMYK------DISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASAIV 771
NP+L PC ++ D S+ + S A S N +GS + I+IASI SASAIV
Sbjct: 752 NPYLRPCHVFSLTVPTPDPGSATGSQSYAVSPANQNQGSGS-NRFNSIEIASIASASAIV 810
Query: 772 LILLTLVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGS 831
+L+ L++LFFY RK P +++ + +E+T+F DIGVPLTYE+++RATG FN SNCIG+
Sbjct: 811 SVLVALIVLFFYTRKWSPKSKIMGTTKKEVTIFTDIGVPLTYENVVRATGSFNASNCIGN 870
Query: 832 GGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891
GGFG TYKAEISPG+LVA+K+LAVGRFQ GVQQFHAEIKTLG + HPNLVTLIGY AS
Sbjct: 871 GGFGATYKAEISPGVLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLHHPNLVTLIGYHASET 929
Query: 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKP 951
EMFLIYNYLP GNLE FI+ R+SRAVDW+ILHKIALDVA ALAYLHDQC PRVLHRDVKP
Sbjct: 930 EMFLIYNYLPDGNLEKFIQERSSRAVDWRILHKIALDVARALAYLHDQCVPRVLHRDVKP 989
Query: 952 SNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYG 1011
SNILLD+DF AYLSDFGL+RLLGTSETHATTGVAGTFGYVAPEYA+TCRVSDKADVYSYG
Sbjct: 990 SNILLDNDFKAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYG 1049
Query: 1012 VVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDML 1071
VVLLEL+SDKKALDPSFSS+G+GFNI++WA MLLRQG+ KD F A LW GPHDDL ++L
Sbjct: 1050 VVLLELLSDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKDFFTAGLWDGGPHDDLVEVL 1109
Query: 1072 HLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
HLA+ CTV++LSTRPTMKQVV+ LKQ+Q
Sbjct: 1110 HLAVVCTVDSLSTRPTMKQVVRRLKQLQ 1137
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255542014|ref|XP_002512071.1| protein with unknown function [Ricinus communis] gi|223549251|gb|EEF50740.1| protein with unknown function [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1296 bits (3354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/1102 (62%), Positives = 825/1102 (74%), Gaps = 31/1102 (2%)
Query: 4 VLPEKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGN 63
+ P+K +LLEFK+ VSDP GILS+W + S HCSW GVSC+S+SRVV+L I+GGD EGN
Sbjct: 26 LFPDKQVLLEFKSFVSDPHGILSTWNSTNSDHCSWSGVSCNSKSRVVSLRISGGDGYEGN 85
Query: 64 SKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEF 123
S+ SC + +FPF FG+RR +C++ KL GKL+PL+G LSELRVLSLPFN FSGE
Sbjct: 86 SRAL-SCSKSLKFPFRRFGIRR-SCVNLVAKLEGKLTPLIGKLSELRVLSLPFNEFSGEI 143
Query: 124 PPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183
P EIW LE LEVLD+EGN +G LP+ FVGLR L VLNL FNR++G+IP +L L++
Sbjct: 144 PLEIWGLENLEVLDLEGNLFTGELPHGFVGLRKLEVLNLGFNRLNGEIPIALSKCMDLKI 203
Query: 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGR 243
LNL+GN++KG +P F+GSF KLR L+L+ NEL G +P+ LG CRYLEHLDLSGN L+G
Sbjct: 204 LNLSGNKLKGSLPSFVGSFSKLRGLYLANNELIGIVPAVLGNKCRYLEHLDLSGNFLIGE 263
Query: 244 IPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELS 303
IP +LG C +L+TLLLFSN LN IPRELG LR+LEVLD+SRN + G+IPTELGNCVELS
Sbjct: 264 IPGTLGNCWRLKTLLLFSNSLNGEIPRELGQLRRLEVLDISRNFIGGVIPTELGNCVELS 323
Query: 304 VLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNL 363
VLVLSNLFD L+ R + E+ V SN N F GSIP+EITTL KL + WAP +
Sbjct: 324 VLVLSNLFDTWLNERTVSEEVPVRLPAVSNEGYNRFQGSIPVEITTLPKLTVFWAPMVTF 383
Query: 364 EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423
GKLPS+WG C+SLEM+NLAQN G++ G+F++C+KL+F+DLSSN LSGELD +L VPC
Sbjct: 384 GGKLPSNWGDCKSLEMVNLAQNGFNGEINGLFEKCRKLNFLDLSSNRLSGELDKELPVPC 443
Query: 424 MALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVS 483
M FDVS N MSG IPRF+ + C + + L G Y +F + R L S
Sbjct: 444 MTHFDVSQNLMSGFIPRFNCSACQSV----TSLHSGLGHVNVYKSFFRYRTRFAPNLPFS 499
Query: 484 AARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFH 543
+ +I+NF NNFTGPI WLPV +R+ +RTDYAFLAG NK TGSFP SLF C++
Sbjct: 500 VSNLAMIYNFGQNNFTGPIRWLPVVTQRMVKRTDYAFLAGGNKFTGSFPKSLFGKCDKLR 559
Query: 544 GMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKL 603
GM+ N+SNN I G IP +IG MC+SLR DAS NQISG VPQSL L LV L+L+GNK+
Sbjct: 560 GMIINVSNNQISGPIPQNIGSMCRSLRFFDASDNQISGSVPQSLGLLKYLVALNLSGNKM 619
Query: 604 QGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLR 663
G++P+SL RLKYL+ +SL NNL+G PSS +L LEV +L++NSL
Sbjct: 620 HGQVPASLSRLKYLKQISLGGNNLSGVFPSSFEQLDPLEVSKLNANSLPA---------- 669
Query: 664 NLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDP 723
KLS H SG + + SLS N S N+LS N T MNCS +GNP
Sbjct: 670 ----------KLSEHNSSGFSTMRSLSSINVSSNDLSESVILNGTVMNCSNALGNPSFSS 719
Query: 724 CQMYKDISSSELTS-SNANSQHNITAPTGSRTED---HKIQIASIVSASAIVLILLTLVI 779
C M+ ++S T+ S+ + N+ + T ++T + ++IASIVSASA+V +LL LV+
Sbjct: 720 CNMFSLSAASPGTAKSDGDQPSNLNSQTETKTGNSGFKPVEIASIVSASAVVSVLLALVV 779
Query: 780 LFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTTYK 839
LFFY R P+ RV+VSE +E+ +F +IGVPL YE+I+ ATG+FN SNCIG+GGFG TYK
Sbjct: 780 LFFYTRNWGPNARVEVSEPKEVKVFANIGVPLLYENIVEATGNFNASNCIGNGGFGATYK 839
Query: 840 AEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899
AEISPGILVA+KKLAVGRFQ GVQQFH EIK LG VRHPNLVTLIGY AS EMFLIYNY
Sbjct: 840 AEISPGILVAIKKLAVGRFQ-GVQQFHNEIKALGRVRHPNLVTLIGYHASDAEMFLIYNY 898
Query: 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD 959
LPGGNLE+FIK R++ AV WK+LHKIALD+ASALA LH QCAPRVLHRDVKPSNILLD+D
Sbjct: 899 LPGGNLEDFIKERSASAVTWKVLHKIALDIASALACLHYQCAPRVLHRDVKPSNILLDND 958
Query: 960 FNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
NAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA+TCR+S+KADVYSYGVVLLELIS
Sbjct: 959 LNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAMTCRLSEKADVYSYGVVLLELIS 1018
Query: 1020 DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTV 1079
DKKALDPSFSSH +GFNI+SWA MLLR GQ KDVF A LW +GPHDDL +MLHLA+RCTV
Sbjct: 1019 DKKALDPSFSSHENGFNIVSWACMLLRNGQAKDVFTAGLWDTGPHDDLVEMLHLAVRCTV 1078
Query: 1080 ETLSTRPTMKQVVQCLKQIQHS 1101
ETLSTRP MKQVVQ LKQI+ S
Sbjct: 1079 ETLSTRPNMKQVVQKLKQIRPS 1100
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356523630|ref|XP_003530440.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1296 bits (3354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 674/1103 (61%), Positives = 829/1103 (75%), Gaps = 22/1103 (1%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESR--VVALNITGGDVSEGNS 64
+K++LLE K+S+SDPSG+L++WQ S HC+W GV CDS +R VVA+N+TG + GN
Sbjct: 26 DKSVLLELKHSLSDPSGLLATWQG--SDHCAWSGVLCDSAARRRVVAINVTG---NGGNR 80
Query: 65 KPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFP 124
KP C AQFPFYGFG+RR +C RG L GKLSP + L+ELRVLSLPFNG GE P
Sbjct: 81 KPPSPCSDYAQFPFYGFGIRR-SCDGFRGALFGKLSPKLSELAELRVLSLPFNGLEGEIP 139
Query: 125 PEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184
EIW +EKLEVLD+EGN +SG LP F GL+NLRVLNL FNR G+IP SL N +SLEVL
Sbjct: 140 EEIWGMEKLEVLDLEGNLISGVLPIRFNGLKNLRVLNLGFNRFVGEIPSSLSNVKSLEVL 199
Query: 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI 244
NLAGN + G + GF+G +LR ++LSYN L G+IP E+G++C LEHLDLSGN L+ I
Sbjct: 200 NLAGNGINGSVSGFVG---RLRGVYLSYNLLGGAIPEEIGEHCGQLEHLDLSGNLLMQGI 256
Query: 245 PSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSV 304
P SLG C +LRT+LL SN+L DVIP ELG LRKLEVLDVSRN L G +P ELGNC ELSV
Sbjct: 257 PGSLGNCSELRTVLLHSNILEDVIPAELGRLRKLEVLDVSRNTLGGQVPMELGNCTELSV 316
Query: 305 LVLSNLFDPLLSGRNIRGELSVGQSDASN-GEKNSFIGSIPMEITTLSKLRIIWAPRLNL 363
L+LSNLF + G+ V Q A N E N F G +P+EI L KLR++WAPR NL
Sbjct: 317 LLLSNLFSSVPDVNGTLGDSGVEQMVAMNIDEFNYFEGPVPVEIMNLPKLRLLWAPRANL 376
Query: 364 EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423
EG SSWG C+SLEMLNLAQN GD CK LHF+DLS+N L+G L +L VPC
Sbjct: 377 EGSFMSSWGKCDSLEMLNLAQNDFTGDFPNQLGGCKNLHFLDLSANNLTGVLAEELPVPC 436
Query: 424 MALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVS 483
M +FDVSGN +SG IP+F C +P S +L + D + Y +F SK LG P+L S
Sbjct: 437 MTVFDVSGNVLSGPIPQFSVGKCASVPSWSGNLFETDDRALPYKSFFASKI-LGGPILAS 495
Query: 484 AARF--MVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNE 541
V HNF NNF + LP+A ++L + YA L G NKL G FP +LF+ C+
Sbjct: 496 LGEVGRSVFHNFGQNNFVS-MESLPIARDKLGKGLVYAILVGENKLAGPFPTNLFEKCDG 554
Query: 542 FHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGN 601
+ ++ N+S N + G IP G MC+SL+ LDAS NQI+G +P L ++ SLV L+L+ N
Sbjct: 555 LNALLLNVSYNMLSGQIPSKFGRMCRSLKFLDASGNQITGPIPVGLGDMVSLVSLNLSRN 614
Query: 602 KLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVN 661
+LQG+I S+ +LK+L+ LSLADNN+ G IP+S+G L SLEVL+LSSNSL+GE+P+G+ N
Sbjct: 615 RLQGQILVSIGQLKHLKFLSLADNNIGGSIPTSLGRLYSLEVLDLSSNSLTGEIPKGIEN 674
Query: 662 LRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFL 721
LRNLT +LL+NNKLSG +P+GLANV++LS FN SFNNLSG FP N ++ CS +GNPFL
Sbjct: 675 LRNLTDVLLNNNKLSGQIPAGLANVSTLSAFNVSFNNLSGSFPSNGNSIKCSNAVGNPFL 734
Query: 722 DPC-QMYKDISSSELTSSNANSQHNITAP--TGSRTED--HKIQIASIVSASAIVLILLT 776
C ++ + S++ + +S + P TG + + + I+IASI SASAIV +LL
Sbjct: 735 RSCNEVSLAVPSADQGQVDNSSSYTAAPPEVTGKKGGNGFNSIEIASITSASAIVSVLLA 794
Query: 777 LVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGT 836
L++LF Y +K P +RV S +E+T+F DIGVPLT+E+++RATG+FN SNCIG+GGFG
Sbjct: 795 LIVLFIYTQKWNPRSRVVGSMRKEVTVFTDIGVPLTFENVVRATGNFNASNCIGNGGFGA 854
Query: 837 TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896
TYKAEI PG LVA+K+LAVGRFQ GVQQFHAEIKTLG +RHPNLVTLIGY AS EMFLI
Sbjct: 855 TYKAEIVPGNLVAIKRLAVGRFQ-GVQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 913
Query: 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956
YNYLPGGNLE FI+ R++RAVDW+ILHKIALD+A ALAYLHDQC PRVLHRDVKPSNILL
Sbjct: 914 YNYLPGGNLEKFIQERSTRAVDWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 973
Query: 957 DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLE 1016
DDD+NAYLSDFGL+RLLGTSETHATTGVAGTFGYVAPEYA+TCRVSDKADVYSYGVVLLE
Sbjct: 974 DDDYNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLE 1033
Query: 1017 LISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALR 1076
L+SDKKALDPSFSS+G+GFNI++WA MLLRQGQ K+ F A LW +GP DDL ++LHLA+
Sbjct: 1034 LLSDKKALDPSFSSYGNGFNIVAWACMLLRQGQAKEFFAAGLWDAGPEDDLVEVLHLAVV 1093
Query: 1077 CTVETLSTRPTMKQVVQCLKQIQ 1099
CTV++LSTRP+MK VV+ LKQ+Q
Sbjct: 1094 CTVDSLSTRPSMKHVVRRLKQLQ 1116
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359472820|ref|XP_003631199.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1283 bits (3321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 685/1107 (61%), Positives = 831/1107 (75%), Gaps = 44/1107 (3%)
Query: 1 SGKVLPEKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVS 60
SG+V+ E+ ILLEFK+SVSDP G+LSSW + HCSW G+SCDS SRV +L ITGG
Sbjct: 32 SGEVVSEREILLEFKSSVSDPYGVLSSWSSENLDHCSWAGISCDSNSRVSSLKITGG--- 88
Query: 61 EGNSKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFS 120
G FSC +QFPF+GFG+RR C +G G+LVG+LSP+V L+ELR+ SLPF+ FS
Sbjct: 89 -GGKSGAFSCSKFSQFPFHGFGIRR-DCFNGSGRLVGELSPVVSKLTELRIFSLPFHEFS 146
Query: 121 GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFES 180
GE +PNE GL L VLNL FN I G+IPFSL N +
Sbjct: 147 GE------------------------IPNEIWGLEKLEVLNLGFNIIAGEIPFSLSNCVN 182
Query: 181 LEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL 240
L +LNLAGN+V G IPGF+GSF KL+ L+LS+N + G++P E+G C LEH+DLSGN L
Sbjct: 183 LRILNLAGNEVNGRIPGFIGSFPKLQGLYLSHNGMIGTVPVEIGNNCWNLEHIDLSGNFL 242
Query: 241 VGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCV 300
VG IP SLG C++LRTLLLFSN +DVIPRELG LRKLEVLD+SRN L+G IP+ELG+CV
Sbjct: 243 VGVIPQSLGNCRRLRTLLLFSNKFDDVIPRELGRLRKLEVLDLSRNSLSGPIPSELGDCV 302
Query: 301 ELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPR 360
ELS+LVL+NLFDPL + R++RG+L +D +KN F GSIPMEITTL KLR++WAPR
Sbjct: 303 ELSILVLTNLFDPLPTDRSLRGKLVSDTAD----DKNHFQGSIPMEITTLPKLRLLWAPR 358
Query: 361 LNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQ 420
LEGK PS+WG C SLEM++LAQN G + GVF CK LHF+DLSSN L+GELD KL
Sbjct: 359 ATLEGKFPSNWGTCSSLEMVSLAQNHFTGAITGVFASCKNLHFLDLSSNRLTGELDEKLP 418
Query: 421 VPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPL 480
VPCM +FDVSGN +SG IP F+++ C M + Y+PS Y+ +F K R L
Sbjct: 419 VPCMNVFDVSGNFISGPIPYFNHHDCLHMASWKLSFMERYNPSLGYLSFFTDKTRFETSL 478
Query: 481 LVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACN 540
S A VIHNF N FTG I ++ +RLR++T+YAFLAG N+L GSFPG+ F CN
Sbjct: 479 PFSDASLAVIHNFGQNQFTGQIPLQHISLQRLRKQTEYAFLAGGNRLFGSFPGNFFGQCN 538
Query: 541 EFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNG 600
+G++ N+S+N I G L+ G +C+SL+ LD S NQISG +P+ L +L SL+ LDL+G
Sbjct: 539 RLNGLLVNVSDNRISG--VLETGTICRSLKFLDVSKNQISGSIPRGLGDLQSLIVLDLSG 596
Query: 601 NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV 660
NKLQG+IP L +LKYL++LSLA NNLTGGIPSS +RSLEVLELSSNSLSGE+P+G+V
Sbjct: 597 NKLQGQIPVELGQLKYLKYLSLAGNNLTGGIPSSFKHVRSLEVLELSSNSLSGEIPQGLV 656
Query: 661 NLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPF 720
LRNLT LLL+NN+LSG + S L V SLS FNASFN+LSG + ++ + ++G+P
Sbjct: 657 ELRNLTVLLLNNNELSGPILSDLTQVKSLSAFNASFNDLSGR-----SQLDNNVMLGSPS 711
Query: 721 LDPCQMY----KDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASAIVLILLT 776
+ + + S+ S+A + + I+IASI+SASAI +L+
Sbjct: 712 HHSGHRHFLAEQSLDHSKSNGSSATPLQSSSEDDDDDDGLSSIEIASIISASAIFSVLVA 771
Query: 777 LVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGT 836
L++LFFY RK P +RVQ SE+RE+T+F DIGVPLT+E+I ATG+FN SNCIG+GGFG
Sbjct: 772 LLVLFFYTRKWIPKSRVQGSETREITVFTDIGVPLTFENIAWATGNFNASNCIGNGGFGA 831
Query: 837 TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896
TYKAEISPG LVAVK+LAVGRF GVQQFHAE+KTLG +RHPNLVTLIGY AS EMFLI
Sbjct: 832 TYKAEISPGALVAVKRLAVGRFTQGVQQFHAEVKTLGRIRHPNLVTLIGYHASKTEMFLI 891
Query: 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956
YNYLPGGNLENFI+ R++ AV+WKILHKIAL +ASALAYLHDQC+PRVLHRDVKPSNILL
Sbjct: 892 YNYLPGGNLENFIQERSATAVNWKILHKIALHIASALAYLHDQCSPRVLHRDVKPSNILL 951
Query: 957 DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLE 1016
D+DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA+TCRVS+KADVYSYGVVLLE
Sbjct: 952 DNDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAMTCRVSEKADVYSYGVVLLE 1011
Query: 1017 LISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALR 1076
LISDKKALDPSFSSH +GFNI+SWA MLLRQGQ KDVFN LW SGPHD+L D+LHLA+
Sbjct: 1012 LISDKKALDPSFSSHANGFNIVSWACMLLRQGQAKDVFNERLWDSGPHDNLVDVLHLAVM 1071
Query: 1077 CTVETLSTRPTMKQVVQCLKQIQHSPN 1103
CTVE+ S RPTMK+VVQ LKQ+Q N
Sbjct: 1072 CTVESFSIRPTMKRVVQRLKQLQPPSN 1098
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224141079|ref|XP_002323902.1| predicted protein [Populus trichocarpa] gi|222866904|gb|EEF04035.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1281 bits (3316), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/1104 (60%), Positives = 830/1104 (75%), Gaps = 16/1104 (1%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
+K++LL+FKNSVSDPSG++S W +++HC W GVSCD+ SRVV+LNITG G
Sbjct: 41 DKSVLLQFKNSVSDPSGLISGWNLISTNHCHWNGVSCDANSRVVSLNITGNGNYRGKKSG 100
Query: 67 FFSCLMTA----QFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGE 122
++ + + YGFG+RR C +G L+GKL PL+ LSELRVLSLPFNGF G
Sbjct: 101 GGGAILCSGDSIELSLYGFGIRR-DCKGSKGILMGKLVPLIARLSELRVLSLPFNGFLGL 159
Query: 123 FPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182
P EIW +EKLEVLD+EGN +SG LP F GLRNLRVLNL FNRI+G+IP SL + LE
Sbjct: 160 IPSEIWGMEKLEVLDLEGNLVSGSLPVSFSGLRNLRVLNLGFNRIEGEIPDSLSRCDGLE 219
Query: 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG 242
+LN+AGN++ G IPGF G F + ++LS N+L GS+P + G C LEHLDLSGN LVG
Sbjct: 220 ILNIAGNRINGTIPGFAGRF---KGVYLSLNQLGGSLPEDFGYNCEKLEHLDLSGNFLVG 276
Query: 243 RIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVEL 302
IPS+LG C LRTLLL+SNM ++IPRELG L KLEVLDVSRN L+G +P ELGNC L
Sbjct: 277 GIPSNLGNCGNLRTLLLYSNMFEEIIPRELGKLGKLEVLDVSRNSLSGSVPPELGNCSAL 336
Query: 303 SVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLN 362
SVLVLSN+FDP RG + + + + N F G IP ++ TL KLR++WAP
Sbjct: 337 SVLVLSNMFDPYQDVNGTRGNGLLDHLSSMDEDFNFFQGGIPADVMTLPKLRMLWAPSAT 396
Query: 363 LEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVP 422
L G L S+W +C+SLEM+NL+ N +G++ F RC KL ++DLSSN L GEL + +VP
Sbjct: 397 LGGMLLSNWDSCDSLEMINLSHNFFKGEIPHGFSRCNKLRYLDLSSNGLYGELLEEFRVP 456
Query: 423 CMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPL-- 480
CM +FDVSGN +SGSIP F + C +P YDPS Y+ +F KA+ G P
Sbjct: 457 CMTVFDVSGNALSGSIPSFYSSSCPPVPSTIEYPLNIYDPSSAYISFFAYKAKAGSPTMS 516
Query: 481 LVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACN 540
L V HNF NNFTG + LP++P RL ++T Y FLAG NKL+G FPG LF+ C+
Sbjct: 517 LGRNGEISVFHNFGDNNFTGTLQSLPISPVRLGKQTAYTFLAGDNKLSGPFPGILFENCD 576
Query: 541 EFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNG 600
+ M+ N+SNN + G IP ++G MC+SL++LDAS NQI+G +P S+ L SLV+LD++
Sbjct: 577 GLNMMIVNVSNNRMSGQIPANMGPMCRSLKLLDASKNQIAGTIPPSVGELVSLVYLDMSW 636
Query: 601 NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV 660
N LQG+IPSSL ++ L++LSL N + G IPSSIG+L++LEVL+LSSN LSGE+P +V
Sbjct: 637 NLLQGQIPSSLSQISGLKYLSLTGNRIVGSIPSSIGKLQTLEVLDLSSNLLSGEIPNDLV 696
Query: 661 NLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPF 720
LRNLTALLL+NNKLSG +PSGLANVT LSIFN SFNNLSGP P + MNCS V+GNP+
Sbjct: 697 RLRNLTALLLNNNKLSGQIPSGLANVTLLSIFNVSFNNLSGPLPSSNNLMNCSSVLGNPY 756
Query: 721 LDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHK-----IQIASIVSASAIVLILL 775
L PC ++ S S + A+ + T+P+G ++ I+IASI SASAI +LL
Sbjct: 757 LHPCHVFSLASPSPDSPGRASEAQSYTSPSGQSQKNRSGGFTSIEIASIASASAIFSVLL 816
Query: 776 TLVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFG 835
L+ LF Y RK P +++ S +E+T+F DIGVPLT+E+++RATG FN SNCIG+GGFG
Sbjct: 817 ALIFLFIYTRKWSPKSKIMGSARKEVTIFTDIGVPLTFENVVRATGSFNASNCIGNGGFG 876
Query: 836 TTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895
+TYKAEISPG+LVA+KKLAVGRFQ G+QQFHAEIKTLG + HPNLVTLIGY AS EMFL
Sbjct: 877 STYKAEISPGVLVAIKKLAVGRFQ-GIQQFHAEIKTLGRLHHPNLVTLIGYHASETEMFL 935
Query: 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955
+YNYLPGGNLE FI+ R++RAVDW+ILHKIALD+A ALAYLHDQC PRVLHRDVKPSNIL
Sbjct: 936 VYNYLPGGNLEKFIQERSTRAVDWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNIL 995
Query: 956 LDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLL 1015
LDDDFNAYLSDFGL+RLLGTSETHATTGVAGTFGYVAPEYA+TCRVSDKADVYSYGVVLL
Sbjct: 996 LDDDFNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLL 1055
Query: 1016 ELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLAL 1075
EL+SDKKALDPSFSS+G+GFNI++WA MLLRQG+ K+ F A LW +GPHDDL ++LH+A+
Sbjct: 1056 ELLSDKKALDPSFSSYGNGFNIVAWACMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHMAV 1115
Query: 1076 RCTVETLSTRPTMKQVVQCLKQIQ 1099
CTV++LSTRPTMKQVV+ LKQ+Q
Sbjct: 1116 VCTVDSLSTRPTMKQVVRRLKQLQ 1139
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356567098|ref|XP_003551760.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1278 bits (3306), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 665/1103 (60%), Positives = 822/1103 (74%), Gaps = 22/1103 (1%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESR--VVALNITGGDVSEGNS 64
+K++LLE K+S+SDPSG+L++WQ S HC+W GV C S +R VVA+N+TG + GN
Sbjct: 42 DKSVLLELKHSLSDPSGLLTTWQG--SDHCAWSGVLCGSATRRRVVAINVTG---NGGNR 96
Query: 65 KPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFP 124
K C AQFP YGFG+RR +C RG L GKLSP + L+ELRVLSLPFN GE P
Sbjct: 97 KTLSPCSDFAQFPLYGFGIRR-SCEGFRGALFGKLSPKLSELTELRVLSLPFNDLEGEIP 155
Query: 125 PEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184
EIW +EKLEVLD+EGN +SG LP F GL+NL+VLNL FNRI G+IP SL +F+SLEVL
Sbjct: 156 EEIWGMEKLEVLDLEGNLISGVLPLRFNGLKNLKVLNLGFNRIVGEIPSSLSSFKSLEVL 215
Query: 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI 244
NLAGN + G +P F+G +LR ++LSYN L G+IP E+G++C L+HLDLSGN L+ I
Sbjct: 216 NLAGNGINGSVPSFVG---RLRGVYLSYNLLGGAIPQEIGEHCGQLDHLDLSGNLLMQAI 272
Query: 245 PSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSV 304
P SLG C +LR +LL SN L DVIP ELG LRKLEVLDVSRN L G +P ELGNC ELSV
Sbjct: 273 PGSLGNCSELRMILLHSNSLEDVIPAELGRLRKLEVLDVSRNTLGGQVPMELGNCTELSV 332
Query: 305 LVLSNLFDPLLSGRNIRGELSVGQSDASN-GEKNSFIGSIPMEITTLSKLRIIWAPRLNL 363
LVLSNLF + +L V Q + N E N F G +P+EI L KLR++WAPR NL
Sbjct: 333 LVLSNLFSSVPDVNGTVRDLGVEQMVSMNIDEFNYFEGPVPVEIMNLPKLRVLWAPRANL 392
Query: 364 EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423
G PSSWG C+SLEMLNLAQN L GD CK LHF+DLS+N +G L +L VPC
Sbjct: 393 AGSFPSSWGKCDSLEMLNLAQNDLTGDFPNQLGGCKNLHFLDLSANNFTGVLAEELPVPC 452
Query: 424 MALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVS 483
M +FDVSGN +SG IP+F +C +P S +L + D + Y +F+SK LG +L S
Sbjct: 453 MTVFDVSGNVLSGPIPQFSVGLCALVPSWSGNLFETDDRALPYKSFFVSKI-LGGTILSS 511
Query: 484 AARF--MVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNE 541
V HNF NNF + LP+A +RL + YA L G NKL G FP +LF+ C+
Sbjct: 512 LGEVGRSVFHNFGQNNFVS-MESLPIARDRLGKGLAYAILVGENKLAGPFPTNLFEKCDG 570
Query: 542 FHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGN 601
+ ++ N+S I G IP G MC+SL+ LDAS NQI+G +P L ++ SLV L+L+ N
Sbjct: 571 LNALLLNVSYTMISGQIPSKFGGMCRSLKFLDASGNQITGPIPVGLGDMVSLVSLNLSKN 630
Query: 602 KLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVN 661
+LQ +IP +L +LK L+ LSLA+NNL+G IP+S+G+L SLEVL+LSSNSL+GE+P+G+ N
Sbjct: 631 RLQDQIPGNLGQLKDLKFLSLAENNLSGSIPTSLGQLYSLEVLDLSSNSLTGEIPKGIEN 690
Query: 662 LRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFL 721
LRNLT +LL+NNKLSG +P+GLANV++LS FN SFNNLSG P N ++ CS +GNPFL
Sbjct: 691 LRNLTDVLLNNNKLSGQIPAGLANVSTLSAFNVSFNNLSGSLPSNGNSIKCSNAVGNPFL 750
Query: 722 DPC-QMYKDISSSELTSSNANSQHNITAP--TGSRTED--HKIQIASIVSASAIVLILLT 776
C ++ + S++ + +S + P TG + + + I+IASI SASAIV +LL
Sbjct: 751 HSCNEVSLAVPSADQGQVDNSSSYTAAPPEVTGKKGGNGFNSIEIASITSASAIVSVLLA 810
Query: 777 LVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGT 836
L++LF Y RK P +RV S +E+T+F DIGVPLT+E+++RATG+FN SNCIG+GGFG
Sbjct: 811 LIVLFIYTRKWNPRSRVVGSTRKEVTVFTDIGVPLTFENVVRATGNFNASNCIGNGGFGA 870
Query: 837 TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896
TYKAEI PG LVA+K+LAVGRFQ G QQFHAEIKTLG +RHPNLVTLIGY AS EMFLI
Sbjct: 871 TYKAEIVPGNLVAIKRLAVGRFQ-GAQQFHAEIKTLGRLRHPNLVTLIGYHASETEMFLI 929
Query: 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956
YNYLPGGNLE FI+ R++RA DW+ILHKIALD+A ALAYLHDQC PRVLHRDVKPSNILL
Sbjct: 930 YNYLPGGNLEKFIQERSTRAADWRILHKIALDIARALAYLHDQCVPRVLHRDVKPSNILL 989
Query: 957 DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLE 1016
DDD+NAYLSDFGL+RLLGTSETHATTGVAGTFGYVAPEYA+TCRVSDKADVYSYGVVLLE
Sbjct: 990 DDDYNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLE 1049
Query: 1017 LISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALR 1076
L+SDKKALDPSFSS+G+GFNI++WA MLLRQGQ K+ F LW +GP DDL ++LHLA+
Sbjct: 1050 LLSDKKALDPSFSSYGNGFNIVAWACMLLRQGQAKEFFATGLWDTGPEDDLVEVLHLAVV 1109
Query: 1077 CTVETLSTRPTMKQVVQCLKQIQ 1099
CTV++LSTRP+MK VV+ LKQ+Q
Sbjct: 1110 CTVDSLSTRPSMKHVVRRLKQLQ 1132
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147803536|emb|CAN77668.1| hypothetical protein VITISV_038106 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1276 bits (3302), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 655/1037 (63%), Positives = 804/1037 (77%), Gaps = 10/1037 (0%)
Query: 71 LMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSL 130
+ + P +G+G+ + C G KL+G LSP++ L+ELR LSLP+N F G+ P EIW +
Sbjct: 98 VAAVELPLFGYGIMK-NCTGGNVKLIGTLSPVIAKLTELRALSLPYNEFGGQIPIEIWGM 156
Query: 131 EKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQ 190
EKLEVLD+EGN +SG LP F GLRN RVLNL FN+I G IP SL N SLE+LNLAGN
Sbjct: 157 EKLEVLDLEGNSMSGSLPIRFGGLRNSRVLNLGFNKIAGVIPSSLSNLMSLEILNLAGNM 216
Query: 191 VKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGK 250
V G IPGF+GSF +LR ++LS+N L GSIPSE+G C+ LE LDLSGN LVG IPSSLG
Sbjct: 217 VNGTIPGFIGSFKELRGVYLSFNRLGGSIPSEIGSNCQKLEDLDLSGNLLVGGIPSSLGN 276
Query: 251 CQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310
C QLR++LLFSN+L +VIP ELG LR LEVLDVSRN L+G IP LGNC +LS LVLSNL
Sbjct: 277 CSQLRSILLFSNLLEEVIPAELGQLRNLEVLDVSRNSLSGSIPPALGNCSQLSALVLSNL 336
Query: 311 FDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSS 370
FDPLL+ +N++G+ + GQ + N + N F G+IP+EITTL KLRIIWAPR LEG+ PS+
Sbjct: 337 FDPLLNIKNMKGDSNSGQLVSGNDDYNYFQGTIPVEITTLPKLRIIWAPRATLEGRFPSN 396
Query: 371 WGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVS 430
WGAC+SLE++NL+QN G++ F RCKKLHF+DLSSN+L+GEL KL VPCM +FDVS
Sbjct: 397 WGACDSLEVINLSQNFFTGEIPEGFSRCKKLHFLDLSSNKLTGELVEKLPVPCMTVFDVS 456
Query: 431 GNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAA--RFM 488
N +SG IPRF Y C ++P + + + S Y+ +F +K + PLL S
Sbjct: 457 CNLLSGRIPRFYYGSCTRVPSNNRYVLESSSLSSAYVSFFANKGIVEAPLLFSKGDDSLS 516
Query: 489 VIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVAN 548
V HNF+ NNF G +P+A +RL ++T Y+FLAG N LTG FP +LF C + +V N
Sbjct: 517 VFHNFASNNFNGTFESMPIASDRLGKQTVYSFLAGENNLTGPFPRNLFDKCYGLNRVVVN 576
Query: 549 LSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP 608
+SNN I G +P +IG +CK+L +LDAS NQI+G +P S+ NL SLV L+L+ N LQGEIP
Sbjct: 577 VSNNRISGQLPTEIGALCKTLTLLDASGNQINGSIPHSIGNLVSLVALNLSSNHLQGEIP 636
Query: 609 SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTAL 668
SSL +++ L++LSLA N LTG IPSS+G L+SLEVLELSSNSLSGE+P +VNLR+LT L
Sbjct: 637 SSLGKIEGLKYLSLAGNILTGPIPSSLGNLQSLEVLELSSNSLSGEIPRDLVNLRSLTVL 696
Query: 669 LLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQMYK 728
LL++NKLSG +PSGLANVT+LS FN SFNNLSGP P N M CS V+GNP L C+++
Sbjct: 697 LLNDNKLSGQIPSGLANVTTLSAFNVSFNNLSGPLPLNDNLMKCSSVLGNPLLRSCRLFS 756
Query: 729 -DISSSELTSSNANSQHNITAPTGSRTED-----HKIQIASIVSASAIVLILLTLVILFF 782
+ SS+ +SQ +P+GS T + I+IASI SASAIV +LL LV+LF
Sbjct: 757 LTVPSSDQQGGVGDSQDYSASPSGSPTRSRSSSFNSIEIASITSASAIVSVLLALVVLFI 816
Query: 783 YVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEI 842
Y RK P +R+ S +E+T+F DIGVPLT+E+++RATG FN SNCIG+GGFG TYKAEI
Sbjct: 817 YTRKCNPKSRILRSARKEVTVFNDIGVPLTFENVVRATGSFNASNCIGNGGFGATYKAEI 876
Query: 843 SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902
SPG+LVA+K+LAVGRFQ GVQQFHAE+KTLG + HPNLVTLIGY AS EMFLIYNYLPG
Sbjct: 877 SPGVLVAIKRLAVGRFQ-GVQQFHAEVKTLGRLDHPNLVTLIGYHASETEMFLIYNYLPG 935
Query: 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNA 962
GNLE FI+ R++RAVDW++LHKIALD+A ALAYLHDQC PRVLHRDVKPSNILLDDDFNA
Sbjct: 936 GNLEKFIQERSTRAVDWRVLHKIALDIARALAYLHDQCVPRVLHRDVKPSNILLDDDFNA 995
Query: 963 YLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKK 1022
YLSDFGL+RLLG SETHATTGVAGTFGYVAPEYA+TCRVSDKADVYSYGVVLLEL+SDKK
Sbjct: 996 YLSDFGLARLLGPSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVVLLELLSDKK 1055
Query: 1023 ALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETL 1082
ALDPSFSS+G+GFNI++W MLLRQG+ K+ F A LW +GPHDDL ++LHLA+ CTV++L
Sbjct: 1056 ALDPSFSSYGNGFNIVAWGCMLLRQGRAKEFFTAGLWDAGPHDDLVEVLHLAVVCTVDSL 1115
Query: 1083 STRPTMKQVVQCLKQIQ 1099
STRPTM+QVV+ LKQ+Q
Sbjct: 1116 STRPTMRQVVRRLKQLQ 1132
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356573540|ref|XP_003554916.1| PREDICTED: LRR receptor-like serine/threonine-protein kinase RPK2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1269 bits (3284), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 657/1106 (59%), Positives = 826/1106 (74%), Gaps = 33/1106 (2%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNT----SSHCSWFGVSCDSESRVVALNITGGDVSEG 62
+K+ LL K S S+P+G+LS+W + T S HCS+ GV CD+ SRVVA+N+TG + G
Sbjct: 42 DKSALLRLKASFSNPAGVLSTWTSATATSDSGHCSFSGVLCDANSRVVAVNVTG---AGG 98
Query: 63 NSKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPL--VGGLSELRVLSLPFNGFS 120
N++ C +QFP YGFG+RR TC +G L G S L + L+ELRVLSLPFN
Sbjct: 99 NNRTSPPCSNFSQFPLYGFGIRR-TCSGSKGSLFGNASSLSFIAELTELRVLSLPFNALE 157
Query: 121 GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFES 180
GE P IW +E LEVLD+EGN +SG LP GL+NLRVLNLAFNRI GDIP S+ + E
Sbjct: 158 GEIPEAIWGMENLEVLDLEGNLISGCLPFRINGLKNLRVLNLAFNRIVGDIPSSIGSLER 217
Query: 181 LEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL 240
LEVLNLAGN++ G +PGF+G +LR ++LS+N+L+G IP E+G+ C LEHLDLS NS+
Sbjct: 218 LEVLNLAGNELNGSVPGFVG---RLRGVYLSFNQLSGIIPREIGENCGNLEHLDLSANSI 274
Query: 241 VGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCV 300
V IP SLG C +LRTLLL+SN+L + IP ELG L+ LEVLDVSRN L+G +P ELGNC+
Sbjct: 275 VRAIPRSLGNCGRLRTLLLYSNLLKEGIPGELGRLKSLEVLDVSRNTLSGSVPRELGNCL 334
Query: 301 ELSVLVLSNLFDPLLSGRNIRGELSVGQSD---ASNGEKNSFIGSIPMEITTLSKLRIIW 357
EL VLVLSNLFDP RG++ G + + N + N F G++P+E+ +L KLRI+W
Sbjct: 335 ELRVLVLSNLFDP-------RGDVDAGDLEKLGSVNDQLNYFEGAMPVEVLSLPKLRILW 387
Query: 358 APRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDV 417
AP +NLEG L SWG CESLEM+NLAQN G+ CKKLHF+DLSSN L+GEL
Sbjct: 388 APMVNLEGGLQGSWGGCESLEMVNLAQNFFSGEFPNQLGVCKKLHFVDLSSNNLTGELSE 447
Query: 418 KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKAR-L 476
+L+VPCM++FDVSGN +SGS+P F NVC +P + +L + S Y +FMSK R
Sbjct: 448 ELRVPCMSVFDVSGNMLSGSVPDFSNNVCPPVPSWNGNLFADGNASPRYASFFMSKVRER 507
Query: 477 GMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLF 536
+ + V+HNF N+FT I LPVA +RL ++ Y FL G N LTG FP LF
Sbjct: 508 SLFTSMGGVGTSVVHNFGQNSFT-DIHSLPVAHDRLGKKCGYTFLVGENNLTGPFPTFLF 566
Query: 537 QACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFL 596
+ C+E ++ N+S N I G IP + G +C+SL+ LDAS N+++G +P + NL SLVFL
Sbjct: 567 EKCDELDALLLNVSYNRISGQIPSNFGGICRSLKFLDASGNELAGTIPLDVGNLVSLVFL 626
Query: 597 DLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVP 656
+L+ N+LQG+IP++L ++K L+ LSLA N L G IP S+G+L SLEVL+LSSNSL+GE+P
Sbjct: 627 NLSRNQLQGQIPTNLGQMKNLKFLSLAGNKLNGSIPISLGQLYSLEVLDLSSNSLTGEIP 686
Query: 657 EGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVI 716
+ + N+RNLT +LL+NN LSGH+P+GLA+VT+LS FN SFNNLSG P N + C +
Sbjct: 687 KAIENMRNLTDVLLNNNNLSGHIPNGLAHVTTLSAFNVSFNNLSGSLPSNSGLIKCRSAV 746
Query: 717 GNPFLDPCQ-MYKDISSSELTSSNANSQHNITAPTGSRTED--HKIQIASIVSASAIVLI 773
GNPFL PC+ + + S +L +A + A TG ++ + I+IASI SASAIVL+
Sbjct: 747 GNPFLSPCRGVSLTVPSGQLGPLDATAP----ATTGKKSGNGFSSIEIASITSASAIVLV 802
Query: 774 LLTLVILFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGG 833
L+ L++LFFY RK P +RV S +E+T+F DIG PLT+E++++ATG+FN NCIG+GG
Sbjct: 803 LIALIVLFFYTRKWKPRSRVISSIRKEVTVFTDIGFPLTFETVVQATGNFNAGNCIGNGG 862
Query: 834 FGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893
FGTTYKAEISPGILVAVK+LAVGRFQ GVQQFHAEIKTLG + HPNLVTLIGY A EM
Sbjct: 863 FGTTYKAEISPGILVAVKRLAVGRFQ-GVQQFHAEIKTLGRLHHPNLVTLIGYHACETEM 921
Query: 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSN 953
FLIYN+L GGNLE FI+ R++R V+WKILHKIALD+A ALAYLHD C PRVLHRDVKPSN
Sbjct: 922 FLIYNFLSGGNLEKFIQERSTRDVEWKILHKIALDIARALAYLHDTCVPRVLHRDVKPSN 981
Query: 954 ILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVV 1013
ILLDDDFNAYLSDFGL+RLLGTSETHATTGVAGTFGYVAPEYA+TCRVSDKADVYSYGVV
Sbjct: 982 ILLDDDFNAYLSDFGLARLLGTSETHATTGVAGTFGYVAPEYAMTCRVSDKADVYSYGVV 1041
Query: 1014 LLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHL 1073
LLEL+SDKKALDPSFSS+ +GFNI++WA MLL+QG+ K+ F A LW +GP DDL ++LHL
Sbjct: 1042 LLELLSDKKALDPSFSSYRNGFNIVAWACMLLKQGRAKEFFTAGLWEAGPGDDLVEVLHL 1101
Query: 1074 ALRCTVETLSTRPTMKQVVQCLKQIQ 1099
A+ CTV+ LSTRPTMKQVV+ LKQ+Q
Sbjct: 1102 AVVCTVDILSTRPTMKQVVRRLKQLQ 1127
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1103 | ||||||
| TAIR|locus:2026408 | 540 | RPK1 "receptor-like protein ki | 0.401 | 0.820 | 0.542 | 2.3e-131 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.610 | 0.564 | 0.315 | 3.7e-124 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.547 | 0.548 | 0.318 | 1.2e-115 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.865 | 0.836 | 0.315 | 2.6e-111 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.580 | 0.581 | 0.308 | 1.3e-110 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.616 | 0.605 | 0.313 | 7.4e-110 | |
| UNIPROTKB|P93194 | 1109 | INRPK1 "Receptor-like protein | 0.550 | 0.547 | 0.313 | 1.2e-108 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.546 | 0.536 | 0.307 | 1.3e-108 | |
| TAIR|locus:2005629 | 1140 | AT1G75640 [Arabidopsis thalian | 0.605 | 0.585 | 0.302 | 5.3e-107 | |
| UNIPROTKB|Q8RZV7 | 1294 | P0413C03.22 "Putative extra sp | 0.257 | 0.219 | 0.418 | 6.3e-107 |
| TAIR|locus:2026408 RPK1 "receptor-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1253 (446.1 bits), Expect = 2.3e-131, Sum P(2) = 2.3e-131
Identities = 244/450 (54%), Positives = 324/450 (72%)
Query: 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP---WNVTTMNCSG 714
GV++L +L++ +L G + + +++ + + + SFN+L G P W + +
Sbjct: 90 GVLHLPDLSSCSSSKRRLGGVISPVVGDLSEIRVLSLSFNDLRGEIPKEIWGLEKLEILD 149
Query: 715 VIGNPFLDPCQMYKDIXXXXXXXXXXXXQHNITAP---TGSRTEDHKIQXXXXXXXXXXX 771
+ GN F+ ++ ++ + ++ + ++ + I+
Sbjct: 150 LKGNNFIGGIRVVDNVVLRKLMSFEDEDEIGPSSADDDSPGKSGLYPIEIASIVSASVIV 209
Query: 772 XXXXXXXXXFFYVRKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGS 831
F Y RK +++VQV E +E+ +F+DIG+PLTYE I+RATG F+ SNCIG
Sbjct: 210 FVLLVLVILFIYTRKWKRNSQVQVDEIKEIKVFVDIGIPLTYEIIVRATGYFSNSNCIGH 269
Query: 832 GGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891
GGFG+TYKAE+SP + AVK+L+VGRFQ G QQFHAEI L VRHPNLV LIGY AS
Sbjct: 270 GGFGSTYKAEVSPTNVFAVKRLSVGRFQ-GDQQFHAEISALEMVRHPNLVMLIGYHASET 328
Query: 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKP 951
EMFLIYNYL GGNL++FIK R+ A++WK+LHKIALDVA AL+YLH+QC+P+VLHRD+KP
Sbjct: 329 EMFLIYNYLSGGNLQDFIKERSKAAIEWKVLHKIALDVARALSYLHEQCSPKVLHRDIKP 388
Query: 952 SNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYG 1011
SNILLD+++NAYLSDFGLS+LLGTS++H TTGVAGTFGYVAPEYA+TCRVS+KADVYSYG
Sbjct: 389 SNILLDNNYNAYLSDFGLSKLLGTSQSHVTTGVAGTFGYVAPEYAMTCRVSEKADVYSYG 448
Query: 1012 VVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDML 1071
+VLLELISDK+ALDPSFSSH +GFNI+SWA M+L QG+ K+VF LW +GP DDL ++L
Sbjct: 449 IVLLELISDKRALDPSFSSHENGFNIVSWAHMMLSQGKAKEVFTTGLWETGPPDDLVEVL 508
Query: 1072 HLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
HLAL+CTV++LS RPTMKQ V+ LK+IQ S
Sbjct: 509 HLALKCTVDSLSIRPTMKQAVRLLKRIQPS 538
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 678 (243.7 bits), Expect = 3.7e-124, Sum P(2) = 3.7e-124
Identities = 230/729 (31%), Positives = 340/729 (46%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTS-SHCSWFGVSCDSESRVVALNITGGDVSEGNSK 65
E T L+ FK S+ +PS +LSSW ++S SHC W GV+C RV +L++ + G
Sbjct: 26 ETTSLISFKRSLENPS-LLSSWNVSSSASHCDWVGVTC-LLGRVNSLSLPSLSL-RGQIP 82
Query: 66 PFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPP 125
S L R CL G + GK+ P + L L+ L L N +G P
Sbjct: 83 KEISSLKNL----------RELCLAGN-QFSGKIPPEIWNLKHLQTLDLSGNSLTGLLPR 131
Query: 126 EIWSLEKLEVLDVEGNFLSGRLPNEF-VGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184
+ L +L LD+ N SG LP F + L L L+++ N + G+IP + +L L
Sbjct: 132 LLSELPQLLYLDLSDNHFSGSLPPSFFISLPALSSLDVSNNSLSGEIPPEIGKLSNLSNL 191
Query: 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI 244
+ N G IP +G+ L+ NG +P E+ K ++L LDLS N L I
Sbjct: 192 YMGLNSFSGQIPSEIGNISLLKNFAAPSCFFNGPLPKEISKL-KHLAKLDLSYNPLKCSI 250
Query: 245 PSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSV 304
P S G+ L L L S L +IP ELG + L+ L +S N L+G +P EL E+ +
Sbjct: 251 PKSFGELHNLSILNLVSAELIGLIPPELGNCKSLKSLMLSFNSLSGPLPLELS---EIPL 307
Query: 305 LVLSNLFDPLLSGR--NIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLN 362
L S + L SG + G+ V D+ N F G IP EI L+ +
Sbjct: 308 LTFSAERNQL-SGSLPSWMGKWKV--LDSLLLANNRFSGEIPHEIEDCPMLKHLSLASNL 364
Query: 363 LEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL-QV 421
L G +P SLE ++L+ N+L G + VFD C L + L++N+++G + L ++
Sbjct: 365 LSGSIPRELCGSGSLEAIDLSGNLLSGTIEEVFDGCSSLGELLLTNNQINGSIPEDLWKL 424
Query: 422 PCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSS-DLCQGYDPS-----FTYMQYFMSKAR 475
P MAL D+ N+ +G IP+ + + M +S + +GY P+ + + +S +
Sbjct: 425 PLMAL-DLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQ 483
Query: 476 L-G-MPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFL-AGANKLTGSFP 532
L G +P + + + N + N F G I P L T L G+N L G P
Sbjct: 484 LTGEIPREIGKLTSLSVLNLNANMFQGKI------PVELGDCTSLTTLDLGSNNLQGQIP 537
Query: 533 GSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLR-----------VLDASHNQISG 581
+ A + +V LS NN+ G IP + + D S+N++SG
Sbjct: 538 DKI-TALAQLQCLV--LSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHHGIFDLSYNRLSG 594
Query: 582 IVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGXXXXX 641
+P+ L LV + L+ N L GEIP+SL RL L L L+ N LTG IP +G
Sbjct: 595 PIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKEMGNSLKL 654
Query: 642 XXXXXXXXXXXXXVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
+PE L +L L L NKL G +P+ L N+ L+ + SFNNLSG
Sbjct: 655 QGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSG 714
Query: 702 PFPWNVTTM 710
++TM
Sbjct: 715 ELSSELSTM 723
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 673 (242.0 bits), Expect = 1.2e-115, Sum P(2) = 1.2e-115
Identities = 204/640 (31%), Positives = 303/640 (47%)
Query: 95 LVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEF--- 151
L GKLSP +GGL L+ L L +NG SG+ P EI + LE+L + N G +P E
Sbjct: 85 LSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGKL 144
Query: 152 VGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLS 211
V L NL + N NRI G +P + N SL L N + G +P +G+ +L
Sbjct: 145 VSLENLIIYN---NRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAG 201
Query: 212 YNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE 271
N ++GS+PSE+G C L L L+ N L G +P +G ++L ++L+ N + IPRE
Sbjct: 202 QNMISGSLPSEIGG-CESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPRE 260
Query: 272 LGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL-SNLFDPLLSGRNIRGELSVG-QS 329
+ LE L + +N+L G IP ELG+ L L L N + + R I G LS +
Sbjct: 261 ISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIP-REI-GNLSYAIEI 318
Query: 330 DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG 389
D S +N+ G IP+E+ + L +++ L G +P ++L L+L+ N L G
Sbjct: 319 DFS---ENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTG 375
Query: 390 DLIGVFDRCKKLHFIDLSSNELSGELDVKLQ-VPCMALFDVSGNHMSGSIPRFDYNVCHQ 448
+ F + L + L N LSG + KL + + D+S NH+SG IP + +
Sbjct: 376 PIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNM 435
Query: 449 MPLQ------SSDLCQGYDPSFTYMQYFMSKARL-G-MPLLVSAARFMVIHNFSGNNFTG 500
+ L S ++ G T +Q +++ L G P + + N F G
Sbjct: 436 IILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRG 495
Query: 501 PICWLPVAPERLRRRTDYAFLAGA-NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIP 559
I P + + L A N TG P + G + N+S+N + G +P
Sbjct: 496 SI------PREVGNCSALQRLQLADNGFTGELPREIGMLSQL--GTL-NISSNKLTGEVP 546
Query: 560 LDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRH 619
+I CK L+ LD N SG +P + +L L L L+ N L G IP +L L L
Sbjct: 547 SEI-FNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTE 605
Query: 620 LSLADNNLTGGIPSSIGXXXXXXXXXXXXXXXXXX-VPEGVVNLRNLTALLLDNNKLSGH 678
L + N G IP +G +P + NL L LLL+NN LSG
Sbjct: 606 LQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGE 665
Query: 679 LPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGN 718
+PS AN++SL +N S+N+L+GP P + ++ S IGN
Sbjct: 666 IPSSFANLSSLLGYNFSYNSLTGPIPL-LRNISMSSFIGN 704
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
Identities = 324/1028 (31%), Positives = 503/1028 (48%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
G ++++ + S+P S P + + L+ L + G L+G LP L+VL+L+
Sbjct: 81 GFITDIDIESVPLQ-LS--LPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLS 137
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N + GDIP+SL +LE L L NQ+ G IP + KL+ L L N L GSIP+EL
Sbjct: 138 SNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTEL 197
Query: 224 GKYCRYLEHLDLSGNSLV-GRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
GK LE + + GN + G+IPS +G C L L L ++ +P LG L+KLE L
Sbjct: 198 GKLSG-LEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLS 256
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIR--GELSVGQSDASNGEKNSFI 340
+ ++G IP++LGNC EL L L ++ LSG R G+L+ + + +NS +
Sbjct: 257 IYTTMISGEIPSDLGNCSELVDLFL---YENSLSGSIPREIGQLT--KLEQLFLWQNSLV 311
Query: 341 GSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKK 400
G IP EI S L++I L G +PSS G LE ++ N G + C
Sbjct: 312 GGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSS 371
Query: 401 LHFIDLSSNELSGELDVKL-QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQ- 458
L + L N++SG + +L + + LF N + GSIP + LQ+ DL +
Sbjct: 372 LVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPP---GLADCTDLQALDLSRN 428
Query: 459 ---GYDPSFTYMQYFMSKARL------G-MPLLVSAARFMVIHNFSGNNFTGPICWLPVA 508
G PS +M ++K L G +P + +V N TG I P
Sbjct: 429 SLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGFNRITGEI---PSG 485
Query: 509 PERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKS 568
L++ F +N+L G P + +C+E M+ +LSNN++ G +P + +
Sbjct: 486 IGSLKKINFLDF--SSNRLHGKVPDEI-GSCSELQ-MI-DLSNNSLEGSLPNPVSSL-SG 539
Query: 569 LRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLT 628
L+VLD S NQ SG +P SL L SL L L+ N G IP+SL L+ L L N L+
Sbjct: 540 LQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGSNELS 599
Query: 629 GGIPSSIGXXXXXXXXXXXXXXXXXX-VPEGVVNLRNLTALLLDNNKLSGHLPSGLANVT 687
G IPS +G +P + +L L+ L L +N L G L + LAN+
Sbjct: 600 GEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSILDLSHNMLEGDL-APLANIE 658
Query: 688 SLSIFNASFNNLSGPFPWNVTTMNCS--GVIGNPFLDPCQMYKDIXXXXXXXXXXXXQHN 745
+L N S+N+ SG P N S + GN L C +D + N
Sbjct: 659 NLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKL--CSSTQD------SCFLTYRKGN 710
Query: 746 ITAPTGSRTEDHKIQXXXXXXXXXXXXXXXXXXXXFFYVRKGFPDTR-VQVSESR--ELT 802
G + K++ R+ + R ++ E+ + T
Sbjct: 711 GLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDNERDSELGETYKWQFT 770
Query: 803 LFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGV 862
F + + + IIR + N IG G G Y+A++ G ++AVKKL G
Sbjct: 771 PFQKLN--FSVDQIIRCLVE---PNVIGKGCSGVVYRADVDNGEVIAVKKLWPAMVNGGH 825
Query: 863 QQ--------FHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS 914
+ F AE+KTLG +RH N+V +G + N L+Y+Y+P G+L + + R
Sbjct: 826 DEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNGSLGSLLHERRG 885
Query: 915 RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974
++DW + ++I L A LAYLH C P ++HRD+K +NIL+ DF Y++DFGL++L+
Sbjct: 886 SSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFEPYIADFGLAKLVD 945
Query: 975 TSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033
+ + VAG++GY+APEY + ++++K+DVYSYGVV+LE+++ K+ +DP+ +
Sbjct: 946 EGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTVP---E 1002
Query: 1034 GFNIISWASMLLRQGQVKDVFNAELWA--SGPHDDLEDMLHLALRCTVETLSTRPTMKQV 1091
G +++ W +G + +V ++ L + D++ +L AL C + RPTMK V
Sbjct: 1003 GIHLVDWVRQ--NRGSL-EVLDSTLRSRTEAEADEMMQVLGTALLCVNSSPDERPTMKDV 1059
Query: 1092 VQCLKQIQ 1099
LK+I+
Sbjct: 1060 AAMLKEIK 1067
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 624 (224.7 bits), Expect = 1.3e-110, Sum P(2) = 1.3e-110
Identities = 214/693 (30%), Positives = 330/693 (47%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
E +LLEFK ++D +G L+SW S+ C+W G++C V ++++ G ++S G P
Sbjct: 27 EGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTHLRTVTSVDLNGMNLS-GTLSP 85
Query: 67 FFSCL-------MTAQF---PF-YGFGMRRRTCLHG--RGKLVGKLSPLVGGLSELRVLS 113
L ++ F P + R + + G + + + L+ L
Sbjct: 86 LICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITLKKLY 145
Query: 114 LPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPF 173
L N G P +I +L L+ L + N L+G +P LR LR++ N G IP
Sbjct: 146 LCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSGVIPS 205
Query: 174 SLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHL 233
+ ESL+VL LA N ++G +P L L L L N L+G IP +G R LE L
Sbjct: 206 EISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISR-LEVL 264
Query: 234 DLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIP 293
L N G IP +GK +++ L L++N L IPRE+G L +D S N+L G IP
Sbjct: 265 ALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIP 324
Query: 294 TELGNCVELSVLVLSNLFDPLLSGRNIR--GELSVGQS-DASNGEKNSFIGSIPMEITTL 350
E G+ + L +L +LF+ +L G R GEL++ + D S N G+IP E+ L
Sbjct: 325 KEFGHILNLKLL---HLFENILLGPIPRELGELTLLEKLDLSINRLN---GTIPQELQFL 378
Query: 351 SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNE 410
L + LEGK+P G + +L+++ N L G + F R + L + L SN+
Sbjct: 379 PYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNK 438
Query: 411 LSGELDVKLQVPCMALFDV--SGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQ 468
LSG + L+ C +L + N ++GS+P +N+ + L + +L Q + +
Sbjct: 439 LSGNIPRDLKT-CKSLTKLMLGDNQLTGSLPIELFNLQN---LTALELHQNW------LS 488
Query: 469 YFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLT 528
+S A LG L + R + + NNFTG I P PE F +N+LT
Sbjct: 489 GNIS-ADLGK--LKNLERLRL----ANNNFTGEI---P--PEIGNLTKIVGFNISSNQLT 536
Query: 529 GSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLE 588
G P L +C + +LS N G+I ++G + L +L S N+++G +P S
Sbjct: 537 GHIPKEL-GSCVTIQRL--DLSGNKFSGYIAQELGQLVY-LEILRLSDNRLTGEIPHSFG 592
Query: 589 NLTSLVFLDLNGNKLQGEIPSSLHRLKYLR-HLSLADNNLTGGIPSSIGXXXXXXXXXXX 647
+LT L+ L L GN L IP L +L L+ L+++ NNL+G IP S+G
Sbjct: 593 DLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLN 652
Query: 648 XXXXXXXVPEGVVNLRNLTALLLDNNKLSGHLP 680
+P + NL +L + NN L G +P
Sbjct: 653 DNKLSGEIPASIGNLMSLLICNISNNNLVGTVP 685
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 656 (236.0 bits), Expect = 7.4e-110, Sum P(2) = 7.4e-110
Identities = 230/734 (31%), Positives = 329/734 (44%)
Query: 9 TILLEFKNSVSDPSGILSSWQTNTS--SHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
T+L K+ P + S+W+ N S + C+WFG++CD V +LN T VS G P
Sbjct: 35 TLLSLLKHLDRVPPQVTSTWKINASEATPCNWFGITCDDSKNVASLNFTRSRVS-GQLGP 93
Query: 67 FFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPE 126
L + Q + T G + +G ++L L L NGFS + P
Sbjct: 94 EIGELKSLQI------LDLST-----NNFSGTIPSTLGNCTKLATLDLSENGFSDKIPDT 142
Query: 127 IWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186
+ SL++LEVL + NFL+G LP + L+VL L +N + G IP S+ + + L L++
Sbjct: 143 LDSLKRLEVLYLYINFLTGELPESLFRIPKLQVLYLDYNNLTGPIPQSIGDAKELVELSM 202
Query: 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS 246
NQ G IP +G+ L++L+L N+L GS+P L L L + NSL G +
Sbjct: 203 YANQFSGNIPESIGNSSSLQILYLHRNKLVGSLPESLNLLGN-LTTLFVGNNSLQGPVRF 261
Query: 247 SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLV 306
C+ L TL L N +P LG L+ L + L+G IP+ LG L++L
Sbjct: 262 GSPNCKNLLTLDLSYNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTIL- 320
Query: 307 LSNLFDPLLSGRNIRGELSVGQSDASNGEK---NSFIGSIPMEITTLSKLRIIWAPRLNL 363
NL + LSG +I EL G + N K N +G IP + L KL +
Sbjct: 321 --NLSENRLSG-SIPAEL--GNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFENRF 375
Query: 364 EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQV-P 422
G++P +SL L + QN L G+L KKL L +N G + L V
Sbjct: 376 SGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLGVNS 435
Query: 423 CMALFDVSGNHMSGSIPRFDYNVCHQMPLQ----SSDLCQGYDPSF-----TYMQYFMSK 473
+ D GN ++G IP N+CH L+ S+L G P+ T ++ + +
Sbjct: 436 SLEEVDFIGNKLTGEIPP---NLCHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILRE 492
Query: 474 ARL-GMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFL-AGANKLTGSF 531
L G+ S + +F+ NNF GPI P L + + + N+ TG
Sbjct: 493 NNLSGLLPEFSQDHSLSFLDFNSNNFEGPI------PGSLGSCKNLSSINLSRNRFTGQI 546
Query: 532 PGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLT 591
P L N G + NLS N + G +P + C SL D N ++G VP + N
Sbjct: 547 PPQLGNLQNL--GYM-NLSRNLLEGSLPAQLS-NCVSLERFDVGFNSLNGSVPSNFSNWK 602
Query: 592 SLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGXXXXXXXXXXXXXXX 651
L L L+ N+ G IP L LK L L +A N G IPSSIG
Sbjct: 603 GLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNG 662
Query: 652 XXX-VPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTM 710
+P + +L LT L + NN L+G L S L +TSL + S N +GP P N+
Sbjct: 663 LTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVSNNQFTGPIPDNLEGQ 721
Query: 711 ---NCSGVIGNPFL 721
S GNP L
Sbjct: 722 LLSEPSSFSGNPNL 735
|
|
| UNIPROTKB|P93194 INRPK1 "Receptor-like protein kinase" [Ipomoea nil (taxid:35883)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 1.2e-108, Sum P(2) = 1.2e-108
Identities = 202/644 (31%), Positives = 300/644 (46%)
Query: 85 RRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLS 144
++ L G G G + +G S L + L N F+G P + +L+ L L + N L
Sbjct: 95 KKVVLSGNG-FFGSIPSQLGNCSLLEHIDLSSNSFTGNIPDTLGALQNLRNLSLFFNSLI 153
Query: 145 GRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLK 204
G P + + +L + N ++G IP ++ N L L L NQ G +P LG+
Sbjct: 154 GPFPESLLSIPHLETVYFTGNGLNGSIPSNIGNMSELTTLWLDDNQFSGPVPSSLGNITT 213
Query: 205 LRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264
L+ L+L+ N L G++P L L +LD+ NSLVG IP C+Q+ T+ L +N
Sbjct: 214 LQELYLNDNNLVGTLPVTLNNL-ENLVYLDVRNNSLVGAIPLDFVSCKQIDTISLSNNQF 272
Query: 265 NDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGE 323
+P LG L L+G IP+ G +L L L+ N F SGR I E
Sbjct: 273 TGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQLTKLDTLYLAGNHF----SGR-IPPE 327
Query: 324 LSVGQSDAS-NGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNL 382
L +S ++N G IP E+ LS+L+ + NL G++P S +SL+ L L
Sbjct: 328 LGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTNNLSGEVPLSIWKIQSLQSLQL 387
Query: 383 AQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQV-PCMALFDVSGNHMSGSIPRF 441
QN L G+L K+L + L N +G + L + + D++ N +G IP
Sbjct: 388 YQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGANSSLEVLDLTRNMFTGHIPP- 446
Query: 442 DYNVCHQMPLQ----SSDLCQGYDPS-----FTYMQYFMSKARL--GMPLLVSAARFMVI 490
N+C Q L+ + +G PS T + + + L G+P V ++
Sbjct: 447 --NLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEENNLRGGLPDFVEKQN-LLF 503
Query: 491 HNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLS 550
+ SGNNFTGPI P + L+ T A +N+L+GS P L H NLS
Sbjct: 504 FDLSGNNFTGPI---PPSLGNLKNVT--AIYLSSNQLSGSIPPELGSLVKLEH---LNLS 555
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
+N + G +P ++ C L LDASHN ++G +P +L +LT L L L N G IP+S
Sbjct: 556 HNILKGILPSELS-NCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGENSFSGGIPTS 614
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSIGXXXXXXXXXXXXXXXXXXVPEGVVNLRNLTALLL 670
L + L +L L N L G IP +G +P + L+ L L +
Sbjct: 615 LFQSNKLLNLQLGGNLLAGDIPP-VGALQALRSLNLSSNKLNGQLPIDLGKLKMLEELDV 673
Query: 671 DNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTT-MNCS 713
+N LSG L L+ + SL+ N S N SGP P ++T +N S
Sbjct: 674 SHNNLSGTLRV-LSTIQSLTFINISHNLFSGPVPPSLTKFLNSS 716
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 651 (234.2 bits), Expect = 1.3e-108, Sum P(2) = 1.3e-108
Identities = 198/644 (30%), Positives = 311/644 (48%)
Query: 95 LVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGL 154
L G +SP +GGL L L+L +N +G+ P EI + KLEV+ + N G +P E L
Sbjct: 97 LSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLEVMFLNNNQFGGSIPVEINKL 156
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
LR N+ N++ G +P + + +LE L N + G +P LG+ KL N+
Sbjct: 157 SQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGPLPRSLGNLNKLTTFRAGQND 216
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW 274
+G+IP+E+GK C L+ L L+ N + G +P +G +L+ ++L+ N + IP+++G
Sbjct: 217 FSGNIPTEIGK-CLNLKLLGLAQNFISGELPKEIGMLVKLQEVILWQNKFSGFIPKDIGN 275
Query: 275 LRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIR--GELS-VGQSDA 331
L LE L + N L G IP+E+GN L L L + L+G + G+LS V + D
Sbjct: 276 LTSLETLALYGNSLVGPIPSEIGNMKSLKKLYL---YQNQLNGTIPKELGKLSKVMEIDF 332
Query: 332 SNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDL 391
S +N G IP+E++ +S+LR+++ + L G +P+ +L L+L+ N L G +
Sbjct: 333 S---ENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLAKLDLSINSLTGPI 389
Query: 392 IGVFDRCKKLHFIDLSSNELSGELD--VKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQ- 448
F + + L N LSG + + L P + D S N +SG IP F +C Q
Sbjct: 390 PPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVV-DFSENQLSGKIPPF---ICQQS 445
Query: 449 ----MPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVS-AARFMVIHNFSG-----NNF 498
+ L S+ + P + + +G L + N S N F
Sbjct: 446 NLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLSAIELDQNRF 505
Query: 499 TGPICWLPVAPE-RLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGH 557
+GP LP PE ++ LA AN+ + + P + + N + N+S+N++ G
Sbjct: 506 SGP---LP--PEIGTCQKLQRLHLA-ANQFSSNLPNEISKLSNL---VTFNVSSNSLTGP 556
Query: 558 IPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYL 617
IP +I CK L+ LD S N G +P L +L L L L+ N+ G IP ++ L +L
Sbjct: 557 IPSEIA-NCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHL 615
Query: 618 RHLSLADNNLTGGIPSSIGXXXXXXXXXXXXXXXXXX-VPEGVVNLRNLTALLLDNNKLS 676
L + N +G IP +G +P + NL L L L+NN LS
Sbjct: 616 TELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLS 675
Query: 677 GHLPSGLANVTSLSIFNASFNNLSGPFPWN--VTTMNCSGVIGN 718
G +P+ N++SL N S+NNL+G P M + +GN
Sbjct: 676 GEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGN 719
|
|
| TAIR|locus:2005629 AT1G75640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 709 (254.6 bits), Expect = 5.3e-107, Sum P(2) = 5.3e-107
Identities = 217/718 (30%), Positives = 335/718 (46%)
Query: 7 EKTILLEFKNSVSDPSGILSSW-QTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSK 65
E L FK S+ DP G L SW Q++ S+ C W GVSC S RV L + ++ G+
Sbjct: 28 ETQALTSFKLSLHDPLGALESWNQSSPSAPCDWHGVSCFS-GRVRELRLPRLHLT-GHLS 85
Query: 66 PFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPP 125
P L Q R+ LH + G + + LR L L +N FSG+FPP
Sbjct: 86 PRLGEL--TQL--------RKLSLH-TNDINGAVPSSLSRCVFLRALYLHYNSFSGDFPP 134
Query: 126 EIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185
EI +L L+VL+ N L+G L + V ++LR ++L+ N I G IP + SL+++N
Sbjct: 135 EILNLRNLQVLNAAHNSLTGNLSDVTVS-KSLRYVDLSSNAISGKIPANFSADSSLQLIN 193
Query: 186 LAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP 245
L+ N G IP LG L L+L N+L G+IPS L C L H ++GN L G IP
Sbjct: 194 LSFNHFSGEIPATLGQLQDLEYLWLDSNQLQGTIPSALAN-CSSLIHFSVTGNHLTGLIP 252
Query: 246 SSLGKCQQLRTLLLFSNMLNDVIPREL-----GWLRKLEVLDVSRNRLNGLIPTELGNCV 300
+LG + L+ + L N +P L G+ + ++ + N G+ CV
Sbjct: 253 VTLGTIRSLQVISLSENSFTGTVPVSLLCGYSGYNSSMRIIQLGVNNFTGIAKPSNAACV 312
Query: 301 ELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNG-----EKNSFIGSIPMEITTLSKLRI 355
++ +L + I G+ +D ++ N F G + ++ L L+
Sbjct: 313 NPNLEILD------IHENRINGDFPAWLTDLTSLVVLDISGNGFSGGVTAKVGNLMALQE 366
Query: 356 IWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGEL 415
+ +L G++P+S C+SL +++ N G + G + + L I L N SG +
Sbjct: 367 LRVANNSLVGEIPTSIRNCKSLRVVDFEGNKFSGQIPGFLSQLRSLTTISLGRNGFSGRI 426
Query: 416 DVKL-QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSS-DLCQGYDPSFTYMQYFMSK 473
L + + +++ NH++G+IP + + L S + G PS +S
Sbjct: 427 PSDLLSLYGLETLNLNENHLTGAIPSEITKLANLTILNLSFNRFSGEVPSNVGDLKSLSV 486
Query: 474 ARLG-------MPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANK 526
+ +P+ +S + + + S +G LPV L D +A N
Sbjct: 487 LNISGCGLTGRIPVSISGLMKLQVLDISKQRISGQ---LPV---ELFGLPDLQVVALGNN 540
Query: 527 LTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQS 586
L G F + + NLS+N GHIP + G + KSL+VL SHN+ISG +P
Sbjct: 541 LLGGVVPEGFSSLVSLKYL--NLSSNLFSGHIPKNYGFL-KSLQVLSLSHNRISGTIPPE 597
Query: 587 LENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGXXXXXXXXXX 646
+ N +SL L+L N L+G IP + +L L+ L L+ N+LTG IP I
Sbjct: 598 IGNCSSLEVLELGSNSLKGHIPVYVSKLSLLKKLDLSHNSLTGSIPDQISKDSSLESLLL 657
Query: 647 XXXXXXXXVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
+PE + L NLTAL L +N+L+ +PS L+ + L+ FN S N+L G P
Sbjct: 658 NSNSLSGRIPESLSRLTNLTALDLSSNRLNSTIPSSLSRLRFLNYFNLSRNSLEGEIP 715
|
|
| UNIPROTKB|Q8RZV7 P0413C03.22 "Putative extra sporogenous cells" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 590 (212.7 bits), Expect = 6.3e-107, Sum P(2) = 6.3e-107
Identities = 121/289 (41%), Positives = 181/289 (62%)
Query: 811 LTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIK 870
+T + I++AT +F+ + IG GGFGT YKA + G VA+K+L G G ++F AE++
Sbjct: 990 VTADDILKATENFSKVHIIGDGGFGTVYKAALPEGRRVAIKRLHGGHQFQGDREFLAEME 1049
Query: 871 TLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALD 928
T+G V+HPNLV L+GY G+E FLIY Y+ G+LE +++ R A+ W KI L
Sbjct: 1050 TIGKVKHPNLVPLLGYCVCGDERFLIYEYMENGSLEMWLRNRADALEALGWPDRLKICLG 1109
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF 988
A LA+LH P ++HRD+K SNILLD++F +SDFGL+R++ ETH +T +AGTF
Sbjct: 1110 SARGLAFLHHGFVPHIIHRDMKSSNILLDENFEPRVSDFGLARIISACETHVSTDIAGTF 1169
Query: 989 GYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048
GY+ PEY LT + + K DVYS+GVV+LEL++ + G G N++ W ++ +G
Sbjct: 1170 GYIPPEYGLTMKSTTKGDVYSFGVVMLELLTGRPPTGQE-EVQGGG-NLVGWVRWMIARG 1227
Query: 1049 QVKDVFNAELWASGP-HDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096
+ ++F+ L S + + +L +A CT + RPTM +VV+ LK
Sbjct: 1228 KQNELFDPCLPVSSVWREQMARVLAIARDCTADEPFKRPTMLEVVKGLK 1276
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9S7I6 | RPK2_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5750 | 0.9809 | 0.9400 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1103 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-111 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-47 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-47 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 6e-45 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-35 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-35 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-34 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-31 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-26 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-25 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-25 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 7e-25 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-24 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-24 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 8e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-23 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-23 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-23 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 5e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 7e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-22 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 6e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-21 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-21 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-21 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-21 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-21 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-21 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-20 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 6e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-19 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-19 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-19 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-19 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 6e-19 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 9e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-18 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-18 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-18 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-18 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-18 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-17 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-17 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-17 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-17 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-17 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-17 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-17 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-17 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-17 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 7e-17 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-17 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-16 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-15 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 1e-15 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-15 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-15 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-15 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-15 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-15 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-15 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-15 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 6e-15 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-14 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-14 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-14 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-14 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-14 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 4e-14 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-14 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-14 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-14 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 5e-14 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-14 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-13 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-13 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-13 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 6e-13 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-12 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-12 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-11 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-11 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-11 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-11 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-11 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 9e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 9e-11 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-10 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 1e-10 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-10 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 8e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-09 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 5e-09 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-09 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 6e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 7e-09 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-09 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 5e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 6e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 7e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 8e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 8e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 9e-07 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-06 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 7e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-04 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-04 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 6e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 0.002 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.003 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 0.004 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.004 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 368 bits (946), Expect = e-111
Identities = 325/1112 (29%), Positives = 499/1112 (44%), Gaps = 214/1112 (19%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
E +LL FK+S++DP LS+W + ++ C W G++C++ SRVV+++++G ++S S
Sbjct: 30 ELELLLSFKSSINDPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88
Query: 67 FFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLS-ELRVLSLPFNGFSGEFPP 125
F + P+ +T +L G + + S LR L+L N F+G P
Sbjct: 89 IF------RLPYI------QTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR 136
Query: 126 EIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185
S+ LE LD+ N LSG +PN+ +L+VL+L N + G IP SL N SLE L
Sbjct: 137 G--SIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLT 194
Query: 186 LAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP 245
LA NQ+ G IP LG L+ ++L YN L+G IP E+G L HLDL N+L G IP
Sbjct: 195 LASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTS-LNHLDLVYNNLTGPIP 253
Query: 246 SSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVL 305
SSLG + L+ L L+ N L+ IP + L+KL LD+S N L+G IP EL ++L L
Sbjct: 254 SSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIP-EL--VIQLQNL 310
Query: 306 VLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG 365
+ +LF N+F G IP+ +T+L +L+++ G
Sbjct: 311 EILHLF------------------------SNNFTGKIPVALTSLPRLQVLQLWSNKFSG 346
Query: 366 KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL----QV 421
++P + G +L +L DLS+N L+GE+ L +
Sbjct: 347 EIPKNLGKHNNLTVL------------------------DLSTNNLTGEIPEGLCSSGNL 382
Query: 422 PCMALFDVSGNHMSGSIPRFDYNVCHQMP---LQSSDLCQGYDPSFTYMQ--YFMSKARL 476
+ LF N + G IP+ C + LQ + FT + YF+
Sbjct: 383 FKLILFS---NSLEGEIPK-SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL----- 433
Query: 477 GMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLF 536
+ S NN G I R+ D L
Sbjct: 434 ---------------DISNNNLQGRIN---------SRKWDMPSLQ-------------- 455
Query: 537 QACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFL 596
+ +L+ N G +P G K L LD S NQ SG VP+ L +L+ L+ L
Sbjct: 456 ---------MLSLARNKFFGGLPDSFG--SKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504
Query: 597 DLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVP 656
L+ NKL GEIP L K L L L+ N L+G IP+S E+ L L+LS N LSGE+P
Sbjct: 505 KLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIP 564
Query: 657 EGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVI 716
+ + N+ +L + + +N L G LPS +G F +N S V
Sbjct: 565 KNLGNVESLVQVNISHNHLHGSLPS------------------TGAF----LAINASAVA 602
Query: 717 GNPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASAIVLILLT 776
GN D+ + TS + P+ I + A +VL L+
Sbjct: 603 GN---------IDLCGGDTTSGLPPCKRVRKTPS------WWFYITCTLGA-FLVLALVA 646
Query: 777 LVILFFYVRKGFPDTRVQVSESRELTLFIDIGV--PLTYESIIRATGDFNTSNCIGSGGF 834
+F R RV+ + F D V +T I+ + + N I G
Sbjct: 647 FGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKE---ENVISRGKK 703
Query: 835 GTTYKAE-ISPGILVAVKKLAVGRFQHGVQQF-HAEIKTLGNVRHPNLVTLIGYRASGNE 892
G +YK + I G+ VK++ + V +EI +G ++HPN+V LIG S
Sbjct: 704 GASYKGKSIKNGMQFVVKEI------NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKG 757
Query: 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPS 952
+LI+ Y+ G NL + R + W+ KIA+ +A AL +LH +C+P V+ ++ P
Sbjct: 758 AYLIHEYIEGKNLSEVL-----RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPE 812
Query: 953 NILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGV 1012
I++D +L L LL T + YVAPE T +++K+D+Y +G+
Sbjct: 813 KIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGL 866
Query: 1013 VLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW--------ASGPH 1064
+L+EL++ K D F HG +I+ WA + ++W S
Sbjct: 867 ILIELLTGKSPADAEFGVHG---SIVEWARYCYSDCHL------DMWIDPSIRGDVSVNQ 917
Query: 1065 DDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096
+++ ++++LAL CT + RP V++ L+
Sbjct: 918 NEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 1e-49
Identities = 71/192 (36%), Positives = 107/192 (55%), Gaps = 8/192 (4%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G GGFGT Y A G VA+K + +++ EI+ L + HPN+V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
N ++L+ Y GG+L++ +K + + + +I L + L YLH ++HR
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSN---GIIHR 116
Query: 948 DVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR-VSDKA 1005
D+KP NILLD D+ L+DFGLS+LL + ++ T V GT Y+APE L S+K+
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 1006 DVYSYGVVLLEL 1017
D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 78/267 (29%), Positives = 123/267 (46%), Gaps = 25/267 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G FG Y A + G LVA+K + + + ++ EIK L ++HPN+V L
Sbjct: 7 LGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVF 66
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++++L+ Y GG+L + +K R + D + SAL YLH + ++HR
Sbjct: 67 EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE--ARFYLRQILSALEYLHSK---GIVHR 121
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+KP NILLD+D + L+DFGL+R L T GT Y+APE L D+
Sbjct: 122 DLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 1008 YSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDL 1067
+S GV+L EL++ K P F + K + + P D+
Sbjct: 180 WSLGVILYELLTGK----PPFPGDDQLLELF------------KKIGKPKPPFPPPEWDI 223
Query: 1068 -EDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ L + V+ R T ++ +Q
Sbjct: 224 SPEAKDLIRKLLVKDPEKRLTAEEALQ 250
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 5e-47
Identities = 90/269 (33%), Positives = 134/269 (49%), Gaps = 21/269 (7%)
Query: 828 CIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNLVTLIG 885
+GSG FGT YKA G +VAVK L + Q EI+ L + HPN+V LI
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ ++L+ Y GG+L +++ + KIAL + L YLH ++
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYL--SRGGPLSEDEAKKIALQILRGLEYLHSN---GII 120
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD-K 1004
HRD+KP NILLD++ ++DFGL++ L S + TT V GT Y+APE L K
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYGPK 179
Query: 1005 ADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPH 1064
DV+S GV+L EL++ K P FS G+ + ++ F+ W+SG
Sbjct: 180 VDVWSLGVILYELLTGK----PPFS--GENILDQLQLIRRILGPPLE--FDEPKWSSGS- 230
Query: 1065 DDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
E+ L +C + S RPT ++++Q
Sbjct: 231 ---EEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 6e-45
Identities = 69/272 (25%), Positives = 127/272 (46%), Gaps = 26/272 (9%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG YK ++ + VAVK L + +++F E + + + HPN+V L
Sbjct: 7 LGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G ++++ Y+ GG+L ++++ + + L AL +A + YL +
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLR-KNRPKLSLSDLLSFALQIARGMEYLESK---N 122
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD 1003
+HRD+ N L+ ++ +SDFGLSR L + + G ++APE + +
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKFTS 182
Query: 1004 KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063
K+DV+S+GV+L E+ + + P S ++ + L+ G L P
Sbjct: 183 KSDVWSFGVLLWEIFTLGEQPYPGMS----NEEVLEY----LKNGYR-------LPQ--P 225
Query: 1064 HDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095
+ ++ L L+C E RPT ++V+ L
Sbjct: 226 PNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 1e-44
Identities = 70/272 (25%), Positives = 127/272 (46%), Gaps = 25/272 (9%)
Query: 829 IGSGGFGTTYKAEISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG YK + + VAVK L + +++F E + + + HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G + ++ Y+PGG+L ++++ + + L AL +A + YL +
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---N 123
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD 1003
+HRD+ N L+ ++ +SDFGLSR L + + G ++APE + +
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 1004 KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063
K+DV+S+GV+L E+ + + P S ++ + L++G L P
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMS----NAEVLEY----LKKGYR-------LPK--P 226
Query: 1064 HDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095
+ ++ L L+C E RPT ++V+ L
Sbjct: 227 PNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-39
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 829 IGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG YK + VAVK L G + ++F E + + HPN+V L
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRL 66
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G G ++++ Y+PGG+L +F++ + K L ++AL +A + YL +
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-EKLTLKDLLQMALQIAKGMEYLESK---N 122
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG---YVAPEYALTCR 1000
+HRD+ N L+ ++ +SDFGLSR + + + G G ++APE +
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRG--GGKLPIKWMAPESLKDGK 180
Query: 1001 VSDKADVYSYGVVLLELIS 1019
+ K+DV+S+GV+L E+ +
Sbjct: 181 FTSKSDVWSFGVLLWEIFT 199
|
Length = 258 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 78/284 (27%), Positives = 126/284 (44%), Gaps = 56/284 (19%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQF-HAEIKTLGNVRHPNLVTLIGY 886
IG G FG Y S G L +K++ + ++ E+K L + HPN++ Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIK---Y 64
Query: 887 RAS---GNEMFLIYNYLPGGNLENFIKARTSRAV---DWKILHKIALDVASALAYLHDQC 940
S ++ ++ Y GG+L IK + + +IL + + AL YLH +
Sbjct: 65 YESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD-WFVQLCLALKYLHSR- 122
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE------ 994
++LHRD+KP NI L + L DFG+S++L ++ A T V GT Y++PE
Sbjct: 123 --KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKP 179
Query: 995 YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054
Y + K+D++S G VL EL L F +G N++ A +L+
Sbjct: 180 Y------NYKSDIWSLGCVLYELC----TLKHPF----EGENLLELALKILK-------- 217
Query: 1055 NAELWASGPHDDLEDMLHLALRCTVETL-----STRPTMKQVVQ 1093
G + + LR V +L RP++ Q++Q
Sbjct: 218 -------GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 827 NCIGSGGFGTTYKAEISPG----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG YK ++ VAVK L + + F E + + + HPN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRA-------VDWKILHKIALDVASALAY 935
L+G ++L+ Y+ GG+L ++++ + K L A+ +A + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAP 993
L + + +HRD+ N L+ +D +SDFGLSR + + + G ++AP
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDV-YDDDYYRKKTGGKLPIRWMAP 176
Query: 994 EYALTCRVSDKADVYSYGVVLLELIS 1019
E + K+DV+S+GV+L E+ +
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFT 202
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 2e-34
Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 14/212 (6%)
Query: 827 NCIGSGGFGTTYKA-EISPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+G G FG+ Y A + G L+AVK + + + ++ EI+ L +++HPN+V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 885 G-YRASGNEMFLIY-NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
G R I+ Y+ GG+L + +K + ++ K + LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLK--KFGKLPEPVIRKYTRQILEGLAYLHSN--- 120
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRV 1001
++HRD+K +NIL+D D L+DFG ++ LG ET T V GT ++APE
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 1002 SDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033
AD++S G ++E+ + K P +S G+
Sbjct: 181 GRAADIWSLGCTVIEMATGK----PPWSELGN 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 10/199 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
F IG GGFG YKA G VA+K + + + ++ EI+ L +HPN+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKL-ESKEKKEKIINEIQILKKCKHPNI 59
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G +E++++ + GG+L++ +K+ T++ + + + ++ L YLH
Sbjct: 60 VKYYGSYLKKDELWIVMEFCSGGSLKDLLKS-TNQTLTESQIAYVCKELLKGLEYLHSN- 117
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLS-RLLGTSETHATTGVAGTFGYVAPEYALTC 999
++HRD+K +NILL D L DFGLS +L T + GT ++APE
Sbjct: 118 --GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVINGK 172
Query: 1000 RVSDKADVYSYGVVLLELI 1018
KAD++S G+ +EL
Sbjct: 173 PYDYKADIWSLGITAIELA 191
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 62/201 (30%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG P G VAVK L + F EI+ L + H N+V
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 884 IG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G + G + LI YLP G+L ++++ R ++ K L + + + YL Q
Sbjct: 72 KGVCEKPGGRSLRLIMEYLPSGSLRDYLQ-RHRDQINLKRLLLFSSQICKGMDYLGSQ-- 128
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG---TFGYVAPEYALT 998
R +HRD+ NIL++ + +SDFGL+++L + + G F Y APE T
Sbjct: 129 -RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECLRT 186
Query: 999 CRVSDKADVYSYGVVLLELIS 1019
+ S +DV+S+GV L EL +
Sbjct: 187 SKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-30
Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 24/285 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVRHP- 878
+ +G G FG Y A LVA+K LA V++F EI+ L ++ HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV-DWKILHKIALDVASALAYLH 937
N+V L + ++L+ Y+ GG+LE+ +K + I + SAL YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 938 DQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHA-----TTGVAGTFGYV 991
+ ++HRD+KP NILLD D L DFGL++LL + + + GT GY+
Sbjct: 119 SK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 992 APEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048
APE L S +D++S G+ L EL++ P F + ++L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL----PPFEGEKNSSATSQTLKIILELP 231
Query: 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ L S P + L + + R + +
Sbjct: 232 T--PSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+ IG G FG + G VAVK L Q F AE + +RHPNLV
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLK--DDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L+G GN ++++ Y+ G+L +++++R + ALDV + YL ++
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK-- 121
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+HRD+ N+L+ +D A +SDFGL++ + + APE +
Sbjct: 122 -NFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSGKLPVKWTAPEALREKKF 176
Query: 1002 SDKADVYSYGVVLLELIS 1019
S K+DV+S+G++L E+ S
Sbjct: 177 STKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 77/279 (27%), Positives = 138/279 (49%), Gaps = 35/279 (12%)
Query: 827 NCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG G FGT K S G ++ K++ G + QQ +E+ L ++HPN+V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 885 GY---RASGNEMFLIYNYLPGGNLENFIK--ARTSRAVDWKILHKIALDVASALAYLH-- 937
R++ ++++ Y GG+L I+ + + ++ + + +I + AL H
Sbjct: 66 DRIIDRSN-QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
VLHRD+KP+NI LD + N L DFGL+++LG + A T V GT Y++PE
Sbjct: 125 SDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLN 183
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV---F 1054
+K+D++S G ++ EL AL P F+ N + AS +++G+ + + +
Sbjct: 184 HMSYDEKSDIWSLGCLIYELC----ALSPPFT----ARNQLQLASK-IKEGKFRRIPYRY 234
Query: 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
++EL ++ ML++ RP+ ++++Q
Sbjct: 235 SSELNEV-----IKSMLNV-------DPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-29
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 6/197 (3%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
D +G G G YK P G + A+KK+ V + +Q E+KTL + P +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G E+ ++ Y+ GG+L + +K + +L IA + L YLH +
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTK- 118
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
++HRD+KPSN+L++ ++DFG+S++L + T V GT Y++PE
Sbjct: 119 -RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176
Query: 1001 VSDKADVYSYGVVLLEL 1017
S AD++S G+ LLE
Sbjct: 177 YSYAADIWSLGLTLLEC 193
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 13/202 (6%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGY 886
IG G FG Y A + G L+AVK++ + +++ E+K L ++HPNLV G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
++++ Y GG LE R +D ++ L + LAYLH ++H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEEL--LEHGRILDEHVIRVYTLQLLEGLAYLHSH---GIVH 122
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG---YVAPEYALTCRVSD 1003
RD+KP+NI LD + L DFG + L + T V G Y+APE +
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 1004 K---ADVYSYGVVLLELISDKK 1022
AD++S G V+LE+ + K+
Sbjct: 183 HGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 59/201 (29%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPN 879
++ + IG G FG YK + G VA+K++++ + + ++ EI L N++HPN
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYLH 937
+V IG + + +++I Y G+L IK ++ ++++ LAYLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ----GLAYLH 116
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+Q V+HRD+K +NIL D L+DFG++ L + V GT ++APE
Sbjct: 117 EQ---GVIHRDIKAANILTTKDGVVKLADFGVATKL-NDVSKDDASVVGTPYWMAPEVIE 172
Query: 998 TCRVSDKADVYSYGVVLLELI 1018
S +D++S G ++EL+
Sbjct: 173 MSGASTASDIWSLGCTVIELL 193
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 30/224 (13%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNV-R 876
DF IG G F T A E A+K K + + + V+ E + L +
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKK-VKYVKIEKEVLTRLNG 60
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
HP ++ L ++ + Y P G L +I+ S A ++ AL YL
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC-TRF-YAAEILLALEYL 118
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA----------- 985
H + ++HRD+KP NILLD D + ++DFG +++L + + +
Sbjct: 119 HSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 986 --------GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDK 1021
GT YV+PE +D+++ G ++ ++++ K
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 828 CIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLI 884
+G G +G YKA + G +VA+KK+ + + G+ A EI L ++HPN+V L+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPS-TALREISLLKELKHPNIVKLL 64
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ +++L++ Y +L+ ++ + + ++ I + LAY H R+
Sbjct: 65 DVIHTERKLYLVFEYCDM-DLKKYLD-KRPGPLSPNLIKSIMYQLLRGLAYCHSH---RI 119
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
LHRD+KP NIL++ D L+DFGL+R G T V T Y APE L +
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHYST 178
Query: 1005 A-DVYSYGVVLLELISDKKAL 1024
A D++S G + E+I+ K L
Sbjct: 179 AVDIWSVGCIFAEMIT-GKPL 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 57/191 (29%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG ++ + VAVK L G + F AE + + +RHP L+ L
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD--PKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
++++ + G+L +++ RA+ L +A VAS +AYL Q +HRD
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRD 128
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+ N+L+ ++ ++DFGL+R++ A G + APE AL R S K+DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188
Query: 1009 SYGVVLLELIS 1019
S+G++L E+++
Sbjct: 189 SFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 58/192 (30%), Positives = 95/192 (49%), Gaps = 5/192 (2%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
IG G FG YK + VAVK ++F E + L HPN+V LIG
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
++++ +PGG+L F++ + +R K+L ++LD A+ + YL + +HRD
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ-MSLDAAAGMEYLESKNC---IHRD 118
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPEYALTCRVSDKADV 1007
+ N L+ ++ +SDFG+SR + G+ + APE R + ++DV
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178
Query: 1008 YSYGVVLLELIS 1019
+SYG++L E S
Sbjct: 179 WSYGILLWETFS 190
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 56/197 (28%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
F+ +G G +G+ YKA G +VA+K + V +Q+ EI L P +
Sbjct: 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE---EDLQEIIKEISILKQCDSPYI 60
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G +++++ Y G++ + +K T++ + + + I L YLH
Sbjct: 61 VKYYGSYFKNTDLWIVMEYCGAGSVSDIMKI-TNKTLTEEEIAAILYQTLKGLEYLHSN- 118
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+ +HRD+K NILL+++ A L+DFG+S L + T V GT ++APE
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 1001 VSDKADVYSYGVVLLEL 1017
++KAD++S G+ +E+
Sbjct: 176 YNNKADIWSLGITAIEM 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 12/209 (5%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQ-QFHAEIKTLGNVRHPNLVTLIGY 886
IG G G +KA + G VA+KK+A+ R + G+ Q EIK L +HP +V L+
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
G+ L+ Y+P L ++ R + + + +AY+H A ++H
Sbjct: 68 FPHGSGFVLVMEYMPSD-LSEVLRDE-ERPLPEAQVKSYMRMLLKGVAYMH---ANGIMH 122
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA- 1005
RD+KP+N+L+ D ++DFGL+RL E + T Y APE R D
Sbjct: 123 RDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGV 182
Query: 1006 DVYSYGVVLLELISDKKALDPSFSSHGDG 1034
D+++ G + EL+ P F D
Sbjct: 183 DLWAVGCIFAELL----NGSPLFPGENDI 207
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-25
Identities = 55/191 (28%), Positives = 98/191 (51%), Gaps = 5/191 (2%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG + + VAVK L G + F E + + +RH LV L +
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
++++ Y+ G+L +F+K+ + + L +A +A +AYL + +HRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRD 128
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+ NIL+ ++ ++DFGL+RL+ E A G + APE A R + K+DV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188
Query: 1009 SYGVVLLELIS 1019
S+G++L E+++
Sbjct: 189 SFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 8e-25
Identities = 59/194 (30%), Positives = 99/194 (51%), Gaps = 9/194 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFH-AEIKTLGNVRHPNLVTLIGY 886
IG G +G YKA + G +VA+KK+ + G+ + EIK L + HPN++ L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+++L++ ++ +L IK R R + ++ + LA+ H + +LH
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDR-QRGLPESLIKSYLYQLLQGLAFCH---SHGILH 121
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA- 1005
RD+KP N+L++ + L+DFGL+R G+ T V T Y APE L +
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV-TRWYRAPELLLGDKGYSTPV 180
Query: 1006 DVYSYGVVLLELIS 1019
D++S G + EL+S
Sbjct: 181 DIWSVGCIFAELLS 194
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN 879
D +G+G G K P G ++AVK + + + +Q E+ L P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPY 60
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V G + ++ + Y+ GG+L+ +K + +IL KIA+ V L YLH++
Sbjct: 61 IVGFYGAFYNNGDISICMEYMDGGSLDKILK-EVQGRIPERILGKIAVAVLKGLTYLHEK 119
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
+++HRDVKPSNIL++ L DFG+S L S A T V GT Y+APE
Sbjct: 120 H--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--AKTFV-GTSSYMAPERIQGN 174
Query: 1000 RVSDKADVYSYGVVLLEL 1017
S K+D++S G+ L+EL
Sbjct: 175 DYSVKSDIWSLGLSLIEL 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/203 (30%), Positives = 98/203 (48%), Gaps = 9/203 (4%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
D+ IG G Y A P VA+K++ + + Q V + E++ + HPN+
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV-DWKILHKIALDVASALAYLHDQ 939
V G+E++L+ YL GG+L + +K+ R D I+ + +V L YLH
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL---GTSETHATTGVAGTFGYVAPEYA 996
+HRD+K NILL +D + ++DFG+S L G GT ++APE
Sbjct: 122 ---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 997 LTCRVSD-KADVYSYGVVLLELI 1018
D KAD++S+G+ +EL
Sbjct: 179 EQVHGYDFKADIWSFGITAIELA 201
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 67/198 (33%), Positives = 93/198 (46%), Gaps = 14/198 (7%)
Query: 829 IGSGGFGTT----YKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+G G FG+ Y + + VAVK L G ++F E + + HP +V LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFI-KARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
G G + L+ P G L ++ K R D K L A VA +AYL +
Sbjct: 63 GV-CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL---AHQVAMGMAYLESK---H 115
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH--ATTGVAGTFGYVAPEYALTCRV 1001
+HRD+ N+LL + A +SDFG+SR LG + ATT + APE +
Sbjct: 116 FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 1002 SDKADVYSYGVVLLELIS 1019
S K+DV+SYGV L E S
Sbjct: 176 SSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 13/198 (6%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKL---AVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+G G FG + G L A+K L + + + V+ E L + HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKE-VEHTLTERNILSRINHPFIVKLH 59
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ +++L+ Y PGG L + + + A ++ AL YLH +
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GI 114
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
++RD+KP NILLD D + L+DFGL++ L SE T GT Y+APE L + K
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLAKELS-SEGSRTNTFCGTPEYLAPEV-LLGKGYGK 172
Query: 1005 A-DVYSYGVVLLELISDK 1021
A D +S GV+L E+++ K
Sbjct: 173 AVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-23
Identities = 56/198 (28%), Positives = 103/198 (52%), Gaps = 5/198 (2%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+F +GSG FG ++ + VA+K L Q F E++ L +RH +L+
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK-QQDFQKEVQALKRLRHKHLI 65
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
+L + G +++I + G+L F+++ + + L +A VA +AYL +Q
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+HRD+ NIL+ +D ++DFGL+RL+ + + ++ + + APE A
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 1002 SDKADVYSYGVVLLELIS 1019
S K+DV+S+G++L E+ +
Sbjct: 182 STKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 81/292 (27%), Positives = 128/292 (43%), Gaps = 38/292 (13%)
Query: 820 TGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVR 876
G+F IG G F YKA G +VA+KK+ + Q EI L +
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 877 HPNLVTLIGYRAS---GNEMFLIYNYLPGGNLENFIK--ARTSRAVDWKILHKIALDVAS 931
HPN+ I Y AS NE+ ++ G+L IK + R + + + K + + S
Sbjct: 61 HPNV---IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
AL ++H + R++HRD+KP+N+ + L D GL R +S+T A + GT Y+
Sbjct: 118 ALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYM 173
Query: 992 APEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051
+PE + K+D++S G +L E+ AL F +GD N+ S + +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNLYSLCKK-IEKCDYP 226
Query: 1052 ----DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
D ++ EL L RC RP + V+Q K++
Sbjct: 227 PLPADHYSEEL------------RDLVSRCINPDPEKRPDISYVLQVAKEMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 60/197 (30%), Positives = 95/197 (48%), Gaps = 11/197 (5%)
Query: 829 IGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG G FG + + I VA+K L G F E +G HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G + +I Y+ G+L+ F++ + L + +AS + YL +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRENDGKFT-VGQLVGMLRGIASGMKYLSEMN---Y 127
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE-THATTGVAGTFGYVAPEYALTCRV-S 1002
+HRD+ NIL++ + +SDFGLSR L SE T+ T G + APE A+ R +
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPE-AIAYRKFT 186
Query: 1003 DKADVYSYGVVLLELIS 1019
+DV+S+G+V+ E++S
Sbjct: 187 SASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 5e-23
Identities = 66/201 (32%), Positives = 101/201 (50%), Gaps = 12/201 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
IG G FG + E + G VAVK + + Q F E + + H NLV L+G
Sbjct: 14 IGEGEFGAVLQGEYT-GQKVAVKNI---KCDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
N ++++ + GNL NF++ R V L + +LDVA + YL + +++HRD
Sbjct: 70 H-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRD 125
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+ NIL+ +D A +SDFGL+R+ + + APE + S K+DV+
Sbjct: 126 LAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVW 181
Query: 1009 SYGVVLLELISDKKALDPSFS 1029
SYGV+L E+ S +A P S
Sbjct: 182 SYGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 7e-23
Identities = 62/194 (31%), Positives = 98/194 (50%), Gaps = 14/194 (7%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA---EIKTLGNVRHPNLVTLI 884
IG G G YKA + + G VA+KK+ + + Q EI + + +HPN+V
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKMRLRK-----QNKELIINEILIMKDCKHPNIVDYY 81
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G+E++++ Y+ GG+L + I R + +I + + +V L YLH Q V
Sbjct: 82 DSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-VCREVLQGLEYLHSQ---NV 137
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
+HRD+K NILL D + L+DFG + L T E V GT ++APE K
Sbjct: 138 IHRDIKSDNILLSKDGSVKLADFGFAAQL-TKEKSKRNSVVGTPYWMAPEVIKRKDYGPK 196
Query: 1005 ADVYSYGVVLLELI 1018
D++S G++ +E+
Sbjct: 197 VDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-22
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 24/207 (11%)
Query: 828 CIGSGGFGTTYKA-EISPGILVAVKKLAVGR----FQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG Y ++ G +AVK++ + V EI+ L N++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKA------RTSRAVDWKILHKIALDVASALAYL 936
G + + Y+PGG++++ +KA +R +IL + YL
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILE--------GVEYL 120
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT--TGVAGTFGYVAPE 994
H ++HRD+K +NIL D N L DFG S+ L T + T V GT +++PE
Sbjct: 121 HSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE 177
Query: 995 YALTCRVSDKADVYSYGVVLLELISDK 1021
KADV+S G ++E++++K
Sbjct: 178 VISGEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-22
Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 6/201 (2%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+GSG FG + + I VA+K + G F E K + + HPNLV L G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE--DDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
+F++ Y+ G L N+++ R + + + L + DV A+ YL +HRD
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+ N L+ +D +SDFGL+R + + ++ G + PE R S K+DV+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVW 185
Query: 1009 SYGVVLLELISDKKALDPSFS 1029
S+GV++ E+ S+ K FS
Sbjct: 186 SFGVLMWEVFSEGKMPYERFS 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-22
Identities = 58/198 (29%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G G FG + + VA+K L G + F E + + +RH LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV-V 70
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
S ++++ Y+ G+L +F+K + + L +A +AS +AY+ +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRD 127
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
++ +NIL+ ++ ++DFGL+RL+ +E A G + APE AL R + K+DV+
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 1009 SYGVVLLELISDKKALDP 1026
S+G++L EL + + P
Sbjct: 188 SFGILLTELTTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 3e-22
Identities = 66/207 (31%), Positives = 107/207 (51%), Gaps = 15/207 (7%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
IG G +G YKA G +VA+KK+ + GV EI L + HPN+V L+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+ N+++L++ +L +L+ F+ A + ++ + LA+ H + RVLH
Sbjct: 68 IHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH---SHRVLH 123
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGT---SETHATTGVAGTFGYVAPEYALTCRV-S 1002
RD+KP N+L++ + L+DFGL+R G + TH T Y APE L C+ S
Sbjct: 124 RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLGCKYYS 179
Query: 1003 DKADVYSYGVVLLELISDKKALDPSFS 1029
D++S G + E+++ ++AL P S
Sbjct: 180 TAVDIWSLGCIFAEMVT-RRALFPGDS 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.6 bits (244), Expect = 4e-22
Identities = 62/201 (30%), Positives = 94/201 (46%), Gaps = 16/201 (7%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHA----EIKTLGNVRHPNLVTL 883
IG G +G YKA G LVA+KK+ R ++ + F EIK L +RHPN+V L
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRHPNIVRL 63
Query: 884 IGYRAS--GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
S +++++ Y+ +L + + + + +I + L YLH
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKC-YMKQLLEGLQYLHSN-- 119
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+LHRD+K SNIL+++D L+DFGL+R + T T Y PE L
Sbjct: 120 -GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATR 178
Query: 1002 SDKA-DVYSYGVVLLELISDK 1021
D++S G +L EL K
Sbjct: 179 YGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 6e-22
Identities = 63/199 (31%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRF---QHGVQQFHA--EIKTLGNVRHPNLVT 882
+G G + YKA G +VA+KK+ +G + G+ F A EIK L ++HPN++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN-FTALREIKLLQELKHPNIIG 66
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSR--AVDWKILHKIALDVASALAYLHDQC 940
L+ + + L++ ++ +LE IK ++ D K + L L YLH
Sbjct: 67 LLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTL---RGLEYLHSN- 121
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+LHRD+KP+N+L+ D L+DFGL+R G+ T V T Y APE R
Sbjct: 122 --WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPELLFGAR 178
Query: 1001 V-SDKADVYSYGVVLLELI 1018
D++S G + EL+
Sbjct: 179 HYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 6e-22
Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 24/210 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG---------VQQFHAEIKTLGNVRHP 878
IG G +G Y A ++ G ++AVK++ + G V+ +EI+TL ++ H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
N+V +G+ + + + Y+PGG++ + + RT + +++ V LAYLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE----THATTGVAGTFGYVAPE 994
+ +LHRD+K N+L+D D +SDFG+S+ S+ + G+ ++APE
Sbjct: 127 K---GILHRDLKADNLLVDADGICKISDFGISK---KSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 995 YALTCR--VSDKADVYSYGVVLLELISDKK 1022
+ S K D++S G V+LE+ + ++
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 28/213 (13%)
Query: 829 IGSGGFGTTYKAEISPGI------LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + E LVAVK L + F E + L N +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI------------LHKIALDVA 930
G G+ +++ Y+ G+L F+++ A K L +IA+ +A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT--- 987
S + YL Q +HRD+ N L+ D + DFG+SR + T++ + V G
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR---VGGHTML 186
Query: 988 -FGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++ PE + + + ++DV+S+GVVL E+ +
Sbjct: 187 PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 1e-21
Identities = 62/202 (30%), Positives = 105/202 (51%), Gaps = 6/202 (2%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG + + VAVK L G + F E + + +RH LV L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP--ESFLEEAQIMKKLRHDKLVQLYAV-V 70
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
S ++++ Y+ G+L +F+K RA+ L +A VA+ +AY+ +HRD
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRD 127
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
++ +NIL+ D ++DFGL+RL+ +E A G + APE AL R + K+DV+
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 1009 SYGVVLLELISDKKALDPSFSS 1030
S+G++L EL++ + P ++
Sbjct: 188 SFGILLTELVTKGRVPYPGMNN 209
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 66/229 (28%), Positives = 104/229 (45%), Gaps = 34/229 (14%)
Query: 829 IGSGGFGTTYKAEISPGIL-------VAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
IG G FG ++A +PG+L VAVK L F E + HPN+V
Sbjct: 13 IGQGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV--------------------DWKI 921
L+G A G M L++ Y+ G+L F++ R+ RA
Sbjct: 72 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131
Query: 922 LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR-LLGTSETHA 980
IA VA+ +AYL ++ + +HRD+ N L+ ++ ++DFGLSR + A
Sbjct: 132 QLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188
Query: 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFS 1029
+ A ++ PE R + ++DV++YGVVL E+ S + P +
Sbjct: 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPYYG 235
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 56/197 (28%), Positives = 89/197 (45%), Gaps = 10/197 (5%)
Query: 829 IGSGGFGTTYKAE-ISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+G G FG + E + G I VAVK L + + F E + ++ H NL+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G + + + ++ P G+L + ++ L A+ +A+ + YL + R
Sbjct: 63 GVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RF 118
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT--FGYVAPEYALTCRVS 1002
+HRD+ NILL D + DFGL R L +E H F + APE T S
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFS 178
Query: 1003 DKADVYSYGVVLLELIS 1019
+DV+ +GV L E+ +
Sbjct: 179 HASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAV----GRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+GSG FG+ Y+ + G AVK++++ Q V+Q EI L ++HPN+V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTS------RAVDWKILHKIALDVASALAYLH 937
+G + +++ +PGG+L +K S R +IL L YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL--------LGLEYLH 119
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
D+ +HRD+K +NIL+D + L+DFG+++ + E G+ ++APE
Sbjct: 120 DR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV--VEFSFAKSFKGSPYWMAPEVIA 174
Query: 998 TCRVSD-KADVYSYGVVLLELISDK 1021
AD++S G +LE+ + K
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 6e-21
Identities = 65/204 (31%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
IG G +G YKA + G +VA+KK+ + GV EI L + HPN+V L+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
S N+++L++ +L +L+ ++ + +D ++ + +AY H RVLH
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLH 122
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGT---SETHATTGVAGTFGYVAPEYALTCR-VS 1002
RD+KP N+L+D + L+DFGL+R G + TH T Y APE L R S
Sbjct: 123 RDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEILLGSRQYS 178
Query: 1003 DKADVYSYGVVLLELISDKKALDP 1026
D++S G + E+++ ++ L P
Sbjct: 179 TPVDIWSIGCIFAEMVN-RRPLFP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 7e-21
Identities = 66/195 (33%), Positives = 103/195 (52%), Gaps = 14/195 (7%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK--KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
IGSG +G YKA +I+ G LVA+K KL G +QQ EI L RHPN+V G
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ---EISMLKECRHPNIVAYFG 67
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
++++++ Y GG+L++ I T + + + + LAYLH+ +
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKI 123
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD-- 1003
HRD+K +NILL +D + L+DFG+S L + + + GT ++APE A R
Sbjct: 124 HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERKGGYD 182
Query: 1004 -KADVYSYGVVLLEL 1017
K D+++ G+ +EL
Sbjct: 183 GKCDIWALGITAIEL 197
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 8e-21
Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 6/191 (3%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG + VA+K + G +F E K + + H LV L G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
++++ Y+ G L N+++ R ++L ++ DV +AYL + + +HRD
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-EMCKDVCEGMAYLESK---QFIHRD 125
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+ N L+DD +SDFGLSR + E ++ G + PE L + S K+DV+
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVW 185
Query: 1009 SYGVVLLELIS 1019
++GV++ E+ S
Sbjct: 186 AFGVLMWEVYS 196
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 9e-21
Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+ IG G FG + G VAVK + + Q F AE + +RH NLV
Sbjct: 7 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLV 62
Query: 882 TLIGYRASGN-EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
L+G ++++ Y+ G+L +++++R + L K +LDV A+ YL
Sbjct: 63 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE--- 119
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
A +HRD+ N+L+ +D A +SDFGL++ +++ V T APE +
Sbjct: 120 ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKK 175
Query: 1001 VSDKADVYSYGVVLLELIS 1019
S K+DV+S+G++L E+ S
Sbjct: 176 FSTKSDVWSFGILLWEIYS 194
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 829 IGSGGFGTTYKAEISPGILV-----AVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
IG G FG + + K+ V + V+ E + L + HP LV L
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEK--GSVRNVLNERRILQELNHPFLVNL 65
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWK--ILHKIALDVASALAYLHDQCA 941
M+L+ + L GG+L + S+ V + + ++ AL YLH +
Sbjct: 66 WYSFQDEENMYLVVDLLLGGDLRYHL----SQKVKFSEEQVKFWICEIVLALEYLHSK-- 119
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
++HRD+KP NILLD+ + +++DF ++ + TT +GT GY+APE L +
Sbjct: 120 -GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPE-VLCRQG 175
Query: 1002 SDKA-DVYSYGVVLLELISDKK 1022
A D +S GV E + K+
Sbjct: 176 YSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 57/191 (29%), Positives = 102/191 (53%), Gaps = 9/191 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G GT Y A +++ G VA+K++ + + Q + EI + +HPN+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G+E++++ YL GG+L + + T +D + + + AL +LH + +V+HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLH---SNQVIHR 139
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K NILL D + L+DFG + ++ +T V GT ++APE K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 1008 YSYGVVLLELI 1018
+S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 2e-20
Identities = 63/201 (31%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG+ P G +VAVKKL +H ++ F EI+ L +++H N+V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH-LRDFEREIEILKSLQHDNIVKY 70
Query: 884 IG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G Y A + L+ YLP G+L ++++ R +D + L A + + YL +
Sbjct: 71 KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER-LDHRKLLLYASQICKGMEYLGSK-- 127
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT---GVAGTFGYVAPEYALT 998
R +HRD+ NIL++ + + DFGL+++L + + G + F Y APE
Sbjct: 128 -RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTE 185
Query: 999 CRVSDKADVYSYGVVLLELIS 1019
+ S +DV+S+GVVL EL +
Sbjct: 186 SKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 62/205 (30%), Positives = 107/205 (52%), Gaps = 16/205 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPN 879
DF +G G +G+ YK + +S A+K++ +G Q + EI+ L +V HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 880 LVTLIGYRAS---GNEMFLIYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALA 934
+ I Y+ + GN++ ++ Y P G+L I R + + + + +I + + L
Sbjct: 61 I---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQ 117
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
LH+Q ++LHRD+K +NILL + + D G+S++L + A T GT Y+APE
Sbjct: 118 ALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVL--KKNMAKT-QIGTPHYMAPE 171
Query: 995 YALTCRVSDKADVYSYGVVLLELIS 1019
S K+D++S G +L E+ +
Sbjct: 172 VWKGRPYSYKSDIWSLGCLLYEMAT 196
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 6/197 (3%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
D + +G G +G Y+ + VAVK L + V++F E + ++HPNL
Sbjct: 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNL 64
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V L+G ++I ++ GNL ++++ + V+ +L +A ++SA+ YL
Sbjct: 65 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--- 121
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+HRD+ N L+ ++ ++DFGLSRL+ A G + APE +
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181
Query: 1001 VSDKADVYSYGVVLLEL 1017
S K+DV+++GV+L E+
Sbjct: 182 FSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 54/194 (27%), Positives = 98/194 (50%), Gaps = 6/194 (3%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
IGSG FG + VA+K + G + F E + + + HP LV L G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE--EDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
+ + L++ ++ G L ++++A+ + + L + LDV +AYL V+HRD
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+ N L+ ++ +SDFG++R + + ++TG + +PE + S K+DV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 1009 SYGVVLLELISDKK 1022
S+GV++ E+ S+ K
Sbjct: 186 SFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 3e-20
Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G FG YKA+ G+ A K + + + ++ F EI L +HPN+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAY 71
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
N+++++ + GG L++ + R + + + + AL +LH +V+HR
Sbjct: 72 FYENKLWILIEFCDGGALDSIMLE-LERGLTEPQIRYVCRQMLEALNFLHSH---KVIHR 127
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD---- 1003
D+K NILL D + L+DFG+S S GT ++APE D
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSA-KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 1004 -KADVYSYGVVLLEL 1017
KAD++S G+ L+EL
Sbjct: 187 YKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-20
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 14/210 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPN 879
DF N IG G FG +K + + A+K++ + + ++ E + L +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD----WKILHKIALDVASALAY 935
++ ++ ++ Y G+L +K + R + W+ +I L LA+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL----GLAH 116
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
LH + ++LHRD+K N+ LD N + D G+++LL + A T + GT Y++PE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPEL 172
Query: 996 ALTCRVSDKADVYSYGVVLLELISDKKALD 1025
++K+DV++ GVVL E + K D
Sbjct: 173 CEDKPYNEKSDVWALGVVLYECCTGKHPFD 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 33/205 (16%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQ-QFHAEIKTLGNVRHPNLVTLIG-- 885
+G G G+ K + ++ K +Q Q E++ + + P +V G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAF 68
Query: 886 YRASGNEMFLIYNYLPGGNLENF---IKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
S + + + Y GG+L++ +K R R + K+L KIA V L+YLH +
Sbjct: 69 LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGR-IGEKVLGKIAESVLKGLSYLHSR--- 124
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG----YVAPE---- 994
+++HRD+KPSNILL L DFG+S L S +AGTF Y+APE
Sbjct: 125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS-------LAGTFTGTSFYMAPERIQG 177
Query: 995 --YALTCRVSDKADVYSYGVVLLEL 1017
Y++T DV+S G+ LLE+
Sbjct: 178 KPYSITS------DVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 73/281 (25%), Positives = 128/281 (45%), Gaps = 43/281 (15%)
Query: 829 IGSGGFGTTYKAEI--SPGILVAVKKLAVGRFQHG---------VQQFHAEIKTLG-NVR 876
+GSG FG YK + L+A+K++ V G + +E+ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNL-ENFI-----KARTSRAVDWKILHKIALDVA 930
HPN+V + ++++ + + G L E+F K R + W I ++ L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY 990
AL YLH + R++HRD+ P+NI+L +D ++DFGL++ T V GT Y
Sbjct: 125 -ALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILY 179
Query: 991 VAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050
PE +KADV+++G +L ++ L P F S N++S A+ ++ V
Sbjct: 180 SCPEIVKNEPYGEKADVWAFGCILYQMC----TLQPPFYST----NMLSLATKIVE--AV 229
Query: 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQV 1091
+ +++ +D+ D++ C RP + QV
Sbjct: 230 YEPLPEGMYS----EDVTDVIT---SCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-20
Identities = 58/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 829 IGSGGFGTTYKAEIS-PG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG+G FG + PG I VA+K L G + + F +E +G HPN++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL--DVASALAYLHDQCAP 942
G + ++ Y+ G+L+ F++ + + ++ + + +AS + YL D
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQ---FTVIQLVGMLRGIASGMKYLSDMGY- 127
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG--YVAPEYALTCR 1000
+HRD+ NIL++ + +SDFGLSR+L A T G + APE +
Sbjct: 128 --VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185
Query: 1001 VSDKADVYSYGVVLLELIS 1019
+ +DV+SYG+V+ E++S
Sbjct: 186 FTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 6e-20
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G G FG + + VA+K L G + F E + + +RH LV L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP--EAFLQEAQIMKKLRHDKLVPLYAV-V 70
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
S ++++ ++ G+L +F+K + + L +A +A +AY+ +HRD
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRD 127
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
++ +NIL+ D+ ++DFGL+RL+ +E A G + APE AL R + K+DV+
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 187
Query: 1009 SYGVVLLELISDKKALDP 1026
S+G++L EL++ + P
Sbjct: 188 SFGILLTELVTKGRVPYP 205
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 6e-20
Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 8/200 (4%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAV-GRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G FG + + LV +K++ V + E + L + HPN++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+ ++ Y PGG L +I+ R + +D + + + AL ++H + +LH
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILH 124
Query: 947 RDVKPSNILLDDDFNAY-LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
RD+K NILLD + DFG+S++L + T V GT Y++PE + K+
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGKPYNQKS 182
Query: 1006 DVYSYGVVLLELISDKKALD 1025
D+++ G VL EL S K+A +
Sbjct: 183 DIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-19
Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 18/198 (9%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G G FG +K + VAVK Q +F +E + L HPN+V LIG
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
++++ +PGG+ +F++ + + K L K ALD A+ +AYL + +HRD
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLR-KKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRD 118
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG-------YVAPEYALTCRV 1001
+ N L+ ++ +SDFG+SR G+ + G + APE R
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR-------QEDDGIYSSSGLKQIPIKWTAPEALNYGRY 171
Query: 1002 SDKADVYSYGVVLLELIS 1019
S ++DV+SYG++L E S
Sbjct: 172 SSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 79/301 (26%), Positives = 136/301 (45%), Gaps = 60/301 (19%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEI---KTLGNVRHPN 879
+G G FG KAE + VAVK L + + +E+ K +G +H N
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIG--KHKN 77
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILHKI 925
++ L+G ++++ Y GNL +F++AR + K L
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
A VA + +L + + +HRD+ N+L+ +D ++DFGL+R + + + T
Sbjct: 138 AYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT--- 191
Query: 986 GTFG-----YVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIIS 1039
T G ++APE AL RV + ++DV+S+GV+L E+ F+ G + I
Sbjct: 192 -TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEI----------FTLGGSPYPGIP 239
Query: 1040 WASM--LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097
+ LL++G + P + +++ HL C E S RPT KQ+V+ L +
Sbjct: 240 VEELFKLLKEGYRME---------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDR 290
Query: 1098 I 1098
+
Sbjct: 291 M 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 68/276 (24%), Positives = 122/276 (44%), Gaps = 27/276 (9%)
Query: 829 IGSGGFGTTYKAEIS-PG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG+G FG ++ + PG + VA+K L G + Q F +E +G H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G +I Y+ G L+ +++ ++++ + +A+ + YL D
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GIAAGMKYLSDM---NY 128
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLL--GTSETHATTGVAGTFGYVAPEYALTCRVS 1002
+HRD+ NIL++ + +SDFGLSR+L T+ T+G + APE + +
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188
Query: 1003 DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062
+DV+S+G+V+ E++S + S+H +V N
Sbjct: 189 SASDVWSFGIVMWEVMSFGERPYWDMSNH-----------------EVMKAINDGFRLPA 231
Query: 1063 PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
P D + L L+C + + RP +V L ++
Sbjct: 232 PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 3e-19
Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 20/198 (10%)
Query: 827 NCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQ-QFHAEIKTLGNVRHPNLVTLI 884
N IGSG GT YK P G L A+K + G + V+ Q EI+ L +V HPN+V
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVI-YGNHEDTVRRQICREIEILRDVNHPNVVKCH 138
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
E+ ++ ++ GG+LE + D + L +A + S +AYLH + +
Sbjct: 139 DMFDHNGEIQVLLEFMDGGSLEG------THIADEQFLADVARQILSGIAYLHRR---HI 189
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
+HRD+KPSN+L++ N ++DFG+SR+L + + V GT Y++PE T ++
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINT-DLNHG 247
Query: 1005 A------DVYSYGVVLLE 1016
A D++S GV +LE
Sbjct: 248 AYDGYAGDIWSLGVSILE 265
|
Length = 353 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (221), Expect = 3e-19
Identities = 60/193 (31%), Positives = 101/193 (52%), Gaps = 10/193 (5%)
Query: 828 CIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
CIG G FG YKA + +VA+K + + + ++ EI+ L R P + G
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
G+++++I Y GG+ + +K +D + I +V L YLH++ +H
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLHEE---GKIH 121
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD-KA 1005
RD+K +NILL ++ + L+DFG+S L ++ + T V GT ++APE + D KA
Sbjct: 122 RDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPE-VIKQSGYDEKA 179
Query: 1006 DVYSYGVVLLELI 1018
D++S G+ +EL
Sbjct: 180 DIWSLGITAIELA 192
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 75/285 (26%), Positives = 131/285 (45%), Gaps = 43/285 (15%)
Query: 829 IGSGGFGTTYKAEIS-PG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG+G FG + + PG I VA+K L G + + F +E +G HPN++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL--DVASALAYLHDQCAP 942
G + +I ++ G L++F++ + + ++ + + +A+ + YL +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQ---FTVIQLVGMLRGIAAGMKYLSEM--- 125
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLL--GTSETHATTGVAGTFG--YVAPEYALT 998
+HRD+ NIL++ + +SDFGLSR L TS+ T+ + G + APE
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185
Query: 999 CRVSDKADVYSYGVVLLELIS--DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056
+ + +DV+SYG+V+ E++S ++ D S +DV NA
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMS----------------------NQDVINA 223
Query: 1057 --ELWASGPHDDLEDMLH-LALRCTVETLSTRPTMKQVVQCLKQI 1098
+ + P D LH L L C + + RP Q+V L ++
Sbjct: 224 IEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 59/198 (29%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 829 IGSGGFGTTYKAE-ISPG----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+GSG FGT YK I G I VA+K L ++ E + +V HP++V L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G +++ LI +P G L ++++ + + L + +A ++YL ++ R
Sbjct: 75 LGI-CLSSQVQLITQLMPLGCLLDYVRNHKDN-IGSQYLLNWCVQIAKGMSYLEEK---R 129
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET--HATTGVAGTFGYVAPEYALTCRV 1001
++HRD+ N+L+ + ++DFGL++LL E HA G ++A E L
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV-PIKWMALESILHRIY 188
Query: 1002 SDKADVYSYGVVLLELIS 1019
+ K+DV+SYGV + EL++
Sbjct: 189 THKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 5e-19
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 33/212 (15%)
Query: 823 FNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA--------EIKTLG 873
+ +G G FG+ Y A G LVA+KK+ ++F++ E+K+L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK--------KKFYSWEECMNLREVKSLR 52
Query: 874 NV-RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASA 932
+ HPN+V L +E++ ++ Y+ G NL +K R + ++ I +
Sbjct: 53 KLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA----TTGVAGTF 988
LA++H HRD+KP N+L+ ++DFGL+R E + T V T
Sbjct: 112 LAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR-----EIRSRPPYTDYV-STR 162
Query: 989 GYVAPEYALTCRV-SDKADVYSYGVVLLELIS 1019
Y APE L S D+++ G ++ EL +
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYT 194
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 6e-19
Identities = 62/233 (26%), Positives = 109/233 (46%), Gaps = 18/233 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
+N +G G FG + ++ A+K++ + + V+ E L ++HPN+
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V + ++++ Y GG+L IK + + + + + + + ++H++
Sbjct: 61 VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK- 119
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
RVLHRD+K NI L + L DFG +RLL + +A T V GT YV PE
Sbjct: 120 --RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENMP 176
Query: 1001 VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR--QGQVK 1051
++K+D++S G +L EL + K F SW +++L+ QG K
Sbjct: 177 YNNKSDIWSLGCILYELCTLKHP-----------FQANSWKNLILKVCQGSYK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-19
Identities = 70/282 (24%), Positives = 118/282 (41%), Gaps = 20/282 (7%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG P G +VAVK L Q + EI L + H N+V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 884 IGYRASGNE--MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G + + LI Y+P G+L +++ ++ L A + +AYLH Q
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLP---KHKLNLAQLLLFAQQICEGMAYLHSQ-- 126
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH---ATTGVAGTFGYVAPEYALT 998
+HRD+ N+LLD+D + DFGL++ + + G + F Y A E
Sbjct: 127 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKE 184
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058
+ S +DV+S+GV L EL++ D S +I + ++ ++ +
Sbjct: 185 NKFSYASDVWSFGVTLYELLTH---CDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGM 241
Query: 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100
P + +++ L C RPT + ++ LK++ H
Sbjct: 242 RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 9e-19
Identities = 66/216 (30%), Positives = 107/216 (49%), Gaps = 15/216 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPN 879
D+ IG G +G YK G +VA+KK+ + + GV EI L ++HPN
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPN 60
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKA-RTSRAVDWKILHKIALDVASALAYLHD 938
+V L + ++LI+ +L +L+ ++ + + +D +++ + + + H
Sbjct: 61 IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH- 118
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL- 997
+ RVLHRD+KP N+L+D+ L+DFGL+R G T V T Y APE L
Sbjct: 119 --SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLG 175
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033
+ R S D++S G + E+ + K P F HGD
Sbjct: 176 SPRYSTPVDIWSIGTIFAEMATKK----PLF--HGD 205
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 5/202 (2%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG + + VAVK L G VQ F E + ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS--VQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
+++I Y+ G+L +F+K+ V L + +A +AY+ + +HRD
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRD 128
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
++ +N+L+ + ++DFGL+R++ +E A G + APE + K+DV+
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188
Query: 1009 SYGVVLLELISDKKALDPSFSS 1030
S+G++L E+++ K P S+
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 1e-18
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 9/196 (4%)
Query: 828 CIGSGGFGTTYKA----EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
CIG G FG Y+ + I VAVK ++F E + HP++V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
IG + N ++++ P G L ++++ +D L + +++ALAYL + R
Sbjct: 73 IGV-ITENPVWIVMELAPLGELRSYLQVNKYS-LDLASLILYSYQLSTALAYLESK---R 127
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD 1003
+HRD+ N+L+ L DFGLSR L + + ++APE R +
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 1004 KADVYSYGVVLLELIS 1019
+DV+ +GV + E++
Sbjct: 188 ASDVWMFGVCMWEILM 203
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 58/202 (28%), Positives = 102/202 (50%), Gaps = 8/202 (3%)
Query: 829 IGSGGFG--TTYKAEISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIG 885
+G G FG T Y+ LV K++ + R ++ EI L ++HPN++
Sbjct: 8 LGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYN 66
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ N + + Y GG L + I + + + +++ + SA++Y+H +L
Sbjct: 67 HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GIL 123
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
HRD+K NI L L DFG+S++LG+ + A T V GT Y++PE + + K+
Sbjct: 124 HRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVKYNFKS 182
Query: 1006 DVYSYGVVLLELISDKKALDPS 1027
D+++ G VL EL++ K+ D +
Sbjct: 183 DIWALGCVLYELLTLKRTFDAT 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 2e-18
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 23/205 (11%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKL--AVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
I G +G + A+ S G + A+K + A ++ V Q E L + P +V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 886 YRASGNEMFLIYNYLPGGN----LENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
++L+ YLPGG+ LEN ++D + ++ AL YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENV------GSLDEDVARIYIAEIVLALEYLH-SNG 113
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSR-------LLGTSETHATTGVAGTFGYVAPE 994
++HRD+KP NIL+D + + L+DFGLS+ + + + GT Y+APE
Sbjct: 114 --IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 995 YALTCRVSDKADVYSYGVVLLELIS 1019
L S D +S G +L E +
Sbjct: 172 VILGQGHSKTVDWWSLGCILYEFLV 196
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 68/214 (31%), Positives = 104/214 (48%), Gaps = 21/214 (9%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQ-QFHAEIKTLGNV 875
R+ +F N IG G +G Y+A + + G +VA+KK+ + + G+ EI L N+
Sbjct: 4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63
Query: 876 RHPNLVTL----IGYRASGNEMFLIYNYLP---GGNLENFIKARTSRAVDWKILHKIALD 928
RHPN+V L +G + +FL+ Y L+N + V + L
Sbjct: 64 RHPNIVELKEVVVGKHL--DSIFLVMEYCEQDLASLLDNMPTPFSESQVK-----CLMLQ 116
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF 988
+ L YLH+ ++HRD+K SN+LL D ++DFGL+R G T V T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TL 172
Query: 989 GYVAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
Y APE L C A D+++ G +L EL++ K
Sbjct: 173 WYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 15/224 (6%)
Query: 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRH 877
+F IG G F Y+A + G+ VA+KK+ + EI L + H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIK--ARTSRAVDWKILHKIALDVASALAY 935
PN++ NE+ ++ G+L IK + R + K + K + + SAL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
+H + RV+HRD+KP+N+ + L D GL R +S+T A + GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177
Query: 996 ALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIIS 1039
+ K+D++S G +L E+ AL F +GD N+ S
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNLYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 3e-18
Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 11/207 (5%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
+G G +G K + G +VA+KK V++ E+K L +RH N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
++L++ Y+ L ++A + + + A+AY H + ++H
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEAS-PGGLPPDAVRSYIWQLLQAIAYCH---SHNIIH 123
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLL-GTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
RD+KP NIL+ + L DFG +R L + T VA T Y APE + K
Sbjct: 124 RDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTNYGKP 182
Query: 1006 -DVYSYGVVLLELISDKKALDPSFSSH 1031
DV++ G ++ EL+ D + L P S
Sbjct: 183 VDVWAIGCIMAELL-DGEPLFPGDSDI 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 30/215 (13%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKL---AVGRFQHGVQQFHAEIKTLGNVRHPN 879
+G G FG YK E+ VA+K L A + Q Q+F E + + +++HPN
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ---QEFRQEAELMSDLQHPN 69
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILHKI 925
+V L+G +++ YL G+L F+ ++D I
Sbjct: 70 IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
A+ +A+ + YL + +HRD+ N L+ + +SDFGLSR + +++ + +
Sbjct: 130 AIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 986 G-TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++ PE L + + ++D++S+GVVL E+ S
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 8/194 (4%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G GGFG ++ + G + A KKL R + G Q E K L V +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ +++ L+ + GG+L+ I A + L +LH + R++
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIV 117
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
+RD+KP N+LLDD N +SD GL+ + G AGT GY+APE
Sbjct: 118 YRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSV 175
Query: 1006 DVYSYGVVLLELIS 1019
D ++ G L E+I+
Sbjct: 176 DWFALGCTLYEMIA 189
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 3e-18
Identities = 60/206 (29%), Positives = 106/206 (51%), Gaps = 8/206 (3%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQ-QFHAEIKTLGNVRHPNL 880
DF + +G+G G K + P L+ +KL + ++ Q E++ L P +
Sbjct: 6 DFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G S E+ + ++ GG+L+ +K ++ + +IL K+++ V LAYL ++
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREK- 122
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+++HRDVKPSNIL++ L DFG+S L S ++ GT Y++PE
Sbjct: 123 -HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 178
Query: 1001 VSDKADVYSYGVVLLELISDKKALDP 1026
S ++D++S G+ L+EL + + P
Sbjct: 179 YSVQSDIWSMGLSLVELAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 4e-18
Identities = 65/216 (30%), Positives = 111/216 (51%), Gaps = 40/216 (18%)
Query: 829 IGSGGFGTTYKAEISPGILV---------AVKKLAVGRFQHGV-QQFHAEIKTLGNVRHP 878
IG G FG KA ILV +K++ + + ++ E+ L N++HP
Sbjct: 8 IGEGSFG---KA-----ILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHP 59
Query: 879 NLVTLIGYRASGNE---MFLIYNYLPGGNLENFIKAR------TSRAVDWKILHKIALDV 929
N+V Y+ S E ++++ +Y GG+L I A+ + +DW + +I L
Sbjct: 60 NIVQ---YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFV--QICL-- 112
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
AL ++HD+ ++LHRD+K NI L D L DFG++R+L ++ A T + GT
Sbjct: 113 --ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPY 166
Query: 990 YVAPEYALTCRVSDKADVYSYGVVLLELISDKKALD 1025
Y++PE ++K+D+++ G VL E+ + K A +
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 4e-18
Identities = 69/280 (24%), Positives = 121/280 (43%), Gaps = 18/280 (6%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG P G VAVK L + + EI+ L N+ H N+V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 884 IGY--RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G GN + LI +LP G+L+ ++ R ++ K K A+ + + YL +
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGSR-- 128
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG---VAGTFGYVAPEYALT 998
+ +HRD+ N+L++ + + DFGL++ + T + + T + F Y APE +
Sbjct: 129 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQ 186
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058
+ +DV+S+GV L EL++ D S +I + ++ V
Sbjct: 187 SKFYIASDVWSFGVTLYELLT---YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK 243
Query: 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
P + E++ L +C S R T + +++ + I
Sbjct: 244 RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 4e-18
Identities = 47/129 (36%), Positives = 74/129 (57%), Gaps = 14/129 (10%)
Query: 596 LDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEV 655
L L+ L+G IP+ + +L++L+ ++L+ N++ G IP S+G + SLEVL+LS NS +G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 656 PEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGV 715
PE + L +L L L+ N LSG +P+ L + ASF N T + +G+
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG---GRLLHRASF---------NFT--DNAGL 528
Query: 716 IGNPFLDPC 724
G P L C
Sbjct: 529 CGIPGLRAC 537
|
Length = 623 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.2 bits (210), Expect = 8e-18
Identities = 56/191 (29%), Positives = 102/191 (53%), Gaps = 9/191 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G GT + A +++ G VA+K++ + + Q + EI + +++PN+V +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G+E+F++ YL GG+L + + T +D + + + AL +LH A +V+HR
Sbjct: 86 LVGDELFVVMEYLAGGSLTDVV---TETCMDEAQIAAVCRECLQALEFLH---ANQVIHR 139
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K N+LL D + L+DFG + T E + + GT ++APE K D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 1008 YSYGVVLLELI 1018
+S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 23/227 (10%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-------HGVQQFHAEIKTLGN 874
+F IG G F Y+A L+ K +A+ + Q Q EI L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATC----LLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQ 58
Query: 875 VRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIK--ARTSRAVDWKILHKIALDVASA 932
+ HPN++ + NE+ ++ G+L IK + R + + + K + + SA
Sbjct: 59 LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
+ ++H + RV+HRD+KP+N+ + L D GL R +S+T A + GT Y++
Sbjct: 119 VEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 993 PEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIIS 1039
PE + K+D++S G +L E+ AL F +GD N+ S
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM----AALQSPF--YGDKMNLFS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 67/231 (29%), Positives = 114/231 (49%), Gaps = 21/231 (9%)
Query: 815 SIIRATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV--QQFHAEIKT 871
++ T + +G G FG A + G VA+KK+ + F V ++ + E+K
Sbjct: 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-MKPFSTPVLAKRTYRELKL 62
Query: 872 LGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS 931
L ++RH N+++L S E L G +L + TSR ++ + + +
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL---TSRPLEKQFIQYFLYQILR 119
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
L Y+H + V+HRD+KPSNIL++++ + + DFGL+R+ + TG T Y
Sbjct: 120 GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYR 172
Query: 992 APEYALTCRVSD-KADVYSYGVVLLELISDKKALDPSF--SSHGDGFNIIS 1039
APE LT + D + D++S G + E++ K P F H + F+II+
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK----PLFPGKDHVNQFSIIT 219
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 15/208 (7%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLA-----VGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+G G +GT Y + G L+AVK++ V + ++ E+ L +++H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
+G N + + ++PGG++ + + R + + K + +AYLH+ C
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPE-PVFCKYTKQILDGVAYLHNNC- 122
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL---GTSETHATT--GVAGTFGYVAPEYA 996
V+HRD+K +N++L + L DFG +R L G TH+ + GT ++APE
Sbjct: 123 --VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKAL 1024
K+D++S G + E+ + K L
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
IG G +G YKA + +A+KK+ + + GV EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
S ++L++ YL +L+ + + A + +++ + +AY H RVLH
Sbjct: 70 VHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLH 125
Query: 947 RDVKPSNILLDDDFNAY-LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL-TCRVSDK 1004
RD+KP N+L+D NA L+DFGL+R G T V T Y APE L + S
Sbjct: 126 RDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEILLGSRHYSTP 184
Query: 1005 ADVYSYGVVLLELISDK 1021
D++S G + E+++ K
Sbjct: 185 VDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 2e-17
Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 12/195 (6%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G G FG YKA+ ++A K+ + + ++ + EI L + HPN+V L+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
N ++++ + GG ++ + R + + + AL YLH+ +++HRD
Sbjct: 73 YENNLWILIEFCAGGAVDA-VMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRD 128
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD----- 1003
+K NIL D + L+DFG+S T GT ++APE + C S
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVM-CETSKDRPYD 186
Query: 1004 -KADVYSYGVVLLEL 1017
KADV+S G+ L+E+
Sbjct: 187 YKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-17
Identities = 59/210 (28%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 829 IGSGGFGTTYKAE---ISP---GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + AE + P ILVAVK L + + FH E + L N++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVK 71
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV------------DWKILHKIALDVA 930
G G+ + +++ Y+ G+L F++A AV ++LH IA +A
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH-IAQQIA 130
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG-VAGTFG 989
+ + YL Q +HRD+ N L+ ++ + DFG+SR + +++ + G
Sbjct: 131 AGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 990 YVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++ PE + + + ++DV+S GVVL E+ +
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 3e-17
Identities = 57/191 (29%), Positives = 100/191 (52%), Gaps = 9/191 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G GT Y A +I+ G VA+K++ + + Q + EI + ++PN+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G+E++++ YL GG+L + + T +D + + + AL +LH +V+HR
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALDFLHSN---QVIHR 139
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K NILL D + L+DFG + T E + + GT ++APE K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 1008 YSYGVVLLELI 1018
+S G++ +E++
Sbjct: 199 WSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 57/191 (29%), Positives = 100/191 (52%), Gaps = 9/191 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G G A + S G VAVKK+ + + Q F+ E+ + + +HPN+V +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFN-EVVIMRDYQHPNIVEMYSSY 85
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G+E++++ +L GG L + + T ++ + + + L V AL++LH Q V+HR
Sbjct: 86 LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHAQ---GVIHR 139
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K +ILL D LSDFG + + E + GT ++APE + D+
Sbjct: 140 DIKSDSILLTSDGRVKLSDFGFCAQV-SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198
Query: 1008 YSYGVVLLELI 1018
+S G++++E++
Sbjct: 199 WSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 54/193 (27%), Positives = 99/193 (51%), Gaps = 10/193 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG + + VA+K L G + F AE + ++HP LV L
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAV-V 70
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI--LHKIALDVASALAYLHDQCAPRVLH 946
+ +++I Y+ G+L +F+K T + I L +A +A +A++ + +H
Sbjct: 71 TQEPIYIITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIH 125
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKAD 1006
RD++ +NIL+ + ++DFGL+RL+ +E A G + APE + K+D
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 185
Query: 1007 VYSYGVVLLELIS 1019
V+S+G++L E+++
Sbjct: 186 VWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 3e-17
Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 10/194 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G G FG YKA+ +A K+ + + ++ + EI+ L HP +V L+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
+++++ + PGG ++ I R + + I + AL YLH +++HRD
Sbjct: 80 WDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRD 135
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD----- 1003
+K N+LL D + L+DFG+S GT ++APE + + D
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDY 194
Query: 1004 KADVYSYGVVLLEL 1017
KAD++S G+ L+E+
Sbjct: 195 KADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 3e-17
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 40/212 (18%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGR-FQHGVQQFHA-----EIKTLGNVRHPNLV 881
IGSG +G A G VA+KK + F A EIK L ++RH N++
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKK--ISNVFDD---LIDAKRILREIKLLRHLRHENII 62
Query: 882 TLI-----GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD------WKILHKIALDVA 930
L+ N+++++ + +L IK+ D ++IL
Sbjct: 63 GLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQIL-------- 113
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA---TTGVAGT 987
L YLH + V+HRD+KPSNIL++ + + + DFGL+R + E T V T
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-T 169
Query: 988 FGYVAPEYALTCRVSDKA-DVYSYGVVLLELI 1018
Y APE L+ KA D++S G + EL+
Sbjct: 170 RWYRAPELLLSSSRYTKAIDIWSVGCIFAELL 201
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-17
Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLA---VGRFQHGVQQFHAEIKTLGNVRH 877
D +G+G FG + + A+K +A V R + Q H E + L V H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQ-EQHVHNEKRVLKEVSH 60
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
P ++ L ++++ Y+PGG L F R S A ++ AL YLH
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYASEIVCALEYLH 118
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ +++RD+KP NILLD + + L+DFG ++ L T + GT Y+APE +
Sbjct: 119 SK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRTWTLCGTPEYLAPE-VI 170
Query: 998 TCRVSDKA-DVYSYGVVLLELIS 1019
+ +KA D ++ G+++ E++
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLV 193
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 58/196 (29%), Positives = 97/196 (49%), Gaps = 12/196 (6%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH---PNLVTLI 884
IG G +G Y+ + G +VA+K + + V E+ L +R PN+
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G G +++I Y GG++ +KA + K + I +V AL Y+H V
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GV 122
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD- 1003
+HRD+K +NIL+ + N L DFG++ LL + + +T GT ++APE + D
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEVITEGKYYDT 181
Query: 1004 KADVYSYGVVLLELIS 1019
KAD++S G+ + E+ +
Sbjct: 182 KADIWSLGITIYEMAT 197
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 31/211 (14%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG-----VQQFHAEIKTLGNVRHPNLVT 882
+G+G F + Y+A ++ G L+AVK++ R V+ EI+ + + HP+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIK--ARTSRAVDWKILHKIALDVASALAYLHDQC 940
++G + L ++ GG++ + + AV ++ L+YLH+
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLR----GLSYLHEN- 122
Query: 941 APRVLHRDVKPSNILLDDD-FNAYLSDFGLSRLLGTSETHA---TTGVAGTFGYVAPE-- 994
+++HRDVK +N+L+D ++DFG + L T A + GT ++APE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 995 ----YALTCRVSDKADVYSYGVVLLELISDK 1021
Y +C DV+S G V++E+ + K
Sbjct: 181 RGEQYGRSC------DVWSVGCVIIEMATAK 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 4e-17
Identities = 70/202 (34%), Positives = 103/202 (50%), Gaps = 26/202 (12%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-----H--PNL 880
IGSG G YK G ++AVK++ + G ++ + I L ++ H P +
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR----RTGNKEENKRI--LMDLDVVLKSHDCPYI 76
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V GY + +++F I L L+ +K R + IL K+ + + AL YL ++
Sbjct: 77 VKCYGYFITDSDVF-ICMELMSTCLDKLLK-RIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLS-RLLGTSETHATTGVAGTFGYVAPEYALTC 999
V+HRDVKPSNILLD N L DFG+S RL+ ++ A T AG Y+APE
Sbjct: 135 G--VIHRDVKPSNILLDASGNVKLCDFGISGRLV---DSKAKTRSAGCAAYMAPERIDPP 189
Query: 1000 RVSDK----ADVYSYGVVLLEL 1017
+ K ADV+S G+ L+EL
Sbjct: 190 DPNPKYDIRADVWSLGISLVEL 211
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 4e-17
Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 9/191 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G GT Y A +++ G VA++++ + + Q + EI + ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G+E++++ YL GG+L + + T +D + + + AL +LH +V+HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVV---TETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K NILL D + L+DFG + T E + + GT ++APE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQI-TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 1008 YSYGVVLLELI 1018
+S G++ +E+I
Sbjct: 200 WSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 6e-17
Identities = 79/272 (29%), Positives = 131/272 (48%), Gaps = 14/272 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
D T + +G+G G+ K + I G ++A K + +G +Q E++ + R P +
Sbjct: 6 DLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYI 65
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V+ G + N + + ++ G+L+ K V+ IL KIA+ V L YL++
Sbjct: 66 VSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVE--ILGKIAVAVVEGLTYLYNV- 122
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
R++HRD+KPSNIL++ L DFG+S L S A T V GT Y++PE +
Sbjct: 123 -HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--ADTFV-GTSTYMSPERIQGGK 178
Query: 1001 VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060
+ K+DV+S G+ ++EL K P S+ D +L Q+ L +
Sbjct: 179 YTVKSDVWSLGISIIELALGKF---PFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS 235
Query: 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVV 1092
S +DL D + C ++ + RPT +Q+
Sbjct: 236 SDFPEDLRDFVD---ACLLKDPTERPTPQQLC 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 58/207 (28%), Positives = 104/207 (50%), Gaps = 19/207 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKL---AVG-----RFQHGVQQFHAEIKTLGNVRHPN 879
IGSG FG+ Y S G L+AVK++ +V R + + EI L ++H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V +G + + + Y+PGG++ + A + ++ + L YLH++
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQILKGLNYLHNR 125
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA-----GTFGYVAPE 994
++HRD+K +NIL+D+ +SDFG+S+ L + T A G+ ++APE
Sbjct: 126 ---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182
Query: 995 YALTCRVSDKADVYSYGVVLLELISDK 1021
+ KAD++S G +++E+++ K
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 7e-17
Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 6/202 (2%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG + A + VAVK + G V+ F AE + ++H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAV-V 70
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
+ +++I ++ G+L +F+K+ L + +A +A++ + +HRD
Sbjct: 71 TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRD 127
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
++ +NIL+ ++DFGL+R++ +E A G + APE + K+DV+
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 187
Query: 1009 SYGVVLLELISDKKALDPSFSS 1030
S+G++L+E+++ + P S+
Sbjct: 188 SFGILLMEIVTYGRIPYPGMSN 209
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 7e-17
Identities = 64/220 (29%), Positives = 110/220 (50%), Gaps = 20/220 (9%)
Query: 801 LTLFIDIGVPLTY-ESIIRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF 858
L + +D G P TY ++ I+ IG G G A + S G LVAVKK+ + R
Sbjct: 9 LQMVVDPGDPRTYLDNFIK----------IGEGSTGIVCIATVKSSGKLVAVKKMDL-RK 57
Query: 859 QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD 918
Q + E+ + + +H N+V + G+E++++ +L GG L + + T ++
Sbjct: 58 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV---THTRMN 114
Query: 919 WKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978
+ + + L V AL+ LH Q V+HRD+K +ILL D LSDFG + + E
Sbjct: 115 EEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV-SKEV 170
Query: 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018
+ GT ++APE + D++S G++++E++
Sbjct: 171 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 8e-17
Identities = 70/212 (33%), Positives = 107/212 (50%), Gaps = 35/212 (16%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV--QQFHAEI---KTLGNVRHPNLVT 882
+G G +G +KA + +VA+KK+ F++ Q+ EI + LG+ HPN+V
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKI-FDAFRNATDAQRTFREIMFLQELGD--HPNIVK 71
Query: 883 LIG-YRASGN-EMFLIYNYLPGGNLENFIKARTSRAVDWKIL---HK--IALDVASALAY 935
L+ +A + +++L++ Y+ +L I+A IL HK I + AL Y
Sbjct: 72 LLNVIKAENDKDIYLVFEYMET-DLHAVIRA--------NILEDVHKRYIMYQLLKALKY 122
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG-----VAGTFGY 990
+H V+HRD+KPSNILL+ D L+DFGL+R L E + VA T Y
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA-TRWY 178
Query: 991 VAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
APE L K D++S G +L E++ K
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 51/194 (26%), Positives = 93/194 (47%), Gaps = 6/194 (3%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+GSG FG + + I VA+K + G + F E K + + HP LV L G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE--EDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
++++ ++ G L N+++ R + + +L + DV + YL +HRD
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGK-LSKDMLLSMCQDVCEGMEYLERN---SFIHRD 125
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVY 1008
+ N L+ +SDFG++R + E +++G + PE + S K+DV+
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 1009 SYGVVLLELISDKK 1022
S+GV++ E+ ++ K
Sbjct: 186 SFGVLMWEVFTEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 63/215 (29%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRH 877
DF +G+G FG G A+K K + + V+ E + L ++RH
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVK-LKQVEHVLNEKRILQSIRH 60
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
P LV L G + ++L+ Y+PGG L F R S + A V AL YLH
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGEL--FSHLRKSGRFPEPVARFYAAQVVLALEYLH 118
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+++RD+KP N+LLD D ++DFG ++ + + T + GT Y+APE +
Sbjct: 119 SL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRV---KGRTYT-LCGTPEYLAPE-II 170
Query: 998 TCRVSDKA-DVYSYGVVLLELISDKKALDPSFSSH 1031
+ KA D ++ G+++ E++ A P F
Sbjct: 171 LSKGYGKAVDWWALGILIYEML----AGYPPFFDD 201
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 2e-16
Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G GT YKA ++AVK + + +Q +E++ L P ++ G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
N + + ++ GG+L+ + R + +L +IA+ V L YL + ++LHR
Sbjct: 69 FVENRISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYL---WSLKILHR 119
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
DVKPSN+L++ L DFG+S L S A T V GT Y+APE + +DV
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--AKTYV-GTNAYMAPERISGEQYGIHSDV 176
Query: 1008 YSYGVVLLELISDKKALDPSFSSHG 1032
+S G+ +EL + + G
Sbjct: 177 WSLGISFMELALGRFPYPQIQKNQG 201
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-16
Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 14/202 (6%)
Query: 827 NCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
IG G FG Y + I AVK L V+QF E + + HPN+++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 883 LIG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
L+G + G+ + ++ Y+ G+L NFI++ T K L L VA + YL +
Sbjct: 61 LLGICLPSEGSPLVVL-PYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK- 117
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE---THATTGVAGTFGYVAPEYAL 997
+ +HRD+ N +LD+ F ++DFGL+R + E H TG ++A E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 998 TCRVSDKADVYSYGVVLLELIS 1019
T + + K+DV+S+GV+L EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-16
Identities = 68/283 (24%), Positives = 126/283 (44%), Gaps = 34/283 (12%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHA---EIKTLGNVRHPNL 880
+GSG FGT +K P I VA+K + + + G Q F + +G++ H +
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI---QDRSGRQTFQEITDHMLAMGSLDHAYI 71
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V L+G G + L+ P G+L + ++ ++D + L + +A + YL +
Sbjct: 72 VRLLGI-CPGASLQLVTQLSPLGSLLDHVRQHRD-SLDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPEYALTC 999
++HR++ NILL D ++DFG++ LL + T ++A E L
Sbjct: 130 ---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059
R + ++DV+SYGV + E++S + +A M R +V D+
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS---------------YGAEPYAGM--RPHEVPDLLEKGER 229
Query: 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102
+ P D+ + ++C + + RPT K++ ++ P
Sbjct: 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 2e-16
Identities = 58/206 (28%), Positives = 104/206 (50%), Gaps = 8/206 (3%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQ-QFHAEIKTLGNVRHPNL 880
DF + +G+G G +K P L+ +KL + ++ Q E++ L P +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G S E+ + ++ GG+L+ +K + + +IL K+++ V L YL ++
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREK- 122
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+++HRDVKPSNIL++ L DFG+S L S ++ GT Y++PE
Sbjct: 123 -HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTH 178
Query: 1001 VSDKADVYSYGVVLLELISDKKALDP 1026
S ++D++S G+ L+E+ + + P
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPP 204
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 59/206 (28%), Positives = 89/206 (43%), Gaps = 36/206 (17%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHPNLVTLIG 885
+G GGFG ++ A+K + QQ H +E + L HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58
Query: 886 YRASGNE--MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL-----------DVASA 932
YR ++ ++++ Y GG L W IL L V A
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGEL-------------WTILRDRGLFDEYTARFYIACVVLA 105
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
YLH++ +++RD+KP N+LLD + L DFG ++ L + + T GT YVA
Sbjct: 106 FEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVA 160
Query: 993 PEYALTCRVSDKADVYSYGVVLLELI 1018
PE L D +S G++L EL+
Sbjct: 161 PEIILNKGYDFSVDYWSLGILLYELL 186
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 8/190 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G FG YK + +VA+K + + + ++ EI L P + G
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G ++++I YL GG+ + +K ++ + I ++ L YLH + R +HR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLK---PGPLEETYIATILREILKGLDYLHSE---RKIHR 125
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K +N+LL + + L+DFG++ L ++ T V F ++APE KAD+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDFKADI 184
Query: 1008 YSYGVVLLEL 1017
+S G+ +EL
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 59/213 (27%), Positives = 105/213 (49%), Gaps = 27/213 (12%)
Query: 829 IGSGGFGTTYKAE---ISP---GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + AE +SP +LVAVK L + F E + L N++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHEHIVK 71
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRA---VDW------------KILHKIAL 927
G G+ + +++ Y+ G+L F++A A VD ++LH IA
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH-IAS 130
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG-VAG 986
+AS + YL Q +HRD+ N L+ + + DFG+SR + +++ + G
Sbjct: 131 QIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++ PE + + + ++DV+S+GV+L E+ +
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 4e-16
Identities = 67/227 (29%), Positives = 108/227 (47%), Gaps = 38/227 (16%)
Query: 808 GVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR-FQHGVQQF 865
VP Y+++ + +GSG +G A + G VA+KKL+ R FQ +
Sbjct: 12 EVPDRYQNL----------SPVGSGAYGQVCSAFDTKTGRKVAIKKLS--RPFQSAI--- 56
Query: 866 HA-----EIKTLGNVRHPNLVTLIG--YRASGNEMFL-IY--NYLPGGNLENFIKARTSR 915
HA E++ L ++ H N++ L+ AS E F +Y +L G +L N +K +
Sbjct: 57 HAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK--CQK 114
Query: 916 AVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975
D I + + L Y+H + ++HRD+KPSNI +++D + DFGL+R
Sbjct: 115 LSDDHIQF-LVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-- 168
Query: 976 SETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDK 1021
TG T Y APE L + D++S G ++ EL++ K
Sbjct: 169 --DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 5e-16
Identities = 62/221 (28%), Positives = 109/221 (49%), Gaps = 33/221 (14%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGIL---VAVKKLAVGRFQHGVQQFHAEIKTLGNV-RH 877
D + IG G FG +A I L A+K L ++ + F E++ L + H
Sbjct: 3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHH 62
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFI-KAR-------------TSRAVDWKILH 923
PN++ L+G + +++ Y P GNL +F+ K+R T+ + + L
Sbjct: 63 PNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLL 122
Query: 924 KIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983
+ A DVA+ + YL ++ + +HRD+ N+L+ ++ + ++DFGLSR E +
Sbjct: 123 QFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR---GEEVY---- 172
Query: 984 VAGTFG-----YVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
V T G ++A E + K+DV+S+GV+L E++S
Sbjct: 173 VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 56/202 (27%), Positives = 96/202 (47%), Gaps = 22/202 (10%)
Query: 829 IGSGGFGTT----YKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+GSG FG YK I VA+K L + + E + + + +P +V +I
Sbjct: 3 LGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKAR-----TSRAVDWKILHKIALDVASALAYLHDQ 939
G + M L+ GG L F+ + S V+ ++H++++ + YL +
Sbjct: 62 GVCEAEALM-LVMEMASGGPLNKFLSGKKDEITVSNVVE--LMHQVSM----GMKYLEGK 114
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYAL 997
+HRD+ N+LL + A +SDFGLS+ LG +++ AG + + APE
Sbjct: 115 ---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECIN 171
Query: 998 TCRVSDKADVYSYGVVLLELIS 1019
+ S ++DV+SYG+ + E S
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 8e-16
Identities = 68/287 (23%), Positives = 136/287 (47%), Gaps = 38/287 (13%)
Query: 829 IGSGGFGTTYKAEISPG----ILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTL 883
+G G FG+ + ++S + VAVK + + + +++F +E + + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 884 IG--YRASGNEMF----LIYNYLPGGNLENFI-KART---SRAVDWKILHKIALDVASAL 933
IG + AS + +I ++ G+L +F+ +R + + L K +D+A +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVA 992
YL ++ +HRD+ N +L +D ++DFGLS+ + + + + +A ++A
Sbjct: 127 EYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183
Query: 993 PEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051
E +L RV + K+DV+++GV + E+ + + P +H + ++ LR G
Sbjct: 184 IE-SLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH-EIYD-------YLRHGNR- 233
Query: 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
P D L+++ L C RPT ++ + L+ I
Sbjct: 234 --------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 9e-16
Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 49/226 (21%)
Query: 822 DFNTSN---CIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH 877
+++ + +G G +G Y A ++S + +A+K++ R VQ H EI ++H
Sbjct: 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPE-RDSRYVQPLHEEIALHSYLKH 64
Query: 878 PNLVTLIGYRASGNEMFLIY-NYLPGGNLENFIKARTSRAVDWKILHK-------IALDV 929
N+V +G S N F I+ +PGG+L ++++ W L +
Sbjct: 65 RNIVQYLG-SDSENGFFKIFMEQVPGGSLSALLRSK------WGPLKDNEQTIIFYTKQI 117
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY-----LSDFGLS-RLLGTSETHATTG 983
L YLHD +++HRD+K N+L+ N Y +SDFG S RL G + T
Sbjct: 118 LEGLKYLHDN---QIVHRDIKGDNVLV----NTYSGVVKISDFGTSKRLAGINP--CTET 168
Query: 984 VAGTFGYVAPEYALTCRVSDK--------ADVYSYGVVLLELISDK 1021
GT Y+APE V DK AD++S G ++E+ + K
Sbjct: 169 FTGTLQYMAPE------VIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGIL---VAVKKLAVGRFQHGVQQFHAEIKTLGNV-RH 877
D + IG G FG KA I L A+K++ + + F E++ L + H
Sbjct: 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 67
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKA--------------RTSRAVDWKILH 923
PN++ L+G ++L Y P GNL +F++ T+ + + L
Sbjct: 68 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127
Query: 924 KIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983
A DVA + YL + + +HRD+ NIL+ +++ A ++DFGLSR E +
Sbjct: 128 HFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY---- 177
Query: 984 VAGTFG-----YVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
V T G ++A E + +DV+SYGV+L E++S
Sbjct: 178 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVG----RFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG Y ++ G +A K++ V EI+ L N++H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 884 IG-YRASGNEMFLIY-NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G R + I+ Y+PGG++++ +KA A+ + K + ++YLH
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN-- 125
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT--TGVAGTFGYVAPEYALTC 999
++HRD+K +NIL D N L DFG S+ L T T V GT +++PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 1000 RVSDKADVYSYGVVLLELISDK 1021
KADV+S G ++E++++K
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 23/212 (10%)
Query: 827 NCIGSGGFGTTY----KAEISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN 879
N +GSG FG Y + PG I VAVK L G ++F E + N HPN
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFI-KARTSRA----VDWKILHKIALDVASALA 934
+V L+G ++I + GG+L +++ AR R + K L I LDVA
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 935 YLHDQCAPRVLHRDVKPSNILL-----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
YL +HRD+ N L+ D D + DFGL+R + S+ + G G
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEG-EGLLP 176
Query: 990 --YVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++APE L + + ++DV+S+GV++ E+++
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 69/206 (33%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTL-GNVRHPNLVTLI 884
IG G FG A+ S G AVK L +Q H AE L N++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ +++ + +Y+ GG L F + R A +VASA+ YLH +
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFLEPRARFYAAEVASAIGYLHSL---NI 117
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
++RD+KP NILLD + L+DFGL + G T+ GT Y+APE L D+
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPE-VLRKEPYDR 175
Query: 1005 A-DVYSYGVVLLELISDKKALDPSFS 1029
D + G VL E++ L P +S
Sbjct: 176 TVDWWCLGAVLYEMLY---GLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 1e-15
Identities = 58/191 (30%), Positives = 97/191 (50%), Gaps = 9/191 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G G A E G VAVKK+ + R Q + E+ + + H N+V +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDL-RKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G+E++++ +L GG L + + T ++ + + + L V AL+YLH+Q V+HR
Sbjct: 89 LVGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHNQ---GVIHR 142
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K +ILL D LSDFG + + E + GT ++APE + D+
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGFCAQV-SKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDI 201
Query: 1008 YSYGVVLLELI 1018
+S G++++E+I
Sbjct: 202 WSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-15
Identities = 67/205 (32%), Positives = 97/205 (47%), Gaps = 13/205 (6%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTL-GNVRHPNLVTLI 884
IG G FG A+ + G AVK L +Q H AE L NV+HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ ++++ + +Y+ GG L F + R+ A ++ASAL YLH +
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLHSL---NI 117
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
++RD+KP NILLD + L+DFGL + G + T+ GT Y+APE
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT 176
Query: 1005 ADVYSYGVVLLELISDKKALDPSFS 1029
D + G VL E++ L P +S
Sbjct: 177 VDWWCLGAVLYEMLY---GLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 61/218 (27%), Positives = 99/218 (45%), Gaps = 29/218 (13%)
Query: 819 ATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-- 875
TG F IG G +G YKA G LVA+K ++ EIK N+
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK------IMDIIEDEEEEIKEEYNILR 57
Query: 876 ---RHPNLVTLIG-YRASG-----NEMFLIYNYLPGGNLENFIKA--RTSRAVDWKILHK 924
HPN+ T G + ++++L+ GG++ + +K + + + + +
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117
Query: 925 IALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGV 984
I + LAYLH+ +V+HRD+K NILL + L DFG+S L ++ T +
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI 174
Query: 985 AGTFGYVAPE-----YALTCRVSDKADVYSYGVVLLEL 1017
GT ++APE ++DV+S G+ +EL
Sbjct: 175 -GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 2e-15
Identities = 52/137 (37%), Positives = 73/137 (53%), Gaps = 30/137 (21%)
Query: 115 PFNGFSGEFPPEI--WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIP 172
P++G +F W ++ L LD +G L G +PN+ LR+L+ +NL+ N I G+IP
Sbjct: 403 PWSGADCQFDSTKGKWFIDGLG-LDNQG--LRGFIPNDISKLRHLQSINLSGNSIRGNIP 459
Query: 173 FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEH 232
SL + SLEVL+ LSYN NGSIP LG+ L
Sbjct: 460 PSLGSITSLEVLD------------------------LSYNSFNGSIPESLGQLTS-LRI 494
Query: 233 LDLSGNSLVGRIPSSLG 249
L+L+GNSL GR+P++LG
Sbjct: 495 LNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 2e-15
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 21/204 (10%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G GGFG ++ + G L A KKL R + G + E + L V +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 886 YRASGNEMFLIYNYLPGGNL--------ENFIKARTSRAVDWKILHKIALDVASALAYLH 937
+ ++ L+ + GG+L E RA + + S L +LH
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY------TAQIISGLEHLH 114
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ R+++RD+KP N+LLD+D N +SD GL+ L ++ T G AGT G++APE
Sbjct: 115 QR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQ 170
Query: 998 TCRVSDKADVYSYGVVLLELISDK 1021
D ++ GV L E+I+ +
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVK--KLAVGRFQHGVQQFHAEIKTLGNVRHP 878
DF IGSG +G YKA ++ G L A+K KL G VQQ EI + + +H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ---EIIMMKDCKHS 66
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
N+V G +++++ + GG+L++ I T + +I + ++ + L YLH
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIAY-VSRETLQGLYYLHS 124
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ +HRD+K +NILL D+ + L+DFG+S + T+ GT ++APE A
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVSAQI-TATIAKRKSFIGTPYWMAPEVAAV 180
Query: 999 CR---VSDKADVYSYGVVLLEL 1017
R + D+++ G+ +EL
Sbjct: 181 ERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 16/217 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNL 880
DF +G+G G K P L+ +KL + + Q E+K L P +
Sbjct: 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYI 61
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G S E+ + ++ GG+L+ +K + + IL KI++ V L YL ++
Sbjct: 62 VGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
++HRDVKPSNIL++ L DFG+S L S A + V GT Y++PE
Sbjct: 120 K--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--MANSFV-GTRSYMSPERLQGTH 174
Query: 1001 VSDKADVYSYGVVLLELI--------SDKKALDPSFS 1029
+ ++D++S G+ L+E+ D K L+ F
Sbjct: 175 YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG 211
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 56/194 (28%), Positives = 87/194 (44%), Gaps = 14/194 (7%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRH-PNLVTLI 884
I G FG+ Y A+ S G A+K L ++ V AE + P + L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
S + ++L+ YL GG+ + IK DW + +V + LH + +
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW--AKQYIAEVVLGVEDLHQR---GI 118
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
+HRD+KP N+L+D + L+DFGLSR ++ GT Y+APE L
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDDKM 173
Query: 1005 ADVYSYGVVLLELI 1018
+D +S G V+ E +
Sbjct: 174 SDWWSLGCVIFEFL 187
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 18/206 (8%)
Query: 823 FNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFH----AEIKTLGNVRH 877
+ IG G +GT YKA +++ G VA+KK+ V + G+ A +K L + H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 878 PNLVTLI----GYRASGNEM--FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS 931
PN+V L+ G R + E+ L++ ++ +L ++ + + + + +
Sbjct: 61 PNIVRLLDVCHGPR-TDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLR 118
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
+ +LH + R++HRD+KP NIL+ D ++DFGL+R+ S A T V T Y
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY--SFEMALTSVVVTLWYR 173
Query: 992 APEYALTCRVSDKADVYSYGVVLLEL 1017
APE L + D++S G + EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 64/263 (24%), Positives = 120/263 (45%), Gaps = 23/263 (8%)
Query: 846 ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905
+LVAVK L + F EIK + +++PN++ L+G S + + +I Y+ G+L
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 906 ENFIKARTSRA----------VDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955
F+ R + V L +A+ +AS + YL + +HRD+ N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 956 LDDDFNAYLSDFGLSRLLGTSETHATTGVAG-TFGYVAPEYALTCRVSDKADVYSYGVVL 1014
+ + + ++DFG+SR L + + + G A ++A E L + + +DV+++GV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 1015 LELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLA 1074
E+ + K + +S D I + QG+ +++ S + L
Sbjct: 222 WEMFTLCK--EQPYSLLSDEQVIENTGEFFRNQGR-------QIYLSQTPLCPSPVFKLM 272
Query: 1075 LRCTVETLSTRPTMKQVVQCLKQ 1097
+RC + RPT ++ L++
Sbjct: 273 MRCWSRDIKDRPTFNKIHHFLRE 295
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 53/193 (27%), Positives = 89/193 (46%), Gaps = 6/193 (3%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G FG + + + VAVK +F E + L HPN+V LIG
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++++ + GG+ F++ R + K L ++ + A+ + YL + +HR
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGMEYLESKHC---IHR 118
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPEYALTCRVSDKAD 1006
D+ N L+ + +SDFG+SR +T G+ + APE R S ++D
Sbjct: 119 DLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESD 178
Query: 1007 VYSYGVVLLELIS 1019
V+S+G++L E S
Sbjct: 179 VWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 3e-15
Identities = 57/197 (28%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHPNLVTLIG 885
+G GGFG ++ + G + A KKL R + G + E + L V P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW-KILHKIALDVASALAYLHDQCAPRV 944
S + L+ + + GG+L+ I R ++ +++H A + + +LH +
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA-QITCGILHLHSM---DI 116
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
++RD+KP N+LLDD N LSD GL+ + + T AGT GY+APE S
Sbjct: 117 VYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174
Query: 1005 ADVYSYGVVLLELISDK 1021
D ++ G + E+++ +
Sbjct: 175 VDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 67/234 (28%), Positives = 99/234 (42%), Gaps = 40/234 (17%)
Query: 819 ATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA----EIKTLG 873
D+ +G G FG YKA +I G +VA+KK+ + + G F EIK L
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG---FPITALREIKILK 62
Query: 874 NVRHPNLVTLIG--YRASGNEMFL---IYNYLP------GGNLEN-FIKARTSRAVDWKI 921
++HPN+V LI +Y P G LEN +K S+ K
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQI---KC 119
Query: 922 LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL-------- 973
L+ + YLH+ +LHRD+K +NIL+D+ ++DFGL+R
Sbjct: 120 YMLQLLE---GINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPK 173
Query: 974 --GTSETHATTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDKKAL 1024
G T T + T Y PE L R + D++ G V E+ + + L
Sbjct: 174 GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 59/198 (29%), Positives = 96/198 (48%), Gaps = 11/198 (5%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHA---EIKTLGNVRHPNLVTLI 884
IG G FG Y A+ S +K++ + + V++ A E+ L ++HPN+VT
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP--VKEKEASKKEVILLAKMKHPNIVTFF 65
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+F++ Y GG+L I + + + ++ L ++HD+ ++
Sbjct: 66 ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KI 122
Query: 945 LHRDVKPSNILLDDD-FNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD 1003
LHRD+K NI L + A L DFG++R L S A T GT Y++PE ++
Sbjct: 123 LHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNRPYNN 181
Query: 1004 KADVYSYGVVLLELISDK 1021
K D++S G VL EL + K
Sbjct: 182 KTDIWSLGCVLYELCTLK 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 4e-15
Identities = 75/297 (25%), Positives = 132/297 (44%), Gaps = 50/297 (16%)
Query: 829 IGSGGFGTTYKAEI--------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPN 879
+G G FG AE + + VAVK L + +E++ + + +H N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW--------------KILHKI 925
++ L+G ++++ Y GNL +++AR +D+ K L
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGV 984
A VA + YL Q + +HRD+ N+L+ +D ++DFGL+R + + + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 985 AGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043
++APE AL RV + ++DV+S+GV+L E+ F+ G + I +
Sbjct: 197 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEI----------FTLGGSPYPGIPVEEL 245
Query: 1044 --LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
LL++G D P + ++ + C S RPT KQ+V+ L ++
Sbjct: 246 FKLLKEGHRMD---------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 4e-15
Identities = 50/176 (28%), Positives = 86/176 (48%), Gaps = 15/176 (8%)
Query: 859 QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE-MFLIYNYLPGGNLENFIKARTSRAV 917
+H +F E + HPN+V L+ + +F ++ Y+PG L + A +
Sbjct: 19 EHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPA 78
Query: 918 DWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLL- 973
++ L V ALA H+Q ++HRD+KP NI++ +A + DFG+ LL
Sbjct: 79 GETG--RLMLQVLDALACAHNQ---GIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLP 133
Query: 974 GTSETHA-----TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKAL 1024
G + TT V GT Y APE V+ +D+Y++G++ LE ++ ++ +
Sbjct: 134 GVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 5e-15
Identities = 63/200 (31%), Positives = 93/200 (46%), Gaps = 19/200 (9%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVTLIGY 886
IG G FGT K P G ++AVK++ + ++ ++ + P +V Y
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF--Y 69
Query: 887 RASGNE------MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
A E M L+ L ++ + +IL KIA+ AL YL ++
Sbjct: 70 GALFREGDCWICMELMDISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL 127
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+++HRDVKPSNILLD + N L DFG+S L S A T AG Y+APE
Sbjct: 128 --KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPSA 183
Query: 1001 VSD---KADVYSYGVVLLEL 1017
++DV+S G+ L E+
Sbjct: 184 RDGYDVRSDVWSLGITLYEV 203
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 51/190 (26%), Positives = 91/190 (47%), Gaps = 8/190 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G FG +K + +VA+K + + + ++ EI L P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G ++++I YL GG+ + ++A + K ++ L YLH + + +HR
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSE---KKIHR 125
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K +N+LL + + L+DFG++ L ++ T V F ++APE KAD+
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIQQSAYDSKADI 184
Query: 1008 YSYGVVLLEL 1017
+S G+ +EL
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-15
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 822 DFNTSNCIGSGGFG----TTYKAEISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV 875
DFN +G+G FG TYK E P VA+K+ + Q V +E K L +
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPP--VAIKRFEKSKIIKQKQVDHVFSERKILNYI 88
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
HP V L G + ++L+ ++ GG F++ D + A + Y
Sbjct: 89 NHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFY--AAQIVLIFEY 146
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
L + +++RD+KP N+LLD D ++DFG ++++ T T + GT Y+APE
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEI 199
Query: 996 ALTCRVSDKADVYSYGVVLLELI 1018
L AD ++ G+ + E++
Sbjct: 200 LLNVGHGKAADWWTLGIFIYEIL 222
|
Length = 340 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-15
Identities = 64/194 (32%), Positives = 96/194 (49%), Gaps = 10/194 (5%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFH--AEIKTL-GNVRHPNLVTLI 884
IG G FG A+ G AVK L + +Q H AE L NV+HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ +++ + +++ GG L F + R+ A ++ASAL YLH + +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL--FFHLQRERSFPEPRARFYAAEIASALGYLH---SINI 117
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
++RD+KP NILLD + L+DFGL + G +++ TT GT Y+APE +
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT 176
Query: 1005 ADVYSYGVVLLELI 1018
D + G VL E++
Sbjct: 177 VDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-15
Identities = 59/211 (27%), Positives = 107/211 (50%), Gaps = 14/211 (6%)
Query: 816 IIRATGDFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIK 870
I++ T +F +GSG FGT YK P I VA+K+L ++ E
Sbjct: 3 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61
Query: 871 TLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVA 930
+ +V +P++ L+G + + + LI +P G L ++++ +L+ + +A
Sbjct: 62 VMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLN-WCVQIA 119
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET--HATTGVAGTF 988
+ YL ++ R++HRD+ N+L+ + ++DFGL++LLG E HA G
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PI 175
Query: 989 GYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++A E L + ++DV+SYGV + EL++
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-14
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG-----VQQFHAEIKTLGNVRHPNLVT 882
IG G +GT YKA + G VA+K + V + G V++ A +K L HPN+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREV-ALLKRLEAFDHPNIVR 66
Query: 883 LIGYRASGN-----EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
L+ A+ ++ L++ ++ +L ++ + + + + L +LH
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLH 125
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
C ++HRD+KP NIL+ L+DFGL+R+ S A T V T Y APE L
Sbjct: 126 ANC---IVHRDLKPENILVTSGGQVKLADFGLARIY--SCQMALTPVVVTLWYRAPEVLL 180
Query: 998 TCRVSDKADVYSYGVVLLELISDK 1021
+ D++S G + E+ K
Sbjct: 181 QSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 60/198 (30%), Positives = 87/198 (43%), Gaps = 17/198 (8%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
IG G +G +K G +VA+KK +++ EI+ L ++HPNLV LI
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
++ L++ Y L + R V ++ KI A+ + H +H
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCHKH---NCIH 123
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA- 1005
RDVKP NIL+ L DFG +R+L T VA T Y APE V D
Sbjct: 124 RDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA-TRWYRAPELL----VGDTQY 178
Query: 1006 ----DVYSYGVVLLELIS 1019
DV++ G V EL++
Sbjct: 179 GPPVDVWAIGCVFAELLT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-14
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 549 LSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP 608
+NN I IP IG++ +L+ LD S N+I + P L NL +L LDL+ N L ++P
Sbjct: 122 DLDNNNITDIPPLIGLLKSNLKELDLSDNKIESL-PSPLRNLPNLKNLDLSFNDLS-DLP 179
Query: 609 SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTAL 668
L L L +L L+ N ++ +P I L +LE L+LS+NS+ E+ + NL+NL+ L
Sbjct: 180 KLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGL 237
Query: 669 LLDNNKLSGHLPSGLANVTSLSIFNASFNNLS-----GPFPWNVTTMNCSGVIGNPFLDP 723
L NNKL LP + N+++L + S N +S G N+ ++ S GN +
Sbjct: 238 ELSNNKLED-LPESIGNLSNLETLDLSNNQISSISSLGSLT-NLRELDLS---GNSLSNA 292
Query: 724 CQMYKDISSSELTSSNANSQHNITAPTGSRTED 756
I+ L + +
Sbjct: 293 ---LPLIALLLLLLELLLNLLLTLKALELKLNS 322
|
Length = 394 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 54/212 (25%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 829 IGSGGFGTTYKAEIS-PGI----LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G FG YK + PG+ LVA+K L +F E + + HPN+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKART---------------SRAVDWKILHKIALD 928
+G + +++ YL G+L F+ R+ ++D IA+
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGT 987
+A+ + YL +H+D+ NIL+ + + +SD GLSR + +++ +
Sbjct: 133 IAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189
Query: 988 FGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++ PE + + S +D++S+GVVL E+ S
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-14
Identities = 57/200 (28%), Positives = 92/200 (46%), Gaps = 8/200 (4%)
Query: 823 FNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHPN 879
F +G GGFG ++ + G + A KKL R + G E + L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V+L + + + L+ + GG+L+ I + A ++ L LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
R+++RD+KP NILLDD + +SD GL+ + E G GT GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNE 176
Query: 1000 RVSDKADVYSYGVVLLELIS 1019
R + D ++ G +L E+I+
Sbjct: 177 RYTFSPDWWALGCLLYEMIA 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 2e-14
Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 29/276 (10%)
Query: 829 IGSGGFGTTYKA------EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLV 881
+G+G FG +A + + VAVK L + +E+K + ++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFI-KARTSRAVDWKILHKIALDVASALAYLHDQC 940
L+G G + +I Y G+L NF+ + R S +L + VA +A+L +
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLS-FSYQVAKGMAFLASK- 160
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG-TFGYVAPEYALTC 999
+HRD+ N+LL + DFGL+R + + G A ++APE C
Sbjct: 161 --NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC 218
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059
+ ++DV+SYG++L E+ S P + +I K+ +
Sbjct: 219 VYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI------------KEGYRMAQP 266
Query: 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095
P ++ + C RPT KQ+VQ +
Sbjct: 267 EHAP----AEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 43/106 (40%), Positives = 60/106 (56%), Gaps = 18/106 (16%)
Query: 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980
IL KIA+ + AL YLH + V+HRDVKPSN+L++ + L DFG+S L S A
Sbjct: 104 ILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS--VA 159
Query: 981 TTGVAGTFGYVAPEYALTCRVSD---------KADVYSYGVVLLEL 1017
T AG Y+APE R++ K+DV+S G+ ++EL
Sbjct: 160 KTIDAGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 18/208 (8%)
Query: 827 NCIGSGGFGTTYKAEIS--PG----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
+G G FG Y+ G + VAVK L + F E + H N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD-----WKILHKIALDVASALAY 935
V LIG F++ + GG+L++F++ R K L A DVA Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 936 LHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLSRLLGTSETHATTGVAG-TFGYV 991
L + +HRD+ N LL A ++DFG++R + + + G A ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 992 APEYALTCRVSDKADVYSYGVVLLELIS 1019
PE L + K DV+S+GV+L E+ S
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 60/215 (27%), Positives = 94/215 (43%), Gaps = 43/215 (20%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA----EIKTLGNVRHPNLVTL 883
IG G FG +KA +VA+KK+ + + G F EIK L ++H N+V L
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEG---FPITALREIKILQLLKHENVVNL 76
Query: 884 I-----------GYRASGNEMFLIYNYLP---GGNLENFIKARTSRAVDWKILH--KIAL 927
I Y+ S +L++ + G L N + V + + K+
Sbjct: 77 IEICRTKATPYNRYKGS---FYLVFEFCEHDLAGLLSN-------KNVKFTLSEIKKVMK 126
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA----TTG 983
+ + L Y+H ++LHRD+K +NIL+ D L+DFGL+R S+ T
Sbjct: 127 MLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 984 VAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLEL 1017
V T Y PE L R D++ G ++ E+
Sbjct: 184 VV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 22/222 (9%)
Query: 811 LTYESIIRATGDFNTSNCIGSGGFGTTYK-AEISPGILVAVKKL-AVGRFQHGVQQFHAE 868
L ES+ T + IG G +G YK G L AVK L + ++ +
Sbjct: 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNI 71
Query: 869 IKTLGNVRHPNLVTLIG--YRA---SGNEMFLIYNYLPGGNLENFIKA--RTSRAVDWKI 921
+++L N HPN+V G Y+A G +++L+ GG++ +K + +D +
Sbjct: 72 LQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM 129
Query: 922 LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981
+ I L +LH+ R++HRDVK +NILL + L DFG+S L ++
Sbjct: 130 ISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 186
Query: 982 TGVAGTFGYVAPEYALTCR------VSDKADVYSYGVVLLEL 1017
T V GT ++APE + C + DV+S G+ +EL
Sbjct: 187 TSV-GTPFWMAPE-VIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 69/225 (30%), Positives = 99/225 (44%), Gaps = 34/225 (15%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA----EIKTL 872
R F+ IG G +G YKA + G LVA+KK+ R + + F EIK L
Sbjct: 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKV---RLDNEKEGFPITAIREIKIL 60
Query: 873 GNVRHPNLVTL----------IGYRASGNEMFLIYNYLPG---GNLENFIKARTSRAVDW 919
+ H N+V L + ++ +L++ Y+ G LE S V +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE-------SGLVHF 113
Query: 920 KILHKIAL--DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977
H + + L Y H + LHRD+K SNILL++ L+DFGL+RL + E
Sbjct: 114 SEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE 170
Query: 978 THATTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDK 1021
+ T T Y PE L R DV+S G +L EL + K
Sbjct: 171 SRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 63/267 (23%), Positives = 117/267 (43%), Gaps = 34/267 (12%)
Query: 847 LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLE 906
LVAVK L + + F E+K L + PN+ L+G + +I Y+ G+L
Sbjct: 48 LVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 907 NFIKAR---------TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957
F++ S+++ + L +A +AS + YL +HRD+ N L+
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVG 164
Query: 958 DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP------EYALTCRVSDKADVYSYG 1011
++ ++DFG+SR L +S+ + G A P E L + + K+DV+++G
Sbjct: 165 KNYTIKIADFGMSRNLYSSDYYRVQGRA-----PLPIRWMAWESVLLGKFTTKSDVWAFG 219
Query: 1012 VVLLELISDKKALDPSFSSHGDGFNIISWAS-MLLRQGQVKDVFNAELWASGPHDDLEDM 1070
V L E+++ + + D +I A G+ +++ P + +D+
Sbjct: 220 VTLWEILTLCRE--QPYEHLTD-QQVIENAGHFFRDDGR-------QIYLPRPPNCPKDI 269
Query: 1071 LHLALRCTVETLSTRPTMKQVVQCLKQ 1097
L L C RPT +++ L++
Sbjct: 270 YELMLECWRRDEEDRPTFREIHLFLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 3e-14
Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 29/206 (14%)
Query: 829 IGSGGFGTTYKAEI----SPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+G GG+G ++ G + A+K K + R Q AE L V+HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 882 TLIGYRASGNEMFLIYNYLPGGNL------ENFIKARTSRAVDWKILHKIALDVASALAY 935
LI +G +++LI YL GG L E T+ L +I+L AL +
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFY----LSEISL----ALEH 115
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR--LLGTSETHATTGVAGTFGYVAP 993
LH Q +++RD+KP NILLD + L+DFGL + + + TH GT Y+AP
Sbjct: 116 LHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYMAP 169
Query: 994 EYALTCRVSDKADVYSYGVVLLELIS 1019
E + D +S G ++ ++++
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLT 195
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 58/198 (29%), Positives = 99/198 (50%), Gaps = 13/198 (6%)
Query: 829 IGSGGFGTTYKAEISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+GSG FGT YK P I VA+K L ++ E + V P + L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G + + + L+ +P G L ++++ R + + L + +A ++YL + R
Sbjct: 75 LGICLT-STVQLVTQLMPYGCLLDYVRENKDR-IGSQDLLNWCVQIAKGMSYLEEV---R 129
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET--HATTGVAGTFGYVAPEYALTCRV 1001
++HRD+ N+L+ + ++DFGL+RLL ET HA G ++A E L R
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV-PIKWMALESILHRRF 188
Query: 1002 SDKADVYSYGVVLLELIS 1019
+ ++DV+SYGV + EL++
Sbjct: 189 THQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 23/231 (9%)
Query: 801 LTLFIDIGVPLTY-ESIIRATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF 858
L + +D G P + E+ I+ IG G G A E G VAVK + + R
Sbjct: 10 LRMVVDQGDPRSLLENYIK----------IGEGSTGIVCIAREKHSGRQVAVKMMDL-RK 58
Query: 859 QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD 918
Q + E+ + + +H N+V + G E++++ +L GG L + + +R +
Sbjct: 59 QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS--QTRLNE 116
Query: 919 WKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978
+I + V AL YLH Q V+HRD+K +ILL D LSDFG + + +
Sbjct: 117 EQIA-TVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI-SKDV 171
Query: 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFS 1029
+ GT ++APE + D++S G++++E++ + P FS
Sbjct: 172 PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP---PYFS 219
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-14
Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 11/197 (5%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+GSG FGT YK P I VA+K L +F E + ++ HP+LV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G S + L+ +P G L +++ + ++L + +A + YL ++ R
Sbjct: 75 LGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDN-IGSQLLLNWCVQIAKGMMYLEER---R 129
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLL-GTSETHATTGVAGTFGYVAPEYALTCRVS 1002
++HRD+ N+L+ + ++DFGL+RLL G + + G ++A E + +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189
Query: 1003 DKADVYSYGVVLLELIS 1019
++DV+SYGV + EL++
Sbjct: 190 HQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 4e-14
Identities = 57/214 (26%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 829 IGSGGFGTTYKAE---ISP---GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + AE + P +LVAVK L + Q F E + L ++H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVR 71
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHK----------------IA 926
G G + +++ Y+ G+L F++ S D KIL IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLR---SHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG-VA 985
+AS + YL + +HRD+ N L+ + DFG+SR + +++ + G
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++ PE L + + ++D++S+GVVL E+ +
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQ-------FHAEIKTLGNVRHPNL 880
+G G FG Y + G +AVK++ F Q+ EI+ L N+RH +
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVP---FDPDSQETSKEVNALECEIQLLKNLRHDRI 66
Query: 881 VTLIGYRASGNE--MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
V G E + + Y+PGG++++ +KA A+ + + + ++YLH
Sbjct: 67 VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS 124
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT--TGVAGTFGYVAPEYA 996
++HRD+K +NIL D N L DFG S+ + T T V GT +++PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVI 181
Query: 997 LTCRVSDKADVYSYGVVLLELISDK 1021
KADV+S ++E++++K
Sbjct: 182 SGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 15/202 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVK--KLAVGRFQHGVQQFHAEIKTLGNVRHP 878
D+ +GSG +G YKA + G L AVK KL G +QQ EI + +H
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ---EIFMVKECKHC 66
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
N+V G S ++++ Y GG+L++ I T + +I + + + LAYLH
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAY-VCRETLQGLAYLHS 124
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ +HRD+K +NILL D+ + L+DFG++ + T+ GT ++APE A
Sbjct: 125 KGK---MHRDIKGANILLTDNGDVKLADFGVAAKI-TATIAKRKSFIGTPYWMAPEVAAV 180
Query: 999 CR---VSDKADVYSYGVVLLEL 1017
+ + D+++ G+ +EL
Sbjct: 181 EKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 5e-14
Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 53/241 (21%)
Query: 823 FNTSNCIGSGGFGTTYKA---EISPGILVAVKKLAVGRFQH-GVQQFHA-EIKTLGNVRH 877
+ CIG G +G YKA G A+KK + Q+ G+ Q EI L ++H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 878 PNLVTLIGYRASGNEM--FLIYNYLPGGNLENFIK-ARTSRAVD----------WKILHK 924
N+V+L+ + +L+++Y +L IK R ++ V W+IL+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN- 119
Query: 925 IALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY----LSDFGLSRL-------L 973
+ YLH VLHRD+KP+NIL+ + + D GL+RL L
Sbjct: 120 -------GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPSFSSHG 1032
+ V T Y APE L R KA D+++ G + EL++ L+P F G
Sbjct: 170 ADLD-----PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT----LEPIF--KG 218
Query: 1033 D 1033
Sbjct: 219 R 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 5e-14
Identities = 65/221 (29%), Positives = 107/221 (48%), Gaps = 40/221 (18%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGV--QQFHAEIKTLGNVRHP 878
+ + IG G +G A P G+ VA+KK + F+H Q+ EIK L +H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK--ISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 879 NLVTLI-----GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD-------WKILHKIA 926
N++ ++ S N+++++ + +L I +T + ++IL
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLI--KTQHLSNDHIQYFLYQILR--- 117
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG--- 983
L Y+H + VLHRD+KPSN+LL+ + + + DFGL+R+ H TG
Sbjct: 118 -----GLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTGFLT 167
Query: 984 --VAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
VA T Y APE L + KA D++S G +L E++S++
Sbjct: 168 EYVA-TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 8e-14
Identities = 63/214 (29%), Positives = 102/214 (47%), Gaps = 33/214 (15%)
Query: 829 IGSGGFGTTYKAEISPGIL---VAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLI 884
IG G FG KA I L A+K++ + + F E++ L + HPN++ L+
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIK-----------AR---TSRAVDWKILHKIALDVA 930
G ++L Y P GNL +F++ A T+ + + L A DVA
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG- 989
+ YL + + +HRD+ NIL+ +++ A ++DFGLSR E + V T G
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY----VKKTMGR 172
Query: 990 ----YVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++A E + +DV+SYGV+L E++S
Sbjct: 173 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 8e-14
Identities = 73/297 (24%), Positives = 131/297 (44%), Gaps = 50/297 (16%)
Query: 829 IGSGGFGTTYKAEI--------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPN 879
+G G FG AE + VAVK L + + +E++ + + +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW--------------KILHKI 925
++ L+G +++I Y GNL +++AR +++ K L
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGV 984
VA + YL Q + +HRD+ N+L+ ++ ++DFGL+R + + + TT
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199
Query: 985 AGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043
++APE AL RV + ++DV+S+GV++ E+ F+ G + I +
Sbjct: 200 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEI----------FTLGGSPYPGIPVEEL 248
Query: 1044 --LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
LL++G D P + ++ + C S RPT KQ+V+ L +I
Sbjct: 249 FKLLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 54/196 (27%), Positives = 98/196 (50%), Gaps = 8/196 (4%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G + T YK + G +VA+K++ + + EI + ++H N+V L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSR-AVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+ N++ L++ Y+ +L+ ++ R A+D + + +A+ H+ RVLH
Sbjct: 68 HTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLH 123
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV-SDKA 1005
RD+KP N+L++ L+DFGL+R G + V T Y AP+ L R S
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSI 182
Query: 1006 DVYSYGVVLLELISDK 1021
D++S G ++ E+I+ +
Sbjct: 183 DIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 14/202 (6%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVG----RFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG Y + G +AVK++ V EI+ L N+ H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 884 IGYRASGNE--MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G E + + ++PGG++++ +K+ A+ + K + ++YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN-- 125
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT--TGVAGTFGYVAPEYALTC 999
++HRD+K +NIL D N L DFG S+ L T T V GT +++PE
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 1000 RVSDKADVYSYGVVLLELISDK 1021
KAD++S G ++E++++K
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 26/207 (12%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVG--RFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
IG G FG Y A ++ +VA+KK++ + Q E++ L +RHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHK-----IALDVASALAYLHDQC 940
+ +L+ Y G A V K L + I LAYLH
Sbjct: 83 CYLREHTAWLVMEYCLG-------SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC- 999
+HRD+K NILL + L+DFG + L+ + + GT ++APE L
Sbjct: 136 R---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAMD 187
Query: 1000 --RVSDKADVYSYGVVLLELISDKKAL 1024
+ K DV+S G+ +EL K L
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 2e-13
Identities = 64/213 (30%), Positives = 96/213 (45%), Gaps = 16/213 (7%)
Query: 826 SNCIGSGGFGTT-YKAEISPGILVAVKKLAV-GRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
S +GSG GT +S G AVK + + G + + AE+ L N ++V
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96
Query: 884 ---IGYRASGNE-----MFLIYNYLPGGNLENFIK--ARTSRAVDWKILHKIALDVASAL 933
+ N + L+ +Y G+L IK A+T+R H+ L L
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---REHEAGLLFIQVL 153
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG-TSETHATTGVAGTFGYVA 992
+H + ++HRD+K +NILL + L DFG S++ T GT YVA
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213
Query: 993 PEYALTCRVSDKADVYSYGVVLLELISDKKALD 1025
PE S KAD++S GV+L EL++ K+ D
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 2e-13
Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 21/216 (9%)
Query: 829 IGSGGFGTTYKAE--ISPGILVAVKKLAVGRFQHGVQ----QFHAEIKTLGNVRHPNLVT 882
IG G +G +KA + G VA+K++ V + G+ + A ++ L HPN+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 883 L-----IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
L + ++ L++ ++ +L ++ V + + + + L +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
RV+HRD+KP NIL+ L+DFGL+R+ S A T V T Y APE L
Sbjct: 128 SH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPEVLL 182
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033
+ D++S G + E+ K P F D
Sbjct: 183 QSSYATPVDLWSVGCIFAEMFRRK----PLFRGSSD 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 54/224 (24%), Positives = 95/224 (42%), Gaps = 30/224 (13%)
Query: 829 IGSGGFGTTYKAEISPGILVA---VKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
IG+G FG E G+ A VK+L F E++ + HPN++ +G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKA---RTSRAVDWKILHKIALDVASALAYLHDQCAP 942
L+ + P G+L+N++++ ++ +L ++A +VAS L +LH
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA--- 119
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSR------LLGTSETHATTGVAGTFGYVAPEYA 996
+H D+ N L D + + D+GL+ T + HA ++APE
Sbjct: 120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-----PLRWLAPELV 174
Query: 997 -------LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033
L + K++++S GV + EL + A D + D
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSD 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 2e-13
Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 28/207 (13%)
Query: 828 CIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNLVTLIG 885
IGSG +G A + G VA+KK+ + ++ E+K L + +H N++ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRD 71
Query: 886 -YRASGNEMFLIYNY--LPGGNLENFIKARTS------RAVDWKILHKIALDVASALAYL 936
R G + +Y L +L + I + R +++L L Y+
Sbjct: 72 ILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLR--------GLKYI 123
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET----HATTGVAGTFGYVA 992
H V+HRD+KPSN+L+++D + DFG++R L +S T T VA T Y A
Sbjct: 124 HSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA-TRWYRA 179
Query: 993 PEYALTC-RVSDKADVYSYGVVLLELI 1018
PE L+ + D++S G + E++
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 68/299 (22%), Positives = 124/299 (41%), Gaps = 49/299 (16%)
Query: 829 IGSGGFGTTYKA---EIS--PGIL-VAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG KA + G VAVK L ++ +E L V HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIK--------------ARTS--------RAVDWK 920
L G + + LI Y G+L +F++ R S RA+
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980
L A ++ + YL + +++HRD+ N+L+ + +SDFGLSR + +++
Sbjct: 128 DLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 981 TTGVAGT-FGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIIS 1039
++A E + ++DV+S+GV+L E+++ P + + +
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE----RLFN 240
Query: 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
LL+ G + P + E+M +L L C + RPT + + L+++
Sbjct: 241 ----LLKTGYRME---------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV--QQFHAEIKTLGNVRHPNLVTLIG 885
+GSG +G+ A + G+ VAVKKL+ FQ + ++ + E++ L +++H N++ L+
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS-RPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 886 YRASG------NEMFLIYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLH 937
N+++L+ +L G +L N +K + T V + I + L Y+H
Sbjct: 84 VFTPARSLEEFNDVYLV-THLMGADLNNIVKCQKLTDDHVQFLIYQ-----ILRGLKYIH 137
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ ++HRD+KPSN+ +++D + DFGL+R TG T Y APE L
Sbjct: 138 ---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIML 190
Query: 998 T-CRVSDKADVYSYGVVLLELISDK 1021
+ D++S G ++ EL++ +
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 2e-13
Identities = 50/190 (26%), Positives = 90/190 (47%), Gaps = 8/190 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G FG +K + +VA+K + + + ++ EI L P + G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++++I YL GG+ + ++ +D + I ++ L YLH + + +HR
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLE---PGPLDETQIATILREILKGLDYLHSE---KKIHR 125
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K +N+LL + L+DFG++ L ++ T V F ++APE KAD+
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADI 184
Query: 1008 YSYGVVLLEL 1017
+S G+ +EL
Sbjct: 185 WSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 3e-13
Identities = 48/206 (23%), Positives = 97/206 (47%), Gaps = 18/206 (8%)
Query: 829 IGSGGFGTTYK---AEISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG Y+ + G VA+K + +F E + ++V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKIL--------HKIALDVASALA 934
L+G ++G ++ + G+L++++++R A + L ++A ++A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG-TFGYVAP 993
YL A + +HRD+ N ++ +D + DFG++R + ++ + G ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190
Query: 994 EYALTCRVSDKADVYSYGVVLLELIS 1019
E + K+DV+S+GVVL E+ +
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 3e-13
Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 50/297 (16%)
Query: 829 IGSGGFGTTYKAE---ISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPN 879
+G G FG +AE I + VAVK L + +E++ + + +H N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD--------------WKILHKI 925
++ L+G +++I Y GNL F++AR D +K L
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGV 984
A VA + YL + R +HRD+ N+L+ +D ++DFGL+R + + + T+
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 985 AGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043
++APE AL RV + ++DV+S+G+++ E+ F+ G + I +
Sbjct: 197 RLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEI----------FTLGGSPYPGIPVEEL 245
Query: 1044 --LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
LLR+G D P + ++ L C + RPT KQ+V+ L ++
Sbjct: 246 FKLLREGHRMDK---------PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 4e-13
Identities = 54/213 (25%), Positives = 98/213 (46%), Gaps = 26/213 (12%)
Query: 829 IGSGGFGTTYKAEI---SPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G FG YK + +PG VA+K L ++F E ++HPN+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKART----------SRAVDWKI-----LHKIAL 927
L+G + +I++Y +L F+ R+ + V + +H I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVH-IVT 131
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG- 986
+A+ + +L V+H+D+ N+L+ D N +SD GL R + ++ + G +
Sbjct: 132 QIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLL 188
Query: 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
+++PE + + S +D++SYGVVL E+ S
Sbjct: 189 PIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 5e-13
Identities = 37/89 (41%), Positives = 55/89 (61%), Gaps = 1/89 (1%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L N + G IP DI + + L+ ++ S N I G +P SL ++TSL LDL+ N G I
Sbjct: 424 GLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIG 636
P SL +L LR L+L N+L+G +P+++G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 9/201 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
IG G +GT +KA +VA+K++ + GV EI L ++H N+V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
S ++ L++ Y +L+ + + +D +I+ + LA+ H VLH
Sbjct: 68 LHSDKKLTLVFEYC-DQDLKKYFDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NVLH 122
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA- 1005
RD+KP N+L++ + L+DFGL+R G + V T Y P+ ++ +
Sbjct: 123 RDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSI 181
Query: 1006 DVYSYGVVLLELISDKKALDP 1026
D++S G + EL + + L P
Sbjct: 182 DMWSAGCIFAELANAGRPLFP 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-13
Identities = 66/263 (25%), Positives = 96/263 (36%), Gaps = 61/263 (23%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKL----AVGRFQHGVQQFHAEIKTLGNV 875
DF IG G FG + + G + A+K L + R Q + AE L +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQ--IAHVRAERDILADA 58
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENF-IKARTSRAVDWKILHKIALDVASALA 934
P +V L ++L+ Y+PGG+L N I+ + ++ AL
Sbjct: 59 DSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDV---FPEETARFYIAELVLALD 115
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS------------------------ 970
+H +HRD+KP NIL+D D + L+DFGL
Sbjct: 116 SVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 971 -RLLGTSETHATT---GVAGTFGYVAPE------YALTCRVSDKADVYSYGVVLLELISD 1020
+ GT Y+APE Y L C D +S GV+L E++
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLEC------DWWSLGVILYEMLYG 226
Query: 1021 KKALDPSFSS---HGDGFNIISW 1040
P F S II+W
Sbjct: 227 ----FPPFYSDTLQETYNKIINW 245
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 18/205 (8%)
Query: 829 IGSGGFGTTYKAEISPGI-------LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+G G FG + A+ GI LV VK L + ++ +F E+ + H N+V
Sbjct: 13 LGRGEFGEVFLAKA-KGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWK-----ILHKIAL--DVASALA 934
L+G ++I Y G+L+ F++A S+ K K+AL +A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
+L + R +HRD+ N L+ +S LS+ + SE + ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 995 YALTCRVSDKADVYSYGVVLLELIS 1019
S K+DV+S+GV++ E+ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFT 213
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-13
Identities = 51/179 (28%), Positives = 80/179 (44%), Gaps = 20/179 (11%)
Query: 872 LGNVRHPNLVTLIGYRASGNEMFLIYNYLP--GGNLENFIKARTSRAVDWKILHKIALDV 929
L NV HP+++ + SG ++ LP +L ++ R SR + I +
Sbjct: 111 LQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKR-SRPLPIDQALIIEKQI 166
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
L YLH Q R++HRDVK NI ++D + D G ++ A G+AGT
Sbjct: 167 LEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVE 221
Query: 990 YVAPEYALTCRVSDKADVYSYGVVLLELISDKKAL---------DPSFSSHGDGFNIIS 1039
APE + + KAD++S G+VL E+++ + + S H IIS
Sbjct: 222 TNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIIS 280
|
Length = 357 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 8/202 (3%)
Query: 823 FNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPN 879
F +G GGFG ++ + G + A KKL R + G E + L V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V+L + + + L+ + GG+L+ I + D + A ++ L LH +
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
R+++RD+KP NILLDD + +SD GL+ + ET G GT GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRVGTVGYMAPEVVKNE 176
Query: 1000 RVSDKADVYSYGVVLLELISDK 1021
R + D + G ++ E+I K
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 1e-12
Identities = 63/208 (30%), Positives = 106/208 (50%), Gaps = 23/208 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV--QQFHAEIKTLGNVRHPNLVTLIG 885
+GSG +G+ A + VAVKKL+ FQ + ++ + E++ L +++H N++ L+
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS-RPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 886 Y---RASG---NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
S NE++L+ N L G +L N +K + + D + I + L Y+H
Sbjct: 82 VFTPATSIENFNEVYLVTN-LMGADLNNIVKCQ--KLSDEHVQFLI-YQLLRGLKYIH-- 135
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT- 998
+ ++HRD+KPSN+ +++D + DFGL+R TG T Y APE L
Sbjct: 136 -SAGIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNW 190
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDP 1026
+ D++S G ++ EL+ KAL P
Sbjct: 191 MHYNQTVDIWSVGCIMAELLKG-KALFP 217
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 64/212 (30%), Positives = 91/212 (42%), Gaps = 36/212 (16%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIG 885
IG G FG Y A S +VAVKK++ Q Q E+K L ++HPN + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL---DVAS-------ALAY 935
+ +L+ Y G A D +HK L ++A+ LAY
Sbjct: 89 CYLKEHTAWLVMEYCLGS------------ASDLLEVHKKPLQEVEIAAITHGALQGLAY 136
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
LH ++HRD+K NILL + L+DFG S++ GT ++APE
Sbjct: 137 LHSHN---MIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEV 188
Query: 996 ALTC---RVSDKADVYSYGVVLLELISDKKAL 1024
L + K DV+S G+ +EL K L
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-12
Identities = 76/254 (29%), Positives = 118/254 (46%), Gaps = 19/254 (7%)
Query: 106 LSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
L+ L L L N + + PP I L+ LD+ N + LP+ L NL+ L+L+F
Sbjct: 115 LTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG 224
N + D+P L N +L L+L+GN++ +P + L L LS N + + S L
Sbjct: 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLS 229
Query: 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
+ L L+LS N L +P S+G L TL L +N ++ + LG L L LD+S
Sbjct: 230 N-LKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLS 285
Query: 285 RNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSF-IGSI 343
N L+ +P L+L L + LL+ + + +L+ S N S S
Sbjct: 286 GNSLSNALPLIALLL-----LLLELLLNLLLTLKALELKLN---SILLNNNILSNGETSS 337
Query: 344 PMEITTLSKLRIIW 357
P ++ L L +W
Sbjct: 338 PEALSILESLNNLW 351
|
Length = 394 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 50/297 (16%)
Query: 829 IGSGGFGTTYKAEI------SPGIL--VAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPN 879
+G G FG AE P + VAVK L + + +E++ + + +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW--------------KILHKI 925
++ L+G +++I Y GNL +++AR +++ K L
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGV 984
A VA + YL + + +HRD+ N+L+ +D ++DFGL+R + + + TT
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 985 AGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043
++APE AL R+ + ++DV+S+GV+L E+ F+ G + + +
Sbjct: 203 RLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEI----------FTLGGSPYPGVPVEEL 251
Query: 1044 --LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
LL++G D P + ++ + C S RPT KQ+V+ L +I
Sbjct: 252 FKLLKEGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 56/159 (35%), Positives = 89/159 (55%), Gaps = 20/159 (12%)
Query: 868 EIKTLGNVRHPNLVTL-IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV-----DWKI 921
E L V HP +V L ++ G +++LI ++L GG+L F R S+ V D K
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEG-KLYLILDFLRGGDL--F--TRLSKEVMFTEEDVKF 102
Query: 922 -LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980
L ++AL AL +LH + +++RD+KP NILLD++ + L+DFGLS+ E A
Sbjct: 103 YLAELAL----ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155
Query: 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
+ GT Y+APE + AD +S+GV++ E+++
Sbjct: 156 YS-FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 193
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 8/199 (4%)
Query: 823 FNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHPN 879
F +G GGFG ++ + G + A K+L R + G E + L V
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V L + + + L+ + GG+L+ I + + + A ++ L LH +
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
++RD+KP NILLDD + +SD GL+ + E + G GT GY+APE
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQ 176
Query: 1000 RVSDKADVYSYGVVLLELI 1018
R + D + G ++ E+I
Sbjct: 177 RYTLSPDYWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 16/202 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRH 877
DF +G+G FG A+ G A+K K + + + VQ E L + H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQ-VQHVAQEKSILMELSH 77
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
P +V ++ N ++ + ++ GG L F R + + ++ A YLH
Sbjct: 78 PFIVNMMCSFQDENRVYFLLEFVVGGEL--FTHLRKAGRFPNDVAKFYHAELVLAFEYLH 135
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ +++RD+KP N+LLD+ + ++DFG ++ + T + GT Y+APE +
Sbjct: 136 SK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE-VI 187
Query: 998 TCRVSDKA-DVYSYGVVLLELI 1018
+ KA D ++ GV+L E I
Sbjct: 188 QSKGHGKAVDWWTMGVLLYEFI 209
|
Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-12
Identities = 61/195 (31%), Positives = 90/195 (46%), Gaps = 12/195 (6%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKT---LGNVRHPNLVTLI 884
IG G FG A + AVK L ++ H + L NV+HP LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ ++++ + +Y+ GG L F + R A ++ASAL YLH + +
Sbjct: 63 FSFQTADKLYFVLDYINGGEL--FYHLQRERCFLEPRARFYAAEIASALGYLH---SLNI 117
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGV-AGTFGYVAPEYALTCRVSD 1003
++RD+KP NILLD + L+DFGL + E + TT GT Y+APE
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175
Query: 1004 KADVYSYGVVLLELI 1018
D + G VL E++
Sbjct: 176 TVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 4e-12
Identities = 35/84 (41%), Positives = 51/84 (60%), Gaps = 1/84 (1%)
Query: 577 NQ-ISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI 635
NQ + G +P + L L ++L+GN ++G IP SL + L L L+ N+ G IP S+
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 636 GELRSLEVLELSSNSLSGEVPEGV 659
G+L SL +L L+ NSLSG VP +
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 60/207 (28%), Positives = 90/207 (43%), Gaps = 26/207 (12%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV--QQFHAEIKTLGNVRHPNLVTLIG 885
IG G FG Y A ++ +VA+KK++ Q Q E++ L +RHPN + G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS-----ALAYLHDQC 940
+ +L+ Y G A V K L ++ + + LAYLH
Sbjct: 83 CYLREHTAWLVMEYCLG-------SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH- 134
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC- 999
++HRDVK NILL + L DFG + ++ + GT ++APE L
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX-----FVGTPYWMAPEVILAMD 187
Query: 1000 --RVSDKADVYSYGVVLLELISDKKAL 1024
+ K DV+S G+ +EL K L
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 6e-12
Identities = 65/209 (31%), Positives = 104/209 (49%), Gaps = 24/209 (11%)
Query: 827 NCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA----EIKTLGNVRHPNLV 881
N I G +G Y+A + G +VA+KKL + + + G F EI L ++HPN+V
Sbjct: 11 NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67
Query: 882 TL--IGYRASGNEMFLIYNYLP---GGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
T+ + ++ ++++++ Y+ +E + V K L L S +A+L
Sbjct: 68 TVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEV--KCLMLQLL---SGVAHL 122
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
HD +LHRD+K SN+LL++ + DFGL+R G+ T V T Y APE
Sbjct: 123 HDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWYRAPELL 178
Query: 997 L-TCRVSDKADVYSYGVVLLELISDKKAL 1024
L S D++S G + EL++ KK L
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-12
Identities = 68/298 (22%), Positives = 123/298 (41%), Gaps = 47/298 (15%)
Query: 829 IGSGGFGTTYKAEI-SP----------------GILVAVKKLAVGRFQHGVQQFHAEIKT 871
+G G FG + E+ +P +LVAVK L ++ F E+K
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 872 LGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSR---------------- 915
L ++ PN++ L+G + + +I Y+ G+L F+ +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 916 -AVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974
A+ + L +AL +AS + YL + +HRD+ N L+ ++ ++DFG+SR L
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 975 TSETHATTGVAG-TFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033
+ + G A ++A E L + + +DV+++GV L E++ K + D
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE--QPYGELTD 247
Query: 1034 GFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQV 1091
+I A R Q + V+ P + + L L+C RP+ +
Sbjct: 248 E-QVIENAGEFFRD-QGRQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDI 298
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 1e-11
Identities = 36/98 (36%), Positives = 52/98 (53%)
Query: 112 LSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDI 171
L L G G P +I L L+ +++ GN + G +P + +L VL+L++N +G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 172 PFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLF 209
P SL SL +LNL GN + G +P LG L R F
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASF 520
|
Length = 623 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 55/211 (26%), Positives = 93/211 (44%), Gaps = 19/211 (9%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
+G G +G K + G +VA+KK V++ EI+ L +RH NLV LI
Sbjct: 9 VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68
Query: 887 RASGNEMFLIYNYLPG---GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
++L++ ++ +LE + +D + K + + + H
Sbjct: 69 FRRKKRLYLVFEFVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHSH---N 120
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD 1003
++HRD+KP NIL+ L DFG +R L T VA T Y APE +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA-TRWYRAPELLVGDTKYG 179
Query: 1004 KA-DVYSYGVVLLELISDKKALDPSFSSHGD 1033
+A D+++ G ++ E+++ +P F D
Sbjct: 180 RAVDIWAVGCLVTEMLTG----EPLFPGDSD 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 67/211 (31%), Positives = 99/211 (46%), Gaps = 29/211 (13%)
Query: 829 IGSGGFGTTYKA---EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVR-HPNLVT 882
+G G +G A E S VA+KK+ F + A E+K L + R H N+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKIT-NVFSKKILAKRALRELKLLRHFRGHKNITC 66
Query: 883 L----IGYRASGNEMFLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYL 936
L I + + NE++L Y L +L I++ + A +++I L Y+
Sbjct: 67 LYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQIL----CGLKYI 121
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT-----TGVAGTFGYV 991
H + VLHRD+KP N+L++ D + DFGL+R G SE T T Y
Sbjct: 122 H---SANVLHRDLKPGNLLVNADCELKICDFGLAR--GFSENPGENAGFMTEYVATRWYR 176
Query: 992 APEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
APE L+ + KA DV+S G +L EL+ K
Sbjct: 177 APEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 15/208 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPG-------ILVAVKKLAVGRFQHGVQQFHAEIKTLGN 874
+F +G+G +G + G + +KK + + + E + L +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 875 VRH-PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASAL 933
+R P LVTL + ++ LI +Y+ GG L + R R + ++ ++ AL
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE-RFKEQEVQIYSG-EIVLAL 118
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+LH +++RD+K NILLD + + L+DFGLS+ E GT Y+AP
Sbjct: 119 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAP 175
Query: 994 EYALTCRVS-DKA-DVYSYGVVLLELIS 1019
+ DKA D +S GV++ EL++
Sbjct: 176 DIVRGGDGGHDKAVDWWSMGVLMYELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 56/180 (31%), Positives = 85/180 (47%), Gaps = 22/180 (12%)
Query: 850 VKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVTLIGYRASGNEMFLIYNYLPGGNL--- 905
+KK + + + E + L VR P LVTL + ++ LI +Y+ GG L
Sbjct: 36 LKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTH 95
Query: 906 ----ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961
E+F ++ R IA ++ AL +LH +++RD+K NILLD + +
Sbjct: 96 LYQREHFTESEV-RVY-------IA-EIVLALDHLHQL---GIIYRDIKLENILLDSEGH 143
Query: 962 AYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKA-DVYSYGVVLLELIS 1019
L+DFGLS+ E GT Y+APE DKA D +S GV+ EL++
Sbjct: 144 VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLT 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 57/196 (29%), Positives = 93/196 (47%), Gaps = 14/196 (7%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLA--VGRFQHGVQQFHAEIKTLGNV-RHPNLVTLI 884
+G G FG + AE+ A+K L V V+ E + L HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ +F + YL GG+L I+ + D A ++ L +LH + +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDLMFHIQ--SCHKFDLPRATFYAAEIICGLQFLHSK---GI 117
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSR--LLGTSETHATTGVAGTFGYVAPEYALTCRVS 1002
++RD+K NILLD D + ++DFG+ + +LG ++ T GT Y+APE L + +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPEILLGQKYN 174
Query: 1003 DKADVYSYGVVLLELI 1018
D +S+GV+L E++
Sbjct: 175 TSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 2e-11
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPG-------ILVAVKKLAVGRFQHGVQQFHAEIKTLGN 874
+F +G+G +G + G + ++K A+ + V+ E L +
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 875 VRH-PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASAL 933
VR P LVTL + ++ LI +Y+ GG + + R + + D + + ++ AL
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY--SGEIILAL 118
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+LH +++RD+K NILLD + + L+DFGLS+ + E T GT Y+AP
Sbjct: 119 EHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 994 EYALTCRVSDKA-DVYSYGVVLLELIS 1019
E KA D +S G+++ EL++
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLT 202
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 17/199 (8%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G +G+ YK P G+ +A+K++ + + Q E+ L P +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 888 ASGNEMFLIYNYLPGGNLEN-FIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+++ Y+ G+L+ + + + +L +I V L +L ++ ++H
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIH 126
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY--------ALT 998
RDVKP+N+L++ + L DFG+S L S A T + G Y+APE T
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--LAKTNI-GCQSYMAPERIKSGGPNQNPT 183
Query: 999 CRVSDKADVYSYGVVLLEL 1017
V +DV+S G+ +LE+
Sbjct: 184 YTVQ--SDVWSLGLSILEM 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 56/212 (26%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 829 IGSGGFG-TTYKAEISPGILVAVKKL----AVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G +G + + G +KKL A R + +Q E + L ++HPN+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ---EAQLLSQLKHPNIVA- 63
Query: 884 IGYRAS----GNEMFLIYNYLPGGNLENFIKART------SRAVDWKILHKIALDVASAL 933
YR S ++++ + GG+L + +K + ++ V+W + +A AL
Sbjct: 64 --YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFV------QIAMAL 115
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
YLH++ +LHRD+K N+ L + D G++R+L A+T + GT Y++P
Sbjct: 116 QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSP 171
Query: 994 EYALTCRVSDKADVYSYGVVLLELISDKKALD 1025
E + K+DV++ G + E+ + K A +
Sbjct: 172 ELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 2e-11
Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 21/211 (9%)
Query: 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAV-GRFQHGVQQFHAEIKTLGNV-RH 877
G F +G+G +G YK + G L A+K + V G + ++Q EI L H
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ---EINMLKKYSHH 62
Query: 878 PNLVTLIGYRASGN------EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS 931
N+ T G N +++L+ + G++ + IK + + + I ++
Sbjct: 63 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
L++LH +V+HRD+K N+LL ++ L DFG+S L + T + GT ++
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWM 178
Query: 992 APEYALTCRVSD-----KADVYSYGVVLLEL 1017
APE D K+D++S G+ +E+
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEM 209
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 30/214 (14%)
Query: 828 CIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLI 884
IG G +G A+ S VA+KK+A F + + EIK L ++ H N++ +
Sbjct: 12 PIGRGAYGIVCSAKNSETNEKVAIKKIA-NAFDNRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 885 G-----YRASGNEMFLIYNYLPGGNLENFIKARTSRAVD------WKILHKIALDVASAL 933
+R + N+++++Y L +L I++ + + D +++L L
Sbjct: 71 DIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLR--------GL 121
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
Y+H + VLHRD+KPSN+LL+ + + + DFGL+R T V T Y AP
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAP 177
Query: 994 EYALTCRVSDKA-DVYSYGVVLLELISDKKALDP 1026
E L C A DV+S G + EL+ +K L P
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 59/195 (30%), Positives = 92/195 (47%), Gaps = 10/195 (5%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLA--VGRFQHGVQQFHAEIKTLGNVR-HPNLVTLI 884
+G G FG A + G L AVK L V V+ E + L R HP L L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ + +F + ++ GG+L I+ SR D A ++ SAL +LHD+ +
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDLMFHIQ--KSRRFDEARARFYAAEITSALMFLHDK---GI 117
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
++RD+K N+LLD + + L+DFG+ + G T+ GT Y+APE
Sbjct: 118 IYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPS 176
Query: 1005 ADVYSYGVVLLELIS 1019
D ++ GV+L E++
Sbjct: 177 VDWWAMGVLLYEMLC 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 26/207 (12%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV--QQFHAEIKTLGNVRHPNLVTLIG 885
IG G FG Y A ++ +VA+KK++ Q Q E+K L ++HPN + G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS-----ALAYLHDQC 940
+ +L+ Y G A V K L ++ + + LAYLH
Sbjct: 93 CYLREHTAWLVMEYCLG-------SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH- 144
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC- 999
++HRD+K NILL + L+DFG + + + + GT ++APE L
Sbjct: 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS-----FVGTPYWMAPEVILAMD 197
Query: 1000 --RVSDKADVYSYGVVLLELISDKKAL 1024
+ K DV+S G+ +EL K L
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 21/211 (9%)
Query: 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHP 878
G F +G+G +G YK + G L A+K + V + ++ EI L H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE--EEIKLEINMLKKYSHHR 73
Query: 879 NLVTLIGY------RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASA 932
N+ T G ++++L+ + G++ + +K A+ + I ++
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
LA+LH A +V+HRD+K N+LL ++ L DFG+S L + T + GT ++A
Sbjct: 134 LAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 189
Query: 993 PEYALTCRVSD------KADVYSYGVVLLEL 1017
PE + C + ++D++S G+ +E+
Sbjct: 190 PE-VIACDENPDATYDYRSDIWSLGITAIEM 219
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 8/199 (4%)
Query: 823 FNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPN 879
F +G GGFG ++ + G + A KKL R + + A E + L V
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V+L + + + L+ + GG+L+ I + D + A ++ L L +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
R+++RD+KP NILLDD + +SD GL+ + ET G GT GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNE 176
Query: 1000 RVSDKADVYSYGVVLLELI 1018
+ + D + G ++ E+I
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 5e-11
Identities = 58/214 (27%), Positives = 93/214 (43%), Gaps = 25/214 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFH-AEIKTLGNVRH-PNLVTLIG 885
IG G +G YKA + + G LVA+KK + + G+ EI L + +V L+
Sbjct: 9 IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68
Query: 886 YRASGNE-----MFLIYNYLPGGNLENFIKA---RTSRAVDWKILHKIALDVASALAYLH 937
+ ++L++ YL +L+ F+ + R + K + + +A+ H
Sbjct: 69 VEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAY-LSDFGLSRLLGT---SETHATTGVAGTFGYVAP 993
V+HRD+KP N+L+D ++D GL R S TH T Y AP
Sbjct: 128 KH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV----TLWYRAP 180
Query: 994 EYALTCR-VSDKADVYSYGVVLLELISDKKALDP 1026
E L S D++S G + E+ K+ L P
Sbjct: 181 EVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFP 213
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 5e-11
Identities = 61/220 (27%), Positives = 89/220 (40%), Gaps = 47/220 (21%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFH--------AEIKTLGNVR-HP 878
IG G F KA G A+K + + F EI+ L + HP
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMK--------KHFKSLEQVNNLREIQALRRLSPHP 58
Query: 879 NLVTLIG--YRASGNEMFLIYNYLPGGNLENFIKAR-------TSRAVDWKILHKIALDV 929
N++ LI + + L++ L NL IK R ++ +++L
Sbjct: 59 NILRLIEVLFDRKTGRLALVFE-LMDMNLYELIKGRKRPLPEKRVKSYMYQLLK------ 111
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
+L ++H + HRD+KP NIL+ DD L+DFG R G T T
Sbjct: 112 --SLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTEYISTRW 163
Query: 990 YVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSF 1028
Y APE LT K D+++ G V E++S L P F
Sbjct: 164 YRAPECLLTDGYYGPKMDIWAVGCVFFEILS----LFPLF 199
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 6e-11
Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 829 IGSGGFGTTYKAEISPG---ILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLI 884
+G G FG+ + +++ + VAVK + + ++ F +E + HPN++ LI
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 885 G--YRASGNEMF----LIYNYLPGGNLENFIKARTSRAVDW------KILHKIALDVASA 932
G + +E + +I ++ G+L +F+ SR D ++L K D+AS
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFL--LYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYV 991
+ YL + +HRD+ N +L+++ N ++DFGLS+ + + + +A ++
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 992 APEYALTCRV-SDKADVYSYGVVLLEL 1017
A E +L RV + K+DV+S+GV + E+
Sbjct: 182 AIE-SLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 8e-11
Identities = 76/318 (23%), Positives = 126/318 (39%), Gaps = 70/318 (22%)
Query: 807 IGVPLTYESIIRATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKL-AVGRFQHGVQQ 864
G + ++S + + IG G +G +K G AVK L + ++
Sbjct: 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEA 63
Query: 865 FHAEIKTLGNVRHPNLVTLIGY-----RASGNEMFLIYNYLPGGNLENFIKA------RT 913
+ +K L + HPN+V G +G++++L+ GG++ + +K R
Sbjct: 64 EYNILKALSD--HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 914 SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973
+ ILH+ + L +LH + +HRDVK +NILL + L DFG+S L
Sbjct: 122 EEPIIAYILHEALM----GLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174
Query: 974 GTSETHATTGVAGTFGYVAPEY-----ALTCRVSDKADVYSYGVVLLELISDKKALDPSF 1028
++ T V GT ++APE L + DV+S G+ +EL
Sbjct: 175 TSTRLRRNTSV-GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL----------- 222
Query: 1029 SSHGDG-------------FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLAL 1075
GDG F I L Q ELW++ + D +
Sbjct: 223 ---GDGDPPLADLHPMRALFKIPRNPPPTLHQ--------PELWSN----EFNDFIR--- 264
Query: 1076 RCTVETLSTRPTMKQVVQ 1093
+C + RPT+ ++Q
Sbjct: 265 KCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 8e-11
Identities = 44/144 (30%), Positives = 71/144 (49%), Gaps = 6/144 (4%)
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
+HP L L + + +F + Y+ GG+L + + SR D A +V AL +
Sbjct: 54 KHPFLTALHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMF 111
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
LH V++RD+K NILLD + + L+DFG+ + G TT GT Y+APE
Sbjct: 112 LHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEI 167
Query: 996 ALTCRVSDKADVYSYGVVLLELIS 1019
D ++ GV++ E+++
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMA 191
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 9e-11
Identities = 49/195 (25%), Positives = 90/195 (46%), Gaps = 8/195 (4%)
Query: 829 IGSGGFGTTYKAEIS-PG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+G+G FG + + P + VA+ L G + F AE TLG H N+V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G GN M ++ Y+ G L++F++ + V +++ + +AS + YL +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLP-GLASGMKYLSEM---GY 128
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
+H+ + +L++ D +S F + + + T + APE S
Sbjct: 129 VHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188
Query: 1005 ADVYSYGVVLLELIS 1019
+DV+S+G+V+ E++S
Sbjct: 189 SDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 47/187 (25%), Positives = 88/187 (47%), Gaps = 25/187 (13%)
Query: 848 VAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM-FLIYNYLPGGNLE 906
V VK + + V E L + H N++ ++ E F++Y Y+ GNL+
Sbjct: 38 VFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLK 97
Query: 907 NFIK------ARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF 960
F++ A +A+ + L +A+ +A ++YLH + V+H+D+ N ++D++
Sbjct: 98 LFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEEL 154
Query: 961 NAYLSDFGLSRLLGTSETHATTGVAGTFG--------YVAPEYALTCRVSDKADVYSYGV 1012
++D LSR L + H G ++A E + S +DV+S+GV
Sbjct: 155 QVKITDNALSRDLFPMDYHC-------LGDNENRPVKWMALESLVNKEYSSASDVWSFGV 207
Query: 1013 VLLELIS 1019
+L EL++
Sbjct: 208 LLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-10
Identities = 48/157 (30%), Positives = 77/157 (49%), Gaps = 8/157 (5%)
Query: 867 AEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIA 926
+E+ L H +V S +++ LI Y GG+L IK R + ++ +++
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQ-EYEVG 172
Query: 927 L---DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET-HATT 982
L + AL +H + ++HRD+K +NI L L DFG S+ S + +
Sbjct: 173 LLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
GT Y+APE R S KAD++S GV+L EL++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 1e-10
Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 17/149 (11%)
Query: 877 HPNLVTLIGYRASG--NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALA 934
+PN + L Y + LI +Y+ G+L + +K + + KI + AL
Sbjct: 68 NPNFIKL--YYSVTTLKGHVLIMDYIKDGDLFDLLK--KEGKLSEAEVKKIIRQLVEALN 123
Query: 935 YLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
LH ++H D+K N+L D YL D+GL +++GT + GT Y +P
Sbjct: 124 DLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 994 EYALTCRVSDKA-DVYSYGVVLLELISDK 1021
E + D + D ++ GV+ EL++ K
Sbjct: 176 E-KIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-10
Identities = 21/39 (53%), Positives = 28/39 (71%), Gaps = 1/39 (2%)
Query: 7 EKTILLEFKNSV-SDPSGILSSWQTNTSSHCSWFGVSCD 44
++ LL FK+S+ DPSG LSSW ++S CSW GV+CD
Sbjct: 4 DRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-10
Identities = 57/197 (28%), Positives = 84/197 (42%), Gaps = 17/197 (8%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKL------AVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+G G FG E + G A+K L A H V E + L N RHP L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV----TESRVLQNTRHPFLT 58
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L + + + + Y GG L F R + ++ SAL YLH +
Sbjct: 59 ALKYAFQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSR-- 114
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
V++RD+K N++LD D + ++DFGL + G S+ GT Y+APE
Sbjct: 115 -DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDY 172
Query: 1002 SDKADVYSYGVVLLELI 1018
D + GVV+ E++
Sbjct: 173 GRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 6/151 (3%)
Query: 868 EIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL 927
E + L N RHP L +L + + + + Y+ GG L F R
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGEL--FFHLSRERVFSEDRTRFYGA 102
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT 987
++ SAL YLH + ++++RD+K N++LD D + ++DFGL + G ++ GT
Sbjct: 103 EIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKTFCGT 158
Query: 988 FGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018
Y+APE D + GVV+ E++
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 26/203 (12%)
Query: 829 IGSGGFGTTY----KAEISPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FGT Y K ++ L +K++ VG + Q + E + L + HP +V
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFI--------KARTSRAVDWKILHKIALDVASALAY 935
+ +I Y G +L+ + ++ +W I + + Y
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH------Y 121
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
+H + R+LHRD+K NI L ++ + DFG+SRLL S ATT GT Y++PE
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMSPE- 175
Query: 996 ALTCRVSD-KADVYSYGVVLLEL 1017
AL + D K+D++S G +L E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 23/189 (12%)
Query: 846 ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905
+LVAVK L ++ F EIK + ++ PN++ L+ + + + +I Y+ G+L
Sbjct: 47 VLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 906 ENFI---------KARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956
F+ + + + L +A +AS + YL + +HRD+ N L+
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163
Query: 957 DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP------EYALTCRVSDKADVYSY 1010
++ ++DFG+SR L + + + G A V P E L + + +DV+++
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRA-----VLPIRWMSWESILLGKFTTASDVWAF 218
Query: 1011 GVVLLELIS 1019
GV L E+++
Sbjct: 219 GVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 39/147 (26%), Positives = 71/147 (48%), Gaps = 14/147 (9%)
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFI----KARTSRAVDWKILHKIALDVAS 931
+HP L L + + +F + Y+ GG+L I + RA + A ++
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFY------AAEIVL 107
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
L +LH++ +++RD+K N+LLD + + ++DFG+ + G T+ GT Y+
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYI 163
Query: 992 APEYALTCRVSDKADVYSYGVVLLELI 1018
APE D ++ GV+L E++
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 3e-10
Identities = 36/83 (43%), Positives = 50/83 (60%), Gaps = 1/83 (1%)
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW 274
L G IP+++ K R+L+ ++LSGNS+ G IP SLG L L L N N IP LG
Sbjct: 430 LRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 275 LRKLEVLDVSRNRLNGLIPTELG 297
L L +L+++ N L+G +P LG
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 829 IGSGGFGTT----YKAEISPGILVAVKKLAVGRFQHGVQ-QFHAEIKTLGNVRHPNLVTL 883
+GSG FGT YK + S VAVK L ++ + E + + +P +V +
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
IG + + M L+ G L F++ ++ V K + ++ V+ + YL +
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQ--KNKHVTEKNITELVHQVSMGMKYLEET---N 115
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTCRV 1001
+HRD+ N+LL A +SDFGLS+ LG E + G + + APE +
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 1002 SDKADVYSYGVVLLELIS 1019
S K+DV+S+GV++ E S
Sbjct: 176 SSKSDVWSFGVLMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 74/303 (24%), Positives = 121/303 (39%), Gaps = 58/303 (19%)
Query: 823 FNTSNCIGSGGFGTT----YKAEISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRH 877
F +G G FG+ K+E VAVK L F +++F E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 878 PNLVTLIGY----RASGNEM--FLIYNYLPGGNLENFIKARTSR------AVDWKILHKI 925
PN++ LIG RA G +I ++ G+L F+ SR + + L +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLM--SRIGEEPFTLPLQTLVRF 118
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+D+AS + YL + +HRD+ N +L+++ ++DFGLS+ +
Sbjct: 119 MIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKI------------ 163
Query: 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD--GFNIISWASM 1043
Y Y C A + LE ++D +++H D F + W M
Sbjct: 164 ----YSGDYYRQGC-----ASKLPVKWLALESLADN-----VYTTHSDVWAFGVTMWEIM 209
Query: 1044 LLRQGQVKDVFNAELWA---SG-----PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095
Q V N+E++ G P D LED+ L +C RP+ + + L
Sbjct: 210 TRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQL 269
Query: 1096 KQI 1098
+ I
Sbjct: 270 ELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 43/143 (30%), Positives = 73/143 (51%), Gaps = 6/143 (4%)
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
HP L L + +F + YL GG+L I+ +S D A ++ L +
Sbjct: 54 EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQ--SSGRFDEARARFYAAEIICGLQF 111
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
LH + +++RD+K N+LLD D + ++DFG+ + E A+T GT Y+APE
Sbjct: 112 LHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYIAPEI 167
Query: 996 ALTCRVSDKADVYSYGVVLLELI 1018
+ ++ D +S+GV+L E++
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-10
Identities = 55/206 (26%), Positives = 90/206 (43%), Gaps = 13/206 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKL--AVGRFQHGVQQFHAEIKTLGNVRHP 878
DF+ + +G G FG E + G + A+K + +V Q V F E L P
Sbjct: 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSP 61
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
+ L + ++L+ Y PGG+L + + R D + ++ A+ +H
Sbjct: 62 WIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-NRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+HRD+KP N+L+D + L+DFG + L ++ + GT Y+APE T
Sbjct: 121 M---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTT 177
Query: 999 CRVSDKA------DVYSYGVVLLELI 1018
K D +S GV+ E+I
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-10
Identities = 35/86 (40%), Positives = 47/86 (54%), Gaps = 3/86 (3%)
Query: 233 LDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLI 292
L L L G IP+ + K + L+++ L N + IP LG + LEVLD+S N NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 293 PTELGNCVELSVLVLSNLFDPLLSGR 318
P LG +L+ L + NL LSGR
Sbjct: 483 PESLG---QLTSLRILNLNGNSLSGR 505
|
Length = 623 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 5e-10
Identities = 58/230 (25%), Positives = 94/230 (40%), Gaps = 38/230 (16%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVK----KLAVGRFQHGVQQFHAEIKTLGNVR 876
F +G G G + G L A+K K + R + V++ E + L +
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK--VKRVLTEQEILATLD 59
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
HP L TL + + L+ +Y PGG L ++ + + + ++ A +V AL YL
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG---------------------- 974
H +++RD+KP NILL + + LSDF LS+
Sbjct: 120 HLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 975 TSETHATTGVA------GTFGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018
SET + GT Y+APE D ++ G++L E++
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-10
Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 829 IGSGGFGTTYKAEISP--GILVAVKKLAVGRFQHGV--QQFHAEIKTLGNVRHPNLVTLI 884
IG G FG + + P G VA+KK+ FQ+ V ++ E+K L +H N+++ +
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65
Query: 885 GYRASGN-----EMFLIYNYLPGGNLENFIKARTSRAVD------WKILHKIALDVASAL 933
+ E++++ L +L I + + D ++IL L
Sbjct: 66 DILQPPHIDPFEEIYVVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILR--------GL 116
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
YLH + +LHRD+KP N+L++ + + DFGL+R+ E+ T T Y AP
Sbjct: 117 KYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 994 EYALTCR-VSDKADVYSYGVVLLELISDK 1021
E + R + D++S G + EL+ +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 8e-10
Identities = 50/203 (24%), Positives = 88/203 (43%), Gaps = 17/203 (8%)
Query: 829 IGSGGFGTTYKAEISPGI---LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
IG+G FG E++ G V VK+L V +F E + +++H NL+ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKIALDVASALAYLHDQCAP 942
L+ + P G+L+ ++++ D L ++A ++A L +LH
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN--- 119
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPEYA----- 996
+H D+ N LL D + D+GLS + + T ++APE
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHG 179
Query: 997 --LTCRVSDKADVYSYGVVLLEL 1017
L + +++V+S GV + EL
Sbjct: 180 NLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 34/206 (16%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
IGSG G A + GI VAVKKL+ FQ+ Q HA E+ L V H N+++
Sbjct: 29 IGSGAQGIVCAAFDTVLGINVAVKKLS-RPFQN---QTHAKRAYRELVLLKCVNHKNIIS 84
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKAR-TSRAVDWKILHKIALDV-ASALAYLHDQ- 939
L+ + P +LE F +D + I +++ ++YL Q
Sbjct: 85 LLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 940 -CAPR------VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
C + ++HRD+KPSNI++ D + DFGL+R T+ T T Y A
Sbjct: 133 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRA 190
Query: 993 PEYALTCRVSDKADVYSYGVVLLELI 1018
PE L + D++S G ++ EL+
Sbjct: 191 PEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 43/175 (24%), Positives = 85/175 (48%), Gaps = 6/175 (3%)
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
HP LV L + + +F + Y+ GG+L + R + + + +++ AL YL
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYL 112
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H++ +++RD+K N+LLD + + L+D+G+ + G T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEIL 168
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051
D ++ GV++ E+++ + D SS N + ++ + Q++
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 25/202 (12%)
Query: 829 IGSGGFGTTYKAE------------ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876
IG G FG Y+ +S +VA K++A H + + + ++TL +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVA-----HTIGERNILVRTLLD-E 54
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
P +V L + ++++L+ +Y+ GG L ++ + R + + IA ++ AL +L
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ-KEGRFSEDRAKFYIA-ELVLALEHL 112
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H +++RD+KP NILLD + L DFGLS+ ++ T GT Y+APE
Sbjct: 113 HKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVL 168
Query: 997 LTCRVSDK-ADVYSYGVVLLEL 1017
L + K D +S GV++ E+
Sbjct: 169 LDEKGYTKHVDFWSLGVLVFEM 190
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 55/213 (25%), Positives = 103/213 (48%), Gaps = 26/213 (12%)
Query: 829 IGSGGFGTT-YKAEISPGILVAVKKLAVGRFQHGV--QQFHAEIKTLGNVRHPNLVTLIG 885
+GSG +GT + G VA+KKL FQ + ++ + E++ L +++H N++ L+
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHENVIGLLD 81
Query: 886 YRASG------NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
++ +L+ ++ G +L +K + + +I + + L Y+H
Sbjct: 82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK--HEKLSEDRIQF-LVYQMLKGLKYIH-- 135
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT- 998
A ++HRD+KP N+ +++D + DFGL+R + TG T Y APE L
Sbjct: 136 -AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE----MTGYVVTRWYRAPEVILNW 190
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSH 1031
+ D++S G ++ E+++ K P F H
Sbjct: 191 MHYTQTVDIWSVGCIMAEMLTGK----PLFKGH 219
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 867 AEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIA 926
AE L V P +V L S +++L+ ++ GG L + ++ R R + A
Sbjct: 42 AERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQ-REGRFDLSRARFYTA 100
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG 986
++ AL LH V++RD+KP NILLD + L DFGL + L + T G
Sbjct: 101 -ELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCG 155
Query: 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
T Y+APE L + D ++ GV+L E+++
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLT 188
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-09
Identities = 61/223 (27%), Positives = 95/223 (42%), Gaps = 26/223 (11%)
Query: 813 YESIIR-------ATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQ- 864
YE I+R D++ IG G FG V KL + +F+ +
Sbjct: 28 YEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL-LSKFEMIKRSD 86
Query: 865 ---FHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI 921
F E + P +V L ++++ Y+PGG+L N + ++ V K
Sbjct: 87 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLM---SNYDVPEKW 143
Query: 922 LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS-RLLGTSETHA 980
+V AL +H ++HRDVKP N+LLD + L+DFG ++ T
Sbjct: 144 AKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRC 200
Query: 981 TTGVAGTFGYVAPEYALTCRVSD-----KADVYSYGVVLLELI 1018
T V GT Y++PE L + D + D +S GV L E++
Sbjct: 201 DTAV-GTPDYISPE-VLKSQGGDGYYGRECDWWSVGVFLFEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 3e-09
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 823 FNTSNC-IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPN 879
F C +G G +G YKA+ G K+ A+ + + A EI L ++HPN
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDG--KDEKEYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 880 LVTL--IGYRASGNEMFLIYNYLPGGNLENFIK-ARTSRA------VDWKILHKIALDVA 930
++ L + S +++L+++Y +L + IK R S+A + ++ + +
Sbjct: 60 VIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQIL 118
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGT--SETHATTGV 984
+ YLH A VLHRD+KP+NIL+ + ++D G +RL + V
Sbjct: 119 DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 985 AGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
TF Y APE L R KA D+++ G + EL++ +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-09
Identities = 58/218 (26%), Positives = 94/218 (43%), Gaps = 10/218 (4%)
Query: 823 FNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH-AEIKTLGNVRHPNL 880
F +G G +G K +VA+KK V++ E+K L ++ N+
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62
Query: 881 VTLI-GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
V L +R G +++L++ Y+ LE ++ + K+ I + A+ + H
Sbjct: 63 VELKEAFRRRG-KLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKN 119
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
++HRD+KP N+L+ + L DFG +R L T T Y +PE L
Sbjct: 120 ---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA 176
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNI 1037
D++S G +L EL SD + L P S F I
Sbjct: 177 PYGKAVDMWSVGCILGEL-SDGQPLFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 3e-09
Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 27/236 (11%)
Query: 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRH 877
DF +G GG+G + A+ G +VA+K++ + V+ E L +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKI----ALDVASAL 933
LV L+ ++L Y+PGG+ + + D + A+D L
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHEL 120
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
Y+H RD+KP N L+D + L+DFGLS+ + ++ V G+ Y+AP
Sbjct: 121 GYIH---------RDLKPENFLIDASGHIKLTDFGLSK-GIVTYANS---VVGSPDYMAP 167
Query: 994 EYALTCRVSDKADVYSYGVVLLELISDKKALDPSF--SSHGDGF-NIISWASMLLR 1046
E D +S G +L E + P F S+ + + N+ W L R
Sbjct: 168 EVLRGKGYDFTVDYWSLGCMLYEFLCGF----PPFSGSTPNETWENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 3e-09
Identities = 58/223 (26%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 809 VPLTYESIIRATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGV--QQF 865
+P Y S+ + +GSG +G+ A + G VA+KKL+ FQ + ++
Sbjct: 13 LPERYTSLKQ----------VGSGAYGSVCSAIDKRTGEKVAIKKLS-RPFQSEIFAKRA 61
Query: 866 HAEIKTLGNVRHPNLVTLIGY---RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKIL 922
+ E+ L +++H N++ L+ SG+E Y +P + K + K+
Sbjct: 62 YRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-LQKIMGHPLSEDKVQ 120
Query: 923 HKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA-- 980
+ + + L Y+H + ++HRD+KP N+ +++D + DFGL+R HA
Sbjct: 121 YLV-YQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-------HADA 169
Query: 981 -TTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDK 1021
TG T Y APE L + D++S G ++ E+++ K
Sbjct: 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 49/199 (24%), Positives = 96/199 (48%), Gaps = 16/199 (8%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G + T +K LVA+K++ + + E+ L N++H N+VTL
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL---DVASALAYLHDQCAPRV 944
+ + L++ YL ++ +K + +H + + + L+Y H + ++
Sbjct: 73 HTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVAPEYAL-TCRVS 1002
LHRD+KP N+L+++ L+DFGL+R ++T++ V T Y P+ L + S
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTEYS 182
Query: 1003 DKADVYSYGVVLLELISDK 1021
D++ G +L E+ + +
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 21/206 (10%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHPNLV---- 881
IG G +G A + G VA+KK+ F+H + EIK L +RHP++V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 882 -TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL-DVASALAYLHDQ 939
L R ++++++ L +L IKA + H+ L + AL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEH---HQFFLYQLLRALKYIH-- 120
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR--LLGTSETHATTGVAGTFGYVAPEY-- 995
V HRD+KP NIL + D + DFGL+R T T T Y APE
Sbjct: 121 -TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 996 ALTCRVSDKADVYSYGVVLLELISDK 1021
+ + + D++S G + E+++ K
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-09
Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 18/187 (9%)
Query: 845 GILVAVKKLAVGRF-------------QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891
G ++ VK+ A GR+ + V E + L N RHP L L + +
Sbjct: 9 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 68
Query: 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKP 951
+ + Y GG L F R ++ SAL YLH + V++RD+K
Sbjct: 69 RLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKL 124
Query: 952 SNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYG 1011
N++LD D + ++DFGL + G + GT Y+APE D + G
Sbjct: 125 ENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLG 183
Query: 1012 VVLLELI 1018
VV+ E++
Sbjct: 184 VVMYEMM 190
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 5e-09
Identities = 54/198 (27%), Positives = 92/198 (46%), Gaps = 18/198 (9%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLA--VGRFQHGVQQFHAEIKTLG-NVRHPNLVTLI 884
+G G FG AE+ G AVK L V V+ E + L +P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQC 940
+ +F + +L GG+L I+ + RA + A ++ L +LH +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFY------AAEIVCGLQFLHSK- 115
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+++RD+K N++LD D + ++DFG+ + + A+T GT Y+APE +
Sbjct: 116 --GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLK 172
Query: 1001 VSDKADVYSYGVVLLELI 1018
+ D +S+GV+L E++
Sbjct: 173 YTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 40/149 (26%), Positives = 75/149 (50%), Gaps = 6/149 (4%)
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
+P LV L + + +FL+ Y+ GG+L + R + + A ++ AL +L
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIALNFL 112
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H++ +++RD+K N+LLD D + L+D+G+ + G T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEIL 168
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALD 1025
D ++ GV++ E+++ + D
Sbjct: 169 RGEEYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 48/206 (23%), Positives = 99/206 (48%), Gaps = 22/206 (10%)
Query: 829 IGSGGFGTTYKAEISPGIL-------VAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+G G FG Y+ I+ G++ VA+K + +F E + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD--------WKILHKIALDVASAL 933
L+G + G +I + G+L++++++ + K + ++A ++A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG--YV 991
AYL+ A + +HRD+ N ++ +DF + DFG++R + ++ + G G ++
Sbjct: 133 AYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVRWM 188
Query: 992 APEYALTCRVSDKADVYSYGVVLLEL 1017
+PE + +DV+S+GVVL E+
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 5e-09
Identities = 50/199 (25%), Positives = 95/199 (47%), Gaps = 16/199 (8%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G + T +K LVA+K++ + + E+ L +++H N+VTL
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL---DVASALAYLHDQCAPRV 944
+ + L++ YL + +K + +H + + + LAY H + +V
Sbjct: 74 HTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KV 125
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVAPEYAL-TCRVS 1002
LHRD+KP N+L+++ L+DFGL+R ++T++ V T Y P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSEYS 183
Query: 1003 DKADVYSYGVVLLELISDK 1021
+ D++ G + E+ S +
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 6e-09
Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-------KLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
IG GGFG Y + G + A+K K+ G ++ + + G+ P +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC--PFI 59
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V + + +++ I + + GG+L + K + A ++ L ++H++
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF 117
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
V++RD+KP+NILLD+ + +SD GL+ + HA+ GT GY+APE
Sbjct: 118 ---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171
Query: 1001 VSD-KADVYSYGVVLLELI 1018
D AD +S G +L +L+
Sbjct: 172 AYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 6e-09
Identities = 50/228 (21%), Positives = 91/228 (39%), Gaps = 35/228 (15%)
Query: 827 NCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHA-------------EIKTL 872
+G G +G KA G +VA+KK+ + + V + E+K +
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 873 GNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASA 932
++H N++ L+ G+ + L+ + + +L+ + + I L + +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQV--KCILLQILNG 131
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG-------------TSETH 979
L LH +HRD+ P+NI ++ ++DFGL+R G
Sbjct: 132 LNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRRE 188
Query: 980 ATTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDKKALDP 1026
T T Y APE + + D++S G + EL++ K L P
Sbjct: 189 EMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT-GKPLFP 235
|
Length = 335 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 36/210 (17%)
Query: 829 IGSGGFG---TTYKAEISPGILVAVKKLAVG-RFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IGSG G Y A + VA+KKL+ + Q ++ + E+ + V H N+++L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 885 GYRASGNEMFLIYNYLPGGNLENF---------IKARTSRAVDWKILHK----IALDVAS 931
+ P +LE F + A + + ++ H+ + +
Sbjct: 83 NV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLC 130
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
+ +LH + ++HRD+KPSNI++ D + DFGL+R GTS T T Y
Sbjct: 131 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYR 185
Query: 992 APEYALTCRVSDKADVYSYGVVLLELISDK 1021
APE L + D++S G ++ E++ K
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 7e-09
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 28/203 (13%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGR-FQHGVQQFHA-----EIKTLGNVRHPNLV 881
IGSG G A + G VA+KKL+ R FQ+ HA E+ + V H N++
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLS--RPFQN---VTHAKRAYRELVLMKLVNHKNII 78
Query: 882 TLIGYRASG------NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
L+ +++L+ L NL I+ +D + + + + + +
Sbjct: 79 GLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQ----MDLDHERMSYLLYQMLCGIKH 133
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
LH + ++HRD+KPSNI++ D + DFGL+R GTS T V T Y APE
Sbjct: 134 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYVV-TRYYRAPEV 188
Query: 996 ALTCRVSDKADVYSYGVVLLELI 1018
L + D++S G ++ E+I
Sbjct: 189 ILGMGYKENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 7e-09
Identities = 56/193 (29%), Positives = 82/193 (42%), Gaps = 9/193 (4%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK--KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG E + G A+K K V + V E + L N RHP L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ + + + Y GG L F R ++ SAL YLH V+
Sbjct: 63 SFQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALGYLHSC---DVV 117
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
+RD+K N++LD D + ++DFGL + G S+ GT Y+APE
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 176
Query: 1006 DVYSYGVVLLELI 1018
D + GVV+ E++
Sbjct: 177 DWWGLGVVMYEMM 189
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 50/199 (25%), Positives = 94/199 (47%), Gaps = 16/199 (8%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G + T YK LVA+K++ + + E+ L +++H N+VTL
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL---DVASALAYLHDQCAPRV 944
+ + L++ YL + +K + +H + L + L Y H + +V
Sbjct: 74 HTEKSLTLVFEYL-----DKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KV 125
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVAPEYAL-TCRVS 1002
LHRD+KP N+L+++ L+DFGL+R ++T++ V T Y P+ L + S
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTDYS 183
Query: 1003 DKADVYSYGVVLLELISDK 1021
+ D++ G + E+ + +
Sbjct: 184 TQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-09
Identities = 58/208 (27%), Positives = 93/208 (44%), Gaps = 25/208 (12%)
Query: 823 FNTSNCIGSGGFGTTYKAEISP-GILVAVKKLA----VGRFQHGVQQFHAE---IKTLGN 874
F +G G FG AE G L A+K L + R + V+ E +T +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDE--VESLMCEKRIFETANS 58
Query: 875 VRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKIALDVAS 931
RHP LV L + + + + Y GG+L I RAV + A V
Sbjct: 59 ERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY------AACVVL 112
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL-LGTSETHATTGVAGTFGY 990
L YLH+ ++++RD+K N+LLD + ++DFGL + +G + +T GT +
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTST--FCGTPEF 167
Query: 991 VAPEYALTCRVSDKADVYSYGVVLLELI 1018
+APE + D + GV++ E++
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEML 195
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 9e-09
Identities = 59/218 (27%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 823 FNTSNC-IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPN 879
F C +G G +G YKA+ G + A+ + + A EI L ++HPN
Sbjct: 2 FEYEGCKVGRGTYGHVYKAKRKDG--KDDRDYALKQIEGTGISMSACREIALLRELKHPN 59
Query: 880 LVTL--IGYRASGNEMFLIYNYLPGGNLENFIK-ARTSRA------VDWKILHKIALDVA 930
+++L + + +++L+++Y +L + IK R S+A + ++ + +
Sbjct: 60 VISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQIL 118
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGT--SETHATTGV 984
+ YLH A VLHRD+KP+NIL+ + ++D G +RL + V
Sbjct: 119 DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 175
Query: 985 AGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
TF Y APE L R KA D+++ G + EL++ +
Sbjct: 176 VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-08
Identities = 54/209 (25%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+ N IG+G FG Y+A + +K+A+ + Q + E+ + N+ H N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAIC----IDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIF 123
Query: 883 LIGY------RASGNEMFL--IYNYLPGGNLENFIK--ARTSRAVDWKILHKIALDVASA 932
L Y + + +FL + ++P + ++K AR + A+ ++ + + A
Sbjct: 124 LKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAY-LSDFGLSR-LLGTSETHATTGVAGTFGY 990
LAY+H + + HRD+KP N+L+D + + L DFG ++ LL + + + F Y
Sbjct: 183 LAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRS--VSYICSRF-Y 236
Query: 991 VAPEYAL-TCRVSDKADVYSYGVVLLELI 1018
APE L + D++S G ++ E+I
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMI 265
|
Length = 440 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 38/133 (28%), Positives = 64/133 (48%), Gaps = 16/133 (12%)
Query: 893 MFLIYNYLPGGNLENFIKARTSRAV--DWKILHKIALDVASALAYLHDQCAPRVLHRDVK 950
++++ Y+PGG+L N + ++ + W + +V AL +H +HRDVK
Sbjct: 118 LYMVMEYMPGGDLVNLM---SNYDIPEKWARFY--TAEVVLALDAIHSM---GFIHRDVK 169
Query: 951 PSNILLDDDFNAYLSDFGLS-RLLGTSETHATTGVAGTFGYVAPEYALTCRVSD----KA 1005
P N+LLD + L+DFG ++ T V GT Y++PE + +
Sbjct: 170 PDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGREC 228
Query: 1006 DVYSYGVVLLELI 1018
D +S GV L E++
Sbjct: 229 DWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 55/212 (25%), Positives = 96/212 (45%), Gaps = 18/212 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLA--VGRFQHGVQQFHAEIKTLGNVRHP 878
DFN +G G FG AE L A+K L V V+ E + L P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 879 NLVT-LIGYRASGNEMFLIYNYLPGGNLENFI----KARTSRAVDWKILHKIALDVASAL 933
+T L + + ++ + Y+ GG+L I K + +AV + A +++ L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFY------AAEISVGL 114
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+LH + +++RD+K N++LD + + ++DFG+ + + T GT Y+AP
Sbjct: 115 FFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-EHMVDGVTTRTFCGTPDYIAP 170
Query: 994 EYALTCRVSDKADVYSYGVVLLELISDKKALD 1025
E D ++YGV+L E+++ + D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 2e-08
Identities = 36/94 (38%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS-ETHATTGVAGTFGY 990
ALAYLH + ++HRDVK NI LD+ NA L DFG + L +T G +GT
Sbjct: 197 ALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253
Query: 991 VAPEYALTCRVSDKADVYSYGVVLLELISDKKAL 1024
+PE K D++S G+VL E+ L
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 47/207 (22%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 829 IGSGGFGTTYKA------EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG Y+ + VAVK + +F E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD--------WKILHKIALDVASALA 934
L+G + G ++ + G+L++++++ A + + + ++A ++A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVA 992
YL+ A + +HRD+ N ++ DF + DFG++R + ++ + G G ++A
Sbjct: 134 YLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGG-KGLLPVRWMA 189
Query: 993 PEYALTCRVSDKADVYSYGVVLLELIS 1019
PE + +D++S+GVVL E+ S
Sbjct: 190 PESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-08
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 8/154 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVK--KLAVGRFQHGVQQFHAEIKTLGNVRHP 878
+F I G FG Y + + L AVK K A ++ V Q AE L + P
Sbjct: 5 EFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSP 64
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
+V L S N ++L+ YL GG++++ + D ++ K +VA AL YLH
Sbjct: 65 FIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGY--FDEEMAVKYISEVALALDYLHR 122
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972
++HRD+KP N+L+ ++ + L+DFGLS++
Sbjct: 123 H---GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 61/225 (27%), Positives = 99/225 (44%), Gaps = 42/225 (18%)
Query: 821 GDFNTSNCIGSGGFGTTYKAEISPGILV---------AVKKLA----VGRFQHGVQQFHA 867
DF T I +G +G Y LV A+KK+ + R Q +QQ
Sbjct: 1 EDFETIKLISNGAYGAVY--------LVRHKETRQRFAMKKINKQNLILRNQ--IQQVFV 50
Query: 868 EIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL 927
E L +P +V++ + + ++ Y+ GG+ +K + VD ++ A
Sbjct: 51 ERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMY-FAE 109
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL-LGTSETHATTG--- 983
V AL YLH+ ++HRD+KP N+L+ + L+DFGLS++ L + T+ G
Sbjct: 110 TVL-ALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIE 165
Query: 984 ----------VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018
V GT Y+APE L D ++ G++L E +
Sbjct: 166 KDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFL 210
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 3e-08
Identities = 53/163 (32%), Positives = 72/163 (44%), Gaps = 14/163 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHP 878
DF+T IG G FG + G + A+K L Q H AE L P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLEN-FIKART-SRAVDWKILHKIALDVASALAYL 936
+V+L ++LI +LPGG+L IK T S V + + L A+ +
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVL----AIEAV 117
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979
H +HRD+KP NIL+D + LSDFGLS G + H
Sbjct: 118 HKL---GFIHRDIKPDNILIDRGGHIKLSDFGLS--TGFHKQH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-08
Identities = 57/170 (33%), Positives = 81/170 (47%), Gaps = 7/170 (4%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
L + L L+ L L FN S + P + +L L LD+ GN +S LP E L L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L+L+ N I ++ SL N ++L L L+ N+++ +P +G+ L L LS N++
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQI-- 267
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267
S S LG L LDLSGNSL +P L LL L +
Sbjct: 268 SSISSLGSLTN-LRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKAL 316
|
Length = 394 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 4e-08
Identities = 36/142 (25%), Positives = 62/142 (43%), Gaps = 7/142 (4%)
Query: 828 CIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGY 886
C K + + LVAVKK+ + ++ EI T ++HPN++ +
Sbjct: 9 CFEDLMIVHLAKHKPT-NTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTS 67
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH-DQCAPRVL 945
+E++++ + G+ E+ +K + + I DV +AL Y+H +
Sbjct: 68 FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGF----I 123
Query: 946 HRDVKPSNILLDDDFNAYLSDF 967
HR VK S+ILL D LS
Sbjct: 124 HRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (137), Expect = 5e-08
Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 29/185 (15%)
Query: 864 QFHAEIKTLGNVRHPNLVTLIG--YRASGNEMFLIYNYLPGGNLENFIKA--RTSRAVDW 919
Q E+ + ++H N+V I + +++++ + G+L I+ + ++
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 920 KILHKIALDVASALAYLHD-QCAP---RVLHRDVKPSNILLD-------------DDFN- 961
+ I + ALAY H+ + P RVLHRD+KP NI L ++ N
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 962 ---AYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL--TCRVSDKADVYSYGVVLLE 1016
A + DFGLS+ +G E+ A + V GT Y +PE L T DK+D+++ G ++ E
Sbjct: 178 RPIAKIGDFGLSKNIGI-ESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYE 235
Query: 1017 LISDK 1021
L S K
Sbjct: 236 LCSGK 240
|
Length = 1021 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 36/115 (31%), Positives = 58/115 (50%), Gaps = 4/115 (3%)
Query: 914 SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973
S +D L + + VA + +L + +HRDV N+LL D A + DFGL+R +
Sbjct: 206 SWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262
Query: 974 GTSETHATTGVAG-TFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPS 1027
+ G A ++APE C + ++DV+SYG++L E+ S K+ P
Sbjct: 263 MNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-08
Identities = 60/214 (28%), Positives = 94/214 (43%), Gaps = 44/214 (20%)
Query: 829 IGSGGFGTTYKAEISPGIL---VAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNL 880
IGSG G A IL VA+KKL+ FQ+ Q HA E+ + V H N+
Sbjct: 32 IGSGAQGIVCAA--YDAILERNVAIKKLS-RPFQN---QTHAKRAYRELVLMKCVNHKNI 85
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENF---------IKARTSRAVDWKILHK----IAL 927
+ L+ + P +LE F + A + + ++ H+ +
Sbjct: 86 IGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLY 133
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT 987
+ + +LH + ++HRD+KPSNI++ D + DFGL+R GTS T T
Sbjct: 134 QMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVT 188
Query: 988 FGYVAPEYALTCRVSDKADVYSYGVVLLELISDK 1021
Y APE L + D++S G ++ E+I
Sbjct: 189 RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 33/94 (35%), Positives = 54/94 (57%), Gaps = 7/94 (7%)
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
A ++ L ++H++ V++RD+KP+NILLD+ + +SD GL+ + HA+
Sbjct: 103 AAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 156
Query: 986 GTFGYVAPEYALTCRVSD-KADVYSYGVVLLELI 1018
GT GY+APE D AD +S G +L +L+
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 6e-08
Identities = 68/253 (26%), Positives = 94/253 (37%), Gaps = 77/253 (30%)
Query: 822 DFNTSNCIGSGGFG-TTYKAEISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHP 878
DF + IG G FG + G + A+KKL Q H AE L +P
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNP 61
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNL-----------EN---FIKARTSRAVDWKILHK 924
+V L N ++LI YLPGG++ E F A T A+D +HK
Sbjct: 62 WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAID--SIHK 119
Query: 925 IALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT-- 982
L Y+H RD+KP N+LLD + LSDFGL G ++H T
Sbjct: 120 --------LGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFY 160
Query: 983 -------------------------------------GVAGTFGYVAPEYALTCRVSDKA 1005
GT Y+APE L + +
Sbjct: 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC 220
Query: 1006 DVYSYGVVLLELI 1018
D +S GV++ E++
Sbjct: 221 DWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 7e-08
Identities = 58/224 (25%), Positives = 97/224 (43%), Gaps = 40/224 (17%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLA--VGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
IG GG G Y A + VA+KK+ + ++F E K ++ HP +V +
Sbjct: 10 IGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYS 69
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKA-------------RTSRAVDWKILHKIALDVASA 932
+ G+ ++ Y+ G L++ +K+ +TS I HKI +
Sbjct: 70 ICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC----AT 125
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET-------------- 978
+ Y+H + VLHRD+KP NILL + D+G + E
Sbjct: 126 IEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 979 HATT---GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
+ T + GT Y+APE L S+ D+Y+ GV+L ++++
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
|
Length = 932 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 30/203 (14%)
Query: 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G + T YK + G LVA+K + + + E L ++H N+V L
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72
Query: 888 ASGNEMFLIYNYL-----------PGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
+ + L++ Y+ PGG +K + L+Y+
Sbjct: 73 HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKL-------------FLFQLLRGLSYI 119
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H + +LHRD+KP N+L+ D L+DFGL+R + +H + T Y P+
Sbjct: 120 HQR---YILHRDLKPQNLLISDTGELKLADFGLAR-AKSVPSHTYSNEVVTLWYRPPDVL 175
Query: 997 L-TCRVSDKADVYSYGVVLLELI 1018
L + S D++ G + +E+I
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMI 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 2e-07
Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGI--LVAVK--KLAVGRFQHGVQQFHAEIKTLG-NVR 876
DFN +G G FG AE G L A+K K V V+ E + L +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNL----ENFIKARTSRAVDWKILHKIALDVASA 932
P L L + + ++ + Y+ GG+L + K + AV + A ++A
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFY------AAEIAIG 113
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
L +LH + +++RD+K N++LD + + ++DFG+ + T GT Y+A
Sbjct: 114 LFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYIA 169
Query: 993 PEYALTCRVSDKADVYSYGVVLLELISDKKALD 1025
PE D +++GV+L E+++ + D
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 49/159 (30%), Positives = 74/159 (46%), Gaps = 36/159 (22%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH--GVQQFHA--EIKTLGNVRHPNLVTL 883
+G G + T YK G LVA+K++ R +H G F A E L +++H N+VTL
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI---RLEHEEGAP-FTAIREASLLKDLKHANIVTL 68
Query: 884 IGYRASGNEMFLIYNYL-----------PGGNLENFIKARTSRAVDWKILHKIALDVASA 932
+ + L++ YL GG + R +++L
Sbjct: 69 HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----LSMHNVRLFLFQLLR--------G 115
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971
LAY H + RVLHRD+KP N+L+ + L+DFGL+R
Sbjct: 116 LAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 23/60 (38%), Positives = 35/60 (58%)
Query: 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNL 627
+L+ LD S+N+++ I + + L +L LDL+GN L P + L LR L L+ NNL
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 37/149 (24%), Positives = 75/149 (50%), Gaps = 6/149 (4%)
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
HP LV L + + +F + ++ GG+L + R + + + +++ AL +L
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLALNFL 112
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H++ +++RD+K N+LLD + + L+D+G+ + G T+ GT Y+APE
Sbjct: 113 HER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAPEIL 168
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALD 1025
D ++ GV++ E+++ + D
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 5e-07
Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 20/183 (10%)
Query: 916 AVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975
A+D + L + VA +++L + +HRD+ NILL + DFGL+R +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
Query: 976 SETHATTGVAG-TFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDG 1034
+ G A ++APE C + ++DV+SYG++L E+ S + P
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326
Query: 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094
+ +I K+ + P +M + C RPT KQ+VQ
Sbjct: 327 YKMI------------KEGYRML----SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370
Query: 1095 LKQ 1097
++Q
Sbjct: 371 IEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 6e-07
Identities = 49/213 (23%), Positives = 96/213 (45%), Gaps = 29/213 (13%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL---- 883
+G G G + A + VAVKK+ + V+ EIK + + H N+V +
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVKHALREIKIIRRLDHDNIVKVYEVL 71
Query: 884 ----------IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASAL 933
+G N ++++ Y+ +L N ++ ++ + L
Sbjct: 72 GPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLF---MYQLLRGL 127
Query: 934 AYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHA---TTGVAGTFG 989
Y+H + VLHRD+KP+N+ ++ +D + DFGL+R++ +H + G+ +
Sbjct: 128 KYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW- 183
Query: 990 YVAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
Y +P L+ KA D+++ G + E+++ K
Sbjct: 184 YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 7e-07
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 10/152 (6%)
Query: 868 EIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG--GNLENFIKARTSRAVDWKILHKI 925
E + L + HP ++ L+ R G L+ LP +L ++ AR R + + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGAR-LRPLGLAQVTAV 265
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL-GTSETHATTGV 984
A + SA+ Y+H + ++HRD+K N+L++ + L DFG + G+ T G+
Sbjct: 266 ARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGI 322
Query: 985 AGTFGYVAPEYALTCRVSDKADVYSYGVVLLE 1016
AGT APE + D++S G+V+ E
Sbjct: 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-07
Identities = 39/131 (29%), Positives = 62/131 (47%), Gaps = 12/131 (9%)
Query: 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPS 952
++++ Y+PGG+L N + ++ V K +V AL +H +HRDVKP
Sbjct: 118 LYMVMEYMPGGDLVNLM---SNYDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPD 171
Query: 953 NILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD-----KADV 1007
N+LLD + L+DFG + GT Y++PE L + D + D
Sbjct: 172 NMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE-VLKSQGGDGYYGRECDW 230
Query: 1008 YSYGVVLLELI 1018
+S GV L E++
Sbjct: 231 WSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 55/210 (26%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILV-AVKKLAVGRFQHGVQQ--FHAEIKTLGNVRHP 878
DF IG G FG ++ V A+K L + F E L N +
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSR-----AVDWKILHKIALDVASAL 933
+ TL N ++L+ +Y GG+L + R A + IA+D L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
Y+H RD+KP NIL+D + + L+DFG L T ++ GT Y++P
Sbjct: 122 HYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISP 172
Query: 994 EYALTC-----RVSDKADVYSYGVVLLELI 1018
E + + D +S GV + E++
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 9e-07
Identities = 23/60 (38%), Positives = 32/60 (53%)
Query: 592 SLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
+L LDL+ N+L + L L+ L L+ NNLT P + L SL L+LS N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 9e-07
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 38/207 (18%)
Query: 829 IGSGGFGTTYKAEIS--PGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLI 884
+G G + T YK IS G LVA+K +++ + + GV F A E L ++H N+V L
Sbjct: 13 LGEGSYATVYKG-ISRINGQLVALKVISM-KTEEGVP-FTAIREASLLKGLKHANIVLLH 69
Query: 885 GYRASGNEMFLIYNYL-----------PGGNLENFIKARTSRAVDWKILHKIALDVASAL 933
+ + ++ Y+ PGG + R +++L L
Sbjct: 70 DIIHTKETLTFVFEYMHTDLAQYMIQHPGG-----LHPYNVRLFMFQLLR--------GL 116
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVA 992
AY+H Q +LHRD+KP N+L+ L+DFGL+R S+T+++ V T Y
Sbjct: 117 AYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRP 171
Query: 993 PEYAL-TCRVSDKADVYSYGVVLLELI 1018
P+ L S D++ G + +E++
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEML 198
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 1e-06
Identities = 22/59 (37%), Positives = 33/59 (55%)
Query: 617 LRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKL 675
L+ L L++N LT + L +L+VL+LS N+L+ PE L +L +L L N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 45/159 (28%), Positives = 74/159 (46%), Gaps = 13/159 (8%)
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
PN+V L Y S + +FL+ + GG L + I + + + + + A ++ AL LH
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALH 102
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ ++ RD+ P+NILLDD + L+ F + S G A Y APE
Sbjct: 103 RE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYCAPEVGG 155
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFN 1036
++ D +S G +L EL++ K ++ H G N
Sbjct: 156 ISEETEACDWWSLGAILFELLTGKTLVE----CHPSGIN 190
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 1e-06
Identities = 48/217 (22%), Positives = 90/217 (41%), Gaps = 22/217 (10%)
Query: 829 IGSGGFGTTYKAEISPGILVA---VKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
IG+G FG +EI VA VK+L +F + ++HPN++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI--LHKIALDVASALAYLHDQCAPR 943
L++ Y G+L++++ + ++ L ++A ++A+ + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---N 119
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGL--SRLLGTSETHATT--GVAGTFGYVAPEYA--- 996
LH D+ N L D + D+G+ SR E + T ++APE
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIGPSRY---KEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 997 ----LTCRVSDKADVYSYGVVLLELISDKKALDPSFS 1029
+T + ++V++ GV L EL + S
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS 213
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-06
Identities = 44/165 (26%), Positives = 74/165 (44%), Gaps = 19/165 (11%)
Query: 864 QFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI---YNYLPGGNLENFIKARTSRAVDWK 920
Q EI LG + H N++ + S ++I Y++ +L +F+ A DWK
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFM---YDEAFDWK 261
Query: 921 ------ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974
I + A+ Y+HD+ +++HRD+K NI L+ D L DFG +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFE 318
Query: 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
G GT +PE + D++S G++LL+++S
Sbjct: 319 KEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-06
Identities = 46/159 (28%), Positives = 72/159 (45%), Gaps = 10/159 (6%)
Query: 868 EIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP--GGNLENFIKARTSRAVDWKILHKI 925
E L + HP+++ L G LI LP +L ++ A+ + A+ IL I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAI-CDIL-AI 187
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
V A+ YLH+ R++HRD+K NI ++ + L DFG + + G A
Sbjct: 188 ERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWA 244
Query: 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKAL 1024
GT APE D++S G+VL E+ + +L
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSL 283
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 57/240 (23%), Positives = 88/240 (36%), Gaps = 54/240 (22%)
Query: 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHP 878
DF + IG G FG + G + A+K L Q H AE L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKI-ALDVASALA 934
+V + ++LI +LPGG++ + + + A + I + A+D L
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT------------ 982
++H RD+KP N+LLD + LSDFGL G + H T
Sbjct: 122 FIH---------RDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNLTHNPPSD 170
Query: 983 ------------------------GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018
GT Y+APE + + D +S GV++ E++
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 3e-06
Identities = 28/81 (34%), Positives = 43/81 (53%)
Query: 95 LVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGL 154
L G + + L L+ ++L N G PP + S+ LEVLD+ N +G +P L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 155 RNLRVLNLAFNRIDGDIPFSL 175
+LR+LNL N + G +P +L
Sbjct: 490 TSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 57/240 (23%), Positives = 87/240 (36%), Gaps = 54/240 (22%)
Query: 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHP 878
DF + IG G FG + G + A+K L Q H AE L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKI-ALDVASALA 934
+V + ++LI +LPGG++ + + T + I + A+D L
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT------------ 982
++H RD+KP N+LLD + LSDFGL G + H T
Sbjct: 122 FIH---------RDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLNHSLPSD 170
Query: 983 ------------------------GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018
GT Y+APE + + D +S GV++ E++
Sbjct: 171 FTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 4e-06
Identities = 23/56 (41%), Positives = 32/56 (57%), Gaps = 1/56 (1%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKL 603
+LSNN + IP +L+VLD S N ++ I P++ L SL LDL+GN L
Sbjct: 6 DLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-06
Identities = 50/171 (29%), Positives = 82/171 (47%), Gaps = 6/171 (3%)
Query: 139 EGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGF 198
+E + L NL L+L N I P +L+ L+L+ N+++ +P
Sbjct: 100 LNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSP 158
Query: 199 LGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLL 258
L + L+ L LS+N+L+ +P L L +LDLSGN + +P + L L
Sbjct: 159 LRNLPNLKNLDLSFNDLS-DLPKLLSN-LSNLNNLDLSGN-KISDLPPEIELLSALEELD 215
Query: 259 LFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L +N + +++ L L+ L L++S N+L +P +GN L L LSN
Sbjct: 216 LSNNSIIELLS-SLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSN 264
|
Length = 394 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 5e-06
Identities = 35/133 (26%), Positives = 63/133 (47%), Gaps = 9/133 (6%)
Query: 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVK 950
N ++L+ +Y GG+L + R + IA ++ A+ +H +HRD+K
Sbjct: 74 NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA-EMVLAIHSIHQL---HYVHRDIK 129
Query: 951 PSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC-----RVSDKA 1005
P N+LLD + + L+DFG + T ++ GT Y++PE + +
Sbjct: 130 PDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPEC 189
Query: 1006 DVYSYGVVLLELI 1018
D +S GV + E++
Sbjct: 190 DWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 6e-06
Identities = 54/211 (25%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGI--LVAVKKLA--VGRFQHGVQQFHAEIKTLG-NVR 876
DFN +G G FG AE G L A+K L V V+ E + L + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK 59
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKI--ALDVASALA 934
P L L + + ++ + Y+ GG+L I+ + +K H + A ++A L
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLF 115
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
+LH + +++RD+K N++LD + + ++DFG+ + + T GT Y+APE
Sbjct: 116 FLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENMWDGVTTKTFCGTPDYIAPE 171
Query: 995 YALTCRVSDKADVYSYGVVLLELISDKKALD 1025
D +++GV+L E+++ + +
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 1e-05
Identities = 24/62 (38%), Positives = 36/62 (58%), Gaps = 1/62 (1%)
Query: 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRN 156
G + P +G ++ L VL L +N F+G P + L L +L++ GN LSGR+P +G R
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA-LGGRL 514
Query: 157 LR 158
L
Sbjct: 515 LH 516
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-05
Identities = 20/60 (33%), Positives = 32/60 (53%)
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
NL+ L+L+ NR+ + + +L+VL+L+GN + + P LR L LS N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-05
Identities = 69/276 (25%), Positives = 110/276 (39%), Gaps = 63/276 (22%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKL----AVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG A ++ L A+K L + R Q V AE L + +V L
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQ--VAHVKAERDILAEADNEWVVKL 66
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL-DVASALAYLHDQCAP 942
+ ++ + +Y+PGG++ + + V ++L + + ++ A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL---IRMEVFPEVLARFYIAELTLAIESVHKM--- 120
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGL--------------------------SRL---- 972
+HRD+KP NIL+D D + L+DFGL S L
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180
Query: 973 --------LGTSETHATT--------GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLE 1016
L T E AT + GT Y+APE L + D +S GV+L E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240
Query: 1017 -LISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051
L+ L P+ + +I+W + L QVK
Sbjct: 241 MLVGQPPFLAPTPTE--TQLKVINWENTLHIPPQVK 274
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 2e-05
Identities = 21/59 (35%), Positives = 31/59 (52%)
Query: 132 KLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQ 190
L+ LD+ N L+ F GL NL+VL+L+ N + P + SL L+L+GN
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 2e-05
Identities = 23/61 (37%), Positives = 32/61 (52%), Gaps = 1/61 (1%)
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
+L+ L+L+ N++ + G L+VL LS N L SI E L LDLSGN+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLT-SISPEAFSGLPSLRSLDLSGNN 59
Query: 240 L 240
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-05
Identities = 33/110 (30%), Positives = 49/110 (44%), Gaps = 27/110 (24%)
Query: 264 LNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGE 323
L IP ++ LR L+ +++S N + G IP LG+ L VL LS
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY-------------- 475
Query: 324 LSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGA 373
NSF GSIP + L+ LRI+ +L G++P++ G
Sbjct: 476 -------------NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 28/145 (19%), Positives = 49/145 (33%), Gaps = 13/145 (8%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV-TLIGYR 887
+ G Y V +K ++ A ++ L R V ++
Sbjct: 6 LKGGLTNRVYLLGTKDEDYV-LKINPSREKGADREREVAILQLLA--RKGLPVPKVLASG 62
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
S +L+ ++ G L+ + IA +A LA LH + H
Sbjct: 63 ESDGWSYLLMEWIEGETLDEVSEEEKE---------DIAEQLAELLAKLHQLPLLVLCHG 113
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRL 972
D+ P NIL+DD + D+ +
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 7e-05
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+ VA + +L + + +HRD+ NILL ++ + DFGL+R + + G A
Sbjct: 179 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 235
Query: 986 G-TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++APE + ++DV+S+GV+L E+ S
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-05
Identities = 22/78 (28%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 363 LEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL-QV 421
L G +P+ L+ +NL+ N +RG++ L +DLS N +G + L Q+
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 422 PCMALFDVSGNHMSGSIP 439
+ + +++GN +SG +P
Sbjct: 490 TSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 8e-05
Identities = 24/61 (39%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 204 KLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM 263
L+ L LS N L IP K L+ LDLSGN+L P + LR+L L N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 264 L 264
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 1e-04
Identities = 39/141 (27%), Positives = 66/141 (46%), Gaps = 25/141 (17%)
Query: 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS--------ALAYLHDQCAP 942
N ++L+ +Y GG+L + S+ D ++ D+A A+ +H
Sbjct: 74 NNLYLVMDYYVGGDLLTLL----SKFED-----RLPEDMARFYLAEMVLAIDSVHQL--- 121
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY--AL--- 997
+HRD+KP N+LLD + + L+DFG L T + GT Y++PE A+
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDG 181
Query: 998 TCRVSDKADVYSYGVVLLELI 1018
R + D +S GV + E++
Sbjct: 182 KGRYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 53/241 (21%), Positives = 89/241 (36%), Gaps = 58/241 (24%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG A ++ L A+K L ++ V AE L + +V L
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYY 68
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ ++ + +Y+PGG++ + + D + ++ A+ +H +
Sbjct: 69 SFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPED--LARFYIAELTCAVESVHKM---GFI 123
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT----------------------- 982
HRD+KP NIL+D D + L+DFGL G TH +
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCT--GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPA 181
Query: 983 -------------------------GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLEL 1017
+ GT Y+APE L + D +S GV+L E+
Sbjct: 182 NCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 241
Query: 1018 I 1018
+
Sbjct: 242 L 242
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+ VA + +L + + +HRD+ NILL ++ + DFGL+R + + G A
Sbjct: 185 SFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241
Query: 986 G-TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++APE + ++DV+S+GV+L E+ S
Sbjct: 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-04
Identities = 60/266 (22%), Positives = 100/266 (37%), Gaps = 61/266 (22%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKL----AVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
IG G FG ++ L A+K L + R Q AE L + +V L
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQ--AAHVKAERDILAEADNEWVVKL 66
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+ ++ + +Y+PGG++ + + D + IA ++ A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFY-IA-ELTCAIESVHKM---G 121
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGL---------SRLLGTSETH--------------- 979
+HRD+KP NIL+D D + L+DFGL S+ + H
Sbjct: 122 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEID 181
Query: 980 ------------------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDK 1021
+ GT Y+APE L + D +S GV+L E++ +
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 1022 KALDPSF---SSHGDGFNIISWASML 1044
P F + +I+W + L
Sbjct: 242 ----PPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-04
Identities = 28/95 (29%), Positives = 50/95 (52%), Gaps = 4/95 (4%)
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+ VA + +L + + +HRD+ NILL ++ + DFGL+R + + G A
Sbjct: 180 SFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSA 236
Query: 986 G-TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
++APE + ++DV+S+GV+L E+ S
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 38.6 bits (91), Expect = 4e-04
Identities = 18/38 (47%), Positives = 25/38 (65%), Gaps = 2/38 (5%)
Query: 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604
+L LD S+NQI+ + P L NL +L LDL+GNK+
Sbjct: 1 TNLETLDLSNNQITDLPP--LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 6e-04
Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 8/126 (6%)
Query: 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956
Y ++N + S + L VA + +L + +HRD+ N+LL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLL 270
Query: 957 DDDFNAYLSDFGLSRLLGTSETHATTGVAGTF---GYVAPEYALTCRVSDKADVYSYGVV 1013
+ DFGL+R + + + G TF ++APE + +DV+SYG++
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 1014 LLELIS 1019
L E+ S
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 22/60 (36%), Positives = 32/60 (53%), Gaps = 2/60 (3%)
Query: 109 LRVLSLPFNGFSGEFPPEIW-SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRI 167
L+ L L N + P + L L+VLD+ GN L+ P F GL +LR L+L+ N +
Sbjct: 2 LKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 20/59 (33%), Positives = 25/59 (42%)
Query: 230 LEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRL 288
L+ LDLS N L + L+ L L N L + P L L LD+S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 0.002
Identities = 57/198 (28%), Positives = 86/198 (43%), Gaps = 44/198 (22%)
Query: 522 AGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIG---HIPLDIGVMCKSLRVLDASHNQ 578
A +N+LT S P +L E LS N I +P +L+ LD HN+
Sbjct: 227 ANSNQLT-SIPATLPDTIQEM-----ELSINRITELPERLP-------SALQSLDLFHNK 273
Query: 579 ISGIVPQSL-ENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG- 636
IS + P++L E L L D + L +PS + HL++ N+LT +P ++
Sbjct: 274 ISCL-PENLPEELRYLSVYDNSIRTLPAHLPSG------ITHLNVQSNSLT-ALPETLPP 325
Query: 637 ELRSLEVLELSSNSLSGEVPEGVVNLR---------------NLTALLLDNNKLSGHLPS 681
L++LE E + SL +P + L +T L + N L+ +LP
Sbjct: 326 GLKTLEAGENALTSLPASLPPELQVLDVSKNQITVLPETLPPTITTLDVSRNALT-NLPE 384
Query: 682 GLANVTSLSIFNASFNNL 699
L +L I AS NNL
Sbjct: 385 NLP--AALQIMQASRNNL 400
|
Length = 754 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.002
Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 19/152 (12%)
Query: 875 VRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS-RAVDWKILHKIALDVASAL 933
V H ++V L G E ++ ++ G L+ F+ ++ WK K+A +ASAL
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKF--KVAKQLASAL 118
Query: 934 AYLHDQCAPRVLHRDVKPSNILL-----DDDFNAY--LSDFGLSRLLGTSETHATTGVAG 986
+YL D+ ++H +V NILL D + + LSD G+ + + +
Sbjct: 119 SYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE----- 170
Query: 987 TFGYVAPEYALTCRV-SDKADVYSYGVVLLEL 1017
++APE + S AD +S+G L E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.003
Identities = 24/75 (32%), Positives = 40/75 (53%)
Query: 341 GSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKK 400
G IP +I+ L L+ I ++ G +P S G+ SLE+L+L+ N G + +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 401 LHFIDLSSNELSGEL 415
L ++L+ N LSG +
Sbjct: 492 LRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.3 bits (85), Expect = 0.003
Identities = 16/37 (43%), Positives = 25/37 (67%), Gaps = 2/37 (5%)
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192
NL L+L+ N+I D+P L N +LE L+L+GN++
Sbjct: 2 NLETLDLSNNQIT-DLP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 16/50 (32%), Positives = 30/50 (60%), Gaps = 3/50 (6%)
Query: 920 KILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969
K++ I D+ + L Y+H+ + H D+KP NI++D + Y+ D+G+
Sbjct: 126 KLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGYIIDYGI 172
|
Length = 294 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.004
Identities = 35/173 (20%), Positives = 70/173 (40%), Gaps = 24/173 (13%)
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF 988
VA+ + +L + +HRD+ N+L+ + + DFGL+R + + + G TF
Sbjct: 248 VANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STF 302
Query: 989 ---GYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045
++APE + +DV+S+G++L E+ + P + +N I +
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
+ D ++ + +C E RP Q+V + +
Sbjct: 363 KPAHASD----------------EIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 46/165 (27%), Positives = 76/165 (46%), Gaps = 27/165 (16%)
Query: 872 LGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRA-VDWKILHKIALDVA 930
+ V H +L + G G+E ++ ++ G L+ ++ R V WKI +A +A
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKIT--VAQQLA 127
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILL-----DDDFNAY--LSDFGLSRLLGTSETHATTG 983
SAL+YL D+ ++H +V NILL + + + LSD G+S + E
Sbjct: 128 SALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVER- 183
Query: 984 VAGTFGYVAPEYALTC-----RVSDKADVYSYGVVLLELISDKKA 1023
++APE C +S AD +S+G LLE+ D +
Sbjct: 184 ----IPWIAPE----CVPGGNSLSTAADKWSFGTTLLEICFDGEV 220
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1103 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.97 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.97 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.87 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.85 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.81 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.79 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.77 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.73 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.72 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.64 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.59 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.48 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.46 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.46 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.45 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.39 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.34 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.3 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.27 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.26 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.24 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.19 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.14 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.11 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.1 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.09 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.0 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.98 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.97 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.96 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.93 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.9 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.89 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.87 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.81 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.78 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.75 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.71 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.71 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.67 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.65 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.63 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.54 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.39 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.35 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.35 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.34 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.32 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.29 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-108 Score=1068.30 Aligned_cols=918 Identities=31% Similarity=0.496 Sum_probs=751.0
Q ss_pred ChhhHHHHHHHHhhccCCCCcccCcCCCCCCCCceeeeEecCCCCeEEEEecCCCCCCCCCCcccccccccccccccccc
Q 043720 4 VLPEKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQFPFYGFGM 83 (1103)
Q Consensus 4 ~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~C~W~GV~C~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 83 (1103)
.+.|++||++||+++.||.+.+++|+.. .|||.|.||+|+..++|+.+++.+..
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~~~v~~L~L~~~~------------------------- 80 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNSSRVVSIDLSGKN------------------------- 80 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCCCcEEEEEecCCC-------------------------
Confidence 5789999999999999998889999754 48999999999988899999987542
Q ss_pred ccceeccCCCccccccCcccCCCCCCCEEEccCCCCcccCCcccc-CCCCCCEEEeecCCCCCCccccccCCCCCCEEEc
Q 043720 84 RRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIW-SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162 (1103)
Q Consensus 84 ~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 162 (1103)
+.|.+++.++.+++|+.|+|++|.++|.+|..+. .+++|++|+|++|.++|.+|. +.+++|++|+|
T Consensus 81 -----------i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L 147 (968)
T PLN00113 81 -----------ISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL 147 (968)
T ss_pred -----------ccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence 3456777889999999999999999999998876 899999999999999998885 56899999999
Q ss_pred cccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcccc
Q 043720 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG 242 (1103)
Q Consensus 163 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~ 242 (1103)
++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..+..+ ++|++|+|++|++++
T Consensus 148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~L~~n~l~~ 226 (968)
T PLN00113 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQM-KSLKWIYLGYNNLSG 226 (968)
T ss_pred cCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCc-CCccEEECcCCccCC
Confidence 9999999999999999999999999999999999999999999999999999999999988874 789999999999999
Q ss_pred ccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccC
Q 043720 243 RIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRG 322 (1103)
Q Consensus 243 ~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~ 322 (1103)
.+|..++++++|++|++++|.+++.+|..++++++|+.|++++|++++.+|..+.++++|+.|++++
T Consensus 227 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~------------- 293 (968)
T PLN00113 227 EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSD------------- 293 (968)
T ss_pred cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcC-------------
Confidence 9999999999999999999999999999999999999999999999999999999999999999985
Q ss_pred cccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCce
Q 043720 323 ELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLH 402 (1103)
Q Consensus 323 ~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 402 (1103)
|.+.+.+|..+.++++|+.|++++|.+.+.+|..++.+++|+.|+|++|.+.+..|..+..+++|+
T Consensus 294 --------------n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~ 359 (968)
T PLN00113 294 --------------NSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLT 359 (968)
T ss_pred --------------CeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCc
Confidence 677888999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeecCCcccccccccc-ccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhh
Q 043720 403 FIDLSSNELSGELDVK-LQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLL 481 (1103)
Q Consensus 403 ~LdLs~N~l~~~~~~~-~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 481 (1103)
.|+|++|++++.+|.. ..+++|+.|++++|++.+.+|..
T Consensus 360 ~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~---------------------------------------- 399 (968)
T PLN00113 360 VLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKS---------------------------------------- 399 (968)
T ss_pred EEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHH----------------------------------------
Confidence 9999999999877754 46788999999999999877642
Q ss_pred hhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCch
Q 043720 482 VSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLD 561 (1103)
Q Consensus 482 ~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~ 561 (1103)
+..++.|..+++++|+++|.+ |.. |.... ....+++++|++.+.+|..
T Consensus 400 ~~~~~~L~~L~L~~n~l~~~~-----------------------------p~~-~~~l~--~L~~L~Ls~N~l~~~~~~~ 447 (968)
T PLN00113 400 LGACRSLRRVRLQDNSFSGEL-----------------------------PSE-FTKLP--LVYFLDISNNNLQGRINSR 447 (968)
T ss_pred HhCCCCCCEEECcCCEeeeEC-----------------------------Chh-HhcCC--CCCEEECcCCcccCccChh
Confidence 334556778888888887632 221 11122 2357999999999999988
Q ss_pred hhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCC
Q 043720 562 IGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSL 641 (1103)
Q Consensus 562 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 641 (1103)
+..+ ++|++|+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|..+.++++|
T Consensus 448 ~~~l-~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 525 (968)
T PLN00113 448 KWDM-PSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL 525 (968)
T ss_pred hccC-CCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCC
Confidence 7765 899999999999998888766 45899999999999999999999999999999999999999999999999999
Q ss_pred cEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCC--ccccccccccCCC
Q 043720 642 EVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWN--VTTMNCSGVIGNP 719 (1103)
Q Consensus 642 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~--~~~~~~~~l~~Np 719 (1103)
++|+|++|.+++.+|..+..+++|+.|+|++|++++.+|..+..+++|+.+++++|++++.+|.. +.++....+.|||
T Consensus 526 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~ 605 (968)
T PLN00113 526 VSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNI 605 (968)
T ss_pred CEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCc
Confidence 99999999999999999999999999999999999999999999999999999999999988863 4456667789999
Q ss_pred CCCCCCCCCCCCCccCCCCCCCCCCCccCCCCCCCCCCceeeeeehhHHHHHHHHHHHHHhhhhcccCCC-CCccccccc
Q 043720 720 FLDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASAIVLILLTLVILFFYVRKGFP-DTRVQVSES 798 (1103)
Q Consensus 720 ~~c~C~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~i~~iv~~~~ivl~l~~~~~~~~~~~~~~~-~~~~~~~~~ 798 (1103)
..|.=..... .+.| .......... +++++++++++++++++++++++++++.. ..+......
T Consensus 606 ~lc~~~~~~~------------~~~c----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 668 (968)
T PLN00113 606 DLCGGDTTSG------------LPPC----KRVRKTPSWW-FYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDG 668 (968)
T ss_pred cccCCccccC------------CCCC----ccccccceee-eehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccc
Confidence 9884211000 0000 0011111111 22222222222222222223333332211 111111100
Q ss_pred cceeeeeecC--CCCCHHHHHHHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC
Q 043720 799 RELTLFIDIG--VPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV 875 (1103)
Q Consensus 799 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 875 (1103)
......++.. ...++++ ....|...+.||+|+||+||+|.. .++..||||++...... ..+|++.++++
T Consensus 669 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l 740 (968)
T PLN00113 669 TWELQFFDSKVSKSITIND---ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKL 740 (968)
T ss_pred cccccccccccchhhhHHH---HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhC
Confidence 0000011111 1123333 345678889999999999999976 56899999998643321 23468899999
Q ss_pred CCCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEE
Q 043720 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955 (1103)
Q Consensus 876 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIl 955 (1103)
+|||||+++|++.+.+..|+||||+++|+|.++++. ++|.++.+++.|+|+|++|||..+.++|+|||+||+||+
T Consensus 741 ~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil 815 (968)
T PLN00113 741 QHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKII 815 (968)
T ss_pred CCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEE
Confidence 999999999999999999999999999999999963 789999999999999999999766679999999999999
Q ss_pred ECCCCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 043720 956 LDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF 1035 (1103)
Q Consensus 956 l~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~ 1035 (1103)
++.++..++. ||....... .....++++|+|||++.+..++.|+|||||||++|||+||+.||+.... ...
T Consensus 816 ~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~---~~~ 886 (968)
T PLN00113 816 IDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG---VHG 886 (968)
T ss_pred ECCCCceEEE-ecccccccc-----CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC---CCC
Confidence 9999888875 665543211 1223678999999999999999999999999999999999999965433 234
Q ss_pred chHHHHHHHHhcCcccccccccccC--CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1036 NIISWASMLLRQGQVKDVFNAELWA--SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....|.............+++.... ........++.+++.+||+.||++||+|+||++.|+++.++
T Consensus 887 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 887 SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred cHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 4566666555444444555555432 23445667789999999999999999999999999998764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-58 Score=597.14 Aligned_cols=579 Identities=30% Similarity=0.436 Sum_probs=497.2
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCcccccc-CCCCCCEEEccccccCCCCCCCCCCCCCCCEEE
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFV-GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (1103)
.+++.|+|++|+++|.+|..+..+++|++|+|++|+++|.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~ 146 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLD 146 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEE
Confidence 4789999999999999999999999999999999999999998765 899999999999999998886 5689999999
Q ss_pred ccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCC
Q 043720 186 LAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265 (1103)
Q Consensus 186 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 265 (1103)
|++|.+++.+|..++++++|++|+|++|.+.+.+|..+..+ ++|++|+|++|++++.+|..++++++|++|+|++|.++
T Consensus 147 Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 147 LSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNL-TSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred CcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhC-cCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999998874 78999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCch
Q 043720 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM 345 (1103)
Q Consensus 266 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~ 345 (1103)
+.+|..++.+++|+.|++++|++++.+|..++++++|+.|++++ |.+.+.+|.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~---------------------------n~l~~~~p~ 278 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQ---------------------------NKLSGPIPP 278 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcC---------------------------CeeeccCch
Confidence 99999999999999999999999999999999999999999985 677888999
Q ss_pred hhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCcccccccccc-ccccce
Q 043720 346 EITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVK-LQVPCM 424 (1103)
Q Consensus 346 ~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~-~~~~~L 424 (1103)
++.++++|+.|++++|.+.+.+|..+.++++|+.|+|++|.+.+..|..+..+++|+.|+|++|++++.+|.. ..+++|
T Consensus 279 ~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L 358 (968)
T PLN00113 279 SIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNL 358 (968)
T ss_pred hHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999887754 478999
Q ss_pred eEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCcccccccc
Q 043720 425 ALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICW 504 (1103)
Q Consensus 425 ~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~ 504 (1103)
+.|++++|+++|.+|.. +.....+..+++++|++++.
T Consensus 359 ~~L~Ls~n~l~~~~p~~----------------------------------------~~~~~~L~~L~l~~n~l~~~--- 395 (968)
T PLN00113 359 TVLDLSTNNLTGEIPEG----------------------------------------LCSSGNLFKLILFSNSLEGE--- 395 (968)
T ss_pred cEEECCCCeeEeeCChh----------------------------------------HhCcCCCCEEECcCCEeccc---
Confidence 99999999999887752 12233466778888887753
Q ss_pred CCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCc
Q 043720 505 LPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584 (1103)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p 584 (1103)
+|.. +..+.. ...+++++|++++.+|..+..+ +.|+.|++++|++++.+|
T Consensus 396 --------------------------~p~~-~~~~~~--L~~L~L~~n~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~~ 445 (968)
T PLN00113 396 --------------------------IPKS-LGACRS--LRRVRLQDNSFSGELPSEFTKL-PLVYFLDISNNNLQGRIN 445 (968)
T ss_pred --------------------------CCHH-HhCCCC--CCEEECcCCEeeeECChhHhcC-CCCCEEECcCCcccCccC
Confidence 2222 122332 3578999999999999988776 999999999999999999
Q ss_pred ccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhccc
Q 043720 585 QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRN 664 (1103)
Q Consensus 585 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 664 (1103)
..+..+++|+.|+|++|++.+.+|..+ ..++|+.|+|++|++++.+|..|.++++|++|+|++|++++.+|..+..+++
T Consensus 446 ~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 524 (968)
T PLN00113 446 SRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKK 524 (968)
T ss_pred hhhccCCCCcEEECcCceeeeecCccc-ccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccC
Confidence 999999999999999999998888866 4689999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCc---cccccccccCCCCCCCCCCCCCCCCccCCCCCCC
Q 043720 665 LTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV---TTMNCSGVIGNPFLDPCQMYKDISSSELTSSNAN 741 (1103)
Q Consensus 665 L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~~~l~~Np~~c~C~~~~~~~~~~~~~~~~~ 741 (1103)
|+.|+|++|.+++.+|..+..+++|+.|++++|++++.+|..+ ..+..+++.+|++.+.++-...+..-......-+
T Consensus 525 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n 604 (968)
T PLN00113 525 LVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGN 604 (968)
T ss_pred CCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCC
Confidence 9999999999999999999999999999999999999988754 4567778999999886653322111111111112
Q ss_pred CCCCccCCCCCC--C-CCCceeeeeehhHHHHHHHHHHHHHhhhhcccCCC
Q 043720 742 SQHNITAPTGSR--T-EDHKIQIASIVSASAIVLILLTLVILFFYVRKGFP 789 (1103)
Q Consensus 742 ~~~~~~~p~~~~--~-~~~~~~i~~iv~~~~ivl~l~~~~~~~~~~~~~~~ 789 (1103)
+..|...++... . ...+....+++++++++++++++++.+++.+.+++
T Consensus 605 ~~lc~~~~~~~~~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 655 (968)
T PLN00113 605 IDLCGGDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGR 655 (968)
T ss_pred ccccCCccccCCCCCccccccceeeeehhHHHHHHHHHHHHHHHHHHHHhh
Confidence 223333322211 1 12234455666676666767666667777766543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=432.78 Aligned_cols=290 Identities=45% Similarity=0.795 Sum_probs=254.6
Q ss_pred CCCCCHHHHHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEE
Q 043720 808 GVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887 (1103)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 887 (1103)
...+++.++..||++|...+.||+|+||+||+|...+|+.||||++.....+. .++|..|+.++.+++|||+|+++|||
T Consensus 62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34589999999999999999999999999999999999999999887765543 56699999999999999999999999
Q ss_pred ecCC-eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 888 ASGN-EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 888 ~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
.+.+ +.++|||||++|+|.++++......++|.++.+||.++|+||+|||+.+.|+|+||||||+|||+|+++.+||+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsD 220 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSD 220 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccC
Confidence 9998 599999999999999999876543789999999999999999999999888999999999999999999999999
Q ss_pred cccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
||+|+..............||.+|+|||+...+..+.|+|||||||++.|++||+.+.+...+ ........|....+.
T Consensus 221 FGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~--~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP--RGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC--cccccHHHHHHHHHH
Confidence 999965432112111111799999999999999999999999999999999999998885542 234458899999999
Q ss_pred cCccccccccccc-CCCCh-hHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1047 QGQVKDVFNAELW-ASGPH-DDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.+.+.+++|+.+. ..++. ....++.+++.+|++.+|++||+|.||++.|+.+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 9999999999987 45553 678889999999999999999999999999987654
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=406.73 Aligned_cols=257 Identities=28% Similarity=0.496 Sum_probs=227.2
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
.+...+.||+|.||+||.|.+.....||+|.++..... .++|.+|+++|++++|++||+++|+|..++.+|||||||+
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 45668889999999999999998889999999876443 4788999999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
.|+|.+|++...+..+...+++.++.|||+||+||+++ ++|||||.++||||+++..+||+|||+|+....+.....
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 99999999986667799999999999999999999999 999999999999999999999999999996665555566
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
.+..-+..|.|||.+....++.|||||||||++|||+|.+...++..+ ..++.+.++...+.+
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~GyRlp 424 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLERGYRLP 424 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhccCcCC
Confidence 666678899999999999999999999999999999996554443322 123334556677788
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.|..||..+.++|..||+.+|++||||+.+...++++..
T Consensus 425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 899999999999999999999999999999999998754
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=377.44 Aligned_cols=252 Identities=28% Similarity=0.436 Sum_probs=215.3
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-eEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-EMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 899 (1103)
+++..+.||+|..|+||++.++ +++.+|+|++.........+++.+|++++++.+||+||+++|+|...+ ..+++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 4566788999999999999777 478899999977777777889999999999999999999999999988 59999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++|+|+++++..+ .+++..+-+|+.+|++||.|||+ + +||||||||+|||++..|.|||||||.+...-.+
T Consensus 160 MDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 99999999998763 49999999999999999999996 6 9999999999999999999999999999877443
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+.||.+..+ ....+......+..+..
T Consensus 233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---~~~~~~~Ll~~Iv~~pp--------- 299 (364)
T KOG0581|consen 233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---PYLDIFELLCAIVDEPP--------- 299 (364)
T ss_pred -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---CCCCHHHHHHHHhcCCC---------
Confidence 45678899999999999999999999999999999999999999986522 22223333333222111
Q ss_pred cCCCCh-hHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPH-DDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...|. .+.+++..++..|+++||.+||+++|+++|
T Consensus 300 -P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 300 -PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred -CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12233 377889999999999999999999999875
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=399.25 Aligned_cols=258 Identities=33% Similarity=0.538 Sum_probs=217.2
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-eEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-EMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 899 (1103)
++...+.||+|+||+||+|.+.....||||++...... ...+.|.+|+.++.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 34556669999999999999995555999999875433 23678999999999999999999999999987 79999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCC-cccCCCCCCcEEECCCC-CEEEeecccccccCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR-VLHRDVKPSNILLDDDF-NAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~ 977 (1103)
+++|+|.++++......+++..+.++|.|||+||+|||++ + ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999885456699999999999999999999999 7 99999999999999997 99999999998764322
Q ss_pred CccccCCcccccccCccccc--cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 978 THATTGVAGTFGYVAPEYAL--TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~--~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
...+...||++|||||++. ...|+.|+|||||||++|||+||+.||..... .+..... +.
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~--------~~~~~~v---------~~ 260 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP--------VQVASAV---------VV 260 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH--------HHHHHHH---------Hh
Confidence 2334468999999999999 56999999999999999999999999984322 1112211 22
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...+...+..++..+..++.+||+.||+.||++.+++..|+.+..
T Consensus 261 ~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 261 GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 233344455688999999999999999999999999999998754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=416.14 Aligned_cols=261 Identities=28% Similarity=0.470 Sum_probs=225.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
..+....+.||+|+||+||+|+.. +.+.||||.++.....+..++|++|++.+..++|||||+++|+|.+++.+
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 345667788999999999999644 35789999999998888899999999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC--------C----cccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC
Q 043720 894 FLIYNYLPGGNLENFIKARTS--------R----AVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~--------~----~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 961 (1103)
|||+|||..|||.+||+.+.. . +++..+.+.||.|||.||+||.++ .+|||||.++|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceE
Confidence 999999999999999986432 2 378899999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCcccc-CCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHH
Q 043720 962 AYLSDFGLSRLLGTSETHATT-GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIIS 1039 (1103)
Q Consensus 962 ~ki~Dfgla~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1103)
|||+|||+++.....+.++.. ...-+.+|||||.+..+++|++||||||||++||+++ |+.||+...-
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn---------- 711 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN---------- 711 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----------
Confidence 999999999998877777655 3445779999999999999999999999999999998 6666652211
Q ss_pred HHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.++.+.+..+...+.|+.+|.++++||..||+..|++||+|+||-..|+...+.
T Consensus 712 --------~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 712 --------QEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred --------HHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 111222222333677899999999999999999999999999999999987554
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=405.84 Aligned_cols=273 Identities=28% Similarity=0.475 Sum_probs=239.3
Q ss_pred CCCCHHHHHHHhcCC---------CCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcC
Q 043720 809 VPLTYESIIRATGDF---------NTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNV 875 (1103)
Q Consensus 809 ~~~~~~~~~~~~~~~---------~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l 875 (1103)
.|++||+-..|..+| .+.++||.|.||+||+|+++- ...||||.++....++...+|..|+.+|.++
T Consensus 608 DP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF 687 (996)
T KOG0196|consen 608 DPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF 687 (996)
T ss_pred CCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC
Confidence 577888766665444 456899999999999997763 4679999999999988999999999999999
Q ss_pred CCCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEE
Q 043720 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955 (1103)
Q Consensus 876 ~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIl 955 (1103)
+||||+++.|+.......++|+|||++|+|+.||+.+.+ ++++.++..+.++||.||.||.++ ++|||||.++|||
T Consensus 688 dHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNIL 763 (996)
T KOG0196|consen 688 DHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNIL 763 (996)
T ss_pred CCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---Cchhhhhhhhhee
Confidence 999999999999999999999999999999999998875 499999999999999999999999 9999999999999
Q ss_pred ECCCCCEEEeecccccccCCCCCcccc--CCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 043720 956 LDDDFNAYLSDFGLSRLLGTSETHATT--GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHG 1032 (1103)
Q Consensus 956 l~~~~~~ki~Dfgla~~~~~~~~~~~~--~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~ 1032 (1103)
|+.+..+||+|||+++....+.....+ +-.-+.+|.|||.+...++|.+||||||||++||.++ |.+||....
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS---- 839 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS---- 839 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc----
Confidence 999999999999999987544422222 2233579999999999999999999999999999886 777765322
Q ss_pred CCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
+.++.+.++...+.+.|.+||..+.+||.+||++|..+||.|.+|+..|.++.++|+
T Consensus 840 --------------NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 840 --------------NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred --------------hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 234455667788889999999999999999999999999999999999999999885
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=367.12 Aligned_cols=200 Identities=33% Similarity=0.574 Sum_probs=182.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|...+.||+|+||+||+|+++ ++..||||.+.+.. .++.++....|+.+++.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467999999999999999999765 47999999998875 4556777899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC------CCEEEeeccccc
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD------FNAYLSDFGLSR 971 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~------~~~ki~Dfgla~ 971 (1103)
|||.||||.+|++++.. +++..++.++.|+|.|+++||++ +||||||||+|||++.. -.+||+|||+|+
T Consensus 89 EyC~gGDLs~yi~~~~~--l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGR--LPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred EeCCCCCHHHHHHHcCC--CCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 99999999999998754 99999999999999999999999 99999999999999864 458999999999
Q ss_pred ccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDP 1026 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 1026 (1103)
.+.. .......+|+|-|||||++....|+.|+|+||+|+++|||++|+.||+.
T Consensus 164 ~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 164 FLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred hCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 8863 3344567999999999999999999999999999999999999999984
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=385.27 Aligned_cols=249 Identities=23% Similarity=0.395 Sum_probs=214.4
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.+|...+.||+|+|+.||+++. ..|+.||+|++.+... ....+.+.+|+++.++++|||||+++++|++.+.+|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 4699999999999999999976 8899999999987543 335677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|+|+.++|.++++++ +++++.+++.+..||+.|+.|||++ +|+|||||..|++++++.+|||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~- 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD- 171 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-
Confidence 999999999999954 4599999999999999999999999 9999999999999999999999999999988643
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......+|||.|.|||++....++..+||||+||++|.|+.|++||+... .......+...+
T Consensus 172 ~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--------vkety~~Ik~~~--------- 234 (592)
T KOG0575|consen 172 GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--------VKETYNKIKLNE--------- 234 (592)
T ss_pred ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--------HHHHHHHHHhcC---------
Confidence 234456799999999999999999999999999999999999999998321 111111111111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...|........+||.++++.||.+|||+++|+.+
T Consensus 235 --Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h 269 (592)
T KOG0575|consen 235 --YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH 269 (592)
T ss_pred --cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 12344667789999999999999999999999864
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=368.87 Aligned_cols=253 Identities=26% Similarity=0.411 Sum_probs=206.8
Q ss_pred cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchh------hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH------GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
+.|.+.+.||+|+||.|-+| +.++|+.||||++.+..... ....+.+|+++|++++||+||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 46888999999999999999 45579999999997653321 234467999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC---CCEEEeecccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD---FNAYLSDFGLS 970 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~Dfgla 970 (1103)
|||||||+||+|.+++-.+.. +.+..-+.+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlA 326 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLA 326 (475)
T ss_pred EEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchh
Confidence 999999999999999976554 77788889999999999999999 99999999999999765 67999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCR---VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
+..+ ........+|||.|.|||++.+.. +..|+|+||+||++|-+++|.+||....+.. -...++..
T Consensus 327 K~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--------sl~eQI~~ 396 (475)
T KOG0615|consen 327 KVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--------SLKEQILK 396 (475)
T ss_pred hccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--------cHHHHHhc
Confidence 9875 445566789999999999997543 3348899999999999999999998543321 02222223
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+.+. +.+. .-.....+..++|.+|+..||++|||++|++++
T Consensus 397 G~y~--f~p~----~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 GRYA--FGPL----QWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred Cccc--ccCh----hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 3221 1111 224567889999999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=383.92 Aligned_cols=498 Identities=28% Similarity=0.369 Sum_probs=357.2
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
..|+.|.+++|.+. .+-+.+.++..|.+|++++|+++ ..|++++.+..++.|+.++|+++ .+|..++++.+|..|+.
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence 45777888888887 55556778888888888888888 77888888888888888888887 78888888888888888
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
++|.+. .+|+.++.+..|..|+..+|+++ ++|++++.. .+|..|++.+|+++ ..|+..-+++.|++||+..|.++.
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~-~~l~~l~~~~n~l~-~l~~~~i~m~~L~~ld~~~N~L~t 197 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNL-SKLSKLDLEGNKLK-ALPENHIAMKRLKHLDCNSNLLET 197 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHH-HHHHHhhccccchh-hCCHHHHHHHHHHhcccchhhhhc
Confidence 888887 56667777888888888888887 788777764 55788888888887 445455558888888888888754
Q ss_pred cccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
+|..++.+.+|..|||.+|++. .+| +|..|..|.+|.++ +++...+|.+
T Consensus 198 -lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g----------------------------~N~i~~lpae 246 (565)
T KOG0472|consen 198 -LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVG----------------------------ENQIEMLPAE 246 (565)
T ss_pred -CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhc----------------------------ccHHHhhHHH
Confidence 7778888888888888888887 445 67777766666665 2333444444
Q ss_pred hhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeE
Q 043720 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL 426 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~ 426 (1103)
.. ..+++|..|||..|+++ ..|+.++-+.+|.+||+|+|.|++.++...++ .|+.
T Consensus 247 ~~-----------------------~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl-hL~~ 301 (565)
T KOG0472|consen 247 HL-----------------------KHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL-HLKF 301 (565)
T ss_pred Hh-----------------------cccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc-eeee
Confidence 43 24555555555555555 34555555666666666666666655555555 6666
Q ss_pred EEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCC
Q 043720 427 FDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLP 506 (1103)
Q Consensus 427 l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~ 506 (1103)
|-+.||++.. .+......+.-.-+.|++++....-+..- +.-.. -.-++ +.|.
T Consensus 302 L~leGNPlrT-----------------iRr~ii~~gT~~vLKyLrs~~~~dglS~s---e~~~e-----~~~t~-~~~~- 354 (565)
T KOG0472|consen 302 LALEGNPLRT-----------------IRREIISKGTQEVLKYLRSKIKDDGLSQS---EGGTE-----TAMTL-PSES- 354 (565)
T ss_pred hhhcCCchHH-----------------HHHHHHcccHHHHHHHHHHhhccCCCCCC---ccccc-----ccCCC-CCCc-
Confidence 6666665541 00000111122334455543222111000 00000 00000 0111
Q ss_pred CCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCccc
Q 043720 507 VAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQS 586 (1103)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~ 586 (1103)
....+..-....++.+..+...+|..+|.....-.....++++|++. ++|..+..+..-++.+++++|.++ -+|..
T Consensus 355 --~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~ 430 (565)
T KOG0472|consen 355 --FPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLE 430 (565)
T ss_pred --ccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHH
Confidence 11111112233455666777889999999888766778999999998 899998877445667888888887 78899
Q ss_pred ccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhccccc
Q 043720 587 LENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLT 666 (1103)
Q Consensus 587 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 666 (1103)
++.+++|..|+|++|-+. .+|..++.+..|+.|++++|+|. .+|..+-.+..|+.+-.++|++..+.|..+.+|.+|.
T Consensus 431 l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~ 508 (565)
T KOG0472|consen 431 LSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT 508 (565)
T ss_pred HHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc
Confidence 999999999999999998 79999999999999999999998 8899888888899988889999977788899999999
Q ss_pred ccccccccCcCCCCccccCCCCCceEeCCCCCCCC
Q 043720 667 ALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701 (1103)
Q Consensus 667 ~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 701 (1103)
+|||.+|.|. .+|+.++++++|++|++.+|+|+.
T Consensus 509 tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr~ 542 (565)
T KOG0472|consen 509 TLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFRQ 542 (565)
T ss_pred eeccCCCchh-hCChhhccccceeEEEecCCccCC
Confidence 9999999999 899999999999999999999984
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=346.51 Aligned_cols=256 Identities=29% Similarity=0.426 Sum_probs=209.7
Q ss_pred CCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEe-EEecC-CeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIG-YRASG-NEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~-~~~~lV~ 897 (1103)
+|++.++||+|.||+||++ ...+|..||.|.+.-+.. ....++...|+.++++++|||||++++ .+.++ ...++||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 5888999999999999999 566799999999986544 345677889999999999999999998 34444 4489999
Q ss_pred eecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCC-CcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAP-RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~-~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
|||.+|+|...++..+ .+.++++.+++++.|++.||.++|++... -|+||||||.||+++.+|.||++|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999997533 36699999999999999999999995322 38999999999999999999999999999885
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
. ........+|||.||+||.+.+..|+.||||||+||++|||+.-++||++. ++......+ .+++.
T Consensus 180 s-~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~--------n~~~L~~KI-~qgd~---- 245 (375)
T KOG0591|consen 180 S-KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD--------NLLSLCKKI-EQGDY---- 245 (375)
T ss_pred c-hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc--------cHHHHHHHH-HcCCC----
Confidence 3 344566789999999999999999999999999999999999999999843 333333332 22221
Q ss_pred cccccCCCC-hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1055 NAELWASGP-HDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1055 ~~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
.+.| .-...++.++|..|+..||+.||+...+++.++
T Consensus 246 -----~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 -----PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -----CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1122 455688999999999999999998655554443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=353.43 Aligned_cols=249 Identities=26% Similarity=0.399 Sum_probs=209.9
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||.++. ++++.+|+|++++...- .+.+...+|..++.+++||+||+++-.|++.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 45799999999999999999954 45899999999876543 3577899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+||+.||.|...|++... +++..++.++.+|+.||.|||++ +|||||+||+|||+|.+|+++++|||+++..-.
T Consensus 104 ld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~- 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK- 177 (357)
T ss_pred EeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc-
Confidence 999999999999987543 99999999999999999999999 999999999999999999999999999986432
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
........+||+.|||||++.+..|+.++|.||+|+++|||++|.+||... +...+...+....
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~--------~~~~~~~~I~~~k-------- 241 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE--------DVKKMYDKILKGK-------- 241 (357)
T ss_pred CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc--------cHHHHHHHHhcCc--------
Confidence 233445589999999999999999999999999999999999999999843 2233333333222
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCC----CHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRP----TMKQVV 1092 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl 1092 (1103)
....+.-...+..+++.+.+..||++|- ++.+|.
T Consensus 242 --~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 242 --LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred --CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhh
Confidence 1122333556789999999999999995 455543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=398.67 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=222.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcC--C----cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP--G----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
...+..+.||+|+||.||.|...+ + ..||||.++...+.+.+.+|.+|..+|+.++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456667889999999999996553 3 3599999999988889999999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhc-----CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 895 LIYNYLPGGNLENFIKART-----SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
+++|||++|+|..|+++.+ ...++..+++.++.|||+|+.||+++ ++|||||.++|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999999752 35689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCC-cccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 970 SRLLGTSETHATTGV-AGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~-~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
|+.....+.+..... .-+.+|||||.+.++.++.|+|||||||++||++|.+.+.++.... . +....
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n----~---~v~~~----- 916 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN----F---EVLLD----- 916 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch----H---HHHHH-----
Confidence 997766666554444 3456999999999999999999999999999999966544432221 1 11111
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
+.... +.+.|..|+..++++|..||+.+|++||+|.+|++.+++|.+.
T Consensus 917 ----~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 917 ----VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred ----HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 11122 5677899999999999999999999999999999999988764
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=336.98 Aligned_cols=264 Identities=22% Similarity=0.301 Sum_probs=206.0
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhh-HHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
+.|+...++|+|+||+||++++++ |+.||||++....+.+. .+-.++|+.++++++|+|+|.++++|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888899999999999997764 99999999977665444 4557899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
||+. ++.+-++... ..++.+.+.+++.|+++|+.|+|++ +++||||||+|||++.+|.+|+||||+|+.... ..
T Consensus 82 ~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pg 155 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PG 155 (396)
T ss_pred ecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Cc
Confidence 9976 6666666554 4589999999999999999999999 999999999999999999999999999998863 33
Q ss_pred ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH-----------HHh
Q 043720 979 HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM-----------LLR 1046 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~~ 1046 (1103)
...+.++.|.+|.|||.+.+ ..|+..+||||.||++.||++|.+-|.+. .+...++..... +..
T Consensus 156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~----SDiDQLy~I~ktLG~L~prhq~iF~~ 231 (396)
T KOG0593|consen 156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR----SDIDQLYLIRKTLGNLIPRHQSIFSS 231 (396)
T ss_pred chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc----chHHHHHHHHHHHcccCHHHHHHhcc
Confidence 34456788999999999877 78999999999999999999999766422 122222211111 001
Q ss_pred cCccccccccccc-----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDVFNAELW-----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+.-+... ..........+.++++.|++.||.+|++-+|++.+
T Consensus 232 N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 232 NPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 1111111111111 11112344568999999999999999999998853
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=354.96 Aligned_cols=263 Identities=24% Similarity=0.333 Sum_probs=207.7
Q ss_pred hcCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCC-eEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGN-EMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lV 896 (1103)
.++|.+.++||.|+||+||+|+ ..++..||||+++..-..-+.-.-.||+..++++. |||||++.+++.+.+ ..|+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 4579999999999999999995 44689999999987644422333568999999998 999999999998887 99999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||| ..+|+++++.+ ++.+++.++..|+.||++||+|+|.+ |+.|||+||+|||++....+||+|||+|+.+...
T Consensus 89 fE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 89 FEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred HHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccC
Confidence 9999 56999999988 68899999999999999999999999 9999999999999998889999999999987543
Q ss_pred CCccccCCcccccccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYA-LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. ..+.++.|.+|+|||++ ..+.|+.+.||||+|||++|+.+-++-|-+.. +..+++..+. +...........
T Consensus 164 p--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s----E~Dqi~KIc~-VLGtP~~~~~~e 236 (538)
T KOG0661|consen 164 P--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS----EIDQIYKICE-VLGTPDKDSWPE 236 (538)
T ss_pred C--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc----HHHHHHHHHH-HhCCCccccchh
Confidence 3 34566889999999987 56789999999999999999999887765322 1111111111 110000000000
Q ss_pred ------------cccc----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 ------------AELW----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ------------~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+... ...-..+..+..++|.+|+.+||++||+|+|++++
T Consensus 237 g~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 237 GYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 0000 01113477889999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=353.86 Aligned_cols=253 Identities=26% Similarity=0.392 Sum_probs=213.6
Q ss_pred HHhcCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 893 (1103)
+...+|..++.||+|+|++||+| +.++++.||||++.+.-. +..++.+..|-..|.++ .||.|++++--|.+...+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 33467999999999999999999 455689999999976532 22356688899999999 799999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+|+||+++|+|.+++++.+. +++...+.+|.+|+.|++|||++ |||||||||+|||+|+++++||+|||.|..+
T Consensus 150 YFvLe~A~nGdll~~i~K~Gs--fde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKYGS--FDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEEecCCCcHHHHHHHhCc--chHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999998754 99999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCCc------------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHH
Q 043720 974 GTSETH------------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 974 ~~~~~~------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
...... ....++||-.|.+||++.+...+..+|+|+||||+|+|+.|++||..... +..+
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--------yliF 296 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--------YLIF 296 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--------HHHH
Confidence 432111 12458999999999999999999999999999999999999999984322 1222
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+... .-+++...++.+.+||++.+..||.+|++..+|.+|
T Consensus 297 qkI~~l-----------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 297 QKIQAL-----------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred HHHHHh-----------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence 222211 123466667889999999999999999999888765
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=361.15 Aligned_cols=261 Identities=25% Similarity=0.381 Sum_probs=211.4
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
..+++.+...||+|.||+||+|.|.. .||||++.++.. .+..+.|+.|+.++++-+|.||+-+.|||..... .+|+
T Consensus 390 p~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiT 466 (678)
T KOG0193|consen 390 PPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIIT 466 (678)
T ss_pred CHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeee
Confidence 34567788999999999999999883 499999988755 3467889999999999999999999999998877 9999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
.+|+|.+|+.+++..+ ..++..+.+.||.|||+||.|||.+ +|||||||+.||++.+++.|||+|||++..-..-.
T Consensus 467 qwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 467 QWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 9999999999998765 3489999999999999999999999 99999999999999999999999999987542221
Q ss_pred -CccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 978 -THATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 978 -~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.......-|...|||||++. ..+|++.+||||||+++|||++|..||..... +.. +.. +..+..
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~---dqI-----ifm-VGrG~l--- 610 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR---DQI-----IFM-VGRGYL--- 610 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh---hhe-----EEE-eccccc---
Confidence 11122334678999999986 45789999999999999999999999872111 100 000 001100
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
- .........++.++.+|+..||..++++||.+.+|+..|+.+.+
T Consensus 611 -~-pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 611 -M-PDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred -C-ccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 0 01122346788999999999999999999999999998888765
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-39 Score=344.13 Aligned_cols=271 Identities=28% Similarity=0.441 Sum_probs=206.6
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhc--CCCCceeEEEeEEecCC----eE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGN--VRHPNLVTLIGYRASGN----EM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~ 893 (1103)
....+..+.||+|.||.||+|.+. ++.||||++... ..+.|..|.++... ++|+||++++++...+. ++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc-CceeEEEecCHH----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 345667788999999999999988 589999999754 45667777666655 58999999999876666 89
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhC------CCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ------CAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
++|+||.+.|+|.+|++.+. ++|....+|+..+++||+|||+. .+|+|+|||||++||||..|+++.|+||
T Consensus 284 wLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred eEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 99999999999999999876 99999999999999999999974 3689999999999999999999999999
Q ss_pred ccccccCCCCCc-cccCCcccccccCccccccCC-CC-----CcchhHHHHHHHHHHHhCCCCCCCCCCCC---------
Q 043720 968 GLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCR-VS-----DKADVYSYGVVLLELISDKKALDPSFSSH--------- 1031 (1103)
Q Consensus 968 gla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~-~~-----~~sDvwslGvil~elltg~~p~~~~~~~~--------- 1031 (1103)
|+|.++...... ...+.+||.+|||||++.+.. .. .+.||||+|.++|||+++...+++...+.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988654432 334578999999999997642 11 26899999999999999887665311110
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
+..... +-....+-.++....+...+. .......+.+.+..||+.||+.|-|+.-+-+++.++....
T Consensus 441 G~hPt~-e~mq~~VV~kK~RP~~p~~W~---~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTL-EEMQELVVRKKQRPKIPDAWR---KHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCH-HHHHHHHHhhccCCCChhhhh---cCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 000001 111111111111111111111 1245667899999999999999999999999999886654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=352.62 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=222.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.....+.++||+|.||+|..+....+..||||+++-+.......+|.+|+++|.+++|||||+++|+|..++.+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 34567788999999999999999988999999999988888889999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
|++|+|.+|+.++...........+|+.|||.||+||.+. ++||||+.++|+|++.++++||+|||+++-+...+.+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999999987544456667788999999999999999 9999999999999999999999999999987777776
Q ss_pred cccC-CcccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 980 ATTG-VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS--DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 980 ~~~~-~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
..++ .+-+.+|||||.+.-++++.++|||+||+++||+++ ...||..... .+.+.. .+.+-.--..
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~--------e~vven---~~~~~~~~~~ 762 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD--------EQVVEN---AGEFFRDQGR 762 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH--------HHHHHh---hhhhcCCCCc
Confidence 6553 345679999999999999999999999999999875 5566652111 011111 0111111112
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
......|.-++..++++|.+||..+-++||+++++...|++..
T Consensus 763 ~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 763 QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 2334557789999999999999999999999999999998753
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=355.98 Aligned_cols=243 Identities=28% Similarity=0.415 Sum_probs=209.5
Q ss_pred CCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
....+.||.|+.|.||.|+++ ++.||||+++.- -..+|+.+++++|+||+.|.|+|.....+|+|||||..
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el--------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~ 196 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL--------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQ 196 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhh--------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecccc
Confidence 344667999999999999998 788999987532 23589999999999999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|-|+..++... .++...+..+..+||.||.|||.+ .|||||||+-||||+.+..|||+|||-++..... ....
T Consensus 197 GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkM 269 (904)
T KOG4721|consen 197 GQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKM 269 (904)
T ss_pred ccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhh
Confidence 99999998754 488999999999999999999999 9999999999999999999999999999876433 3455
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
.+.||..|||||++...+.++|+|||||||++|||+||..||..-++.. .+-.+-...+....
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA-----------------IIwGVGsNsL~Lpv 332 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA-----------------IIWGVGSNSLHLPV 332 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe-----------------eEEeccCCcccccC
Confidence 6789999999999999999999999999999999999999987332210 11111223344567
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
|..|++.+.-|++.||+-.|..||+|++|+.+|+-.
T Consensus 333 PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 333 PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 889999999999999999999999999999999754
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=367.35 Aligned_cols=263 Identities=23% Similarity=0.362 Sum_probs=216.4
Q ss_pred HHHhcCCCCcceeccCCcccEEEEEEcCC-----cEEEEEEccc--ccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec
Q 043720 817 IRATGDFNTSNCIGSGGFGTTYKAEISPG-----ILVAVKKLAV--GRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS 889 (1103)
Q Consensus 817 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~-----~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 889 (1103)
+-..++..+.+.||+|+||+||+|.++.+ ..||||..+. ....+...+|++|+++|+.++|||||+++|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 33445667779999999999999966542 2389999885 3446678999999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 890 GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
..++|+|||+|.||+|.+||++..+ .++..+..+++.+.|.||+|||++ +++||||.++|+|++.++.+||+|||+
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGL 308 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGL 308 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCcccc
Confidence 9999999999999999999998764 599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
++... ..........-+.+|+|||.+....|++++|||||||++||+++ |..||.+... .+....+.
T Consensus 309 s~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~--------~~v~~kI~--- 376 (474)
T KOG0194|consen 309 SRAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN--------YEVKAKIV--- 376 (474)
T ss_pred ccCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH--------HHHHHHHH---
Confidence 87542 11111112234679999999999999999999999999999999 6777763321 11121111
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+...+...+.++..++.+||..+|++||+|.++.+.++.+...
T Consensus 377 ------~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 377 ------KNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK 423 (474)
T ss_pred ------hcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence 22333445567788999999999999999999999999999998654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=348.20 Aligned_cols=258 Identities=26% Similarity=0.468 Sum_probs=210.9
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC--eEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN--EMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 897 (1103)
.+|...+.||+|+||+||++...+ |+..|||.+....... .+.+.+|+.++.+++|||||+++|...... .++++|
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 357778899999999999996654 8999999998774443 677899999999999999999999854444 699999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecccccccCC-
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGT- 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~- 975 (1103)
||+++|+|.+++++..+ .+++..+.+++.||++||+|||++ +||||||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999999998776 699999999999999999999999 9999999999999999 79999999999987653
Q ss_pred -CCCccccCCcccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 -SETHATTGVAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 -~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
..........||+.|||||++..+. ...++||||+||++.||+||+.||... .....+.........
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-------~~~~~~~~~ig~~~~---- 240 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-------FEEAEALLLIGREDS---- 240 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-------cchHHHHHHHhccCC----
Confidence 2222344678999999999998643 335899999999999999999998732 111222222221221
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
....+...+.+..+++.+|+..+|++||||++++++-....
T Consensus 241 -----~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 241 -----LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ 281 (313)
T ss_pred -----CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence 11345567788999999999999999999999998765433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=357.06 Aligned_cols=250 Identities=23% Similarity=0.420 Sum_probs=213.8
Q ss_pred cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
..|..-..||+|+.|.||.| +..+++.||||++...... ..+-+.+|+.+|+..+|+|||++++.+..+++.|+||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~-~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP-KKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC-chhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35777788999999999999 5667899999999765433 456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
|+||+|.+.+.... +++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+... ..
T Consensus 352 m~ggsLTDvVt~~~---~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~-~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR---MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE-QS 424 (550)
T ss_pred cCCCchhhhhhccc---ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc-cC
Confidence 99999999997755 99999999999999999999999 9999999999999999999999999999877533 33
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.+...+|||.|||||++....|++|+||||||++++||+.|++||....+ .+-...+...+ ...
T Consensus 425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--------lrAlyLIa~ng--------~P~ 488 (550)
T KOG0578|consen 425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG--------TPK 488 (550)
T ss_pred ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--------HHHHHHHhhcC--------CCC
Confidence 66678999999999999999999999999999999999999999974322 11111222222 122
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+......+.+++.+||+.||++||+++|++++
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 34456677889999999999999999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=320.87 Aligned_cols=263 Identities=26% Similarity=0.374 Sum_probs=207.5
Q ss_pred cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhh-HHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.+|...+++|+|.||.||+| +.++|+.||||+++.....+. .....+|+..++.++|+||+.++++|...+.+-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 36778889999999999999 566799999999998765543 3457899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
||+. +|+..++... ..++..++..++.++.+|++|+|++ .|+||||||.|+|++.+|.+||+|||+|+.++....
T Consensus 82 fm~t-dLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred eccc-cHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 9964 9999998754 5689999999999999999999999 999999999999999999999999999999876554
Q ss_pred ccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc-----
Q 043720 979 HATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD----- 1052 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1052 (1103)
.... .+.|.+|.|||.+.+. .|+..+||||.|||+.||+-|.+-|. ..+ +-.++. .+-........++
T Consensus 157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fp-G~s---DidQL~-~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFP-GDS---DIDQLS-KIFRALGTPTPDQWPEMT 230 (318)
T ss_pred cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCC-CCc---hHHHHH-HHHHHcCCCCcccCcccc
Confidence 4333 3679999999998764 69999999999999999998875443 221 111111 1111111111000
Q ss_pred ----c-----ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 ----V-----FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ----~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. +...........+..++.+++.+|+..||.+|.+++|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 11111111234456778999999999999999999999875
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=336.60 Aligned_cols=270 Identities=24% Similarity=0.359 Sum_probs=209.2
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhc--CCCCceeEEEeEEecCC----e
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGN--VRHPNLVTLIGYRASGN----E 892 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~ 892 (1103)
...+..+.+.||+|.||+||+|+|+ |+.||||++.... .+.+.+|.++.+. ++|+||+.+++....+. .
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ 283 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ 283 (513)
T ss_pred hhheeEEEEEecCccccceeecccc-CCceEEEEecccc----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence 3457888999999999999999999 8999999997543 3455666666655 49999999999875543 7
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-----CCCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-----QCAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-----~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
+|+|++|.+.|||.|||.+.. ++.+..++++..+|.||+|||. +.+|.|+|||||++||||.+++.+.|+|+
T Consensus 284 LwLvTdYHe~GSL~DyL~r~t---v~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNRNT---VTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEEeeecccCCcHHHHHhhcc---CCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 899999999999999998754 8999999999999999999995 45799999999999999999999999999
Q ss_pred ccccccCCCCCc---cccCCcccccccCccccccCC-----CC-CcchhHHHHHHHHHHHhC----------CCCCCCCC
Q 043720 968 GLSRLLGTSETH---ATTGVAGTFGYVAPEYALTCR-----VS-DKADVYSYGVVLLELISD----------KKALDPSF 1028 (1103)
Q Consensus 968 gla~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~-----~~-~~sDvwslGvil~elltg----------~~p~~~~~ 1028 (1103)
|+|......... .....+||.+|||||++.... -+ ..+||||||.++||+.-+ +.||++.-
T Consensus 361 GLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~V 440 (513)
T KOG2052|consen 361 GLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVV 440 (513)
T ss_pred eeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCC
Confidence 999877544322 345678999999999985432 12 258999999999999853 45665443
Q ss_pred CCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1029 SSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
+.+....+ ....+-.......++.++ ...++...+.++|+.||..+|..|-++-.|.+.|.++.++++
T Consensus 441 p~DPs~ee----MrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~e 508 (513)
T KOG2052|consen 441 PSDPSFEE----MRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSDE 508 (513)
T ss_pred CCCCCHHH----HhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence 33222111 111111222222222222 235678889999999999999999999999999999987653
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=365.88 Aligned_cols=495 Identities=25% Similarity=0.377 Sum_probs=365.6
Q ss_pred ccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcC
Q 043720 151 FVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYL 230 (1103)
Q Consensus 151 l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L 230 (1103)
+..-..|+.|++++|.++ .+-..+.++..|.+|++.+|+++ ..|.+++.+.+++.|+.++|+++ .+|+.++.. .+|
T Consensus 41 wW~qv~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~-~~l 116 (565)
T KOG0472|consen 41 WWEQVDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSL-ISL 116 (565)
T ss_pred hhhhcchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhh-hhh
Confidence 344456677777777776 55556667777777777777777 55666777777777777777777 777777764 457
Q ss_pred cEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccC
Q 043720 231 EHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 231 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
..|+.++|.+. .+|+.++.+..|..++..+|+++. .|..+..+.+|..|++.+|.+....|..+. ++.|+.||.-
T Consensus 117 ~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N~i~s-lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~-- 191 (565)
T KOG0472|consen 117 VKLDCSSNELK-ELPDSIGRLLDLEDLDATNNQISS-LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCN-- 191 (565)
T ss_pred hhhhcccccee-ecCchHHHHhhhhhhhcccccccc-CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccc--
Confidence 77777777777 566777777777777777777765 566777777777777888877755444444 7778887774
Q ss_pred cCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccc
Q 043720 311 FDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGD 390 (1103)
Q Consensus 311 ~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 390 (1103)
.+..+.+|.+++.|.+|..|++..|++. .+| +|.+++.|.+|+++.|+|.-.
T Consensus 192 --------------------------~N~L~tlP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~~l 243 (565)
T KOG0472|consen 192 --------------------------SNLLETLPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIEML 243 (565)
T ss_pred --------------------------hhhhhcCChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHHhh
Confidence 4567788889999999999999999988 455 899999999999999999977
Q ss_pred cchhhhccCCceEeecCCccccccccccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHH
Q 043720 391 LIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYF 470 (1103)
Q Consensus 391 ~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (1103)
+.+...++++|..|||++|+++..+.....+.+|+.||+|+|.+++-.+....-.+..+-+++.+ ....-
T Consensus 244 pae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is~Lp~sLgnlhL~~L~leGNP----------lrTiR 313 (565)
T KOG0472|consen 244 PAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDISSLPYSLGNLHLKFLALEGNP----------LRTIR 313 (565)
T ss_pred HHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccccCCcccccceeeehhhcCCc----------hHHHH
Confidence 77777899999999999999999888888999999999999999976655422111111111100 01111
Q ss_pred HhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcc-cccccEEec
Q 043720 471 MSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACN-EFHGMVANL 549 (1103)
Q Consensus 471 ~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~-~~~~~~l~l 549 (1103)
......|....+..+|....-+ | ++.- .++..-.+..|.+.|.... .-+...|++
T Consensus 314 r~ii~~gT~~vLKyLrs~~~~d-------g--------lS~s---------e~~~e~~~t~~~~~~~~~~~~i~tkiL~~ 369 (565)
T KOG0472|consen 314 REIISKGTQEVLKYLRSKIKDD-------G--------LSQS---------EGGTETAMTLPSESFPDIYAIITTKILDV 369 (565)
T ss_pred HHHHcccHHHHHHHHHHhhccC-------C--------CCCC---------cccccccCCCCCCcccchhhhhhhhhhcc
Confidence 1222222222222222210000 0 0000 1111112334555554333 234567899
Q ss_pred CCCcccccCCchhhhcCC--CccEEECcCCcCCCCCcccccCCCCCC-EEEccCCcCCCCCCcccccCccCcEEeccCcc
Q 043720 550 SNNNIIGHIPLDIGVMCK--SLRVLDASHNQISGIVPQSLENLTSLV-FLDLNGNKLQGEIPSSLHRLKYLRHLSLADNN 626 (1103)
Q Consensus 550 s~n~~~~~ip~~~~~~~~--~L~~L~L~~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 626 (1103)
++-+++ .+|.+++...+ -.+.++++.|++. .+|..+..+..++ .+.+++|.+. .+|..++.+++|..|+|++|-
T Consensus 370 s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~ 446 (565)
T KOG0472|consen 370 SDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNL 446 (565)
T ss_pred cccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccch
Confidence 999998 99999987632 2789999999999 7788888877665 4566666665 899999999999999999999
Q ss_pred cCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCC-
Q 043720 627 LTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPW- 705 (1103)
Q Consensus 627 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~- 705 (1103)
+. .+|.+++.+..|+.||+|.|+|. ..|..+..+..|+.+-.++|++....|+.+.+|.+|.+||+.+|.+...+|.
T Consensus 447 Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~L 524 (565)
T KOG0472|consen 447 LN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPIL 524 (565)
T ss_pred hh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhh
Confidence 98 78999999999999999999998 7999888889999999999999977777799999999999999999998885
Q ss_pred -CccccccccccCCCCC
Q 043720 706 -NVTTMNCSGVIGNPFL 721 (1103)
Q Consensus 706 -~~~~~~~~~l~~Np~~ 721 (1103)
++..+.++.+.|||+.
T Consensus 525 gnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 525 GNMTNLRHLELDGNPFR 541 (565)
T ss_pred ccccceeEEEecCCccC
Confidence 7888999999999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=338.28 Aligned_cols=262 Identities=25% Similarity=0.385 Sum_probs=214.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++...||.|..++||+|+.. .++.||||++..+......+.+.+|+..|+.++||||++++..|..+...|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 57999999999999999999554 58999999999998888889999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
|.+|++.+.++..-...+++..+..|.+++++||.|||.+ |.||||+|+.||||+.+|.|||+|||.+..+......
T Consensus 106 Ma~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R 182 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR 182 (516)
T ss_pred hcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence 9999999999988777899999999999999999999999 9999999999999999999999999987665433221
Q ss_pred ---cccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 980 ---ATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 980 ---~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.....+|++.|||||++.. ..|+.|+||||||++..|+.+|..||....+. +....... +......
T Consensus 183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--------kvLl~tLq-n~pp~~~ 253 (516)
T KOG0582|consen 183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--------KVLLLTLQ-NDPPTLL 253 (516)
T ss_pred eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--------HHHHHHhc-CCCCCcc
Confidence 1255689999999999643 46899999999999999999999999744321 11111111 1111000
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
-.....+........+.+++..|+++||++|||+++++++
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 0000011122344579999999999999999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=325.73 Aligned_cols=237 Identities=25% Similarity=0.412 Sum_probs=205.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|+..+.||.|+||.|..++.+ +|..+|+|++.+... ...++....|..+++.+.||+++++++.+.+.+..||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46899999999999999999665 588999999987654 234677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||++||.|..++++... +++..++.+|.+|+.|++|||+. +|++||+||+|||+|++|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk~~r--F~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSGR--FSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-- 196 (355)
T ss_pred eccCCccHHHHHHhcCC--CCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence 99999999999997654 99999999999999999999999 999999999999999999999999999987642
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....+|||.|+|||++....|..++|.|||||++|||+.|.+||+...+ .+... +++...
T Consensus 197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~--------~~iY~---------KI~~~~ 257 (355)
T KOG0616|consen 197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP--------IQIYE---------KILEGK 257 (355)
T ss_pred --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh--------HHHHH---------HHHhCc
Confidence 35567999999999999999999999999999999999999999984332 11111 222222
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCC
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTR 1085 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~R 1085 (1103)
+ .+|.....++.+|+.+.++.|-.+|
T Consensus 258 v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 V--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred c--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 2 3566677889999999999999998
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=351.39 Aligned_cols=263 Identities=24% Similarity=0.395 Sum_probs=230.8
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEcC-----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS 889 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 889 (1103)
+++...+.....++||.|.||.||+|...+ .-.||||+.+.+...+..+.|++|+.+|+.++|||||+++|+|.+
T Consensus 383 nyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 383 NYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred cceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 344444556777899999999999995432 346999999998888889999999999999999999999999987
Q ss_pred CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 890 GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
.+.|+|||.++.|.|.+|++.++. .++...+..++.||+.||+|||+. .+|||||..+||||.....||++|||+
T Consensus 463 -~P~WivmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 463 -QPMWIVMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -cceeEEEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 478999999999999999998764 489999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
++.+.....+......-+..|||||.++...++.++|||.|||++||++. |..||.+- ++.
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv------------------kNs 599 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV------------------KNS 599 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc------------------ccc
Confidence 99988777776665556789999999999999999999999999999985 88888732 234
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
++...++..-+.+.|..||+.++.++.+||+.+|.+||.+.|+...|+++.+
T Consensus 600 DVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 600 DVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred ceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 5555667777888899999999999999999999999999999999988765
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=349.38 Aligned_cols=263 Identities=25% Similarity=0.359 Sum_probs=208.8
Q ss_pred cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 896 (1103)
+.|+.+++||+|+||.||+| +..+|+.||+|++..+..++ ...-..+||.+|+++.||||+++.+...+. +.+|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 35777888999999999999 56679999999999887543 455677999999999999999999988776 789999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+|||++ ||.-++... +-.+++.++..++.|++.||+|+|++ +|+|||||.+|||||.+|.+||+|||+|+++...
T Consensus 197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 999976 898888653 34599999999999999999999999 9999999999999999999999999999998777
Q ss_pred CCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH-------HhcC
Q 043720 977 ETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML-------LRQG 1048 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~~~ 1048 (1103)
.....+..+-|.+|.|||.+.+. .|+.++|+||.|||+.||++|++.|.+.... .++...++.+ |...
T Consensus 272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv----eQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV----EQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH----HHHHHHHHHhCCCChhccccc
Confidence 66667788889999999998764 6999999999999999999999888743321 1111111110 0000
Q ss_pred ccc--ccc------cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1049 QVK--DVF------NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1049 ~~~--~~~------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
.+. ..+ ...+.. .....+....+|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 000 000 000100 02334566889999999999999999999885
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=360.81 Aligned_cols=262 Identities=24% Similarity=0.404 Sum_probs=209.6
Q ss_pred hcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC-C
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG-N 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~ 891 (1103)
.++|++.+.||+|+||.||+|.. ..++.||||++.........+.+.+|+.++..+ +||||+++++++... +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 45799999999999999999964 235689999998665555567899999999999 899999999988764 4
Q ss_pred eEEEEEeecCCCChHHHHHhhcC---------------------------------------------------------
Q 043720 892 EMFLIYNYLPGGNLENFIKARTS--------------------------------------------------------- 914 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 914 (1103)
.+++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 68999999999999999975321
Q ss_pred ---CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc-cccCCcccccc
Q 043720 915 ---RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGY 990 (1103)
Q Consensus 915 ---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y 990 (1103)
..+++.++.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 2477888999999999999999999 9999999999999999999999999999865332222 22233456789
Q ss_pred cCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHH
Q 043720 991 VAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLED 1069 (1103)
Q Consensus 991 ~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1103)
+|||++.+..++.++|||||||++|||++ |..||...... .... .....+. ....+..++..
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-------~~~~-~~~~~~~---------~~~~~~~~~~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-------EEFC-QRLKDGT---------RMRAPENATPE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-------HHHH-HHHhcCC---------CCCCCCCCCHH
Confidence 99999999999999999999999999997 88888632210 0111 1111111 11123445678
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1070 MLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1070 l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
+.+++.+||+.||++||++.|+++.|+++.+.
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=358.64 Aligned_cols=380 Identities=27% Similarity=0.256 Sum_probs=207.9
Q ss_pred CCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecc
Q 043720 132 KLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLS 211 (1103)
Q Consensus 132 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 211 (1103)
.-++||+++|+++..-+..|.++++|+.++|.+|.++ .||...+...+|+.|+|.+|.++..-...+..++.|+.||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 3445666666666666666666666666666666666 666555555556666666666665555556666666666666
Q ss_pred cccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCc
Q 043720 212 YNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 212 ~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
.|.++ .||..-+..-.++++|+|++|+++..-...|.++.+|..|.|+.|+++...+..|.+|++|+.|+|.+|+|.
T Consensus 158 rN~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~ir-- 234 (873)
T KOG4194|consen 158 RNLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIR-- 234 (873)
T ss_pred hchhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhcccccee--
Confidence 66665 454433332234555555555555444444555555555555555555544444444555555555555543
Q ss_pred CCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccc
Q 043720 292 IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSW 371 (1103)
Q Consensus 292 ~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~ 371 (1103)
-.--..|
T Consensus 235 -------------------------------------------------------------------------ive~ltF 241 (873)
T KOG4194|consen 235 -------------------------------------------------------------------------IVEGLTF 241 (873)
T ss_pred -------------------------------------------------------------------------eehhhhh
Confidence 1112234
Q ss_pred cccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEecCCccccccCCCCccccccccc
Q 043720 372 GACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPL 451 (1103)
Q Consensus 372 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~ 451 (1103)
.+|++|+.|.|..|.|.....+.|..|.++++|+|+.|+++..-.
T Consensus 242 qgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~----------------------------------- 286 (873)
T KOG4194|consen 242 QGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNE----------------------------------- 286 (873)
T ss_pred cCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhc-----------------------------------
Confidence 555555555566666655555566666666666666555542100
Q ss_pred ccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccC
Q 043720 452 QSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSF 531 (1103)
Q Consensus 452 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 531 (1103)
T Consensus 287 -------------------------------------------------------------------------------- 286 (873)
T KOG4194|consen 287 -------------------------------------------------------------------------------- 286 (873)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred CcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCccc
Q 043720 532 PGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL 611 (1103)
Q Consensus 532 p~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 611 (1103)
+ +++.+ +.|+.|+||+|.|..+.++.+...++|++|+||+|+|+...+.+|
T Consensus 287 -g---------------------------~lfgL-t~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf 337 (873)
T KOG4194|consen 287 -G---------------------------WLFGL-TSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSF 337 (873)
T ss_pred -c---------------------------ccccc-chhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHH
Confidence 0 00111 445555555555555555555555555555555555554445555
Q ss_pred ccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChh---hhhhcccccccccccccCcCCCCccccCCCC
Q 043720 612 HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPE---GVVNLRNLTALLLDNNKLSGHLPSGLANVTS 688 (1103)
Q Consensus 612 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 688 (1103)
..+..|++|+|++|+++..-...|..+++|++|||++|.|+..+.+ .|..|++|+.|+|.+|+|......+|.+++.
T Consensus 338 ~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~ 417 (873)
T KOG4194|consen 338 RVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEA 417 (873)
T ss_pred HHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcc
Confidence 5555556666666655544445555555666666666655544433 3445566666666666665444455556666
Q ss_pred CceEeCCCCCCCCCCCCCcccc--ccccccCCCCCCCCCCCCCCCC
Q 043720 689 LSIFNASFNNLSGPFPWNVTTM--NCSGVIGNPFLDPCQMYKDISS 732 (1103)
Q Consensus 689 L~~l~l~~N~l~~~~p~~~~~~--~~~~l~~Np~~c~C~~~~~~~~ 732 (1103)
|++|||.+|.|.+..|+.|..+ +.+.+.---+.|||++.=...|
T Consensus 418 LE~LdL~~NaiaSIq~nAFe~m~Lk~Lv~nSssflCDCql~Wl~qW 463 (873)
T KOG4194|consen 418 LEHLDLGDNAIASIQPNAFEPMELKELVMNSSSFLCDCQLKWLAQW 463 (873)
T ss_pred cceecCCCCcceeecccccccchhhhhhhcccceEEeccHHHHHHH
Confidence 6666666666655555544432 3333555567899998443333
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=350.32 Aligned_cols=264 Identities=25% Similarity=0.424 Sum_probs=228.2
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
+++....+..+.++||.|.||.||.|.|+. .-.||||.++.+.. .+++|..|+.+|+.++|||+|+++|+|.....+
T Consensus 261 kWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM--eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 261 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred hhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch--hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 333444567888999999999999998885 56799999986654 478999999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+|+|||..|+|.+|+++-....++.-.++.+|.||+.||+||..+ ++|||||.++|+||.++..|||+|||+++.+
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 9999999999999999987767788888999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCC-CCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDK-KALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
..+......+...+..|.|||-+....++.|+|||+|||++||+.|.+ .||. . .+.. .+.+
T Consensus 416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP-G-------idlS----------qVY~ 477 (1157)
T KOG4278|consen 416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP-G-------IDLS----------QVYG 477 (1157)
T ss_pred cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC-C-------ccHH----------HHHH
Confidence 655555555666688999999999999999999999999999999854 4432 1 1111 2234
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
+++...+.+.+..|++++++||..||++.|.+||+|+|+-+.+|.+-++
T Consensus 478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 5566777788999999999999999999999999999999999987543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.16 Aligned_cols=248 Identities=27% Similarity=0.452 Sum_probs=213.2
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccc-cchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVG-RFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|.+.+.||+|.||+||+|+- .+.+.||+|.+.+. +.+++.+.+.+|++++++++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4688888999999999999954 46889999998665 345577889999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+.| +|..++..... ++++.+..|+.+++.||.|||+. +|.|||+||+||++.+.+.+|++|||+|+.... ..
T Consensus 82 ~a~g-~L~~il~~d~~--lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDGK--LPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT 154 (808)
T ss_pred hhhh-hHHHHHHhccC--CCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence 9976 99999987554 99999999999999999999999 999999999999999999999999999997754 33
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
...+...|||-|||||...+..|+..+|.||+||++|||++|++||.. ..+.+.++.+.... .
T Consensus 155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a--------~si~~Lv~~I~~d~---------v 217 (808)
T KOG0597|consen 155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA--------RSITQLVKSILKDP---------V 217 (808)
T ss_pred eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH--------HHHHHHHHHHhcCC---------C
Confidence 445567899999999999999999999999999999999999999982 22333333333222 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+......+..++...+.+||..|-+-.+++.+
T Consensus 218 --~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 218 --KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred --CCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 2344677889999999999999999999888754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=342.83 Aligned_cols=250 Identities=24% Similarity=0.382 Sum_probs=215.1
Q ss_pred cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
..|....+||+|.||.||+| +...++.||+|++..+..+..++++.+|+.++.+++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 35777788999999999999 55678999999999999888899999999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
|.||++.+.++... .+++..+.-|++++..|+.|||.+ +.+|||||+.||++..+|.+|++|||.+........
T Consensus 93 ~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred hcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 99999999998654 358888888999999999999999 999999999999999999999999999987754433
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
....++|||.|||||++....|+.|+||||||++.+||.+|.+|+....+. .+.-.+.....
T Consensus 167 rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm------------------rvlflIpk~~P 228 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM------------------RVLFLIPKSAP 228 (467)
T ss_pred ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc------------------eEEEeccCCCC
Confidence 337789999999999999889999999999999999999999998744331 11111111211
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+.....+.+.+.+++..|+.+||+.||+|++++++
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 22233566779999999999999999999999975
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=346.62 Aligned_cols=250 Identities=31% Similarity=0.442 Sum_probs=208.0
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc----hhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCe
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF----QHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNE 892 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 892 (1103)
..++|.+.+.||+|.||+|+.|.. .+++.||||++..... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 356899999999999999999954 4689999997766421 123556778999999998 9999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-CCEEEeeccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-FNAYLSDFGLSR 971 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~ 971 (1103)
+|+||||+.+|+|.+++... ..+.+..+.+++.|++.|++|+|++ +|+||||||+||+++.+ +++||+|||++.
T Consensus 95 ~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~ 169 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSA 169 (370)
T ss_pred EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEecccccc
Confidence 99999999999999999883 3488899999999999999999999 99999999999999999 999999999998
Q ss_pred ccCCCCCccccCCcccccccCccccccCC-CC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTCR-VS-DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
... .........+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||+... .......+ ..+
T Consensus 170 ~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~--------~~~l~~ki-~~~- 238 (370)
T KOG0583|consen 170 ISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN--------VPNLYRKI-RKG- 238 (370)
T ss_pred ccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc--------HHHHHHHH-hcC-
Confidence 764 2334456679999999999999877 75 68999999999999999999998421 11111111 111
Q ss_pred ccccccccccCCCChhH-HHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDD-LEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
. ...+... ..++..++.+|+..||.+|+++.+|.+
T Consensus 239 -------~--~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~ 274 (370)
T KOG0583|consen 239 -------E--FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILE 274 (370)
T ss_pred -------C--ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence 1 1223333 678999999999999999999999983
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.60 Aligned_cols=249 Identities=24% Similarity=0.366 Sum_probs=212.1
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+-|++++.||+|+.|.|-.|++ .+|+.+|||++.+... +.....+.+|+.+|+-+.||||+++++++....++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5688999999999999999955 5799999999976522 233567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|.|.+|+-.++. +++.+..+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|..-. .
T Consensus 92 Eyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--P 164 (786)
T ss_pred EecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--C
Confidence 99999999999987654 89999999999999999999999 99999999999999999999999999998642 2
Q ss_pred CccccCCcccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVS-DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
...-...||+|.|.|||++.+..|. .++||||+|||+|.++||+.||++.. +...... ++.+.
T Consensus 165 gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN--------ir~LLlK-V~~G~------- 228 (786)
T KOG0588|consen 165 GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN--------IRVLLLK-VQRGV------- 228 (786)
T ss_pred CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc--------HHHHHHH-HHcCc-------
Confidence 2334456899999999999999884 68999999999999999999998321 1222211 22222
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
...|...+.++++|+.+|+..||+.|.++.||.+|-
T Consensus 229 ---f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP 264 (786)
T KOG0588|consen 229 ---FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP 264 (786)
T ss_pred ---ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence 234678889999999999999999999999999873
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=338.09 Aligned_cols=251 Identities=18% Similarity=0.248 Sum_probs=204.1
Q ss_pred CCcceeccCCcccEEEEEEcCCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEec----CCeEEEEE
Q 043720 824 NTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRAS----GNEMFLIY 897 (1103)
Q Consensus 824 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 897 (1103)
.....||+|++|.||+|... |+.||||++...... ...+.+.+|+.++++++||||++++|++.+ ....++||
T Consensus 23 ~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~ 101 (283)
T PHA02988 23 YTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLIL 101 (283)
T ss_pred CCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEE
Confidence 33467999999999999884 899999999765332 225778899999999999999999999876 45789999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... .+++....+++.+++.|+.|||+.. +++||||||+||++++++.+||+|||+++......
T Consensus 102 Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 102 EYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred EeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 9999999999998653 4889999999999999999999732 78899999999999999999999999988653221
Q ss_pred CccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
....++..|+|||++.+ ..++.++|||||||++|||++|+.||..... ..........+
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~--------~~~~~~i~~~~------- 238 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT--------KEIYDLIINKN------- 238 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcC-------
Confidence 23457889999999976 6789999999999999999999999973211 11222211111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+..++..+.+++.+||+.||++|||++|+++.|++++.
T Consensus 239 --~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 239 --NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred --CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1122334567889999999999999999999999999998763
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=349.32 Aligned_cols=367 Identities=24% Similarity=0.248 Sum_probs=280.1
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
+.-+.|+|++|.++..-+..|.++++|++++|.+|.++ .||...+...+|+.|+|.+|.|+..-..++.-++.|+.|||
T Consensus 78 ~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 78 SQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDL 156 (873)
T ss_pred cceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhh
Confidence 34568999999999888899999999999999999999 89998888889999999999999777788999999999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
|.|.++...-..|..-.++++|+|++|+++ .+...-|..+.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It-~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iri 235 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRIT-TLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRI 235 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeecccccc-ccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceee
Confidence 999999665567887789999999999999 7776666667899999999999996666778889999999999999986
Q ss_pred cccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
.---.|.+|++|+.|.|.+|.++..-..
T Consensus 236 ve~ltFqgL~Sl~nlklqrN~I~kL~DG---------------------------------------------------- 263 (873)
T KOG4194|consen 236 VEGLTFQGLPSLQNLKLQRNDISKLDDG---------------------------------------------------- 263 (873)
T ss_pred ehhhhhcCchhhhhhhhhhcCcccccCc----------------------------------------------------
Confidence 5456688888888888888888743222
Q ss_pred hhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccc-ccee
Q 043720 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQV-PCMA 425 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~-~~L~ 425 (1103)
.|..+.++++|+|+.|+++..-.+++.++++|+.||||+|.|...-+..|.+ ++|+
T Consensus 264 -----------------------~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~ 320 (873)
T KOG4194|consen 264 -----------------------AFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLK 320 (873)
T ss_pred -----------------------ceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccce
Confidence 3444455555555555555555555555555555555555554321112211 1122
Q ss_pred EEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccC
Q 043720 426 LFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWL 505 (1103)
Q Consensus 426 ~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~ 505 (1103)
+|+|++|++
T Consensus 321 ~LdLs~N~i----------------------------------------------------------------------- 329 (873)
T KOG4194|consen 321 ELDLSSNRI----------------------------------------------------------------------- 329 (873)
T ss_pred eEecccccc-----------------------------------------------------------------------
Confidence 222222222
Q ss_pred CCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcc
Q 043720 506 PVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQ 585 (1103)
Q Consensus 506 ~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~ 585 (1103)
+ .++++-+..+..|++|+|++|.|+-+-..
T Consensus 330 -------------------------------------------------~-~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~ 359 (873)
T KOG4194|consen 330 -------------------------------------------------T-RLDEGSFRVLSQLEELNLSHNSIDHLAEG 359 (873)
T ss_pred -------------------------------------------------c-cCChhHHHHHHHhhhhcccccchHHHHhh
Confidence 2 22222222336788899999999877777
Q ss_pred cccCCCCCCEEEccCCcCCCCCCc---ccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhc
Q 043720 586 SLENLTSLVFLDLNGNKLQGEIPS---SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNL 662 (1103)
Q Consensus 586 ~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 662 (1103)
+|..+++|+.|||++|.|+..+.+ .|..|++|+.|.|.+|+|..+....|.++.+|+.|||.+|.|..+-|++|..+
T Consensus 360 af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m 439 (873)
T KOG4194|consen 360 AFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM 439 (873)
T ss_pred HHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc
Confidence 888899999999999988866543 46778889999999999986666788889999999999999888888888888
Q ss_pred cccccccccc
Q 043720 663 RNLTALLLDN 672 (1103)
Q Consensus 663 ~~L~~L~L~~ 672 (1103)
.|++|-+..
T Consensus 440 -~Lk~Lv~nS 448 (873)
T KOG4194|consen 440 -ELKELVMNS 448 (873)
T ss_pred -hhhhhhhcc
Confidence 888887653
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=337.05 Aligned_cols=256 Identities=22% Similarity=0.365 Sum_probs=209.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.+|++.+.||+|+||.||+|.++ .+..||+|+++........+.+.+|+..+++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46888999999999999999653 36789999998766555567899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.+++.... ..+++.++++++.|++.|++|||++ +++||||||+||+++.++.+|++|||.+......
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 85 TEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999998643 3589999999999999999999999 9999999999999999999999999987654222
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.........++..|+|||.+.+..++.++|||||||++||+++ |+.||..... ....... ..+
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~--------~~~~~~~-~~~------- 224 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG--------QDVIKAV-EDG------- 224 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHH-HCC-------
Confidence 2222222345678999999999999999999999999999875 9998863211 1111111 111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
...+.+..++..+.+++.+||+.+|++||+++||.+.|+++
T Consensus 225 --~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 --FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 11223455678899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=353.01 Aligned_cols=259 Identities=26% Similarity=0.419 Sum_probs=207.3
Q ss_pred hcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 892 (1103)
.++|++.+.||+|+||+||+|.+ ..+..||||+++........+.+.+|+.+++.+ +||||+++++++..++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45799999999999999999963 235689999997655444567789999999999 89999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcC----------------------------------------------------------
Q 043720 893 MFLIYNYLPGGNLENFIKARTS---------------------------------------------------------- 914 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~---------------------------------------------------------- 914 (1103)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999975321
Q ss_pred ---------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 915 ---------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 915 ---------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
..+++..+.+++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 2478889999999999999999999 9999999999999999999999999999866433221
Q ss_pred c-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 980 A-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 980 ~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
. .....++..|+|||++.+..++.++|||||||++|||++ |..||..... .. .+.. ....+
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~----~~---~~~~-~~~~~--------- 333 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV----DS---KFYK-MIKEG--------- 333 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc----hH---HHHH-HHHhC---------
Confidence 1 122345678999999999999999999999999999998 7777753211 00 1111 11111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
.....+...+.++.+++.+||+.||++||+++||++.|++.
T Consensus 334 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 334 YRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 11112233457899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=332.69 Aligned_cols=257 Identities=25% Similarity=0.351 Sum_probs=207.6
Q ss_pred HHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch-------------hhHHHHHHHHHHHhcCCCCceeEE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ-------------HGVQQFHAEIKTLGNVRHPNLVTL 883 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l 883 (1103)
+.-++|++.+.||+|.||.|-+|+. .+++.||||++.+.... ...+.+.+|+.+|++++|||||++
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 3457899999999999999999954 46899999999765321 124678999999999999999999
Q ss_pred EeEEec--CCeEEEEEeecCCCChHHHHHhhcCCc-ccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC
Q 043720 884 IGYRAS--GNEMFLIYNYLPGGNLENFIKARTSRA-VDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF 960 (1103)
Q Consensus 884 ~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 960 (1103)
+++..+ .+.+|||+|||..|.+...- ..+. ++..++++++.+++.||+|||.+ +|+||||||+|+|++++|
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCC
Confidence 999866 46899999999888776532 2333 89999999999999999999999 999999999999999999
Q ss_pred CEEEeecccccccCCCCC----ccccCCcccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043720 961 NAYLSDFGLSRLLGTSET----HATTGVAGTFGYVAPEYALTCR----VSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032 (1103)
Q Consensus 961 ~~ki~Dfgla~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 1032 (1103)
+|||+|||.+..+..... ......+|||.|+|||.+.++. .+.+.||||+||++|-|+.|+.||...+.
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--- 324 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--- 324 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH---
Confidence 999999999987633211 1223468999999999987632 35678999999999999999999984332
Q ss_pred CCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
.+..++++...+..+...+...++.++|++++.+||+.|-+..+|..+..-
T Consensus 325 --------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 325 --------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred --------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 112233444455444445677889999999999999999999999877543
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.80 Aligned_cols=262 Identities=24% Similarity=0.355 Sum_probs=214.3
Q ss_pred hcCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-----eE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-----EM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~ 893 (1103)
.++|.+.+.+|+|+|+-||.++ ..++..||+|++.... .++.+..++|++..++++||||++++++...+. ..
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 3579999999999999999995 5678999999998776 557888999999999999999999998764433 58
Q ss_pred EEEEeecCCCChHHHHHhhcC--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
|++++|...|+|.+.++.... ..+++.++++|+.+|++||++||+. .|+++||||||.||++++++.+++.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999999976433 4699999999999999999999998 4569999999999999999999999999987
Q ss_pred ccCCCCCc--------cccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH
Q 043720 972 LLGTSETH--------ATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 972 ~~~~~~~~--------~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
...-.... .......|..|.|||.+. +...++++|||||||++|+|+.|..||+...++++
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~Gg-------- 249 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGG-------- 249 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCC--------
Confidence 65321111 122335788999999884 55678999999999999999999999985544222
Q ss_pred HHHHHhcCcccc-cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1041 ASMLLRQGQVKD-VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1041 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
.+.- +.......+.....+..+.+++++|++.||.+||++.+++.+++.+.
T Consensus 250 --------SlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 250 --------SLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred --------eEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 2211 22223333334457889999999999999999999999999998764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=340.35 Aligned_cols=263 Identities=24% Similarity=0.425 Sum_probs=207.0
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-----------------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-----------------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 883 (1103)
++|.+.+.||+|+||.||+|.+.+ +..||+|++..........++.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999997532 346999998776555566789999999999999999999
Q ss_pred EeEEecCCeEEEEEeecCCCChHHHHHhhcC-----------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCccc
Q 043720 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTS-----------------RAVDWKILHKIALDVASALAYLHDQCAPRVLH 946 (1103)
Q Consensus 884 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~-----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 946 (1103)
++++...+..++||||+++|+|.+++..... ..+++.++.+++.|++.||+|||+. +|+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cccc
Confidence 9999999999999999999999999865321 2467888999999999999999999 9999
Q ss_pred CCCCCCcEEECCCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhC--CCC
Q 043720 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISD--KKA 1023 (1103)
Q Consensus 947 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg--~~p 1023 (1103)
|||||+||++++++.+||+|||+++......... .....++..|+|||++....++.++||||||+++|||+++ ..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 9999999999999999999999998654333221 2233457899999999888899999999999999999974 455
Q ss_pred CCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1024 LDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
|.... ................. ......+..++..+.+++.+||+.||++||++.||.+.|++
T Consensus 242 ~~~~~-----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELT-----DEQVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCC-----HHHHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 55221 11111112111111110 11112234567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=355.55 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=218.7
Q ss_pred cCCCCcceeccCCcccEEEEEEcCC-cEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEE-ec------CC
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPG-ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYR-AS------GN 891 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~-~~------~~ 891 (1103)
.++++.+.|.+|+|+.||.|....+ ..||+|++... .++..+.+++|+++|+++. |+|||.+++.. .. ..
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 4677889999999999999977665 99999999887 6667899999999999997 99999999932 11 23
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
++++.||||++|.|-++|..+....+++.++++|+.++++|+++||.. +|+|||||||-+|||++.++..|+||||.|.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 789999999999999999987777799999999999999999999987 8889999999999999999999999999986
Q ss_pred ccCCCCCc--------cccCCcccccccCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH
Q 043720 972 LLGTSETH--------ATTGVAGTFGYVAPEYA---LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 972 ~~~~~~~~--------~~~~~~g~~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
-.-..... ......-|+.|+|||++ .+..+++|+|||||||++|-++.+..||+...
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg------------ 262 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG------------ 262 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc------------
Confidence 43222211 11123568999999987 57789999999999999999999999998331
Q ss_pred HHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1041 ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
--.++...+..+........+..||..||++||++||++.+|++.+.++...|
T Consensus 263 ---------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 263 ---------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred ---------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 12334444444555688899999999999999999999999999999998765
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=351.56 Aligned_cols=262 Identities=25% Similarity=0.411 Sum_probs=209.5
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG 890 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 890 (1103)
...++|++.+.||+|+||.||+|... ++..||||+++........+.+.+|+.+++.+ +|+||+++++++...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 33457999999999999999998642 23579999998765555567789999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhc---------------------------------------------------------
Q 043720 891 NEMFLIYNYLPGGNLENFIKART--------------------------------------------------------- 913 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------- 913 (1103)
+..++||||+++|+|.++++...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999986532
Q ss_pred -----------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc-cc
Q 043720 914 -----------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-AT 981 (1103)
Q Consensus 914 -----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~ 981 (1103)
...+++.++.+++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++........ ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 12478889999999999999999999 9999999999999999999999999999765432221 11
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .. .+. ..... ....
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~----~~---~~~-~~~~~---------~~~~ 334 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV----NS---KFY-KMVKR---------GYQM 334 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc----cH---HHH-HHHHc---------ccCc
Confidence 22335678999999998899999999999999999997 9999863211 00 011 11111 1111
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
..+...+.++.+++.+||+.||++||++.+|++.|+++.
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 122334578999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=331.25 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=206.5
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
..++|+.++.||+|+||+||.|+.+ +|..+|+|++++... ...++.+..|-.+|....+|.||+++-.|.+.+.+|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4578999999999999999999554 699999999988754 3457789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||++||++..+|.+.. .+++..+..++.+++.|++-+|.. |++||||||+|+|||..|++|++|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~ 293 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK 293 (550)
T ss_pred EEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhh
Confidence 999999999999998765 499999999999999999999999 999999999999999999999999999843211
Q ss_pred ----------------------CCCc------------------------cccCCcccccccCccccccCCCCCcchhHH
Q 043720 976 ----------------------SETH------------------------ATTGVAGTFGYVAPEYALTCRVSDKADVYS 1009 (1103)
Q Consensus 976 ----------------------~~~~------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvws 1009 (1103)
.+.. .....+|||-|+|||++.+..|+..+|.||
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS 373 (550)
T KOG0605|consen 294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS 373 (550)
T ss_pred hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence 0000 011357999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCC--
Q 043720 1010 YGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT-- 1087 (1103)
Q Consensus 1010 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-- 1087 (1103)
+|||+|||+.|.+||....+. ..|......... +..+......++..++|.+|+. ||++|--
T Consensus 374 LG~ImyEmLvGyPPF~s~tp~-------~T~rkI~nwr~~--------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~ 437 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFCSETPQ-------ETYRKIVNWRET--------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSK 437 (550)
T ss_pred HHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhhh--------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcc
Confidence 999999999999999854432 222221111111 1112223344789999999999 9999985
Q ss_pred -HHHHHH
Q 043720 1088 -MKQVVQ 1093 (1103)
Q Consensus 1088 -~~evl~ 1093 (1103)
+.||.+
T Consensus 438 G~~EIK~ 444 (550)
T KOG0605|consen 438 GAEEIKK 444 (550)
T ss_pred cHHHHhc
Confidence 555543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=337.47 Aligned_cols=250 Identities=32% Similarity=0.540 Sum_probs=200.6
Q ss_pred CcceeccCCcccEEEEEEc-----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 825 TSNCIGSGGFGTTYKAEIS-----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.+.||.|.||.||+|.+. .+..|+||+++.....+..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999877 36789999997655555688999999999999999999999999988889999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC-
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET- 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 978 (1103)
+++|+|.++++......+++.++.+|+.||++||+|||++ +++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999987556699999999999999999999999 999999999999999999999999999987632222
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
...........|+|||.+....++.++||||||+++|||++ |+.||... ....+.... .. .
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~--------~~~~~~~~~-~~---------~ 221 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY--------DNEEIIEKL-KQ---------G 221 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS--------CHHHHHHHH-HT---------T
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc--------ccccccccc-cc---------c
Confidence 22334456789999999999889999999999999999999 66776522 112222222 11 1
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
.....+..++..+.+++.+||+.+|++||++.++++.|
T Consensus 222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 12233455678899999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=304.46 Aligned_cols=251 Identities=26% Similarity=0.375 Sum_probs=214.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
-++|++++.||+|.||.||.|+.+ ++..||+|++.+.... .....+.+|+++-..++||||+++++++.+....|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357999999999999999999655 5788999999766432 2356788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+||..+|.+...++......+++.....++.|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 9999999999999987777899999999999999999999999 99999999999999999999999999987532
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
...+...+||.-|.|||...+..++.++|+|++|++.||++.|.+||..... . +.+.++...
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-----~------------etYkrI~k~ 237 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-----S------------ETYKRIRKV 237 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-----H------------HHHHHHHHc
Confidence 4556678999999999999999999999999999999999999999983221 0 111111111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
...++...+..+.++|.+|+..+|.+|....|++++=
T Consensus 238 --~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 238 --DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred --cccCCcccChhHHHHHHHHhccCccccccHHHHhhhH
Confidence 1233466778899999999999999999999998763
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=335.68 Aligned_cols=257 Identities=25% Similarity=0.443 Sum_probs=211.5
Q ss_pred cCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||.||+|.... ...||+|++...........+.+|+..+++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 468899999999999999996543 25799999876655556678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC
Q 043720 895 LIYNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF 960 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 960 (1103)
++|||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999976422 3478899999999999999999999 999999999999999999
Q ss_pred CEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchH
Q 043720 961 NAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 961 ~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1103)
.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||..... .
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986543332 22334456789999999998899999999999999999998 9989873221 1
Q ss_pred HHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1039 SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
+... .+..+ .....+..++.++.+++.+||+.||++||+++||+++|+++
T Consensus 234 ~~~~-~i~~~---------~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 234 EVIE-MIRSR---------QLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHH-HHHcC---------CcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1111 11111 11223456778899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=350.40 Aligned_cols=258 Identities=25% Similarity=0.443 Sum_probs=224.6
Q ss_pred CCCCcceeccCCcccEEEEEEcC-----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
+....++||+|+||+||+|.|-. ..+||+|++......+...++.+|+.+|.+++|||++|++|+|.... ..+|
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv 775 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV 775 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence 45567889999999999996543 35799999988887778899999999999999999999999998866 8899
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
++||+.|+|.+|++.+++ .+..+..+.|..|||+||.|||++ .+|||||.++||||++-..+||+|||+++....+
T Consensus 776 tq~mP~G~LlDyvr~hr~-~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 776 TQLMPLGCLLDYVREHRD-NIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHhcccchHHHHHHHhhc-cccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 999999999999998654 588899999999999999999999 9999999999999999999999999999988655
Q ss_pred CCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 977 ETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 977 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
+.. ......-.+.|||=|.+....|+.++|||||||++||++| |..|++... .+++.+++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~------------------~~eI~dll 913 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP------------------AEEIPDLL 913 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC------------------HHHhhHHH
Confidence 432 2223334678999999999999999999999999999998 777776321 23455666
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
+...+.+.|.-++.+++.++.+||..|++.||.|+++...+.++.+.|
T Consensus 914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 667778889999999999999999999999999999999999998877
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=330.66 Aligned_cols=256 Identities=24% Similarity=0.421 Sum_probs=211.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||+||+|...++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 356899999999999999999888888999998765432 357889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||++.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999999876666689999999999999999999999 9999999999999999999999999999876433222
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||++....++.++||||||+++|||++ |+.||..... ...... .... .
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~-~~~~---------~ 221 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN--------SDVMSA-LQRG---------Y 221 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH--------HHHHHH-HHcC---------C
Confidence 2233345678999999988889999999999999999998 8888853211 111111 1111 0
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
..+.....+.++.+++.+|++.+|++||+++++.+.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1112234567799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-37 Score=337.69 Aligned_cols=252 Identities=25% Similarity=0.397 Sum_probs=218.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecCCe-EEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE-MFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lV~ 897 (1103)
++|..++++|+|+||.++.++++ ++..|++|++......+ ..+...+|+.++++++|||||.+.+.+..++. .++||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 57889999999999999999655 47789999998776533 44578899999999999999999999988887 99999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
+|++||++.+.+.+.++..++++.+.+++.|++.|+.|||+. .|+|||||+.||++++++.||++|||+|+..++..
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 999999999999998888899999999999999999999999 99999999999999999999999999999987554
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....++||+.||.||.+.+.+|..|+||||+||++|||++-+++|..... ...+..+...
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m--------~~Li~ki~~~---------- 221 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM--------SELILKINRG---------- 221 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch--------HHHHHHHhhc----------
Confidence 244567899999999999999999999999999999999999999984322 2222222211
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+.+.....++..+|..|+..+|+.||++.+++.+
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1234466778889999999999999999999999975
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=340.38 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=217.5
Q ss_pred CCCCcceeccCCcccEEEEEEcC--C--cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP--G--ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+....+.||+|.||+|++|.|.. | -.||||.++.+.......+|.+|+.+|-+++|+|++++||+..+ ..+.|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 35556789999999999997764 3 46899999988777688999999999999999999999999988 7889999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|.++.|+|.+.+++.....+-...+..++.|||.||.||.++ ++||||+.++|+++-....|||+|||+.+-++..+
T Consensus 190 ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999999986667788999999999999999999999 99999999999999999899999999999886555
Q ss_pred Cccc--cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 978 THAT--TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISD-KKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 978 ~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.+.. ....-...|+|||.+....++.++|||+|||++|||+|+ ..||-+..+ + .+-+.+
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g--------~----------qIL~~i 328 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG--------I----------QILKNI 328 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH--------H----------HHHHhc
Confidence 4321 122346789999999999999999999999999999985 456542211 1 122334
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
|...+...+..|+++++++++.||..+|.+||+|.+|.+.+-..++
T Consensus 329 D~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~ea 374 (1039)
T KOG0199|consen 329 DAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEA 374 (1039)
T ss_pred cccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhc
Confidence 5566677889999999999999999999999999999866544443
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=345.80 Aligned_cols=265 Identities=22% Similarity=0.341 Sum_probs=212.9
Q ss_pred HHHHhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEe
Q 043720 816 IIRATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRA 888 (1103)
Q Consensus 816 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 888 (1103)
+....++|.+.+.||+|+||+||+|... .+..||||++.........+.+.+|+.+++++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 3444678999999999999999999653 134699999976655556678999999999996 999999999999
Q ss_pred cCCeEEEEEeecCCCChHHHHHhhc-------------------------------------------------------
Q 043720 889 SGNEMFLIYNYLPGGNLENFIKART------------------------------------------------------- 913 (1103)
Q Consensus 889 ~~~~~~lV~E~~~~gsL~~~l~~~~------------------------------------------------------- 913 (1103)
+.+..|+||||+++|+|.+++....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 9999999999999999999986532
Q ss_pred ---------------------------------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcE
Q 043720 914 ---------------------------------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNI 954 (1103)
Q Consensus 914 ---------------------------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NI 954 (1103)
...+++.++.+++.|+++|++|||+. +|+||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhE
Confidence 12377888899999999999999999 999999999999
Q ss_pred EECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCC
Q 043720 955 LLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHG 1032 (1103)
Q Consensus 955 ll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~ 1032 (1103)
++++++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~-- 346 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD-- 346 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--
Confidence 9999999999999999865432221 2223456788999999998899999999999999999997 88887632110
Q ss_pred CCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.........+ .....+..++..+.+++.+||+.+|++||++.+|.+.|+++.+
T Consensus 347 ------~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 347 ------STFYNKIKSG---------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred ------HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 0011111111 1112234566789999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=334.70 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=204.6
Q ss_pred CCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 823 FNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
|+..+.||+|+||+||+|.. .+++.||||++...... .....+.+|+.++++++|++|+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999965 56899999998754332 2345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.+++.......+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-- 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC--
Confidence 9999999988765555689999999999999999999999 99999999999999999999999999998653222
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...... ..... ..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~----~~~~~~-~~~~~----------~~ 221 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV----KREEVD-RRVKE----------DQ 221 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch----hHHHHH-HHhhc----------cc
Confidence 2234578999999999999999999999999999999999999997432210 000011 00000 01
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++||+ +++++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 1223445678899999999999999997 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=328.80 Aligned_cols=256 Identities=26% Similarity=0.421 Sum_probs=211.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|++|.||+|...+++.||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..|+||||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456889999999999999999887788999999875432 346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++...+..+++..+..++.|++.|+.|||+. +++||||||+||++++++.+||+|||+++........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999999876555689999999999999999999999 9999999999999999999999999999876533322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
...+...+..|+|||+..+..++.++||||||+++|||++ |+.||..... ..... .... ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~-~~~~---------~~ 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN--------AEVLQ-QVDQ---------GY 221 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH-HHHc---------CC
Confidence 2223334568999999998899999999999999999999 8888763211 01111 1111 11
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1122344567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=328.32 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=210.9
Q ss_pred cCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|.+.. ...||||+++..........+.+|+.++++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 468899999999999999997753 4579999988766666677899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.+++....+ .+++.++.+++.|++.|++|||++ +|+||||||+||++++++.++++|||+++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 84 TEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 999999999999976543 589999999999999999999999 9999999999999999999999999999877522
Q ss_pred CC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 977 ET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 977 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.. .......++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... ....
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~-~~~~------ 224 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN--------QDVIKA-VEDG------ 224 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH--------HHHHHH-HHcC------
Confidence 22 12223345678999999998899999999999999999998 8888753211 111111 1111
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
...+.+..++..+.+++.+||+.+|++||++.||+++|+++
T Consensus 225 ---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ---YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ---CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122345567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=319.29 Aligned_cols=248 Identities=23% Similarity=0.382 Sum_probs=211.2
Q ss_pred cCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.+|++.+.||+|.||.|-+|+ +..|+.||||.++++..+ ++.-.+.+|+++|..++||||+.++++|+..+.+.+||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 468888999999999999994 477999999999887654 34556889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||..+|.|++|+..... +++.+.+.++.||+.|+.|+|.+ ++||||||.+|||+|+++++||+|||++-.+..
T Consensus 133 EYaS~GeLYDYiSer~~--LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~-- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISERGS--LSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYAD-- 205 (668)
T ss_pred EecCCccHHHHHHHhcc--ccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhcc--
Confidence 99999999999987654 99999999999999999999999 999999999999999999999999999987743
Q ss_pred CccccCCcccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVS-DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
....+.++|+|-|.+||++++.+|. +.+|-||+||++|.++.|.-||++-+ .. ....++..+.+.
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D--------hk-~lvrQIs~GaYr----- 271 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD--------HK-RLVRQISRGAYR----- 271 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch--------HH-HHHHHhhccccc-----
Confidence 3445678999999999999999884 68999999999999999999998321 11 122223333221
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
....+....-+|.+|+..+|++|.+..||..+-
T Consensus 272 ------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 272 ------EPETPSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 123345677899999999999999999998763
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=327.36 Aligned_cols=252 Identities=23% Similarity=0.410 Sum_probs=206.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||.||+|+++++..+|+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM--SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc--cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 45888899999999999999998888999998864432 2467889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++|+|.++++... ..+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+|++|||.++.........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999997643 3488999999999999999999999 99999999999999999999999999988654333322
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+......... .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~--------~~~~~~i~~~~----------~ 219 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN--------YEVVEMISRGF----------R 219 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHHHCCC----------C
Confidence 333445678999999988889999999999999999999 8888863221 11122111111 0
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
...+...+..+.+++.+||+.+|++||+++|+++.|.
T Consensus 220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112234567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=328.96 Aligned_cols=255 Identities=25% Similarity=0.418 Sum_probs=209.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.+|.+.+.||+|+||.||+|... .++.||+|++.... ...+.+.+|++++++++|+||+++++++...+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 35888899999999999999655 58899999986542 3456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.......+++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999999876556689999999999999999999999 9999999999999999999999999999876443322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||++.+..++.++||||||+++|||++ |..||..... ....... . ...
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~--------~~~~~~~-~---------~~~ 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--------SQVYELL-E---------KGY 222 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHHH-H---------CCC
Confidence 2223334678999999998899999999999999999998 8888753211 1111111 1 111
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....+...+..+.+++.+||..+|++||++.++.+.|+.+
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1223445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=330.49 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=214.5
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+...+|++.+.||+|+||+||+|...++..+|+|++...... ....+.+|+.+++.++|+||+++++++...+..++||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL-KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh-hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 345679999999999999999998888999999998765432 3567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++...+..+++.++.+++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 82 ELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred eecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 999999999999876666789999999999999999999999 99999999999999999999999999997664322
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......++..|+|||.+....++.++||||||+++|+|++ |+.||..... ........ .
T Consensus 159 -~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~----------~ 219 (261)
T cd05148 159 -YLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN--------HEVYDQIT----------A 219 (261)
T ss_pred -ccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHH----------h
Confidence 22224456778999999988889999999999999999998 7888863221 11111111 1
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
......+..++..+.++|.+|+..||++||+++++++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 111223445667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=341.01 Aligned_cols=254 Identities=21% Similarity=0.317 Sum_probs=206.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++..++||||+++++++...+..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999766 488999999976532 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence 9999999999997643 488999999999999999999999 999999999999999999999999999976532
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........... ......
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~--------~~~~~~i~~~~---~~~~~~ 220 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP--------NETWENLKYWK---ETLQRP 220 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH--------HHHHHHHHhcc---ccccCC
Confidence 23445789999999999999999999999999999999999999973221 11111111100 111111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+.++.+++.+|+..+|++||+++|++++
T Consensus 221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 1111112446778999999999999999999999976
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=308.84 Aligned_cols=265 Identities=23% Similarity=0.296 Sum_probs=204.6
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhH-HHHHHHHHHHhcCCCCceeEEEeEEec--CCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 895 (1103)
.++|+..++|++|+||.||+|+. ++++.||+|+++.+..++.. -...+||.++.+++|||||.+..+... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 34688999999999999999954 46899999999887644322 246799999999999999999988754 457999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|||||+. ||...++... .++...++..++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||+|+.++.
T Consensus 155 VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred eHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 9999976 9999998876 5689999999999999999999999 999999999999999999999999999999875
Q ss_pred CCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH--hcCcccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL--RQGQVKD 1052 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 1052 (1103)
+. ...+..+-|.+|.|||.+.+. .|+++.|+||+|||+.||+++++-|.+... ..++...+...- ....+..
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE----~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE----IDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch----HHHHHHHHHHhCCCccccCCC
Confidence 53 344556779999999998764 689999999999999999999987764321 111111111100 0111111
Q ss_pred ccccc--------------ccCCCChh-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 VFNAE--------------LWASGPHD-DLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~--------------~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+.+.. ++..+... ....-.+++..++..||++|-|+.|.+++
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 11111 11111111 33567889999999999999999998864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=334.70 Aligned_cols=246 Identities=23% Similarity=0.335 Sum_probs=203.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36889999999999999999765 689999999865432 224567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~- 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR- 154 (291)
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence 9999999999998654 488999999999999999999999 9999999999999999999999999999765321
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~--------- 214 (291)
T cd05612 155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP--------FGIYEKILAGK--------- 214 (291)
T ss_pred ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC---------
Confidence 2235689999999999998899999999999999999999999873211 11111111111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+......+.+++.+|++.||.+||+ ++|++++
T Consensus 215 --~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 215 --LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred --cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 1123334567899999999999999995 8888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=340.33 Aligned_cols=243 Identities=24% Similarity=0.355 Sum_probs=205.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|.+.++||+|.||+|++|..+ +++.+|||+++++.. .++++..+.|..++... +||.++.++.++...++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 457999999999999999999665 578999999998765 44678888898888877 59999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+.||++..+.+. ..+++..+..+|..|+.||.|||++ +|||||||.+|||+|.+|.+||+|||+++..-
T Consensus 447 vmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m- 519 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM- 519 (694)
T ss_pred EEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-
Confidence 9999999995555443 3499999999999999999999999 99999999999999999999999999998642
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.....+...+|||.|||||++.+..|+.++|.|||||++|||+.|..||.+... . .....+ +.
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-----e---e~FdsI---------~~ 582 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-----E---EVFDSI---------VN 582 (694)
T ss_pred CCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-----H---HHHHHH---------hc
Confidence 123356678999999999999999999999999999999999999999974321 0 011111 11
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTM 1088 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1088 (1103)
.+ ..+|...+.+.+.++++++..+|++|--+
T Consensus 583 d~--~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 583 DE--VRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred CC--CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11 23567788899999999999999999855
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=317.39 Aligned_cols=264 Identities=24% Similarity=0.340 Sum_probs=205.8
Q ss_pred HhcCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccc-cchhhHHHHHHHHHHHhcCCCCceeEEEeEEec-----CC
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVG-RFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-----GN 891 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~ 891 (1103)
....|...+.||+|+||.|+.|. ..+|+.||||++... ......++..+|+.+++.++|+||+.+.+++.. -.
T Consensus 20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 34456668899999999999994 456899999999732 334457888999999999999999999998755 45
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+|+|+|+| +.+|...++.... ++...+..++.|+++|+.|+|+. +|+|||+||.|++++.+...||+|||+|+
T Consensus 100 DvYiV~elM-etDL~~iik~~~~--L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQD--LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCcc--ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccccee
Confidence 889999999 5699999987543 99999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCC-CCccccCCcccccccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH-----
Q 043720 972 LLGTS-ETHATTGVAGTFGYVAPEYA-LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML----- 1044 (1103)
Q Consensus 972 ~~~~~-~~~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 1044 (1103)
..... .....+..+.|.+|.|||++ ....|+.+.||||.|||+.||++|++-|.+....+ ..+.+...
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~-----Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVH-----QLQLILELLGTPS 248 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHH-----HHHHHHHhcCCCC
Confidence 87433 22344677889999999987 45789999999999999999999998887544211 11111111
Q ss_pred ------HhcCccccccc-------ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 ------LRQGQVKDVFN-------AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 ------~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+........+. ..+. .......+...+++.+|+..||.+|+|++|.+++
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~-~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFS-SIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHH-HHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00000000000 0110 1113556778999999999999999999999875
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=339.42 Aligned_cols=263 Identities=24% Similarity=0.396 Sum_probs=209.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEec-CC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRAS-GN 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 891 (1103)
.++|++.+.||+|+||.||+|... +++.||+|++.........+.+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 347999999999999999999532 24789999997665555567788999999999 79999999998764 46
Q ss_pred eEEEEEeecCCCChHHHHHhhcC---------------------------------------------------------
Q 043720 892 EMFLIYNYLPGGNLENFIKARTS--------------------------------------------------------- 914 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 914 (1103)
.+++++||+++++|.+++.....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 78999999999999999865321
Q ss_pred --CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc-cccCCccccccc
Q 043720 915 --RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYV 991 (1103)
Q Consensus 915 --~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~ 991 (1103)
..+++..+.+++.||+.|++|||+. +|+||||||+||++++++.+||+|||+++.+...... ......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 2578999999999999999999999 9999999999999999999999999999876433222 222345567899
Q ss_pred CccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHH
Q 043720 992 APEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDM 1070 (1103)
Q Consensus 992 aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1070 (1103)
|||++.+..++.++|||||||++|||++ |..||...... .. ......... ....+.....++
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~-------~~-~~~~~~~~~---------~~~~~~~~~~~~ 305 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID-------EE-FCRRLKEGT---------RMRAPEYATPEI 305 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc-------HH-HHHHHhccC---------CCCCCccCCHHH
Confidence 9999999999999999999999999998 88888632110 01 111111111 111233455779
Q ss_pred HHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1071 LHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1071 ~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
.+++.+||+.+|++||++.|++++|+++.+.+
T Consensus 306 ~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~~ 337 (337)
T cd05054 306 YSIMLDCWHNNPEDRPTFSELVEILGDLLQEN 337 (337)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhcC
Confidence 99999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=336.79 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=209.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCc----EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGI----LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.+|+..+.||+|+||+||+|.+. ++. .||||++.........+++.+|+.+++.++||||++++|++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46999999999999999999754 233 48999987655555667899999999999999999999998765 5789
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+||+++|+|.++++... ..+++..+.+++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 999999999999998754 3488899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
..... .....++..|+|||++.+..++.++||||||+++|||++ |+.||+... ...+.. ....
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~--------~~~~~~-~~~~------ 226 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP--------ASEISS-ILEK------ 226 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC--------HHHHHH-HHhC------
Confidence 32221 222334678999999999999999999999999999998 888886321 111111 1111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
......+..++..+.+++.+||..+|++||++.++++.+.++.+.+
T Consensus 227 ---~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 227 ---GERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ---CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 1111223345567899999999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=336.84 Aligned_cols=264 Identities=25% Similarity=0.371 Sum_probs=207.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||.||+|... ++..||+|++.........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 357999999999999999999765 5788999998776555556789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.++++... .+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (331)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence 999999999997654 4889999999999999999999852 6999999999999999999999999998765322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH-hc--Cc------
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL-RQ--GQ------ 1049 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~--~~------ 1049 (1103)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .......... .. +.
T Consensus 158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHhcccccccccCCccccCc
Confidence 223456899999999999989999999999999999999999999643210 0000000000 00 00
Q ss_pred ---------------------ccc----cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1050 ---------------------VKD----VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1050 ---------------------~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
..+ ..............+.++.+++.+||+.||++||++.|++++-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~ 302 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT 302 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence 000 0000000001123457899999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=342.42 Aligned_cols=261 Identities=21% Similarity=0.269 Sum_probs=199.9
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.+|++.+.||+|+||.||+|.. .+++.||+|+.. ...+.+|+.++++++||||+++++++......++|+|+
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 5799999999999999999955 468899999643 23467899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+. ++|.+++.... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 165 ~~-~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 165 YK-TDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred CC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 94 78999887653 488999999999999999999999 9999999999999999999999999999754332223
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc----------
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ---------- 1049 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---------- 1049 (1103)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.......................+.
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 3445679999999999999899999999999999999999998876433221111000000000000000
Q ss_pred --ccccc---------cccccC--CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 --VKDVF---------NAELWA--SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 --~~~~~---------~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+ .+.... ......+.++.+++.+||+.||++|||++|++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h 376 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF 376 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000000 0012346678999999999999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=337.74 Aligned_cols=243 Identities=23% Similarity=0.290 Sum_probs=199.5
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.||+|+||+||+|... +|+.||||+++.... ......+.+|+.++++++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999654 689999999876432 334567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccC
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 983 (1103)
+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~ 154 (323)
T cd05571 81 ELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccc
Confidence 9999997643 489999999999999999999999 999999999999999999999999999875322 1222334
Q ss_pred CcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCC
Q 043720 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063 (1103)
Q Consensus 984 ~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1103)
..|++.|+|||++.+..++.++||||+||++|||++|+.||..... ........ .+. ...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~--------~~~~~~~~-~~~----------~~~p 215 (323)
T cd05571 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELIL-MEE----------IRFP 215 (323)
T ss_pred eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH--------HHHHHHHH-cCC----------CCCC
Confidence 5789999999999999999999999999999999999999963211 11111111 110 1223
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1064 HDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1064 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+.++.+++.+|++.||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 45567899999999999999999 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.94 Aligned_cols=263 Identities=20% Similarity=0.325 Sum_probs=202.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... +++.||+|+++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999655 68899999987654444456778999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
++ ++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~ 158 (288)
T cd07871 85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K 158 (288)
T ss_pred CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence 96 59999987543 3478899999999999999999999 99999999999999999999999999997643222 1
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH------------h
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL------------R 1046 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 1046 (1103)
......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .......... .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVK-----EELHLIFRLLGTPTEETWPGITS 233 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCChHHhhcccc
Confidence 2234567899999998865 56889999999999999999999998643211 0000000000 0
Q ss_pred cCcccccccccccC----CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDVFNAELWA----SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+.... ........++.+++.+|++.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 234 NEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred chhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 00000111111000 0012335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=330.20 Aligned_cols=268 Identities=19% Similarity=0.249 Sum_probs=203.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 36889999999999999999775 578899999876533 2345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++++.+..+.+. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 9988766655433 23589999999999999999999999 999999999999999999999999999987643333
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCcchHHHHHHHHhcCcc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG--------DGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~ 1050 (1103)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||........ .... ..+..........
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 234 (287)
T cd07848 156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLP-AEQMKLFYSNPRF 234 (287)
T ss_pred ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCC-HHHHHhhhccchh
Confidence 333445789999999999988899999999999999999999999874321000 0000 0000000000000
Q ss_pred ccccccccc------CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDVFNAELW------ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+... .......+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 00111245679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=328.63 Aligned_cols=268 Identities=24% Similarity=0.369 Sum_probs=207.6
Q ss_pred CCCcceeccCCcccEEEEEE-----cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEEE
Q 043720 823 FNTSNCIGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMFL 895 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 895 (1103)
|+..+.||+|+||+||++.. .++..||+|++...........+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37889999999999988642 357889999997765544567888999999999999999999987653 46899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++++|.+++.... +++.++..++.|+++|++|||++ +|+||||||+||++++++.+|++|||+++....
T Consensus 86 v~e~~~~~~l~~~~~~~~---l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 86 IMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred EecCCCCCCHHHHHHHcC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 999999999999997643 89999999999999999999999 999999999999999999999999999986643
Q ss_pred CCCcc--ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETHA--TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
..... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ...+...........+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE---MIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh---hhcccccccchhhhhhh
Confidence 32211 12223566799999998888999999999999999999999998643211000 00000000000011111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
.+.....+.+..++..+.+++.+||+.+|++||+++++++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 2222222334556788999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=326.75 Aligned_cols=259 Identities=24% Similarity=0.389 Sum_probs=206.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCc----EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGI----LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|++.+.||+|+||+||+|.+. +++ .|++|++..........++..|+..++++.||||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46888999999999999999764 343 4788887654444455778889999999999999999998864 55788
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
++||+++|+|.+++.... ..+++..+..++.|++.|++|||++ +++||||||+||++++++.+|++|||+++....
T Consensus 86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 999999999999997643 3589999999999999999999999 999999999999999999999999999986543
Q ss_pred CCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......++..|+|||++.+..++.++||||||+++||+++ |+.||..... . -.......+.
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~----~~~~~~~~~~---- 228 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----H----EVPDLLEKGE---- 228 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----H----HHHHHHHCCC----
Confidence 3221 2233456779999999998899999999999999999998 8888863221 0 0111111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
....+..++..+.+++.+||..+|++||++.|+++.|..+.+.|
T Consensus 229 -----~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 229 -----RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred -----cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 11122234567889999999999999999999999999987665
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=341.16 Aligned_cols=264 Identities=21% Similarity=0.366 Sum_probs=211.3
Q ss_pred HHHHhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEe
Q 043720 816 IIRATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRA 888 (1103)
Q Consensus 816 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 888 (1103)
.....++|.+.+.||+|+||.||+|.+. .+..||||++.........+.+.+|+.++.++. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3444567889999999999999999764 246899999987655555667899999999997 999999999999
Q ss_pred cCCeEEEEEeecCCCChHHHHHhhcC------------------------------------------------------
Q 043720 889 SGNEMFLIYNYLPGGNLENFIKARTS------------------------------------------------------ 914 (1103)
Q Consensus 889 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------ 914 (1103)
..+..++|+||+++|+|.+++++...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999975321
Q ss_pred ------------------------------------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCC
Q 043720 915 ------------------------------------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPS 952 (1103)
Q Consensus 915 ------------------------------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~ 952 (1103)
..+++..+.+++.|++.|++|||+. +++||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence 2357778899999999999999999 9999999999
Q ss_pred cEEECCCCCEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 043720 953 NILLDDDFNAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSS 1030 (1103)
Q Consensus 953 NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~ 1030 (1103)
||++++++.+|++|||+++....... .......+++.|+|||.+....++.++||||||+++|||++ |+.||.....
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~- 347 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM- 347 (401)
T ss_pred eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc-
Confidence 99999999999999999986532221 12223456789999999998889999999999999999998 8888753211
Q ss_pred CCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1031 HGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
..........+ .....+..++.++.+++.+||..+|++||+++||++.|+++.
T Consensus 348 -------~~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 -------NEQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -------hHHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 01111111111 111233445678999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=325.03 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=205.7
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||.|+..++..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 35788899999999999999888777899998875432 2467899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++|+|.++++.... .+++.++++++.|++.|++|||+. +++|+||||+||+++.++.+||+|||.++.........
T Consensus 82 ~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 82 SNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 99999999976443 589999999999999999999999 99999999999999999999999999987654333222
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++..|+|||...+..++.++||||||+++|||++ |..||..... ........ ... .
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~-~~~---------~ 219 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--------SETVEKVS-QGL---------R 219 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHHHh-cCC---------C
Confidence 233345678999999988889999999999999999998 8888763211 11111111 111 1
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
...+...+..+.+++.+||+.+|++||++.++++.++
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 1112234578999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=337.94 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=203.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46899999999999999999765 588999999875432 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR- 171 (329)
T ss_pred cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence 9999999999998654 488889999999999999999999 9999999999999999999999999999865322
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .+.
T Consensus 172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~--------~~~~~~i~-~~~-------- 231 (329)
T PTZ00263 172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP--------FRIYEKIL-AGR-------- 231 (329)
T ss_pred ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH--------HHHHHHHh-cCC--------
Confidence 2235789999999999999999999999999999999999999963211 11111111 111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+......+.+++.+||+.||++||+ ++|++++
T Consensus 232 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 232 --LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1123334567899999999999999996 6777754
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=315.12 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=214.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+.|++.+.||+|.-|+||+++.++ +..+|+|++.+... .+...++..|.++|+.++||.+..+++.++.+...|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 357888999999999999998775 58999999987654 334567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC--
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-- 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~-- 975 (1103)
|||+||+|...++++.++.+++..++.+|.+++-||+|||-+ |||+|||||+||||.++|++-++||.++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 999999999999999999999999999999999999999999 999999999999999999999999998754311
Q ss_pred -------------------------------C-C---------------------CccccCCcccccccCccccccCCCC
Q 043720 976 -------------------------------S-E---------------------THATTGVAGTFGYVAPEYALTCRVS 1002 (1103)
Q Consensus 976 -------------------------------~-~---------------------~~~~~~~~g~~~y~aPE~~~~~~~~ 1002 (1103)
. . ......++||-.|+|||++.+...+
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0112245799999999999999999
Q ss_pred CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCC
Q 043720 1003 DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETL 1082 (1103)
Q Consensus 1003 ~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 1082 (1103)
.++|.|+|||++|||+.|..||.+... .+....++......+........+.+||++.+.+||
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~-----------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP 376 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNN-----------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP 376 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCc-----------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence 999999999999999999999985432 112233344444444444667889999999999999
Q ss_pred CCCCC----HHHHHHH
Q 043720 1083 STRPT----MKQVVQC 1094 (1103)
Q Consensus 1083 ~~RPs----~~evl~~ 1094 (1103)
++|-- ++||.++
T Consensus 377 ~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhccccchHHhhcC
Confidence 99998 7777654
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=322.88 Aligned_cols=253 Identities=27% Similarity=0.453 Sum_probs=207.6
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||.||+|...++..||+|.+...... .+.+.+|+.++++++|++++++++++.. ...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYM 82 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEec
Confidence 468899999999999999998888889999998764432 4678999999999999999999998854 5689999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.++++......+++.++..++.+++.|++|||+. +++||||||+||++++++.++++|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 83 SKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 999999999876555689999999999999999999999 99999999999999999999999999998764433222
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++..|+|||+..+..++.++||||||+++|||++ |..||..... ........ . ...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~--------~~~~~~~~-~---------~~~ 221 (260)
T cd05070 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--------REVLEQVE-R---------GYR 221 (260)
T ss_pred ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH--------HHHHHHHH-c---------CCC
Confidence 333345678999999988889999999999999999999 7888753211 11111111 1 111
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
.+.+...+..+.+++.+|+..+|++|||++++.+.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 12234556789999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=323.04 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=207.1
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|...++..||+|++..... ..+.+.+|++++++++|+||+++++++.+ +..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~--~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc--CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 46899999999999999999887777899999875433 23578999999999999999999998754 5679999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++|+|.++++......+++..+..++.|+++||+|+|+. +++||||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~ 159 (262)
T cd05071 83 SKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 159 (262)
T ss_pred CCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence 999999999875555689999999999999999999999 99999999999999999999999999998765433333
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++..|+|||+..+..++.++||||||+++|||++ |..||..... ...... ... ...
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~--------~~~~~~-~~~---------~~~ 221 (262)
T cd05071 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQ-VER---------GYR 221 (262)
T ss_pred ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh--------HHHHHH-Hhc---------CCC
Confidence 334456778999999988889999999999999999999 7777753211 011111 111 111
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
...+...+..+.+++.+|++.+|++||+++++++.|++.
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 122345667899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=326.67 Aligned_cols=258 Identities=21% Similarity=0.383 Sum_probs=206.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
+.++|++.+.||+|+||+||+|... .+..||||++..........++.+|+.+++.++|+||+++++++..+..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567999999999999999999653 2567999998655444456678999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcC--------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEE
Q 043720 893 MFLIYNYLPGGNLENFIKARTS--------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYL 964 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 964 (1103)
.++||||+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 9999999999999999976321 2357788999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHH
Q 043720 965 SDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWAS 1042 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1042 (1103)
+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||..... .....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~--------~~~~~ 232 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--------EQVLR 232 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH
Confidence 9999987654332221 122345778999999998889999999999999999999 6777753211 11111
Q ss_pred HHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1043 MLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
... .... ...+..++..+.+++.+|++.+|++||++.|+++.|++
T Consensus 233 ~~~-~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 233 FVM-EGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred HHH-cCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111 1110 11233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=328.21 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=209.6
Q ss_pred cCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|.+.+.||+|+||.||+|...+ +..||||++......+..+.+.+|+++++.++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468889999999999999997643 47899999987666556788999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhc------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCE
Q 043720 895 LIYNYLPGGNLENFIKART------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNA 962 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 962 (1103)
+||||+++++|.++++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997642 13478899999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHH
Q 043720 963 YLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 963 ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
|++|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |..||..... ...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~--------~~~ 233 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN--------EEV 233 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHH
Confidence 9999999976533222 11223345789999999999999999999999999999998 9988863211 111
Q ss_pred HHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1041 ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
... ...+ .....+...+..+.+++.+||..||++||++.||++.|++
T Consensus 234 ~~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 234 IEC-ITQG---------RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHH-HHcC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 111 1111 1112233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=322.95 Aligned_cols=255 Identities=24% Similarity=0.422 Sum_probs=209.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||.||+|..++++.||+|++..... ..+.+.+|+.++++++|+||+++++++. .+..++||||
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM--SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC--cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 356889999999999999999988899999999875443 3467889999999999999999999874 4578999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++....+..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||++.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999999876666789999999999999999999999 9999999999999999999999999999766433333
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||++....++.++||||||+++|||++ |+.||..... ........ . ..
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~-~---------~~ 220 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN--------PEVIQNLE-R---------GY 220 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh--------HHHHHHHH-c---------CC
Confidence 3334456778999999998889999999999999999999 9988863221 11111111 1 11
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....+...+.++.+++.+|+..+|++||+++++.+.|+.+
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 1122334567899999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=326.36 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=207.5
Q ss_pred cCCCCcceeccCCcccEEEEEE-----cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.+|++.+.||+|+||+||+|.. ..+..||+|.+...........+.+|+.++++++||||+++++++..+...|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688889999999999999964 24678999999865555556789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhc---------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC
Q 043720 896 IYNYLPGGNLENFIKART---------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF 960 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 960 (1103)
||||+++++|.+++.... ...+++.++..++.|++.|++|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999986432 13478889999999999999999999 999999999999999999
Q ss_pred CEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchH
Q 043720 961 NAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 961 ~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1103)
.+|++|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||..... .
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~--------~ 233 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN--------Q 233 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH--------H
Confidence 999999999986543222 12233345678999999988889999999999999999998 8888763211 1
Q ss_pred HHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1039 SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
.......... ....+..++.++.+++.+|++.||++||++.+|.++|..
T Consensus 234 -~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 -EVIEMVRKRQ---------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1111111111 112334566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=327.28 Aligned_cols=259 Identities=24% Similarity=0.385 Sum_probs=209.5
Q ss_pred CCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
+|++.+.||+|+||+||+|... ....+|+|.+.........+.+.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4778899999999999999653 2357899988766655566789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhc----------------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCc
Q 043720 896 IYNYLPGGNLENFIKART----------------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSN 953 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~N 953 (1103)
|+||+.+++|.+++.... ...+++.+++.++.|++.|++|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 999999999999987532 13478899999999999999999999 99999999999
Q ss_pred EEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043720 954 ILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSH 1031 (1103)
Q Consensus 954 Ill~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~ 1031 (1103)
|++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999765332221 1223345678999999988889999999999999999998 8888853211
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
..+. .... .......+...+.++.+++.+|++.+|++||+++|+++.|+++...
T Consensus 236 ------~~~~-~~~~---------~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 236 ------ERLF-NLLK---------TGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred ------HHHH-HHHh---------CCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1111 1111 1111223345567899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=321.50 Aligned_cols=250 Identities=26% Similarity=0.418 Sum_probs=204.1
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
+|++.+.||+|+||.||+|.++.+..+|+|++..... ....+.+|+++++.++|+||+++++++...+..++||||++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM--SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 5888999999999999999888778899999864432 23568889999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+++|.++++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+|||+++..........
T Consensus 83 ~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 83 NGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 9999999976543 589999999999999999999999 999999999999999999999999999876543222222
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... .. ....
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~-~~---------~~~~ 220 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN--------SEVVESV-SA---------GYRL 220 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH--------HHHHHHH-Hc---------CCcC
Confidence 22234568999999998899999999999999999999 7888763211 0111111 11 1111
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
..+..++.++.+++.+||..+|++||++.|+++.|
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 22344677899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=328.65 Aligned_cols=265 Identities=20% Similarity=0.311 Sum_probs=201.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.+++.++||||+++++++......++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999765 6889999999765544445567889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+. ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++...... .
T Consensus 84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 995 68888887643 3488899999999999999999999 9999999999999999999999999998754322 1
Q ss_pred ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc--------
Q 043720 979 HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ-------- 1049 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1049 (1103)
.......+++.|+|||++.+ ..++.++||||+||++|||++|+.||...... ...............
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 233 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI----QDQLERIFLVLGTPNEDTWPGVH 233 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhCCCChhhccchh
Confidence 22334567899999998865 45788999999999999999999999743210 000000000000000
Q ss_pred -ccccccccccCCCC---------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 -VKDVFNAELWASGP---------HDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 -~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.............+ ......+.+++.+|++.||++|||+.|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 00000000000000 1123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=329.21 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=211.1
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCC
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGN 891 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 891 (1103)
..++|++.+.||+|+||.||+|.... ...||+|++......+...++.+|+.+++++ +|+||+++++++..++
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34578899999999999999997642 3679999988665555567789999999999 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhh--------------cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC
Q 043720 892 EMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~ 957 (1103)
..++||||+++|+|.++++.. ....+++..+++++.|++.|++|||+. +|+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEc
Confidence 999999999999999999753 234688999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 043720 958 DDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGF 1035 (1103)
Q Consensus 958 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1103)
+++.+|++|||+++......... .....++..|+|||++.+..++.++|||||||++||+++ |..||....
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------- 239 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------- 239 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCC-------
Confidence 99999999999998764332211 222335678999999988899999999999999999998 888875221
Q ss_pred chHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1036 NIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
..+.... .. .......+..++..+.+++.+|+..+|++|||+.|+++.|+++.
T Consensus 240 -~~~~~~~-~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 240 -VEELFKL-LK---------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred -HHHHHHH-HH---------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111 11 11112234455678999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=326.52 Aligned_cols=263 Identities=24% Similarity=0.345 Sum_probs=198.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc--CCcEEEEEEcccccchh-hHHHHHHHHHHHhcC---CCCceeEEEeEEe-----c
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS--PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNV---RHPNLVTLIGYRA-----S 889 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~ 889 (1103)
.+|++.+.||+|+||+||+|... +++.||||++......+ ....+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36889999999999999999753 46889999987654322 234566677776665 6999999999885 2
Q ss_pred CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 890 GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
....++||||+. ++|.+++.......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 456899999995 6999999876666689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC-
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG- 1048 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 1048 (1103)
++..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ..............
T Consensus 157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~-----~~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH-----HHHHHHHHHHhCCCC
Confidence 9865432 233445689999999999888999999999999999999999999974321 11111111100000
Q ss_pred --cc-------ccccccccc---CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 --QV-------KDVFNAELW---ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 --~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ...+..... .......+..+.+++.+|++.||++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 000000000 00012345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=335.27 Aligned_cols=246 Identities=25% Similarity=0.374 Sum_probs=203.0
Q ss_pred cCCCCcceeccCCcccEEEEEEcC--CcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP--GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||.||+|.... +..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 469999999999999999997543 36899999865432 33456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 110 ~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~ 184 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR 184 (340)
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence 99999999999998654 489999999999999999999999 9999999999999999999999999999865321
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||..... ........ .+.
T Consensus 185 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--------~~~~~~i~-~~~------- 244 (340)
T PTZ00426 185 ----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP--------LLIYQKIL-EGI------- 244 (340)
T ss_pred ----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH--------HHHHHHHh-cCC-------
Confidence 2345789999999999988899999999999999999999999973211 01111111 111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+..+.+++.+|++.||++|+ +++|++++
T Consensus 245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 112334456789999999999999995 88888765
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=331.53 Aligned_cols=240 Identities=25% Similarity=0.328 Sum_probs=196.3
Q ss_pred eccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||+|+||+||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999665 57899999987543 233456788999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCc
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 985 (1103)
.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ........
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~ 154 (312)
T cd05585 81 FHHLQREG--RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFC 154 (312)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccC-CCcccccc
Confidence 99997643 489999999999999999999999 9999999999999999999999999998754222 22233457
Q ss_pred ccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChh
Q 043720 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065 (1103)
Q Consensus 986 g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1103)
|++.|+|||++.+..++.++||||+||++|||++|+.||.... ........... . ...+..
T Consensus 155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~--------~~~~~~~~~~~---------~--~~~~~~ 215 (312)
T cd05585 155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN--------VNEMYRKILQE---------P--LRFPDG 215 (312)
T ss_pred CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCC--------HHHHHHHHHcC---------C--CCCCCc
Confidence 8999999999999999999999999999999999999997321 11222221111 0 122344
Q ss_pred HHHHHHHHHHHccccCCCCCCC---HHHHHH
Q 043720 1066 DLEDMLHLALRCTVETLSTRPT---MKQVVQ 1093 (1103)
Q Consensus 1066 ~~~~l~~li~~cl~~dP~~RPs---~~evl~ 1093 (1103)
.+..+.+++.+||+.||++||+ +.|+++
T Consensus 216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 5677899999999999999985 556554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=334.00 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=202.8
Q ss_pred CCCCcceeccCCcccEEEEEE----cCCcEEEEEEcccccc---hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 893 (1103)
+|++.+.||+|+||+||+++. .+++.||+|++..... ....+.+.+|+.+++.+ +|++|+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999965 3578999999875432 22345678899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.+
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999997654 489999999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
............|++.|+|||++.+. .++.++|||||||++|||++|+.||....... .......... ..
T Consensus 156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~~~~~~~~~~-~~---- 226 (332)
T cd05614 156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN----TQSEVSRRIL-KC---- 226 (332)
T ss_pred cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC----CHHHHHHHHh-cC----
Confidence 44333334456789999999998765 47889999999999999999999996332211 1111111111 10
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
....+...+..+.+++.+|++.||++|| ++++++++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 227 ------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 1122334567789999999999999999 77788764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=328.57 Aligned_cols=259 Identities=24% Similarity=0.406 Sum_probs=209.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 892 (1103)
.++|.+.+.||+|+||.||+|... .+..||||+++........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 457999999999999999999642 24579999987665555567899999999999 79999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.++||||+.+|+|.++++......+++.++.+++.+++.|++|||++ +|+|+||||+||+++.++.+|++|||++..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999999865545589999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 973 LGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 973 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
....... ......++..|+|||.+.+..++.++||||+||++|||++ |..||...... .. .......+
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~-------~~-~~~~~~~~-- 260 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD-------SK-FYKLIKEG-- 260 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch-------HH-HHHHHHcC--
Confidence 5432221 1222345778999999998889999999999999999998 88887632210 00 11111111
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
.....+...+..+.+++.+|++.+|++||++.|+++.|++.
T Consensus 261 -------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 -------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred -------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 11112233456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=331.35 Aligned_cols=201 Identities=28% Similarity=0.462 Sum_probs=176.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... ++..+|+|.+...........+.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367999999999999999999766 5788999988766545556779999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.++++... .+++..+..++.+++.|++|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 157 (333)
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh--
Confidence 999999999997643 4888999999999999999999742 7999999999999999999999999998755322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPS 1027 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~ 1027 (1103)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred -ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123346889999999999888999999999999999999999999743
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=324.33 Aligned_cols=257 Identities=23% Similarity=0.341 Sum_probs=206.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|.+.+.||+|+||.||+|.+.. +..||+|.+...........+.+|+.+++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4578999999999999999997653 5789999887665555567799999999999999999999999998999
Q ss_pred EEEEeecCCCChHHHHHhhcC-----CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEEEe
Q 043720 894 FLIYNYLPGGNLENFIKARTS-----RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAYLS 965 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~ 965 (1103)
++||||+++++|.++++.... ..+++.++.+++.||+.|++|||++ +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999976532 2589999999999999999999999 999999999999998654 59999
Q ss_pred ecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHH
Q 043720 966 DFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 966 Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||..... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~--------~~~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN--------QEVMEF 233 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHHH
Confidence 999998663222211 112233568999999998899999999999999999997 8888763211 111111
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
.... .....+...+..+.+++.+|++.+|++||++.+|+++|++
T Consensus 234 ~~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 234 VTGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred HHcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 1111 1122344556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=339.06 Aligned_cols=249 Identities=29% Similarity=0.432 Sum_probs=198.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|+..+.||+|+||+||+|... +++.||||++.........+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 35677889999999999999765 58999999997665555567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.+.. ...+..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++...... .
T Consensus 154 ~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 223 (353)
T PLN00034 154 MDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-D 223 (353)
T ss_pred CCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-c
Confidence 9999986532 256678889999999999999999 99999999999999999999999999998654322 1
Q ss_pred cccCCcccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 980 ATTGVAGTFGYVAPEYALT-----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
......|+..|+|||++.. ...+.++|||||||++|||++|+.||..... . .|........
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~-----~---~~~~~~~~~~------ 289 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQ-----G---DWASLMCAIC------ 289 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCC-----c---cHHHHHHHHh------
Confidence 2234578999999998743 2345689999999999999999999973211 1 1111111000
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+...+.++.+++.+||+.||++||+++|++++
T Consensus 290 -~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 -MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111233456789999999999999999999999986
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=331.34 Aligned_cols=243 Identities=23% Similarity=0.292 Sum_probs=198.7
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.||+|+||.||++... +|..||+|++..... ......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999654 689999999876432 334567788999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccC
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 983 (1103)
+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... ......
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~ 154 (323)
T cd05595 81 ELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKT 154 (323)
T ss_pred cHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccc
Confidence 9999887643 489999999999999999999999 9999999999999999999999999998753221 222334
Q ss_pred CcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCC
Q 043720 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063 (1103)
Q Consensus 984 ~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1103)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ... ...+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~~~-~~~----------~~~p 215 (323)
T cd05595 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELIL-MEE----------IRFP 215 (323)
T ss_pred ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCC----------CCCC
Confidence 5789999999999999999999999999999999999999863211 01111111 110 1123
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1064 HDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1064 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+..+.+++.+||..||++|| ++.+++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 44567889999999999999998 88888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=323.67 Aligned_cols=261 Identities=26% Similarity=0.434 Sum_probs=210.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCc----EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGI----LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
..+|+..+.||+|+||+||+|.+. ++. .||+|++.........+++.+|+.+++.+.|+||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence 346888999999999999999754 343 48999987665555677899999999999999999999998764 578
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+++||+++|+|.++++... ..+++.++..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++...
T Consensus 85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 9999999999999997643 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 975 TSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 975 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
..... ......+++.|+|||...+..++.++||||||+++|||++ |..||..... ..... .....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~----~~~~~---- 227 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-----REIPD----LLEKG---- 227 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHH----HHHCC----
Confidence 32221 1222344678999999998899999999999999999998 8888763211 11111 11111
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
.....+...+..+.+++.+||..||++||++.|+++.|+++.+.|+
T Consensus 228 -----~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 228 -----ERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred -----CcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 1111233456778999999999999999999999999999988774
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=318.02 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=200.3
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
+.||+|+||+||+|... +++.||+|.+......+....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 35899999999999664 68899999887655555567899999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc-ccCC
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA-TTGV 984 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~ 984 (1103)
.++++... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.+|++|||++.......... ....
T Consensus 81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence 99997543 3588999999999999999999999 99999999999999999999999999987543221111 1111
Q ss_pred cccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCC
Q 043720 985 AGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063 (1103)
Q Consensus 985 ~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1103)
..+..|+|||.+.+..++.++||||||+++|||++ |..||..... .. ....... ......+
T Consensus 157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~--------~~-~~~~~~~---------~~~~~~~ 218 (252)
T cd05084 157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN--------QQ-TREAIEQ---------GVRLPCP 218 (252)
T ss_pred CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH--------HH-HHHHHHc---------CCCCCCc
Confidence 23457999999998889999999999999999998 7777753211 01 1111111 1111223
Q ss_pred hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1064 HDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1064 ~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
...+..+.+++.+|++.+|++||++.|+.+.|++
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 4456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=297.15 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=206.1
Q ss_pred hcCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+|+.||++. -.+|+.+|+|++..... ....+++.+|+.+-+.++|||||++.+.+.+.+..|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 3568888899999999999994 44689999998865543 335788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~ 974 (1103)
|+|+|++|..-+-.+ -..++..+-.++.||++++.|+|.+ +|||||+||+|+++-. .-.+|++|||+|..++
T Consensus 90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 999999997655433 2278888899999999999999999 9999999999999953 3358999999999886
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
......+.+|||+|||||++...+|+..+|||+.||++|-++.|..||..... ...... +..+.+ -+
T Consensus 165 --~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~--------~rlye~-I~~g~y--d~ 231 (355)
T KOG0033|consen 165 --DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYEQ-IKAGAY--DY 231 (355)
T ss_pred --CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH--------HHHHHH-Hhcccc--CC
Confidence 45566788999999999999999999999999999999999999999984321 111111 112211 12
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+.+. -....++..+++.+|+..||.+|.|+.|.+++
T Consensus 232 ~~~~----w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H 267 (355)
T KOG0033|consen 232 PSPE----WDTVTPEAKSLIRRMLTVNPKKRITADEALKH 267 (355)
T ss_pred CCcc----cCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence 2222 23455678999999999999999999998864
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=319.64 Aligned_cols=256 Identities=25% Similarity=0.436 Sum_probs=211.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|.+.+.||+|+||+||+|..+++..||||.+..... ..+++.+|+.++++++|+|++++++++......++||||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM--SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc--CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 457999999999999999999888888999999875433 346789999999999999999999999998999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++....+..+++.++..++.+++.|++|||+. +++|+||+|+||++++++.+|++|||.+.........
T Consensus 83 ~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 83 MSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred cCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 9999999999876656689999999999999999999999 9999999999999999999999999999876543222
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... ........ . ..
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~~-~---------~~ 221 (261)
T cd05034 160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN--------REVLEQVE-R---------GY 221 (261)
T ss_pred hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH-c---------CC
Confidence 2233345678999999998889999999999999999998 8888753211 11111111 0 11
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....+...+..+.+++.+|+..+|++||+++++.+.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 1122334467899999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.71 Aligned_cols=253 Identities=25% Similarity=0.439 Sum_probs=206.0
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|.+.+.||+|+||.||+|....+..||+|++..... ..+.+.+|+.++++++|+|++++++++.. +..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFM 82 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcC
Confidence 45888899999999999999888777899998765432 34678899999999999999999998854 5678999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.++++......+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++|+|||.+..........
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 999999999876555689999999999999999999999 99999999999999999999999999997664333222
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++..|+|||+..+..++.++||||||+++|||++ |..||..... ...... .... ..
T Consensus 160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~-~~~~---------~~ 221 (260)
T cd05069 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN--------REVLEQ-VERG---------YR 221 (260)
T ss_pred cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH-HHcC---------CC
Confidence 233445678999999998889999999999999999999 8888763211 011111 1111 11
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
...+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 12234556789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=331.27 Aligned_cols=243 Identities=23% Similarity=0.301 Sum_probs=199.4
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.||+|+||.||++... +++.||||++..... ......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999654 589999999976432 334567889999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccC
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 983 (1103)
+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~ 154 (328)
T cd05593 81 ELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKT 154 (328)
T ss_pred CHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccccc
Confidence 9999987643 489999999999999999999999 9999999999999999999999999998753221 222334
Q ss_pred CcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCC
Q 043720 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063 (1103)
Q Consensus 984 ~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1103)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .. ....+
T Consensus 155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~--------~~~~~~~~-~~----------~~~~p 215 (328)
T cd05593 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELIL-ME----------DIKFP 215 (328)
T ss_pred ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH--------HHHHHHhc-cC----------CccCC
Confidence 5789999999999988999999999999999999999999963211 11111111 00 01223
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1064 HDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1064 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+.++.+++.+|++.||++|| ++.|++++
T Consensus 216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 44567789999999999999997 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.52 Aligned_cols=260 Identities=25% Similarity=0.370 Sum_probs=210.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||.||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47899999999999999999654 68999999876532 2334567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||+++++|.+++.... ...+++..+..++.|+++|++|||++ +++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 24478899999999999999999999 999999999999999999999999999886543
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.. .......+++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ....+.... ....
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~------~~~~~~~~~-~~~~------ 224 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLFSLCQKI-EQCD------ 224 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc------cHHHHHHHH-hcCC------
Confidence 22 122334678899999999888889999999999999999999999863321 111222111 1111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
.........+..+.+++.+||+.+|++||++.+|++.+++++
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 001112345577999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=325.43 Aligned_cols=259 Identities=25% Similarity=0.438 Sum_probs=208.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
.+|.+.+.||+|+||+||++... ++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 83 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence 46888999999999999999642 34568999887543 334677999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhc-----------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEE
Q 043720 895 LIYNYLPGGNLENFIKART-----------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY 963 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 963 (1103)
+||||+++++|.++++... ...+++.++.+++.|++.||+|||++ +++||||||+||++++++.+|
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 9999999999999997543 13489999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHH
Q 043720 964 LSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
++|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||..... ....
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~--------~~~~ 232 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN--------NEVI 232 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HHHH
Confidence 9999999865432221 1223345778999999998889999999999999999998 8888763211 1111
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
. ....+.. ...+...+..+.+++.+||+.+|.+||++.|+.+.|+++.++
T Consensus 233 ~-~i~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 233 E-CITQGRV---------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred H-HHHcCCc---------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 1 1111111 111223456799999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=328.27 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=209.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 890 (1103)
.++|.+.+.||+|+||.||+|... ....||+|.+..........++.+|+.+++.+ +|+||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357999999999999999999653 23569999998655455567788999999999 799999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
+..|+||||+++|+|.+++..... ..+++.++++++.|++.|++|||++ +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999976432 3478899999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1103)
++++.+|++|||.++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~------ 247 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 247 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC------
Confidence 999999999999987654322111 122234568999999998889999999999999999998 777775211
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....... .... .....+...+.++.+++.+|++.+|++||++.+|++.|+++.+.
T Consensus 248 --~~~~~~~-~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 248 --VEELFKL-LKEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred --HHHHHHH-HHcC---------CCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111111 1111 11123345567899999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=330.08 Aligned_cols=252 Identities=19% Similarity=0.289 Sum_probs=199.6
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.++.++ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 578999999976532 23456678899888777 799999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|..++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (329)
T cd05618 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccc
Confidence 99999887643 489999999999999999999999 9999999999999999999999999998753221 12233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||...............+......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~ 224 (329)
T cd05618 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----------IRI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC----------CCC
Confidence 4578999999999999999999999999999999999999996432222222222222222222111 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPT------MKQVVQC 1094 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 1094 (1103)
+......+.+++.+|++.||++||+ +.+++++
T Consensus 225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 3445677899999999999999998 4666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=340.61 Aligned_cols=253 Identities=23% Similarity=0.349 Sum_probs=206.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|.+.+.||+|+||+||+|... +++.||||++..... ......+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 36889999999999999999765 689999999976532 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~ 155 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK 155 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence 999999999999875 3489999999999999999999999 99999999999999999999999999998664332
Q ss_pred ----------------------------CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 043720 978 ----------------------------THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFS 1029 (1103)
Q Consensus 978 ----------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~ 1029 (1103)
........|++.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 1123345689999999999999999999999999999999999999974321
Q ss_pred CCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 043720 1030 SHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT-MKQVVQC 1094 (1103)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1094 (1103)
........... .....+.....+..+.+++.+|+. ||++||+ ++|++++
T Consensus 236 --------~~~~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 236 --------QETYNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred --------HHHHHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 11111111100 111111122256789999999997 9999999 9999875
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=315.85 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=203.0
Q ss_pred ceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChH
Q 043720 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLE 906 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 906 (1103)
+.||+|+||.||+|...++..||+|++...........+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 35899999999999888889999999876655555667899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcc
Q 043720 907 NFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG 986 (1103)
Q Consensus 907 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g 986 (1103)
+++.... ..+++..+..++.+++.|+.|+|+. +++||||+|+||++++++.+|++|||++...............+
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 81 SFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence 9987643 3478999999999999999999999 99999999999999999999999999987543322222222344
Q ss_pred cccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChh
Q 043720 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065 (1103)
Q Consensus 987 ~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1103)
+..|+|||++.+..++.++||||||+++||+++ |..||..... .... ...... .....+..
T Consensus 157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~--------~~~~-~~~~~~---------~~~~~~~~ 218 (250)
T cd05085 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN--------QQAR-EQVEKG---------YRMSCPQK 218 (250)
T ss_pred cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH--------HHHH-HHHHcC---------CCCCCCCC
Confidence 678999999998889999999999999999998 8888863211 0111 111111 11122344
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1066 DLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1066 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
.+..+.+++.+|++.+|++||++.|+++.|.
T Consensus 219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 5678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=310.08 Aligned_cols=268 Identities=23% Similarity=0.346 Sum_probs=204.6
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCc-eeEEEeEEecCC------
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPN-LVTLIGYRASGN------ 891 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~------ 891 (1103)
..|+..++||+|+||+||+|+. .+|+.||+|++.....++ .-....+|+.++++++|+| ||++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 3466677799999999999954 468899999998876532 2345789999999999999 999999998877
Q ss_pred eEEEEEeecCCCChHHHHHhhcC--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
.+++||||++ -+|.+|+..... ..++...+..++.||+.|++|||++ +|+||||||+||+|+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 8999999995 599999988653 3577789999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
|+.+..+.. ..+..++|.+|.|||++.+. .|+...||||+|||++||+++++-|..... .....-+.......
T Consensus 167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCCC
Confidence 997653322 24456789999999999876 689999999999999999999887764322 11111111111111
Q ss_pred ---cccccc-cccccCCC-----C-------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 043720 1049 ---QVKDVF-NAELWASG-----P-------HDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQI 1098 (1103)
Q Consensus 1049 ---~~~~~~-~~~~~~~~-----~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1098 (1103)
.+.... -++....+ + ........+++.+|++.+|.+|.|++.++++ +..+
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 111110 00000000 1 1111468899999999999999999999987 5444
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=340.43 Aligned_cols=254 Identities=21% Similarity=0.294 Sum_probs=204.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 457999999999999999999665 588999999865422 22345678899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.++++... +++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 122 ~Ey~~gg~L~~~l~~~~---l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 122 MEYMPGGDLVNLMSNYD---IPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999997643 78888999999999999999999 9999999999999999999999999999876433
Q ss_pred CCccccCCcccccccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTC----RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
.........|++.|+|||++.+. .++.++|||||||++|||++|+.||..... ............
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~i~~~~~--- 264 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMDHKN--- 264 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH--------HHHHHHHHcCCC---
Confidence 33233456799999999998643 478899999999999999999999974221 111111111110
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLST--RPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1094 (1103)
....+.....+..+.+++.+|+..+|++ ||+++|++++
T Consensus 265 ----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 ----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred ----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0111112235678899999999999988 9999999865
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=325.38 Aligned_cols=257 Identities=25% Similarity=0.399 Sum_probs=205.7
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-C--cEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-G--ILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||.||+|..++ + ..+++|.++........+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999997654 3 347888887544444567889999999999 799999999999999999999
Q ss_pred EeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCE
Q 043720 897 YNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNA 962 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 962 (1103)
+||+++++|.++++.... ..+++..+.+++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999976421 2478899999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHH
Q 043720 963 YLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 963 ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
||+|||++...... ........+..|+|||+.....++.++|||||||++|||++ |+.||..... ....
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~--------~~~~ 228 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC--------AELY 228 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH--------HHHH
Confidence 99999998643211 11111223567999999998889999999999999999997 9888863211 1111
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
... ........+..++..+.+++.+|+..+|.+||+++++++.|+++..
T Consensus 229 ~~~----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 229 EKL----------PQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHH----------hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 111 1111112234456789999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=322.58 Aligned_cols=264 Identities=25% Similarity=0.447 Sum_probs=208.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-----------------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-----------------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 882 (1103)
.++|++.+.||+|+||.||+|.... +..||+|++.........+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3579999999999999999986542 24689999887766666788999999999999999999
Q ss_pred EEeEEecCCeEEEEEeecCCCChHHHHHhhcC---------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCc
Q 043720 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTS---------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSN 953 (1103)
Q Consensus 883 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~N 953 (1103)
+++++..++..++|+||+++++|.+++..... ..+++..++.++.|++.|++|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999976541 2589999999999999999999999 99999999999
Q ss_pred EEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCC
Q 043720 954 ILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS--DKKALDPSFSS 1030 (1103)
Q Consensus 954 Ill~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~ 1030 (1103)
|+++.++.++++|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ +..||....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-- 238 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-- 238 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC--
Confidence 99999999999999998765433221 2233456789999999988889999999999999999998 556664211
Q ss_pred CCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1031 HGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
............... ........+..++.++.+++.+|++.||++||++.||++.|++
T Consensus 239 ---~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 239 ---DQQVIENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred ---hHHHHHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111111111110000 1111112233456789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=329.44 Aligned_cols=252 Identities=19% Similarity=0.286 Sum_probs=200.3
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||||+++.... ....+.+.+|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999665 588999999976432 23456688899999988 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (329)
T cd05588 81 GDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTS 154 (329)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCccc
Confidence 99999987643 489999999999999999999999 9999999999999999999999999998743211 12233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||+..............+......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~ 224 (329)
T cd05588 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ----------IRI 224 (329)
T ss_pred cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC----------CCC
Confidence 4578999999999999999999999999999999999999997432222111122222222222111 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCC------HHHHHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPT------MKQVVQC 1094 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs------~~evl~~ 1094 (1103)
+...+..+.+++.+|++.||++||+ ++|++++
T Consensus 225 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 3345567899999999999999997 5677643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=323.85 Aligned_cols=259 Identities=24% Similarity=0.427 Sum_probs=208.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
.+|.+.+.||+|+||.||+|... ++..+++|.+..... ...+.+.+|+..+++++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL-AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH-HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 45888899999999999999643 345688898765433 34567899999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC
Q 043720 895 LIYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF 960 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 960 (1103)
+||||+++++|.+++.... ...+++..+++++.|++.|++|||++ +|+||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999997542 13478999999999999999999999 999999999999999999
Q ss_pred CEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchH
Q 043720 961 NAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 961 ~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1103)
.++|+|||++........ .......++..|+|||++.+..++.++||||||+++|||++ |+.||..... .
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~ 232 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN--------T 232 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------H
Confidence 999999999976543222 12233456789999999999899999999999999999999 8888763221 1
Q ss_pred HHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1039 SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.... ....+. ....+..++..+.+++.+||+.+|++||++++|++.|+++.+.
T Consensus 233 ~~~~-~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 EVIE-CITQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHH-HHhCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111 111111 1112334567899999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.45 Aligned_cols=243 Identities=26% Similarity=0.378 Sum_probs=197.6
Q ss_pred ceeccCCcccEEEEEE----cCCcEEEEEEcccccc---hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 827 NCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.||+|+||.||+++. ..++.||||++..... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999965 3578999999876432 22345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++... .+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (323)
T cd05584 82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T 155 (323)
T ss_pred CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence 99999999997653 478888999999999999999999 99999999999999999999999999987542222 2
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......... + .
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~--------~~~~~~~~~-~--------~-- 216 (323)
T cd05584 156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR--------KKTIDKILK-G--------K-- 216 (323)
T ss_pred cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH--------HHHHHHHHc-C--------C--
Confidence 23345789999999999988899999999999999999999999973221 111111111 1 0
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+..+.+++.+|++.+|++|| ++.+++++
T Consensus 217 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 122334567789999999999999999 78887764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=326.24 Aligned_cols=258 Identities=26% Similarity=0.418 Sum_probs=205.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCc--EEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGI--LVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|++.+.||+|+||+||+|..+ ++. .+|+|.+.........+.+.+|+.++.++ +|+||+++++++..++..|+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 357889999999999999999764 343 46777776544455567889999999999 89999999999999999999
Q ss_pred EEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC
Q 043720 896 IYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 961 (1103)
||||+++++|.++++... ...+++.+++.++.|++.|++|||++ +++||||||+||++++++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence 999999999999997542 13478999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHH
Q 043720 962 AYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 962 ~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||+| |..||..... ...
T Consensus 163 ~kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~ 232 (303)
T cd05088 163 AKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AEL 232 (303)
T ss_pred EEeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh--------HHH
Confidence 99999999864321 111112234668999999988889999999999999999998 9988863211 111
Q ss_pred HHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1041 ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.... . .......+...+..+.+++.+||+.+|++||++.++++.++++..
T Consensus 233 ~~~~-~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 233 YEKL-P---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred HHHH-h---------cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111 1 111111233455678999999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.58 Aligned_cols=247 Identities=25% Similarity=0.408 Sum_probs=199.6
Q ss_pred eccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||+|+||+||+|.+. .+..||+|++.........+.+.+|+.++++++|+||+++++++.. ...++||||+++++|
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L 81 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL 81 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence 899999999999654 3557999998766555556779999999999999999999998864 578999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc--ccC
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA--TTG 983 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--~~~ 983 (1103)
.+++.... ..+++.++.+++.|++.|++|||++ +++||||||+||+++.++.+|++|||++.......... ...
T Consensus 82 ~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 82 NKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 99997543 4589999999999999999999999 99999999999999999999999999997654332221 122
Q ss_pred CcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 984 ~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
..++..|+|||.+....++.++||||||+++||+++ |..||..... ..+... ...+ .....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~-~~~~---------~~~~~ 219 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG--------PEVMSF-IEQG---------KRLDC 219 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH--------HHHHHH-HHCC---------CCCCC
Confidence 233578999999988889999999999999999996 9988863211 111111 1111 11223
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 445678899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=338.57 Aligned_cols=253 Identities=22% Similarity=0.319 Sum_probs=199.5
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.|+..+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999955 4578999999976432 2345678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997654 388899999999999999999999 999999999999999999999999999754311000
Q ss_pred ----------------------------------------------ccccCCcccccccCccccccCCCCCcchhHHHHH
Q 043720 979 ----------------------------------------------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGV 1012 (1103)
Q Consensus 979 ----------------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGv 1012 (1103)
......+||+.|+|||++.+..++.++|||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0012357999999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHH--ccccCCCCCCCHHH
Q 043720 1013 VLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALR--CTVETLSTRPTMKQ 1090 (1103)
Q Consensus 1013 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~e 1090 (1103)
++|||++|+.||...... .......... .....+.......++.+++.+ |+..+|..||+++|
T Consensus 237 il~elltG~~Pf~~~~~~--------~~~~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT--------ETQLKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHHhCCCCCcCCCHH--------HHHHHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999743210 0011111000 011111122345678888887 55666777999999
Q ss_pred HHHH
Q 043720 1091 VVQC 1094 (1103)
Q Consensus 1091 vl~~ 1094 (1103)
++++
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=326.22 Aligned_cols=260 Identities=25% Similarity=0.430 Sum_probs=210.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 890 (1103)
.++|.+.+.||+|+||.||+|+.. ++..||+|.+.........+.+.+|+.+++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 457889999999999999999642 24579999987655555667899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 891 NEMFLIYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
+..|+||||+++|+|.+++.... ...+++.++..++.|+++|++|||++ +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 99999999999999999997642 13478889999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1103)
++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~------- 243 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI------- 243 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC-------
Confidence 999999999999998764332222 222345678999999988889999999999999999998 67776421
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
....+.... ... .....+..++..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 244 -~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 244 -PVEELFKLL-KEG---------HRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred -CHHHHHHHH-HcC---------CcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 112222221 111 1112234566789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=321.88 Aligned_cols=253 Identities=24% Similarity=0.317 Sum_probs=204.5
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.|++.+.||+|+||+||++... +++.||+|++...... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 3778899999999999999754 6899999998754332 223557789999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.+++.......+++..+..++.|++.|++|||+. +++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE- 156 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence 99999999998765545689999999999999999999999 99999999999999999999999999987653222
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......|++.|+|||++.+..++.++||||+|+++|||++|+.||..... ......... .... .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~----~~~~~~~~~-~~~~----------~ 220 (285)
T cd05605 157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE----KVKREEVER-RVKE----------D 220 (285)
T ss_pred -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch----hhHHHHHHH-Hhhh----------c
Confidence 22344689999999999988899999999999999999999999973221 111111111 1100 0
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
....+...+..+.+++.+||+.||++|| ++++++++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 1122344567789999999999999999 88888764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=321.97 Aligned_cols=260 Identities=23% Similarity=0.374 Sum_probs=211.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec-CCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 893 (1103)
.++|++.+.||+|+||.||+|.+.. +..|++|++.........+.+.+|+.++++++|+||+++++++.. +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4578889999999999999998765 788999998766555567889999999999999999999998766 5678
Q ss_pred EEEEeecCCCChHHHHHhhcC------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 894 FLIYNYLPGGNLENFIKARTS------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
++++||+++++|.+++..... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCC
Confidence 999999999999999976432 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 968 GLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 968 gla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
|+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||..... ..+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~ 233 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--------FEMAAYLK 233 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--------HHHHHHHH
Confidence 9998654333221 122345678999999988889999999999999999999 9998863211 11111111
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.+ .....+..++..+.+++.+||..||++||++.++++.|+++..
T Consensus 234 -~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 -DG---------YRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -cC---------CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 1111233456789999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=323.86 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=206.2
Q ss_pred CCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
+|.+.+.||+|+||+||+|... .+..||||++.........+.+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4777888999999999999653 2578999999866555456778999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC
Q 043720 896 IYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 961 (1103)
++||+.+++|.+++.... ...+++..+.+++.|++.|++|+|++ +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999986321 13478888999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHH
Q 043720 962 AYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIIS 1039 (1103)
Q Consensus 962 ~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1103)
+||+|||+++........ ......+++.|+|||.+....++.++||||||+++|||++ |..||.... ...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~--------~~~ 234 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD 234 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 999999998865433221 1223345779999999988889999999999999999998 777765321 112
Q ss_pred HHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
+...... .. ....+..++..+.+++.+||+.+|++||++++|++.|+.
T Consensus 235 ~~~~i~~-~~---------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRN-RQ---------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHc-CC---------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 2222111 11 112345677889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.76 Aligned_cols=250 Identities=28% Similarity=0.454 Sum_probs=208.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||.||+|... ++.||+|++..... ..+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 46888999999999999999876 88999999976543 4678899999999999999999999999899999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.++++......+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++......
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--- 156 (256)
T cd05039 83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--- 156 (256)
T ss_pred CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc---
Confidence 999999999876655689999999999999999999999 99999999999999999999999999998653211
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+..|+|||++....++.++||||||+++|||++ |..||..... .. .......+ ..
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~-~~~~~~~~---------~~ 217 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KD-VVPHVEKG---------YR 217 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH--------HH-HHHHHhcC---------CC
Confidence 12334668999999988889999999999999999997 8888763211 11 11111111 11
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
...+...+..+.+++.+|+..+|++||+++|+++.|+.+
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 122334567899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=316.22 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=212.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||.||+|... +++.||+|.++.... ....+.+.+|++++++++|++++++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999776 789999998864322 334677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||+++++|.+++.... ...+++.++.+++.++++|++|||+. +++||||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987532 24588999999999999999999999 999999999999999999999999999876533
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.... .....+..... .+
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~------- 223 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE-KC------- 223 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC------ccHHHHHhhhh-cC-------
Confidence 221 2233467889999999998889999999999999999999999986322 11111111111 11
Q ss_pred ccccCCCC-hhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1056 AELWASGP-HDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1056 ~~~~~~~~-~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+ ...+..+.+++.+||..+|++||++.+|++.|+++.+
T Consensus 224 --~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 224 --DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred --CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 111112 2456789999999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=345.73 Aligned_cols=251 Identities=24% Similarity=0.300 Sum_probs=203.8
Q ss_pred CCCCcceeccCCcccEEEEEEc-C-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-P-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.|.+.+.||+|+||.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..|+||||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~-~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND-ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 4888999999999999999544 3 5778888775443 33456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 900 LPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 900 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
+++|+|.++++.. ....+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988653 234588999999999999999999999 99999999999999999999999999998764332
Q ss_pred C-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 T-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
. .......||++|+|||++.+..++.++|||||||++|||++|+.||..... ......... +..
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~--------~~~~~~~~~-~~~------ 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ--------REIMQQVLY-GKY------ 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-CCC------
Confidence 2 123445789999999999999999999999999999999999999863211 111111111 111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++||++++++++
T Consensus 289 ---~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 289 ---DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ---CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 11233456789999999999999999999998753
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=333.85 Aligned_cols=254 Identities=22% Similarity=0.294 Sum_probs=205.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||+|+++.... .+..+.+.+|+.+++.++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 36889999999999999999654 688999999976533 334567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK 156 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence 9999999999998753 3589999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccCCcccccccCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 978 THATTGVAGTFGYVAPEYAL------TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
........|++.|+|||++. ...++.++|||||||++|||++|+.||..... ............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~~~~~-- 226 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS--------AKTYNNIMNFQR-- 226 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH--------HHHHHHHHcCCC--
Confidence 33334457899999999986 45678899999999999999999999973221 111222211111
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.....+..+.+++.+|+. +|++||++++++++
T Consensus 227 -----~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 227 -----FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred -----ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 01111122356778999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=337.49 Aligned_cols=255 Identities=22% Similarity=0.309 Sum_probs=202.7
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
..++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467999999999999999999765 578999999865322 2234568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999754 378899999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccCCcccccccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTC----RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
..........||+.|+|||++... .++.++||||+||++|||++|+.||..... ............
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~--------~~~~~~i~~~~~-- 264 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL--------VGTYSKIMDHKN-- 264 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCc--
Confidence 333333456799999999998654 377899999999999999999999973221 111111111110
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLST--RPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1094 (1103)
....+.....+..+.+++.+|+..++.+ ||++.|++++
T Consensus 265 -----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 -----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred -----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0111112234567889999999865544 8999999876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=318.95 Aligned_cols=256 Identities=26% Similarity=0.465 Sum_probs=208.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.+|++.+.||+|+||.||+|... .+..||+|.++........+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999764 23479999987665555667899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.+++.... ..+++.++.+++.|++.|++|||+. +++||||||+||+++.++.++++|||++......
T Consensus 84 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 84 TEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999997653 3589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCccc--cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ETHAT--TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
..... ....++..|+|||++.+..++.++||||||+++||+++ |..||..... ... .... ...
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-----~~~---~~~~-~~~----- 225 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----QDV---IKAI-EEG----- 225 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-----HHH---HHHH-hCC-----
Confidence 22211 12223568999999998889999999999999999887 9988863211 111 1111 111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
...+.+...+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11122344567889999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=328.10 Aligned_cols=246 Identities=23% Similarity=0.323 Sum_probs=196.8
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHH---hcCCCCceeEEEeEEecCCeEEEE
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTL---GNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
|++.+.||+|+||+||+|... +++.||||+++.... ....+.+.+|+.++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567889999999999999655 589999999975432 22345566666554 567899999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|..+++.. .+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999988653 489999999999999999999999 9999999999999999999999999998753221
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
........|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 155 -~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~--------~~~~~~i~~~~-------- 217 (324)
T cd05589 155 -GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE--------EEVFDSIVNDE-------- 217 (324)
T ss_pred -CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC--------
Confidence 2223446789999999999999999999999999999999999999873211 11111111111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+..+.+++.+|++.||++|| ++.+++++
T Consensus 218 ---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~ 257 (324)
T cd05589 218 ---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ 257 (324)
T ss_pred ---CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence 112334567789999999999999999 56666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=316.43 Aligned_cols=252 Identities=26% Similarity=0.400 Sum_probs=205.3
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc----hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
+.|++.+.||+|++|.||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999965 4689999999865432 2234678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+||+++++|.+++.... .+++..+.+++.|++.|+.|||+. +++||||+|+||++++++.++|+|||+++....
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999997654 388899999999999999999999 999999999999999999999999999876543
Q ss_pred CCCccc--cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETHAT--TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~~~--~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||..... ... .......
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~-~~~~~~~------ 222 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA-------MAA-IFKIATQ------ 222 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch-------HHH-HHHHhcc------
Confidence 222111 334578899999999998899999999999999999999999863211 011 1111101
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+...+..+.+++.+||..+|++||++.|++++
T Consensus 223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 223 ---PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11112344566789999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=331.48 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=206.3
Q ss_pred hcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEec-CC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRAS-GN 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~~ 891 (1103)
.++|++.+.||+|+||+||+|.. ..++.||||+++..........+.+|+.++.++ +|+||+++++++.. +.
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45799999999999999999963 347889999997665555567789999999999 68999999998765 45
Q ss_pred eEEEEEeecCCCChHHHHHhhcC---------------------------------------------------------
Q 043720 892 EMFLIYNYLPGGNLENFIKARTS--------------------------------------------------------- 914 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------- 914 (1103)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 68999999999999999875321
Q ss_pred --------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc-cccCCc
Q 043720 915 --------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVA 985 (1103)
Q Consensus 915 --------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~ 985 (1103)
..+++.++.+++.|+++|++|||++ +|+||||||+||++++++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 2367888999999999999999999 9999999999999999999999999999765322221 122234
Q ss_pred ccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCCh
Q 043720 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPH 1064 (1103)
Q Consensus 986 g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1103)
+++.|+|||.+.+..++.++||||||+++|||++ |..||..... . .... .....+. ....+.
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~---~~~~-~~~~~~~---------~~~~~~ 305 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI----D---EEFC-RRLKEGT---------RMRAPD 305 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc----c---HHHH-HHHhccC---------CCCCCC
Confidence 5678999999988899999999999999999997 8888753211 0 0111 1111111 111122
Q ss_pred hHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1065 DDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1065 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....++.+++.+||+.+|++||++.||+++|+.+.+.
T Consensus 306 ~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 306 YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 3346789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=335.38 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=198.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++.+++|++|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46889999999999999999655 588999999975432 233467888999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997653 489999999999999999999999 99999999999999999999999999987543211
Q ss_pred C----------------------------------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 043720 978 T----------------------------------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKA 1023 (1103)
Q Consensus 978 ~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p 1023 (1103)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0 001245799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccc--cCCCCCCCHHHHHHH
Q 043720 1024 LDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTV--ETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~evl~~ 1094 (1103)
|..... ............ . ...+.......++.+++.+++. .++..||+++||+++
T Consensus 236 f~~~~~--------~~~~~~i~~~~~--~-----~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 236 FCSETP--------QETYKKVMNWKE--T-----LIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCH--------HHHHHHHHcCcC--c-----ccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 973221 111111111000 0 0001111234567777777543 344457999999876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.69 Aligned_cols=259 Identities=21% Similarity=0.347 Sum_probs=206.8
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
..++|++.+.||+|+||.||+|..+ .+..||+|.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3567999999999999999999653 2458999998765544455678899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcC--------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEE
Q 043720 893 MFLIYNYLPGGNLENFIKARTS--------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYL 964 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 964 (1103)
.|+||||+++|+|.++++.... ...++..+.+++.|++.|++|||++ +|+||||||+||++++++.+|+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999976321 2346778899999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHH
Q 043720 965 SDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWAS 1042 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~ 1042 (1103)
+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.... ..++..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~--------~~~~~~ 232 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS--------NEQVLK 232 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHH
Confidence 9999987654322211 122345678999999998889999999999999999998 677775321 111222
Q ss_pred HHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1043 MLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....... ...+..++..+.+++.+|++.+|++||++.++++.+++.
T Consensus 233 ~~~~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDGGY----------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcCCC----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 2111111 112334457899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=321.82 Aligned_cols=263 Identities=22% Similarity=0.404 Sum_probs=206.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-----------------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-----------------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l 883 (1103)
++|++.+.||+|+||+||++... ++..||+|++..........++.+|+.+++.++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56899999999999999998543 2346899998866555566789999999999999999999
Q ss_pred EeEEecCCeEEEEEeecCCCChHHHHHhhcC---------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcE
Q 043720 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTS---------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNI 954 (1103)
Q Consensus 884 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NI 954 (1103)
++++...+..++||||+++++|.+++..... ..+++.++.+++.|++.|++|||++ +++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheE
Confidence 9999999999999999999999999976432 2367789999999999999999999 999999999999
Q ss_pred EECCCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCC
Q 043720 955 LLDDDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS--DKKALDPSFSSH 1031 (1103)
Q Consensus 955 ll~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~~ 1031 (1103)
++++++.++++|||+++.+....... .....+++.|+|||......++.++|||||||++|||++ |..||.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-- 239 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-- 239 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh--
Confidence 99999999999999998654332221 222344678999999888889999999999999999998 6677653211
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
................ ....+.+..++..+.+++.+||+.||++||++.||.+.|++
T Consensus 240 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 240 ---EQVIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred ---HHHHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111111111111100 11112233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=311.36 Aligned_cols=257 Identities=24% Similarity=0.358 Sum_probs=196.3
Q ss_pred CCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-----eEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-----EMFL 895 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l 895 (1103)
.|...+++|.|+||.||+|.... ++.||||++-.+.. .-.+|+++|+.+.|||||++.-++.... ...+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 46678899999999999996654 68999998865433 2237999999999999999988775432 3468
Q ss_pred EEeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-CCEEEeecccccc
Q 043720 896 IYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-FNAYLSDFGLSRL 972 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~ 972 (1103)
|||||+. +|.++++.. .+..++...++-+..||++|++|||+. +|+||||||+|+|||.+ |.+||||||.|+.
T Consensus 100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 9999965 999999852 234588888999999999999999998 99999999999999966 8899999999998
Q ss_pred cCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC---
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG--- 1048 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 1048 (1103)
....+.. ..+..|..|+|||.+.+ ..|+.+.||||.||++.||+.|++-|.+..+ ..++...+ ......
T Consensus 176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~----~dQL~eIi-k~lG~Pt~e 248 (364)
T KOG0658|consen 176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS----VDQLVEII-KVLGTPTRE 248 (364)
T ss_pred eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH----HHHHHHHH-HHhCCCCHH
Confidence 8655544 44567899999999876 4699999999999999999999988864322 11111111 111100
Q ss_pred -------cccccccccc----cCC-CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 -------QVKDVFNAEL----WAS-GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 -------~~~~~~~~~~----~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+.-.+.+ +.. .....++++.+++.+++..+|.+|.++.|++.+
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 1011111111 111 345667889999999999999999999999854
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=305.00 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=211.0
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
|+++.+||+|+||.||+|.++ .|+.||||.+.++. +.+++..|+.+|++...|+||+++|.+......|+|||||.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s---DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT---DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc---hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 556778999999999999555 59999999998764 56889999999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
.|++.+.++.+. +++++.++..+....++||+|||.. .-+|||||+.|||++.+|.+|++|||.|..+.. .-.++
T Consensus 112 AGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR 186 (502)
T ss_pred CCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence 999999998754 6799999999999999999999999 899999999999999999999999999987632 23345
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
..+.|||.|||||++..-.|..++||||+|++..||..|++||..--+.. ....--..+.-...
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR----------------AIFMIPT~PPPTF~ 250 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR----------------AIFMIPTKPPPTFK 250 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc----------------eeEeccCCCCCCCC
Confidence 67889999999999999999999999999999999999999987332211 00001111222233
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.++....++.++++.|+.+.|++|.++.+++++
T Consensus 251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 466778899999999999999999999999876
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=318.04 Aligned_cols=256 Identities=25% Similarity=0.452 Sum_probs=208.4
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-C---cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-G---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|+..+.||+|+||.||+|.... + ..+|+|++.........+.+..|+.++++++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 468888999999999999997652 3 379999987665555567899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.++++... ..+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 85 TEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999997643 4589999999999999999999999 9999999999999999999999999998766432
Q ss_pred CCcc--ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ETHA--TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......+..|+|||++....++.++||||||+++|||++ |+.||..... ..+..... ..
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~--------~~~~~~i~-~~----- 226 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN--------HEVMKAIN-DG----- 226 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHh-cC-----
Confidence 2211 112223567999999988889999999999999999997 9999863211 11222111 11
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
...+.+...+.++.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ----FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11122345567899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=315.56 Aligned_cols=247 Identities=27% Similarity=0.369 Sum_probs=199.5
Q ss_pred eeccCCcccEEEEEEc---CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 828 CIGSGGFGTTYKAEIS---PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
.||+|+||+||+|.++ ++..||+|+++.... ....+++.+|+.+++.+.||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5899999999999653 578899999875543 234567899999999999999999999885 45678999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc--c
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA--T 981 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--~ 981 (1103)
+|.+++.... .+++..+.+++.|++.|++|||++ +|+||||||+||++++++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05116 81 PLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155 (257)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence 9999997643 489999999999999999999999 99999999999999999999999999998764433221 1
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
....++..|+|||.+....++.++||||||+++|||++ |+.||..... ..+.... ..+ ...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~i-~~~---------~~~ 217 (257)
T cd05116 156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG--------NEVTQMI-ESG---------ERM 217 (257)
T ss_pred CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-HCC---------CCC
Confidence 22234679999999988888999999999999999998 8888863211 1111111 111 112
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
+.+..++.++.++|.+||+.||++||++++|.+.|++.
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 23445678899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=315.88 Aligned_cols=254 Identities=24% Similarity=0.453 Sum_probs=208.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+||+++++++.. ...+++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35789999999999999999988778889999887542 235678899999999999999999999887 778999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.......+++..+..++.+++.|++|||+. +++||||+|+||+++.++.+|++|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999876556688999999999999999999999 9999999999999999999999999999766433333
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||++....++.++||||||+++|++++ |+.||..... ..... ..... .
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~-----~~~~~----~~~~~---------~ 220 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-----PEVIR----ALERG---------Y 220 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH-----HHHHH----HHhCC---------C
Confidence 3333445678999999998889999999999999999999 8888763211 11111 11111 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
....+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111233456779999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=316.51 Aligned_cols=251 Identities=23% Similarity=0.365 Sum_probs=207.8
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
+|++.+.||+|+||.||++... ++..||+|.+.........+.+.+|+.+++.++|+||+++++++..++..|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999655 588999999876555556678889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.+++.......+++..+..++.|++.|+.|||+. +|+|+||||+||++++++.++++|||.+....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-~~ 156 (255)
T cd08219 81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-AY 156 (255)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-cc
Confidence 999999999776556689999999999999999999999 99999999999999999999999999987654322 12
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....+++.|+|||++.+..++.++||||||+++|+|++|+.||.... ........ ..+.. .
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~--------~~~~~~~~-~~~~~---------~ 218 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS--------WKNLILKV-CQGSY---------K 218 (255)
T ss_pred cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC--------HHHHHHHH-hcCCC---------C
Confidence 234568889999999998889999999999999999999999987321 11111111 11111 1
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+...+..+.+++.+||+.||++||++.|++..
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1233455678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.57 Aligned_cols=260 Identities=25% Similarity=0.440 Sum_probs=208.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 890 (1103)
.++|.+.+.||+|+||.||+|... ....||+|++...........+..|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 357889999999999999999642 24579999988655555667889999999999 699999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 891 NEMFLIYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
+..++||||+++|+|.+++.... ...+++.++.+++.|++.|++|||++ +++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999997642 13488899999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1103)
++++.+|++|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||....
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~------ 241 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP------ 241 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC------
Confidence 999999999999998654322211 112234467999999998889999999999999999999 777775221
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
........ .... ....+..++.++.+++.+|+..+|++||++.|+++.|+++..
T Consensus 242 --~~~~~~~~-~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 242 --VEELFKLL-REGH---------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred --HHHHHHHH-HcCC---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111111 1111 112234556788999999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.52 Aligned_cols=257 Identities=21% Similarity=0.366 Sum_probs=208.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|++.+.||+|+||.||+|.... +..||+|.+...........+.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578889999999999999996542 4689999987665555567889999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC--------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 894 FLIYNYLPGGNLENFIKARTS--------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
++||||+++|+|.+++..... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 999999999999999975332 2368889999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHH
Q 043720 966 DFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 966 Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
|||+++........ ......++..|+|||.+.+..++.++||||||+++||+++ |..||..... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~--------~~~~~~ 233 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN--------EEVLKF 233 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH--------HHHHHH
Confidence 99998765433321 2223346789999999988889999999999999999998 8888752211 111111
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
. ..+. ....+..++..+.+++.+||+.+|++||++.++++.|++
T Consensus 234 ~-~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 234 V-IDGG---------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred H-hcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1 1111 112234457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=321.27 Aligned_cols=263 Identities=24% Similarity=0.423 Sum_probs=204.7
Q ss_pred cCCCCcceeccCCcccEEEEEEcC---------------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP---------------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 885 (1103)
++|++.+.||+|+||.||++.... ...||+|++...........+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 579999999999999999986532 23589999876555555677999999999999999999999
Q ss_pred EEecCCeEEEEEeecCCCChHHHHHhhcC----------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEE
Q 043720 886 YRASGNEMFLIYNYLPGGNLENFIKARTS----------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955 (1103)
Q Consensus 886 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~----------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIl 955 (1103)
++...+..++||||+++++|.+++..... ..+++..+.+++.|++.|++|||+. +++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEE
Confidence 99999999999999999999999965321 2368889999999999999999999 9999999999999
Q ss_pred ECCCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh--CCCCCCCCCCCCC
Q 043720 956 LDDDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS--DKKALDPSFSSHG 1032 (1103)
Q Consensus 956 l~~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~~~ 1032 (1103)
+++++.+|++|||++.......... .....++..|+|||++....++.++||||||+++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 9999999999999997654332221 222345678999999988889999999999999999998 4556552211
Q ss_pred CCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
.............. ........+...+..+.+++.+||+.+|++||++++|++.|++
T Consensus 239 --~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 239 --EQVIENTGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 11111111111100 0111112233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=334.90 Aligned_cols=253 Identities=25% Similarity=0.341 Sum_probs=202.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 36889999999999999999765 589999999976432 234566889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 155 (364)
T cd05599 81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH 155 (364)
T ss_pred CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence 9999999999997643 489999999999999999999999 99999999999999999999999999987542211
Q ss_pred Cc-------------------------------------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhC
Q 043720 978 TH-------------------------------------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISD 1020 (1103)
Q Consensus 978 ~~-------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg 1020 (1103)
.. .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence 00 11134689999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 043720 1021 KKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT---MKQVVQC 1094 (1103)
Q Consensus 1021 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 1094 (1103)
+.||..... ........... .....+.....+..+.+++.+|+. +|.+|++ ++|++++
T Consensus 236 ~~Pf~~~~~--------~~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 236 YPPFCSDNP--------QETYRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred CCCCCCCCH--------HHHHHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999973321 11111111111 001111112345678899999996 9999998 8888764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=345.31 Aligned_cols=255 Identities=26% Similarity=0.332 Sum_probs=206.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-----
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----- 891 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 891 (1103)
..++|.+.+.||+|+||+||+|.. .+++.||||++..... ......+.+|+.++..++|+|++++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 346899999999999999999964 4689999999876543 344567889999999999999999988765432
Q ss_pred ---eEEEEEeecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 892 ---EMFLIYNYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 892 ---~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
.+++||||+++|+|.++++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEe
Confidence 3689999999999999997543 24688999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 967 FGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 967 fgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... .........
T Consensus 187 FGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~--------~~~~~~~~~ 258 (496)
T PTZ00283 187 FGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN--------MEEVMHKTL 258 (496)
T ss_pred cccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHh
Confidence 999987643222 22334578999999999999999999999999999999999999996321 111222111
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. +. ....+...+..+.+++.+||+.||++||++.+++++
T Consensus 259 ~-~~---------~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 A-GR---------YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred c-CC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 1 11 112244566789999999999999999999999864
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.29 Aligned_cols=242 Identities=23% Similarity=0.337 Sum_probs=193.6
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||||+++.... ....+.+..|..++... +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 578899999976532 23345556677777654 899999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~ 154 (316)
T cd05592 81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence 99999997643 489999999999999999999999 99999999999999999999999999997543222 2334
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........ .. ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~--------~~~~~~i~-~~----------~~~~ 215 (316)
T cd05592 155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE--------DELFDSIL-ND----------RPHF 215 (316)
T ss_pred cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-cC----------CCCC
Confidence 55789999999999998999999999999999999999999973211 11111111 10 1122
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMK-QVVQ 1093 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1093 (1103)
+...+.++.+++.+||+.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 334567789999999999999999875 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=321.53 Aligned_cols=257 Identities=28% Similarity=0.456 Sum_probs=208.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|++.+.||+|+||.||+|... ++..||+|++..........++.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457899999999999999999753 46789999998765555667899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC--------------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCc
Q 043720 894 FLIYNYLPGGNLENFIKARTS--------------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSN 953 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~--------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~N 953 (1103)
++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999975321 2478889999999999999999999 99999999999
Q ss_pred EEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043720 954 ILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSH 1031 (1103)
Q Consensus 954 Ill~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~ 1031 (1103)
|++++++.++++|||++......... .......+..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 99999999999999998765332221 1222344678999999998899999999999999999998 7777753211
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
..+.... ..+.. ...+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 239 ------~~~~~~~-~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 239 ------EEVIYYV-RDGNV---------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred ------HHHHHHH-hcCCC---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111111 11111 11233456789999999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=329.89 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=197.3
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----CeEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 894 (1103)
+|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4788899999999999999654 689999999875322 23446788999999999999999999987543 3589
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~ 154 (338)
T cd07859 81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAF 154 (338)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence 9999995 69999987654 489999999999999999999999 99999999999999999999999999997543
Q ss_pred CCCC--ccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-------CcchHHHHHH
Q 043720 975 TSET--HATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD-------GFNIISWASM 1043 (1103)
Q Consensus 975 ~~~~--~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~ 1043 (1103)
.... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||......... ......+...
T Consensus 155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (338)
T cd07859 155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234 (338)
T ss_pred cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence 2211 12234578999999999865 67889999999999999999999998643210000 0000000000
Q ss_pred HHhcCccccccc---ccccC---CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 LLRQGQVKDVFN---AELWA---SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~~~~---~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+........+. ..... ......+..+.+++.+||+.||++||+++|++++
T Consensus 235 -i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 235 -VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred -hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000 00000 0011235668899999999999999999999965
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=314.40 Aligned_cols=251 Identities=22% Similarity=0.388 Sum_probs=207.7
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..+.||+|++|.||+|... +++.|++|.+.... .....+.+.+|+.+++.++|||++++++++...+..|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778889999999999999765 58899999987543 234567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++......+++..+.+++.+++.|+.|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~- 156 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN- 156 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence 9999999999876556789999999999999999999999 999999999999999999999999999886643322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......+++.|+|||+..+..++.++||||||+++|||++|+.||..... ...... ...+ ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~-~~~~---------~~ 218 (256)
T cd08529 157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ--------GALILK-IIRG---------VF 218 (256)
T ss_pred hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-HHcC---------CC
Confidence 22334678899999999998899999999999999999999999873321 111111 1111 11
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 12223456789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=313.75 Aligned_cols=249 Identities=29% Similarity=0.456 Sum_probs=201.6
Q ss_pred ceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||.||+|.... +..||+|.+.........+++.+|+.+++.+.|+||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999995432 26899999987665555678999999999999999999999876 4568999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc-
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT- 981 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~- 981 (1103)
++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++..........
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 99999998754 489999999999999999999999 999999999999999999999999999986643332211
Q ss_pred -cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 982 -TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 982 -~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
....++..|+|||.+.+..++.++||||||+++|||++ |+.||..... .+..... .... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--------~~~~~~~-~~~~---------~ 216 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--------AEVIAML-ESGE---------R 216 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHH-HcCC---------c
Confidence 12223468999999998899999999999999999998 8988863321 1111111 1111 1
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
...+..++..+.+++.+|+..+|++||++.++++.|+++.
T Consensus 217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 1233445678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=326.05 Aligned_cols=237 Identities=24% Similarity=0.351 Sum_probs=193.1
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|..+ +++.||||++..... ....+.+..|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 578999999875432 23456677888888876 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (320)
T cd05590 81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTS 154 (320)
T ss_pred chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCccc
Confidence 99999987654 489999999999999999999999 9999999999999999999999999998753221 22233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ........ ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~--------~~~~~~i~-~~~----------~~~ 215 (320)
T cd05590 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE--------DDLFEAIL-NDE----------VVY 215 (320)
T ss_pred ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHh-cCC----------CCC
Confidence 45789999999999999999999999999999999999999973221 11111111 111 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTM 1088 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~ 1088 (1103)
+...+.++.+++.+|++.||++||++
T Consensus 216 ~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 216 PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 33455778999999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=317.29 Aligned_cols=247 Identities=25% Similarity=0.338 Sum_probs=197.7
Q ss_pred eccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||+|+||+||++... +++.||+|++...... ...+.+..|+.+++.++|+||+++.+++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999654 6889999998754332 2345678899999999999999999999999999999999999999
Q ss_pred HHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccC
Q 043720 906 ENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983 (1103)
Q Consensus 906 ~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 983 (1103)
.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 9887542 234589999999999999999999999 999999999999999999999999999976543222 2334
Q ss_pred CcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCC
Q 043720 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063 (1103)
Q Consensus 984 ~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1063 (1103)
..|++.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .... ...+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~---------~~~~--~~~~ 221 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKV----ENKELKQRI---------LNDS--VTYP 221 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcch----hHHHHHHhh---------cccC--CCCc
Confidence 578999999999999999999999999999999999999997432110 000011100 0111 1223
Q ss_pred hhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1064 HDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1064 ~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+..+.+++.+|++.||++|| ++++++++
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 44667899999999999999999 67777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=316.93 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=209.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|.+.+.||+|+||.||+|...+ ...||||...........+.+.+|+.++++++||||+++++++.. ...++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458888999999999999996543 356899998776555566789999999999999999999999876 457899
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.+++.... ..+++.++..++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++.....
T Consensus 85 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 85 MELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 99999999999997643 3489999999999999999999999 9999999999999999999999999999866443
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.........++..|+|||.+....++.++||||||+++||+++ |..||...... .. ... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-----~~---~~~-~~~~------- 224 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-----DV---IGR-IENG------- 224 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-----HH---HHH-HHcC-------
Confidence 3323333345678999999988889999999999999999996 99998633210 11 111 1111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.....+..++..+.+++.+|+..+|++||++.++++.|+++...
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 225 --ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11122345667899999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=291.13 Aligned_cols=252 Identities=24% Similarity=0.365 Sum_probs=204.8
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch-------hhHHHHHHHHHHHhcCC-CCceeEEEeEEecCC
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ-------HGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGN 891 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 891 (1103)
..|+..+.+|.|..++|.++.+ .+|..+|+|++...... +..+.-.+|+.+++++. ||+|+++.++++...
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 4677888899999999999844 46889999998765432 22445678999999995 999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+++|+|.|+.|.|.+|+..... ++++...+|+.|+.+|++|||.+ +||||||||+|||++++.++||+|||+++
T Consensus 97 F~FlVFdl~prGELFDyLts~Vt--lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVT--LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred hhhhhhhhcccchHHHHhhhhee--ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999987643 89999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCccccCCcccccccCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYAL------TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
....+ .+-...+|||+|+|||.+. ...|+..+|+||+||++|.++.|.+||.--. ..- .-+.+
T Consensus 172 ~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--------Qml-MLR~I 240 (411)
T KOG0599|consen 172 QLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--------QML-MLRMI 240 (411)
T ss_pred ccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--------HHH-HHHHH
Confidence 87544 3455679999999999884 3457788999999999999999999986110 001 11112
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+.++ +..+.-.+......++|.+|++.||.+|.|++|++++
T Consensus 241 meGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH 283 (411)
T KOG0599|consen 241 MEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH 283 (411)
T ss_pred Hhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence 222211 1112223556678999999999999999999999875
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=337.56 Aligned_cols=385 Identities=28% Similarity=0.359 Sum_probs=295.2
Q ss_pred CCCCCCCEEEccCCCCc-ccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 104 GGLSELRVLSLPFNGFS-GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 104 ~~l~~L~~L~L~~n~l~-g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
+-|+..+-.|+++|.++ +.+|.....+++++.|.|...++. .+|++++.+.+|++|.+++|++. .+-..+..|+.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34566777889999998 678988989999999999999888 89999999999999999999988 6777888888899
Q ss_pred EEEccCCcCCC-CCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCc-cccCCCCCCEEeCC
Q 043720 183 VLNLAGNQVKG-VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLF 260 (1103)
Q Consensus 183 ~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~ 260 (1103)
.+++..|++.. -+|..+-.+..|+.||||+|++. ++|..+-. .+++-.|+||+|+|. .||. .+.+++.|-.|||+
T Consensus 82 sv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~-AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS 158 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEY-AKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLS 158 (1255)
T ss_pred HHhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhh-hcCcEEEEcccCccc-cCCchHHHhhHhHhhhccc
Confidence 99999888863 36777778888888888888888 88888765 477888888888888 4554 45678888888888
Q ss_pred CccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCccc
Q 043720 261 SNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFI 340 (1103)
Q Consensus 261 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~ 340 (1103)
+|++.. +|..+..|..|+.|+|++|.+...--..+..+++|+.|.+++
T Consensus 159 ~NrLe~-LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~------------------------------- 206 (1255)
T KOG0444|consen 159 NNRLEM-LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSN------------------------------- 206 (1255)
T ss_pred cchhhh-cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccc-------------------------------
Confidence 888865 677778888888888888887644333344444455555543
Q ss_pred ccCchhhhccccccccccCCcc-ccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccc
Q 043720 341 GSIPMEITTLSKLRIIWAPRLN-LEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL 419 (1103)
Q Consensus 341 ~~ip~~~~~L~~L~~L~l~~n~-l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~ 419 (1103)
.+ -...+|.++..+.+|..+|||.|.+. ..|+.+.++.+|+.|+||+|+|+..
T Consensus 207 --------------------TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL----- 260 (1255)
T KOG0444|consen 207 --------------------TQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITEL----- 260 (1255)
T ss_pred --------------------ccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeee-----
Confidence 22 12245667777777777777777776 5677777777888888777776521
Q ss_pred cccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccc
Q 043720 420 QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFT 499 (1103)
Q Consensus 420 ~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~ 499 (1103)
T Consensus 261 -------------------------------------------------------------------------------- 260 (1255)
T KOG0444|consen 261 -------------------------------------------------------------------------------- 260 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcC
Q 043720 500 GPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQI 579 (1103)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l 579 (1103)
...+. .+.+|++|+||+|++
T Consensus 261 -----------------------------------------------------------~~~~~-~W~~lEtLNlSrNQL 280 (1255)
T KOG0444|consen 261 -----------------------------------------------------------NMTEG-EWENLETLNLSRNQL 280 (1255)
T ss_pred -----------------------------------------------------------eccHH-HHhhhhhhccccchh
Confidence 00011 125688899999999
Q ss_pred CCCCcccccCCCCCCEEEccCCcCCC-CCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhh
Q 043720 580 SGIVPQSLENLTSLVFLDLNGNKLQG-EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEG 658 (1103)
Q Consensus 580 ~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~ 658 (1103)
+ .+|++++++++|+.|++.+|+++- -+|+.++++.+|+.+..++|.+. .+|..++.+..|+.|.|+.|++. .+|++
T Consensus 281 t-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPea 357 (1255)
T KOG0444|consen 281 T-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEA 357 (1255)
T ss_pred c-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhh
Confidence 8 789999999999999999998872 37888999999999999999987 88999999999999999999987 68888
Q ss_pred hhhcccccccccccccCcCCCCccccCCCCCceEeC
Q 043720 659 VVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNA 694 (1103)
Q Consensus 659 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l 694 (1103)
+.-++.|+.|||.+|.=-..+|.--..-++|+.-++
T Consensus 358 IHlL~~l~vLDlreNpnLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 358 IHLLPDLKVLDLRENPNLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred hhhcCCcceeeccCCcCccCCCCcchhhhcceeeec
Confidence 988999999999988654355543333355665444
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=347.24 Aligned_cols=260 Identities=22% Similarity=0.332 Sum_probs=206.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+++.+|+.++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999665 589999999875432 234567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhc---------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecc
Q 043720 898 NYLPGGNLENFIKART---------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFG 968 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 968 (1103)
||+++|+|.++++... ....++..+.+++.||++||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999987421 12356778899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043720 969 LSRLLGTSET-----------------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSH 1031 (1103)
Q Consensus 969 la~~~~~~~~-----------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 1031 (1103)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 11123468999999999999999999999999999999999999997422110
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhh
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRP-TMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 1099 (1103)
. .+ ... ..++.. .......+..+.+++.+|++.||++|| +++++.+.|+...
T Consensus 239 -----i-~~------~~~---i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 239 -----I-SY------RDV---ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred -----h-hh------hhh---ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0 00 000 000000 011234567789999999999999996 6777888887764
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.09 Aligned_cols=249 Identities=27% Similarity=0.437 Sum_probs=203.9
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe-cCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA-SGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~ 899 (1103)
.+|++.+.||+|+||.||+|... +..||+|.+.... ..+.+.+|+.++++++|+|++++++++. .++..++|+||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 81 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc---hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence 46888999999999999999766 7889999886443 3467889999999999999999999764 55678999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++......+++..+.+++.|++.|++|||++ +++||||||+||++++++.+|++|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 9999999999876655689999999999999999999999 99999999999999999999999999987543221
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
....++..|+|||++....++.++||||||+++|||++ |+.||... ......... ..+ .
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~-~~~---------~ 216 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI--------PLKDVVPRV-EKG---------Y 216 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHH-hcC---------C
Confidence 22334668999999998889999999999999999998 88887521 111111111 111 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....+..++..+.+++.+|++.+|++||+++++++.|+++
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1122345567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=325.40 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=199.4
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCC-CceeEEEeEEecCCeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRH-PNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 897 (1103)
+|++.+.||+|+||.||+|... +++.||||++..... ....+.+..|+.++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999665 478899999876432 3345678889999999975 56888999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999997654 388999999999999999999999 99999999999999999999999999987532211
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||..... ......... .
T Consensus 156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~-~--------- 216 (324)
T cd05587 156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE--------DELFQSIME-H--------- 216 (324)
T ss_pred -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHc-C---------
Confidence 223345689999999999999999999999999999999999999973221 111111111 1
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTM-----KQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1094 (1103)
....+...+..+.+++.+|++.||++|++. .++.++
T Consensus 217 -~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 217 -NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 112234456778999999999999999976 565543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=315.93 Aligned_cols=255 Identities=23% Similarity=0.415 Sum_probs=203.8
Q ss_pred CCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe-----
Q 043720 823 FNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE----- 892 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 892 (1103)
|.+.+.||+|+||.||+|.... +..||||+++.... ......+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997642 36799999876543 3345678999999999999999999998866554
Q ss_pred -EEEEEeecCCCChHHHHHhhc----CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 893 -MFLIYNYLPGGNLENFIKART----SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 893 -~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
.++|+||+++|+|..++.... ...+++..+..++.|++.|++|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 799999999999999986532 23589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 968 GLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 968 gla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
|+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||..... ........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~--------~~~~~~~~ 229 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN--------HEIYDYLR 229 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHH
Confidence 9998764333222 122234678999999988889999999999999999999 7777753211 11121111
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
. + .....+..++..+.+++.+|++.||++||++.|+++.|+++
T Consensus 230 ~-~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 230 H-G---------NRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred c-C---------CCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1 1 11122345667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=317.27 Aligned_cols=255 Identities=26% Similarity=0.474 Sum_probs=206.5
Q ss_pred CCCCcceeccCCcccEEEEEEcC-C---cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP-G---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+|++.+.||+|+||.||+|.... + ..||||++..........+|..|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 57888999999999999997653 2 3699999977655556778999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++... ..+++.++..++.|++.|++|||++ +++||||||+||+++.++.+|++|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 85 EFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred ecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999997653 4589999999999999999999999 99999999999999999999999999987654322
Q ss_pred Cccc-c-CC--cccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 978 THAT-T-GV--AGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 978 ~~~~-~-~~--~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
.... . .. ..+..|+|||++.+..++.++||||||+++|||++ |..||..... .....+. ..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-----~~~~~~i----~~----- 226 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----QDVINAI----EQ----- 226 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-----HHHHHHH----Hc-----
Confidence 2111 1 11 12457999999998899999999999999999986 8888863211 1111111 10
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....+.+..++..+.+++.+||..+|++||++.+|++.|+++
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 227 ----DYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111122345567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=319.45 Aligned_cols=255 Identities=23% Similarity=0.392 Sum_probs=205.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
.+|...+.||+|+||+||+|... ++..+|+|.+.... ....+.+.+|++.++.++|+||+++++++...+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL 83 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence 46788899999999999999532 35678999876543 335678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcC-------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC
Q 043720 895 LIYNYLPGGNLENFIKARTS-------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 961 (1103)
+||||+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence 99999999999999976432 3478899999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHH
Q 043720 962 AYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIIS 1039 (1103)
Q Consensus 962 ~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1103)
+||+|||++.......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~ 232 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN--------TE 232 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH--------HH
Confidence 9999999987654322211 222345678999999999899999999999999999998 8888753211 01
Q ss_pred HHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
...... .. .....+..++..+.+++.+||+.||++||++.||++.|++
T Consensus 233 ~~~~~~-~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 233 AIECIT-QG---------RELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHH-cC---------ccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111 11 1112234556779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=328.82 Aligned_cols=243 Identities=23% Similarity=0.289 Sum_probs=197.9
Q ss_pred ceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 827 NCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.||+|+||+||+|.. .+++.||+|++..... ......+..|+.+++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999965 4689999999976432 234566788999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (325)
T cd05594 81 ELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMK 154 (325)
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccc
Confidence 9999987643 48999999999999999999997 7 9999999999999999999999999998753222 12223
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ........ ... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~--------~~~~~~i~-~~~----------~~~ 215 (325)
T cd05594 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------EKLFELIL-MEE----------IRF 215 (325)
T ss_pred cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCH--------HHHHHHHh-cCC----------CCC
Confidence 45689999999999999999999999999999999999999963211 11111111 110 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
+...+.++.+++.+|++.||++|+ ++++++++
T Consensus 216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 334567789999999999999996 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=325.59 Aligned_cols=243 Identities=24% Similarity=0.319 Sum_probs=196.7
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||||++..... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999765 478999999876432 33456677888888866 799999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05591 81 GDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTT 154 (321)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccC-Ccccc
Confidence 99999987654 488999999999999999999999 9999999999999999999999999998754222 22233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ........... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~--------~~~~~~i~~~~-----------~~~ 215 (321)
T cd05591 155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE--------DDLFESILHDD-----------VLY 215 (321)
T ss_pred ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH--------HHHHHHHHcCC-----------CCC
Confidence 45789999999999999999999999999999999999999973321 11111111111 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCC-------CHHHHHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRP-------TMKQVVQC 1094 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RP-------s~~evl~~ 1094 (1103)
+...+.++.+++.+|++.||++|| ++.+++++
T Consensus 216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 233456789999999999999999 77777754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=315.58 Aligned_cols=255 Identities=23% Similarity=0.401 Sum_probs=200.2
Q ss_pred CCCcceeccCCcccEEEEEEcCC---cEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------Ce
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPG---ILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------NE 892 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 892 (1103)
|.+.+.||+|+||.||+|..... ..||+|.++... .....+.+.+|+.+++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678899999999999976543 268999887653 234467889999999999999999999987432 25
Q ss_pred EEEEEeecCCCChHHHHHhh----cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecc
Q 043720 893 MFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFG 968 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 968 (1103)
.++|+||+++|+|.+++... ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999988532 123478999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 969 LSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 969 la~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
+++......... .....+++.|+|||+..+..++.++||||||+++|||++ |+.||..... ..... ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~--------~~~~~-~~~ 228 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN--------SEIYD-YLR 228 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH--------HHHHH-HHH
Confidence 998764333211 122345678999999999999999999999999999999 7777753111 11111 111
Q ss_pred cCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
.+.. ...+...+..+.+++.+||+.+|++||++.++++.|+++
T Consensus 229 ~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 229 QGNR---------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred cCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 112334567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=320.36 Aligned_cols=263 Identities=23% Similarity=0.393 Sum_probs=207.6
Q ss_pred CCCCcceeccCCcccEEEEEE-----cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 894 (1103)
-|++.+.||+|+||.||+|.. .++..||+|.++........+.+.+|+.+++.++|||++++.+++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 468889999999999999964 347889999987665555667899999999999999999999998775 5689
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+++++|.+++.+.. ..+++.++..++.|++.|++|||++ +++||||||+||+++.++.+||+|||+++...
T Consensus 85 lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 9999999999999997643 3489999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC-------CCCcchHHHHHHHH
Q 043720 975 TSETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSH-------GDGFNIISWASMLL 1045 (1103)
Q Consensus 975 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~ 1045 (1103)
..... ......++..|+|||++.+..++.++||||||+++|||++++.|........ ........+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR-VL 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH-HH
Confidence 33221 1223456778999999988889999999999999999999887653221100 00001111111 11
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
. .....+.+..++..+.+++.+|++.+|++||+++++++.++++
T Consensus 240 ~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 E---------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred H---------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1 1111222344667899999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=315.35 Aligned_cols=260 Identities=25% Similarity=0.393 Sum_probs=210.2
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||.||+|.. .++..||||.+..... ....+++.+|+.+++.++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999975 4789999998865332 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||+++++|.++++.. ....+++..+.+++.++++|++|||++ +++|+||+|+||+++.++.++++|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998742 224589999999999999999999999 999999999999999999999999999876543
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
... ......++..|+|||++.+..++.++||||||+++|||++|..||..... ....+......
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~~--------- 222 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM------NLYSLCKKIEQ--------- 222 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc------hHHHHhhhhhc---------
Confidence 221 22334678899999999888899999999999999999999999863211 11111111110
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
...........+..+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00011112345678999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=317.09 Aligned_cols=265 Identities=24% Similarity=0.399 Sum_probs=204.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 893 (1103)
.+|++.+.||+|+||+||+|..+ ++..||+|++.... ....+.+.+|++++++++||||+++++++.. ....
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 46888999999999999999643 47899999987543 3345788999999999999999999998754 3468
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++|+||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 99999999999999997643 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCcc--ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC----CCC---cchHHHHHHH
Q 043720 974 GTSETHA--TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSH----GDG---FNIISWASML 1044 (1103)
Q Consensus 974 ~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~----~~~---~~~~~~~~~~ 1044 (1103)
....... .....++..|+|||++.+..++.++||||||+++|||++|..++....... +.. ........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 236 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI-- 236 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH--
Confidence 4332211 111223456999999998889999999999999999999887654221100 000 00000000
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
+..........+..++..+.+++.+||+.+|++|||+.||++.|++++
T Consensus 237 -------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 237 -------ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred -------HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 011111122234456678999999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=312.88 Aligned_cols=253 Identities=30% Similarity=0.453 Sum_probs=197.5
Q ss_pred ceeccCCcccEEEEEEc----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe-cCCeEEEEEeecC
Q 043720 827 NCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA-SGNEMFLIYNYLP 901 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lV~E~~~ 901 (1103)
+.||+|+||+||+|... .+..||+|++.........+.+.+|+.+++.++||||+++++++. .++..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 35899999999999653 245799999865444445678899999999999999999999775 4566899999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC---
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET--- 978 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~--- 978 (1103)
+|+|.++++... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++.......
T Consensus 81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 999999997643 3367788899999999999999999 999999999999999999999999999875532211
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.......++..|+|||++....++.++||||||+++|||++|+.|+.... .............
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-------~~~~~~~~~~~~~---------- 219 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-------DSFDITVYLLQGR---------- 219 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC-------CHHHHHHHHhcCC----------
Confidence 11123345678999999988889999999999999999999665533211 1111111111111
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
....+...+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 111223345679999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=309.85 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=211.6
Q ss_pred cCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
+-|++.+.||+|.|.+|-.|+ .-+|..||||++.+..... ....+.+|+.+|+.++|||||++|++......+|+|+|
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE 97 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE 97 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence 458888999999999999994 4479999999998765543 45678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE-CCCCCEEEeecccccccCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL-DDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
.-++|+|.+|+-+.. ..+.+....+++.||+.|+.|+|.. .+|||||||+||.+ .+-|-||++|||++-.+.++
T Consensus 98 LGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG- 172 (864)
T KOG4717|consen 98 LGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG- 172 (864)
T ss_pred ecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCc-
Confidence 999999999998765 4599999999999999999999999 99999999999977 56788999999999887544
Q ss_pred CccccCCcccccccCccccccCCCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSD-KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~-~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
..-...+|+..|.|||++.+..|+. ++||||+|||+|.+++|+.||...... +.+..++|-
T Consensus 173 -~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS-----------------ETLTmImDC 234 (864)
T KOG4717|consen 173 -KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS-----------------ETLTMIMDC 234 (864)
T ss_pred -chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch-----------------hhhhhhhcc
Confidence 3445678999999999999988865 789999999999999999999854331 122233333
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ..|.-...+..++|..|+..||++|.+.+||...
T Consensus 235 KY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 235 KY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred cc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 33 3466677889999999999999999999999753
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=312.85 Aligned_cols=252 Identities=25% Similarity=0.427 Sum_probs=204.8
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
.+|++.+.||+|+||.||+|.+..++.+|+|++...... ...+.+|++++++++||+++++++++......++||||+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 468888999999999999998877889999998754332 457889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.++++... ..++++.+..++.+++.|++|||+. +++||||||+||+++.++.+||+|||.++.........
T Consensus 82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 82 EHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999997643 3478999999999999999999999 99999999999999999999999999987654332222
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++.+|+|||++.+..++.++||||||+++|||++ |+.||..... ........ .+ ..
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~-~~---------~~ 219 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN--------SEVVETIN-AG---------FR 219 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH--------HHHHHHHh-CC---------CC
Confidence 223345678999999998889999999999999999998 8888863211 11111111 00 01
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
...+...+..+.+++.+||+.+|++||++.|+++.|+
T Consensus 220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 1112234577999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=336.33 Aligned_cols=253 Identities=23% Similarity=0.326 Sum_probs=199.2
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3688999999999999999965 4689999999865432 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~ 155 (377)
T cd05629 81 EFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH 155 (377)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 9999999999997643 488899999999999999999999 99999999999999999999999999986432110
Q ss_pred Cc----------------------------------------------cccCCcccccccCccccccCCCCCcchhHHHH
Q 043720 978 TH----------------------------------------------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYG 1011 (1103)
Q Consensus 978 ~~----------------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslG 1011 (1103)
.. .....+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG 235 (377)
T cd05629 156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG 235 (377)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence 00 00124689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCC---CCH
Q 043720 1012 VVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTR---PTM 1088 (1103)
Q Consensus 1012 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~ 1088 (1103)
|++|||++|+.||..... ........... .....+........+.+++.+|+. +|.+| +++
T Consensus 236 vil~elltG~~Pf~~~~~--------~~~~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~ 299 (377)
T cd05629 236 AIMFECLIGWPPFCSENS--------HETYRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA 299 (377)
T ss_pred hhhhhhhcCCCCCCCCCH--------HHHHHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence 999999999999963221 11111111100 001111112345678899999997 66665 599
Q ss_pred HHHHHH
Q 043720 1089 KQVVQC 1094 (1103)
Q Consensus 1089 ~evl~~ 1094 (1103)
.|++++
T Consensus 300 ~~~l~h 305 (377)
T cd05629 300 HEIKSH 305 (377)
T ss_pred HHHhcC
Confidence 998876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=330.64 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=205.3
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 891 (1103)
++....++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+++
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 34445678999999999999999999765 578999999865322 223456788999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
..|+||||+++|+|.++++... ++...+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~~~---~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999999997643 78889999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCccccccC----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTC----RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
..............||+.|+|||++... .++.++|||||||++|||++|+.||..... ......+...
T Consensus 191 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~--------~~~~~~i~~~ 262 (371)
T cd05622 191 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL--------VGTYSKIMNH 262 (371)
T ss_pred EcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH--------HHHHHHHHcC
Confidence 7654333333456799999999998653 378899999999999999999999973221 1112222111
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHHH
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLST--RPTMKQVVQCL 1095 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~L 1095 (1103)
.. ....+.....+..+.+++.+|+..++.+ ||++.|++++.
T Consensus 263 ~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~ 305 (371)
T cd05622 263 KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL 305 (371)
T ss_pred CC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence 11 0111122345677899999999844433 78999998864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=314.37 Aligned_cols=254 Identities=23% Similarity=0.356 Sum_probs=202.1
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG-DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc-chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 4699999999999999999975 4688999999865432 2345688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++... .+++.++..++.|++.|++|||+. +|+|||++|+||+++.++.+||+|||++....... .
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 161 (267)
T cd06646 88 CGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A 161 (267)
T ss_pred CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence 99999999987543 488999999999999999999999 99999999999999999999999999998663221 2
Q ss_pred cccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
......+++.|+|||.+. ...++.++||||+||++|||++|+.||......... . ..... ....+
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~-~--------~~~~~---~~~~~ 229 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL-F--------LMSKS---NFQPP 229 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh-e--------eeecC---CCCCC
Confidence 223456788999999874 345778999999999999999999998633211000 0 00000 00000
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
. .......+..+.+++.+||+.+|++||+++++++++
T Consensus 230 ~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 K--LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred C--CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1 111223457899999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=317.00 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=196.6
Q ss_pred eccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||+|+||+||++..+ +|+.||+|++...... .....+..|++++++++||||+++++++..+...|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999655 5899999998654322 2234566799999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCc
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 985 (1103)
.+++.......+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence 9998766555689999999999999999999999 99999999999999999999999999987654322 223446
Q ss_pred ccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChh
Q 043720 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065 (1103)
Q Consensus 986 g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1103)
|++.|+|||++.+..++.++||||+||++|||++|+.||..... ............. .... .....
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~----~~~~~~~~~~~~~---------~~~~-~~~~~ 221 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKE----KVAKEELKRRTLE---------DEVK-FEHQN 221 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcc----hhhHHHHHHHhhc---------cccc-ccccc
Confidence 88999999999988899999999999999999999999863221 1111111111110 0110 01123
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1066 DLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1066 ~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+.++.+++.+||+.||++||+++|+++.
T Consensus 222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 222 FTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred CCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 45678999999999999999999766543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=323.76 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=199.2
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+|++.+.||+|+||+||+|... +++.||||++..... ....+.+..|..++... +|++|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788999999999999999665 478999999876432 22345567788888777 5899999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD- 154 (323)
T ss_pred cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCC-
Confidence 9999999999987653 388999999999999999999999 9999999999999999999999999998754321
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
........|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......... . .
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~--------~~~~~~i~~-~--------~ 217 (323)
T cd05616 155 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE--------DELFQSIME-H--------N 217 (323)
T ss_pred CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH--------HHHHHHHHh-C--------C
Confidence 2223345789999999999999999999999999999999999999973221 111111111 1 0
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTM-----KQVVQ 1093 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1093 (1103)
...+...+.++.+++.+|++.||++|++. .++.+
T Consensus 218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~ 256 (323)
T cd05616 218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 256 (323)
T ss_pred --CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence 12234456778999999999999999985 56554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=314.24 Aligned_cols=249 Identities=27% Similarity=0.430 Sum_probs=198.5
Q ss_pred eeccCCcccEEEEEEcC-Cc--EEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 828 CIGSGGFGTTYKAEISP-GI--LVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
.||+|+||.||+|..++ +. .+|+|.++........+.+.+|+.++.++ +||||+++++++...+..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999997654 33 57888887554455567889999999999 7999999999999999999999999999
Q ss_pred ChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 904 NLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 904 sL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
+|.++++... ...+++.++.+++.|++.|++|||+. +++||||||+||++++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 9999997642 12478899999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
+..... .........+..|+|||++....++.++||||||+++|||++ |+.||..... ........ .
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~--------~~~~~~~~-~- 226 (270)
T cd05047 159 SRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC--------AELYEKLP-Q- 226 (270)
T ss_pred ccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH--------HHHHHHHh-C-
Confidence 863221 111112233567999999988889999999999999999997 9998863211 11111111 1
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
......+...+.++.+++.+||+.+|.+||++.|+++.|++|.
T Consensus 227 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 227 --------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred --------CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 1111223345567899999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=336.34 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=200.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+.++++++|+||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36889999999999999999654 588999999865432 223567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+....
T Consensus 81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999997653 478889999999999999999999 99999999999999999999999999975331000
Q ss_pred ------------------------------------------CccccCCcccccccCccccccCCCCCcchhHHHHHHHH
Q 043720 978 ------------------------------------------THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLL 1015 (1103)
Q Consensus 978 ------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ 1015 (1103)
........||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 00112357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCC---CHHHHH
Q 043720 1016 ELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRP---TMKQVV 1092 (1103)
Q Consensus 1016 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~evl 1092 (1103)
||++|+.||..... ........... ..............+.+++.+|+ .+|++|+ ++.|++
T Consensus 236 ell~G~~Pf~~~~~--------~~~~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell 299 (376)
T cd05598 236 EMLVGQPPFLADTP--------AETQLKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK 299 (376)
T ss_pred ehhhCCCCCCCCCH--------HHHHHHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence 99999999974321 11111111000 00111112234566788888876 5999999 889988
Q ss_pred HH
Q 043720 1093 QC 1094 (1103)
Q Consensus 1093 ~~ 1094 (1103)
++
T Consensus 300 ~h 301 (376)
T cd05598 300 AH 301 (376)
T ss_pred CC
Confidence 65
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=322.55 Aligned_cols=243 Identities=22% Similarity=0.315 Sum_probs=197.4
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||||+++.... ......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999765 478999999976532 23456677888998887 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (318)
T cd05570 81 GDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTS 154 (318)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCccc
Confidence 99999987653 489999999999999999999999 9999999999999999999999999998753221 12223
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.... ......... ... ...
T Consensus 155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~--------~~~~~~~i~-~~~----------~~~ 215 (318)
T cd05570 155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD--------EDELFQSIL-EDE----------VRY 215 (318)
T ss_pred ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC--------HHHHHHHHH-cCC----------CCC
Confidence 4568999999999999999999999999999999999999996321 111111111 110 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCH-----HHHHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTM-----KQVVQC 1094 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~~ 1094 (1103)
+...+..+.+++.+||+.||++||++ .+++++
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 33456778999999999999999999 877654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=317.23 Aligned_cols=254 Identities=24% Similarity=0.382 Sum_probs=202.3
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC-----
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG----- 890 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----- 890 (1103)
.+.+.|+..+.||+|+||+||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 35677899999999999999999655 57889999986543 2346788999999998 699999999988653
Q ss_pred -CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 891 -NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 891 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
..+|+||||+++++|.+++.......+++..+..++.|++.|++|||++ +|+||||+|+||++++++.+||+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999999876556689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
+....... .......|++.|+|||++. ...++.++||||+||++|||++|+.||...... .... .
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-------~~~~--~ 227 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-------RALF--L 227 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-------HHHH--H
Confidence 87653222 2233456889999999985 345788999999999999999999998632210 0010 0
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..... .........+..+.+++.+||..+|.+||++.|++++
T Consensus 228 ~~~~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 IPRNP--------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred HhcCC--------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00000 0111122345678999999999999999999999864
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-34 Score=311.58 Aligned_cols=250 Identities=26% Similarity=0.424 Sum_probs=203.3
Q ss_pred ceeccCCcccEEEEEEcC--C--cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEISP--G--ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|++|.||+|.+.. + ..||||.+.........+.+.+|+..+++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 358999999999997643 2 36999999877665567889999999999999999999999988 889999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc--c
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH--A 980 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~--~ 980 (1103)
++|.+++.......+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++......... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 156 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM 156 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence 9999999876534689999999999999999999999 9999999999999999999999999999876443221 1
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||..... .+......... ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~--------~~~~~~~~~~~---------~~ 219 (257)
T cd05040 157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG--------SQILKKIDKEG---------ER 219 (257)
T ss_pred ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHHHhcC---------Cc
Confidence 123456789999999999899999999999999999999 9998862211 11111111100 11
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
...+...+..+.+++.+|++.+|++||++.|+++.|.+
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 11233456789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=325.48 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=208.8
Q ss_pred cCCCCcceeccCCcccEEEEEEcC--------CcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCC
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP--------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGN 891 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 891 (1103)
.+|++.+.||+|+||.||+|.... +..||+|.+.........+++.+|+.+++++ +||||+++++++...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 468899999999999999996421 2468999888665555678899999999999 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC
Q 043720 892 EMFLIYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~ 957 (1103)
..++|+||+++|+|.+++.... ...+++.++.+++.|++.|++|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999997642 23478899999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 043720 958 DDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGF 1035 (1103)
Q Consensus 958 ~~~~~ki~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1103)
+++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~-------- 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI-------- 240 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC--------
Confidence 99999999999998654322211 122234568999999999999999999999999999998 77777522
Q ss_pred chHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1036 NIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
....+..... .. .....+..++..+.+++.+|++.+|++||++.|+++.|+++..
T Consensus 241 ~~~~~~~~~~-~~---------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 241 PVEELFKLLK-EG---------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred CHHHHHHHHH-cC---------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1122222111 11 1112234456789999999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=315.24 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=208.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|+..+.||+|+||+||+|..+ ....|++|.+.........+.+.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46888999999999999999764 246799998876554445678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcC-------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 895 LIYNYLPGGNLENFIKARTS-------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
+||||+++|+|.++++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 99999999999999986552 1589999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 968 GLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 968 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||..... ...... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~--------~~~~~~-~~ 232 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD--------EEVLNR-LQ 232 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch--------HHHHHH-HH
Confidence 9987554333333344456788999999988888999999999999999999 6777752211 111111 11
Q ss_pred cCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
.+. .....+...+..+.+++.+|++.+|++||++.|+++.|++
T Consensus 233 ~~~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 233 AGK--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cCC--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 111 1112234566789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-34 Score=321.18 Aligned_cols=242 Identities=25% Similarity=0.370 Sum_probs=193.6
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||||+++.... ....+.+..|..++... +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999765 478999999876532 23345567778887764 899999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.++++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~ 154 (316)
T cd05619 81 GDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTC 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Ccee
Confidence 99999997643 488999999999999999999999 99999999999999999999999999987532211 2233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....... .... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~i-~~~~----------~~~ 215 (316)
T cd05619 155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE--------EELFQSI-RMDN----------PCY 215 (316)
T ss_pred eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhCC----------CCC
Confidence 45689999999999998999999999999999999999999973211 1111111 1110 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMK-QVVQ 1093 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1093 (1103)
+.....++.+++.+|++.||++||++. ++.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 233456789999999999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-34 Score=319.02 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=213.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccch--hhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 895 (1103)
...|++.+.||+|.||.||++..+. |+.+|+|++.+.... ...+.+.+|+.+|+++. |||||.+.+++.+...+++
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 4568888999999999999997665 999999999876553 24578999999999998 9999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC----CCEEEeeccccc
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD----FNAYLSDFGLSR 971 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~ 971 (1103)
|||++.||.|.+.+... . +++.++..++.|++.++.|||+. +|+|||+||+|+|+... +.+|++|||++.
T Consensus 114 vmEL~~GGeLfd~i~~~--~-~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~ 187 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK--H-YSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK 187 (382)
T ss_pred EEEecCCchHHHHHHHc--c-CCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence 99999999999999877 2 89999999999999999999999 99999999999999633 479999999999
Q ss_pred ccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.... .......+||+.|+|||++....|+.++||||+||++|.|++|..||....... ... .+..+.+
T Consensus 188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--------~~~-~i~~~~~- 255 (382)
T KOG0032|consen 188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--------IFL-AILRGDF- 255 (382)
T ss_pred EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--------HHH-HHHcCCC-
Confidence 8765 445667899999999999999999999999999999999999999998433210 011 1222222
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+....-......+.++|.+|+..||.+|+++.+++++
T Consensus 256 -----~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 256 -----DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred -----CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 12222234556788999999999999999999999987
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=321.91 Aligned_cols=241 Identities=22% Similarity=0.316 Sum_probs=193.7
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||.||+|... +++.||+|+++.... ....+.+..|..++... +||+|+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999765 588999999976432 23445667788887754 899999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (316)
T cd05620 81 GDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS 154 (316)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence 99999987643 488999999999999999999999 9999999999999999999999999998743211 22234
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... ....... ... ....
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~--------~~~~~~~-~~~----------~~~~ 215 (316)
T cd05620 155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE--------DELFESI-RVD----------TPHY 215 (316)
T ss_pred ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHH-HhC----------CCCC
Confidence 56789999999999999999999999999999999999999963211 1111111 111 0112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH-HHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMK-QVV 1092 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~-evl 1092 (1103)
+.....++.+++.+|++.||++||++. ++.
T Consensus 216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 333556789999999999999999985 555
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=335.02 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=197.9
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.|+..+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5888999999999999999654 578999999876432 3345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC-
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE- 977 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~- 977 (1103)
|+++|+|.+++.+.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997653 478899999999999999999999 99999999999999999999999999975331100
Q ss_pred ---------------------------------------------CccccCCcccccccCccccccCCCCCcchhHHHHH
Q 043720 978 ---------------------------------------------THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGV 1012 (1103)
Q Consensus 978 ---------------------------------------------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGv 1012 (1103)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCC---HH
Q 043720 1013 VLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT---MK 1089 (1103)
Q Consensus 1013 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ 1089 (1103)
++|||++|+.||..... ........... .....+......+++.+++.+|+ .+|++|++ +.
T Consensus 237 il~elltG~~Pf~~~~~--------~~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 237 ILYEMLVGQPPFLAQTP--------LETQMKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHhCCCCCCCCCH--------HHHHHHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999974321 11111111100 01111112234566778888765 59999997 88
Q ss_pred HHHHH
Q 043720 1090 QVVQC 1094 (1103)
Q Consensus 1090 evl~~ 1094 (1103)
|++++
T Consensus 301 ei~~h 305 (382)
T cd05625 301 EIKAH 305 (382)
T ss_pred HHhcC
Confidence 87754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=321.27 Aligned_cols=263 Identities=20% Similarity=0.314 Sum_probs=201.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|.+.+.||+|+||+||+|..+ +++.||+|++...........+.+|+.++++++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56889999999999999999655 57889999987665444456678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 964 8988887643 3478899999999999999999999 99999999999999999999999999987643222 1
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh------------
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR------------ 1046 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 1046 (1103)
......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+ ..........
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVED-----ELHLIFRLLGTPTEETWPGISS 234 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-----HHHHHHHHhCCCCHHHHhhhcc
Confidence 2233467899999998865 468889999999999999999999996432110 0000000000
Q ss_pred cCccccccccccc----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDVFNAELW----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......-.+... .......+.++.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 286 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH 286 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence 0000000000000 00112345678899999999999999999999873
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=315.11 Aligned_cols=252 Identities=25% Similarity=0.359 Sum_probs=202.1
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||.||+|.. .+++.||+|++.........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999964 568899999987665555567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~--- 148 (279)
T cd06619 81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS--- 148 (279)
T ss_pred CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence 9999997652 267888999999999999999999 9999999999999999999999999999765322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......++..|+|||++.+..++.++||||||+++|+|++|+.||.......... ....+..... ... ...
T Consensus 149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~-~~~-----~~~-- 219 (279)
T cd06619 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL-MPLQLLQCIV-DED-----PPV-- 219 (279)
T ss_pred cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccccccc-chHHHHHHHh-ccC-----CCC--
Confidence 2234578899999999999899999999999999999999999997533221111 0111111110 010 000
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+.++.+++.+|++.+|++||+++|++++
T Consensus 220 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 -LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred -CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0112244678999999999999999999999876
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=314.55 Aligned_cols=259 Identities=27% Similarity=0.469 Sum_probs=210.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-C----cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-G----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.+|++.+.||+|+||+||+|.... | ..||+|+............+.+|+..+++++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 568889999999999999997543 3 36899988776655566789999999999999999999999987 78899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+||+++|+|.++++... ..+++..+..++.|++.|++|||+. +++||||||+||++++++.+|++|||+++....
T Consensus 86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 999999999999998653 3489999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
..... .....++..|+|||.+....++.++||||||+++||+++ |+.||..... ..+..... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~~-~~----- 227 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA--------VEIPDLLE-KG----- 227 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH--------HHHHHHHh-CC-----
Confidence 32211 122234568999999988889999999999999999998 9999863211 11111111 11
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
.....+..+...+.+++.+||..+|++||++.++++.|+++.+.|
T Consensus 228 ----~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 228 ----ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 111223345567899999999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=325.65 Aligned_cols=239 Identities=25% Similarity=0.350 Sum_probs=195.4
Q ss_pred ceeccCCcccEEEEEE----cCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 827 NCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
+.||+|+||+||+++. .+|+.||+|++...... .....+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5699999999999864 35789999999765432 234567789999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+|+|.+++.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....... ...
T Consensus 82 ~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~ 155 (318)
T cd05582 82 GGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA 155 (318)
T ss_pred CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence 999999997643 489999999999999999999999 99999999999999999999999999987653322 223
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
....|++.|+|||.+.+..++.++|||||||++|||++|+.||..... ......... .. ..
T Consensus 156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~--------~~~~~~i~~-~~----------~~ 216 (318)
T cd05582 156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR--------KETMTMILK-AK----------LG 216 (318)
T ss_pred ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH--------HHHHHHHHc-CC----------CC
Confidence 345789999999999988899999999999999999999999873211 111111111 10 12
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHH
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQ 1090 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1090 (1103)
.+...+..+.+++.+||+.||++||++.+
T Consensus 217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 217 MPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 23345677899999999999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=316.94 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=204.6
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.+|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.+.|+||+++++.+..+...|+||||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc-hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 4788999999999999999965 46889999998765443 356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++.. .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 99 ~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~ 171 (296)
T cd06654 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (296)
T ss_pred cCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence 9999999998653 378899999999999999999999 99999999999999999999999999987653222 1
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||...... ..+.. ...... ..
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~-------~~~~~-~~~~~~--------~~ 235 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL-------RALYL-IATNGT--------PE 235 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH-------HhHHH-HhcCCC--------CC
Confidence 223346788999999999888899999999999999999999999743211 11111 111110 00
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||..+|++||++.|++++
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 11233455778999999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=328.90 Aligned_cols=266 Identities=21% Similarity=0.309 Sum_probs=200.3
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-----eEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-----EMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 894 (1103)
+|+..+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.+++.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999965 468999999986542 2234567889999999999999999999998776 789
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+|+||+. ++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~ 154 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEE 154 (372)
T ss_pred EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence 9999996 6888888654 3489999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC--------CcchHHHH----
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGD--------GFNIISWA---- 1041 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~--------~~~~~~~~---- 1041 (1103)
...........+++.|+|||++.+. .++.++||||+||++|||++|+.||......... ......+.
T Consensus 155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 234 (372)
T cd07853 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE 234 (372)
T ss_pred cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence 4333333445678999999998764 4788999999999999999999999743211000 00000000
Q ss_pred --HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1042 --SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1042 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......... ................++.+++.+|++.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 235 GARAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0000000000 000000001122335678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=316.51 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=202.6
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
|+..+.||+|+||+||+|... +++.||||.+...... ...+.+.+|+.++++++|++++++++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667788999999999999654 6889999998654332 2235577899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.......+++.++..++.|++.|+.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-- 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc--
Confidence 9999999999765555689999999999999999999999 99999999999999999999999999987543222
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ...... ..... ...
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~----~~~~~~-~~~~~----------~~~ 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEV-ERLVK----------EVQ 221 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCcc----chHHHH-Hhhhh----------hhh
Confidence 223346899999999999989999999999999999999999999743211 000000 00000 000
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++||+ +.|++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 1123345567899999999999999999 8888863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=308.81 Aligned_cols=252 Identities=24% Similarity=0.394 Sum_probs=208.0
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..+.||+|+||.||.++. .+++.+++|++.... .....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 478899999999999999954 458899999987653 234567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.......+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999876555689999999999999999999999 999999999999999999999999999986643322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......+++.|+|||++.+..++.++||||||+++|||++|+.||..... ........ .+. .
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--------~~~~~~~~-~~~---------~ 218 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP--------LNLVVKIV-QGN---------Y 218 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-cCC---------C
Confidence 23345688999999999888889999999999999999999999863211 11111111 111 1
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
...+...+.++.+++.+||..+|++||++.|++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 111234567799999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=322.52 Aligned_cols=238 Identities=27% Similarity=0.337 Sum_probs=190.5
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHH-HHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIK-TLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +|+.||||++..... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999765 689999999875432 223344555554 56788999999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (323)
T cd05575 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS 154 (323)
T ss_pred CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence 99999997643 488999999999999999999999 9999999999999999999999999998753221 22233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........... . ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~---------~--~~~ 215 (323)
T cd05575 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------TAEMYDNILNK---------P--LRL 215 (323)
T ss_pred cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC--------HHHHHHHHHcC---------C--CCC
Confidence 4578999999999999999999999999999999999999997321 11111111111 0 111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMK 1089 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 1089 (1103)
+...+..+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 233467789999999999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.40 Aligned_cols=263 Identities=24% Similarity=0.359 Sum_probs=204.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||.||+|... ++..||+|.+...........+.+|++++++++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36889999999999999999655 57889999887654444556788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++.. ..+++..+..++.|+++||+|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--- 153 (308)
T cd06615 81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 153 (308)
T ss_pred cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence 9999999999865 34889999999999999999999732 8999999999999999999999999998754322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc---------
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV--------- 1050 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 1050 (1103)
......++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...+..........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-----LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-----HHHhhcCccccccccCCcccccC
Confidence 1234568899999999988889999999999999999999999986432111 00000000000000
Q ss_pred ---------------cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1051 ---------------KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1051 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
................+.++.+++.+|+..+|++||++.|++++-
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 288 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP 288 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 000000000000112456799999999999999999999999773
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=318.89 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=206.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCc----EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGI----LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|+..+.||+|+||.||+|.+. ++. .||+|.+..........++.+|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 46888899999999999999654 343 57889887655544556789999999999999999999998764 4679
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
++||+++|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 86 v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 86 VTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 999999999999987643 3478899999999999999999999 999999999999999999999999999986643
Q ss_pred CCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ... .......
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~--------~~~-~~~~~~~----- 227 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT--------REI-PDLLEKG----- 227 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHH-HHHHHCC-----
Confidence 2221 2223445678999999998899999999999999999997 8888863211 111 1111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
.....+..++..+.+++.+||..+|++||+++++++.++++...+
T Consensus 228 ----~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 228 ----ERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 111122334567899999999999999999999999999986554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.99 Aligned_cols=249 Identities=27% Similarity=0.453 Sum_probs=206.5
Q ss_pred ceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||.||+|.... +..||+|.+.........+.+.+|+..++.++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 468999999999997654 7889999998766555578899999999999999999999999999999999999999
Q ss_pred CChHHHHHhhc-------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 903 GNLENFIKART-------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 903 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
++|.++++... ...+++.++.+++.|++.|++|||++ +++||||+|+||++++++.+|++|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 99999998752 24589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... .......++..|+|||.+....++.++||||+|+++|||++ |..||.... ......... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~-~------ 222 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS--------NEEVLEYLR-K------ 222 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHH-c------
Confidence 321 22334567889999999988889999999999999999999 588876331 111111111 1
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
......+...+.++.+++.+|+..+|++||++.|++++|+
T Consensus 223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 223 ---GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1112234455788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=321.45 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=200.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||++... +++.||+|++..... ....+.+.+|+.++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46889999999999999999765 588999999875322 223566889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.+.. ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 9999999999997642 3488999999999999999999999 99999999999999999999999999987664433
Q ss_pred CccccCCcccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 978 THATTGVAGTFGYVAPEYALT-----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
........|++.|+|||++.. ..++.++||||+||++|||++|+.||..... ...............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~--------~~~~~~i~~~~~~~~ 228 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHKEHFQ 228 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH--------HHHHHHHHcCCCccc
Confidence 333334568999999999863 4578899999999999999999999973211 111111111111000
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCC--CCCCHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLS--TRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~evl~~ 1094 (1103)
. .......+..+.+++.+|+..+++ .||++.+++++
T Consensus 229 ~------~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 F------PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred C------CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0 111123566788899887765443 47899999876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=320.45 Aligned_cols=244 Identities=20% Similarity=0.288 Sum_probs=195.2
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999665 578999999976533 23456688999999888 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (327)
T cd05617 81 GDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTS 154 (327)
T ss_pred CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCcee
Confidence 99999887643 489999999999999999999999 9999999999999999999999999998753221 12233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||....... ......+......... ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~----------~~~ 222 (327)
T cd05617 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNP--DMNTEDYLFQVILEKP----------IRI 222 (327)
T ss_pred cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCc--ccccHHHHHHHHHhCC----------CCC
Confidence 4578999999999999999999999999999999999999996432211 1111122222221111 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTM 1088 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~ 1088 (1103)
+...+..+.+++.+|++.||++|+++
T Consensus 223 p~~~~~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 223 PRFLSVKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred CCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 33455678999999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.02 Aligned_cols=249 Identities=26% Similarity=0.401 Sum_probs=202.3
Q ss_pred ceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChH
Q 043720 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLE 906 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 906 (1103)
+.||+|+||.||+|...+++.||+|++.........+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999877799999999877655556678999999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc-cCCc
Q 043720 907 NFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT-TGVA 985 (1103)
Q Consensus 907 ~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~-~~~~ 985 (1103)
++++... ..+++..+..++.+++.|++|||++ +++||||+|+||+++.++.+||+|||++........... ....
T Consensus 81 ~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (251)
T cd05041 81 TFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ 156 (251)
T ss_pred HHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence 9997643 3578999999999999999999999 999999999999999999999999999976532211111 1223
Q ss_pred ccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCCh
Q 043720 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPH 1064 (1103)
Q Consensus 986 g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1103)
++..|+|||.+.+..++.++||||||+++|||++ |..||..... ...... .. .......+.
T Consensus 157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~--------~~~~~~-~~---------~~~~~~~~~ 218 (251)
T cd05041 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN--------QQTRER-IE---------SGYRMPAPQ 218 (251)
T ss_pred ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH--------HHHHHH-Hh---------cCCCCCCCc
Confidence 3567999999988889999999999999999999 7777753211 011111 11 111112234
Q ss_pred hHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1065 DDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1065 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
..+..+.+++.+|+..+|++||++.|+++.|++
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 556789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=311.48 Aligned_cols=249 Identities=23% Similarity=0.376 Sum_probs=207.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
..|+..+.||+|+||.||+|... ++..||+|++...........+.+|+.+++++.|+||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35778889999999999999765 58899999988665555678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++.. .+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++++|||++....... .
T Consensus 84 ~~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~ 156 (277)
T cd06640 84 LGGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-I 156 (277)
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc-c
Confidence 9999999998753 388899999999999999999999 99999999999999999999999999997654322 1
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......++..|+|||++.+..++.++||||||+++|||++|+.||...... ..... . .....
T Consensus 157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--------~~~~~-~---------~~~~~ 218 (277)
T cd06640 157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPM--------RVLFL-I---------PKNNP 218 (277)
T ss_pred ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChH--------hHhhh-h---------hcCCC
Confidence 223346788999999998888999999999999999999999998743221 00000 0 01111
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+..+.+++.+||+.+|++||++.+++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 22344567889999999999999999999999876
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=309.52 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=194.5
Q ss_pred ceeccCCcccEEEEEEcC---CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 827 NCIGSGGFGTTYKAEISP---GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.||+|+||.||+|...+ +..+|+|.+...........+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 358999999999997653 45799999877655555567899999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcC---CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 904 NLENFIKARTS---RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 904 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
+|.++++.... ...++..+.+++.|++.|++|||+. +++||||||+||+++.++.+|++|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999976432 2456778889999999999999999 99999999999999999999999999987543322211
Q ss_pred -ccCCcccccccCccccccC-------CCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 981 -TTGVAGTFGYVAPEYALTC-------RVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 981 -~~~~~g~~~y~aPE~~~~~-------~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.....++..|+|||++... .++.++||||||+++|||++ |+.||...... .. ...... +...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-----~~---~~~~~~-~~~~ 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-----QV---LTYTVR-EQQL 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-----HH---HHHHhh-cccC
Confidence 2234567889999988542 35789999999999999996 99898632210 00 011111 1111
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
...++.. ....+..+.+++.+|+ .+|++||+++||.+.|+
T Consensus 229 ~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 1111111 2234556888999999 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=334.52 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=193.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-------- 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------- 890 (1103)
..+|++.+.||+|+||+||+|... +++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 457999999999999999999664 58899999885432 2345799999999999999998876331
Q ss_pred CeEEEEEeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeec
Q 043720 891 NEMFLIYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDF 967 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Df 967 (1103)
...++||||++ +++.+++... ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 24679999996 5888877642 235589999999999999999999999 999999999999998665 6999999
Q ss_pred ccccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 968 GLSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 968 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
|+++...... ......|++.|+|||++.+ ..++.++||||+||++|||++|.+||...... ....... ....
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~----~~~~~i~-~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV----DQLVRII-QVLG 288 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHH-HHhC
Confidence 9998654322 2234578999999998865 46899999999999999999999998743211 0011100 0000
Q ss_pred c----------Cccc-----ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 Q----------GQVK-----DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~----------~~~~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .... ......+....+...+.++.+++.+||..||++||++.|++++
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h 351 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD 351 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence 0 0000 0000111111233456789999999999999999999999854
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=334.04 Aligned_cols=372 Identities=29% Similarity=0.396 Sum_probs=293.3
Q ss_pred cCCCCCCEEEeecCCCC-CCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCc
Q 043720 128 WSLEKLEVLDVEGNFLS-GRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLR 206 (1103)
Q Consensus 128 ~~l~~L~~L~Ls~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 206 (1103)
+-|+-.+-+|+++|.++ +..|.....+++++.|.|...++. .+|..++.|.+|++|.+++|++. .+-+.++.++.|+
T Consensus 4 gVLpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LR 81 (1255)
T KOG0444|consen 4 GVLPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLR 81 (1255)
T ss_pred cccceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhH
Confidence 34567788999999999 668999999999999999999998 89999999999999999999998 5666788899999
Q ss_pred EeecccccCCCC-CChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccC
Q 043720 207 VLFLSYNELNGS-IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285 (1103)
Q Consensus 207 ~L~L~~N~l~g~-ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 285 (1103)
.+++.+|++..+ ||..++.+ ..|+.||||+|+++ ..|..+...+++-.|+|++|+|..+...-|.+|..|-+||||+
T Consensus 82 sv~~R~N~LKnsGiP~diF~l-~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~ 159 (1255)
T KOG0444|consen 82 SVIVRDNNLKNSGIPTDIFRL-KDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSN 159 (1255)
T ss_pred HHhhhccccccCCCCchhccc-ccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhcccc
Confidence 999999998744 89999985 67999999999998 7888888888899999999999764334456788888888888
Q ss_pred CcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccc
Q 043720 286 NRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG 365 (1103)
Q Consensus 286 N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~ 365 (1103)
|++. .+|..+..+..|++|+|++|.. ...+|+
T Consensus 160 NrLe-~LPPQ~RRL~~LqtL~Ls~NPL---------------------------------~hfQLr-------------- 191 (1255)
T KOG0444|consen 160 NRLE-MLPPQIRRLSMLQTLKLSNNPL---------------------------------NHFQLR-------------- 191 (1255)
T ss_pred chhh-hcCHHHHHHhhhhhhhcCCChh---------------------------------hHHHHh--------------
Confidence 8887 5566666666666666665311 111111
Q ss_pred cCCccccccccCcEEEcCCcccc-cccchhhhccCCceEeecCCccccccccccccccceeEEEecCCccccccCCCCcc
Q 043720 366 KLPSSWGACESLEMLNLAQNVLR-GDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYN 444 (1103)
Q Consensus 366 ~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~ 444 (1103)
.+-.+++|+.|.+++.+=+ ..+|.++..+.+|..+
T Consensus 192 ----QLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dv---------------------------------------- 227 (1255)
T KOG0444|consen 192 ----QLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDV---------------------------------------- 227 (1255)
T ss_pred ----cCccchhhhhhhcccccchhhcCCCchhhhhhhhhc----------------------------------------
Confidence 1112334444444443311 1223333333333333
Q ss_pred cccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeecc
Q 043720 445 VCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGA 524 (1103)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (1103)
T Consensus 228 -------------------------------------------------------------------------------- 227 (1255)
T KOG0444|consen 228 -------------------------------------------------------------------------------- 227 (1255)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCC
Q 043720 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604 (1103)
Q Consensus 525 ~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 604 (1103)
|+|.|++. .+|+.+... .+|+.|+||+|+|+ .+......-.+|++|+||.|+++
T Consensus 228 -----------------------DlS~N~Lp-~vPecly~l-~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt 281 (1255)
T KOG0444|consen 228 -----------------------DLSENNLP-IVPECLYKL-RNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT 281 (1255)
T ss_pred -----------------------cccccCCC-cchHHHhhh-hhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc
Confidence 44444444 566666665 89999999999999 44555566689999999999999
Q ss_pred CCCCcccccCccCcEEeccCcccC-CCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccc
Q 043720 605 GEIPSSLHRLKYLRHLSLADNNLT-GGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGL 683 (1103)
Q Consensus 605 ~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l 683 (1103)
.+|++++++++|+.|++.+|+++ .-+|..++.|.+|+++..++|.+. .+|++++.|.+|+.|.|++|++- .+|+.+
T Consensus 282 -~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaI 358 (1255)
T KOG0444|consen 282 -VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAI 358 (1255)
T ss_pred -cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhh
Confidence 89999999999999999999998 458999999999999999999998 89999999999999999999998 899999
Q ss_pred cCCCCCceEeCCCCCCCCCCC
Q 043720 684 ANVTSLSIFNASFNNLSGPFP 704 (1103)
Q Consensus 684 ~~l~~L~~l~l~~N~l~~~~p 704 (1103)
.-++.|+.||+..|+=--.+|
T Consensus 359 HlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 359 HLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred hhcCCcceeeccCCcCccCCC
Confidence 999999999999987554444
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=313.13 Aligned_cols=250 Identities=26% Similarity=0.437 Sum_probs=200.8
Q ss_pred ceeccCCcccEEEEEEcC-------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 827 NCIGSGGFGTTYKAEISP-------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.||+|+||.||+|...+ +..||||.+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 358999999999997643 2579999987665455667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhc-----CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-----CEEEeeccc
Q 043720 900 LPGGNLENFIKART-----SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-----NAYLSDFGL 969 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-----~~ki~Dfgl 969 (1103)
+++++|.++++... ...+++.++..++.|++.|++|||+. +++|+||+|+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 23478899999999999999999999 999999999999999877 899999999
Q ss_pred ccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 970 SRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 970 a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
+......... ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~--------~~~~~~~-~~ 228 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN--------QEVLQHV-TA 228 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH--------HHHHHHH-hc
Confidence 8765332221 1222345678999999999999999999999999999998 8888863211 1111111 11
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
......+...+..+.+++.+||..+|++||++++|++.|++
T Consensus 229 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 229 ---------GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ---------CCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11112234556789999999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.57 Aligned_cols=252 Identities=26% Similarity=0.486 Sum_probs=206.3
Q ss_pred CCCcceeccCCcccEEEEEEcC-----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 823 FNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
|++.+.||.|+||.||+|.... +..||+|++.........+.+..|+..++.++|+||+++++++...+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567889999999999997664 38899999977665556788999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++......+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||++.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999875544489999999999999999999999 99999999999999999999999999998765443
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
........+++.|+|||.+.+..++.++||||+|+++|||++ |..||... .......... ...
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~--------~~~~~~~~~~-~~~------- 221 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM--------SNEEVLEYLK-KGY------- 221 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--------CHHHHHHHHh-cCC-------
Confidence 333223346789999999988889999999999999999998 67776531 1111111111 111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
....+...+.++.+++.+|+..+|++|||+.|+++.|
T Consensus 222 --~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 --RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 1122334667899999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=319.65 Aligned_cols=242 Identities=23% Similarity=0.319 Sum_probs=195.9
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+|+..+.||+|+||+||+|... +++.||||++..... ....+.+..|..++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4778899999999999999654 588999999876432 234566788888988885 678888999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD- 154 (323)
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC-
Confidence 9999999999997643 389999999999999999999999 9999999999999999999999999998754222
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
........|++.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 155 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~--------~~~~~~i~~~~--------- 217 (323)
T cd05615 155 GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE--------DELFQSIMEHN--------- 217 (323)
T ss_pred CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCC---------
Confidence 1223345689999999999998999999999999999999999999974321 11111111110
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTM 1088 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1088 (1103)
...+...+..+.+++.+|++.+|++|++.
T Consensus 218 --~~~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 --VSYPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred --CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 12233455678999999999999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=312.30 Aligned_cols=249 Identities=25% Similarity=0.424 Sum_probs=206.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|+..+.||.|+||.||+|... +++.||+|++...........+.+|+.+++.++|+|++++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36888899999999999999655 58899999998765555667889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++.. .+++..+..++.|++.|+.|||++ +++||||+|+||++++++.++++|||+++...... .
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S 153 (274)
T ss_pred eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence 9999999999865 489999999999999999999999 99999999999999999999999999998765332 2
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......+++.|+|||++.+..++.++||||||+++|||++|+.||..... ...... ...... +.
T Consensus 154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~--------~~~~~~-~~~~~~-----~~-- 217 (274)
T cd06609 154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP--------MRVLFL-IPKNNP-----PS-- 217 (274)
T ss_pred ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCch--------HHHHHH-hhhcCC-----CC--
Confidence 23345678899999999988899999999999999999999999863321 011111 111110 11
Q ss_pred CCCChh-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHD-DLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.... .+.++.+++.+|+..+|++||++++++++
T Consensus 218 --~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 --LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred --CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 55678999999999999999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=319.88 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=197.7
Q ss_pred cceeccCCcccEEEE-EEcCCcEEE---EEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC--eEEEEEee
Q 043720 826 SNCIGSGGFGTTYKA-EISPGILVA---VKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN--EMFLIYNY 899 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~-~~~~~~~va---vK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~E~ 899 (1103)
...||+|+|-+||+| +..+|..|| ||.-.........++|..|+.+++.++|||||+++.++.+.. ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 456999999999999 434465554 444444455566789999999999999999999999887755 48899999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~ 978 (1103)
+..|+|..|+++.+. +..+.+..|++||++||.|||++ .|+|+|||||-.||+|+. .|.|||+|+|+|+..+.+.
T Consensus 125 ~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~- 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH- 200 (632)
T ss_pred ccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccc-
Confidence 999999999998765 88899999999999999999999 899999999999999985 5789999999999875332
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
...+.|||.|||||... ..|.+.+||||||+++.||.|+..||.... +..+..+....+.+...+-.
T Consensus 201 --aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-------n~AQIYKKV~SGiKP~sl~k--- 267 (632)
T KOG0584|consen 201 --AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-------NPAQIYKKVTSGIKPAALSK--- 267 (632)
T ss_pred --cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-------CHHHHHHHHHcCCCHHHhhc---
Confidence 23478999999999887 679999999999999999999999987332 23334444333332211111
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
--.+++.++|.+|+.. .++|||+.|+++.
T Consensus 268 ------V~dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 268 ------VKDPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred ------cCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 1135689999999999 9999999999863
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=316.73 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=196.4
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcC---CCCceeEEEeEEec-----CC
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNV---RHPNLVTLIGYRAS-----GN 891 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 891 (1103)
+|++.+.||+|+||+||+|... +++.||+|.++...... ....+.+|+.+++.+ .||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4788899999999999999655 58899999987643322 223456677776665 69999999998754 34
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
..++||||+. ++|.++++......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 6899999996 5999999876555689999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc---C
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ---G 1048 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~ 1048 (1103)
..... .......++..|+|||++.+..++.++||||+||++|||++|++||...... ........ .... .
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~----~~~~~~~~-~~~~~~~~ 229 (288)
T cd07863 157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA----DQLGKIFD-LIGLPPED 229 (288)
T ss_pred cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH----HHHHHHHH-HhCCCChh
Confidence 65422 1223456789999999999888999999999999999999999998643211 00000000 0000 0
Q ss_pred ccc-------ccccccc---cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 QVK-------DVFNAEL---WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 ~~~-------~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... ..+.+.. ........+.++.+++.+|++.||++||++.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 000 0000000 001112345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=321.88 Aligned_cols=241 Identities=26% Similarity=0.316 Sum_probs=190.9
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHH-HHHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEI-KTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||+|++..... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999665 578899999875432 12233444444 456788999999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.+++.... .+.+..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~ 154 (325)
T cd05602 81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTS 154 (325)
T ss_pred CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCcc
Confidence 99999997643 378888999999999999999999 9999999999999999999999999998754221 22234
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++||||+||++|||++|+.||..... .......... . ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~---------~--~~~ 215 (325)
T cd05602 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT--------AEMYDNILNK---------P--LQL 215 (325)
T ss_pred cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH--------HHHHHHHHhC---------C--cCC
Confidence 55789999999999999999999999999999999999999973211 1111111111 0 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMKQVV 1092 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1092 (1103)
....+..+.+++.+|++.||++||++.+.+
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 216 KPNITNSARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred CCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence 234567789999999999999999887443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=309.66 Aligned_cols=252 Identities=22% Similarity=0.398 Sum_probs=203.9
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-----hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
+|+..+.||+|+||+||+|...+++.+|||.+..... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999888899999998865432 22346688999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+||+++++|.+++.+.. .+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997643 378999999999999999999999 9999999999999999999999999998765321
Q ss_pred C-----CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 977 E-----THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 977 ~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
. ........++..|+|||++.+..++.++||||||+++|||++|+.||..... ..... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-------~~~~~-~~~~~~--- 224 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR-------LAAMF-YIGAHR--- 224 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh-------HHHHH-Hhhhcc---
Confidence 1 1112345678899999999988899999999999999999999999963211 00000 000000
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+...+.++.+++.+||+.+|++||++.|++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 225 -----GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 00111233456778999999999999999999999863
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=307.49 Aligned_cols=250 Identities=25% Similarity=0.421 Sum_probs=205.4
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|+..+.||+|+||.||+|.... ++.|++|.+..... .+.+.+|++++++++|+||+++++++......|+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 578999999999999999998765 78999999865432 67899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+.+++|.+++.... ..+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999997543 4589999999999999999999999 999999999999999999999999999886643321
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......++..|+|||++.+..++.++||||||+++|||++|+.||....... .. ...... ....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~-------~~--~~~~~~-------~~~~ 218 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-------AI--FMIPNK-------PPPT 218 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh-------hh--hhhccC-------CCCC
Confidence 2233457889999999998899999999999999999999999987432210 00 000000 0001
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+......+.+++.+|++.+|++||++.|++++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11233455679999999999999999999999863
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=322.86 Aligned_cols=266 Identities=23% Similarity=0.303 Sum_probs=198.1
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-----
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----- 891 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 891 (1103)
..++|++.+.||+|+||.||+|... .+..||||++..... ......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3568999999999999999999654 589999999875432 334567889999999999999999999886543
Q ss_pred -eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 892 -EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 892 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
..|+||||+++ ++.+.++. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a 170 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 170 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCc
Confidence 57999999964 67766643 278889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC----------CCCcchHHH
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSH----------GDGFNIISW 1040 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~----------~~~~~~~~~ 1040 (1103)
+.... ........|++.|+|||.+.+..++.++||||+||++|||++|+.||....... .........
T Consensus 171 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (359)
T cd07876 171 RTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR 248 (359)
T ss_pred ccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence 75432 222334578999999999999999999999999999999999999997432100 000000000
Q ss_pred ----HHHHHhcC-ccc-----cccccccc---CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1041 ----ASMLLRQG-QVK-----DVFNAELW---ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1041 ----~~~~~~~~-~~~-----~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........ ... +.+..... ..........+.+++.+|++.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 000 00000000 00111234668999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=311.77 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=201.9
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
|+..+.||+|+||+||+|... +++.||+|.+...... .....+.+|+++++.++|++++++.+++..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999664 5889999998654332 2345578899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.......+++..+..++.|++.|+.|||++ +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-- 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence 9999999998765555699999999999999999999999 99999999999999999999999999987653221
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......|+..|+|||++.+..++.++||||+|+++|||++|+.||..... ......+... .... .
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~----~~~~~~~~~~-~~~~----------~ 221 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE----KVKREEVDRR-VLET----------E 221 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHh-hhcc----------c
Confidence 22345689999999999988999999999999999999999999973221 0000111111 0000 0
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+...+..+.+++.+|++.||++||+ +.+++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 1123344567899999999999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=311.28 Aligned_cols=254 Identities=30% Similarity=0.515 Sum_probs=202.2
Q ss_pred CCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhH-HHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 823 FNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
|++.+.||+|+||+||+|.... ++.||+|++......... ....+|+..+++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 5678899999999999997665 568999999877654333 23466999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.+++... ..+++..+..++.|+++||++||+. +|+|+||||+||++++++.++|+|||.+... ......
T Consensus 81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~ 154 (260)
T PF00069_consen 81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNEN 154 (260)
T ss_dssp TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSE
T ss_pred cccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence 999999999843 3489999999999999999999999 9999999999999999999999999999764 222334
Q ss_pred ccCCcccccccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+++.|+|||++. +..++.++||||+|+++|+|++|+.||.... ............ ... .....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~-----~~~~~~~~~~~~-~~~----~~~~~- 223 (260)
T PF00069_consen 155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN-----SDDQLEIIEKIL-KRP----LPSSS- 223 (260)
T ss_dssp BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS-----HHHHHHHHHHHH-HTH----HHHHT-
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccc-----chhhhhhhhhcc-ccc----ccccc-
Confidence 44567899999999998 8889999999999999999999999988431 001111111110 000 00000
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+.+++.+|++.||++||++.+++++
T Consensus 224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0111223789999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=327.47 Aligned_cols=262 Identities=21% Similarity=0.265 Sum_probs=198.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
...|.+.+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+|||++++++..++..++|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 446999999999999999999765 478899996432 345689999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
++. ++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 241 ~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 241 KYR-SDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred ccC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 994 79999887643 3589999999999999999999999 999999999999999999999999999986533222
Q ss_pred -ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc--cccc-
Q 043720 979 -HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV--KDVF- 1054 (1103)
Q Consensus 979 -~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~- 1054 (1103)
.......||+.|+|||++.+..++.++|||||||++|||++|..++.......... ....-....+..... .++.
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~-~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERR-PYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccC-CcHHHHHHHHHhhccccccCCC
Confidence 12234578999999999999999999999999999999999887664322111111 111111111111110 0000
Q ss_pred --c------------ccccCCCC-------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 --N------------AELWASGP-------HDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 --~------------~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ........ ......+.+++.+||+.||++|||+.|++++
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 00000000 1223468899999999999999999999976
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=313.29 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=204.8
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
..+|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++|+||+++++++..++..|+|||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 35799999999999999999975 46899999998765433 34668899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.+++.+. .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~- 169 (297)
T cd06656 97 YLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 169 (297)
T ss_pred ccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-
Confidence 99999999998754 378899999999999999999999 99999999999999999999999999987653322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......... . .... ....
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~-------~-~~~~--------~~~~ 233 (297)
T cd06656 170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-------Y-LIAT--------NGTP 233 (297)
T ss_pred cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe-------e-eecc--------CCCC
Confidence 2223446788999999999888999999999999999999999999643221100 0 0000 0000
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+...+..+.+++.+||..+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233455678999999999999999999999973
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=320.20 Aligned_cols=238 Identities=26% Similarity=0.341 Sum_probs=190.0
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHH-HHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIK-TLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +++.||+|++..... ......+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999765 588999999875432 223344555554 67889999999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|..++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~ 154 (321)
T cd05603 81 GELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS 154 (321)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence 99999887543 488889999999999999999999 9999999999999999999999999998753222 22233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||.... ........... . ...
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~---------~--~~~ 215 (321)
T cd05603 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD--------VSQMYDNILHK---------P--LQL 215 (321)
T ss_pred cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC--------HHHHHHHHhcC---------C--CCC
Confidence 4578999999999998899999999999999999999999997321 11111111111 1 112
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMK 1089 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~ 1089 (1103)
+......+.+++.+|++.||++||++.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 334556789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=307.16 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=192.7
Q ss_pred ceeccCCcccEEEEEEcC---CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 827 NCIGSGGFGTTYKAEISP---GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.||+|+||+||+|.... ...+|+|.+...........+.+|+..++.++|+||+++++++...+..++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 358999999999996543 45788888766555555677899999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcC---CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc-
Q 043720 904 NLENFIKARTS---RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH- 979 (1103)
Q Consensus 904 sL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~- 979 (1103)
+|.+++..... ...++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999977543 2346788899999999999999999 9999999999999999999999999998654322211
Q ss_pred cccCCcccccccCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 980 ATTGVAGTFGYVAPEYALT-------CRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
......++..|+|||++.. ..++.++|||||||++|||++ |..||..... ........... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~~~~~~~~~-~~ 228 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--------EQVLKQVVREQ-DI 228 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--------HHHHHHHhhcc-Cc
Confidence 1233345678999998742 456789999999999999999 6667652211 01111111111 11
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
....+. .+...+..+.+++..|+ .||++||+++||++.|.
T Consensus 229 ~~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 229 KLPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred cCCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 111111 12345567788999998 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=314.03 Aligned_cols=265 Identities=24% Similarity=0.385 Sum_probs=209.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 893 (1103)
.+|+..+.||+|+||+||+|.+. .+..||||++.........+.+.+|+.+++.+.|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35778899999999999999754 3688999999766544456789999999999999999999999877 5678
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+...
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 99999999999999997654 2489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-------CcchHHHHHHH
Q 043720 974 GTSETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD-------GFNIISWASML 1044 (1103)
Q Consensus 974 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~ 1044 (1103)
...... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ......+. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 238 (284)
T cd05038 160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL-EL 238 (284)
T ss_pred ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH-HH
Confidence 532221 111234456799999998888999999999999999999999988643221100 00001111 11
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
. ........+..++.++.+++.+|++.+|++||++.||+++|++|.
T Consensus 239 ~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 239 L---------KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred H---------HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1 111112223445678999999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=328.82 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=198.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|+..+.||+|+||+||+|... +++.||||++..... ......+.+|+.++..++|++|+++++.+.+.+..|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999665 589999999875432 334567888999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~ 155 (360)
T cd05627 81 EFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH 155 (360)
T ss_pred eCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence 9999999999997653 489999999999999999999999 99999999999999999999999999987542110
Q ss_pred C----------------------------------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 043720 978 T----------------------------------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKA 1023 (1103)
Q Consensus 978 ~----------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p 1023 (1103)
. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence 0 011235789999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 043720 1024 LDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT---MKQVVQC 1094 (1103)
Q Consensus 1024 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 1094 (1103)
|..... ........... .....+.......++.+++.+|+ .||++|++ +.|++++
T Consensus 236 f~~~~~--------~~~~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 236 FCSETP--------QETYRKVMNWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCH--------HHHHHHHHcCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence 974321 11111111100 00001111224567888888876 49999995 5666654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.49 Aligned_cols=259 Identities=27% Similarity=0.389 Sum_probs=207.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... +++.||+|++.........+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46888899999999999999655 58899999987665555667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
+++++|.++++... .+++..+..++.+++.|+.|||+ . +++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 99999999987643 48999999999999999999997 5 8999999999999999999999999998654221
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc---chHHHHHHHHhcCccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF---NIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||........... ....+........ .
T Consensus 158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~ 230 (284)
T cd06620 158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------P 230 (284)
T ss_pred -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------C
Confidence 12235688999999999888899999999999999999999999985433211111 1111111111110 0
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
+. ......+..+.+++.+|++.||++||++.|++++..
T Consensus 231 ~~---~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 231 PR---LPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CC---CCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 00 011235677999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=308.15 Aligned_cols=247 Identities=28% Similarity=0.439 Sum_probs=201.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||.||++.. .++.||+|.+.... ..+.+.+|+.++++++|||++++++++... ..++||||+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~---~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~ 80 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV---TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM 80 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc---hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence 4588899999999999999975 47889999986543 346788999999999999999999998765 479999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.++++......+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 999999999876555689999999999999999999999 9999999999999999999999999998754321
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......+..|+|||++.+..++.++||||||+++|||++ |+.||..... ....... .. ...
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~--------~~~~~~~-~~---------~~~ 215 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL--------KEVKECV-EK---------GYR 215 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH--------HHHHHHH-hC---------CCC
Confidence 112234568999999998899999999999999999998 8888763211 1111111 11 111
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
...+...+..+.+++.+||+.+|++||+++++++.|++
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 MEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 12234456788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=306.96 Aligned_cols=251 Identities=22% Similarity=0.375 Sum_probs=204.7
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec-CCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E 898 (1103)
+|++.+.||+|++|.||++... +++.||+|++..... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4788999999999999999654 478899999876543 3345678899999999999999999998764 456899999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.++++......+++.++..++.+++.|++|||+. +++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999999876556689999999999999999999999 99999999999999999999999999997664322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.......+++.|+|||++.+..++.++||||+|+++|||++|+.||.... ......... .+..
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~--------~~~~~~~~~-~~~~-------- 219 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD--------MNSLVYRII-EGKL-------- 219 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHH-hcCC--------
Confidence 22334567899999999999999999999999999999999999986321 111111111 1111
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+|++.+|++||++.+++++
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 -PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred -CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 12234556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=312.71 Aligned_cols=264 Identities=26% Similarity=0.404 Sum_probs=200.2
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|++.+.||+|++|+||+|... ++..||||++...... ...+.+.+|+.++++++||||+++++++..++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999765 6899999998764332 2346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
++ ++|.++++.... ..+++.++..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 689999876433 5689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH-------Hh----
Q 043720 979 HATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML-------LR---- 1046 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------~~---- 1046 (1103)
.......+++.|+|||++.+. .++.++||||||+++|||++|+.||....... ......... +.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID----QLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHHHhCCCChhhhhcchh
Confidence 122234568899999988654 57889999999999999999999987432100 000000000 00
Q ss_pred cCccccccc---ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDVFN---AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+. ...........+.++.+++.+||+.||++||++.+|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 000000000 000001112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=315.73 Aligned_cols=263 Identities=20% Similarity=0.319 Sum_probs=201.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|.+.+.||+|+||.||+|... +++.||+|.+...........+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56889999999999999999665 57899999987655444456678899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
++ ++|.+++.... ..+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~- 159 (301)
T cd07873 86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK- 159 (301)
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence 96 59999887643 3488999999999999999999999 999999999999999999999999999876432221
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH------------h
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL------------R 1046 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------~ 1046 (1103)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...... .......... .
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 234 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-----EQLHFIFRILGTPTEETWPGILS 234 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHcCCCChhhchhhhc
Confidence 2223456889999998865 45788999999999999999999998743210 0000000000 0
Q ss_pred cCcccccccccccC----CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDVFNAELWA----SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......-.+.... ......+..+.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h 286 (301)
T cd07873 235 NEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH 286 (301)
T ss_pred cccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000000000000 0112345678999999999999999999999863
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=318.90 Aligned_cols=194 Identities=28% Similarity=0.433 Sum_probs=170.9
Q ss_pred CCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-C-----CceeEEEeEEecCCeEE
Q 043720 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-H-----PNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~~ 894 (1103)
+|.+.+.||+|+||.|.+| +.++++.||||+++.... -..+...|+.+|..++ | -|+|+++++|...++.|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence 7899999999999999999 566799999999986533 3455667899999886 3 68999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC--CEEEeecccccc
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF--NAYLSDFGLSRL 972 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~ki~Dfgla~~ 972 (1103)
+|+|.+ .-+|+++++.+.-..++...++.|+.||+.||..||+. +|||+||||+|||+.+.+ .+||+|||.|+.
T Consensus 265 iVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 265 IVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999 45999999998888899999999999999999999999 999999999999997544 699999999987
Q ss_pred cCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALD 1025 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~ 1025 (1103)
..... ..+..+..|+|||++.+.+|+.+.||||||||++||++|.+-|.
T Consensus 341 ~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfp 389 (586)
T KOG0667|consen 341 ESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFP 389 (586)
T ss_pred cCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccC
Confidence 64322 24566889999999999999999999999999999999975554
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=322.14 Aligned_cols=256 Identities=21% Similarity=0.300 Sum_probs=200.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+++.. +++.||+|++..... ......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47889999999999999999765 578899999865322 223456888999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999998643 3488899999999999999999999 99999999999999999999999999998764433
Q ss_pred CccccCCcccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 978 THATTGVAGTFGYVAPEYALT-----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
........|++.|+|||++.+ ..++.++|||||||++|||++|+.||..... .............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~--------~~~~~~i~~~~~~-- 226 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL--------VETYGKIMNHEER-- 226 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH--------HHHHHHHHcCCCc--
Confidence 333334578999999999875 4678899999999999999999999973211 1111111111100
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLST--RPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1094 (1103)
. . ........+.++.+++.+|+..++++ |+++++++++
T Consensus 227 -~--~-~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 227 -F--Q-FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred -c--c-CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 0 01111234577899999999876554 4688888765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=315.94 Aligned_cols=195 Identities=26% Similarity=0.436 Sum_probs=161.3
Q ss_pred cceeccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeEEEEEeec
Q 043720 826 SNCIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEMFLIYNYL 900 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~ 900 (1103)
.++||+|+||+||+|... +++.||+|.+..... ...+.+|+.++++++||||+++++++.. +...|+||||+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA 82 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence 467999999999999764 467899998865432 3457789999999999999999998854 45789999999
Q ss_pred CCCChHHHHHhhc-------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE----CCCCCEEEeeccc
Q 043720 901 PGGNLENFIKART-------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGL 969 (1103)
Q Consensus 901 ~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgl 969 (1103)
. ++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 5 58988876421 13488899999999999999999999 99999999999999 4567899999999
Q ss_pred ccccCCCCC--ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 043720 970 SRLLGTSET--HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPS 1027 (1103)
Q Consensus 970 a~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~ 1027 (1103)
++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 987643322 12335678999999999876 45889999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=325.08 Aligned_cols=260 Identities=22% Similarity=0.262 Sum_probs=199.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.+|++.+.||+|+||.||+|... .+..||||.+... ....+|+.++++++||||+++++++......|+||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 47999999999999999999643 3578999987643 23457999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|++. ++|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 166 e~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 166 PKYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hhcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 9995 6899988543 4589999999999999999999999 99999999999999999999999999997664332
Q ss_pred Cc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc--ccc--
Q 043720 978 TH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ--VKD-- 1052 (1103)
Q Consensus 978 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~-- 1052 (1103)
.. ......||+.|+|||++....++.++|||||||++|||++|+.||....... ....+...... ..... ...
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~l~~i~~~-~~~~~~~~~~~~ 317 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKS-SSSQLRSIIRC-MQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCC-cHHHHHHHHHH-hccCccccCCcc
Confidence 22 2335678999999999999999999999999999999999999997543221 00001000000 00000 000
Q ss_pred ---------cccccccCCC-------ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 ---------VFNAELWASG-------PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ---------~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+... ....+.++.++|.+|+..||++||++.|++.+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000000 01234568899999999999999999999875
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=313.15 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=203.5
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
.|+..+.||+|+||.||+|... +++.||+|.+.........+.+.+|+.++++++||||+++++++..+...|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3666778999999999999654 578899999876655556678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.+++... .+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++....... ..
T Consensus 85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06642 85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence 999999998653 488999999999999999999999 99999999999999999999999999987654322 12
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....++..|+|||++.+..++.++||||||+++|||++|+.|+...... . ... ..... ...
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~-----~---~~~-~~~~~---------~~~ 219 (277)
T cd06642 158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPM-----R---VLF-LIPKN---------SPP 219 (277)
T ss_pred hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchh-----h---HHh-hhhcC---------CCC
Confidence 22345788999999999888999999999999999999999998632211 0 000 01011 111
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+..+.+++.+||+.+|++||++.+++++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 1223456778999999999999999999999984
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=316.23 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=203.6
Q ss_pred CCCcceeccCCcccEEEEEEcCCc-EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPGI-LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~~-~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
|+++..||.|+||.||+|..++.. ..|.|++.. ...+..++|+-|++++..+.||+||++++.|...+.+|+..|||.
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet-kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET-KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcc-cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 556777999999999999776543 345555543 445578899999999999999999999999988899999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
||-....+-.-. ..+++.++.-++++++.||.|||++ .|+|||||+.|||++-+|.++++|||.+... .......
T Consensus 113 GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn-~~t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN-KSTRQKR 187 (1187)
T ss_pred CchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc-hhHHhhh
Confidence 999998886643 5699999999999999999999999 9999999999999999999999999998653 2334456
Q ss_pred cCCcccccccCcccc-----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 982 TGVAGTFGYVAPEYA-----LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~-----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
..+.|||.|||||+. ++.+|+.++||||||+++.||..+.+|-.. .+.......+.+.+ ..
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe--------lnpMRVllKiaKSe-PP----- 253 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE--------LNPMRVLLKIAKSE-PP----- 253 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc--------cchHHHHHHHhhcC-CC-----
Confidence 778999999999986 477899999999999999999999988552 22222222222111 11
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .-.|......+.+++++|+..||..||++++++++
T Consensus 254 T--LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 254 T--LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred c--ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 1 12345667789999999999999999999999875
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=320.19 Aligned_cols=239 Identities=26% Similarity=0.314 Sum_probs=190.3
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHH-HHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIK-TLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|... +|+.||||++..... ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 46999999999999654 689999999875432 223345555654 56778999999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|..++.... .+++..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++..... .....
T Consensus 81 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 154 (325)
T cd05604 81 GELFFHLQRER--SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTT 154 (325)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcc
Confidence 99999887643 489999999999999999999999 9999999999999999999999999998753211 22233
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...|++.|+|||++.+..++.++|||||||++|||++|+.||..... ......... . .. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~--------~~~~~~~~~-~--------~~--~~ 215 (325)
T cd05604 155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV--------AEMYDNILH-K--------PL--VL 215 (325)
T ss_pred cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH--------HHHHHHHHc-C--------Cc--cC
Confidence 45789999999999999999999999999999999999999973211 111111111 1 10 11
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMKQ 1090 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~e 1090 (1103)
.......+.+++.+|++.+|.+||++.+
T Consensus 216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 216 RPGASLTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence 2234567889999999999999998863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=306.30 Aligned_cols=257 Identities=25% Similarity=0.416 Sum_probs=208.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||.|+||+||+|... ++..+|+|++.........+.+.+|+..++.++|+|++++++.+..++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46889999999999999999754 57899999997665555678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
+++++|.++++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999986533 4689999999999999999999999 999999999999999999999999999877654332
Q ss_pred c---cccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 979 H---ATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 979 ~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
. ......|+..|+|||++... .++.++||||||+++|||++|+.||...... ..........
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--------~~~~~~~~~~------ 223 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--------KVLMLTLQND------ 223 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--------hhHHHHhcCC------
Confidence 2 22344688999999998776 7889999999999999999999999743221 0011111110
Q ss_pred cccccCC-CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWAS-GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....... .....+..+.+++.+|+..||++||++.|++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0011000 112456788999999999999999999999874
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=310.42 Aligned_cols=253 Identities=21% Similarity=0.374 Sum_probs=203.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccc-cchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVG-RFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 897 (1103)
...|++.++||+|+.+.||++...+.+.||+|++... .+.+...-|..|+..|.+++ |.+||++++|-..++..||||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4569999999999999999999888888888877554 44556788999999999995 999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||- ..+|.+++++.......| .++.+..|++.++.+.|.+ +|||.||||.|+++-+ |.+||+|||.|.....+.
T Consensus 440 E~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred ecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 987 569999999876654445 7888999999999999999 9999999999999864 599999999998876544
Q ss_pred Ccc-ccCCcccccccCccccccCC-----------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 978 THA-TTGVAGTFGYVAPEYALTCR-----------VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 978 ~~~-~~~~~g~~~y~aPE~~~~~~-----------~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
... ....+||+.||+||.+.... .+.++||||+|||+|+|+.|+.||..- . ..|
T Consensus 514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~--n~~----- 579 (677)
T KOG0596|consen 514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------I--NQI----- 579 (677)
T ss_pred cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------H--HHH-----
Confidence 332 34568999999999985432 456899999999999999999999711 0 012
Q ss_pred hcCcccccccccccCCCCh-hHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPH-DDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+..+.++....+++. ....+++++++.|+..||++||+..|++++
T Consensus 580 --aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 --AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred --HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 22333444433222221 122339999999999999999999999875
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=311.91 Aligned_cols=260 Identities=22% Similarity=0.386 Sum_probs=205.0
Q ss_pred CHHHHHHHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEec
Q 043720 812 TYESIIRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRAS 889 (1103)
Q Consensus 812 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 889 (1103)
+..+...+.+.|++.+.||+|+||+||+|.. ..++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 4445555678899999999999999999966 458899999886543 2346688899999998 69999999998853
Q ss_pred ------CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEE
Q 043720 890 ------GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY 963 (1103)
Q Consensus 890 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 963 (1103)
....|+||||+++|+|.+++.......+++..+..++.|++.|++|||+. +|+|+||+|+||++++++.++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEE
Confidence 46789999999999999999876656688889999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchH
Q 043720 964 LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1103)
|+|||++....... .......|++.|+|||.+. ...++.++|||||||++|||++|+.||.......
T Consensus 162 l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~------- 233 (282)
T cd06636 162 LVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR------- 233 (282)
T ss_pred EeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHh-------
Confidence 99999987553221 1223456889999999875 3567889999999999999999999986432110
Q ss_pred HHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1039 SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .... .. ...........+..+.+++.+||+.||++||++.|++++
T Consensus 234 ~-~~~~-~~--------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 234 A-LFLI-PR--------NPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred h-hhhH-hh--------CCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 0 0000 00 000011123456789999999999999999999999763
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=313.81 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=204.7
Q ss_pred CCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 823 FNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
|.-.+.||.|+||.||.|+ ..+.+.||||++..... .+...++..|+..+++++|||+|.+.|++......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5567789999999999994 45688999999965533 34567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
| -|+-.+.+.-.+ +++-+.++..|..+.+.||+|||+. +.||||||+.|||+++.|.||++|||.|....+
T Consensus 108 C-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---- 178 (948)
T KOG0577|consen 108 C-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---- 178 (948)
T ss_pred H-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence 9 568888887654 5588899999999999999999999 999999999999999999999999999976543
Q ss_pred cccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
...++|||.|||||++. .+.|+-|+||||+|++..|+...++|+...... ..-..+.+++...+
T Consensus 179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAM---------SALYHIAQNesPtL--- 245 (948)
T KOG0577|consen 179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---------SALYHIAQNESPTL--- 245 (948)
T ss_pred -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHH---------HHHHHHHhcCCCCC---
Confidence 34578999999999985 578999999999999999999999987633221 01112222221111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
........+..++..|+++-|.+|||..+++++---
T Consensus 246 -----qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 246 -----QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred -----CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 134567789999999999999999999999986443
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=316.81 Aligned_cols=253 Identities=25% Similarity=0.367 Sum_probs=205.6
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
+|+..+.||+|+||+||+|... +++.||+|.+...... ...+.+..|+++++.++|+||+++++.+..+...|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888999999999999999665 4899999999765443 255678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+.+++|.++++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999999876556789999999999999999999999 999999999999999999999999999875532211
Q ss_pred c----------------------------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC
Q 043720 979 H----------------------------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSS 1030 (1103)
Q Consensus 979 ~----------------------------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~ 1030 (1103)
. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0 111346788999999999888999999999999999999999998633210
Q ss_pred CCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCC----HHHHHHH
Q 043720 1031 HGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT----MKQVVQC 1094 (1103)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~evl~~ 1094 (1103)
..+.. . .............+..+.+++.+|++.+|++||+ ++|++++
T Consensus 239 -------~~~~~-~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 239 -------ETFSN-I---------LKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred -------HHHHH-H---------hcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 11111 1 1111111112225678999999999999999999 7777653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=315.50 Aligned_cols=258 Identities=20% Similarity=0.265 Sum_probs=196.0
Q ss_pred CcceeccC--CcccEEEEEE-cCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 825 TSNCIGSG--GFGTTYKAEI-SPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 825 ~~~~lg~G--~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
+.+.||+| +||+||++.. .+|+.||||++...... ...+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45679999 6789999955 46899999999765433 33456778999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC-c
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET-H 979 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~ 979 (1103)
++|+|.+++.......+++..+.+++.|++.||+|||++ +|+||||||+||+++.++.++++||+.+........ .
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 999999999775555689999999999999999999999 999999999999999999999999986543311110 0
Q ss_pred -----cccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 980 -----ATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 980 -----~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
......++..|+|||++.+ ..++.++|||||||++|||++|+.||....... ...... ......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--------~~~~~~-~~~~~~ 229 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--------MLLEKL-NGTVPC 229 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--------HHHHHh-cCCccc
Confidence 1112346678999999875 458899999999999999999999997322100 000000 000000
Q ss_pred cc-------------------c-----------------ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 VF-------------------N-----------------AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~-------------------~-----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. + ..............+.+++.+||+.||++|||++|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~ 307 (327)
T cd08227 230 LLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 307 (327)
T ss_pred cccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence 00 0 000001122345678999999999999999999999874
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=317.80 Aligned_cols=256 Identities=21% Similarity=0.294 Sum_probs=200.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||++... .++.||+|++..... ......+.+|+.++..++|++|+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36889999999999999999765 477899999865322 223455888999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++++.. ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 9999999999998643 3488999999999999999999999 99999999999999999999999999987654333
Q ss_pred CccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 978 THATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
........|++.|+|||++. ...++.++|||||||++|||++|+.||.... ...............
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~--------~~~~~~~i~~~~~~~- 227 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIMNHKERF- 227 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC--------HHHHHHHHhCCCccc-
Confidence 33334457899999999986 3467889999999999999999999997321 111222221111000
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLST--RPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1094 (1103)
.........+..+.+++.+|+..++++ |++++|++++
T Consensus 228 -----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 -----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred -----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001112345677889999988654444 6899999876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=306.32 Aligned_cols=251 Identities=23% Similarity=0.415 Sum_probs=206.4
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|++.+.||+|+||.||++... +++.||+|++..... ....+++.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4788999999999999999554 588999999875432 33456889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.......+++.++.+++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE- 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence 9999999999876555688999999999999999999999 999999999999999999999999999976543221
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......|++.|+|||++.+..++.++||||||+++|+|++|+.||.... .......... +. .
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~--------~~~~~~~~~~-~~---------~ 218 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN--------MKNLVLKIIR-GS---------Y 218 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC--------HHHHHHHHhc-CC---------C
Confidence 1223457889999999998889999999999999999999999986321 1111111111 11 0
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+.++.+++.+||+.+|++||++.||+++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11234456779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=321.27 Aligned_cols=266 Identities=22% Similarity=0.265 Sum_probs=198.7
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------ 890 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 890 (1103)
..++|++.+.||+|+||.||+|... .++.||||++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4568999999999999999999654 588999999876433 33456788899999999999999999987543
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
...|+||||+++ ++.+++.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 357999999964 77777653 278889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC-------cchHH----
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDG-------FNIIS---- 1039 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~-------~~~~~---- 1039 (1103)
+..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||........-. .....
T Consensus 167 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 865322 22334578999999999999899999999999999999999999996432100000 00000
Q ss_pred ---HHHHHHhc-Ccccccccc-----ccc---CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1040 ---WASMLLRQ-GQVKDVFNA-----ELW---ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1040 ---~~~~~~~~-~~~~~~~~~-----~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........ ........+ ... ..........+.+++.+|++.||++|||+.|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000 000000000 000 00112234578999999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=306.98 Aligned_cols=250 Identities=24% Similarity=0.427 Sum_probs=202.4
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch--------hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--------HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
+|.+.+.||+|+||.||+|.. .+++.||+|.+...... +..+.+.+|+.++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477888999999999999965 45789999988654321 223568899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.++|+||+++++|.++++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997653 488899999999999999999999 999999999999999999999999999887
Q ss_pred cCCCCC-----ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 973 LGTSET-----HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 973 ~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
...... .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||..... ..-..... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~ 226 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ--------LQAIFKIG-E 226 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccH--------HHHHHHHh-c
Confidence 642211 111234578899999999988899999999999999999999999873211 00000000 0
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+...+..+.+++.+||+.||++||++.|++++
T Consensus 227 ---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 227 ---------NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred ---------cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11112234556789999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=309.53 Aligned_cols=250 Identities=23% Similarity=0.404 Sum_probs=204.5
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.+|++.+.||.|+||+||+|.. .+++.||+|.+...... ..+.+.+|+..++.++|||++++++++...+..|+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP-KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc-hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 4688999999999999999964 56899999998765433 456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++... .+++.++..++.+++.|++|||+. +++||||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 98 LAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred cCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 9999999998754 389999999999999999999999 999999999999999999999999999876543222
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||..... ........... . ..
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--------~~~~~~~~~~~-~-------~~ 234 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--------LRALYLIATNG-T-------PE 234 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhcC-C-------cc
Confidence 22334678899999999988899999999999999999999999874321 01111111111 0 00
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.++|.+||..||++||++.+++++
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 11233456678999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=317.46 Aligned_cols=244 Identities=25% Similarity=0.447 Sum_probs=202.0
Q ss_pred eeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChH
Q 043720 828 CIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLE 906 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~ 906 (1103)
+||+|.||+||-|+.. +..++|||.+.....+ ..+.+.+|+..-+.++|.|||+++|.+.+++.+-+.||-++||+|.
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr-~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR-EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch-hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 6999999999999544 5677999998765544 5678899999999999999999999999999999999999999999
Q ss_pred HHHHhhcCCcc--cHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC-CCCCEEEeecccccccCCCCCccccC
Q 043720 907 NFIKARTSRAV--DWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTG 983 (1103)
Q Consensus 907 ~~l~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~ 983 (1103)
++++..=+ ++ .+.++-.+.+||++||.|||+. .|||||||-.||||+ -.|.+||+|||-+++... -...+..
T Consensus 661 sLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET 735 (1226)
T KOG4279|consen 661 SLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET 735 (1226)
T ss_pred HHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence 99987533 34 6778888999999999999999 999999999999995 678999999999988743 3344556
Q ss_pred CcccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 984 VAGTFGYVAPEYALTC--RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 984 ~~g~~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
+-||..|||||++-.+ .|+.++|||||||++.||.||++||.....+.. . ..+-+- -...++
T Consensus 736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA--------A--MFkVGm------yKvHP~ 799 (1226)
T KOG4279|consen 736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA--------A--MFKVGM------YKVHPP 799 (1226)
T ss_pred cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH--------h--hhhhcc------eecCCC
Confidence 7799999999999654 488899999999999999999999984432210 0 011110 112345
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
.|.....+...+|.+|+.+||.+||+++++++
T Consensus 800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 57888899999999999999999999999985
|
|
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=307.35 Aligned_cols=253 Identities=23% Similarity=0.358 Sum_probs=201.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||.||+|... +++.||+|+++.... .....+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG-EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 46888889999999999999654 588999999876533 2345688899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++... .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.+||+|||++...... ..
T Consensus 88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06645 88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IA 161 (267)
T ss_pred cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-cc
Confidence 99999999997654 489999999999999999999999 9999999999999999999999999998765422 22
Q ss_pred cccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
......|++.|+|||++. ...++.++||||+||++|||++|+.||....... ...... .... ..+
T Consensus 162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--------~~~~~~-~~~~---~~~ 229 (267)
T cd06645 162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--------ALFLMT-KSNF---QPP 229 (267)
T ss_pred ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--------hHHhhh-ccCC---CCC
Confidence 233456889999999874 4557889999999999999999999986322110 000000 0100 001
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ......+..+.+++.+|++.+|++||++++++++
T Consensus 230 ~~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 230 KL--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred cc--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 10 1112344678999999999999999999998864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=305.79 Aligned_cols=251 Identities=25% Similarity=0.378 Sum_probs=197.9
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc----hhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 893 (1103)
.+|+..+.||+|+||.||+|.. .++..||+|++..... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999965 4588999998865422 2345678899999999999999999998865 4678
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++++||+++++|.+++.... .+++.....++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++...
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~ 156 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 156 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence 99999999999999997654 388899999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 974 GTSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 974 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
..... .......++..|+|||++.+..++.++||||+||++|||++|+.||..... .. .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~-------~~-~~~~~~~~~--- 225 (266)
T cd06651 157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA-------MA-AIFKIATQP--- 225 (266)
T ss_pred ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch-------HH-HHHHHhcCC---
Confidence 32211 112234578899999999988899999999999999999999999873211 01 111111000
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+......+.+++ +||..+|++||+++||+++
T Consensus 226 ------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 226 ------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 01122334456677777 7888999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=319.82 Aligned_cols=262 Identities=22% Similarity=0.286 Sum_probs=194.7
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
...+|++.+.||+|+||.||+|... .++.||+|+.... ....|+.++++++|+||+++++++...+..++|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3457999999999999999999765 4678999975432 2346899999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+ .++|.+++.... ..+++..+.+++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 137 e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 137 PHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred Ecc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 999 468999887643 4589999999999999999999999 999999999999999999999999999875322
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc--chHHHHHHHHhc-Ccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF--NIISWASMLLRQ-GQVKDVF 1054 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~--~~~~~~~~~~~~-~~~~~~~ 1054 (1103)
........|++.|+|||++.+..++.++|||||||++|||+++..++........... ............ +.....+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 1222345689999999999999999999999999999999997666532221110000 000000000000 0000000
Q ss_pred c-------------cc--ccCC-------CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 N-------------AE--LWAS-------GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~-------------~~--~~~~-------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .. .+.. .....+..+.++|.+||+.||++|||+.|++++
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h 351 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY 351 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence 0 00 0000 011234456779999999999999999999875
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=339.37 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=199.8
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEM 893 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 893 (1103)
...++|++.+.||+|+||+||+|... .+..||+|++..... ......+..|+.+++.++|||||++++++.. ...+
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 34568999999999999999999665 467899998875433 3345778999999999999999999998754 4578
Q ss_pred EEEEeecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCC----CCcccCCCCCCcEEECC---------
Q 043720 894 FLIYNYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCA----PRVLHRDVKPSNILLDD--------- 958 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~----~~ivH~Dlk~~NIll~~--------- 958 (1103)
|+||||+++|+|.+++.... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999997632 2458999999999999999999998521 25999999999999964
Q ss_pred --------CCCEEEeecccccccCCCCCccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 043720 959 --------DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSF 1028 (1103)
Q Consensus 959 --------~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~ 1028 (1103)
.+.+||+|||++...... .......|++.|+|||++.. ..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 234899999999865322 22234578999999999854 458899999999999999999999996321
Q ss_pred CCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1029 SSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
. ........ .... .. .....+..+.++|.+||+.+|++||++.|+++
T Consensus 248 ~-------~~qli~~l-k~~p-------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 248 N-------FSQLISEL-KRGP-------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred c-------HHHHHHHH-hcCC-------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 1 11122111 1110 00 01223567899999999999999999999984
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-33 Score=304.90 Aligned_cols=240 Identities=22% Similarity=0.303 Sum_probs=188.4
Q ss_pred ceeccCCcccEEEEEEcC-------------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 827 NCIGSGGFGTTYKAEISP-------------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
+.||+|+||.||+|.+.. ...|++|++.... ......+.+|+.+++.++||||+++++++......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 358999999999997542 2358888876543 23456788899999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC-------EEEee
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN-------AYLSD 966 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~-------~ki~D 966 (1103)
++||||+++|+|..++.... ..+++..+.+++.||++|++|||++ +|+||||||+||+++.++. ++++|
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999887543 3489999999999999999999999 9999999999999987664 89999
Q ss_pred cccccccCCCCCccccCCcccccccCccccc-cCCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELI-SDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
||++..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..|+..... ... ...
T Consensus 156 ~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--------~~~-~~~ 221 (262)
T cd05077 156 PGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL--------AEK-ERF 221 (262)
T ss_pred CCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch--------hHH-HHH
Confidence 999875432 12345678899999886 466889999999999999998 57776652211 000 011
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
. ... . .........+.+++.+||+.||++||++.+|+++++
T Consensus 222 ~-~~~--------~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 222 Y-EGQ--------C--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred H-hcC--------c--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 1 110 0 011223467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.68 Aligned_cols=252 Identities=20% Similarity=0.332 Sum_probs=191.3
Q ss_pred eeccCCcccEEEEEEcCC---cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCC
Q 043720 828 CIGSGGFGTTYKAEISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGN 904 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 904 (1103)
.||+|+||+||+|...++ ..+++|.+.........+.+.+|+..++.++||||+++++++......|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 599999999999965443 34667776655444556789999999999999999999999999999999999999999
Q ss_pred hHHHHHhhcC--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC-Cccc
Q 043720 905 LENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE-THAT 981 (1103)
Q Consensus 905 L~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~-~~~~ 981 (1103)
|.++++.... ...++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999986432 3467778889999999999999999 99999999999999999999999999986432211 1222
Q ss_pred cCCcccccccCcccccc-------CCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 982 TGVAGTFGYVAPEYALT-------CRVSDKADVYSYGVVLLELISD-KKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
....++..|+|||++.. ..++.++||||||+++|||+++ ..||.... ........... .....
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~--------~~~~~~~~~~~-~~~~~ 229 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS--------DREVLNHVIKD-QQVKL 229 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHHhh-ccccc
Confidence 34567889999998743 2457799999999999999975 55654211 11122222211 11222
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
.++.. .......+.+++..|| .+|++||++++|++.|.
T Consensus 230 ~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 230 FKPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 22222 2234567888999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=304.13 Aligned_cols=250 Identities=26% Similarity=0.423 Sum_probs=204.7
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..+.||+|+||.||+|.. .+++.+|||++..... ......+.+|+.++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 478889999999999999965 4688999999876532 33467789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~ 978 (1103)
+++++|.++++......+++..+.+++.++++|++|||++ +++||||+|+||++++++ .+|++|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~- 156 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS- 156 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence 9999999999876656689999999999999999999999 999999999999998654 57999999998664322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ......... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~--------~~~~~~~~~-~~--------- 217 (256)
T cd08220 157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL--------PALVLKIMS-GT--------- 217 (256)
T ss_pred -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch--------HHHHHHHHh-cC---------
Confidence 22334678899999999988889999999999999999999999863221 111111111 10
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+...+..+.+++.+||+.+|++||++.|++++
T Consensus 218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 111233456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=306.40 Aligned_cols=254 Identities=27% Similarity=0.411 Sum_probs=207.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|+..+.||+|+||.||+|... +++.||+|++.........+.+.+|++++++++||||+++++++...+..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999766 58899999988765555667899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
+++++|.+++.... ..+++..+.+++.|++.|++|||+ . +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence 99999999998753 458899999999999999999999 8 999999999999999999999999999876532211
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
....++..|+|||++.+..++.++||||||+++|+|++|+.||....... ..............
T Consensus 157 ---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~---------- 220 (265)
T cd06605 157 ---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP---DGIFELLQYIVNEP---------- 220 (265)
T ss_pred ---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc---ccHHHHHHHHhcCC----------
Confidence 12567889999999999899999999999999999999999987443211 11111221111111
Q ss_pred cCCCChh-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHD-DLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.. .+..+.++|.+||..+|++||++.+++++
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0111111 56779999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=305.23 Aligned_cols=255 Identities=22% Similarity=0.367 Sum_probs=200.9
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.+++.+.....||+|+||+||+|... ++..||+|.+...... ..+.+.+|+.++++++|+||+++++++..++..++|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR-YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH-HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 34556666778999999999999654 5788999988755433 456889999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcc--cHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeeccccccc
Q 043720 897 YNYLPGGNLENFIKARTSRAV--DWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLL 973 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~ 973 (1103)
+||+++++|.++++.... .+ ++..+..++.|++.|++|||+. +|+||||||+||+++. ++.++|+|||.+...
T Consensus 84 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 84 MEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 999999999999986432 24 7888999999999999999999 9999999999999976 678999999998765
Q ss_pred CCCCCccccCCcccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCR--VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.... .......+++.|+|||++.... ++.++||||||+++|+|++|+.||...... ....+.....
T Consensus 160 ~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~-----~~~~~~~~~~------ 227 (268)
T cd06624 160 AGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP-----QAAMFKVGMF------ 227 (268)
T ss_pred ccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh-----hhhHhhhhhh------
Confidence 3222 1222345789999999986543 788999999999999999999998632110 0000100000
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+.....++.+++.+||+.+|++||++.|++++
T Consensus 228 -----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 228 -----KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -----ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 01112234456779999999999999999999999874
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=303.80 Aligned_cols=249 Identities=25% Similarity=0.432 Sum_probs=203.7
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc----hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
+|+..+.||+|+||+||+|... +++.|++|.+..... ++..+.+.+|+.+++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4677889999999999999766 789999999866432 23456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+||+++++|.++++... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997653 488999999999999999999999 9999999999999999999999999998765332
Q ss_pred CCccccCCcccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||..... ............
T Consensus 156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~~~~~~------ 219 (258)
T cd06632 156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--------VAAVFKIGRSKE------ 219 (258)
T ss_pred c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--------HHHHHHHHhccc------
Confidence 2 223456788999999987766 88999999999999999999999874321 111111111011
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+......+.+++.+||+.+|++||++.+++++
T Consensus 220 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 220 ---LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred ---CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 111233456778999999999999999999999864
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=303.87 Aligned_cols=254 Identities=25% Similarity=0.391 Sum_probs=205.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||.||+|... +++.+|+|++...... ..+.+.+|++++++++||||+++++++..++..|++|||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 57889999999999999999764 5788999998765443 567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++... ..+++.++..++.|++.|++|||+. +++|+||+|+||++++++.+||+|||.+....... .
T Consensus 82 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~ 156 (262)
T cd06613 82 CGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-A 156 (262)
T ss_pred CCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh-h
Confidence 99999999987652 3488999999999999999999999 99999999999999999999999999987654321 1
Q ss_pred cccCCcccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTC---RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
......++..|+|||.+... .++.++||||||+++|||++|+.||...... .. ... ...... ..
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~-------~~-~~~-~~~~~~----~~ 223 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM-------RA-LFL-ISKSNF----PP 223 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH-------HH-HHH-HHhccC----CC
Confidence 22345678899999999776 7889999999999999999999998632210 00 000 111100 00
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+.++.+++.+||..+|.+||++.+|+++
T Consensus 224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 224 -PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred -ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0011233456779999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=338.84 Aligned_cols=262 Identities=23% Similarity=0.386 Sum_probs=217.5
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEe
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRA 888 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 888 (1103)
...++..+.+.+|+|+||.|++|... ....||||+.+......+.+.+..|+++|+.+ +|+||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33445566679999999999999533 14679999999888878889999999999999 6999999999999
Q ss_pred cCCeEEEEEeecCCCChHHHHHhhc------------C--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcE
Q 043720 889 SGNEMFLIYNYLPGGNLENFIKART------------S--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNI 954 (1103)
Q Consensus 889 ~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NI 954 (1103)
+.+..++|+||+..|+|.+|++..+ . ..++..+++.++.|||.||+||++. ++||||+.++||
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNV 449 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNV 449 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhE
Confidence 9999999999999999999998866 0 1388999999999999999999999 999999999999
Q ss_pred EECCCCCEEEeecccccccCCCCCccccCCc--ccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043720 955 LLDDDFNAYLSDFGLSRLLGTSETHATTGVA--GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032 (1103)
Q Consensus 955 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~--g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 1032 (1103)
|++++..+||+|||+|+.......+...... -+..|||||.+....|+.|+|||||||++|||+|.+.+.++....
T Consensus 450 Li~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-- 527 (609)
T KOG0200|consen 450 LITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-- 527 (609)
T ss_pred EecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc--
Confidence 9999999999999999977655555433222 355799999999999999999999999999999955444432110
Q ss_pred CCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
.... .+.+....+...|..+..+++++|+.||+.+|++||+++++.+.++..
T Consensus 528 ----~~~l----------~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 528 ----TEEL----------LEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ----HHHH----------HHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 0111 112333445567888899999999999999999999999999999884
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=305.20 Aligned_cols=254 Identities=24% Similarity=0.429 Sum_probs=203.0
Q ss_pred CCCCcceeccCCcccEEEEEEcC--CcEEEEEEccccc---------chhhHHHHHHHHHHHhc-CCCCceeEEEeEEec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP--GILVAVKKLAVGR---------FQHGVQQFHAEIKTLGN-VRHPNLVTLIGYRAS 889 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 889 (1103)
.|++.+.||+|+||+||+|.... ++.+|+|.+.... ......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788899999999999997765 6889999886432 22344567788888865 799999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 890 GNEMFLIYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
++..++||||+++++|.+++... ....+++..+++++.|++.|+.|||+ . +++|+||+|+||+++.++.+|++|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 23458899999999999999999996 5 899999999999999999999999
Q ss_pred cccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
||.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..... ........
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~--------~~~~~~~~- 226 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM--------LSLATKIV- 226 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH--------HHHHHHHh-
Confidence 99998654332 33445688899999999988899999999999999999999999863211 11111111
Q ss_pred cCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
... .........+..+.+++.+||+.||++||++.|+.+++++
T Consensus 227 ~~~--------~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 227 EAV--------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred hcc--------CCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 111 1111112345779999999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=304.85 Aligned_cols=261 Identities=25% Similarity=0.364 Sum_probs=204.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 897 (1103)
++|+..+.||.|++|.||+|... +++.||+|.+...........+.+|++++++++||||+++++++.. .+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36788899999999999999764 5889999998866555566789999999999999999999998865 34789999
Q ss_pred eecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||+++++|.+++... ....+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999987642 234578899999999999999999999 999999999999999999999999999875432
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.. .....++..|+|||.+.+..++.++||||+|+++|||++|+.||+..............+. .... ... +.
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~-~~~-~~ 229 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI---VNMP-NPE-LK 229 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH---hcCC-chh-hc
Confidence 21 1234567899999999988999999999999999999999999985433111111211221 1101 000 00
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. .......+..+.+++.+||+.+|++||++.|++++
T Consensus 230 ~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~ 266 (287)
T cd06621 230 DE--PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH 266 (287)
T ss_pred cC--CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence 00 01112346779999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=319.31 Aligned_cols=266 Identities=23% Similarity=0.280 Sum_probs=198.0
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------ 890 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 890 (1103)
..++|++.+.||+|+||.||+|... .++.||||++..... ....+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3568999999999999999999654 588999999876432 33456788999999999999999999987543
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
...|+||||++ +++.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 35799999996 478877753 278889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-------CcchHHHH--
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD-------GFNIISWA-- 1041 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~-- 1041 (1103)
+..... .......+++.|+|||++.+..++.++|||||||++|||++|+.||........- ......+.
T Consensus 174 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (364)
T cd07875 174 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK 251 (364)
T ss_pred cccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence 865322 2223456899999999999999999999999999999999999999643210000 00000000
Q ss_pred -----HHHHhc-Ccccc-----cccccc---cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1042 -----SMLLRQ-GQVKD-----VFNAEL---WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1042 -----~~~~~~-~~~~~-----~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...... ..... .+.... ...........+.+++.+|++.||++|||+.|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00000 000000 000111224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=311.37 Aligned_cols=254 Identities=24% Similarity=0.416 Sum_probs=203.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... .+..||+|.+...........+.+|+.++++++|+||+++++++...+..|+||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999766 68999999987654444567889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhc-CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKART-SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
+++++|.++++... ...+++..+.+++.+++.|+.|||+.+ +|+||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 99999999987642 235899999999999999999999632 8999999999999999999999999998765322
Q ss_pred ccccCCcccccccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 979 HATTGVAGTFGYVAPEYALTC------RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
......+++.|+|||.+.+. .++.++||||+||++|||++|+.||..... .....-..... ..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~-~~---- 225 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETY-----ANIFAQLSAIV-DG---- 225 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcch-----hhHHHHHHHHh-hc----
Confidence 12234578899999998544 347899999999999999999999863211 00010011000 01
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+.++.+++.+|++.+|++||++.+++++
T Consensus 226 -----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 226 -----DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred -----CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 0112234466789999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=311.42 Aligned_cols=195 Identities=26% Similarity=0.428 Sum_probs=160.5
Q ss_pred cceeccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeEEEEEeec
Q 043720 826 SNCIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEMFLIYNYL 900 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~E~~ 900 (1103)
...||+|+||+||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++|+||+
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 357999999999999765 35789999886543 23457789999999999999999998854 56789999999
Q ss_pred CCCChHHHHHhhc-------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE----CCCCCEEEeeccc
Q 043720 901 PGGNLENFIKART-------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGL 969 (1103)
Q Consensus 901 ~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgl 969 (1103)
+ ++|.+++.... ...+++..+.+++.|++.||+|||+. +|+||||||+||++ ++++.+||+|||+
T Consensus 83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 E-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred C-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 6 58888875321 23478899999999999999999999 99999999999999 5667899999999
Q ss_pred ccccCCCCCc--cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 043720 970 SRLLGTSETH--ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPS 1027 (1103)
Q Consensus 970 a~~~~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~ 1027 (1103)
++........ ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9876433221 2234568999999999876 45789999999999999999999999743
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=309.63 Aligned_cols=260 Identities=24% Similarity=0.351 Sum_probs=202.1
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEe---
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRA--- 888 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~--- 888 (1103)
+.+.++.++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 11 ~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 11 DSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD--IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred ecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc--hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 344556789999999999999999999654 578999998764322 235678899999999 6999999999873
Q ss_pred --cCCeEEEEEeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEE
Q 043720 889 --SGNEMFLIYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYL 964 (1103)
Q Consensus 889 --~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 964 (1103)
.++..++||||+++++|.++++.. ....+++..+..++.|+++|+.|||+. +++||||||+||++++++.+|+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence 345789999999999999988642 234588899999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHH
Q 043720 965 SDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIIS 1039 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 1039 (1103)
+|||+++..... ........|++.|+|||++. ...++.++||||+||++|||++|+.||...... ..
T Consensus 166 ~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~-------~~ 237 (286)
T cd06638 166 VDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM-------RA 237 (286)
T ss_pred ccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh-------HH
Confidence 999998765332 22233446889999999875 345788999999999999999999998743210 00
Q ss_pred HHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
. .... ...... ...+...+..+.+++.+||+.||++||++.|++++.
T Consensus 238 ~----~~~~---~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 L----FKIP---RNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred H----hhcc---ccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 0 0000 000000 111223446799999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=305.76 Aligned_cols=239 Identities=23% Similarity=0.312 Sum_probs=186.8
Q ss_pred eeccCCcccEEEEEEcC-------------------------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeE
Q 043720 828 CIGSGGFGTTYKAEISP-------------------------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 882 (1103)
.||+|+||.||+|.+.. ...||+|++..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 59999999999996421 23588888865432 23467888999999999999999
Q ss_pred EEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC--
Q 043720 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-- 960 (1103)
Q Consensus 883 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-- 960 (1103)
+++++......++||||+++|+|..+++... ..+++..+.+++.|+++||+|||++ +|+||||||+||++++.+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999987543 3588999999999999999999999 999999999999997643
Q ss_pred -----CEEEeecccccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHH-hCCCCCCCCCCCCCC
Q 043720 961 -----NAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELI-SDKKALDPSFSSHGD 1033 (1103)
Q Consensus 961 -----~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~ell-tg~~p~~~~~~~~~~ 1033 (1103)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++|||+ +|+.||......
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--- 228 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS--- 228 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH---
Confidence 3899999987643211 22346788999998865 56889999999999999995 688887632211
Q ss_pred CcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1034 GFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
....+ ... .. ..+......+.+++.+||+.+|++||++++|++.|+
T Consensus 229 --~~~~~----~~~---------~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 --EKERF----YEK---------KH--RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred --HHHHH----HHh---------cc--CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 00111 100 00 111223356899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=305.94 Aligned_cols=252 Identities=24% Similarity=0.387 Sum_probs=201.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.|++.+.||+|+||.||+|... ++..||+|++.... ....+.+.+|+.+++.++|+||+++++++..++..|+||||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 56889999999999999999765 48899999987543 33567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|..++.+.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++...... ..
T Consensus 91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 99999998886543 4589999999999999999999999 9999999999999999999999999998754322 12
Q ss_pred cccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
......+++.|+|||++. ...++.++|||||||++|||++|+.||..... ...........
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--------~~~~~~~~~~~------ 231 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSE------ 231 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--------HHHHHHHhcCC------
Confidence 223445788999999884 44567899999999999999999999863211 11111111110
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+. ...+...+.++.+++.+||+.+|++||++.|++++
T Consensus 232 ~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 PPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred Ccc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 000 11233455678999999999999999999999863
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=302.90 Aligned_cols=251 Identities=24% Similarity=0.352 Sum_probs=199.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc----hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 893 (1103)
.+|++.+.||+|+||.||+|... ++..||||++..... ....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 46889999999999999999664 589999998864321 23456788999999999999999999988663 568
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++++|.+++.... .+++..+.+++.|++.||+|||++ +++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999997653 378888999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 974 GTSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 974 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
..... .......++..|+|||.+.+..++.++||||||+++|||++|+.||..... .... ......
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-------~~~~-~~~~~~---- 224 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEA-------MAAI-FKIATQ---- 224 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccch-------HHHH-HHHhcC----
Confidence 32211 122334678899999999888899999999999999999999999863211 0111 111000
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+......+.+++.+|+. +|++||+++|++++
T Consensus 225 -----~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 -----PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 11112244556678899999994 99999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=329.70 Aligned_cols=266 Identities=21% Similarity=0.242 Sum_probs=191.1
Q ss_pred HHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC------CCceeEEEeEEec
Q 043720 817 IRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR------HPNLVTLIGYRAS 889 (1103)
Q Consensus 817 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 889 (1103)
....++|++.+.||+|+||+||+|... .++.||||+++... .....+..|+.+++.++ |.+++++++++..
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 345678999999999999999999654 57889999986432 12334555666666654 4568999998876
Q ss_pred C-CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCC-------
Q 043720 890 G-NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDF------- 960 (1103)
Q Consensus 890 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~------- 960 (1103)
. +.+|+|||++ +++|.+++.+.. .+++..+..|+.||+.||+|||+ . +||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccc
Confidence 4 5789999988 778999887653 48999999999999999999997 6 999999999999998765
Q ss_pred ---------CEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043720 961 ---------NAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSH 1031 (1103)
Q Consensus 961 ---------~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 1031 (1103)
.+||+|||.+.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||+......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~ 352 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352 (467)
T ss_pred ccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 49999999876432 22345678999999999999999999999999999999999999997432100
Q ss_pred CCC-------cchHHHHHH--------HHh-cCccccccccccc----C-C--CChhHHHHHHHHHHHccccCCCCCCCH
Q 043720 1032 GDG-------FNIISWASM--------LLR-QGQVKDVFNAELW----A-S--GPHDDLEDMLHLALRCTVETLSTRPTM 1088 (1103)
Q Consensus 1032 ~~~-------~~~~~~~~~--------~~~-~~~~~~~~~~~~~----~-~--~~~~~~~~l~~li~~cl~~dP~~RPs~ 1088 (1103)
... .....|... ... ........++... . . ........+.+||.+||+.||++|||+
T Consensus 353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta 432 (467)
T PTZ00284 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA 432 (467)
T ss_pred HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence 000 000001100 000 0000000000000 0 0 000113557899999999999999999
Q ss_pred HHHHHH
Q 043720 1089 KQVVQC 1094 (1103)
Q Consensus 1089 ~evl~~ 1094 (1103)
+|++++
T Consensus 433 ~e~L~H 438 (467)
T PTZ00284 433 RQMTTH 438 (467)
T ss_pred HHHhcC
Confidence 999974
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=304.87 Aligned_cols=249 Identities=24% Similarity=0.406 Sum_probs=202.5
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC---CCceeEEEeEEecCCeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR---HPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.|+..+.||+|+||.||+|.. .+++.||+|++.........+++.+|+.++++++ |||++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999975 5689999999877655556678889999999986 999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++.. .+++..+..++.+++.|+.|||+. +++||||+|+||++++++.++++|||++.......
T Consensus 82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155 (277)
T ss_pred ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence 999999999998754 489999999999999999999999 99999999999999999999999999998765433
Q ss_pred CccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||...... .+... ......+
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--------~~~~~------~~~~~~~ 220 (277)
T cd06917 156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF--------RAMML------IPKSKPP 220 (277)
T ss_pred -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh--------hhhhc------cccCCCC
Confidence 223344688899999988654 4688999999999999999999998743211 11100 0000001
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... ....+.++.+++.+||+.||++||++.|++++
T Consensus 221 ~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 110 11255789999999999999999999999864
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=305.50 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=203.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... ++..||+|++.... ....+.+.+|+.++++++|+||+++++++..+...|+||||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES-EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 46888999999999999999764 58899999987543 33457788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.... ..+++..+.+++.|++.|+.|||+. +|+|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~ 158 (280)
T cd06611 84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q 158 (280)
T ss_pred cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence 99999999987643 3589999999999999999999999 99999999999999999999999999987653222 2
Q ss_pred cccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
......+++.|+|||.+. ...++.++||||||+++|||++|+.||..... ........ ....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~---- 225 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--------MRVLLKIL-KSEP---- 225 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--------HHHHHHHh-cCCC----
Confidence 223456789999999874 34567899999999999999999999873211 11111111 1100
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+ ....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 226 -~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 -P--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -C--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0 011233455678999999999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=310.33 Aligned_cols=261 Identities=22% Similarity=0.358 Sum_probs=201.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|+..+.||+|+||.||+|..+ +++.||+|++....... ..+.+.+|+++++.++||||+++++++..++..|+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36888999999999999999775 58999999986544332 35678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++++++.++..... .+++.++..++.|+++|++|||+. +++||||+|+||++++++.++++|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~- 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 154 (286)
T ss_pred cCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence 999999988776533 389999999999999999999999 99999999999999999999999999987654332
Q ss_pred ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc----c-
Q 043720 979 HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK----D- 1052 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~- 1052 (1103)
.......++..|+|||++.+ ..++.++||||||+++|||++|+.||..... ...+.......+... .
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 227 (286)
T cd07846 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD-------IDQLYHIIKCLGNLIPRHQEI 227 (286)
T ss_pred cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch-------HHHHHHHHHHhCCCchhhHHH
Confidence 22234567889999999865 4578899999999999999999988863221 111111000000000 0
Q ss_pred ---------ccccccc-----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 ---------VFNAELW-----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ---------~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+... .......+..+.+++.+||+.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 228 FQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000 00122456779999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=316.92 Aligned_cols=262 Identities=22% Similarity=0.328 Sum_probs=196.8
Q ss_pred HHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG----- 890 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 890 (1103)
...++|++.+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 3457899999999999999999965 4678999999875432 22345677899999999999999999887543
Q ss_pred -CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 891 -NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 891 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
...|+++|++ +++|.++++.. .+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCcc
Confidence 4579999998 78999888643 389999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH----
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML---- 1044 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 1044 (1103)
++.... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||...... .....+....
T Consensus 165 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~ 236 (343)
T cd07878 165 ARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIMEVVGTPS 236 (343)
T ss_pred ceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCC
Confidence 986532 2234568999999999876 56889999999999999999999998643210 0000000000
Q ss_pred ------HhcCcccccccc------cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 ------LRQGQVKDVFNA------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 ------~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
............ .............+.+++.+|++.||++|||++|++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 237 PEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000 00000001223457899999999999999999999965
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.23 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=204.1
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..+.||+|+||.||+|... +++.||+|+++..... ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4788899999999999999654 6889999998766543 4577899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.... .+++..+..++.++++|++|||+. +++|+||+|+||++++++.+||+|||++.........
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~ 155 (264)
T cd06626 81 CSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT 155 (264)
T ss_pred CCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence 99999999998643 378899999999999999999999 9999999999999999999999999998876443332
Q ss_pred cc---cCCcccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 980 AT---TGVAGTFGYVAPEYALTCR---VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 980 ~~---~~~~g~~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.. ....+++.|+|||++.+.. ++.++||||||+++||+++|+.||..... .+.........
T Consensus 156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~---------~~~~~~~~~~~---- 222 (264)
T cd06626 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN---------EFQIMFHVGAG---- 222 (264)
T ss_pred ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc---------hHHHHHHHhcC----
Confidence 22 2356788999999998766 88899999999999999999999963221 01111100000
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+........+.+++.+|++.+|++||++.|++.+
T Consensus 223 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 --HKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred --CCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000011122336778899999999999999999998753
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=309.75 Aligned_cols=263 Identities=23% Similarity=0.328 Sum_probs=199.0
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..+.||+|+||.||+|... +|+.||+|++...... .....+.+|+.++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4778899999999999999765 5889999998764332 2235677899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
++ ++|.+++.... ..+++..+..++.||++||.|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~- 154 (284)
T cd07839 81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR- 154 (284)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence 96 58888887543 3489999999999999999999999 999999999999999999999999999986543222
Q ss_pred cccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh------------
Q 043720 980 ATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR------------ 1046 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------ 1046 (1103)
......+++.|+|||++.+. .++.++|||||||++|||++|+.|+....... ...........
T Consensus 155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07839 155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD----DQLKRIFRLLGTPTEESWPGVSK 230 (284)
T ss_pred CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH----HHHHHHHHHhCCCChHHhHHhhh
Confidence 22334578899999998764 46889999999999999999999875432210 00000000000
Q ss_pred cCccccc--cc-ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDV--FN-AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~--~~-~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....... .. ...+.........++.+++.+|++.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 231 LPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 0000000 00 000011122345778899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.85 Aligned_cols=264 Identities=22% Similarity=0.349 Sum_probs=198.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|+..+.||+|++|+||+|... +++.||||.+...........+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999765 68899999987654433345577899999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+. ++|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 85 LD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred CC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 97 59999987654 3588999999999999999999999 999999999999999999999999999875432211
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc-----------
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ----------- 1047 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 1047 (1103)
......++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... ............
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE----DQLHKIFRVLGTPTEETWPGVSS 234 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH----HHHHHHHHhcCCCChhhhhhhhh
Confidence 1122346789999998865 457889999999999999999999986432100 000000000000
Q ss_pred -Cccccc----c-cccccCCC-ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 -GQVKDV----F-NAELWASG-PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 -~~~~~~----~-~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...... . ........ .......+.+++.+|++.+|++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 235 NPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred ccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 000000 0 00000000 01112677899999999999999999998763
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=304.70 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=200.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|+..+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36888999999999999999766 5899999998754332 234567899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++++++..+++... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 155 (286)
T cd07847 81 YCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155 (286)
T ss_pred ccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence 999988888776433 489999999999999999999999 999999999999999999999999999987643321
Q ss_pred ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH----------HHhc
Q 043720 979 HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM----------LLRQ 1047 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----------~~~~ 1047 (1103)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||....... ........ ....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 230 (286)
T cd07847 156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVD----QLYLIRKTLGDLIPRHQQIFST 230 (286)
T ss_pred -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCChHHhhhccc
Confidence 2223457789999999865 557889999999999999999999986432110 00000000 0000
Q ss_pred Ccc-cccccccccCC-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQV-KDVFNAELWAS-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~-~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... .....+..... .....+..+.+++.+||+.+|++||++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 231 NQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 000 00000000000 011235678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=305.14 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=204.1
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
-|+..+.||+|+||.||+|... ++..||+|++.........+.+.+|+.++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 4778889999999999999654 688999999876555555678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.+++... .+++..+..++.+++.|+.|||+. +++|+||+|+||+++.++.++++|||++....... ..
T Consensus 85 ~~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06641 85 GGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch-hh
Confidence 999999998753 388999999999999999999999 99999999999999999999999999987653322 12
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....++..|+|||++.+..++.++|||||||++|+|++|..||..... ..+.... .... ..
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~-~~~~---------~~ 219 (277)
T cd06641 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP--------MKVLFLI-PKNN---------PP 219 (277)
T ss_pred hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch--------HHHHHHH-hcCC---------CC
Confidence 2334678899999999888889999999999999999999999863211 1111111 1110 11
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+..+.+++.+|++.+|++||++++++++
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1233456778999999999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=304.01 Aligned_cols=255 Identities=23% Similarity=0.421 Sum_probs=200.0
Q ss_pred CCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC------
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------ 891 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 891 (1103)
|.+.+.||+|+||+||+|... .++.||||++..... ....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566788999999999999653 368899999876543 334667889999999999999999999875532
Q ss_pred eEEEEEeecCCCChHHHHHhhc----CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 892 EMFLIYNYLPGGNLENFIKART----SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
..++++||+.+|+|.+++.... ...+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 3478999999999999875422 12478899999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 968 GLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 968 gla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
|.++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||..... . .......
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~-----~---~~~~~~~ 229 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN-----S---EIYNYLI 229 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH-----H---HHHHHHH
Confidence 999866433221 1222345678999999998889999999999999999999 7777752211 1 1111111
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
.... ...+...+..+.+++.+|++.+|++||++.|+++.|+++
T Consensus 230 ~~~~----------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 230 KGNR----------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred cCCc----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1110 111234557899999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=304.48 Aligned_cols=261 Identities=25% Similarity=0.354 Sum_probs=203.0
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4788899999999999999764 689999999876553 33456789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+ +++|.++++... ..+++.++..++.|+++|++|||+. +++|+||+|+||+++.++.++++|||++.........
T Consensus 81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155 (286)
T ss_pred c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence 9 999999987644 4589999999999999999999999 9999999999999999999999999999876543322
Q ss_pred cccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc---------
Q 043720 980 ATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ--------- 1049 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 1049 (1103)
......++..|+|||.+.+. .++.++||||+|+++|||++|.++|..... ...+.......+.
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-------IEQLAIVFRTLGTPNEETWPGL 228 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-------HHHHHHHHHHcCCCChHHHhhc
Confidence 23345688999999998654 468899999999999999999777653211 1111111000000
Q ss_pred --cc---ccccccc----cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 --VK---DVFNAEL----WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 --~~---~~~~~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ....... ........+..+.+++.+|+..+|++||++++++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 0000000 000112345789999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.20 Aligned_cols=250 Identities=24% Similarity=0.400 Sum_probs=199.4
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
|++.+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+.+++.++|||++++++++..++..++|+||++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~ 85 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA 85 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence 677888999999999999765 47788999886543 3346778899999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+++|..++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+|++|||++...... ....
T Consensus 86 ~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 86 GGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred CCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 999999886532 4589999999999999999999999 9999999999999999999999999998764322 1222
Q ss_pred cCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 982 TGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
....+++.|+|||++. ...++.++|||||||++|||++|+.||..... ............ .
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~~------~ 226 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--------MRVLLKIAKSEP------P 226 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--------HHHHHHHhhcCC------C
Confidence 3456889999999983 45577899999999999999999999863211 111111111100 0
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+...+..+.+++.+||+.+|++||++.+++++
T Consensus 227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 227 --TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred --CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 011233455789999999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=299.83 Aligned_cols=238 Identities=24% Similarity=0.345 Sum_probs=189.2
Q ss_pred ceeccCCcccEEEEEEcCCc-----------EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 827 NCIGSGGFGTTYKAEISPGI-----------LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
+.||+|+||.||+|...... .|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 35899999999999776432 5778876654332 5788999999999999999999999988 77899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-------CEEEeecc
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-------NAYLSDFG 968 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-------~~ki~Dfg 968 (1103)
||||+++|+|.++++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||
T Consensus 78 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 78 VEEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999987542 588999999999999999999999 999999999999999887 79999999
Q ss_pred cccccCCCCCccccCCcccccccCccccccC--CCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYALTC--RVSDKADVYSYGVVLLELISD-KKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
++..... .....++..|+|||++... .++.++||||||+++|||++| ..||..... . .+.....
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~-----~---~~~~~~~ 220 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS-----S---EKERFYQ 220 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCc-----h---hHHHHHh
Confidence 9986533 2233466789999998776 788999999999999999995 666653211 0 1111110
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
.. . ..+......+.+++.+||..+|++||++.|+++.|+
T Consensus 221 -~~--------~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 -DQ--------H---RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -cC--------C---CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 00 0 011111267899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.15 Aligned_cols=251 Identities=26% Similarity=0.457 Sum_probs=203.6
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV~ 897 (1103)
+|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+..|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999954 4678999999875433 3345678899999999999999999997754 45689999
Q ss_pred eecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHH-----hCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 898 NYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLH-----DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH-----~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
||+++++|.++++... ...+++..++.++.++++|++||| +. +++|+||+|+||+++.++.+|++|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997642 346899999999999999999999 76 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
........ ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.... ....... ....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~-~~~~-- 225 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN--------QLQLASK-IKEG-- 225 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC--------HHHHHHH-HhcC--
Confidence 87643322 1234468899999999998889999999999999999999999987322 1111111 1111
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+..+.+++.+|++.+|++||++.+|+++
T Consensus 226 -------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 226 -------KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred -------CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1112344566789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=304.36 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=200.4
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc---------hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF---------QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 891 (1103)
+|...+.||+|+||.||+|... +++.||+|.+..... ....+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4677889999999999999654 588999998864321 112356788999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
..++||||+++++|.++++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999998753 488999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCc-cccCCcccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 972 LLGTSETH-ATTGVAGTFGYVAPEYALTCR--VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 972 ~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
........ ......++..|+|||.+.... ++.++||||||+++||+++|..||..... ..... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-------~~~~~-~~~~~- 227 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA-------IAAMF-KLGNK- 227 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch-------HHHHH-Hhhcc-
Confidence 64322111 123446788999999987654 78899999999999999999999862211 11111 11111
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+... .....+..+.+++.+|+..+|++||++++|+++
T Consensus 228 ~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPD----VSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCcc----ccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 111111111 122356789999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=305.29 Aligned_cols=240 Identities=22% Similarity=0.318 Sum_probs=188.9
Q ss_pred ceeccCCcccEEEEEEcC--------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 827 NCIGSGGFGTTYKAEISP--------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
+.||+|+||+||+|.... ...||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 358999999999996542 2348888775432 3345678899999999999999999999999899999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC--------EEEeecccc
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN--------AYLSDFGLS 970 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~ki~Dfgla 970 (1103)
|+++|+|.++++... ..+++..+.+++.||+.|++|||++ +|+||||||+||+++.++. ++++|||.+
T Consensus 80 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 80 YVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred cCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999998654 3588999999999999999999999 9999999999999987765 699999988
Q ss_pred cccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCC-CCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKK-ALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|+. |+..... ..... ....
T Consensus 156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~--------~~~~~-~~~~- 220 (258)
T cd05078 156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS--------QKKLQ-FYED- 220 (258)
T ss_pred cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH--------HHHHH-HHHc-
Confidence 65432 123456789999999976 457889999999999999999964 4331110 00000 0000
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
....+.....++.+++.+||+.+|++||+++++++.|+
T Consensus 221 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 ----------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ----------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11223334467899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=305.40 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=203.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888999999999999999765 578999999876433 3345778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++++.+..+.+.. ..+++.++..++.+++.|++|||+. +++|||++|+||++++++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 99887676655443 3489999999999999999999999 999999999999999999999999999987654443
Q ss_pred ccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH------------
Q 043720 979 HATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL------------ 1045 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 1045 (1103)
.......++..|+|||++.+. .++.++||||||+++|+|++|+.||...... ..........
T Consensus 156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T cd07833 156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDI-----DQLYLIQKCLGPLPPSHQELFS 230 (288)
T ss_pred ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHhCCCCHHHhhhcc
Confidence 233445678899999999887 8899999999999999999999988633211 0000000000
Q ss_pred hcCcc-----ccccccc-ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQV-----KDVFNAE-LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~-----~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..... ....+.. ....++...+.++.++|++||..+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 231 SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred cCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 00000 0000000 0001122346889999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=306.31 Aligned_cols=252 Identities=26% Similarity=0.398 Sum_probs=195.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHH-HhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKT-LGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||.||+|... +|+.||+|++......+....+..|+.. ++..+||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 36888999999999999999765 5899999998765444344556666664 666789999999999999999999999
Q ss_pred ecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 899 YLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|++ |+|.++++.. ....+++..++.++.|++.|++|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6898888653 2246899999999999999999999853 8999999999999999999999999998765322
Q ss_pred CCccccCCcccccccCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALT----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||..... . ......... ...
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~---~~~~~~~~~-~~~-- 225 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT----P---FQQLKQVVE-EPS-- 225 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc----C---HHHHHHHHh-cCC--
Confidence 12233467889999998864 4568899999999999999999999863211 0 111111111 100
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
... .....+.++.+++.+||..+|++||+++++++
T Consensus 226 ---~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 ---PQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 11234577999999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=306.12 Aligned_cols=263 Identities=19% Similarity=0.282 Sum_probs=199.4
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++++|.+.+.||+|+||.||+|.. .+++.||+|++...........+.+|+.+++.++|+||+++++++..++..|+|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 346799999999999999999965 4688999999876654444456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+. +++.+++.... ..+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9995 68888776543 3478888999999999999999999 99999999999999999999999999987543221
Q ss_pred CccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh-cC-------
Q 043720 978 THATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR-QG------- 1048 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~------- 1048 (1103)
.......+++.|+|||.+.+. .++.++||||||+++|||++|+.||+..... ..-....+. .+
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~-------~~~~~~~~~~~~~~~~~~~ 229 (291)
T cd07870 158 -QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV-------FEQLEKIWTVLGVPTEDTW 229 (291)
T ss_pred -CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH-------HHHHHHHHHHcCCCChhhh
Confidence 122334568899999998754 5788999999999999999999999743221 000000000 00
Q ss_pred ----cccccccccccCC---------CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 ----QVKDVFNAELWAS---------GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 ----~~~~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
............. ........+.+++.+|+..||++|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 230 PGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred hhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 0000000000000 001124678899999999999999999998753
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=319.18 Aligned_cols=241 Identities=23% Similarity=0.298 Sum_probs=187.9
Q ss_pred eccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC---CCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV---RHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
||+|+||+||+|... +++.||||++..... ......+..|..++... .||+|+++++++......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999665 589999999865432 22334455666666655 699999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++....... ....
T Consensus 81 g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~ 154 (330)
T cd05586 81 GELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN 154 (330)
T ss_pred ChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence 99999987643 489999999999999999999999 99999999999999999999999999987542222 2233
Q ss_pred CCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 983 GVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
...|++.|+|||++.+. .++.++||||+||++|||++|+.||..... ....... ..+.. ..
T Consensus 155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~--------~~~~~~i-~~~~~------~~--- 216 (330)
T cd05586 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT--------QQMYRNI-AFGKV------RF--- 216 (330)
T ss_pred CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH--------HHHHHHH-HcCCC------CC---
Confidence 45789999999998754 478999999999999999999999973211 1111111 11110 00
Q ss_pred CChhHHHHHHHHHHHccccCCCCCC----CHHHHHH
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRP----TMKQVVQ 1093 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RP----s~~evl~ 1093 (1103)
........+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0112456788999999999999999 4566654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=300.43 Aligned_cols=253 Identities=26% Similarity=0.408 Sum_probs=209.3
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|++|.||+|... +++.||||++.........+.+.+|+..+.+++|+|++++++++...+..++|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999766 48999999988765545568899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
+++++|.+++... ..+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+........
T Consensus 81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~ 155 (264)
T cd06623 81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD 155 (264)
T ss_pred cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence 9999999999865 348999999999999999999999 8 999999999999999999999999999886643322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
. .....++..|+|||.+.+..++.++||||||+++|||++|+.||..... ....+.........
T Consensus 156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-----~~~~~~~~~~~~~~---------- 219 (264)
T cd06623 156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-----PSFFELMQAICDGP---------- 219 (264)
T ss_pred c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-----cCHHHHHHHHhcCC----------
Confidence 2 2234578899999999988999999999999999999999999874322 01111111111110
Q ss_pred cCCCChh-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHD-DLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.. .+..+.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0112223 56789999999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=307.20 Aligned_cols=262 Identities=25% Similarity=0.375 Sum_probs=203.9
Q ss_pred CCHHHHHHHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEe
Q 043720 811 LTYESIIRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRA 888 (1103)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 888 (1103)
++++++.++.++|++.+.||+|+||.||+|.. .+++.+|+|++..... ....+.+|+.+++++ +|||++++++++.
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 34455666788999999999999999999966 4688999999865322 245677899999998 7999999999886
Q ss_pred cC-----CeEEEEEeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC
Q 043720 889 SG-----NEMFLIYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961 (1103)
Q Consensus 889 ~~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 961 (1103)
.. +..++|+||+++++|.++++.. ....+++..+..++.|++.|++|||+. +++||||||+||++++++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence 53 4689999999999999998642 234589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCccccCCcccccccCccccccC-----CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 043720 962 AYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC-----RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFN 1036 (1103)
Q Consensus 962 ~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1103)
+||+|||++........ ......++..|+|||++... .++.++|||||||++|||++|+.||......
T Consensus 167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~------ 239 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV------ 239 (291)
T ss_pred EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH------
Confidence 99999999876543221 22334678899999987543 3678999999999999999999998632210
Q ss_pred hHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1037 IISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.-.... ....... ...+......+.++|.+||+.+|++||++.|++++
T Consensus 240 --~~~~~~-~~~~~~~-------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 240 --KTLFKI-PRNPPPT-------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHHHH-hcCCCCC-------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 001111 1111111 11123344679999999999999999999999874
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=289.61 Aligned_cols=265 Identities=24% Similarity=0.345 Sum_probs=221.5
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEE
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 887 (1103)
+++.....+++....+-+|.||.||.|.|.+ .+.|-||.++....+-....+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444445667777789999999999996553 4668899998888887888899999999999999999999987
Q ss_pred ec-CCeEEEEEeecCCCChHHHHHh------hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC
Q 043720 888 AS-GNEMFLIYNYLPGGNLENFIKA------RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF 960 (1103)
Q Consensus 888 ~~-~~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~ 960 (1103)
.+ ....++++.++.-|+|..|++. ...+.++..++..++.|++.|++|||++ +|||.||.++|.+|++.-
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhhe
Confidence 55 4567889999999999999982 1224577889999999999999999999 999999999999999999
Q ss_pred CEEEeecccccccCCCCCcccc-CCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchH
Q 043720 961 NAYLSDFGLSRLLGTSETHATT-GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 961 ~~ki~Dfgla~~~~~~~~~~~~-~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~ 1038 (1103)
++|++|=.+++...+.+.+.-. ....+..||+||.+....|+.++|||||||++|||+| |+.|+..-++ +
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP-----f--- 505 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP-----F--- 505 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH-----H---
Confidence 9999999999998777665433 3345679999999999999999999999999999998 7777763221 1
Q ss_pred HHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1039 SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
++...+.+..+...|.+||+++..+|.-||..+|++||+++|++..|.++.
T Consensus 506 ----------Em~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 506 ----------EMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred ----------HHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 222333445566778999999999999999999999999999999999874
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=304.84 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=202.3
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCC----
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGN---- 891 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 891 (1103)
.++++|++.+.||+|+||.||+|... +++.|++|++..... ..+.+.+|+.+++++ .|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 35678999999999999999999765 578899999875543 346789999999999 6999999999986644
Q ss_pred --eEEEEEeecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 892 --EMFLIYNYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 892 --~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
..++||||+++++|.++++... +..+++..+..++.|++.|++|||+. +++|+||+|+||++++++.+|++||
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~ 157 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDF 157 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCC
Confidence 5899999999999999987644 45689999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccCCcccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHH
Q 043720 968 GLSRLLGTSETHATTGVAGTFGYVAPEYALT-----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWAS 1042 (1103)
Q Consensus 968 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1103)
|++...... ........++..|+|||++.. ..++.++||||||+++|+|++|+.||..... ... ..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~-~~ 228 (275)
T cd06608 158 GVSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP-------MRA-LF 228 (275)
T ss_pred ccceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch-------HHH-HH
Confidence 998765322 222334568889999998753 3467899999999999999999999863211 000 01
Q ss_pred HHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1043 MLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... .... +. ...+...+..+.+++.+|+..||++|||+.|++++
T Consensus 229 ~~~-~~~~-----~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 229 KIP-RNPP-----PT--LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred Hhh-ccCC-----CC--CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 111 1100 01 11123355789999999999999999999999863
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=301.55 Aligned_cols=254 Identities=23% Similarity=0.418 Sum_probs=203.3
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-----hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
+|+..+.||+|++|.||+|.. .+++.||+|++..... ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999964 5689999999875432 1235678999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLG 974 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~ 974 (1103)
|+||+++++|.++++... .+++..+..++.|++.|++|||++ +++|+||+|+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997643 488999999999999999999999 999999999999998776 59999999987764
Q ss_pred CCCCc---cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 975 TSETH---ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 975 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
..... ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||..... .............
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~---- 226 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKH-----SNHLALIFKIASA---- 226 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC-----cchHHHHHHHhcc----
Confidence 33211 12234678899999999888899999999999999999999999863221 1111111111000
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+.....++.+++.+|+..+|++||++.|++++
T Consensus 227 -----~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 -----TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -----CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 01112334556789999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=303.65 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=203.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 36888999999999999999665 589999999865432 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~- 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR- 154 (290)
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence 9999999999998753 489999999999999999999999 9999999999999999999999999999865433
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||..... ........ .+.
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~-------- 214 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP--------IQIYEKIL-EGK-------- 214 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-cCC--------
Confidence 2344688999999999888889999999999999999999999873221 11111111 110
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+..+.+++.+||..+|++|| +++|++++
T Consensus 215 --~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 --VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred --ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 112333467789999999999999999 77777643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-32 Score=304.38 Aligned_cols=256 Identities=23% Similarity=0.346 Sum_probs=201.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||.||++... .++.||+|.+..... ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36888999999999999999765 478999999876542 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++... .+++..+..++.+++.|++|||+. +++||||||+||+++.++.+|++|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~ 155 (305)
T cd05609 81 EYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155 (305)
T ss_pred ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence 9999999999997653 488999999999999999999999 99999999999999999999999999886421110
Q ss_pred C--------------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 978 T--------------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 978 ~--------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
. .......++..|+|||++....++.++||||||+++|||++|+.||..... ..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~--------~~~~~~ 227 (305)
T cd05609 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP--------EELFGQ 227 (305)
T ss_pred cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 0 011124578899999999888899999999999999999999999863211 111221
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
..... .. ........+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 228 ~~~~~-~~-------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDD-IE-------WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhcc-cC-------CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 11111 00 001112356778999999999999999997666555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=306.40 Aligned_cols=255 Identities=27% Similarity=0.387 Sum_probs=198.3
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..+.||+|+||+||++... +++.||+|++...........+.+|+..+.++. |+||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4666778999999999999654 589999999987655556678899999999996 99999999999999999999999
Q ss_pred cCCCChHHHHH---hhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 900 LPGGNLENFIK---ARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 900 ~~~gsL~~~l~---~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+. +++.++.. ......+++..+.+++.+++.|++|||+.. +++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 85 46655432 223355899999999999999999999632 8999999999999999999999999999765432
Q ss_pred CCccccCCcccccccCccccccC---CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTC---RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.. .....|+..|+|||++... .++.++||||+|+++|||++|+.||.... ........... .
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-------~~~~~~~~~~~-~----- 226 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-------SVFDQLTQVVK-G----- 226 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-------hHHHHHhhhcC-C-----
Confidence 21 2233578899999998766 68899999999999999999999986321 00111111100 0
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+..........+..+.+++.+||+.+|++||++.+|+++
T Consensus 227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 01111122223466789999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=304.41 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=203.5
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||.||+|.. .++..||+|.+...... ..+.+.+|+.++++++||||+++++++...+..|+|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP-KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch-HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 5789999999999999999965 46788999998654333 456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++.+.. +++.++..++.+++.|+.|||++ +++||||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~~---l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 98 LAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCCcHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 99999999997643 78899999999999999999999 999999999999999999999999998876543222
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......+++.|+|||.+....++.++||||||+++|++++|+.||........ .......+ ...
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--------~~~~~~~~--------~~~ 234 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--------LYLIATNG--------TPE 234 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--------eeehhcCC--------CCC
Confidence 22334678899999999888899999999999999999999999974322110 00000000 000
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||..+|++||++.+++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11223345678999999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-32 Score=297.09 Aligned_cols=251 Identities=24% Similarity=0.378 Sum_probs=204.4
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|...+.||+|+||.||+|... +|..||+|.+..... ....+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999665 578899999876432 22456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC-EEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN-AYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~ki~Dfgla~~~~~~~~ 978 (1103)
+++++|.+++.......+++..+..++.++++|++|||+. +++|+||+|+||++++++. +|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 9999999999876655689999999999999999999999 9999999999999998864 69999999876643221
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......|++.|+|||+..+..++.++||||||+++|||++|+.||.... ...+....... ..
T Consensus 158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~-~~-------- 219 (257)
T cd08225 158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN--------LHQLVLKICQG-YF-------- 219 (257)
T ss_pred -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHhcc-cC--------
Confidence 2233457889999999988889999999999999999999999986321 12222222111 10
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+..+.+++.+|+..+|++||++.|++++
T Consensus 220 -~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 220 -APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11123445679999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=297.84 Aligned_cols=247 Identities=25% Similarity=0.356 Sum_probs=205.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh--hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.+.|..-++||+|+||+||-+..+ +|..+|.|++.+.+.+. ...-...|..++.+++.++||.+--++...+..|+|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 356888899999999999999655 58999999987665432 345577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+..|.||+|.-++-...+..++++.+..+|.+|+.||++||+. .||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~- 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPE- 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCC-
Confidence 9999999999999887777899999999999999999999999 999999999999999999999999999997743
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc-ccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD-VFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1055 (1103)
.....+.+||.+|||||++.+..|+...|.||+||++|||+.|+.||..-.. -+.| ++++. +..
T Consensus 340 -g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke-------Kvk~-------eEvdrr~~~ 404 (591)
T KOG0986|consen 340 -GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE-------KVKR-------EEVDRRTLE 404 (591)
T ss_pred -CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh-------hhhH-------HHHHHHHhc
Confidence 3444556999999999999999999999999999999999999999972111 1111 11110 111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCC
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPT 1087 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1087 (1103)
.. ..++....++...+....++.||++|--
T Consensus 405 ~~--~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 DP--EEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred ch--hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 11 2345667788889999999999999963
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=338.93 Aligned_cols=277 Identities=28% Similarity=0.315 Sum_probs=168.1
Q ss_pred CCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccC
Q 043720 109 LRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188 (1103)
Q Consensus 109 L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (1103)
|+.|+|++|.+. .+|..+..+.+|+.|+++.|.+. ..|.+.+++.+|++|+|..|++. ..|.++..+.+|+.|+++.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 555566555554 55555555555666666665555 55555555556666666655555 5555555555566666666
Q ss_pred CcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccc
Q 043720 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268 (1103)
Q Consensus 189 n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 268 (1103)
|.+. .+|..+..++.+..+..++|.....++ . ..++.++|..|.+.+.++..+..++. .|+|++|.+..
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg----~--~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~-- 192 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRLG----Q--TSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV-- 192 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhhhc----c--ccchhhhhhhhhcccchhcchhhhhe--eeecccchhhh--
Confidence 5555 455555555555555555552111111 1 11555566666665555555555554 56666666541
Q ss_pred cccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhh
Q 043720 269 PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEIT 348 (1103)
Q Consensus 269 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~ 348 (1103)
-.+..+.+|+.|....|+++... -.-++|+.|+.+. |.++...+ -.
T Consensus 193 -~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~---------------------------n~l~~~~~--~p 238 (1081)
T KOG0618|consen 193 -LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADH---------------------------NPLTTLDV--HP 238 (1081)
T ss_pred -hhhhhccchhhhhhhhcccceEE----ecCcchheeeecc---------------------------Ccceeecc--cc
Confidence 23445556666666666654211 1223455555543 22221111 11
Q ss_pred ccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEE
Q 043720 349 TLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFD 428 (1103)
Q Consensus 349 ~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ 428 (1103)
.-.+|++++++.|++++ +|++++.+.+|+.|+..+|+|. ..|..+..+++|+.|++.+|++.-.++...++.+|+.||
T Consensus 239 ~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLd 316 (1081)
T KOG0618|consen 239 VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLD 316 (1081)
T ss_pred ccccceeeecchhhhhc-chHHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeee
Confidence 22578888888888884 4588888888999988888884 566777788888888888888887777777788888888
Q ss_pred ecCCccc
Q 043720 429 VSGNHMS 435 (1103)
Q Consensus 429 ls~N~l~ 435 (1103)
|..|+|.
T Consensus 317 L~~N~L~ 323 (1081)
T KOG0618|consen 317 LQSNNLP 323 (1081)
T ss_pred ehhcccc
Confidence 8888876
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-32 Score=302.05 Aligned_cols=268 Identities=24% Similarity=0.338 Sum_probs=200.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV 896 (1103)
++|+..+.||+|+||.||+|... +++.||+|.++.....+ ....+.+|+.++++++||||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999766 58899999997654332 234577899999999999999999998777 899999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
+||++ ++|.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159 (293)
T ss_pred ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence 99996 59999987644 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC--------cchHHHHHH--H-
Q 043720 977 ETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDG--------FNIISWASM--L- 1044 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~--------~~~~~~~~~--~- 1044 (1103)
.. ......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||.......... .....|... .
T Consensus 160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 21 22334568899999998754 46889999999999999999999987432110000 000000000 0
Q ss_pred -HhcCcccccccccccCCCChh-HHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 -LRQGQVKDVFNAELWASGPHD-DLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 -~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..................+.. ....+.+++.+|++.+|++||+++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 000000011111111112222 46778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=312.57 Aligned_cols=271 Identities=24% Similarity=0.343 Sum_probs=210.9
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC------eEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------EMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 894 (1103)
-|...+.||+|+||.||+|++ .+|+.||||.+.........+...+|++++++++|+|||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 355667899999999999984 5699999999988777777889999999999999999999999865543 568
Q ss_pred EEEeecCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC--CCCC--EEEeeccc
Q 043720 895 LIYNYLPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD--DDFN--AYLSDFGL 969 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~--~~~~--~ki~Dfgl 969 (1103)
+|||||.+|||+..+++-.+ ..+++.+++.+..+++.||.|||++ +||||||||.||++- ++|+ .||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999987544 5699999999999999999999999 999999999999984 3343 79999999
Q ss_pred ccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
|+.... .......+||..|.+||.... ..|+..+|.|||||++||..||..||.+..++..... ..|....-+..
T Consensus 171 Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~--~~~~~~tkkp~ 246 (732)
T KOG4250|consen 171 ARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKE--IMWHIITKKPS 246 (732)
T ss_pred cccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccch--hhhhhhccCCC
Confidence 997743 346778899999999999984 8889999999999999999999999987655432211 11211111111
Q ss_pred ccccccccc----cc----CCCC----hhHHHHHHHHHHHccccCCCCCC--CHHHHHHHHHhhh
Q 043720 1049 QVKDVFNAE----LW----ASGP----HDDLEDMLHLALRCTVETLSTRP--TMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1049 ~~~~~~~~~----~~----~~~~----~~~~~~l~~li~~cl~~dP~~RP--s~~evl~~L~~i~ 1099 (1103)
...-...+. +. .+++ ......+..++..++..+|++|. .+.+....+..|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 111111111 11 1112 23345567788899999999999 7777777777664
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=297.93 Aligned_cols=243 Identities=23% Similarity=0.323 Sum_probs=198.9
Q ss_pred eccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||.|+||.||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999765 488999999876543 23457799999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCc
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 985 (1103)
.+++.+.. .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+....... ......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~ 153 (262)
T cd05572 81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC 153 (262)
T ss_pred HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence 99998653 388999999999999999999999 99999999999999999999999999998664332 223346
Q ss_pred ccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChh
Q 043720 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065 (1103)
Q Consensus 986 g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1103)
+++.|+|||.+.+..++.++|+||+|+++|+|++|..||..... +......... ........+..
T Consensus 154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~~---------~~~~~~~~~~~ 218 (262)
T cd05572 154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE------DPMEIYNDIL---------KGNGKLEFPNY 218 (262)
T ss_pred CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC------CHHHHHHHHh---------ccCCCCCCCcc
Confidence 78899999999888899999999999999999999999974321 1111111111 11111223344
Q ss_pred HHHHHHHHHHHccccCCCCCCC-----HHHHHH
Q 043720 1066 DLEDMLHLALRCTVETLSTRPT-----MKQVVQ 1093 (1103)
Q Consensus 1066 ~~~~l~~li~~cl~~dP~~RPs-----~~evl~ 1093 (1103)
.+..+.+++.+||+.+|++||+ ++|+++
T Consensus 219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 4678999999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=325.06 Aligned_cols=267 Identities=19% Similarity=0.253 Sum_probs=190.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC--CcEEEEEE--------------ccc--ccchhhHHHHHHHHHHHhcCCCCcee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP--GILVAVKK--------------LAV--GRFQHGVQQFHAEIKTLGNVRHPNLV 881 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~E~~~l~~l~h~niv 881 (1103)
.++|++.+.||+|+||+||++..+. +..+++|. +.+ .........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999986542 22222221 100 01122345688999999999999999
Q ss_pred EEEeEEecCCeEEEEEeecCCCChHHHHHhhcC---CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC
Q 043720 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTS---RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD 958 (1103)
Q Consensus 882 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~ 958 (1103)
++++++...+..|+|+|++. +++.+++..... ......++..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 99999999999999999994 588887754321 1234567788999999999999999 9999999999999999
Q ss_pred CCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchH
Q 043720 959 DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 959 ~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1103)
++.+||+|||+++.+............|++.|+|||++.+..++.++|||||||++|||++|+.++....... ......
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~-~~~~~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK-PGKQLL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC-HHHHHH
Confidence 9999999999998775444444445679999999999999999999999999999999999986543221110 000111
Q ss_pred HHHH-----------------HHHhcCcccc---cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1039 SWAS-----------------MLLRQGQVKD---VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1039 ~~~~-----------------~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.... ..+....+.. .+...+ .....+.++.+++.+|++.||++||++.|++++
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h 454 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLI---RNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL 454 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHH---HhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 1000 0000000000 000000 001234567788999999999999999999874
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=305.34 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=198.9
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
|.....||+|+||.||++... ++..||||++.... ....+.+.+|+..++.++|+||+++++.+..++..|+||||++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 102 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE 102 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence 334466999999999999654 58899999986543 2345678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+++|.+++... .+++.++..++.||+.|++|||++ +|+||||||+||++++++.++|+|||++....... ...
T Consensus 103 ~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 175 (292)
T cd06658 103 GGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR 175 (292)
T ss_pred CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence 99999998643 388999999999999999999999 99999999999999999999999999987553222 222
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... . ..... .... +.... .
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~-----~---~~~~~-~~~~-----~~~~~--~ 239 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP-----L---QAMRR-IRDN-----LPPRV--K 239 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----H---HHHHH-HHhc-----CCCcc--c
Confidence 335678999999999888899999999999999999999999863211 0 11111 1110 11111 1
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........+.+++.+|+..||++||+++|++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 122345578899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-32 Score=301.20 Aligned_cols=253 Identities=25% Similarity=0.412 Sum_probs=206.0
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++.|+..+.||+|++|.||+|... ++..|++|++..... ..+.+.+|++.++.++|+|++++++++...+..|+|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 3456888899999999999999776 688999999876543 4577889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.+++.... ..+++..+..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 170 (286)
T cd06614 95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK 170 (286)
T ss_pred eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence 9999999999998764 3589999999999999999999999 99999999999999999999999999887653222
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......++..|+|||++.+..++.++||||||+++|+|++|+.||..... ........ ......
T Consensus 171 -~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~~----- 235 (286)
T cd06614 171 -SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP--------LRALFLIT-TKGIPP----- 235 (286)
T ss_pred -hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hcCCCC-----
Confidence 122334578899999999888899999999999999999999999863211 01111111 111100
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+..+.+++.+|++.+|.+||++.+++++
T Consensus 236 --~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 270 (286)
T cd06614 236 --LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH 270 (286)
T ss_pred --CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11122356779999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=303.29 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=199.7
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
|+....||+|+||.||+|... +++.||+|++...... ..+.+.+|+.+++.++|||++++++++..++..|+|+||++
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ-RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc-hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 334557999999999999654 6899999998654433 45678899999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||++....... ...
T Consensus 102 ~~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 102 GGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 99999987653 388999999999999999999999 99999999999999999999999999987553322 222
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
....++..|+|||++.+..++.++||||||+++|||++|+.||..... .. ... ....... ....
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-----~~---~~~-~~~~~~~-------~~~~ 238 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP-----VQ---AMK-RLRDSPP-------PKLK 238 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HH---HHH-HHhccCC-------CCcc
Confidence 345688999999999988899999999999999999999999863211 11 111 1111100 0011
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+..+.+++.+|++.+|++||++++++++
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 122345678999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.9e-32 Score=301.35 Aligned_cols=263 Identities=25% Similarity=0.387 Sum_probs=199.8
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..+.||+|+||.||+|... +++.||||++...... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4788899999999999999665 6889999998765432 2345788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+. ++|.+++.......+++..+..++.|++.|++|||+. +++||||+|+||++++++.+|++|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~- 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR- 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence 95 6899999876656689999999999999999999999 999999999999999999999999999876543221
Q ss_pred cccCCcccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc-----------
Q 043720 980 ATTGVAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ----------- 1047 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~----------- 1047 (1103)
......+++.|+|||++.+.. ++.++||||||+++|||+||+.||..... ..............
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE----IDQLFRIFRTLGTPDEVVWPGVTSL 231 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHhCCCChhhhhhhhHH
Confidence 122334678999999886644 58899999999999999999999863221 00011100000000
Q ss_pred ----CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 ----GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........... ..........+.+++.+|++.||++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 232 PDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 00000000000 00011234567899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=300.42 Aligned_cols=248 Identities=24% Similarity=0.318 Sum_probs=204.5
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
+|++.+.||+|+||.||+|... ++..||+|++..... ....+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788899999999999999765 589999999976432 2356789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.+++... ..+++.++..++.|+++|++|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 99999999999765 3489999999999999999999999 99999999999999999999999999988654322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ...+....... .
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~----------~ 217 (258)
T cd05578 155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT------IRDQIRAKQET----------A 217 (258)
T ss_pred -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc------HHHHHHHHhcc----------c
Confidence 223456788999999998888999999999999999999999998744321 11111111110 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCH--HHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTM--KQVV 1092 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~--~evl 1092 (1103)
....+...+..+.+++.+||+.||++||++ +|++
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 122344556889999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=302.83 Aligned_cols=248 Identities=25% Similarity=0.373 Sum_probs=198.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
..|+..+.||+|+||+||+|... +++.||+|++.... ..+..+++.+|+.+++.++||||+++.+++...+..|+|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999765 58899999886432 2334567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+. |++.+++.... ..+++..+..++.|++.|+.|||+. +|+||||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~- 168 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA- 168 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence 9996 68877776433 3489999999999999999999999 9999999999999999999999999998754321
Q ss_pred CccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 978 THATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
....+++.|+|||++. ...++.++||||||+++|||++|+.||..... ........ ....
T Consensus 169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~--------~~~~~~~~-~~~~---- 231 (307)
T cd06607 169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIA-QNDS---- 231 (307)
T ss_pred ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH--------HHHHHHHh-cCCC----
Confidence 2346788999999874 45688899999999999999999999863211 11111110 0000
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
........+..+.+++.+||+.+|++||++.+++++.
T Consensus 232 ----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 268 (307)
T cd06607 232 ----PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR 268 (307)
T ss_pred ----CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 0011223556799999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-35 Score=334.82 Aligned_cols=475 Identities=25% Similarity=0.307 Sum_probs=341.9
Q ss_pred cccCcccCCCCCCCEEEccCCCCcccCC-ccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCC
Q 043720 97 GKLSPLVGGLSELRVLSLPFNGFSGEFP-PEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSL 175 (1103)
Q Consensus 97 g~~~~~l~~l~~L~~L~L~~n~l~g~~p-~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 175 (1103)
..||..+-.-..++.|+++.|.+- ..| +.+.+.-+|+.|||++|+++ ..|..+..+.+|+.|+++.|.|. .+|.+.
T Consensus 11 ~~ip~~i~~~~~~~~ln~~~N~~l-~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~ 87 (1081)
T KOG0618|consen 11 ELIPEQILNNEALQILNLRRNSLL-SRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSC 87 (1081)
T ss_pred cccchhhccHHHHHhhhccccccc-cCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhh
Confidence 456666666666999999999765 333 23344556999999999998 89999999999999999999999 889999
Q ss_pred CCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC
Q 043720 176 RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR 255 (1103)
Q Consensus 176 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 255 (1103)
.++.+|++|.|.+|.+. ..|..+..+.+|++|++++|+|. .+|.-+... ..++.+..++|.... .++... ++
T Consensus 88 ~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~l-t~~~~~~~s~N~~~~----~lg~~~-ik 159 (1081)
T KOG0618|consen 88 SNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVL-TAEEELAASNNEKIQ----RLGQTS-IK 159 (1081)
T ss_pred hhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CCchhHHhh-hHHHHHhhhcchhhh----hhcccc-ch
Confidence 99999999999999998 78999999999999999999998 899888764 668899999993321 233333 88
Q ss_pred EEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCC
Q 043720 256 TLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGE 335 (1103)
Q Consensus 256 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 335 (1103)
.++|..|.+.+.++.++..+.. .|||++|.+. -..+.++.+|+.|....|....+.
T Consensus 160 ~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~------------------- 215 (1081)
T KOG0618|consen 160 KLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE------------------- 215 (1081)
T ss_pred hhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE-------------------
Confidence 8999999999988888888777 7999999987 245677777877777643221111
Q ss_pred CCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccc
Q 043720 336 KNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGEL 415 (1103)
Q Consensus 336 ~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~ 415 (1103)
-..++|+.|+.+.|.+....+. ..-.+|+++++++|++++.+ +++..+.+|+.++..+|+|+..+
T Consensus 216 ------------~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~~lp 280 (1081)
T KOG0618|consen 216 ------------ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRLVALP 280 (1081)
T ss_pred ------------ecCcchheeeeccCcceeeccc--cccccceeeecchhhhhcch-HHHHhcccceEecccchhHHhhH
Confidence 1236788888888888844332 22357888899999888766 88888888999998888887666
Q ss_pred cccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCC
Q 043720 416 DVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSG 495 (1103)
Q Consensus 416 ~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~ 495 (1103)
..+.....|+.+.+.+|.++- ||. .....+.+..++|..
T Consensus 281 ~ri~~~~~L~~l~~~~nel~y-ip~----------------------------------------~le~~~sL~tLdL~~ 319 (1081)
T KOG0618|consen 281 LRISRITSLVSLSAAYNELEY-IPP----------------------------------------FLEGLKSLRTLDLQS 319 (1081)
T ss_pred HHHhhhhhHHHHHhhhhhhhh-CCC----------------------------------------cccccceeeeeeehh
Confidence 666677778888888777762 221 122345566677777
Q ss_pred CccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECc
Q 043720 496 NNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDAS 575 (1103)
Q Consensus 496 n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~ 575 (1103)
|++.. +|..+|.-.. .....++.|.|.+. ..|..-....+.|+.|+|.
T Consensus 320 N~L~~------------------------------lp~~~l~v~~-~~l~~ln~s~n~l~-~lp~~~e~~~~~Lq~Lyla 367 (1081)
T KOG0618|consen 320 NNLPS------------------------------LPDNFLAVLN-ASLNTLNVSSNKLS-TLPSYEENNHAALQELYLA 367 (1081)
T ss_pred ccccc------------------------------cchHHHhhhh-HHHHHHhhhhcccc-ccccccchhhHHHHHHHHh
Confidence 77653 2222221111 11123445555554 3343222223567778888
Q ss_pred CCcCCCCCcccccCCCCCCEEEccCCcCCCCCCc-ccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCc
Q 043720 576 HNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGE 654 (1103)
Q Consensus 576 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 654 (1103)
+|.+++..-..+.+..+|+.|+|++|+|. .+|+ .+.++..|++|+||+|+++ .+|.++.++..|++|...+|+|. .
T Consensus 368 nN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~ 444 (1081)
T KOG0618|consen 368 NNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-S 444 (1081)
T ss_pred cCcccccchhhhccccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-e
Confidence 88887666667777778888888888877 4444 4577777888888888887 67777777788888888888877 5
Q ss_pred ChhhhhhcccccccccccccCcCC-CCccccCCCCCceEeCCCCCC
Q 043720 655 VPEGVVNLRNLTALLLDNNKLSGH-LPSGLANVTSLSIFNASFNNL 699 (1103)
Q Consensus 655 ~~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~l~l~~N~l 699 (1103)
.| .+.+++.|+.+|||.|+|+-. +|... ..++|++||+++|.-
T Consensus 445 fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 445 FP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNLKYLDLSGNTR 488 (1081)
T ss_pred ch-hhhhcCcceEEecccchhhhhhhhhhC-CCcccceeeccCCcc
Confidence 66 677777888888888877632 33332 226777777777764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-32 Score=324.53 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=194.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec--------
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-------- 889 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------- 889 (1103)
-..+|+..+.||+|+||.||+++.+ +|+.||||++...........+.+|+..+.+++|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3457888999999999999999776 7999999999887766667889999999999999999999732000
Q ss_pred ----------------------------------------------------------------------C---------
Q 043720 890 ----------------------------------------------------------------------G--------- 890 (1103)
Q Consensus 890 ----------------------------------------------------------------------~--------- 890 (1103)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh
Q 043720 891 --------------------------------NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938 (1103)
Q Consensus 891 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~ 938 (1103)
..+|+-||||+..+++++++++.-.. .....++++.+|++|+.|+|+
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH~ 715 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIHD 715 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHHh
Confidence 12689999999988888887654211 467889999999999999999
Q ss_pred CCCCCcccCCCCCCcEEECCCCCEEEeecccccccC-----------------CCCCccccCCcccccccCccccccC--
Q 043720 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG-----------------TSETHATTGVAGTFGYVAPEYALTC-- 999 (1103)
Q Consensus 939 ~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~-----------------~~~~~~~~~~~g~~~y~aPE~~~~~-- 999 (1103)
+ +||||||||.||++++++.|||+|||+|.... .+.....++.+||.-|+|||++.+.
T Consensus 716 ~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 716 Q---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred C---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 9 99999999999999999999999999998721 0111234567899999999999654
Q ss_pred -CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHcc
Q 043720 1000 -RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCT 1078 (1103)
Q Consensus 1000 -~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 1078 (1103)
.|+.|+|+||+||+++||+. ||...+.. ..... -.+.+.+... ..+..+....-.++|.+|+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER-------a~iL~-~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll 855 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEMLY---PFGTSMER-------ASILT-NLRKGSIPEP------ADFFDPEHPEEASLIRWLL 855 (1351)
T ss_pred ccccchhhhHHHHHHHHHHhc---cCCchHHH-------HHHHH-hcccCCCCCC------cccccccchHHHHHHHHHh
Confidence 49999999999999999994 56533220 11111 1111111111 1122233344578999999
Q ss_pred ccCCCCCCCHHHHHH
Q 043720 1079 VETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1079 ~~dP~~RPs~~evl~ 1093 (1103)
+.||.+||||.|++.
T Consensus 856 ~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 856 SHDPSKRPTATELLN 870 (1351)
T ss_pred cCCCccCCCHHHHhh
Confidence 999999999999985
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.2e-32 Score=300.66 Aligned_cols=264 Identities=22% Similarity=0.344 Sum_probs=201.3
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
+|+..+.||+|++|+||+|... +|..||||++.........+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4788999999999999999775 588999999987655545667788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhc-CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 901 PGGNLENFIKART-SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 901 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
++ +|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.++++|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 74 8999887643 24589999999999999999999999 999999999999999999999999999976533221
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHH-----------HHHhc
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWAS-----------MLLRQ 1047 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~ 1047 (1103)
......++..|+|||++.+ ..++.++||||||+++|||++|+.||...... ........ .....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE----DQLLKIFRIMGTPTESTWPGISQL 231 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhHHHHhcC
Confidence 2223456889999998865 45688999999999999999999998743211 00000000 00000
Q ss_pred Ccccccccc---cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQVKDVFNA---ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+.. ..........+..+.+++.+|++.||++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000000000 00001112345678899999999999999999999863
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=302.47 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=201.2
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
|+..+.||+|+||.||+|... ++..||+|++..... .+....+.+|+.++++++|+|++++++++..++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 777888999999999999754 588999999865432 23456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+. |++.+++.... ..+++.++..++.+++.|+.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---- 177 (317)
T cd06635 107 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP---- 177 (317)
T ss_pred CC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC----
Confidence 96 58888776543 4489999999999999999999999 999999999999999999999999998865432
Q ss_pred cccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.....+++.|+|||++. ...++.++|||||||++|||++|+.||..... ...........
T Consensus 178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~-------- 240 (317)
T cd06635 178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQNE-------- 240 (317)
T ss_pred -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--------HHHHHHHHhcc--------
Confidence 22345788999999873 45688899999999999999999999863211 11111111111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
.........+..+.+++.+|++.+|++||++.+++++...+...|
T Consensus 241 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 241 -SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred -CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 001112344567899999999999999999999999876554443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.7e-31 Score=297.55 Aligned_cols=249 Identities=23% Similarity=0.368 Sum_probs=200.8
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
.|...+.||+|++|.||+|.. .+++.|++|++..... ...+.+.+|+.+++.+.|+||+++++++...+..++|+||+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~ 98 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFL 98 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch-hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEecc
Confidence 355567899999999999965 4688999998865432 23566889999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+....... ..
T Consensus 99 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~ 171 (285)
T cd06648 99 EGGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PR 171 (285)
T ss_pred CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cc
Confidence 999999999763 388999999999999999999999 99999999999999999999999999887553222 22
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ .... +. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~--------~~~~~~~~-~~~~-----~~--~ 235 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP--------LQAMKRIR-DNLP-----PK--L 235 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH--------HHHHHHHH-hcCC-----CC--C
Confidence 2335688999999999888899999999999999999999999863211 11111111 1110 00 0
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+..+.+++.+||+.+|++||++.+++++
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 236 KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred cccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 1122355779999999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=300.69 Aligned_cols=263 Identities=27% Similarity=0.392 Sum_probs=199.7
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
|++.+.||.|++|+||+|... +|..||+|++......+ ....+.+|++++++++|||++++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 567889999999999999654 68999999987654332 3456888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
+ ++|.+++.......+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++++|||.+........ .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence 5 6999999876645689999999999999999999999 999999999999999999999999999976533221 1
Q ss_pred ccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH-----------hcC
Q 043720 981 TTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL-----------RQG 1048 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 1048 (1103)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||...... ........... ...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI----DQLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCChHHhhhhhhch
Confidence 2223568899999988664 5688999999999999999999998643210 00000000000 000
Q ss_pred ccccccc---ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 QVKDVFN---AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 ~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+. ...........+..+.+++.+|++.+|++||+++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000000 000011123345678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.9e-32 Score=298.26 Aligned_cols=245 Identities=25% Similarity=0.330 Sum_probs=196.1
Q ss_pred eccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||+|+||+||+|... +|+.||+|++..... ......+..|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999544 688999999865432 22345667899999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCc
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 985 (1103)
.+++.......+++.++..++.|++.|+.|||+. +++||||+|+||++++++.+|++|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 9999876655689999999999999999999999 999999999999999999999999999876533 22223446
Q ss_pred ccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChh
Q 043720 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065 (1103)
Q Consensus 986 g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1103)
++..|+|||++.+..++.++||||+|+++|+|++|+.||....... ..... . .... . .....+..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~-~----~~~~----~--~~~~~~~~ 220 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV----EKEEL-K----RRTL----E--MAVEYPDK 220 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc----cHHHH-H----hccc----c--ccccCCcc
Confidence 7889999999988889999999999999999999999986432210 00000 0 0000 0 01122334
Q ss_pred HHHHHHHHHHHccccCCCCCC-----CHHHHHH
Q 043720 1066 DLEDMLHLALRCTVETLSTRP-----TMKQVVQ 1093 (1103)
Q Consensus 1066 ~~~~l~~li~~cl~~dP~~RP-----s~~evl~ 1093 (1103)
.+..+.+++.+||+.+|++|| ++.++++
T Consensus 221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred CCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 567889999999999999999 6666764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=300.90 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=200.0
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch----hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ----HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
+|+..+.||+|+||.||+|... +++.||||++...... .....+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999764 5899999999765432 2235577899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+ +++|.++++... ..+++..+.+++.|+++||+|||++ +|+||||+|+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 899999997654 3589999999999999999999999 9999999999999999999999999999876443
Q ss_pred CCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH--------Hhc
Q 043720 977 ETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML--------LRQ 1047 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~~ 1047 (1103)
.. ......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|...... .......... ...
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI----DQLGKIFEALGTPTEENWPGV 230 (298)
T ss_pred Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccH----HHHHHHHHHcCCCchhhhhhc
Confidence 22 2223356788999998854 45788999999999999999997776532210 0000000000 000
Q ss_pred CcccccccccccCC-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQVKDVFNAELWAS-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.............. ........+.+++.+||+.+|++||+++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 00000000000000 112345778999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-31 Score=289.90 Aligned_cols=250 Identities=26% Similarity=0.440 Sum_probs=205.5
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
+|+..+.||+|++|.||+|... ++..+++|++..... ...+.+.+|+..++.++|++++++++++......++++||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 4778899999999999999775 688999999977654 35678999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.+++.... ..+++..+..++.+++.|++|||+. +++||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 80 SGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 9999999998753 3589999999999999999999998 999999999999999999999999999887644332
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ......... ......
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~~-~~~~~~------- 217 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP--------MKALFKIAT-NGPPGL------- 217 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch--------HHHHHHHHh-cCCCCc-------
Confidence 3345678899999999888899999999999999999999999873211 111111111 111110
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+..+.+++.+|++.||++||++.|++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1112235679999999999999999999999864
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=294.59 Aligned_cols=251 Identities=25% Similarity=0.448 Sum_probs=208.2
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|++.+.||+|+||.||++... ++..||+|++..... ....+.+.+|+++++.++|+|++++.+.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4778899999999999999665 588999999977544 24567788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 900 LPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
+++++|.++++... ...+++.++..++.+++.|++|||+. +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998753 35689999999999999999999999 99999999999999999999999999998764432
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......|++.|+|||...+..++.++||||+|+++|+|++|+.||.... ............
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~--------~~~~~~~~~~~~--------- 219 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN--------LLELALKILKGQ--------- 219 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc--------HHHHHHHHhcCC---------
Confidence 22334468889999999988889999999999999999999999986322 111122111111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+...+..+.+++.+||..+|++||++.|++++
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112233556789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=282.39 Aligned_cols=242 Identities=24% Similarity=0.312 Sum_probs=204.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|+..++||+|.||.|..++.+ +++.+|+|++++... +++++.-..|-.+++..+||.+..+.-.+...+..|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 467999999999999999999655 589999999987643 44567778899999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+.||.|.-.+.+.+ .+++...+.+-..|+.||.|||++ +||+||+|.+|.|+|++|++||+|||+++.- -.
T Consensus 247 MeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~-I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE-IK 320 (516)
T ss_pred EEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc-cc
Confidence 99999999998887643 489999999999999999999999 9999999999999999999999999999753 23
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......++|||.|+|||++....|..++|.|.+||++|||++|+.||+... ...+ ...+.. .
T Consensus 321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~d-----h~kL---FeLIl~---------e 383 (516)
T KOG0690|consen 321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKD-----HEKL---FELILM---------E 383 (516)
T ss_pred ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccc-----hhHH---HHHHHh---------h
Confidence 3345667899999999999999999999999999999999999999998321 1111 111110 1
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCC
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRP 1086 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1086 (1103)
. ..+|....++...++...+.+||.+|-
T Consensus 384 d--~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 D--LKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred h--ccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1 234666778889999999999999996
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=302.60 Aligned_cols=260 Identities=19% Similarity=0.301 Sum_probs=194.8
Q ss_pred eeccC--CcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 828 CIGSG--GFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 828 ~lg~G--~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
.||+| +||+||+|... +|+.||||++..... .+..+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 89999999764 689999999876543 334578899999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc---
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA--- 980 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~--- 980 (1103)
++.++++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 999999876555689999999999999999999999 99999999999999999999999998654332111100
Q ss_pred ---ccCCcccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHH--------------
Q 043720 981 ---TTGVAGTFGYVAPEYALTC--RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWA-------------- 1041 (1103)
Q Consensus 981 ---~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-------------- 1041 (1103)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||....... ......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ----MLLQKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH----HHHHHhcCCCCCCccccccc
Confidence 1112345679999998763 47889999999999999999999986432100 000000
Q ss_pred --HHH----------------HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1042 --SML----------------LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1042 --~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... ..........+..........+...+.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000 00000001111111122234566789999999999999999999999854
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=293.88 Aligned_cols=251 Identities=24% Similarity=0.363 Sum_probs=200.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc----chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR----FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 893 (1103)
.+|++.+.||+|+||.||+|... ++..||+|++.... .......+.+|+.++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46889999999999999999654 58999999875432 233456789999999999999999999998664 568
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++|+||+++++|.+++.... .+++..+.+++.|++.|++|||+. +++|+||+|+||+++.++.++|+|||+++..
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999997643 378899999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 974 GTSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 974 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
..... .......++..|+|||++.+..++.++|||||||++||+++|+.||..... ... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~-~~~~~------ 222 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA-------MAA-IFKIA------ 222 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH-------HHH-HHHHH------
Confidence 32111 112345688999999999988889999999999999999999999863211 011 11111
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........+....+.+.+++.+|+. +|..||++.+++++
T Consensus 223 ---~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 223 ---TQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred ---cCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 0111122345566789999999999 57999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=297.06 Aligned_cols=259 Identities=24% Similarity=0.280 Sum_probs=195.5
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecC--CeEEEEEe
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASG--NEMFLIYN 898 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~E 898 (1103)
|++.+.||+|+||.||+|... +++.||+|+++............+|+..+.++. |+|++++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 567888999999999999654 588999999876543333345567899999885 99999999999887 88999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++ +++.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||++........
T Consensus 81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~ 154 (282)
T cd07831 81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP 154 (282)
T ss_pred cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCC
Confidence 996 58888887643 3589999999999999999999999 9999999999999999 9999999999986643222
Q ss_pred ccccCCcccccccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH-----------h
Q 043720 979 HATTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL-----------R 1046 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~ 1046 (1103)
.....++..|+|||++. +..++.++||||+||++|||++|..||..... .....+..... .
T Consensus 155 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 155 --YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE-----LDQIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred --cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCH-----HHHHHHHHHHcCCCCHHHHHhhc
Confidence 22345788999999764 45578899999999999999999999864321 11111111100 0
Q ss_pred cCccccccccccc----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDVFNAELW----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+... .......+..+.+++.+|++.+|++||++++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 00112456889999999999999999999999874
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=298.03 Aligned_cols=262 Identities=23% Similarity=0.330 Sum_probs=198.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|++|+||+|... +++.||+|++...... ...+.+.+|++++++++|+||+++++++......|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46889999999999999999765 6889999998765332 234678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecccccccCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~ 977 (1103)
|++ +++.+++.......+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.+||+|||++.......
T Consensus 82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~ 157 (294)
T PLN00009 82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV 157 (294)
T ss_pred ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence 995 5888888765555578889999999999999999999 9999999999999985 5579999999997654321
Q ss_pred CccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh-cCcccccc-
Q 043720 978 THATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR-QGQVKDVF- 1054 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~- 1054 (1103)
.......+++.|+|||++.+ ..++.++||||+|+++|+|+||+.||...... ......... ........
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~ 229 (294)
T PLN00009 158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI-------DELFKIFRILGTPNEETWP 229 (294)
T ss_pred -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-------HHHHHHHHHhCCCChhhcc
Confidence 12233456889999998865 45788999999999999999999998643211 000000000 00000000
Q ss_pred ------c-----ccccC----CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 ------N-----AELWA----SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ------~-----~~~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+ +.... ......+.++.+++.+|++.+|++||++.+++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 230 GVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred ccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00000 0112345678999999999999999999999864
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-31 Score=291.01 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=207.8
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMFLIY 897 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 897 (1103)
+|...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|+..+++++|+||+++++.+... +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4777889999999999999766 689999999876543 23567889999999999999999999999988 8999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.+++.... .+++.++..++.++++|++|||+. +++|+|++|+||+++.++.++|+|||.+.......
T Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 155 (260)
T cd06606 81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE 155 (260)
T ss_pred EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence 9999999999998764 589999999999999999999999 99999999999999999999999999998765433
Q ss_pred Cc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 TH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.. ......++..|+|||.......+.++||||||+++|+|++|+.||..... ........ . ..
T Consensus 156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~---~------~~ 219 (260)
T cd06606 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-------PMAALYKI---G------SS 219 (260)
T ss_pred ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc-------hHHHHHhc---c------cc
Confidence 21 12345678899999999888899999999999999999999999874320 11111111 0 01
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+...+..+.+++.+|++.+|++||++.|++++
T Consensus 220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 11122344457889999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=296.56 Aligned_cols=243 Identities=23% Similarity=0.320 Sum_probs=189.1
Q ss_pred eeccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHH---hcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 828 CIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTL---GNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
.||+|+||.||++... +++.||+|.+...... .....+.+|..++ ....||+|+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999664 5889999988654332 2223344444433 33479999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||++++++.++++|||++...... ..
T Consensus 81 ~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~ 152 (279)
T cd05633 81 GGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KP 152 (279)
T ss_pred CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Cc
Confidence 999999987654 489999999999999999999999 9999999999999999999999999998755322 12
Q ss_pred cCCcccccccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 982 TGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
....|+..|+|||.+. +..++.++||||+||++|||++|..||....... .. ....... ....
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~-~~~~~~~----------~~~~ 216 (279)
T cd05633 153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-----KH-EIDRMTL----------TVNV 216 (279)
T ss_pred cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-----HH-HHHHHhh----------cCCc
Confidence 2346899999999886 4567899999999999999999999997432211 01 1111000 0111
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
..+...+.++.+++.+|+..||++|| +++|++++
T Consensus 217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 22344567899999999999999999 59999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=275.82 Aligned_cols=265 Identities=22% Similarity=0.349 Sum_probs=204.9
Q ss_pred CHHHHHHHhcCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEec
Q 043720 812 TYESIIRATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRAS 889 (1103)
Q Consensus 812 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 889 (1103)
+++++-+.+++ .||+|+|+.|--+ ...+|..||||++.+. ..+...++.+|++++...+ |+||+.+++||++
T Consensus 74 ~F~d~YkLt~e-----~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 74 KFEDMYKLTSE-----LLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred hHHHHHHhHHH-----HhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 45666666654 4999999999988 5678999999999876 4567788999999999996 9999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC---EEEee
Q 043720 890 GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN---AYLSD 966 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~D 966 (1103)
+..+|+|||.|.||.|...++++.- +++.++.+++++|+.||.+||.+ +|.|||+||+|||-.+... +||+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred cceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeec
Confidence 9999999999999999999987654 99999999999999999999999 9999999999999976544 89999
Q ss_pred cccccccC--C----CCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC---CC
Q 043720 967 FGLSRLLG--T----SETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSS---HG 1032 (1103)
Q Consensus 967 fgla~~~~--~----~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~---~~ 1032 (1103)
|.+..-.. . .....-...+|+-.|||||+.. ...|+.+.|.||+|||+|-|++|.+||.+.-+. .+
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 98875331 1 1122234567899999999873 346888999999999999999999999754331 11
Q ss_pred CCcchHHH---HHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1033 DGFNIISW---ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1033 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
....-..- ....+..+. .++.|.++ ..+..+..+++...+..|+.+|-++.+++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGk-YeFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGK-YEFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CCCccHHHHHHHHHHHhccC-CcCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 11111111 111111111 12222221 234566788899999999999999999886
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.9e-31 Score=305.05 Aligned_cols=266 Identities=23% Similarity=0.302 Sum_probs=199.4
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------ 890 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 890 (1103)
..++|+..+.||+|+||.||+|... +++.||||++.... .......+.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999654 68999999986542 233456677899999999999999999987543
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
...|+||||+. ++|.+++... ++..++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~ 165 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 165 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccc
Confidence 35799999995 5888887643 78889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC-------CCcchHHHHHH
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG-------DGFNIISWASM 1043 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~~ 1043 (1103)
+..... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||........ .......+...
T Consensus 166 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (353)
T cd07850 166 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243 (353)
T ss_pred eeCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence 865432 223344678899999999999999999999999999999999999864321000 00000000000
Q ss_pred -------HHhcCc------cccccccccc----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 -------LLRQGQ------VKDVFNAELW----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 -------~~~~~~------~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...... ..+.+..... ...+...+..+.+++.+|++.||++||++.|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 0000111000 00122346678999999999999999999999865
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=308.24 Aligned_cols=267 Identities=23% Similarity=0.341 Sum_probs=199.7
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----CeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 893 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++...........+.+|+.++++++|+||+++++++... ...
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 46899999999999999999965 468999999986544444566788999999999999999999987554 358
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+|+||++ +++.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 99999996 5888887643 489999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCCc--cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 974 GTSETH--ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 974 ~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
...... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||..... ................
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~-----~~~~~~~~~~~~~~~~ 231 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDY-----LHQLNLILGVLGTPSQ 231 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCCH
Confidence 432221 1233567899999998754 5688999999999999999999999863221 0000000000000000
Q ss_pred ---ccccc-----------cccc---CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 043720 1051 ---KDVFN-----------AELW---ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQI 1098 (1103)
Q Consensus 1051 ---~~~~~-----------~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1098 (1103)
....+ .... .........++.+++.+||+.+|++||++.|++++ ++..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 00000 0000 00011235678999999999999999999999986 4443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=293.62 Aligned_cols=249 Identities=25% Similarity=0.408 Sum_probs=204.9
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|++.+.||+|+||.||++... +++.+|+|++..... ......+.+|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999544 678999999876543 33456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 900 LPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
+++++|.+++.... ...+++..+..++.+++.|++|||+. +++|+||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 24589999999999999999999999 9999999999999999999999999999876443
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......+++.|+|||.+.+..++.++|+||+|+++|||++|+.||..... .... ......
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~-~~~~~~--------- 216 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM--------QDLR-YKVQRG--------- 216 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHH-HHHhcC---------
Confidence 22234578899999999998899999999999999999999999863221 1111 111111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+.++.+++.+|++.+|++||++.|++++
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1112233566789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-31 Score=300.19 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=195.0
Q ss_pred CcceeccCCcccEEEEEEcCCcEEEEEEcccc-cchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 825 TSNCIGSGGFGTTYKAEISPGILVAVKKLAVG-RFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.+.+|.|+++.||++.. +++.||||++... ...+..+.+.+|+.+++.++|+||+++++++...+..+++|||+++|
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344455555655565544 5899999999765 34456678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC-----
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET----- 978 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~----- 978 (1103)
+|.++++......+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999876555689999999999999999999999 999999999999999999999999998865532111
Q ss_pred -ccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc-
Q 043720 979 -HATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF- 1054 (1103)
Q Consensus 979 -~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1054 (1103)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... ..... .. +.....+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~-------~~~~~-~~-~~~~~~~~ 232 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ-------MLLEK-VR-GTVPCLLD 232 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHHH-Hh-ccCccccc
Confidence 11223356778999999865 357889999999999999999999997432110 00000 00 0000000
Q ss_pred -----------------------cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 -----------------------NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 -----------------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..............++.+++.+||..||++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 233 KSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred cCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 0000111223445678999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=297.47 Aligned_cols=262 Identities=23% Similarity=0.309 Sum_probs=196.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCe-----
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNE----- 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 892 (1103)
++|++.+.||+|+||+||+|... +++.||+|++...... .....+.+|+.+++.+. |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 36888999999999999999765 5899999988665332 23457888999999995 6999999999877665
Q ss_pred EEEEEeecCCCChHHHHHhhc---CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecc
Q 043720 893 MFLIYNYLPGGNLENFIKART---SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFG 968 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfg 968 (1103)
.|+||||+++ ++.+++.... ...+++..++.++.||++||+|||++ +|+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 8999999975 8999886543 23589999999999999999999999 9999999999999998 8899999999
Q ss_pred cccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
++..+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||..... ...........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-------~~~~~~~~~~~ 228 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE-------LQQLLHIFKLL 228 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHHHHh
Confidence 9876533211 1223356789999998865 4578999999999999999999999863221 11111100000
Q ss_pred Ccc-----ccccc-----------ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQV-----KDVFN-----------AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~-----~~~~~-----------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+.. ..... +..........+..+.++|.+||..||++||+++|++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000 00000 000000112356778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=296.62 Aligned_cols=262 Identities=26% Similarity=0.330 Sum_probs=199.7
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEEEEEe
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMFLIYN 898 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~E 898 (1103)
|++.+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.+++.++|+|++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999766 48899999998764 223356788999999999999999999999887 89999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++ ++|.+++.... ..+++.++..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~ 155 (287)
T cd07840 81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS 155 (287)
T ss_pred ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence 997 48999887653 3589999999999999999999999 999999999999999999999999999987654432
Q ss_pred ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC---cccc--
Q 043720 979 HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG---QVKD-- 1052 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~-- 1052 (1103)
.......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ............. ....
T Consensus 156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL-----EQLEKIFELCGSPTDENWPGVS 230 (287)
T ss_pred ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCCchhhccccc
Confidence 22334456789999997764 45788999999999999999999998743211 0000000000000 0000
Q ss_pred ------------cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 ------------VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.............++..+.+++.+|++.+|++||++++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000000011126778999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=299.62 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=198.6
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|.... ++.||||.++..........+.+|+..+.+.. |+||+++++++..+...|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568899999999999999998765 89999999976554445566777887776665 999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
||+. +++.+++.... ..+++..+.+++.++++|++|||+ . +|+||||+|+||++++++.+||+|||++......
T Consensus 94 e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 94 ELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred eccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 9984 57877776543 368999999999999999999997 5 8999999999999999999999999998765332
Q ss_pred CCccccCCcccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCR----VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
.. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..... ..+......... ..
T Consensus 169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~~~~~~~~~~-~~- 237 (296)
T cd06618 169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-------EFEVLTKILQEE-PP- 237 (296)
T ss_pred Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-------HHHHHHHHhcCC-CC-
Confidence 22 22335778999999987553 78899999999999999999999863211 011111111111 00
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
. .......+.++.+++.+||+.||++||++.+++++-
T Consensus 238 ----~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 238 ----S--LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ----C--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 0 111123557799999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=300.66 Aligned_cols=269 Identities=22% Similarity=0.311 Sum_probs=198.5
Q ss_pred CCCCcceeccCCcccEEEEEEcC---CcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP---GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 894 (1103)
+|++.+.||+|+||.||+|.... ++.||+|.+..... ....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 47788999999999999997654 78999999986431 22346678899999999999999999999888 8899
Q ss_pred EEEeecCCCChHHHHHhhcC---CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC----CCCEEEeec
Q 043720 895 LIYNYLPGGNLENFIKARTS---RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD----DFNAYLSDF 967 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ki~Df 967 (1103)
+||||+++ ++.+++..... ..+++..++.++.|++.|++|||+. +|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 77777754322 3588999999999999999999999 9999999999999999 899999999
Q ss_pred ccccccCCCCC--ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcc--hHHH--
Q 043720 968 GLSRLLGTSET--HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFN--IISW-- 1040 (1103)
Q Consensus 968 gla~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~--~~~~-- 1040 (1103)
|++........ .......++..|+|||++.+ ..++.++||||||+++|||++|+.||............ ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643322 12334567889999998766 45788999999999999999999999754332100000 0000
Q ss_pred -HHHH-----------HhcCcccccccccccCCCC-----------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1041 -ASML-----------LRQGQVKDVFNAELWASGP-----------HDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1041 -~~~~-----------~~~~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.... ..........+.......+ .....++.+++.+|++.||++|||+.|++++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 0000000000000000111 1334568999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=296.80 Aligned_cols=258 Identities=19% Similarity=0.273 Sum_probs=186.4
Q ss_pred cCCCCcceeccCCcccEEEEEEcCC----cEEEEEEcccccchhh----------HHHHHHHHHHHhcCCCCceeEEEeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPG----ILVAVKKLAVGRFQHG----------VQQFHAEIKTLGNVRHPNLVTLIGY 886 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~niv~l~~~ 886 (1103)
++|++.+.||+|+||+||+|...++ ..+|+|+......... ......+...+..+.|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 5799999999999999999976643 4566665433221110 0112334455667789999999997
Q ss_pred EecCC----eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCE
Q 043720 887 RASGN----EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNA 962 (1103)
Q Consensus 887 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 962 (1103)
+.... ..++++|++. .++.+.++... ..++..+..++.|++.|++|||+. +|+||||||+||+++.++.+
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~ 165 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRG 165 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcE
Confidence 65543 4477888774 47777766532 257788999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 043720 963 YLSDFGLSRLLGTSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFN 1036 (1103)
Q Consensus 963 ki~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1103)
+|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~----~~ 241 (294)
T PHA02882 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHN----GN 241 (294)
T ss_pred EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccc----hH
Confidence 99999999876432211 122346899999999999999999999999999999999999999743211 01
Q ss_pred hHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1037 IISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
....... +.......... ....++..+.+++..|+..+|++||++.++++.+
T Consensus 242 ~~~~~~~----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKC----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHH----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1100000 00000001111 1223467899999999999999999999999876
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=295.24 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=199.8
Q ss_pred CCCCcceeccCCcccEEEEEE----cCCcEEEEEEcccccc---hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 893 (1103)
+|++.+.||+|+||.||+|.. .+|..||+|++..... ....+.+.+|+.+++++ +|++|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999965 3688999999875432 22346678899999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+||||+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||++++++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999997653 488899999999999999999999 9999999999999999999999999999865
Q ss_pred CCCCCccccCCcccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTC--RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
............|+..|+|||.+... .++.++||||||+++|+|++|+.||..... ......+........
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~----~~~~~~~~~~~~~~~--- 228 (290)
T cd05613 156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE----KNSQAEISRRILKSE--- 228 (290)
T ss_pred ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc----cccHHHHHHHhhccC---
Confidence 43333333345688899999998653 467899999999999999999999863211 111111111111110
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+......+.+++.+|++.||++|| ++.+++++
T Consensus 229 --------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 --------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred --------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 112334567789999999999999997 66777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-32 Score=300.22 Aligned_cols=250 Identities=25% Similarity=0.369 Sum_probs=210.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.+.|.+.+.||+|.|++|..|++. ++..||||.+.+..-. ...+.+.+|+++|+.++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 457899999999999999999554 6999999999876543 23456889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+.+|.+.+|+.+... +.+.....++.|+..|++|+|++ .|||||||++||+++.+..+||+|||++..+. .
T Consensus 135 eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--c
Confidence 99999999999988654 66688899999999999999999 99999999999999999999999999999885 3
Q ss_pred CccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||+...-..-. +.++..
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------------~rvl~g 270 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------------PRVLRG 270 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------------chheee
Confidence 445667899999999999998876 56899999999999999999999854322111 111122
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
.++. +.....+..+++++++..+|.+|++.+++.++-
T Consensus 271 k~rI--p~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~ 307 (596)
T KOG0586|consen 271 KYRI--PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR 307 (596)
T ss_pred eecc--cceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence 2222 233445678999999999999999999998653
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-33 Score=332.86 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=208.2
Q ss_pred hcCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+-++.....||.|.||.||.| ...+|.-.|||.++.... ....+.+.+|..++..+.|||+|+++|+-.+.+..++.|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 446777889999999999999 566799999998876543 334567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|||++|+|.+.++.... .++.....+..|++.|++|||++ +||||||||.||+++.+|.+|.+|||.|..+....
T Consensus 1314 EyC~~GsLa~ll~~gri--~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEHGRI--EDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHhccCcHHHHHHhcch--hhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 99999999999986543 66667777889999999999999 99999999999999999999999999998875543
Q ss_pred C---ccccCCcccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 978 T---HATTGVAGTFGYVAPEYALTCR---VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 978 ~---~~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
. .......||+.|||||++.+.. ..-++||||+||++.||+||+.||...+. .|...+.-
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn---------e~aIMy~V----- 1454 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN---------EWAIMYHV----- 1454 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc---------hhHHHhHH-----
Confidence 1 2234678999999999997543 45589999999999999999999973322 23322211
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
-..-.+..|.....+-.+++..|+..||+.|.++.|++++
T Consensus 1455 ---~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 ---AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ---hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 1122334566677888999999999999999999998875
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=279.41 Aligned_cols=270 Identities=24% Similarity=0.319 Sum_probs=200.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-----CcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEec-CCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 893 (1103)
..|+....||+|.||.||+|.-++ ...+|+|+++...+.. ......+|+..++.++||||+.+..++.+ +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468999999999999999993322 2368999997664422 23567899999999999999999998877 7789
Q ss_pred EEEEeecCCCChHHHHHhhc---CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC----CCEEEee
Q 043720 894 FLIYNYLPGGNLENFIKART---SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD----FNAYLSD 966 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~D 966 (1103)
++++||.+. +|.+.++-.. .+.++...+..|..||+.|+.|||+. -|+||||||.||||..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999977 9999886432 25688999999999999999999999 89999999999999877 8999999
Q ss_pred cccccccCCCCCc--cccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC--CcchHHHH
Q 043720 967 FGLSRLLGTSETH--ATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGD--GFNIISWA 1041 (1103)
Q Consensus 967 fgla~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~--~~~~~~~~ 1041 (1103)
||+++.+..+-.. ....++-|.+|.|||.+.+. .||.+.||||.|||+.||+|-++-|......-.+ ++..-+..
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 9999998765433 34567889999999998875 5888999999999999999988777543221111 12222211
Q ss_pred HHH--HhcCcccccc---------------cccccCCC--------ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1042 SML--LRQGQVKDVF---------------NAELWASG--------PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1042 ~~~--~~~~~~~~~~---------------~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+.. .......+.. ....+... ...-++...+++.+++..||.+|-++++.+++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 111 0000000000 00000000 00012236789999999999999999998875
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=297.67 Aligned_cols=267 Identities=27% Similarity=0.336 Sum_probs=200.7
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC----
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN---- 891 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 891 (1103)
...++|++.+.||+|+||.||+|..+ +++.||+|+++.... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999775 588999999876543 223456788999999999999999999887654
Q ss_pred ------eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 892 ------EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 892 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
..++|+||+++ ++.+++... ...+++..+..++.|++.||+|||+. +|+||||+|+||++++++.+||+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~ 158 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLA 158 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeC
Confidence 78999999975 787777654 23589999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 966 DFGLSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 966 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
|||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||..... ..........
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~-----~~~~~~~~~~ 233 (302)
T cd07864 159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQE-----LAQLELISRL 233 (302)
T ss_pred cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHH
Confidence 999998764433222233356788999998764 4578899999999999999999999873221 1111111111
Q ss_pred HhcCc---ccccc--------ccc-----ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 LRQGQ---VKDVF--------NAE-----LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 ~~~~~---~~~~~--------~~~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..... ..... +.. .........+..+.+++.+||+.+|++||++++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 00000 00000 000 0000112346789999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-31 Score=295.52 Aligned_cols=256 Identities=23% Similarity=0.311 Sum_probs=202.6
Q ss_pred CCCCcceeccCCcccEEEEEE----cCCcEEEEEEcccccc---hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 893 (1103)
+|++.+.||+|+||.||+|.. .+++.||||+++.... ....+.+.+|+.++.++ +||+|+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377788999999999999964 3568899999875432 22346688999999999 599999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||+++..
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987643 488999999999999999999999 9999999999999999999999999998776
Q ss_pred CCCCCccccCCcccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCR--VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
............|+..|+|||.+.+.. .+.++||||||+++|||++|..||...... .............
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~----~~~~~~~~~~~~~---- 227 (288)
T cd05583 156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ----NSQSEISRRILKS---- 227 (288)
T ss_pred ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc----chHHHHHHHHHcc----
Confidence 444333333456889999999987655 788999999999999999999998632111 1111111111110
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
....+...+..+.+++.+||+.+|++||+++++.+.|+.
T Consensus 228 -------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 228 -------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred -------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 012233455678999999999999999998888776654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=269.91 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=201.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++.+....||.|.-|+||++... .|...|||.+......++.+++...++++..-+ +|.||+.+|+|..+...++.||
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 34555667999999999999766 478999999998888888888999998887765 8999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
.|. .-+..+++.- ..++++..+-++...+++||.||.++. +|+|||+||+|||+|+.|.+|+||||.+.++-.+..
T Consensus 172 lMs-~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 172 LMS-TCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHH-HHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 983 3555555544 356899999999999999999998764 999999999999999999999999999987744333
Q ss_pred ccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 979 HATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.+...|-+.|||||.+. ...|+.++||||||++++|+.||+.||..... ++ .....+.. ++. .
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t----dF---e~ltkvln-~eP-P--- 313 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT----DF---EVLTKVLN-EEP-P--- 313 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc----cH---HHHHHHHh-cCC-C---
Confidence 33446788999999985 44688899999999999999999999974332 11 11222221 111 1
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .+........+++++..|+.+|+.+||...+++++
T Consensus 314 -~--L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 314 -L--LPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred -C--CCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 1 12223367889999999999999999999998865
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-31 Score=288.55 Aligned_cols=248 Identities=27% Similarity=0.472 Sum_probs=205.0
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|++.+.||+|++|.||+|... +++.|++|.+...... ...+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999655 5789999999776432 3567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.+++... ..+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 155 (254)
T cd06627 81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD 155 (254)
T ss_pred CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence 9999999999865 3489999999999999999999999 9999999999999999999999999999876543322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ...... .. .. ..
T Consensus 156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~-------~~~~~~-~~-~~---------~~ 216 (254)
T cd06627 156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP-------MAALFR-IV-QD---------DH 216 (254)
T ss_pred -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH-------HHHHHH-Hh-cc---------CC
Confidence 2345678899999999888889999999999999999999999863211 111111 00 01 11
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
...+...+..+.+++.+|+..+|++||++.|++.
T Consensus 217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1223345678999999999999999999999985
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-31 Score=297.55 Aligned_cols=264 Identities=26% Similarity=0.340 Sum_probs=197.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 895 (1103)
.++|++.+.||+|+||.||+|... +|+.||+|+++...... ....+.+|+.++++++|+|++++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 457999999999999999999764 58999999987554322 233566899999999999999999998654 56899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||++ ++|.+++.... ..+++.++..++.|+++|++|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999996 58999887643 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC------
Q 043720 976 SETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG------ 1048 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 1048 (1103)
.. .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... .............
T Consensus 161 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-----~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 161 PA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-----EQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred cc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHhcCCCChhhch
Confidence 32 12223345788999999865 45789999999999999999999998633211 1110000000000
Q ss_pred -----ccccccccccc-----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 -----QVKDVFNAELW-----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 -----~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+..... ..........+.++|.+|++.||++||++.|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00000000000 00011235678899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=294.30 Aligned_cols=246 Identities=25% Similarity=0.400 Sum_probs=197.2
Q ss_pred eccCCcccEEEEEEcC-CcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||+|+||.||++.... ++.||+|++..... ....+.+.+|++++++++|+||+++++.+..+...|+|+||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999997764 89999999875533 24567789999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC-------
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET------- 978 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~------- 978 (1103)
.+++++.. .+++..+..++.|+++||+|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998754 489999999999999999999999 999999999999999999999999999876533211
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.......++..|+|||......++.++||||||+++||+++|+.||..... ......... +. .
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-~~--------~ 218 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP--------EEIFQNILN-GK--------I 218 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHhc-CC--------c
Confidence 122344678899999999888899999999999999999999999873321 111111111 10 0
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
........+..+.+++.+|++.+|++||++.++.+.|+
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01111113678899999999999999999955554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=291.56 Aligned_cols=258 Identities=24% Similarity=0.335 Sum_probs=197.1
Q ss_pred CCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchh-hHHHHHHHHHHHhcC---CCCceeEEEeEEecCCe-----
Q 043720 823 FNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQH-GVQQFHAEIKTLGNV---RHPNLVTLIGYRASGNE----- 892 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 892 (1103)
|++.+.||+|+||.||+|..+. +..||+|++......+ ....+.+|+.+++++ .|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999998764 8999999997554332 234566777776665 59999999999988776
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.+++|||+. ++|.++++......+++.++..++.|+++||+|||+. +++|+||+|+||++++++.+||+|||.+..
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 999999996 5899998875555689999999999999999999999 999999999999999999999999999977
Q ss_pred cCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc--
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV-- 1050 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1050 (1103)
..... ......++..|+|||++.+..++.++||||||+++|||++|+.||..... ..........-..
T Consensus 157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~--------~~~~~~~~~~~~~~~ 226 (287)
T cd07838 157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE--------ADQLDKIFDVIGLPS 226 (287)
T ss_pred ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh--------HHHHHHHHHHcCCCC
Confidence 64322 12233568899999999988899999999999999999999988863221 1111111110000
Q ss_pred -----------ccccccccc---CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 -----------KDVFNAELW---ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 -----------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+..... ..........+.+++.+||+.||++||++.|++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 227 EEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred hHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 000000000 01112345678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=293.98 Aligned_cols=266 Identities=24% Similarity=0.362 Sum_probs=199.6
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEeec
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
|++.+.||+|+||+||+|... +++.||||++.............+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567888999999999999775 478899999876544333345567999999999 999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
+|+|.+++.......+++.++..++.|++.++.|||+. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 154 (283)
T cd07830 81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-- 154 (283)
T ss_pred -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence 88999999876545689999999999999999999999 999999999999999999999999999976543222
Q ss_pred ccCCcccccccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC--------CCcchHHHHHHHHhcCccc
Q 043720 981 TTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG--------DGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.....++..|+|||++. ...++.++||||||+++|||++|+.||........ .......|...........
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 23345788999999874 45578899999999999999999998863321100 0000001111111011111
Q ss_pred ccccccc---cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAEL---WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+.... ........+.++.+++.+||+.+|++||+++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0000000 000111225679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=287.16 Aligned_cols=242 Identities=24% Similarity=0.302 Sum_probs=188.5
Q ss_pred ceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHH-hcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTL-GNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||.||+|... +++.||||++..... ......+..|..++ ...+|+|++++++++..++..|+|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46899999999999664 588999999875432 22233444555444 445899999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
++|.++++... .+++..+.+++.|++.||.|||+. +++||||+|+||++++++.+||+|||++..... ..
T Consensus 82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~ 151 (260)
T cd05611 82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK 151 (260)
T ss_pred CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence 99999997653 488999999999999999999999 999999999999999999999999999875432 22
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
...++..|+|||.+.+..++.++||||+|+++|||++|..||..... ........ .... ......
T Consensus 152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~------~~~~~~ 216 (260)
T cd05611 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP--------DAVFDNIL-SRRI------NWPEEV 216 (260)
T ss_pred cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hccc------CCCCcc
Confidence 34578899999999888889999999999999999999999863221 11111111 1100 001111
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
...++..+.+++.+||+.+|++||++.++.+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 2245678999999999999999997754444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=293.98 Aligned_cols=245 Identities=25% Similarity=0.402 Sum_probs=197.2
Q ss_pred cceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCC
Q 043720 826 SNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGN 904 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gs 904 (1103)
...||+|+||.||+|... +++.||||++.... ......+.+|+.+++.++|+|++++++++..++..++||||+++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 456999999999999764 68999999886543 3345678999999999999999999999999999999999999999
Q ss_pred hHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCC
Q 043720 905 LENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGV 984 (1103)
Q Consensus 905 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~ 984 (1103)
|.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++....... ......
T Consensus 104 L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~ 176 (292)
T cd06657 104 LTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL 176 (292)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence 99988643 378999999999999999999999 99999999999999999999999999987653322 222335
Q ss_pred cccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCCh
Q 043720 985 AGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPH 1064 (1103)
Q Consensus 985 ~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1064 (1103)
.+++.|+|||++.+..++.++||||+|+++|||++|+.||..... ....... ... ..... ....
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~--------~~~~~~~-~~~-----~~~~~--~~~~ 240 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP--------LKAMKMI-RDN-----LPPKL--KNLH 240 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHH-Hhh-----CCccc--CCcc
Confidence 678899999999888889999999999999999999999863211 1111111 110 00111 1112
Q ss_pred hHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1065 DDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1065 ~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+..+.+++.+|++.+|.+||++.+++++
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 345678899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-31 Score=297.71 Aligned_cols=264 Identities=22% Similarity=0.326 Sum_probs=195.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecCC------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------ 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 891 (1103)
.++|++.+.||+|+||.||+|... +++.||||++....... ....+.+|+.++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357999999999999999999665 58999999986543322 2345678999999999999999999886643
Q ss_pred --eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 892 --EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 892 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
..++||||+. +++.+++.... ..+++.++..++.|++.|++|||++ +++|+||||+||+++.++.+||+|||+
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCC
Confidence 4599999996 58888886543 3589999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc---cccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 970 SRLLGTSETH---ATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 970 a~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||...... ..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-----~~~~~~~~~~ 240 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-----HQLTLISQLC 240 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHHHh
Confidence 9866433221 12234577899999988654 4688999999999999999999988643211 0000001000
Q ss_pred hcCcccc---------cccc---------cccCC-CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKD---------VFNA---------ELWAS-GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~---------~~~~---------~~~~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+ ..+. ..... ........+.++|.+|+..||++||+++|++++
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 241 -GSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred -CCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000 00000 000123457899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=287.18 Aligned_cols=248 Identities=20% Similarity=0.287 Sum_probs=192.6
Q ss_pred HHHHhcCCCCccee--ccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCC
Q 043720 816 IIRATGDFNTSNCI--GSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGN 891 (1103)
Q Consensus 816 ~~~~~~~~~~~~~l--g~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 891 (1103)
.....++|++.+.+ |+|+||.||++..+ ++..+|+|.+........ |+.....+ +|||++++++++...+
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~------e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI------EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh------hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 33345677777776 99999999999654 578899998865432211 22222212 6999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLS 970 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla 970 (1103)
..|+||||+++++|.++++... .+++.++..++.|+++|++|||+. +++||||+|+||+++.++ .++|+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999998754 589999999999999999999999 999999999999999988 9999999998
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
...... ....++..|+|||++.+..++.++||||+|+++|||++|+.||..... .......+.... ..
T Consensus 158 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~---~~~~~~~~~~~~--~~-- 225 (267)
T PHA03390 158 KIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED---EELDLESLLKRQ--QK-- 225 (267)
T ss_pred eecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc---chhhHHHHHHhh--cc--
Confidence 765322 223578899999999988899999999999999999999999973322 111112222111 00
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCC-HHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT-MKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~~ 1094 (1103)
........+..+.+++.+|++.+|.+||+ ++|++++
T Consensus 226 --------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 226 --------KLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred --------cCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 01122346678999999999999999995 6888753
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=292.07 Aligned_cols=261 Identities=25% Similarity=0.338 Sum_probs=200.3
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
|+..+.||+|++|.||+|... +++.+++|++...... .....+.+|+.++++++|+||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567788999999999999664 6889999998765433 34567888999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++ ++.+++.... ..+++.++..++.++++|++|||+. +|+|+||+|+||++++++.+||+|||.+....... ..
T Consensus 81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~ 154 (283)
T cd05118 81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP 154 (283)
T ss_pred CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence 65 8988887643 4589999999999999999999999 99999999999999999999999999998765433 12
Q ss_pred ccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc---Cccccccc-
Q 043720 981 TTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ---GQVKDVFN- 1055 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~- 1055 (1103)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||..... ............. .......+
T Consensus 155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd05118 155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE-----IDQLFKIFRTLGTPDPEVWPKFTSL 229 (283)
T ss_pred ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHcCCCchHhcccchhh
Confidence 2234577899999998776 788999999999999999999998863221 0000000000000 00000000
Q ss_pred ----------ccc--cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 ----------AEL--WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ----------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... ........+.++.++|.+||+.||.+||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000 001122456789999999999999999999999864
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-32 Score=285.24 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=202.7
Q ss_pred cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchh------hHHHHHHHHHHHhcCCCCceeEEEeEEec-CCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH------GVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 892 (1103)
++|-+.+.||+|+|++||+| +....+.||||+-....... ..+...+|..+-+.+.||.||++++++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 46778889999999999999 66678899999876554321 23457899999999999999999998854 567
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC---CCCCEEEeeccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD---DDFNAYLSDFGL 969 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgl 969 (1103)
+|-|+|||+|-+|+-|++..+- +++++++.|+.||+.||.||.+. +++|+|-||||.|||+- ..|.+||+|||+
T Consensus 543 FCTVLEYceGNDLDFYLKQhkl--mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGL 619 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKL--MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGL 619 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhh--hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecch
Confidence 8999999999999999987654 89999999999999999999998 88999999999999994 557899999999
Q ss_pred ccccCCCCCc------cccCCcccccccCcccccc----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHH
Q 043720 970 SRLLGTSETH------ATTGVAGTFGYVAPEYALT----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIIS 1039 (1103)
Q Consensus 970 a~~~~~~~~~------~~~~~~g~~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~ 1039 (1103)
+..+...... ......||.+|++||.+.- ..++.|+||||.|||+|+++.|+.||+-...+
T Consensus 620 SKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--------- 690 (775)
T KOG1151|consen 620 SKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--------- 690 (775)
T ss_pred hhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH---------
Confidence 9988544332 2334579999999998743 35788999999999999999999999844331
Q ss_pred HHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
..+.....+.+..+ +..+.-.....+...+|++|+++.-++|....++..
T Consensus 691 --QdILqeNTIlkAtE--VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 691 --QDILQENTILKATE--VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --HHHHhhhchhccee--ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 11122222222111 112222345577899999999999999988877653
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-31 Score=292.75 Aligned_cols=250 Identities=25% Similarity=0.396 Sum_probs=204.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 896 (1103)
++|.+.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.+++++. |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 36888999999999999999665 689999999876332 234567889999999998 99999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.+++++.. .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~ 155 (280)
T cd05581 81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN 155 (280)
T ss_pred EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence 99999999999998754 499999999999999999999999 9999999999999999999999999998866433
Q ss_pred CC-------------------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcch
Q 043720 977 ET-------------------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNI 1037 (1103)
Q Consensus 977 ~~-------------------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~ 1037 (1103)
.. .......++..|+|||......++.++||||||++++++++|+.||.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-------- 227 (280)
T cd05581 156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE-------- 227 (280)
T ss_pred cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH--------
Confidence 21 122334578899999999888899999999999999999999999873321
Q ss_pred HHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCH----HHHHHH
Q 043720 1038 ISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTM----KQVVQC 1094 (1103)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~evl~~ 1094 (1103)
........ ......+...+..+.+++.+||+.+|++||++ +|++++
T Consensus 228 ~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 228 YLTFQKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHHHHHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 11111111 01112334446779999999999999999999 777653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-31 Score=299.13 Aligned_cols=268 Identities=26% Similarity=0.379 Sum_probs=200.4
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccc-cchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC--CeE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVG-RFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG--NEM 893 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~ 893 (1103)
..++|++.+.||+|+||.||+|... +++.||||++... ........+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467889999999999999999765 5889999988643 2223445677899999999 999999999988653 468
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+||||++ ++|.++++.. .+++..+..++.|++.||+|||+. +|+||||+|+||+++.++.+||+|||++...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~ 157 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSL 157 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcc
Confidence 99999996 5999998764 488899999999999999999999 9999999999999999999999999999866
Q ss_pred CCCCC----ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH----
Q 043720 974 GTSET----HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML---- 1044 (1103)
Q Consensus 974 ~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---- 1044 (1103)
..... .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||...... .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~-----~~~~~~~~~~~~~ 232 (337)
T cd07852 158 SELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTL-----NQLEKIIEVIGPP 232 (337)
T ss_pred ccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHhCCC
Confidence 43322 12234568899999998754 45788999999999999999999998633211 000000000
Q ss_pred -------HhcCccccccc----ccc--cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 043720 1045 -------LRQGQVKDVFN----AEL--WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQI 1098 (1103)
Q Consensus 1045 -------~~~~~~~~~~~----~~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1098 (1103)
..........+ ... ........+.++.+++.+||+.+|++||++.+++++ ++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 00000000000 000 000112246789999999999999999999999976 4444
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=301.24 Aligned_cols=264 Identities=22% Similarity=0.318 Sum_probs=199.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec----CCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS----GNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 893 (1103)
.++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 367999999999999999999654 589999999876533 2345677889999999999999999987753 3578
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++...
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEEehhh-hhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceee
Confidence 99999995 69999987543 389999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCC---ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh---
Q 043720 974 GTSET---HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR--- 1046 (1103)
Q Consensus 974 ~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 1046 (1103)
..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...... ...........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~-----~~~~~~~~~~g~~~ 232 (334)
T cd07855 158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYV-----HQLKLILSVLGSPS 232 (334)
T ss_pred cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChH-----HHHHHHHHHhCCCh
Confidence 33221 11234578899999998865 46889999999999999999999999643211 00000000000
Q ss_pred --------cCcccccccc-cccCC-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 --------QGQVKDVFNA-ELWAS-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 --------~~~~~~~~~~-~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+..+. ..... .....+.++.+++.+|++.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0000000000 00000 012346779999999999999999999999874
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=289.06 Aligned_cols=243 Identities=22% Similarity=0.318 Sum_probs=188.6
Q ss_pred eeccCCcccEEEEEE-cCCcEEEEEEcccccch--hhHHHHHHHH---HHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 828 CIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEI---KTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
.||+|+||.||+|.. .+++.||+|.+...... .....+..|. ..++...||+|+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 389999999999965 45889999998764322 1112233333 34445679999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+++|.+++... ..+++.++..++.|+++|++|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~ 152 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P 152 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence 99999998754 3489999999999999999999999 99999999999999999999999999987653221 2
Q ss_pred cCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 982 TGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||........ .. ....... ...
T Consensus 153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-----~~-~~~~~~~----------~~~ 216 (278)
T cd05606 153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-----HE-IDRMTLT----------MAV 216 (278)
T ss_pred cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-----HH-HHHHhhc----------cCC
Confidence 234688999999998754 688999999999999999999999974422110 00 0000000 011
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
..+...+..+.+++.+|+..+|++|| ++.|++++
T Consensus 217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 12333467899999999999999999 99999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=295.45 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=198.3
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.|+..+.||+|+||.||+|... ++..||+|.+.... .....+++.+|+.+++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3667788999999999999764 57889999886432 23345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+. |++.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||++......
T Consensus 96 ~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-- 168 (308)
T ss_pred ccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence 996 68888776543 4488999999999999999999999 9999999999999999999999999998765322
Q ss_pred ccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 979 HATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
....+++.|+|||.+. ...++.++|||||||++|||++|+.||..... ........ ....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~~~-~~~~----- 231 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIA-QNES----- 231 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccH--------HHHHHHHh-hcCC-----
Confidence 2345788999999874 35678899999999999999999999863211 00111111 1110
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
........+..+.++|.+||+.+|++||++.+++++-....
T Consensus 232 ---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 232 ---PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred ---CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 00112245567899999999999999999999998755443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=300.42 Aligned_cols=266 Identities=23% Similarity=0.325 Sum_probs=200.5
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----Ce
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 892 (1103)
..+|.+.+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 35789999999999999999965 468999999986532 223355677899999999999999999987654 35
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+|+||+. ++|.+++.... .+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~ 157 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLART 157 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence 899999995 69999987643 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH------
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL------ 1045 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 1045 (1103)
..... .......++..|+|||.+.. ..++.++||||||+++|+|++|+.||..... ...........
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~ 231 (337)
T cd07858 158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-----VHQLKLITELLGSPSEE 231 (337)
T ss_pred cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-----HHHHHHHHHHhCCCChH
Confidence 64322 22234467889999998764 4688999999999999999999999864311 00000000000
Q ss_pred -----hcCccccc-------ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 043720 1046 -----RQGQVKDV-------FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQI 1098 (1103)
Q Consensus 1046 -----~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1098 (1103)
........ ...... .....++.++.+++.+|++.+|++||+++|++++ ++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00000000 000000 0112456778999999999999999999999987 5544
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=269.84 Aligned_cols=253 Identities=23% Similarity=0.282 Sum_probs=199.0
Q ss_pred hcCCCCcc-eeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEec----CCe
Q 043720 820 TGDFNTSN-CIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRAS----GNE 892 (1103)
Q Consensus 820 ~~~~~~~~-~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 892 (1103)
+++|.+.. +||-|-.|.|..+.++ +++.+|+|++... ....+|++.--.. .|||||.+++++.. ...
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 6899999999999555 5889999988643 3445666654444 59999999998754 346
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeeccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGL 969 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgl 969 (1103)
..+|||.|+||.|.+.++.+....+++.++..|+.||+.|+.|||+. +|+||||||+|+|.+. +..+|++|||+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEeccccc
Confidence 78999999999999999999888999999999999999999999999 9999999999999974 44689999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
|+.... .......+.||.|.|||++-...|+...|+||+||++|-|++|.+||+...... +..=.+..++.+.
T Consensus 211 AK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----ispgMk~rI~~gq 283 (400)
T KOG0604|consen 211 AKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----ISPGMKRRIRTGQ 283 (400)
T ss_pred ccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----CChhHHhHhhccC
Confidence 986543 334455678999999999999899999999999999999999999998543321 1111222222221
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+ ++.++++ ...+.+..++|+.++..+|.+|-+..|+..+
T Consensus 284 y-~FP~pEW-----s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 284 Y-EFPEPEW-----SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred c-cCCChhH-----hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 1 1112221 3456778999999999999999999998764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=274.73 Aligned_cols=254 Identities=26% Similarity=0.348 Sum_probs=196.7
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeec
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
.+....||.|+||+|++-.++ .|+..|||+++......+.+++..|.+...+- +.|+||+++|++..++..|+.||.|
T Consensus 66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 344566999999999999665 58999999999888777778888888765554 6999999999999999999999999
Q ss_pred CCCChHHHHHh---hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 901 PGGNLENFIKA---RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 901 ~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
..++..+-+. -....+++..+-.|...+++||+||-+.. .|+|||+||+|||++..|.+|+||||.+..+..+
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 4577665432 33355899999999999999999998654 9999999999999999999999999999766432
Q ss_pred CccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
...+.-.|-..|||||.+.. ..|+.+|||||+|+++||+.||..|+..+.+. .+-.. ++-.+....+..
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-------feql~-~Vv~gdpp~l~~ 292 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-------FEQLC-QVVIGDPPILLF 292 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-------HHHHH-HHHcCCCCeecC
Confidence 23334467788999999953 34888999999999999999999998744320 00111 112222222111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
+. ........+..+|.-|+.+|.+.||.++++.+
T Consensus 293 ~~----~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 293 DK----ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred cc----cccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 11 12335577999999999999999999999875
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=296.41 Aligned_cols=268 Identities=24% Similarity=0.343 Sum_probs=205.3
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-----eEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-----EMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 894 (1103)
+|++.+.||+|+||.||+|... .++.||||++..... ....+.+.+|+.+++.++|+||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4788899999999999999765 489999999876532 334577899999999999999999999987765 789
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||++ ++|.++++... .+++..+..++.+++.||+|||+. +|+||||||+||+++.++.++++|||++....
T Consensus 81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~ 154 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVD 154 (330)
T ss_pred EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence 9999997 58999987643 589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC--ccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH------
Q 043720 975 TSET--HATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL------ 1045 (1103)
Q Consensus 975 ~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------ 1045 (1103)
.... .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...... ..........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~ 229 (330)
T cd07834 155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-----DQLNLIVEVLGTPSEE 229 (330)
T ss_pred ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHhcCCCChh
Confidence 4321 123344678899999999877 7899999999999999999999998643210 0000000000
Q ss_pred -----hcCcccccccc------cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhc
Q 043720 1046 -----RQGQVKDVFNA------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQIQH 1100 (1103)
Q Consensus 1046 -----~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 1100 (1103)
......+.+.. ..........+..+.+++.+||+.+|++||++.+++++ ++++..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 00000000000 00001112346778999999999999999999999985 555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=292.11 Aligned_cols=245 Identities=25% Similarity=0.373 Sum_probs=194.9
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
|...+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999654 588999999865432 23446788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+. |++.+++.... ..+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 103 ~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~----- 172 (313)
T cd06633 103 CL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS----- 172 (313)
T ss_pred CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence 95 68888876543 4589999999999999999999999 99999999999999999999999999886432
Q ss_pred cccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
......|+..|+|||++. ...++.++||||||+++|||++|..||..... ........... ..
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~--------~~~~~~~~~~~-~~----- 238 (313)
T cd06633 173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--------MSALYHIAQND-SP----- 238 (313)
T ss_pred CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHhcC-CC-----
Confidence 122346788999999984 45678899999999999999999999864321 11111111111 00
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ......+..+.+++.+|++.+|.+||++.+++++
T Consensus 239 ~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 239 T---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred C---CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0112334568999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=296.41 Aligned_cols=266 Identities=22% Similarity=0.320 Sum_probs=198.7
Q ss_pred HHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec-CCeE
Q 043720 817 IRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNEM 893 (1103)
Q Consensus 817 ~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 893 (1103)
..++++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++++++||||+++.+++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446788999999999999999999644 789999998865322 2345678899999999999999999998865 5678
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+|+||+ +++|.++++.. .+++..+..++.|+++|++|||+. +|+||||+|+||++++++.+|++|||.+...
T Consensus 86 ~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 9999999 56999888643 378888999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-------CcchHHHHHHHH
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD-------GFNIISWASMLL 1045 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~~~~~ 1045 (1103)
.. ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......... .....++.....
T Consensus 159 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 159 DP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 32 1233456889999998765 56889999999999999999999998633210000 000001111000
Q ss_pred hcCcccccc-cccccCCC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDVF-NAELWASG-----PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~-~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... ..+.+ ........ ....+..+.++|.+|++.+|++||++++++.+
T Consensus 235 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SEN-TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred chh-hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000 00000 00000000 11345789999999999999999999999865
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=296.83 Aligned_cols=261 Identities=20% Similarity=0.352 Sum_probs=196.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------C
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------N 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 891 (1103)
.++|...+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 368999999999999999999754 689999999875432 22345688999999999999999999988654 3
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+++|+||+. .++.++.. ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||+++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 5699999995 47776652 2488999999999999999999999 99999999999999999999999999987
Q ss_pred ccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc---
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ--- 1047 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 1047 (1103)
.... ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||..... ...+ ......
T Consensus 166 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~-------~~~~-~~~~~~~~~ 233 (342)
T cd07879 166 HADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY-------LDQL-TQILKVTGV 233 (342)
T ss_pred CCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHH-HHHHHhcCC
Confidence 5422 2234467889999999876 4688899999999999999999999974321 0000 000000
Q ss_pred -----------Cccccccc--ccc----cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhc
Q 043720 1048 -----------GQVKDVFN--AEL----WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQIQH 1100 (1103)
Q Consensus 1048 -----------~~~~~~~~--~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 1100 (1103)
........ +.. ...........+.+++.+||+.||++||+++|++++ +++.++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00000000 000 000011244668899999999999999999999965 666543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=316.99 Aligned_cols=257 Identities=21% Similarity=0.282 Sum_probs=210.3
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 891 (1103)
++....++|.+.+.||+|+||.|..++++ +++.||+|++.+-.. ......|..|-++|..-..+=|+.++-.|.+..
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 34445678999999999999999999776 478899999976433 234577999999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
+.|+|||||+||+|-.+|.+.. .++++.++.++..|+-||.-+|+. |+|||||||+|||+|..|++|++|||.+.
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsCl 223 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCL 223 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHH
Confidence 9999999999999999998876 589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCccccc----c-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYAL----T-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~----~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
.+.....-.....+|||-|.+||++. + +.|+..+|.||+||++|||+.|..||+.. .++.....
T Consensus 224 km~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad--------slveTY~K--- 292 (1317)
T KOG0612|consen 224 KMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD--------SLVETYGK--- 292 (1317)
T ss_pred hcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH--------HHHHHHHH---
Confidence 88766666667789999999999985 3 67899999999999999999999999832 12222222
Q ss_pred cCcccccccccccCCCC--hhHHHHHHHHHHHccccCCCCCCC---HHHHHHH
Q 043720 1047 QGQVKDVFNAELWASGP--HDDLEDMLHLALRCTVETLSTRPT---MKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~evl~~ 1094 (1103)
+++..-...+| ...+....+||.+.+. +|+.|-. +.|+..|
T Consensus 293 ------Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H 338 (1317)
T KOG0612|consen 293 ------IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH 338 (1317)
T ss_pred ------HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence 22222222223 4466778888887664 5667766 7776654
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-31 Score=299.29 Aligned_cols=265 Identities=20% Similarity=0.257 Sum_probs=192.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC---------
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--------- 890 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------- 890 (1103)
.+|.+.+.||.|+||+||+|... ++..||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 57999999999999999999654 588999999866544 3457788999999999999999999766543
Q ss_pred -----CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEE
Q 043720 891 -----NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYL 964 (1103)
Q Consensus 891 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki 964 (1103)
...|+|+||++ ++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++. ++.+|+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 35799999996 5999888643 388999999999999999999999 9999999999999974 557899
Q ss_pred eecccccccCCCCCcc--ccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-------C
Q 043720 965 SDFGLSRLLGTSETHA--TTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD-------G 1034 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~~~--~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~-------~ 1034 (1103)
+|||.+.......... .....++..|+|||.+.. ..++.++|||||||++|||++|+.||......... .
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 9999997653221111 122356889999998654 56788999999999999999999999743210000 0
Q ss_pred cchHHHHHHHHhcCcccccccccccCC-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWAS-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........... ............... .......++.+++.+|+..||++||++.|++++
T Consensus 237 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 237 VVREEDRNELL-NVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred CCChHHhhhhh-hhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 00000000000 000000000000000 012345678899999999999999999999853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-30 Score=295.28 Aligned_cols=267 Identities=22% Similarity=0.345 Sum_probs=199.3
Q ss_pred HHHHHHHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC
Q 043720 813 YESIIRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG 890 (1103)
Q Consensus 813 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 890 (1103)
..++....++|++.+.||+|+||.||+|.. .+++.||+|++..... ....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 345666778999999999999999999964 5689999999875432 22346688899999999999999999987543
Q ss_pred ------CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEE
Q 043720 891 ------NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYL 964 (1103)
Q Consensus 891 ------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki 964 (1103)
...|++++++ +++|.++++.. .+++..+..++.|+++|++|||+. +|+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 3478888887 78999888653 389999999999999999999999 9999999999999999999999
Q ss_pred eecccccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 965 SDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
+|||++..... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... .........
T Consensus 162 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~ 233 (345)
T cd07877 162 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI----DQLKLILRL 233 (345)
T ss_pred ecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHH
Confidence 99999875432 2234467889999998866 56788999999999999999999998532210 000000000
Q ss_pred H----------HhcCcccccc---c---ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 L----------LRQGQVKDVF---N---AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~----------~~~~~~~~~~---~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .........+ . .............++.+++.+|++.||++||++.+++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 234 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred hCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0 0000000000 0 000000011235678999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=294.88 Aligned_cols=263 Identities=21% Similarity=0.342 Sum_probs=196.4
Q ss_pred HhcCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-----
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----- 891 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 891 (1103)
..++|++.+.||+|+||.||+|. ..++..||||++..... ....+.+.+|+.++++++||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 46789999999999999999995 44689999999865332 223456889999999999999999999886543
Q ss_pred -eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 892 -EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 892 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
.+++||||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.+|++|||++
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 469999999 77999888643 389999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC-------CCcchHHHHH
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHG-------DGFNIISWAS 1042 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~-------~~~~~~~~~~ 1042 (1103)
..... ......+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||........ .......+..
T Consensus 166 ~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T cd07880 166 RQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241 (343)
T ss_pred ccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 76532 2233456889999999876 4578899999999999999999999874321000 0000000000
Q ss_pred HHHhcCccccccc--ccc----cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1043 MLLRQGQVKDVFN--AEL----WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1043 ~~~~~~~~~~~~~--~~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
... ......... +.. ...........+.+++.+|++.||++||++.++++
T Consensus 242 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 242 KLQ-SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred hhc-chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 000000000 000 00011234567899999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=294.50 Aligned_cols=262 Identities=21% Similarity=0.302 Sum_probs=195.8
Q ss_pred cCCCC-cceeccCCcccEEEEEEc-CCcEEEEEEcccccchhh-------------HHHHHHHHHHHhcCCCCceeEEEe
Q 043720 821 GDFNT-SNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHG-------------VQQFHAEIKTLGNVRHPNLVTLIG 885 (1103)
Q Consensus 821 ~~~~~-~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~-------------~~~~~~E~~~l~~l~h~niv~l~~ 885 (1103)
++|.. .+.||+|+||+||+|... +++.||||++........ ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 567999999999999654 689999999865432210 124778999999999999999999
Q ss_pred EEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 886 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
++..++..++||||+. |+|.+++.... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.+|++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~ 161 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIA 161 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEEC
Confidence 9999999999999996 69999987643 388999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC-------------CccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043720 966 DFGLSRLLGTSE-------------THATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSH 1031 (1103)
Q Consensus 966 Dfgla~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 1031 (1103)
|||++....... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~- 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI- 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-
Confidence 999997654111 1111223467889999998764 4688999999999999999999998743211
Q ss_pred CCCcchHHHHHHHHhcCc---cc------------ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1032 GDGFNIISWASMLLRQGQ---VK------------DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~---~~------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.............. .. ....... .......+.++.+++.+|++.+|++||+++|++.+
T Consensus 241 ----~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 241 ----DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred ----HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 11111111000000 00 0000000 00112335678999999999999999999999864
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=286.65 Aligned_cols=250 Identities=23% Similarity=0.323 Sum_probs=196.4
Q ss_pred CCCCcceeccCCcccEEEEEEcC-CcEEEEEEccccc----chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGR----FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
+|.+.+.||+|+||+||++.... +..+++|+++... .......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 47888999999999999996653 4445555554322 122345677899999999999999999999998999999
Q ss_pred EeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 897 YNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||+++++|.++++.. ....+++.++..++.|+++|+.|||+. +++|+||+|+||++++ +.+|++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998752 235689999999999999999999999 9999999999999975 579999999987654
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.... ......+++.|+|||...+..++.++||||||+++|+|++|..||.... ......... ..
T Consensus 157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~--------~~~~~~~~~-~~------ 220 (260)
T cd08222 157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN--------FLSVVLRIV-EG------ 220 (260)
T ss_pred CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHHH-cC------
Confidence 3222 2233457889999999988888999999999999999999999986221 111111111 11
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+.++.+++.+|+..+|++||++.|++++
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 ---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 1112234566789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=287.04 Aligned_cols=261 Identities=25% Similarity=0.385 Sum_probs=199.1
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
|+..+.||+|.||.||+|... +++.||+|++..... ....+.+..|+.++++++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 556788999999999999766 489999999987542 223467788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
+ ++|.+++.... ..+++..+.+++.+++.|++|||+. +|+||||+|+||++++++.+||+|||.+........ .
T Consensus 81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~ 154 (282)
T cd07829 81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T 154 (282)
T ss_pred C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence 7 59999998753 3489999999999999999999999 999999999999999999999999999876643222 2
Q ss_pred ccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh---------cCc-
Q 043720 981 TTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR---------QGQ- 1049 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~~- 1049 (1103)
.....++..|+|||.+.+. .++.++||||||+++|||++|+.||..... ............ ...
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE-----IDQLFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHHHhCCCcHHHHHhhccc
Confidence 2233457789999998766 788999999999999999999988863221 000000000000 000
Q ss_pred --ccccccc---cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 --VKDVFNA---ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 --~~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.. ..........+..+.+++.+|+..+|++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000 00000011235679999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=280.76 Aligned_cols=241 Identities=23% Similarity=0.329 Sum_probs=201.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 896 (1103)
.+|....+||+|+||.|..|+-+ +.+.+|||+++++.. ..+++.-+.|..++..- +-|.++.++.++..-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 47999999999999999999544 468899999988754 23456667788888776 578999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+.||+|--.++.-.. +.+..+..+|.+||-||-+||++ +|++||||..|||++.+|++||+|||++..-- -
T Consensus 429 MEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-F 502 (683)
T ss_pred EEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc-c
Confidence 999999999988887544 88889999999999999999999 99999999999999999999999999997532 2
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
....+...+|||.|+|||++...+|+..+|.||+||++|||+.|++||++.+. .. ... .+.+.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE-----~e---lF~---------aI~eh 565 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-----DE---LFQ---------AIMEH 565 (683)
T ss_pred CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH-----HH---HHH---------HHHHc
Confidence 23345568999999999999999999999999999999999999999984322 11 111 11222
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCC
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRP 1086 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1086 (1103)
. -.+|...+.+..++.+..+.+.|.+|-
T Consensus 566 n--vsyPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 566 N--VSYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred c--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence 2 245677778899999999999999995
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=292.19 Aligned_cols=265 Identities=23% Similarity=0.321 Sum_probs=194.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-hHHHHHHHHHHHhcCCCCceeEEEeEEecC-------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGYRASG------- 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 890 (1103)
.++|++.+.||+|+||.||+|... +++.||||++......+ ....+.+|++++++++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999765 58899999986654322 234677899999999999999999876443
Q ss_pred -CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 891 -NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 891 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
..+++|+||+.+ ++..++... ...+++.++..++.|+++||+|||++ +|+||||||+||++++++.+|++|||+
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~ 161 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGL 161 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCcc
Confidence 357999999964 777777653 23599999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCc----------cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchH
Q 043720 970 SRLLGTSETH----------ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 970 a~~~~~~~~~----------~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1103)
++........ ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....... ..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~-----~~ 236 (311)
T cd07866 162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID-----QL 236 (311)
T ss_pred chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH-----HH
Confidence 9765432211 1123456788999998765 457889999999999999999999986432210 00
Q ss_pred HHHHHHHhc---------CcccccccccccCCC-------ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1039 SWASMLLRQ---------GQVKDVFNAELWASG-------PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1039 ~~~~~~~~~---------~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.-....... .......+....... .......+.+++.+|++.||++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 000000000 000000000000000 01223668899999999999999999998864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-31 Score=284.11 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=200.5
Q ss_pred cceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 826 SNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
.+.||+|.||+||-|+++ +|+.||||++.+-+.. +....+.+|+.+++.++||.||.+.-.|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 467999999999999654 6999999999887663 33467889999999999999999999999999999999999 55
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEEEeecccccccCCCCCcc
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~~~~~~~~ 980 (1103)
+..+.+-......+++..-..++.||+.||.|||.+ +|||+||||+|||+.... .+|+||||+|++.+ +...
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIg--EksF 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIG--EKSF 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecc--hhhh
Confidence 777766555556799998899999999999999999 999999999999996543 59999999999885 3455
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
+..++|||.|+|||++.+..|...-|+||.|||+|.-++|..||..... +..++.+.. ++.+.-
T Consensus 723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----------IndQIQNAa---FMyPp~-- 786 (888)
T KOG4236|consen 723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----------INDQIQNAA---FMYPPN-- 786 (888)
T ss_pred hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----------hhHHhhccc---cccCCC--
Confidence 6678999999999999999999999999999999999999999984322 111221111 111111
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.-.++....+++|...++..=++|.|..+.+.+
T Consensus 787 -PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 787 -PWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -chhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 113455678899999999999999998876643
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=280.41 Aligned_cols=237 Identities=27% Similarity=0.345 Sum_probs=195.4
Q ss_pred eccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCCh
Q 043720 829 IGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL 905 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL 905 (1103)
||+|+||.||++... +++.||+|++...... .....+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999765 4889999998765432 2466889999999999999999999999999999999999999999
Q ss_pred HHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCc
Q 043720 906 ENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985 (1103)
Q Consensus 906 ~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~ 985 (1103)
.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||++....... .......
T Consensus 81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~ 154 (250)
T cd05123 81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC 154 (250)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence 99998654 489999999999999999999998 99999999999999999999999999998754322 1233456
Q ss_pred ccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChh
Q 043720 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065 (1103)
Q Consensus 986 g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1103)
++..|+|||...+...+.++|+||||+++||+++|+.||..... ......... .....+..
T Consensus 155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--------~~~~~~~~~-----------~~~~~~~~ 215 (250)
T cd05123 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--------KEIYEKILK-----------DPLRFPEF 215 (250)
T ss_pred CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHhc-----------CCCCCCCC
Confidence 78899999999888889999999999999999999999863211 111111111 11123344
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHH
Q 043720 1066 DLEDMLHLALRCTVETLSTRPTMKQ 1090 (1103)
Q Consensus 1066 ~~~~l~~li~~cl~~dP~~RPs~~e 1090 (1103)
.+..+.+++.+||..||++||++++
T Consensus 216 ~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 216 LSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCHHHHHHHHHHhcCCHhhCCCccc
Confidence 4678899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=294.92 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=196.9
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe----
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE---- 892 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 892 (1103)
..++|++.+.||+|++|.||+|... +++.||||++..... ....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3567999999999999999999765 578999999865422 2234667889999999999999999987766554
Q ss_pred --EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 893 --MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 893 --~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
.++|+||+ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||+|+||+++.++.+||+|||++
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999999 67999998753 489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc-C
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ-G 1048 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~ 1048 (1103)
...... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...... ......... +
T Consensus 166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--------~~~~~i~~~~~ 233 (343)
T cd07851 166 RHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--------DQLKRIMNLVG 233 (343)
T ss_pred cccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--------HHHHHHHHhcC
Confidence 865322 233467889999998865 46788999999999999999999998633210 011110000 0
Q ss_pred c-------------ccccccc---ccc---CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 Q-------------VKDVFNA---ELW---ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 ~-------------~~~~~~~---~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ....+.. ... .......+.++.+++.+|++.+|++||++.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 0 0000000 000 00011235779999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-30 Score=290.81 Aligned_cols=266 Identities=22% Similarity=0.273 Sum_probs=192.9
Q ss_pred CCCCcceeccCCcccEEEEEEc-C--CcEEEEEEcccccch-hhHHHHHHHHHHHhcC-CCCceeEEEeEEec----CCe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-P--GILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNV-RHPNLVTLIGYRAS----GNE 892 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~ 892 (1103)
+|++.+.||+|+||.||+|... . +..||+|++...... ...+.+.+|+.+++++ .||||+++++++.. ...
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999765 3 678999998654322 2356788899999999 59999999987533 245
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+++||+. ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~ 154 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ--PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARG 154 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence 788999985 69999987543 489999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCc---cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC-------CcchHHHH
Q 043720 973 LGTSETH---ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD-------GFNIISWA 1041 (1103)
Q Consensus 973 ~~~~~~~---~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~-------~~~~~~~~ 1041 (1103)
....... ......|+..|+|||++.+ ..++.++||||+|+++|+|++|+.||........- ......+.
T Consensus 155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 234 (332)
T cd07857 155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL 234 (332)
T ss_pred cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 5432221 1234568899999998765 46889999999999999999999998643210000 00000000
Q ss_pred HHHHhcCccccc------ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1042 SMLLRQGQVKDV------FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1042 ~~~~~~~~~~~~------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...... ..... ................+.+++.+|++.||++||++.|++++
T Consensus 235 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 235 SRIGSP-KAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred Hhhhhh-hHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000 00000 00000000111235678999999999999999999999853
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=245.89 Aligned_cols=264 Identities=22% Similarity=0.346 Sum_probs=200.1
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhh-HHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+|+..++||+|.||+||+|+.. +++.||+|+++.+...+. -....+|+-+++.++|+|||+++++...+...-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4666788999999999999654 578899999988766544 34678999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
| ..+|..|...-. ..++.+.++.++.|+.+|+.++|++ ++.|||+||+|.+|+.+|..|++|||+++.++-+...
T Consensus 83 c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrc 157 (292)
T KOG0662|consen 83 C-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRC 157 (292)
T ss_pred h-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEe
Confidence 9 569999987643 4589999999999999999999999 9999999999999999999999999999988755433
Q ss_pred cccCCcccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH--hcCcc---ccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL--RQGQV---KDV 1053 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~ 1053 (1103)
....+-|.+|.+|+++.+.. |++..|+||.||++.|+...+.|..+.....+ +....++..- ..+.+ .+.
T Consensus 158 -ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd---qlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 158 -YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD---QLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred -eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH---HHHHHHHHhCCCccccCCccccC
Confidence 23345689999999998764 78889999999999999987777664432211 1111111100 00111 111
Q ss_pred ccccccCCCC-----hhH----HHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 FNAELWASGP-----HDD----LEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~-----~~~----~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.|-.....++ .+. ...=.+++.+.+.-+|.+|.++++.+++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 1111111111 111 1223578888899999999999998864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=311.27 Aligned_cols=146 Identities=32% Similarity=0.507 Sum_probs=131.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|.+.+.||+|+||+||+|... +++.||||+++.... ......+.+|+.+++.++|+||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57899999999999999999766 689999999875432 234567889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
||+.+++|.++++... .+++..+++++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 378899999999999999999999 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=294.59 Aligned_cols=260 Identities=23% Similarity=0.394 Sum_probs=212.9
Q ss_pred HHHHHHHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEec-
Q 043720 813 YESIIRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRAS- 889 (1103)
Q Consensus 813 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~- 889 (1103)
++.+...++.|++...||+|.+|.||+++. ++++.+|||+.....+.+ ++++.|+++++.. .|||++.++|++..
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 334444567799999999999999999954 468889999887665443 5667788888888 59999999998854
Q ss_pred ----CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 890 ----GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 890 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
++.+|+|||||.+|+.-++++...+..+.|..+..|++.++.|+.|||.. .++|||+|-.|||++.++.||++
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence 56899999999999999999988888899999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH
Q 043720 966 DFGLSRLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 966 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
|||++..+.. ....+....|||.|||||++. ...|+.++|+||+|++..||--|.+|+....+..
T Consensus 166 DFGvSaQlds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr--------- 235 (953)
T KOG0587|consen 166 DFGVSAQLDS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR--------- 235 (953)
T ss_pred eeeeeeeeec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------
Confidence 9999987643 234455678999999999985 3456778999999999999999999987543311
Q ss_pred HHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1041 ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+. -.-.+......+.....++.++|..|+..|-++||++.+++++
T Consensus 236 --aLF~-----IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 236 --ALFL-----IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred --hhcc-----CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 1110 0112233334567778899999999999999999999998864
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=275.36 Aligned_cols=220 Identities=24% Similarity=0.236 Sum_probs=177.0
Q ss_pred CCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChHHHHH
Q 043720 832 GGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIK 910 (1103)
Q Consensus 832 G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~ 910 (1103)
|.+|.||++.. .+++.||+|++.... .+.+|...+....|||++++++++...+..++||||+++|+|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 89999999955 468899999987543 22344455555679999999999999999999999999999999997
Q ss_pred hhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccc
Q 043720 911 ARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY 990 (1103)
Q Consensus 911 ~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y 990 (1103)
+.. .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 78 ~~~--~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 78 KFL--NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred Hhc--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 654 389999999999999999999999 9999999999999999999999999987655322 2233456789
Q ss_pred cCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHH
Q 043720 991 VAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDM 1070 (1103)
Q Consensus 991 ~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1070 (1103)
+|||......++.++||||+|+++|||++|+.|+....... . .......+...+..+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~----------------~-------~~~~~~~~~~~~~~~ 205 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI----------------N-------THTTLNIPEWVSEEA 205 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc----------------c-------cccccCCcccCCHHH
Confidence 99999988889999999999999999999998765221100 0 000011223345678
Q ss_pred HHHHHHccccCCCCCCCHH
Q 043720 1071 LHLALRCTVETLSTRPTMK 1089 (1103)
Q Consensus 1071 ~~li~~cl~~dP~~RPs~~ 1089 (1103)
.+++.+|++.||++||++.
T Consensus 206 ~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 206 RSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHccCCHHHhcCCC
Confidence 9999999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=287.96 Aligned_cols=240 Identities=25% Similarity=0.314 Sum_probs=193.5
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+++|+....+|.|+|+.|-.+.. .+++..+||++.... .+-.+|+.++... .||||++..+.+.++.+.|+||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 34677778899999999998854 457889999987652 2233566555555 6999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE-CCCCCEEEeecccccccCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL-DDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll-~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|.+.++-+.+.+...+. .. ..+..|+.+|+.++.|||++ +||||||||+|||+ ++.++++|+|||.++.....
T Consensus 396 e~l~g~ell~ri~~~~~--~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE--FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hhccccHHHHHHHhcch--hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 99999988888776543 33 67778999999999999999 99999999999999 68999999999999876543
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
....+-|..|.|||++....|++++|+||||+++|+|++|+.||.....+ .+.. ..+
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-------~ei~-~~i----------- 526 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-------IEIH-TRI----------- 526 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-------HHHH-Hhh-----------
Confidence 22335578999999999999999999999999999999999999743221 0011 111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...++.........+|+.+|++.||.+||+++++..+
T Consensus 527 -~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 527 -QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred -cCCccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 1112235667789999999999999999999999765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-30 Score=270.59 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=200.0
Q ss_pred hcCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CC-----ceeEEEeEEecCCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HP-----NLVTLIGYRASGNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~ 892 (1103)
+++|.+...+|+|+||.|-++ +...+..||||+++.. ....+..+-|++++.++. +. -+|.+.+|+...++
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V--~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV--DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH--HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 678999999999999999999 4445899999998743 334566778999999993 22 36788889999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC--------------
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-------------- 958 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-------------- 958 (1103)
.|+|+|.+ |-++.++++.+...+++..++..++.|+++++++||+. +++|.||||+||++.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccc
Confidence 99999999 66999999998888899999999999999999999999 9999999999999931
Q ss_pred ------CCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043720 959 ------DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032 (1103)
Q Consensus 959 ------~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 1032 (1103)
+..+|++|||.|+...... ...+.|..|.|||++.+..++.++||||+|||++|+.||..-|+.-..
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen--- 314 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN--- 314 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc---
Confidence 3458999999998653222 456779999999999999999999999999999999999988874331
Q ss_pred CCcchHHHHHHH-----------------HhcCccc-----------ccccccc----cCCCChhHHHHHHHHHHHcccc
Q 043720 1033 DGFNIISWASML-----------------LRQGQVK-----------DVFNAEL----WASGPHDDLEDMLHLALRCTVE 1080 (1103)
Q Consensus 1033 ~~~~~~~~~~~~-----------------~~~~~~~-----------~~~~~~~----~~~~~~~~~~~l~~li~~cl~~ 1080 (1103)
.+.+. ....+ ...+.++ .+.+... ...........+.+|+.+|+..
T Consensus 315 -~EHLa-MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 315 -LEHLA-MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred -HHHHH-HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 11110 00000 0000000 0000000 0011123456699999999999
Q ss_pred CCCCCCCHHHHHHH
Q 043720 1081 TLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1081 dP~~RPs~~evl~~ 1094 (1103)
||.+|+|++|++.+
T Consensus 393 DP~~RiTl~EAL~H 406 (415)
T KOG0671|consen 393 DPARRITLREALSH 406 (415)
T ss_pred CccccccHHHHhcC
Confidence 99999999999865
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-31 Score=259.48 Aligned_cols=264 Identities=25% Similarity=0.358 Sum_probs=196.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhh-HHHHHHHHHHHhcCCCCceeEEEeEEec--------C
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGYRAS--------G 890 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 890 (1103)
+.|+...+||+|.||+||+|+.+ +|+.||+|++-.+..++. -....+|+.++..+.|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 45666788999999999999665 477789988765443322 3456789999999999999999987744 3
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
..+|+||++|+. +|.-.+.... ..++..++.+++.++..||.|+|.. .|+|||+|+.|+||+.+|.+||+|||++
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~-vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRK-VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCcc-ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccc
Confidence 368999999976 8988887653 4589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 971 RLLGTSET---HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 971 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
+.+..+.. ...+..+-|..|.+||.+.+ ..|+.+.|||..||++.||+||.+-+.....+ .....+.....
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteq-----qql~~Is~LcG 246 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQ-----QQLHLISQLCG 246 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHH-----HHHHHHHHHhc
Confidence 87754332 22334566899999998865 56899999999999999999999877644321 11111111110
Q ss_pred ---cCcccccccccccCC-----C-------------ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 ---QGQVKDVFNAELWAS-----G-------------PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ---~~~~~~~~~~~~~~~-----~-------------~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+.+..+..-+++.. . +-.-.+...+++.+++..||.+|+++++++.+
T Consensus 247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 011111111000000 0 00112357889999999999999999999865
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=243.97 Aligned_cols=205 Identities=27% Similarity=0.399 Sum_probs=171.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++......||+|++|.|-+.++. +|+..|||.++.....+..++..+|+++..+. .+|.+|+++|.....+..++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344555677999999999888554 68999999998877777778888899877665 6999999999999999999999
Q ss_pred eecCCCChHHHHHh--hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|.|. .+|..+-++ ..+..+++..+-+||..+++||.|||++. .++|||+||+|||++.+|++||||||.+..+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9994 588887654 23456899999999999999999999986 999999999999999999999999999987643
Q ss_pred CCCccccCCcccccccCccccc----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC
Q 043720 976 SETHATTGVAGTFGYVAPEYAL----TCRVSDKADVYSYGVVLLELISDKKALDPSFS 1029 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~----~~~~~~~sDvwslGvil~elltg~~p~~~~~~ 1029 (1103)
+.. .+.-.|-..|||||.+. ...|+.|+||||+|+++.||.+++.||+.+..
T Consensus 202 SiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 202 SIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred hhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 322 22234667899999884 34789999999999999999999999985443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-30 Score=290.96 Aligned_cols=243 Identities=25% Similarity=0.364 Sum_probs=188.7
Q ss_pred CCcceeccCCccc-EEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeecC
Q 043720 824 NTSNCIGSGGFGT-TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 824 ~~~~~lg~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
...+.+|.|+.|+ ||+|... |+.||||++-.. ....+.+|+..++.- +|||||++++...+.+..|++.|.|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEE----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC-CceehHHHHhhH----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 3345689999986 7999877 889999988543 334567899999998 5999999999999999999999999
Q ss_pred CCChHHHHHhh-cC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---C--CCEEEeecccccccC
Q 043720 902 GGNLENFIKAR-TS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---D--FNAYLSDFGLSRLLG 974 (1103)
Q Consensus 902 ~gsL~~~l~~~-~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~--~~~ki~Dfgla~~~~ 974 (1103)
..+|.++++.. .. ........+.+..|+++|++|||+. +||||||||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999874 11 1112145577889999999999998 9999999999999975 3 469999999999885
Q ss_pred CCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 975 TSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISD-KKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 975 ~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.+.. ....+..||.+|+|||.+....-+.++||||+||++|+.++| .+||+.....+ ..+......
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------~NIl~~~~~- 731 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------ANILTGNYT- 731 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------hhhhcCccc-
Confidence 4433 234567899999999999988888899999999999999997 89998432211 111111110
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
-.......++ ...+||.+|++++|..||++.+|+.
T Consensus 732 -----L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 732 -----LVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred -----eeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0001111122 7899999999999999999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=279.62 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=207.1
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCc-EEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGI-LVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~-~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.+++.+..||-|+||.|-.+..+... .+|+|.+++... +...+.+..|-.+|...+.|.||++|--+.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999999766443 378888876532 345677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|-|-||.++..++++.. ++......++..+.+|++|||++ +||+|||||+|.+++.+|.+|+.|||+|+..+...
T Consensus 500 EaClGGElWTiLrdRg~--Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGS--FDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred HhhcCchhhhhhhhcCC--cccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 99999999999998764 99999999999999999999999 99999999999999999999999999999886543
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
++-.++|||.|.|||++.+...+.++|.||+|+++||+++|.+||...++. ..+ ..+.+.-+
T Consensus 575 --KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm-------ktY-n~ILkGid-------- 636 (732)
T KOG0614|consen 575 --KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM-------KTY-NLILKGID-------- 636 (732)
T ss_pred --ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH-------HHH-HHHHhhhh--------
Confidence 344679999999999999999999999999999999999999999855432 111 11111111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
....|..+.....++|++....+|.+|-- ..||.+|
T Consensus 637 -~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH 677 (732)
T KOG0614|consen 637 -KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH 677 (732)
T ss_pred -hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence 12345677788899999999999999975 5555554
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-29 Score=254.76 Aligned_cols=250 Identities=19% Similarity=0.306 Sum_probs=202.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|.+.++||+|+|..|..++++ +.+.+|+|++++.-. .+.+.-++.|..+..+- +||.+|.+..++......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999665 578899999987643 33444456676666655 69999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|.||++||+|--.+++.+. ++++.++.+...|+-||.|||++ +|++||+|..|||+|.+|++|++|+|+++.- -
T Consensus 329 vieyv~ggdlmfhmqrqrk--lpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~-l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG-L 402 (593)
T ss_pred EEEEecCcceeeehhhhhc--CcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC-C
Confidence 9999999999888876544 99999999999999999999999 9999999999999999999999999999753 2
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.....+..++|||.|.|||++.+..|.+.+|.|++||+++||+.|+.||+--.. +..+.+..++....+-...
T Consensus 403 ~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm-~n~d~ntedylfqvilekq------ 475 (593)
T KOG0695|consen 403 GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGM-DNPDMNTEDYLFQVILEKQ------ 475 (593)
T ss_pred CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecC-CCcccchhHHHHHHHhhhc------
Confidence 333455678999999999999999999999999999999999999999984432 2233344444444332221
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCC
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRP 1086 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1086 (1103)
+ ..|.....+...+++.-+.+||++|-
T Consensus 476 --i--riprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 476 --I--RIPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred --c--cccceeehhhHHHHHHhhcCCcHHhc
Confidence 1 12334445567888899999999885
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=265.92 Aligned_cols=239 Identities=30% Similarity=0.430 Sum_probs=195.0
Q ss_pred CcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChHHHHHh
Q 043720 833 GFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKA 911 (1103)
Q Consensus 833 ~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~ 911 (1103)
+||.||+|.... ++.+|+|++.........+.+.+|+..+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998764 8999999998765544368899999999999999999999999999999999999999999999976
Q ss_pred hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCccccccc
Q 043720 912 RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991 (1103)
Q Consensus 912 ~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~ 991 (1103)
... +++..+..++.+++.++.|||+. +++|+||+|+||+++.++.++++|||.+....... ......++..|+
T Consensus 81 ~~~--~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~ 153 (244)
T smart00220 81 RGR--LSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM 153 (244)
T ss_pred ccC--CCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence 543 88999999999999999999999 99999999999999999999999999998764432 333456788999
Q ss_pred CccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHH
Q 043720 992 APEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDML 1071 (1103)
Q Consensus 992 aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1071 (1103)
+||......++.++||||+|+++|++++|..||..... . ...... ........ .......+.++.
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~----~---~~~~~~-~~~~~~~~-------~~~~~~~~~~~~ 218 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ----L---LELFKK-IGKPKPPF-------PPPEWKISPEAK 218 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc----H---HHHHHH-HhccCCCC-------ccccccCCHHHH
Confidence 99999888889999999999999999999999863211 1 111111 11110000 000001557899
Q ss_pred HHHHHccccCCCCCCCHHHHHH
Q 043720 1072 HLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1072 ~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
+++.+|+..+|++||++.++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHccCCchhccCHHHHhh
Confidence 9999999999999999999987
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.4e-29 Score=272.51 Aligned_cols=214 Identities=25% Similarity=0.415 Sum_probs=180.8
Q ss_pred HHHHHHHh---cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeE
Q 043720 813 YESIIRAT---GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886 (1103)
Q Consensus 813 ~~~~~~~~---~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~ 886 (1103)
|..+.++. .-|..++.||-|+||+|.++ +.++...||+|.+.+... ...+..++.|-++|..-..+=||+++-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44444443 34778899999999999999 455577899999987655 3356778999999999999999999999
Q ss_pred EecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 887 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
|.+.+.+|+||||++||++-.+|-+..- +++..++.++.+++.|+++.|.+ |+|||||||.|||||.+|++|++|
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTD 772 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTD 772 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeee
Confidence 9999999999999999999999877653 88888999999999999999999 999999999999999999999999
Q ss_pred cccccccCC---CC-----Cc---------------------------------cccCCcccccccCccccccCCCCCcc
Q 043720 967 FGLSRLLGT---SE-----TH---------------------------------ATTGVAGTFGYVAPEYALTCRVSDKA 1005 (1103)
Q Consensus 967 fgla~~~~~---~~-----~~---------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~s 1005 (1103)
||+++-+.- .. .+ .....+||+.|+|||++....|+..+
T Consensus 773 FGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~c 852 (1034)
T KOG0608|consen 773 FGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLC 852 (1034)
T ss_pred ccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccc
Confidence 999864310 00 00 01124699999999999999999999
Q ss_pred hhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043720 1006 DVYSYGVVLLELISDKKALDPSFSSH 1031 (1103)
Q Consensus 1006 DvwslGvil~elltg~~p~~~~~~~~ 1031 (1103)
|.||.|||+|||+.|+.||-...+.+
T Consensus 853 dwws~gvil~em~~g~~pf~~~tp~~ 878 (1034)
T KOG0608|consen 853 DWWSVGVILYEMLVGQPPFLADTPGE 878 (1034)
T ss_pred hhhHhhHHHHHHhhCCCCccCCCCCc
Confidence 99999999999999999998665544
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=294.32 Aligned_cols=262 Identities=19% Similarity=0.270 Sum_probs=171.4
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcC-----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeE------E
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY------R 887 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 887 (1103)
..++|++.+.||+|+||+||+|.... +..||||++...... +.+..| .+....+.++..+... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 45789999999999999999997654 689999987643221 111111 1111122222222111 2
Q ss_pred ecCCeEEEEEeecCCCChHHHHHhhcC------------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCC
Q 043720 888 ASGNEMFLIYNYLPGGNLENFIKARTS------------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDV 949 (1103)
Q Consensus 888 ~~~~~~~lV~E~~~~gsL~~~l~~~~~------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dl 949 (1103)
..+...++|+||+.+++|.++++.... .......+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 456789999999999999999875421 0112344668999999999999999 9999999
Q ss_pred CCCcEEECC-CCCEEEeecccccccCCCCCccccCCcccccccCccccccC----------------------CCCCcch
Q 043720 950 KPSNILLDD-DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC----------------------RVSDKAD 1006 (1103)
Q Consensus 950 k~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~----------------------~~~~~sD 1006 (1103)
||+|||++. ++.+||+|||+++.......+......++++|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999985 57899999999987654444445566789999999965321 2345679
Q ss_pred hHHHHHHHHHHHhCCCCCCCCCCC-----CCCCcchHHHHHHHHhcCccccccccccc--CCCChhHHHHHHHHHHHccc
Q 043720 1007 VYSYGVVLLELISDKKALDPSFSS-----HGDGFNIISWASMLLRQGQVKDVFNAELW--ASGPHDDLEDMLHLALRCTV 1079 (1103)
Q Consensus 1007 vwslGvil~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~ 1079 (1103)
|||+||++|||+++..+++..... .........|....... ..+... .+..........+|+.+|++
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 999999999999876554311000 00001111221111000 000000 00001112345689999999
Q ss_pred cCCCCCCCHHHHHHH
Q 043720 1080 ETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1080 ~dP~~RPs~~evl~~ 1094 (1103)
.||++|||++|++++
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999975
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=283.93 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=183.2
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-----------------cCCcEEEEEEcccccchh-------------hHHHHHHH
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-----------------SPGILVAVKKLAVGRFQH-------------GVQQFHAE 868 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-----------------~~~~~vavK~~~~~~~~~-------------~~~~~~~E 868 (1103)
..++|++.++||+|+||+||+|.. ..++.||||++....... ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999953 235689999986543211 11234457
Q ss_pred HHHHhcCCCCce-----eEEEeEEec--------CCeEEEEEeecCCCChHHHHHhhcC---------------------
Q 043720 869 IKTLGNVRHPNL-----VTLIGYRAS--------GNEMFLIYNYLPGGNLENFIKARTS--------------------- 914 (1103)
Q Consensus 869 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~--------------------- 914 (1103)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...+
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777643 3568999999999999999874311
Q ss_pred -CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCc
Q 043720 915 -RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993 (1103)
Q Consensus 915 -~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aP 993 (1103)
..+++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++...............+++.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 1246778899999999999999999 999999999999999999999999999976543322222223457899999
Q ss_pred cccccCC--------------------C--CCcchhHHHHHHHHHHHhCCC-CCCCCCCCCCC----CcchHHHHHHHHh
Q 043720 994 EYALTCR--------------------V--SDKADVYSYGVVLLELISDKK-ALDPSFSSHGD----GFNIISWASMLLR 1046 (1103)
Q Consensus 994 E~~~~~~--------------------~--~~~sDvwslGvil~elltg~~-p~~~~~~~~~~----~~~~~~~~~~~~~ 1046 (1103)
|.+.... + ..+.||||+||++|||++|.. |+......... ......|.. ..
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~--~~ 457 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM--YK 457 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh--hc
Confidence 9875322 1 134799999999999999875 55421111000 011111111 00
Q ss_pred cCcccccccccccCCCChhHHHHHHHHHHHccccCC---CCCCCHHHHHHH
Q 043720 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETL---STRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~evl~~ 1094 (1103)
.. ....+..........+++.+|+..+| .+|+|++|+++|
T Consensus 458 ~~--------~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 458 GQ--------KYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred cc--------CCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 11 11111123345678899999999866 789999999875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=259.17 Aligned_cols=266 Identities=25% Similarity=0.343 Sum_probs=200.0
Q ss_pred hcCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC--------CCceeEEEeEEec-
Q 043720 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR--------HPNLVTLIGYRAS- 889 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~~- 889 (1103)
.++|.+.++||.|.|++||+| +....+.||+|+.+.+. ...+..+.||.++++++ ..+||++++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 357999999999999999999 56678999999988664 34567788999999984 2579999998855
Q ss_pred ---CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-------
Q 043720 890 ---GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD------- 959 (1103)
Q Consensus 890 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~------- 959 (1103)
+.++|||+|++ |.+|..+++...-+.++...+++|++||+.||.|||..| +|+|.||||+|||+..+
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 55899999999 779999999877788999999999999999999999999 99999999999999310
Q ss_pred ----C---------------------------------------------------------------------------
Q 043720 960 ----F--------------------------------------------------------------------------- 960 (1103)
Q Consensus 960 ----~--------------------------------------------------------------------------- 960 (1103)
+
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence 0
Q ss_pred --------------------------------------------------------------------------------
Q 043720 961 -------------------------------------------------------------------------------- 960 (1103)
Q Consensus 961 -------------------------------------------------------------------------------- 960 (1103)
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence
Q ss_pred CEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC--CCCcchH
Q 043720 961 NAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSH--GDGFNII 1038 (1103)
Q Consensus 961 ~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~ 1038 (1103)
+|||+|||-|..+... .+.-..|..|+|||++.+..|++.+||||++|++||+.||..-|++-.+.. .++..+.
T Consensus 392 ~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 0233333333222111 011124678999999999999999999999999999999999998654432 2222222
Q ss_pred HHHHHH-------Hh-cCccccccccc----------c---------cCCCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 043720 1039 SWASML-------LR-QGQVKDVFNAE----------L---------WASGPHDDLEDMLHLALRCTVETLSTRPTMKQV 1091 (1103)
Q Consensus 1039 ~~~~~~-------~~-~~~~~~~~~~~----------~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1091 (1103)
..++.. .. .....++++.. . +-..+.+...++.+++.-||+.+|++||||++.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 222211 11 11122232221 1 123467778889999999999999999999999
Q ss_pred HHH
Q 043720 1092 VQC 1094 (1103)
Q Consensus 1092 l~~ 1094 (1103)
+++
T Consensus 548 l~h 550 (590)
T KOG1290|consen 548 LKH 550 (590)
T ss_pred hcC
Confidence 864
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-28 Score=236.43 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=194.8
Q ss_pred cCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecC--CeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASG--NEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lV 896 (1103)
++|++.+++|+|.+++||.|. ..+.+.++||+++-. ..+.+++|+.++..+. ||||++++++..+. ....+|
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 578999999999999999994 456788999998643 3567899999999998 99999999988664 467899
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLGT 975 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~ 975 (1103)
+||+.+.+....-.. ++..++..++.++++||.|+|++ ||+|||+||.|+++|... ..+++|+|+|.++.+
T Consensus 114 FE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999999888776543 77788999999999999999999 999999999999999654 599999999998865
Q ss_pred CCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC------
Q 043720 976 SETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG------ 1048 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------ 1048 (1103)
...+. ..+.+..|.-||.+.+ ..|+..-|+|||||++..|+..+.||.-..+..+ +++.... .....
T Consensus 186 ~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D---QLVkIak-VLGt~el~~Yl 259 (338)
T KOG0668|consen 186 GKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD---QLVKIAK-VLGTDELYAYL 259 (338)
T ss_pred Cceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH---HHHHHHH-HhChHHHHHHH
Confidence 54433 3356778899999875 4578889999999999999999999974433211 1111110 00000
Q ss_pred -cccccccccc-----------cCCC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 -QVKDVFNAEL-----------WASG-----PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 -~~~~~~~~~~-----------~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+.-.+++.. |..+ ..-..+++.+++.+.+..|..+|||++|...+
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 0000111111 1111 12234778999999999999999999998753
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-29 Score=249.46 Aligned_cols=263 Identities=24% Similarity=0.377 Sum_probs=195.9
Q ss_pred CCCCcceeccCCcccEEEE-EEcCCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----CeEE
Q 043720 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 894 (1103)
+.+-.+.||-|+||+||.+ +-++|+.||.|++.... .-...+.+-+|+.++..++|.|++..+++.... .+.|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3455678999999999998 55679999999885432 122456788999999999999999988876543 2568
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+|+|.|. .+|.+.+-. ...++.+.++-+..||++|+.|||+. +|.||||||.|.+++.+...||||||+++...
T Consensus 134 V~TELmQ-SDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELMQ-SDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHH-hhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 8888884 477776643 24588888999999999999999999 99999999999999999999999999999876
Q ss_pred CCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc--
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK-- 1051 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1051 (1103)
.++....+..+-|..|.|||++.+. .|+.+.||||.||++.|++.++.-|....+ ....+.+.........+
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-----iqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-----IEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-----HHHHHHHHHHhCCCcHHHH
Confidence 6665556666778999999999875 589999999999999999998888764322 11122222111111100
Q ss_pred ---------ccccccc---------cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1052 ---------DVFNAEL---------WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1052 ---------~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
.++.... ....+.....+...+...++..||++|.+..+.+.++
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0111111 1111223345567888899999999999999887654
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=237.44 Aligned_cols=212 Identities=34% Similarity=0.594 Sum_probs=186.4
Q ss_pred eccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChHH
Q 043720 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLEN 907 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~ 907 (1103)
||+|.+|.||++.... ++.+++|++.........+.+.+|+..++.++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997765 899999999876554346789999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecccccccCCCCCccccCCcc
Q 043720 908 FIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGTSETHATTGVAG 986 (1103)
Q Consensus 908 ~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~~~~~~~~g 986 (1103)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus 81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 81 LLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 998652 3488999999999999999999999 9999999999999999 89999999999987643321 2333456
Q ss_pred cccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChh
Q 043720 987 TFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065 (1103)
Q Consensus 987 ~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1065 (1103)
...|++||..... .++.++|+|++|+++++|
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 7899999999877 788999999999999999
Q ss_pred HHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1066 DLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1066 ~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 4589999999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-27 Score=260.20 Aligned_cols=200 Identities=24% Similarity=0.354 Sum_probs=171.9
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchh--hHH-----HHHHHHHHHhcCC---CCceeEEEeE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQH--GVQ-----QFHAEIKTLGNVR---HPNLVTLIGY 886 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~--~~~-----~~~~E~~~l~~l~---h~niv~l~~~ 886 (1103)
+...+|...+.+|.|+||.|+.|.++. ...|+||.+.+.+.-. +++ .+-.|+++|..++ |+||++++++
T Consensus 558 ~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdf 637 (772)
T KOG1152|consen 558 KKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDF 637 (772)
T ss_pred cccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhe
Confidence 445679999999999999999997664 5678999987765311 122 2556999999997 9999999999
Q ss_pred EecCCeEEEEEeecC-CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 887 RASGNEMFLIYNYLP-GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 887 ~~~~~~~~lV~E~~~-~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
|++++.+|++||... +.+|.+++..+++ +++.+...|++||+.|+++||++ +|||||||-+||.++.+|.+|++
T Consensus 638 FEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 638 FEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred eecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEe
Confidence 999999999999863 5599999987665 99999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccCCcccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCC
Q 043720 966 DFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVS-DKADVYSYGVVLLELISDKKALD 1025 (1103)
Q Consensus 966 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~ 1025 (1103)
|||.|..... .....++||..|.|||++.+..|- ..-|||++|+++|.++....||+
T Consensus 713 dfgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999876543 234567899999999999988874 45799999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-27 Score=237.48 Aligned_cols=249 Identities=19% Similarity=0.299 Sum_probs=192.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEe-EEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIG-YRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~-~~~~~~~~~lV 896 (1103)
.+.|.+.+.+|+|.||.+-.++++. .+.+++|-+...... .++|.+|..---.+ .|.||+.-++ .|...+.++++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3579999999999999999998775 678999988766544 58899998877777 5999998876 56777889999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC--CCCCEEEeecccccccC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD--DDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgla~~~~ 974 (1103)
+||++.|+|.+-+... .+.+....+++.|++.|+.|||++ ++||||||.+||||- +..++|+||||..+..+
T Consensus 101 qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred eccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999999988654 388889999999999999999999 999999999999993 33479999999998765
Q ss_pred CCCCccccCCcccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALT-----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
....+ ...+..|.+||.... ....+.+|||.||+++|.++||+.||......+.....+.+|.. +.
T Consensus 175 ~tV~~----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~-----rk 245 (378)
T KOG1345|consen 175 TTVKY----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK-----RK 245 (378)
T ss_pred ceehh----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc-----cc
Confidence 43222 223567999997743 23456789999999999999999999966555544444444433 22
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQV 1091 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ev 1091 (1103)
.... +.......+.+.++.++-+.++|++|=-..++
T Consensus 246 ~~~~------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~ 281 (378)
T KOG1345|consen 246 NPAL------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA 281 (378)
T ss_pred CccC------chhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence 2211 11123445678889999999999999433333
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=241.43 Aligned_cols=256 Identities=25% Similarity=0.354 Sum_probs=196.9
Q ss_pred cCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------Ce
Q 043720 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------NE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 892 (1103)
.+|.-.+.+|.|.- .|..| +.-.+++||+|+...... ....++..+|..++..+.|+|+++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35666778888888 55555 444589999999866522 33467788999999999999999999988553 36
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+|||+| .++|...+... ++-+.+..+..|++.|+.|||+. +|+||||||+||++..++.+||.|||+|+.
T Consensus 96 ~y~v~e~m-~~nl~~vi~~e----lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~ 167 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILME----LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLART 167 (369)
T ss_pred HHHHHHhh-hhHHHHHHHHh----cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcc
Confidence 89999999 56999988732 67789999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc--
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV-- 1050 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1050 (1103)
-+.. ...+.++.+..|.|||++.+..|.+.+||||.||++.||++|+.-|.+.. .+-+|.+..-.-+..
T Consensus 168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d-------~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD-------HIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch-------HHHHHHHHHHHhcCCCH
Confidence 5432 45667788999999999999889999999999999999999998876322 223332222111111
Q ss_pred -------------------------cccccccccC---CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 -------------------------KDVFNAELWA---SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 -------------------------~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+.+....+. ..+.-....+.+++.+|+..+|++|-|+++++++
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111111 1122334567899999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-27 Score=264.02 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=204.2
Q ss_pred hcCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|+..+++|.|.+|.||+|+ ...++..|||+++..... ..+-..+|+-+++..+|||||.++|.+...+..++.||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d-d~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD-DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc-cccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 3579999999999999999995 446899999999876544 56777889999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
||.+|+|.+.-+.. .++++.++..+++...+|++|||++ +-+|||||-.||++++.|.+|++|||.+..+... .
T Consensus 93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat-i 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT-I 166 (829)
T ss_pred ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh-h
Confidence 99999999976644 4589999999999999999999999 9999999999999999999999999998776432 3
Q ss_pred ccccCCcccccccCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 979 HATTGVAGTFGYVAPEYA---LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.++..+.||+.|||||+. ..+.|..++|||+.|+...|+-.-++|...-.++ +...... . ..++
T Consensus 167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--------r~l~LmT--k---S~~q 233 (829)
T KOG0576|consen 167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--------RALFLMT--K---SGFQ 233 (829)
T ss_pred hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--------HHHHHhh--c---cCCC
Confidence 355678899999999986 3567889999999999999998777664322111 0111100 0 0111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
+. ...........+.++++.|+..+|++||++..+++
T Consensus 234 pp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CC-cccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 11 12223455677899999999999999999988765
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-24 Score=232.45 Aligned_cols=199 Identities=32% Similarity=0.516 Sum_probs=173.7
Q ss_pred CCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecC
Q 043720 823 FNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
|.+.+.||+|++|+||+|.... ++.+|+|.+.........+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5567889999999999997775 889999999876544356788999999999999999999999999999999999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccc
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+++|.+++...... +++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+...........
T Consensus 81 ~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 81 GGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999999865422 78899999999999999999999 999999999999999999999999999987654321122
Q ss_pred cCCcccccccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 043720 982 TGVAGTFGYVAPEYA-LTCRVSDKADVYSYGVVLLELISDKKALD 1025 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~~ 1025 (1103)
....++..|++||.. ....++.++|||+||++++||++|+.||+
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~ 201 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFS 201 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcc
Confidence 344677889999998 67778889999999999999999999996
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.5e-25 Score=235.51 Aligned_cols=270 Identities=22% Similarity=0.305 Sum_probs=199.8
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEe
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRA 888 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 888 (1103)
+.+....+.|..+++||+|.|++||+|... ..+.||+|.+...... ..+..|++++..+. +.||+++.+++.
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~r 105 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFR 105 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhc
Confidence 334455678999999999999999999433 4788999999876544 56889999999995 999999999999
Q ss_pred cCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC-CCCCEEEeec
Q 043720 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDF 967 (1103)
Q Consensus 889 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Df 967 (1103)
.++...+|+||+++....++... ++..++..++..+.+||.++|.. ||||||+||.|++.+ ..+.-.|.||
T Consensus 106 nnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 106 NNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred cCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 99999999999999999998865 66789999999999999999999 999999999999997 4567899999
Q ss_pred ccccccCC----------------C-----------------C----------CccccCCcccccccCcccccc-CCCCC
Q 043720 968 GLSRLLGT----------------S-----------------E----------THATTGVAGTFGYVAPEYALT-CRVSD 1003 (1103)
Q Consensus 968 gla~~~~~----------------~-----------------~----------~~~~~~~~g~~~y~aPE~~~~-~~~~~ 1003 (1103)
|+|..+.. . . ........||+||.|||++.. ..-+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 99983210 0 0 001123469999999999864 44578
Q ss_pred cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHH-----HH-HhcCc---cc-----c---------ccc--cc-
Q 043720 1004 KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWAS-----ML-LRQGQ---VK-----D---------VFN--AE- 1057 (1103)
Q Consensus 1004 ~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----~~-~~~~~---~~-----~---------~~~--~~- 1057 (1103)
++||||.|||+.-+++++.||.......+....+..... .. ...+. .+ . .++ .-
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 999999999999999999999754432211111111100 00 00000 00 0 000 00
Q ss_pred ------cc-CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 ------LW-ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ------~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+ .....-.+..+++++.+|++.||.+|-+++|.+++
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 00 01112234578999999999999999999999864
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=240.41 Aligned_cols=202 Identities=24% Similarity=0.271 Sum_probs=170.6
Q ss_pred HHHhcCCCCcceeccCCcccEEEEE-EcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC------CCceeEEEeEEec
Q 043720 817 IRATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR------HPNLVTLIGYRAS 889 (1103)
Q Consensus 817 ~~~~~~~~~~~~lg~G~fg~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~ 889 (1103)
+....+|.+....|+|-|++|.+|. ...|..||||++..... ..+.=+.|+++|+++. --|+++++..|..
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3445689999999999999999994 44588999999976532 2344567999999995 4688999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeec
Q 043720 890 GNEMFLIYNYLPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDF 967 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Df 967 (1103)
.+++|||||-+ .-+|.+.+++... ..+...++..++.|+.-||.+|-.. +|+|.||||.||||++.. .+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccC
Confidence 99999999998 5599999987543 5688899999999999999999998 999999999999998765 5799999
Q ss_pred ccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 043720 968 GLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPS 1027 (1103)
Q Consensus 968 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~ 1027 (1103)
|.|...+.. ..+.+.-+..|.|||++.+..|+...|+||.||++||+.||+..|.+.
T Consensus 582 GSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 582 GSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred ccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 999876433 333445577899999999999999999999999999999999888643
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.7e-26 Score=240.45 Aligned_cols=444 Identities=22% Similarity=0.233 Sum_probs=280.7
Q ss_pred EEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccC-C
Q 043720 111 VLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG-N 189 (1103)
Q Consensus 111 ~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~-n 189 (1103)
..+-++-+++ ++|..+. +.-.+++|..|+|+...|.+|+.+++|+.||||+|.|+.+-|.+|.++++|..|-+.+ |
T Consensus 50 ~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~N 126 (498)
T KOG4237|consen 50 IVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNN 126 (498)
T ss_pred eEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCC
Confidence 3455666666 7776664 4667899999999977778899999999999999999988899999999988887766 9
Q ss_pred cCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCc-cccCCCCCCEEeCCCccCCccc
Q 043720 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVI 268 (1103)
Q Consensus 190 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~L~L~~N~l~~~~ 268 (1103)
+|+......|+++..|+.|.+.-|++. .++...+.-+++|..|.+.+|.+. .++. ++..+..++.+.+..|.+-.
T Consensus 127 kI~~l~k~~F~gL~slqrLllNan~i~-Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~ic-- 202 (498)
T KOG4237|consen 127 KITDLPKGAFGGLSSLQRLLLNANHIN-CIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFIC-- 202 (498)
T ss_pred chhhhhhhHhhhHHHHHHHhcChhhhc-chhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCcccc--
Confidence 999766678999999999999999998 777777777788999999999988 4454 78888899999988887422
Q ss_pred cccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCc-hhh
Q 043720 269 PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIP-MEI 347 (1103)
Q Consensus 269 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip-~~~ 347 (1103)
.++++.+.. ++..| |.+++...-..-..+.+..+.......+....+--..... ......+.-| ..|
T Consensus 203 ---dCnL~wla~-~~a~~------~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~--~~d~~d~~cP~~cf 270 (498)
T KOG4237|consen 203 ---DCNLPWLAD-DLAMN------PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLS--SEDFPDSICPAKCF 270 (498)
T ss_pred ---ccccchhhh-HHhhc------hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhc--cccCcCCcChHHHH
Confidence 112222211 11111 1112222222222222222222222221111000000000 0111222223 247
Q ss_pred hccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccc-cccceeE
Q 043720 348 TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL-QVPCMAL 426 (1103)
Q Consensus 348 ~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~-~~~~L~~ 426 (1103)
..|++|+.|+|++|.++++-+.+|.++..|++|.|..|+|..+....|.++.+|+.|+|++|+|+...|..+ .+..|..
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~ 350 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLST 350 (498)
T ss_pred hhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeee
Confidence 899999999999999999999999999999999999999999999999999999999999999998776555 5677999
Q ss_pred EEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCC
Q 043720 427 FDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLP 506 (1103)
Q Consensus 427 l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~ 506 (1103)
|++-.|++... |+...+ +.++..+...+.|.= .+.-++..+.++.+.|...-|.
T Consensus 351 l~l~~Np~~Cn--------C~l~wl---------------~~Wlr~~~~~~~~~C-q~p~~~~~~~~~dv~~~~~~c~-- 404 (498)
T KOG4237|consen 351 LNLLSNPFNCN--------CRLAWL---------------GEWLRKKSVVGNPRC-QSPGFVRQIPISDVAFGDFRCG-- 404 (498)
T ss_pred eehccCcccCc--------cchHHH---------------HHHHhhCCCCCCCCC-CCCchhccccchhccccccccC--
Confidence 99999988631 111111 112222221111100 0011112222333333221111
Q ss_pred CCccccccccceeeeeccccccccCCcchhh-hcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcc
Q 043720 507 VAPERLRRRTDYAFLAGANKLTGSFPGSLFQ-ACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQ 585 (1103)
Q Consensus 507 ~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~-~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~ 585 (1103)
.+.-.+..+..... .|..+ .++...|+..+. .+|..|. ...++|++.+|.++ .+|.
T Consensus 405 -----------------~~ee~~~~~s~~cP~~c~c~-~tVvRcSnk~lk-~lp~~iP---~d~telyl~gn~~~-~vp~ 461 (498)
T KOG4237|consen 405 -----------------GPEELGCLTSSPCPPPCTCL-DTVVRCSNKLLK-LLPRGIP---VDVTELYLDGNAIT-SVPD 461 (498)
T ss_pred -----------------CccccCCCCCCCCCCCcchh-hhhHhhcccchh-hcCCCCC---chhHHHhcccchhc-ccCH
Confidence 11112222222211 12221 233445554444 7777776 45677888888887 4455
Q ss_pred cccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCc
Q 043720 586 SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADN 625 (1103)
Q Consensus 586 ~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 625 (1103)
. .+..| .+|||+|++...-...|.++++|..|.|++|
T Consensus 462 ~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 462 E--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred H--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 4 55666 7788888777544556777777777777665
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.3e-24 Score=217.25 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=204.1
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
+..+..+|.+...|+.|+|+|+ |..+++|++.+.... ...++|..|.-.++-+.||||++++|.|.......++..||
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 3455667899999999999999 667888888776543 23467999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe--ecccccccCCCCC
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS--DFGLSRLLGTSET 978 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~--Dfgla~~~~~~~~ 978 (1103)
+.|+|+..++...+-..+..++.++|.++|+|++|||+. .|-|----+.++.|++|++.+++|. |--++.
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-------
Confidence 999999999998877788899999999999999999997 4445555789999999999887774 322221
Q ss_pred ccccCCcccccccCccccccCCCC---CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVS---DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~---~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
...+..-.|.||+||.+...+.+ .++|+|||++++||+-|+..||....+.+ .-.++.-
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-----------------cgmkial 403 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-----------------CGMKIAL 403 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-----------------hhhhhhh
Confidence 11233447899999999766543 37899999999999999999998544321 1122333
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
..++...|......+.+++.-|+..||.+||.++.|+-.||++.
T Consensus 404 eglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 EGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 45556678888899999999999999999999999999999875
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-22 Score=262.78 Aligned_cols=346 Identities=19% Similarity=0.220 Sum_probs=220.7
Q ss_pred ChhcccCCCCcEeeccccc------CCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccc
Q 043720 196 PGFLGSFLKLRVLFLSYNE------LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269 (1103)
Q Consensus 196 p~~l~~l~~L~~L~L~~N~------l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 269 (1103)
+..|..|.+|+.|.+..+. +...+|.++..+..+|+.|++.++.++ .+|..+ ...+|+.|+|.+|++.. +|
T Consensus 551 ~~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~-L~ 627 (1153)
T PLN03210 551 ENAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEK-LW 627 (1153)
T ss_pred HHHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccc-cc
Confidence 3457778888888776553 333567666666667888888888776 667666 46788888888888765 66
Q ss_pred ccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhc
Q 043720 270 RELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITT 349 (1103)
Q Consensus 270 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~ 349 (1103)
..+..+++|+.|+|++|...+.+| .++.+++|+.|++++ +.....+|..+.+
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~---------------------------c~~L~~lp~si~~ 679 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSD---------------------------CSSLVELPSSIQY 679 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecC---------------------------CCCccccchhhhc
Confidence 677778888888888776545666 377778888888874 3334567777777
Q ss_pred cccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEe
Q 043720 350 LSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDV 429 (1103)
Q Consensus 350 L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~l 429 (1103)
+++|+.|++++|...+.+|..+ ++++|+.|+|++|.....+|.. ..+|+.|+|++|.+.. +|....+++|..|++
T Consensus 680 L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~~l~~L~~L~l 754 (1153)
T PLN03210 680 LNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNLRLENLDELIL 754 (1153)
T ss_pred cCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccccccccccccc
Confidence 7777777777776666666655 6777777777777544444432 3456666666666542 333334444444444
Q ss_pred cCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCc
Q 043720 430 SGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAP 509 (1103)
Q Consensus 430 s~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~ 509 (1103)
.++... .+.+
T Consensus 755 ~~~~~~-------------------------------------------------------------~l~~--------- 764 (1153)
T PLN03210 755 CEMKSE-------------------------------------------------------------KLWE--------- 764 (1153)
T ss_pred cccchh-------------------------------------------------------------hccc---------
Confidence 332110 0000
Q ss_pred cccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccC
Q 043720 510 ERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLEN 589 (1103)
Q Consensus 510 ~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~ 589 (1103)
.+. .++.......++|+.|+|++|...+.+|..+++
T Consensus 765 -------------------------------------------~~~-~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~ 800 (1153)
T PLN03210 765 -------------------------------------------RVQ-PLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQN 800 (1153)
T ss_pred -------------------------------------------ccc-ccchhhhhccccchheeCCCCCCccccChhhhC
Confidence 000 011111112256777777777666667777777
Q ss_pred CCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccc
Q 043720 590 LTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALL 669 (1103)
Q Consensus 590 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 669 (1103)
+++|+.|+|++|...+.+|..+ .+++|+.|+|++|.....+|.. .++|++|+|++|.|+ .+|..+..+++|+.|+
T Consensus 801 L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~ 875 (1153)
T PLN03210 801 LHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLD 875 (1153)
T ss_pred CCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEE
Confidence 7777777777764444666655 6777777777776544445433 356777777777777 5677777777788777
Q ss_pred ccc-ccCcCCCCccccCCCCCceEeCCCC
Q 043720 670 LDN-NKLSGHLPSGLANVTSLSIFNASFN 697 (1103)
Q Consensus 670 L~~-N~l~~~~p~~l~~l~~L~~l~l~~N 697 (1103)
|++ |++. .+|..+..++.|+.++++++
T Consensus 876 L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 876 MNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred CCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 777 4555 56666677777777777665
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-22 Score=259.00 Aligned_cols=267 Identities=21% Similarity=0.207 Sum_probs=124.2
Q ss_pred ccCCCCCCEEEeecCC------CCCCccccccCCC-CCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhc
Q 043720 127 IWSLEKLEVLDVEGNF------LSGRLPNEFVGLR-NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFL 199 (1103)
Q Consensus 127 l~~l~~L~~L~Ls~n~------l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l 199 (1103)
|..+.+|+.|.+..+. +...+|..+..++ +|+.|++.+|.++ .+|..+ ...+|++|+|++|++. .++..+
T Consensus 554 F~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~ 630 (1153)
T PLN03210 554 FKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGV 630 (1153)
T ss_pred HhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccccc
Confidence 4445555555554332 1223444444432 3555555555554 445444 2445555555555554 334444
Q ss_pred ccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCC
Q 043720 200 GSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLE 279 (1103)
Q Consensus 200 ~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 279 (1103)
..+++|+.|+|++|...+.+|. +. .+++|++|+|++|.....+|..++++++|+.|++++|..-+.+|..+ ++++|+
T Consensus 631 ~~l~~Lk~L~Ls~~~~l~~ip~-ls-~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 631 HSLTGLRNIDLRGSKNLKEIPD-LS-MATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred ccCCCCCEEECCCCCCcCcCCc-cc-cCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 4555555555554433224442 22 23445555555544333455555555555555555543333344333 445555
Q ss_pred EEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccC
Q 043720 280 VLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAP 359 (1103)
Q Consensus 280 ~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~ 359 (1103)
.|++++|...+.+|.. ..+|+.|++++|. ...+|..+ .+++|+.|.+.
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~----------------------------i~~lP~~~-~l~~L~~L~l~ 755 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETA----------------------------IEEFPSNL-RLENLDELILC 755 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCc----------------------------cccccccc-ccccccccccc
Confidence 5555555433333322 2344444444311 11223222 23444444443
Q ss_pred Cccc-------cccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEecC
Q 043720 360 RLNL-------EGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSG 431 (1103)
Q Consensus 360 ~n~l-------~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~ 431 (1103)
.+.. ....+..+...++|+.|+|++|...+.+|..+.++++|+.|+|++|...+.+|....+++|+.|++++
T Consensus 756 ~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~~L~sL~~L~Ls~ 834 (1153)
T PLN03210 756 EMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGINLESLESLDLSG 834 (1153)
T ss_pred ccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCCCccccCEEECCC
Confidence 3211 11111222334567777777776666667777777777777777765433334333344444444443
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.4e-24 Score=268.02 Aligned_cols=195 Identities=19% Similarity=0.225 Sum_probs=139.1
Q ss_pred CCC-CceeEEEeEE-------ecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCccc
Q 043720 875 VRH-PNLVTLIGYR-------ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946 (1103)
Q Consensus 875 l~h-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 946 (1103)
++| +||+++++++ .....++.++||+ +++|.++++.. ...+++.++..++.||++||+|||++ +|+|
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIvH 103 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIVV 103 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence 345 5777788876 2234678889988 66999999753 34589999999999999999999999 9999
Q ss_pred CCCCCCcEEECC-------------------CCCEEEeecccccccCCCC---------------CccccCCcccccccC
Q 043720 947 RDVKPSNILLDD-------------------DFNAYLSDFGLSRLLGTSE---------------THATTGVAGTFGYVA 992 (1103)
Q Consensus 947 ~Dlk~~NIll~~-------------------~~~~ki~Dfgla~~~~~~~---------------~~~~~~~~g~~~y~a 992 (1103)
|||||+|||++. ++.+|++|||+++...... ........||+.|||
T Consensus 104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A 183 (793)
T PLN00181 104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS 183 (793)
T ss_pred ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence 999999999965 3455666666665321100 000112357889999
Q ss_pred ccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHH
Q 043720 993 PEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLH 1072 (1103)
Q Consensus 993 PE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1072 (1103)
||++.+..|+.++|||||||++|||++|..|+.... ...... ... ...+. ..........
T Consensus 184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----------~~~~~~-~~~----~~~~~-----~~~~~~~~~~ 243 (793)
T PLN00181 184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----------RTMSSL-RHR----VLPPQ-----ILLNWPKEAS 243 (793)
T ss_pred hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----------HHHHHH-HHh----hcChh-----hhhcCHHHHH
Confidence 999999999999999999999999999887754110 001110 000 01111 1112234568
Q ss_pred HHHHccccCCCCCCCHHHHHHH
Q 043720 1073 LALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1073 li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
++.+||+++|.+||++.|++++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHhCCCChhhCcChHHHhhc
Confidence 8899999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=209.07 Aligned_cols=169 Identities=20% Similarity=0.201 Sum_probs=128.1
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|+|.++++... ..+++.+++.++.|+++||+|||++ + ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc-----
Confidence 68999998643 4599999999999999999999998 5 999999999999999 99987654321
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
..|++.|+|||++.+..++.++|||||||++|||++|+.||..... ............. .. .+.. ...
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~-------~~~~~~~~~~~~~--~~-~~~~-~~~ 131 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERE-------LSAILEILLNGMP--AD-DPRD-RSN 131 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccch-------hcHHHHHHHHHhc--cC-Cccc-ccc
Confidence 2578999999999999999999999999999999999999863321 1111111111110 00 0000 011
Q ss_pred ChhHHH--HHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1063 PHDDLE--DMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1063 ~~~~~~--~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...... .+.+++.+||..+|++||++.|+++++..+..
T Consensus 132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 222333 69999999999999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.3e-22 Score=237.68 Aligned_cols=83 Identities=30% Similarity=0.372 Sum_probs=52.2
Q ss_pred CccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEecc
Q 043720 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELS 647 (1103)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 647 (1103)
+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..++++++|+.|+|+
T Consensus 383 ~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs 453 (788)
T PRK15387 383 GLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLE 453 (788)
T ss_pred ccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECC
Confidence 46666666776663 3332 245667777777776 355432 35666777777776 566667777777777777
Q ss_pred CccccCcChhhh
Q 043720 648 SNSLSGEVPEGV 659 (1103)
Q Consensus 648 ~N~l~~~~~~~~ 659 (1103)
+|+|++..+..+
T Consensus 454 ~N~Ls~~~~~~L 465 (788)
T PRK15387 454 GNPLSERTLQAL 465 (788)
T ss_pred CCCCCchHHHHH
Confidence 777776655554
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.9e-24 Score=226.32 Aligned_cols=416 Identities=23% Similarity=0.217 Sum_probs=283.1
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccc-cccCCCCCCCCCCCCCCCEEEc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF-NRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
.-..+.|..|+|+..-|.+|..+.+|+.||||+|.|+..-|++|.++++|..|-+.+ |+|+..-...|++|.+|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 456889999999966667899999999999999999999999999999998887766 9999444457899999999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccc------------cccCccccCCCCC
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLV------------GRIPSSLGKCQQL 254 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~------------~~~p~~l~~l~~L 254 (1103)
.-|++.-...+.|..+++|..|.+.+|.+. .++...+..+..++.+.+..|.+- ...|..++...-.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 999999888899999999999999999998 888877777788999999999832 1223344444444
Q ss_pred CEEeCCCccCCccccccccC-CCCCCEEEccCCcCCCcCCc-cccCCCCCCeEecccCcCccccCccccCcccccccCCC
Q 043720 255 RTLLLFSNMLNDVIPRELGW-LRKLEVLDVSRNRLNGLIPT-ELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332 (1103)
Q Consensus 255 ~~L~L~~N~l~~~~p~~l~~-l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~ 332 (1103)
.-..+.++++...-+..|.. +.++..=..+.....+..|. .|..+++|+.|+|+|
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsn----------------------- 283 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSN----------------------- 283 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCC-----------------------
Confidence 44555555555443333321 12222112222323333343 478888888888875
Q ss_pred CCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCcccc
Q 043720 333 NGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412 (1103)
Q Consensus 333 ~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~ 412 (1103)
|.+++.-+.+|..+.++++|+|..|++...--..|.++.+|+.|+|.+|+|+...|.+|..+..|..|+|-.|.+.
T Consensus 284 ----N~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 284 ----NKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred ----CccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 5566666777888888999999999998888888999999999999999999999999999999999999999987
Q ss_pred ccccccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEe
Q 043720 413 GELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHN 492 (1103)
Q Consensus 413 ~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 492 (1103)
....-.|-...|+.=...+|.=.+.+ ......+++ ++....++.- .|...+
T Consensus 360 CnC~l~wl~~Wlr~~~~~~~~~Cq~p-----~~~~~~~~~-----dv~~~~~~c~----------~~ee~~--------- 410 (498)
T KOG4237|consen 360 CNCRLAWLGEWLRKKSVVGNPRCQSP-----GFVRQIPIS-----DVAFGDFRCG----------GPEELG--------- 410 (498)
T ss_pred CccchHHHHHHHhhCCCCCCCCCCCC-----chhccccch-----hccccccccC----------CccccC---------
Confidence 64433332222222112222222211 111122221 1111111110 000000
Q ss_pred cCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEE
Q 043720 493 FSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVL 572 (1103)
Q Consensus 493 l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L 572 (1103)
-.+.+.| +++--.-. +..--+|++...+|..+-... ..+.+.+|.+. .+|.+.. .+| .+
T Consensus 411 ----~~~s~~c----P~~c~c~~---tVvRcSnk~lk~lp~~iP~d~-----telyl~gn~~~-~vp~~~~---~~l-~~ 469 (498)
T KOG4237|consen 411 ----CLTSSPC----PPPCTCLD---TVVRCSNKLLKLLPRGIPVDV-----TELYLDGNAIT-SVPDELL---RSL-LL 469 (498)
T ss_pred ----CCCCCCC----CCCcchhh---hhHhhcccchhhcCCCCCchh-----HHHhcccchhc-ccCHHHH---hhh-hc
Confidence 0000111 01111111 111124455556666553322 34678889887 8998843 678 99
Q ss_pred ECcCCcCCCCCcccccCCCCCCEEEccCC
Q 043720 573 DASHNQISGIVPQSLENLTSLVFLDLNGN 601 (1103)
Q Consensus 573 ~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 601 (1103)
||++|+|+...-..|.++++|.+|.||+|
T Consensus 470 dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 470 DLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred ccccCceehhhcccccchhhhheeEEecC
Confidence 99999999777778999999999999987
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=234.27 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=207.2
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
..-..|+|++|+++ .+|+.+. ++|+.|++++|+++ .+|.. .++|++|+|++|+|+ .+|.. .++|+.|++
T Consensus 201 ~~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 201 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 45678999999998 7998886 48999999999999 57753 589999999999999 67753 468999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
++|.++ .+|..+ ++|+.|++++|+++ .+|.. .++|++|+|++|++++ +|.. ..+|+.|++++|.+++
T Consensus 270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt-~LP~~----p~~L~~LdLS~N~L~~-Lp~l---p~~L~~L~Ls~N~L~~ 336 (788)
T PRK15387 270 FSNPLT-HLPALP---SGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLAS-LPAL---PSELCKLWAYNNQLTS 336 (788)
T ss_pred cCCchh-hhhhch---hhcCEEECcCCccc-ccccc----ccccceeECCCCcccc-CCCC---cccccccccccCcccc
Confidence 999998 455433 57889999999998 77753 4679999999999995 5543 2468889999999987
Q ss_pred cccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
+|.. ..+|+.|+|++|+|++ +|... .+|+.|++++| .+. .+|..
T Consensus 337 -LP~l---p~~Lq~LdLS~N~Ls~-LP~lp---~~L~~L~Ls~N---------------------------~L~-~LP~l 380 (788)
T PRK15387 337 -LPTL---PSGLQELSVSDNQLAS-LPTLP---SELYKLWAYNN---------------------------RLT-SLPAL 380 (788)
T ss_pred -cccc---ccccceEecCCCccCC-CCCCC---cccceehhhcc---------------------------ccc-cCccc
Confidence 5532 2589999999999995 56543 46777888753 222 34533
Q ss_pred hhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeE
Q 043720 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL 426 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~ 426 (1103)
.++|+.|++++|.+.+ +|.. .++|+.|++++|+|++. |.. ..+|+.|+|++|+|+..+..+..++.|+.
T Consensus 381 ---~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~LssI-P~l---~~~L~~L~Ls~NqLt~LP~sl~~L~~L~~ 449 (788)
T PRK15387 381 ---PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTSL-PML---PSGLLSLSVYRNQLTRLPESLIHLSSETT 449 (788)
T ss_pred ---ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCCC-Ccc---hhhhhhhhhccCcccccChHHhhccCCCe
Confidence 2578999999999985 5543 36899999999999974 433 35788999999999965445668999999
Q ss_pred EEecCCccccccCC
Q 043720 427 FDVSGNHMSGSIPR 440 (1103)
Q Consensus 427 l~ls~N~l~g~ip~ 440 (1103)
|++++|+|+|.+|.
T Consensus 450 LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 450 VNLEGNPLSERTLQ 463 (788)
T ss_pred EECCCCCCCchHHH
Confidence 99999999987765
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=218.51 Aligned_cols=171 Identities=20% Similarity=0.191 Sum_probs=132.6
Q ss_pred CHHHHHHHhcCCCCcceeccCCcccEEEEEEc--CCcEEEEEEccccc----chhhHHHHHHHHHHHhcCCCCceeE-EE
Q 043720 812 TYESIIRATGDFNTSNCIGSGGFGTTYKAEIS--PGILVAVKKLAVGR----FQHGVQQFHAEIKTLGNVRHPNLVT-LI 884 (1103)
Q Consensus 812 ~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~-l~ 884 (1103)
.-.......++|.+.+.||+|+||+||+|.+. +++.||||++.... .....+.+.+|++++++++|+|+++ ++
T Consensus 9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~ 88 (365)
T PRK09188 9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL 88 (365)
T ss_pred cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence 33344456678999999999999999999765 47778999865331 2234567999999999999999985 44
Q ss_pred eEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCC-CCCcEEECCCCCEE
Q 043720 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDV-KPSNILLDDDFNAY 963 (1103)
Q Consensus 885 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~k 963 (1103)
++ +..|+||||+++++|... . . .. ...++.++++|++|||++ +|+|||| ||+||+++.++.+|
T Consensus 89 ~~----~~~~LVmE~~~G~~L~~~-~--~---~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 89 AT----GKDGLVRGWTEGVPLHLA-R--P---HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred Ec----CCcEEEEEccCCCCHHHh-C--c---cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEE
Confidence 32 457999999999999632 1 1 11 146788999999999999 9999999 99999999999999
Q ss_pred EeecccccccCCCCCcc-------ccCCcccccccCcccccc
Q 043720 964 LSDFGLSRLLGTSETHA-------TTGVAGTFGYVAPEYALT 998 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~~~-------~~~~~g~~~y~aPE~~~~ 998 (1103)
|+|||+|+.+....... .....+++.|+|||++..
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 99999998775432111 134567888999999854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.7e-20 Score=211.48 Aligned_cols=259 Identities=21% Similarity=0.268 Sum_probs=197.6
Q ss_pred CCCCcceeccCCcccEEEEEEcCC--cEEEEEEcccccchhhHHHHHHHHHHHhcCCC----CceeEEEeEE-ecCCeEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPG--ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH----PNLVTLIGYR-ASGNEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~ 894 (1103)
+|.+.+.||+|+||.||.+..... ..+|+|........... .+..|..++..+.. +++.++++.. ......|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence 799999999999999999976543 57888887765433222 67788888888863 6888999888 5777889
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-----CCEEEeeccc
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-----FNAYLSDFGL 969 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~ki~Dfgl 969 (1103)
+||+.+ |.+|.++.+......++..+..+|+.|++.+|+++|+. |++||||||.|+++... ..+.+.|||+
T Consensus 98 iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 98 IVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 999998 78999988776667799999999999999999999999 99999999999999755 3599999999
Q ss_pred ccccC--CCCC-------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH
Q 043720 970 SRLLG--TSET-------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 970 a~~~~--~~~~-------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
++.+. .... .......||.+|++++...+...+.+.|+||++.++.|++.|..||....... .....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~----~~~~~ 249 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD----LKSKF 249 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc----hHHHH
Confidence 99332 1111 11234569999999999999999999999999999999999999985322110 01111
Q ss_pred HHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1041 ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
... ........ .....+..+.++...+-..+...+|....+.+.+++..
T Consensus 250 ~~~-----~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKD-----PRKLLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHH-----hhhhcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 100 00000000 22234456777777777799999999999999987754
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.2e-21 Score=235.50 Aligned_cols=347 Identities=20% Similarity=0.234 Sum_probs=203.4
Q ss_pred CCChhhHHHHHHHHhhccCCCCcccC----cCCCCCCCCceee----------------eEecCCCCeEEEEecCCCCCC
Q 043720 2 GKVLPEKTILLEFKNSVSDPSGILSS----WQTNTSSHCSWFG----------------VSCDSESRVVALNITGGDVSE 61 (1103)
Q Consensus 2 ~~~~~~~~aLl~~k~~~~d~~~~l~s----W~~~~~~~C~W~G----------------V~C~~~~~v~~l~l~~~~~~~ 61 (1103)
|--.+|.+.++++.+.+.-| +++++ |+..+ |+|.=.. |.|. ...|+.++..|.....
T Consensus 59 ~~~~~~~~~~~~~~~~l~~p-~~~~~~~~~~~~~~-~fc~~~~~~~~~l~~~~~~~~~tv~~~-~~~vt~l~~~g~~~~~ 135 (754)
T PRK15370 59 TASPEEIKSKFECLRMLAFP-AYADNIQYSRGGAD-QYCILSENSQEILSIVFNTEGYTVEGG-GKSVTYTRVTESEQAS 135 (754)
T ss_pred CCCHHHHHHHHHHHHHhcCC-chhhccccccCCCC-cccccCCcchhhheeeecCCceEEecC-CCcccccccccccccc
Confidence 45567899999999999766 35666 98754 7895444 6675 3456666655532221
Q ss_pred CCCCccccccccccccccccccccceeccCCCccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecC
Q 043720 62 GNSKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGN 141 (1103)
Q Consensus 62 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n 141 (1103)
....+.-..-..+.-..|...... ..-..+......+.. +-..+...|+|++++++ .+|..+. +.|+.|+|++|
T Consensus 136 ~~~~~~~~~~~~~~w~~w~~~~~~-~~~~~r~~a~~r~~~--Cl~~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N 209 (754)
T PRK15370 136 SASGSKDAVNYELIWSEWVKEAPA-KEAANREEAVQRMRD--CLKNNKTELRLKILGLT-TIPACIP--EQITTLILDNN 209 (754)
T ss_pred cCCCCCChhhHHHHHHHHHhcCCC-CccccHHHHHHHHHh--hcccCceEEEeCCCCcC-cCCcccc--cCCcEEEecCC
Confidence 111110000000000000000000 000000000111111 12245678888888888 6777664 57888899988
Q ss_pred CCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCCh
Q 043720 142 FLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221 (1103)
Q Consensus 142 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~ 221 (1103)
.++ .+|..+. ++|++|+|++|+|+ .+|..+. .+|+.|+|++|+++ .+|..+. ++|+.|++++|+++ .+|.
T Consensus 210 ~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~ 279 (754)
T PRK15370 210 ELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPE 279 (754)
T ss_pred CCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-cccc
Confidence 888 6776654 58888888888888 6776654 47888888888888 5676654 47888888888888 6777
Q ss_pred hHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCC
Q 043720 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVE 301 (1103)
Q Consensus 222 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 301 (1103)
.+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|.++. +|..+. ++|+.|++++|.+++ +|..+. ++
T Consensus 280 ~l~---~sL~~L~Ls~N~Lt-~LP~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~s 347 (754)
T PRK15370 280 NLP---EELRYLSVYDNSIR-TLPAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PE 347 (754)
T ss_pred ccC---CCCcEEECCCCccc-cCcccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--Cc
Confidence 654 46888888888887 4565443 467888888888876 454432 578888888888874 565553 56
Q ss_pred CCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEE
Q 043720 302 LSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLN 381 (1103)
Q Consensus 302 L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~ 381 (1103)
|+.|++++| ++. .+|..+. ++|+.|++++|++. .+|..+. .+|+.|+
T Consensus 348 L~~L~Ls~N---------------------------~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~Ld 394 (754)
T PRK15370 348 LQVLDVSKN---------------------------QIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQ 394 (754)
T ss_pred ccEEECCCC---------------------------CCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHh
Confidence 777777643 221 2333332 35556666666555 2343332 2455556
Q ss_pred cCCccccccc---chhhhccCCceEeecCCcccc
Q 043720 382 LAQNVLRGDL---IGVFDRCKKLHFIDLSSNELS 412 (1103)
Q Consensus 382 Ls~N~l~~~~---~~~~~~l~~L~~LdLs~N~l~ 412 (1103)
+++|+|...+ +..+..++++..|+|.+|+++
T Consensus 395 Ls~N~L~~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 395 ASRNNLVRLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred hccCCcccCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 6666555321 122233355555555555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.6e-21 Score=228.04 Aligned_cols=254 Identities=17% Similarity=0.225 Sum_probs=189.8
Q ss_pred CCcceeccCCcccEEEEEEc-CCcEEEEEEccc----ccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 824 NTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAV----GRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 824 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~----~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
...+.+|.|++|.|+.+... .....+.|.+.. ... ......+..|+-+-..+.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34667999999988877433 333344444331 111 112223667888888899999988888777777666679
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|||++ +|..++... ..++..++..++.|+..|++|+|++ +|.|||+|++|++++.+|.+||+|||.+..+..+.
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 999998765 2388899999999999999999999 99999999999999999999999999998775443
Q ss_pred C---ccccCCcccccccCccccccCCCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 978 T---HATTGVAGTFGYVAPEYALTCRVSD-KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 978 ~---~~~~~~~g~~~y~aPE~~~~~~~~~-~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
. ....+.+|+..|+|||++.+..|.. ..||||.|+++..|.+|+.||......+... ...........
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~--------~~~~~~~~~~~ 546 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF--------KTNNYSDQRNI 546 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch--------hhhcccccccc
Confidence 3 4567889999999999999999876 4799999999999999999997554432211 00000000000
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
.... .......+.....++.+|++.||.+|-++++|++
T Consensus 547 ~~~~--~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGP--NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccCh--HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000 1112345677889999999999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-18 Score=198.98 Aligned_cols=261 Identities=29% Similarity=0.420 Sum_probs=200.0
Q ss_pred CCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchh--hHHHHHHHHHHHhcCCCC-ceeEEEeEEecCCeEEEEEee
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHP-NLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lV~E~ 899 (1103)
|...+.||.|+||.||++... ..+++|.+....... ....+.+|+..++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667788999999999999776 788999998776554 478899999999999988 799999999877778999999
Q ss_pred cCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccCCCC
Q 043720 900 LPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~ 977 (1103)
+.++++.+++..... ..+.......++.+++.+++|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765432 1488899999999999999999999 999999999999999988 69999999998654333
Q ss_pred Cc-----cccCCcccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 978 TH-----ATTGVAGTFGYVAPEYALT---CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 978 ~~-----~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
.. ......|+..|+|||.+.. ..+....|+|++|++++++++|..||...... ........ ......
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~----~~~~~~~~-~~~~~~ 231 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS----SATSQTLK-IILELP 231 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc----ccHHHHHH-HHHhcC
Confidence 22 2356689999999999987 57888999999999999999999996533221 00011111 111111
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. .................+.+++.+|+..+|..|.+..+....
T Consensus 232 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred Cc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00 000000000002233578899999999999999999887764
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-20 Score=223.81 Aligned_cols=97 Identities=30% Similarity=0.499 Sum_probs=57.9
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcc----cCCCCCc
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI----GELRSLE 642 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~----~~l~~L~ 642 (1103)
++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ +.++.+.
T Consensus 346 ~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~ 418 (754)
T PRK15370 346 PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPT 418 (754)
T ss_pred CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCcc
Confidence 35666666666665 3444332 46666777777666 4555443 25777777777776 444433 3457788
Q ss_pred EEeccCccccCcChhhhhhcccccccccccccCcC
Q 043720 643 VLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSG 677 (1103)
Q Consensus 643 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 677 (1103)
.|+|.+|.|+. ..+.+|+.| ++.+.+.|
T Consensus 419 ~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 419 RIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred EEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 88888888872 344555555 44455543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.7e-21 Score=223.35 Aligned_cols=251 Identities=19% Similarity=0.242 Sum_probs=185.4
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHH--HhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKT--LGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++...+.||.+.|=.|.+|+++.|. |+||++-+....-..+.|++++.- ....+|||++++.-+.......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6778889999999999999998887 999999776654444555443333 4455899999999888888888999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+.+ +|+|.+..++ .+...+.+.||.|++.|+..+|.. +|+|||||.+||||+.-..+.++||..-+...-++..
T Consensus 103 vkh-nLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred Hhh-hhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 955 9999997654 378888899999999999999999 9999999999999999999999999866544222111
Q ss_pred --c----ccCCcccccccCccccccC-----------CCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCcchHHHH
Q 043720 980 --A----TTGVAGTFGYVAPEYALTC-----------RVSDKADVYSYGVVLLELISD-KKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 980 --~----~~~~~g~~~y~aPE~~~~~-----------~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
. ......-.+|.|||.+... ..+++.||||+||++.|+++. +++|. +.+..
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-----------LSQL~ 245 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-----------LSQLL 245 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-----------HHHHH
Confidence 1 1111223589999988531 156788999999999999985 55554 23333
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
..........+.+-..+ + ...++.++..|++.||++|-++++.++.-..
T Consensus 246 aYr~~~~~~~e~~Le~I-----e--d~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 246 AYRSGNADDPEQLLEKI-----E--DVSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hHhccCccCHHHHHHhC-----c--CccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 32211111111111111 1 1258899999999999999999999987544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=179.29 Aligned_cols=257 Identities=22% Similarity=0.294 Sum_probs=194.1
Q ss_pred hcCCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCC-CceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|.++++||.|+||.+|.| ...+|..||||+-...... ..+..|..+.+.+++ ..|..+.-+..+...-.+||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 467999999999999999999 5667999999987654432 456788889888874 67777778888888889999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~ 974 (1103)
|.. |-+|.++..- ..+.++.++++-.|-|++.-++|+|.+ +++||||||+|+|+.- ...+.++|||+|+.+.
T Consensus 91 dLL-GPsLEdLfnf-C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNF-CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred ecc-CccHHHHHHH-HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 999 6799887753 234599999999999999999999999 9999999999999963 3468999999999875
Q ss_pred CCCC------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 975 TSET------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 975 ~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
.... .......||.+|.+-....+.+-+.+.|+-|+|.++.++--|..||.+-.... +..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t--------------k~Q 231 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT--------------KKQ 231 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh--------------HHH
Confidence 4332 22345679999999888887777889999999999999999999998543321 111
Q ss_pred cccccccccccCC---CChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1049 QVKDVFNAELWAS---GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
+++++.+.....+ .-...|.++.-.+..|-..--++-|...-+.+.+.-+
T Consensus 232 KyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriL 284 (341)
T KOG1163|consen 232 KYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRIL 284 (341)
T ss_pred HHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHH
Confidence 1111111111100 1123466777778888877777888776666555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.1e-18 Score=177.19 Aligned_cols=258 Identities=18% Similarity=0.266 Sum_probs=195.2
Q ss_pred CCCCcceeccCCcccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEee
Q 043720 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.|.++++||+|.||+++.| .+-++++||||.-.... ....+..|....+.+. .++|...+-|...+-+-.+|+|.
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 6999999999999999999 45579999999765543 3456677888887774 78998888888888888999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-----CCEEEeecccccccC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-----FNAYLSDFGLSRLLG 974 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-----~~~ki~Dfgla~~~~ 974 (1103)
+ |-+|.|+..- .++.++.+++..+|.|++.-++|+|++ .+|.|||||+|+||... ..+.|+|||+|+.+.
T Consensus 106 L-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 106 L-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred h-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9 6688887653 445699999999999999999999999 99999999999999643 358999999999986
Q ss_pred CCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 975 TSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 975 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
.+.+. ......||-+||+-....+.+-+.+.|.-|+|-++++++-|..||.+-..... .....+.+
T Consensus 181 Dp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn--------K~kYeKIG 252 (449)
T KOG1165|consen 181 DPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN--------KEKYEKIG 252 (449)
T ss_pred CccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch--------HHHHHHhc
Confidence 65543 23355799999999999999999999999999999999999999985433211 11111122
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
+-......+. .....|.++..-+...-..+-.+-|..+-+...+..+
T Consensus 253 e~Kr~T~i~~---Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 253 ETKRSTPIEV---LCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred cccccCCHHH---HHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 2111111111 1123466677776666677777888877666555443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.5e-19 Score=180.71 Aligned_cols=141 Identities=17% Similarity=0.196 Sum_probs=109.1
Q ss_pred cceeccCCcccEEEEEEcCCcEEEEEEcccccchhh-------------------------HHHHHHHHHHHhcCCCCce
Q 043720 826 SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHG-------------------------VQQFHAEIKTLGNVRHPNL 880 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~-------------------------~~~~~~E~~~l~~l~h~ni 880 (1103)
...||+|+||+||+|...+|+.||||+++....... ......|+..+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 457999999999999887899999999976532110 1123459999999987776
Q ss_pred eEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHH-HhCCCCCcccCCCCCCcEEECCC
Q 043720 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL-HDQCAPRVLHRDVKPSNILLDDD 959 (1103)
Q Consensus 881 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivH~Dlk~~NIll~~~ 959 (1103)
.....+... ..++||||++++++....... ..++..++.+++.|++.++.|+ |+. +|+||||||+||+++ +
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-C
Confidence 433332222 238999999988776553322 3488999999999999999999 788 999999999999998 4
Q ss_pred CCEEEeecccccccC
Q 043720 960 FNAYLSDFGLSRLLG 974 (1103)
Q Consensus 960 ~~~ki~Dfgla~~~~ 974 (1103)
+.++++|||+|....
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.2e-18 Score=183.77 Aligned_cols=197 Identities=21% Similarity=0.263 Sum_probs=142.6
Q ss_pred CCCceeEEEeEEec---------------------------CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHH
Q 043720 876 RHPNLVTLIGYRAS---------------------------GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALD 928 (1103)
Q Consensus 876 ~h~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ 928 (1103)
+|||||+++++|.+ ...+|+||..++ .+|.+|+-.+. .+.....-+..|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ 349 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ 349 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence 49999999987533 236799999884 59999997655 455666778899
Q ss_pred HHHHHHHHHhCCCCCcccCCCCCCcEEE--CCCC--CEEEeecccccccCC-----CCCccccCCcccccccCccccccC
Q 043720 929 VASALAYLHDQCAPRVLHRDVKPSNILL--DDDF--NAYLSDFGLSRLLGT-----SETHATTGVAGTFGYVAPEYALTC 999 (1103)
Q Consensus 929 ia~gL~~LH~~~~~~ivH~Dlk~~NIll--~~~~--~~ki~Dfgla~~~~~-----~~~~~~~~~~g~~~y~aPE~~~~~ 999 (1103)
+++|+.|||.+ +|.|||+|++|||+ |+|+ ...|+|||.+---.. +-........|.-.-||||+....
T Consensus 350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 99999999999 99999999999999 3443 378999998743211 011112233567788999998653
Q ss_pred C------CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHH
Q 043720 1000 R------VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHL 1073 (1103)
Q Consensus 1000 ~------~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 1073 (1103)
+ ...|+|.|+.|.+.||+++...||+......- ....++ +......+..++..+.++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-------------~~r~Yq----e~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-------------DTRTYQ----ESQLPALPSRVPPVARQL 489 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-------------chhhhh----hhhCCCCcccCChHHHHH
Confidence 2 23489999999999999999999984211110 011111 111233467788999999
Q ss_pred HHHccccCCCCCCCHHHHHHHHH
Q 043720 1074 ALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1074 i~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
+...++.||++|++..=....|.
T Consensus 490 V~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHhcCCccccCCccHHHhHHH
Confidence 99999999999999765555443
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.8e-19 Score=182.61 Aligned_cols=178 Identities=13% Similarity=0.163 Sum_probs=135.8
Q ss_pred HHHHHH--HhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchh--hHHH------HHHHHHHHhcCCCCceeE
Q 043720 813 YESIIR--ATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQH--GVQQ------FHAEIKTLGNVRHPNLVT 882 (1103)
Q Consensus 813 ~~~~~~--~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~h~niv~ 882 (1103)
|.++.. ..++|...+.+|.|+||.||.++. ++..+|||++....... .... +.+|+..+.++.|++|..
T Consensus 21 ~~~~~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~ 99 (232)
T PRK10359 21 YKEIFDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLAS 99 (232)
T ss_pred HHHHHHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCc
Confidence 444433 368899999999999999999866 47789999996543221 1222 689999999999999999
Q ss_pred EEeEEecC--------CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcE
Q 043720 883 LIGYRASG--------NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNI 954 (1103)
Q Consensus 883 l~~~~~~~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NI 954 (1103)
+.+++... +..++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||++|+||
T Consensus 100 ~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Ni 166 (232)
T PRK10359 100 LNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNF 166 (232)
T ss_pred ceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHE
Confidence 98875432 35899999999999988732 222 2456999999999999 999999999999
Q ss_pred EECCCCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHH
Q 043720 955 LLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018 (1103)
Q Consensus 955 ll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ell 1018 (1103)
+++.++ ++++|||.......... . ..+.....|..++|+|+||+++....
T Consensus 167 li~~~g-i~liDfg~~~~~~e~~a--~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 167 IVSKNG-LRIIDLSGKRCTAQRKA--K-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEeCCC-EEEEECCCcccccchhh--H-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 999988 99999998865421111 0 11334455667999999999887654
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=183.48 Aligned_cols=232 Identities=20% Similarity=0.268 Sum_probs=152.8
Q ss_pred CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCC----------CceeEEEeE---
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRH----------PNLVTLIGY--- 886 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h----------~niv~l~~~--- 886 (1103)
+...+.||.|+++.||.+... +++.+|||++..... ....+.+++|.-....+.+ -.++-.++.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999665 489999999876543 3356778888776666432 122222221
Q ss_pred ------EecC---C-----eEEEEEeecCCCChHHHHHh---hcC--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccC
Q 043720 887 ------RASG---N-----EMFLIYNYLPGGNLENFIKA---RTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947 (1103)
Q Consensus 887 ------~~~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~ 947 (1103)
+... . ..+++|+-+ -+||.+++.. ... ..+....+..+..|+++.+++||+. ++||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 1111 1 236788888 4688887653 221 2345556677779999999999999 99999
Q ss_pred CCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCcccccc--------CCCCCcchhHHHHHHHHHHHh
Q 043720 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT--------CRVSDKADVYSYGVVLLELIS 1019 (1103)
Q Consensus 948 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDvwslGvil~ellt 1019 (1103)
||+|+|++++++|.++++||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|++
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988765432221 233578999997643 357889999999999999999
Q ss_pred CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCC
Q 043720 1020 DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTR 1085 (1103)
Q Consensus 1020 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1085 (1103)
++.||+...+..... ....... +.++.+.++|..+++++|.+|
T Consensus 246 ~~lPf~~~~~~~~~~----------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE----------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG----------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCcccccc----------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999998543221111 0112233 888999999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.9e-18 Score=171.31 Aligned_cols=188 Identities=16% Similarity=0.085 Sum_probs=141.1
Q ss_pred CCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchh---hHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEe
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQH---GVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E 898 (1103)
+.+...|++|+||+||.+.- ++.+++.+.+....... ....+.+|+++++++. |+++.+++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567899999999998865 58888887776554321 1235789999999995 5889999887 44699999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCC-CCCcEEECCCCCEEEeecccccccCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDV-KPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dl-k~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|+.|.+|.+.... ....++.+++.+++++|+. +|+|||| ||+||+++.++.++|+|||++.......
T Consensus 79 yI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 79 YLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred eecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 9999998754321 1134778999999999999 9999999 7999999999999999999998654332
Q ss_pred Cc----c--------ccCCcccccccCccccccC-CCC-CcchhHHHHHHHHHHHhCCCCCCCC
Q 043720 978 TH----A--------TTGVAGTFGYVAPEYALTC-RVS-DKADVYSYGVVLLELISDKKALDPS 1027 (1103)
Q Consensus 978 ~~----~--------~~~~~g~~~y~aPE~~~~~-~~~-~~sDvwslGvil~elltg~~p~~~~ 1027 (1103)
.. . ......++.|++|+...-. ..+ .+.+.++-|..+|.++|++.+....
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 10 0 0112246777777754332 222 4679999999999999999887643
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.6e-18 Score=196.74 Aligned_cols=217 Identities=27% Similarity=0.444 Sum_probs=164.8
Q ss_pred HhcCCCCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCc-ccCCCC
Q 043720 872 LGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV-LHRDVK 950 (1103)
Q Consensus 872 l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i-vH~Dlk 950 (1103)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+... ...+++.....++++|++||+|+|+. +| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeeec
Confidence 46788999999999999999999999999999999999873 35689999999999999999999988 55 999999
Q ss_pred CCcEEECCCCCEEEeecccccccCCC-CCccccCCcccccccCccccccCC-------CCCcchhHHHHHHHHHHHhCCC
Q 043720 951 PSNILLDDDFNAYLSDFGLSRLLGTS-ETHATTGVAGTFGYVAPEYALTCR-------VSDKADVYSYGVVLLELISDKK 1022 (1103)
Q Consensus 951 ~~NIll~~~~~~ki~Dfgla~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~-------~~~~sDvwslGvil~elltg~~ 1022 (1103)
+.|.+++..+.+|++|||+....... .........-..-|.|||.+.... .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998766321 111111112345799999987531 4567999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1023 ALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1023 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
||+........ ..+...+. . .....+.+.+.... ..++.+..++.+||..+|++||++++|...++.+.+
T Consensus 157 ~~~~~~~~~~~-~eii~~~~----~-~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDP-DEIILRVK----K-GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCCh-HHHHHHHH----h-cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99854332222 11111111 1 11222222222111 444579999999999999999999999998887654
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.8e-19 Score=199.17 Aligned_cols=225 Identities=25% Similarity=0.295 Sum_probs=183.0
Q ss_pred eccCCcccEEEE----EEcCCcEEEEEEcccccchh-hHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEeecCC
Q 043720 829 IGSGGFGTTYKA----EISPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 829 lg~G~fg~V~~~----~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+|+|+||.|+.+ ..+.|..+|+|+.++..... .......|-.++..++ ||.+|++.-.+......+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999987 23447889999887764422 2225567888888887 99999999999999999999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT 982 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~ 982 (1103)
|++...+.... .+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||+++..-....
T Consensus 82 g~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---- 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---- 152 (612)
T ss_pred chhhhccccCC--chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh----
Confidence 99988887654 377778888899999999999999 999999999999999999999999999986532222
Q ss_pred CCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCC
Q 043720 983 GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062 (1103)
Q Consensus 983 ~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1062 (1103)
.+||..|||||++. ....++|.||||++++||+||..||.. .....+.+ .....
T Consensus 153 -~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~------------~~~~~Il~-----------~~~~~ 206 (612)
T KOG0603|consen 153 -ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG------------DTMKRILK-----------AELEM 206 (612)
T ss_pred -cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch------------HHHHHHhh-----------hccCC
Confidence 18999999999998 456789999999999999999999983 11111111 12345
Q ss_pred ChhHHHHHHHHHHHccccCCCCCCCH
Q 043720 1063 PHDDLEDMLHLALRCTVETLSTRPTM 1088 (1103)
Q Consensus 1063 ~~~~~~~l~~li~~cl~~dP~~RPs~ 1088 (1103)
|......+.+++..+...+|..|--.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 67778888999999999999999754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.3e-17 Score=172.88 Aligned_cols=140 Identities=17% Similarity=0.214 Sum_probs=110.9
Q ss_pred cceeccCCcccEEEEEEcCCcEEEEEEcccccchh-------------------------hHHHHHHHHHHHhcCCCCce
Q 043720 826 SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQH-------------------------GVQQFHAEIKTLGNVRHPNL 880 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~-------------------------~~~~~~~E~~~l~~l~h~ni 880 (1103)
...||+|+||+||+|...+|+.||||++....... ....+..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46799999999999987789999999987653210 01224678999999999887
Q ss_pred eEEEeEEecCCeEEEEEeecCCCChHHH-HHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECC
Q 043720 881 VTLIGYRASGNEMFLIYNYLPGGNLENF-IKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDD 958 (1103)
Q Consensus 881 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~ 958 (1103)
.....+... ..++||||++++++... +.. ..++..+..+++.+++.++.++|+ . +|+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-
Confidence 544443332 24899999988755443 432 237788999999999999999999 8 999999999999999
Q ss_pred CCCEEEeecccccccC
Q 043720 959 DFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 959 ~~~~ki~Dfgla~~~~ 974 (1103)
++.++++|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.2e-19 Score=202.29 Aligned_cols=273 Identities=27% Similarity=0.262 Sum_probs=148.9
Q ss_pred EEEccCCCCc-ccCCccccCCCCCCEEEeecCCCCC----CccccccCCCCCCEEEccccccCC------CCCCCCCCCC
Q 043720 111 VLSLPFNGFS-GEFPPEIWSLEKLEVLDVEGNFLSG----RLPNEFVGLRNLRVLNLAFNRIDG------DIPFSLRNFE 179 (1103)
Q Consensus 111 ~L~L~~n~l~-g~~p~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~ 179 (1103)
.|+|..+.++ +..+..+..+..|++|+++++.++. .++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666665 3344445556667777777777642 245555566667777777766652 1233455566
Q ss_pred CCCEEEccCCcCCCCCChhcccCCC---CcEeecccccCCCCC----ChhHHhhcCcCcEEECcCCccccc----cCccc
Q 043720 180 SLEVLNLAGNQVKGVIPGFLGSFLK---LRVLFLSYNELNGSI----PSELGKYCRYLEHLDLSGNSLVGR----IPSSL 248 (1103)
Q Consensus 180 ~L~~L~L~~n~l~~~~p~~l~~l~~---L~~L~L~~N~l~g~i----p~~~~~~~~~L~~L~L~~N~l~~~----~p~~l 248 (1103)
+|++|++++|.+.+..+..+..+.+ |++|++++|++++.. ...+....++|++|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 6777777766666555555544444 666666666665321 112222114566666666666522 22334
Q ss_pred cCCCCCCEEeCCCccCCcc----ccccccCCCCCCEEEccCCcCCCc----CCccccCCCCCCeEecccCcCccccCccc
Q 043720 249 GKCQQLRTLLLFSNMLNDV----IPRELGWLRKLEVLDVSRNRLNGL----IPTELGNCVELSVLVLSNLFDPLLSGRNI 320 (1103)
Q Consensus 249 ~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~~~~~~l~~~~~ 320 (1103)
..+++|++|++++|.+++. ++..+..+++|+.|+|++|.+++. ++..+..+++|+.|++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~l------------- 228 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNL------------- 228 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEec-------------
Confidence 4455566666666666531 223344445666666666665432 1222333444444444
Q ss_pred cCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCcccc-----ccccCcEEEcCCccccc----cc
Q 043720 321 RGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWG-----ACESLEMLNLAQNVLRG----DL 391 (1103)
Q Consensus 321 ~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~-----~l~~L~~L~Ls~N~l~~----~~ 391 (1103)
++|.+.+.....+. ..++|+.|++++|.++. ..
T Consensus 229 --------------------------------------s~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l 270 (319)
T cd00116 229 --------------------------------------GDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDL 270 (319)
T ss_pred --------------------------------------CCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHH
Confidence 44444332111111 23677788888887762 23
Q ss_pred chhhhccCCceEeecCCcccccc----ccccc-cc-cceeEEEecCCcc
Q 043720 392 IGVFDRCKKLHFIDLSSNELSGE----LDVKL-QV-PCMALFDVSGNHM 434 (1103)
Q Consensus 392 ~~~~~~l~~L~~LdLs~N~l~~~----~~~~~-~~-~~L~~l~ls~N~l 434 (1103)
...+..+++|+++|+++|.++.. ..... .. +.++.+++.+|++
T Consensus 271 ~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 271 AEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred HHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 34555667788888888888753 22222 33 5677888877754
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=1e-19 Score=170.56 Aligned_cols=158 Identities=33% Similarity=0.574 Sum_probs=107.9
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
+.+++..+.|.||+|.++ .+|+.|+.+.+|+.|++++|+++ .+|.+++.+++|++|+++-|++. .+|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 445667777778888777 67777777777888888877777 77777777777777777777777 7777777777777
Q ss_pred EEEccCCcCCC-CCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCC
Q 043720 183 VLNLAGNQVKG-VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS 261 (1103)
Q Consensus 183 ~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 261 (1103)
.|||++|.+.. .+|+.|-.|+.|+.|+|++|.|. .+|..++++ ++|+.|.+..|.+- .+|..++.+++|++|++.+
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~l-t~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKL-TNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhh-cceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 77777777753 35666666666666666666665 566666553 44666666666554 4555555555555555555
Q ss_pred ccCCc
Q 043720 262 NMLND 266 (1103)
Q Consensus 262 N~l~~ 266 (1103)
|+++-
T Consensus 183 nrl~v 187 (264)
T KOG0617|consen 183 NRLTV 187 (264)
T ss_pred ceeee
Confidence 55543
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=9.9e-20 Score=170.65 Aligned_cols=172 Identities=29% Similarity=0.415 Sum_probs=154.9
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccC
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 624 (1103)
+.|.||+|+++ .+|+.|..+ .+|++|++++|+|+ .+|..++.+++|+.|+++-|++. ..|..|+.++.|+.|||++
T Consensus 36 TrLtLSHNKl~-~vppnia~l-~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlty 111 (264)
T KOG0617|consen 36 TRLTLSHNKLT-VVPPNIAEL-KNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTY 111 (264)
T ss_pred hhhhcccCcee-ecCCcHHHh-hhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccc
Confidence 35789999998 899999988 89999999999999 77899999999999999999998 8999999999999999999
Q ss_pred cccC-CCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCC
Q 043720 625 NNLT-GGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPF 703 (1103)
Q Consensus 625 N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~ 703 (1103)
|++. ..+|..|..++.|+.|+|++|.+. .+|..++++++|+.|.+.+|.+- .+|..++.++.|+.|.+.+|+++-.+
T Consensus 112 nnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~vlp 189 (264)
T KOG0617|consen 112 NNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLP 189 (264)
T ss_pred cccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeeecC
Confidence 9998 468999999999999999999998 88999999999999999999998 89999999999999999999999888
Q ss_pred CCC--c---cccccccccCCCCCC
Q 043720 704 PWN--V---TTMNCSGVIGNPFLD 722 (1103)
Q Consensus 704 p~~--~---~~~~~~~l~~Np~~c 722 (1103)
|+. + ..-....+..|||..
T Consensus 190 pel~~l~l~~~k~v~r~E~NPwv~ 213 (264)
T KOG0617|consen 190 PELANLDLVGNKQVMRMEENPWVN 213 (264)
T ss_pred hhhhhhhhhhhHHHHhhhhCCCCC
Confidence 852 1 122233488999974
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.8e-19 Score=200.22 Aligned_cols=252 Identities=26% Similarity=0.286 Sum_probs=173.7
Q ss_pred EEEeecCCCC-CCccccccCCCCCCEEEccccccCCC----CCCCCCCCCCCCEEEccCCcCCC------CCChhcccCC
Q 043720 135 VLDVEGNFLS-GRLPNEFVGLRNLRVLNLAFNRIDGD----IPFSLRNFESLEVLNLAGNQVKG------VIPGFLGSFL 203 (1103)
Q Consensus 135 ~L~Ls~n~l~-~~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~n~l~~------~~p~~l~~l~ 203 (1103)
.|+|.++.++ +..+..+..+.+|++|+++++.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 5788888887 55666777888899999999998642 56667778889999999988873 2334567788
Q ss_pred CCcEeecccccCCCCCChhHHhhcC--cCcEEECcCCcccc----ccCccccCC-CCCCEEeCCCccCCcc----ccccc
Q 043720 204 KLRVLFLSYNELNGSIPSELGKYCR--YLEHLDLSGNSLVG----RIPSSLGKC-QQLRTLLLFSNMLNDV----IPREL 272 (1103)
Q Consensus 204 ~L~~L~L~~N~l~g~ip~~~~~~~~--~L~~L~L~~N~l~~----~~p~~l~~l-~~L~~L~L~~N~l~~~----~p~~l 272 (1103)
+|++|++++|.+.+..+..+..... +|++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 8888888888887655555554422 28888888888763 233345555 7778888888777742 33445
Q ss_pred cCCCCCCEEEccCCcCCCc----CCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhh
Q 043720 273 GWLRKLEVLDVSRNRLNGL----IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEIT 348 (1103)
Q Consensus 273 ~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~ 348 (1103)
..+++|+.|++++|.+++. ++..+..+++|+.|++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L----------------------------------------- 200 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDL----------------------------------------- 200 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEec-----------------------------------------
Confidence 5666777777777777642 2222333345555555
Q ss_pred ccccccccccCCcccccc----CCccccccccCcEEEcCCcccccccchhhhc-----cCCceEeecCCccccc--c--c
Q 043720 349 TLSKLRIIWAPRLNLEGK----LPSSWGACESLEMLNLAQNVLRGDLIGVFDR-----CKKLHFIDLSSNELSG--E--L 415 (1103)
Q Consensus 349 ~L~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~LdLs~N~l~~--~--~ 415 (1103)
++|.+.+. ++..+..+++|++|++++|.+++.....+.. .++|++|++++|.++. . +
T Consensus 201 ----------~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l 270 (319)
T cd00116 201 ----------NNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDL 270 (319)
T ss_pred ----------cCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHH
Confidence 44444322 3345667889999999999999754444432 3799999999999972 1 1
Q ss_pred -cccccccceeEEEecCCccccc
Q 043720 416 -DVKLQVPCMALFDVSGNHMSGS 437 (1103)
Q Consensus 416 -~~~~~~~~L~~l~ls~N~l~g~ 437 (1103)
.....+++|+.+++++|+++..
T Consensus 271 ~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 271 AEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HHHHhcCCCccEEECCCCCCcHH
Confidence 2233568899999999999854
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.3e-16 Score=162.66 Aligned_cols=137 Identities=17% Similarity=0.212 Sum_probs=106.1
Q ss_pred CCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-----CCCceeEEEeEEecCC---e-E
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-----RHPNLVTLIGYRASGN---E-M 893 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~-~ 893 (1103)
+.-.+.||+|+||.||. ...++. .+||++...... ..+.+.+|+.+++.+ .||||++++|++.++. . +
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 34467899999999996 333344 479988764332 456789999999999 5799999999998863 4 3
Q ss_pred EEEEee--cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHH-HHHHhCCCCCcccCCCCCCcEEECC----CCCEEEee
Q 043720 894 FLIYNY--LPGGNLENFIKARTSRAVDWKILHKIALDVASAL-AYLHDQCAPRVLHRDVKPSNILLDD----DFNAYLSD 966 (1103)
Q Consensus 894 ~lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL-~~LH~~~~~~ivH~Dlk~~NIll~~----~~~~ki~D 966 (1103)
.+|+|| +.+++|.+++++.. +++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|+|
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~~---~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQCR---YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEecCCCCcchhHHHHHHccc---ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 478999 55799999997632 5554 35677888777 999999 9999999999999974 33799999
Q ss_pred cccc
Q 043720 967 FGLS 970 (1103)
Q Consensus 967 fgla 970 (1103)
|+-+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5433
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-16 Score=191.52 Aligned_cols=246 Identities=20% Similarity=0.251 Sum_probs=179.9
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC---CCceeEEEeEEecCCeEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR---HPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 895 (1103)
....|.+.+.||+|+||+||+|...+|+.||+|+-+-....+ |.==.+++.+++ -+-|+.+..++.-.+..++
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 345688899999999999999988889999999866544322 111122333333 2445555556666778899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-------CCCEEEeecc
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-------DFNAYLSDFG 968 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~ki~Dfg 968 (1103)
|+||.+.|+|.+++.. .+.+++.....++.|+++.+++||.. +||||||||+|+|+.. ...++|+|||
T Consensus 772 v~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999984 35599999999999999999999999 9999999999999952 3358999999
Q ss_pred cccccCC-CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 969 LSRLLGT-SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 969 la~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
.+..+.- .+.......++|-.+-.+|...+..+++.+|-|.++.+++-|+.|+..-. ..
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~--------------------~~ 906 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV--------------------KN 906 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh--------------------cC
Confidence 9987642 22345667788999999999999999999999999999999999984320 00
Q ss_pred CcccccccccccCCCChh-HHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1048 GQVKDVFNAELWASGPHD-DLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
+. ...++..+ +.. -.+.+.+++..+|..|-..=|...++...++++
T Consensus 907 g~-~~~~~~~~----~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~ 953 (974)
T KOG1166|consen 907 GS-SWMVKTNF----PRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEV 953 (974)
T ss_pred Cc-ceeccccc----hhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHH
Confidence 00 00000100 111 112356667777776666667777777776664
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=4e-17 Score=181.02 Aligned_cols=175 Identities=25% Similarity=0.413 Sum_probs=132.4
Q ss_pred CeEEEEEeecCCCChHHHHHhhc-CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKART-SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
...|+.|++|+..+|.+|+..+. ...-++.....++.|++.|++| + +.+|+|+||.||+...+..+||+|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence 35799999999999999997433 3456788899999999999999 6 999999999999999999999999999
Q ss_pred ccccCCCC-----CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHH
Q 043720 970 SRLLGTSE-----THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 970 a~~~~~~~-----~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
........ ....+...||..||+||.+.+..|+.|+||||||++++|++. -..+++.. ... .
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-----------~t~-~ 470 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-----------ATL-T 470 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------Hhh-h
Confidence 98765444 334566789999999999999999999999999999999997 22222100 000 0
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVV 1092 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1092 (1103)
.++ ...+++..+.+++ .-+.++.+++++.|.+||++.++.
T Consensus 471 d~r----~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~~ 510 (516)
T KOG1033|consen 471 DIR----DGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEVA 510 (516)
T ss_pred hhh----cCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHHh
Confidence 011 1122222222222 335788999999999999555543
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.64 E-value=8.5e-16 Score=163.94 Aligned_cols=143 Identities=19% Similarity=0.193 Sum_probs=112.4
Q ss_pred CCCCcceeccCCcccEEEEE--EcCCcEEEEEEcccccch-----------------------hhHHHHHHHHHHHhcCC
Q 043720 822 DFNTSNCIGSGGFGTTYKAE--ISPGILVAVKKLAVGRFQ-----------------------HGVQQFHAEIKTLGNVR 876 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~--~~~~~~vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 876 (1103)
-|.+.+.||+|+||.||+|. ..+|+.||||+++..... .....+.+|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999997 567999999998754311 01123578999999997
Q ss_pred CC--ceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCC-cccCCCCCCc
Q 043720 877 HP--NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR-VLHRDVKPSN 953 (1103)
Q Consensus 877 h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-ivH~Dlk~~N 953 (1103)
+. .+.+++++ ...++||||++++++..+.... ......+...++.|++.++++||+. + |+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhh
Confidence 53 34455543 2358999999998887765322 2356667789999999999999999 9 9999999999
Q ss_pred EEECCCCCEEEeecccccccC
Q 043720 954 ILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 954 Ill~~~~~~ki~Dfgla~~~~ 974 (1103)
|+++ ++.++++|||.+....
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEEE-CCCEEEEEChhhhccC
Confidence 9999 7899999999987543
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.3e-15 Score=185.45 Aligned_cols=153 Identities=31% Similarity=0.561 Sum_probs=100.8
Q ss_pred CCChhhHHHHHHHHhhccCCCCcccCcCCCCCCCC-----ceeeeEecCCCCeEEEEecCCCCCCCCCCccccccccccc
Q 043720 2 GKVLPEKTILLEFKNSVSDPSGILSSWQTNTSSHC-----SWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQF 76 (1103)
Q Consensus 2 ~~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~C-----~W~GV~C~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~ 76 (1103)
.+.+.|.+||++||+++.+|.. .+|+. |+| .|.||.|+.....
T Consensus 368 ~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~--------------------------- 415 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTK--------------------------- 415 (623)
T ss_pred ccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCC---------------------------
Confidence 3577899999999999977643 58963 344 7999999621000
Q ss_pred cccccccccceeccCCCccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCC
Q 043720 77 PFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRN 156 (1103)
Q Consensus 77 ~~~~~~~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~ 156 (1103)
....++.|+|++|.+.|.+|..++++++|+.|+|++|.++|.+|..++.+++
T Consensus 416 ----------------------------~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~ 467 (623)
T PLN03150 416 ----------------------------GKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITS 467 (623)
T ss_pred ----------------------------CceEEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCC
Confidence 0012345677777777777777777777777777777777777777777777
Q ss_pred CCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccC-CCCcEeeccccc
Q 043720 157 LRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSF-LKLRVLFLSYNE 214 (1103)
Q Consensus 157 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l-~~L~~L~L~~N~ 214 (1103)
|++|+|++|+++|.+|..++++++|++|+|++|+++|.+|..++.+ .++..+++.+|.
T Consensus 468 L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 468 LEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred CCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 7777777777776666666666666666666666666666555432 233444444443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.6e-15 Score=157.08 Aligned_cols=144 Identities=20% Similarity=0.218 Sum_probs=112.4
Q ss_pred HHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch---------------------hhHHHHHHHHHHHhc
Q 043720 816 IIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ---------------------HGVQQFHAEIKTLGN 874 (1103)
Q Consensus 816 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~l~~ 874 (1103)
+.+....|.+.+.||+|+||.||+|...+|+.||||++...... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33333447788999999999999998888999999987643210 011236778999998
Q ss_pred CCCC--ceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCC
Q 043720 875 VRHP--NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPS 952 (1103)
Q Consensus 875 l~h~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~ 952 (1103)
+.|+ .+.+.++. ...++||||+++++|.+.... .....++.+++.++.++|+. +|+||||+|+
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~ 154 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEF 154 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcc
Confidence 8777 44444442 345899999999998775421 34567889999999999999 9999999999
Q ss_pred cEEECCCCCEEEeecccccccC
Q 043720 953 NILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 953 NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
||++++++.++|+|||++....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=3.8e-15 Score=157.84 Aligned_cols=135 Identities=20% Similarity=0.372 Sum_probs=113.7
Q ss_pred ceeccCCcccEEEEEEcCCcEEEEEEcccccch-------hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-------HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.||+|++|.||+|.. .|..|+||+....... .....+.+|+.++..+.|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5699999999999987 5788999986543221 1234578899999999999988777777677788999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
++|++|.+++.... . .+..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986532 1 7888999999999999999 999999999999999 78999999998864
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.3e-16 Score=184.13 Aligned_cols=211 Identities=23% Similarity=0.310 Sum_probs=146.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
..+|+.++.|..|++|.||..+++. .+++|+|+ .+.. .+.+- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccc------hhhhc--cccccCCccee-----------------
Confidence 3579999999999999999997764 67788843 2221 01110 22222334433
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC--
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS-- 976 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~-- 976 (1103)
||-...++.... ++.. ++.+++|+|+. +|+|||+||+|.+|+.-|++|++|||+++..-..
T Consensus 136 ----gDc~tllk~~g~--lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGP--LPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ----chhhhhcccCCC--Ccch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 444455544322 2222 27899999999 9999999999999999999999999998653110
Q ss_pred ----------CC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 977 ----------ET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 977 ----------~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
.. .....++|||.|.|||++....|...+|.|++|+|+||++-|+.||....+. ..+...
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe--------elfg~v 270 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE--------ELFGQV 270 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH--------HHHhhh
Confidence 00 1234568999999999999999999999999999999999999999854321 011111
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHH
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMK 1089 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1089 (1103)
+. |.-.|.+.....+.++++++.+.++.+|.+|--..
T Consensus 271 is--------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 271 IS--------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred hh--------hhccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 11 11112222445567889999999999999997443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.5e-15 Score=155.02 Aligned_cols=131 Identities=21% Similarity=0.404 Sum_probs=106.8
Q ss_pred eeccCCcccEEEEEEcCCcEEEEEEcccccch-------hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 828 CIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-------HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 828 ~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
.||+|+||+||+|.+. +..|++|+....... .....+.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999854 788999986543211 12356788999999999887655555555566679999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
+|++|.+++.... . .++.+++.++.++|+. +++|||++|+||+++ ++.++++|||++..
T Consensus 80 ~g~~l~~~~~~~~---~------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN---D------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH---H------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999999875432 1 7899999999999999 999999999999999 78999999999875
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.5e-14 Score=174.51 Aligned_cols=138 Identities=23% Similarity=0.340 Sum_probs=112.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccc--cc-----hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVG--RF-----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~--~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
...|...+.||+|+||+||+|.+... .+++|+.... .. ....+.+.+|+++++.++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 34556788999999999999987644 3444433211 11 1123568899999999999999988888777777
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.++||||+++++|.+++. ....++.++++++.|||+. +++|||+||+||++ +++.++|+|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999999885 3467899999999999999 99999999999999 677999999999875
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.2e-13 Score=143.16 Aligned_cols=137 Identities=21% Similarity=0.246 Sum_probs=98.7
Q ss_pred cceeccCCcccEEEEEEcCCcEEEEEEcccccchh--hHH---------------------HHHHHHHHHhcCCCC--ce
Q 043720 826 SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQH--GVQ---------------------QFHAEIKTLGNVRHP--NL 880 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~--~~~---------------------~~~~E~~~l~~l~h~--ni 880 (1103)
.+.||+|+||+||+|...+++.||||++....... ... ....|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 46799999999999988789999999986543211 011 113456666665433 24
Q ss_pred eEEEeEEecCCeEEEEEeecCCCChHHH-HHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECC
Q 043720 881 VTLIGYRASGNEMFLIYNYLPGGNLENF-IKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDD 958 (1103)
Q Consensus 881 v~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~ 958 (1103)
.+.+++ ...++||||++++++... +.... .. .+...++.+++.++.++|. . +|+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-
Confidence 444443 235899999998544321 11111 11 5678899999999999999 7 999999999999999
Q ss_pred CCCEEEeecccccccC
Q 043720 959 DFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 959 ~~~~ki~Dfgla~~~~ 974 (1103)
++.++++|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.48 E-value=5.7e-15 Score=158.99 Aligned_cols=269 Identities=24% Similarity=0.258 Sum_probs=186.2
Q ss_pred ceeeeEecCCCC------------eEEEEecCCCCCCCCCCccccccccccccccc----cccccceeccCCCcccc---
Q 043720 37 SWFGVSCDSESR------------VVALNITGGDVSEGNSKPFFSCLMTAQFPFYG----FGMRRRTCLHGRGKLVG--- 97 (1103)
Q Consensus 37 ~W~GV~C~~~~~------------v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~g--- 97 (1103)
.|.||+||++.| ....+.+|+++.++++.++...+..+...+|- ........+...++.+.
T Consensus 30 ~w~GvEWDd~~RGKH~G~vdgk~YF~~q~P~GGSFik~~kV~~p~d~~~t~~ery~e~~s~~sd~~~~~si~nK~vE~iG 109 (505)
T KOG3207|consen 30 KWYGVEWDDPVRGKHDGIVDGKRYFQTQHPNGGSFIKPGKVKFPTDLLRTFKERYYEKYSYSSDLESVLSISNKQVEFIG 109 (505)
T ss_pred cceeeEecCCCccccCceecceeeeeeecCCCccccCCccCCCCccHHHHHHHHHHHhhcCCcchhhHhhhcCceeEEec
Confidence 699999998643 44567889999999888777766665544432 22111111111122111
Q ss_pred --ccCcccCCCCCCCEEEccCCCCcccCC-ccccCCCCCCEEEeecCCCCC--CccccccCCCCCCEEEccccccCCCCC
Q 043720 98 --KLSPLVGGLSELRVLSLPFNGFSGEFP-PEIWSLEKLEVLDVEGNFLSG--RLPNEFVGLRNLRVLNLAFNRIDGDIP 172 (1103)
Q Consensus 98 --~~~~~l~~l~~L~~L~L~~n~l~g~~p-~~l~~l~~L~~L~Ls~n~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p 172 (1103)
+|...=.++..|+...|.+..+....- .-...|++++.||||.|-+.. .+-.....|++|+.|+|+.|++.....
T Consensus 110 fDki~akQsn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~ 189 (505)
T KOG3207|consen 110 FDKIAAKQSNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFIS 189 (505)
T ss_pred HHHHHHHhhhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcc
Confidence 222333688999999999998762221 245679999999999998872 344556789999999999999974333
Q ss_pred CCC-CCCCCCCEEEccCCcCCCC-CChhcccCCCCcEeecccccCC--CCCChhHHhhcCcCcEEECcCCccccccC--c
Q 043720 173 FSL-RNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELN--GSIPSELGKYCRYLEHLDLSGNSLVGRIP--S 246 (1103)
Q Consensus 173 ~~l-~~l~~L~~L~L~~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~--g~ip~~~~~~~~~L~~L~L~~N~l~~~~p--~ 246 (1103)
... ..++.|+.|.|+.|.|+-. +...+..+|+|..|+|.+|..- ...+..+ +..|++|||++|++-. .+ .
T Consensus 190 s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i---~~~L~~LdLs~N~li~-~~~~~ 265 (505)
T KOG3207|consen 190 SNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKI---LQTLQELDLSNNNLID-FDQGY 265 (505)
T ss_pred ccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhh---hhHHhhccccCCcccc-ccccc
Confidence 222 3578999999999999833 2233567899999999999422 1233333 3559999999999862 33 4
Q ss_pred cccCCCCCCEEeCCCccCCcc-cccc-----ccCCCCCCEEEccCCcCCCc-CCccccCCCCCCeEeccc
Q 043720 247 SLGKCQQLRTLLLFSNMLNDV-IPRE-----LGWLRKLEVLDVSRNRLNGL-IPTELGNCVELSVLVLSN 309 (1103)
Q Consensus 247 ~l~~l~~L~~L~L~~N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~l~~ 309 (1103)
..+.++.|+.|+++.+.++.+ .|+. ...+++|++|+++.|++... .-..+..+++|+.|.+..
T Consensus 266 ~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~ 335 (505)
T KOG3207|consen 266 KVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITL 335 (505)
T ss_pred ccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccc
Confidence 678899999999999999874 4544 46689999999999999632 123445566666666543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.2e-13 Score=134.62 Aligned_cols=135 Identities=19% Similarity=0.172 Sum_probs=114.1
Q ss_pred CcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCC--CceeEEEeEEecCCeEEEEEeecCC
Q 043720 825 TSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH--PNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| ..+.+++++....+..++++||+++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 35679999999999998764 7899998865443 4678899999999976 5899999998888889999999988
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.+++.|||.++.
T Consensus 78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4456677899999999999986334799999999999999989999999998863
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.46 E-value=5.8e-13 Score=142.56 Aligned_cols=137 Identities=23% Similarity=0.330 Sum_probs=106.8
Q ss_pred cceec-cCCcccEEEEEEcCCcEEEEEEcccccc------------hhhHHHHHHHHHHHhcCCCCce--eEEEeEEecC
Q 043720 826 SNCIG-SGGFGTTYKAEISPGILVAVKKLAVGRF------------QHGVQQFHAEIKTLGNVRHPNL--VTLIGYRASG 890 (1103)
Q Consensus 826 ~~~lg-~G~fg~V~~~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 890 (1103)
...|| .|+.|+||.++.. +..++||.+..... ......+.+|+.++.++.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 8999999999876 77899998854321 1233567889999999998775 6677764332
Q ss_pred -C---eEEEEEeecCC-CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 891 -N---EMFLIYNYLPG-GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 891 -~---~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
. ..++|||++++ .+|.+++... .++.. .+.+++.++.+||+. +|+||||||+|||++.++.++++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999988653 24443 356899999999999 99999999999999998899999
Q ss_pred eccccccc
Q 043720 966 DFGLSRLL 973 (1103)
Q Consensus 966 Dfgla~~~ 973 (1103)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.1e-14 Score=174.43 Aligned_cols=254 Identities=24% Similarity=0.301 Sum_probs=191.8
Q ss_pred cCCCCcceeccCCcccEEEEEEcC--CcEEEEEEccccc-chhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP--GILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 896 (1103)
..|...+.||+|+|+.|-.+.... ...+|+|.+.... ..........|..+-+.+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 457888889999999998885543 4456666665443 2233445556888878886 99999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHH-hCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH-DQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLG 974 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~ 974 (1103)
.||..++++.+.+........+......+..|+..++.|+| .. +++|+|+||+|.+++..+ ..+++|||+|..+.
T Consensus 100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~ 176 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYR 176 (601)
T ss_pred cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence 99999999998883222224666777889999999999999 77 999999999999999999 99999999998876
Q ss_pred C--CCCccccCCcc-cccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 975 T--SETHATTGVAG-TFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 975 ~--~~~~~~~~~~g-~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
. .........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++......... ..|
T Consensus 177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~---~~~---------- 243 (601)
T KOG0590|consen 177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY---SSW---------- 243 (601)
T ss_pred ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc---eee----------
Confidence 5 33334455677 9999999999885 44567899999999999999999988554332111 111
Q ss_pred ccccccccc--CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1051 KDVFNAELW--ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1051 ~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
.+.... ............++..+++..+|+.|.+.+++..
T Consensus 244 ---~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 244 ---KSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ---cccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence 111110 1112334455778888999999999999887653
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.39 E-value=9.5e-13 Score=160.40 Aligned_cols=92 Identities=40% Similarity=0.699 Sum_probs=64.8
Q ss_pred CCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhccccccccccc
Q 043720 593 LVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDN 672 (1103)
Q Consensus 593 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 672 (1103)
++.|+|++|.++|.+|..++.+++|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..+..+++|+.|+|++
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~ 499 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNG 499 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcC
Confidence 56667777777766776777777777777777777767776677777777777777777777777777777777777777
Q ss_pred ccCcCCCCcccc
Q 043720 673 NKLSGHLPSGLA 684 (1103)
Q Consensus 673 N~l~~~~p~~l~ 684 (1103)
|+++|.+|..+.
T Consensus 500 N~l~g~iP~~l~ 511 (623)
T PLN03150 500 NSLSGRVPAALG 511 (623)
T ss_pred CcccccCChHHh
Confidence 777777776654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.4e-14 Score=157.38 Aligned_cols=182 Identities=29% Similarity=0.442 Sum_probs=148.2
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEE
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
.|+.-...||+.|++. ++|..+..+..|+.+.|..|.+. .||..+.++..|++|||+.|+++ .+|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4556667788888887 88888888888888888888888 88888888888888888888888 8888888776 8888
Q ss_pred EccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccC
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 264 (1103)
-+++|+++ .+|..++.+..|..||.+.|++. .+|+.++.+ .+|+.|.+..|++. .+|..+..| .|..||++.|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l-~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYL-TSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhH-HHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCce
Confidence 88888888 67777888888888888888887 888888775 56888888888887 567777755 488888888888
Q ss_pred CccccccccCCCCCCEEEccCCcCCCcCCcccc
Q 043720 265 NDVIPRELGWLRKLEVLDVSRNRLNGLIPTELG 297 (1103)
Q Consensus 265 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 297 (1103)
+. +|-.|.+|+.|++|-|.+|.|. ..|..++
T Consensus 224 s~-iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 224 SY-LPVDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred ee-cchhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 76 7888888888888888888887 4455554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=9.5e-13 Score=136.81 Aligned_cols=206 Identities=19% Similarity=0.267 Sum_probs=143.3
Q ss_pred HHHHHhcCCCCceeEEEeEEecC-----CeEEEEEeecCCCChHHHHHhhcC--CcccHHHHHHHHHHHHHHHHHHHhCC
Q 043720 868 EIKTLGNVRHPNLVTLIGYRASG-----NEMFLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQC 940 (1103)
Q Consensus 868 E~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~ 940 (1103)
-...+-++.|.|||+++.|+.+. ....++.|||..|++..+|++... ..+......+|+.||..||.|||+.
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 34455566799999999987553 357899999999999999987543 5577788899999999999999996
Q ss_pred CCCcccCCCCCCcEEECCCCCEEEeeccccccc---CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHH
Q 043720 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL---GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLEL 1017 (1103)
Q Consensus 941 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~---~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~el 1017 (1103)
.|.|+|+++..+-|++..+|-+||+--.-.... ............+-++|.|||+-.....+.++|||+||....||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 899999999999999999999998632111110 00001111222456899999998877788899999999999999
Q ss_pred HhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1018 ISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1018 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
..+..--....+ ......- ........... .=..++.+|++..|..||+|.+++.+.
T Consensus 276 ailEiq~tnseS----~~~~ee~------ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 276 AILEIQSTNSES----KVEVEEN------IANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHheeccCCCcc----eeehhhh------hhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence 887643221111 0000000 00000000111 114568899999999999999988653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.3e-11 Score=143.77 Aligned_cols=167 Identities=20% Similarity=0.244 Sum_probs=113.6
Q ss_pred ceeeeeecCCCCCHHHHHHHh------------cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhh------
Q 043720 800 ELTLFIDIGVPLTYESIIRAT------------GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHG------ 861 (1103)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~------ 861 (1103)
+.....|...|+++++++... ..|+ .+.||.|++|.||+|+.++|+.||||+.+....+.-
T Consensus 85 ~L~~Lqd~v~p~~~~~~~~~l~~elg~~~~~~F~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~ 163 (437)
T TIGR01982 85 ELSLLQDRVPPFDFKVARKVIEAALGGPLEELFAEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIAL 163 (437)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHhCcCHHHHHhhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHH
Confidence 333444555666665554432 2233 367999999999999999999999999854321100
Q ss_pred ---------------------------------HHHHHHHHHHHhcCC----CCceeEEEeEE-ecCCeEEEEEeecCCC
Q 043720 862 ---------------------------------VQQFHAEIKTLGNVR----HPNLVTLIGYR-ASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 862 ---------------------------------~~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lV~E~~~~g 903 (1103)
.-+|.+|+..+.++. |.+-+.+-.++ ...+..++||||++|+
T Consensus 164 l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~ 243 (437)
T TIGR01982 164 LYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGI 243 (437)
T ss_pred HHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCc
Confidence 012455666665552 32223332222 2244579999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHH-HHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVAS-ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~-gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+|.++...... .. ...+++..++. .+..+|.. +++|+|++|.||+++.++.++++|||++..+.
T Consensus 244 ~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 244 PLSDIAALDEA-GL---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99988754321 12 23456666666 47888988 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.8e-13 Score=151.72 Aligned_cols=182 Identities=28% Similarity=0.406 Sum_probs=161.6
Q ss_pred ccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCC
Q 043720 96 VGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSL 175 (1103)
Q Consensus 96 ~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 175 (1103)
...+|.....+..|+.+.|..|.+. .||..++++..|..|||+.|+++ .+|..+..|+ |+.|-+++|+++ .+|..+
T Consensus 87 ~~elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~i 162 (722)
T KOG0532|consen 87 FSELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEI 162 (722)
T ss_pred cccCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCccc
Confidence 3578888999999999999999998 99999999999999999999999 8899888886 999999999999 999999
Q ss_pred CCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC
Q 043720 176 RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR 255 (1103)
Q Consensus 176 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 255 (1103)
+.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|++++. ++ |..||++.|+++ .+|-.|.+|..|+
T Consensus 163 g~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~-Lp-Li~lDfScNkis-~iPv~fr~m~~Lq 237 (722)
T KOG0532|consen 163 GLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCS-LP-LIRLDFSCNKIS-YLPVDFRKMRHLQ 237 (722)
T ss_pred ccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhC-Cc-eeeeecccCcee-ecchhhhhhhhhe
Confidence 99999999999999998 67888999999999999999998 99999985 45 999999999999 8999999999999
Q ss_pred EEeCCCccCCccccccccCC---CCCCEEEccCCc
Q 043720 256 TLLLFSNMLNDVIPRELGWL---RKLEVLDVSRNR 287 (1103)
Q Consensus 256 ~L~L~~N~l~~~~p~~l~~l---~~L~~L~Ls~N~ 287 (1103)
+|-|.+|.++. .|..++.. .=.++|+..-++
T Consensus 238 ~l~LenNPLqS-PPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 238 VLQLENNPLQS-PPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred eeeeccCCCCC-ChHHHHhccceeeeeeecchhcc
Confidence 99999999987 46555432 233455555543
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.6e-12 Score=146.14 Aligned_cols=191 Identities=35% Similarity=0.506 Sum_probs=149.8
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCC-CCCEEEccccccCCCCCCCCCCCCCCCEEEccC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLR-NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (1103)
..|++..|.+.. .+..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|++. .+|..++++++|+.|++++
T Consensus 96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 357777777742 2334556688889999999988 7787777775 8999999999988 7777888889999999999
Q ss_pred CcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccc
Q 043720 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268 (1103)
Q Consensus 189 n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 268 (1103)
|+++ .+|...+..++|+.|++++|+++ .+|..+.. ...|++|.+++|.+. ..+..+.++.++..+.+.+|++.. +
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~-~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~ 247 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIEL-LSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-L 247 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhh-hhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-c
Confidence 9988 56665667888999999999988 88877543 355889999988644 466778888888888888888876 3
Q ss_pred cccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccC
Q 043720 269 PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 269 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
+..++.++++++|++++|+++.. +. ++.+.+++.|+++++
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~~i-~~-~~~~~~l~~L~~s~n 287 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQISSI-SS-LGSLTNLRELDLSGN 287 (394)
T ss_pred cchhccccccceecccccccccc-cc-ccccCccCEEeccCc
Confidence 67788888899999999988844 33 888888888888753
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.24 E-value=5.9e-12 Score=147.09 Aligned_cols=188 Identities=34% Similarity=0.478 Sum_probs=163.5
Q ss_pred cccCCCCCCCEEEccCCCCcccCCccccCCC-CCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCC
Q 043720 101 PLVGGLSELRVLSLPFNGFSGEFPPEIWSLE-KLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFE 179 (1103)
Q Consensus 101 ~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~ 179 (1103)
..+..++.++.|++.+|.++ .+|+....+. +|+.|++++|++. .+|..++.+++|+.|++++|+++ .+|...+.++
T Consensus 110 ~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~ 186 (394)
T COG4886 110 SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLS 186 (394)
T ss_pred hhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhh
Confidence 44567789999999999999 8888888885 9999999999999 88888999999999999999999 8888887899
Q ss_pred CCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeC
Q 043720 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLL 259 (1103)
Q Consensus 180 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 259 (1103)
+|+.|++++|+++ .+|...+....|++|.+++|.+. .++..+... .++..|.+.+|++. .++..++.+++++.|++
T Consensus 187 ~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~-~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~ 262 (394)
T COG4886 187 NLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNL-KNLSGLELSNNKLE-DLPESIGNLSNLETLDL 262 (394)
T ss_pred hhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhc-ccccccccCCceee-eccchhccccccceecc
Confidence 9999999999999 67776666778999999999655 667667664 67999999999998 45788999999999999
Q ss_pred CCccCCccccccccCCCCCCEEEccCCcCCCcCCcccc
Q 043720 260 FSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELG 297 (1103)
Q Consensus 260 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 297 (1103)
++|.++...+ ++.+.+++.|++++|.+....|....
T Consensus 263 s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~ 298 (394)
T COG4886 263 SNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIAL 298 (394)
T ss_pred cccccccccc--ccccCccCEEeccCccccccchhhhc
Confidence 9999998544 89999999999999999977665443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.4e-10 Score=133.09 Aligned_cols=167 Identities=17% Similarity=0.237 Sum_probs=130.0
Q ss_pred EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHH
Q 043720 841 EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWK 920 (1103)
Q Consensus 841 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~ 920 (1103)
...++.+|.|.+++.... .......+-++.++.++||+|+++++.....+..|+|+|.+. -|..++++.. ..
T Consensus 33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----~~ 104 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----KE 104 (690)
T ss_pred eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----HH
Confidence 444678888888876655 445667888999999999999999999999999999999984 6888887643 46
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCccccccCC
Q 043720 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000 (1103)
Q Consensus 921 ~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~ 1000 (1103)
.....+.||+.||.+||+.| +++|+++....|+|+..|..||++|-++........ ......--..|..|+.+-...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence 67778899999999999776 999999999999999999999999998865421111 111111223566676543322
Q ss_pred CCCcchhHHHHHHHHHHHhC
Q 043720 1001 VSDKADVYSYGVVLLELISD 1020 (1103)
Q Consensus 1001 ~~~~sDvwslGvil~elltg 1020 (1103)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 236999999999999998
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.7e-11 Score=138.07 Aligned_cols=248 Identities=23% Similarity=0.263 Sum_probs=183.5
Q ss_pred CCCCcceecc--CCcccEEEEEE---cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEE
Q 043720 822 DFNTSNCIGS--GGFGTTYKAEI---SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~--G~fg~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 894 (1103)
.|...+.+|. |.+|.||.+.. .++..+|+|+-+.... ......=++|+...+.+ .|++.++.+..+..++..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4667788999 99999999966 4578899998544332 12223345677777777 4999999899999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHH----HHHHHHhCCCCCcccCCCCCCcEEECCC-CCEEEeeccc
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS----ALAYLHDQCAPRVLHRDVKPSNILLDDD-FNAYLSDFGL 969 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgl 969 (1103)
+-+|++ +.++.++.+... ..++...++.+..+... |+.++|+. +++|-|+||.||+...+ ...+.+|||+
T Consensus 195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcce
Confidence 999999 578888887643 34777888888888888 99999999 99999999999999999 7899999999
Q ss_pred ccccCCCCCcc----ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 970 SRLLGTSETHA----TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 970 a~~~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
....+...... .....|...|++||..++ .++.++|+|++|.++.+-.++........- ..|.. .
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--------~~W~~--~ 338 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKN--------SSWSQ--L 338 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCC--------CCccc--c
Confidence 98886554322 222367789999997765 567899999999999999998876543210 01110 0
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
++.. +..++......++...+..|++.+|..|++++.+..
T Consensus 339 r~~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 RQGY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred cccc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 0110 111112222344555889999999999999887764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.7e-11 Score=140.18 Aligned_cols=144 Identities=17% Similarity=0.216 Sum_probs=96.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccch---------------------------------hhH----
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQ---------------------------------HGV---- 862 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---------------------------------~~~---- 862 (1103)
.+|+. +.||+|++|.||+|.+++ |+.||||+.+....+ +..
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 789999999999999987 999999999744210 001
Q ss_pred --HHHHHHHHHHhcCC----CCceeEEEeEEec-CCeEEEEEeecCCCChHHHH--HhhcC--CcccHHHHHHHHHHHHH
Q 043720 863 --QQFHAEIKTLGNVR----HPNLVTLIGYRAS-GNEMFLIYNYLPGGNLENFI--KARTS--RAVDWKILHKIALDVAS 931 (1103)
Q Consensus 863 --~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~ia~ 931 (1103)
-++.+|+..+.+++ +...+.+=.++.+ ....++||||++|+.+.++- +.... ..+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 12445555555542 3444443333322 45678999999999998753 22110 113333333334443
Q ss_pred HHHHHHhCCCCCcccCCCCCCcEEECCCC----CEEEeecccccccCC
Q 043720 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDF----NAYLSDFGLSRLLGT 975 (1103)
Q Consensus 932 gL~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgla~~~~~ 975 (1103)
... +++|+|++|.||+++.++ ++++.|||++..+..
T Consensus 277 -----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 446 999999999999999888 999999999987643
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4.3e-11 Score=89.79 Aligned_cols=41 Identities=51% Similarity=1.039 Sum_probs=31.4
Q ss_pred ChhhHHHHHHHHhhcc-CCCCcccCcCCCC-CCCCceeeeEec
Q 043720 4 VLPEKTILLEFKNSVS-DPSGILSSWQTNT-SSHCSWFGVSCD 44 (1103)
Q Consensus 4 ~~~~~~aLl~~k~~~~-d~~~~l~sW~~~~-~~~C~W~GV~C~ 44 (1103)
.+.|++|||+||+++. ||.+.+++|+.+. .+||+|.||+||
T Consensus 1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 3689999999999998 6778999999763 689999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.4e-11 Score=124.61 Aligned_cols=131 Identities=25% Similarity=0.306 Sum_probs=107.8
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
+.|++||||+|.|+ .+.+...-+++++.|++|+|.|. .+- .+..+.+|+.||||+|.++ .+..+=..|-+.+.|.|
T Consensus 284 q~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~-~v~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L 359 (490)
T KOG1259|consen 284 QELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIR-TVQ-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL 359 (490)
T ss_pred hhhhhccccccchh-hhhhhhhhccceeEEecccccee-eeh-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence 67899999999998 56777777899999999999998 333 3888999999999999998 56667677889999999
Q ss_pred cCccccCcChhhhhhcccccccccccccCcCCC-CccccCCCCCceEeCCCCCCCCCC
Q 043720 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHL-PSGLANVTSLSIFNASFNNLSGPF 703 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~l~l~~N~l~~~~ 703 (1103)
+.|.|. .-..+..+-+|..||+++|+|.... -..++++|.|+++.+.+|++.+.+
T Consensus 360 a~N~iE--~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 360 AQNKIE--TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred hhhhHh--hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 999987 2346788889999999999997432 367889999999999999888744
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.8e-10 Score=115.92 Aligned_cols=131 Identities=19% Similarity=0.192 Sum_probs=96.5
Q ss_pred cceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCcee-EEEeEEecCCeEEEEEeecCCCC
Q 043720 826 SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV-TLIGYRASGNEMFLIYNYLPGGN 904 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lV~E~~~~gs 904 (1103)
.+.++.|.++.||+++.. +..|++|....... ....+.+|+.+++.+.+.+++ +++.+.. ...++||||+++.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 456899999999999876 77899998765432 123467888888888655544 4555443 23479999999988
Q ss_pred hHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC--CCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 905 LENFIKARTSRAVDWKILHKIALDVASALAYLHDQC--APRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 905 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
+.+. . . ....++.+++++++.||+.. ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~----~---~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTE----D---F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc----c---c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 7653 0 1 11235678999999999982 12359999999999999 66899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.9e-12 Score=132.24 Aligned_cols=94 Identities=22% Similarity=0.275 Sum_probs=52.3
Q ss_pred cCcccCCCCCCCEEEccCCCCccc----CCccccCCCCCCEEEeecCC---CCCCcccc-------ccCCCCCCEEEccc
Q 043720 99 LSPLVGGLSELRVLSLPFNGFSGE----FPPEIWSLEKLEVLDVEGNF---LSGRLPNE-------FVGLRNLRVLNLAF 164 (1103)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~n~l~g~----~p~~l~~l~~L~~L~Ls~n~---l~~~~p~~-------l~~l~~L~~L~Ls~ 164 (1103)
+-+.+.....++.|+||+|.|... +-+.+.+.++|+..++|.-. +...+|+. +...++|++||||+
T Consensus 22 v~~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSD 101 (382)
T KOG1909|consen 22 VEEELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSD 101 (382)
T ss_pred HHHHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccc
Confidence 334566777888888888887633 33445566777777776532 22334433 23345666666666
Q ss_pred cccCCCCCCCC----CCCCCCCEEEccCCcCC
Q 043720 165 NRIDGDIPFSL----RNFESLEVLNLAGNQVK 192 (1103)
Q Consensus 165 N~l~~~~p~~l----~~l~~L~~L~L~~n~l~ 192 (1103)
|-|...-+..| .+++.|++|+|.+|.+.
T Consensus 102 NA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg 133 (382)
T KOG1909|consen 102 NAFGPKGIRGLEELLSSCTDLEELYLNNCGLG 133 (382)
T ss_pred cccCccchHHHHHHHHhccCHHHHhhhcCCCC
Confidence 66653333322 23445555555555544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-09 Score=111.55 Aligned_cols=138 Identities=14% Similarity=0.186 Sum_probs=100.3
Q ss_pred cceeccCCcccEEEEEEcC-------CcEEEEEEcccccc---------------------hhhHHHH----HHHHHHHh
Q 043720 826 SNCIGSGGFGTTYKAEISP-------GILVAVKKLAVGRF---------------------QHGVQQF----HAEIKTLG 873 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~-------~~~vavK~~~~~~~---------------------~~~~~~~----~~E~~~l~ 873 (1103)
...||.|.-+.||.|...+ +..+|||+++.... ....+.+ ++|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3469999999999996542 47999998864311 0112223 37999999
Q ss_pred cCCC--CceeEEEeEEecCCeEEEEEeecCCCChHH-HHHhhcCCcccHHHHHHHHHHHHHHHHHH-HhCCCCCcccCCC
Q 043720 874 NVRH--PNLVTLIGYRASGNEMFLIYNYLPGGNLEN-FIKARTSRAVDWKILHKIALDVASALAYL-HDQCAPRVLHRDV 949 (1103)
Q Consensus 874 ~l~h--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~gL~~L-H~~~~~~ivH~Dl 949 (1103)
++.. -++.+.+++ ...++||||+.++.+.. .++. ..++.++...+..+++.+|..+ |.. ++||||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCC
Confidence 8853 455566654 45689999997654422 2322 1245566778889999999999 888 9999999
Q ss_pred CCCcEEECCCCCEEEeecccccccC
Q 043720 950 KPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 950 k~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
++.||+++ ++.++|+|||.+....
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.1e-10 Score=130.89 Aligned_cols=250 Identities=20% Similarity=0.157 Sum_probs=179.3
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc--CCcEEEEEEcccccchhhH-HHHHHHHHHHhcC-CCCceeEEEeEEecCCeEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS--PGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 894 (1103)
...+|..+..||.|.|+.|+....+ ++..|++|........... ..-..|+.+...+ .|.++++.+..+...+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457889999999999999998543 5788999988766443222 2234566666665 5899999888887778888
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-CCEEEeeccccccc
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-FNAYLSDFGLSRLL 973 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~~~ 973 (1103)
+--||+++++........ ..+++..++++..|++.++.++|++ .++|+|+||+||++..+ +..+++|||....+
T Consensus 343 ip~e~~~~~s~~l~~~~~--~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRSVTS--QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred CchhhhcCcchhhhhHHH--HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccc
Confidence 999999999888776322 3377788999999999999999999 99999999999999886 77899999988643
Q ss_pred CCCCCccccCCccccccc--CccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 974 GTSETHATTGVAGTFGYV--APEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~--aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.... ....+.-+++ +++......+..+.|+|+||.-+.|.+++..--. ... +|.. +..
T Consensus 418 ~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~-~~~---------~~~~--i~~---- 477 (524)
T KOG0601|consen 418 AFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE-SGV---------QSLT--IRS---- 477 (524)
T ss_pred ceec----ccccccccccccchhhccccccccccccccccccccccccCcccCc-ccc---------ccee--eec----
Confidence 2111 1111223344 5566667788899999999999999998874221 111 0100 000
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
... .........+..+.+.++.+++..||++.+...+.+-.+
T Consensus 478 -----~~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 478 -----GDT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred -----ccc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 100 111222367888999999999999999999887665543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=9.6e-11 Score=126.85 Aligned_cols=130 Identities=25% Similarity=0.214 Sum_probs=89.9
Q ss_pred EEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCC--cccccCccCcEEecc
Q 043720 546 VANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP--SSLHRLKYLRHLSLA 623 (1103)
Q Consensus 546 ~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~ 623 (1103)
.|.|+.++++-.=-.++...+++|+.|+|+.|....+.......+..|++|||++|++.. .+ ...+.++.|+.|+++
T Consensus 201 ~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~-~~~~~~~~~l~~L~~Lnls 279 (505)
T KOG3207|consen 201 QLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLID-FDQGYKVGTLPGLNQLNLS 279 (505)
T ss_pred eEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccc-cccccccccccchhhhhcc
Confidence 445555555532223444456889999999996443444455567889999999998873 34 356788999999999
Q ss_pred CcccCCC-CCCc-----ccCCCCCcEEeccCccccCcCh--hhhhhcccccccccccccCcC
Q 043720 624 DNNLTGG-IPSS-----IGELRSLEVLELSSNSLSGEVP--EGVVNLRNLTALLLDNNKLSG 677 (1103)
Q Consensus 624 ~N~l~~~-~p~~-----~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L~~N~l~~ 677 (1103)
.+.++.. .|+. ...+++|++|+++.|+|. ..+ +.+..+++|+.|....|.|+.
T Consensus 280 ~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~-~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 280 STGIASIAEPDVESLDKTHTFPKLEYLNISENNIR-DWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccCcchhcCCCccchhhhcccccceeeecccCccc-cccccchhhccchhhhhhcccccccc
Confidence 9998853 2333 345788999999999986 333 245566778888888888863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.3e-09 Score=101.91 Aligned_cols=145 Identities=21% Similarity=0.283 Sum_probs=109.0
Q ss_pred CcceeccCCcccEEEEEEcCCcEEEEEEcccccc-------hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 825 TSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-------QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
....+-+|+-+.|+++.+. |+...||.-..... +-..++.++|+..+.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4567899999999999888 77777775543322 113456788999999986544443333444445557899
Q ss_pred eecCC-CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEEEeeccccccc
Q 043720 898 NYLPG-GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAYLSDFGLSRLL 973 (1103)
Q Consensus 898 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~ 973 (1103)
||+++ .++.+++..........+....++..|-+.+.-||.. +|+||||.++||++..++ .+.++|||++..-
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 99965 4889998876655555555578999999999999999 999999999999996554 3589999998653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.00 E-value=4.5e-10 Score=112.15 Aligned_cols=102 Identities=32% Similarity=0.337 Sum_probs=30.6
Q ss_pred CCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccc-cCccccCCCCCCE
Q 043720 178 FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGR-IPSSLGKCQQLRT 256 (1103)
Q Consensus 178 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~ 256 (1103)
+.+|+.|+|++|.++. +. .+..++.|+.|++++|+++ .+++.+...+++|++|+|++|++... .-..+..+++|+.
T Consensus 41 l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~ 117 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRV 117 (175)
T ss_dssp -TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--E
T ss_pred hcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcce
Confidence 3444444444444442 11 2444555555555555555 44444433345555555555555421 1123445556666
Q ss_pred EeCCCccCCccc---cccccCCCCCCEEE
Q 043720 257 LLLFSNMLNDVI---PRELGWLRKLEVLD 282 (1103)
Q Consensus 257 L~L~~N~l~~~~---p~~l~~l~~L~~L~ 282 (1103)
|+|.+|.++..- ...+..+++|+.||
T Consensus 118 L~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 118 LSLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EE-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred eeccCCcccchhhHHHHHHHHcChhheeC
Confidence 666666555320 11234455555554
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.98 E-value=1.5e-10 Score=118.88 Aligned_cols=108 Identities=26% Similarity=0.226 Sum_probs=67.1
Q ss_pred hhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCC
Q 043720 197 GFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR 276 (1103)
Q Consensus 197 ~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 276 (1103)
..+..+..|++||||+|.++ .+.+++ ++.+.++.|++|+|.+.. + +++..+++|+.|||++|.++. +-.+-.++-
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESv-KL~Pkir~L~lS~N~i~~-v-~nLa~L~~L~~LDLS~N~Ls~-~~Gwh~KLG 352 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESV-KLAPKLRRLILSQNRIRT-V-QNLAELPQLQLLDLSGNLLAE-CVGWHLKLG 352 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhh-hhccceeEEeccccceee-e-hhhhhcccceEeecccchhHh-hhhhHhhhc
Confidence 33445566777777777776 565554 345667777777777762 2 336667777777777777765 344455566
Q ss_pred CCCEEEccCCcCCCcCCccccCCCCCCeEecccCc
Q 043720 277 KLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311 (1103)
Q Consensus 277 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~ 311 (1103)
+++.|.|+.|.+... ..++++-+|..||+++|.
T Consensus 353 NIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~ 385 (490)
T KOG1259|consen 353 NIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQ 385 (490)
T ss_pred CEeeeehhhhhHhhh--hhhHhhhhheeccccccc
Confidence 777777777776532 345566666666666543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.3e-10 Score=112.33 Aligned_cols=120 Identities=31% Similarity=0.445 Sum_probs=33.2
Q ss_pred CccEEECcCCcCCCCCccccc-CCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcc-cCCCCCcEEe
Q 043720 568 SLRVLDASHNQISGIVPQSLE-NLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLE 645 (1103)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~l~~L~~L~ 645 (1103)
.+++|+|++|+|+.+ +.++ .+.+|+.|+|++|.|+ .++ .+..+++|+.|++++|+|+. +...+ ..+++|++|+
T Consensus 20 ~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~-~l~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L~ 94 (175)
T PF14580_consen 20 KLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQIT-KLE-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQELY 94 (175)
T ss_dssp ------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EEE
T ss_pred ccccccccccccccc--cchhhhhcCCCEEECCCCCCc-ccc-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEEE
Confidence 456666666666633 2343 3556666666666666 232 35556666666666666653 32223 2456666666
Q ss_pred ccCccccCcC-hhhhhhcccccccccccccCcCCCCc----cccCCCCCceEe
Q 043720 646 LSSNSLSGEV-PEGVVNLRNLTALLLDNNKLSGHLPS----GLANVTSLSIFN 693 (1103)
Q Consensus 646 Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~l~ 693 (1103)
|++|+|...- -..+..+++|+.|+|.+|+++.. +. .+..+|+|+.||
T Consensus 95 L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~~-~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 95 LSNNKISDLNELEPLSSLPKLRVLSLEGNPVCEK-KNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp -TTS---SCCCCGGGGG-TT--EEE-TT-GGGGS-TTHHHHHHHH-TT-SEET
T ss_pred CcCCcCCChHHhHHHHcCCCcceeeccCCcccch-hhHHHHHHHHcChhheeC
Confidence 6666664311 12344555666666666665522 21 234455555554
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.97 E-value=4.9e-09 Score=102.43 Aligned_cols=132 Identities=22% Similarity=0.395 Sum_probs=100.5
Q ss_pred ceeccCCcccEEEEEEcCCcEEEEEEcccccch-------hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-------HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
..+++|+-+.+|.+.+. |..+++|.-...... -......+|+.++.+.+--.|.-..=+..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999886 545666654332211 1234567899999998765665555556666777899999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
++|..|.+++... ...++..+-.-+.-||.. +|||+|+.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 244666777778889999 999999999999998774 99999999974
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=8.1e-11 Score=124.26 Aligned_cols=111 Identities=29% Similarity=0.358 Sum_probs=77.2
Q ss_pred cCCCccEEECcCCcCCC----CCcccccCCCCCCEEEccCCcCCCC----CCcccccCccCcEEeccCcccCCCCCCcc-
Q 043720 565 MCKSLRVLDASHNQISG----IVPQSLENLTSLVFLDLNGNKLQGE----IPSSLHRLKYLRHLSLADNNLTGGIPSSI- 635 (1103)
Q Consensus 565 ~~~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~- 635 (1103)
..+.|+.+.+++|.|.. .+...|..+++|+.|||.+|.|+.. +...+..+++|+.|++++|.+...-...|
T Consensus 183 ~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~~Ga~a~~ 262 (382)
T KOG1909|consen 183 SHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLENEGAIAFV 262 (382)
T ss_pred hccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccccccccHHHHH
Confidence 33678888888888862 1334677889999999999988743 34556778889999999988874322222
Q ss_pred ----cCCCCCcEEeccCccccCcCh----hhhhhcccccccccccccC
Q 043720 636 ----GELRSLEVLELSSNSLSGEVP----EGVVNLRNLTALLLDNNKL 675 (1103)
Q Consensus 636 ----~~l~~L~~L~Ls~N~l~~~~~----~~~~~l~~L~~L~L~~N~l 675 (1103)
...++|++|.+.+|.|+..-- ..+...+.|+.|+|++|++
T Consensus 263 ~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l 310 (382)
T KOG1909|consen 263 DALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRL 310 (382)
T ss_pred HHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCcccc
Confidence 236788888888888873221 2333457777777777777
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.93 E-value=4.1e-09 Score=112.52 Aligned_cols=143 Identities=17% Similarity=0.223 Sum_probs=110.3
Q ss_pred ceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCC--CceeEEEeEEecC---CeEEEEEeecC
Q 043720 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH--PNLVTLIGYRASG---NEMFLIYNYLP 901 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~lV~E~~~ 901 (1103)
+.|+.|.++.||++...+|..+++|.............+.+|+.+++.+.+ ..+.+++.+.... +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 568999999999998876789999998665432235678899999999975 3456677776654 35689999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC-----------------------------------------
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC----------------------------------------- 940 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~----------------------------------------- 940 (1103)
|+++.+.+.. ..++..+...++.++++++.+||+..
T Consensus 84 G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 84 GRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9888775432 23666777788888888888888521
Q ss_pred ------------CCCcccCCCCCCcEEECC--CCCEEEeecccccc
Q 043720 941 ------------APRVLHRDVKPSNILLDD--DFNAYLSDFGLSRL 972 (1103)
Q Consensus 941 ------------~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~ 972 (1103)
...++|+|+.+.||+++. ++.+.|+||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 66689999998763
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.90 E-value=5.2e-08 Score=105.48 Aligned_cols=264 Identities=16% Similarity=0.172 Sum_probs=165.7
Q ss_pred CCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeE------EecC-CeEE
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGY------RASG-NEMF 894 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~-~~~~ 894 (1103)
....+.||+|+.+.+|-...- ...+.|++....... -.+.+..|... .||-+-.=+.| ...+ ....
T Consensus 13 i~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAA----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecchh--hchhheeecCCCchH----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 345677999999999976322 123556665543321 11233444444 46554431221 1112 2367
Q ss_pred EEEeecCCC-ChHHHHH---h-hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccc
Q 043720 895 LIYNYLPGG-NLENFIK---A-RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969 (1103)
Q Consensus 895 lV~E~~~~g-sL~~~l~---~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgl 969 (1103)
+.|+.+.+. .+..+.. + +.-....|..+++++..+|.+.+.||+. |.+-||+.++|+||++++.|.+.|-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccc
Confidence 788877654 2222221 1 1114578999999999999999999999 999999999999999999999988654
Q ss_pred ccccCCCCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhC-CCCCCCCCCCCCCCcchHHHHHH
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISD-KKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
-.... ........+|...|.+||.-. +..-+...|-|.+|+++++++.| ++||.+-............
T Consensus 164 fqi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~---- 237 (637)
T COG4248 164 FQINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET---- 237 (637)
T ss_pred eeecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh----
Confidence 44332 222334557899999999764 34456778999999999999987 8998754433222222110
Q ss_pred HHhcCcccccccccc--c----CCCChhHHHHHHHHHHHccccC--CCCCCCHHHHHHHHHhhhcC
Q 043720 1044 LLRQGQVKDVFNAEL--W----ASGPHDDLEDMLHLALRCTVET--LSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~--~----~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~evl~~L~~i~~~ 1101 (1103)
.+..+.+...-+... + ...-.-.++++..+..+|+... +.-||+++.++..|..++++
T Consensus 238 ~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~ 303 (637)
T COG4248 238 DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ 303 (637)
T ss_pred hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence 111111111111111 0 0111234577888999998764 56899999999998887654
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=2.3e-10 Score=133.83 Aligned_cols=196 Identities=33% Similarity=0.382 Sum_probs=138.3
Q ss_pred CCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCE
Q 043720 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183 (1103)
Q Consensus 104 ~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (1103)
..+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|+|++|+|+... .+..++.|+.
T Consensus 69 ~~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~ 144 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKE 144 (414)
T ss_pred HHhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheecccccccccc--chhhccchhh
Confidence 35667777778888887 34445777888999999999988 55555778899999999999988433 3566777999
Q ss_pred EEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCcc
Q 043720 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM 263 (1103)
Q Consensus 184 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 263 (1103)
|++++|.++.. ..+..++.|+.+++++|++. .+.......+.+++.+++.+|.+.. ...+..+..+..+++..|.
T Consensus 145 L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~-~ie~~~~~~~~~l~~l~l~~n~i~~--i~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 145 LNLSGNLISDI--SGLESLKSLKLLDLSYNRIV-DIENDELSELISLEELDLGGNSIRE--IEGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred heeccCcchhc--cCCccchhhhcccCCcchhh-hhhhhhhhhccchHHHhccCCchhc--ccchHHHHHHHHhhccccc
Confidence 99999998832 33556888999999999888 5554201334668888898888862 2345555566666888888
Q ss_pred CCccccccccCCCC--CCEEEccCCcCCCcCCccccCCCCCCeEecccCc
Q 043720 264 LNDVIPRELGWLRK--LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311 (1103)
Q Consensus 264 l~~~~p~~l~~l~~--L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~ 311 (1103)
++..-+ +..+.. |+.+++++|++. .++..+..+..+..|++.+|.
T Consensus 220 i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~ 266 (414)
T KOG0531|consen 220 ISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNR 266 (414)
T ss_pred ceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcc
Confidence 876422 222333 788888888887 334566677777777776543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.87 E-value=6.4e-10 Score=132.81 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=179.2
Q ss_pred HHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 816 IIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 816 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
+....+.+.+.+-+-+|.++.++.+.-. .|...++|+...... ....+....+-.+.-..++|.+++..--+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 3345567888888999999999988443 243444454433221 1112233334344444456888776666666778
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.++|++|+.+++|...++... ..+.+........+..+.+|||+. .+.|+|++|.|.+...++..+++|||....
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~ 953 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSK 953 (1205)
T ss_pred cchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccc
Confidence 999999999999999998754 255556667778889999999998 899999999999999999999999984332
Q ss_pred cCC---------------------CC---------CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 043720 973 LGT---------------------SE---------THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKK 1022 (1103)
Q Consensus 973 ~~~---------------------~~---------~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~ 1022 (1103)
.+- .. ........+|+.|.+||...+......+|.|+.|++++|.++|..
T Consensus 954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen 954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence 210 00 011234568999999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHHHHHHHhcCcccccccc-cccCCCChhHHHHHHHHHHHccccCCCCCCCHH
Q 043720 1023 ALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA-ELWASGPHDDLEDMLHLALRCTVETLSTRPTMK 1089 (1103)
Q Consensus 1023 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1089 (1103)
||....++.. .+.+... .-|...+........+++.+.+..+|.+|-.+.
T Consensus 1034 p~na~tpq~~-----------------f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQI-----------------FENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCcchhhh-----------------hhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 9985543211 1111111 113344566677789999999999999998765
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.81 E-value=4.2e-09 Score=131.05 Aligned_cols=297 Identities=20% Similarity=0.118 Sum_probs=130.2
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCC--CCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNF--LSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
+....+...+-+|.+. .++.... .+.|++|-+.+|. +....++.|..++.|++|||++|.=-+.+|..+++|-+|+
T Consensus 521 ~~~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~Lr 598 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLR 598 (889)
T ss_pred chhheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhh
Confidence 3345555555555554 3333222 2356666666664 3322233355566666666666544445666666666666
Q ss_pred EEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcc--ccccCccccCCCCCCEEeCC
Q 043720 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL--VGRIPSSLGKCQQLRTLLLF 260 (1103)
Q Consensus 183 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l--~~~~p~~l~~l~~L~~L~L~ 260 (1103)
+|+|++..++ .+|..++++..|.+|++..+.-...+ +.+...+.+|++|.+..-.. +...-..+.++.+|+.+...
T Consensus 599 yL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~-~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 599 YLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESI-PGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred cccccCCCcc-ccchHHHHHHhhheeccccccccccc-cchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 6666666665 55666666666666666655543233 23333245566665544432 12222233344444444432
Q ss_pred CccCCccccccccCCCCCC----EEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCccccc-c-cCCCCC
Q 043720 261 SNMLNDVIPRELGWLRKLE----VLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVG-Q-SDASNG 334 (1103)
Q Consensus 261 ~N~l~~~~p~~l~~l~~L~----~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~-~-~~~~~~ 334 (1103)
.... .+-..+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++.+............... . ......
T Consensus 677 ~~s~--~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~ 753 (889)
T KOG4658|consen 677 ISSV--LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVS 753 (889)
T ss_pred cchh--HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHH
Confidence 2222 0011111122222 2222222222 3344555566666666654433211110000000000 0 000000
Q ss_pred CCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccc-cchhhhccCCceEeecCC
Q 043720 335 EKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGD-LIGVFDRCKKLHFIDLSS 408 (1103)
Q Consensus 335 ~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~LdLs~ 408 (1103)
..+.-....+.+..-.++|+.|++..+.....+.+....+..+..+.+..+.+.+. ......+++++..+.+++
T Consensus 754 ~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~ 828 (889)
T KOG4658|consen 754 ILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSF 828 (889)
T ss_pred hhccccccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccCc
Confidence 00011111233333445666666666666666555555666666555555555554 344444444444444443
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.78 E-value=7.9e-08 Score=104.00 Aligned_cols=140 Identities=16% Similarity=0.175 Sum_probs=100.3
Q ss_pred eccCCcccEEEEEEcCCcEEEEEEcccccchhh----------HHHHHHHHHHHhcCCCCce--eEEEeEEec-----CC
Q 043720 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHG----------VQQFHAEIKTLGNVRHPNL--VTLIGYRAS-----GN 891 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~ 891 (1103)
+-......|+++.+. |+.|.||........+. ...+.+|+..+.++...+| .+.+++... ..
T Consensus 30 v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 443344446677664 78899997744332211 1247789998888853333 334444432 23
Q ss_pred eEEEEEeecCCC-ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-------CCCEE
Q 043720 892 EMFLIYNYLPGG-NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-------DFNAY 963 (1103)
Q Consensus 892 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-------~~~~k 963 (1103)
..++|+|++++. +|.+++........+......++.+++..+..||+. +|+|+|++++|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEE
Confidence 578999999876 899998653333456667788999999999999999 9999999999999975 46799
Q ss_pred Eeecccccc
Q 043720 964 LSDFGLSRL 972 (1103)
Q Consensus 964 i~Dfgla~~ 972 (1103)
++||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998853
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=8.2e-10 Score=129.13 Aligned_cols=246 Identities=25% Similarity=0.321 Sum_probs=132.0
Q ss_pred CCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEe
Q 043720 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208 (1103)
Q Consensus 129 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 208 (1103)
.+..++.+++..|.+. .+-..+..+++|+.|++.+|+|. .+...+..+++|++|++++|.|+...+ +..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~-~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIE-KIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhh-hhhcccccccceeeeeccccchh-hcccchhhhhcchheeccccccccccc--hhhccchhhh
Confidence 3455555556666665 33334555666666666666666 333335555666666666666654322 3444455555
Q ss_pred ecccccCCCCCChhHHhhcCcCcEEECcCCccccccC-ccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCc
Q 043720 209 FLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP-SSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNR 287 (1103)
Q Consensus 209 ~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 287 (1103)
++++|.++ .+...- .+..|+.+++++|+++..-+ . +..+.+++.+++.+|.+... ..+..+..+..+++..|.
T Consensus 146 ~l~~N~i~-~~~~~~--~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~ 219 (414)
T KOG0531|consen 146 NLSGNLIS-DISGLE--SLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNK 219 (414)
T ss_pred eeccCcch-hccCCc--cchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhccccc
Confidence 55555555 322111 13445555555555542211 1 34444455555555544432 222233333333444444
Q ss_pred CCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccc--cccccccCCccccc
Q 043720 288 LNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLS--KLRIIWAPRLNLEG 365 (1103)
Q Consensus 288 l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~--~L~~L~l~~n~l~~ 365 (1103)
++.. .+ +..+. +|+.+++++|.+..
T Consensus 220 i~~~------------------------~~-----------------------------l~~~~~~~L~~l~l~~n~i~~ 246 (414)
T KOG0531|consen 220 ISKL------------------------EG-----------------------------LNELVMLHLRELYLSGNRISR 246 (414)
T ss_pred ceec------------------------cC-----------------------------cccchhHHHHHHhcccCcccc
Confidence 4311 10 00011 46677777777663
Q ss_pred cCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCcccccc---ccc--cccccceeEEEecCCccccccCC
Q 043720 366 KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGE---LDV--KLQVPCMALFDVSGNHMSGSIPR 440 (1103)
Q Consensus 366 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~---~~~--~~~~~~L~~l~ls~N~l~g~ip~ 440 (1103)
. +..+..+.++..|++.+|++... ..+.....+..+.+..|++... ... ....+.+..+.+.+|......+.
T Consensus 247 ~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (414)
T KOG0531|consen 247 S-PEGLENLKNLPVLDLSSNRISNL--EGLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISSL 323 (414)
T ss_pred c-cccccccccccccchhhcccccc--ccccccchHHHhccCcchhcchhhhhccccccccccccccccccCcccccccc
Confidence 3 25566778888888888887743 2345566777788888887632 112 34567788888888888765553
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=7.6e-08 Score=99.86 Aligned_cols=137 Identities=20% Similarity=0.213 Sum_probs=100.6
Q ss_pred CCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc---------------------hhhHHHHHHHHHHHhcCCCC--c
Q 043720 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF---------------------QHGVQQFHAEIKTLGNVRHP--N 879 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h~--n 879 (1103)
..++..||.|.-+.||.|....|.++|||.-+.+.. .-.....++|.+.|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 445678999999999999999999999996654422 01133467899999998644 6
Q ss_pred eeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC
Q 043720 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD 959 (1103)
Q Consensus 880 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~ 959 (1103)
|.+.+++ +..++||||++|--|...- ++.+....++..|.+-+...-.. ||||+|+.+-||+++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecC
Confidence 6666665 5678999999886665532 12333444555555555555566 99999999999999999
Q ss_pred CCEEEeeccccccc
Q 043720 960 FNAYLSDFGLSRLL 973 (1103)
Q Consensus 960 ~~~ki~Dfgla~~~ 973 (1103)
|.+.++||-.+...
T Consensus 239 g~~~vIDwPQ~v~~ 252 (304)
T COG0478 239 GDIVVIDWPQAVPI 252 (304)
T ss_pred CCEEEEeCcccccC
Confidence 99999999876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.1e-07 Score=96.74 Aligned_cols=127 Identities=22% Similarity=0.296 Sum_probs=85.0
Q ss_pred cEEEEEEcCCcEEEEEEcccccc-------------------------hhhHHHHHHHHHHHhcCCCC--ceeEEEeEEe
Q 043720 836 TTYKAEISPGILVAVKKLAVGRF-------------------------QHGVQQFHAEIKTLGNVRHP--NLVTLIGYRA 888 (1103)
Q Consensus 836 ~V~~~~~~~~~~vavK~~~~~~~-------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 888 (1103)
.||.|...+|..+|||+.+.... ........+|+..|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999998864321 00123467899999999765 455666553
Q ss_pred cCCeEEEEEeecC--CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHH-HHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 889 SGNEMFLIYNYLP--GGNLENFIKARTSRAVDWKILHKIALDVASALAY-LHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 889 ~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~-LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. +|+|||+.+.||+++++ .+.|+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEE
Confidence 3479999998 55555443322 2234566677888886666 4787 99999999999999988 99999
Q ss_pred ecccccccC
Q 043720 966 DFGLSRLLG 974 (1103)
Q Consensus 966 Dfgla~~~~ 974 (1103)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.67 E-value=9.4e-09 Score=84.39 Aligned_cols=58 Identities=41% Similarity=0.536 Sum_probs=23.4
Q ss_pred CCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCcc
Q 043720 593 LVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNS 650 (1103)
Q Consensus 593 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 650 (1103)
|++|++++|+|+...+..|..+++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444444444442222333444444444444444443333344444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.65 E-value=1.6e-08 Score=83.09 Aligned_cols=60 Identities=43% Similarity=0.562 Sum_probs=32.3
Q ss_pred cCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccC
Q 043720 616 YLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKL 675 (1103)
Q Consensus 616 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 675 (1103)
+|++|+|++|+|+...+..|.++++|++|++++|+|+.+.|.+|..+++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 455555555555544444555555555555555555544445555555555555555543
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.63 E-value=5.6e-07 Score=100.46 Aligned_cols=167 Identities=21% Similarity=0.276 Sum_probs=125.3
Q ss_pred cccEEEE-EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec----CCeEEEEEeecCC-CChHH
Q 043720 834 FGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS----GNEMFLIYNYLPG-GNLEN 907 (1103)
Q Consensus 834 fg~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~ 907 (1103)
..+.|++ ...+|..|+.|++...+.... ..-..-++.++++.|.|||++.+++.. +...++||+|+++ ++|.+
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~-nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST-NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc-ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 3578999 445799999999955443321 122345778889999999999998763 4478999999886 47766
Q ss_pred HHHhh-------------cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 908 FIKAR-------------TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 908 ~l~~~-------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+--.. .+...++..+|.++.|++.||.++|+. |..-+-+.+++|+++.+.+++|...|..-...
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 54221 123467889999999999999999999 99999999999999999999999888776554
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKK 1022 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~ 1022 (1103)
.+.. |-+.. -.+-|.=.||.+++.+.||..
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 3321 11111 135799999999999999974
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2e-08 Score=125.04 Aligned_cols=86 Identities=34% Similarity=0.385 Sum_probs=46.4
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
+..++.|+.|||++|.=-+.+|.+|++|-+|++|+|+++.++ .+|..+++|+.|.+||+..+.-...+|.....+++|+
T Consensus 567 f~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr 645 (889)
T KOG4658|consen 567 FRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLR 645 (889)
T ss_pred HhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhccccc
Confidence 444555555555555444455555555555555555555555 5555555555555555555544334444444455555
Q ss_pred EEEccCC
Q 043720 183 VLNLAGN 189 (1103)
Q Consensus 183 ~L~L~~n 189 (1103)
+|.+..-
T Consensus 646 ~L~l~~s 652 (889)
T KOG4658|consen 646 VLRLPRS 652 (889)
T ss_pred EEEeecc
Confidence 5555433
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.9e-08 Score=114.88 Aligned_cols=150 Identities=17% Similarity=0.243 Sum_probs=105.4
Q ss_pred HHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcccc--------CCcccccccCcccccc
Q 043720 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATT--------GVAGTFGYVAPEYALT 998 (1103)
Q Consensus 927 ~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~--------~~~g~~~y~aPE~~~~ 998 (1103)
.+++.|+.|+|... ++||++|.|++|.+++.+.+||+.|+.+........+... -..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 45559999999874 9999999999999999999999999988655332211111 1123457999999999
Q ss_pred CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHcc
Q 043720 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCT 1078 (1103)
Q Consensus 999 ~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 1078 (1103)
...+.++|+||+|+++|.+..|+.+.-....... .+ ......+..-...++...+.++.+=+.+++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~----~~----------~~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLL----SY----------SFSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcc----hh----------hhhhcccccccccccccCcHHHHHHHHHHh
Confidence 8889999999999999999955544322211100 00 000011111122345678889999999999
Q ss_pred ccCCCCCCCHHHHH
Q 043720 1079 VETLSTRPTMKQVV 1092 (1103)
Q Consensus 1079 ~~dP~~RPs~~evl 1092 (1103)
..++..||++.++.
T Consensus 250 ~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLL 263 (700)
T ss_pred cCCcccCcchhhhh
Confidence 99999999777664
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.9e-08 Score=91.06 Aligned_cols=109 Identities=23% Similarity=0.371 Sum_probs=81.8
Q ss_pred CCccEEECcCCcCCCCCcccc---cCCCCCCEEEccCCcCCCCCCcccc-cCccCcEEeccCcccCCCCCCcccCCCCCc
Q 043720 567 KSLRVLDASHNQISGIVPQSL---ENLTSLVFLDLNGNKLQGEIPSSLH-RLKYLRHLSLADNNLTGGIPSSIGELRSLE 642 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 642 (1103)
..+..++|++|+|. -+++.. .....|...+|++|.+. ..|..|. .++.++.|+|++|.|+ .+|.++..++.|+
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr 103 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR 103 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh
Confidence 34567788888876 445544 34456667788888888 5666554 4568888888888888 6787888888888
Q ss_pred EEeccCccccCcChhhhhhcccccccccccccCcCCCC
Q 043720 643 VLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLP 680 (1103)
Q Consensus 643 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 680 (1103)
.|+++.|.|. ..|..+..+.+|-.|+..+|.+. .+|
T Consensus 104 ~lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid 139 (177)
T KOG4579|consen 104 SLNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EID 139 (177)
T ss_pred hcccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCc
Confidence 8888888888 67887878888888888888876 444
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.8e-06 Score=89.09 Aligned_cols=107 Identities=27% Similarity=0.412 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHhcCCCC--ceeEEEeEEecC----CeEEEEEeecCCC-ChHHHHHhhcCCcccHHHHHHHHHHHHHHHH
Q 043720 862 VQQFHAEIKTLGNVRHP--NLVTLIGYRASG----NEMFLIYNYLPGG-NLENFIKARTSRAVDWKILHKIALDVASALA 934 (1103)
Q Consensus 862 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~ 934 (1103)
...+.+|...+..+... .+.+.+++.... ...++|+|++++. +|.+++..... .+......++.+++..++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~ 132 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIA 132 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHH
Confidence 34577888888777533 334555555442 2458999999874 89999986433 556678889999999999
Q ss_pred HHHhCCCCCcccCCCCCCcEEECCCC---CEEEeeccccccc
Q 043720 935 YLHDQCAPRVLHRDVKPSNILLDDDF---NAYLSDFGLSRLL 973 (1103)
Q Consensus 935 ~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~ 973 (1103)
-||+. +|+|+|+++.|||++.++ .+.++||+-++..
T Consensus 133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999 999999999999999887 7999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.35 E-value=8.5e-09 Score=117.92 Aligned_cols=127 Identities=33% Similarity=0.403 Sum_probs=100.9
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCC-cccCCCCCcEEe
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPS-SIGELRSLEVLE 645 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~ 645 (1103)
..|.+.+.+.|.+. ....++.-++.|+.|||++|+++... .+..+++|++|||++|.++ .+|. ...++. |+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 45788999999998 66788888999999999999999433 7889999999999999999 5564 233444 99999
Q ss_pred ccCccccCcChhhhhhcccccccccccccCcCCCC-ccccCCCCCceEeCCCCCCC
Q 043720 646 LSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLP-SGLANVTSLSIFNASFNNLS 700 (1103)
Q Consensus 646 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~l~l~~N~l~ 700 (1103)
|++|.++. -..+.+|.+|+.|||+.|-|.+.-- .-+..+..|+.|+|.+|++.
T Consensus 239 lrnN~l~t--L~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTT--LRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHh--hhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 99999983 3457899999999999999875422 12345667777788888774
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=9.5e-09 Score=117.54 Aligned_cols=128 Identities=31% Similarity=0.330 Sum_probs=94.0
Q ss_pred CCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEE
Q 043720 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLD 234 (1103)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~ 234 (1103)
..|.+.+.++|++. .+..++.-++.|+.|+|++|+++.. +.+..+++|++|||++|.+. .+|.---..+. |+.|.
T Consensus 164 n~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~ 238 (1096)
T KOG1859|consen 164 NKLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN 238 (1096)
T ss_pred hhHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence 35777778888887 6677777778888888888888743 36778888888888888887 77654433444 88888
Q ss_pred CcCCccccccCccccCCCCCCEEeCCCccCCccc-cccccCCCCCCEEEccCCcCC
Q 043720 235 LSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI-PRELGWLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 235 L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 289 (1103)
+++|.++.. ..+.++.+|+.||+++|-|.+.- -.-+..|..|+.|.|.+|.+.
T Consensus 239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 888888732 35677888888888888877631 122455677888888888775
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.32 E-value=1e-05 Score=82.73 Aligned_cols=140 Identities=14% Similarity=0.133 Sum_probs=104.1
Q ss_pred eccCCcccEEEEEEcCCcEEEEEEcccccc-----hhhHHHHHHHHHHHhcCCC--CceeEEEeEE--ec--CCeEEEEE
Q 043720 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRF-----QHGVQQFHAEIKTLGNVRH--PNLVTLIGYR--AS--GNEMFLIY 897 (1103)
Q Consensus 829 lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h--~niv~l~~~~--~~--~~~~~lV~ 897 (1103)
-|+|+-+-|+..... |..+-+|.-..... +-....|.+|+..+.++.. -.+.+...+. .. ....++|+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 477888889998776 44688887642111 2346789999999999853 2244444221 11 22468999
Q ss_pred eecCC-CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC--EEEeecccccc
Q 043720 898 NYLPG-GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN--AYLSDFGLSRL 972 (1103)
Q Consensus 898 E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~ 972 (1103)
|-+.+ .+|.+++....-.+.+......+..++++.+.-||+. ++.|+|+.++||+++.++. ++++||--++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98753 5999998765444567788889999999999999999 9999999999999986667 99999987654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.29 E-value=3.1e-06 Score=99.21 Aligned_cols=142 Identities=25% Similarity=0.299 Sum_probs=94.6
Q ss_pred ceeccCCcccEEEEEEcCCcEEEEEEcccccch-----------------------------hhH----------HHHHH
Q 043720 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-----------------------------HGV----------QQFHA 867 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------------------------~~~----------~~~~~ 867 (1103)
+.|+.++-|.||+|++++|+.||||+.+-+..+ ... -++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 679999999999999999999999988533110 001 12445
Q ss_pred HHHHHhcCC-----CCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHH-HHHHHhCCC
Q 043720 868 EIKTLGNVR-----HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASA-LAYLHDQCA 941 (1103)
Q Consensus 868 E~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~g-L~~LH~~~~ 941 (1103)
|+..+.+++ .+.+.=..=|..-.+...++|||++|..+.+...-.. ...+.+.+ +..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~d-- 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRD-- 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhc--
Confidence 666555552 2333222222333456799999999999988843222 22553333 3333332 2223234
Q ss_pred CCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 942 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
+++|.|..|.||+++.+|++.+.|||+.....+
T Consensus 285 -gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 -GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999887643
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1103 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-56 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-55 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-36 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-34 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-27 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-34 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 6e-27 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 6e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-24 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-20 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 7e-20 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-20 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 7e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 8e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 8e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-20 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-20 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 9e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-19 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-19 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-19 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-19 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 5e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-19 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 7e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 7e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-19 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-18 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-18 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-18 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-18 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-18 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-18 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-18 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-18 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-18 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-18 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 4e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 4e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 4e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 5e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 6e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 6e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 7e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 7e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 7e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 7e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 7e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 7e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-18 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 8e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-18 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 8e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 9e-18 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 9e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 9e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 1e-17 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-17 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-17 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-17 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-17 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-17 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-17 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-17 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-17 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-17 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-17 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 6e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-17 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 8e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 8e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-17 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-16 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-16 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-16 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-16 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-16 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-16 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-16 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-16 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 6e-16 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 6e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-16 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-16 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-16 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-16 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 7e-16 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-16 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-15 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-15 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-15 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-15 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 9e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-14 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-14 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-14 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-14 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-14 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-14 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-14 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-14 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-14 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-14 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-14 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-14 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-14 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-14 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-14 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 5e-14 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 5e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 6e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 6e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 7e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-14 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 7e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 7e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 9e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-14 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 9e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-13 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-13 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-13 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 4e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 5e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-13 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 5e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 5e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 5e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 6e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 6e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 6e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-13 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 7e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 7e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 7e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-13 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 7e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 7e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 8e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 8e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-13 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 8e-13 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-13 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-12 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-12 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-12 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-12 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-12 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 4e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 6e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-12 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 7e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-12 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-12 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 8e-12 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 8e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-11 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-11 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-11 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-11 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-11 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-11 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-11 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-11 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-11 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 5e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 5e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 5e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 5e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 5e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 6e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-11 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-10 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-10 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-10 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 5e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-10 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 7e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-10 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 8e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 8e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 8e-10 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 8e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 9e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 9e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-09 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-09 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-09 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-09 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-09 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-09 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-09 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-09 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-09 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-09 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-09 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 4e-09 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-09 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-09 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-09 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-09 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-09 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 5e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-09 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 6e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-09 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 9e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 9e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 9e-09 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 9e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-08 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-08 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-08 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-08 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-07 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 3e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 3e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-07 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-07 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 6e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 8e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-06 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 1e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-06 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-06 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-06 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-06 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-06 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-06 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-06 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-06 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-06 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-06 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-06 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-06 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 5e-06 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 5e-06 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 5e-06 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-06 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 6e-06 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-06 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-06 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-06 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-06 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-06 | ||
| 3b2d_A | 603 | Crystal Structure Of Human Rp105MD-1 Complex Length | 7e-06 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 7e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-06 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-06 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-06 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-06 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-06 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-06 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 8e-06 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-06 | ||
| 3rg1_A | 612 | Crystal Structure Of The Rp105MD-1 Complex Length = | 9e-06 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 9e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-05 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 3e-04 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-05 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3B2D|A Chain A, Crystal Structure Of Human Rp105MD-1 Complex Length = 603 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 413 bits (1065), Expect = e-130
Identities = 157/714 (21%), Positives = 265/714 (37%), Gaps = 117/714 (16%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKP 66
E L+ FK+ + D +L W ++ + C++ GV+C +V +++++ ++ G S
Sbjct: 13 EIHQLISFKDVLPDK-NLLPDW-SSNKNPCTFDGVTCRD-DKVTSIDLSSKPLNVGFSA- 68
Query: 67 FFSCLMTAQFPFYGFGMRRRTCLHGRG-KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPP 125
+ L + G +S + L L L N SG
Sbjct: 69 ---------VSSSLLSLTGLESLFLSNSHINGSVSGF-KCSASLTSLDLSRNSLSGPVTT 118
Query: 126 --EIWSLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNLAFNRIDGDIPFSLR---NFE 179
+ S L+ L+V N L + L +L VL+L+ N I G
Sbjct: 119 LTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCG 178
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
L+ L ++GN++ G + + + L L +S N + IP LG C L+HLD+SGN
Sbjct: 179 ELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIPF-LGD-CSALQHLDISGNK 234
Query: 240 LVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTEL-GN 298
L G ++ C +L+ L + SN IP L+ L+ L ++ N+ G IP L G
Sbjct: 235 LSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGA 292
Query: 299 CVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWA 358
C L+ L LS N F G++P + S L +
Sbjct: 293 CDTLTGLDLSG---------------------------NHFYGAVPPFFGSCSLLESLAL 325
Query: 359 PRLNLEGKLPSSW-GACESLEMLNLAQNVLRGDL-IGVFDRCKKLHFIDLSSNELSGEL- 415
N G+LP L++L+L+ N G+L + + L +DLSSN SG +
Sbjct: 326 SSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPIL 385
Query: 416 --DVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSK 473
+ + + N +G IP L + +
Sbjct: 386 PNLCQNPKNTLQELYLQNNGFTGKIP--------------PTLSN-----CSELVSL--- 423
Query: 474 ARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFL-AGANKLTGSFP 532
+ S N +G I P L + L N L G P
Sbjct: 424 ------------------HLSFNYLSGTI------PSSLGSLSKLRDLKLWLNMLEGEIP 459
Query: 533 GSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTS 592
L L N++ G IP + C +L + S+N+++G +P+ + L +
Sbjct: 460 QELMYVKT---LETLILDFNDLTGEIPSGLS-NCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 593 LVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS 652
L L L+ N G IP+ L + L L L N G IP+++ + +++N ++
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIA 571
Query: 653 GEVPEGVVNLRNLTALLLDNN--KLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
G+ + N N + G L +++ + N + G
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTS 625
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-127
Identities = 174/675 (25%), Positives = 266/675 (39%), Gaps = 92/675 (13%)
Query: 94 KLVGKLSP---LVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNE 150
+ G L G EL+ L++ N SG+ + LE LDV N S +P
Sbjct: 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-F 218
Query: 151 FVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFL 210
L+ L+++ N++ GD ++ L++LN++ NQ G IP L+ L L
Sbjct: 219 LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSL 276
Query: 211 SYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPR 270
+ N+ G IP L C L LDLSGN G +P G C L +L L SN + +P
Sbjct: 277 AENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPM 336
Query: 271 E-LGWLRKLEVLDVSRNRLNGLIPTELGNC-VELSVLVLS-NLFD---PLLSGRNIRGEL 324
+ L +R L+VLD+S N +G +P L N L L LS N F +N + L
Sbjct: 337 DTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTL 396
Query: 325 SVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQ 384
N N F G IP ++ S+L + L G +PSS G+ L L L
Sbjct: 397 QE--LYLQN---NGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWL 451
Query: 385 NVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL--FDVSGNHMSGSIPRFD 442
N+L G++ K L + L N+L+GE+ L C L +S N ++G IP
Sbjct: 452 NMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLS-NCTNLNWISLSNNRLTGEIP--- 507
Query: 443 YNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPI 502
+ + S N+F+G I
Sbjct: 508 -----------KWIG-----RLENLAIL---------------------KLSNNSFSGNI 530
Query: 503 ----CWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHI 558
L N G+ P ++F+ ++ N I G
Sbjct: 531 PAELGDCR----SLIW-----LDLNTNLFNGTIPAAMFK-------QSGKIAANFIAGKR 574
Query: 559 PLDIGVMCKSLRVLDASHN--QISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKY 616
+ I + + N + GI + L L++ ++ G +
Sbjct: 575 YVYIK-NDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGS 633
Query: 617 LRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676
+ L ++ N L+G IP IG + L +L L N +SG +P+ V +LR L L L +NKL
Sbjct: 634 MMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693
Query: 677 GHLPSGLANVTSLSIFNASFNNLSGPFPWNV--TTMNCSGVIGNPFL-----DPCQMYKD 729
G +P ++ +T L+ + S NNLSGP P T + + NP L C
Sbjct: 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNA 753
Query: 730 ISSSELTSSNANSQH 744
+ S+ + H
Sbjct: 754 DGYAHHQRSHHHHHH 768
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-109
Identities = 142/623 (22%), Positives = 232/623 (37%), Gaps = 99/623 (15%)
Query: 100 SPLVGGLSELRVLSLPFNGFSGEFPPEIW---SLEKLEVLDVEGNFLSGRLPNEFVGLRN 156
L+ L VL L N SG +L+ L + GN +SG + N
Sbjct: 144 VSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVN 201
Query: 157 LRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELN 216
L L+++ N IP L + +L+ L+++GN++ G + + +L++L +S N+
Sbjct: 202 LEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV 260
Query: 217 GSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL-GKCQQLRTLLLFSNMLNDVIPRELGWL 275
G IP + L++L L+ N G IP L G C L L L N +P G
Sbjct: 261 GPIPPLP---LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 276 RKLEVLDVSRNRLNGLIPTE-LGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNG 334
LE L +S N +G +P + L L VL LS
Sbjct: 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSF------------------------- 352
Query: 335 EKNSFIGSIPMEITTLS-KLRIIWAPRLNLEGKLPSSWGAC--ESLEMLNLAQNVLRGDL 391
N F G +P +T LS L + N G + + +L+ L L N G +
Sbjct: 353 --NEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI 410
Query: 392 IGVFDRCKKLHFIDLSSNELSGELDVKL-QVPCMALFDVSGNHMSGSIPRFDYNVCHQMP 450
C +L + LS N LSG + L + + + N + G IP
Sbjct: 411 PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP----------- 459
Query: 451 LQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPE 510
+L ++ N+ TG I P
Sbjct: 460 ---QELMYV-----KTLETL---------------------ILDFNDLTGEI------PS 484
Query: 511 RLRRRTDYAFL-AGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSL 569
L T+ ++ N+LTG P + + + LSNN+ G+IP ++G C+SL
Sbjct: 485 GLSNCTNLNWISLSNNRLTGEIPKWI---GRLENLAILKLSNNSFSGNIPAELG-DCRSL 540
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADN--NL 627
LD + N +G +P ++ + + N + G+ + + A N
Sbjct: 541 IWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEF 596
Query: 628 TGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVT 687
G + L + ++S G N ++ L + N LSG++P + ++
Sbjct: 597 QGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656
Query: 688 SLSIFNASFNNLSGPFPWNVTTM 710
L I N N++SG P V +
Sbjct: 657 YLFILNLGHNDISGSIPDEVGDL 679
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 269 bits (689), Expect = 4e-77
Identities = 135/545 (24%), Positives = 195/545 (35%), Gaps = 142/545 (26%)
Query: 180 SLEVLNLAGNQ---VKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLS 236
+ ++L+ + L S L LFLS + +NGS+ L LDLS
Sbjct: 51 KVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKC--SASLTSLDLS 108
Query: 237 GNSLVGRIPS--SLGKCQQLRTLLLFSNMLNDVIPRELGW-LRKLEVLDVSRNRLNGLIP 293
NSL G + + SLG C L+ L + SN L+ G L LEVLD+S N ++G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 294 TEL---GNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTL 350
C EL L +S N G + +
Sbjct: 169 VGWVLSDGCGELKHLAISG---------------------------NKISGDVDV----- 196
Query: 351 SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNE 410
C +LE L+++ N I C L +D+S N+
Sbjct: 197 ---------------------SRCVNLEFLDVSSNNFSTG-IPFLGDCSALQHLDISGNK 234
Query: 411 LSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYF 470
L SG R L+ ++
Sbjct: 235 L-----------------------SGDFSRAISTCTE---LKLLNI-------------- 254
Query: 471 MSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGS 530
S N F GPI P P L+ NK TG
Sbjct: 255 -----------------------SSNQFVGPI---P--PLPLKSLQ--YLSLAENKFTGE 284
Query: 531 FPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP-QSLEN 589
P L AC+ G+ +LS N+ G +P G C L L S N SG +P +L
Sbjct: 285 IPDFLSGACDTLTGL--DLSGNHFYGAVPPFFG-SCSLLESLALSSNNFSGELPMDTLLK 341
Query: 590 LTSLVFLDLNGNKLQGEIPSSLHRLKY-LRHLSLADNNLTGGIPSSIGE--LRSLEVLEL 646
+ L LDL+ N+ GE+P SL L L L L+ NN +G I ++ + +L+ L L
Sbjct: 342 MRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYL 401
Query: 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWN 706
+N +G++P + N L +L L N LSG +PS L +++ L N L G P
Sbjct: 402 QNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQE 461
Query: 707 VTTMN 711
+ +
Sbjct: 462 LMYVK 466
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-23
Identities = 34/130 (26%), Positives = 54/130 (41%), Gaps = 7/130 (5%)
Query: 589 NLTSLVFLDLNGNKLQ---GEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLE 645
+ +DL+ L + SSL L L L L+++++ G + SL L+
Sbjct: 48 RDDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLD 106
Query: 646 LSSNSLSGEVPEGV--VNLRNLTALLLDNNKLSGHLP-SGLANVTSLSIFNASFNNLSGP 702
LS NSLSG V + L L + +N L SG + SL + + S N++SG
Sbjct: 107 LSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGA 166
Query: 703 FPWNVTTMNC 712
+
Sbjct: 167 NVVGWVLSDG 176
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-07
Identities = 21/78 (26%), Positives = 38/78 (48%), Gaps = 4/78 (5%)
Query: 639 RSLEVLELSSNSLS---GEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNAS 695
+ ++LSS L+ V +++L L +L L N+ ++G + SL+ + S
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLS 108
Query: 696 FNNLSGPFPWNVTTMNCS 713
N+LSGP + +CS
Sbjct: 109 RNSLSGPVTTLTSLGSCS 126
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-116
Identities = 107/287 (37%), Positives = 176/287 (61%), Gaps = 2/287 (0%)
Query: 812 TYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKT 871
+ + A+ +F+ N +G GGFG YK ++ G LVAVK+L R Q G QF E++
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 872 LGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFI--KARTSRAVDWKILHKIALDV 929
+ H NL+ L G+ + E L+Y Y+ G++ + + + + +DW +IAL
Sbjct: 81 ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGS 140
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
A LAYLHD C P+++HRDVK +NILLD++F A + DFGL++L+ +TH TT V GT G
Sbjct: 141 ARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIG 200
Query: 990 YVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049
++APEY T + S+K DV+ YGV+LLELI+ ++A D + ++ D ++ W LL++ +
Sbjct: 201 HIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260
Query: 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096
++ + + +L + +++E ++ +AL CT + RP M +VV+ L+
Sbjct: 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 330 bits (849), Expect = e-105
Identities = 99/292 (33%), Positives = 156/292 (53%), Gaps = 9/292 (3%)
Query: 812 TYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKT 871
+ AT +F+ IG G FG YK + G VA+K+ Q G+++F EI+T
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEIET 88
Query: 872 LGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLEN--FIKARTSRAVDWKILHKIALDV 929
L RHP+LV+LIG+ NEM LIY Y+ GNL+ + + ++ W+ +I +
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL-LGTSETHATTGVAGTF 988
A L YLH + ++HRDVK NILLD++F ++DFG+S+ +TH +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTL 205
Query: 989 GYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048
GY+ PEY + R+++K+DVYS+GVVL E++ + A+ S + N+ WA G
Sbjct: 206 GYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNG 263
Query: 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100
Q++ + + L + L A++C + RP+M V+ L+
Sbjct: 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 313 bits (804), Expect = 2e-98
Identities = 94/302 (31%), Positives = 157/302 (51%), Gaps = 22/302 (7%)
Query: 812 TYESIIRATGDFN------TSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQ-- 863
++ + T +F+ N +G GGFG YK + VAVKKLA +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 864 -QFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV-DWKI 921
QF EIK + +H NLV L+G+ + G+++ L+Y Y+P G+L + + W +
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 922 LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHA 980
KIA A+ + +LH+ +HRD+K +NILLD+ F A +SDFGL+R ++T
Sbjct: 135 RCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040
T+ + GT Y+APE L ++ K+D+YS+GVVLLE+I+ A+D ++
Sbjct: 192 TSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ----LLLDI 246
Query: 1041 ASMLLR-QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
+ + ++D + ++ +E M +A +C E + RP +K+V Q L+++
Sbjct: 247 KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305
Query: 1100 HS 1101
S
Sbjct: 306 AS 307
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 288 bits (738), Expect = 1e-84
Identities = 118/631 (18%), Positives = 206/631 (32%), Gaps = 86/631 (13%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
S+L L + FN S P L L+VL+++ N LS F NL L+L
Sbjct: 46 TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLM 105
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N I ++L L+L+ N + G L+ L LS N++ EL
Sbjct: 106 SNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEEL 165
Query: 224 GKYC-RYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW---LRKLE 279
+ L+ L+LS N + P +L L L + L + +L +
Sbjct: 166 DIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIR 225
Query: 280 VLDVSRNRLNGLIPTELGNC--VELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
L +S ++L+ T L++L LS N
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY---------------------------N 258
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI----- 392
+ L +L + N++ S ++ LNL ++ + +
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 393 ----GVFDRCKKLHFIDLSSNELSGELDVKLQ-VPCMALFDVSGNHMS-GSIPRFDYNVC 446
F K L +++ N++ G + + +S + S ++ +
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 447 HQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLP 506
PL +L + + S A + L + + N +
Sbjct: 379 AHSPLHILNL------TKNKISKIESDAFSWLGHL-------EVLDLGLNEIGQELTGQE 425
Query: 507 VAP-ERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNI--IGHIP 559
E + +L+ NK S F + + L + + P
Sbjct: 426 WRGLENIF----EIYLSY-NKYLQLTRNS-------FALVPSLQRLMLRRVALKNVDSSP 473
Query: 560 LDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ--------GEIPSSL 611
++L +LD S+N I+ I LE L L LDL N L G L
Sbjct: 474 SPFQ-PLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFL 532
Query: 612 HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLD 671
L +L L+L N +L L++++L N+L+ N +L +L L
Sbjct: 533 KGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQ 592
Query: 672 NNKLSGHLPSGLANV-TSLSIFNASFNNLSG 701
N ++ +L+ + FN
Sbjct: 593 KNLITSVEKKVFGPAFRNLTELDMRFNPFDC 623
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 9e-79
Identities = 110/626 (17%), Positives = 203/626 (32%), Gaps = 82/626 (13%)
Query: 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRI 167
V + + P ++ + VL++ N L F L L++ FN I
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 168 DGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYC 227
P + L+VLNL N++ + L L L N + + K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVK-Q 120
Query: 228 RYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWL--RKLEVLDVSR 285
+ L LDLS N L + + + L+ LLL +N + + EL L+ L++S
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 286 NRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM 345
N++ P L L L+N S+
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNN---------------------------VQLGPSLTE 213
Query: 346 EIT---TLSKLRIIWAPRLNLEGKLPSSWGACE--SLEMLNLAQNVLRGDLIGVFDRCKK 400
++ + +R + L +++ + +L ML+L+ N L F +
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 401 LHFIDLSSNELSGELDVKLQVPCMAL--FDVSGNHMSG-----SIPRFDYNVCHQMP-LQ 452
L + L N + L + ++ + S+P+ D + L+
Sbjct: 274 LEYFFLEYNNIQHLFSHSLH-GLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 453 SSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERL 512
++ + S G+ L + S + +
Sbjct: 333 HLNM------EDNDIPGIKSNMFTGLINLKY-------LSLSNSFTSLRTLTNETFVSLA 379
Query: 513 RRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKS 568
L NK++ + F + +L N I + ++
Sbjct: 380 HSPLHILNLTK-NKISKIESDA-------FSWLGHLEVLDLGLNEIGQELTGQEWRGLEN 431
Query: 569 LRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG--EIPSSLHRLKYLRHLSLADNN 626
+ + S+N+ + S + SL L L L+ PS L+ L L L++NN
Sbjct: 432 IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNN 491
Query: 627 LTGGIPSSIGELRSLEVLELSSNSLS--------GEVPEGVVNLRNLTALLLDNNKLSGH 678
+ + L LE+L+L N+L+ G + L +L L L++N
Sbjct: 492 IANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEI 551
Query: 679 LPSGLANVTSLSIFNASFNNLSGPFP 704
++ L I + NNL+
Sbjct: 552 PVEVFKDLFELKIIDLGLNNLNTLPA 577
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 8e-71
Identities = 119/640 (18%), Positives = 200/640 (31%), Gaps = 104/640 (16%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L L+VL+L N S L L + N + N FV +NL L+L+
Sbjct: 70 QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLS 129
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSF--LKLRVLFLSYNELNGSIPS 221
N + + E+L+ L L+ N+++ + L F L+ L LS N++ P
Sbjct: 130 HNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQ---QLRTLLLFSNMLNDVIPRELGWLR-- 276
L L L+ L + L +R L L ++ L+ L+
Sbjct: 190 CFHA-IGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
Query: 277 KLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEK 336
L +LD+S N LN + +L L
Sbjct: 249 NLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEY--------------------------- 281
Query: 337 NSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFD 396
N+ + L +R LNL+ S +++ L F
Sbjct: 282 NNIQHLFSHSLHGLFNVRY-----LNLKR----------SFTKQSISLASLPKIDDFSFQ 326
Query: 397 RCKKLHFIDLSSNELSGELDVKLQ-VPCMALFDVSGNHMS-GSIPRFDYNVCHQMPLQSS 454
K L +++ N++ G + + +S + S ++ + PL
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386
Query: 455 DLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAP-ERLR 513
+L + + S A + L + + N + E +
Sbjct: 387 NL------TKNKISKIESDAFSWLGHLE-------VLDLGLNEIGQELTGQEWRGLENIF 433
Query: 514 RRTDYAFLAGANKLTGSFPGSLFQ---------ACNEFHGMVA--------------NLS 550
+L+ NK S + + +LS
Sbjct: 434 ----EIYLSY-NKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQIS--------GIVPQSLENLTSLVFLDLNGNK 602
NNNI I D+ + L +LD HN ++ G L+ L+ L L+L N
Sbjct: 489 NNNIAN-INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 603 LQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VN 661
L L+ + L NNL S SL+ L L N ++ +
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPA 607
Query: 662 LRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
RNLT L + N S V ++ + + LS
Sbjct: 608 FRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSS 647
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 2e-70
Identities = 108/628 (17%), Positives = 191/628 (30%), Gaps = 86/628 (13%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
+ L L L N + L LD+ N LS V L NL+ L L+
Sbjct: 94 AFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLS 153
Query: 164 FNRIDG--DIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
N+I + SL+ L L+ NQ+K PG + +L LFL+ +L S+
Sbjct: 154 NNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTE 213
Query: 222 ELGKYCR--YLEHLDLSGNSLVGRIPSSLGKCQ--QLRTLLLFSNMLNDVIPRELGWLRK 277
+L + +L LS + L ++ + L L L N LN V WL +
Sbjct: 214 KLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGELSVGQSDASNGEK 336
LE + N + L L + L L + +S
Sbjct: 274 LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISL------------------- 314
Query: 337 NSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI--GV 394
S L L + ++ G + + +L+ L+L+ + +
Sbjct: 315 ASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNET 374
Query: 395 FD--RCKKLHFIDLSSNELSGELDV------KLQVPCMALFDVSGNHMSGSIPRFDYNVC 446
F LH ++L+ N++S L+V D+ N + + ++
Sbjct: 375 FVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEV-----LDLGLNEIGQELTGQEWRGL 429
Query: 447 HQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLP 506
+ L S+ + +P L +
Sbjct: 430 EN--IFEIYL------SYNKYLQLTRNSFALVPSLQRL-------MLRRVALKN----VD 470
Query: 507 VAPERLRRRTD--YAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNI------ 554
+P + + L+ N + G+ +L +NN+
Sbjct: 471 SSPSPFQPLRNLTILDLSN-NNIANINDDM-------LEGLEKLEILDLQHNNLARLWKH 522
Query: 555 -IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHR 613
P+ L +L+ N I + ++L L +DL N L S +
Sbjct: 523 ANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNN 582
Query: 614 LKYLRHLSLADNNLTGGIPSSIGE-LRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDN 672
L+ L+L N +T G R+L L++ N ++ + +
Sbjct: 583 QVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE----SIAWFVNWINET 638
Query: 673 NKLSGHLPSGLANVTSLSIFNASFNNLS 700
+ L S T
Sbjct: 639 HTNIPELSSHYLCNTPPHYHGFPVRLFD 666
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 7e-50
Identities = 83/519 (15%), Positives = 154/519 (29%), Gaps = 115/519 (22%)
Query: 205 LRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264
V S+ +L +P +L + L+L+ N L ++ + QL +L + N +
Sbjct: 6 HEVADCSHLKLT-QVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 265 NDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGEL 324
+ + P L L+VL++ N L+ L C L+ L L +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMS--------------- 106
Query: 325 SVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQ 384
NS L L+L+
Sbjct: 107 ------------NSIQKIKNNPFVKQKNLIT------------------------LDLSH 130
Query: 385 NVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQV-PCMAL--FDVSGNHMSGSIPRF 441
N L +G + + L + LS+N++ +L + +L ++S N + P
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
Query: 442 DYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGP 501
+ + L L +
Sbjct: 191 FHAIGR---LFGLFL-------------------------------------NNVQLGPS 210
Query: 502 ICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLD 561
+ L+ ++L+ + F + + +LS NN+
Sbjct: 211 LTEKLCLELANTSIR-NLSLSN-SQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDS 267
Query: 562 IGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGN---------KLQGEIPSSLH 612
L +N I + SL L ++ +L+L + L S
Sbjct: 268 FA-WLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326
Query: 613 RLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV----NLRNLTAL 668
LK L HL++ DN++ G + L +L+ L LS++ S L L
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHIL 386
Query: 669 LLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV 707
L NK+S + + L + + N +
Sbjct: 387 NLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQE 425
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-47
Identities = 74/364 (20%), Positives = 125/364 (34%), Gaps = 38/364 (10%)
Query: 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEF---------PPEIWSLEKLEVLDVEGNFLS 144
+ S + GL +R L+L + L+ LE L++E N +
Sbjct: 283 NIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIP 342
Query: 145 GRLPNEFVGLRNLRVLNLAFNRIDGDIP----FSLRNFESLEVLNLAGNQVKGVIPGFLG 200
G N F GL NL+ L+L+ + F L +LNL N++ +
Sbjct: 343 GIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFS 402
Query: 201 SFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLF 260
L VL L NE+ + + + + + LS N + +S L+ L+L
Sbjct: 403 WLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLR 462
Query: 261 SNMLNDV--IPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSG 317
L +V P LR L +LD+S N + + L +L +L L N L
Sbjct: 463 RVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARL--- 519
Query: 318 RNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESL 377
K++ G + LS L I+ + + L
Sbjct: 520 -----------------WKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFEL 562
Query: 378 EMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL--FDVSGNHMS 435
++++L N L VF+ L ++L N ++ L D+ N
Sbjct: 563 KIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFD 622
Query: 436 GSIP 439
+
Sbjct: 623 CTCE 626
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-32
Identities = 39/168 (23%), Positives = 67/168 (39%), Gaps = 4/168 (2%)
Query: 546 VANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG 605
VA+ S+ + +P D+ ++ VL+ +HNQ+ + + + L LD+ N +
Sbjct: 8 VADCSHLKL-TQVPDDLP---TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 606 EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
P +L L+ L+L N L+ + +L L L SNS+ V +NL
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCS 713
L L +N LS + +L S N + + S
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-32
Identities = 49/213 (23%), Positives = 79/213 (37%), Gaps = 13/213 (6%)
Query: 94 KLVGKLSPLV-GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSG--RLPNE 150
++ +L+ GL + + L +N + + L+ L + L P+
Sbjct: 416 EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 151 FVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQ--------VKGVIPGFLGSF 202
F LRNL +L+L+ N I L E LE+L+L N G FL
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGL 535
Query: 203 LKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262
L +L L N + L+ +DL N+L S L++L L N
Sbjct: 536 SHLHILNLESNGFDEIPVEVFKD-LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKN 594
Query: 263 MLNDVIPRELG-WLRKLEVLDVSRNRLNGLIPT 294
++ V + G R L LD+ N + +
Sbjct: 595 LITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-29
Identities = 68/393 (17%), Positives = 134/393 (34%), Gaps = 42/393 (10%)
Query: 337 NSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFD 396
+ + +P ++ + + ++ L +++ L L++ N + +
Sbjct: 13 HLKLTQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 397 RCKKLHFIDLSSNELSGELDVKLQVPCMAL--FDVSGNHMSGSIPRFDYNVCHQMP-LQS 453
+ L ++L NELS L K C L + N + N + L +
Sbjct: 71 KLPMLKVLNLQHNELSQ-LSDKTFAFCTNLTELHLMSNSIQKIKN----NPFVKQKNLIT 125
Query: 454 SDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLR 513
DL S + ++ + L + + S N +
Sbjct: 126 LDL------SHNGLSSTKLGTQVQLENL----QEL---LLSNNKIQALK---SEELDIFA 169
Query: 514 RRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMC--KSLRV 571
+ +N++ PG F A G+ L+N + + + + S+R
Sbjct: 170 NSSLKKLELSSNQIKEFSPGC-FHAIGRLFGL--FLNNVQLGPSLTEKLCLELANTSIRN 226
Query: 572 LDASHNQISGIVPQSLENL--TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
L S++Q+S + L T+L LDL+ N L S L L + L NN+
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 630 GIPSSIGELRSLEVLELSSN---------SLSGEVPEGVVNLRNLTALLLDNNKLSGHLP 680
S+ L ++ L L + SL L+ L L +++N + G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 681 SGLANVTSLSIFNASFNNLSGPFPWNVTTMNCS 713
+ + +L + S + S N T ++ +
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-29
Identities = 41/206 (19%), Positives = 76/206 (36%), Gaps = 21/206 (10%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMC-KSLRVLDASHNQI 579
N L+ + G+ + LSNN I ++ + SL+ L+ S NQI
Sbjct: 131 NGLSSTKLGT-------QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 580 SGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL---HRLKYLRHLSLADNNLTGGIPSSIG 636
P + L L LN +L + L +R+LSL+++ L+ ++
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 637 ELR--SLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNA 694
L+ +L +L+LS N+L+ + L L L+ N + L + ++ N
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 695 SFNNLSGPFPWNVTTMNCSGVIGNPF 720
+ + + F
Sbjct: 304 KRSFTKQSISLA----SLPKIDDFSF 325
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 6e-26
Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 15/183 (8%)
Query: 96 VGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLS--------GRL 147
V L L +L L N + + LEKLE+LD++ N L+ G
Sbjct: 469 VDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGP 528
Query: 148 PNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRV 207
GL +L +LNL N D ++ L++++L N + + + + L+
Sbjct: 529 IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKS 588
Query: 208 LFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267
L L N + G R L LD+ N C+ + + + N +
Sbjct: 589 LNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF-------DCTCESIAWFVNWINETHTN 641
Query: 268 IPR 270
IP
Sbjct: 642 IPE 644
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-17
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 3/114 (2%)
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNS 650
S D + KL ++P L + L+L N L ++ L L++ N+
Sbjct: 4 VSHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 651 LSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
+S PE L L L L +N+LS A T+L+ + N++
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKN 114
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 4e-74
Identities = 85/621 (13%), Positives = 169/621 (27%), Gaps = 98/621 (15%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSG----RLPNEFVGLRNLRV 159
+ LSL G SG P I L +LEVL + + P +
Sbjct: 78 NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ 137
Query: 160 LNLAFNRIDGDIPFSL--RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
+F L + + + I LK + N +
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI-T 196
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
+ + + L + + V + + + + L+
Sbjct: 197 FVSKAVMR-LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT-----EDLKWDNLKD 250
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSN----LFDPLLSGRNIRGELSVGQS---- 329
L ++V +PT L E+ ++ ++ + L + VG+
Sbjct: 251 LTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQII 310
Query: 330 DASNGEKNSFI-GSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLR 388
N+ + + + KL ++ LEG ++G+ L LNLA N +
Sbjct: 311 YIGY---NNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQIT 366
Query: 389 GDLIGVFDRCKKLHFIDLSSNELSG--ELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVC 446
+++ + + N+L + V M+ D S N +
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG----KNF 422
Query: 447 HQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLP 506
+ + N S N +
Sbjct: 423 DPLDPTPFKGIN--------VSSI---------------------NLSNNQISKFP---- 449
Query: 507 VAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMC 566
E + + L+ S+ N + N + +
Sbjct: 450 --KE---------LFSTGSPLS-----SINLMGNMLTEI-----PKNSLKDENENFK-NT 487
Query: 567 KSLRVLDASHNQISGIVPQ-SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSL--- 622
L +D N+++ + L LV +DL+ N P+ L+ +
Sbjct: 488 YLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546
Query: 623 ---ADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHL 679
N P I SL L++ SN + V E + N++ L + +N
Sbjct: 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIKDNPNISID 603
Query: 680 PSGLANVTSLSIFNASFNNLS 700
S + ++ ++
Sbjct: 604 LSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 3e-72
Identities = 85/632 (13%), Positives = 190/632 (30%), Gaps = 130/632 (20%)
Query: 113 SLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGD-- 170
+ + + + + S ++ L +EG SGR+P+ L L VL L + +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 171 --IPFSLRNFESLEVLNLAGNQVKGVIPGFLG--SFLKLRVLFLSYNELNGSIPSELGKY 226
P + S E + + F L ++ + SI
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI- 181
Query: 227 CRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRN 286
+ N++ + ++ + +LR + ++ E E
Sbjct: 182 TLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----A 235
Query: 287 RLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346
+ + N +L+ + + N + +P
Sbjct: 236 QQYKTEDLKWDNLKDLTDVEVYN---------------------------CPNLTKLPTF 268
Query: 347 ITTLSKLRIIW--------APRLNLEGKLPSSWGACESLEMLNLAQNVLR-GDLIGVFDR 397
+ L ++++I +L + + + E ++++ + N L+ + +
Sbjct: 269 LKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQK 328
Query: 398 CKKLHFIDLSSNELSGELD-----VKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQ 452
KKL ++ N+L G+L +KL +++ N ++ F
Sbjct: 329 MKKLGMLECLYNQLEGKLPAFGSEIKLAS-----LNLAYNQITEIPANFCGF-------- 375
Query: 453 SSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTG-PICWLPVAPER 511
++ +F+ N P + +
Sbjct: 376 -----------TEQVENL---------------------SFAHNKLKYIPNIFDAKSVSV 403
Query: 512 LRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCK 567
+ N++ + + NLSNN I P ++
Sbjct: 404 MSA-----IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISK-FPKELFSTGS 457
Query: 568 SLRVLDASHNQISGI-------VPQSLENLTSLVFLDLNGNKLQGEIPSSLH--RLKYLR 618
L ++ N ++ I ++ +N L +DL NKL + L YL
Sbjct: 458 PLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLV 516
Query: 619 HLSLADNNLTGGIPSSIGELRSLEVLEL------SSNSLSGEVPEGVVNLRNLTALLLDN 672
+ L+ N+ + P+ +L+ + N E PEG+ +LT L + +
Sbjct: 517 GIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGS 575
Query: 673 NKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
N + + + ++S+ + N
Sbjct: 576 NDIRK-VNEKIT--PNISVLDIKDNPNISIDL 604
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-44
Identities = 53/338 (15%), Positives = 106/338 (31%), Gaps = 55/338 (16%)
Query: 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRN 156
+ + + +L +L +N G P S KL L++ N ++ N
Sbjct: 320 FPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 157 LRVLNLAFNRIDGDIP--FSLRNFESLEVLNLAGNQVKGV-------IPGFLGSFLKLRV 207
+ L+ A N++ IP F ++ + ++ + N++ V + + +
Sbjct: 379 VENLSFAHNKL-KYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 208 LFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG-------RIPSSLGKCQQLRTLLLF 260
+ LS N+++ L ++L GN L + L ++ L
Sbjct: 438 INLSNNQISKFPKELFST-GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 261 SNMLNDVIPREL--GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGR 318
N L + + L L +D+S N + PT+ N L + N D G
Sbjct: 497 FNKLTK-LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRD--AQG- 551
Query: 319 NIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGAC 374
N + P IT L L + K+
Sbjct: 552 ------------------NRTLREWPEGITLCPSLTQ-----LQIGSNDIRKVNEK--IT 586
Query: 375 ESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
++ +L++ N + + L ++
Sbjct: 587 PNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-44
Identities = 60/401 (14%), Positives = 132/401 (32%), Gaps = 82/401 (20%)
Query: 95 LVGKLSPLVGGLSELRVLSLPFNGF--------SGEFPPEIWSLEKLEVLDVEGN-FLSG 145
+ KL + L E++++++ N + + EK++++ + N +
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTF 320
Query: 146 RLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKL 205
+ ++ L +L +N+++G +P + + L LNLA NQ+ + F G ++
Sbjct: 321 PVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQV 379
Query: 206 RVLFLSYNELNGSIPSELG-KYCRYLEHLDLSGNSLVG-------RIPSSLGKCQQLRTL 257
L ++N+L IP+ K + +D S N + + + K + ++
Sbjct: 380 ENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438
Query: 258 LLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL-------IPTELGNCVELSVLVLSNL 310
L +N ++ L +++ N L + N L+ + L
Sbjct: 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF- 497
Query: 311 FDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI--TTLSKLRIIWAPRLNLEG--- 365
N + + + TTL L ++L
Sbjct: 498 --------------------------NK-LTKLSDDFRATTLPYLVG-----IDLSYNSF 525
Query: 366 -KLPSSWGACESLEML------NLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSG---EL 415
K P+ +L+ + N + C L + + SN++ ++
Sbjct: 526 SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI 585
Query: 416 DVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDL 456
+ V D+ N + VC + L
Sbjct: 586 TPNISV-----LDIKDNPNISIDLSY---VCPYIEAGMYML 618
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 2e-33
Identities = 44/394 (11%), Positives = 109/394 (27%), Gaps = 63/394 (15%)
Query: 332 SNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDL 391
N E + + + + + ++ + G++P + G LE+L L + + +
Sbjct: 62 FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNE 121
Query: 392 IGVFD----RCKKLHFIDLSSNELSG---ELDVKLQVPCMALFDVSGNHMSGSIPRFDYN 444
+ D + + ++ + SI +
Sbjct: 122 RLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 445 VCHQMPLQSSDLCQGYDPS----FTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTG 500
+ + T ++ F + F
Sbjct: 182 TLKDTQIGQLSNNITFVSKAVMRLTKLRQF---------------------YMGNSPFVA 220
Query: 501 PICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSL--FQACNEFHGMVANLSNNNIIGHI 558
E + + + + + N + +
Sbjct: 221 ENICEAWENENSEY----------AQQYKTEDLKWDNLKDLTDV-----EVYNCPNLTKL 265
Query: 559 PLDIGVMCKSLRVLDASHNQISGI--------VPQSLENLTSLVFLDLNGNKLQ-GEIPS 609
P + +++++ + N+ + + + N L+ + +
Sbjct: 266 PTFLK-ALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVET 324
Query: 610 SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALL 669
SL ++K L L N L G +P + G L L L+ N ++ + L
Sbjct: 325 SLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLS 383
Query: 670 LDNNKLSGHLPS--GLANVTSLSIFNASFNNLSG 701
+NKL +P+ +V+ +S + S+N +
Sbjct: 384 FAHNKLKY-IPNIFDAKSVSVMSAIDFSYNEIGS 416
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-24
Identities = 31/189 (16%), Positives = 66/189 (34%), Gaps = 21/189 (11%)
Query: 94 KLVGKLSPLVGGLSELRVLSLPFNGFSG-------EFPPEIWSLEKLEVLDVEGNFLSGR 146
++ L S L ++L N + + + L +D+ N L+
Sbjct: 444 QISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK- 502
Query: 147 LPNEFV--GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL------NLAGNQVKGVIPGF 198
L ++F L L ++L++N P N +L+ + GN+ P
Sbjct: 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEG 561
Query: 199 LGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLL 258
+ L L + N++ + ++ + LD+ N + S + + +
Sbjct: 562 ITLCPSLTQLQIGSNDIR-KVNEKI---TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
Query: 259 LFSNMLNDV 267
LF + D+
Sbjct: 618 LFYDKTQDI 626
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-23
Identities = 24/167 (14%), Positives = 46/167 (27%), Gaps = 10/167 (5%)
Query: 547 ANLSNNNIIGHIPLDIGVMCKS---LRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKL 603
AN + N + GV S + L SG VP ++ LT L L L +
Sbjct: 58 ANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 604 QG----EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELR--SLEVLELSSNSLSGEVPE 657
+ P + + L ++S+ + +
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
T + +N ++ + + +T L F +
Sbjct: 178 SSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENI 223
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 4e-10
Identities = 17/102 (16%), Positives = 31/102 (30%), Gaps = 4/102 (3%)
Query: 621 SLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSG--- 677
+ + S+ + L L SG VP+ + L L L L ++
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 678 -HLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGN 718
P G++ S + F + S +I +
Sbjct: 123 LFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKD 164
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 2e-72
Identities = 83/319 (26%), Positives = 128/319 (40%), Gaps = 31/319 (9%)
Query: 808 GVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHA 867
GV L E++ + G FG +KA++ VAVK + Q Q
Sbjct: 11 GVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS--WQNEY 67
Query: 868 EIKTLGNVRHPNLVTLIGY----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILH 923
E+ +L ++H N++ IG + +++LI + G+L +F+KA V W L
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV---VSWNELC 124
Query: 924 KIALDVASALAYLH-------DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976
IA +A LAYLH D P + HRD+K N+LL ++ A ++DFGL+
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184
Query: 977 ETHA-TTGVAGTFGYVAPEYA-----LTCRVSDKADVYSYGVVLLELISDKKALDPSFSS 1030
++ T G GT Y+APE + D+Y+ G+VL EL S A D
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244
Query: 1031 HGDGFNIISWASMLLRQGQVKDVFN------AELWASGPHDDLEDMLHLALRCTVETLST 1084
+ F L Q V + W H + + C
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ--KHAGMAMLCETIEECWDHDAEA 302
Query: 1085 RPTMKQVVQCLKQIQHSPN 1103
R + V + + Q+Q N
Sbjct: 303 RLSAGCVGERITQMQRLTN 321
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 251 bits (644), Expect = 2e-72
Identities = 100/608 (16%), Positives = 185/608 (30%), Gaps = 59/608 (9%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
+ L L FN +S +L+VLD+ + + L +L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY 226
I + SL+ L + + +G L+ L +++N + E
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 227 CRYLEHLDLSGNSLVGRIPSSLGKCQQLR----TLLLFSNMLNDVIPRELGWLRKLEVLD 282
LEHLDLS N + + L Q+ +L L N +N + P +R L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLT 206
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGS 342
+ N + + L+ L + L + K++ G
Sbjct: 207 LRNNFDSLNVMKTCIQ--GLAGLEVHRLVLGEFRNEGNLEKFD----------KSALEGL 254
Query: 343 IPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLH 402
+ I + + + ++ +L + + F
Sbjct: 255 CNLTIEEFRLAYL-----DYYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQ 307
Query: 403 FIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDP 462
++L + + +KL + + N + D L+ DL
Sbjct: 308 HLELVNCKFGQFPTLKL--KSLKRLTFTSNKGGNAFSEVDLP-----SLEFLDL------ 354
Query: 463 SFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAP--ERLRRRTDYAF 520
S +S + + S N E L
Sbjct: 355 SRN----GLSFKGCCSQSDFGTTSLKYL-DLSFNGVITMSSNFLGLEQLEHLD------- 402
Query: 521 LAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
+ L S+F + ++S+ + + SL VL + N
Sbjct: 403 FQH-SNLKQMSEFSVFLSLRNLI--YLDISHTHTRVAFNGIFNGL-SSLEVLKMAGNSFQ 458
Query: 581 G-IVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELR 639
+P L +L FLDL+ +L+ P++ + L L+ L+++ NN L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 640 SLEVLELSSNSLSGEVPEGVVNL-RNLTALLLDNNKLSGHLPSG--LANVTSLSIFNASF 696
SL+VL+ S N + + + + +L L L N + L +
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEV 578
Query: 697 NNLSGPFP 704
+ P
Sbjct: 579 ERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-64
Identities = 109/568 (19%), Positives = 183/568 (32%), Gaps = 80/568 (14%)
Query: 154 LRNLRVL--NLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLS 211
+ N+ L F +I ++PFS +N L+L+ N ++ + SF +L+VL LS
Sbjct: 7 VPNITYQCMELNFYKIPDNLPFSTKN------LDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 212 YNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE 271
E+ +L L L+GN + + L+ L+ L +
Sbjct: 61 RCEIQTIEDGAYQS-LSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP 119
Query: 272 LGWLRKLEVLDVSRNRLNGL-IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSD 330
+G L+ L+ L+V+ N + +P N L L LS+
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSS--------------------- 158
Query: 331 ASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNV 386
N ++ L ++ ++ L+L + L L L N
Sbjct: 159 ------NKIQSIYCTDLRVLHQMPLLNL-SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNF 211
Query: 387 LRGDLI-GVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSG----SIPRF 441
+++ L L E E + L + + G +I F
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN---------LEKFDKSALEGLCNLTIEEF 262
Query: 442 DYNVCHQMPLQSSDLCQGYDPSFTYMQYF-MSKARLGMPLLVSAARFMVIHNFSGNNFTG 500
DL T + F + + S F
Sbjct: 263 RLAYLDYYLDDIIDLFNC----LTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQ 318
Query: 501 PICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNI--IGHI 558
P + +R + G N + SL +LS N + G
Sbjct: 319 ----FPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL---------EFLDLSRNGLSFKGCC 365
Query: 559 PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS-LHRLKYL 617
SL+ LD S N + + + L L LD + L+ S L+ L
Sbjct: 366 SQSDF-GTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 618 RHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKLS 676
+L ++ + L SLEVL+++ NS + LRNLT L L +L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 677 GHLPSGLANVTSLSIFNASFNNLSGPFP 704
P+ +++SL + N S NN
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-64
Identities = 102/623 (16%), Positives = 186/623 (29%), Gaps = 130/623 (20%)
Query: 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFL-SGRLPNEFV 152
+ GLS L+ L + I L+ L+ L+V N + S +LP F
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 153 GLRNLRVLNLAFNRIDGDIPFSLRNFESLEV----LNLAGNQVKGVIPGFLGSFLKLRVL 208
L NL L+L+ N+I LR + + L+L+ N + + PG ++L L
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKE-IRLHKL 205
Query: 209 FLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI---PSSLGKCQQLRTLLLFSNMLN 265
L N + ++ + LE L + L L + L
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 266 ------DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRN 319
D I L + + + + L L N
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVN---------- 313
Query: 320 IRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEM 379
F +++ +L +L + +G S SLE
Sbjct: 314 -----------------CKFGQFPTLKLKSLKRLTF-----TSNKGGNAFSEVDLPSLEF 351
Query: 380 LNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIP 439
L+L++N L F S G L+ D+S N +
Sbjct: 352 LDLSRN--------------GLSFKGCCSQSDFG--TTSLKY-----LDLSFNGVITMSS 390
Query: 440 RFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFT 499
F +++ +F +N
Sbjct: 391 NFL--------------------GLEQLEHL---------------------DFQHSNLK 409
Query: 500 GPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNII 555
LR Y ++ +F G F+G+ + ++ N+
Sbjct: 410 Q--MSEFSVFLSLRNLI-YLDISH-THTRVAFNGI-------FNGLSSLEVLKMAGNSFQ 458
Query: 556 GHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLK 615
+ DI ++L LD S Q+ + P + +L+SL L+++ N L
Sbjct: 459 ENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 518
Query: 616 YLRHLSLADNNLTGGIPSSIGEL-RSLEVLELSSNSLSGEVPEG--VVNLRNLTALLLDN 672
L+ L + N++ + SL L L+ N + + +++ LL++
Sbjct: 519 SLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEV 578
Query: 673 NKLSGHLPSGLANVTSLSIFNAS 695
++ PS + N +
Sbjct: 579 ERMECATPSDKQG-MPVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 222 bits (569), Expect = 3e-62
Identities = 109/610 (17%), Positives = 194/610 (31%), Gaps = 102/610 (16%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
EL+VL L SL L L + GN + F GL +L+ L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSE 222
+ F + + ++L+ LN+A N ++ +P + + L L LS N++ ++
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 223 LGKYC---RYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE-LGWLRKL 278
L LDLS N + I K +L L L +N + + + + L L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 279 EVLDVSRNRLNG------LIPTELGNCVELSVLVLS------------NLFDPL------ 314
EV + + L L++ +LF+ L
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSF 287
Query: 315 -LSGRNIRGELSVGQS------DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKL 367
L I + + N F +++ +L +L + +G
Sbjct: 288 SLVSVTIERVKDFSYNFGWQHLELVN---CKFGQFPTLKLKSLKRLTF-----TSNKGGN 339
Query: 368 PSSWGACESLEMLNLAQNVL--RGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMA 425
S SLE L+L++N L +G L ++DLS N + L + +
Sbjct: 340 AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLE 399
Query: 426 LFDVSGNHMSGSIPRFDYNVCHQMP-LQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSA 484
D +++ ++V + L D+ S T+ + + G+ L
Sbjct: 400 HLDFQHSNLKQMSE---FSVFLSLRNLIYLDI------SHTHTRVAFNGIFNGLSSL--- 447
Query: 485 ARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHG 544
+ +GN+F LT
Sbjct: 448 ----EVLKMAGNSFQENFLP--------------DIFTELRNLT---------------- 473
Query: 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604
+LS + P SL+VL+ SHN + + L SL LD + N +
Sbjct: 474 -FLDLSQCQLEQLSPTAFN-SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 531
Query: 605 GEIPSSLHRL-KYLRHLSLADNNLTGGIPSS--IGELRSLEVLELSSNSLSGEVPEGVVN 661
L L L+L N+ + ++ L + + P +
Sbjct: 532 TSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS---D 588
Query: 662 LRNLTALLLD 671
+ + L L+
Sbjct: 589 KQGMPVLSLN 598
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-22
Identities = 48/204 (23%), Positives = 76/204 (37%), Gaps = 25/204 (12%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
N + G+ F G+ + N+ IG K+L+ L+ +HN I
Sbjct: 86 NPIQSLALGA-------FSGLSSLQKLVAVETNLASLENFPIG-HLKTLKELNVAHNLIQ 137
Query: 581 GI-VPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLR----HLSLADNNLTGGIPSSI 635
+P+ NLT+L LDL+ NK+Q + L L + L L+ N + P +
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 636 GELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKLSGHL------PSGLANVTS 688
E+R L L L +N S V + + L L L + S L + +
Sbjct: 198 KEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 689 LSIFNASFNNLSGPFPWNVTTMNC 712
L+I L + NC
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNC 280
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 9e-72
Identities = 80/309 (25%), Positives = 128/309 (41%), Gaps = 44/309 (14%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTS-SHCSWFGVSCDSE---SRVVALNITGGDVSEG 62
+K LL+ K + +P+ LSSW T + +W GV CD++ RV L+++G +
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN---- 61
Query: 63 NSKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLP-FNGFSG 121
L + + L L L + N G
Sbjct: 62 --------------------------LPKPYPI----PSSLANLPYLNFLYIGGINNLVG 91
Query: 122 EFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESL 181
PP I L +L L + +SG +P+ ++ L L+ ++N + G +P S+ + +L
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 182 EVLNLAGNQVKGVIPGFLGSFLKL-RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL 240
+ GN++ G IP GSF KL + +S N L G IP L +DLS N L
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFAN-LN-LAFVDLSRNML 209
Query: 241 VGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCV 300
G G + + + L N L + ++G + L LD+ NR+ G +P L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 301 ELSVLVLSN 309
L L +S
Sbjct: 269 FLHSLNVSF 277
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-57
Identities = 67/304 (22%), Positives = 106/304 (34%), Gaps = 39/304 (12%)
Query: 112 LSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGR--LPNEFVGLRNLRVLNLA-FNRID 168
+ G ++ LD+ G L +P+ L L L + N +
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 169 GDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCR 228
G IP ++ L L + V G IP FL L L SYN L+G++P +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISS-LP 149
Query: 229 YLEHLDLSGNSLVGRIPSSLGKCQQLRTLL-LFSNMLNDVIPRELGWLRKLEVLDVSRNR 287
L + GN + G IP S G +L T + + N L IP L L +D+SRN
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNM 208
Query: 288 LNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI 347
L G G+ + L+ NS + ++
Sbjct: 209 LEGDASVLFGSDKNTQKIHLAK---------------------------NSLAFDLG-KV 240
Query: 348 TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDL--IGVFDRCKKLHFID 405
L + + G LP + L LN++ N L G++ G ++
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNL---QRFDVSA 297
Query: 406 LSSN 409
++N
Sbjct: 298 YANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-57
Identities = 62/286 (21%), Positives = 107/286 (37%), Gaps = 33/286 (11%)
Query: 103 VGGLSELRVLSLPFNGFSGEF--PPEIWSLEKLEVLDVEG-NFLSGRLPNEFVGLRNLRV 159
+ L L + P + +L L L + G N L G +P L L
Sbjct: 46 DTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHY 105
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSI 219
L + + G IP L ++L L+ + N + G +P + S L + N ++G+I
Sbjct: 106 LYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI 165
Query: 220 PSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLE 279
P G + + + +S N L G+IP + L + L NML G + +
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQ 224
Query: 280 VLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSF 339
+ +++N L + ++G L+ L L N N
Sbjct: 225 KIHLAKNSLAFDLG-KVGLSKNLNGLDLRN---------------------------NRI 256
Query: 340 IGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQN 385
G++P +T L L + NL G++P G + ++ A N
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANN 301
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-48
Identities = 58/214 (27%), Positives = 103/214 (48%), Gaps = 9/214 (4%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSN 551
+ SG N P +P + L + ++ G N L G P ++ + + H + +++
Sbjct: 56 DLSGLNLPKPY-PIPSSLANLPYLN-FLYIGGINNLVGPIPPAIAK-LTQLHYL--YITH 110
Query: 552 NNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL 611
N+ G IP + K+L LD S+N +SG +P S+ +L +LV + +GN++ G IP S
Sbjct: 111 TNVSGAIPDFLS-QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 612 HRLKYL-RHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLL 670
L ++++ N LTG IP + L +L ++LS N L G+ + +N + L
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHL 228
Query: 671 DNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
N L+ L + +L+ + N + G P
Sbjct: 229 AKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP 261
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-46
Identities = 60/291 (20%), Positives = 103/291 (35%), Gaps = 67/291 (23%)
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGV--IPGFLGSFLKLRVLFLS-YNELN 216
+ G + + + L+L+G + IP L + L L++ N L
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 217 GSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR 276
G IP + K L +L ++ ++ G IP L + + L TL N L+ +P + L
Sbjct: 91 GPIPPAIAK-LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLP 149
Query: 277 KLEVLDVSRNRLNGLIPTELGNCVELS-VLVLSNLFDPLLSGRNIRGELSVGQSDASNGE 335
L + NR++G IP G+ +L + +S
Sbjct: 150 NLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR-------------------------- 183
Query: 336 KNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVF 395
N G IP L +L ++L++N+L GD +F
Sbjct: 184 -NRLTGKIPPTF-----------------ANL--------NLAFVDLSRNMLEGDASVLF 217
Query: 396 DRCKKLHFIDLSSNELSGELD-----VKLQVPCMALFDVSGNHMSGSIPRF 441
K I L+ N L+ +L L D+ N + G++P+
Sbjct: 218 GSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG-----LDLRNNRIYGTLPQG 263
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-44
Identities = 69/351 (19%), Positives = 123/351 (35%), Gaps = 81/351 (23%)
Query: 337 NSFIGSIPMEITTLSKLRIIWAPRLNLEG--KLPSSWGACESLEMLNLA-QNVLRGDLIG 393
+++G + T ++ + LNL +PSS L L + N L G +
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPP 95
Query: 394 VFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQS 453
+ +LH++ ++ ++SG+IP
Sbjct: 96 AIAKLTQLHYLYIT-----------------------HTNVSGAIP-------------- 118
Query: 454 SDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLR 513
L Q + +FS N +G + P +
Sbjct: 119 DFLSQ-----IKTLVTL---------------------DFSYNALSGTL------PPSIS 146
Query: 514 RRTDYAFLA-GANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVL 572
+ + N+++G+ P S F M +S N + G IP + +L +
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSM--TISRNRLTGKIPPTFANL--NLAFV 202
Query: 573 DASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIP 632
D S N + G + + + L N L ++ + K L L L +N + G +P
Sbjct: 203 DLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLP 261
Query: 633 SSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKL--SGHLPS 681
+ +L+ L L +S N+L GE+P+G NL+ NNK LP+
Sbjct: 262 QGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPA 311
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 3e-43
Identities = 55/205 (26%), Positives = 92/205 (44%), Gaps = 14/205 (6%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFL-AGANKLTGSFPGSLFQACNEFHGMVANLS 550
+ N +G I P+ L + L N L+G+ P S+ G+
Sbjct: 107 YITHTNVSGAI------PDFLSQIKTLVTLDFSYNALSGTLPPSISS-LPNLVGI--TFD 157
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
N I G IP G K + S N+++G +P + NL +L F+DL+ N L+G+
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVL 216
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLL 670
K + + LA N+L + +G ++L L+L +N + G +P+G+ L+ L +L +
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 671 DNNKLSGHLPSG--LANVTSLSIFN 693
N L G +P G L + N
Sbjct: 276 SFNNLCGEIPQGGNLQRFDVSAYAN 300
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-40
Identities = 77/417 (18%), Positives = 132/417 (31%), Gaps = 131/417 (31%)
Query: 244 IPSSLGKCQQLR----TLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG--LIPTELG 297
I LG L T + V+ ++ LD+S L IP+ L
Sbjct: 14 IKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLA 73
Query: 298 NCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIW 357
N L+ L + + N+ +G IP I L++L ++
Sbjct: 74 NLPYLNFLYIGGI--------------------------NNLVGPIPPAIAKLTQLHYLY 107
Query: 358 APRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDV 417
N+ G +P + K L +D S N L
Sbjct: 108 ITHTNVSGAIPDFLS------------------------QIKTLVTLDFSYNAL------ 137
Query: 418 KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLG 477
SG++P + +
Sbjct: 138 -----------------SGTLP--------------PSISS-----LPNLVGI------- 154
Query: 478 MPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQ 537
F GN +G I P + + ++ N+LTG P +
Sbjct: 155 --------------TFDGNRISGAI---PDSYGSFSKLFTSMTISR-NRLTGKIPPTFAN 196
Query: 538 ACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
+ +LS N + G + G K+ + + + N ++ + + +L LD
Sbjct: 197 ----LNLAFVDLSRNMLEGDASVLFG-SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLD 250
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNS-LSG 653
L N++ G +P L +LK+L L+++ NNL G IP G L+ +V ++N L G
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCG 306
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 1e-35
Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 3/136 (2%)
Query: 572 LDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGE--IPSSLHRLKYLRHLSLAD-NNLT 628
D + G++ + + LDL+G L IPSSL L YL L + NNL
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 629 GGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTS 688
G IP +I +L L L ++ ++SG +P+ + ++ L L N LSG LP ++++ +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 689 LSIFNASFNNLSGPFP 704
L N +SG P
Sbjct: 151 LVGITFDGNRISGAIP 166
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 8e-63
Identities = 110/588 (18%), Positives = 184/588 (31%), Gaps = 74/588 (12%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
+ L FN L L LD+ + + F L L L N
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTAN 91
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
+ +L ++L+ L + + L + L L+L N ++ SI G
Sbjct: 92 PLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS-SIKLPKGF 150
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLR--TLLLFSNMLNDVIPRELGWLRKLEVLDV 283
L+ LD N++ + QQ +L L N + I + L+
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSAVFQSLNF 209
Query: 284 SRNRLNGLIPTELGNC--VELSVLVLSNLFDPLLSGRNIRG--ELSVGQSDASNGEKNSF 339
+ +I L N L + ++ D +S G E+SV + + F
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQK---HYF 266
Query: 340 IGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLIGVF 395
S L+ L+L +LPS +L+ L L+ N
Sbjct: 267 FNISSNTFHCFSGLQ-----ELDLTATHLSELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 396 DRCKKLHFIDLSSNELSGELDVKLQVPCMALF--DVSGNHMSGSIPRFDYNVCHQMPLQS 453
L + + N EL L D+S + +++
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDD-----------------IET 364
Query: 454 SDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLR 513
SD C + +++Q N S N +L
Sbjct: 365 SDCCNLQLRNLSHLQSL---------------------NLSYNEPLSLKTEAFKECPQLE 403
Query: 514 RRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA-NLSNNNIIGHIPLDIGVMCKSLRVL 572
LA +L S FQ H + NLS++ + + +L+ L
Sbjct: 404 ----LLDLAF-TRLKVKDAQSPFQ---NLHLLKVLNLSHSL-LDISSEQLFDGLPALQHL 454
Query: 573 DASHNQISGIVPQ---SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
+ N Q SL+ L L L L+ L + LK + H+ L+ N LT
Sbjct: 455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS 514
Query: 630 GIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSG 677
++ L+ + L L+SN +S +P + L + L N L
Sbjct: 515 SSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-48
Identities = 92/547 (16%), Positives = 165/547 (30%), Gaps = 84/547 (15%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L L L N + + L+ L +S + L L L
Sbjct: 78 QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFL--SYNELNGSIPS 221
N I E L+VL+ N + + + S + L L + N++ I
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEP 196
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKC--QQLRTLLLFSNMLNDVIPRELGWLRK-- 277
+ L+ G + I L Q L D+ P L +
Sbjct: 197 GAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMS 255
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
+E +++ ++ + L L L+
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTA---------------------------T 288
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI-GVFD 396
+ +P + LS L+ + E S SL L++ N R +L G +
Sbjct: 289 H-LSELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLE 347
Query: 397 RCKKLHFIDLSSNELSGELDVKLQVPCMALF--------DVSGNHMSGSIPRFDYNVCHQ 448
+ L +DLS +++ + L ++S N +
Sbjct: 348 NLENLRELDLSHDDIE-----TSDCCNLQLRNLSHLQSLNLSYNEPLSLKT----EAFKE 398
Query: 449 MP-LQSSDLCQGYDPSFTYMQYFMSKARL-GMPLLVSAARFMVIHNFSGNNFTGPICWLP 506
P L+ DL +FT ++ +++ + LL N S + L
Sbjct: 399 CPQLELLDL------AFTRLKVKDAQSPFQNLHLLKVL-------NLSHSLLDISSEQLF 445
Query: 507 VAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDI 562
L+ + L G N N + LS + + I
Sbjct: 446 DGLPALQ----HLNLQG-NHFPKGNIQKT----NSLQTLGRLEILVLSFCD-LSSIDQHA 495
Query: 563 GVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSL 622
K + +D SHN+++ ++L +L + L+L N + +PS L L R ++L
Sbjct: 496 FTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINL 554
Query: 623 ADNNLTG 629
N L
Sbjct: 555 RQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-46
Identities = 101/569 (17%), Positives = 172/569 (30%), Gaps = 110/569 (19%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRV--LN 161
L L L N S P+ + EKL+VLD + N + + L+ LN
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 162 LAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLG--SFLKLRVLFLSYNELNGSI 219
L N I I + + LN G Q VI L + L + +
Sbjct: 186 LNGNDI-AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDIS 244
Query: 220 PSELGKYCR-YLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKL 278
P+ C +E ++L + ++ L+ L L + L++ +P L L L
Sbjct: 245 PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTL 303
Query: 279 EVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNS 338
+ L +S N+ L N L+ L + N+
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKG---------------------------NT 336
Query: 339 FIGSIPME-ITTLSKLRIIWAPRLNLE-------GKLPSSWGACESLEMLNLAQNVLRGD 390
+ + L LR L+L L+ LNL+ N
Sbjct: 337 KRLELGTGCLENLENLRE-----LDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSL 391
Query: 391 LIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL--FDVSGNHMSGSIPRFDYNVCHQ 448
F C +L +DL+ L + L ++S + + S +
Sbjct: 392 KTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE----QLFDG 447
Query: 449 MP-LQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPV 507
+P LQ +L GN+F
Sbjct: 448 LPALQHLNL-------------------------------------QGNHFPKGNIQKTN 470
Query: 508 APERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIG 563
+ + L R L+ L+ + F + +LS+N + ++
Sbjct: 471 SLQTLGRLE-ILVLSF-CDLSSIDQHA-------FTSLKMMNHVDLSHNRLT-SSSIEAL 520
Query: 564 VMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623
K + L+ + N IS I+P L L+ ++L N L + + +L
Sbjct: 521 SHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSN----IYFLEWYKEN 575
Query: 624 DNNLTGGIPSSIGELRSLEVLELSSNSLS 652
L + L + LS +LS
Sbjct: 576 MQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 3e-42
Identities = 84/502 (16%), Positives = 142/502 (28%), Gaps = 108/502 (21%)
Query: 206 RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
+ LN IP L E L+ S N L ++ + L L L +
Sbjct: 15 KTYNCENLGLN-EIPGTLP---NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELS 325
+ +L+ L ++ N L + T L L L
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQ---------------- 114
Query: 326 VGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQN 385
+ I SI ++LE L L N
Sbjct: 115 ------------TGISSID-----------------------FIPLHNQKTLESLYLGSN 139
Query: 386 VLRGDLIGVFDRCKKLHFIDLSSN---ELSGELDVKLQVPCMALFDVSGNHMSGSIPRFD 442
+ + +KL +D +N LS E LQ +++GN ++G +
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG----IE 195
Query: 443 YNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPI 502
QS + G I
Sbjct: 196 PGAFDSAVFQSLNF-------------------------------------GGTQNLLVI 218
Query: 503 CWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDI 562
+ ++ F ++F+ E NL + I +
Sbjct: 219 F-KGLKNSTIQSLWLGTFED--MDDE-DISPAVFEGLCEMSVESINLQKHYFFN-ISSNT 273
Query: 563 GVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSL 622
L+ LD + +S + P L L++L L L+ NK + S L HLS+
Sbjct: 274 FHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 623 ADNNLTGGIPS-SIGELRSLEVLELSSNSL--SGEVPEGVVNLRNLTALLLDNNKLSGHL 679
N + + + L +L L+LS + + S + NL +L +L L N+
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 680 PSGLANVTSLSIFNASFNNLSG 701
L + + +F L
Sbjct: 393 TEAFKECPQLELLDLAFTRLKV 414
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-31
Identities = 57/361 (15%), Positives = 105/361 (29%), Gaps = 73/361 (20%)
Query: 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIW--SLEKLEVLDVEGNFLSGRLPNEFVGL 154
+ P + + L+ + +++ L + E P F GL
Sbjct: 192 AGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251
Query: 155 R--NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSY 212
++ +NL + + F L+ L+L + +P L L+ L LS
Sbjct: 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSA 310
Query: 213 NELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLN--DVIP 269
N+ L HL + GN+ + + L + LR L L + + D
Sbjct: 311 NKFENLCQISASN-FPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 270 RELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQS 329
+L L L+ L++S N L C +L +L L+
Sbjct: 370 LQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAF-------------------- 409
Query: 330 DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG 389
S + L++LNL+ ++L
Sbjct: 410 -------TRLKVKDA-----------------------QSPFQNLHLLKVLNLSHSLLDI 439
Query: 390 DLIGVFDRCKKLHFIDLSSNELSGELDV---------KLQVPCMALFDVSGNHMSGSIPR 440
+FD L ++L N +L++ +S +S
Sbjct: 440 SSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEI-----LVLSFCDLSSIDQH 494
Query: 441 F 441
Sbjct: 495 A 495
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-26
Identities = 38/157 (24%), Positives = 66/157 (42%), Gaps = 4/157 (2%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L+ + L+VL+ SH+ + Q + L +L L+L GN
Sbjct: 406 DLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGN 465
Query: 608 ---PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRN 664
+SL L L L L+ +L+ + L+ + ++LS N L+ E + +L+
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKG 525
Query: 665 LTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
+ L L +N +S LPS L ++ N N L
Sbjct: 526 IY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-20
Identities = 34/184 (18%), Positives = 65/184 (35%), Gaps = 8/184 (4%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
N + + + + NL+ N+I I + L+ Q ++
Sbjct: 163 NAIH-YLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAF-DSAVFQSLNFGGTQNLLVIF 219
Query: 585 QSLEN--LTSLVFLDLNGNKLQGEIPSSLHRLK--YLRHLSLADNNLTGGIPSSIGELRS 640
+ L+N + SL + P+ L + ++L + ++
Sbjct: 220 KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSG 279
Query: 641 LEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L+ L+L++ LS E+P G+V L L L+L NK +N SL+ + N
Sbjct: 280 LQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKR 338
Query: 701 GPFP 704
Sbjct: 339 LELG 342
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-60
Identities = 84/633 (13%), Positives = 174/633 (27%), Gaps = 137/633 (21%)
Query: 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
+ + LSL G G P I L +L+VL + + +
Sbjct: 319 LDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEE 378
Query: 163 AFNRIDGDI-PFSLRNFESLEVLNLAGNQVKGV---IPGFLGSFLKLRVLFL--SYNELN 216
+RI L + L + +L + + P S + L+ + N +
Sbjct: 379 RKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRI- 437
Query: 217 GSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR 276
I + + L+ + + + + + L+
Sbjct: 438 TFISKAIQR-LTKLQIIYFANSPF-----TYDNIAVDWEDANSDYAKQYENEELSWSNLK 491
Query: 277 KLEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGELSVGQSDASNGE 335
L +++ +P L + EL L ++ N S +
Sbjct: 492 DLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG-------------------ISAAQ 532
Query: 336 KNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSW--GACESLEMLNLAQNVLRGDLIG 393
+ + + T K++I + NLE P+S L +L+ N +R +
Sbjct: 533 LKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLDCVHNKVRH--LE 589
Query: 394 VFDRCKKLHFIDLSSNELS------GELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCH 447
F KL + L N++ +++ S N + F+ +
Sbjct: 590 AFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEG-----LGFSHNKLKYIPNIFNAKSVY 644
Query: 448 QMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPV 507
+ S D S N +
Sbjct: 645 V--MGSVDF-------------------------------------SYNKIGSEGRNISC 665
Query: 508 APERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCK 567
+ + + N++ P ++
Sbjct: 666 SMDDYKGINASTVTLSYNEIQK----------------------------FPTELFATGS 697
Query: 568 SLRVLDASHNQISGI-------VPQSLENLTSLVFLDLNGNKLQGEIPSSLH--RLKYLR 618
+ + S+N ++ I + +N L +DL NKL + L YL
Sbjct: 698 PISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLS 756
Query: 619 HLSLADNNLTGGIPSSIGELRSLEVLEL------SSNSLSGEVPEGVVNLRNLTALLLDN 672
++ ++ N + P+ L+ + N + + P G+ +L L + +
Sbjct: 757 NMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGS 815
Query: 673 NKLSGHLPSGLANVTSLSIFNASFNNL-SGPFP 704
N + + L L I + + N S
Sbjct: 816 NDIR-KVDEKL--TPQLYILDIADNPNISIDVT 845
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 197 bits (501), Expect = 5e-52
Identities = 93/675 (13%), Positives = 192/675 (28%), Gaps = 132/675 (19%)
Query: 13 EFKNSVSDPSGILSSWQTNTSSHCSWF---GVSCDSESRVVALNITGGDVSEGNSKPFFS 69
+ + + + +W N W GV D+ RV L++ G
Sbjct: 287 RYYSGTINNTIHSLNWNFNKE-LDMWGDQPGVDLDNNGRVTGLSLAG------F------ 333
Query: 70 CLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWS 129
G++ +G L+EL+VLS + +
Sbjct: 334 ------------------------GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDE 369
Query: 130 LEKLEVLDVEGNFLSGRLPNEFVG----LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185
++ + + + F+ L +L A NR P + SL+
Sbjct: 370 ELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
Query: 186 LAG--NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGR 243
+ N++ I + KL++++ + + + E +
Sbjct: 430 IGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVD------WEDANSDYAKQYEN 482
Query: 244 IPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL---------IPT 294
S + L + L++ +P L L +L+ L+++ NR +
Sbjct: 483 EELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLAD 542
Query: 295 ELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME--ITTLSK 352
+ ++ + + N+ + P + + K
Sbjct: 543 DEDTGPKIQIFYMGY---------------------------NN-LEEFPASASLQKMVK 574
Query: 353 LRIIWAPRLNLEG---KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSN 409
L + L+ + ++G L L L N + ++ + S N
Sbjct: 575 LGL-----LDCVHNKVRHLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHN 629
Query: 410 ELSGELDVKLQVPCMAL--FDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYM 467
+L ++ + D S N + ++ + +S +
Sbjct: 630 KLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTV----------- 678
Query: 468 QYFMSKARLGM--PLLVSAARFMVIHNFSGNNFTG-PICWLPVAPERLRRRTDYAFL-AG 523
+S + L + + S N T P L + +
Sbjct: 679 --TLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 524 ANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASH------N 577
NKLT S F+A + ++S N P L+ H N
Sbjct: 737 FNKLT-SLSDD-FRATTLPYLSNMDVSYNCF-SSFPTQPL-NSSQLKAFGIRHQRDAEGN 792
Query: 578 QISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGE 637
+I P + SL+ L + N ++ ++ L L L +ADN +S+
Sbjct: 793 RILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCP 849
Query: 638 LRSLEVLELSSNSLS 652
+ L +
Sbjct: 850 YIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 135 bits (340), Expect = 3e-32
Identities = 64/522 (12%), Positives = 146/522 (27%), Gaps = 64/522 (12%)
Query: 208 LFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267
+ + E I + E LD ++ +M D
Sbjct: 257 VPIQLKETAEYIKDYKALKAIW-EALDGKNWRYYSGTINNTIHSLNWNFNKEL-DMWGDQ 314
Query: 268 IPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN----LFDPLLSGRNIRGE 323
+L ++ L ++ G +P +G EL VL + L + +
Sbjct: 315 PGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPD 374
Query: 324 LSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLA 383
+S + + L+ + + P + ++L
Sbjct: 375 MSEERKHRIRMHYKKMFLDYDQRLNLSDLLQ-------DAINRNPEMKPI-KKDSRISLK 426
Query: 384 QNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDY 443
+ + ++ FI + L+ KLQ+ + + + D+
Sbjct: 427 DTQIG-------NLTNRITFISKAIQRLT-----KLQI-----IYFANSPFTYDNIAVDW 469
Query: 444 NVCHQMPLQSSDLCQGYDPSFTYMQ-----YFMSKARLG-MPLLVSAARFMVIHNFSGNN 497
+ + + + S++ ++ + + +P + + N + N
Sbjct: 470 EDAN---SDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNR 526
Query: 498 FTGP---ICWLPVAPERLRRRTDYAFL-AGANKLTGSFPGSLFQACNEFHGMVANLSNNN 553
+ G N L + Q + + + +N
Sbjct: 527 GISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLL--DCVHNK 584
Query: 554 IIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS--SL 611
+ H+ G L L +NQI I + L + NKL+ IP+ +
Sbjct: 585 V-RHLE-AFG-TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNA 640
Query: 612 HRLKYLRHLSLADNNLTG-----GIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLT 666
+ + + + N + + + + LS N + E ++
Sbjct: 641 KSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPIS 700
Query: 667 ALLLDNNKLS-------GHLPSGLANVTSLSIFNASFNNLSG 701
++L NN ++ N L+ + FN L+
Sbjct: 701 TIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS 742
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 7e-31
Identities = 36/234 (15%), Positives = 80/234 (34%), Gaps = 26/234 (11%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWS------LEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
+ + + +N I + + N + F +
Sbjct: 641 KSVYVMGSVDFSYNKIGS-EGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPI 699
Query: 158 RVLNLAFNRID-------GDIPFSLRNFESLEVLNLAGNQVKGVIPGF-LGSFLKLRVLF 209
+ L+ N + + +N L ++L N++ + F + L +
Sbjct: 700 STIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMD 759
Query: 210 LSYNELNGSIPSELGKYCRYLEHLDL------SGNSLVGRIPSSLGKCQQLRTLLLFSNM 263
+SYN + S P++ L+ + GN ++ + P+ + C L L + SN
Sbjct: 760 VSYNCFS-SFPTQPLN-SSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSND 817
Query: 264 LNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSG 317
+ + +L +L +LD++ N + T + +E + VL + G
Sbjct: 818 IRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQDIRG 868
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-22
Identities = 36/234 (15%), Positives = 70/234 (29%), Gaps = 23/234 (9%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFLA-GANKLTGSFPGSLFQACNEFHGMVANLS 550
+ +G G + P+ + + T+ L+ G + T S +
Sbjct: 329 SLAGFGAKGRV------PDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMS---EER 379
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHN------QISGIVPQSLENLTSLVFLDLNGNKLQ 604
+ I H + L + D + ++ I S +L +L N++
Sbjct: 380 KHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLT-NRIT 438
Query: 605 GEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRN 664
I ++ RL L+ + A++ T + E NL++
Sbjct: 439 F-ISKAIQRLTKLQIIYFANSPFTYDNIAV-----DWEDANSDYAKQYENEELSWSNLKD 492
Query: 665 LTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGN 718
LT + L N LP L ++ L N + N +
Sbjct: 493 LTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDT 546
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-21
Identities = 30/199 (15%), Positives = 70/199 (35%), Gaps = 21/199 (10%)
Query: 94 KLVGKLSPLVGGLSELRVLSLPFNGFS-------GEFPPEIWSLEKLEVLDVEGNFLSGR 146
++ + L S + + L N + + L +D+ N L+
Sbjct: 684 EIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS- 742
Query: 147 LPNEFV--GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL------AGNQVKGVIPGF 198
L ++F L L +++++N P N L+ + GN++ P
Sbjct: 743 LSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTG 801
Query: 199 LGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLL 258
+ + L L + N++ + +L L LD++ N + +S+ + +
Sbjct: 802 ITTCPSLIQLQIGSNDIR-KVDEKL---TPQLYILDIADNPNISIDVTSVCPYIEAGMYV 857
Query: 259 LFSNMLNDVIPRELGWLRK 277
L + D+ + + +
Sbjct: 858 LLYDKTQDIRGCDALGIER 876
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 3e-17
Identities = 32/249 (12%), Positives = 69/249 (27%), Gaps = 15/249 (6%)
Query: 465 TYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGA 524
TY Q + ++ L V F VI N + PI A + A
Sbjct: 223 TYSQSGIKRSELETQS-VRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEAL 281
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKS---LRVLDASHNQISG 581
+ + N + N + GV + + L + G
Sbjct: 282 DGKNWRYYSGTINN----TIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKG 337
Query: 582 IVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPS-SIGELRS 640
VP ++ LT L L + + + + +
Sbjct: 338 RVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQR 397
Query: 641 LEVLELSSNSLS-----GEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNAS 695
L + +L ++++ + + T + N+++ + + +T L I +
Sbjct: 398 LNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFA 456
Query: 696 FNNLSGPFP 704
+ +
Sbjct: 457 NSPFTYDNI 465
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 2e-60
Identities = 101/581 (17%), Positives = 184/581 (31%), Gaps = 83/581 (14%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
SEL+ L L L L L + GN + P F GL +L L
Sbjct: 53 SNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAV 112
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSE 222
++ F + +L+ LN+A N + +P + + L + LSYN + ++
Sbjct: 113 ETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172
Query: 223 ---LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW-LRKL 278
L + + LD+S N + I + +L L L N + I + L L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPI-DFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGL 231
Query: 279 EVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNS 338
V + E+ + L + + L+ +
Sbjct: 232 HVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT-------------------YTN 272
Query: 339 FIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRC 398
++ L+ + + ++++ + L++ + L+
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQF---PTLDL 327
Query: 399 KKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQ 458
L + L+ N+ S K+ +P ++ D+S N +S S
Sbjct: 328 PFLKSLTLTMNKGSISFK-KVALPSLSYLDLSRNALSFSGCC------------------ 368
Query: 459 GYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAP--ERLRRRT 516
S + LG L + S N + L
Sbjct: 369 -------------SYSDLGTNSLRH-------LDLSFNGAIIMSANFMGLEELQHL---- 404
Query: 517 DYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASH 576
+ L S F + + + ++S N I + SL L +
Sbjct: 405 ---DFQH-STLKRVTEFSAFLSLEKLLYL--DISYTNT-KIDFDGIFLGLTSLNTLKMAG 457
Query: 577 NQISGIVPQS-LENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI 635
N + N T+L FLDL+ +L+ L L+ L+++ NNL S
Sbjct: 458 NSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHY 517
Query: 636 GELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676
+L SL L+ S N + ++L L NN ++
Sbjct: 518 NQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 9e-56
Identities = 93/599 (15%), Positives = 188/599 (31%), Gaps = 61/599 (10%)
Query: 121 GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFES 180
G P I + + LS ++P++ + + ++L+FN + +S NF
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 181 LEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL 240
L+ L+L+ +++ + L L L+ N + P LE+L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG-LTSLENLVAVETKL 116
Query: 241 VGRIPSSLGKCQQLRTLLLFSNMLNDV-IPRELGWLRKLEVLDVSRNRLNGLIPTELGNC 299
+G+ L+ L + N ++ +P L L +D+S N + + +L
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 300 VELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAP 359
E + LS L N I I + KL +
Sbjct: 177 RENPQVNLS-----LDMSLN-------------------PIDFIQDQAFQGIKLHELTLR 212
Query: 360 RLNLEGKLPS-SWGACESLEMLNLAQNVLRGDL------IGVFDRCKKLHFIDLSSNELS 412
+ L + L + + + + + + +
Sbjct: 213 GNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTN 272
Query: 413 GELDVKLQVPCMA---LFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQY 469
D ++ C+A ++G + + + + L Q +++
Sbjct: 273 DFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKS 332
Query: 470 -FMSKARLGMPLLVSAARFMVIHNFSGNNFT--GPICWLPVAPERLRRRTDYAFLAGANK 526
++ + + A + + S N + G + + LR + L+ N
Sbjct: 333 LTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR----HLDLSF-NG 387
Query: 527 LTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI 582
F G+ + ++ + + + L LD S+
Sbjct: 388 AI-IMSA-------NFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKID 439
Query: 583 VPQSLENLTSLVFLDLNGNKLQGEIPSS-LHRLKYLRHLSLADNNLTGGIPSSIGELRSL 641
LTSL L + GN + S+ L L L+ L L L
Sbjct: 440 FDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL 499
Query: 642 EVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
++L +S N+L L +L+ L N++ SL+ FN + N+++
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 4e-51
Identities = 100/564 (17%), Positives = 174/564 (30%), Gaps = 88/564 (15%)
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218
++ +P + S + ++L+ N +K + +F +L+ L LS E+
Sbjct: 15 TYQCMDQKLS-KVPDDI--PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETI 71
Query: 219 IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKL 278
+L +L L+GN + P S L L+ L + +G L L
Sbjct: 72 EDKAWHG-LHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 279 EVLDVSRNRLNGL-IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
+ L+V+ N ++ +P N L + LS N
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSY---------------------------N 163
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLI- 392
++ L + L++ + L L L N +++
Sbjct: 164 YIQTITVNDLQFLRENP-QVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMK 222
Query: 393 GVFDRCKKLHFIDLSSNELSGELDVK---------LQVPCMALFDVSGNHMSGSIPRFDY 443
LH L E E +++ L + F ++ +
Sbjct: 223 TCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI---- 278
Query: 444 NVCHQMP-LQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTG-P 501
H + + + L + ++Y + + P
Sbjct: 279 VKFHCLANVSAMSL------AGVSIKYLEDVPKH---------FKWQSLSIIRCQLKQFP 323
Query: 502 ICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNI--IGHIP 559
LP L+ L NK + SF + + +LS N + G
Sbjct: 324 TLDLP----FLK----SLTLTM-NKGSISFKKVALPSLSYL-----DLSRNALSFSGCCS 369
Query: 560 LDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP-SSLHRLKYLR 618
+ SLR LD S N I+ + L L LD + L+ S+ L+ L
Sbjct: 370 YS-DLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 619 HLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKLSG 677
+L ++ N L SL L+++ NS V N NLT L L +L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQ 487
Query: 678 HLPSGLANVTSLSIFNASFNNLSG 701
+ L + N S NNL
Sbjct: 488 ISWGVFDTLHRLQLLNMSHNNLLF 511
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-33
Identities = 49/216 (22%), Positives = 72/216 (33%), Gaps = 4/216 (1%)
Query: 97 GKLSPLVGGLSELRVLSLPFNGFS--GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGL 154
G +S L L L L N S G L LD+ N + F+GL
Sbjct: 340 GSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFMGL 398
Query: 155 RNLRVLNLAFNRIDGDIPFS-LRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
L+ L+ + + FS + E L L+++ K G L L ++ N
Sbjct: 399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGN 458
Query: 214 ELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELG 273
+ S + L LDLS L +L+ L + N L +
Sbjct: 459 SFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYN 518
Query: 274 WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L L LD S NR+ L+ L+N
Sbjct: 519 QLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTN 554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 42/171 (24%), Positives = 72/171 (42%), Gaps = 5/171 (2%)
Query: 532 PGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLT 591
PGSL + + + +P DI S + +D S N + + S N +
Sbjct: 1 PGSLNPCIEVVPNITYQCMDQKL-SKVPDDIP---SSTKNIDLSFNPLKILKSYSFSNFS 56
Query: 592 SLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
L +LDL+ +++ + H L +L +L L N + P S L SLE L L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 652 SGEVPEGVVNLRNLTALLLDNNKLSG-HLPSGLANVTSLSIFNASFNNLSG 701
+ + L L L + +N + LP+ +N+T+L + S+N +
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT 167
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-24
Identities = 61/359 (16%), Positives = 114/359 (31%), Gaps = 29/359 (8%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKL----EVLDVEGNFLSGRLPNEFVG 153
KL L+ L + L +N ++ L + LD+ N + F G
Sbjct: 144 KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQG 203
Query: 154 LRNLRVLNLAFNRIDGDIP-FSLRNFESLEVLNLAGNQVKG------VIPGFLGSFLKLR 206
+ L L L N +I L+N L V L + K P + +
Sbjct: 204 I-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVT 262
Query: 207 VLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
+ N S + + L+G S+ + + K + ++L + L
Sbjct: 263 IDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLK 320
Query: 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGEL 324
L L+ L ++ N+ + I + LS L LS N
Sbjct: 321 QFPT---LDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGT 375
Query: 325 SVGQS-DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLP-SSWGACESLEMLNL 382
+ + D S N + L +L+ + L+ S++ + E L L++
Sbjct: 376 NSLRHLDLSF---NG-AIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDI 431
Query: 383 AQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALF--DVSGNHMSGSIP 439
+ + D G+F L+ + ++ N + L D+S +
Sbjct: 432 SYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-56
Identities = 76/276 (27%), Positives = 129/276 (46%), Gaps = 22/276 (7%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG+G FGT ++AE G VAVK L F V +F E+ + +RHPN+V +G
Sbjct: 45 IGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 888 ASGNEMFLIYNYLPGGNLENFI-KARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+ ++ YL G+L + K+ +D + +A DVA + YLH P ++H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLH-NRNPPIVH 162
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKAD 1006
R++K N+L+D + + DFGLSRL S ++ AGT ++APE ++K+D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 1007 VYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDD 1066
VYS+GV+L EL + ++ P N + + + + ++ P +
Sbjct: 222 VYSFGVILWELATLQQ---PW-----GNLNPAQVVAAVGFKCKRLEI---------PRNL 264
Query: 1067 LEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102
+ + C RP+ ++ L+ + S
Sbjct: 265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA 300
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-56
Identities = 68/329 (20%), Positives = 111/329 (33%), Gaps = 50/329 (15%)
Query: 811 LTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAE-- 868
+ IG G +G YK + VAVK Q F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVF----SFANRQNFINEKN 57
Query: 869 IKTLGNVRHPNLVTLIGY-----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILH 923
I + + H N+ I E L+ Y P G+L ++ T DW
Sbjct: 58 IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSC 114
Query: 924 KIALDVASALAYLH------DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS- 976
++A V LAYLH D P + HRD+ N+L+ +D +SDFGLS L +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 977 ------ETHATTGVAGTFGYVAPEYA-------LTCRVSDKADVYSYGVVLLELISDKKA 1023
E +A GT Y+APE + D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 1024 LDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA-----------ELWASGPHDDLEDMLH 1072
L P + +++ + + +D+ E W + +
Sbjct: 235 LFP--GESVPEYQ-MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSL-AVRSLKE 290
Query: 1073 LALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
C + R T + + + ++
Sbjct: 291 TIEDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-55
Identities = 70/284 (24%), Positives = 131/284 (46%), Gaps = 37/284 (13%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQ------HGVQQFHAEIKTLGNVRHPNLV 881
IG GGFG +K + +VA+K L +G + Q+F E+ + N+ HPN+V
Sbjct: 27 IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L G N ++ ++P G+L + + + + + W + ++ LD+A + Y+
Sbjct: 87 KLYG--LMHNPPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQ-NQN 142
Query: 942 PRVLHRDVKPSNILLD-----DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE-- 994
P ++HRD++ NI L A ++DFGLS+ H+ +G+ G F ++APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETI 198
Query: 995 YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054
A ++KAD YS+ ++L +++ + P F + I + +M+ +G +
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEG---P-FD--EYSYGKIKFINMIREEGLRPTI- 251
Query: 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
P D + ++ C RP +V+ L ++
Sbjct: 252 --------PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 5e-55
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 28/282 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+ +G G FG KA+ VA+K++ + + F E++ L V HPN+V
Sbjct: 9 EIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQI---ESESERKAFIVELRQLSRVNHPNIV 64
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFI-KARTSRAVDWKILHKIALDVASALAYLHDQC 940
L G A N + L+ Y GG+L N + A L + +AYLH
Sbjct: 65 KLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 941 APRVLHRDVKPSNILLDDDFNAY-LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
++HRD+KP N+LL + DFG + + T T G+ ++APE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGS 178
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059
S+K DV+S+G++L E+I+ +K P + + ++ +
Sbjct: 179 NYSEKCDVFSWGIILWEVITRRK---P-------------FDEIGGPAFRIMWAVHNGTR 222
Query: 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
+ + + L RC + S RP+M+++V+ + +
Sbjct: 223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 7e-54
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 33/278 (11%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGY- 886
+ G +K G + VK L V + + F+ E L HPN++ ++G
Sbjct: 18 LNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 887 -RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
LI +++P G+L N + T+ VD K ALD+A +A+LH P +
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIP 135
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD-- 1003
+ ++++D+D A +S + + G +VAPE AL + D
Sbjct: 136 RHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPE-ALQKKPEDTN 188
Query: 1004 --KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061
AD++S+ V+L EL++ + P F+ + + + +G +
Sbjct: 189 RRSADMWSFAVLLWELVTRE---VP-FA----DLSNMEIGMKVALEGLRPTI-------- 232
Query: 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
P + L C E + RP +V L+++Q
Sbjct: 233 -PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-52
Identities = 71/281 (25%), Positives = 115/281 (40%), Gaps = 35/281 (12%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHG---VQQFHAEIKTLGNVRHPNLVTLIG 885
IG GGFG Y+A G VAVK + ++ E K ++HPN++ L G
Sbjct: 15 IGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ L+ + GG L + + + IL A+ +A + YLHD+ ++
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLS---GKRIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 946 HRDVKPSNILLDDDFNAY--------LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
HRD+K SNIL+ ++DFGL+R + AG + ++APE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAWMAPEVIR 187
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057
S +DV+SYGV+L EL++ + P G + ++ A + +
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGE---VPF-----RGIDGLAVAYGVAMNKLALPI---- 235
Query: 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
P E L C +RP+ ++ L I
Sbjct: 236 -----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 8e-51
Identities = 71/290 (24%), Positives = 115/290 (39%), Gaps = 37/290 (12%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G FG K G ++ +K+L + + + F E+K + + HPN++ IG
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKEL-IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
+ I Y+ GG L IK W A D+AS +AYLH ++HR
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIK-SMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIHR 132
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT-------------TGVAGTFGYVAPE 994
D+ N L+ ++ N ++DFGL+RL+ +T V G ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 995 YALTCRVSD-KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053
+ R D K DV+S+G+VL E+I A L R
Sbjct: 193 -MINGRSYDEKVDVFSFGIVLCEIIGRVNA----------------DPDYLPRTMDFGLN 235
Query: 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
L P + + +RC RP+ ++ L+ ++
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 2e-50
Identities = 66/306 (21%), Positives = 116/306 (37%), Gaps = 43/306 (14%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
IG G +G + + G VAVK EI +RH N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA--SWFRETEIYQTVLMRHENILGFIAA 99
Query: 887 ----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH----- 937
S +++LI +Y G+L +++K+ T +D K + K+A S L +LH
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKSTT---LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH---ATTGVAGTFGYVAPE 994
Q P + HRD+K NIL+ + ++D GL+ + GT Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216
Query: 995 ------YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048
+ AD+YS+G++L E+ + + + ++
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ------LPYHDLVPSDP 270
Query: 1049 QVKDVFNA-----------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097
+D+ W+ + L M L C ++R T +V + L +
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWS--SDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
Query: 1098 IQHSPN 1103
+ S +
Sbjct: 329 MSESQD 334
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-49
Identities = 72/282 (25%), Positives = 132/282 (46%), Gaps = 37/282 (13%)
Query: 829 IGSGGFGTTYKAEISPGIL---VAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLI 884
IGSG FGT YK G VAVK L V +Q F E+ L RH N++ +
Sbjct: 32 IGSGSFGTVYK-----GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
GY ++ ++ ++ + G +L + + A ++ + K L IA A + YLH A +
Sbjct: 87 GY-STAPQLAIVTQWCEGSSLYHHLHASETK-FEMKKLIDIARQTARGMDYLH---AKSI 141
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLG-TSETHATTGVAGTFGYVAPE---YALTCR 1000
+HRD+K +NI L +D + DFGL+ S +H ++G+ ++APE +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 1001 VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL-- 1058
S ++DVY++G+VL EL++ + + ++++ R ++ V L
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQ----------------LPYSNINNRDQIIEMVGRGSLSP 245
Query: 1059 -WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
+ + + M L C + RP+ +++ ++++
Sbjct: 246 DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 8e-49
Identities = 125/678 (18%), Positives = 230/678 (33%), Gaps = 78/678 (11%)
Query: 130 LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPF-SLRNFESLEVLNLAG 188
L E L + N++ + F L L++L L I + RN +L +L+L
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 189 NQVKGVIPGFLGSFLKLRVLFLSYNEL-NGSIPSELGKYCRYLEHLDLSGNSLVG-RIPS 246
+++ + P L L L + L + + + + L LDLS N + +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 247 SLGKCQQLRTLLLFSNMLNDVIPRELGWLR--KLEVLDVSRNRLNGLIPTELGNC----- 299
S GK L+++ SN + V EL L+ L ++ N L + + G C
Sbjct: 143 SFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFR 202
Query: 300 -VELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWA 358
+ L +L +S + N + S + S I + + I
Sbjct: 203 NMVLEILDVSGNGWTVDITGNFSNAI-------SKSQAFSLILAHHIMGAGFGFHNIKDP 255
Query: 359 PRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVK 418
+ G S S+ L+L+ + VF+ K L ++L+ N+++ ++ +
Sbjct: 256 DQNTFAGLARS------SVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADE 308
Query: 419 LQVPCMAL--FDVSGNHMSGSIPRFDYNVCHQMP-LQSSDLCQGYDPSFTYMQYFMSKAR 475
L ++S N + + + +P + DL ++ +
Sbjct: 309 AFYGLDNLQVLNLSYNL----LGELYSSNFYGLPKVAYIDL------QKNHIAIIQDQTF 358
Query: 476 LGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSL 535
+ L + + N T I ++P FL+G NKL +L
Sbjct: 359 KFLEKLQTL-------DLRDNALTT-IHFIP--------SIPDIFLSG-NKLVTLPKINL 401
Query: 536 FQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSL-ENLTSLV 594
+ +LS N + L + L++L + N+ S SL
Sbjct: 402 T-------ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLE 454
Query: 595 FLDLNGNKLQGEIPSSLHR-----LKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSN 649
L L N LQ + L L +L+ L L N L P L +L L L+SN
Sbjct: 455 QLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSN 514
Query: 650 SLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG--PFPWNV 707
L+ + NL L + N+L P SLS+ + + N +
Sbjct: 515 RLT-VLSHN-DLPANLEILDISRNQLLAPNPDVF---VSLSVLDITHNKFICECELSTFI 569
Query: 708 TTMNCSGVIGNPFLDPCQMYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSA 767
+N + V P + + + S + K + + +
Sbjct: 570 NWLNHTNVT---IAGPPADIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTV 626
Query: 768 SAIVLILLTLVILFFYVR 785
+ + ++ L + F
Sbjct: 627 TLTLFLMTILTVTKFRGF 644
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 5e-33
Identities = 88/507 (17%), Positives = 156/507 (30%), Gaps = 91/507 (17%)
Query: 206 RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
R+ F + L +P L E L LS N + SS +QL+ L L S
Sbjct: 7 RIAFYRFCNLT-QVPQVL----NTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 266 DVIPRE-LGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGEL 324
I +E L L +LD+ +++ L P L L L
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYF--------------- 106
Query: 325 SVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQ 384
+ ++ L+ +L L+L++
Sbjct: 107 -------------CGLSDAVLKDGYFRNLK---------------------ALTRLDLSK 132
Query: 385 NVLRG-DLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDY 443
N +R L F + L ID SSN++ + +
Sbjct: 133 NQIRSLYLHPSFGKLNSLKSIDFSSNQIF------------------------LVCEHEL 168
Query: 444 NVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARL-GMPLLVSAARFMVIHNFSGNNFTGPI 502
L L S + + M L + NF+ I
Sbjct: 169 EPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAI 228
Query: 503 CWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDI 562
L A + + + F +LS+ + + +
Sbjct: 229 SKSQAFSLILAHHIMGAGFGF-HNIK-DPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRV 285
Query: 563 GVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSL 622
K L+VL+ ++N+I+ I ++ L +L L+L+ N L S+ + L + ++ L
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 623 ADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSG 682
N++ + L L+ L+L N+L+ + + ++ + L NKL LP
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPKI 399
Query: 683 LANVTSLSIFNASFNNLS-GPFPWNVT 708
+ + NL F V
Sbjct: 400 NLTANLIHLSENRLENLDILYFLLRVP 426
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-24
Identities = 61/355 (17%), Positives = 109/355 (30%), Gaps = 42/355 (11%)
Query: 104 GGLSELRVLSLPFNGFSG-EFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLR--NLRVL 160
L L L L N P L L+ +D N + +E L+ L
Sbjct: 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFF 179
Query: 161 NLAFNRIDGDIPFSLRNFE------SLEVLNLAGNQVKGVIPGFLGSFL----------- 203
+LA N + + LE+L+++GN I G + +
Sbjct: 180 SLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILA 239
Query: 204 -KLRVLFLSYNELNGSIPSELGKYCR-YLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS 261
+ ++ + + R + HLDLS + + L+ L L
Sbjct: 240 HHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAY 299
Query: 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN---------LFD 312
N +N + L L+VL++S N L L + +++ + L F
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFK 359
Query: 313 PL-------LSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG 365
L L + + S + + ++P T + + + NL
Sbjct: 360 FLEKLQTLDLRDNALT-TIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENL-- 416
Query: 366 KLPSSWGACESLEMLNLAQNVLRG-DLIGVFDRCKKLHFIDLSSNELSGELDVKL 419
+ L++L L QN L + L N L + +L
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETEL 471
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-24
Identities = 52/226 (23%), Positives = 83/226 (36%), Gaps = 23/226 (10%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
S +R L L ++ L+ L+VL++ N ++ F GL NL+VLNL++
Sbjct: 265 RSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSY 323
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE---------- 214
N + + + ++L N + + KL+ L L N
Sbjct: 324 NLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSI 383
Query: 215 ----LNGSIPSELGKYCRYLEHLDLSGNSLVG-RIPSSLGKCQQLRTLLLFSNMLNDVIP 269
L+G+ L K + LS N L I L + L+ L+L N +
Sbjct: 384 PDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSG 443
Query: 270 REL-GWLRKLEVLDVSRNRLNGLIPTEL-----GNCVELSVLVLSN 309
+ LE L + N L TEL L VL L++
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNH 489
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-22
Identities = 53/226 (23%), Positives = 86/226 (38%), Gaps = 21/226 (9%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
L +L+VL+L +N + + L+ L+VL++ N L + F GL + ++L
Sbjct: 288 TLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQK 347
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGV---------------IPGFLGSFLKLRVLF 209
N I + + E L+ L+L N + + + L ++
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH 407
Query: 210 LSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL-GKCQQLRTLLLFSNMLNDVI 268
LS N L +L+ L L+ N + L L L NML
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 269 PRELGW-----LRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
EL W L L+VL ++ N LN L P + L L L++
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNS 513
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 3e-10
Identities = 31/122 (25%), Positives = 52/122 (42%), Gaps = 10/122 (8%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEI-----WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLR 158
L L L N + E+ L L+VL + N+L+ P F L LR
Sbjct: 448 SENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALR 507
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218
L+L NR+ + + +LE+L+++ NQ+ P F+ L VL +++N+
Sbjct: 508 GLSLNSNRL-TVLSHND-LPANLEILDISRNQLLAPNPDV---FVSLSVLDITHNKFICE 562
Query: 219 IP 220
Sbjct: 563 CE 564
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 2e-48
Identities = 65/303 (21%), Positives = 116/303 (38%), Gaps = 47/303 (15%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAE--IKTLGNVRHPNLVTLI 884
C+G G +G ++ G VAVK + + E + +RH N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIF----SSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 885 GY----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH--- 937
R S +++LI +Y G+L ++++ T +D +I L +AS LA+LH
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT---LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 938 --DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL---GTSETHATTGVAGTFGYVA 992
Q P + HRD+K NIL+ + ++D GL+ + GT Y+A
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 993 PE------YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046
PE + D++++G+VL E+ + + ++
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK------PPFYDVVPN 239
Query: 1047 QGQVKDVFNA-----------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095
+D+ W S L + L C + S R T ++ + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFS--DPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 1096 KQI 1098
+I
Sbjct: 298 TKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 173 bits (439), Expect = 9e-48
Identities = 65/303 (21%), Positives = 119/303 (39%), Gaps = 37/303 (12%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAE--IKTLGNVRHPNLVTLI 884
IG G FG ++ + G VAVK + + E I +RH N++ I
Sbjct: 48 ESIGKGRFGEVWRGKWR-GEEVAVKIF----SSREERSWFREAEIYQTVMLRHENILGFI 102
Query: 885 G----YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH--- 937
+ +++L+ +Y G+L +++ T V + + K+AL AS LA+LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEI 159
Query: 938 --DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH---ATTGVAGTFGYVA 992
Q P + HRD+K NIL+ + ++D GL+ ++ A GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 993 PE------YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046
PE +AD+Y+ G+V E+ + ++ + + + + +
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 1047 QGQVKDVFN------AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100
+ + W S + L M + C + R T ++ + L Q+
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQS--CEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336
Query: 1101 SPN 1103
Sbjct: 337 QEG 339
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 9e-46
Identities = 56/291 (19%), Positives = 104/291 (35%), Gaps = 50/291 (17%)
Query: 829 IGSGGFGTTYKAEISPGIL---VAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLI 884
IG G FG Y G VA++ + + R ++ F E+ RH N+V +
Sbjct: 41 IGKGRFGQVYH-----GRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G S + +I + G L + ++ +D +IA ++ + YLH A +
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRL----LGTSETHATTGVAGTFGYVAPE------ 994
LH+D+K N+ D+ ++DFGL + G ++APE
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 995 ---YALTCRVSDKADVYSYGVVLLELISDK---KALDPSFSSHGDGFNIISWASMLLRQG 1048
S +DV++ G + EL + + K G ++
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG--------MKPN 262
Query: 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
+++ + L C RPT +++ L+++
Sbjct: 263 LS------------QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP 301
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-43
Identities = 101/544 (18%), Positives = 184/544 (33%), Gaps = 72/544 (13%)
Query: 171 IPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYL 230
IP +L S + L+L+ N ++ + SF +L+VL LS E+ +I + +L
Sbjct: 22 IPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHL 78
Query: 231 EHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG 290
L L+GN + + L+ L+ L + +G L+ L+ L+V+ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 291 L-IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITT 349
+P N L L LS+ N ++
Sbjct: 139 FKLPEYFSNLTNLEHLDLSS---------------------------NKIQSIYCTDLRV 171
Query: 350 LSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLI-GVFDRCKKLHFI 404
L ++ ++ L+L + L L L N +++ L
Sbjct: 172 LHQMPLLNL-SLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVH 230
Query: 405 DLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSF 464
L E + L+ + + + +I F DL
Sbjct: 231 RLVLGEFRN--EGNLEKFDKSALE---GLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285
Query: 465 TYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGA 524
++ ++ R+ + + + N F + + L+R T +
Sbjct: 286 SFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP------TLKLKSLKRLTFTS----- 334
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCK--SLRVLDASHNQ 578
NK +F + + +LS N + SL+ LD S N
Sbjct: 335 NKGGNAFS---------EVDLPSLEFLDLSRNGL-SFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 579 ISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS-LHRLKYLRHLSLADNNLTGGIPSSIGE 637
+ + + L L LD + L+ S L+ L +L ++ +
Sbjct: 385 VITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
Query: 638 LRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASF 696
L SLEVL+++ NS + LRNLT L L +L P+ +++SL + N +
Sbjct: 444 LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMAS 503
Query: 697 NNLS 700
N L
Sbjct: 504 NQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-42
Identities = 92/539 (17%), Positives = 181/539 (33%), Gaps = 56/539 (10%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192
+ LD+ N L F L+VL+L+ I + ++ L L L GN ++
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL-VGRIPSSLGKC 251
+ G L+ L L S+ + + + L+ L+++ N + ++P
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 252 QQLRTLLLFSNMLNDVIPRELGWLRKLEV----LDVSRNRLNGLIPTELGNCVELSVLVL 307
L L L SN + + +L L ++ + LD+S N +N I + L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207
Query: 308 SNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM-EITTLSKLRIIWAPRLNLEG- 365
N FD L + L+ + + G++ + + L L + L
Sbjct: 208 RNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYL 267
Query: 366 -----KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRC-KKLHFIDLSSNELSGELDVKL 419
+ + ++ +L + ++ + L ++ + L
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL 327
Query: 420 QVPCMALFDVSGNHMSGSIPRFDYNVCHQMP-LQSSDLCQGYDPSFTYMQYFMSKARLGM 478
+ + N + +P L+ DL + + + S++ G
Sbjct: 328 KR-----LTFTSNKGG-NAFSE-----VDLPSLEFLDLSR----NGLSFKGCCSQSDFGT 372
Query: 479 PLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQA 538
L + S N + L + ++ + L S+F
Sbjct: 373 TSLKY-------LDLSFNGVIT----MSSNFLGLEQ-LEHLDFQH-SNLKQMSEFSVF-- 417
Query: 539 CNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQ-SLENLTSL 593
+ ++S+ + I SL VL + N L +L
Sbjct: 418 ----LSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 594 VFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS 652
FLDL+ +L+ P++ + L L+ L++A N L L SL+ + L +N
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-40
Identities = 91/512 (17%), Positives = 159/512 (31%), Gaps = 74/512 (14%)
Query: 210 LSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269
IP L ++LDLS N L S +L+ L L + +
Sbjct: 14 CMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIED 69
Query: 270 RELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQS 329
L L L ++ N + L L LV
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVE-------------------- 109
Query: 330 DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG------KLPSSWGACESLEMLNLA 383
+ I L L+ LN+ KLP + +LE L+L+
Sbjct: 110 -------TNLASLENFPIGHLKTLK-----ELNVAHNLIQSFKLPEYFSNLTNLEHLDLS 157
Query: 384 QNVLRGDLIGVFDRCKKLHF----IDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIP 439
N ++ ++ +DLS N ++ + + + N S ++
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVM 217
Query: 440 RFDYNVCHQMP-LQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNF 498
+ + L+ L G + ++ F A G+ L I F
Sbjct: 218 K---TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLT-------IEEFRLAYL 267
Query: 499 TGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHI 558
+ + L + ++ ++ + S L N
Sbjct: 268 DYYLDDIIDLFNCLTNVSSFSLVS--VTIERVKDFSYNFGWQHLE-----LVNCKFGQFP 320
Query: 559 PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ--GEIPSSLHRLKY 616
L KSL+ L + N+ S +L SL FLDL+ N L G S
Sbjct: 321 TLK----LKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 617 LRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKL 675
L++L L+ N + + S+ L LE L+ ++L V ++LRNL L + +
Sbjct: 375 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 433
Query: 676 SGHLPSGLANVTSLSIFNASFNNLSGPFPWNV 707
++SL + + N+ F ++
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-40
Identities = 94/548 (17%), Positives = 179/548 (32%), Gaps = 70/548 (12%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
+ + L+L+FN + +S +F L+VL+L+ +++ + G S L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV-IPRELG 273
+ S+ L+ L +L +G + L+ L + N++ +P
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 274 WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASN 333
L LE LD+S N++ + L + L +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYC---------------TDLRVLHQMPLLNLSLDLS------ 185
Query: 334 GEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPS-SWGACESLEMLNLAQNVLRGD-- 390
+ + I +L + + LE+ L R +
Sbjct: 186 ---LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGN 242
Query: 391 ----LIGVFDRCKKLHF-------IDLSSNELSGELDVKLQVPCMALFDVSGNHMS---- 435
+ L +D +++ + V +L V+ +
Sbjct: 243 LEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY 302
Query: 436 -GSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFS 494
+ C + L +FT + + + + +P L F+ + S
Sbjct: 303 NFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSL----EFL---DLS 355
Query: 495 GNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA----NLS 550
N + C + Y L+ N + + F G+ +
Sbjct: 356 RNGLSFKGC-CSQSDFGTTS-LKYLDLSF-NGVI-TMSS-------NFLGLEQLEHLDFQ 404
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS- 609
++N+ + + ++L LD SH L+SL L + GN Q
Sbjct: 405 HSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 464
Query: 610 SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNLTAL 668
L+ L L L+ L P++ L SL+VL ++SN L VP+G+ L +L +
Sbjct: 465 IFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKI 523
Query: 669 LLDNNKLS 676
L N
Sbjct: 524 WLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-37
Identities = 99/540 (18%), Positives = 181/540 (33%), Gaps = 74/540 (13%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
EL+VL L SL L L + GN + F GL +L+ L
Sbjct: 49 FSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSE 222
+ F + + ++L+ LN+A N ++ +P + + L L LS N++ ++
Sbjct: 109 ETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTD 168
Query: 223 LGKYCR---YLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW-LRKL 278
L + LDLS N + I K +L L L +N + + + L L
Sbjct: 169 LRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGL 227
Query: 279 EVLD------VSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332
EV + L + L L++ +
Sbjct: 228 EVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL---------------- 271
Query: 333 NGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI 392
+ + F + +L + I + + LE++N
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGW-------QHLELVNCKFGQFP---- 320
Query: 393 GVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQ 452
+ K L + +SN+ ++ +P + D+S N +S + L+
Sbjct: 321 --TLKLKSLKRLTFTSNKGG-NAFSEVDLPSLEFLDLSRNGLS-FKGCCSQSDFGTTSLK 376
Query: 453 SSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERL 512
DL SF + MS LG+ L +F +N +
Sbjct: 377 YLDL------SFNGVIT-MSSNFLGLEQLEHL-------DFQHSNLK----QMS-EFSVF 417
Query: 513 RRRTDYAFL-AGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCK 567
+ +L +F G F+G+ + ++ N+ + DI +
Sbjct: 418 LSLRNLIYLDISHTHTRVAFNGI-------FNGLSSLEVLKMAGNSFQENFLPDIFTELR 470
Query: 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNL 627
+L LD S Q+ + P + +L+SL L++ N+L+ RL L+ + L N
Sbjct: 471 NLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-26
Identities = 59/338 (17%), Positives = 99/338 (29%), Gaps = 37/338 (10%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
+ L L FN +S +L+VLD+ + + L +L L L N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY 226
I + SL+ L + + +G L+ L +++N + E
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 227 CRYLEHLDLSGNSLVGRIPSSLGKCQQLR----TLLLFSNMLNDVIPRELGWLRKLEVLD 282
LEHLDLS N + + L Q+ +L L N +N I +L L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSD------------ 330
+ N + + L+ L + L + +
Sbjct: 207 LRNNFDSLNVMK--TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 331 -----ASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPS-----------SWGAC 374
+ + F + +L + I +
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 375 ESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
+SL+ L N L F+DLS N LS
Sbjct: 325 KSLKRLTFTSNKGGN--AFSEVDLPSLEFLDLSRNGLS 360
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 43/188 (22%), Positives = 72/188 (38%), Gaps = 4/188 (2%)
Query: 105 GLSELRVLSLPFNG--FSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
L L L L NG F G + L+ LD+ N + + + F+GL L L+
Sbjct: 345 DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 403
Query: 163 AFNRIDGDIPFS-LRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
+ + FS + +L L+++ + G L VL ++ N +
Sbjct: 404 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
++ R L LDLS L P++ L+ L + SN L V L L+ +
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKI 523
Query: 282 DVSRNRLN 289
+ N +
Sbjct: 524 WLHTNPWD 531
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-24
Identities = 36/158 (22%), Positives = 64/158 (40%), Gaps = 5/158 (3%)
Query: 544 GMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKL 603
+ N IP ++ S + LD S N + + S + L LDL+ ++
Sbjct: 9 NITYQCMELNFY-KIPDNLP---FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI 64
Query: 604 QGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLR 663
Q + L +L L L N + + L SL+ L +L+ + +L+
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 664 NLTALLLDNNKL-SGHLPSGLANVTSLSIFNASFNNLS 700
L L + +N + S LP +N+T+L + S N +
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-18
Identities = 56/329 (17%), Positives = 98/329 (29%), Gaps = 50/329 (15%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPE-IWSLEKLEVLDVEGNF------LSGRLPNE 150
+ P L L+L N S I L LEV + L +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 151 FVGLRNLRVLNLAFNRIDG---DIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRV 207
GL NL + +D DI ++ +L ++ V +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQH 308
Query: 208 LFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN-- 265
L L + +L L+ L + N G S + L L L N L+
Sbjct: 309 LELVNCKFGQFPTLKLKS----LKRLTFTSNKG-GNAFSEVD-LPSLEFLDLSRNGLSFK 362
Query: 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELS 325
+ L+ LD+S N + + + +L L +
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQH---------------- 405
Query: 326 VGQSDASNGEKNSFIGSIPMEI-TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQ 384
++ + +L L + + + SLE+L +A
Sbjct: 406 -----------SNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 385 NVLRGDLI-GVFDRCKKLHFIDLSSNELS 412
N + + + +F + L F+DLS +L
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLE 483
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-14
Identities = 35/119 (29%), Positives = 54/119 (45%), Gaps = 3/119 (2%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNL 162
L L L + I++ L LEVL + GN + F LRNL L+L
Sbjct: 419 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 477
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
+ +++ P + + SL+VLN+A NQ+K V G L+ ++L N + S P
Sbjct: 478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 7e-07
Identities = 19/94 (20%), Positives = 36/94 (38%), Gaps = 3/94 (3%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
N +F +F + +LS + + SL+VL+ + NQ+ +
Sbjct: 455 NSFQENFLPDIFTELRNLTFL--DLSQCQL-EQLSPTAFNSLSSLQVLNMASNQLKSVPD 511
Query: 585 QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLR 618
+ LTSL + L+ N P + ++L
Sbjct: 512 GIFDRLTSLQKIWLHTNPWDCSCPRIDYLSRWLN 545
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 4e-42
Identities = 89/576 (15%), Positives = 176/576 (30%), Gaps = 97/576 (16%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
+ ++ L L FN + ++ + L+VL ++ + ++ + F L +L L+L+ N
Sbjct: 25 TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDN 84
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSELG 224
+ SL+ LNL GN + + + + L+ L + E I
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
L L++ SL SL + + L L + ++ L + L++
Sbjct: 145 AGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELR 204
Query: 285 RNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIP 344
L + L S + +L+ + L + + E
Sbjct: 205 DTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE--------- 255
Query: 345 MEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFI 404
+E + + + ++ L++ Q L DL V+ +K+ I
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 405 DLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSF 464
V + + +P + + S
Sbjct: 316 -----------------------TVENSKVF-LVPC---SFSQHLK------------SL 336
Query: 465 TYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGA 524
++ + S N L+
Sbjct: 337 EFL------------------------DLSENLMVEEYLKNSACKGAWPS-LQTLVLSQ- 370
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
N L S+ + + ++S N +P + +R L+ S I
Sbjct: 371 NHLR-----SMQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWP-EKMRFLNLSSTGIR 423
Query: 581 GIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRS 640
+ +L LD++ N L L RL + L ++ N L +P +
Sbjct: 424 VV---KTCIPQTLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLKT-LPDASL-FPV 474
Query: 641 LEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKL 675
L V+++S N L VP+G+ L +L + L N
Sbjct: 475 LLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-38
Identities = 99/580 (17%), Positives = 184/580 (31%), Gaps = 82/580 (14%)
Query: 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188
S + V D + +P+ ++ L+L+FN+I LR +L+VL L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG-RIPSS 247
+++ + S L L LS N L+ S+ S L++L+L GN + S
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSL 118
Query: 248 LGKCQQLRTLLLFSNMLNDVIPRE-LGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLV 306
L+TL + + I R L L L++ L L + ++ L
Sbjct: 119 FPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 307 LSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGK 366
L + + + LS +R + NL
Sbjct: 179 LHL---------------------------SESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 367 LPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL 426
S E + F+ KL L +E+
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-------------F 258
Query: 427 FDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAAR 486
D + N + P V +++ + + Y+ Y +S + +
Sbjct: 259 DDCTLNGLGDFNPSESDVVSELGKVETVTI-RRLHIPQFYLFYDLSTVYSLLEKVK---- 313
Query: 487 FMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMV 546
+ C + L L+ N + + +
Sbjct: 314 ---RITVENSKVFLVPCSFSQHLKSLEFLD----LSE-NLMVEEYLKN----SACKGAWP 361
Query: 547 A----NLSNNNIIGHIPLDIGVMCK--SLRVLDASHNQISGIVPQSLENLTSLVFLDLNG 600
+ LS N++ + ++ +L LD S N + P S + + FL+L+
Sbjct: 362 SLQTLVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFHPM-PDSCQWPEKMRFLNLSS 419
Query: 601 NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV 660
++ + + + + L L +++NNL L L+ L +S N L +P+
Sbjct: 420 TGIR-VVKTCI--PQTLEVLDVSNNNLDS-FSLF---LPRLQELYISRNKLK-TLPDAS- 470
Query: 661 NLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNL 699
L + + N+L +P G +TSL N
Sbjct: 471 LFPVLLVMKISRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 2e-38
Identities = 95/499 (19%), Positives = 157/499 (31%), Gaps = 54/499 (10%)
Query: 210 LSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269
SIPS L ++ LDLS N + L C L+ L+L S+ +N +
Sbjct: 12 GRSRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEG 67
Query: 270 RELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGELSVGQ 328
L LE LD+S N L+ L + G L L L N + L ++
Sbjct: 68 DAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 329 SDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLR 388
N E S I ++ L+ L + L+L S + + L L +
Sbjct: 128 LRIGNVETFSEIR--RIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESA 185
Query: 389 GDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQ 448
L D + +++L L+ L V ++ + +N +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 449 MPLQSSDLCQG--YDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLP 506
+ +L + D + + F +VS + +
Sbjct: 246 LLRYILELSEVEFDDCTLNGLGDF----NPSESDVVSELGKVETVTIRRLHIPQ------ 295
Query: 507 VAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMC 566
L + + + + N+ + +P
Sbjct: 296 ------------------FYLFYDLSTV-YSLLEKVKRI--TVENSKVF-LVPCSFSQHL 333
Query: 567 KSLRVLDASHNQISGIVPQS---LENLTSLVFLDLNGNKLQ--GEIPSSLHRLKYLRHLS 621
KSL LD S N + ++ SL L L+ N L+ + L LK L L
Sbjct: 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393
Query: 622 LADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPS 681
++ N +P S + L LSS + V + + L L + NN L
Sbjct: 394 ISRNTFHP-MPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLD-SFSL 448
Query: 682 GLANVTSLSIFNASFNNLS 700
L + L I S N L
Sbjct: 449 FLPRLQELYI---SRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-36
Identities = 97/534 (18%), Positives = 171/534 (32%), Gaps = 83/534 (15%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
+ L+VL L + + + +SL LE LD+ N LS + F L +L+ LNL
Sbjct: 48 ACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLM 106
Query: 164 FNRIDGDIPFSL-RNFESLEVLNLAGNQVKGVIP-GFLGSFLKLRVLFLSYNELNGSIPS 221
N SL N +L+ L + + I L L + L + S
Sbjct: 107 GNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQS 165
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
+ K R + HL L + + +R L L L L +
Sbjct: 166 QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPM 225
Query: 282 DVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341
R + L ++L +L G D + E +
Sbjct: 226 KKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLN------GLGDFNPSESDVVSE 279
Query: 342 SIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKL 401
+E T+ +L I P+ L L + + E ++ + + + + K L
Sbjct: 280 LGKVETVTIRRLHI---PQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSL 336
Query: 402 HFIDLSSNELS----GELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMP-LQSSDL 456
F+DLS N + K P + +S NH+ S+ + + + L S D+
Sbjct: 337 EFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQK-TGEILLTLKNLTSLDI 394
Query: 457 CQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVA---PERLR 513
S N F +P + PE++R
Sbjct: 395 -------------------------------------SRNTFH----PMPDSCQWPEKMR 413
Query: 514 RRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLD 573
+ L+ + + Q ++SNNN + L + L+ L
Sbjct: 414 ----FLNLSS-TGIR-VVKTCIPQTLEVL-----DVSNNN-LDSFSLFL----PRLQELY 457
Query: 574 ASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNL 627
S N++ + L+ + ++ N+L+ RL L+ + L N
Sbjct: 458 ISRNKLKTL--PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 5e-21
Identities = 43/190 (22%), Positives = 72/190 (37%), Gaps = 16/190 (8%)
Query: 105 GLSELRVLSLPFNGFSGEFPPE---IWSLEKLEVLDVEGNFLS--GRLPNEFVGLRNLRV 159
L L L L N E+ + L+ L + N L + + L+NL
Sbjct: 332 HLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTS 391
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSI 219
L+++ N +P S + E + LNL+ ++ V L VL +S N L+ S
Sbjct: 392 LDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVV---KTCIPQTLEVLDVSNNNLD-SF 446
Query: 220 PSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLE 279
L + L+ L +S N L +P + L + + N L V L L+
Sbjct: 447 SLFLPR----LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTSLQ 500
Query: 280 VLDVSRNRLN 289
+ + N +
Sbjct: 501 KIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-18
Identities = 65/476 (13%), Positives = 141/476 (29%), Gaps = 93/476 (19%)
Query: 233 LDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLI 292
D S IPS L +++L L N + + +L L+VL + +R+N +
Sbjct: 10 CDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIE 66
Query: 293 PTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSK 352
+ L L LS+ N +++LS
Sbjct: 67 GDAFYSLGSLEHLDLSD---------------------------NH--------LSSLS- 90
Query: 353 LRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG-DLIGVFDRCKKLHFIDLSSNEL 411
S +G SL+ LNL N + + +F L + + + E
Sbjct: 91 ---------------SSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 412 SGELDVKLQVPCMAL--FDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQY 469
E+ +L ++ + + + L + +
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRD--IHHLTL------HLSESAF 186
Query: 470 FMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTG 529
+ + + R++ + + + F + +++
Sbjct: 187 LLEIFADILSSV----RYLELRDTNLARFQFSPLPVDEVSSPMKKL---------AFRGS 233
Query: 530 SFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLEN 589
F + + LS C + D + ++ +
Sbjct: 234 VLTDESFNELLKLLRYILELSEVEFDD---------CTLNGLGDFNPSESDVVSELGKVE 284
Query: 590 LTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSN 649
++ L + L ++ + L+ ++ +++ ++ + S L+SLE L+LS N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344
Query: 650 SLSGEV---PEGVVNLRNLTALLLDNNKLS--GHLPSGLANVTSLSIFNASFNNLS 700
+ E +L L+L N L L + +L+ + S N
Sbjct: 345 LMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 2e-17
Identities = 35/209 (16%), Positives = 65/209 (31%), Gaps = 5/209 (2%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI-VPQSLENLTSLVFLDLNGNKLQGE 606
+LS+N++ + SL+ L+ N + V NLT+L L + + E
Sbjct: 80 DLSDNHL-SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSE 138
Query: 607 IP-SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
I L L L + +L S+ +R + L L + + + L ++
Sbjct: 139 IRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSV 198
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQ 725
L L + L+ S L S + L +
Sbjct: 199 RYLELRDTNLARFQFSPLPVDEVSSPMK-KLAFRGSVLTDESFNELLKLLRYILELSEVE 257
Query: 726 MYKDISSSELTSSNANSQHNITAPTGSRT 754
D + + L N + ++ T
Sbjct: 258 FD-DCTLNGLGDFNPSESDVVSELGKVET 285
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-09
Identities = 26/113 (23%), Positives = 44/113 (38%), Gaps = 5/113 (4%)
Query: 589 NLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSS 648
+ + D IPS L ++ L L+ N +T + +L+VL L S
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 649 NSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
+ ++ + +L +L L L +N LS S ++SL N N
Sbjct: 60 SRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 1e-05
Identities = 14/57 (24%), Positives = 23/57 (40%), Gaps = 3/57 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604
+S N + L + L V+ S NQ+ + + LTSL + L+ N
Sbjct: 457 YISRNKLKT---LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 17/76 (22%), Positives = 25/76 (32%), Gaps = 2/76 (2%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
L L L+ L + N P+ L V+ + N L F L +L
Sbjct: 442 NLDSFSLFLPRLQELYISRNKLK--TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSL 499
Query: 158 RVLNLAFNRIDGDIPF 173
+ + L N D P
Sbjct: 500 QKIWLHTNPWDCSCPR 515
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-39
Identities = 60/289 (20%), Positives = 122/289 (42%), Gaps = 25/289 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPN 879
+ IG G FG + G +K++ + R ++ E+ L N++HPN
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V ++++ +Y GG+L I A+ + + + AL ++HD+
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR 144
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
++LHRD+K NI L D L DFG++R+L ++ A + GT Y++PE
Sbjct: 145 ---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENK 200
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK---DVFNA 1056
++K+D+++ G VL EL L +F + ++ + + + G ++
Sbjct: 201 PYNNKSDIWALGCVLYELC----TLKHAF----EAGSMKN-LVLKIISGSFPPVSLHYSY 251
Query: 1057 ELWASGPHDDLEDMLHL--ALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
+L + + R +V ++ + + + ++ Q
Sbjct: 252 DLR-----SLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAE 295
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-38
Identities = 68/303 (22%), Positives = 122/303 (40%), Gaps = 46/303 (15%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876
R DF IGSGGFG +KA+ G +K++ ++ E+K L +
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLD 62
Query: 877 HPNLVTLIGY----------------RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWK 920
H N+V G R+ +F+ + G LE +I+ R +D
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980
+ ++ + + Y+H + ++++RD+KPSNI L D + DFGL L
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT 179
Query: 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040
+ GT Y++PE + + D+Y+ G++L EL+ +F + +
Sbjct: 180 RS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD---TAF----ETSKFFT- 229
Query: 1041 ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHL--ALRCTVETLSTRPTMKQVVQCLKQI 1098
LR G + D+F+ + L+ +L R + T+ + K
Sbjct: 230 ---DLRDGIISDIFDKKE-----KTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP-EKNE 280
Query: 1099 QHS 1101
+H+
Sbjct: 281 RHT 283
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 21/212 (9%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIG- 885
IG+G +G K S G ++ K+L G + Q +E+ L ++HPN+V
Sbjct: 14 IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 886 -YRASGNEMFLIYNYLPGGNLENFIKARTSRAVD------WKILHKIALDVASALAYLHD 938
+ ++++ Y GG+L + I T +++ ++ L AL H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL----ALKECHR 129
Query: 939 QCAP--RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
+ VLHRD+KP+N+ LD N L DFGL+R+L + A T V GT Y++PE
Sbjct: 130 RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQM 188
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALDPSF 1028
++K+D++S G +L EL AL P F
Sbjct: 189 NRMSYNEKSDIWSLGCLLYELC----ALMPPF 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 63/228 (27%), Positives = 100/228 (43%), Gaps = 23/228 (10%)
Query: 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVRH 877
+F IG G F Y+A + G+ VA+KK+ + EI L + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD------WKILHKIALDVAS 931
PN++ NE+ ++ G+L IK + WK ++
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS---- 147
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
AL ++H + RV+HRD+KP+N+ + L D GL R + T A + V GT Y+
Sbjct: 148 ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYM 203
Query: 992 APEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIIS 1039
+PE + K+D++S G +L E+ AL F +GD N+ S
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMA----ALQSPF--YGDKMNLYS 245
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 3e-36
Identities = 55/226 (24%), Positives = 96/226 (42%), Gaps = 28/226 (12%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876
R DF C+G GGFG ++A+ A+K++ + + ++ E+K L +
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 877 HPNLVTLIGY------------RASGNEMFLIYNYLPGGNLENFIKARTSRA-VDWKILH 923
HP +V + +++ NL++++ R + + +
Sbjct: 62 HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121
Query: 924 KIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983
I L +A A+ +LH + ++HRD+KPSNI D + DFGL + E T
Sbjct: 122 HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 984 VA-----------GTFGYVAPEYALTCRVSDKADVYSYGVVLLELI 1018
GT Y++PE S K D++S G++L EL+
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-36
Identities = 57/238 (23%), Positives = 95/238 (39%), Gaps = 54/238 (22%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876
R DF +G G FG KA A+KK+ + + +E+ L ++
Sbjct: 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK--LSTILSEVMLLASLN 60
Query: 877 HPNLVTLIG-------------YRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWK 920
H +V + +F+ Y G L + I + R W+
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL------- 973
+ +I AL+Y+H Q ++HRD+KP NI +D+ N + DFGL++ +
Sbjct: 121 LFRQIL----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173
Query: 974 -------GTSETHATTGVAGTFGYVAPE-------YALTCRVSDKADVYSYGVVLLEL 1017
S + T+ + GT YVA E Y ++K D+YS G++ E+
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHY------NEKIDMYSLGIIFFEM 224
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 5e-36
Identities = 45/326 (13%), Positives = 92/326 (28%), Gaps = 46/326 (14%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLR-- 155
L P LS+ + + ++ G L +
Sbjct: 24 ALRPYHDVLSQWQRHYNADRNRW-HSAWRQANSNNPQIETRTGRALK-ATADLLEDATQP 81
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
L L + P L+ + + + +P + F L L L+ N L
Sbjct: 82 GRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPL 139
Query: 216 NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKC---------QQLRTLLLFSNMLND 266
++P+ + L L + + +P L L++L L +
Sbjct: 140 R-ALPASIAS-LNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRS 197
Query: 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSV 326
+P + L+ L+ L + + L+ L + + +L L L
Sbjct: 198 -LPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRG----------------- 238
Query: 327 GQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNV 386
+ + + P + L+ + + LP LE L+L V
Sbjct: 239 ----------CTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCV 288
Query: 387 LRGDLIGVFDRCKKLHFIDLSSNELS 412
L + + I + + +
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-30
Identities = 44/208 (21%), Positives = 74/208 (35%), Gaps = 13/208 (6%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEF------ 151
+L + + L L+L N P I SL +L L + LP
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 152 ---VGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208
GL NL+ L L + I +P S+ N ++L+ L + + + + + KL L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEEL 234
Query: 209 FLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268
L + P G L+ L L S + +P + + QL L L + +
Sbjct: 235 DLRGCTALRNYPPIFGG-RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 269 PRELGWLRKLEVLDVSRNRLNGLIPTEL 296
P + L ++ V + L
Sbjct: 294 PSLIAQLPANCIILVPPHLQAQLDQHRP 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 32/161 (19%), Positives = 55/161 (34%), Gaps = 10/161 (6%)
Query: 548 NLSNNNIIGHIPLDIGVM--------CKSLRVLDASHNQISGIVPQSLENLTSLVFLDLN 599
++ + +P + +L+ L I + P S+ NL +L L +
Sbjct: 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSL-PASIANLQNLKSLKIR 214
Query: 600 GNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV 659
+ L + ++H L L L L P G L+ L L S +P +
Sbjct: 215 NSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDI 273
Query: 660 VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L L L LPS +A + + I + +
Sbjct: 274 HRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 7e-28
Identities = 53/324 (16%), Positives = 94/324 (29%), Gaps = 54/324 (16%)
Query: 130 LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189
E L +G+ + + + + N + ++ G
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWH----SAWRQANSNNPQIETRTGR 66
Query: 190 QVKGVIPGFLG--SFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSS 247
+K L + L L L P + + +L+H+ + L+ +P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFR-LSHLQHMTIDAAGLM-ELPDT 122
Query: 248 LGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLV- 306
+ + L TL L N L +P + L +L L + +P L +
Sbjct: 123 MQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
Query: 307 LSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG- 365
L NL L IR S+P I L L+ L +
Sbjct: 182 LVNLQSLRLEWTGIR--------------------SLPASIANLQNLKS-----LKIRNS 216
Query: 366 ---KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSS-NELS------GEL 415
L + LE L+L + +F L + L + L L
Sbjct: 217 PLSALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRL 276
Query: 416 DVKLQVPCMALFDVSGNHMSGSIP 439
+L+ D+ G +P
Sbjct: 277 -TQLEK-----LDLRGCVNLSRLP 294
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 33/166 (19%), Positives = 64/166 (38%), Gaps = 15/166 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L + + P + L+ + + + P +++ L L L N L+ +
Sbjct: 87 ELRSVPLP-QFPDQAFRL-SHLQHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPLR-AL 142
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIG---------ELRSLEVLELSSNSLSGEVPEG 658
P+S+ L LR LS+ +P + L +L+ L L + +P
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS 201
Query: 659 VVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
+ NL+NL +L + N+ LS L + ++ L + +P
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP 246
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 34/163 (20%), Positives = 60/163 (36%), Gaps = 14/163 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMC-KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGE 606
+ + L+ + P L+ L + ++ L E
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLM-E 118
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPE--------- 657
+P ++ + L L+LA N L +P+SI L L L + + E+PE
Sbjct: 119 LPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASG 177
Query: 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L NL +L L+ + LP+ +AN+ +L + LS
Sbjct: 178 EHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 36/175 (20%), Positives = 62/175 (35%), Gaps = 10/175 (5%)
Query: 521 LAGANKLTGSFPGSL--FQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDA 574
+ +LT P L A E G+V L I +P I + ++L+ L
Sbjct: 157 IRACPELT-ELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANL-QNLKSLKI 213
Query: 575 SHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSS 634
++ +S + ++ +L L LDL G P L+ L L D + +P
Sbjct: 214 RNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLD 272
Query: 635 IGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSL 689
I L LE L+L +P + L +L+ + + +
Sbjct: 273 IHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 39/182 (21%), Positives = 70/182 (38%), Gaps = 12/182 (6%)
Query: 103 VGGLSELRVL---------SLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVG 153
+ L+ LR L LP S + E L L+ L +E + LP
Sbjct: 146 IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN 204
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
L+NL+ L + + + + ++ + LE L+L G P G L+ L L
Sbjct: 205 LQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 214 ELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELG 273
++P ++ + LE LDL G + R+PS + + +L+ ++ +
Sbjct: 264 SNLLTLPLDIHR-LTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPV 322
Query: 274 WL 275
Sbjct: 323 AR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 9e-20
Identities = 26/173 (15%), Positives = 48/173 (27%), Gaps = 11/173 (6%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+ + + + D + N + G L+
Sbjct: 18 YFQGSTALRPYHDVLSQW-QRHYNADRNRWHS----AWRQANSNNPQIETRTGRALK-AT 71
Query: 608 PSSLHRLKY--LRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
L L L L P L L+ + + + L E+P+ + L
Sbjct: 72 ADLLEDATQPGRVALELRSVPLPQ-FPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGL 129
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGN 718
L L N L LP+ +A++ L + P + + + SG
Sbjct: 130 ETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 18/138 (13%), Positives = 34/138 (24%), Gaps = 23/138 (16%)
Query: 584 PQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLR-----------------HLSLADNN 626
+ + L G+ L + + + +
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRT 64
Query: 627 LTG--GIPSSIGELRS--LEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSG 682
+ + LEL S L + P+ L +L + +D L LP
Sbjct: 65 GRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDT 122
Query: 683 LANVTSLSIFNASFNNLS 700
+ L + N L
Sbjct: 123 MQQFAGLETLTLARNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 8e-10
Identities = 27/196 (13%), Positives = 53/196 (27%), Gaps = 45/196 (22%)
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
+ E+L G++ + L + Q+ ++ +
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65
Query: 286 NRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM 345
L L + + + L L + P
Sbjct: 66 RALKAT-ADLLEDATQPGRVALE------LRSVPLP--------------------QFPD 98
Query: 346 EITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRG--DLIGVFDRCK 399
+ LS L+ + ++ +LP + LE L LA+N LR I
Sbjct: 99 QAFRLSHLQ-----HMTIDAAGLMELPDTMQQFAGLETLTLARNPLRALPASIA---SLN 150
Query: 400 KLHFIDLSSNELSGEL 415
+L + + + EL
Sbjct: 151 RLRELSIRACPELTEL 166
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 3e-35
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG P G VAVK L + + EI+ L N+ H N+V
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 884 IG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G GN + LI +LP G+L+ ++ ++ ++ K K A+ + + YL +
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKGMDYLGSR-- 145
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTC 999
+ +HRD+ N+L++ + + DFGL++ + T + + T + APE +
Sbjct: 146 -QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS 204
Query: 1000 RVSDKADVYSYGVVLLELIS 1019
+ +DV+S+GV L EL++
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 26/289 (8%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG+ P G +VAVKKL +H ++ F EI+ L +++H N+V
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEILKSLQHDNIVKY 76
Query: 884 IG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G Y A + LI YLP G+L ++++ R +D L + + + YL +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTK-- 133
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTC 999
R +HRD+ NIL++++ + DFGL+++L + G + APE
Sbjct: 134 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES 192
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059
+ S +DV+S+GVVL EL + + + M+ V + EL
Sbjct: 193 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-----VFHLI--ELL 245
Query: 1060 ASG-----PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
+ P +++ + C ++ RP+ + + + QI+ +
Sbjct: 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 4e-35
Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 8/195 (4%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G FG + + + LVAVK +F E + L HPN+V LIG
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++++ + GG+ F++ + K L ++ D A+ + YL + +HR
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHR 237
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSDKA 1005
D+ N L+ + +SDFG+SR A+ G APE R S ++
Sbjct: 238 DLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG-LRQVPVKWTAPEALNYGRYSSES 296
Query: 1006 DVYSYGVVLLELISD 1020
DV+S+G++L E S
Sbjct: 297 DVWSFGILLWETFSL 311
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G FG + + VA+K L G + F E + + +RH LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
S ++++ Y+ G+L +F+K T + + L +A +AS +AY+ +H
Sbjct: 248 -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 303
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKAD 1006
RD++ +NIL+ ++ ++DFGL+RL+ +E A G + APE AL R + K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 1007 VYSYGVVLLELIS 1019
V+S+G++L EL +
Sbjct: 364 VWSFGILLTELTT 376
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-34
Identities = 53/198 (26%), Positives = 87/198 (43%), Gaps = 18/198 (9%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG---VQQFHAEIKTLGNVRHPNLVTLI 884
+G GG G Y+AE +VA+K ++ + E +T G ++ P++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALAYLHDQC 940
+ ++++ + G +L ++ + RAV I + SAL H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVA------IVRQIGSALDAAHAA- 153
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
HRDVKP NIL+ D AYL DFG++ + GT Y+APE
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 1001 VSDKADVYSYGVVLLELI 1018
+ +AD+Y+ VL E +
Sbjct: 212 ATYRADIYALTCVLYECL 229
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-34
Identities = 63/298 (21%), Positives = 105/298 (35%), Gaps = 50/298 (16%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY- 886
+G GGF E + G A+K++ Q ++ E HPN++ L+ Y
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 887 ---RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWK---ILHKIALDVASALAYLHDQC 940
R + +E +L+ + G L N I+ + IL + L + L +H
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL-WLLLGICRGLEAIHA-- 152
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA--------GTFGYVA 992
HRD+KP+NILL D+ L D G + + T Y A
Sbjct: 153 -KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 993 PE------YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046
PE + C + ++ DV+S G VL ++ + D F +
Sbjct: 212 PELFSVQSH---CVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV-------- 260
Query: 1047 QGQVKDVFNAELWASGPH--DDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102
Q Q+ P L +L+ RP + ++ L+ +Q
Sbjct: 261 QNQLS-------IPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQPPA 308
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-34
Identities = 54/194 (27%), Positives = 99/194 (51%), Gaps = 6/194 (3%)
Query: 827 NCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
+ +G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
++I ++ GNL ++++ + V +L +A ++SA+ YL + +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFI 340
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
HR++ N L+ ++ ++DFGLSRL+ A G + APE + S K+
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 1006 DVYSYGVVLLELIS 1019
DV+++GV+L E+ +
Sbjct: 401 DVWAFGVLLWEIAT 414
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-34
Identities = 71/287 (24%), Positives = 127/287 (44%), Gaps = 26/287 (9%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG+ P G +VAVKKL +H ++ F EI+ L +++H N+V
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH-LRDFEREIEILKSLQHDNIVKY 107
Query: 884 IG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G Y A + LI YLP G+L ++++ R +D L + + + YL +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGMEYLGTK-- 164
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTC 999
R +HRD+ NIL++++ + DFGL+++L + + G + APE
Sbjct: 165 -RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES 223
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059
+ S +DV+S+GVVL EL + + + M+ V + EL
Sbjct: 224 KFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI-----VFHLI--ELL 276
Query: 1060 ASG-----PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
+ P +++ + C ++ RP+ + + + QI+
Sbjct: 277 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ 323
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-34
Identities = 59/337 (17%), Positives = 115/337 (34%), Gaps = 40/337 (11%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
++L +L+L N ++ SL L LD+ N++ E + ++ L+ A
Sbjct: 55 APFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAA 107
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N I + S + + + LA N++ + G +++ L L NE++ +EL
Sbjct: 108 NNNI-SRVSCS--RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAEL 164
Query: 224 GKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDV 283
LEHL+L N + + + +L+TL L SN L + E + + +
Sbjct: 165 AASSDTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISL 221
Query: 284 SRNRLNGLIPTELGNCVELSVLVLSN----------LFDPLLSGRNIRGELSVGQSDASN 333
N+L I L L L F + + + +V + N
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ-TVKKLTGQN 279
Query: 334 GEKNSFIGSIPMEITTLSKLRIIWAPRL---------------NLEGKLPSSWGACESLE 378
E+ + L +A RL + +L
Sbjct: 280 EEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQR 339
Query: 379 MLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGEL 415
++ + R + V R + ++ L ++
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQV 376
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 1e-32
Identities = 74/547 (13%), Positives = 159/547 (29%), Gaps = 74/547 (13%)
Query: 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188
+ + ++ V + L L + N++ L+L+ N + L F LE+LNL+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL 248
N + + L S LR L L+ N + + +E L + N++ R+ S
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNI-SRVSCSR 118
Query: 249 GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL-IPTELGNCVELSVLVL 307
G Q + + L +N + + + G +++ LD+ N ++ + + L L L
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 308 SNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG-- 365
N I + ++ +KL+ L+L
Sbjct: 177 QY---------------------------NF-IYDVKGQV-VFAKLK-----TLDLSSNK 202
Query: 366 --KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423
+ + + + ++L N L + + L DL N
Sbjct: 203 LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKN 261
Query: 424 MALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVS 483
+ V+ + + + C P+ + L
Sbjct: 262 QRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPA----PFADRLIALKRKEHA- 316
Query: 484 AARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFH 543
+ T + R R + + +
Sbjct: 317 -------LLSGQGSETERLECERENQARQRE----IDALK-EQYR-TVIDQVTLRKQAKI 363
Query: 544 GMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKL 603
+ + + L + QI + + E + L L +
Sbjct: 364 --TLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIE--LQHATEEQSPLQLLRAIVKRY 419
Query: 604 -QGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNL 662
+ + + +R + + T + + +L+ S + + E VV
Sbjct: 420 EEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELVVRE 479
Query: 663 RNLTALL 669
+NL + L
Sbjct: 480 QNLASQL 486
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 51/331 (15%), Positives = 119/331 (35%), Gaps = 53/331 (16%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLR 158
+ + + ++ + + S ++ LD+ GN LS + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218
+LNL+ N + + + +L L+L N V+ ++ G + L + N ++
Sbjct: 62 LLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQELLVGP-----SIETLHAANNNIS-R 113
Query: 219 IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL-GWLRK 277
+ G + +++ L+ N + G +++ L L N ++ V EL
Sbjct: 114 VSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
LE L++ N + + ++ +L L LS+ N
Sbjct: 171 LEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSS---------------------------N 201
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGD-LI 392
+ + E + + + ++L + + ++LE +L N L
Sbjct: 202 K-LAFMGPEFQSAAGVT-----WISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 393 GVFDRCKKLHFIDLSSN-ELSGELDVKLQVP 422
F + +++ + + +L+G+ + + VP
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-28
Identities = 54/345 (15%), Positives = 99/345 (28%), Gaps = 43/345 (12%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
LS LR L L N E+ +E L N +S R+ + + + LA
Sbjct: 77 ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSR--GQGKKNIYLA 128
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSE 222
N+I ++ L+L N++ V S L L L YN + + +
Sbjct: 129 NNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ 187
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
+ L+ LDLS N L + + + L +N L I + L + + LE D
Sbjct: 188 V--VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFD 243
Query: 283 VSRNRLNGLIPTELG----NCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNS 338
+ N + + ++ + L + G +
Sbjct: 244 LRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPF 303
Query: 339 F--------------------IGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLE 378
+ E ++ R I A + + ++
Sbjct: 304 ADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKI 363
Query: 379 MLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423
L + L + +L ++LQ
Sbjct: 364 TLEQKKKALDEQVSNGRRA-----HAELDGTLQQAVGQIELQHAT 403
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 31/153 (20%), Positives = 60/153 (39%), Gaps = 11/153 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
++++++ + +++ LD S N +S I L T L L+L+ N L
Sbjct: 16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L L LR L L +N + + S+E L ++N++S V +
Sbjct: 73 TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKN 124
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
+ L NNK++ + + + N +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-19
Identities = 25/140 (17%), Positives = 56/140 (40%), Gaps = 10/140 (7%)
Query: 561 DIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHL 620
+I ++ + + + + ++ ++ LDL+GN L + L L L
Sbjct: 4 EIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELL 63
Query: 621 SLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLP 680
+L+ N L + L +L L+L++N + E+ ++ L NN +S
Sbjct: 64 NLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSC 116
Query: 681 SGLANVTSLSIFNASFNNLS 700
S ++ + + N ++
Sbjct: 117 SRGQGKKNIYL---ANNKIT 133
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 2e-18
Identities = 35/245 (14%), Positives = 73/245 (29%), Gaps = 36/245 (14%)
Query: 102 LVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLN 161
L L L+L +N + ++ KL+ LD+ N L+ + EF + ++
Sbjct: 164 LAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWIS 220
Query: 162 LAFNRIDGDIPFSLRNFESLEVLNLAGNQVK-GVIPGFLGSFLKLRVLFLSYNELNGSIP 220
L N++ I +LR ++LE +L GN G + F +++ + + +
Sbjct: 221 LRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLT 276
Query: 221 SELGKYCRYLEHLDLSGNSL----------------------------VGRIPSSLGKCQ 252
+ + C R+
Sbjct: 277 GQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQA 336
Query: 253 QLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFD 312
+ R + VI + + L+ + L+ + EL + +
Sbjct: 337 RQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQ 396
Query: 313 PLLSG 317
L
Sbjct: 397 IELQH 401
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 9e-18
Identities = 25/153 (16%), Positives = 49/153 (32%), Gaps = 5/153 (3%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L N I ++ +L L+ +N I + + L LDL+ NKL +
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV--KGQVVFAKLKTLDLSSNKLA-FM 206
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ +SL +N L I ++ ++LE +L N +N
Sbjct: 207 GPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRV 264
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
+ + T ++ +
Sbjct: 265 QTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 6e-11
Identities = 17/181 (9%), Positives = 41/181 (22%), Gaps = 32/181 (17%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+LS+N + + + + + +N++ I ++L +L DL GN
Sbjct: 197 DLSSNKLA-FMGPEFQ-SAAGVTWISLRNNKLVLI-EKALRFSQNLEHFDLRGNGFHCGT 253
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS--------------- 652
K R ++A + + E + +
Sbjct: 254 LRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR 312
Query: 653 -------------GEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNL 699
+ N + + + + L
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKAL 372
Query: 700 S 700
Sbjct: 373 D 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-10
Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLT 666
I + + D++L + S +++ L+LS N LS + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 667 ALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +N L L ++++L + + N +
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 18/147 (12%), Positives = 36/147 (24%), Gaps = 6/147 (4%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L N D K+ RV + + + Q+ E T +
Sbjct: 243 DLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300
Query: 608 PSSLHRLKYLRHLSLA----DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLR 663
RL L+ A + T + ++ + + + +
Sbjct: 301 APFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 664 NLTALLLDNNKLSGHLPSGLANVTSLS 690
L L + +G L
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELD 387
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 4e-06
Identities = 17/75 (22%), Positives = 28/75 (37%)
Query: 630 GIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSL 689
I ++ +++ +SL + + N+ L L N LS + LA T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 690 SIFNASFNNLSGPFP 704
+ N S N L
Sbjct: 61 ELLNLSSNVLYETLD 75
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 9e-04
Identities = 12/135 (8%), Positives = 31/135 (22%), Gaps = 2/135 (1%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
E +LS + E + + +D + + + L
Sbjct: 312 RKEHALLSGQGSETE-RLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
+D + R L+ + + L++L +
Sbjct: 371 ALDEQVSNGRRAHAELDGTLQQAVG-QIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSV 429
Query: 226 YCRYLEHLDLSGNSL 240
+ D+ +
Sbjct: 430 QNNAIRDWDMYQHKE 444
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 66/325 (20%), Positives = 114/325 (35%), Gaps = 48/325 (14%)
Query: 89 LHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLP 148
L G+ V + + L+ L L+L N + + +L KL L + N ++
Sbjct: 49 LVVAGEKVASIQGI-EYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--I 103
Query: 149 NEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208
+ L NLR L L + I P + N + LNL N + L + L L
Sbjct: 104 SALQNLTNLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLSDLSP-LSNMTGLNYL 160
Query: 209 FLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268
++ +++ P + L L L+ N + S L L + N + D+
Sbjct: 161 TVTESKVKDVTP--IAN-LTDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQITDIT 215
Query: 269 PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQ 328
P + + +L L + N++ L P L N +L+ L +
Sbjct: 216 P--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGT------------------- 252
Query: 329 SDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLR 388
N I I + L+KL+++ + S L L L N L
Sbjct: 253 ----NQ-----ISDIN-AVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG 300
Query: 389 GDLIGVFDRCKKLHFIDLSSNELSG 413
+ + V L + LS N ++
Sbjct: 301 NEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 59/313 (18%), Positives = 116/313 (37%), Gaps = 38/313 (12%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
G + L L P N L + ++ ++ + L ++ L +A
Sbjct: 1 GAATLATLPAPINQIF-----PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAG 53
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG 224
++ I + +LE LNL GNQ+ + P L + +KL L++ N++ + S L
Sbjct: 54 EKVA-SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQ 107
Query: 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
L L L+ +++ S L ++ +L L +N + L + L L V+
Sbjct: 108 N-LTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLS-PLSNMTGLNYLTVT 163
Query: 285 RNRLNGLIPTELGNCVELSVLVLSN----LFDPLLSGRNIRGELSVGQSDASNGEKNSFI 340
+++ + P + N +L L L+ PL S ++ + N
Sbjct: 164 ESKVKDVTP--IANLTDLYSLSLNYNQIEDISPLASLTSLH-YFTAY--------VNQIT 212
Query: 341 GSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKK 400
P + +++L + + S L L + N + I K
Sbjct: 213 DITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQISD--INAVKDLTK 266
Query: 401 LHFIDLSSNELSG 413
L +++ SN++S
Sbjct: 267 LKMLNVGSNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 45/216 (20%), Positives = 86/216 (39%), Gaps = 16/216 (7%)
Query: 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVG 153
+ LSPL ++ L L++ + I +L L L + N + +
Sbjct: 143 HNLSDLSPL-SNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIED--ISPLAS 197
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
L +L N+I P + N L L + N++ + P L + +L L + N
Sbjct: 198 LTSLHYFTAYVNQITDITPVA--NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTN 253
Query: 214 ELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELG 273
+++ + + L+ L++ N + S L QL +L L +N L + +G
Sbjct: 254 QISD--INAVKD-LTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 274 WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L L L +S+N + + P L + ++ +N
Sbjct: 309 GLTNLTTLFLSQNHITDIRP--LASLSKMDSADFAN 342
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-26
Identities = 36/153 (23%), Positives = 68/153 (44%), Gaps = 11/153 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N I P+ L L +N+I+ + P L NL+ L +L++ N++
Sbjct: 205 TAYVNQITDITPVA---NMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-- 257
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+++ L L+ L++ N ++ S + L L L L++N L E E + L NLT
Sbjct: 258 INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT 315
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L N ++ LA+++ + + + +
Sbjct: 316 LFLSQNHITD--IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 8e-25
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L+ N I PL SL A NQI+ I P + N+T L L + NK+
Sbjct: 183 SLNYNQIEDISPLA---SLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-- 235
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
S L L L L + N ++ +++ +L L++L + SN +S + NL L +
Sbjct: 236 LSPLANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNS 291
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
L L+NN+L + +T+L+ S N+++
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 37/154 (24%), Positives = 72/154 (46%), Gaps = 12/154 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L ++ + + +S+ L + +++ I Q +E LT+L +L+LNGN++
Sbjct: 28 VLQKASVTDVVTQE---ELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDIS 82
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P L L L +L + N +T S++ L +L L L+ +++S + NL + +
Sbjct: 83 P--LSNLVKLTNLYIGTNKIT--DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYS 136
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
L L N S L+N+T L+ + + +
Sbjct: 137 LNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKD 169
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-24
Identities = 36/155 (23%), Positives = 70/155 (45%), Gaps = 12/155 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NL N+ + + + M L L + +++ + P + NLT L L LN N+++
Sbjct: 138 NLGANHNLSDLS-PLSNM-TGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDIS 193
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P L L L + + N +T + + + L L++ +N ++ + NL LT
Sbjct: 194 P--LASLTSLHYFTAYVNQITD--ITPVANMTRLNSLKIGNNKITD--LSPLANLSQLTW 247
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
L + N++S + + ++T L + N N +S
Sbjct: 248 LEIGTNQISD--INAVKDLTKLKMLNVGSNQISDI 280
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 3e-23
Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 12/154 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NL+ N I PL L L N+I+ I +L+NLT+L L LN + +
Sbjct: 72 NLNGNQITDISPLS---NLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISD-- 124
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
S L L + L+L N+ S + + L L ++ + + + NL +L +
Sbjct: 125 ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKD--VTPIANLTDLYS 181
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
L L+ N++ S LA++TSL F A N ++
Sbjct: 182 LSLNYNQIED--ISPLASLTSLHYFTAYVNQITD 213
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 39/155 (25%), Positives = 63/155 (40%), Gaps = 12/155 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L+ +NI PL + L+ N L N+T L +L + +K++
Sbjct: 116 YLNEDNISDISPLA---NLTKMYSLNLGANHNLSD-LSPLSNMTGLNYLTVTESKVKDVT 171
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P + L L LSL N + S + L SL N ++ V N+ L +
Sbjct: 172 P--IANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITD--ITPVANMTRLNS 225
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
L + NNK++ S LAN++ L+ N +S
Sbjct: 226 LKIGNNKITD--LSPLANLSQLTWLEIGTNQISDI 258
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 1e-19
Identities = 34/154 (22%), Positives = 56/154 (36%), Gaps = 13/154 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
I P ++ +V E L S+ L + G K+
Sbjct: 6 ATLPAPINQIFPDA---DLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS-- 58
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L L +L+L N +T S + L L L + +N ++ + NL NL
Sbjct: 59 IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRE 114
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
L L+ + +S S LAN+T + N N+
Sbjct: 115 LYLNEDNISD--ISPLANLTKMYSLNLGANHNLS 146
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 1e-17
Identities = 30/133 (22%), Positives = 52/133 (39%), Gaps = 10/133 (7%)
Query: 569 LRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLT 628
L I+ I P +L + L + + L+ + L +A +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 629 GGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTS 688
I L +LE L L+ N ++ + NL LT L + NK++ S L N+T+
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTN 111
Query: 689 LSIFNASFNNLSG 701
L + +N+S
Sbjct: 112 LRELYLNEDNISD 124
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 30/118 (25%), Positives = 49/118 (41%), Gaps = 7/118 (5%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
LSPL LS+L L + N S + L KL++L+V N +S + L L
Sbjct: 235 DLSPL-ANLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQL 289
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
L L N++ + + +L L L+ N + + P L S K+ + +
Sbjct: 290 NSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 3e-04
Identities = 16/88 (18%), Positives = 34/88 (38%), Gaps = 6/88 (6%)
Query: 617 LRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676
L+ + P +L L S++ V + L ++T L++ K++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 677 GHLPSGLANVTSLSIFNASFNNLSGPFP 704
G+ +T+L N + N ++ P
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP 83
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 4e-34
Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 11/201 (5%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVRH 877
DF +G G FG Y A E ++A+K L + + Q E++ ++RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
PN++ L GY ++LI Y P G + + + + D + ++A+AL+Y H
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV--YRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ RV+HRD+KP N+LL ++DFG S S GT Y+ PE
Sbjct: 127 SK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL--CGTLDYLPPEMIE 180
Query: 998 TCRVSDKADVYSYGVVLLELI 1018
+K D++S GV+ E +
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFL 201
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-34
Identities = 50/193 (25%), Positives = 97/193 (50%), Gaps = 6/193 (3%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G+G FG + A + VAVK + G V+ F AE + ++H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS--VEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+ +++I ++ G+L +F+K+ L + +A +A++ + +H
Sbjct: 252 -VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIH 307
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKAD 1006
RD++ +NIL+ ++DFGL+R++ +E A G + APE + K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367
Query: 1007 VYSYGVVLLELIS 1019
V+S+G++L+E+++
Sbjct: 368 VWSFGILLMEIVT 380
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-34
Identities = 58/193 (30%), Positives = 100/193 (51%), Gaps = 6/193 (3%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G FG + + VA+K L G + F E + + +RH LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLVQLYAV 330
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
S ++++ Y+ G+L +F+K T + + L +A +AS +AY+ +H
Sbjct: 331 -VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVH 386
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKAD 1006
RD++ +NIL+ ++ ++DFGL+RL+ +E A G + APE AL R + K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 1007 VYSYGVVLLELIS 1019
V+S+G++L EL +
Sbjct: 447 VWSFGILLTELTT 459
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 15/200 (7%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG P G +VAVK L + EI L + H +++
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 884 IG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G A + L+ Y+P G+L +++ ++ L A + +AYLH Q
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLP---RHSIGLAQLLLFAQQICEGMAYLHAQ-- 153
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTC 999
+HRD+ N+LLD+D + DFGL++ + + G + APE
Sbjct: 154 -HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY 212
Query: 1000 RVSDKADVYSYGVVLLELIS 1019
+ +DV+S+GV L EL++
Sbjct: 213 KFYYASDVWSFGVTLYELLT 232
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 10/196 (5%)
Query: 829 IGSGGFGTTYKAEISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG+ + I VA+K L G + ++ E + + + +P +V LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ L+ GG L F+ + + + ++ V+ + YL ++ +
Sbjct: 78 V-CQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 132
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTCRVSD 1003
HRD+ N+LL + A +SDFGLS+ LG +++ T AG + + APE + S
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 1004 KADVYSYGVVLLELIS 1019
++DV+SYGV + E +S
Sbjct: 193 RSDVWSYGVTMWEALS 208
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 54/195 (27%), Positives = 98/195 (50%), Gaps = 10/195 (5%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G+G FG + + VAVK L G F AE + ++H LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+ +++I Y+ G+L +F+K + + L +A +A +A++ ++ +H
Sbjct: 77 -VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIH 132
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSDK 1004
RD++ +NIL+ D + ++DFGL+RL+ +E A G F APE + K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG--AKFPIKWTAPEAINYGTFTIK 190
Query: 1005 ADVYSYGVVLLELIS 1019
+DV+S+G++L E+++
Sbjct: 191 SDVWSFGILLTEIVT 205
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 9e-33
Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 14/198 (7%)
Query: 828 CIGSGGFGTTYKA-EISPGILVAVKKLAV-GRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
IG G F T YK + + VA +L + Q+F E + L ++HPN+V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 886 Y----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
+ L+ + G L+ ++K + + K+L + L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQFLHT-RT 149
Query: 942 PRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
P ++HRD+K NI + + + D GL+ L S A V GT ++APE +
Sbjct: 150 PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEM-YEEK 205
Query: 1001 VSDKADVYSYGVVLLELI 1018
+ DVY++G+ +LE+
Sbjct: 206 YDESVDVYAFGMCMLEMA 223
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-32
Identities = 51/203 (25%), Positives = 82/203 (40%), Gaps = 25/203 (12%)
Query: 828 CIGSGGFGTTYKAE--ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
CI GG G Y A G V +K L AE + L V HP++V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 886 Y-----RASGNEMFLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHD 938
+ R +++ Y+ G +L+ + A+ L++ AL+YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIA------YLLEILPALSYLHS 200
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+++ D+KP NI+L ++ L D G + + + GT G+ APE T
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAPEIVRT 251
Query: 999 CRVSDKADVYSYGVVLLELISDK 1021
+ D+Y+ G L L D
Sbjct: 252 -GPTVATDIYTVGRTLAALTLDL 273
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 58/200 (29%), Positives = 94/200 (47%), Gaps = 14/200 (7%)
Query: 829 IGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG+ P G LVAVK+L + F EI+ L + +V
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ-QRDFQREIQILKALHSDFIVKY 89
Query: 884 IG--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
G Y + L+ YLP G L +F++ +R +D L + + + YL +
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGMEYLGSR-- 146
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTC 999
R +HRD+ NIL++ + + ++DFGL++LL + + G + APE
Sbjct: 147 -RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 1000 RVSDKADVYSYGVVLLELIS 1019
S ++DV+S+GVVL EL +
Sbjct: 206 IFSRQSDVWSFGVVLYELFT 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 14/196 (7%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG-----VQQFHAEIKTLGNVRHPNLVT 882
+G GG T Y AE I VA+K + +++F E+ + H N+V+
Sbjct: 19 LGGGGMSTVYLAEDTILNIKVAIKAI---FIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
+I + +L+ Y+ G L +I++ + + + + HD
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM--- 130
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVS 1002
R++HRD+KP NIL+D + + DFG+++ L + T V GT Y +PE A
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 1003 DKADVYSYGVVLLELI 1018
+ D+YS G+VL E++
Sbjct: 191 ECTDIYSIGIVLYEML 206
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 43/225 (19%), Positives = 94/225 (41%), Gaps = 24/225 (10%)
Query: 810 PLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAE 868
L ++S+ ++ IGSGG ++ + A+K + + + + E
Sbjct: 17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNE 76
Query: 869 IKTLGNVRHPNL--VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIA 926
I L ++ + + L Y + ++++ +L +++K + +++D
Sbjct: 77 IAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYW 133
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL--GTSETHATTGV 984
++ A+ +H ++H D+KP+N L+ D L DFG++ + T+ +
Sbjct: 134 KNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-Q 188
Query: 985 AGTFGYVAPE-----------YALTCRVSDKADVYSYGVVLLELI 1018
GT Y+ PE ++S K+DV+S G +L +
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-32
Identities = 51/289 (17%), Positives = 102/289 (35%), Gaps = 51/289 (17%)
Query: 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188
+ + ++ V + L L + N++ L+L+ N + L F LE+LNL+
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL 248
N + + L S LR L L+ N + + +E L + N++ R+ S
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNNYVQ-ELLV-----GPSIETLHAANNNI-SRVSCSR 118
Query: 249 GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL-IPTELGNCVELSVLVL 307
G Q + + L +N + + + G +++ LD+ N ++ + + L L L
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 308 SNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG-- 365
N I + ++ +KL+ L+L
Sbjct: 177 QY---------------------------NF-IYDVKGQV-VFAKLK-----TLDLSSNK 202
Query: 366 --KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
+ + + + ++L N L + + L DL N
Sbjct: 203 LAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 50/331 (15%), Positives = 114/331 (34%), Gaps = 53/331 (16%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLR 158
+ + + ++ + + S ++ LD+ GN LS + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218
+LNL+ N + + L + +L L+L N V+ L + L + N ++
Sbjct: 62 LLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-R 113
Query: 219 IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV-IPRELGWLRK 277
+ G + +++ L+ N + G +++ L L N ++ V
Sbjct: 114 VSCSRG---QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
LE L++ N + + +L L LS+ N
Sbjct: 171 LEHLNLQYNFIYDV--KGQVVFAKLKTLDLSS---------------------------N 201
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGD-LI 392
+ + E + + + ++L + + ++LE +L N L
Sbjct: 202 K-LAFMGPEFQSAAGVT-----WISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 393 GVFDRCKKLHFIDLSSN-ELSGELDVKLQVP 422
F + +++ + + +L+G+ + + VP
Sbjct: 256 DFFSKNQRVQTVAKQTVKKLTGQNEEECTVP 286
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 32/153 (20%), Positives = 61/153 (39%), Gaps = 11/153 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
++++++ + +++ LD S N +S I L T L L+L+ N L E
Sbjct: 16 KVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-ET 73
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L L LR L L +N + + S+E L ++N++S V +
Sbjct: 74 L-DLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCS--RGQGKKN 124
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
+ L NNK++ + + + N +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 31/158 (19%), Positives = 60/158 (37%), Gaps = 8/158 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI-VPQSLENLTSLVFLDLNGNKLQGE 606
L+NN I LD G ++ LD N+I + + + +L L+L N + +
Sbjct: 126 YLANNKITMLRDLDEGCR-SRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLT 666
+ + L+ L L+ N L + + + L +N L + + + +NL
Sbjct: 184 VKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 667 ALLLDNNKLS-GHLPSGLANVTSL-SIFNASFNNLSGP 702
L N G L + + ++ + L+G
Sbjct: 241 HFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQ 278
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 5e-19
Identities = 24/134 (17%), Positives = 54/134 (40%), Gaps = 10/134 (7%)
Query: 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNN 626
++ + + + + ++ ++ LDL+GN L + L L L+L+ N
Sbjct: 10 NRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNV 69
Query: 627 LTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANV 686
L + L +L L+L++N + E+ ++ L NN +S S
Sbjct: 70 LYE--TLDLESLSTLRTLDLNNNYVQ-ELL----VGPSIETLHAANNNISRVSCSRGQGK 122
Query: 687 TSLSIFNASFNNLS 700
++ + + N ++
Sbjct: 123 KNIYL---ANNKIT 133
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 29/113 (25%), Positives = 50/113 (44%), Gaps = 7/113 (6%)
Query: 588 ENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELS 647
+N + + L+ + S ++ L L+ N L+ + + LE+L LS
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 648 SNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
SN L E + + +L L L L+NN + L G S+ +A+ NN+S
Sbjct: 67 SNVLY-ETLD-LESLSTLRTLDLNNNYVQ-ELLVG----PSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 8e-15
Identities = 27/186 (14%), Positives = 67/186 (36%), Gaps = 12/186 (6%)
Query: 104 GGLSELRVLSLPFNGFSG-EFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
G S ++ L L N F S + LE L+++ NF+ + + V L+ L+L
Sbjct: 141 GCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQ-VVFAKLKTLDL 198
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
+ N++ + ++ + ++L N++ +I L L L N + +
Sbjct: 199 SSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRD 256
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
+ ++ + ++ + + TL + + +P ++
Sbjct: 257 FFSKNQRVQTVAKQTVK---KLTGQNEEECTVPTLGHYGAYCCEDLPAPFA----DRLIA 309
Query: 283 VSRNRL 288
+ +
Sbjct: 310 LGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 18/94 (19%), Positives = 36/94 (38%), Gaps = 2/94 (2%)
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLT 666
I + + D++L + S +++ L+LS N LS + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 667 ALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +N L L ++++L + + N +
Sbjct: 62 LLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 3e-06
Identities = 17/75 (22%), Positives = 28/75 (37%)
Query: 630 GIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSL 689
I ++ +++ +SL + + N+ L L N LS + LA T L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 690 SIFNASFNNLSGPFP 704
+ N S N L
Sbjct: 61 ELLNLSSNVLYETLD 75
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 1e-32
Identities = 50/210 (23%), Positives = 86/210 (40%), Gaps = 20/210 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNL 880
F + +G G GT + VAVK++ + E++ L HPN+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP-ECFSFADR---EVQLLRESDEHPNV 80
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
+ ++ L+ +++ + + + + + S LA+LH
Sbjct: 81 IRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPIT-LLQQTTSGLAHLHSL- 137
Query: 941 APRVLHRDVKPSNILL-----DDDFNAYLSDFGLSRLL--GTSETHATTGVAGTFGYVAP 993
++HRD+KP NIL+ A +SDFGL + L G +GV GT G++AP
Sbjct: 138 --NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 994 EY---ALTCRVSDKADVYSYGVVLLELISD 1020
E + D++S G V +IS+
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 53/201 (26%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVRH 877
DF+ +G G FG Y A E ++A+K L + + Q EI+ ++RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
PN++ + Y ++L+ + P G L + + + D + ++A AL Y H
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL--YKELQKHGRFDEQRSATFMEELADALHYCH 131
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
++ +V+HRD+KP N+L+ ++DFG S + T GT Y+ PE
Sbjct: 132 ER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIE 185
Query: 998 TCRVSDKADVYSYGVVLLELI 1018
+K D++ GV+ E +
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFL 206
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 12/197 (6%)
Query: 829 IGSGGFGTTYKAEISPG---ILVAVKKLAVGRFQHGVQQ-FHAEIKTLGNVRHPNLVTLI 884
+GSG FGT K VAVK L ++ AE + + +P +V +I
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 84
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G L+ G L ++ + +R V K + ++ V+ + YL +
Sbjct: 85 GI-CEAESWMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMKYLEES---NF 138
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF--GYVAPEYALTCRVS 1002
+HRD+ N+LL A +SDFGLS+ L E + G + + APE + S
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 1003 DKADVYSYGVVLLELIS 1019
K+DV+S+GV++ E S
Sbjct: 199 SKSDVWSFGVLMWEAFS 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 829 IGSGGFGTTYKAEISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+GSG FGT YK P I VA+K+L ++ E + +V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G + + LI +P G L ++++ + + L + +A + YL D+ R
Sbjct: 83 LGI-CLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPEYALTCRVS 1002
++HRD+ N+L+ + ++DFGL++LLG E ++A E L +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 1003 DKADVYSYGVVLLELIS 1019
++DV+SYGV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 22/208 (10%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVRH 877
DF N +G G F Y+A I G+ VA+K + VQ+ E+K ++H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
P+++ L Y N ++L+ G + ++K R + + H + + + + YLH
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH 129
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVAPE-- 994
+LHRD+ SN+LL + N ++DFGL+ L E H T GT Y++PE
Sbjct: 130 SH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEIA 184
Query: 995 ----YALTCRVSDKADVYSYGVVLLELI 1018
+ ++DV+S G + L+
Sbjct: 185 TRSAH------GLESDVWSLGCMFYTLL 206
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 4e-32
Identities = 78/275 (28%), Positives = 112/275 (40%), Gaps = 28/275 (10%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAV-GRFQHGVQQFHAEIKTLGNV-RHP 878
F + +G G +G +K G L AVK+ R + AE+ + V +HP
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
V L G ++L G +L+ +A + + ++ D ALA+LH
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVW-GYLRDTLLALAHLHS 175
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
Q ++H DVKP+NI L L DFGL LGT+ G Y+APE L
Sbjct: 176 Q---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPE-LLQ 229
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058
ADV+S G+ +LE+ + + P W + RQG + F A L
Sbjct: 230 GSYGTAADVFSLGLTILEVACNMEL--P--------HGGEGWQQL--RQGYLPPEFTAGL 277
Query: 1059 WASGP-HDDLEDMLHL--ALRCTVETLSTRPTMKQ 1090
S L ML LR T E L P ++Q
Sbjct: 278 --SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 41/213 (19%), Positives = 89/213 (41%), Gaps = 24/213 (11%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNL 880
++ IGSGG ++ + A+K + + + + EI L ++ +
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 881 --VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
+ L Y + ++++ +L +++K + +++D ++ A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL--GTSETHATTGVAGTFGYVAPE-- 994
++H D+KP+N L+ D L DFG++ + T+ + GT Y+ PE
Sbjct: 127 H---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGTVNYMPPEAI 181
Query: 995 ---------YALTCRVSDKADVYSYGVVLLELI 1018
++S K+DV+S G +L +
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 214
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-32
Identities = 54/193 (27%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
IGSG FG + VA+K + G + F E + + + HP LV L G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
+ L+ ++ G L ++++ + + L + LDV +AYL + V+HRD
Sbjct: 74 EQAPICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEA---CVIHRD 129
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSDKAD 1006
+ N L+ ++ +SDFG++R + + ++TG F +PE R S K+D
Sbjct: 130 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG--TKFPVKWASPEVFSFSRYSSKSD 187
Query: 1007 VYSYGVVLLELIS 1019
V+S+GV++ E+ S
Sbjct: 188 VWSFGVLMWEVFS 200
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 13/199 (6%)
Query: 829 IGSGGFGT----TYKAEISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + A + VAVK L + F E+ + ++ H NL+
Sbjct: 26 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
L G M ++ P G+L + ++ L + A+ VA + YL +
Sbjct: 86 LYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGYLESK--- 140
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCR 1000
R +HRD+ N+LL + DFGL R L ++ H + APE T
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT 200
Query: 1001 VSDKADVYSYGVVLLELIS 1019
S +D + +GV L E+ +
Sbjct: 201 FSHASDTWMFGVTLWEMFT 219
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 10/199 (5%)
Query: 827 NCIGSGGFGT----TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
IGSG G + + VA+K L G + + F +E +G HPN++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
L G G ++ Y+ G+L+ F++ + L + V + + YL D
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ-FTIMQLVGMLRGVGAGMRYLSDL--- 170
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCR 1000
+HRD+ N+L+D + +SDFGLSR+L A T G APE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 1001 VSDKADVYSYGVVLLELIS 1019
S +DV+S+GVV+ E+++
Sbjct: 231 FSSASDVWSFGVVMWEVLA 249
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 53/196 (27%), Positives = 94/196 (47%), Gaps = 10/196 (5%)
Query: 829 IGSGGFGTTYKAEISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG+ + I VA+K L G + ++ E + + + +P +V LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ L+ GG L F+ + + + ++ V+ + YL ++ +
Sbjct: 404 V-CQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 458
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSD 1003
HR++ N+LL + A +SDFGLS+ LG +++ T AG + APE + S
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 1004 KADVYSYGVVLLELIS 1019
++DV+SYGV + E +S
Sbjct: 519 RSDVWSYGVTMWEALS 534
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 8e-32
Identities = 47/215 (21%), Positives = 81/215 (37%), Gaps = 21/215 (9%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN 879
+ S+ +G G ++ G L A+K F V E + L + H N
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68
Query: 880 LVTLIGY--RASGNEMFLIYNYLPGGNLENFIKAR-TSRAVDWKILHKIALDVASALAYL 936
+V L + LI + P G+L ++ + + + DV + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 937 HDQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
+ ++HR++KP NI+ D L+DFG +R L E + + GT Y+
Sbjct: 129 REN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLH 183
Query: 993 PE-YALTCRVSD-------KADVYSYGVVLLELIS 1019
P+ Y D D++S GV +
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 56/194 (28%), Positives = 98/194 (50%), Gaps = 10/194 (5%)
Query: 829 IGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G +G Y+ + VAVK L + V++F E + ++HPNLV L+G
Sbjct: 21 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++I ++ GNL ++++ + V +L +A ++SA+ YL + +HR
Sbjct: 79 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHR 135
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSDKA 1005
D+ N L+ ++ ++DFGLSRL+ A G F APE + S K+
Sbjct: 136 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG--AKFPIKWTAPESLAYNKFSIKS 193
Query: 1006 DVYSYGVVLLELIS 1019
DV+++GV+L E+ +
Sbjct: 194 DVWAFGVLLWEIAT 207
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 1e-31
Identities = 57/197 (28%), Positives = 86/197 (43%), Gaps = 27/197 (13%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+GSG F + + G L A+K K R EI L ++H N+VTL
Sbjct: 17 LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR----DSSLENEIAVLKKIKHENIVTLE 72
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQC 940
S +L+ + GG L + I R A + V SA+ YLH+
Sbjct: 73 DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL------VIQQVLSAVKYLHEN- 125
Query: 941 APRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
++HRD+KP N+L +++ ++DFGLS++ + + GT GYVAPE
Sbjct: 126 --GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMSTACGTPGYVAPEVLA 180
Query: 998 TCRVSDKADVYSYGVVL 1014
S D +S GV+
Sbjct: 181 QKPYSKAVDCWSIGVIT 197
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 51/193 (26%), Positives = 95/193 (49%), Gaps = 10/193 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+GSG FG + VAVK + G +F E +T+ + HP LV G +
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
++++ Y+ G L N++++ + ++ L ++ DV +A+L + +HRD
Sbjct: 74 KEYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRD 129
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSDKAD 1006
+ N L+D D +SDFG++R + + ++ G F APE + S K+D
Sbjct: 130 LAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG--TKFPVKWSAPEVFHYFKYSSKSD 187
Query: 1007 VYSYGVVLLELIS 1019
V+++G+++ E+ S
Sbjct: 188 VWAFGILMWEVFS 200
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 59/196 (30%), Positives = 95/196 (48%), Gaps = 20/196 (10%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+GSG FG + E S G+ +K + R Q ++Q AEI+ L ++ HPN++ +
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDW------KILHKIALDVASALAYLHDQCA 941
+ M+++ GG L I + +R +++ ++ +ALAY H Q
Sbjct: 90 EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQM----MNALAYFHSQ-- 143
Query: 942 PRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
V+H+D+KP NIL + DFGL+ L + E AGT Y+APE
Sbjct: 144 -HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPE-VFK 199
Query: 999 CRVSDKADVYSYGVVL 1014
V+ K D++S GVV+
Sbjct: 200 RDVTFKCDIWSAGVVM 215
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-31
Identities = 64/316 (20%), Positives = 119/316 (37%), Gaps = 52/316 (16%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
++PL L+ L L+L N + + +L L L++ N +S + GL +L
Sbjct: 104 DITPL-ANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSL 158
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
+ L+ N++ P + N +LE L+++ N+V + L L L + N+++
Sbjct: 159 QQLSFG-NQVTDLKPLA--NLTTLERLDISSNKVSDISV--LAKLTNLESLIATNNQISD 213
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
P L+ L L+GN L +L L L L +N ++++ P L L K
Sbjct: 214 ITPLG---ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGLTK 266
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
L L + N+++ + P L L+ L L+ N
Sbjct: 267 LTELKLGANQISNISP--LAGLTALTNLELNE---------------------------N 297
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDR 397
P I+ L L + N+ S + L+ L N + +
Sbjct: 298 QLEDISP--ISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSD--VSSLAN 351
Query: 398 CKKLHFIDLSSNELSG 413
++++ N++S
Sbjct: 352 LTNINWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 7e-30
Identities = 68/315 (21%), Positives = 108/315 (34%), Gaps = 37/315 (11%)
Query: 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
L ++ L G + L L ++ N L+ L L + +
Sbjct: 42 QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILM 97
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
N+I P + N +L L L NQ+ + P L + L L LS N ++ S
Sbjct: 98 NNNQIADITPLA--NLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD--ISA 151
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
L L+ L L L L + SN ++D+ L L LE L
Sbjct: 152 LSG-LTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLI 205
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSN----LFDPLLSGRNIRGELSVGQSDASNGEKNS 338
+ N+++ + P LG L L L+ L S N+ +L + N
Sbjct: 206 ATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLT-DLDLA--------NNQ 254
Query: 339 FIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRC 398
P ++ L+KL + + S +L L L +N L I
Sbjct: 255 ISNLAP--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED--ISPISNL 308
Query: 399 KKLHFIDLSSNELSG 413
K L ++ L N +S
Sbjct: 309 KNLTYLTLYFNNISD 323
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-26
Identities = 50/212 (23%), Positives = 79/212 (37%), Gaps = 16/212 (7%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
++PL G L+ L LSL N + SL L LD+ N +S L GL L
Sbjct: 213 DITPL-GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN-LAP-LSGLTKL 267
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L L N+I P + +L L L NQ++ + P + + L L L +N ++
Sbjct: 268 TELKLGANQISNISPLA--GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
P L+ L N + SSL + L N ++D+ P L L +
Sbjct: 324 ISPVS---SLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTR 376
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
+ L ++ N + +
Sbjct: 377 ITQLGLNDQAWTNAPVNYKANVSIPNTVKNVT 408
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-25
Identities = 56/290 (19%), Positives = 101/290 (34%), Gaps = 32/290 (11%)
Query: 153 GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSY 212
L L + + + + + + L +K + + L + S
Sbjct: 22 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDG--VEYLNNLTQINFSN 77
Query: 213 NELNGSIP-SELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE 271
N+L P L K L + ++ N + P L L L LF+N + D+ P
Sbjct: 78 NQLTDITPLKNLTK----LVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP-- 129
Query: 272 LGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRG--ELSVGQS 329
L L L L++S N ++ + L L L N L N+ L +
Sbjct: 130 LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTDLKPLANLTTLERLDIS-- 185
Query: 330 DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG 389
N + I + L+ L + A + + G +L+ L+L N L+
Sbjct: 186 ------SNK-VSDIS-VLAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD 235
Query: 390 DLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIP 439
IG L +DL++N++S + + + + N +S P
Sbjct: 236 --IGTLASLTNLTDLDLANNQISNLAPLS-GLTKLTELKLGANQISNISP 282
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-24
Identities = 47/155 (30%), Positives = 69/155 (44%), Gaps = 13/155 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+NN I PL + +L L + NQ+ I L +LT+L LDL N++
Sbjct: 205 IATNNQISDITPLG---ILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLA 259
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P L L L L L N ++ S + L +L LEL+ N L + NL+NLT
Sbjct: 260 P--LSGLTKLTELKLGANQISN--ISPLAGLTALTNLELNENQLED--ISPISNLKNLTY 313
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
L L N +S S ++++T L N +S
Sbjct: 314 LTLYFNNISD--ISPVSSLTKLQRLFFYNNKVSDV 346
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-23
Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 13/151 (8%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
N + PL +L LD S N++S I L LT+L L N++ P
Sbjct: 164 GNQVTDLKPLA---NLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITP-- 216
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLL 670
L L L LSL N L ++ L +L L+L++N +S + L LT L L
Sbjct: 217 LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISN--LAPLSGLTKLTELKL 272
Query: 671 DNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
N++S S LA +T+L+ + N L
Sbjct: 273 GANQISN--ISPLAGLTALTNLELNENQLED 301
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-22
Identities = 51/157 (32%), Positives = 74/157 (47%), Gaps = 13/157 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L+ N + L +L LD ++NQIS + P L LT L L L N++
Sbjct: 227 SLNGNQLKDIGTLA---SLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS 281
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P L L L +L L +N L S I L++L L L N++S V +L L
Sbjct: 282 P--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQR 335
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
L NNK+S S LAN+T+++ +A N +S P
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQISDLTP 370
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-22
Identities = 36/157 (22%), Positives = 64/157 (40%), Gaps = 14/157 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L N+ + + L A I I +E L +L ++ + N+L
Sbjct: 30 VLGKTNVTDTVSQT---DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 84
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P L L L + + +N + + + L +L L L +N ++ + + NL NL
Sbjct: 85 P--LKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNR 138
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
L L +N +S S L+ +TSL + N ++ P
Sbjct: 139 LELSSNTISD--ISALSGLTSLQQLSFG-NQVTDLKP 172
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-21
Identities = 44/154 (28%), Positives = 66/154 (42%), Gaps = 14/154 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L NN I PL +L L+ S N IS I L LTSL L
Sbjct: 118 TLFNNQITDIDPLK---NLTNLNRLELSSNTISDISA--LSGLTSLQQLSFGNQVTD--- 169
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L L L L ++ N ++ S + +L +LE L ++N +S + L NL
Sbjct: 170 LKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD--ITPLGILTNLDE 225
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
L L+ N+L LA++T+L+ + + N +S
Sbjct: 226 LSLNGNQLKD--IGTLASLTNLTDLDLANNQISN 257
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-21
Identities = 31/156 (19%), Positives = 62/156 (39%), Gaps = 12/156 (7%)
Query: 547 ANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGE 606
A ++ + I I D ++ V +L + L + ++
Sbjct: 6 ATITQDTPINQIFTDTA--LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-- 59
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLT 666
+ L L ++ ++N LT + + L L + +++N ++ + NL NLT
Sbjct: 60 SIDGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIAD--ITPLANLTNLT 115
Query: 667 ALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
L L NN+++ L N+T+L+ S N +S
Sbjct: 116 GLTLFNNQITD--IDPLKNLTNLNRLELSSNTISDI 149
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-21
Identities = 38/155 (24%), Positives = 63/155 (40%), Gaps = 11/155 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L N I PL +L L+ + NQ+ I P + NL +L +L L N +
Sbjct: 271 KLGANQISNISPLA---GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDIS 325
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P + L L+ L +N ++ SS+ L ++ L N +S + NL +T
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQISD--LTPLANLTRITQ 379
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
L L++ + + ANV+ + L P
Sbjct: 380 LGLNDQAWTNAPVNYKANVSIPNTVKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-16
Identities = 39/232 (16%), Positives = 87/232 (37%), Gaps = 37/232 (15%)
Query: 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIP-SELGKYCRYLEHLDLSGNSLVGRIPSS 247
+ + + + L + ++ ++L + + L + +
Sbjct: 12 TPINQIFT--DTALAEKMKTVLGKTNVTDTVSQTDLDQ----VTTLQADRLGI--KSIDG 63
Query: 248 LGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL 307
+ L + +N L D+ P L L KL + ++ N++ + P L N L+ L L
Sbjct: 64 VEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTL 119
Query: 308 SN----LFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNL 363
N DPL + N+ L + ++ I I ++ L+ L+ +L+
Sbjct: 120 FNNQITDIDPLKNLTNLN-RLELS---------SNTISDIS-ALSGLTSLQ-----QLSF 163
Query: 364 EGKL--PSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSG 413
++ +LE L+++ N + I V + L + ++N++S
Sbjct: 164 GNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISD 213
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-15
Identities = 24/128 (18%), Positives = 48/128 (37%), Gaps = 10/128 (7%)
Query: 577 NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG 636
I+ I L + L + + L + L + +
Sbjct: 12 TPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVE 65
Query: 637 ELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASF 696
L +L + S+N L+ + NL L +L++NN+++ + LAN+T+L+
Sbjct: 66 YLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIAD--ITPLANLTNLTGLTLFN 121
Query: 697 NNLSGPFP 704
N ++ P
Sbjct: 122 NQITDIDP 129
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-13
Identities = 27/130 (20%), Positives = 42/130 (32%), Gaps = 8/130 (6%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NN + L ++ L A HNQIS + P L NLT + L LN
Sbjct: 337 FFYNNKVSDVSSLAN---LTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAP 391
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ + + L P++I + S +++ N S E
Sbjct: 392 VNYKANVSIPNTVKNVTGALI--APATISDGGSYTEPDITWNLPS-YTNEVSYTFSQPVT 448
Query: 668 LLLDNNKLSG 677
+ SG
Sbjct: 449 IGKGTTTFSG 458
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 50/199 (25%), Positives = 85/199 (42%), Gaps = 17/199 (8%)
Query: 829 IGSGGFGT----TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+G G FG Y I VAVK ++F +E + N+ HP++V LI
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G ++I P G L ++++ + + L +L + A+AYL
Sbjct: 80 GI-IEEEPTWIIMELYPYGELGHYLERNKNS-LKVLTLVLYSLQICKAMAYLESI---NC 134
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG----VAGTFGYVAPEYALTCR 1000
+HRD+ NIL+ L DFGLSR + + + + + +PE R
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM----SPESINFRR 190
Query: 1001 VSDKADVYSYGVVLLELIS 1019
+ +DV+ + V + E++S
Sbjct: 191 FTTASDVWMFAVCMWEILS 209
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-31
Identities = 56/193 (29%), Positives = 93/193 (48%), Gaps = 10/193 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888
+G+G FG + VA+K + G +F E K + N+ H LV L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948
+F+I Y+ G L N+++ R + L ++ DV A+ YL + + LHRD
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESK---QFLHRD 145
Query: 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSDKAD 1006
+ N L++D +SDFGLSR + E ++ G F PE + + S K+D
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG--SKFPVRWSPPEVLMYSKFSSKSD 203
Query: 1007 VYSYGVVLLELIS 1019
++++GV++ E+ S
Sbjct: 204 IWAFGVLMWEIYS 216
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-31
Identities = 47/209 (22%), Positives = 85/209 (40%), Gaps = 25/209 (11%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVR 876
+ +G GGF ++ + + A K K + + H ++ EI ++
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLA 99
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
H ++V G+ + +F++ +L K R +A+ + YL
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYL 157
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVAPE- 994
H RV+HRD+K N+ L++D + DFGL+ + E GT Y+APE
Sbjct: 158 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEV 212
Query: 995 -----YALTCRVSDKADVYSYGVVLLELI 1018
+ S + DV+S G ++ L+
Sbjct: 213 LSKKGH------SFEVDVWSIGCIMYTLL 235
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 9e-31
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 12/194 (6%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
IG G FG + G VAVK + Q F AE + +RH NLV L+G
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA---QAFLAEASVMTQLRHSNLVQLLGV 254
Query: 887 -RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
++++ Y+ G+L +++++R + L K +LDV A+ YL +
Sbjct: 255 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFV 311
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
HRD+ N+L+ +D A +SDFGL++ +++ V T APE + S K+
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTKS 367
Query: 1006 DVYSYGVVLLELIS 1019
DV+S+G++L E+ S
Sbjct: 368 DVWSFGILLWEIYS 381
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 49/209 (23%), Positives = 85/209 (40%), Gaps = 25/209 (11%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVR 876
+ +G GGF ++ + + A K K + + H ++ EI ++
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLK-PHQREKMSMEISIHRSLA 73
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR------TSRAVDWKILHKIALDVA 930
H ++V G+ + +F++ +L K R +R L +I
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR----YYLRQIV---- 125
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFG 989
YLH RV+HRD+K N+ L++D + DFGL+ + E GT
Sbjct: 126 LGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPN 180
Query: 990 YVAPEYALTCRVSDKADVYSYGVVLLELI 1018
Y+APE S + DV+S G ++ L+
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLL 209
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 40/214 (18%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPN 879
++ IGSGG ++ + A+K + + + + EI L ++ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 880 L--VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
+ L Y + ++++ +L +++K + +++D ++ A+ +H
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIH 172
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL--GTSETHATTGVAGTFGYVAPE- 994
++H D+KP+N L+ D L DFG++ + T+ + G Y+ PE
Sbjct: 173 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDS-QVGAVNYMPPEA 227
Query: 995 ----------YALTCRVSDKADVYSYGVVLLELI 1018
++S K+DV+S G +L +
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 261
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-30
Identities = 58/309 (18%), Positives = 100/309 (32%), Gaps = 39/309 (12%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
+ S+ +G G ++ G L A+K F V E + L + H N+
Sbjct: 10 LWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNI 69
Query: 881 VTLIGY--RASGNEMFLIYNYLPGGNLENFIKAR-TSRAVDWKILHKIALDVASALAYLH 937
V L + LI + P G+L ++ + + + DV + +L
Sbjct: 70 VKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 938 DQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+ ++HR++KP NI+ D L+DFG +R L E + + GT Y+ P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHP 184
Query: 994 E-YALTCRVSD-------KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045
+ Y D D++S GV + F ++
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS----LPFRPFEGPRRNKEVMYKII 240
Query: 1046 RQGQVKDVFNAELWASGPHDDLEDM-----LHLALRCTVETL---------STRPTMKQV 1091
+ + +GP D DM L L+ + + Q
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF 300
Query: 1092 VQCLKQIQH 1100
I H
Sbjct: 301 FAETSDILH 309
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-30
Identities = 64/301 (21%), Positives = 116/301 (38%), Gaps = 52/301 (17%)
Query: 823 FNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLG-NVRHPNLV 881
+ +G G GT G VAVK++ + F EIK L + HPN++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI-DFCDIALM---EIKLLTESDDHPNVI 72
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILH-----KIALDVASALAYL 936
+ +++ NL++ ++++ + K+ + +AS +A+L
Sbjct: 73 RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131
Query: 937 HDQCAPRVLHRDVKPSNILLD-------------DDFNAYLSDFGLSRLLG---TSETHA 980
H +++HRD+KP NIL+ ++ +SDFGL + L +S
Sbjct: 132 HSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 981 TTGVAGTFGYVAPE-------YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033
+GT G+ APE R++ D++S G V ++S K P +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK--HPFGDKYSR 246
Query: 1034 GFNIISWASMLLRQGQVKDVFNAELWASGPHDDL-EDMLHLALRCTVETLSTRPTMKQVV 1092
NII + +F+ + L + L + RPT +V+
Sbjct: 247 ESNII------------RGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294
Query: 1093 Q 1093
+
Sbjct: 295 R 295
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 51/199 (25%), Positives = 86/199 (43%), Gaps = 23/199 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+GSG F K + G A K +L+ R ++ E+ L +RHPN++T
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKIALDVASALAYLHDQ 939
L + ++ LI + GG L +F+ + T + + + YLH +
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEA-----TQFLKQILDGVHYLHSK 127
Query: 940 CAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
R+ H D+KP NI+L + L DFG++ + + GT +VAPE
Sbjct: 128 ---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPEI 182
Query: 996 ALTCRVSDKADVYSYGVVL 1014
+ +AD++S GV+
Sbjct: 183 VNYEPLGLEADMWSIGVIT 201
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 1e-30
Identities = 37/322 (11%), Positives = 81/322 (25%), Gaps = 53/322 (16%)
Query: 808 GVPLTYESII-RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG--VQ 863
T +S++ + + G + ++ A+K +G ++
Sbjct: 48 NAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE 107
Query: 864 QFHAEIKTLGNVRHPNLVTLIGY--------------------RASGNEMFLIYNY---- 899
+ H + + + G + + + NY
Sbjct: 108 RLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLM 167
Query: 900 -LPGGNLENFIKA-----RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSN 953
+LE LH + + A L + ++H P N
Sbjct: 168 PAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDN 224
Query: 954 ILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL--TCRVSDKADVYSYG 1011
+ + D L D +GT + Y E+ T + + + G
Sbjct: 225 LFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLG 280
Query: 1012 VVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDML 1071
+ + + L F G L G F + D ++ ++
Sbjct: 281 LSIYRVW----CLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP---DFVKTLI 333
Query: 1072 HLALRCTVETLSTRPTMKQVVQ 1093
L R + ++
Sbjct: 334 GRFLNFDRR---RRLLPLEAME 352
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 829 IGSGGFGTTYKAEISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+GSG FGT YK P I VA+K+L ++ E + +V +P++ L
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G + + LI +P G L ++++ + + L + +A + YL D+ R
Sbjct: 83 LGI-CLTSTVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKGMNYLEDR---R 137
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPEYALTCRVS 1002
++HRD+ N+L+ + ++DFGL++LLG E ++A E L +
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 1003 DKADVYSYGVVLLELIS 1019
++DV+SYGV + EL++
Sbjct: 198 HQSDVWSYGVTVWELMT 214
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 50/197 (25%), Positives = 96/197 (48%), Gaps = 11/197 (5%)
Query: 829 IGSGGFGTTYKAEISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
+GSG FGT +K P I V +K + + Q + +G++ H ++V L
Sbjct: 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+G G+ + L+ YLP G+L + ++ + ++L + +A + YL +
Sbjct: 81 LGL-CPGSSLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKGMYYLEEH---G 135
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPEYALTCRVS 1002
++HR++ N+LL ++DFG++ LL + A T ++A E + +
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 1003 DKADVYSYGVVLLELIS 1019
++DV+SYGV + EL++
Sbjct: 196 HQSDVWSYGVTVWELMT 212
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 11/196 (5%)
Query: 829 IGSGGFGT----TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG G FG Y + +P + VA+K ++F E T+ HP++V LI
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G + N +++I G L +F++ R +D L A +++ALAYL + R
Sbjct: 83 GV-ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLESK---RF 137
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV-SD 1003
+HRD+ N+L+ + L DFGLSR + S + + ++APE ++ R +
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE-SINFRRFTS 196
Query: 1004 KADVYSYGVVLLELIS 1019
+DV+ +GV + E++
Sbjct: 197 ASDVWMFGVCMWEILM 212
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 53/194 (27%), Positives = 90/194 (46%), Gaps = 18/194 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G F + + G+ A K + + Q+ E + ++HPN+V L
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 887 RASGNEMFLIYNYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRV 944
+ +L+++ + GG L I AR S A + +I ++AY H +
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI----LESIAYCHSN---GI 126
Query: 945 LHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+HR++KP N+LL L+DFGL+ + ++ A G AGT GY++PE L
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPE-VLKKDP 183
Query: 1002 SDK-ADVYSYGVVL 1014
K D+++ GV+L
Sbjct: 184 YSKPVDIWACGVIL 197
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-30
Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 19/225 (8%)
Query: 810 PLTYESIIRATGDF---------NTSNCIGSGGFGTTYKAEISPG----ILVAVKKLAVG 856
P T+E + +F + +G+G FG + I VA+K L VG
Sbjct: 25 PHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG 84
Query: 857 RFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRA 916
+ + F E +G HPN++ L G + ++ Y+ G+L++F++ ++
Sbjct: 85 YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ- 143
Query: 917 VDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976
L + +AS + YL D +HRD+ NIL++ + +SDFGL R+L
Sbjct: 144 FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 977 ETHATTGVAGTFGY--VAPEYALTCRVSDKADVYSYGVVLLELIS 1019
A T G +PE + + +DV+SYG+VL E++S
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 57/206 (27%), Positives = 91/206 (44%), Gaps = 28/206 (13%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG-----VQQFHAEIKTLGNVRHPNLVT 882
+G GG + A + VAVK L R +F E + + HP +V
Sbjct: 20 LGFGGMSEVHLARDLRDHRDVAVKVL---RADLARDPSFYLRFRREAQNAAALNHPAIVA 76
Query: 883 L--IG--YRASGNEMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALA 934
+ G +G +++ Y+ G L + + RA++ + D AL
Sbjct: 77 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE------VIADACQALN 130
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT-TG-VAGTFGYVA 992
+ H ++HRDVKP+NI++ + DFG++R + S T T V GT Y++
Sbjct: 131 FSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 993 PEYALTCRVSDKADVYSYGVVLLELI 1018
PE A V ++DVYS G VL E++
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVL 213
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-30
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 32/206 (15%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-------KLAVGRFQHGVQQFHAEIKTLGNVR-HPN 879
IG G + + G AVK +L+ + + + E L V HP+
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAY 935
++TLI S + MFL+++ + G L +++ + + I + A+++
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR------SIMRSLLEAVSF 215
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
LH ++HRD+KP NILLDD+ LSDFG S L + GT GY+APE
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLE--PGEKLRELCGTPGYLAPE- 269
Query: 996 ALTCRVSD-------KADVYSYGVVL 1014
L C + + + D+++ GV+L
Sbjct: 270 ILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 54/195 (27%), Positives = 80/195 (41%), Gaps = 21/195 (10%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G FG K + AVK + E++ L + HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAP 942
+ +++ GG L + I R A I V S + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR------IIKQVFSGITYMHKH--- 140
Query: 943 RVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
++HRD+KP NILL + D + + DFGLS + GT Y+APE L
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE-VLRG 197
Query: 1000 RVSDKADVYSYGVVL 1014
+K DV+S GV+L
Sbjct: 198 TYDEKCDVWSAGVIL 212
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-30
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 21/196 (10%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G F + ++ G A + + Q+ E + ++HPN+V L
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAP 942
+ +LI++ + GG L I AR A + A+ + H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASH------CIQQILEAVLHCHQM--- 129
Query: 943 RVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
V+HR++KP N+LL L+DFGL+ + E A G AGT GY++PE L
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTPGYLSPE-VLRK 187
Query: 1000 RVSDK-ADVYSYGVVL 1014
K D+++ GV+L
Sbjct: 188 DPYGKPVDLWACGVIL 203
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-30
Identities = 91/556 (16%), Positives = 160/556 (28%), Gaps = 131/556 (23%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLR--- 155
++P + L+ + + E P E +++ + P R
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 156 ----------NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKL 205
L L + +P + LE L + N + +P S L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116
Query: 206 RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
V + L+ P LE+L +S N L ++P L L+ + + +N L
Sbjct: 117 LVDNNNLKALSDLPPL--------LEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK 166
Query: 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELS 325
+P LE + N+L L EL N L+ + N
Sbjct: 167 K-LPDLPP---SLEFIAAGNNQLEEL--PELQNLPFLTAIYADN---------------- 204
Query: 326 VGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQN 385
NS + +P +L + N+ +LP L + N
Sbjct: 205 -----------NS-LKKLPDLPLSLESIVA----GNNILEELP-ELQNLPFLTTIYADNN 247
Query: 386 VLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNV 445
+L+ + D L +++ N L+ D+ + DVS N S + N+
Sbjct: 248 LLK----TLPDLPPSLEALNVRDNYLT---DLPELPQSLTFLDVSENIFS-GLSELPPNL 299
Query: 446 CHQMPLQSSDLCQGYDPSF-TYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICW 504
+ L +S ++ N S N
Sbjct: 300 YY---LNASSNEIRSLCDLPPSLEEL---------------------NVSNNKLIE---- 331
Query: 505 LPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQ------ACNEFH------GMVANLSNN 552
LP P RL R +A N L P N V +L N
Sbjct: 332 LPALPPRLER-----LIASFNHLA-EVPELPQNLKQLHVEYNPLREFPDIPESVEDLRMN 385
Query: 553 NIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLH 612
+ + +P +L+ L N + P E++ L +N ++ +
Sbjct: 386 SHLAEVPELPQ----NLKQLHVETNPLREF-PDIPESVED---LRMNSERVVDPYEFAHE 437
Query: 613 RLKYLRHLSLADNNLT 628
L ++
Sbjct: 438 TTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 63/315 (20%), Positives = 103/315 (32%), Gaps = 69/315 (21%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
L L L ++ N E PE+ +L L + + N L +LP+ +L
Sbjct: 164 SLKKLPDLPPSLEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDL---PLSL 217
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
+ N ++ ++P L+N L + N +K +P S L L + N L
Sbjct: 218 ESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT- 270
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
+P L LD+S N + L L SN + +
Sbjct: 271 DLPELPQS----LTFLDVSENIF-SGLSELPP---NLYYLNASSNEIRS-LCDLPP---S 318
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
LE L+VS N+L L P L L+ S N
Sbjct: 319 LEELNVSNNKLIEL-PALPPR---LERLIASF---------------------------N 347
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDR 397
+ +P L +L + + N + P + E L M + L V +
Sbjct: 348 H-LAEVPELPQNLKQLHVEY----NPLREFPDIPESVEDLRMNSH--------LAEVPEL 394
Query: 398 CKKLHFIDLSSNELS 412
+ L + + +N L
Sbjct: 395 PQNLKQLHVETNPLR 409
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 54/288 (18%), Positives = 97/288 (33%), Gaps = 43/288 (14%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
L L L + N PE+ +L L + + N L LP+ +L
Sbjct: 206 SLKKLPDLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDL---PPSL 259
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
LN+ N + D+P ++ L+V + + + L L S NE+
Sbjct: 260 EALNVRDNYLT-DLPELPQSLTFLDVSENIFSG----LSELPPN---LYYLNASSNEIR- 310
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
S+ LE L++S N L+ +P+ + L L+ N L + +P
Sbjct: 311 SLCDLPPS----LEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ---N 358
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
L+ L V N L P + +L + L N++ +L V
Sbjct: 359 LKQLHVEYNPLREF-PDIPESVEDLRMNSHLAEVPELPQ--NLK-QLHVE---------T 405
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQN 385
+ + P ++ LR+ + + + LE +
Sbjct: 406 NPLREFPDIPESVEDLRMN---SERVVDPYEFAHETTDKLEDDVFEHH 450
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-17
Identities = 34/181 (18%), Positives = 62/181 (34%), Gaps = 37/181 (20%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENL-------------TSLV 594
L +++ + +P++ KS + ++ P
Sbjct: 16 PLRHSSNLTEMPVEAE-NVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAH 74
Query: 595 FLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSG- 653
L+LN L +P +L L + N+LT +P L+SL V + +LS
Sbjct: 75 ELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDL 129
Query: 654 ---------------EVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNN 698
++PE + N L + +DNN L LP ++ ++ N
Sbjct: 130 PPLLEYLGVSNNQLEKLPE-LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEE 187
Query: 699 L 699
L
Sbjct: 188 L 188
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 1e-16
Identities = 38/153 (24%), Positives = 60/153 (39%), Gaps = 23/153 (15%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NN++ +P SL + A +N + L+NL L + + N L+ +
Sbjct: 201 YADNNSLK-KLPDLPL----SLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TL 252
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P L+ L++ DN LT +P L L+V E + LS P NL
Sbjct: 253 PDLPPSLE---ALNVRDNYLTD-LPELPQSLTFLDVSENIFSGLSELPP-------NLYY 301
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L +N++ L ++ L N S N L
Sbjct: 302 LNASSNEIR-SLCDLPPSLEEL---NVSNNKLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-15
Identities = 29/168 (17%), Positives = 59/168 (35%), Gaps = 22/168 (13%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
++ L L L++ N E P +LE L N L+ +P +NL
Sbjct: 308 EIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPEL---PQNL 359
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
+ L++ +N + + P + E L + + +P + L+ L + N L
Sbjct: 360 KQLHVEYNPLR-EFPDIPESVEDLRMNSHLAE-----VPELPQN---LKQLHVETNPLR- 409
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
P +E L ++ +V + +L + + +
Sbjct: 410 EFPDIPES----VEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-14
Identities = 31/139 (22%), Positives = 50/139 (35%), Gaps = 20/139 (14%)
Query: 589 NLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELR--------- 639
+ T L + + L E+P +K A + P GE R
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 640 ----SLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNAS 695
LEL++ LS +PE +L +L+ N L+ LP ++ SL + N +
Sbjct: 68 CLDRQAHELELNNLGLS-SLPE---LPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNN 122
Query: 696 FNNLSGPFPWNVTTMNCSG 714
LS P + + S
Sbjct: 123 LKALSD-LPPLLEYLGVSN 140
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-14
Identities = 31/153 (20%), Positives = 59/153 (38%), Gaps = 22/153 (14%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N+SNN +I +P L L AS N ++ + P+ +NL L + N L+ E
Sbjct: 323 NVSNNKLI-ELPALPP----RLERLIASFNHLAEV-PELPQNLKQL---HVEYNPLR-EF 372
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P ++ LR N+ +P +L+ L + +N L E P+ ++
Sbjct: 373 PDIPESVEDLRM-----NSHLAEVPELPQ---NLKQLHVETNPLR-EFPD---IPESVED 420
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L +++ ++ L ++
Sbjct: 421 LRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-30
Identities = 57/197 (28%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
DF + +G+G G +K P G+++A K + + Q E++ L P +
Sbjct: 34 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 93
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G S E+ + ++ GG+L+ +K + + +IL K+++ V L YL ++
Sbjct: 94 VGFYGAFYSDGEISICMEHMDGGSLDQVLK--KAGRIPEQILGKVSIAVIKGLTYLREKH 151
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+++HRDVKPSNIL++ L DFG+S L ++ A + GT Y++PE
Sbjct: 152 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANS-FVGTRSYMSPERLQGTH 206
Query: 1001 VSDKADVYSYGVVLLEL 1017
S ++D++S G+ L+E+
Sbjct: 207 YSVQSDIWSMGLSLVEM 223
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-30
Identities = 47/193 (24%), Positives = 76/193 (39%), Gaps = 18/193 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+GSG FG ++ E + G + K + + EI + + HP L+ L
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKYTVKNEISIMNQLHHPKLINLHDAF 117
Query: 888 ASGNEMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALAYLHDQCAPR 943
EM LI +L GG L + I A + V L ++H+
Sbjct: 118 EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV-----INYMRQACEGLKHMHEH---S 169
Query: 944 VLHRDVKPSNILLDDDFNAYL--SDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
++H D+KP NI+ + + + DFGL+ L E T + APE V
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPV 227
Query: 1002 SDKADVYSYGVVL 1014
D+++ GV+
Sbjct: 228 GFYTDMWAIGVLG 240
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 52/200 (26%), Positives = 84/200 (42%), Gaps = 25/200 (12%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+GSG F K E S G+ A K + R ++ E+ L V H N++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHD 938
L + ++ LI + GG L +F+ + S A + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLHT 133
Query: 939 QCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
+ ++ H D+KP NI+L + L DFGL+ + + GT +VAPE
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 995 YALTCRVSDKADVYSYGVVL 1014
+ +AD++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 6e-30
Identities = 54/213 (25%), Positives = 93/213 (43%), Gaps = 16/213 (7%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876
+ G + +G+GGFG + G VA+K+ +++ EI+ + +
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 877 HPNLVTLI------GYRASGNEMFLIYNYLPGGNLENFIKAR-TSRAVDWKILHKIALDV 929
HPN+V+ A + L Y GG+L ++ + + + D+
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY---LSDFGLSRLLGTSETHATTGVAG 986
+SAL YLH+ R++HRD+KP NI+L + D G ++ L T V G
Sbjct: 131 SSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFV-G 185
Query: 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
T Y+APE + + D +S+G + E I+
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 50/206 (24%), Positives = 79/206 (38%), Gaps = 31/206 (15%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK--------KLAVGRFQHGVQQFHAEIKTLGNV-RHP 878
+G G + AVK + Q + E+ L V HP
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALA 934
N++ L + FL+++ + G L +++ + + I + +
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK------IMRALLEVIC 138
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
LH ++HRD+KP NILLDDD N L+DFG S L V GT Y+APE
Sbjct: 139 ALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPSYLAPE 193
Query: 995 ------YALTCRVSDKADVYSYGVVL 1014
+ D++S GV++
Sbjct: 194 IIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-30
Identities = 50/199 (25%), Positives = 84/199 (42%), Gaps = 23/199 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+GSG F K E S G+ A K + R + E+ L ++HPN++T
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKIALDVASALAYLHDQ 939
L + ++ LI + GG L +F+ + T + + + + YLH
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEA-----TEFLKQILNGVYYLHSL 133
Query: 940 CAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
++ H D+KP NI+L + DFGL+ + + GT +VAPE
Sbjct: 134 ---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEI 188
Query: 996 ALTCRVSDKADVYSYGVVL 1014
+ +AD++S GV+
Sbjct: 189 VNYEPLGLEADMWSIGVIT 207
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-30
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 22/196 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G F + + G+ A K + + Q+ E + ++HPN+V L
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAP 942
+ +L+++ + GG L I AR A + ++AY H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH------CIQQILESIAYCHSN--- 147
Query: 943 RVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
++HR++KP N+LL L+DFGL+ + ++ A G AGT GY++PE L
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPE-VLKK 204
Query: 1000 RVSDK-ADVYSYGVVL 1014
K D+++ GV+L
Sbjct: 205 DPYSKPVDIWACGVIL 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-30
Identities = 53/200 (26%), Positives = 85/200 (42%), Gaps = 25/200 (12%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+GSG F K E S G+ A K + R ++ E+ L V HPN++T
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHD 938
L + ++ LI + GG L +F+ + S A + + YLH
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS------FIKQILDGVNYLHT 133
Query: 939 QCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
+ ++ H D+KP NI+L + L DFGL+ + + GT +VAPE
Sbjct: 134 K---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--FKNIFGTPEFVAPE 188
Query: 995 YALTCRVSDKADVYSYGVVL 1014
+ +AD++S GV+
Sbjct: 189 IVNYEPLGLEADMWSIGVIT 208
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 11/198 (5%)
Query: 829 IGSGGFGTTYKA-----EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
IG+G FG YK + VA+K L G + F E +G H N++ L
Sbjct: 52 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
G + M +I Y+ G L+ F++ + L + +A+ + YL +
Sbjct: 112 EGVISKYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGMKYLANM---N 167
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRV 1001
+HRD+ NIL++ + +SDFGLSR+L T G APE +
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 1002 SDKADVYSYGVVLLELIS 1019
+ +DV+S+G+V+ E+++
Sbjct: 228 TSASDVWSFGIVMWEVMT 245
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-29
Identities = 50/195 (25%), Positives = 91/195 (46%), Gaps = 10/195 (5%)
Query: 828 CIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G +G Y ++S + +A+K++ R Q H EI +++H N+V +G
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPE-RDSRYSQPLHEEIALHKHLKHKNIVQYLGS 87
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDW-KILHKIALDVASALAYLHDQCAPRVL 945
+ + + +PGG+L ++++ D + + + L YLHD +++
Sbjct: 88 FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIV 144
Query: 946 HRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV--S 1002
HRD+K N+L++ +SDFG S+ L T GT Y+APE
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203
Query: 1003 DKADVYSYGVVLLEL 1017
AD++S G ++E+
Sbjct: 204 KAADIWSLGCTIIEM 218
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-29
Identities = 51/198 (25%), Positives = 81/198 (40%), Gaps = 17/198 (8%)
Query: 827 NCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG ++ + G AVKK+ + F+ + E+ + P +V L G
Sbjct: 64 PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR---VE---ELVACAGLSSPRIVPLYG 117
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
G + + L GG+L IK + L YLH + R+L
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQALEGLEYLHTR---RIL 172
Query: 946 HRDVKPSNILLDDD-FNAYLSDFGLSRLLGTSETHATTG----VAGTFGYVAPEYALTCR 1000
H DVK N+LL D A L DFG + L + + GT ++APE +
Sbjct: 173 HGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP 232
Query: 1001 VSDKADVYSYGVVLLELI 1018
K D++S ++L ++
Sbjct: 233 CDAKVDIWSSCCMMLHML 250
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 1e-29
Identities = 61/200 (30%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 829 IGSGGFGTTYKAEISPG----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG G FG Y + I AVK L V QF E + + HPN+++L+
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 885 GY-RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
G S ++ Y+ G+L NFI+ + K L L VA + YL + +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---K 148
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV---APEYALTCR 1000
+HRD+ N +LD+ F ++DFGL+R + E ++ G V A E +L +
Sbjct: 149 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE-SLQTQ 207
Query: 1001 V-SDKADVYSYGVVLLELIS 1019
+ K+DV+S+GV+L EL++
Sbjct: 208 KFTTKSDVWSFGVLLWELMT 227
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-29
Identities = 52/194 (26%), Positives = 84/194 (43%), Gaps = 22/194 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G Y+ + A+K L + V+ EI L + HPN++ L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKEIF 117
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAPR 943
+ E+ L+ + GG L + I + A D + A+AYLH+
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD------AVKQILEAVAYLHEN---G 168
Query: 944 VLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
++HRD+KP N+L D ++DFGLS+++ V GT GY APE C
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILRGCA 226
Query: 1001 VSDKADVYSYGVVL 1014
+ D++S G++
Sbjct: 227 YGPEVDMWSVGIIT 240
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 58/194 (29%), Positives = 93/194 (47%), Gaps = 16/194 (8%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY-R 887
IG G FG + G VAVK + Q F AE + +RH NLV L+G
Sbjct: 29 IGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++++ Y+ G+L +++++R + L K +LDV A+ YL +HR
Sbjct: 85 EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHR 141
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY--VAPEYALTCRVSDKA 1005
D+ N+L+ +D A +SDFGL++ + G APE + S K+
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDT--GKLPVKWTAPEALREKKFSTKS 195
Query: 1006 DVYSYGVVLLELIS 1019
DV+S+G++L E+ S
Sbjct: 196 DVWSFGILLWEIYS 209
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 55/194 (28%), Positives = 82/194 (42%), Gaps = 21/194 (10%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G +G A + I A KK+ + V +F EI+ + ++ HPN++ L
Sbjct: 17 IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAPR 943
+++L+ GG L + + A I DV SA+AY H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR------IMKDVLSAVAYCHKL---N 126
Query: 944 VLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
V HRD+KP N L D L DFGL+ + T GT YV+P+ L
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQ-VLEGL 183
Query: 1001 VSDKADVYSYGVVL 1014
+ D +S GV++
Sbjct: 184 YGPECDEWSAGVMM 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-29
Identities = 47/196 (23%), Positives = 77/196 (39%), Gaps = 14/196 (7%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
IG G F + G AVK + E ++HP++V L
Sbjct: 32 IGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW--KILHKIALDVASALAYLHDQCA 941
+ +S +++++ ++ G +L I R + + + AL Y HD
Sbjct: 92 LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-- 149
Query: 942 PRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
++HRDVKP +LL ++ L FG++ LG G GT ++APE
Sbjct: 150 -NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGLVAGGRVGTPHFMAPEVVKR 207
Query: 999 CRVSDKADVYSYGVVL 1014
DV+ GV+L
Sbjct: 208 EPYGKPVDVWGCGVIL 223
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-29
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG + G AVK ++ + + + E++ L + HPN++ L
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKIALDVASALAYLHDQCAP 942
+ +L+ GG L + I +R + +I V S + Y+H
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA-----ARIIRQVLSGITYMHKN--- 145
Query: 943 RVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
+++HRD+KP N+LL D N + DFGLS S+ GT Y+APE L
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM--KDKIGTAYYIAPE-VLHG 202
Query: 1000 RVSDKADVYSYGVVLLELIS 1019
+K DV+S GV+L L+S
Sbjct: 203 TYDEKCDVWSTGVILYILLS 222
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-29
Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 30/204 (14%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-----KLAVGRFQHG--VQQFHAEIKTLGNVRHPNL 880
+GSG G A E VA+K K A+G + EI+ L + HP +
Sbjct: 18 LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYL 936
+ + + + + +++ + GG L + + + A+ YL
Sbjct: 78 IKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKL------YFYQMLLAVQYL 130
Query: 937 HDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
H+ ++HRD+KP N+LL ++D ++DFG S++LG ET + GT Y+AP
Sbjct: 131 HEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAP 185
Query: 994 E---YALTCRVSDKADVYSYGVVL 1014
E T + D +S GV+L
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-29
Identities = 52/200 (26%), Positives = 90/200 (45%), Gaps = 22/200 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK-----KLAVGRFQHG--VQQFHAEIKTLGNVRHPNL 880
+GSG G A E VA++ K A+G + EI+ L + HP +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
+ + + + + +++ + GG L + + + + A+ YLH+
Sbjct: 203 IKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKR--LKEATCKLYFYQMLLAVQYLHEN- 258
Query: 941 APRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE--- 994
++HRD+KP N+LL ++D ++DFG S++LG ET + GT Y+APE
Sbjct: 259 --GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGTPTYLAPEVLV 314
Query: 995 YALTCRVSDKADVYSYGVVL 1014
T + D +S GV+L
Sbjct: 315 SVGTAGYNRAVDCWSLGVIL 334
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-29
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 23/216 (10%)
Query: 816 IIRATGDFNT----SNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG-VQQFHAEI 869
I G + +GSG +G + + A+K + + E+
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 870 KTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS---RAVDWKILHKIA 926
L + HPN++ L + +L+ GG L + I R I
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDA-----AVII 142
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTG 983
V S + YLH ++HRD+KP N+LL + D + DFGLS + +
Sbjct: 143 KQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM--KE 197
Query: 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
GT Y+APE L + +K DV+S GV+L L++
Sbjct: 198 RLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLA 232
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-29
Identities = 46/227 (20%), Positives = 92/227 (40%), Gaps = 40/227 (17%)
Query: 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHA------------- 867
D+ + G F E A+KK + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKD-NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 868 ---EIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR------TSRAVD 918
E++ + ++++ +T G + +E+++IY Y+ ++ F + + +
Sbjct: 90 FKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 919 WKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978
+++ I V ++ +Y+H++ + HRDVKPSNIL+D + LSDFG S + +
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKI 207
Query: 979 HATTGVAGTFGYVAPE-------YALTCRVSDKADVYSYGVVLLELI 1018
+ GT+ ++ PE Y K D++S G+ L +
Sbjct: 208 K-GS--RGTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMF 246
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-29
Identities = 64/333 (19%), Positives = 125/333 (37%), Gaps = 44/333 (13%)
Query: 109 LRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRID 168
+ + F E +L +++ + + + R + +LNL +I+
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82
Query: 169 GDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCR 228
++ +++ L + N ++ + P + L VL L N+L+ S+P +
Sbjct: 83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTP 141
Query: 229 YLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRL 288
L L +S N+L + L+ L L SN L V +L + L +VS N L
Sbjct: 142 KLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLL 198
Query: 289 NGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEIT 348
+ L + + L S+ NS I + +
Sbjct: 199 -----STLAIPIAVEELDASH---------------------------NS-INVVRGPV- 224
Query: 349 TLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSS 408
+L I+ NL + L ++L+ N L + F + ++L + +S+
Sbjct: 225 -NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISN 281
Query: 409 NELSGELDVKLQ-VPCMALFDVSGNHMSGSIPR 440
N L L++ Q +P + + D+S NH+ + R
Sbjct: 282 NRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 312
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 64/315 (20%), Positives = 113/315 (35%), Gaps = 58/315 (18%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLN 161
++ L + FN PP + ++ L VL +E N LS LP F L L+
Sbjct: 90 AYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 147
Query: 162 LAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
++ N ++ + + SL+ L L+ N++ + L L +SYN L+ ++
Sbjct: 148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAI 203
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
+ +E LD S NS+ + + +L L L N L D L L +
Sbjct: 204 PIA-----VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEV 253
Query: 282 DVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341
D+S N L ++ L L +SN N +
Sbjct: 254 DLSYNELEKIMYHPFVKMQRLERLYISN---------------------------NR-LV 285
Query: 342 SIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLIGVFDR 397
++ + + L++ L+L + + + LE L L N + +
Sbjct: 286 ALNLYGQPIPTLKV-----LDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTH-- 338
Query: 398 CKKLHFIDLSSNELS 412
L + LS N+
Sbjct: 339 -HTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 32/155 (20%), Positives = 64/155 (41%), Gaps = 8/155 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N+ + +P + + + +L+ + QI I + ++ L + N ++
Sbjct: 51 TFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLP 109
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNL 665
P + L L L N+L+ +P I L L +S+N+L + + +L
Sbjct: 110 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL 167
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +N+L+ S + ++ N S+N LS
Sbjct: 168 QNLQLSSNRLTHVDLSLIPSLFHA---NVSYNLLS 199
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 6e-21
Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 13/155 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NL++ I I +++ L N I + P +N+ L L L N L +
Sbjct: 75 NLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 132
Query: 608 PSSL-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
P + H L LS+++NNL I SL+ L+LSSN L+ V + +L
Sbjct: 133 PRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSL 188
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
+ N L S LA ++ +AS N+++
Sbjct: 189 FHANVSYNLL-----STLAIPIAVEELDASHNSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 7e-21
Identities = 30/145 (20%), Positives = 56/145 (38%), Gaps = 9/145 (6%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L +NN+ + L +D S+N++ I+ + L L ++ N+L +
Sbjct: 232 KLQHNNLT---DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 287
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L+ L L+ N+L + + + LE L L NS+ + L
Sbjct: 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKN 343
Query: 668 LLLDNNKLSG-HLPSGLANVTSLSI 691
L L +N L + NV ++
Sbjct: 344 LTLSHNDWDCNSLRALFRNVARPAV 368
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 35/180 (19%), Positives = 68/180 (37%), Gaps = 11/180 (6%)
Query: 529 GSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDI-----GVMCKSLRVLDASHNQISGIV 583
P C + + + + I D+ + + +++ ++ + +
Sbjct: 2 NVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLP 61
Query: 584 PQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLE 642
L++ + L+LN +++ EI + + ++ L + N + P + L
Sbjct: 62 AALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLT 120
Query: 643 VLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
VL L N LS +P G+ N LT L + NN L + TSL S N L+
Sbjct: 121 VLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-19
Identities = 38/170 (22%), Positives = 69/170 (40%), Gaps = 25/170 (14%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENL----------------T 591
++SNNN+ I D SL+ L S N+++ + + +L
Sbjct: 147 SMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLSTLAIPI 205
Query: 592 SLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
++ LD + N + + + L L L NNLT + + L ++LS N L
Sbjct: 206 AVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 260
Query: 652 SGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
++ V ++ L L + NN+L L + +L + + S N+L
Sbjct: 261 E-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL 308
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 2e-19
Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 14/153 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L N++ +P I L L S+N + I + + TSL L L+ N+L +
Sbjct: 123 VLERNDL-SSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV 180
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
SL + L H +++ N L+ ++ ++E L+ S NS++ V V LT
Sbjct: 181 DLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTI 230
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +N L+ + L N L + S+N L
Sbjct: 231 LKLQHNNLTD--TAWLLNYPGLVEVDLSYNELE 261
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-18
Identities = 36/153 (23%), Positives = 59/153 (38%), Gaps = 13/153 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N+S N + + + I ++ LDASHN I+ + LT L L N L
Sbjct: 192 NVSYNLL-STLAIPI-----AVEELDASHNSINVVRGPVNVELTIL---KLQHNNLTD-- 240
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L L + L+ N L + +++ LE L +S+N L + + L
Sbjct: 241 TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +N L H+ L N++
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 8e-14
Identities = 30/150 (20%), Positives = 58/150 (38%), Gaps = 10/150 (6%)
Query: 101 PLVGGLSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRV 159
+ L + L +N + + +++LE L + N L L + L+V
Sbjct: 242 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 299
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSI 219
L+L+ N + + + F+ LE L L N + + L + L+ L LS+N+ + +
Sbjct: 300 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWDCNS 355
Query: 220 PSELGKYCRYLEHLDLSGNSLVGRIPSSLG 249
L R + + +I L
Sbjct: 356 LRALF---RNVARPAVDDADQHCKIDYQLE 382
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 5/89 (5%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLR 158
L+ + L+VL L N ++LE L ++ N + L L+
Sbjct: 287 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLK 342
Query: 159 VLNLAFNRIDGD-IPFSLRNFESLEVLNL 186
L L+ N D + + RN V +
Sbjct: 343 NLTLSHNDWDCNSLRALFRNVARPAVDDA 371
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 1e-28
Identities = 50/196 (25%), Positives = 85/196 (43%), Gaps = 10/196 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
+ + +G G FG +K E + G+ +A K + R ++ EI + + H NL
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT-RGMKDKEEVKNEISVMNQLDHANL 148
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
+ L S N++ L+ Y+ GG L + I + + + + + ++H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTIL-FMKQICEGIRHMHQM- 206
Query: 941 APRVLHRDVKPSNILLDDDFNAYL--SDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+LH D+KP NIL + + DFGL+R E GT ++APE
Sbjct: 207 --YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNY 262
Query: 999 CRVSDKADVYSYGVVL 1014
VS D++S GV+
Sbjct: 263 DFVSFPTDMWSVGVIA 278
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 54/210 (25%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLA------------VGRFQHGVQQFHAEIKTLGNV 875
+GSG +G E + A+K + + ++ + EI L ++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKIALDVASA 932
HPN++ L +L+ + GG L I R I + S
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA-----ANIMKQILSG 158
Query: 933 LAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
+ YLH ++HRD+KP NILL + N + DFGLS GT
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL--RDRLGTAY 213
Query: 990 YVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
Y+APE L + ++K DV+S GV++ L+
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-28
Identities = 64/308 (20%), Positives = 111/308 (36%), Gaps = 50/308 (16%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
+ VL++ +G + P + + L + N L+ LP LR L ++ N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPAL---PPELRTLEVSGN 91
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
++ +P L + + + + G L L++ N+L S+P
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLPALPSG-------LCKLWIFGNQLT-SLPVLPPG 142
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L+ L +S N L +P+ +L L ++N L +P L+ L VS
Sbjct: 143 ----LQELSVSDNQL-ASLPALPS---ELCKLWAYNNQLTS-LPMLPS---GLQELSVSD 190
Query: 286 NRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIP 344
N+L L PT +L L S ++ EL V + + S+P
Sbjct: 191 NQLASL-PTLPSELYKLWAYNNRLTSLPALPS--GLK-ELIVS---------GNRLTSLP 237
Query: 345 MEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFI 404
+ + L +L + N LP L L++ +N L L +
Sbjct: 238 VLPSELKELMV----SGNRLTSLPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETTV 289
Query: 405 DLSSNELS 412
+L N LS
Sbjct: 290 NLEGNPLS 297
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-27
Identities = 69/310 (22%), Positives = 108/310 (34%), Gaps = 56/310 (18%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
+ + L +P N + P +L L+V GN L+ LP GL L + +
Sbjct: 60 PAHITTLVIPDNNLT-SLPALP---PELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLT 114
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
+ L L + GNQ+ +P L+ L +S N+L S+P+ +
Sbjct: 115 HLPALP-------SGLCKLWIFGNQLT-SLPVLPPG---LQELSVSDNQLA-SLPALPSE 162
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L L N L +P L+ L + N L +P L KL +
Sbjct: 163 ----LCKLWAYNNQLT-SLPMLPS---GLQELSVSDNQLAS-LPTLPSELYKLWAYN--- 210
Query: 286 NRLNGLIPTELGNCVELSVLVLSNL----FDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341
NRL L P L L++S L S ++ EL V + +
Sbjct: 211 NRLTSL-PALPSG---LKELIVSGNRLTSLPVLPS--ELK-ELMVS---------GNRLT 254
Query: 342 SIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKL 401
S+PM + L L + N +LP S S +NL N L +++
Sbjct: 255 SLPMLPSGLLSLSV----YRNQLTRLPESLIHLSSETTVNLEGNPLS---ERTLQALREI 307
Query: 402 HFIDLSSNEL 411
S +
Sbjct: 308 TSAPGYSGPI 317
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 97.7 bits (243), Expect = 6e-21
Identities = 48/224 (21%), Positives = 74/224 (33%), Gaps = 23/224 (10%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
+L+ L SEL L N + P L+ L V N L+ LP L L
Sbjct: 152 QLASLPALPSELCKLWAYNNQLT-SLPMLP---SGLQELSVSDNQLA-SLPTLPSELYKL 206
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
N + L+ L ++GN++ +P L+ L +S N L
Sbjct: 207 WAYNNRLTSLPALPS-------GLKELIVSGNRLTS-LPVLPSE---LKELMVSGNRLT- 254
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
S+P L L + N L R+P SL T+ L N L++ + L +
Sbjct: 255 SLPMLPSG----LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITS 309
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIR 321
R + + L L ++ P G
Sbjct: 310 APGYSGPIIRFDMAGASAPRETRALH-LAAADWLVPAREGEPAP 352
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 92.6 bits (230), Expect = 2e-19
Identities = 39/196 (19%), Positives = 68/196 (34%), Gaps = 22/196 (11%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NN + +P+ L+ L S NQ++ + P L L + L
Sbjct: 167 WAYNNQLT-SLPMLPS----GLQELSVSDNQLASL-PTLPSELYKLWAYNNRLTSLPALP 220
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L+ L ++ N LT +P EL+ L +S N L+ +P L +
Sbjct: 221 SG-------LKELIVSGNRLTS-LPVLPSELKELM---VSGNRLT-SLPM---LPSGLLS 265
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQMY 727
L + N+L+ LP L +++S + N N LS + + + P +
Sbjct: 266 LSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 728 KDISSSELTSSNANSQ 743
A +
Sbjct: 325 ASAPRETRALHLAAAD 340
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.6 bits (217), Expect = 8e-18
Identities = 27/150 (18%), Positives = 52/150 (34%), Gaps = 17/150 (11%)
Query: 565 MCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624
+ VL+ + ++ + ++T+ L + N L +P+ LR L ++
Sbjct: 38 LNNGNAVLNVGESGLTTLPDCLPAHITT---LVIPDNNLT-SLPAL---PPELRTLEVSG 90
Query: 625 NNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLA 684
N LT +P L L + L L L + N+L+ LP
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLWIFGNQLT-SLPVLPP 141
Query: 685 NVTSLSIFNASFNNLSGPFPWNVTTMNCSG 714
+ LS+ + +L P + +
Sbjct: 142 GLQELSVSDNQLASLP-ALPSELCKLWAYN 170
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 87.3 bits (216), Expect = 1e-17
Identities = 37/176 (21%), Positives = 69/176 (39%), Gaps = 18/176 (10%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
++S+N + +P L L A +N+++ + P L L ++GN+L +
Sbjct: 187 SVSDNQLA-SLPTLPS----ELYKLWAYNNRLTSL-PALPSGLKEL---IVSGNRLT-SL 236
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
P L + L ++ N LT +P L L + N L+ +PE +++L + T
Sbjct: 237 PVLPSEL---KELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT-RLPESLIHLSSETT 288
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDP 723
+ L+ N LS L +TS ++ + +L P
Sbjct: 289 VNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVP 344
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 75/463 (16%), Positives = 125/463 (26%), Gaps = 137/463 (29%)
Query: 239 SLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGN 298
++V ++ + L L + + L +P L + L + N L L P
Sbjct: 29 AVVQKMRACL--NNGNAVLNVGESGLTT-LPDCLP--AHITTLVIPDNNLTSL-PALPPE 82
Query: 299 CVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWA 358
L +SG + S+P+ L +L I
Sbjct: 83 LRTLE-----------VSGNQLT--------------------SLPVLPPGLLELSI--- 108
Query: 359 PRLNLEG-KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELD- 416
+ LP+ L L + N L L + ++L D L
Sbjct: 109 --FSNPLTHLPAL---PSGLCKLWIFGNQLT-SLPVLPPGLQELSVSDNQLASLPALPSE 162
Query: 417 -VKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKAR 475
KL N ++ S+P + +Q
Sbjct: 163 LCKL--------WAYNNQLT-SLP----------------------MLPSGLQEL----- 186
Query: 476 LGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSL 535
+ S N LP P L + Y N+LT S P
Sbjct: 187 ----------------SVSDNQLAS----LPTLPSELYKLWAYN-----NRLT-SLPALP 220
Query: 536 FQACNEFHGMVANLS----NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLT 591
+ L + N + +P+ L+ L S N+++ + P L
Sbjct: 221 -----------SGLKELIVSGNRLTSLPVLPS----ELKELMVSGNRLTSL-PMLPSGLL 264
Query: 592 SLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
SL + N+L +P SL L ++L N L+ ++ E+ S
Sbjct: 265 SL---SVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRF 320
Query: 652 SGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNA 694
R L L + L A +F
Sbjct: 321 DMAGASAPRETRALH--LAAADWLVPAREGEPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 3e-16
Identities = 66/347 (19%), Positives = 109/347 (31%), Gaps = 84/347 (24%)
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
VLN+ + + +P L + + L + N L S+P+ + L L++SGN
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE----LRTLEVSGNQ 92
Query: 240 LVGRIPSSLGKCQQLRTLLLFSNMLNDV----------------IPRELGWLRKLEVLDV 283
L +P +L L + +P L+ L V
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLPALPSGLCKLWIFGNQLTSLPVLPP---GLQELSV 148
Query: 284 SRNRLNGLIPTELGNCVELSVL--VLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341
S N+L L P +L L++L L S ++ ELSV N +
Sbjct: 149 SDNQLASL-PALPSELCKLWAYNNQLTSL-PMLPS--GLQ-ELSVSD--------NQ-LA 194
Query: 342 SIPMEITTLSKL-----RIIWAP-------RLNLEG----KLPSSWGACESLEMLNLAQN 385
S+P + L KL R+ P L + G LP L+ L ++ N
Sbjct: 195 SLPTLPSELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPS---ELKELMVSGN 251
Query: 386 VLRG--DLIGVFDRCKKLHFIDLSSNELS------GELDVKLQVPCMALFDVSGNHMSGS 437
L L L + + N+L+ L ++ GN +S
Sbjct: 252 RLTSLPMLPS------GLLSLSVYRNQLTRLPESLIHLS-SETT-----VNLEGNPLS-E 298
Query: 438 IPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSA 484
P S + + + + + LV A
Sbjct: 299 RTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 2e-12
Identities = 38/202 (18%), Positives = 70/202 (34%), Gaps = 33/202 (16%)
Query: 213 NELNGSIPSELGK-YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE 271
+ ++ ++ L++ + L +P L + TL++ N L +P
Sbjct: 24 SRGRAAVVQKMRACLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLTS-LPAL 79
Query: 272 LGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGELSVGQSD 330
+L L+VS N+L L P +ELS+ L S + +L +
Sbjct: 80 PP---ELRTLEVSGNQLTSL-PVLPPGLLELSIFSNPLTHLPALPS--GLC-KLWIF--- 129
Query: 331 ASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGD 390
+ + S+P+ L +L + N LP+ L N L
Sbjct: 130 ------GNQLTSLPVLPPGLQELSV----SDNQLASLPALPSELCKLWAYNNQLTSL-PM 178
Query: 391 LIGVFDRCKKLHFIDLSSNELS 412
L L + +S N+L+
Sbjct: 179 LPS------GLQELSVSDNQLA 194
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 66.8 bits (163), Expect = 2e-11
Identities = 39/228 (17%), Positives = 68/228 (29%), Gaps = 24/228 (10%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
+L+ L S L+ L + N + P +L+ L V GN L+ LP L
Sbjct: 212 RLTSLPALPSGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPML---PSGL 263
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L++ N++ +P SL + S +NL GN + L +
Sbjct: 264 LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDM 322
Query: 218 SIPSELGKYCRYLEHLDLS------GNSLVGRIPSSLGKCQQLRTLLLFSNMLN------ 265
+ S + G G+ LF + L+
Sbjct: 323 AGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNADAFSLFLDRLSETENFI 382
Query: 266 ---DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310
+ WL +L + R + +C + L +
Sbjct: 383 KDAGFKAQISSWLAQLAEDEALRANTFAMATEATSSCEDRVTFFLHQM 430
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-28
Identities = 56/195 (28%), Positives = 94/195 (48%), Gaps = 9/195 (4%)
Query: 829 IGSGGFGT----TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG G FG Y + +P + VA+K ++F E T+ HP++V LI
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G + N +++I G L +F++ R +D L A +++ALAYL + R
Sbjct: 458 GV-ITENPVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTALAYLESK---RF 512
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDK 1004
+HRD+ N+L+ + L DFGLSR + S + + ++APE R +
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 1005 ADVYSYGVVLLELIS 1019
+DV+ +GV + E++
Sbjct: 573 SDVWMFGVCMWEILM 587
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-28
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
D+ IGSG A VA+K++ + + Q + + EI+ + HPN+
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNI 75
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKIL---HKIAL---DVASALA 934
V+ +E++L+ L GG++ + IK ++ + IA +V L
Sbjct: 76 VSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF-G---Y 990
YLH +HRDVK NILL +D + ++DFG+S L T V TF G +
Sbjct: 136 YLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 991 VAPEYALTCRVSD-KADVYSYGVVLLELI 1018
+APE R D KAD++S+G+ +EL
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELA 221
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 39/262 (14%), Positives = 76/262 (29%), Gaps = 43/262 (16%)
Query: 822 DFNTSNCIGSGGFGTTYKAE------ISPGILVAVKKL---AVGRFQHGVQQFHAEIKTL 872
+ +G G F Y+A +K F G Q ++ L
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ----LMERL 121
Query: 873 GNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFI---KARTSRAVDWKILHKIALDV 929
+ N L+ G L N I K + + ++ A+ +
Sbjct: 122 KPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILL-----------DDDFNAYLSDFGLSRLLGT-SE 977
+ +HD ++H D+KP N +L D L D G S + +
Sbjct: 182 LYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNI 1037
T T G+ E + + D + + ++ G +
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCML------------FGTYMKV 286
Query: 1038 ISWASMLLRQGQVKDVFNAELW 1059
+ +G + + + ++W
Sbjct: 287 KNEGGECKPEGLFRRLPHLDMW 308
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 51/200 (25%), Positives = 91/200 (45%), Gaps = 8/200 (4%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP 878
F IG G FG +K + +VA+K + + + ++ EI L P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
+ G ++++I YL GG+ + ++ +D + I ++ L YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS 137
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ + +HRD+K +N+LL + L+DFG++ L ++ T GT ++APE
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 193
Query: 999 CRVSDKADVYSYGVVLLELI 1018
KAD++S G+ +EL
Sbjct: 194 SAYDSKADIWSLGITAIELA 213
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 12/199 (6%)
Query: 829 IGSGGFGTTYKAEISPG----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG G FG Y E I A+K L+ V+ F E + + HPN++ LI
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALI 88
Query: 885 GYRASGNEM-FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
G + ++ Y+ G+L FI++ R K L L VA + YL +Q +
Sbjct: 89 GIMLPPEGLPHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---K 144
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV---APEYALTCR 1000
+HRD+ N +LD+ F ++DFGL+R + E ++ V A E T R
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 1001 VSDKADVYSYGVVLLELIS 1019
+ K+DV+S+GV+L EL++
Sbjct: 205 FTTKSDVWSFGVLLWELLT 223
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 76/500 (15%), Positives = 165/500 (33%), Gaps = 52/500 (10%)
Query: 207 VLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266
++ S N L +P +L + L++S N + S + +LR L++ N +
Sbjct: 4 LVDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS-NLFDPLLSGRNIRGELS 325
+ + ++LE LD+S N+L + N L L LS N FD L +
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVKISCHPTVN---LKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 326 VGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQN 385
+ S S + I L+ +++ + +L
Sbjct: 117 LKFLGLST---THLEKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIV 171
Query: 386 VLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNV 445
+L + + L+
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCS------------------------ 207
Query: 446 CHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICW- 504
+ + + + + T + L + + + S G + +
Sbjct: 208 -YFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFR 266
Query: 505 -LPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIG 563
+ L+ + + + G +++ + + + N + + + +
Sbjct: 267 DFDYSGTSLKALS---IHQVVSDVFGFPQSYIYEIFSNMN--IKNFTVSG-TRMVHMLCP 320
Query: 564 VMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ--GEIPSSLHRLKYLRHLS 621
LD S+N ++ V ++ +LT L L L N+L+ +I ++K L+ L
Sbjct: 321 SKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLD 380
Query: 622 LADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLP 680
++ N+++ +SL L +SSN L+ + + + L L +NK+ +P
Sbjct: 381 ISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIP 437
Query: 681 SGLANVTSLSIFNASFNNLS 700
+ + +L N + N L
Sbjct: 438 KQVVKLEALQELNVASNQLK 457
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-26
Identities = 85/524 (16%), Positives = 169/524 (32%), Gaps = 71/524 (13%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192
+L++ N++S ++ + L LR+L ++ NRI + + LE L+L+ N++
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQ 252
+ + L+ L LS+N + + L+ L LS L +
Sbjct: 83 KI---SCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLN 139
Query: 253 QLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFD 312
+ LL+ + L+ + + + +V L
Sbjct: 140 ISKVLLVLGE--TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL--- 194
Query: 313 PLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWG 372
NI+ L + + + TL+ + W + + + +
Sbjct: 195 -----SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT-- 247
Query: 373 ACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGN 432
++ +++ L+G L D S L L + V +
Sbjct: 248 ---TVWYFSISNVKLQGQL--------DFRDFDYSGTSLK-ALSIH---------QVVSD 286
Query: 433 HMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHN 492
+ Y + M +++ + L +
Sbjct: 287 VFG-FPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHL---------------D 330
Query: 493 FSGNNFTGPICWLPVAPERLRRRTDYAFLA-GANKLTGSFPGSLFQACNEFHGMVA---- 547
FS N T E T+ L N+L L + M +
Sbjct: 331 FSNNLLTD------TVFENCGHLTELETLILQMNQLK-----ELSKIAEMTTQMKSLQQL 379
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
++S N++ KSL L+ S N ++ + + L + LDL+ NK++ I
Sbjct: 380 DISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SI 436
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
P + +L+ L+ L++A N L L SL+ + L +N
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 2e-24
Identities = 92/507 (18%), Positives = 175/507 (34%), Gaps = 63/507 (12%)
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
+LN++ N + + + S KLR+L +S+N + + + K+ + LE+LDLS N
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNK 80
Query: 240 LVGRIPSSLGKCQQLRTLLLFSNMLNDV-IPRELGWLRKLEVLDVSRNRLNGLIPTELGN 298
LV I L+ L L N + + I +E G + +L+ L +S L
Sbjct: 81 LVK-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSS------ 131
Query: 299 CVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWA 358
P+ + L +G++ + + L I++
Sbjct: 132 ------------VLPIAHLNISKVLLVLGETYGEKEDPEGL------QDFNTESLHIVFP 173
Query: 359 PRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVK 418
L S +LE+ N+ + KL SN ++
Sbjct: 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETT 233
Query: 419 LQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGM 478
+ + ++ F + + LQ + +D S T ++ +
Sbjct: 234 WN----SFIRILQLVWHTTVWYFSIS---NVKLQGQLDFRDFDYSGTSLKAL--SIHQVV 284
Query: 479 PLLVSAARFMVIHNFSGNNFTGPICW----LPVAPERLRRRTDYAFLAGANKLTGSFPGS 534
+ + + FS N + + + + N LT + +
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN-NLLTDTVFEN 343
Query: 535 LFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCK--SLRVLDASHNQISGIVPQSL- 587
+ L N + + + + SL+ LD S N +S +
Sbjct: 344 -------CGHLTELETLILQMNQL-KELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDC 395
Query: 588 ENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELS 647
SL+ L+++ N L I L ++ L L N + IP + +L +L+ L ++
Sbjct: 396 SWTKSLLSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIKS-IPKQVVKLEALQELNVA 452
Query: 648 SNSLSGEVPEGV-VNLRNLTALLLDNN 673
SN L VP+G+ L +L + L N
Sbjct: 453 SNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 35/161 (21%), Positives = 64/161 (39%), Gaps = 10/161 (6%)
Query: 546 VANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG 605
+ + S N +I H+P D+ + +L+ S N IS + + +L+ L L ++ N++Q
Sbjct: 4 LVDRSKNGLI-HVPKDLS---QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 606 EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV--NLR 663
S + L +L L+ N L I +L+ L+LS N+ +P N+
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMS 115
Query: 664 NLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
L L L L +A++ +
Sbjct: 116 QLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED 156
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 38/205 (18%), Positives = 75/205 (36%), Gaps = 7/205 (3%)
Query: 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRI 167
+ + L +F SL+ L + V + + N+ + N +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312
Query: 168 DGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYC 227
L+ + N + + G +L L L N+L +
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTT 371
Query: 228 RY--LEHLDLSGNSLVGRIPSSL-GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
+ L+ LD+S NS+ + L +L + SN+L D I R L +++VLD+
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLH 429
Query: 285 RNRLNGLIPTELGNCVELSVLVLSN 309
N++ + P ++ L L +++
Sbjct: 430 SNKIKSI-PKQVVKLEALQELNVAS 453
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 7/185 (3%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
S + + + +G + LD N L+ + L L L L
Sbjct: 298 IFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQM 357
Query: 165 NRID--GDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFL-KLRVLFLSYNELNGSIPS 221
N++ I +SL+ L+++ N V S+ L L +S N L +I
Sbjct: 358 NQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFR 417
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
L ++ LDL N + IP + K + L+ L + SN L V L L+ +
Sbjct: 418 CLP---PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473
Query: 282 DVSRN 286
+ N
Sbjct: 474 WLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 3e-16
Identities = 49/320 (15%), Positives = 105/320 (32%), Gaps = 17/320 (5%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
+ +L++ N S + +I SL KL +L + N + + F + L L+L+ N+
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNK 80
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
+ I +L+ L+L+ N + I G+ +L+ L LS L S +
Sbjct: 81 LVK-ISC--HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKC--QQLRTLLLFSNMLNDVIPRELGWLRKLEVLDV 283
L L P L + L + + + ++ + + LE+ ++
Sbjct: 138 LNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197
Query: 284 SRNRLNGLIP---------TELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNG 334
+ L++ + ++ + + +V SN
Sbjct: 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNV 257
Query: 335 --EKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI 392
+ T+L L I + ++ + N + R +
Sbjct: 258 KLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHM 317
Query: 393 GVFDRCKKLHFIDLSSNELS 412
+ +D S+N L+
Sbjct: 318 LCPSKISPFLHLDFSNNLLT 337
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 2e-14
Identities = 39/211 (18%), Positives = 78/211 (36%), Gaps = 8/211 (3%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
L L + + + F + + + + + L+ + N
Sbjct: 275 LKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNN 334
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLK---LRVLFLSYNELNGSIPSE 222
+ + + + LE L L NQ+K + + L+ L +S N ++
Sbjct: 335 LLTDTVFENCGHLTELETLILQMNQLKE-LSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
+ + L L++S N L I L +++ L L SN + IP+++ L L+ L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLS-NLFD 312
V+ N+L + L + L N +D
Sbjct: 451 VASNQLKSVPDGIFDRLTSLQKIWLHTNPWD 481
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 3e-14
Identities = 57/309 (18%), Positives = 97/309 (31%), Gaps = 63/309 (20%)
Query: 108 ELRVLSLPFNGFSGEFPPEIW--SLEKLEVLDV--EGNFLSGRLPNEFVGLRNLRVLNLA 163
L + +N F +W ++ + +V +G L+ L + +
Sbjct: 226 TLNNIETTWNSFI-RILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
+ + F ++ + N + + V L S N L E
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLL-TDTVFEN 343
Query: 224 GKYCRYLEHLDLSGNSL--VGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL-GWLRKLEV 280
+ LE L L N L + +I + + L+ L + N ++ + W + L
Sbjct: 344 CGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403
Query: 281 LDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFI 340
L++S N L I L + VL L + N I
Sbjct: 404 LNMSSNILTDTIFRCLP--PRIKVLDLHS---------------------------NK-I 433
Query: 341 GSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKK 400
SIP ++ L L+ LN+A N L+ G+FDR
Sbjct: 434 KSIPKQVVKLEALQE------------------------LNVASNQLKSVPDGIFDRLTS 469
Query: 401 LHFIDLSSN 409
L I L +N
Sbjct: 470 LQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 5e-13
Identities = 54/439 (12%), Positives = 121/439 (27%), Gaps = 76/439 (17%)
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
+L++S+N ++ L +++ + +L +L++S+ N
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISH---------------------------N 55
Query: 338 SFIGSIPMEI-TTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRG-DL 391
I + + + +L L+L K+ +L+ L+L+ N +
Sbjct: 56 R-IQYLDISVFKFNQELE-----YLDLSHNKLVKISCHP--TVNLKHLDLSFNAFDALPI 107
Query: 392 IGVFDRCKKLHFIDLSSNEL-SGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMP 450
F +L F+ LS+ L + + + V G +
Sbjct: 108 CKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTES 167
Query: 451 LQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPE 510
L + L +S + ++ N + +
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTV-----ANLELSNIKCVLEDNKCSYFLSIL-------AK 215
Query: 511 RLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLR 570
+ T + + Q ++SN + G +
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRD-------- 267
Query: 571 VLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGG 630
S +L +L + + + + +
Sbjct: 268 ------------FDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 631 IPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS--GHLPSGLANVTS 688
++ L+ S+N L+ V E +L L L+L N+L + + S
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKS 375
Query: 689 LSIFNASFNNLSGPFPWNV 707
L + S N++S
Sbjct: 376 LQQLDISQNSVSYDEKKGD 394
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 3e-28
Identities = 38/250 (15%), Positives = 73/250 (29%), Gaps = 43/250 (17%)
Query: 808 GVPLTYESII-RATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKL------------ 853
G P ES + +G +A G V
Sbjct: 64 GQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIK 123
Query: 854 -------AVGRFQHGVQQFHAE-----IKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL- 900
+ + Q A+ I V+ P +I R +M+++ +
Sbjct: 124 QMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFL 183
Query: 901 ---PGGNLENFIKA-----RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPS 952
NL+ F + T +++ ++ L V LA LH ++H ++P
Sbjct: 184 YPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPV 240
Query: 953 NILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADV 1007
+I+LD +L+ F G S A ++ D
Sbjct: 241 DIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDT 300
Query: 1008 YSYGVVLLEL 1017
++ G+ + +
Sbjct: 301 WTLGLAIYWI 310
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 3e-28
Identities = 47/212 (22%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 829 IGSGGFGTTYKAEI----SPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTL 883
+G G FG+ +A++ + VAVK L +++F E + HP++ L
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 884 IG------YRASGNEMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASAL 933
+G + +I ++ G+L F+ A + + L + +D+A +
Sbjct: 91 VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGM 150
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV-- 991
YL + +HRD+ N +L +D ++DFGLSR + + + + G +
Sbjct: 151 EYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKLPV 203
Query: 992 ---APEYALTCRV-SDKADVYSYGVVLLELIS 1019
A E +L + + +DV+++GV + E+++
Sbjct: 204 KWLALE-SLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 14/200 (7%)
Query: 829 IGSGGFGTTYKAEI----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
IG G FG Y + I AVK L V QF E + + HPN+++L+
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 885 GY-RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
G S ++ Y+ G+L NFI+ + K L L VA + +L + +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---K 212
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV---APEYALTCR 1000
+HRD+ N +LD+ F ++DFGL+R + E + G V A E +L +
Sbjct: 213 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE-SLQTQ 271
Query: 1001 V-SDKADVYSYGVVLLELIS 1019
+ K+DV+S+GV+L EL++
Sbjct: 272 KFTTKSDVWSFGVLLWELMT 291
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-28
Identities = 55/199 (27%), Positives = 83/199 (41%), Gaps = 19/199 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
+G G FG K + AVK + E++ L + HPN++ L
Sbjct: 30 LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTS---RAVDWKILHKIALDVASALAYLHDQCAPR 943
+ +++ GG L + I R +I V S + Y+H
Sbjct: 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA-----ARIIKQVFSGITYMHKH---N 141
Query: 944 VLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
++HRD+KP NILL + D + + DFGLS + GT Y+APE L
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM--KDRIGTAYYIAPE-VLRGT 198
Query: 1001 VSDKADVYSYGVVLLELIS 1019
+K DV+S GV+L L+S
Sbjct: 199 YDEKCDVWSAGVILYILLS 217
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 5e-28
Identities = 63/316 (19%), Positives = 120/316 (37%), Gaps = 37/316 (11%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
L+ ++++ + + P + ++E+L++ + F ++ L + F
Sbjct: 50 LNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 108
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG 224
N I P +N L VL L N + + G + KL L +S N L I +
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTF 167
Query: 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
+ L++L LS N L + SL L + N+L+ L +E LD S
Sbjct: 168 QATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDAS 219
Query: 285 RNRLNGLIPTELGNCVELSVLVLSNL----FDPLLSGRNIRGELSVGQSDASNGEKNSFI 340
N +N + VEL++L L + LL+ + E+ + ++ + F+
Sbjct: 220 HNSINVV---RGPVNVELTILKLQHNNLTDTAWLLNYPGLV-EVDLSYNELEKIMYHPFV 275
Query: 341 GSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLIGVFD 396
+ +L RL + L +L++L+L+ N L +
Sbjct: 276 K--------MQRLE-----RLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQP 321
Query: 397 RCKKLHFIDLSSNELS 412
+ +L + L N +
Sbjct: 322 QFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-27
Identities = 64/336 (19%), Positives = 125/336 (37%), Gaps = 44/336 (13%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
+ + F E +L +++ + + + R + +LNL
Sbjct: 26 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDL 85
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
+I+ ++ +++ L + N ++ + P + L VL L N+L+ S+P +
Sbjct: 86 QIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFH 144
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L L +S N+L + L+ L L SN L V +L + L +VS
Sbjct: 145 NTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSY 201
Query: 286 NRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM 345
N L + L + + L S+ NS I +
Sbjct: 202 NLL-----STLAIPIAVEELDASH---------------------------NS-INVVRG 228
Query: 346 EITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFID 405
+ +L I+ NL + L ++L+ N L + F + ++L +
Sbjct: 229 PV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLY 284
Query: 406 LSSNELSGELDVKLQ-VPCMALFDVSGNHMSGSIPR 440
+S+N L L++ Q +P + + D+S NH+ + R
Sbjct: 285 ISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL-HVER 318
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-25
Identities = 89/562 (15%), Positives = 173/562 (30%), Gaps = 93/562 (16%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLN 161
++ L + FN PP + ++ L VL +E N LS LP F L L+
Sbjct: 96 AYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLS 153
Query: 162 LAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
++ N ++ + + SL+ L L+ N++ + L L +SYN L+ ++
Sbjct: 154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLLS-TLAI 209
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
+ +E LD S NS+ + + +L L L N L D L L +
Sbjct: 210 PIA-----VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLTDT--AWLLNYPGLVEV 259
Query: 282 DVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341
D+S N L ++ L L +SN N +
Sbjct: 260 DLSYNELEKIMYHPFVKMQRLERLYISN---------------------------NR-LV 291
Query: 342 SIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLIGVFDR 397
++ + + L++ L+L + + + LE L L N + +
Sbjct: 292 ALNLYGQPIPTLKV-----LDLSHNHLLHVERNQPQFDRLENLYLDHNSIVTLKLSTH-- 344
Query: 398 CKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLC 457
L + LS N+ C +L + N ++ D + L+ C
Sbjct: 345 -HTLKNLTLSHNDWD----------CNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCC 393
Query: 458 QGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTD 517
+ D + + L+ + ++
Sbjct: 394 KESDKPY-------------LDRLLQYIALTSVVEKVQRAQGRCSA----TDTINSVQSL 436
Query: 518 YAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNI-----IGHIPLDIGVMCKSLRVL 572
++ + L NE V L+N I + + +I + R+
Sbjct: 437 SHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLP 496
Query: 573 DASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIP 632
+ S + + +L L + Q + + K L + L +
Sbjct: 497 KDGLARSSDNLNKVFTHLKERQAFKL--RETQARRTEADAKQKETEDLEQENIALEKQLD 554
Query: 633 SSIGE-LRSLEVLELSSNSLSG 653
+ + + L +
Sbjct: 555 NKRAKQAELRQETSLKRQKVKQ 576
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.9 bits (241), Expect = 1e-20
Identities = 31/155 (20%), Positives = 65/155 (41%), Gaps = 8/155 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N+ + +P + + + +L+ + QI I + ++ L + N ++
Sbjct: 57 TFKNSTM-RKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLP 115
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNL 665
P + L L L N+L+ +P I L L +S+N+L + + +L
Sbjct: 116 PHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSL 173
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +N+L+ S + ++ ++ S+N LS
Sbjct: 174 QNLQLSSNRLTHVDLSLIPSLFHANV---SYNLLS 205
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-20
Identities = 46/261 (17%), Positives = 85/261 (32%), Gaps = 13/261 (4%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L +NN+ + L +D S+N++ I+ + L L ++ N+L +
Sbjct: 238 KLQHNNLT---DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-AL 293
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L+ L L+ N+L + + + LE L L NS+ + L
Sbjct: 294 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKN 349
Query: 668 LLLDNNKLSG-HLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLD-PCQ 725
L L +N L + NV ++ + + + + C P+LD Q
Sbjct: 350 LTLSHNDWDCNSLRALFRNVARPAVDD---ADQHCKIDYQLEHGLCCKESDKPYLDRLLQ 406
Query: 726 MYKDISSSELTSSNANSQHNITAPTGSRTEDHKIQIASIVSASAIVLILLTLVILFFYVR 785
S E ++ H I V + + L V+
Sbjct: 407 YIALTSVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQ 466
Query: 786 KGFPDTRVQVSESRELTLFID 806
+ + Q + L ID
Sbjct: 467 QLTNEQIQQEQLLQGLHAEID 487
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 95.0 bits (236), Expect = 3e-20
Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 13/155 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NL++ I I +++ L N I + P +N+ L L L N L +
Sbjct: 81 NLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SL 138
Query: 608 PSSL-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
P + H L LS+++NNL I SL+ L+LSSN L+ V + +L
Sbjct: 139 PRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLS--LIPSL 194
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
+ N L S LA ++ +AS N+++
Sbjct: 195 FHANVSYNLL-----STLAIPIAVEELDASHNSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-19
Identities = 34/171 (19%), Positives = 67/171 (39%), Gaps = 11/171 (6%)
Query: 538 ACNEFHGMVANLSNNNIIGHIPLDI-----GVMCKSLRVLDASHNQISGIVPQSLENLTS 592
C + + + + I D+ + + +++ ++ + + L++
Sbjct: 17 KCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQ 76
Query: 593 LVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
+ L+LN +++ EI + + ++ L + N + P + L VL L N L
Sbjct: 77 VELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDL 135
Query: 652 SGEVPEGV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
S +P G+ N LT L + NN L + TSL S N L+
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT 184
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 2e-18
Identities = 36/153 (23%), Positives = 59/153 (38%), Gaps = 13/153 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N+S N + + + I ++ LDASHN I+ + LT L L N L +
Sbjct: 198 NVSYNLL-STLAIPI-----AVEELDASHNSINVVRGPVNVELTI---LKLQHNNLT-DT 247
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L L + L+ N L + +++ LE L +S+N L + + L
Sbjct: 248 A-WLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +N L H+ L N++
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-16
Identities = 56/327 (17%), Positives = 111/327 (33%), Gaps = 27/327 (8%)
Query: 101 PLVGGLSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRV 159
+ L + L +N + + +++LE L + N L L + L+V
Sbjct: 248 AWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV 305
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSI 219
L+L+ N + + + F+ LE L L N + + L + L+ L LS+N+ +
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD--- 358
Query: 220 PSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLE 279
+ L R + + QL L + R L ++
Sbjct: 359 CNSLRALFRNVARPAVDDA------DQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTS 412
Query: 280 VLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNG----- 334
V++ + T+ N V+ ++ L G N + E V + A
Sbjct: 413 VVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQG-NEQLEAEVNELRAEVQQLTNE 471
Query: 335 --EKNSFIGSIPMEI-TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDL 391
++ + + EI T L + R+ L + + + L + R
Sbjct: 472 QIQQEQLLQGLHAEIDTNLRRYRLPKDGLARSSDNLNKVFTHLKERQAFKLRETQARRTE 531
Query: 392 IGVFDRCKKLHFIDLSSNELSGELDVK 418
+ K+ ++ + L +LD K
Sbjct: 532 A--DAKQKETEDLEQENIALEKQLDNK 556
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 9e-06
Identities = 35/191 (18%), Positives = 69/191 (36%), Gaps = 21/191 (10%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLR 158
L+ + L+VL L N ++LE L ++ N + L L+
Sbjct: 293 LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLK 348
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218
L L+ N D + +L F ++ + I L L + Y +
Sbjct: 349 NLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLD---- 402
Query: 219 IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKL 278
R L+++ L+ S+V ++ + G+C T+ ++ + + + L+
Sbjct: 403 ---------RLLQYIALT--SVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451
Query: 279 EVLDVSRNRLN 289
E L+ N L
Sbjct: 452 EQLEAEVNELR 462
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 44/193 (22%), Positives = 74/193 (38%), Gaps = 19/193 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G FG ++ E S K + V EI L RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESF 70
Query: 888 ASGNEMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALAYLHDQCAPR 943
S E+ +I+ ++ G ++ I R + V AL +LH
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFELNEREI-----VSYVHQVCEALQFLHSH---N 122
Query: 944 VLHRDVKPSNILLDDDFNAYL--SDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+ H D++P NI+ ++ + +FG +R L + + Y APE V
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVV 180
Query: 1002 SDKADVYSYGVVL 1014
S D++S G ++
Sbjct: 181 STATDMWSLGTLV 193
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-28
Identities = 51/214 (23%), Positives = 87/214 (40%), Gaps = 28/214 (13%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGY 886
+ GGF Y+A+ + G A+K+L + + E+ + + HPN+V
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 887 RA-------SGNEMFLIYNYLPGGNLENFIKARTSRAV--DWKILHKIALDVASALAYLH 937
+ +G FL+ L G L F+K SR +L KI A+ ++H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVL-KIFYQTCRAVQHMH 153
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA-----------G 986
Q P ++HRD+K N+LL + L DFG + + ++ +
Sbjct: 154 RQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212
Query: 987 TFGYVAPE---YALTCRVSDKADVYSYGVVLLEL 1017
T Y PE + +K D+++ G +L L
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 8e-28
Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 17/221 (7%)
Query: 806 DIGVPLTYESII-RATGDFN-----TSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF 858
GV L E++ ++ +FN TS +G G F + S G A K L R
Sbjct: 8 SSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR 67
Query: 859 -QHGVQQFHAEIKTLGNVRH-PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRA 916
Q + EI L + P ++ L + +E+ LI Y GG + + +
Sbjct: 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM 127
Query: 917 VDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLL 973
V + ++ + + YLH ++H D+KP NILL + + DFG+SR +
Sbjct: 128 VSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVL 1014
G + + GT Y+APE ++ D+++ G++
Sbjct: 185 GHACELRE--IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-27
Identities = 54/241 (22%), Positives = 84/241 (34%), Gaps = 53/241 (21%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
IG G +G A E + A+K V++ E++ + + HPN+ L
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILH-------------------- 923
+ L+ GG+L + + + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 924 ------------------KIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYL- 964
I + SAL YLH+Q + HRD+KP N L + + +
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIK 210
Query: 965 -SDFGLSRLLG---TSETHATTGVAGTFGYVAPE--YALTCRVSDKADVYSYGVVLLELI 1018
DFGLS+ E + T AGT +VAPE K D +S GV+L L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 1019 S 1019
Sbjct: 271 M 271
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 51/193 (26%), Positives = 82/193 (42%), Gaps = 18/193 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G+G FG ++ E + G A K + + + EI+T+ +RHP LV L
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 888 ASGNEMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALAYLHDQCAPR 943
NEM +IY ++ GG L + + + V L ++H+
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA-----VEYMRQVCKGLCHMHEN---N 275
Query: 944 VLHRDVKPSNILLDDDFNAYL--SDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+H D+KP NI+ + L DFGL+ L ++ GT + APE A V
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV--TTGTAEFAAPEVAEGKPV 333
Query: 1002 SDKADVYSYGVVL 1014
D++S GV+
Sbjct: 334 GYYTDMWSVGVLS 346
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 60/309 (19%), Positives = 96/309 (31%), Gaps = 54/309 (17%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L LR L L N P + L L LD+ N + L F L NL+ L +
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N + + SLE L L + + L L VL L + +N +I
Sbjct: 137 DNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDYS 195
Query: 224 GKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDV 283
K L+ L++S + + + L +L + L V + L L L++
Sbjct: 196 FKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNL 255
Query: 284 SRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSI 343
S N ++ + + L + L + L + +
Sbjct: 256 SYNPISTIEGSMLHELLRLQEIQLVG---------------------------GQ-LAVV 287
Query: 344 PMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHF 403
L L +LN++ N L VF L
Sbjct: 288 EPY--AFRGLN---------------------YLRVLNVSGNQLTTLEESVFHSVGNLET 324
Query: 404 IDLSSNELS 412
+ L SN L+
Sbjct: 325 LILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 58/259 (22%), Positives = 89/259 (34%), Gaps = 30/259 (11%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
R+L+L NRI +F LE L L N V V PG + LR L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNR 91
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW 274
L IP + L LD+S N +V + L++L + N L + R
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSG 150
Query: 275 LRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNG 334
L LE L + + L + L + L VL L +
Sbjct: 151 LNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRH------------------------- 185
Query: 335 EKNSFIGSIPMEI-TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIG 393
+ I +I L +L+++ + + +L L++ L
Sbjct: 186 --LN-INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYL 242
Query: 394 VFDRCKKLHFIDLSSNELS 412
L F++LS N +S
Sbjct: 243 AVRHLVYLRFLNLSYNPIS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 37/156 (23%), Positives = 68/156 (43%), Gaps = 7/156 (4%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L N I + D L L+ + N +S + P + NL +L L L N+L+ I
Sbjct: 38 DLGKNRI-KTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK-LI 95
Query: 608 PS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNL 665
P L L L +++N + + +L +L+ LE+ N L + L +L
Sbjct: 96 PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSL 154
Query: 666 TALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
L L+ L+ +P+ L+++ L + N++
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 6e-21
Identities = 31/165 (18%), Positives = 59/165 (35%), Gaps = 9/165 (5%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
F + + +N++ +I SL L ++ I ++L +L L+ L
Sbjct: 124 FQDLYNLKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLR 182
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPE 657
L + S RL L+ L ++ + + +L L ++ +L+ VP
Sbjct: 183 LRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPY 241
Query: 658 GV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
+L L L L N +S + L + L L+
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 9e-21
Identities = 33/153 (21%), Positives = 58/153 (37%), Gaps = 3/153 (1%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L+ N + + +LR L N++ I L++L LD++ NK+ +
Sbjct: 62 ELNENIV-SAVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILL 120
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNLT 666
L L+ L + DN+L + L SLE L L +L+ +P +L L
Sbjct: 121 DYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLI 179
Query: 667 ALLLDNNKLSGHLPSGLANVTSLSIFNASFNNL 699
L L + ++ + L + S
Sbjct: 180 VLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 37/163 (22%), Positives = 64/163 (39%), Gaps = 10/163 (6%)
Query: 541 EFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNG 600
+ +P I R+LD N+I + + L L+LN
Sbjct: 10 SAQDRAVLCHRKRFV-AVPEGI---PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNE 65
Query: 601 NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV 659
N + P + + L LR L L N L IP + L +L L++S N + + + +
Sbjct: 66 NIVSAVEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYM 123
Query: 660 -VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
+L NL +L + +N L ++ + + SL NL+
Sbjct: 124 FQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-16
Identities = 37/156 (23%), Positives = 63/156 (40%), Gaps = 7/156 (4%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L + NI I L+VL+ SH + + +L L + L +
Sbjct: 182 RLRHLNI-NAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AV 239
Query: 608 PS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNL 665
P ++ L YLR L+L+ N ++ S + EL L+ ++L L+ V L L
Sbjct: 240 PYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYL 298
Query: 666 TALLLDNNKLSGHLPSGL-ANVTSLSIFNASFNNLS 700
L + N+L+ L + +V +L N L+
Sbjct: 299 RVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 14/67 (20%), Positives = 26/67 (38%), Gaps = 5/67 (7%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
H ++ L + + LRVL+ S NQ++ + ++ +L L
Sbjct: 268 LHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLI 326
Query: 598 LNGNKLQ 604
L+ N L
Sbjct: 327 LDSNPLA 333
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 47/212 (22%), Positives = 81/212 (38%), Gaps = 17/212 (8%)
Query: 820 TGDFNTSNCIGSG--GFGTTYKA-EISPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNV 875
G + IG G T A G V V+++ + + V E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
HPN+V + NE++++ +++ G+ ++ I ++ + I V AL Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV---- 991
+H +HR VK S+IL+ D YLS + + + V
Sbjct: 144 IHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLP 200
Query: 992 --APEYALTCRVS---DKADVYSYGVVLLELI 1018
+PE L + K+D+YS G+ EL
Sbjct: 201 WLSPE-VLQQNLQGYDAKSDIYSVGITACELA 231
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 50/211 (23%), Positives = 100/211 (47%), Gaps = 28/211 (13%)
Query: 829 IGSGGFGTTYKAEI----SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTL 883
+G G FG+ + + + VAVK + + Q +++F +E + + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 884 IG-----YRASGNEMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALA 934
+G + +I ++ G+L ++ + + + L K +D+A +
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV--- 991
YL ++ LHRD+ N +L DD ++DFGLS+ + + + + G +
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMPVK 214
Query: 992 --APEYALTCRV-SDKADVYSYGVVLLELIS 1019
A E +L RV + K+DV+++GV + E+ +
Sbjct: 215 WIAIE-SLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-27
Identities = 37/277 (13%), Positives = 83/277 (29%), Gaps = 56/277 (20%)
Query: 790 DTRVQVSESRELTLFIDIGVPLTYESII-RATGDFNTSNCIGSGGFGTTYKA-EISPGIL 847
+ ++S T + G P ES + +G +A + G
Sbjct: 41 EYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGES 100
Query: 848 VAVK-----KLAVGRFQHGVQQFHAEIKTLGNVR----------------------HPNL 880
V + +++ ++ L ++ +
Sbjct: 101 FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKM 160
Query: 881 VTLIGYRASGNEM--FLIYNYLPGGNLENFI-----KARTSRAVDWKILHKIALDVASAL 933
+ + + F +Y NL+ F + T +++ ++ L V L
Sbjct: 161 IRVRLDERDMWVLSRFFLY-PRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 219
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
A LH ++H ++P +I+LD +L+ F G + + G+ P
Sbjct: 220 ASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARVV-----SSVSRGFEPP 271
Query: 994 EYALT-----------CRVSDKADVYSYGVVLLELIS 1019
E ++ D ++ G+V+ +
Sbjct: 272 ELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 45/210 (21%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG Y+ P VA+K + +F E + ++V
Sbjct: 33 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKAR--------TSRAVDWKILHKIALDVASALA 934
L+G + G +I + G+L++++++ + ++A ++A +A
Sbjct: 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV--- 991
YL+ + +HRD+ N ++ +DF + DFG++R + ++ + G G +
Sbjct: 153 YLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLPVR 205
Query: 992 --APEYALTCRVSDKADVYSYGVVLLELIS 1019
+PE + +DV+S+GVVL E+ +
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 9/200 (4%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP 878
F+ +G G +G+ YKA G +VA+K++ V + +Q+ EI + P
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV---ESDLQEIIKEISIMQQCDSP 84
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
++V G +++++ Y G++ + I+ R + +I I L YLH
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-ILQSTLKGLEYLHF 143
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
R +HRD+K NILL+ + +A L+DFG++ L + T + GT ++APE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQE 199
Query: 999 CRVSDKADVYSYGVVLLELI 1018
+ AD++S G+ +E+
Sbjct: 200 IGYNCVADIWSLGITAIEMA 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 48/204 (23%), Positives = 81/204 (39%), Gaps = 21/204 (10%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTL- 883
+G G +G + AVK K + R +G EI+ L +RH N++ L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 884 -IGYRASGNEMFLIYNYLPGGNLENF---IKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+ Y +M+++ Y G E + R ++ L YLH Q
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI----DGLEYLHSQ 128
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL--GTSETHATTGVAGTFGYVAPEYAL 997
++H+D+KP N+LL +S G++ L ++ T G+ + PE A
Sbjct: 129 ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS-QGSPAFQPPEIAN 184
Query: 998 TCRVSD--KADVYSYGVVLLELIS 1019
K D++S GV L + +
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITT 208
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 42/214 (19%), Positives = 82/214 (38%), Gaps = 39/214 (18%)
Query: 829 IGSGGFGTTYKAE--------ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
+G G F +K V +K L ++ + F + + H +L
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHL 74
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G G+E L+ ++ G+L+ ++K + ++ ++A +A+A+ +L +
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC-INILWKLEVAKQLAAAMHFLEEN- 132
Query: 941 APRVLHRDVKPSNILLDDDFNAY--------LSDFGLSRLLGTSETHATTGVAGTFGY-- 990
++H +V NILL + + LSD G+S + +
Sbjct: 133 --TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-----------ILQE 179
Query: 991 ----VAPEYALTCRV-SDKADVYSYGVVLLELIS 1019
V PE + + D +S+G L E+ S
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 58/219 (26%), Positives = 91/219 (41%), Gaps = 35/219 (15%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLV 881
+G+G FG +A + VAVK L + +E+K L + H N+V
Sbjct: 31 LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKAR----------------TSRAVDWKILHKI 925
L+G G +I Y G+L NF++ + A+D + L
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+ VA +A+L + +HRD+ NILL + DFGL+R + + V
Sbjct: 151 SYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY----VV 203
Query: 986 GTFGYV-----APEYALTCRVSDKADVYSYGVVLLELIS 1019
+ APE C + ++DV+SYG+ L EL S
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 62/215 (28%), Positives = 98/215 (45%), Gaps = 35/215 (16%)
Query: 829 IGSGGFGTTYKAEISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLI 884
IG G FG KA I + A+K++ + + F E++ L + HPN++ L+
Sbjct: 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI--------------LHKIALDVA 930
G ++L Y P GNL +F++ D L A DVA
Sbjct: 93 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY 990
+ YL + + +HRD+ NIL+ +++ A ++DFGLSR G T G
Sbjct: 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTM-----GR 202
Query: 991 V-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
+ A E +L V + +DV+SYGV+L E++S
Sbjct: 203 LPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-27
Identities = 54/215 (25%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLV 881
+G+G FG +A + VAVK L + +E+K + ++ +H N+V
Sbjct: 54 LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKAR------------TSRAVDWKILHKIALDV 929
L+G G + +I Y G+L NF++ + + + L + V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
A +A+L + +HRDV N+LL + A + DFGL+R + + +
Sbjct: 174 AQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVKGNA 226
Query: 990 YV-----APEYALTCRVSDKADVYSYGVVLLELIS 1019
+ APE C + ++DV+SYG++L E+ S
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 9e-27
Identities = 54/200 (27%), Positives = 101/200 (50%), Gaps = 9/200 (4%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP 878
+ IG G GT Y A +++ G VA++++ + + Q + EI + ++P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNL-QQQPKKELIINEILVMRENKNP 77
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
N+V + G+E++++ YL GG+L + + +D + + + AL +LH
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHS 134
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+V+HRD+K NILL D + L+DFG + ++ +T + GT ++APE
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTR 190
Query: 999 CRVSDKADVYSYGVVLLELI 1018
K D++S G++ +E+I
Sbjct: 191 KAYGPKVDIWSLGIMAIEMI 210
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 55/209 (26%), Positives = 95/209 (45%), Gaps = 23/209 (11%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIK-TLGNVRHPN 879
D +G G +G K P G ++AVK++ ++ ++ ++ V P
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPF 67
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYLH 937
VT G ++++ + +L+ F K + + IL KIA+ + AL +LH
Sbjct: 68 TVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ V+HRDVKPSN+L++ + DFG+S L AG Y+APE
Sbjct: 127 SKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDI--DAGCKPYMAPE--- 179
Query: 998 TCRVSD---------KADVYSYGVVLLEL 1017
R++ K+D++S G+ ++EL
Sbjct: 180 --RINPELNQKGYSVKSDIWSLGITMIEL 206
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 42/225 (18%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG KA + VAVK L ++ +E L V HP+++
Sbjct: 31 LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKAR----------------------TSRAVDWK 920
L G + + LI Y G+L F++ RA+
Sbjct: 91 LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980
L A ++ + YL + +++HRD+ NIL+ + +SDFGLSR + +++
Sbjct: 151 DLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY- 206
Query: 981 TTGVAGTFGYV-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
V + G + A E +L + + ++DV+S+GV+L E+++
Sbjct: 207 ---VKRSQGRIPVKWMAIE-SLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP 878
+ +G G FG YKA G L A K + + + ++ + EI+ L HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIET-KSEEELEDYIVEIEILATCDHP 76
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
+V L+G +++++ + PGG ++ + + +I + + AL +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCRQMLEALNFLHS 135
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ R++HRD+K N+L+ + + L+DFG+S + + + GT ++APE +
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMC 191
Query: 999 CRVSD-----KADVYSYGVVLLELI 1018
+ D KAD++S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEMA 216
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 59/228 (25%), Positives = 93/228 (40%), Gaps = 41/228 (17%)
Query: 807 IGVPLTYESIIRATGDFN----TSNCIGSGGFGTTYKA-EISPGILVAVK-----KLAVG 856
+GV + + R + F IG G + + + + AVK K
Sbjct: 4 VGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPT 63
Query: 857 RFQHGVQQFHAEIKTLG-NVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTS- 914
EI+ L +HPN++TL G ++++ + GG L + I +
Sbjct: 64 E----------EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFF 113
Query: 915 ---RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL-DDDFNAY---LSDF 967
A + + + YLH Q V+HRD+KPSNIL D+ N + DF
Sbjct: 114 SEREASA------VLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDF 164
Query: 968 GLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA-DVYSYGVVL 1014
G ++ L +E T +VAPE L + D A D++S GV+L
Sbjct: 165 GFAKQL-RAENGLLMTPCYTANFVAPE-VLERQGYDAACDIWSLGVLL 210
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 44/231 (19%), Positives = 81/231 (35%), Gaps = 45/231 (19%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNV-RHP 878
+F+ IGSG FG+ +K + G + A+K+ Q E+ + +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYL 936
++V A + M + Y GG+L + I R L + L V L Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAY-------------------LSDFGLSRLLGTSE 977
H ++H D+KPSNI + + D G + + +
Sbjct: 132 HSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 978 THATTGVAGTFGYVAPE-------YALTCRVSDKADVYSYGVVLLELISDK 1021
G ++A E + KAD+++ + ++ +
Sbjct: 189 V-----EEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAE 228
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 54/200 (27%), Positives = 95/200 (47%), Gaps = 9/200 (4%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP 878
++ IG G G A E G VAVK + + R Q + E+ + + +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDL-RKQQRRELLFNEVVIMRDYQHF 102
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
N+V + G E++++ +L GG L + + ++ + + + V ALAYLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHA 159
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
Q V+HRD+K +ILL D LSDFG + + + GT ++APE
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISR 215
Query: 999 CRVSDKADVYSYGVVLLELI 1018
+ + D++S G++++E++
Sbjct: 216 SLYATEVDIWSLGIMVIEMV 235
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 42/225 (18%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLV 881
+GSG FG A I VAVK L + +E+K + + H N+V
Sbjct: 53 LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI-------------------- 921
L+G ++LI+ Y G+L N+++++ + + +I
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 922 -LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980
L A VA + +L + +HRD+ N+L+ + DFGL+R + + +
Sbjct: 173 DLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY- 228
Query: 981 TTGVAGTFGYV-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
V + APE +L + + K+DV+SYG++L E+ S
Sbjct: 229 ---VVRGNARLPVKWMAPE-SLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 59/205 (28%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKT-LGNVRHPN 879
D IG G +G+ K P G ++AVK++ + +Q ++ + + P
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPY 82
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKA---RTSRAVDWKILHKIALDVASALAYL 936
+V G + ++ + + F K + +IL KI L AL +L
Sbjct: 83 IVQFYGALFREGDCWICMELMSTS-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL 141
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE-- 994
+ +++HRD+KPSNILLD N L DFG+S L ++ A T AG Y+APE
Sbjct: 142 KENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERI 197
Query: 995 --YALTCRVSDKADVYSYGVVLLEL 1017
A ++DV+S G+ L EL
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYEL 222
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 54/220 (24%), Positives = 100/220 (45%), Gaps = 37/220 (16%)
Query: 829 IGSGGFGTTYKAEI--------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPN 879
+G G FG AE + VAVK L + + +E++ + + +H N
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILHKI 925
++ L+G +++I Y GNL +++AR + +K L
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+A + YL Q + +HRD+ N+L+ ++ ++DFGL+R + + +
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 215
Query: 986 GTFGYV-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
T G + APE AL RV + ++DV+S+GV++ E+ +
Sbjct: 216 TTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 34/217 (15%)
Query: 829 IGSGGFGTTYKAE---ISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G FG YK +PG VA+K L ++F E ++HPN+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILHKIALD 928
L+G + +I++Y G+L F+ R A++ +
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG-- 986
+A+ + YL V+H+D+ N+L+ D N +SD GL R + ++ + G +
Sbjct: 137 IAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 987 ---TFGYVAPEYALTCRV-SDKADVYSYGVVLLELIS 1019
APE A+ S +D++SYGVVL E+ S
Sbjct: 194 IRWM----APE-AIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 66/245 (26%), Positives = 100/245 (40%), Gaps = 33/245 (13%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGY 886
+G G F K AVK ++ R + Q+ EI L HPN+V L
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS-KRMEANTQK---EITALKLCEGHPNIVKLHEV 74
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAP 942
FL+ L GG L IK + A I + SA++++HD
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASY------IMRKLVSAVSHMHDV--- 125
Query: 943 RVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
V+HRD+KP N+L +D+ + DFG +RL + T Y APE L
Sbjct: 126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK-PPDNQPLKTPCFTLHYAAPE-LLNQ 183
Query: 1000 RVSDKA-DVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR--QGQVKDVFNA 1056
D++ D++S GV+L ++S + F SH S ++ + +G F
Sbjct: 184 NGYDESCDLWSLGVILYTMLSGQ----VPFQSHDRSLTCTSAVEIMKKIKKGDFS--FEG 237
Query: 1057 ELWAS 1061
E W +
Sbjct: 238 EAWKN 242
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 5e-26
Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLV 881
+G G FG +A+ + VAVK L G + +E+K L ++ H N+V
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 882 TLIGY-RASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILHKIA 926
L+G G + +I + GNL +++++ + + L +
Sbjct: 95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG 986
VA + +L + + +HRD+ NILL + + DFGL+R + + V
Sbjct: 155 FQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRK 207
Query: 987 TFGYV-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
+ APE + RV + ++DV+S+GV+L E+ S
Sbjct: 208 GDARLPLKWMAPE-TIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 6e-26
Identities = 72/300 (24%), Positives = 128/300 (42%), Gaps = 56/300 (18%)
Query: 829 IGSGGFGTTYKAE---ISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPN 879
+G G FG AE I + VAVK L + + +E++ + + +H N
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILHKI 925
++ L+G +++I Y GNL +++AR + +K L
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+A + YL Q + +HRD+ N+L+ ++ ++DFGL+R + + +
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----KK 261
Query: 986 GTFGYV-----APEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFS-SHGDGFNII 1038
T G + APE AL RV + ++DV+S+GV++ E+ + P + F
Sbjct: 262 TTNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFT--LGGSPYPGIPVEELFK-- 316
Query: 1039 SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
LL++G D P + ++ + C S RPT KQ+V+ L +I
Sbjct: 317 -----LLKEGHRMDK---------PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 7/210 (3%)
Query: 105 GLSELRVLSLPFNGFSGEF--PPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
L++L LSL NG S + + L+ LD+ N + + + F+GL L L+
Sbjct: 50 KLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDF 108
Query: 163 AFNRIDGDIPFSL-RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
+ + FS+ + +L L+++ + G L VL ++ N +
Sbjct: 109 QHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP 168
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKC-QQLRTLLLFSNMLNDVIPRELGWLRKLEV 280
++ R L LDLS L ++ + L+ L + N + L L+V
Sbjct: 169 DIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227
Query: 281 LDVSRNRLNGLIPTELGNCVE-LSVLVLSN 309
LD S N + EL + L+ L L+
Sbjct: 228 LDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 35/164 (21%), Positives = 67/164 (40%), Gaps = 10/164 (6%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKL--QG 605
++ + +P I S L+ N++ + + LT L L L+ N L +G
Sbjct: 13 RCNSKGLT-SVPTGIPS---SATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68
Query: 606 EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRN 664
S L++L L+ N + + S+ L LE L+ ++L V ++LRN
Sbjct: 69 CCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 127
Query: 665 LTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLSGPFPWNV 707
L L + + +G ++SL + + N+ F ++
Sbjct: 128 LIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 170
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 7e-21
Identities = 48/191 (25%), Positives = 72/191 (37%), Gaps = 6/191 (3%)
Query: 122 EFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRID--GDIPFSLRNFE 179
P I L++E N L F L L L+L+ N + G S
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
SL+ L+L+ N V + FLG +L L ++ L + R L +LD+S
Sbjct: 79 SLKYLDLSFNGVITMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 240 LVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE-LGWLRKLEVLDVSRNRLNGLIPTELGN 298
L L + N + + LR L LD+S+ +L L PT +
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 197
Query: 299 CVELSVLVLSN 309
L VL +S+
Sbjct: 198 LSSLQVLNMSH 208
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 35/156 (22%), Positives = 61/156 (39%), Gaps = 4/156 (2%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+ ++N+ + + ++L LD SH L+SL L + GN Q
Sbjct: 107 DFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 166
Query: 608 PS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNL 665
L+ L L L+ L P++ L SL+VL +S N+ + L +L
Sbjct: 167 LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSL 225
Query: 666 TALLLDNNKLSGHLPSGLANV-TSLSIFNASFNNLS 700
L N + L + +SL+ N + N+ +
Sbjct: 226 QVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 52/251 (20%), Positives = 86/251 (34%), Gaps = 43/251 (17%)
Query: 170 DIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELN-GSIPSELGKYCR 228
+P + S L L N+++ + G +L L LS N L+ S+
Sbjct: 21 SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 229 YLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL-GWLRKLEVLDVSRNR 287
L++LDLS N ++ + S+ +QL L + L + + LR L LD+S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 288 LNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI 347
L VL ++ NSF + +I
Sbjct: 138 TRVAFNGIFNGLSSLEVLKMAG---------------------------NSFQENFLPDI 170
Query: 348 -TTLSKLRIIWAPRLNLEG----KLPSSWGAC-ESLEMLNLAQNVLRGDLIGVFDRCKKL 401
T L L L+L +L + SL++LN++ N + L
Sbjct: 171 FTELRNLT-----FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSL 225
Query: 402 HFIDLSSNELS 412
+D S N +
Sbjct: 226 QVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 40/138 (28%), Positives = 59/138 (42%), Gaps = 3/138 (2%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGN-FLSGRLPNEFVGLRNLRVLNL 162
L L L + I L LEVL + GN F LP+ F LRNL L+L
Sbjct: 124 SLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL 182
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
+ +++ P + + SL+VLN++ N + L+VL S N + S E
Sbjct: 183 SQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQE 242
Query: 223 LGKYCRYLEHLDLSGNSL 240
L + L L+L+ N
Sbjct: 243 LQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 25/117 (21%), Positives = 48/117 (41%), Gaps = 7/117 (5%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
F+G+ + ++ N+ + DI ++L LD S Q+ + P + +L+SL L+
Sbjct: 146 FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLN 205
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI--GELRSLEVLELSSNSLS 652
++ N L L+ L + N++ SL L L+ N +
Sbjct: 206 MSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 7e-26
Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 16/198 (8%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G +G A VAVK + + R + EI + H N+V G+R
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 888 ASGNEMFLIYNYLPGGNLENFI--KARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
GN +L Y GG L + I + H++ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGI---GIT 127
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRL--LGTSETHATTGVAGTFGYVAPEYALTCRVSD 1003
HRD+KP N+LLD+ N +SDFGL+ + E GT YVAPE L R
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPE-LLKRREFH 185
Query: 1004 --KADVYSYGVVLLELIS 1019
DV+S G+VL +++
Sbjct: 186 AEPVDVWSCGIVLTAMLA 203
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-25
Identities = 56/220 (25%), Positives = 102/220 (46%), Gaps = 37/220 (16%)
Query: 829 IGSGGFGTTYKAEI--------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPN 879
+G G FG AE + VAVK L + + +E++ + + +H N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW--------------KILHKI 925
++ L+G +++I Y GNL +++AR +++ K L
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
A VA + YL + + +HRD+ N+L+ +D ++DFGL+R + + +
Sbjct: 197 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----KK 249
Query: 986 GTFGYV-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
T G + APE AL R+ + ++DV+S+GV+L E+ +
Sbjct: 250 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 53/252 (21%), Positives = 96/252 (38%), Gaps = 43/252 (17%)
Query: 858 FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV 917
+ +I+ + N V + + +++ NL++++ R S
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 918 D-----WKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972
I +IA A+ +LH + ++HRD+KPSNI D + DFGL
Sbjct: 161 REHGVCLHIFIQIA----EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 213
Query: 973 LGTSETHAT-----------TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDK 1021
+ E T TG GT Y++PE S K D++S G++L EL+
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-- 271
Query: 1022 KALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVET 1081
SFS+ + II+ +R + +F + + M+ +
Sbjct: 272 -----SFSTQMERVRIIT----DVRNLKFPLLFTQK------YPQEHMMVQ---DMLSPS 313
Query: 1082 LSTRPTMKQVVQ 1093
+ RP +++
Sbjct: 314 PTERPEATDIIE 325
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 17/65 (26%), Positives = 31/65 (47%), Gaps = 1/65 (1%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
DF C+G GGFG ++A+ A+K++ + + ++ E+K L + HP +
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 881 VTLIG 885
V
Sbjct: 67 VRYFN 71
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 13/203 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGN-VRHPN 879
D +GSG G +K G ++AVK++ + ++ ++ + P
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPY 85
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V G + ++F+ + + +K R + +IL K+ + + AL YL ++
Sbjct: 86 IVQCFGTFITNTDVFIAMELMGTCAEK--LKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
V+HRDVKPSNILLD+ L DFG+S L + A AG Y+APE
Sbjct: 144 --HGVIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRSAGCAAYMAPERIDPP 199
Query: 1000 RVSD-----KADVYSYGVVLLEL 1017
+ +ADV+S G+ L+EL
Sbjct: 200 DPTKPDYDIRADVWSLGISLVEL 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 61/296 (20%), Positives = 109/296 (36%), Gaps = 47/296 (15%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG Y+ ++ + VAVK L + F E + H N+V
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILH-----KIALDVASALAYLH 937
IG F++ + GG+L++F++ R L +A D+A YL
Sbjct: 98 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 157
Query: 938 DQCAPRVLHRDVKPSNILLD---DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV--- 991
+ +HRD+ N LL A + DFG++R + + + G +
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC----AMLPVK 210
Query: 992 --APEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFS-SHGDGFNIISWASMLLRQ 1047
PE A + + K D +S+GV+L E+ S P S S+ + +
Sbjct: 211 WMPPE-AFMEGIFTSKTDTWSFGVLLWEIFS--LGYMPYPSKSNQEVLE-------FVTS 260
Query: 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
G + P + + + +C RP +++ ++ P+
Sbjct: 261 GGR-------MDP--PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD 307
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-25
Identities = 53/216 (24%), Positives = 96/216 (44%), Gaps = 33/216 (15%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + AE +LVAVK L + F E + L N++H ++V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA-RKDFQREAELLTNLQHEHIVK 81
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW--------------KILHKIALD 928
G G+ + +++ Y+ G+L F++A A+ + IA
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG-- 986
+AS + YL Q +HRD+ N L+ + + DFG+SR + +++ + G
Sbjct: 142 IASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198
Query: 987 ---TFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
PE + + + ++DV+S+GV+L E+ +
Sbjct: 199 IRWM----PPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 53/212 (25%), Positives = 94/212 (44%), Gaps = 19/212 (8%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RH 877
G F +G+G +G YK + G L A+K + V ++ EI L H
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT--GDEEEEIKQEINMLKKYSHH 80
Query: 878 PNLVTLIG------YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS 931
N+ T G ++++L+ + G++ + IK + + + I ++
Sbjct: 81 RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 140
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
L++LH +V+HRD+K N+LL ++ L DFG+S L + T GT ++
Sbjct: 141 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWM 196
Query: 992 APEYALTCRVSD-----KADVYSYGVVLLELI 1018
APE D K+D++S G+ +E+
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMA 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-25
Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 24/202 (11%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G +G A VAVK + + R + EI + H N+V G+R
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 888 ASGNEMFLIYNYLPGGNLENFI--KARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
GN +L Y GG L + I + H++ + + YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLM----AGVVYLHGI---GIT 127
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRL--LGTSETHATTGVAGTFGYVAPE------YAL 997
HRD+KP N+LLD+ N +SDFGL+ + E GT YVAPE +
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFH- 185
Query: 998 TCRVSDKADVYSYGVVLLELIS 1019
++ DV+S G+VL +++
Sbjct: 186 ----AEPVDVWSCGIVLTAMLA 203
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 53/216 (24%), Positives = 93/216 (43%), Gaps = 34/216 (15%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + AE +LVAVK L Q F E + L ++H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA-RQDFQREAELLTMLQHQHIVR 107
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDW-------------KILHKIALDV 929
G G + +++ Y+ G+L F+++ A L +A V
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
A+ + YL +HRD+ N L+ + DFG+SR + +++ + G
Sbjct: 168 AAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR----VGGRT 220
Query: 990 YV-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
+ PE ++ R + ++DV+S+GVVL E+ +
Sbjct: 221 MLPIRWMPPE-SILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 50/206 (24%), Positives = 86/206 (41%), Gaps = 30/206 (14%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGY 886
+G G + AVK + + H + E++ L + H N++ LI +
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEK-QPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAP 942
+ +L++ + GG++ + I R A + DVASAL +LH++
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV------VVQDVASALDFLHNK--- 130
Query: 943 RVLHRDVKPSNILL---DDDFNAYLSDFGLSRLL------GTSETHATTGVAGTFGYVAP 993
+ HRD+KP NIL + + DF L + T G+ Y+AP
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAP 190
Query: 994 E----YALTCRVSDKA-DVYSYGVVL 1014
E ++ + DK D++S GV+L
Sbjct: 191 EVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 60/302 (19%), Positives = 107/302 (35%), Gaps = 59/302 (19%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG Y+ ++ + VAVK L + F E + H N+V
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILH-----KIALDVASALAYLH 937
IG F++ + GG+L++F++ R L +A D+A YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE 198
Query: 938 DQCAPRVLHRDVKPSNILLD---DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV--- 991
+ +HRD+ N LL A + DFG++R + + + G +
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR----KGGCAMLPVK 251
Query: 992 --APEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM----- 1043
PE A + + K D +S+GV+L E+ S P + S
Sbjct: 252 WMPPE-AFMEGIFTSKTDTWSFGVLLWEIFS--LGYMP-------------YPSKSNQEV 295
Query: 1044 --LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
+ G + P + + + +C RP +++ ++
Sbjct: 296 LEFVTSGGR-------MDP--PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346
Query: 1102 PN 1103
P+
Sbjct: 347 PD 348
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 42/225 (18%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
IG G FG ++A P +VAVK L F E + +PN+V
Sbjct: 55 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI--------------------- 921
L+G A G M L++ Y+ G+L F+++ + V
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 922 -LHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980
IA VA+ +AYL ++ + +HRD+ N L+ ++ ++DFGLSR + +++ +
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY- 230
Query: 981 TTGVAGTFGYV-----APEYALTCRV-SDKADVYSYGVVLLELIS 1019
A + PE ++ + ++DV++YGVVL E+ S
Sbjct: 231 ---KADGNDAIPIRWMPPE-SIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 58/202 (28%), Positives = 88/202 (43%), Gaps = 12/202 (5%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLIG 885
IG G +G +K G +VA+KK +++ A EI+ L ++HPNLV L+
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKI-ALREIRMLKQLKHPNLVNLLE 69
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ L++ Y + + + R V ++ I A+ + H +
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKH---NCI 124
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
HRDVKP NIL+ L DFG +RLL + VA T Y +PE +
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDTQYGPP 183
Query: 1006 -DVYSYGVVLLELISDKKALDP 1026
DV++ G V EL+S L P
Sbjct: 184 VDVWAIGCVFAELLS-GVPLWP 204
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 26/154 (16%), Positives = 61/154 (39%), Gaps = 8/154 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L+N N+ ++ +++ L ++ + P + L++L L + G + +
Sbjct: 50 TLANINVTDLTGIEY---AHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGKDVTSDK 104
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+L L L L ++ + I + I L + ++LS N ++ + L L +
Sbjct: 105 IPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKS 163
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
L + + + G+ + L+ A + G
Sbjct: 164 LNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 28/162 (17%), Positives = 60/162 (37%), Gaps = 8/162 (4%)
Query: 130 LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189
+ L + + ++ L N++ L + + + +LE L + G
Sbjct: 43 MNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHA-TNYNP-ISGLSNLERLRIMGK 98
Query: 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLG 249
V L L +L +S++ + SI +++ + +DLS N + I L
Sbjct: 99 DVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT-LPKVNSIDLSYNGAITDI-MPLK 156
Query: 250 KCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL 291
+L++L + + ++D + KL L + G
Sbjct: 157 TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-18
Identities = 24/157 (15%), Positives = 62/157 (39%), Gaps = 10/157 (6%)
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
+ +L + LA + D+ + +++ L + P + L L +
Sbjct: 43 MNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK 98
Query: 214 ELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM-LNDVIPREL 272
++ L L LD+S ++ I + + ++ ++ L N + D++P L
Sbjct: 99 DVTSDKIPNLSG-LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP--L 155
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L +L+ L++ + ++ + + +L+ L +
Sbjct: 156 KTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFS 190
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 26/120 (21%), Positives = 49/120 (40%), Gaps = 4/120 (3%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
+P+ GLS L L + + + P + L L +LD+ + + + L +
Sbjct: 80 NYNPI-SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKV 138
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
++L++N DI L+ L+ LN+ + V + F KL L+ + G
Sbjct: 139 NSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 1e-15
Identities = 20/151 (13%), Positives = 58/151 (38%), Gaps = 10/151 (6%)
Query: 549 LSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP 608
L + +IP + + S + + SL ++ L + ++
Sbjct: 8 LKASQDNVNIPD------STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DL- 59
Query: 609 SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTAL 668
+ + ++ L++ + + T + I L +LE L + ++ + + L +LT L
Sbjct: 60 TGIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLL 117
Query: 669 LLDNNKLSGHLPSGLANVTSLSIFNASFNNL 699
+ ++ + + + + ++ + S+N
Sbjct: 118 DISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 4e-15
Identities = 29/164 (17%), Positives = 59/164 (35%), Gaps = 8/164 (4%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
++ L ++L + + I ++ L + + N GL NL L +
Sbjct: 41 AQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIM 96
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
+ D +L SL +L+++ + I + + K+ + LSYN I L
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPL 155
Query: 224 GKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267
L+ L++ + + + +L L FS +
Sbjct: 156 KT-LPELKSLNIQFDGVHD--YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 30/157 (19%), Positives = 53/157 (33%), Gaps = 11/157 (7%)
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
+ L + +I + SL + LA V + + ++ L ++
Sbjct: 22 FKAYLNGLLGQSSTA-NITEA--QMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNI 76
Query: 214 ELNGSIP-SELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL 272
P S L LE L + G + +L L L + + +D I ++
Sbjct: 77 HATNYNPISGLSN----LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L K+ +D+S N I L EL L +
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 8e-10
Identities = 19/124 (15%), Positives = 51/124 (41%), Gaps = 9/124 (7%)
Query: 577 NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG 636
+Q + +P + + L + + + L +++LA+ N+T + + I
Sbjct: 11 SQDNVNIP--DSTFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVTD-L-TGIE 63
Query: 637 ELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASF 696
+++ L +++ + + L NL L + ++ L+ +TSL++ + S
Sbjct: 64 YAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISH 121
Query: 697 NNLS 700
+
Sbjct: 122 SAHD 125
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 1e-09
Identities = 32/242 (13%), Positives = 71/242 (29%), Gaps = 62/242 (25%)
Query: 173 FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEH 232
F++ L + + + L + L+ + + + + +Y ++
Sbjct: 17 IPDSTFKAYLNGLLGQSSTANITEAQM---NSLTYITLANINVT-DL-TGI-EYAHNIKD 70
Query: 233 LDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLI 292
L ++ + + L L + + L L L +LD+S + + I
Sbjct: 71 LTINNIHA--TNYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 293 PTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSK 352
T++ +++ + LS N I I L
Sbjct: 129 LTKINTLPKVNSIDLSY---------------------------NGAITDI----MPLKT 157
Query: 353 LRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
L L+ LN+ + + D G + KL+ + S +
Sbjct: 158 L---------------------PELKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIG 194
Query: 413 GE 414
G+
Sbjct: 195 GK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 13/60 (21%), Positives = 22/60 (36%), Gaps = 6/60 (10%)
Query: 548 NLSNNNIIGHI-PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGE 606
+LS N I I PL L+ L+ + + +E+ L L + G+
Sbjct: 142 DLSYNGAITDIMPLK---TLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLIG 885
IG G +GT +KA +VA+K++ + GV A EI L ++H N+V L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVP-SSALREICLLKELKHKNIVRLHD 68
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
S ++ L++ + +L+ + + +D +I+ + L + H + VL
Sbjct: 69 VLHSDKKLTLVFEFCDQ-DLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSR---NVL 123
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV-SDK 1004
HRD+KP N+L++ + L++FGL+R G + V T Y P+ ++ S
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTS 182
Query: 1005 ADVYSYGVVLLELISDKKAL 1024
D++S G + EL + + L
Sbjct: 183 IDMWSAGCIFAELANAGRPL 202
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 31/216 (14%)
Query: 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVK-----KLAVGRFQHGVQQFHA--EIKTL 872
++T + +GSG FG + A V VK K+ + + EI L
Sbjct: 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAIL 83
Query: 873 GNVRHPNLVTLIGYRASGNEMFLIY-NYLPGGNLENFI--KARTSRAVDWKILHKIALDV 929
V H N++ ++ + L+ + G +L FI R + I ++
Sbjct: 84 SRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV--- 140
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
SA+ YL + ++HRD+K NI++ +DF L DFG + L + T GT
Sbjct: 141 -SAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIE 194
Query: 990 YVAPE------YALTCRVSDKADVYSYGVVLLELIS 1019
Y APE Y + +++S GV L L+
Sbjct: 195 YCAPEVLMGNPYR-----GPELEMWSLGVTLYTLVF 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 63/202 (31%), Positives = 97/202 (48%), Gaps = 25/202 (12%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG E G VAVK L + + V + EI+ L RHP+++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 886 YRASGNEMFLIYNYLPGGNLENFI--KARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
++ + F++ Y+ GG L ++I R ++ +I SA+ Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQIL----SAVDYCHRH---M 131
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE------YAL 997
V+HRD+KP N+LLD NA ++DFGLS ++ E T+ G+ Y APE YA
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISGRLYA- 188
Query: 998 TCRVSDKADVYSYGVVLLELIS 1019
+ D++S GV+L L+
Sbjct: 189 ----GPEVDIWSCGVILYALLC 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 55/205 (26%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG--VQQFHAEIKTLGNVR 876
F+ IG G FG Y A ++ +VA+KK++ Q Q E++ L +R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
HPN + G + +L+ Y G + + + + + + LAYL
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYL 170
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H ++HRDVK NILL + L DFG + ++ + + GT ++APE
Sbjct: 171 HSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVI 222
Query: 997 LTCRVSD---KADVYSYGVVLLELI 1018
L K DV+S G+ +EL
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELA 247
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-23
Identities = 45/246 (18%), Positives = 82/246 (33%), Gaps = 38/246 (15%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLR---------- 155
+++ L L S P + ++ VL++ N L LP L
Sbjct: 58 INQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPASLEYLDACDNRLS 113
Query: 156 -------NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208
+L+ L++ N++ +P LE +N NQ+ ++P S L VL
Sbjct: 114 TLPELPASLKHLDVDNNQLT-MLPELPAL---LEYINADNNQLT-MLPELPTS---LEVL 165
Query: 209 FLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN--- 265
+ N+L +P LE LD+S N L +P+ + +F
Sbjct: 166 SVRNNQLT-FLPELPES----LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRI 219
Query: 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELS 325
IP + L + + N L+ I L ++ + G+
Sbjct: 220 THIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRP 279
Query: 326 VGQSDA 331
+ +
Sbjct: 280 LADAVT 285
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.9 bits (246), Expect = 2e-21
Identities = 52/291 (17%), Positives = 82/291 (28%), Gaps = 66/291 (22%)
Query: 106 LSELRVLSLPFNGFS-------GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLR 158
L SL N F ++ EK + N L +
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFS 62
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218
L L + +P +L + VL + N + +P S L L N L+ +
Sbjct: 63 ELQLNRLNLS-SLPDNL--PPQITVLEITQNALI-SLPELPAS---LEYLDACDNRLS-T 114
Query: 219 IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKL 278
+P L+HLD+ N L +P L + +N L +P L
Sbjct: 115 LPELPAS----LKHLDVDNNQLT-MLPELPA---LLEYINADNNQLTM-LPELPT---SL 162
Query: 279 EVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNS 338
EVL V N+L L P + L L +S N
Sbjct: 163 EVLSVRNNQLTFL-PELPES---LEALDVST---------------------------N- 190
Query: 339 FIGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQN 385
+ S+P +P + + + + L N
Sbjct: 191 LLESLPAVPVRNHHSEETEI-FFRCRENRITHIPENILSLDPTCTIILEDN 240
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 98.1 bits (244), Expect = 4e-21
Identities = 53/303 (17%), Positives = 88/303 (29%), Gaps = 61/303 (20%)
Query: 102 LVGGLSELRVLSLPFNGF--SGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRV 159
+ +LP + E + + L + LS LP+ + V
Sbjct: 29 YFSAWDKWEKQALPGENRNEAVSLLKECL-INQFSELQLNRLNLS-SLPDNL--PPQITV 84
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSI 219
L + N + +P SLE L+ N++ +P S L+ L + N+L +
Sbjct: 85 LEITQNALI-SLP---ELPASLEYLDACDNRLS-TLPELPAS---LKHLDVDNNQLT-ML 135
Query: 220 PSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLE 279
P LE+++ N L +P L L + +N L +P LE
Sbjct: 136 PELPAL----LEYINADNNQLT-MLPELPT---SLEVLSVRNNQLTF-LPELPE---SLE 183
Query: 280 VLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSF 339
LDVS N L L P + N
Sbjct: 184 ALDVSTNLLESL-PAVPVRNHHSEETEIFF--------------------RCRE---NR- 218
Query: 340 IGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLIGVF 395
I IP I +L + LE + ++ + + G
Sbjct: 219 ITHIPENILSLDPTC-----TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 396 DRC 398
+
Sbjct: 274 NTL 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 96.6 bits (240), Expect = 1e-20
Identities = 42/208 (20%), Positives = 77/208 (37%), Gaps = 43/208 (20%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
L+ S P +L ++ N +I +P SL LDA N++S + P
Sbjct: 69 LNLS-SLPDNLPPQITVL-----EITQNALI-SLPELPA----SLEYLDACDNRLSTL-P 116
Query: 585 QSLENLT-----------------SLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNL 627
+ +L L +++ + N+L +P L LS+ +N L
Sbjct: 117 ELPASLKHLDVDNNQLTMLPELPALLEYINADNNQLT-MLPELPTSL---EVLSVRNNQL 172
Query: 628 TGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALL----LDNNKLSGHLPSGL 683
T +P SLE L++S+N L +P V + N+++ H+P +
Sbjct: 173 TF-LPELPE---SLEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENI 226
Query: 684 ANVTSLSIFNASFNNLSGPFPWNVTTMN 711
++ N LS +++
Sbjct: 227 LSLDPTCTIILEDNPLSSRIRESLSQQT 254
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-20
Identities = 41/214 (19%), Positives = 80/214 (37%), Gaps = 37/214 (17%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFL-AGANKLTGSFPGSLFQACNEFHGMVANLS 550
+ N LP P L L A N+L+ + P L + ++
Sbjct: 86 EITQNALIS----LPELPASLEY------LDACDNRLS-TLP-ELPASLKHL-----DVD 128
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
NN + +P L ++A +NQ++ + P+ +L L + N+L +P
Sbjct: 129 NNQLT-MLPELPA----LLEYINADNNQLTML-PELPTSLEVL---SVRNNQLT-FLPEL 178
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSIGELRSLE----VLELSSNSLSGEVPEGVVNLRNLT 666
L L ++ N L +P+ E N ++ +PE +++L
Sbjct: 179 PESL---EALDVSTNLLES-LPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTC 233
Query: 667 ALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
++L++N LS + L+ T+ ++ S
Sbjct: 234 TIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 5e-19
Identities = 46/216 (21%), Positives = 74/216 (34%), Gaps = 21/216 (9%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
+ L L N S P SL+ L DV+ N L+ LP L +N N
Sbjct: 99 PASLEYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-MLPEL---PALLEYINADNN 150
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
++ +P + LEVL++ NQ+ +P S L L +S N L S+P+ +
Sbjct: 151 QL-TMLPELPTS---LEVLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVR 201
Query: 226 YCR---YLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
N + IP ++ T++L N L+ I L
Sbjct: 202 NHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYH 260
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGR 318
R + + L+ V + + S
Sbjct: 261 GPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDV 296
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 1e-16
Identities = 40/194 (20%), Positives = 73/194 (37%), Gaps = 38/194 (19%)
Query: 525 NKLTGSFPGSLFQACNEFHGM-VANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI- 582
N ++ F A +++ + + N + + + L + +S +
Sbjct: 20 NTIS-GTYADYFSAWDKWEKQALPGENRNEAVSLLK---ECLINQFSELQLNRLNLSSLP 75
Query: 583 --VPQSLENL--------------TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNN 626
+P + L SL +LD N+L +P LK HL + +N
Sbjct: 76 DNLPPQITVLEITQNALISLPELPASLEYLDACDNRLS-TLPELPASLK---HLDVDNNQ 131
Query: 627 LTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANV 686
LT +P LE + +N L+ +PE +L L + NN+L+ LP ++
Sbjct: 132 LT-MLPELPA---LLEYINADNNQLT-MLPE---LPTSLEVLSVRNNQLT-FLPELPESL 182
Query: 687 TSLSIFNASFNNLS 700
+L + S N L
Sbjct: 183 EAL---DVSTNLLE 193
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 80.4 bits (198), Expect = 1e-15
Identities = 60/339 (17%), Positives = 99/339 (29%), Gaps = 72/339 (21%)
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAG---NQVKGVIPGFLGSFLKLRVLFLSYNELN 216
N +N I G ++ E L G N+ ++ L + L L+ L+
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS 72
Query: 217 GSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR 276
S+P L + L+++ N+L+ +P L L N L+ +P
Sbjct: 73 -SLPDNLPP---QITVLEITQNALI-SLPELPA---SLEYLDACDNRLST-LPELPA--- 120
Query: 277 KLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEK 336
L+ LDV N+L L P L + N
Sbjct: 121 SLKHLDVDNNQLTML-PELPAL---LEYINADN--------------------------- 149
Query: 337 NSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG--DLIGV 394
N + +P T+L L + R N LP ESLE L+++ N+L +
Sbjct: 150 NQ-LTMLPELPTSLEVLSV----RNNQLTFLPEL---PESLEALDVSTNLLESLPAVPVR 201
Query: 395 FDRCKKLH-FIDLSSNELS------GELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCH 447
++ F N ++ LD + N +S S R +
Sbjct: 202 NHHSEETEIFFRCRENRITHIPENILSLD-PTCT-----IILEDNPLS-SRIRESLSQQT 254
Query: 448 QMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAAR 486
P A +
Sbjct: 255 AQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQ 293
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 1e-11
Identities = 37/205 (18%), Positives = 61/205 (29%), Gaps = 37/205 (18%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLS- 550
+ N T LP P L A N+LT P +L
Sbjct: 126 DVDNNQLT----MLPELPALLEY-----INADNNQLT-MLPELP-----------TSLEV 164
Query: 551 ---NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSL----VFLDLNGNKL 603
NN + +P SL LD S N + + P +F N++
Sbjct: 165 LSVRNNQLTFLPELPE----SLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRI 219
Query: 604 QGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLR 663
IP ++ L + L DN L+ I S+ + + S + +G N
Sbjct: 220 T-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS--MSDGQQNTL 276
Query: 664 NLTALLLDNNKLSGHLPSGLANVTS 688
+ + S ++ +
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 3e-10
Identities = 48/243 (19%), Positives = 77/243 (31%), Gaps = 25/243 (10%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
+L+ L + L VLS+ N + P E LE LDV N L LP V +
Sbjct: 151 QLTMLPELPTSLEVLSVRNNQLT-FLPE---LPESLEALDVSTNLLE-SLPAVPVRNHHS 205
Query: 158 R----VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
NRI IP ++ + + + L N + S + +
Sbjct: 206 EETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDYHGPR 263
Query: 214 ELNGSIPSELGKYCRYLEH-----LDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268
+ R L + S V +I + + T F + L+D +
Sbjct: 264 IYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFSAFLDRLSDTV 323
Query: 269 ---------PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRN 319
+ WL KL R + + +C + L +NL LL +
Sbjct: 324 SARNTSGFREQVAAWLEKLSASAELRQQSFAVAADATESCEDRVALTWNNLRKTLLVHQA 383
Query: 320 IRG 322
G
Sbjct: 384 SEG 386
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 49/226 (21%), Positives = 87/226 (38%), Gaps = 36/226 (15%)
Query: 808 GVPLTYESIIRATGDFN-----TSNCIGSGGFGTTYKA-EISPGILVAVKKLA----VGR 857
G+ + ++ + +G G G + G A+K L +
Sbjct: 11 GLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ 70
Query: 858 FQHGVQQFHAEIKTLGNV-RHPNLVTLIGY----RASGNEMFLIYNYLPGGNLENFIKAR 912
E+ P++V ++ + +I + GG L + I+ R
Sbjct: 71 ----------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQER 120
Query: 913 TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGL 969
+A + +I D+ +A+ +LH + HRDVKP N+L + D L+DFG
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177
Query: 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA-DVYSYGVVL 1014
++ + T YVAPE L DK+ D++S GV++
Sbjct: 178 AKETTQNA---LQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIM 219
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 55/196 (28%), Positives = 88/196 (44%), Gaps = 24/196 (12%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNVRHPNLVTLIGY 886
IG G F A I G VA+K + + +Q+ E++ + + HPN+V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 887 RASGNEMFLIYNYLPGGNLENFIKAR------TSRAVDWKILHKIALDVASALAYLHDQC 940
+ ++LI Y GG + +++ A +R+ +I+ SA+ Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIV--------SAVQYCHQKR 134
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
++HRD+K N+LLD D N ++DFG S G Y APE +
Sbjct: 135 ---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPE-LFQGK 188
Query: 1001 VSD--KADVYSYGVVL 1014
D + DV+S GV+L
Sbjct: 189 KYDGPEVDVWSLGVIL 204
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 11/201 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLIGY 886
+G G +G YKA+ S G +VA+K++ + G+ A EI L + HPN+V+LI
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIP-STAIREISLLKELHHPNIVSLIDV 87
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
S + L++ ++ +L+ + + + + +A+ H R+LH
Sbjct: 88 IHSERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILH 142
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV-SDKA 1005
RD+KP N+L++ D L+DFGL+R G T V T Y AP+ + + S
Sbjct: 143 RDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYSTSV 201
Query: 1006 DVYSYGVVLLELISDKKALDP 1026
D++S G + E+I+ K L P
Sbjct: 202 DIWSIGCIFAEMIT-GKPLFP 221
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 49/221 (22%), Positives = 85/221 (38%), Gaps = 46/221 (20%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVK-----KLAVGRFQHGVQQFHA--------------- 867
IG G +G A + A+K KL
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 868 -----EIKTLGNVRHPNLVTL--IGYRASGNEMFLIYNYLPGGNLENFIKA-RTSRAVDW 919
EI L + HPN+V L + + + +++++ + G + S
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 920 KILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979
D+ + YLH Q +++HRD+KPSN+L+ +D + ++DFG+S S+
Sbjct: 141 FYFQ----DLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 980 ATTGVAGTFGYVAPEYALTCRVSDK------ADVYSYGVVL 1014
+ GT ++APE + + K DV++ GV L
Sbjct: 194 LSN-TVGTPAFMAPE---SLSETRKIFSGKALDVWAMGVTL 230
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 57/224 (25%), Positives = 96/224 (42%), Gaps = 32/224 (14%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
IGSG G A + VA+KKL+ FQ+ Q HA E+ + V H N++
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLS-RPFQN---QTHAKRAYRELVLMKCVNHKNIIG 88
Query: 883 LI------GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
L+ +++++ + NL I+ +L+++ + +L
Sbjct: 89 LLNVFTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSYLLYQML----CGIKHL 143
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H ++HRD+KPSNI++ D + DFGL+R + T T Y APE
Sbjct: 144 HSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 198
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
L + D++S G ++ E+I F + H D +N +
Sbjct: 199 LGMGYKENVDIWSVGCIMGEMIKGG----VLFPGTDHIDQWNKV 238
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-23
Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLIG 885
+G G +G K G +VA+KK V+ A EIK L +RH NLV L+
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK-KIAMREIKLLKQLRHENLVNLLE 91
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+L++ ++ + + ++ +D++++ K + + + + H ++
Sbjct: 92 VCKKKKRWYLVFEFVDH-TILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSH---NII 146
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
HRD+KP NIL+ L DFG +R L VA T Y APE + KA
Sbjct: 147 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKYGKA 205
Query: 1006 -DVYSYGVVLLELISDKKALDP 1026
DV++ G ++ E+ + L P
Sbjct: 206 VDVWAIGCLVTEMFM-GEPLFP 226
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 56/220 (25%), Positives = 92/220 (41%), Gaps = 20/220 (9%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA----EI--- 869
AT + IG G +GT YKA + G VA+K + V G E+
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 870 KTLGNVRHPNLVTLI-----GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHK 924
+ L HPN+V L+ ++ L++ ++ +L ++ + + +
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKD 124
Query: 925 IALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGV 984
+ L +LH ++HRD+KP NIL+ L+DFGL+R+ T V
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL-TPVV 180
Query: 985 AGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKAL 1024
T Y APE L + D++S G + E+ +K L
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-22
Identities = 79/477 (16%), Positives = 144/477 (30%), Gaps = 105/477 (22%)
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
+ ++L+ N + + L+ L + I + + L L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 240 LVGRIPSSLGKCQQLRTLLLFSNMLND-VIPREL-GWLRKLEVLDVSRNRLNGLIPTELG 297
+ + L L L L+ V+ L LE+L + N
Sbjct: 91 FLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN---------- 140
Query: 298 NCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIW 357
+ + ++ F + + L+ + + SI E L +
Sbjct: 141 ----IKKIQPASFFLNMRRFHVLD--LTFNK-----------VKSICEED--LLNFQGKH 181
Query: 358 APRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDV 417
L L S+ + ++ + L + G + + +DLS
Sbjct: 182 FTLLRLS-----------SITLQDMNEYWLGWEKCGNPFKNTSITTLDLS---------- 220
Query: 418 KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLG 477
GN S+ + ++ +QS L Y+
Sbjct: 221 -------------GNGFKESMAKRFFDAIAGTKIQSLILSNSYN---------------- 251
Query: 478 MPLLVSAARFMVIHNFSGNNFTG-PICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLF 536
+ +F NF + D L+ +K+ + S+F
Sbjct: 252 -----------MGSSFGHTNFKDPDNFTFKGLEASGVKTCD---LSK-SKIF-ALLKSVF 295
Query: 537 QACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFL 596
+ L+ N I I + L L+ S N + I + ENL L L
Sbjct: 296 SHFTDL--EQLTLAQNEI-NKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVL 352
Query: 597 DLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSL 651
DL+ N ++ + S L L+ L+L N L +P I L SL+ + L +N
Sbjct: 353 DLSYNHIR-ALGDQSFLGLPNLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 8e-21
Identities = 79/461 (17%), Positives = 140/461 (30%), Gaps = 92/461 (19%)
Query: 234 DLSGNSL--VGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL 291
L V +P+ + + L N + ++ L+ L+ L V + +
Sbjct: 16 ICINRGLHQVPELPAHV------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLV 69
Query: 292 IPTEL-GNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTL 350
I L +L L N +
Sbjct: 70 IRNNTFRGLSSLIILKLDY---------------------------NQ-FLQLETGA--F 99
Query: 351 SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI--GVFDRCKKLHFIDLSS 408
+ L +LE+L L Q L G ++ F L + L
Sbjct: 100 NGLA---------------------NLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRD 138
Query: 409 NELS----GELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSF 464
N + + + + D++ N + SI D L
Sbjct: 139 NNIKKIQPASFFLNM--RRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDM 195
Query: 465 TYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTD--YAFLA 522
+ + G P ++ + SGN F + T L+
Sbjct: 196 NEYW--LGWEKCGNPFKNTSIT---TLDLSGNGFK---ESMAKRFFDAIAGTKIQSLILS 247
Query: 523 GANKLTGSFPGSLFQACNE--FHGMVA------NLSNNNIIGHIPLDIGVMCKSLRVLDA 574
+ + SF + F+ + F G+ A +LS + I + + L L
Sbjct: 248 NSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLTL 306
Query: 575 SHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSS 634
+ N+I+ I + LT L+ L+L+ N L L L L L+ N++ +
Sbjct: 307 AQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQ 365
Query: 635 I-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNN 673
L +L+ L L +N L VP+G+ L +L + L N
Sbjct: 366 SFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-20
Identities = 70/332 (21%), Positives = 117/332 (35%), Gaps = 47/332 (14%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNL 162
L +L+ L + L L +L ++ N +L F GL NL VL L
Sbjct: 52 RLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTL 110
Query: 163 AFNRIDGDI--PFSLRNFESLEVLNLAGNQVKGVIP-GFLGSFLKLRVLFLSYNELNGSI 219
+DG + + SLE+L L N +K + P F + + VL L++N++ SI
Sbjct: 111 TQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SI 169
Query: 220 PSE--LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
E L ++ L LS +L + L
Sbjct: 170 CEEDLLNFQGKHFTLLRLSSITL----------------QDMNEYWLGWEKCGNPFKNTS 213
Query: 278 LEVLDVSRNRLNGLIP---TELGNCVELSVLVLSNLFDPLLS-GRNIRGELSVGQSDASN 333
+ LD+S N + + ++ L+LSN ++ S G +
Sbjct: 214 ITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLE 273
Query: 334 GEK-------NSFIGSIPMEI-TTLSKLRIIWAPRLNLEG----KLPS-SWGACESLEML 380
S I ++ + + + L +L L K+ ++ L L
Sbjct: 274 ASGVKTCDLSKSKIFALLKSVFSHFTDLE-----QLTLAQNEINKIDDNAFWGLTHLLKL 328
Query: 381 NLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
NL+QN L +F+ KL +DLS N +
Sbjct: 329 NLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 6/138 (4%)
Query: 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNN 626
+ +D S N I+ + S L L FL + I + + L L L L N
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 627 LTGGIPSSI-GELRSLEVLELSSNSL-SGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGL 683
+ + L +LEVL L+ +L + L +L L+L +N + P+
Sbjct: 91 FL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 684 -ANVTSLSIFNASFNNLS 700
N+ + + +FN +
Sbjct: 150 FLNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-15
Identities = 37/194 (19%), Positives = 63/194 (32%), Gaps = 26/194 (13%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
N + S F + + I + SL +L +NQ
Sbjct: 40 NSIAELNETS-------FSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92
Query: 581 GIVPQSLENLTSLVFLDLNGNKLQGEI--PSSLHRLKYLRHLSLADNNLTGGIPSSI-GE 637
+ + L +L L L L G + + L L L L DNN+ P+S
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 638 LRSLEVLELSSNSLSGEVPEGV-----------VNLRNLTALLLDNNKLSGHLPSGLANV 686
+R VL+L+ N + + E + L ++T ++ L
Sbjct: 153 MRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKN 211
Query: 687 TSLSIFNASFNNLS 700
TS++ + S N
Sbjct: 212 TSITTLDLSGNGFK 225
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 69/338 (20%), Positives = 115/338 (34%), Gaps = 66/338 (19%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIW--SLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLN 161
GL+ L VL+L G + L LE+L + N + P F+ +R VL+
Sbjct: 101 GLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLD 160
Query: 162 LAFNRIDGDIPFSLRNFES--LEVLNLAGNQVKGVIPGFL-----GSFLK---LRVLFLS 211
L FN++ L NF+ +L L+ ++ + +L G+ K + L LS
Sbjct: 161 LTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLS 220
Query: 212 YNELNGSIPSELGKYCR-------YLEHLDLSGNSLVGRIPSSLGKCQ-------QLRTL 257
N S+ L + G+S ++T
Sbjct: 221 GNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTC 280
Query: 258 LLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSG 317
L + + ++ LE L +++N +N + L L LS
Sbjct: 281 DLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLS--------- 331
Query: 318 RNIRGELSVGQSDASNGEKNSFIGSIPMEI-TTLSKLRIIWAPRLNLEG-KLPS-SWGA- 373
+F+GSI + L KL L+L + + +
Sbjct: 332 -------------------QNFLGSIDSRMFENLDKLE-----VLDLSYNHIRALGDQSF 367
Query: 374 --CESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSN 409
+L+ L L N L+ G+FDR L I L +N
Sbjct: 368 LGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 3e-10
Identities = 33/135 (24%), Positives = 56/135 (41%), Gaps = 3/135 (2%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
S ++ L + ++S LE L + N ++ N F GL +L LNL+ N
Sbjct: 275 SGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQN 333
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
+ N + LEVL+L+ N ++ + L+ L L N+L S+P +
Sbjct: 334 FLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLK-SVPDGIFD 392
Query: 226 YCRYLEHLDLSGNSL 240
L+ + L N
Sbjct: 393 RLTSLQKIWLHTNPW 407
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-22
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 30/200 (15%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVK----KLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVT 882
+G G G + A+K R E++ + P++V
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----------EVELHWRASQCPHIVR 119
Query: 883 LIGY----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
++ A + ++ L GG L + I+ R +A + +I + A+ YLH
Sbjct: 120 IVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179
Query: 939 QCAPRVLHRDVKPSNILL-DDDFNAYL--SDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
+ HRDVKP N+L NA L +DFG ++ + + T T YVAPE
Sbjct: 180 I---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPE- 233
Query: 996 ALTCRVSDKA-DVYSYGVVL 1014
L DK+ D++S GV++
Sbjct: 234 VLGPEKYDKSCDMWSLGVIM 253
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 1e-22
Identities = 54/199 (27%), Positives = 97/199 (48%), Gaps = 11/199 (5%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLIGY 886
IG G +G YKA+ + G A+KK+ + + G+ EI L ++H N+V L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIP-STTIREISILKELKHSNIVKLYDV 68
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
+ + L++ +L +L+ + ++ L + + +AY HD+ RVLH
Sbjct: 69 IHTKKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLH 123
Query: 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV-SDKA 1005
RD+KP N+L++ + ++DFGL+R G T + T Y AP+ + + S
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYSTTI 182
Query: 1006 DVYSYGVVLLELISDKKAL 1024
D++S G + E+++ L
Sbjct: 183 DIWSVGCIFAEMVN-GTPL 200
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 48/200 (24%), Positives = 81/200 (40%), Gaps = 23/200 (11%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVR----HP 878
+G GGFGT + ++ + VA+K ++ E+ L V HP
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 879 NLVTLIGYRASGNEMFLIYNY-LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
++ L+ + + L+ LP +L ++I + + V +A+ + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCH 156
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAY-LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
+ V+HRD+K NIL+D L DFG LL GT Y PE+
Sbjct: 157 SR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYSPPEW- 209
Query: 997 LTCRVSD--KADVYSYGVVL 1014
++ A V+S G++L
Sbjct: 210 ISRHQYHALPATVWSLGILL 229
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 4e-22
Identities = 53/278 (19%), Positives = 98/278 (35%), Gaps = 21/278 (7%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192
++ LD+ N ++ ++ NL+ L L N I+ S + SLE L+L+ N +
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKC 251
+ + L L L N + L + L+ L + +I
Sbjct: 114 NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGL 173
Query: 252 QQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311
L L + ++ L P+ L ++ + L + + L+ + + L L +
Sbjct: 174 TFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTD 233
Query: 312 DPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSW 371
L + S+ S GE NS I ++ + ++
Sbjct: 234 ---LDTFHF--------SELSTGETNSLIKKFTFRNVKITDESLF---------QVMKLL 273
Query: 372 GACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSN 409
L L ++N L+ G+FDR L I L +N
Sbjct: 274 NQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-19
Identities = 40/156 (25%), Positives = 65/156 (41%), Gaps = 5/156 (3%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+LSNN I +I C +L+ L + N I+ I S +L SL LDL+ N L +
Sbjct: 58 DLSNNRI-TYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NL 115
Query: 608 PSSL-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRN 664
SS L L L+L N +S+ L L++L + + ++ L
Sbjct: 116 SSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTF 175
Query: 665 LTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L +D + L + P L ++ ++S
Sbjct: 176 LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 5e-16
Identities = 40/195 (20%), Positives = 72/195 (36%), Gaps = 12/195 (6%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIW--SLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLN 161
LS L L+L N + L KL++L V ++ + F GL L L
Sbjct: 122 PLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 162 LAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
+ + + P SL++ +++ L L Q ++ F+ + L L +L+ S
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 222 ELG-------KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW 274
EL ++ ++ SL ++ L + L L N L V
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDR 299
Query: 275 LRKLEVLDVSRNRLN 289
L L+ + + N +
Sbjct: 300 LTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 36/137 (26%), Positives = 55/137 (40%), Gaps = 6/137 (4%)
Query: 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNN 626
+++ LD S+N+I+ I L+ +L L L N + I S L L HL L+ N
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY 111
Query: 627 LTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSG-L 683
L+ + SS L SL L L N + +L L L + N +
Sbjct: 112 LS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDF 170
Query: 684 ANVTSLSIFNASFNNLS 700
A +T L ++L
Sbjct: 171 AGLTFLEELEIDASDLQ 187
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 39/171 (22%), Positives = 68/171 (39%), Gaps = 11/171 (6%)
Query: 540 NEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVF 595
++ V L++N I I D SL LD S+N +S + + L+SL F
Sbjct: 70 SDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTF 128
Query: 596 LDLNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSG 653
L+L GN + +SL L L+ L + + + I L LE LE+ ++ L
Sbjct: 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQ- 187
Query: 654 EVPEGV-VNLRNLTALLLDNNKLSGHLPSGL-ANVTSLSIFNASFNNLSGP 702
+++N++ L+L + L +S+ +L
Sbjct: 188 SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTF 237
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 32/163 (19%), Positives = 56/163 (34%), Gaps = 10/163 (6%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHN-QISGIVPQSLENLTSLVFLDLNGNKLQGE 606
NL N + L++L + + I + LT L L+++ + LQ
Sbjct: 130 NLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSG----EVPEGV--- 659
P SL ++ + HL L + + S+E LEL L E+ G
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249
Query: 660 -VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
+ + + + L + L ++ L S N L
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS 291
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 2e-14
Identities = 25/137 (18%), Positives = 54/137 (39%), Gaps = 12/137 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG-- 605
+ +++ +++ L Q ++ ++ +S+ L+L L
Sbjct: 180 EIDASDL-QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFH 238
Query: 606 --EIPS----SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV 659
E+ + SL + R++ + D +L + + ++ L LE S N L VP+G+
Sbjct: 239 FSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLNQISGLLELEFSRNQLKS-VPDGI 296
Query: 660 V-NLRNLTALLLDNNKL 675
L +L + L N
Sbjct: 297 FDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 12/83 (14%), Positives = 32/83 (38%), Gaps = 3/83 (3%)
Query: 548 NLSNNNI--IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG 605
+L + + + + + R + + + + + L ++ L+ L+ + N+L+
Sbjct: 233 DLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQV-MKLLNQISGLLELEFSRNQLKS 291
Query: 606 EIPSSLHRLKYLRHLSLADNNLT 628
RL L+ + L N
Sbjct: 292 VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 99.8 bits (249), Expect = 4e-22
Identities = 51/204 (25%), Positives = 73/204 (35%), Gaps = 7/204 (3%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
++ + G S E P I L++ N + + F L +L VL L N
Sbjct: 54 NQFSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNS 110
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY 226
I + SL L L N + + G KLR L+L N + SIPS
Sbjct: 111 IRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 227 CRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L LDL + I + L+ L L + D+ L L LE L++S
Sbjct: 170 VPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSG 227
Query: 286 NRLNGLIPTELGNCVELSVLVLSN 309
N + P L L + N
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMN 251
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.4 bits (240), Expect = 5e-21
Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 6/207 (2%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L L VL L N + L L L++ N+L+ F L LR L L
Sbjct: 97 HLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLR 155
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAG-NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
N I+ ++ SL L+L +++ + G L+ L L + +P+
Sbjct: 156 NNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN- 213
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
LE L++SGN P S L+ L + ++ ++ + L L L+
Sbjct: 214 -LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELN 272
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSN 309
++ N L+ L L L L +
Sbjct: 273 LAHNNLSSLPHDLFTPLRYLVELHLHH 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 41/165 (24%), Positives = 66/165 (40%), Gaps = 12/165 (7%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASH-NQISGIVPQSLENLTSLVFL 596
F + L NN I IP SL LD ++ I + E L +L +L
Sbjct: 143 FEYLSKLRELWLRNNPI-ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYL 201
Query: 597 DLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVP 656
+L ++ ++P+ L L L L ++ N+ P S L SL+ L + ++ +S +
Sbjct: 202 NLGMCNIK-DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIE 258
Query: 657 EGV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNL 699
L +L L L +N LS LP + L + N
Sbjct: 259 RNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 48/156 (30%), Positives = 61/156 (39%), Gaps = 8/156 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NL NNI I D L VL N I I + L SL L+L N L I
Sbjct: 81 NLMENNI-QMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VI 138
Query: 608 PS-SLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRN 664
PS + L LR L L +N + IPS + SL L+L + EG L N
Sbjct: 139 PSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFN 197
Query: 665 LTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L L + +P+ L + L S N+
Sbjct: 198 LKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHFP 231
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 38/154 (24%), Positives = 59/154 (38%), Gaps = 10/154 (6%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
+ +P I + R L+ N I I + +L L L L N ++ +
Sbjct: 62 TRRGLSEVPQGIPS---NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGA 118
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTAL 668
+ L L L L DN LT IPS L L L L +N + +P + +L L
Sbjct: 119 FNGLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRL 176
Query: 669 -LLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
L + KL ++ G + +L N N+
Sbjct: 177 DLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK 209
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 3e-17
Identities = 39/184 (21%), Positives = 65/184 (35%), Gaps = 6/184 (3%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
GL+ L L L N + P L KL L + N + F + +L L+L
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLG 179
Query: 164 -FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
+++ + +L+ LNL +K +P + L L +S N I
Sbjct: 180 ELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTP-LVGLEELEMSGNHFP-EIRPG 236
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
L+ L + + + ++ L L L N L+ + LR L L
Sbjct: 237 SFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELH 296
Query: 283 VSRN 286
+ N
Sbjct: 297 LHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 8e-17
Identities = 62/265 (23%), Positives = 85/265 (32%), Gaps = 49/265 (18%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
N R LNL N I + R+ LEVL L N ++ + G L L L N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFS-NMLNDVIPREL 272
L IPS +Y L L L N + IPS + + L L L L +
Sbjct: 135 LT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAF 192
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332
L L+ L++ + + L V L L +S
Sbjct: 193 EGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSG----------------------- 227
Query: 333 NGEKNSFIGSIPME-ITTLSKLRIIWAPRLNLEG----KLPSSWGA---CESLEMLNLAQ 384
N I LS L+ +L + + A SL LNLA
Sbjct: 228 ----NH-FPEIRPGSFHGLSSLK-----KLWVMNSQVSLIER--NAFDGLASLVELNLAH 275
Query: 385 NVLRGDLIGVFDRCKKLHFIDLSSN 409
N L +F + L + L N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 8e-16
Identities = 32/138 (23%), Positives = 50/138 (36%), Gaps = 4/138 (2%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
+ L L L + L L+ L++ + +P L L L ++
Sbjct: 169 RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMS 226
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N P S SL+ L + +QV + L L L++N L+ S+P +L
Sbjct: 227 GNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDL 285
Query: 224 GKYCRYLEHLDLSGNSLV 241
RYL L L N
Sbjct: 286 FTPLRYLVELHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 6e-14
Identities = 36/135 (26%), Positives = 50/135 (37%), Gaps = 14/135 (10%)
Query: 521 LAGANKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASH 576
L KL G+ F G+ NL NI +P + L L+ S
Sbjct: 178 LGELKKLEYISEGA-------FEGLFNLKYLNLGMCNIK-DMPNLTPL--VGLEELEMSG 227
Query: 577 NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG 636
N I P S L+SL L + +++ ++ L L L+LA NNL+
Sbjct: 228 NHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFT 287
Query: 637 ELRSLEVLELSSNSL 651
LR L L L N
Sbjct: 288 PLRYLVELHLHHNPW 302
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 99.9 bits (249), Expect = 6e-22
Identities = 60/204 (29%), Positives = 98/204 (48%), Gaps = 31/204 (15%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG + G VAVK K+ +++ EI+ L RHP+++
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR---EIQNLKLFRHPHIIK 80
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFI--KARTSRAVDWKILHKIALDVASALAYLHDQC 940
L ++ +++F++ Y+ GG L ++I R ++ +I S + Y H
Sbjct: 81 LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQIL----SGVDYCHRH- 135
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE------ 994
V+HRD+KP N+LLD NA ++DFGLS ++ E T+ G+ Y APE
Sbjct: 136 --MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVISGRL 191
Query: 995 YALTCRVSDKADVYSYGVVLLELI 1018
YA + D++S GV+L L+
Sbjct: 192 YA-----GPEVDIWSSGVILYALL 210
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 7e-22
Identities = 52/204 (25%), Positives = 79/204 (38%), Gaps = 7/204 (3%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
++ + E P I +L++ N + N F LR+L +L L+ N
Sbjct: 43 NQFSKVICVRKNLR-EVPDGI--STNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNH 99
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY 226
I + +L L L N++ + G KL+ L+L N + SIPS
Sbjct: 100 IRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNR 158
Query: 227 CRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L LDL + I + LR L L L + IP L L KL+ LD+S
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE-IP-NLTPLIKLDELDLSG 216
Query: 286 NRLNGLIPTELGNCVELSVLVLSN 309
N L+ + P + L L +
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQ 240
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 49/207 (23%), Positives = 76/207 (36%), Gaps = 6/207 (2%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L L +L L N L L L++ N L+ FV L L+ L L
Sbjct: 86 HLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLR 144
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAG-NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
N I+ ++ SL L+L ++ + G LR L L+ L IP+
Sbjct: 145 NNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNL 203
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
L+ LDLSGN L P S L+ L + + + + L+ L ++
Sbjct: 204 TP--LIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEIN 261
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSN 309
++ N L L L + L +
Sbjct: 262 LAHNNLTLLPHDLFTPLHHLERIHLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 45/165 (27%), Positives = 70/165 (42%), Gaps = 12/165 (7%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASH-NQISGIVPQSLENLTSLVFL 596
F + L NN I IP SLR LD ++S I + E L++L +L
Sbjct: 132 FVYLSKLKELWLRNNPI-ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYL 190
Query: 597 DLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVP 656
+L L+ EIP+ L L L L L+ N+L+ P S L L+ L + + + +
Sbjct: 191 NLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIE 247
Query: 657 EGV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNL 699
NL++L + L +N L+ LP + L + N
Sbjct: 248 RNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-19
Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 8/156 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDL-NGNKLQGE 606
L +N + IP V L+ L +N I I + + SL LDL +L
Sbjct: 118 ELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYI 176
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNL 665
+ L LR+L+LA NL IP+ + L L+ L+LS N LS + G L +L
Sbjct: 177 SEGAFEGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSGNHLS-AIRPGSFQGLMHL 233
Query: 666 TALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
L + +++ + N+ SL N + NNL+
Sbjct: 234 QKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 7e-18
Identities = 40/154 (25%), Positives = 67/154 (43%), Gaps = 10/154 (6%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
+ +P I + R+L+ NQI I S ++L L L L+ N ++ +
Sbjct: 51 VRKNLREVPDGIST---NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGA 107
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTAL 668
+ L L L L DN LT IP+ L L+ L L +N + +P + +L L
Sbjct: 108 FNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRL 165
Query: 669 -LLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
L + +LS ++ G +++L N + NL
Sbjct: 166 DLGELKRLS-YISEGAFEGLSNLRYLNLAMCNLR 198
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 1e-17
Identities = 35/150 (23%), Positives = 62/150 (41%), Gaps = 7/150 (4%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
N + S P F +L + +I +LR L+ + + I
Sbjct: 146 NPIE-SIPSYAFNRIPSLR--RLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-- 200
Query: 585 QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVL 644
+L L L LDL+GN L P S L +L+ L + + + ++ L+SL +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 645 ELSSNSLSGEVPEGVV-NLRNLTALLLDNN 673
L+ N+L+ +P + L +L + L +N
Sbjct: 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 2e-17
Identities = 45/185 (24%), Positives = 75/185 (40%), Gaps = 8/185 (4%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNL 162
GL+ L L L N + P L KL+ L + N + +P+ F + +LR L+L
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167
Query: 163 A-FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
R+ + +L LNLA ++ IP +KL L LS N L+ +I
Sbjct: 168 GELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTP-LIKLDELDLSGNHLS-AIRP 224
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
+ +L+ L + + + ++ Q L + L N L + L LE +
Sbjct: 225 GSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERI 284
Query: 282 DVSRN 286
+ N
Sbjct: 285 HLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 83.3 bits (206), Expect = 9e-17
Identities = 62/258 (24%), Positives = 96/258 (37%), Gaps = 35/258 (13%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
N R+LNL N+I S ++ LE+L L+ N ++ + G L L L N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL-GKCQQLRTLLLFS-NMLNDVIPREL 272
L +IP+ Y L+ L L N + IPS + LR L L L+ +
Sbjct: 124 LT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAF 181
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332
L L L+++ L IP L ++L L LS
Sbjct: 182 EGLSNLRYLNLAMCNLRE-IPN-LTPLIKLDELDLSG----------------------- 216
Query: 333 NGEKNSFIGSIPMEI-TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDL 391
N + +I L L+ +W + ++ +++ +SL +NLA N L
Sbjct: 217 ----NH-LSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLP 271
Query: 392 IGVFDRCKKLHFIDLSSN 409
+F L I L N
Sbjct: 272 HDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 29/138 (21%), Positives = 51/138 (36%), Gaps = 4/138 (2%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
+ LR L L L L L++ L +P L L L+L+
Sbjct: 158 RIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLS 215
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N + P S + L+ L + +Q++ + + L + L++N L +P +L
Sbjct: 216 GNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274
Query: 224 GKYCRYLEHLDLSGNSLV 241
+LE + L N
Sbjct: 275 FTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 9e-09
Identities = 46/211 (21%), Positives = 62/211 (29%), Gaps = 53/211 (25%)
Query: 202 FLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS 261
R+L L N++ I K+ R+LE L LS N + + L TL LF
Sbjct: 63 STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFD 121
Query: 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIR 321
N L + +L KL+ L + N + + L L L
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGE------------ 169
Query: 322 GELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLN 381
+ I L +L LN
Sbjct: 170 ---------------LKRLSYISEG--AFEGL---------------------SNLRYLN 191
Query: 382 LAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
LA LR I KL +DLS N LS
Sbjct: 192 LAMCNLRE--IPNLTPLIKLDELDLSGNHLS 220
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 8e-22
Identities = 41/158 (25%), Positives = 61/158 (38%), Gaps = 16/158 (10%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
+T + P L + E H L N I + +L L S N IS +
Sbjct: 181 TNIT-TIPQGLPPSLTELH-----LDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDN 233
Query: 585 QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG------GIPSSIGEL 638
SL N L L LN NKL ++P L KY++ + L +NN++ P +
Sbjct: 234 GSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292
Query: 639 RSLEVLELSSNSLS-GEVPEGV-VNLRNLTALLLDNNK 674
S + L SN + E+ + A+ L N K
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 41/156 (26%), Positives = 66/156 (42%), Gaps = 11/156 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
LS N + +P M K+L+ L N+I+ + L ++ ++L N L+
Sbjct: 106 YLSKNQL-KELPEK---MPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG 161
Query: 608 --PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRN 664
+ +K L ++ +AD N+T IP + SL L L N ++ +V L N
Sbjct: 162 IENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNN 217
Query: 665 LTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L L N +S LAN L + + N L
Sbjct: 218 LAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV 253
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 53/301 (17%), Positives = 102/301 (33%), Gaps = 49/301 (16%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192
+LD++ N ++ +F L+NL L L N+I P + LE L L+ NQ+K
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL-VGRIPS-SLGK 250
+P L+ L + NE+ + + + ++L N L I + +
Sbjct: 114 -ELPE--KMPKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG 169
Query: 251 CQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN- 309
++L + + + IP+ L L L + N++ + L L+ L LS
Sbjct: 170 MKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 226
Query: 310 --------LFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRL 361
++R EL + N+ + +P + ++ +
Sbjct: 227 SISAVDNGSLANT---PHLR-ELHLN---------NNKLVKVPGGLADHKYIQ-----VV 268
Query: 362 NLEG-----------KLPSSWGACESLEMLNLAQNVLRGDLI--GVFDRCKKLHFIDLSS 408
L P S ++L N ++ I F + L +
Sbjct: 269 YLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
Query: 409 N 409
Sbjct: 329 Y 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 46/179 (25%), Positives = 75/179 (41%), Gaps = 15/179 (8%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQI--SGI 582
N+L P + + E + N I + + + V++ N + SGI
Sbjct: 110 NQLK-ELPEKMPKTLQELR-----VHENEI-TKVRKSVFNGLNQMIVVELGTNPLKSSGI 162
Query: 583 VPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLE 642
+ + + L ++ + + IP L L L L N +T +S+ L +L
Sbjct: 163 ENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 219
Query: 643 VLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L LS NS+S V G N +L L L+NNKL +P GLA+ + + NN+S
Sbjct: 220 KLGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS 276
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 39/161 (24%), Positives = 70/161 (43%), Gaps = 11/161 (6%)
Query: 543 HGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNK 602
H V S+ + +P D+ +LD +N+I+ I +NL +L L L NK
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 87
Query: 603 LQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VN 661
+ P + L L L L+ N L +P + ++L+ L + N ++ +V + V
Sbjct: 88 ISKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNG 143
Query: 662 LRNLTALLLDNNKL-SGHLPSG-LANVTSLSIFNASFNNLS 700
L + + L N L S + +G + LS + N++
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-19
Identities = 32/159 (20%), Positives = 63/159 (39%), Gaps = 15/159 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+++ NI IP + SL L N+I+ + SL+ L +L L L+ N +
Sbjct: 177 RIADTNI-TTIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVD 232
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-------V 660
SL +LR L L +N L +P + + + ++V+ L +N++S +
Sbjct: 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNT 290
Query: 661 NLRNLTALLLDNNKLSGH-LPSGL-ANVTSLSIFNASFN 697
+ + + L +N + + V +
Sbjct: 291 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 7e-16
Identities = 37/165 (22%), Positives = 62/165 (37%), Gaps = 11/165 (6%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
G+ +L + + + P + L L ++GN ++ GL NL L L+F
Sbjct: 169 GMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF 225
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL-----NGSI 219
N I SL N L L+L N++ +PG L ++V++L N + N
Sbjct: 226 NSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFC 284
Query: 220 PSELGKYCRYLEHLDLSGNSL-VGRIPSSLGKC-QQLRTLLLFSN 262
P + L N + I S +C + L +
Sbjct: 285 PPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-21
Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQF----HAEIKTLGNVRHPNLVTL 883
G G FGT + G+ VA+KK+ Q +F ++ L + HPN+V L
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKKV----IQD--PRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 884 IGY-----RASGNEMFL--IYNYLPGGNLENFIKARTSRAVDWKILHK--IALDVASALA 934
Y +++L + Y+P L + R V + + ++
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIG 143
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLS--DFGLSRLLGTSETHATTGVAGTFGYVA 992
LH V HRD+KP N+L+++ + L DFG ++ L SE + + + Y A
Sbjct: 144 CLHLPSV-NVCHRDIKPHNVLVNEA-DGTLKLCDFGSAKKLSPSEPN-VAYICSRY-YRA 199
Query: 993 PEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
PE + A D++S G + E++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 58/317 (18%), Positives = 100/317 (31%), Gaps = 54/317 (17%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
+ +L L N S + L+ L L + N +S F LR L+ L ++ N
Sbjct: 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNH 113
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL-NGSIPSELGK 225
+ +IP +L SL L + N+++ V G + + + N L N
Sbjct: 114 LV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
+ L +L +S L IP L + L L L N + + +L KL L +
Sbjct: 171 GLK-LNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGH 226
Query: 286 NRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM 345
N++ + L L L L N N + +P
Sbjct: 227 NQIRMIENGSLSFLPTLRELHLDN---------------------------NK-LSRVPA 258
Query: 346 EITTLSKLRIIWAPRLNLEG----KLPSS-------WGACESLEMLNLAQNVLRGDLI-- 392
+ L L+ + L K+ + ++L N + +
Sbjct: 259 GLPDLKLLQ-----VVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQP 313
Query: 393 GVFDRCKKLHFIDLSSN 409
F I +
Sbjct: 314 ATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 6e-21
Identities = 45/159 (28%), Positives = 65/159 (40%), Gaps = 18/159 (11%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
KLT P L + NE H L +N I I L+ + L L HNQI I
Sbjct: 182 AKLT-GIPKDLPETLNELH-----LDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIEN 234
Query: 585 QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-------GE 637
SL L +L L L+ NKL +P+ L LK L+ + L NN+T + + +
Sbjct: 235 GSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITK-VGVNDFCPVGFGVK 292
Query: 638 LRSLEVLELSSNSLS-GEVPEGV-VNLRNLTALLLDNNK 674
+ L +N + EV + + A+ N K
Sbjct: 293 RAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 4e-20
Identities = 45/177 (25%), Positives = 76/177 (42%), Gaps = 31/177 (17%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+S N+++ IP + + SL L N+I + L ++ +++ GN L+
Sbjct: 108 YISKNHLV-EIPPN---LPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSG 163
Query: 608 --PSSLHRLKYLRHLSLADNNLTG---GIPSSIGELR------------------SLEVL 644
P + LK L +L +++ LTG +P ++ EL L L
Sbjct: 164 FEPGAFDGLK-LNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRL 222
Query: 645 ELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L N + + G L L L LDNNKLS +P+GL ++ L + NN++
Sbjct: 223 GLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT 277
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 43/176 (24%), Positives = 72/176 (40%), Gaps = 13/176 (7%)
Query: 530 SFPGSLFQACNEF---HGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQS 586
S P + C H V S+ + +P +I +LD +N IS +
Sbjct: 18 SLPPTYSAMCPFGCHCHLRVVQCSDLGLK-AVPKEIS---PDTTLLDLQNNDISELRKDD 73
Query: 587 LENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646
+ L L L L NK+ + L+ L+ L ++ N+L IP ++ SL L +
Sbjct: 74 FKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRI 130
Query: 647 SSNSLSGEVPEGV-VNLRNLTALLLDNNKL-SGHLPSGLANVTSLSIFNASFNNLS 700
N + +VP+GV LRN+ + + N L + G + L+ S L+
Sbjct: 131 HDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT 185
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 6e-19
Identities = 39/163 (23%), Positives = 63/163 (38%), Gaps = 15/163 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L NN+I + D + L L +N+IS I ++ L L L ++ N L EI
Sbjct: 60 DLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EI 117
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL-SGEVPEGVVNLRNLT 666
P +L L L + DN + LR++ +E+ N L + G + L
Sbjct: 118 PPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLN 175
Query: 667 ALLLDNNKLSGHLPSGL-ANVTSL--------SIFNASFNNLS 700
L + KL+ +P L + L +I S
Sbjct: 176 YLRISEAKLT-GIPKDLPETLNELHLDHNKIQAIELEDLLRYS 217
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 5e-18
Identities = 36/158 (22%), Positives = 68/158 (43%), Gaps = 18/158 (11%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+S + IP D + ++L L HN+I I + L + L L L N+++
Sbjct: 178 RISEAKLT-GIPKD---LPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE 233
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-------V 660
SL L LR L L +N L+ +P+ + +L+ L+V+ L +N+++ +V V
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGV 291
Query: 661 NLRNLTALLLDNNKLS-GHLP----SGLANVTSLSIFN 693
+ L NN + + + + ++ N
Sbjct: 292 KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGN 329
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 41/194 (21%), Positives = 75/194 (38%), Gaps = 18/194 (9%)
Query: 105 GLSELRVLSLPFNGF-SGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
GL + + + N + F P + KL L + L+ +P + L L+L
Sbjct: 145 GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLD 201
Query: 164 FNRIDGDIP-FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
N+I I L + L L L NQ++ + G L LR L L N+L+ +P+
Sbjct: 202 HNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSS-------LGKCQQLRTLLLFSNML--NDVIPRELG 273
L + L+ + L N++ ++ + K + LF+N + +V P
Sbjct: 260 L-PDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFR 317
Query: 274 WLRKLEVLDVSRNR 287
+ + +
Sbjct: 318 CVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 1e-13
Identities = 47/258 (18%), Positives = 77/258 (29%), Gaps = 59/258 (22%)
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
+ +L+L N I + + L L L N++ + KL+ L++S N L
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 216 NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV-IPRELGW 274
IP L L L + N + + + + + N L +
Sbjct: 115 V-EIPPNL---PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFD 170
Query: 275 LRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNG 334
KL L +S +L G+ L+ L L +
Sbjct: 171 GLKLNYLRISEAKLTGIPKDLPET---LNELHLDH------------------------- 202
Query: 335 EKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGV 394
N I +I +E L + L L L N +R G
Sbjct: 203 --NK-IQAIELE--DLLRYS---------------------KLYRLGLGHNQIRMIENGS 236
Query: 395 FDRCKKLHFIDLSSNELS 412
L + L +N+LS
Sbjct: 237 LSFLPTLRELHLDNNKLS 254
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 48/204 (23%), Positives = 77/204 (37%), Gaps = 2/204 (0%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
+ + + L N S + L +L + N L+ F GL L L+L+ N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 167 IDGDIPFS-LRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK 225
+ + L L+L ++ + PG L+ L+L N L ++P + +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L HL L GN + + L LLL N + V P L +L L +
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 286 NRLNGLIPTELGNCVELSVLVLSN 309
N L+ L L L L L++
Sbjct: 211 NNLSALPTEALAPLRALQYLRLND 234
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 47/170 (27%), Positives = 67/170 (39%), Gaps = 14/170 (8%)
Query: 540 NEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHN-QISGIVPQSLENLTSLV 594
F L +N + I L LD S N Q+ + P + L L
Sbjct: 50 ASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLH 108
Query: 595 FLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLS 652
L L+ LQ E+ L L++L L DN L +P +L +L L L N +S
Sbjct: 109 TLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS 166
Query: 653 GEVPEGV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
VPE L +L LLL N+++ H+ ++ L NNLS
Sbjct: 167 -SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 46/185 (24%), Positives = 73/185 (39%), Gaps = 6/185 (3%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNL 162
L +L L N + L LE LD+ N + F GL L L+L
Sbjct: 54 ACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112
Query: 163 AFNRIDGDIPF-SLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
+ ++ R +L+ L L N ++ + L LFL N ++ S+P
Sbjct: 113 DRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS-SVPE 170
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
+ L+ L L N + P + +L TL LF+N L+ + L LR L+ L
Sbjct: 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYL 230
Query: 282 DVSRN 286
++ N
Sbjct: 231 RLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 6e-20
Identities = 36/165 (21%), Positives = 61/165 (36%), Gaps = 9/165 (5%)
Query: 539 CNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDL 598
C + + + +P+ I + + + N+IS + S +L L L
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGIPA---ASQRIFLHGNRISHVPAASFRACRNLTILWL 63
Query: 599 NGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPE 657
+ N L ++ L L L L+DN + + L L L L L E+
Sbjct: 64 HSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122
Query: 658 GV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
G+ L L L L +N L LP ++ +L+ N +S
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 43/256 (16%), Positives = 64/256 (25%), Gaps = 53/256 (20%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
+ + L NRI S R +L +L L N + + L L LS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVIPRELG 273
S+ L L L L + L+ L L N L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFR 150
Query: 274 WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASN 333
L L L + NR++ + L L+L
Sbjct: 151 DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ------------------------ 186
Query: 334 GEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIG 393
N + + L L L L N L
Sbjct: 187 ---NR-VAHVHPH--AFRDLG---------------------RLMTLYLFANNLSALPTE 219
Query: 394 VFDRCKKLHFIDLSSN 409
+ L ++ L+ N
Sbjct: 220 ALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 7/137 (5%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
FHG+ +L + + + +L+ L N + + + +L +L L
Sbjct: 101 FHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPE 657
L+GN++ + L L L L N + P + +L L L L +N+LS +P
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPT 218
Query: 658 GV-VNLRNLTALLLDNN 673
LR L L L++N
Sbjct: 219 EALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 4e-15
Identities = 46/139 (33%), Positives = 65/139 (46%), Gaps = 5/139 (3%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNL 162
GL L L L G E P ++ L L+ L ++ N L LP++ F L NL L L
Sbjct: 103 GLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFL 160
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
NRI + R SL+ L L N+V V P +L L+L N L+ ++P+E
Sbjct: 161 HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS-ALPTE 219
Query: 223 LGKYCRYLEHLDLSGNSLV 241
R L++L L+ N V
Sbjct: 220 ALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 6e-14
Identities = 32/114 (28%), Positives = 51/114 (44%), Gaps = 5/114 (4%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
F G+ A L +N + +P D +L L N+IS + ++ L SL L
Sbjct: 125 FRGLAALQYLYLQDNAL-QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL 183
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
L+ N++ P + L L L L NNL+ ++ LR+L+ L L+ N
Sbjct: 184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 2e-06
Identities = 31/187 (16%), Positives = 53/187 (28%), Gaps = 41/187 (21%)
Query: 232 HLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL 291
L +P + + + L N ++ V R L +L + N L +
Sbjct: 15 TTSCPQQGLQ-AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 292 IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI-TTL 350
L L LS+ N+ + S+ L
Sbjct: 72 DAAAFTGLALLEQLDLSD---------------------------NAQLRSVDPATFHGL 104
Query: 351 SKLRIIWAPRLNLEG----KLPSSW-GACESLEMLNLAQNVLRGDLIGVFDRCKKLHFID 405
+L L+L+ +L +L+ L L N L+ F L +
Sbjct: 105 GRLH-----TLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLF 159
Query: 406 LSSNELS 412
L N +S
Sbjct: 160 LHGNRIS 166
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 1e-21
Identities = 54/204 (26%), Positives = 84/204 (41%), Gaps = 33/204 (16%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVRH--PNL 880
+GSGGFG+ Y +S + VA+K +++ + E+ L V +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 881 VTLIGYRASGNEMFLIYNY-LPGGNLENFIKAR------TSRAVDWKILHKIALDVASAL 933
+ L+ + + LI P +L +FI R +R V A+
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR--------SFFWQVLEAV 162
Query: 934 AYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
+ H+ VLHRD+K NIL+D + L DFG LL +T T GT Y
Sbjct: 163 RHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL--KDTVYTD-FDGTRVYSP 216
Query: 993 PEYALTCRVSD--KADVYSYGVVL 1014
PE+ + A V+S G++L
Sbjct: 217 PEW-IRYHRYHGRSAAVWSLGILL 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 1e-21
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 32/205 (15%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVK-----KLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT 882
+G G FG A VA+K L V++ EI L +RHP+++
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER---EISYLKLLRHPHIIK 73
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFI--KARTSRAVDWKILHKIALDVASALAYLHDQC 940
L + ++ ++ Y GG L ++I K R + + +I A+ Y H
Sbjct: 74 LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQII----CAIEYCHRH- 127
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE------ 994
+++HRD+KP N+LLDD+ N ++DFGLS ++ T+ G+ Y APE
Sbjct: 128 --KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVINGKL 183
Query: 995 YALTCRVSDKADVYSYGVVLLELIS 1019
YA + DV+S G+VL ++
Sbjct: 184 YA-----GPEVDVWSCGIVLYVMLV 203
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-21
Identities = 95/533 (17%), Positives = 185/533 (34%), Gaps = 91/533 (17%)
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
+ L+L+ N + + + +LRVL LS+N + S+ + + + LE+LD+S N
Sbjct: 53 RTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNR 111
Query: 240 LVGRIPSSLGKCQQLRTLLLFSNMLNDVIPR--ELGWLRKLEVLDVSRNRLNGLIPTELG 297
L I LR L L N DV+P E G L KL L +S +
Sbjct: 112 LQN-ISC--CPMASLRHLDLSFNDF-DVLPVCKEFGNLTKLTFLGLSAAKFR-------- 159
Query: 298 NCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIW 357
+L +L +++L + + + G++++ + L +++
Sbjct: 160 ---QLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN-------------TTVLHLVF 203
Query: 358 APRLNLEGKLPSSWGACESLEMLNLAQNVLRG----DLIGVFDRCKKLHFIDLSSNELSG 413
P ++ S A L++ N+ N + R L + L E +
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 414 ELDVK----LQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQY 469
+ VK + ++ ++ I R ++ L+S + + F + +
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETA-LKSLMIEHVKNQVFLFSKE 322
Query: 470 FMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTG 529
+ M + S ++ + + + N T
Sbjct: 323 ALYSVFAEMNIK----------MLSISDTPF----IHMVCPPSPSSFTFLNFTQ-NVFTD 367
Query: 530 SFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI--VPQSL 587
S + L+ L N + V
Sbjct: 368 SVFQG-------CSTLK---------------------RLQTLILQRNGLKNFFKVALMT 399
Query: 588 ENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646
+N++SL LD++ N L + + L+L+ N LTG + + ++VL+L
Sbjct: 400 KNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVKVLDL 457
Query: 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNN 698
+N + +P+ V +L+ L L + +N+L +P G +TSL N
Sbjct: 458 HNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 6e-16
Identities = 47/179 (26%), Positives = 72/179 (40%), Gaps = 22/179 (12%)
Query: 533 GSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTS 592
GS+ NE MV + SN N+ H+P D+ + L S N IS + + L+
Sbjct: 23 GSMTPFSNELESMV-DYSNRNLT-HVPKDL---PPRTKALSLSQNSISELRMPDISFLSE 77
Query: 593 LVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL 651
L L L+ N+++ + + + L +L ++ N L I + SL L+LS N
Sbjct: 78 LRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NISC--CPMASLRHLDLSFNDF 133
Query: 652 SGEVPEGVV--NLRNLTALLLDNNKL---------SGHLPSGLANVTSLSIFNASFNNL 699
+P NL LT L L K HL L ++ S I +L
Sbjct: 134 D-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL 191
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 1e-13
Identities = 63/331 (19%), Positives = 109/331 (32%), Gaps = 22/331 (6%)
Query: 98 KLSPLV-GGLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLR 155
+L LSELRVL L N + + LE LDV N L + +
Sbjct: 66 ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMA 121
Query: 156 NLRVLNLAFNRIDGDIPFS--LRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSY- 212
+LR L+L+FN D +P N L L L+ + + + + + L L + L
Sbjct: 122 SLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPV-AHLHLSCILLDLV 179
Query: 213 -NELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVIPR 270
+ G L + HL NSL + S+ L+ + N N
Sbjct: 180 SYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLM 239
Query: 271 ELGW----LRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSV 326
L + + +L + N+++ ++ R R E +
Sbjct: 240 TFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTY 299
Query: 327 GQS-----DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLN 381
++ + + F+ S + +++ I + + S LN
Sbjct: 300 SETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLN 359
Query: 382 LAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
QNV + K+L + L N L
Sbjct: 360 FTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 73.0 bits (179), Expect = 2e-13
Identities = 79/468 (16%), Positives = 141/468 (30%), Gaps = 82/468 (17%)
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
+ L +S+N ++ L ++ EL VL LS+ N
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSH---------------------------N 86
Query: 338 SFIGSIPMEI-TTLSKLRIIWAPRLNLEG-KLPS-SWGACESLEMLNLAQNVLRG-DLIG 393
I S+ + L L++ +L + S SL L+L+ N +
Sbjct: 87 R-IRSLDFHVFLFNQDLE-----YLDVSHNRLQNISCCPMASLRHLDLSFNDFDVLPVCK 140
Query: 394 VFDRCKKLHFIDLSSNEL-SGELDV--KLQVPCMALFDVSGNHMSGSIPRFD-------Y 443
F KL F+ LS+ + +L L + C+ L VS + G +
Sbjct: 141 EFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLH 200
Query: 444 NVCHQMPLQSSDLCQGYDP----SFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFT 499
V H L S + + + ++ + M L R + N + +
Sbjct: 201 LVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIE 260
Query: 500 GPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACN-EFHGMVANLSNNNIIGHI 558
+ R +T F ++ N +
Sbjct: 261 TTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFS 320
Query: 559 PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLR 618
+ + + + S + I + +S FL+ N + LK L+
Sbjct: 321 KEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQ 380
Query: 619 HLSLADNNLT---------------------------GGIPSSIGELRSLEVLELSSNSL 651
L L N L + S+ VL LSSN L
Sbjct: 381 TLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNML 440
Query: 652 SGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNL 699
+G V + + L L NN++ +P + ++ +L N + N L
Sbjct: 441 TGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 3e-13
Identities = 54/289 (18%), Positives = 87/289 (30%), Gaps = 60/289 (20%)
Query: 126 EIWSLEKLEVLDV--EGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183
+E L + ++ L++L + ++ F + +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL--V 241
L+ + + S L + N + + L+ L L N L
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVF-TDSVFQGCSTLKRLQTLILQRNGLKNF 392
Query: 242 GRIPSSLGKCQQLRTLLLFSNMLNDVIPREL-GWLRKLEVLDVSRNRLNGLIPTELGNCV 300
++ L TL + N LN W + VL++S N L G + L
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--P 450
Query: 301 ELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPR 360
++ VL L N N I SIP ++T L L+
Sbjct: 451 KVKVLDLHN-----------------------NR-----IMSIPKDVTHLQALQE----- 477
Query: 361 LNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSN 409
LN+A N L+ GVFDR L +I L N
Sbjct: 478 -------------------LNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 6e-13
Identities = 37/206 (17%), Positives = 72/206 (34%), Gaps = 5/206 (2%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFN 165
L L + + F ++ + + + + LN N
Sbjct: 304 LKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQN 363
Query: 166 RIDGDIPFSLRNFESLEVLNLAGNQVKGV--IPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
+ + L+ L L N +K + + L L +S N LN
Sbjct: 364 VFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRT 423
Query: 224 GKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDV 283
+ + L+LS N L G + L +++ L L +N + IP+++ L+ L+ L+V
Sbjct: 424 CAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRI-MSIPKDVTHLQALQELNV 480
Query: 284 SRNRLNGLIPTELGNCVELSVLVLSN 309
+ N+L + L + L +
Sbjct: 481 ASNQLKSVPDGVFDRLTSLQYIWLHD 506
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 41/185 (22%), Positives = 68/185 (36%), Gaps = 7/185 (3%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
+E+ + L + S L+ N + + L+ L+ L L
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386
Query: 165 NRID--GDIPFSLRNFESLEVLNLAGNQV-KGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
N + + +N SLE L+++ N + + VL LS N L GS+
Sbjct: 387 NGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
L ++ LDL N + IP + Q L+ L + SN L V L L+ +
Sbjct: 447 CLP---PKVKVLDLHNNRI-MSIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYI 502
Query: 282 DVSRN 286
+ N
Sbjct: 503 WLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 3e-12
Identities = 91/498 (18%), Positives = 172/498 (34%), Gaps = 73/498 (14%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSL-RNFESLEVLNLAGNQV 191
+ L + N +S + L LRVL L+ NRI + F + + LE L+++ N++
Sbjct: 54 TKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRL 112
Query: 192 KGVIPGFLGSFLKLRVLFLSYNELNGSIP--SELGKYCRYLEHLDLSGNSLVGRIPSSLG 249
+ + + S LR L LS+N+ + +P E G L L LS L
Sbjct: 113 QNISCCPMAS---LRHLDLSFNDFD-VLPVCKEFGN-LTKLTFLGLSAAKFRQ---LDLL 164
Query: 250 KCQQLRTLLLFSNMLNDVIPR---ELGWLRKLEVLDVSRNR-----------LNGLIPTE 295
L + ++++ I E + VL + + +N L +
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQ 224
Query: 296 LGN--CVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKL 353
L N + + L L G + F P + L+
Sbjct: 225 LSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284
Query: 354 RIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSG 413
+ R++ E + S A +SL + ++ V ++ +++ LS ++
Sbjct: 285 NLTITERIDRE-EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTP- 342
Query: 414 ELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYF-MS 472
+ + C + S + F NV Q + +Q +
Sbjct: 343 ----FIHMVC------PPSPSSFTFLNFTQNVFTDSVFQGCS-------TLKRLQTLILQ 385
Query: 473 KARL----GMPLLVSAARFMVIHNFSGNNFT-GPICWLPVAPERLRRRTDYAFLAGANKL 527
+ L + L+ + + S N+ E + L+ N L
Sbjct: 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESIL----VLNLSS-NML 440
Query: 528 TGSFPGSLFQACNEFHGMVANLS----NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIV 583
TGS F + + +NN I IP D+ + ++L+ L+ + NQ+ +
Sbjct: 441 TGSV----------FRCLPPKVKVLDLHNNRIMSIPKDVTHL-QALQELNVASNQLKSVP 489
Query: 584 PQSLENLTSLVFLDLNGN 601
+ LTSL ++ L+ N
Sbjct: 490 DGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.7 bits (168), Expect = 5e-12
Identities = 58/373 (15%), Positives = 104/373 (27%), Gaps = 47/373 (12%)
Query: 376 SLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS----GELDVKLQ----------- 420
L +L L+ N +R VF + L ++D+S N L + L+
Sbjct: 77 ELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCCPMA-SLRHLDLSFNDFDV 135
Query: 421 VPCMALFD---------VSGNHM-SGSIPRFDYN--VCHQMPLQSSDLCQGYDPSFTYMQ 468
+P F +S + + C + L S + G S
Sbjct: 136 LPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPN 195
Query: 469 ------YFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLA 522
F + + + +S + + L L R +
Sbjct: 196 TTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT 255
Query: 523 GAN-KLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMC----KSLRVLDASHN 577
+ + T LFQ N+ N I I + KSL + +
Sbjct: 256 LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQ 315
Query: 578 QISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGE 637
+ L+ + L+ N T +
Sbjct: 316 VFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCST 375
Query: 638 LRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANV-----TSLSIF 692
L+ L+ L L N L + + +N+++L + L+ L S + S+ +
Sbjct: 376 LKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS-LNSHAYDRTCAWAESILVL 433
Query: 693 NASFNNL-SGPFP 704
N S N L F
Sbjct: 434 NLSSNMLTGSVFR 446
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 45/202 (22%), Positives = 73/202 (36%), Gaps = 9/202 (4%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSL-ENLTSLVFLDLNGNKLQGE 606
++S+N + +I SLR LD S N + NLT L FL L+ K +
Sbjct: 106 DVSHNRL-QNISCC---PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQL 161
Query: 607 IPSSLHRLK-YLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
+ L L L ++ GG S+ + VL L + S + +++ L
Sbjct: 162 DLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHLVFHPNSLFSVQVNMSVNAL 220
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQ 725
L L N KL+ L S + N++ TT CS + F
Sbjct: 221 GHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT--LQHIETTWKCSVKLFQFFWPRPV 278
Query: 726 MYKDISSSELTSSNANSQHNIT 747
Y +I + +T + +
Sbjct: 279 EYLNIYNLTITERIDREEFTYS 300
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 2e-21
Identities = 44/153 (28%), Positives = 77/153 (50%), Gaps = 13/153 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NL ++ + + S+ + A+++ I + Q ++ L ++ L LNGNKL +I
Sbjct: 27 NLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DI 80
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L LK L L L +N + + SS+ +L+ L+ L L N +S G+V+L L +
Sbjct: 81 -KPLTNLKNLGWLFLDENKIK-DL-SSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLES 135
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L NNK++ + L+ +T L + N +S
Sbjct: 136 LYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.2 bits (218), Expect = 5e-18
Identities = 47/202 (23%), Positives = 73/202 (36%), Gaps = 11/202 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L N I L K L+ L HN IS I L +L L L L NK+
Sbjct: 93 FLDENKIKDLSSLK---DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI--TD 145
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L RL L LSL DN ++ I + L L+ L LS N +S + L+NL
Sbjct: 146 ITVLSRLTKLDTLSLEDNQISD-I-VPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDV 201
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQMY 727
L L + + + +N+ + + +L P + + +
Sbjct: 202 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
Query: 728 KDISSSELTSSNANSQHNITAP 749
I +T A ++ +
Sbjct: 262 SFIFYQPVTIGKAKARFHGRVT 283
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 84.0 bits (207), Expect = 1e-16
Identities = 31/157 (19%), Positives = 63/157 (40%), Gaps = 14/157 (8%)
Query: 545 MVANLSNNNIIGHI-PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKL 603
M ++ + I I P D + ++ V L S+ + N + +
Sbjct: 1 MGETITVSTPIKQIFPDDA---FAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 604 QGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLR 663
+ + + L + L L N LT I + L++L L L N + ++ + +L+
Sbjct: 56 K-SV-QGIQYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIK-DL-SSLKDLK 109
Query: 664 NLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L +L L++N +S +GL ++ L N ++
Sbjct: 110 KLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT 144
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 83.2 bits (205), Expect = 2e-16
Identities = 49/304 (16%), Positives = 102/304 (33%), Gaps = 51/304 (16%)
Query: 153 GLRNLRVLNLAFNRIDGDIPFS--------------------LRNFESLEVLNLAGNQVK 192
NL + + + ++ ++ L L GN++
Sbjct: 19 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT 78
Query: 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQ 252
+ P L + L LFL N++ + S L K + L+ L L N + + L
Sbjct: 79 DIKP--LTNLKNLGWLFLDENKIK-DL-SSL-KDLKKLKSLSLEHNGI--SDINGLVHLP 131
Query: 253 QLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN--- 309
QL +L L +N + D+ L L KL+ L + N+++ + L +L L LS
Sbjct: 132 QLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHI 187
Query: 310 -LFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLP 368
L +N+ L + + + L + N +G L
Sbjct: 188 SDLRALAGLKNLD-VLEL--------FSQECLNKPINHQSNLVVPNTVK----NTDGSLV 234
Query: 369 SSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFD 428
+ + + + ++ L + + + ++ + ++ P ++
Sbjct: 235 TPEIIS---DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYT 291
Query: 429 VSGN 432
VS +
Sbjct: 292 VSYD 295
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 9e-16
Identities = 44/194 (22%), Positives = 74/194 (38%), Gaps = 14/194 (7%)
Query: 89 LHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLP 148
+ + + + L + L L N + P + +L+ L L ++ N + L
Sbjct: 48 IIANNSDIKSVQGI-QYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-DLS 103
Query: 149 NEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208
+ L+ L+ L+L N I DI L + LE L L N++ + L KL L
Sbjct: 104 S-LKDLKKLKSLSLEHNGIS-DIN-GLVHLPQLESLYLGNNKITDITV--LSRLTKLDTL 158
Query: 209 FLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268
L N+++ I L L++L LS N + +L + L L LFS +
Sbjct: 159 SLEDNQIS-DI-VPLAG-LTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKP 213
Query: 269 PRELGWLRKLEVLD 282
L +
Sbjct: 214 INHQSNLVVPNTVK 227
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 1e-15
Identities = 50/269 (18%), Positives = 87/269 (32%), Gaps = 54/269 (20%)
Query: 157 LRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELN 216
+ I I F F NL V + + + + +++
Sbjct: 1 MGETITVSTPIK-QI-FPDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 217 GSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR 276
S+ + +Y + L L+GN L I L + L L L N + D+ L L+
Sbjct: 57 -SV-QGI-QYLPNVTKLFLNGNKLT-DI-KPLTNLKNLGWLFLDENKIKDLSS--LKDLK 109
Query: 277 KLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEK 336
KL+ L + N ++ + L + +L L L N N
Sbjct: 110 KLKSLSLEHNGISDING--LVHLPQLESLYLGN-----------------------NK-- 142
Query: 337 NSFIGSIPMEITTLSKLRIIWAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLI 392
I I ++ L+KL L+LE + L+ L L++N + +
Sbjct: 143 ---ITDIT-VLSRLTKLDT-----LSLEDNQISDI-VPLAGLTKLQNLYLSKNHISD--L 190
Query: 393 GVFDRCKKLHFIDLSSNELSGELDVKLQV 421
K L ++L S E +
Sbjct: 191 RALAGLKNLDVLELFSQECLNKPINHQSN 219
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 8e-04
Identities = 22/94 (23%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
++ L L++L LSL N S + L KL+ L + N +S GL+NL
Sbjct: 145 DITVL-SRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISD--LRALAGLKNL 199
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQV 191
VL L N + +
Sbjct: 200 DVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 57/224 (25%), Positives = 97/224 (43%), Gaps = 32/224 (14%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
IGSG G A + VA+KKL+ FQ+ Q HA E+ + V H N+++
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLS-RPFQN---QTHAKRAYRELVLMKCVNHKNIIS 125
Query: 883 LI------GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
L+ +++L+ + NL I+ +L+++ + +L
Sbjct: 126 LLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSYLLYQMLC----GIKHL 180
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H ++HRD+KPSNI++ D + DFGL+R + T T Y APE
Sbjct: 181 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVI 235
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
L + D++S G ++ E++ K F + D +N +
Sbjct: 236 LGMGYKENVDIWSVGCIMGEMVRHK----ILFPGRDYIDQWNKV 275
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 6e-21
Identities = 24/196 (12%), Positives = 54/196 (27%), Gaps = 42/196 (21%)
Query: 828 CIGSGGFGTTYKAE-ISPGILVAVKKL--AVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
G ++A + VA+ + +Q+ + L + P + ++
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAP 942
+ ++ ++ GG+L+ S A+ +A+A H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGAIR------AMQSLAAAADAAHRA--- 148
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVS 1002
V PS + + D + L + +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVL---------------------AYPATMPD-------AN 180
Query: 1003 DKADVYSYGVVLLELI 1018
+ D+ G L L+
Sbjct: 181 PQDDIRGIGASLYALL 196
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 7e-21
Identities = 54/212 (25%), Positives = 90/212 (42%), Gaps = 29/212 (13%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRH 877
DF +G G F T A E++ A+K K + + V E + + H
Sbjct: 31 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDH 89
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVA------- 930
P V L +++ +Y G L R
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGEL--LKYIRKIG--------SFDETCTRFYTAEI 139
Query: 931 -SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG-VAGTF 988
SAL YLH + ++HRD+KP NILL++D + ++DFG +++L A GT
Sbjct: 140 VSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 989 GYVAPEYALTCRVSDKA-DVYSYGVVLLELIS 1019
YV+PE LT + + K+ D+++ G ++ +L++
Sbjct: 197 QYVSPE-LLTEKSACKSSDLWALGCIIYQLVA 227
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 57/219 (26%), Positives = 95/219 (43%), Gaps = 20/219 (9%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKA--EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTL- 872
RA + IG G +G +KA + G VA+K++ V + G+ E+ L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMP-LSTIREVAVLR 66
Query: 873 --GNVRHPNLVTLI-----GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKI 925
HPN+V L ++ L++ ++ +L ++ V + + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDM 125
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
+ L +LH RV+HRD+KP NIL+ L+DFGL+R+ T+ V
Sbjct: 126 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-TSVVV 181
Query: 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKAL 1024
T Y APE L + D++S G + E+ +K L
Sbjct: 182 -TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 8e-21
Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 18/205 (8%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLIG 885
+G G +G YKA + VA+K++ + + GV A E+ L ++H N++ L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVP-GTAIREVSLLKELQHRNIIELKS 100
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ + LI+ Y +L+ ++ + V +++ + + + + H + R L
Sbjct: 101 VIHHNHRLHLIFEYAEN-DLKKYMD--KNPDVSMRVIKSFLYQLINGVNFCHSR---RCL 154
Query: 946 HRDVKPSNILLDDDFNAY-----LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
HRD+KP N+LL + + DFGL+R G T + T Y PE L R
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEILLGSR 213
Query: 1001 V-SDKADVYSYGVVLLELISDKKAL 1024
S D++S + E++ K L
Sbjct: 214 HYSTSVDIWSIACIWAEMLM-KTPL 237
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 9e-21
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 20/206 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHP 878
F +G GGFG ++ + G + A KKL R + G E + L V
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNL------ENFIKARTSRAVDWKILHKIALDVASA 932
+V+L + + + L+ + GG+L +RAV + A ++
Sbjct: 245 FVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY------AAEICCG 298
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
L LH + R+++RD+KP NILLDD + +SD GL+ + +T G GT GY+A
Sbjct: 299 LEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRVGTVGYMA 353
Query: 993 PEYALTCRVSDKADVYSYGVVLLELI 1018
PE R + D ++ G +L E+I
Sbjct: 354 PEVVKNERYTFSPDWWALGCLLYEMI 379
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 1e-20
Identities = 55/207 (26%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH--GVQQFHA--EIKTLGNVRHPNLVTL 883
+G+G + T YK + G+ VA+K++ + G A EI + ++H N+V L
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV---KLDSEEGTP-STAIREISLMKELKHENIVRL 68
Query: 884 IGYRASGNEMFLIYNYLP---GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
+ N++ L++ ++ +++ T R ++ ++ + LA+ H+
Sbjct: 69 YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN- 127
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
++LHRD+KP N+L++ L DFGL+R G ++ V T Y AP+ + R
Sbjct: 128 --KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSR 184
Query: 1001 V-SDKADVYSYGVVLLELISDKKALDP 1026
S D++S G +L E+I+ K L P
Sbjct: 185 TYSTSIDIWSCGCILAEMIT-GKPLFP 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 1e-20
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 13/204 (6%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA----EIKTLGNVRHPNLVTL 883
+G G F T YKA + + +VA+KK+ +G + EIK L + HPN++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+ + + L+++++ +LE IK S + + L L YLH
Sbjct: 78 LDAFGHKSNISLVFDFMET-DLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQH---W 132
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSD 1003
+LHRD+KP+N+LLD++ L+DFGL++ G+ T V T Y APE R+
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLFGARMYG 191
Query: 1004 KA-DVYSYGVVLLELISDKKALDP 1026
D+++ G +L EL+ + P
Sbjct: 192 VGVDMWAVGCILAELLL-RVPFLP 214
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 57/197 (28%), Positives = 77/197 (39%), Gaps = 27/197 (13%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IGSG FG LVAVK + R + EI ++RHPN+V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 888 ASGNEMFLIYNYLPGGNLENFI--KARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ + +I Y GG L I R S ++ S ++Y H ++
Sbjct: 86 LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLL----SGVSYCHSM---QIC 138
Query: 946 HRDVKPSNILLDDDF--NAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE------YAL 997
HRD+K N LLD + DFG S+ +T GT Y+APE Y
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEYD- 195
Query: 998 TCRVSDKADVYSYGVVL 1014
ADV+S GV L
Sbjct: 196 ----GKIADVWSCGVTL 208
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-20
Identities = 57/238 (23%), Positives = 91/238 (38%), Gaps = 49/238 (20%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKL--------AVGRFQHGVQQFHA-----EIKTLGNV 875
I SG +G S GI VA+K++ V F EI+ L +
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSD---SFLCKRVLREIRLLNHF 86
Query: 876 RHPNLVTLI-----GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD-------WKILH 923
HPN++ L + ++++L+ + +L I + + IL
Sbjct: 87 HHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFMYHILL 145
Query: 924 KIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983
L LH V+HRD+ P NILL D+ + + DF L+R + T
Sbjct: 146 --------GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTH 192
Query: 984 VAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
Y APE + + K D++S G V+ E+ + K F S+ + N I
Sbjct: 193 YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK----ALFRGSTFYNQLNKI 246
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-20
Identities = 61/202 (30%), Positives = 94/202 (46%), Gaps = 9/202 (4%)
Query: 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHP 878
F +G GGFG + ++ + G L A KKL R + G Q E K L V
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKI--ALDVASALAYL 936
+V+L + ++ L+ + GG++ I ++ I + S L +L
Sbjct: 246 FIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHL 305
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H + +++RD+KP N+LLDDD N +SD GL+ + T G AGT G++APE
Sbjct: 306 HQR---NIIYRDLKPENVLLDDDGNVRISDLGLAV-ELKAGQTKTKGYAGTPGFMAPELL 361
Query: 997 LTCRVSDKADVYSYGVVLLELI 1018
L D ++ GV L E+I
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMI 383
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 40/191 (20%), Positives = 72/191 (37%), Gaps = 13/191 (6%)
Query: 106 LSELRVLSLPFNGFSGEFPP-EIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
L+ L + ++ + + W L+VL + + L L+L+
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 165 NRIDGDIPFS----LRNFESLEVLNLAGNQVK---GVIPGFLGSFLKLRVLFLSYNELNG 217
N G+ F +L+VL L ++ GV + ++L+ L LS+N L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
+ + + L L+LS L ++P L +L L L N L+ P L +
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPSPDE-LPQ 297
Query: 278 LEVLDVSRNRL 288
+ L + N
Sbjct: 298 VGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 2e-19
Identities = 49/215 (22%), Positives = 79/215 (36%), Gaps = 24/215 (11%)
Query: 525 NKLTGSFPGSLFQACN----EFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
++TG+ P L +A + + N+S + + L+VL +
Sbjct: 105 LEVTGTAPPPLLEATGPDLNILN--LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSL 162
Query: 581 GIVPQSLENLTSLVFLDLNGNKLQGEIPSS----LHRLKYLRHLSLADNNLT---GGIPS 633
+ + +L LDL+ N GE + L+ L+L + + G +
Sbjct: 163 NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSA 222
Query: 634 SIGELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIF 692
L+ L+LS NSL L +L L L +P GL LS+
Sbjct: 223 LAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVL 279
Query: 693 NASFNNLSG-PFPW---NVTTMNCSGVIGNPFLDP 723
+ S+N L P P V ++ GNPFLD
Sbjct: 280 DLSYNRLDRNPSPDELPQVGNLSLK---GNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 2e-17
Identities = 49/223 (21%), Positives = 74/223 (33%), Gaps = 18/223 (8%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPN---EFVGLRNLRVL 160
GG S +L +I L+ L V + R+ +G+ L+ L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 161 NLAFNRIDGDIPFSLRNF--ESLEVLNLAGNQVKGVIPGF--LGSFLK--LRVLFLSYNE 214
L + G P L L +LNL L +LK L+VL ++
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAH 160
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQ----QLRTLLLFSNMLN---DV 267
+ E + L LDLS N +G C L+ L L + + V
Sbjct: 161 SL-NFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 268 IPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVE-LSVLVLSN 309
+L+ LD+S N L + L+ L LS
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSF 262
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 29/165 (17%), Positives = 54/165 (32%), Gaps = 10/165 (6%)
Query: 550 SNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP-QSLENLTSLVFLDLNGNKLQGEIP 608
S N +G +++ +SL L + + + + SL L + ++ I
Sbjct: 26 SAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRIL 85
Query: 609 SSLHRL---KYLRHLSLADNNLTGGIPSSIGEL--RSLEVLELSSNSLSGEVPE----GV 659
R+ L+ L+L + +TG P + E L +L L + S +
Sbjct: 86 FGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQ 145
Query: 660 VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
L L + + +LS + S N G
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 6e-08
Identities = 37/240 (15%), Positives = 72/240 (30%), Gaps = 17/240 (7%)
Query: 217 GSIPSELGKYCRYLEHLDLSGN-SLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPR---EL 272
G+ EL R LE+L + + + K L+ L + + + I +
Sbjct: 32 GAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRV 91
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS------NLFDPLLSGRNIRGELSV 326
+ L+ L + + G P L + +L+ D L+ + +
Sbjct: 92 LGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGL 151
Query: 327 GQSDASNGEKNSFIGSIPMEITTLSKLRI----IWAPRLNLEGKLPSSWGACESLEMLNL 382
+ +F LS L + R + P + + L + N
Sbjct: 152 KVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNA 211
Query: 383 AQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL--FDVSGNHMSGSIPR 440
G + +L +DLS N L L ++S + +P+
Sbjct: 212 GMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPK 270
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 3e-06
Identities = 23/97 (23%), Positives = 36/97 (37%), Gaps = 6/97 (6%)
Query: 95 LVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVG 153
G S L +L+ L L N +L L++ L ++P
Sbjct: 216 PSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL-- 272
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQ 190
L VL+L++NR+D P + L+L GN
Sbjct: 273 PAKLSVLDLSYNRLDR-NPSPDE-LPQVGNLSLKGNP 307
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 3e-20
Identities = 44/153 (28%), Positives = 76/153 (49%), Gaps = 13/153 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
NL ++ + + S+ + A+++ I + Q ++ L ++ L LNGNKL +I
Sbjct: 30 NLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DI 83
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L LK L L L +N + SS+ +L+ L+ L L N +S G+V+L L +
Sbjct: 84 -KPLANLKNLGWLFLDENKVK--DLSSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLES 138
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L NNK++ + L+ +T L + N +S
Sbjct: 139 LYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 5e-19
Identities = 52/212 (24%), Positives = 89/212 (41%), Gaps = 18/212 (8%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
++ +E +L + L ++ + + + + L N+
Sbjct: 16 QIFSD-DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNV 70
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L L N++ DI L N ++L L L N+VK + L KL+ L L +N ++
Sbjct: 71 TKLFLNGNKLT-DI-KPLANLKNLGWLFLDENKVKDLSS--LKDLKKLKSLSLEHNGIS- 125
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
I L + LE L L N + + L + +L TL L N ++D++P L L K
Sbjct: 126 DING-L-VHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTK 179
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L+ L +S+N ++ L L L VL L +
Sbjct: 180 LQNLYLSKNHISDL--RALAGLKNLDVLELFS 209
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 7e-17
Identities = 46/218 (21%), Positives = 88/218 (40%), Gaps = 16/218 (7%)
Query: 92 RGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEF 151
+ K V L+ + + + I L + L + GN L+ +
Sbjct: 32 KKKSVTDAVTQ-NELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKP-L 86
Query: 152 VGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLS 211
L+NL L L N++ D+ SL++ + L+ L+L N + + L +L L+L
Sbjct: 87 ANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLG 142
Query: 212 YNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE 271
N++ + + L + L+ L L N + L +L+ L L N ++D+ R
Sbjct: 143 NNKI--TDITVLSR-LTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDL--RA 195
Query: 272 LGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L L+ L+VL++ N V + + ++
Sbjct: 196 LAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTD 233
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 8e-17
Identities = 42/155 (27%), Positives = 62/155 (40%), Gaps = 11/155 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L N + L K L+ L HN IS I L +L L L L NK+
Sbjct: 96 FLDENKVKDLSSLK---DLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKI--TD 148
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L RL L LSL DN ++ + L L+ L LS N +S + L+NL
Sbjct: 149 ITVLSRLTKLDTLSLEDNQISD--IVPLAGLTKLQNLYLSKNHIS--DLRALAGLKNLDV 204
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
L L + + + +N+ + + +L P
Sbjct: 205 LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 2e-13
Identities = 46/260 (17%), Positives = 85/260 (32%), Gaps = 68/260 (26%)
Query: 153 GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSY 212
NL + + + S++ + + +K V + + LFL+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 213 NELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL 272
N+L I L + L L L N + + SSL ++L++L L N ++D+ L
Sbjct: 78 NKLT-DI-KPLAN-LKNLGWLFLDENKVK-DL-SSLKDLKKLKSLSLEHNGISDING--L 130
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332
L +LE L + N++ + L +L L L +
Sbjct: 131 VHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED----------------------- 165
Query: 333 NGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI 392
N +I+ + L L+ L L++N + +
Sbjct: 166 ----N--------QISDIVPLA------------------GLTKLQNLYLSKNHISD--L 193
Query: 393 GVFDRCKKLHFIDLSSNELS 412
K L ++L S E
Sbjct: 194 RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 39/178 (21%), Positives = 65/178 (36%), Gaps = 26/178 (14%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L +N I L L L +N+I+ I L LT L L L N++ +I
Sbjct: 118 SLEHNGISDINGLV---HLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQIS-DI 171
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
L L L++L L+ N+++ ++ L++L+VLEL S + NL
Sbjct: 172 -VPLAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNT 228
Query: 668 L-----------------LLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVT 708
+ + + HLP V+ + + F VT
Sbjct: 229 VKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVT 286
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 24/124 (19%), Positives = 49/124 (39%), Gaps = 10/124 (8%)
Query: 577 NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG 636
I I + + +L + + + L + + ++++ + I
Sbjct: 12 TPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SV-QGIQ 65
Query: 637 ELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASF 696
L ++ L L+ N L+ + + NL+NL L LD NK+ S L ++ L +
Sbjct: 66 YLPNVTKLFLNGNKLT--DIKPLANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEH 121
Query: 697 NNLS 700
N +S
Sbjct: 122 NGIS 125
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 9e-12
Identities = 46/192 (23%), Positives = 76/192 (39%), Gaps = 14/192 (7%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
+ PL L L L L N + + L+KL+ L +E N +S + V L L
Sbjct: 82 DIKPL-ANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGIS-DING-LVHLPQL 136
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L L N+I DI L L+ L+L NQ+ ++P L KL+ L+LS N ++
Sbjct: 137 ESLYLGNNKIT-DIT-VLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHIS- 191
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
+ L + L+ L+L + + + T+ + V P +
Sbjct: 192 DL-RAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDG--SLVTPEIISDDGD 247
Query: 278 LEVLDVSRNRLN 289
E +V +
Sbjct: 248 YEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 38/240 (15%), Positives = 63/240 (26%), Gaps = 88/240 (36%)
Query: 173 FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEH 232
FS F NL V + + + + +++
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK---------------- 59
Query: 233 LDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLI 292
+ G + + L L N L D+ P L L+ L L + N++ L
Sbjct: 60 -SVQG----------IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDLS 106
Query: 293 PTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSK 352
L + +L L L + I+ ++
Sbjct: 107 S--LKDLKKLKSLSLEH-----------------------------------NGISDING 129
Query: 353 LRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
L LE L L N + I V R KL + L N++S
Sbjct: 130 L------------------VHLPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQIS 169
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 4e-20
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 829 IGSGGFGTTYKA---EISPGILVAVKKL-AVGRFQHGVQQFHAEIKTLGNVRHPNLVTLI 884
+G G +G YKA + A+K++ G + EI L ++HPN+++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR----EIALLRELKHPNVISLQ 84
Query: 885 G--YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS-------ALAY 935
+ +++L+++Y +L + IK + + K + V S + Y
Sbjct: 85 KVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAY----LSDFGLSRLLGT---SETHATTGVAGTF 988
LH VLHRD+KP+NIL+ + ++D G +RL + V TF
Sbjct: 144 LHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 989 GYVAPEYALTCRVSDKA-DVYSYGVVLLELISDKKAL 1024
Y APE L R KA D+++ G + EL++ + +
Sbjct: 200 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI 235
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 54/225 (24%), Positives = 105/225 (46%), Gaps = 35/225 (15%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
+GSG +G+ A G VA+KKL+ FQ + A E+ L +++H N++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLS-RPFQS---EIFAKRAYRELLLLKHMQHENVIG 87
Query: 883 LI------GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
L+ + + +L+ ++ +L+ + + S +++++ L Y+
Sbjct: 88 LLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIMGLKFSEEKIQYLVYQML----KGLKYI 142
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
H + V+HRD+KP N+ +++D + DFGL+R ++ T V T Y APE
Sbjct: 143 H---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYVV-TRWYRAPEVI 195
Query: 997 LTCRVSDKA-DVYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
L+ ++ D++S G ++ E+++ K F + D I
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGK----TLFKGKDYLDQLTQI 236
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 24/203 (11%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-EIKTLGNVRHPNLVTLIGY 886
IG+G FG Y+A++ G LVA+KK+ Q ++F E++ + + H N+V L +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKV----LQD--KRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 887 RASGNEMF------LIYNYLPGGNLENFIKARTSRAVDWKILHK--IALDVASALAYLHD 938
S E L+ +Y+P + + + +++ + +LAY+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAY-LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ HRD+KP N+LLD D L DFG ++ L E + + + + Y APE
Sbjct: 175 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYIC-SRYYRAPELIF 229
Query: 998 TCRVSDKA-DVYSYGVVLLELIS 1019
+ DV+S G VL EL+
Sbjct: 230 GATDYTSSIDVWSAGCVLAELLL 252
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 48/219 (21%), Positives = 88/219 (40%), Gaps = 16/219 (7%)
Query: 87 TCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGR 146
T L G V + + L+ L L L N + + +L K+ L++ GN L
Sbjct: 44 TTLSAFGTGVTTIEGV-QYLNNLIGLELKDNQITD--LAPLKNLTKITELELSGNPLKN- 99
Query: 147 LPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLR 206
+ GL++++ L+L +I P + +L+VL L NQ+ + P L L+
Sbjct: 100 -VSAIAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQITNISP--LAGLTNLQ 154
Query: 207 VLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266
L + +++ + + L L L N + S L L + L +N ++D
Sbjct: 155 YLSIGNAQVS-DL-TPLAN-LSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISD 209
Query: 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVL 305
V P L L ++ ++ + N V +V+
Sbjct: 210 VSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 35/153 (22%), Positives = 68/153 (44%), Gaps = 13/153 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+N+ + + L A ++ I + ++ L +L+ L+L N++
Sbjct: 25 AAGKSNVTDTVTQA---DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITD-- 77
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L L + L L+ N L S+I L+S++ L+L+S ++ + L NL
Sbjct: 78 LAPLKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQV 133
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L LD N+++ S LA +T+L + +S
Sbjct: 134 LYLDLNQITN--ISPLAGLTNLQYLSIGNAQVS 164
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 13/153 (8%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+ + + +L L+ NQI+ + P L+NLT + L+L+GN L +
Sbjct: 47 SAFGTGVTTIEGVQ---YLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPL--KN 99
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
S++ L+ ++ L L +T + + L +L+VL L N ++ + L NL
Sbjct: 100 VSAIAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQIT--NISPLAGLTNLQY 155
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L + N ++S + LAN++ L+ A N +S
Sbjct: 156 LSIGNAQVSDL--TPLANLSKLTTLKADDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 9e-18
Identities = 37/181 (20%), Positives = 71/181 (39%), Gaps = 15/181 (8%)
Query: 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188
+L + + ++ L + L+ + I ++ +L L L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL 248
NQ+ + P L + K+ L LS N L S + + ++ LDL+ + + L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPL--KNVSAIAG-LQSIKTLDLTSTQI--TDVTPL 125
Query: 249 GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS 308
L+ L L N + ++ P L L L+ L + +++ L P L N +L+ L
Sbjct: 126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKAD 181
Query: 309 N 309
+
Sbjct: 182 D 182
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 8e-17
Identities = 36/155 (23%), Positives = 64/155 (41%), Gaps = 11/155 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L++ I PL +L+VL NQI+ I P L LT+L +L + ++ ++
Sbjct: 113 DLTSTQITDVTPLA---GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DL 166
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L L L L DN ++ S + L +L + L +N +S + N NL
Sbjct: 167 -TPLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISDV--SPLANTSNLFI 221
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702
+ L N ++ N+ ++ P
Sbjct: 222 VTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAP 256
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 47/260 (18%), Positives = 92/260 (35%), Gaps = 46/260 (17%)
Query: 153 GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSY 212
L N + + + + + + + + L+ G V + + L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKD 72
Query: 213 NELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL 272
N++ + + L + L+LSGN L + S++ Q ++TL L S + DV P L
Sbjct: 73 NQI--TDLAPLKN-LTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--L 125
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332
L L+VL + N++ + P L L L + N
Sbjct: 126 AGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGN----------------------- 160
Query: 333 NGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLI 392
+ + + LSKL + A + S + +L ++L N + +
Sbjct: 161 AQ-----VSDLT-PLANLSKLTTLKADDNKISD--ISPLASLPNLIEVHLKNNQISD--V 210
Query: 393 GVFDRCKKLHFIDLSSNELS 412
L + L++ ++
Sbjct: 211 SPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 39/178 (21%), Positives = 71/178 (39%), Gaps = 26/178 (14%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L N I PL +L+ L + Q+S + L NL+ L L + NK+ +I
Sbjct: 135 YLDLNQITNISPLA---GLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DI 188
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
S L L L + L +N ++ S + +L ++ L++ +++ + NL
Sbjct: 189 -SPLASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNV 245
Query: 668 LL-----------------LDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVT 708
+ + L+ +L S + NV+ + +F N + PF VT
Sbjct: 246 VKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVPFSGTVT 303
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 9e-13
Identities = 24/127 (18%), Positives = 46/127 (36%), Gaps = 10/127 (7%)
Query: 574 ASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPS 633
I+ I P L + + + + + + L + LS +T
Sbjct: 4 TQPTAINVIFP--DPALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVTT--IE 57
Query: 634 SIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFN 693
+ L +L LEL N ++ + NL +T L L N L S +A + S+ +
Sbjct: 58 GVQYLNNLIGLELKDNQIT--DLAPLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLD 113
Query: 694 ASFNNLS 700
+ ++
Sbjct: 114 LTSTQIT 120
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-19
Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLA----VGRFQHGVQQFHAEIKTLGNVR 876
F IG G FG + + A+K + V R + V+ E++ + +
Sbjct: 16 HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE--VRNVFKELQIMQGLE 73
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNL-------ENFIKARTSRAVDWKILHKI-ALD 928
HP LV L +MF++ + L GG+L +F + K+ +
Sbjct: 74 HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV----------KLFICE 123
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF 988
+ AL YL +Q R++HRD+KP NILLD+ + +++DF ++ +L T +AGT
Sbjct: 124 LVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTK 178
Query: 989 GYVAPEYALTCRVS--DKA-DVYSYGVVLLELI 1018
Y+APE + + + A D +S GV EL+
Sbjct: 179 PYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELL 211
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 2e-19
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH--GVQQFHA--EIKTLGNVRHPNLVTL 883
+G G + T YK LVA+K++ R +H G A E+ L +++H N+VTL
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEI---RLEHEEGAP-CTAIREVSLLKDLKHANIVTL 65
Query: 884 IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR 943
+ + L++ YL +L+ ++ ++ + + LAY H Q +
Sbjct: 66 HDIIHTEKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---K 120
Query: 944 VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV-S 1002
VLHRD+KP N+L+++ L+DFGL+R V T Y P+ L S
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYS 179
Query: 1003 DKADVYSYGVVLLELISDKKALDP 1026
+ D++ G + E+ + + L P
Sbjct: 180 TQIDMWGVGCIFYEMAT-GRPLFP 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 37/157 (23%), Positives = 66/157 (42%), Gaps = 9/157 (5%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+LS+NN+ +L L SHN ++ I ++ + +L +LDL+ N L +
Sbjct: 45 DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLH-TL 103
Query: 608 PS-SLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV----VN 661
L+ L L L +N++ + + ++ L+ L LS N +S P +
Sbjct: 104 DEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNK 161
Query: 662 LRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNN 698
L L L L +NKL + L + + +N
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 44/183 (24%), Positives = 77/183 (42%), Gaps = 20/183 (10%)
Query: 558 IPLDIGVMCKSLRVLDASHNQISGIVPQ-SLENLTSLVFLDLNGNKLQGEIPS-SLHRLK 615
+P + +LD SHN +S + + + LT+L L L+ N L I S + +
Sbjct: 33 VPQSLPS---YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 616 YLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNN 673
LR+L L+ N+L + + +L++LEVL L +N + V ++ L L L N
Sbjct: 89 NLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQN 146
Query: 674 KLSGHLPSG----LANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVI-----GNPFLDPC 724
++S P + L + + S N L ++ + NP C
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC 205
Query: 725 QMY 727
++Y
Sbjct: 206 KLY 208
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 39/158 (24%), Positives = 59/158 (37%), Gaps = 9/158 (5%)
Query: 133 LEVLDVEGNFLSGRLPNE--FVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQ 190
+LD+ N LS RL E L NL L L+ N ++ + +L L+L+ N
Sbjct: 41 TALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNH 99
Query: 191 VKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP----S 246
+ + L VL L N + + + L+ L LS N + R P
Sbjct: 100 LHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK 157
Query: 247 SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
K +L L L SN L + +L L +
Sbjct: 158 DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 75.7 bits (186), Expect = 1e-14
Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 9/160 (5%)
Query: 155 RNLRVLNLAFNRIDGDIP--FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSY 212
+L+L+ N + + ++ +L L L+ N + + LR L LS
Sbjct: 39 SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 213 NELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVIP-- 269
N L+ ++ L + LE L L N +V + + QL+ L L N ++
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVEL 155
Query: 270 -RELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS 308
++ L KL +LD+S N+L L T+L L
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 3e-11
Identities = 37/143 (25%), Positives = 53/143 (37%), Gaps = 10/143 (6%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNL 162
L+ L L L N + E + + L LD+ N L L F L+ L VL L
Sbjct: 62 RLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLL 119
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLK---LRVLFLSYNELNGSI 219
N I + + L+ L L+ NQ+ + K L +L LS N+L +
Sbjct: 120 YNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KL 178
Query: 220 PSELGKYCRYLEH--LDLSGNSL 240
P + L L N L
Sbjct: 179 PLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 2e-10
Identities = 25/110 (22%), Positives = 49/110 (44%), Gaps = 8/110 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+LS+N++ + + ++L VL +N I + + E++ L L L+ N++
Sbjct: 94 DLSSNHL-HTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RF 151
Query: 608 P----SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSL--EVLELSSNSL 651
P ++L L L L+ N L + + +L + L L +N L
Sbjct: 152 PVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 31/107 (28%), Positives = 44/107 (41%), Gaps = 4/107 (3%)
Query: 205 LRVLFLSYNELNGSIPSELG-KYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSN 262
+L LS+N L + +E L L LS N L I S + LR L L SN
Sbjct: 41 TALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHL-NFISSEAFVPVPNLRYLDLSSN 98
Query: 263 MLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L+ + L+ LEVL + N + + + +L L LS
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQ 145
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 42/205 (20%), Positives = 72/205 (35%), Gaps = 50/205 (24%)
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPS--SLGKCQQLRTLLLFSNMLNDVIPRELGWL 275
++P L Y LDLS N+L R+ + + + L +LLL N LN + +
Sbjct: 32 NVPQSLP---SYTALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPV 87
Query: 276 RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGE 335
L LD+S N L+ L + L VL+L N
Sbjct: 88 PNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYN-------------------------- 121
Query: 336 KNSFIGSIPMEI-TTLSKLRIIWAPRLNLEG----KLP----SSWGACESLEMLNLAQNV 386
N I + +++L+ +L L + P L +L+L+ N
Sbjct: 122 -NH-IVVVDRNAFEDMAQLQ-----KLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNK 174
Query: 387 LRGDLIGVFDRCKKL--HFIDLSSN 409
L+ + + + + L +N
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 38/213 (17%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
IG G +G A + + VA+KK++ F+H Q + EIK L RH N++
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISP--FEH---QTYCQRTLREIKILLRFRHENIIG 89
Query: 883 LIG-YRASGNEMF----LIYNYLPGGNLENFIKART-----SRAVDWKILHKIALDVASA 932
+ RA E ++ + + +L +K + ++IL
Sbjct: 90 INDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILR--------G 140
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA---TTGVAGTFG 989
L Y+H + VLHRD+KPSN+LL+ + + DFGL+R+ H T VA T
Sbjct: 141 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA-TRW 196
Query: 990 YVAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
Y APE L + K+ D++S G +L E++S++
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 6e-19
Identities = 55/234 (23%), Positives = 94/234 (40%), Gaps = 46/234 (19%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA--EIKTLGN 874
+ IG G FG +KA G VA+KK+ + + G A EIK L
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQL 72
Query: 875 VRHPNLVTLIG--------YRASGNEMFLIYNYL----------PGGNL-ENFIKARTSR 915
++H N+V LI Y ++L++++ + IK
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK----- 127
Query: 916 AVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975
++ + + L Y+H ++LHRD+K +N+L+ D L+DFGL+R
Sbjct: 128 --------RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSL 176
Query: 976 SETHA----TTGVAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDKKAL 1024
++ T V T Y PE L R D++ G ++ E+ + + +
Sbjct: 177 AKNSQPNRYTNRVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-19
Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 31/205 (15%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAV-----GRFQHGVQQFHAEIKTLGNVRHPNLVTL 883
IG+G FG ++A++ VA+KK+ R E++ + V+HPN+V L
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR----------ELQIMRIVKHPNVVDL 97
Query: 884 I------GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILH--KIALDVASALAY 935
G + + L+ Y+P + + +L + +LAY
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAY-LSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
+H + HRD+KP N+LLD L DFG +++L E + + + + Y APE
Sbjct: 157 IHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYIC-SRYYRAPE 211
Query: 995 YALTCRVSDKA-DVYSYGVVLLELI 1018
D++S G V+ EL+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELM 236
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 1e-18
Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV--- 875
DF+ IG GGFG Y G + A+K L R + G E L V
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKART----SRAVDWKILHKIALDVAS 931
P +V + + +++ I + + GG+L + + + A ++
Sbjct: 250 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY------AAEIIL 303
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
L ++H++ V++RD+KP+NILLD+ + +SD GL+ + H GT GY+
Sbjct: 304 GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYM 357
Query: 992 APEYALTCRVSDKA-DVYSYGVVLLELI 1018
APE D + D +S G +L +L+
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLL 385
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 70/274 (25%), Positives = 130/274 (47%), Gaps = 63/274 (22%)
Query: 785 RKGFPDTRVQVSESRELTLFIDIGVPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISP 844
R F R ++++ T++ VP Y+++ + +GSG +G+ A +
Sbjct: 12 RPTF--YRQELNK----TIWE---VPERYQNL----------SPVGSGAYGSVCAAFDTK 52
Query: 845 -GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVTLI------GYRASGNE 892
G+ VAVKKL+ FQ HA E++ L +++H N++ L+ N+
Sbjct: 53 TGLRVAVKKLS-RPFQS---IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108
Query: 893 MFLIYNYLPGGNLENFIKART-----SRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++L+ + + G +L N +K + + + ++IL L Y+H + ++HR
Sbjct: 109 VYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILR--------GLKYIH---SADIIHR 156
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA-D 1006
D+KPSN+ +++D + DFGL+R + T VA T Y APE L ++ D
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYVA-TRWYRAPEIMLNWMHYNQTVD 212
Query: 1007 VYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
++S G ++ EL++ + F + H D +I
Sbjct: 213 IWSVGCIMAELLTGR----TLFPGTDHIDQLKLI 242
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 55/239 (23%), Positives = 103/239 (43%), Gaps = 49/239 (20%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLI- 884
+G GG G + A + VA+KK+ HA EIK + + H N+V +
Sbjct: 19 LGCGGNGLVFSAVDNDCDKRVAIKKIV---LTDPQSVKHALREIKIIRRLDHDNIVKVFE 75
Query: 885 -------------GYRASGNEMFLIYNYLPGGNLENFIKART-----SRAVDWKILHKIA 926
G N ++++ Y+ +L N ++ +R +++L
Sbjct: 76 ILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLR--- 131
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHA---TT 982
L Y+H + VLHRD+KP+N+ ++ +D + DFGL+R++ +H +
Sbjct: 132 -----GLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 983 GVAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
G+ T Y +P L+ KA D+++ G + E+++ K F + + +I
Sbjct: 184 GLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK----TLFAGAHELEQMQLI 237
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 52/226 (23%), Positives = 97/226 (42%), Gaps = 36/226 (15%)
Query: 808 GVPLTYESIIRATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFH 866
G Y+ + + +G G + ++A I+ V VK L + ++
Sbjct: 33 GNQDDYQLVRK----------LGRGKYSEVFEAINITNNEKVVVKILK--PVKK--KKIK 78
Query: 867 AEIKTLGNVR-HPNLVTL--IGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD---WK 920
EIK L N+R PN++TL I L++ ++ + + + T + ++
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYE 138
Query: 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETH 979
IL AL Y H ++HRDVKP N+++D + L D+GL+ + +
Sbjct: 139 IL--------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
Query: 980 ATTGVAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDKKAL 1024
VA + + PE + ++ D + D++S G +L +I K+
Sbjct: 188 -NVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 64/361 (17%), Positives = 113/361 (31%), Gaps = 74/361 (20%)
Query: 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
L+ L L + + I L L L N ++ L NL L
Sbjct: 38 EEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLAC 92
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL------- 215
N++ ++ + L LN N++ + + L L + N L
Sbjct: 93 DSNKL-TNLDVT--PLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNCARNTLTEIDVSH 146
Query: 216 -----------NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264
N I L LD S N + + + + L L +N +
Sbjct: 147 NTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLLNRLNCDTNNI 203
Query: 265 NDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGEL 324
+ +L +L LD S N+L + ++ +L+ S N EL
Sbjct: 204 TKL---DLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSV---------NPLTEL 248
Query: 325 SVGQS------DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLE 378
V + + I +T ++L A +L + L
Sbjct: 249 DVSTLSKLTTLHCIQTD----LLEID--LTHNTQLIYFQAEGCRKIKELDVT--HNTQLY 300
Query: 379 MLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDV----KLQVPCMALFDVSGNHM 434
+L+ + +L + KL ++ L++ EL+ ELDV KL+ H+
Sbjct: 301 LLDCQAAGIT-EL--DLSQNPKLVYLYLNNTELT-ELDVSHNTKLKS-----LSCVNAHI 351
Query: 435 S 435
Sbjct: 352 Q 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 7e-18
Identities = 57/331 (17%), Positives = 114/331 (34%), Gaps = 41/331 (12%)
Query: 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
+ + L L+ N + + L KL L+ + N L+ + L LN
Sbjct: 81 LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNC 134
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
A N + +I S + L L+ N+ + + +L L S+N++ S+
Sbjct: 135 ARNTLT-EIDVS--HNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITELDVSQ 189
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
L L+ N++ ++ L + QL L SN L ++ ++ L +L D
Sbjct: 190 NKL----LNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFD 239
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGS 342
S N L L ++ +L+ L E+ + + +
Sbjct: 240 CSVNPLTEL---DVSTLSKLTTLHCIQ---------TDLLEIDLTHNTQLIYFQAEGCRK 287
Query: 343 IPM-EITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKL 401
I ++T ++L ++ + +L S L L L L +L KL
Sbjct: 288 IKELDVTHNTQLYLLDCQAAGIT-ELDLS--QNPKLVYLYLNNTELT-ELD--VSHNTKL 341
Query: 402 HFIDLSSNELSGELDVKLQVPCMALFDVSGN 432
+ + + + ++P + +
Sbjct: 342 KSLSCVNAHIQ-DFSSVGKIPALNNNFEAEG 371
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 4e-15
Identities = 36/153 (23%), Positives = 63/153 (41%), Gaps = 18/153 (11%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
++NNI LD+ +L L N+++ + + LT L +L+ + NKL ++
Sbjct: 70 ICTSNNITT---LDLS-QNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT-KL 121
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
S L +L+ A N LT + L L+ N ++ V LT
Sbjct: 122 DVSQ--NPLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTT 174
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L NK++ L ++ L+ N NN++
Sbjct: 175 LDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT 204
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 8e-14
Identities = 41/264 (15%), Positives = 88/264 (33%), Gaps = 29/264 (10%)
Query: 149 NEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208
N++ N A + S +L L+ + + + + L L
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKL 69
Query: 209 FLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268
+ N + S+ L +L N L + + +L L +N L +
Sbjct: 70 ICTSNNITTLDLSQNTN----LTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL- 121
Query: 269 PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQ 328
++ L L+ +RN L + ++ + +L+ L ++ ++ + +
Sbjct: 122 --DVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLN--KKITKLDVTPQTQLTT 174
Query: 329 SDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLR 388
D S + I + ++ L + N+ KL L L+ + N L
Sbjct: 175 LDCSFNK----ITELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT 225
Query: 389 GDLIGVFDRCKKLHFIDLSSNELS 412
++ +L + D S N L+
Sbjct: 226 -EID--VTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-13
Identities = 33/153 (21%), Positives = 51/153 (33%), Gaps = 18/153 (11%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N NNI LD+ L LD S N+++ I + LT L + D + N L E+
Sbjct: 197 NCDTNNITK---LDLN-QNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-EL 248
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
S L L L +L + L + E+ V + L
Sbjct: 249 DVST--LSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGCRKIKELD--VTHNTQLYL 301
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L ++ L L+ L + L+
Sbjct: 302 LDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 25/153 (16%), Positives = 55/153 (35%), Gaps = 18/153 (11%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+ S+N + +D+ L D S N ++ + + L+ L L L EI
Sbjct: 218 DCSSNKLTE---IDVT-PLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EI 269
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ L + + + L +L+ + ++ E+ + L
Sbjct: 270 DLT--HNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY 322
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L+N +L+ L +++ T L + ++
Sbjct: 323 LYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ 352
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 49/301 (16%), Positives = 88/301 (29%), Gaps = 49/301 (16%)
Query: 125 PEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184
+ + + + L L L+ + I D+ + L L
Sbjct: 12 NDWFPDDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKL 69
Query: 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI 244
N + + L L L N+L + L K L +L+ N L
Sbjct: 70 ICTSNNITT-LD--LSQNTNLTYLACDSNKLTNLDVTPLTK----LTYLNCDTNKL---T 119
Query: 245 PSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSV 304
+ + L L N L ++ ++ +L LD N+ + + +L+
Sbjct: 120 KLDVSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTT 174
Query: 305 LVLSNLFDPLLSGRNIRGELSVGQS------DASNGEKNSFIGSIPMEITTLSKLRIIWA 358
L S N EL V Q+ + I + + +L
Sbjct: 175 LDCSF---------NKITELDVSQNKLLNRLNCDTNN----ITKLD--LNQNIQLT---- 215
Query: 359 PRLNLEG-KLPS-SWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELD 416
L+ KL L + + N L +L KL + +L E+D
Sbjct: 216 -FLDCSSNKLTEIDVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL-EID 270
Query: 417 V 417
+
Sbjct: 271 L 271
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 34/155 (21%), Positives = 59/155 (38%), Gaps = 17/155 (10%)
Query: 546 VANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG 605
+ + P D + A+ ++ S E L +L LD + + +
Sbjct: 3 LKAGQTQSFNDWFPDD------NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT- 55
Query: 606 EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
++ + +L L L NN+T + + + +L L SN L+ + V L L
Sbjct: 56 DMT-GIEKLTGLTKLICTSNNIT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKL 108
Query: 666 TALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
T L D NKL+ S L+ N + N L+
Sbjct: 109 TYLNCDTNKLTKLDVSQN---PLLTYLNCARNTLT 140
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-11
Identities = 31/221 (14%), Positives = 69/221 (31%), Gaps = 34/221 (15%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
N LT S + +++ +D+ L A + I
Sbjct: 243 NPLT-ELDVSTLSKLTTL-----HCIQTDLLE---IDLT-HNTQLIYFQAEGCRK--IKE 290
Query: 585 QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVL 644
+ + T L LD + E+ L + L +L L + LT + + L+ L
Sbjct: 291 LDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSL 344
Query: 645 ELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704
+ + + V + L + ++ + N+L+
Sbjct: 345 SCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT-----------ITMPKETLTNNSLTIAVS 391
Query: 705 WNVTTMNCSGVIGNPFLDPCQMYKDISSSELTSSNANSQHN 745
++ + G N +Y D +++ +T N ++ +
Sbjct: 392 PDLL--DQFGNPMNIEPGDGGVY-DQATNTITWENLSTDNP 429
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 7e-05
Identities = 30/164 (18%), Positives = 51/164 (31%), Gaps = 29/164 (17%)
Query: 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
V ++L +L G + ++ KL L + L+ L L+ L+
Sbjct: 293 VTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSC 346
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE 222
I D S+ +L A Q + L+ N L ++ +
Sbjct: 347 VNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPK-----------ETLTNNSLTIAVSPD 393
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266
L LD GN + P G Q + + N+ D
Sbjct: 394 L---------LDQFGNPM-NIEPGDGGVYDQATNTITWENLSTD 427
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 60/230 (26%), Positives = 103/230 (44%), Gaps = 44/230 (19%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
+GSG +G A G VA+KKL FQ + A E++ L ++RH N++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLY-RPFQS---ELFAKRAYRELRLLKHMRHENVIG 88
Query: 883 LI------GYRASGNEMFLIYNYLPGGNLENFIKART-----SRAVDWKILHKIALDVAS 931
L+ + +L+ ++ G +L +K + + +++L
Sbjct: 89 LLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLK-------- 139
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
L Y+H A ++HRD+KP N+ +++D + DFGL+R +++ T V T Y
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMTGYVV-TRWYR 192
Query: 992 APEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
APE L + D++S G ++ E+I+ K F S H D I
Sbjct: 193 APEVILNWMRYTQTVDIWSVGCIMAEMITGK----TLFKGSDHLDQLKEI 238
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 4e-18
Identities = 60/238 (25%), Positives = 100/238 (42%), Gaps = 49/238 (20%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
+G G +G A P G +VA+KK+ F A EIK L + +H N++T
Sbjct: 19 LGEGAYGVVCSATHKPTGEIVAIKKIEP--FDK---PLFALRTLREIKILKHFKHENIIT 73
Query: 883 LI-----GYRASGNEMFLIYNYLPGGNLENFIKART-----SRAVDWKILHKIALDVASA 932
+ + NE+++I + +L I + + ++ L A
Sbjct: 74 IFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDDHIQYFIYQTLR--------A 124
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF---G 989
+ LH V+HRD+KPSN+L++ + + + DFGL+R++ S +
Sbjct: 125 VKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181
Query: 990 YV------APEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPSF--SSHGDGFNII 1038
+V APE LT +A DV+S G +L EL + P F + +I
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR----PIFPGRDYRHQLLLI 235
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-18
Identities = 51/213 (23%), Positives = 82/213 (38%), Gaps = 28/213 (13%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKL--AVGRFQHGVQQFHAEIKTLGNVRHP 878
DF IG G FG + + A+K L + F E L N
Sbjct: 75 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVA-------- 930
+ TL N ++L+ +Y GG+L + K ++ ++A
Sbjct: 135 WITTLHYAFQDDNNLYLVMDYYVGGDLLTLLS---------KFEDRLPEEMARFYLAEMV 185
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY 990
A+ +H +HRD+KP NIL+D + + L+DFG L T ++ GT Y
Sbjct: 186 IAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDY 242
Query: 991 VAPEYALTCRVSDK-----ADVYSYGVVLLELI 1018
++PE D +S GV + E++
Sbjct: 243 ISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 14/153 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N N+NI + +L+ L SHNQIS + P L++LT L L +N N+L+ +
Sbjct: 47 NGDNSNIQSLAGMQ---FFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-NL 100
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTA 667
+ + L L L +N L S+ L++LE+L + +N L + L L
Sbjct: 101 -NGIPSAC-LSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK--SIVMLGFLSKLEV 154
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L L N+++ GL + ++ + +
Sbjct: 155 LDLHGNEITN--TGGLTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-17
Identities = 29/154 (18%), Positives = 63/154 (40%), Gaps = 15/154 (9%)
Query: 548 NLSNNNIIGHI-PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGE 606
++ I + P + + ++ +V + L+ + + + + +Q
Sbjct: 2 SIQRPTPINQVFPDP---GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-S 55
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLT 666
+ + + L+ L L+ N ++ S + +L LE L ++ N L G+ + L+
Sbjct: 56 L-AGMQFFTNLKELHLSHNQISD--LSPLKDLTKLEELSVNRNRLK--NLNGIPSA-CLS 109
Query: 667 ALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L LDNN+L L ++ +L I + N L
Sbjct: 110 RLFLDNNELRD--TDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 5e-14
Identities = 39/157 (24%), Positives = 68/157 (43%), Gaps = 14/157 (8%)
Query: 153 GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSY 212
GL N NL + D+ S + ++ N + ++ + + F L+ L LS+
Sbjct: 17 GLANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLSH 72
Query: 213 NELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL 272
N+++ + K LE L ++ N L + + + L L L +N L D L
Sbjct: 73 NQIS-DLSPL--KDLTKLEELSVNRNRL--KNLNGIPSA-CLSRLFLDNNELRDTDS--L 124
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L+ LE+L + N+L ++ LG +L VL L
Sbjct: 125 IHLKNLEILSIRNNKLKSIVM--LGFLSKLEVLDLHG 159
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 40/215 (18%), Positives = 75/215 (34%), Gaps = 19/215 (8%)
Query: 96 VGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLR 155
V L LS ++ + + + L+ L + N +S L L
Sbjct: 31 VTDLVSQ-KELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQIS-DLSP-LKDLT 85
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
L L++ NR+ ++ L L L N+++ L L +L + N+L
Sbjct: 86 KLEELSVNRNRLK-NLNGI--PSACLSRLFLDNNELRDTDS--LIHLKNLEILSIRNNKL 140
Query: 216 NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWL 275
SI LG LE LDL GN + L + +++ + L + + +
Sbjct: 141 K-SI-VMLGF-LSKLEVLDLHGNEI--TNTGGLTRLKKVNWIDLTGQKCVNE---PVKYQ 192
Query: 276 RKLEVLDVSRNRLNGLI-PTELGNCVELSVLVLSN 309
+L + + ++ I P + N +
Sbjct: 193 PELYITNTVKDPDGRWISPYYISNGGSYVDGCVLW 227
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 22/125 (17%), Positives = 48/125 (38%), Gaps = 8/125 (6%)
Query: 577 NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG 636
I+ + P L + V +L + S L +++ + ++N+ + +
Sbjct: 7 TPINQVFP--DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQ--SLAGMQ 60
Query: 637 ELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASF 696
+L+ L LS N +S + +L L L ++ N+L A ++ L + N
Sbjct: 61 FFTNLKELHLSHNQIS--DLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDNNEL 118
Query: 697 NNLSG 701
+
Sbjct: 119 RDTDS 123
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 25/145 (17%), Positives = 48/145 (33%), Gaps = 14/145 (9%)
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG 224
I+ + F + NL V ++ ++ + + S+
Sbjct: 7 TPIN-QV-FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG--M 59
Query: 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
++ L+ L LS N + + S L +L L + N L ++ L L +
Sbjct: 60 QFFTNLKELHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLKNLNGIP---SACLSRLFLD 114
Query: 285 RNRLNGLIPTELGNCVELSVLVLSN 309
N L L + L +L + N
Sbjct: 115 NNELRDTDS--LIHLKNLEILSIRN 137
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 21/105 (20%), Positives = 32/105 (30%), Gaps = 7/105 (6%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
++ NN + + L L VLD N+I+ L L + ++DL G K E
Sbjct: 134 SIRNNKLKSIVMLG---FLSKLEVLDLHGNEITNTGG--LTRLKKVNWIDLTGQKCVNEP 188
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS 652
L + D P I S +
Sbjct: 189 VKYQPELYITNTVKDPDGRWIS--PYYISNGGSYVDGCVLWELPV 231
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 8e-18
Identities = 52/217 (23%), Positives = 77/217 (35%), Gaps = 34/217 (15%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLA----VGRFQHGVQQFHAEIKTLGNVR 876
DF IG G F G + A+K + + R + V F E L N
Sbjct: 62 DFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGE--VSCFREERDVLVNGD 119
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVA------ 930
+ L N ++L+ Y GG+L + K +I ++A
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLS---------KFGERIPAEMARFYLAE 170
Query: 931 --SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF 988
A+ +H +HRD+KP NILLD + L+DFG L T + GT
Sbjct: 171 IVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227
Query: 989 GYVAPEYALTCRVSDKADVY-------SYGVVLLELI 1018
Y++PE Y + GV E+
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMF 264
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 4e-17
Identities = 47/202 (23%), Positives = 85/202 (42%), Gaps = 14/202 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRH 877
F+ +G+G FG G A+K K V + + ++ E + L V
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNF 100
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
P LV L + ++++ Y+ GG + F R A + YLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM--FSHLRRIGRFSEPHARFYAAQIVLTFEYLH 158
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+++RD+KP N+L+D ++DFG ++ + T + GT +APE L
Sbjct: 159 SL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIIL 211
Query: 998 TCRVSDKADVYSYGVVLLELIS 1019
+ + D ++ GV++ E+ +
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAA 233
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 35/144 (24%), Positives = 63/144 (43%), Gaps = 18/144 (12%)
Query: 557 HIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLK 615
++P I + N I I P + L +DL+ N++ E+ + L+
Sbjct: 29 NLPETI-------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 616 YLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNN 673
L L L N +T +P S+ L SL++L L++N ++ + +L NL L L +N
Sbjct: 81 SLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 674 KLSGHLPSG----LANVTSLSIFN 693
KL + G L + ++ +
Sbjct: 139 KLQ-TIAKGTFSPLRAIQTMHLAQ 161
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 36/129 (27%), Positives = 52/129 (40%), Gaps = 12/129 (9%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
N + PG+ F +LSNN I + D +SL L N+I+
Sbjct: 42 NTIKVIPPGA-------FSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 581 GIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRS 640
+ E L SL L LN NK+ + L L LSL DN L + LR+
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRA 153
Query: 641 LEVLELSSN 649
++ + L+ N
Sbjct: 154 IQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 36/131 (27%), Positives = 58/131 (44%), Gaps = 5/131 (3%)
Query: 110 RVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRID 168
+ L N PP +KL +D+ N +S P+ F GLR+L L L N+I
Sbjct: 35 TEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 169 GDIPFSL-RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYC 227
++P SL SL++L L N++ + L +L L N+L +I
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 228 RYLEHLDLSGN 238
R ++ + L+ N
Sbjct: 152 RAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 35/136 (25%), Positives = 60/136 (44%), Gaps = 4/136 (2%)
Query: 179 ESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGN 238
E++ + L N +K + PG + KLR + LS N+++ + + + R L L L GN
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 239 SLVGRIPSSL-GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELG 297
+ +P SL L+ LLL +N +N + L L +L + N+L +
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS 149
Query: 298 NCVELSVLVL-SNLFD 312
+ + L N F
Sbjct: 150 PLRAIQTMHLAQNPFI 165
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 23/87 (26%), Positives = 42/87 (48%), Gaps = 4/87 (4%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIW-SLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNL 162
GL L L L N + E P ++ L L++L + N ++ L + F L NL +L+L
Sbjct: 78 GLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSL 135
Query: 163 AFNRIDGDIPFSLRNFESLEVLNLAGN 189
N++ + +++ ++LA N
Sbjct: 136 YDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 83.6 bits (207), Expect = 7e-17
Identities = 57/205 (27%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHP 878
+F +G G FG + + G A+K L + H E + L N RHP
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFI-KART---SRAVDWKILHKIALDVASALA 934
L L + + + + Y GG L + + R RA + ++ SAL
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY------GAEIVSALD 262
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
YLH + V++RD+K N++LD D + ++DFGL + G + GT Y+APE
Sbjct: 263 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE 319
Query: 995 YALTCRVSDKA-DVYSYGVVLLELI 1018
L +A D + GVV+ E++
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMM 343
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-17
Identities = 55/216 (25%), Positives = 82/216 (37%), Gaps = 37/216 (17%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLA----VGRFQHGVQQFHAEIKTLGNVR 876
D+ IG G FG S + A+K L+ + R F E +
Sbjct: 70 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD--SAFFWEERDIMAFAN 127
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL----DVASA 932
P +V L ++++ Y+PGG+L N + + K A +V A
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-------DVPEKWARFYTAEVVLA 180
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
L +H +HRDVKP N+LLD + L+DFG + GT Y++
Sbjct: 181 LDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237
Query: 993 PE----------YALTCRVSDKADVYSYGVVLLELI 1018
PE Y C D +S GV L E++
Sbjct: 238 PEVLKSQGGDGYYGREC------DWWSVGVFLYEML 267
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 1e-16
Identities = 46/236 (19%), Positives = 87/236 (36%), Gaps = 47/236 (19%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVRHPNLVT 882
IG G +G Y A VA+KK+ F+ EI L ++ ++
Sbjct: 34 IGRGSYGYVYLAYDKNTEKNVAIKKVN-RMFED---LIDCKRILREITILNRLKSDYIIR 89
Query: 883 LI-----GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHK--IALDVASALAY 935
L +E++++ +L+ K + H I ++ +
Sbjct: 90 LYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTP----IFLTEEHIKTILYNLLLGENF 144
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF------- 988
+H ++HRD+KP+N LL+ D + + DFGL+R + + +
Sbjct: 145 IH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201
Query: 989 --------GYV------APEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPSFS 1029
+V APE L K+ D++S G + EL++ ++ +
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 2e-16
Identities = 50/236 (21%), Positives = 84/236 (35%), Gaps = 54/236 (22%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQF-HAEIKTLGNVRHPNLVTLIGY 886
+G+G FG + G A+KK+ Q ++ + E+ + + H N++ L+ Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKKV----LQD--PRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKI--------------------LHKIA 926
+ + P + + K + LHK+
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 927 LDVAS-------------------ALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSD 966
A+ ++H + HRD+KP N+L++ D L D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELISDK 1021
FG ++ L SE + F Y APE L + D++S G V ELI K
Sbjct: 186 FGSAKKLIPSEPS-VAYICSRF-YRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.2 bits (203), Expect = 2e-16
Identities = 48/243 (19%), Positives = 91/243 (37%), Gaps = 54/243 (22%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA--EIKTLGNVRHPNLVTLI- 884
IG+G +G +A +VA+KK+ F+ + EI L + H ++V ++
Sbjct: 61 IGTGSYGHVCEAYDKLEKRVVAIKKIL-RVFEDLIDCKRILREIAILNRLNHDHVVKVLD 119
Query: 885 ----GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVD------WKILHKIALDVASALA 934
+E++++ + + + + +L +
Sbjct: 120 IVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLV--------GVK 170
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF------ 988
Y+H + +LHRD+KP+N L++ D + + DFGL+R + E +
Sbjct: 171 YVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 989 --------------GYV------APEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPS 1027
G+V APE L +A DV+S G + EL++ K
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287
Query: 1028 FSS 1030
+
Sbjct: 288 HAD 290
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 43/155 (27%), Positives = 65/155 (41%), Gaps = 11/155 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
N N+ +P D+ +L S N + +L T L L+L+ +L ++
Sbjct: 16 NCDKRNL-TALPPDLPK---DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KL 70
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGV-VNLRNLT 666
L L L L+ N L +P L +L VL++S N L+ +P G L L
Sbjct: 71 QVD-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQ 127
Query: 667 ALLLDNNKLSGHLPSGL-ANVTSLSIFNASFNNLS 700
L L N+L LP GL L + + NNL+
Sbjct: 128 ELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 9e-16
Identities = 51/185 (27%), Positives = 76/185 (41%), Gaps = 20/185 (10%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
N L +F + + NL + + +D + L LD SHNQ+ + P
Sbjct: 41 NLLY-TFSLATLMPYTRLTQL--NLDRAEL-TKLQVDGTL--PVLGTLDLSHNQLQSL-P 93
Query: 585 QSLENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLE 642
+ L +L LD++ N+L +P L L+ L L N L +P + LE
Sbjct: 94 LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLE 151
Query: 643 VLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
L L++N+L+ E+P G+ L NL LLL N L +P G L N
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN---- 205
Query: 702 PFPWN 706
PW
Sbjct: 206 --PWL 208
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 40/157 (25%), Positives = 62/157 (39%), Gaps = 6/157 (3%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192
+L + N L + L LNL + L L+L+ NQ++
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDG--TLPVLGTLDLSHNQLQ 90
Query: 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL-GKC 251
+P + L VL +S+N L S+P + L+ L L GN L +P L
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 252 QQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRL 288
+L L L +N L ++ L L L+ L + N L
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 4/154 (2%)
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
+ +L+L+ N + +L + L LNL ++ + G+ L L LS+N+L
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL 89
Query: 216 NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWL 275
S+P L LD+S N L +L +L+ L L N L + P L
Sbjct: 90 Q-SLPLLGQTLPA-LTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPT 147
Query: 276 RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
KLE L ++ N L L L L L+L
Sbjct: 148 PKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 42/141 (29%), Positives = 51/141 (36%), Gaps = 9/141 (6%)
Query: 101 PLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVL 160
+ G L L L L N P +L L VLDV N L+ GL L+ L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 161 NLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIP 220
L N + P L LE L+LA N + + G L L L L N L +IP
Sbjct: 130 YLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIP 188
Query: 221 S---ELGKYCRYLEHLDLSGN 238
L L GN
Sbjct: 189 KGFFGSHL----LPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 36/117 (30%), Positives = 50/117 (42%), Gaps = 5/117 (4%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
L L L L VL + FN + P L +L+ L ++GN L P L
Sbjct: 92 LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKL 150
Query: 158 RVLNLAFNRIDGDIPFSL-RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
L+LA N + ++P L E+L+ L L N + + GF GS L FL N
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGS-HLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 35/134 (26%), Positives = 51/134 (38%), Gaps = 8/134 (5%)
Query: 178 FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIP--SELGKYCRYLEHLDL 235
+ +L+L+ N + L + +L L L EL + L L LDL
Sbjct: 30 PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDGTLPV----LGTLDL 84
Query: 236 SGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTE 295
S N L +P L L + N L + L L +L+ L + N L L P
Sbjct: 85 SHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGL 143
Query: 296 LGNCVELSVLVLSN 309
L +L L L+N
Sbjct: 144 LTPTPKLEKLSLAN 157
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKT----LG 873
F +G G FG + + L A+K L + + K L
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVL---KKATLKVRDRVRTKMERDILV 81
Query: 874 NVRHPNLVTLIGYRASGNEMFLIYNYLPGGNL-------ENFIKARTSRAVDWKILHKI- 925
V HP +V L + +++LI ++L GG+L F + K
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV----------KFY 131
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
++A AL +LH +++RD+KP NILLD++ + L+DFGLS+ E A +
Sbjct: 132 LAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FC 187
Query: 986 GTFGYVAPEYALTCRVSDKA-DVYSYGVVLLELI 1018
GT Y+APE + R ++ D +S+GV++ E++
Sbjct: 188 GTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEML 220
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-16
Identities = 40/195 (20%), Positives = 70/195 (35%), Gaps = 41/195 (21%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGY 886
+G G G + A+K L + E++ + P++V ++
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKML------QDCPKARREVELHWRASQCPHIVRIVDV 79
Query: 887 ----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
A + ++ L GG L + I+ R +A + +I + A+ YLH
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI--- 136
Query: 943 RVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
+ HRDVKP N+L + L+DFG A E
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFGF----------------------AKE-TTGE 173
Query: 1000 RVSDKADVYSYGVVL 1014
+ D++S GV++
Sbjct: 174 KYDKSCDMWSLGVIM 188
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 46/140 (32%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNN 626
+ LD N++S + ++ LT L L LN NKLQ +P+ + LK L L + DN
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNK 96
Query: 627 LTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSG-- 682
L +P + +L +L L L N L +P V +L LT L L N+L LP G
Sbjct: 97 LQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 683 --LANVTSLSIFNASFNNLS 700
L ++ L ++N N L
Sbjct: 154 DKLTSLKELRLYN---NQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 43/154 (27%), Positives = 65/154 (42%), Gaps = 8/154 (5%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
+N + +P LR+L + N++ + + L +L L + NKLQ +P
Sbjct: 45 QSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIG 103
Query: 611 L-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTA 667
+ +L L L L N L +P + L L L L N L +P+GV L +L
Sbjct: 104 VFDQLVNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKE 161
Query: 668 LLLDNNKLSGHLPSGL-ANVTSLSIFNASFNNLS 700
L L NN+L +P G +T L N L
Sbjct: 162 LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 51/189 (26%), Positives = 81/189 (42%), Gaps = 24/189 (12%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
NKL+ + FH + L++N + +P I K+L L + N++
Sbjct: 47 NKLSSLPSKA-------FHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 581 GIVPQSLENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTGGIPSSI-GEL 638
+ + L +L L L+ N+L+ +P + L L +LSL N L +P + +L
Sbjct: 99 ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKL 156
Query: 639 RSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFN 697
SL+ L L +N L VPEG L L L LDNN+L ++ L + N
Sbjct: 157 TSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
Query: 698 NLSGPFPWN 706
PW+
Sbjct: 216 ------PWD 218
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 57/182 (31%), Positives = 76/182 (41%), Gaps = 25/182 (13%)
Query: 113 SLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR---IDG 169
SLP F L KL +L + N L F L+NL L + N+ +
Sbjct: 51 SLPSKAFHR--------LTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPI 102
Query: 170 DIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS----ELGK 225
+ L N L L L NQ+K + P S KL L L YNEL S+P +L
Sbjct: 103 GVFDQLVN---LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTS 158
Query: 226 YCRYLEHLDLSGNSLVGRIPSSL-GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
L+ L L N L R+P K +L+TL L +N L V L KL++L +
Sbjct: 159 ----LKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 285 RN 286
N
Sbjct: 214 EN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 4e-11
Identities = 42/113 (37%), Positives = 57/113 (50%), Gaps = 6/113 (5%)
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSN 649
LDL NKL + HRL LR L L DN L +P+ I EL++LE L ++ N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDN 95
Query: 650 SLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGL-ANVTSLSIFNASFNNLS 700
L +P GV L NL L LD N+L LP + ++T L+ + +N L
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ 146
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 50/188 (26%), Positives = 78/188 (41%), Gaps = 23/188 (12%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRI---DGDIPFSLRNFESLEVLNLAGN 189
+ LD++ N LS F L LR+L L N++ I L+N LE L + N
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN---LETLWVTDN 95
Query: 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS----ELGKYCRYLEHLDLSGNSLVGRIP 245
+++ + G + L L L N+L S+P L K L +L L N L +P
Sbjct: 96 KLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTK----LTYLSLGYNELQ-SLP 149
Query: 246 S----SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVE 301
L L+ L L++N L V L +L+ L + N+L + + +
Sbjct: 150 KGVFDKLTS---LKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEK 206
Query: 302 LSVLVLSN 309
L +L L
Sbjct: 207 LKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 7e-08
Identities = 41/178 (23%), Positives = 68/178 (38%), Gaps = 16/178 (8%)
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
+ + L+L N++ + L +L L N+++ + G L L+++ N+L
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL 97
Query: 216 NGSIPSELGKYCRYLEHLDLSGN---SLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL 272
++P + L L L N SL R+ SL K L L L N L +
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTK---LTYLSLGYNELQSLPKGVF 153
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN---------LFDPLLSGRNIR 321
L L+ L + N+L + EL L L N FD L + ++
Sbjct: 154 DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQ 211
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 32/207 (15%)
Query: 205 LRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL-GKCQQLRTLLLFSNM 263
+ L L N+L+ S+PS+ L L L+ N L +P+ + + + L TL + N
Sbjct: 39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNK 96
Query: 264 LNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGE 323
L + L L L + RN+L L P + +L+ L L
Sbjct: 97 LQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGY-------------- 142
Query: 324 LSVGQSDASNGEKNSFIGSIPMEI-TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNL 382
N + S+P + L+ L+ + L+ ++ L+ L L
Sbjct: 143 -------------NE-LQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKL 188
Query: 383 AQNVLRGDLIGVFDRCKKLHFIDLSSN 409
N L+ G FD +KL + L N
Sbjct: 189 DNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.1 bits (196), Expect = 7e-16
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGR-FQHGVQQFH--AEIKTLGN 874
F +G GG+G ++ G + A+K L ++ H AE L
Sbjct: 18 CFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEE 77
Query: 875 VRHPNLVTLIGYRASGNEMFLIYNYLPGGNL-------ENFIKARTSRAVDWKILHKI-A 926
V+HP +V LI +G +++LI YL GG L F++
Sbjct: 78 VKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA----------CFYL 127
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG 986
+++ AL +LH + +++RD+KP NI+L+ + L+DFGL + + T G
Sbjct: 128 AEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCG 183
Query: 987 TFGYVAPEYALTCRVSDKA-DVYSYGVVLLELI 1018
T Y+APE L ++A D +S G ++ +++
Sbjct: 184 TIEYMAPE-ILMRSGHNRAVDWWSLGALMYDML 215
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 7e-16
Identities = 31/172 (18%), Positives = 64/172 (37%), Gaps = 13/172 (7%)
Query: 540 NEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQ-ISGIVPQSLENLTSLV 594
+ F + +S + + + + ++ + + ++ I P +L+ L L
Sbjct: 49 HAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLK 108
Query: 595 FLDLNGNKLQGEIP--SSLHRLKYLRHLSLADNNLTGGIPSSI--GELRSLEVLELSSNS 650
FL + L+ P + ++ L + DN IP + G L+L +N
Sbjct: 109 FLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNG 167
Query: 651 LSGEVPEGVVNLRNLTALLLDNNKLSGHLPSG-LANVTS-LSIFNASFNNLS 700
+ V N L A+ L+ NK + V S S+ + S +++
Sbjct: 168 FT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 42/213 (19%), Positives = 75/213 (35%), Gaps = 20/213 (9%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNLAF 164
L E + ++P + FS L + + V + +L + F L + + +
Sbjct: 38 LIETHLRTIPSHAFSN--------LPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRN 89
Query: 165 NRIDGDIP-FSLRNFESLEVLNLAGNQVKGVIPG--FLGSFLKLRVLFLSYNELNGSIPS 221
R I +L+ L+ L + +K + P + S +L ++ N SIP
Sbjct: 90 TRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPV 148
Query: 222 E-LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL--GWLRKL 278
C L L N + +L + L N VI ++ G
Sbjct: 149 NAFQGLCNETLTLKLYNNGF-TSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGP 207
Query: 279 EVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311
+LDVS+ + L L + L L+ N +
Sbjct: 208 SLLDVSQTSVTALPSKGLEH---LKELIARNTW 237
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 20/120 (16%), Positives = 44/120 (36%), Gaps = 5/120 (4%)
Query: 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNN 626
S + L + I + NL ++ + ++ + ++ S S + L + H+ + +
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 627 LTGGIPSSI-GELRSLEVLELSSNSLSGEVPEG--VVNLRNLTALLLDNNKLSGHLPSGL 683
I EL L+ L + + L P+ V + L + +N +P
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 9e-11
Identities = 22/139 (15%), Positives = 43/139 (30%), Gaps = 11/139 (7%)
Query: 566 CKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLAD 624
C + I I P + +L L L+ IPS + L + + ++
Sbjct: 10 CHQEEDFRVTCKDIQRI-PSLPPSTQTL---KLIETHLR-TIPSHAFSNLPNISRIYVSI 64
Query: 625 NNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLP-- 680
+ + S L + +E+ + + L L L + N L P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDL 123
Query: 681 SGLANVTSLSIFNASFNNL 699
+ + + I + N
Sbjct: 124 TKVYSTDIFFILEITDNPY 142
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 4e-09
Identities = 31/166 (18%), Positives = 57/166 (34%), Gaps = 15/166 (9%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNE--FVGLRNLRVLN 161
LS++ + + P+ L L+ L + L P+ +L
Sbjct: 78 NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILE 136
Query: 162 LAFN----RIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
+ N I + L N L L N + G+ + KL ++L+ N+
Sbjct: 137 ITDNPYMTSIPVNAFQGLCN--ETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT 193
Query: 218 SIPSE-LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262
I + G LD+S S+ +PS + L+ L+ +
Sbjct: 194 VIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG--LEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 7e-08
Identities = 19/142 (13%), Positives = 41/142 (28%), Gaps = 10/142 (7%)
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFL---KLRVLFL 210
+ + L L + + N ++ + ++ + + SF K+ + +
Sbjct: 30 PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES--HSFYNLSKVTHIEI 87
Query: 211 SYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP--SSLGKCQQLRTLLLFSNMLNDVI 268
I + K L+ L + L P + + L + N I
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSI 146
Query: 269 PREL--GWLRKLEVLDVSRNRL 288
P G + L + N
Sbjct: 147 PVNAFQGLCNETLTLKLYNNGF 168
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 7e-07
Identities = 23/135 (17%), Positives = 50/135 (37%), Gaps = 6/135 (4%)
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
S + L L ++ + + + +++S + + S + H+++
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 240 LVGRIPSS-LGKCQQLRTLLLFSNMLNDVIP--RELGWLRKLEVLDVSRNRLNGLIPTEL 296
+ I L + L+ L +F+ L + P ++ +L+++ N IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 297 --GNCVELSVLVLSN 309
G C E L L N
Sbjct: 151 FQGLCNETLTLKLYN 165
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 7e-16
Identities = 34/171 (19%), Positives = 62/171 (36%), Gaps = 13/171 (7%)
Query: 540 NEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASH-NQISGIVPQSLENLTSLV 594
F G +S N+++ I D+ L + N + I P++ +NL +L
Sbjct: 48 GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQ 107
Query: 595 FLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSI--GELRSLEVLELSSNSL 651
+L ++ ++ +P L + DN I + G +L L+ N +
Sbjct: 108 YLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 652 SGEVPEGVVN-LRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
E+ N + L DNN L LP+ + I + S +
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 37/208 (17%), Positives = 70/208 (33%), Gaps = 5/208 (2%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNLA- 163
L +S LE +++ N + + + F L L + +
Sbjct: 30 RNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSE- 222
N + P + +N +L+ L ++ +K + L+ +L + N +I
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 223 LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
L L+ N + S+ Q L +N L ++ +LD
Sbjct: 149 FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILD 208
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSNL 310
+SR R++ L L N +L NL
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRARSTYNL 236
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 7e-14
Identities = 34/168 (20%), Positives = 58/168 (34%), Gaps = 14/168 (8%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
F + + N + +I + +L+ L S+ I + + V LD
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 134
Query: 598 LNGNKLQGEIPS-SLHRLKY-LRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGE 654
+ N I S L + L L N + I +S + E+ +N+L E
Sbjct: 135 IQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-E 192
Query: 655 VPEGV-VNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLS 700
+P V L + ++ LPS L N+ L + NL
Sbjct: 193 LPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARST--YNLK 237
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 20/136 (14%), Positives = 48/136 (35%), Gaps = 9/136 (6%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
+ + IP D+ ++ L ++ I + L ++++ N + I +
Sbjct: 17 QESKVTEIPSDL---PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 73
Query: 611 -LHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTA 667
L L + + N I L +L+ L +S+ + +P+ ++
Sbjct: 74 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVL 132
Query: 668 L-LLDNNKLSGHLPSG 682
L + DN + +
Sbjct: 133 LDIQDNINIH-TIERN 147
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 33/185 (17%), Positives = 58/185 (31%), Gaps = 12/185 (6%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLP-NEFVGLR-NLRVLN 161
L L+ L + G P + +LD++ N + N FVGL +L
Sbjct: 102 NLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILW 160
Query: 162 LAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS 221
L N I + + E+ N ++ + +L +S ++ S+PS
Sbjct: 161 LNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS 219
Query: 222 ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281
+ + L + +L K L L W R++ L
Sbjct: 220 YGLENLKKLRARSTYNLKKLP----TLEKLVALMEASLTYPSHCC---AFANWRRQISEL 272
Query: 282 DVSRN 286
N
Sbjct: 273 HPICN 277
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 20/135 (14%), Positives = 46/135 (34%), Gaps = 3/135 (2%)
Query: 178 FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSG 237
+ L +++ + G F L + +S N++ I +++ L + +
Sbjct: 29 PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 238 NSLVGRIPSS-LGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTEL 296
+ + I L+ LL+ + + + + +LD+ N I
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 297 --GNCVELSVLVLSN 309
G E +L L+
Sbjct: 149 FVGLSFESVILWLNK 163
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 22/74 (29%), Positives = 33/74 (44%), Gaps = 4/74 (5%)
Query: 549 LSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP 608
LS+NN + +P D+ +LD S +I + LENL L K ++P
Sbjct: 184 LSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP 240
Query: 609 SSLHRLKYLRHLSL 622
+L +L L SL
Sbjct: 241 -TLEKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 31/212 (14%), Positives = 61/212 (28%), Gaps = 56/212 (26%)
Query: 205 LRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP----SSLGKCQQLRTLLLF 260
L +L I LE +++S N ++ I S+L K ++R +
Sbjct: 32 AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIR--IEK 88
Query: 261 SNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNI 320
+N L + P L L+ L +S + L + ++ +L + +
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQD----------- 137
Query: 321 RGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEML 380
N I +I + L +L
Sbjct: 138 ----------------NINIHTIER--NSFVGL--------------------SFESVIL 159
Query: 381 NLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
L +N ++ F+ + +N L
Sbjct: 160 WLNKNGIQEIHNSAFNGTQLDELNLSDNNNLE 191
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 9e-16
Identities = 31/141 (21%), Positives = 54/141 (38%), Gaps = 15/141 (10%)
Query: 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNN 626
S + LD S N + + S + L LDL+ ++Q I L +L L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 627 LTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNNKLSGHLP---- 680
+ + L SL+ L +L+ + +L+ L L + +N +
Sbjct: 88 IQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ-SFKLPEY 144
Query: 681 -SGLANVTSLSIFNASFNNLS 700
S L N+ L + + N +
Sbjct: 145 FSNLTNLEHLDLSS---NKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 1e-15
Identities = 40/165 (24%), Positives = 68/165 (41%), Gaps = 15/165 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG-E 606
L+ N I + L SL+ L A ++ + + +L +L L++ N +Q +
Sbjct: 82 ILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFK 140
Query: 607 IPSSLHRLKYLRHLSLADNNLT---GGIPSSIGELRSLEV-LELSSNSLSGEVPEGVVNL 662
+P L L HL L+ N + + ++ L + L+LS N ++ + G
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 663 RNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLSGPFPWN 706
L L LD N+L +P G +TSL N PW+
Sbjct: 200 IRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN------PWD 237
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 37/170 (21%), Positives = 57/170 (33%), Gaps = 15/170 (8%)
Query: 542 FHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
F +LS I I L L + N I + + L+SL L
Sbjct: 48 FFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV 106
Query: 598 LNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTG-GIPSSIGELRSLEVLELSSNSLSGEV 655
L + + LK L+ L++A N + +P L +LE L+LSSN + +
Sbjct: 107 AVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SI 164
Query: 656 PEGV-VNLRNLTA----LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
L + L L N ++ + G L N L
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK 213
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 48/196 (24%), Positives = 74/196 (37%), Gaps = 10/196 (5%)
Query: 98 KLSPLV-GGLSELRVLSLPFNGFSGEFPPEI-WSLEKLEVLDVEGNFLSGRLPNEFVGLR 155
L EL+VL L SL L L + GN + F GL
Sbjct: 42 HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLS 100
Query: 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVI-PGFLGSFLKLRVLFLSYNE 214
+L+ L + F + + ++L+ LN+A N ++ P + + L L LS N+
Sbjct: 101 SLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNK 160
Query: 215 LNGSIPSE----LGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPR 270
+ SI L + LDLS N + I K +L+ L L +N L V
Sbjct: 161 IQ-SIYCTDLRVLHQMPLLNLSLDLSLNPM-NFIQPGAFKEIRLKELALDTNQLKSVPDG 218
Query: 271 ELGWLRKLEVLDVSRN 286
L L+ + + N
Sbjct: 219 IFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 46/206 (22%), Positives = 79/206 (38%), Gaps = 22/206 (10%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIP---FSLRNFESLEVLNLAGN 189
+ LD+ N L F L+VL+L+ I I + + L L L GN
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQ--SLSHLSTLILTGN 86
Query: 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL-VGRIPSSL 248
++ + G L+ L L S+ + + + L+ L+++ N + ++P
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYF 145
Query: 249 GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEV----LDVSRNRLNGLIPTELGNCVELSV 304
L L L SN + + +L L ++ + LD+S N +N I + L
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKE 204
Query: 305 LVLSN---------LFDPLLSGRNIR 321
L L +FD L S + I
Sbjct: 205 LALDTNQLKSVPDGIFDRLTSLQKIW 230
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 8e-12
Identities = 25/113 (22%), Positives = 42/113 (37%), Gaps = 6/113 (5%)
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSN 649
S LDL+ N L+ S L+ L L+ + I L L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGN 86
Query: 650 SLSGEVPEGV-VNLRNLTALLLDNNKLSGHLPSGLA-NVTSLSIFNASFNNLS 700
+ + G L +L L+ L+ L + ++ +L N + N +
Sbjct: 87 PIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQ 137
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 7e-11
Identities = 53/237 (22%), Positives = 88/237 (37%), Gaps = 38/237 (16%)
Query: 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS 239
S + L+L+ N ++ + SF +L+VL LS E+ +I + +L L L+GN
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 240 LVGRIPSSL-GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTEL-G 297
+ + L+ L+ L + +G L+ L+ L+V+ N + E
Sbjct: 88 I-QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146
Query: 298 NCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI-TTLSKLRII 356
N L L LS+ N I SI L ++ ++
Sbjct: 147 NLTNLEHLDLSS---------------------------NK-IQSIYCTDLRVLHQMPLL 178
Query: 357 WAPRLNLEG----KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSN 409
L+L + L+ L L N L+ G+FDR L I L +N
Sbjct: 179 N-LSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.3 bits (194), Expect = 1e-15
Identities = 59/207 (28%), Positives = 102/207 (49%), Gaps = 24/207 (11%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVK---KLAVGRFQHGVQQFHAEIKTLGNVRH 877
DF +G+G FG + G A+K K V R + V+ + E L V H
Sbjct: 7 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTH 65
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFI-KART---SRAVDWKILHKI-ALDVASA 932
P ++ + G ++F+I +Y+ GG L + + K++ A K A +V A
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-------KFYAAEVCLA 118
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992
L YLH + +++RD+KP NILLD + + ++DFG ++ + T + GT Y+A
Sbjct: 119 LEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----TYTLCGTPDYIA 171
Query: 993 PEYALTCRVSDKADVYSYGVVLLELIS 1019
PE T + D +S+G+++ E+++
Sbjct: 172 PEVVSTKPYNKSIDWWSFGILIYEMLA 198
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 32/129 (24%), Positives = 57/129 (44%), Gaps = 6/129 (4%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L+NN I LR ++ S+N+I+ I + E + + + L N+L+ +
Sbjct: 38 RLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NV 96
Query: 608 PSSL-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRN 664
+ L+ L+ L L N +T + + L S+ +L L N ++ V G L +
Sbjct: 97 QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS 154
Query: 665 LTALLLDNN 673
L+ L L N
Sbjct: 155 LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 27/144 (18%), Positives = 60/144 (41%), Gaps = 17/144 (11%)
Query: 557 HIPLDIGVMCKSLRVLDASHNQISGIVPQSL-ENLTSLVFLDLNGNKLQGEIPSSLHRLK 615
HIP L ++N+ + + + + L L ++ + NK+ +
Sbjct: 29 HIPQYT-------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGAS 81
Query: 616 YLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGV-VNLRNLTALLLDNN 673
+ + L N L + + L SL+ L L SN ++ V + L ++ L L +N
Sbjct: 82 GVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDN 139
Query: 674 KLSGHLPSG----LANVTSLSIFN 693
+++ + G L ++++L++
Sbjct: 140 QIT-TVAPGAFDTLHSLSTLNLLA 162
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 25/134 (18%), Positives = 46/134 (34%), Gaps = 10/134 (7%)
Query: 134 EVLDVEGNFLSGRLPN-EFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192
L + N + F L LR +N + N+I + + + L N+++
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP----SSL 248
V L+ L L N + + ++ + L L N + + +L
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTL 152
Query: 249 GKCQQLRTLLLFSN 262
L TL L +N
Sbjct: 153 HS---LSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-07
Identities = 26/133 (19%), Positives = 49/133 (36%), Gaps = 4/133 (3%)
Query: 156 NLRVLNLAFNRIDGDIPFSL-RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
L L N + + L +N + N++ + G + + L+ N
Sbjct: 33 YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNR 92
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVIPRELG 273
L ++ ++ K L+ L L N + + + S +R L L+ N + V P
Sbjct: 93 LE-NVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFD 150
Query: 274 WLRKLEVLDVSRN 286
L L L++ N
Sbjct: 151 TLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 28/110 (25%), Positives = 44/110 (40%), Gaps = 2/110 (1%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIW-SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L +LR ++ N + + + + + + N L F GL +L+ L L
Sbjct: 55 KLPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLR 113
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
NRI S S+ +L+L NQ+ V PG + L L L N
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 25/120 (20%), Positives = 43/120 (35%), Gaps = 9/120 (7%)
Query: 206 RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
L L+ NE + + K L ++ S N + + + +LL SN L
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE 94
Query: 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN---------LFDPLLS 316
+V + L L+ L + NR+ + + +L L + FD L S
Sbjct: 95 NVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHS 154
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 2e-15
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHP 878
DF+ +G G FG + G A+K L + H E + L N RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFI-KART---SRAVDWKILHKIALDVASALA 934
L L + + + + Y GG L + + R RA + ++ SAL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY------GAEIVSALE 119
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPE 994
YLH + V++RD+K N++LD D + ++DFGL + G S+ GT Y+APE
Sbjct: 120 YLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPE 175
Query: 995 YALTCRVSDKA-DVYSYGVVLLELI 1018
L +A D + GVV+ E++
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMM 199
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 3e-15
Identities = 43/212 (20%), Positives = 75/212 (35%), Gaps = 11/212 (5%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLR 158
+L L S E+ S ++L+ L+ E + L + +R L
Sbjct: 341 WCRDSATDEQLFRCELSVE-KSTVLQSELESCKELQELEPENKW---CLLTIILLMRALD 396
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218
L + + L+ ++ + +RVL L++ +L
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-V 455
Query: 219 IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKL 278
+ + + HLDLS N L +P +L + L L N L +V + L +L
Sbjct: 456 LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENV--DGVANLPRL 510
Query: 279 EVLDVSRNRLNGL-IPTELGNCVELSVLVLSN 309
+ L + NRL L +C L +L L
Sbjct: 511 QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQG 542
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 7/106 (6%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L++ ++ L+ + LD SHN++ + P +L L L L + N L+ +
Sbjct: 447 HLAHKDLTVLCHLE---QLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALE-NV 501
Query: 608 PSSLHRLKYLRHLSLADNNLTG-GIPSSIGELRSLEVLELSSNSLS 652
+ L L+ L L +N L + L +L L NSL
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.2 bits (171), Expect = 2e-12
Identities = 40/153 (26%), Positives = 60/153 (39%), Gaps = 8/153 (5%)
Query: 550 SNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS 609
+ + V LD ++ + L L L +
Sbjct: 400 YEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVLC 457
Query: 610 SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALL 669
L +L + HL L+ N L +P ++ LR LEVL+ S N+L E +GV NL L LL
Sbjct: 458 HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL--ENVDGVANLPRLQELL 514
Query: 670 LDNNKLSGHLPS--GLANVTSLSIFNASFNNLS 700
L NN+L + L + L + N N+L
Sbjct: 515 LCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 3e-12
Identities = 32/134 (23%), Positives = 56/134 (41%), Gaps = 8/134 (5%)
Query: 122 EFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESL 181
E + VL + L+ L + L + L+L+ NR+ +P +L L
Sbjct: 432 ENSVLKMEYADVRVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCL 488
Query: 182 EVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSL 240
EVL + N ++ + G + + +L+ L L N L + L C L L+L GNSL
Sbjct: 489 EVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQSAAIQPLVS-CPRLVLLNLQGNSL 545
Query: 241 VGRIPSSLGKCQQL 254
+ + ++
Sbjct: 546 C-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 66.7 bits (162), Expect = 2e-11
Identities = 32/137 (23%), Positives = 53/137 (38%), Gaps = 12/137 (8%)
Query: 569 LRVLDASHNQISGIVPQSLENLTSLVFLDLNG-----NKLQGEIPSSLHRLKYLRHLSLA 623
+R LD + + Q L ++ + +K E +R L LA
Sbjct: 392 MRALDPLLYEKETL--QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGL 683
+LT + + +L + L+LS N L +P + LR L L +N L ++ G+
Sbjct: 450 HKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GV 504
Query: 684 ANVTSLSIFNASFNNLS 700
AN+ L N L
Sbjct: 505 ANLPRLQELLLCNNRLQ 521
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 4e-10
Identities = 30/127 (23%), Positives = 48/127 (37%), Gaps = 7/127 (5%)
Query: 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDG 169
RVL L + + L + LD+ N L LP LR L VL + N ++
Sbjct: 444 RVLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE- 499
Query: 170 DIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCR 228
++ + N L+ L L N+++ L S +L +L L N L +
Sbjct: 500 NVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL-CQEEGIQERLAE 557
Query: 229 YLEHLDL 235
L +
Sbjct: 558 MLPSVSS 564
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 50.5 bits (120), Expect = 2e-06
Identities = 38/226 (16%), Positives = 75/226 (33%), Gaps = 21/226 (9%)
Query: 230 LEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML---NDVIPRELGWLRKLEVLDVSRN 286
L +LS + S L C++L+ L + ++ R L L + +
Sbjct: 351 LFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFS 409
Query: 287 RLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346
L + P +L L + ++R L + + + +
Sbjct: 410 TLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVR-VLHL---------AHKDLTVLC-H 458
Query: 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDL 406
+ L + + L LP + A LE+L + N L ++ G +L + L
Sbjct: 459 LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLL 515
Query: 407 SSNELSGELDVKLQVPCMAL--FDVSGNHMSGSIPRFDYNVCHQMP 450
+N L ++ V C L ++ GN + + +P
Sbjct: 516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEMLP 560
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 3e-05
Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 9/73 (12%)
Query: 548 NLSNNNI--IGHIPLDIGVMCKSLRVLDASHNQISGI-VPQSLENLTSLVFLDLNGNKLQ 604
S+N + + + L+ L +N++ Q L + LV L+L GN L
Sbjct: 492 QASDNALENVDGVA-----NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
Query: 605 GEIPSSLHRLKYL 617
+ RL +
Sbjct: 547 -QEEGIQERLAEM 558
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 7e-15
Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP----GILVAVK---KLAVGRFQHGVQQFHAEIKTLGN 874
+F +G+G +G + G L A+K K + + + E + L +
Sbjct: 55 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 114
Query: 875 VRH-PNLVTLIGYRASGNEMFLIYNYLPGGNL-------ENFIKARTSRAVDWKILHKI- 925
+R P LVTL + ++ LI +Y+ GG L E F + +I
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV----------QIY 164
Query: 926 ALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVA 985
++ AL +LH +++RD+K NILLD + + L+DFGLS+ ET
Sbjct: 165 VGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221
Query: 986 GTFGYVAPEYALTCRVS-DKA-DVYSYGVVLLELI 1018
GT Y+AP+ DKA D +S GV++ EL+
Sbjct: 222 GTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELL 256
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 64/247 (25%), Positives = 104/247 (42%), Gaps = 57/247 (23%)
Query: 829 IGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHA-----EIKTLGNVR-HPNLV 881
+G G +G +K+ G +VAVKK+ FQ+ A EI L + H N+V
Sbjct: 17 LGKGAYGIVWKSIDRRTGEVVAVKKIF-DAFQNST---DAQRTFREIMILTELSGHENIV 72
Query: 882 TL--IGYRASGNEMFLIYNYLPGGNLENFIKART-----SRAVDWKILHKIALDVASALA 934
L + + +++L+++Y+ +L I+A + V ++++ +
Sbjct: 73 NLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANILEPVHKQYVVYQLIK--------VIK 123
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF------ 988
YLH + +LHRD+KPSNILL+ + + ++DFGLSR
Sbjct: 124 YLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENF 180
Query: 989 --------GYV------APEYALTCRVSDKA-DVYSYGVVLLELISDKKALDPSF--SSH 1031
YV APE L K D++S G +L E++ K P F SS
Sbjct: 181 DDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK----PIFPGSST 236
Query: 1032 GDGFNII 1038
+ I
Sbjct: 237 MNQLERI 243
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 2e-13
Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKL--AVGRFQHGVQQFHAEIKTLGNV-RH 877
DFN +G G FG +E L AVK L V V+ E + L +
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNL----ENFIKARTSRAVDWKILHKIALDVASAL 933
P L L + + ++ + Y+ GG+L + + + AV + A ++A L
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGL 455
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+L + +++RD+K N++LD + + ++DFG+ + + T GT Y+AP
Sbjct: 456 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAP 511
Query: 994 EYALTCRVSDKADVYSYGVVLLELI 1018
E D +++GV+L E++
Sbjct: 512 EIIAYQPYGKSVDWWAFGVLLYEML 536
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 24/209 (11%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKL----AVGRFQHGVQQFHAEIKTLGNV- 875
DF+ IG G + + A+K + + E
Sbjct: 10 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDED--IDWVQTEKHVFEQAS 67
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKART----SRAVDWKILHKIALDVAS 931
HP LV L + + +F + Y+ GG+L ++ + A + + +++
Sbjct: 68 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY------SAEISL 121
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
AL YLH++ +++RD+K N+LLD + + L+D+G+ + G T+ GT Y+
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 177
Query: 992 APEYALTCRVSDKA-DVYSYGVVLLELIS 1019
APE L + D ++ GV++ E+++
Sbjct: 178 APE-ILRGEDYGFSVDWWALGVLMFEMMA 205
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 56/206 (27%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLG-NVRH 877
DF +G G FG + AE A+K L E + L H
Sbjct: 18 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFI-KART---SRAVDWKILHKIALDVASAL 933
P L + + +F + YL GG+L I SRA + A ++ L
Sbjct: 78 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY------AAEIILGL 131
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+LH + +++RD+K NILLD D + ++DFG+ + T GT Y+AP
Sbjct: 132 QFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAP 187
Query: 994 EYALTCRVSDKA-DVYSYGVVLLELI 1018
E L + + + D +S+GV+L E++
Sbjct: 188 E-ILLGQKYNHSVDWWSFGVLLYEML 212
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 4e-13
Identities = 46/207 (22%), Positives = 91/207 (43%), Gaps = 20/207 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKL--AVGRFQHGVQQFHAEIKTLGNV-RH 877
DF+ IG G + + A++ + + + E H
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKART----SRAVDWKILHKIALDVASAL 933
P LV L + + +F + Y+ GG+L ++ + A + + +++ AL
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY------SAEISLAL 166
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
YLH++ +++RD+K N+LLD + + L+D+G+ + G T+ GT Y+AP
Sbjct: 167 NYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAP 222
Query: 994 EYALTCRVSDKA-DVYSYGVVLLELIS 1019
E L + D ++ GV++ E+++
Sbjct: 223 E-ILRGEDYGFSVDWWALGVLMFEMMA 248
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 4e-13
Identities = 48/214 (22%), Positives = 89/214 (41%), Gaps = 33/214 (15%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVR---------- 876
+G G F T + A+ + VA+K + R + + EIK L V
Sbjct: 27 LGWGHFSTVWLAKDMVNNTHVAMK---IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 877 -HPNLVTLIGY----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS 931
+++ L+ + +G + +++ L G NL IK R + + +I+ +
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY------LSDFGLSRLLGTSETHATTGVA 985
L Y+H +C ++H D+KP N+L++ + ++D G + T
Sbjct: 143 GLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196
Query: 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS 1019
T Y +PE L AD++S ++ ELI+
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELIT 230
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 5e-13
Identities = 52/206 (25%), Positives = 95/206 (46%), Gaps = 20/206 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKL--AVGRFQHGVQQFHAEIKTLGNV-RH 877
DFN +G G FG +E L AVK L V V+ E + L +
Sbjct: 21 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNL----ENFIKARTSRAVDWKILHKIALDVASAL 933
P L L + + ++ + Y+ GG+L + + + AV + A ++A L
Sbjct: 81 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY------AAEIAIGL 134
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+L + +++RD+K N++LD + + ++DFG+ + + T GT Y+AP
Sbjct: 135 FFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYIAP 190
Query: 994 EYALTCRVSDKA-DVYSYGVVLLELI 1018
E + + K+ D +++GV+L E++
Sbjct: 191 E-IIAYQPYGKSVDWWAFGVLLYEML 215
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 5e-13
Identities = 38/149 (25%), Positives = 58/149 (38%), Gaps = 22/149 (14%)
Query: 534 SLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSL 593
L M A LS K+ + L S N I I SL + +L
Sbjct: 29 ELHGMIPPIEKMDATLST--------------LKACKHLALSTNNIEKI--SSLSGMENL 72
Query: 594 VFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS- 652
L L N ++ +I + L L ++ N + S I +L +L VL +S+N ++
Sbjct: 73 RILSLGRNLIK-KIENLDAVADTLEELWISYNQIA--SLSGIEKLVNLRVLYMSNNKITN 129
Query: 653 -GEVPEGVVNLRNLTALLLDNNKLSGHLP 680
GE+ + + L L LLL N L
Sbjct: 130 WGEI-DKLAALDKLEDLLLAGNPLYNDYK 157
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-11
Identities = 42/202 (20%), Positives = 80/202 (39%), Gaps = 24/202 (11%)
Query: 83 MRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNF 142
M + T + ++ + +V +E L + + +L+ + L + N
Sbjct: 1 MAKATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNN 59
Query: 143 LSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSF 202
+ ++ + G+ NLR+L+L N I I ++LE L ++ NQ+ + G +
Sbjct: 60 IE-KISS-LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLSG-IEKL 114
Query: 203 LKLRVLFLSYNELNGSIPSELG--KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLF 260
+ LRVL++S N++ E+ LE L L+GN L + R ++
Sbjct: 115 VNLRVLYMSNNKITN--WGEIDKLAALDKLEDLLLAGNPLY-NDYKENNATSEYRIEVVK 171
Query: 261 SNMLNDVIPRELGWLRKLEVLD 282
L L+ LD
Sbjct: 172 -------------RLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 2e-10
Identities = 29/151 (19%), Positives = 55/151 (36%), Gaps = 32/151 (21%)
Query: 160 LNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSI 219
L+ I+ + +L ++ + L L+ N ++ I L LR+L L N +
Sbjct: 30 LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRILSLGRNLI---- 82
Query: 220 PSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLE 279
+ +E+LD L L + N + + + L L
Sbjct: 83 --------KKIENLD--------------AVADTLEELWISYNQIASL--SGIEKLVNLR 118
Query: 280 VLDVSRNRLNGLIPTE-LGNCVELSVLVLSN 309
VL +S N++ + L +L L+L+
Sbjct: 119 VLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 4e-09
Identities = 28/126 (22%), Positives = 60/126 (47%), Gaps = 8/126 (6%)
Query: 577 NQISGIVPQSLENLTSLVFLDLNG--NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSS 634
+ I + T ++L+G ++ ++ ++L LK +HL+L+ NN+ I SS
Sbjct: 9 DAIRIFEERKSVVATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KI-SS 65
Query: 635 IGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNA 694
+ + +L +L L N + ++ L L + N+++ L SG+ + +L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYM 122
Query: 695 SFNNLS 700
S N ++
Sbjct: 123 SNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 19/75 (25%), Positives = 31/75 (41%), Gaps = 6/75 (8%)
Query: 548 NLSNNNIIGHI-PLDIGVMCKSLRVLDASHNQISGIVP-QSLENLTSLVFLDLNGNKLQG 605
+S N I + ++ +LRVL S+N+I+ L L L L L GN L
Sbjct: 99 WISYNQI-ASLSGIE---KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154
Query: 606 EIPSSLHRLKYLRHL 620
+ + +Y +
Sbjct: 155 DYKENNATSEYRIEV 169
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLG-NVRH 877
DF+ IG G FG A + + AVK L ++ H +E L NV+H
Sbjct: 39 DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNL-------ENFIKARTSRAVDWKILHKI-ALDV 929
P LV L + ++++ + +Y+ GG L F++ R + A ++
Sbjct: 99 PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA----------RFYAAEI 148
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFG 989
ASAL YLH +++RD+KP NILLD + L+DFGL + T+ GT
Sbjct: 149 ASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 990 YVAPEYALTCRVSDKA-DVYSYGVVLLE 1016
Y+APE L + D+ D + G VL E
Sbjct: 205 YLAPE-VLHKQPYDRTVDWWCLGAVLYE 231
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 41/145 (28%), Positives = 64/145 (44%), Gaps = 17/145 (11%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
LD ++ + + LT L +L+L+ N+LQ L L L LA+N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA- 96
Query: 630 GIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKLSGHLPSG----L 683
+P + L L+ L L N L +P GV L L L L+ N+L +P+G L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKL 154
Query: 684 ANVTSL--------SIFNASFNNLS 700
N+ +L S+ + +F+ L
Sbjct: 155 TNLQTLSLSTNQLQSVPHGAFDRLG 179
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 38/159 (23%), Positives = 61/159 (38%), Gaps = 12/159 (7%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
+ + + L L+ +NQ+ + ++LT L L L N+L +P
Sbjct: 43 QSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLA-SLPLG 101
Query: 611 L-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVVN-LRNLTA 667
+ L L L L N L +PS + L L+ L L++N L +P G + L NL
Sbjct: 102 VFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQT 159
Query: 668 LLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWN 706
L L N+L + L F N ++
Sbjct: 160 LSLSTNQLQSVPHGAFDRLGKLQTITL-FGN-----QFD 192
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 4e-09
Identities = 45/156 (28%), Positives = 65/156 (41%), Gaps = 7/156 (4%)
Query: 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRID- 168
L L G + L KL L+++ N L F L L L LA N++
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 169 --GDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY 226
+ L L+ L L GNQ+K + G KL+ L L+ N+L SIP+
Sbjct: 98 LPLGVFDHLTQ---LDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDK 153
Query: 227 CRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262
L+ L LS N L + + +L+T+ LF N
Sbjct: 154 LTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 43/156 (27%), Positives = 66/156 (42%), Gaps = 18/156 (11%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
L + F G+ NL N + + + L L ++NQ++
Sbjct: 45 TGLATLSDAT-------FRGLTKLTWLNLDYNQL-QTLSAGVFDDLTELGTLGLANNQLA 96
Query: 581 GIVPQSLENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNNLTGGIPSSI-GEL 638
+ ++LT L L L GN+L+ +PS + RL L+ L L N L IP+ +L
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKL 154
Query: 639 RSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNN 673
+L+ L LS+N L VP G L L + L N
Sbjct: 155 TNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 69.2 bits (169), Expect = 2e-12
Identities = 34/145 (23%), Positives = 64/145 (44%), Gaps = 4/145 (2%)
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
L ++ ++S + F+ L E + + + L + VA + +
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF 208
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT-FGYVAPE 994
L + + +HRD+ NILL + + DFGL+R + + G A ++APE
Sbjct: 209 LASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265
Query: 995 YALTCRVSDKADVYSYGVVLLELIS 1019
+ ++DV+S+GV+L E+ S
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 25/98 (25%), Positives = 45/98 (45%), Gaps = 8/98 (8%)
Query: 829 IGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLV 881
+G G FG +A+ + VAVK L G + +E+K L ++ H N+V
Sbjct: 30 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89
Query: 882 TLIGY-RASGNEMFLIYNYLPGGNLENFIKARTSRAVD 918
L+G G + +I + GNL +++++ + V
Sbjct: 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 127
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 20/206 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNV-RH 877
+F +G G FG A G L AVK L E + L H
Sbjct: 24 NFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNL----ENFIKARTSRAVDWKILHKIALDVASAL 933
P L L + + +F + ++ GG+L + + +RA + A ++ SAL
Sbjct: 84 PFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFY------AAEIISAL 137
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+LHD+ +++RD+K N+LLD + + L+DFG+ + G T GT Y+AP
Sbjct: 138 MFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAP 193
Query: 994 EYALTCRVSDKA-DVYSYGVVLLELI 1018
E L + A D ++ GV+L E++
Sbjct: 194 E-ILQEMLYGPAVDWWAMGVLLYEML 218
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 4e-12
Identities = 22/119 (18%), Positives = 42/119 (35%), Gaps = 13/119 (10%)
Query: 125 PEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFES---L 181
+ + + LD+ G + + N L ++ + N I L F L
Sbjct: 13 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRL 66
Query: 182 EVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG--KYCRYLEHLDLSGN 238
+ L + N++ + G + L L L+ N L +L + L +L + N
Sbjct: 67 KTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 28/131 (21%), Positives = 55/131 (41%), Gaps = 11/131 (8%)
Query: 546 VANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSL-ENLTSLVFLDLNGNKLQ 604
+ L+ I R LD +I I ++L L +D + N+++
Sbjct: 1 MVKLTAELIEQAAQYT---NAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR 55
Query: 605 GEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS--GEVPEGVVNL 662
++ L+ L+ L + +N + L L L L++NSL G++ + + +L
Sbjct: 56 -KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASL 112
Query: 663 RNLTALLLDNN 673
++LT L + N
Sbjct: 113 KSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 22/83 (26%), Positives = 36/83 (43%), Gaps = 6/83 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ--G 605
+ S+N I + + L+ L ++N+I I + L L L L N L G
Sbjct: 48 DFSDNEIRKLDGFP---LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELG 104
Query: 606 EIPSSLHRLKYLRHLSLADNNLT 628
++ L LK L +L + N +T
Sbjct: 105 DL-DPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 6e-10
Identities = 23/128 (17%), Positives = 50/128 (39%), Gaps = 7/128 (5%)
Query: 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG 242
++ L ++ + ++ R L L ++ + LG + +D S N +
Sbjct: 1 MVKLTAELIE-QAAQ-YTNAVRDRELDLRGYKI--PVIENLGATLDQFDAIDFSDNEIR- 55
Query: 243 RIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL-IPTELGNCVE 301
++ ++L+TLL+ +N + + L L L ++ N L L L +
Sbjct: 56 KL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 302 LSVLVLSN 309
L+ L +
Sbjct: 115 LTYLCILR 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-09
Identities = 29/133 (21%), Positives = 48/133 (36%), Gaps = 15/133 (11%)
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELN-- 216
++ L I+ N L+L G ++ VI + + + S NE+
Sbjct: 1 MVKLTAELIE-QAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL 57
Query: 217 GSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM---LNDVIPRELG 273
P R L+ L ++ N + L L+L +N L D+ P L
Sbjct: 58 DGFPL-----LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP--LA 110
Query: 274 WLRKLEVLDVSRN 286
L+ L L + RN
Sbjct: 111 SLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 22/130 (16%), Positives = 39/130 (30%), Gaps = 29/130 (22%)
Query: 571 VLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGG 630
++ + I N LDL G K+ I + L + +DN +
Sbjct: 1 MVKLTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-- 55
Query: 631 IPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLS 690
L+ LR L LL++NN++ + L+
Sbjct: 56 ---------KLDGFP---------------LLRRLKTLLVNNNRICRIGEGLDQALPDLT 91
Query: 691 IFNASFNNLS 700
+ N+L
Sbjct: 92 ELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 26/109 (23%), Positives = 39/109 (35%), Gaps = 9/109 (8%)
Query: 87 TCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFS--GEFPPEIWSLEKLEVLDVEGNFLS 144
L RG + + L L + + N FP L +L+ L V N +
Sbjct: 22 RELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLDGFP----LLRRLKTLLVNNNRIC 77
Query: 145 GRLPNEFVGLRNLRVLNLAFNRID--GDIPFSLRNFESLEVLNLAGNQV 191
L +L L L N + GD+ L + +SL L + N V
Sbjct: 78 RIGEGLDQALPDLTELILTNNSLVELGDLDP-LASLKSLTYLCILRNPV 125
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 27/117 (23%), Positives = 41/117 (35%), Gaps = 16/117 (13%)
Query: 106 LSELRVLSLPFNGFSGEFPPEI----WSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLN 161
R L L P I +L++ + +D N + +L F LR L+ L
Sbjct: 18 AVRDRELDLRGYKI-----PVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLL 70
Query: 162 LAFNRIDGDIPFSLRNFESLEVLNLAGNQV---KGVIPGFLGSFLKLRVLFLSYNEL 215
+ NRI + L L L N + + P L S L L + N +
Sbjct: 71 VNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDP--LASLKSLTYLCILRNPV 125
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 1e-11
Identities = 31/106 (29%), Positives = 46/106 (43%), Gaps = 6/106 (5%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
VLD + I +L FL L L + S+L +L L+ L L++N + G
Sbjct: 29 LVLDNCKSNDGKI-EGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFG 85
Query: 630 GIPSSIGELRSLEVLELSSNSLS--GEVPEGVVNLRNLTALLLDNN 673
G+ +L +L L LS N L + E + L L +L L N
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 59.4 bits (144), Expect = 3e-10
Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 10/85 (11%)
Query: 548 NLSNNNI--IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ- 604
+L N + + ++P L+ L+ S N+I G + E L +L L+L+GNKL+
Sbjct: 55 SLINVGLISVSNLP-----KLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKD 109
Query: 605 -GEIPSSLHRLKYLRHLSLADNNLT 628
+ L +L+ L+ L L + +T
Sbjct: 110 ISTL-EPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-09
Identities = 29/135 (21%), Positives = 48/135 (35%), Gaps = 10/135 (7%)
Query: 129 SLEKLEVLDVEGNFLS-GRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187
+ + L ++ + G++ NL L+L + + +L L+ L L+
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVS-NLPKLPKLKKLELS 79
Query: 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG--KYCRYLEHLDLSGNSLVGRI- 244
N++ G + L L LS N+L S L K L+ LDL +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEVTNLND 137
Query: 245 --PSSLGKCQQLRTL 257
S QL L
Sbjct: 138 YRESVFKLLPQLTYL 152
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-09
Identities = 36/129 (27%), Positives = 50/129 (38%), Gaps = 14/129 (10%)
Query: 572 LDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLT--G 629
+D + ++ + LV LD + G+I L LSL + L
Sbjct: 8 MDMKRRIHLELRNRTPAAVRELV-LDNCKSND-GKIEGLTAEFVNLEFLSLINVGLISVS 65
Query: 630 GIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS-----GHLPSGLA 684
+P L L+ LELS N + G + L NLT L L NKL L L
Sbjct: 66 NLPK----LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPL-KKLE 120
Query: 685 NVTSLSIFN 693
+ SL +FN
Sbjct: 121 CLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 29/110 (26%), Positives = 43/110 (39%), Gaps = 3/110 (2%)
Query: 201 SFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLF 260
+ +R L L + N L LE L L L+ + S+L K +L+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELS 79
Query: 261 SNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTE-LGNCVELSVLVLSN 309
N + + L L L++S N+L + E L L L L N
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 2e-08
Identities = 29/114 (25%), Positives = 46/114 (40%), Gaps = 8/114 (7%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
+ +R L L + + + LE L + L + N L L+ L L+
Sbjct: 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELSE 80
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVK---GVIPGFLGSFLKLRVLFLSYNEL 215
NRI G + +L LNL+GN++K + P L L+ L L E+
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP--LKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 22/87 (25%), Positives = 33/87 (37%), Gaps = 3/87 (3%)
Query: 224 GKYCRYLEHLDLSGNSL-VGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
+ + L L G+I + L L L + L V L L KL+ L+
Sbjct: 20 NRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLE 77
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSN 309
+S NR+ G + L+ L LS
Sbjct: 78 LSENRIFGGLDMLAEKLPNLTHLNLSG 104
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 14/149 (9%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
++L NQI+ + P ++L +L L L N+L L L L L N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 630 GIPSSI-GELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTS 688
+PS++ L L+ L + N L+ E+P G+ L +LT L LD N+L ++S
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 689 LS-IFNASFNNLSGPFPWNVTTMNCSGVI 716
L+ + F N PW+ C ++
Sbjct: 161 LTHAY--LFGN-----PWDCE---CRDIM 179
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 36/124 (29%), Positives = 54/124 (43%), Gaps = 3/124 (2%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
++N I + + +L+ L NQ+ + ++LT L LDL N+L +
Sbjct: 48 HDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAV 107
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALL 669
RL +L+ L + N LT +P I L L L L N L +P G L +LT
Sbjct: 108 FDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKS-IPHGAFDRLSSLTHAY 165
Query: 670 LDNN 673
L N
Sbjct: 166 LFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 31/114 (27%), Positives = 48/114 (42%), Gaps = 10/114 (8%)
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
++L L N+I P + +L+ L L NQ+ + G S +L VL L N+L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLT- 101
Query: 218 SIPS----ELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267
+PS L L+ L + N L +P + + L L L N L +
Sbjct: 102 VLPSAVFDRLVH----LKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSI 150
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 37/131 (28%), Positives = 54/131 (41%), Gaps = 17/131 (12%)
Query: 525 NKLTGSFPGSLFQACNEFHGMVA----NLSNNNIIGHIPLDIGV--MCKSLRVLDASHNQ 578
N++T PG F ++ L +N + L +GV L VLD NQ
Sbjct: 50 NQITKLEPGV-------FDSLINLKELYLGSNQLGA---LPVGVFDSLTQLTVLDLGTNQ 99
Query: 579 ISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGEL 638
++ + + L L L + NKL E+P + RL +L HL+L N L + L
Sbjct: 100 LTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRL 158
Query: 639 RSLEVLELSSN 649
SL L N
Sbjct: 159 SSLTHAYLFGN 169
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 44/150 (29%), Positives = 69/150 (46%), Gaps = 25/150 (16%)
Query: 568 SLRVLDASHNQISGIVPQSL---ENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624
++R L N++ + + LT+L +L L GN+LQ +L L+ L L +
Sbjct: 64 NVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 625 NNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKLSGHLPSG 682
N L +P + +L +L L L+ N L +P+GV L NLT L L N+L LP G
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQS-LPEG 175
Query: 683 ----LANVTSL--------SIFNASFNNLS 700
L + L S+ + F+ L+
Sbjct: 176 VFDKLTQLKDLRLYQNQLKSVPDGVFDRLT 205
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 5e-08
Identities = 48/170 (28%), Positives = 66/170 (38%), Gaps = 29/170 (17%)
Query: 106 LSELRVLSLPFNGFS--GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L +R L+L N L L L + GN L F L NL+ L L
Sbjct: 62 LPNVRYLALGGNKLHDISALK----ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLV 117
Query: 164 FNRID---GDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIP 220
N++ + L N L LNLA NQ++ + G L L LSYN+L S+P
Sbjct: 118 ENQLQSLPDGVFDKLTN---LTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLP 173
Query: 221 S----ELGKYCRYLEHLDLSGNSLVGRIPS----SLGKCQQLRTLLLFSN 262
+L + L+ L L N L +P L L+ + L N
Sbjct: 174 EGVFDKLTQ----LKDLRLYQNQL-KSVPDGVFDRLTS---LQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 4/125 (3%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
N + +P + +L+ L NQ+ + + LT+L +L+L N+LQ
Sbjct: 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGV 152
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRNLTAL 668
+L L L L+ N L +P + +L L+ L L N L VP+GV L +L +
Sbjct: 153 FDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQYI 210
Query: 669 LLDNN 673
L +N
Sbjct: 211 WLHDN 215
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 3e-11
Identities = 55/205 (26%), Positives = 81/205 (39%), Gaps = 33/205 (16%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKL-AVGRFQHGVQQFHAEIKTLGNVRH------PNL 880
IG G FG KA VA+K + RF Q EI+ L ++R N+
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR---QAAEEIRILEHLRKQDKDNTMNV 161
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
+ ++ N + + + L NL IK + ++ K A + L LH
Sbjct: 162 IHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN- 219
Query: 941 APRVLHRDVKPSNILLDDDFNAY--LSDFGLSRLLGTSETHATTGVAGTFGYV------A 992
R++H D+KP NILL + + DFG S + T Y+ A
Sbjct: 220 --RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYT--------YIQSRFYRA 267
Query: 993 PEYALTCRVSDKADVYSYGVVLLEL 1017
PE L R D++S G +L EL
Sbjct: 268 PEVILGARYGMPIDMWSLGCILAEL 292
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 4/105 (3%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
VLD S + + + L FL L I ++L +L L+ L L+DN ++G
Sbjct: 22 LVLDNSRSNEGKL-EGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELSDNRVSG 78
Query: 630 GIPSSIGELRSLEVLELSSNSLSG-EVPEGVVNLRNLTALLLDNN 673
G+ + +L L LS N + E + L NL +L L N
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-11
Identities = 22/84 (26%), Positives = 41/84 (48%), Gaps = 8/84 (9%)
Query: 548 NLSNNNI--IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG 605
+ N + I ++P L+ L+ S N++SG + E +L L+L+GNK++
Sbjct: 48 STINVGLTSIANLP-----KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKD 102
Query: 606 -EIPSSLHRLKYLRHLSLADNNLT 628
L +L+ L+ L L + +T
Sbjct: 103 LSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 24/113 (21%), Positives = 42/113 (37%), Gaps = 7/113 (6%)
Query: 129 SLEKLEVLDVEGN-FLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187
+ ++ L ++ + G+L L L+ + I +L L+ L L+
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIA-NLPKLNKLKKLELS 72
Query: 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG--KYCRYLEHLDLSGN 238
N+V G + L L LS N++ S + K L+ LDL
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 3e-10
Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 14/116 (12%)
Query: 585 QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLT--GGIPSSIGELRSLE 642
++ ++ LV LD + + G++ + L LS + LT +P L L+
Sbjct: 14 RTPSDVKELV-LDNSRSNE-GKLEGLTDEFEELEFLSTINVGLTSIANLPK----LNKLK 67
Query: 643 VLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSG-----HLPSGLANVTSLSIFN 693
LELS N +SG + NLT L L NK+ L L N+ SL +FN
Sbjct: 68 KLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPL-KKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 7e-10
Identities = 29/112 (25%), Positives = 49/112 (43%), Gaps = 4/112 (3%)
Query: 106 LSELRVLSLPFNGFS-GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
S+++ L L + + G+ E+LE L L+ + N L L+ L L+
Sbjct: 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSD 73
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNEL 215
NR+ G + +L LNL+GN++K + L L+ L L E+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 25/110 (22%), Positives = 40/110 (36%), Gaps = 3/110 (2%)
Query: 201 SFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLF 260
+ ++ L L + N L LE L L I ++L K +L+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 261 SNMLNDVIPRELGWLRKLEVLDVSRNRLNGL-IPTELGNCVELSVLVLSN 309
N ++ + L L++S N++ L L L L L N
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 9e-08
Identities = 20/87 (22%), Positives = 38/87 (43%), Gaps = 3/87 (3%)
Query: 224 GKYCRYLEHLDLSGNSL-VGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLD 282
+ ++ L L + G++ + ++L L + L + L L KL+ L+
Sbjct: 13 NRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLE 70
Query: 283 VSRNRLNGLIPTELGNCVELSVLVLSN 309
+S NR++G + C L+ L LS
Sbjct: 71 LSDNRVSGGLEVLAEKCPNLTHLNLSG 97
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 7e-11
Identities = 37/173 (21%), Positives = 66/173 (38%), Gaps = 30/173 (17%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTL---------GNVRHP 878
IGSGGFG Y A + A + V ++G +E+K
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG--PLFSELKFYQRVAKKDCIKKWIER 102
Query: 879 NLVTLIG---YRASGNEM-------FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALD 928
+ +G + SG F++ L G +L+ + + ++ +
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ--NGTFKKSTVLQLGIR 159
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLD--DDFNAYLSDFGLSRLLGTSETH 979
+ L Y+H+ +H D+K +N+LL + YL+D+GLS + H
Sbjct: 160 MLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 7e-11
Identities = 35/209 (16%), Positives = 60/209 (28%), Gaps = 55/209 (26%)
Query: 810 PLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAV-------GRFQHGV 862
P+ + + T IG G FG ++ I+ VA+K +A+ G Q
Sbjct: 10 PVPFSHCL-PTEKLQRCEKIGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTF 67
Query: 863 QQFHAEIKTL---------GNVRHPNLVTLIG---------------------------- 885
++ EI R + L
Sbjct: 68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSAND 127
Query: 886 --YRASGNEMFLIYNYLPGGN-LENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
+++F++ + GG LE +S I + ++LA
Sbjct: 128 RPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSS----LATAKSILHQLTASLAVAEASL-- 181
Query: 943 RVLHRDVKPSNILLDDDFNAYLSDFGLSR 971
R HRD+ N+LL L +
Sbjct: 182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 9e-11
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 5/106 (4%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
L NQ + +VP+ L N L +DL+ N++ S + L L L+ N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 630 GIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNN 673
IP L+SL +L L N +S VPEG +L L+ L + N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 12/89 (13%)
Query: 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADN 625
K L ++D S+N+IS + QS N+T L+ L L+ N+L+ IP LK LR LSL N
Sbjct: 54 KHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLSLHGN 112
Query: 626 NLTGGIPSSIGE-----LRSLEVLELSSN 649
++ S + E L +L L + +N
Sbjct: 113 DI-----SVVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 23/94 (24%), Positives = 41/94 (43%), Gaps = 16/94 (17%)
Query: 620 LSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKLSGH 678
L L N T +P + + L +++LS+N +S + N+ L L+L N+L
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 679 LPSG----LANVTSL--------SIFNASFNNLS 700
+P L ++ L + +FN+LS
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLS 126
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 29/113 (25%), Positives = 47/113 (41%), Gaps = 18/113 (15%)
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L L N+ +P L N++ L +++L+ N++ + + +L L LSYN L
Sbjct: 34 TELYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 218 SIPS----ELGKYCRYLEHLDLSGNSLVGRIP----SSLGKCQQLRTLLLFSN 262
IP L L L L GN + +P + L L L + +N
Sbjct: 92 CIPPRTFDGLKS----LRLLSLHGNDI-SVVPEGAFNDLSA---LSHLAIGAN 136
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 45/156 (28%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVTLIGY 886
IGSG FG Y I+ G VA+K + Q H E K ++ + T+
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLHIESKIYKMMQGGVGIPTIRWC 73
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
A G+ ++ L G +LE+ SR K + +A + S + Y+H + +H
Sbjct: 74 GAEGDYNVMVMELL-GPSLEDLFN-FCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 128
Query: 947 RDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETH 979
RDVKP N L+ Y+ DFGL++ + TH
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 164
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 64.2 bits (157), Expect = 1e-10
Identities = 63/373 (16%), Positives = 120/373 (32%), Gaps = 64/373 (17%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEI----WSLEKLEVLDVEGNFLSG--------- 145
+ L+ L + +V+ L G + +I L L++ N L
Sbjct: 20 WAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQG 79
Query: 146 -RLPNEFVGLRNLRVLNLAFNRID----GDIPFSLRNFESLEVLNLAGNQ-----VKGVI 195
+ P+ ++ L+L + G + +LR +L+ L+L+ N ++ +
Sbjct: 80 LQTPS-----CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLC 134
Query: 196 PGFLGSFLKLRVLFLSYNELNGSIPSELG---KYCRYLEHLDLSGNSL----VGRIPSSL 248
G L +L L L Y L+ + L + + L +S N + V + L
Sbjct: 135 EGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGL 194
Query: 249 GKCQ-QLRTLLLFSNMLND----VIPRELGWLRKLEVLDVSRNRL-----NGLIPTELGN 298
QL L L S + + + L L + N+L L P L
Sbjct: 195 KDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHP 254
Query: 299 CVELSVLVLSN----------LFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEIT 348
L L + L L + +++ ELS+ ++ + ++
Sbjct: 255 SSRLRTLWIWECGITAKGCGDLCRVLRAKESLK-ELSLAGNELGDEGARLLCETLLEPGC 313
Query: 349 TLSKLRIIWAPRLNLEG--KLPSSWGACESLEMLNLAQNVLRGD-----LIGVFDRCKKL 401
L L + + S L L ++ N L G+ L
Sbjct: 314 QLESLW-VKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVL 372
Query: 402 HFIDLSSNELSGE 414
+ L+ ++S
Sbjct: 373 RVLWLADCDVSDS 385
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-09
Identities = 43/187 (22%), Positives = 62/187 (33%), Gaps = 42/187 (22%)
Query: 548 NLSNNNIIGHIPLDIGVM---------CKSLRVLDASHNQIS----GIVPQSLENLTSLV 594
L +N + D+G+ LR L I+ G + + L SL
Sbjct: 233 ALGSNKL-----GDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLK 287
Query: 595 FLDLNGNKLQGEIPSSL-----HRLKYLRHLSLADNNLTG----GIPSSIGELRSLEVLE 645
L L GN+L E L L L + + T S + + R L L+
Sbjct: 288 ELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQ 347
Query: 646 LSSNSLSGEVPEGVVNL--------RNLTALLLDNNKLS----GHLPSGLANVTSLSIFN 693
+S+N L GV L L L L + +S L + L SL +
Sbjct: 348 ISNNRLED---AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 404
Query: 694 ASFNNLS 700
S N L
Sbjct: 405 LSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 34/187 (18%), Positives = 54/187 (28%), Gaps = 42/187 (22%)
Query: 548 NLSNNNIIGHIPLDIGVM---------CKSLRVLDASHNQISGI----VPQSLENLTSLV 594
+LS+N + D G+ L L + +S + L
Sbjct: 119 HLSDNLLG-----DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 595 FLDLNGNKLQGE----IPSSLHRLKY-LRHLSLADNNLT----GGIPSSIGELRSLEVLE 645
L ++ N + + L L L L +T + + SL L
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 646 LSSNSLSGEVPEGVVNL--------RNLTALLLDNNKLS----GHLPSGLANVTSLSIFN 693
L SN L G+ L L L + ++ G L L SL +
Sbjct: 234 LGSNKLGD---VGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELS 290
Query: 694 ASFNNLS 700
+ N L
Sbjct: 291 LAGNELG 297
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 3e-08
Identities = 33/178 (18%), Positives = 63/178 (35%), Gaps = 28/178 (15%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS----GIVPQSLENLTSLVFLDLNGNKL 603
++ + ++ + + +V+ ++ + +L +L L+L N+L
Sbjct: 9 DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNEL 68
Query: 604 QGEIPSSL-----HRLKYLRHLSLADNNLT----GGIPSSIGELRSLEVLELSSNSLSGE 654
+ ++ LSL + LT G + S++ L +L+ L LS N L
Sbjct: 69 GDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG-- 126
Query: 655 VPEGVVNL--------RNLTALLLDNNKLS----GHLPSGLANVTSLSIFNASFNNLS 700
G+ L L L L+ LS L S L S N+++
Sbjct: 127 -DAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-07
Identities = 31/153 (20%), Positives = 52/153 (33%), Gaps = 19/153 (12%)
Query: 567 KSLRVLDASHNQISGI-VPQSLENLTSLVFLDLNGNKLQGE----IPSSLHRLKYLRHLS 621
++ LD ++S + L L + L+ L I S+L L L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 622 LADNNLTGGIPSSIGEL-----RSLEVLELSSNSLSGE----VPEGVVNLRNLTALLLDN 672
L N L + + ++ L L + L+G + + L L L L +
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 673 NKLSG----HLPSGLANV-TSLSIFNASFNNLS 700
N L L GL + L + +LS
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLS 155
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 2e-04
Identities = 46/247 (18%), Positives = 79/247 (31%), Gaps = 46/247 (18%)
Query: 205 LRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL----VGRIPSSLGKCQQLRTLLLF 260
++ L + EL+ + +EL + + + L L I S+L L L L
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 261 SNMLNDVIPRELGWL-----RKLEVLDVSRNRLN----GLIPTELGNCVELSVLVLSN-- 309
SN L DV + K++ L + L G++ + L L L LS+
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 310 --------LFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRL 361
L + LL + +L + + + + + L
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLE----YCSLSAASCEPLASVLRAKPDFK-----EL 175
Query: 362 NLEGKLPSSWGA---CE-------SLEMLNLAQNVLRGD----LIGVFDRCKKLHFIDLS 407
+ + G C+ LE L L + D L G+ L + L
Sbjct: 176 TVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALG 235
Query: 408 SNELSGE 414
SN+L
Sbjct: 236 SNKLGDV 242
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 37/172 (21%), Positives = 68/172 (39%), Gaps = 15/172 (8%)
Query: 815 SIIRATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLG 873
++ +F IG G FG + + VA+K + + Q H E +
Sbjct: 3 GVLMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK---LEPMKSRAPQLHLEYRFYK 59
Query: 874 NVRH-PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASA 932
+ + + + G ++ L G +LE+ R K + IA+ + S
Sbjct: 60 QLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFD-LCDRTFSLKTVLMIAIQLISR 117
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNA-----YLSDFGLSRLLGTSETH 979
+ Y+H + +++RDVKP N L+ N ++ DF L++ ET
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 28/172 (16%), Positives = 61/172 (35%), Gaps = 25/172 (14%)
Query: 829 IGSGGFGTTYKAE---------ISPGILVAVK------KLAVGRFQHGVQQFHAEI---K 870
G Y+A ++K +L + ++ K
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 871 TLGNVRHPNLVTLIGYRASGNEM-FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDV 929
L + + T +G+ ++ FL+ L G +L++ + + + + ++A +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILL--DDDFNAYLSDFGLSRLLGTSETH 979
AL +LH+ +H +V NI + +D L+ +G + S H
Sbjct: 169 LDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 3e-10
Identities = 17/81 (20%), Positives = 31/81 (38%), Gaps = 1/81 (1%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+ N + H+ L LR L + + + P + L L+L+ N L+ +
Sbjct: 37 YIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SL 95
Query: 608 PSSLHRLKYLRHLSLADNNLT 628
+ L+ L L+ N L
Sbjct: 96 SWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 62.1 bits (150), Expect = 3e-10
Identities = 22/94 (23%), Positives = 35/94 (37%), Gaps = 2/94 (2%)
Query: 583 VPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSL 641
L +L L + + + L L LR+L++ + L P + L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 642 EVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKL 675
L LS N+L + V +L L+L N L
Sbjct: 83 SRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 8e-10
Identities = 22/86 (25%), Positives = 37/86 (43%), Gaps = 2/86 (2%)
Query: 567 KSLRVLDASHNQ-ISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADN 625
++L L + Q + + + L L L L + + L+ P + H L L+L+ N
Sbjct: 31 ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN 90
Query: 626 NLTGGIPSSIGELRSLEVLELSSNSL 651
L + + SL+ L LS N L
Sbjct: 91 ALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 19/96 (19%), Positives = 28/96 (29%), Gaps = 4/96 (4%)
Query: 606 EIPSSLHRLKYLRHLSLADNNLTGGIPS-SIGELRSLEVLELSSNSLSGEVPEGV-VNLR 663
+ L + L L + + + + L L L + + L V
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 664 NLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNL 699
L+ L L N L L SL S N L
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 8e-07
Identities = 22/97 (22%), Positives = 38/97 (39%), Gaps = 3/97 (3%)
Query: 170 DIPFSLRNFESLEVLNLAGNQVKGVIP-GFLGSFLKLRVLFLSYNELNGSIPSELGKYCR 228
D L E+L L + Q + L +LR L + + L + + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 229 YLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
L L+LS N+L + + L+ L+L N L+
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.3 bits (122), Expect = 1e-06
Identities = 24/95 (25%), Positives = 38/95 (40%), Gaps = 3/95 (3%)
Query: 148 PNEFVGLRNLRVLNLAFNRIDGDIP-FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLR 206
+ G NL L + + + LR L L + + ++ V P +L
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLS 83
Query: 207 VLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLV 241
L LS+N L S+ + + L+ L LSGN L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 19/101 (18%), Positives = 31/101 (30%), Gaps = 5/101 (4%)
Query: 631 IPSSIGELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNNKLSGHLPSGLANVTSL 689
+ +L L + + + + L L L + + L P L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 690 SIFNASFNNLSGPFPWNV---TTMNCSGVIGNPFLDPCQMY 727
S N SFN L W ++ + GNP C +
Sbjct: 83 SRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHCSCALR 122
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 6e-06
Identities = 21/86 (24%), Positives = 34/86 (39%), Gaps = 2/86 (2%)
Query: 105 GLSELRVLSLPFNGFSGEFPPE-IWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
G L L + + L +L L + + L P+ F L LNL+
Sbjct: 29 GAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGN 189
FN ++ + + SL+ L L+GN
Sbjct: 89 FNALES-LSWKTVQGLSLQELVLSGN 113
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 20/81 (24%), Positives = 32/81 (39%), Gaps = 2/81 (2%)
Query: 230 LEHLDLSGNSLVGRIPS-SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRL 288
L L + + + L +LR L + + L V P + +L L++S N L
Sbjct: 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92
Query: 289 NGLIPTELGNCVELSVLVLSN 309
L + + L LVLS
Sbjct: 93 ESLSWKTVQG-LSLQELVLSG 112
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-10
Identities = 50/199 (25%), Positives = 82/199 (41%), Gaps = 19/199 (9%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKL-AVGRFQHGVQQFHAEIKTLGNVRHP------NL 880
IG G FG KA VA+K + F + Q E++ L + +
Sbjct: 62 IGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLN---QAQIEVRLLELMNKHDTEMKYYI 118
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V L + N + L++ L NL + ++ R V + K A + +AL +L
Sbjct: 119 VHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE 177
Query: 941 APRVLHRDVKPSNILLDDDFNAY--LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
++H D+KP NILL + + + DFG S + + F Y +PE L
Sbjct: 178 L-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ--LGQRI-YQYIQSRF-YRSPEVLLG 232
Query: 999 CRVSDKADVYSYGVVLLEL 1017
D++S G +L+E+
Sbjct: 233 MPYDLAIDMWSLGCILVEM 251
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-10
Identities = 37/172 (21%), Positives = 64/172 (37%), Gaps = 25/172 (14%)
Query: 829 IGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIG-- 885
IG GGFG Y A+++ V V + + E+K P +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 886 ----------YRASGNEMFLIYNY------LPGGNLENFIKARTSRAVDWKILHKIALDV 929
Y SG +Y G +L+ + ++ K + +++L +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYE-ANAKRFSRKTVLQLSLRI 161
Query: 930 ASALAYLHDQCAPRVLHRDVKPSNILLD--DDFNAYLSDFGLSRLLGTSETH 979
L Y+H+ +H D+K SN+LL+ + YL D+GL+ H
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 61.8 bits (150), Expect = 4e-10
Identities = 43/197 (21%), Positives = 74/197 (37%), Gaps = 20/197 (10%)
Query: 129 SLEKLEVLDVEGNFLSGRLPNEFV-GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187
S +++ +D+ + + + + L+ L+L R+ I +L +L LNL+
Sbjct: 91 SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLS 150
Query: 188 G-NQVKGVIPGFLGSFL-KLRVLFLSYNEL--NGSIPSELGKYCRYLEHLDLSG------ 237
G + L S +L L LS+ + + + L+LSG
Sbjct: 151 GCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQ 210
Query: 238 NSLVGRIPSSLGKCQQLRTL-LLFSNMLNDVIPRELGWLRKLEVLDVSRNRL---NGLIP 293
S + + C L L L S ML + +E L L+ L +SR L+
Sbjct: 211 KSDLSTLVRR---CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLL- 266
Query: 294 TELGNCVELSVLVLSNL 310
ELG L L + +
Sbjct: 267 -ELGEIPTLKTLQVFGI 282
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 4e-06
Identities = 52/267 (19%), Positives = 85/267 (31%), Gaps = 33/267 (12%)
Query: 27 SWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQFPFYGFGMRRR 86
W S W + D + + ++TG +S+G Q F R
Sbjct: 38 RWYRLASDESLWQ--TLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRV 95
Query: 87 TCLHGRGKLVGK--LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEG--NF 142
+ ++ L ++ S+L+ LSL S + L L++ G F
Sbjct: 96 QHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 155
Query: 143 LSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSL---RNFESLEVLNLAGNQVKGVIPGFL 199
L L LNL++ + + E++ LNL+G
Sbjct: 156 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSG----------- 204
Query: 200 GSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG-RIPSSLGKCQQLRTLL 258
L S S L + C L HLDLS + ++ + L+ L
Sbjct: 205 -----------YRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS 253
Query: 259 L-FSNMLNDVIPRELGWLRKLEVLDVS 284
L + ELG + L+ L V
Sbjct: 254 LSRCYDIIPETLLELGEIPTLKTLQVF 280
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 43/221 (19%), Positives = 69/221 (31%), Gaps = 50/221 (22%)
Query: 192 KGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL-VGRIPSSLGK 250
K + P G L V+ P ++H+DLS + + V + L +
Sbjct: 57 KNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQ 116
Query: 251 CQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310
C +L+ L L L+D I L L L+ L C S L L
Sbjct: 117 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN-------------LSGCSGFSEFALQTL 163
Query: 311 FDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSS 370
+ L +L + W + +
Sbjct: 164 LSSC---------------------------------SRLDELNLSWCFDFTEKHVQVAV 190
Query: 371 WGACESLEMLNLA---QNVLRGDLIGVFDRCKKLHFIDLSS 408
E++ LNL+ +N+ + DL + RC L +DLS
Sbjct: 191 AHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 231
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 4e-10
Identities = 53/266 (19%), Positives = 90/266 (33%), Gaps = 77/266 (28%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGR-FQHGVQQFHAEIKTL-----GNVRHPN-- 879
+G G F T + + I VA+K V + +H + EI+ L + PN
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFVAMK---VVKSAEHYTETALDEIRLLKSVRNSDPNDPNRE 101
Query: 880 -LVTLIGY----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALA 934
+V L+ +G + +++ L G +L +I + + + KI V L
Sbjct: 102 MVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLD 160
Query: 935 YLHDQCAPRVLHRDVKPSNILL-------------------------------------- 956
YLH +C R++H D+KP NILL
Sbjct: 161 YLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218
Query: 957 -----------DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
+ ++D G + + T T Y + E + + A
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVH----KHFTEDIQTRQYRSLEVLIGSGYNTPA 274
Query: 1006 DVYSYGVVLLELISDKKALDPSFSSH 1031
D++S + EL + D F H
Sbjct: 275 DIWSTACMAFELATG----DYLFEPH 296
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 6e-10
Identities = 32/158 (20%), Positives = 63/158 (39%), Gaps = 15/158 (9%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVTLIGY 886
IG G FG ++ + VA+K + Q E +T + + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 74
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
G L+ + L G +LE+ + R K + A + + + +H++ +++
Sbjct: 75 GQEGLHNVLVIDLL-GPSLEDLLD-LCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 129
Query: 947 RDVKPSNILLDDDFNA-----YLSDFGLSRLLGTSETH 979
RD+KP N L+ + Y+ DFG+ + T
Sbjct: 130 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK 167
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 8e-10
Identities = 45/153 (29%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
LD N + + + LTSL L L GNKLQ ++L L +L+L+ N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 630 GIPSSI-GELRSLEVLELSSNSLSGEVPEGVVN-LRNLTALLLDNNKLSGHLPSG----L 683
+P+ + +L L+ L L++N L +P+GV + L L L L N+L +P G L
Sbjct: 90 SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRL 147
Query: 684 ANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVI 716
++ + + + N PW+ T C G+
Sbjct: 148 TSLQYIWLHD---N------PWDCT---CPGIR 168
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-08
Identities = 37/126 (29%), Positives = 61/126 (48%), Gaps = 6/126 (4%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSS 610
N + +P + SL L N++ + LTSL +L+L+ N+LQ +P+
Sbjct: 36 ETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNG 94
Query: 611 L-HRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRNLTA 667
+ +L L+ L+L N L +P + +L L+ L L N L VP+GV L +L
Sbjct: 95 VFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSLQY 152
Query: 668 LLLDNN 673
+ L +N
Sbjct: 153 IWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 37/140 (26%), Positives = 58/140 (41%), Gaps = 23/140 (16%)
Query: 134 EVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRID---GDIPFSLRNFESLEVLNLAGNQ 190
LD+E N L F L +L L L N++ + L + L LNL+ NQ
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS---LTYLNLSTNQ 87
Query: 191 VKGVIPGFLGSFLKLRVLFLSYNELNGSIPS----ELGKYCRYLEHLDLSGNSLVGRIPS 246
++ + G +L+ L L+ N+L S+P +L + L+ L L N L +P
Sbjct: 88 LQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQ----LKDLRLYQNQL-KSVPD 141
Query: 247 ----SLGKCQQLRTLLLFSN 262
L L+ + L N
Sbjct: 142 GVFDRLTS---LQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 34/118 (28%), Positives = 51/118 (43%), Gaps = 12/118 (10%)
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L+L N + SL L L GN+++ + G L L LS N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQ- 89
Query: 218 SIPS----ELGKYCRYLEHLDLSGNSLVGRIPSSL-GKCQQLRTLLLFSNMLNDVIPR 270
S+P+ +L + L+ L L+ N L +P + K QL+ L L+ N L V P
Sbjct: 90 SLPNGVFDKLTQ----LKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSV-PD 141
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 4e-09
Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 4/106 (3%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
L+ N++ + + LT L L L+ N++Q +L L L L +N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ- 89
Query: 630 GIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRNLTALLLDNN 673
+P+ + +L L+ L L +N L VP+G+ L +L + L N
Sbjct: 90 SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 40/130 (30%), Positives = 57/130 (43%), Gaps = 17/130 (13%)
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSN 649
+S L+L NKLQ +L L LSL+ N + +P + +L L +L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPDGVFDKLTKLTILYLHEN 86
Query: 650 SLSGEVPEGVV-NLRNLTALLLDNNKLSGHLPSG-LANVTSLS-IFNASFNNLSGPFPWN 706
L +P GV L L L LD N+L +P G +TSL I+ N PW+
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQKIW--LHTN-----PWD 137
Query: 707 VTTMNCSGVI 716
+ C +
Sbjct: 138 CS---CPRID 144
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 27/82 (32%), Positives = 39/82 (47%), Gaps = 2/82 (2%)
Query: 569 LRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL-HRLKYLRHLSLADNNL 627
L L S NQI + + LT L L L+ NKLQ +P+ + +L L+ L+L N L
Sbjct: 54 LTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQL 112
Query: 628 TGGIPSSIGELRSLEVLELSSN 649
L SL+ + L +N
Sbjct: 113 KSVPDGIFDRLTSLQKIWLHTN 134
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 4e-09
Identities = 92/578 (15%), Positives = 174/578 (30%), Gaps = 139/578 (24%)
Query: 127 IWSLEK----------LEVLDVEGNFLSGRLPNEFVG-LRNLRVLNLAFNRIDGDI-PFS 174
W+L EVL + FL + E R+ +R+ D F+
Sbjct: 68 FWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127
Query: 175 LRN---FESLEVLNLAGNQVKG----VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYC 227
N + L A +++ +I G LGS GK
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS----------------------GKTW 165
Query: 228 RYLEHLDLSGNSLVGRIPS-----SLGKCQQLRTLL-----LFSNMLNDVIPRELGWLRK 277
+ + ++ +L C T+L L + + R
Sbjct: 166 --VALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 278 LEVLDVSRNRLNGLIPTE-LGNCVELSVLVLSNLFDP------------LLSGRNIRGEL 324
+ + L L+ ++ NC L LVL N+ + LL+ R
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENC--L--LVLLNVQNAKAWNAFNLSCKILLTTRFK---- 275
Query: 325 SVGQSDASNGEKNSFIGSIPMEIT-TLSKLRIIWAPRLNLE-GKLPSSWGACE-SLEMLN 381
V +D + + I +T T +++ + L+ LP + L+
Sbjct: 276 QV--TDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE--VLTTNPRRLS 331
Query: 382 LAQNVLRGDLIGVFDR-----CKKL-HFIDLSSNELSGELDVKLQVPCMALFDVSGNHMS 435
+ +R D + +D C KL I+ S N L + + +++F S +
Sbjct: 332 IIAESIR-DGLATWDNWKHVNCDKLTTIIESSLNVLE-PAEYRKMFDRLSVFPPSAH--- 386
Query: 436 GSIPR---------FDYNVCHQM--PLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSA 484
IP + + L L + T S + + L V
Sbjct: 387 --IPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--SIPS---IYLELKVKL 439
Query: 485 ARFMVIHNFSGNNFTGPICWLP--VAPERLRRRTDYAF------LAGAN--KLTGSFPGS 534
+H +++ P + + P L Y + L + F
Sbjct: 440 ENEYALHRSIVDHYNIPKTFDSDDLIPPYLD---QYFYSHIGHHLKNIEHPERMTLFR-M 495
Query: 535 LFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLV 594
+F +F + + +++ + G + +L+ L I P+ + +++
Sbjct: 496 VFL---DFRFLEQKIRHDSTAWNAS---GSILNTLQQLKFYKPYICDNDPKYERLVNAIL 549
Query: 595 -FLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGI 631
FL +I +L KY L +A I
Sbjct: 550 DFLP--------KIEENLICSKYTDLLRIALMAEDEAI 579
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.9 bits (139), Expect = 2e-08
Identities = 62/424 (14%), Positives = 112/424 (26%), Gaps = 145/424 (34%)
Query: 386 VLRGDLIGVFDRCKKLHFIDLSSNELSG-ELDVKLQVP-----CMALFDVSGNHMSGSIP 439
V + FD CK D+ + LS E+D + + LF + +
Sbjct: 24 VFEDAFVDNFD-CK--DVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQ 80
Query: 440 RF-------DYN----VCHQMPLQSSDLCQGY----DPSFT----YMQYFMSKARL---- 476
+F +Y Q S + + Y D + + +Y +S+ +
Sbjct: 81 KFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKL 140
Query: 477 ----------------GMP------LLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRR 514
G+ + + + I WL +
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQC----KMDFKIFWLNLK----NC 192
Query: 515 RTDYAFLAGANKL----TGSFPGSLFQACNEFHGMVA----------------------N 548
+ L KL ++ + N + + N
Sbjct: 193 NSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLN 252
Query: 549 LSNNNIIGHIPLDIGVMCKSL---R---VLDASHNQISGIVP--QSLENLT-----SLV- 594
+ N ++ CK L R V D + + LT SL+
Sbjct: 253 VQNAKAWNA--FNLS--CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL 308
Query: 595 -FLDLNGNKLQGE-----------IPSSLH----RLKYLRHLSLADNNLTGGIPSSI--- 635
+LD L E I S+ +H++ + LT I SS+
Sbjct: 309 KYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNC--DKLTTIIESSLNVL 366
Query: 636 --GELRSL---------------EVLELSSNSLSGEVPEGVVN-LRNLTALLLDNNKLSG 677
E R + +L L + VVN L + + + +
Sbjct: 367 EPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI 426
Query: 678 HLPS 681
+PS
Sbjct: 427 SIPS 430
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 59.3 bits (143), Expect = 5e-09
Identities = 42/156 (26%), Positives = 69/156 (44%), Gaps = 13/156 (8%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGY 886
IGSG FG Y I VA+K V + Q E K ++ + + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENV---KTKHPQLLYESKIYRILQGGTGIPNVRWF 71
Query: 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946
G+ L+ + L G +LE+ SR + K + +A + + + ++H + LH
Sbjct: 72 GVEGDYNVLVMDLL-GPSLEDLFN-FCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 947 RDVKPSNILLDDDFNA---YLSDFGLSRLLGTSETH 979
RD+KP N L+ A Y+ DFGL++ + TH
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH 162
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 39/220 (17%), Positives = 82/220 (37%), Gaps = 16/220 (7%)
Query: 106 LSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGR-LPNEFVGLRNLRVLNLA 163
++ ++ + G+ + + S LE + ++ ++ L +N +VL L+
Sbjct: 79 FADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLS 138
Query: 164 FNRI--DGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLK----LRVLFLS--YNEL 215
+ +L+ L+L + V V +L F L L +S +E+
Sbjct: 139 SCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEV 198
Query: 216 NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLL--FSNMLNDV----IP 269
+ S L C L+ L L+ + ++ + L + QL L ++ + +
Sbjct: 199 SFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLS 258
Query: 270 RELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309
L ++L L + + +P C L+ L LS
Sbjct: 259 VALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSY 298
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 7e-07
Identities = 46/281 (16%), Positives = 84/281 (29%), Gaps = 39/281 (13%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
+R + L D + G V I S+ L + L
Sbjct: 66 PKVRSVELKGKPHFADFNLVPDGW---------GGYVYPWIEAMSSSYTWLEEIRLKRMV 116
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGR--IPSSLGKCQQLRTLLLFSNMLNDVIPREL 272
+ + K + + L LS + + C+ L+ L L + ++DV L
Sbjct: 117 VTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWL 176
Query: 273 GWL----RKLEVLDVSRNRLN---GLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELS 325
L L++S + + C L L L+ +
Sbjct: 177 SHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNR---------------A 221
Query: 326 VGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQN 385
V + + + P + L R ++ L + C+ L L+ +
Sbjct: 222 VPLEKLA-----TLLQRAPQ-LEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275
Query: 386 VLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL 426
+ L V+ C +L ++LS + VKL C L
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKL 316
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 30/167 (17%), Positives = 64/167 (38%), Gaps = 14/167 (8%)
Query: 548 NLSNNNIIGHIPL-DIGVMCKSLRVLDASHNQISGIVPQSL----ENLTSLVFLDLNG-- 600
LS+ L I C++L+ LD + + + L + TSLV L+++
Sbjct: 136 VLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA 195
Query: 601 NKLQGE-IPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELS--SNSLSGEVPE 657
+++ + + R L+ L L + + + LE L + + +V
Sbjct: 196 SEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYS 255
Query: 658 GVV----NLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700
G+ + L L + + +LP+ + + L+ N S+ +
Sbjct: 256 GLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQ 302
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.4 bits (110), Expect = 5e-05
Identities = 49/348 (14%), Positives = 100/348 (28%), Gaps = 38/348 (10%)
Query: 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIW-----SLEKLEVLDVEGNFLSGRLPNEFVG 153
LS + L L++ + + E L+ L + +L
Sbjct: 176 LSHFPDTYTSLVSLNI--SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQR 233
Query: 154 LRNLRVLNLAFNRIDGD------IPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRV 207
L L + + +L + L L+ + V +P +L
Sbjct: 234 APQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTT 293
Query: 208 LFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS------ 261
L LSY + +L C L+ L + + C+ LR L +F
Sbjct: 294 LNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVM 353
Query: 262 ---NMLNDVIPRELGW-LRKLEVLDVSRNRLNGLIPTELG-NCVELSVLVLSNLFDPLLS 316
L + + KLE + ++ + N ++ L +
Sbjct: 354 EPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPD 413
Query: 317 GRNIR----GELSVGQS-------DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG 365
+ G ++ + S + I + L + +A + G
Sbjct: 414 YLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAG-DSDLG 472
Query: 366 KLPSSWGACESLEMLNLAQNVLRGD-LIGVFDRCKKLHFIDLSSNELS 412
+ C+SL L + L+ + + + + +SS +S
Sbjct: 473 -MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 81/572 (14%), Positives = 172/572 (30%), Gaps = 96/572 (16%)
Query: 135 VLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRI-DGDIPFSLRNFESLEVLNLAGNQVKG 193
V D G ++ + L + L + D + ++F++ +VL L+ +G
Sbjct: 85 VPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSS--CEG 142
Query: 194 V----IPGFLGSFLKLRVLFLSYNELN---GSIPSELGKYCRYLEHLDLSG------NSL 240
+ + L+ L L ++++ G S L L++S S
Sbjct: 143 FSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSA 202
Query: 241 VGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCV 300
+ R+ + C L++L L + + + L +LE L G
Sbjct: 203 LERLVTR---CPNLKSLKLNRAVPLEKLATLLQRAPQLEELG-------------TGGYT 246
Query: 301 ELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPR 360
+ + LSG LS G ++ +P + S+L
Sbjct: 247 AEVRPDVYSGLSVALSGCKELRCLS--------GFWDAVPAYLPAVYSVCSRLT-----T 293
Query: 361 LNLEG------KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGE 414
LNL L C L+ L + + L + CK DL +
Sbjct: 294 LNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCK-----DLRELRVFP- 347
Query: 415 LDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDL-CQGY-DPSFTYMQYFMS 472
+ + P +AL + +S P+ L+S C+ + + +
Sbjct: 348 SEPFVMEPNVALTEQGLVSVSMGCPK----------LESVLYFCRQMTNAALITIARNRP 397
Query: 473 K-ARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSF 531
R + ++ A + F + LRR L+ + LT
Sbjct: 398 NMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCK----DLRR------LSLSGLLTDKV 447
Query: 532 PGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASH-NQISGIVPQSLENL 590
+ + + +++ + C SLR L+ + + L
Sbjct: 448 FEYIGTYAKKMEML--SVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKL 505
Query: 591 TSLVFLDLNGNKLQGE----IPSSLHRLK--YLRHLSLADNNLTGGIPSSIGELRSLEVL 644
++ L ++ + + + +L + D+ + R++
Sbjct: 506 ETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVIDERGAPDSRPESCPVERVFIYRTVA-- 563
Query: 645 ELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676
++P V N+ + + ++
Sbjct: 564 -----GPRFDMPGFVWNMDQDSTMRFSRQIIT 590
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 31/103 (30%), Positives = 51/103 (49%), Gaps = 2/103 (1%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
L++N + + L L+ NQ++GI P + E + + L L NK++ EI
Sbjct: 35 LLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EI 93
Query: 608 PSSL-HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSN 649
+ + L L+ L+L DN ++ +P S L SL L L+SN
Sbjct: 94 SNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 22/108 (20%)
Query: 607 IPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSNSLSGEVPEGVV-NLRN 664
IP L L DN L + G L L LEL N L+ + +
Sbjct: 27 IPLHTTELL------LNDNELGRISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASH 79
Query: 665 LTALLLDNNKLSGHLPSG----LANVTSLSIFN--------ASFNNLS 700
+ L L NK+ + + L + +L++++ SF +L+
Sbjct: 80 IQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLN 126
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 5e-08
Identities = 32/197 (16%), Positives = 51/197 (25%), Gaps = 49/197 (24%)
Query: 548 NLSNNNIIGHIPLDIGV--------MCKSLRVLDASHNQISGIVP----------QSLEN 589
LS N I G K L + + S + Q+L
Sbjct: 38 VLSGNTI-G----TEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLK 92
Query: 590 LTSLVFLDLNGNKLQGE----IPSSLHRLKYLRHLSLADNNLT-------------GGIP 632
L + L+ N + L + L HL L +N L +
Sbjct: 93 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVN 152
Query: 633 SSIGELRSLEVLELSSNSLSGE----VPEGVVNLRNLTALLLDNNKL-----SGHLPSGL 683
L + N L + + R L + + N + L GL
Sbjct: 153 KKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212
Query: 684 ANVTSLSIFNASFNNLS 700
A L + + N +
Sbjct: 213 AYCQELKVLDLQDNTFT 229
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 27/171 (15%), Positives = 45/171 (26%), Gaps = 41/171 (23%)
Query: 567 KSLRVLDASHNQIS--GIVP--QSLENLTSLVFLDLNGNKLQGE----IPSSLHRLKYLR 618
S+ + I+ L S+ + L+GN + E + ++ K L
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 619 HLSLADNNL----------TGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNL------ 662
+D + ++ + L + LS N+ P L
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFG---PTAQEPLIDFLSK 120
Query: 663 -RNLTALLLDNNKLS-------------GHLPSGLANVTSLSIFNASFNNL 699
L L L NN L + N L N L
Sbjct: 121 HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 28/195 (14%), Positives = 55/195 (28%), Gaps = 42/195 (21%)
Query: 155 RNLRVLNLAFNRIDGD----IPFSLRNFESLEVLNLAGNQ--VKGVIPGFLGSFLK---- 204
++ +L + I + + L +S++ + L+GN + +L +
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAAR--WLSENIASKKD 61
Query: 205 LRVLFLSYNELNGSIP---------SELGKYCRYLEHLDLSGNSL----VGRIPSSLGKC 251
L + S + C L + LS N+ + L K
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 121
Query: 252 QQLRTLLLFSNMLND-------------VIPRELGWLRKLEVLDVSRNRLNG----LIPT 294
L L L +N L + ++ L + RNRL
Sbjct: 122 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181
Query: 295 ELGNCVELSVLVLSN 309
+ L + +
Sbjct: 182 TFQSHRLLHTVKMVQ 196
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-07
Identities = 28/173 (16%), Positives = 52/173 (30%), Gaps = 41/173 (23%)
Query: 566 CKSLRVLDASHNQIS-------GIVPQSLENLTSLVFLDLNGNKLQGEIP-------SSL 611
S++ + S N I S ++L F D+ +++ EIP +L
Sbjct: 31 DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQAL 90
Query: 612 HRLKYLRHLSLADNNLTGGIPSSIGEL----RSLEVLELSSNSLSGEVPEGVVNL----- 662
+ L + L+DN + + LE L L +N L P+ +
Sbjct: 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQ 147
Query: 663 -----------RNLTALLLDNNKLSG----HLPSGLANVTSLSIFNASFNNLS 700
L +++ N+L + L N +
Sbjct: 148 ELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIR 200
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 34/220 (15%), Positives = 63/220 (28%), Gaps = 44/220 (20%)
Query: 132 KLEVLDVEGNFLSGRLPNEFVGL----RNLRVLNLAFNRI-------------DGDIPFS 174
KL + + N + L L L N + + +
Sbjct: 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 154
Query: 175 LRNFESLEVLNLAGNQV--KGVIPGFLGSFLK----LRVLFLSYNELN----GSIPSELG 224
+N L + N++ + + L + + N + + E
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMK--EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGL 212
Query: 225 KYCRYLEHLDLSGNSL----VGRIPSSLGKCQQLRTLLLFSNMLNDV----IPRELGWL- 275
YC+ L+ LDL N+ + +L LR L L +L+ + L
Sbjct: 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 272
Query: 276 -RKLEVLDVSRNRLN-----GLIPTELGNCVELSVLVLSN 309
L+ L + N + L +L L L+
Sbjct: 273 NIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG 312
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 33/241 (13%), Positives = 69/241 (28%), Gaps = 46/241 (19%)
Query: 205 LRVLFLSYNELNGSIPSELG---KYCRYLEHLDLSGNSL----VGRIPSSLGKCQQLRTL 257
+ L + + + ++ + LSGN++ + ++ + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 258 LLFSNMLNDV----------IPRELGWLRKLEVLDVSRNRL--NGLIP--TELGNCVELS 303
V + + L KL + +S N P L L
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 125
Query: 304 VLVLSNLFDPLLSGRN---IRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPR 360
L L N N + + ++ + L + I R
Sbjct: 126 HLYLHN---------NGLGPQAGAKIARALQELAVNKKAKNA-----PPLRSI-ICGRNR 170
Query: 361 LNLEG--KLPSSWGACESLEMLNLAQNVLRGD-----LIGVFDRCKKLHFIDLSSNELSG 413
L + ++ + L + + QN +R + L+ C++L +DL N +
Sbjct: 171 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 414 E 414
Sbjct: 231 L 231
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 21/102 (20%), Positives = 42/102 (41%), Gaps = 18/102 (17%)
Query: 155 RNLRVLNLAFNRIDGD----IPFSLRNFESLEVLNLAGNQV--KGVIPGFLGSFLK---- 204
+ L+VL+L N + +L+++ +L L L + +G +
Sbjct: 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA--AVVDAFSKLEN 273
Query: 205 --LRVLFLSYNELNG----SIPSELGKYCRYLEHLDLSGNSL 240
L+ L L YNE+ ++ + + + L L+L+GN
Sbjct: 274 IGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 29/153 (18%), Positives = 51/153 (33%), Gaps = 33/153 (21%)
Query: 548 NLSNNNIIGHIPLDIGVM---------CKSLRVLDASHNQIS--GIVP--QSLENLTSLV 594
+ N I G+ C+ L+VLD N + G +L++ +L
Sbjct: 193 KMVQNGIR-----PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLR 247
Query: 595 FLDLNGNKLQGE----IPSSLHRL--KYLRHLSLADNNLTGGIPSSIGE-----LRSLEV 643
L LN L + + +L L+ L L N + ++ + L
Sbjct: 248 ELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLF 307
Query: 644 LELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676
LEL+ N S E V + + + +
Sbjct: 308 LELNGNRFS---EEDDV-VDEIREVFSTRGRGE 336
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 52/220 (23%), Positives = 77/220 (35%), Gaps = 41/220 (18%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKL-AVGRFQHGVQQFHAEIKTLGNVRH-----PNLV 881
+G G FG + I AVK + + ++ E L +++ N+V
Sbjct: 43 MGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTR---SAKIEADILKKIQNDDINNNNIV 99
Query: 882 TLIG---YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
G Y + M LI+ L G +L I + + +++ AL YL
Sbjct: 100 KYHGKFMYY---DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGT----FG----- 989
+ H D+KP NILLDD + G T G FG
Sbjct: 156 M---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212
Query: 990 ------------YVAPEYALTCRVSDKADVYSYGVVLLEL 1017
Y APE L +D++S+G VL EL
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.0 bits (126), Expect = 3e-07
Identities = 34/166 (20%), Positives = 58/166 (34%), Gaps = 23/166 (13%)
Query: 548 NLSNNNIIGHIPLDIG-VMCKSLRVLDASHNQIS-----GIVPQSLENLTSLVFLDLNGN 601
L+N I G L IG +L+ L+ + I+ L NL LV +
Sbjct: 173 LLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVED 232
Query: 602 KLQGEIPSSL------HRLKYLRHLSLADNNLTGGIPSSIGE---LRSLEVLELSSNSLS 652
+ R L+ L + D + E L LE +++S+ L+
Sbjct: 233 YGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLT 292
Query: 653 GE----VPEGVVNLRNLTALLLDNNKLSG----HLPSGLANVTSLS 690
E + + V +++L + + N LS L L +S
Sbjct: 293 DEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVS 338
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 1e-06
Identities = 23/152 (15%), Positives = 53/152 (34%), Gaps = 17/152 (11%)
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQV-KGVIPGFLGSFLK-LRVLFLS 211
L + +LN + ++ + +L+ L + + V+ LGS L L L L
Sbjct: 168 LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLY 227
Query: 212 YNELNGSIPSEL--------GKYCRYLEHLDLSGNSLVGRIPSSLGKCQ---QLRTLLLF 260
+ ++ L+ L + + + QL T+ +
Sbjct: 228 VGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287
Query: 261 SNMLNDV----IPRELGWLRKLEVLDVSRNRL 288
+ +L D + + ++ L+ +++ N L
Sbjct: 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYL 319
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 4e-07
Identities = 46/356 (12%), Positives = 99/356 (27%), Gaps = 53/356 (14%)
Query: 99 LSPLVGGLSELRVLSLPFNGFS--GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRN 156
L + L + + F +LE+ + + V R
Sbjct: 212 LETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRK 271
Query: 157 LRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG-NQVKGVIPGFLGSFLKLRVLFLSYNEL 215
L L L ++P + L+L + L VL
Sbjct: 272 LCRLGL-SYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIG 330
Query: 216 NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGK------------CQQLRTLLLFSNM 263
+ + L +YC+ L+ L + + + G CQ+L + ++ +
Sbjct: 331 DRGL-EVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSD 389
Query: 264 LNDV----IPRELGWLRKLEVLDVSRNRLNGLIPTELG------NCVELSVLVLSNLFDP 313
+ + I L L ++ + R +P + G C +L
Sbjct: 390 ITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLR--- 446
Query: 314 LLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGA 373
G +D + I + + + + + EG L
Sbjct: 447 -----------QGGLTDLG-------LSYIGQYSPNVRWMLLGYV-GESDEG-LMEFSRG 486
Query: 374 CESLEMLNLAQ-NVLRGDLIGVFDRCKKLHFIDLSSNELS--GELDVKLQVPCMAL 426
C +L+ L + + + L ++ + S G+ +++ P +
Sbjct: 487 CPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNI 542
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 30/175 (17%), Positives = 60/175 (34%), Gaps = 25/175 (14%)
Query: 132 KLEVLDVEGN--------FLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFS------LRN 177
+LE + V + + L N L + R++ L D+P L
Sbjct: 379 ELEYMAVYVSDITNESLESIGTYLKN----LCDFRLVLLDREERITDLPLDNGVRSLLIG 434
Query: 178 FESLEVLNLAGN--QVKGVIPGFLGSFLK-LRVLFLSYNELNGSIPSELGKYCRYLEHLD 234
+ L + + ++G + +R + L Y + E + C L+ L+
Sbjct: 435 CKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLE 494
Query: 235 LSGNSLVGR-IPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR---KLEVLDVSR 285
+ G R I +++ K LR L + + + R +E++ R
Sbjct: 495 MRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRR 549
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 44/298 (14%), Positives = 87/298 (29%), Gaps = 41/298 (13%)
Query: 136 LDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVI 195
+ + RL F NLR L L N+ G V +
Sbjct: 57 MALCYTATPDRLSRRF---PNLRSLKLKGKPRAAMFNLIPENW---------GGYVTPWV 104
Query: 196 PGFLGSFLKLRVLFLSYNEL-NGSIPSELGKYCRYLEHLDLSGNSLVGR--IPSSLGKCQ 252
+ +L+ + + + + LE L L S + S + C+
Sbjct: 105 TEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGLLSIVTHCR 164
Query: 253 QLRTLLLFSNMLNDVIPRELGWL----RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS 308
+++TLL+ + ++ + L L LEVL+ + ++S L
Sbjct: 165 KIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFY-----------MTEFAKISPKDLE 213
Query: 309 NLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLP 368
+ + R++ + V + + L + +
Sbjct: 214 TIAR---NCRSLV-SVKV------GDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKY 263
Query: 369 SSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL 426
+ L L L + ++ +F ++ +DL L E L C L
Sbjct: 264 MNLVFPRKLCRLGL-SYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNL 320
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 27/157 (17%), Positives = 48/157 (30%), Gaps = 13/157 (8%)
Query: 548 NLSNNNIIGHIPL-DIGVMCKSLRVLDASHNQISGIVPQSL----ENLTSLVFLDLNGNK 602
L + L I C+ ++ L + S + L ++ TSL L+ +
Sbjct: 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTE 203
Query: 603 LQGEIPSSL----HRLKYLRHLSLADNNLT--GGIPSSIGELRSLEVLELSSNSLSGEVP 656
P L + L + + D + G + L L+ + E
Sbjct: 204 FAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKY 263
Query: 657 EGVVNLRNLTALLLDNNKLSG--HLPSGLANVTSLSI 691
+V R L L L + L A + L +
Sbjct: 264 MNLVFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDL 300
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 47/220 (21%), Positives = 79/220 (35%), Gaps = 45/220 (20%)
Query: 829 IGSGGFGTTYKA--EISPGILVAVKKL-AVGRFQHGVQQFHAEIKTLGNVRHP------N 879
+G G FG + VA+K + VG+++ EI L ++
Sbjct: 27 LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYRE---AARLEINVLKKIKEKDKENKFL 83
Query: 880 LVTLIG---YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
V + + M + + L G N F+K + + +A + AL +L
Sbjct: 84 CVLMSDWFNFH---GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFL 139
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAY-------------------LSDFGLSRLLGTSE 977
H+ ++ H D+KP NIL + ++DFG + T +
Sbjct: 140 HEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFD 192
Query: 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLEL 1017
T + T Y PE L + DV+S G +L E
Sbjct: 193 HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEY 232
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 34/163 (20%), Positives = 60/163 (36%), Gaps = 31/163 (19%)
Query: 566 CKSLRVLDASHNQISGIVPQSL-----ENLTSLVFLDLNGNKLQGE----IPSSLHRLK- 615
+ LD S N + I L S+ L+L+GN L + + L +
Sbjct: 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA 80
Query: 616 YLRHLSLADNNLTGGIPSSIGEL-----RSLEVLELSSNSLSGEVPEGVVNL-------- 662
+ L+L+ N L+ + + ++ VL+L N S +
Sbjct: 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEFKQAFSNLP 137
Query: 663 RNLTALLLDNNKLSG----HLPSGLANV-TSLSIFNASFNNLS 700
++T+L L N L L LA + +++ N NNL+
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA 180
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 33/187 (17%), Positives = 59/187 (31%), Gaps = 34/187 (18%)
Query: 155 RNLRVLNLAFNRIDGD----IPFSLRNFE-SLEVLNLAGNQV--KGVIPGFLGSFLK--- 204
+ VL+L +N + N S+ LNL GN + K L L
Sbjct: 109 FTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD--ELIQILAAIP 166
Query: 205 --LRVLFLSYNELN----GSIPSELGKYCRYLEHLDLSGNSL----VGRIPSSLGKCQ-Q 253
+ L L N L + L + LDLS N L +
Sbjct: 167 ANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNH 226
Query: 254 LRTLLLFSNMLNDVIPRELGWLRK----LEVLDVSRNRLNGL-------IPTELGNCVEL 302
+ +L L N L+ L L+ L+ + + + + + + N ++
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 303 SVLVLSN 309
++ +
Sbjct: 287 ILVDKNG 293
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-06
Identities = 27/185 (14%), Positives = 55/185 (29%), Gaps = 36/185 (19%)
Query: 548 NLSNNNI----IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSL-----ENLTSLVFLDL 598
NL NN+ + + + S+ LD S N + L +V L+L
Sbjct: 173 NLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNL 232
Query: 599 NGNKLQGE----IPSSLHRLKYLRHLSLADNNLTG-------GIPSSIGELRSLEVLELS 647
N L G + LK+L+ + L + + + ++ ++ + +++ +
Sbjct: 233 CLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKN 292
Query: 648 SNSLSGEVPEGVVNL--------RNLTALLLDNNKLS-----GHLPSGLANVTSLSIFNA 694
+ P + + L N L L L
Sbjct: 293 GKEIH---PSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESIQ 349
Query: 695 SFNNL 699
+ L
Sbjct: 350 TCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 31/158 (19%), Positives = 49/158 (31%), Gaps = 24/158 (15%)
Query: 155 RNLRVLNLAFNRIDGDIPFSL-----RNFESLEVLNLAGNQVKGVIPGFLGSFLK----- 204
+ L+L+ N + L S+ LNL+GN + L L
Sbjct: 22 HGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81
Query: 205 LRVLFLSYNELNG----SIPSELGKYCRYLEHLDLSGNSL----VGRIPSSLGKC-QQLR 255
+ L LS N L+ + L + LDL N + +
Sbjct: 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASIT 141
Query: 256 TLLLFSNMLNDVIPRELGWL-----RKLEVLDVSRNRL 288
+L L N L EL + + L++ N L
Sbjct: 142 SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL 179
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 25/133 (18%), Positives = 41/133 (30%), Gaps = 19/133 (14%)
Query: 175 LRNFESLEVLNLAGNQ-----VKGVIPGFLGSFLKLRVLFLSYNELN----GSIPSELGK 225
+ L+L+ N +I F + + L LS N L + L
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 226 YCRYLEHLDLSGNSL----VGRIPSSLGKCQ-QLRTLLLFSNMLNDVIPRELG-----WL 275
+ L+LSGN L + +L + L L N + E
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 276 RKLEVLDVSRNRL 288
+ L++ N L
Sbjct: 138 ASITSLNLRGNDL 150
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 32/185 (17%), Positives = 63/185 (34%), Gaps = 35/185 (18%)
Query: 548 NLSNNNI----IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSL-----ENLTSLVFLDL 598
NLS N++ + + + ++ L+ S N +S L ++ LDL
Sbjct: 57 NLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDL 116
Query: 599 NGNKLQGE----IPSSLHRL-KYLRHLSLADNNLTGGIPSSIGEL-----RSLEVLELSS 648
N + + L + L+L N+L + ++ ++ L L
Sbjct: 117 GWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRG 176
Query: 649 NSLSGEVPEGVVNL--------RNLTALLLDNNKLS----GHLPSGLANV-TSLSIFNAS 695
N+L+ + L ++T+L L N L L +++ + N
Sbjct: 177 NNLA---SKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLC 233
Query: 696 FNNLS 700
N L
Sbjct: 234 LNCLH 238
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 28/153 (18%), Positives = 50/153 (32%), Gaps = 30/153 (19%)
Query: 575 SHNQISGI----VPQSLENLTSLVFLDLNGNKLQGEIPSSL-----HRLKYLRHLSLADN 625
++ V + + LDL+ N L L + + L+L+ N
Sbjct: 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGN 61
Query: 626 NLTGGIPSSIGEL-----RSLEVLELSSNSLSGEVPEGVVNL--------RNLTALLLDN 672
+L + ++ ++ L LS N LS + L +T L L
Sbjct: 62 SLGFKNSDELVQILAAIPANVTSLNLSGNFLS---YKSSDELVKTLAAIPFTITVLDLGW 118
Query: 673 NKLSG----HLPSGLANV-TSLSIFNASFNNLS 700
N S +N+ S++ N N+L
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG 151
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 4e-06
Identities = 48/224 (21%), Positives = 81/224 (36%), Gaps = 53/224 (23%)
Query: 829 IGSGGFGTTYKA--EISPGILVAVKKL-AVGRFQHGVQQFHAEIKTLGNVRHP------N 879
+G G FG + + G VAVK + V R+ +EI+ L ++
Sbjct: 22 LGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCE---AARSEIQVLEHLNTTDPNSTFR 78
Query: 880 LVTLIG---YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
V ++ + + +++ L G + +FIK + K+A + ++ +L
Sbjct: 79 CVQMLEWFEHH---GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFL 134
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-----------------SETH 979
H ++ H D+KP NIL + + R T E H
Sbjct: 135 HSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191
Query: 980 ATTGVAGTFGYV------APEYALTCRVSDKADVYSYGVVLLEL 1017
+T V APE L S DV+S G +L+E
Sbjct: 192 ST--------LVSTRHYRAPEVILALGWSQPCDVWSIGCILIEY 227
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 1e-05
Identities = 24/139 (17%), Positives = 46/139 (33%), Gaps = 25/139 (17%)
Query: 585 QSLENLTSLVFLDLNGNKLQGE-----IPSSLHRLKYLRHLSLADNNLTGGIPSSIGEL- 638
+ N L ++LN +L Y++ S+ + ++ E+
Sbjct: 30 RIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEML 89
Query: 639 ---RSLEVLELSSNSLSGEVPEGVVNL-------RNLTALLLDNNKLS------GHLPSG 682
+L+ L + SN +S G++ L +L L +DN + +
Sbjct: 90 KVNNTLKSLNVESNFIS---GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANM 146
Query: 683 LANVTSLSIFNASFNNLSG 701
L T+L F F
Sbjct: 147 LEKNTTLLKFGYHFTQQGP 165
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Length = 185 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 6e-04
Identities = 16/129 (12%), Positives = 35/129 (27%), Gaps = 26/129 (20%)
Query: 548 NLSNNNIIGHIPLDIGVMC--------KSLRVLDASHNQISGIVPQS----LENLTSLVF 595
NL+N I + ++ + + V + L+ +L
Sbjct: 42 NLNNIMNIP----VPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKS 97
Query: 596 LDLNGNKLQGE----IPSSLHRLKYLRHLSLADNNLTGGIP--SSIGEL----RSLEVLE 645
L++ N + G + +L L L + + + G I + +L
Sbjct: 98 LNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFG 157
Query: 646 LSSNSLSGE 654
Sbjct: 158 YHFTQQGPR 166
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 31/156 (19%), Positives = 55/156 (35%), Gaps = 25/156 (16%)
Query: 567 KSLRVLDASHNQISGIVPQSL-----ENLTSLVFLDLNGNKLQGEIPSSLHR-LKYLRHL 620
SLR L+ + +++ + + +L ++L +L +L R L
Sbjct: 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKL 131
Query: 621 SLADNNLTGGIPSSIGE-LRS----LEVLELSSNSLSGEVPEGVVNL-------RNLTAL 668
L N+L + + L + L LS+N L+ GV L ++T L
Sbjct: 132 GLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLT---AAGVAVLMEGLAGNTSVTHL 188
Query: 669 LLDNNKLS----GHLPSGLANVTSLSIFNASFNNLS 700
L + L L + L L N ++N
Sbjct: 189 SLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAG 224
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 34/152 (22%), Positives = 53/152 (34%), Gaps = 21/152 (13%)
Query: 156 NLRVLNLAFNRIDGDIPFSL-RNFESLEVLNLAGNQV--KGVIPGFLGSFLK-----LRV 207
L +NLA ++D +L F L L N + + L L +
Sbjct: 102 ALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKD--LRDLLLHDQCQITT 159
Query: 208 LFLSYNELNGSIPSELG---KYCRYLEHLDLSGNSL----VGRIPSSLGKCQQLRTLLLF 260
L LS N L + + L + HL L L + + + L + +QL+ L +
Sbjct: 160 LRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVA 219
Query: 261 SNMLNDVIPRELGWL----RKLEVLDVSRNRL 288
N D L LE+L + N L
Sbjct: 220 YNGAGDTAALALARAAREHPSLELLHLYFNEL 251
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 4/85 (4%)
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSN 649
T+ L L N++ P RL L L L +N LT +P+ + +L L L L+ N
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDN 88
Query: 650 SLSGEVPEGVV-NLRNLTALLLDNN 673
L +P G NL++LT + L NN
Sbjct: 89 QLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 3e-05
Identities = 29/85 (34%), Positives = 41/85 (48%), Gaps = 4/85 (4%)
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI-GELRSLEVLELSSN 649
T L LN N++ P L L+ L N LT IP+ + +L L L+L+ N
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDN 91
Query: 650 SLSGEVPEGVV-NLRNLTALLLDNN 673
L +P G NL++LT + L NN
Sbjct: 92 HLKS-IPRGAFDNLKSLTHIYLYNN 115
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Length = 197 | Back alignment and structure |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 28/138 (20%), Positives = 51/138 (36%), Gaps = 26/138 (18%)
Query: 587 LENLTSLVFLDLNGNKLQG-----EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGEL--- 638
E+ T L +++N K + + K++ SLA+ ++ + EL
Sbjct: 37 REDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIET 96
Query: 639 -RSLEVLELSSNSLSGEVPEGVVNL-------RNLTALLLDNNKLSG-------HLPSGL 683
SL VL + SN L+ PE + L +++ DN + S + +
Sbjct: 97 SPSLRVLNVESNFLT---PELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAI 153
Query: 684 ANVTSLSIFNASFNNLSG 701
SL SF ++
Sbjct: 154 EENESLLRVGISFASMEA 171
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1103 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.97 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.96 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.96 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.95 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.95 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.95 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.92 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.91 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.9 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.89 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.89 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.89 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.88 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.88 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.87 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.86 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.86 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.86 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.84 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.84 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.83 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.83 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.83 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.82 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.82 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.81 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.81 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.78 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.78 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.76 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.76 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.76 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.75 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.74 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.74 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.73 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.73 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.71 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.7 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.69 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.67 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.66 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.64 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.62 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.62 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.61 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.59 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.58 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.58 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.52 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.51 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.51 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.49 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.49 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.48 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.46 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.44 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.42 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.38 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.37 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.33 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.32 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.26 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.2 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.11 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.03 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 99.01 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.91 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.9 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.84 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.81 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.74 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.7 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.67 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.6 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.35 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.34 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.33 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.3 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.08 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.07 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 97.98 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.94 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.77 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.52 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.45 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.42 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.4 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.22 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.96 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.8 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.76 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.59 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 96.41 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.38 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.24 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 95.49 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.41 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.36 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.53 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 87.48 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 82.15 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 81.7 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-76 Score=742.09 Aligned_cols=651 Identities=30% Similarity=0.426 Sum_probs=426.2
Q ss_pred CChhhHHHHHHHHhhccCCCCcccCcCCCCCCCCceeeeEecCCCCeEEEEecCCCCCCCCCCccccccccccccccccc
Q 043720 3 KVLPEKTILLEFKNSVSDPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQFPFYGFG 82 (1103)
Q Consensus 3 ~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~C~W~GV~C~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (1103)
..++|++|||+||+++.||. .++||+.+ .|||+|.||+|+ .+||+++++++..+.+... ..... +. .
T Consensus 9 ~~~~~~~all~~k~~~~~~~-~l~~W~~~-~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~-~l~~~-----l~----~ 75 (768)
T 3rgz_A 9 SLYREIHQLISFKDVLPDKN-LLPDWSSN-KNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFS-AVSSS-----LL----S 75 (768)
T ss_dssp CHHHHHHHHHHHHTTCSCTT-SSTTCCTT-SCGGGSTTEEEE-TTEEEEEECTTSCCCEEHH-HHHHH-----TT----T
T ss_pred CCHHHHHHHHHHHhhCCCcc-cccCCCCC-CCCcCCcceEEC-CCcEEEEECCCCCcCCccC-ccChh-----Hh----c
Confidence 46789999999999999998 99999854 589999999999 7899999998754321000 00000 00 0
Q ss_pred cccceeccCCCccccccCcccCCCCCCCEEEccCCCCcccCCc--cccCCCCCCEEEeecCCCCCCccccc-cCCCCCCE
Q 043720 83 MRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPP--EIWSLEKLEVLDVEGNFLSGRLPNEF-VGLRNLRV 159 (1103)
Q Consensus 83 ~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~--~l~~l~~L~~L~Ls~n~l~~~~p~~l-~~l~~L~~ 159 (1103)
......++....-.-.+|+.++++++|++|+|++|.++|.+|. .++++++|++|||++|.+++.+|..+ .++++|++
T Consensus 76 L~~L~~l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~ 155 (768)
T 3rgz_A 76 LTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155 (768)
T ss_dssp CTTCCEEECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSE
T ss_pred cCcccccCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCE
Confidence 0000001101111112334455555555555555555554544 45555555555555555554444443 44555555
Q ss_pred EEccccccCCCCCCC---CCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECc
Q 043720 160 LNLAFNRIDGDIPFS---LRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLS 236 (1103)
Q Consensus 160 L~Ls~N~l~~~~p~~---l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~ 236 (1103)
|+|++|++++..|.. +.++++|++|++++|.+++.+|. +.+++|++|+|++|++++.+|. ++. +++|++|+|+
T Consensus 156 L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~--~~l~~L~~L~Ls~n~l~~~~~~-l~~-l~~L~~L~Ls 231 (768)
T 3rgz_A 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV--SRCVNLEFLDVSSNNFSTGIPF-LGD-CSALQHLDIS 231 (768)
T ss_dssp EECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC--TTCTTCCEEECCSSCCCSCCCB-CTT-CCSCCEEECC
T ss_pred EECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc--ccCCcCCEEECcCCcCCCCCcc-ccc-CCCCCEEECc
Confidence 555555555444443 44455555555555555444332 4445555555555555544443 322 3445555555
Q ss_pred CCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCC-CCCCeEecccCcCccc
Q 043720 237 GNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNC-VELSVLVLSNLFDPLL 315 (1103)
Q Consensus 237 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l-~~L~~L~l~~~~~~~l 315 (1103)
+|++++.+|..++++++|++|++++|.+++.+|.. .+++|++|++++|+++|.+|..+... ++|+.|+++
T Consensus 232 ~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls------- 302 (768)
T 3rgz_A 232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS------- 302 (768)
T ss_dssp SSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECC-------
T ss_pred CCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECc-------
Confidence 55555444555555555555555555554444432 44555555555555555555544443 555555554
Q ss_pred cCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCcc-ccccccCcEEEcCCcccccccchh
Q 043720 316 SGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSS-WGACESLEMLNLAQNVLRGDLIGV 394 (1103)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~-~~~l~~L~~L~Ls~N~l~~~~~~~ 394 (1103)
.|.+.+.+|..++.+++|+.|++++|.+.+.+|.. +.++++|++|+|++|++++..|..
T Consensus 303 --------------------~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~ 362 (768)
T 3rgz_A 303 --------------------GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362 (768)
T ss_dssp --------------------SSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTT
T ss_pred --------------------CCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHH
Confidence 46666677777777777777777777777777655 777777777777777777777777
Q ss_pred hhccC-CceEeecCCccccccccccc-c--ccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHH
Q 043720 395 FDRCK-KLHFIDLSSNELSGELDVKL-Q--VPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYF 470 (1103)
Q Consensus 395 ~~~l~-~L~~LdLs~N~l~~~~~~~~-~--~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 470 (1103)
+.+++ +|++|+|++|++++.++... . +++|+.|++++|+++|.+|....+ ...++...+..
T Consensus 363 l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~---l~~L~~L~Ls~------------ 427 (768)
T 3rgz_A 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSN---CSELVSLHLSF------------ 427 (768)
T ss_dssp HHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGG---CTTCCEEECCS------------
T ss_pred HHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEEECCCCccccccCHHHhc---CCCCCEEECcC------------
Confidence 77766 77777777777776554433 2 566777777777777766643211 11112111111
Q ss_pred HhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeee-eccccccccCCcchhhhcccccccEEec
Q 043720 471 MSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFL-AGANKLTGSFPGSLFQACNEFHGMVANL 549 (1103)
Q Consensus 471 ~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~lp~~~~~~~~~~~~~~l~l 549 (1103)
+......|..+..++.|..+++++|++++.+ +..+.....+..+ ...|++.+.+|..+ ..+.. ...|++
T Consensus 428 -N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~------p~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~--L~~L~L 497 (768)
T 3rgz_A 428 -NYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI------PQELMYVKTLETLILDFNDLTGEIPSGL-SNCTN--LNWISL 497 (768)
T ss_dssp -SEEESCCCGGGGGCTTCCEEECCSSCCCSCC------CGGGGGCTTCCEEECCSSCCCSCCCGGG-GGCTT--CCEEEC
T ss_pred -CcccCcccHHHhcCCCCCEEECCCCcccCcC------CHHHcCCCCceEEEecCCcccCcCCHHH-hcCCC--CCEEEc
Confidence 1112234555667778888888888888643 2223333333333 34556666777664 34444 458999
Q ss_pred CCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCccc------------------
Q 043720 550 SNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL------------------ 611 (1103)
Q Consensus 550 s~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~------------------ 611 (1103)
++|++++.+|.++..+ ++|++|+|++|++++.+|..+.++++|++|+|++|+++|.+|..+
T Consensus 498 ~~N~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~ 576 (768)
T 3rgz_A 498 SNNRLTGEIPKWIGRL-ENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 576 (768)
T ss_dssp CSSCCCSCCCGGGGGC-TTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEE
T ss_pred cCCccCCcCChHHhcC-CCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhcccccccc
Confidence 9999999999998876 899999999999999999999999999999999999887777543
Q ss_pred ----------------------------------------------------ccCccCcEEeccCcccCCCCCCcccCCC
Q 043720 612 ----------------------------------------------------HRLKYLRHLSLADNNLTGGIPSSIGELR 639 (1103)
Q Consensus 612 ----------------------------------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 639 (1103)
..+++|+.|+|++|+++|.+|..|++++
T Consensus 577 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~ 656 (768)
T 3rgz_A 577 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMP 656 (768)
T ss_dssp EEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCT
T ss_pred ccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccc
Confidence 3457899999999999999999999999
Q ss_pred CCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCC--CccccccccccC
Q 043720 640 SLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPW--NVTTMNCSGVIG 717 (1103)
Q Consensus 640 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~--~~~~~~~~~l~~ 717 (1103)
+|++|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..+..++.|+.||+++|+++|.+|. .+.++....+.|
T Consensus 657 ~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~g 736 (768)
T 3rgz_A 657 YLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLN 736 (768)
T ss_dssp TCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCS
T ss_pred cCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcC
Confidence 999999999999999999999999999999999999999999999999999999999999999996 466778888999
Q ss_pred CCCCCCCC
Q 043720 718 NPFLDPCQ 725 (1103)
Q Consensus 718 Np~~c~C~ 725 (1103)
||..|.-.
T Consensus 737 N~~Lcg~~ 744 (768)
T 3rgz_A 737 NPGLCGYP 744 (768)
T ss_dssp CTEEESTT
T ss_pred CchhcCCC
Confidence 99998643
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-60 Score=597.14 Aligned_cols=570 Identities=28% Similarity=0.371 Sum_probs=493.7
Q ss_pred ccccc---cCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccc--cccCCCCCCEEEccccccC
Q 043720 94 KLVGK---LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPN--EFVGLRNLRVLNLAFNRID 168 (1103)
Q Consensus 94 ~~~g~---~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~--~l~~l~~L~~L~Ls~N~l~ 168 (1103)
.+.|. +|+.+++|++|+.++++.+++. .+|..++++++|++|||++|.++|.+|. .++.+++|++|+|++|.++
T Consensus 61 ~l~g~~~~l~~~l~~L~~L~~l~~~~~~~~-~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~ 139 (768)
T 3rgz_A 61 PLNVGFSAVSSSLLSLTGLESLFLSNSHIN-GSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD 139 (768)
T ss_dssp CCCEEHHHHHHHTTTCTTCCEEECTTSCEE-ECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEE
T ss_pred CcCCccCccChhHhccCcccccCCcCCCcC-CCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccC
Confidence 46677 9999999999999999999886 5778999999999999999999999999 9999999999999999999
Q ss_pred CCCCCCC-CCCCCCCEEEccCCcCCCCCChh---cccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcccccc
Q 043720 169 GDIPFSL-RNFESLEVLNLAGNQVKGVIPGF---LGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI 244 (1103)
Q Consensus 169 ~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~---l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~ 244 (1103)
+.+|..+ .++++|++|+|++|++++..|.. ++++++|++|++++|++++.+|. ..+++|++|+|++|++++.+
T Consensus 140 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~---~~l~~L~~L~Ls~n~l~~~~ 216 (768)
T 3rgz_A 140 FPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV---SRCVNLEFLDVSSNNFSTGI 216 (768)
T ss_dssp CCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBC---TTCTTCCEEECCSSCCCSCC
T ss_pred CcCCHHHhccCCCCCEEECCCCccCCcCChhhhhhccCCCCCEEECCCCcccccCCc---ccCCcCCEEECcCCcCCCCC
Confidence 9999877 89999999999999999988877 88999999999999999987775 34688999999999999888
Q ss_pred CccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcc
Q 043720 245 PSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGEL 324 (1103)
Q Consensus 245 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~ 324 (1103)
|. ++++++|++|++++|.+++.+|.++..+++|++|+|++|++++.+|.. .+++|++|++++
T Consensus 217 ~~-l~~l~~L~~L~Ls~n~l~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~--~l~~L~~L~L~~--------------- 278 (768)
T 3rgz_A 217 PF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAE--------------- 278 (768)
T ss_dssp CB-CTTCCSCCEEECCSSCCCSCHHHHTTTCSSCCEEECCSSCCEESCCCC--CCTTCCEEECCS---------------
T ss_pred cc-cccCCCCCEEECcCCcCCCcccHHHhcCCCCCEEECCCCcccCccCcc--ccCCCCEEECcC---------------
Confidence 87 999999999999999999999999999999999999999999988876 899999999985
Q ss_pred cccccCCCCCCCCcccccCchhhhcc-ccccccccCCccccccCCccccccccCcEEEcCCcccccccchh-hhccCCce
Q 043720 325 SVGQSDASNGEKNSFIGSIPMEITTL-SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGV-FDRCKKLH 402 (1103)
Q Consensus 325 ~~~~~~~~~~~~n~~~~~ip~~~~~L-~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~~L~ 402 (1103)
|.+.+.+|..+..+ ++|+.|++++|.+.+.+|..|+++++|++|+|++|++.+.+|.. |.++++|+
T Consensus 279 ------------n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~ 346 (768)
T 3rgz_A 279 ------------NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346 (768)
T ss_dssp ------------SEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCC
T ss_pred ------------CccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCC
Confidence 77888999999876 99999999999999999999999999999999999999777754 99999999
Q ss_pred EeecCCccccccccccc-ccc-ceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchh
Q 043720 403 FIDLSSNELSGELDVKL-QVP-CMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPL 480 (1103)
Q Consensus 403 ~LdLs~N~l~~~~~~~~-~~~-~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (1103)
+|+|++|++++.+|... .++ +|+.|++++|+++|.+|...... ....++...+ ..+......|.
T Consensus 347 ~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~-~~~~L~~L~L-------------~~n~l~~~~p~ 412 (768)
T 3rgz_A 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQN-PKNTLQELYL-------------QNNGFTGKIPP 412 (768)
T ss_dssp EEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCS-TTCCCCEEEC-------------CSSEEEEECCG
T ss_pred EEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhc-ccCCccEEEC-------------CCCccccccCH
Confidence 99999999998777654 566 89999999999999888643210 0011222111 11222223566
Q ss_pred hhhcccceEEEecCCCccccccccCCCCccccccccceeeee-ccccccccCCcchhhhcccccccEEecCCCcccccCC
Q 043720 481 LVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLA-GANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIP 559 (1103)
Q Consensus 481 ~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip 559 (1103)
.+..++.|+.+++++|++++.+ +..+........+. ..|.+.+.+|..+. .+. ..+.|++++|++++.+|
T Consensus 413 ~l~~l~~L~~L~Ls~N~l~~~~------p~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~--~L~~L~L~~N~l~~~~p 483 (768)
T 3rgz_A 413 TLSNCSELVSLHLSFNYLSGTI------PSSLGSLSKLRDLKLWLNMLEGEIPQELM-YVK--TLETLILDFNDLTGEIP 483 (768)
T ss_dssp GGGGCTTCCEEECCSSEEESCC------CGGGGGCTTCCEEECCSSCCCSCCCGGGG-GCT--TCCEEECCSSCCCSCCC
T ss_pred HHhcCCCCCEEECcCCcccCcc------cHHHhcCCCCCEEECCCCcccCcCCHHHc-CCC--CceEEEecCCcccCcCC
Confidence 7888899999999999998743 22233333333333 45666777887653 333 35689999999999999
Q ss_pred chhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcc----
Q 043720 560 LDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI---- 635 (1103)
Q Consensus 560 ~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---- 635 (1103)
..+..+ ++|++|+|++|++++.+|.+|+.+++|++|+|++|++++.+|..+..+++|+.|+|++|+++|.+|..+
T Consensus 484 ~~l~~l-~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~ 562 (768)
T 3rgz_A 484 SGLSNC-TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562 (768)
T ss_dssp GGGGGC-TTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECCGGGGGCTTCCEEECCSSEEESBCCGGGGTTT
T ss_pred HHHhcC-CCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCCHHHcCCCCCCEEECCCCccCCcCChHHhccc
Confidence 998876 999999999999999999999999999999999999999999999999999999999999998777543
Q ss_pred ------------------------------------------------------------------cCCCCCcEEeccCc
Q 043720 636 ------------------------------------------------------------------GELRSLEVLELSSN 649 (1103)
Q Consensus 636 ------------------------------------------------------------------~~l~~L~~L~Ls~N 649 (1103)
+.+++|++|||++|
T Consensus 563 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N 642 (768)
T 3rgz_A 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYN 642 (768)
T ss_dssp TCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSCTTSCEEEEECCCSCSSSBCCCEEECCSS
T ss_pred chhhhhccccccccccccccccccccccccccccccccchhhhccccccccccccceecccCchhhhccccccEEECcCC
Confidence 34678999999999
Q ss_pred cccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCcc---ccccccccCCCCC
Q 043720 650 SLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVT---TMNCSGVIGNPFL 721 (1103)
Q Consensus 650 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~---~~~~~~l~~Np~~ 721 (1103)
+++|.+|..++.+++|+.|+|++|+++|.+|..++++++|+.||+++|+++|.+|..+. .+..+++.+|+..
T Consensus 643 ~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~ls~N~l~ 717 (768)
T 3rgz_A 643 MLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLS 717 (768)
T ss_dssp CCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEECCCGGGGGCCCCSEEECCSSEEE
T ss_pred cccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECcCCccc
Confidence 99999999999999999999999999999999999999999999999999999997655 4566679999775
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=568.01 Aligned_cols=564 Identities=21% Similarity=0.166 Sum_probs=424.6
Q ss_pred ccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCC
Q 043720 96 VGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSL 175 (1103)
Q Consensus 96 ~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 175 (1103)
.+..+..++++++|++|+|++|.+++..|..++++++|++|+|++|.+++..+..|+++++|++|+|++|++++..|..+
T Consensus 38 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 117 (680)
T 1ziw_A 38 RRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117 (680)
T ss_dssp CCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCSCTT
T ss_pred CCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEECCCCccCccChhHc
Confidence 33334468899999999999999999889999999999999999999995555579999999999999999997777889
Q ss_pred CCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHh-hcCcCcEEECcCCccccccCccccCCCCC
Q 043720 176 RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGK-YCRYLEHLDLSGNSLVGRIPSSLGKCQQL 254 (1103)
Q Consensus 176 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~-~~~~L~~L~L~~N~l~~~~p~~l~~l~~L 254 (1103)
+++++|++|+|++|.+++..|..++++++|++|++++|++++..+..+.. .+++|++|++++|++++..|..+..+++|
T Consensus 118 ~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L 197 (680)
T 1ziw_A 118 VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRL 197 (680)
T ss_dssp TTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCBCHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEE
T ss_pred cccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccccCHHHhhccccccccEEECCCCcccccChhhhhhhhhh
Confidence 99999999999999999988888999999999999999999655554432 24679999999999998888888888888
Q ss_pred CEEeCCCccCCcccccccc---CCCCCCEEEccCCcCCCcCCccccCCCC--CCeEecccCcCccccCccccCccccccc
Q 043720 255 RTLLLFSNMLNDVIPRELG---WLRKLEVLDVSRNRLNGLIPTELGNCVE--LSVLVLSNLFDPLLSGRNIRGELSVGQS 329 (1103)
Q Consensus 255 ~~L~L~~N~l~~~~p~~l~---~l~~L~~L~Ls~N~l~~~~p~~l~~l~~--L~~L~l~~~~~~~l~~~~~~~~~~~~~~ 329 (1103)
+.|++++|.+.+.....+. ..++|+.|++++|.+++..|..+..++. |+.|++++
T Consensus 198 ~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~-------------------- 257 (680)
T 1ziw_A 198 FGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSY-------------------- 257 (680)
T ss_dssp CEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTT--------------------
T ss_pred hhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChhHhhccCcCCCCEEECCC--------------------
Confidence 8888877776543222221 2467788888888887777777777654 88888874
Q ss_pred CCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCccccc---------ccchhhhccCC
Q 043720 330 DASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG---------DLIGVFDRCKK 400 (1103)
Q Consensus 330 ~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---------~~~~~~~~l~~ 400 (1103)
|.+.+..|..++.+++|+.|++++|.+.+..|..|.++++|+.|+|++|...+ .....|..+++
T Consensus 258 -------n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i~~~~~~~l~~ 330 (680)
T 1ziw_A 258 -------NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKC 330 (680)
T ss_dssp -------SCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEECTTTTTTCTT
T ss_pred -------CCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhcccccccccccChhhcccCCC
Confidence 44455556666677777777777777777777777777777777777665442 11125666777
Q ss_pred ceEeecCCccccccccc-cccccceeEEEecCCcccccc-CCCCcccccccccccccccccccCCCchhhHHHhhhhcCc
Q 043720 401 LHFIDLSSNELSGELDV-KLQVPCMALFDVSGNHMSGSI-PRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGM 478 (1103)
Q Consensus 401 L~~LdLs~N~l~~~~~~-~~~~~~L~~l~ls~N~l~g~i-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 478 (1103)
|++|+|++|++++..+. +..+++|+.|++++|.+++.. +...+..+
T Consensus 331 L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~-------------------------------- 378 (680)
T 1ziw_A 331 LEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL-------------------------------- 378 (680)
T ss_dssp CCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGG--------------------------------
T ss_pred CCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhccc--------------------------------
Confidence 77777777777765544 335677777777777654321 11100000
Q ss_pred hhhhhcccceEEEecCCCccccccccCCCCccccccccceeeee-ccccccccCCcchhhhcccccccEEecCCCccccc
Q 043720 479 PLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLA-GANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGH 557 (1103)
Q Consensus 479 ~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ 557 (1103)
....+..+++++|++++... ..+.....+..+. ..|.+.+.+|...|..+..+ ..+++++|++.+.
T Consensus 379 -----~~~~L~~L~L~~n~l~~~~~------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L--~~L~Ls~n~l~~~ 445 (680)
T 1ziw_A 379 -----AHSPLHILNLTKNKISKIES------DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENI--FEIYLSYNKYLQL 445 (680)
T ss_dssp -----TTSCCCEEECTTSCCCEECT------TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTC--CEEECCSCSEEEC
T ss_pred -----ccCcCceEECCCCCCCeECh------hhhhCCCCCCEEeCCCCcCccccCcccccCcccc--cEEecCCCCccee
Confidence 01234455555555554211 1111112222222 23344455666666666554 5799999999866
Q ss_pred CCchhhhcCCCccEEECcCCcCC--CCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCC----
Q 043720 558 IPLDIGVMCKSLRVLDASHNQIS--GIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGI---- 631 (1103)
Q Consensus 558 ip~~~~~~~~~L~~L~L~~N~l~--~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~---- 631 (1103)
.|..+.. +++|++|++++|.++ +.+|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|++++..
T Consensus 446 ~~~~~~~-~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 524 (680)
T 1ziw_A 446 TRNSFAL-VPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHAN 524 (680)
T ss_dssp CTTTTTT-CTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCGGGGSTTS
T ss_pred Chhhhhc-CcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccccccCEEeCCCCCccccchhhc
Confidence 6666654 599999999999997 578999999999999999999999877788999999999999999998642
Q ss_pred ----CCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCC--
Q 043720 632 ----PSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPW-- 705 (1103)
Q Consensus 632 ----p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~-- 705 (1103)
+..|.++++|++|+|++|+|+.+.+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++++.+|.
T Consensus 525 ~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 604 (680)
T 1ziw_A 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604 (680)
T ss_dssp TTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHH
T ss_pred cCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHh
Confidence 23478999999999999999966566799999999999999999977777889999999999999999998876
Q ss_pred --CccccccccccCCCCCCCCCC-CCCCCC
Q 043720 706 --NVTTMNCSGVIGNPFLDPCQM-YKDISS 732 (1103)
Q Consensus 706 --~~~~~~~~~l~~Np~~c~C~~-~~~~~~ 732 (1103)
.+..+..+.+.+|||.|||++ ..+..|
T Consensus 605 ~~~~~~L~~l~l~~N~~~c~c~~~~~~~~~ 634 (680)
T 1ziw_A 605 GPAFRNLTELDMRFNPFDCTCESIAWFVNW 634 (680)
T ss_dssp HHHHTTCSEEECTTCCCCBCCCCCSSEECC
T ss_pred cccccccCEEEccCCCcccCCccHHHHHHH
Confidence 356788889999999999996 444444
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-57 Score=557.06 Aligned_cols=493 Identities=20% Similarity=0.299 Sum_probs=333.5
Q ss_pred hhhHHHHHHHHhhccCC-CC-------cccCcCCCCCCCCce---eeeEecCCCCeEEEEecCCCCCCCCCCcccccccc
Q 043720 5 LPEKTILLEFKNSVSDP-SG-------ILSSWQTNTSSHCSW---FGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMT 73 (1103)
Q Consensus 5 ~~~~~aLl~~k~~~~d~-~~-------~l~sW~~~~~~~C~W---~GV~C~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~ 73 (1103)
.+|++||.+||.++.++ +. ..++|+.+ .|||.| .||+|+..+||+++++.+.
T Consensus 29 ~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~-~~~c~w~~~~GV~C~~~~~V~~L~L~~~---------------- 91 (636)
T 4eco_A 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFN-KELDMWGAQPGVSLNSNGRVTGLSLEGF---------------- 91 (636)
T ss_dssp HHHHHHHHHHHHHTTGGGCCCCC------CCCCCS-SCGGGTTCCTTEEECTTCCEEEEECTTS----------------
T ss_pred HHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCC-CCcccccCCCCeEEcCCCCEEEEEecCc----------------
Confidence 46999999999998544 22 34589875 589999 9999998899999998764
Q ss_pred ccccccccccccceeccCCCccccccCcccCCCCCCCEEEccCCCC------cc------cCCccccCCCCCCEEEeecC
Q 043720 74 AQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGF------SG------EFPPEIWSLEKLEVLDVEGN 141 (1103)
Q Consensus 74 ~~~~~~~~~~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~n~l------~g------~~p~~l~~l~~L~~L~Ls~n 141 (1103)
.+.|.+|+++++|++|++|+|++|.+ .| .+|... +..|+ ++++.|
T Consensus 92 --------------------~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~ 148 (636)
T 4eco_A 92 --------------------GASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKT 148 (636)
T ss_dssp --------------------CCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHH
T ss_pred --------------------ccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHh
Confidence 35689999999999999999999976 33 555544 56677 888888
Q ss_pred CCCCCccccccCC-CCCCEEEccccccCCCCCCCCCCCCCCCEEEcc--CCcCCCCCChhcccCCCCcEeecccccCCCC
Q 043720 142 FLSGRLPNEFVGL-RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA--GNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218 (1103)
Q Consensus 142 ~l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~--~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ 218 (1103)
.+.+.+|..+..+ ..+..+++....+. ......++.+++. +|+++| +|..++++++|++|+|++|+++|.
T Consensus 149 ~l~~~~~~~~~~~~~~l~~~~l~~~~~~------~~~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~ 221 (636)
T 4eco_A 149 FVDYDPREDFSDLIKDCINSDPQQKSIK------KSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAE 221 (636)
T ss_dssp HTCCCGGGGSCHHHHHHHHHCTTSCCCC------CCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGG
T ss_pred hhccCchhhHHHHHHHHhhcCccccccc------cccccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccc
Confidence 8888888777632 33333333322222 1111222323232 456666 666666666666666666666654
Q ss_pred -----------------CChhHH--hhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCcc-CCc-cccccccCC--
Q 043720 219 -----------------IPSELG--KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM-LND-VIPRELGWL-- 275 (1103)
Q Consensus 219 -----------------ip~~~~--~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~-l~~-~~p~~l~~l-- 275 (1103)
+|..++ . +++|++|+|++|++.+.+|..++++++|++|++++|+ +++ .+|..++.+
T Consensus 222 ~~~~~~~~~~~~~~~~~ip~~l~~~~-l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~ 300 (636)
T 4eco_A 222 NICEAWENENSEYAQQYKTEDLKWDN-LKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALAD 300 (636)
T ss_dssp GBSSSCSCTTSHHHHHHTTSCCCGGG-CTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHH
T ss_pred cccccccccccchhcccCchhhhhcc-cCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhc
Confidence 666665 4 3557777777777666677777777777777777776 666 666666655
Q ss_pred ----CCCCEEEccCCcCCCcCCc--cccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhc
Q 043720 276 ----RKLEVLDVSRNRLNGLIPT--ELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITT 349 (1103)
Q Consensus 276 ----~~L~~L~Ls~N~l~~~~p~--~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~ 349 (1103)
++|+.|+|++|+++ .+|. .++++++|+.|++++ |.+.|.+| .++.
T Consensus 301 ~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~---------------------------N~l~g~ip-~~~~ 351 (636)
T 4eco_A 301 APVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLY---------------------------NQLEGKLP-AFGS 351 (636)
T ss_dssp SGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCS---------------------------CCCEEECC-CCEE
T ss_pred cccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcC---------------------------CcCccchh-hhCC
Confidence 67777777777777 6666 677777777777763 55666677 6777
Q ss_pred cccccccccCCccccccCCcccccccc-CcEEEcCCcccccccchhhhccC--CceEeecCCccccccccccc-------
Q 043720 350 LSKLRIIWAPRLNLEGKLPSSWGACES-LEMLNLAQNVLRGDLIGVFDRCK--KLHFIDLSSNELSGELDVKL------- 419 (1103)
Q Consensus 350 L~~L~~L~l~~n~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~~~~~~~l~--~L~~LdLs~N~l~~~~~~~~------- 419 (1103)
+++|+.|++++|.+. .+|..+..+++ |++|+|++|+++ .+|..+..++ +|++|+|++|++++.+|...
T Consensus 352 l~~L~~L~L~~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~ 429 (636)
T 4eco_A 352 EIKLASLNLAYNQIT-EIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTP 429 (636)
T ss_dssp EEEESEEECCSSEEE-ECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSC
T ss_pred CCCCCEEECCCCccc-cccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcchhhhccccccc
Confidence 777777777777777 67777888887 888888888887 5566666544 78888888887776543221
Q ss_pred -cccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCcc
Q 043720 420 -QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNF 498 (1103)
Q Consensus 420 -~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~ 498 (1103)
.+++|+
T Consensus 430 ~~~~~L~------------------------------------------------------------------------- 436 (636)
T 4eco_A 430 FKGINVS------------------------------------------------------------------------- 436 (636)
T ss_dssp CCCCCEE-------------------------------------------------------------------------
T ss_pred ccCCCCC-------------------------------------------------------------------------
Confidence 112222
Q ss_pred ccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCc
Q 043720 499 TGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQ 578 (1103)
Q Consensus 499 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~ 578 (1103)
.|++++|++. .+|..++..+++|++|+|++|+
T Consensus 437 -----------------------------------------------~L~Ls~N~l~-~lp~~~~~~l~~L~~L~Ls~N~ 468 (636)
T 4eco_A 437 -----------------------------------------------SINLSNNQIS-KFPKELFSTGSPLSSINLMGNM 468 (636)
T ss_dssp -----------------------------------------------EEECCSSCCC-SCCTHHHHTTCCCSEEECCSSC
T ss_pred -----------------------------------------------EEECcCCccC-cCCHHHHccCCCCCEEECCCCC
Confidence 3445555554 4555555444666666666666
Q ss_pred CCCCCcccccCCC-------CCCEEEccCCcCCCCCCcccc--cCccCcEEeccCcccCCCCCCcccCCCCCcEEec---
Q 043720 579 ISGIVPQSLENLT-------SLVFLDLNGNKLQGEIPSSLH--RLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL--- 646 (1103)
Q Consensus 579 l~~~~p~~~~~l~-------~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L--- 646 (1103)
|+.+.+..+.... +|++|+|++|+|+ .+|..+. .+++|+.|+|++|++++ +|..+..+++|++|+|
T Consensus 469 l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N 546 (636)
T 4eco_A 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLT-KLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ 546 (636)
T ss_dssp CSBCCSSSSEETTEECTTGGGCCEEECCSSCCC-BCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSC
T ss_pred CCCcCHHHhccccccccccCCccEEECcCCcCC-ccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCC
Confidence 6633333333222 6777777777776 5666665 67777777777777775 6666677777777777
Q ss_pred ---cCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCC
Q 043720 647 ---SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702 (1103)
Q Consensus 647 ---s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~ 702 (1103)
++|++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+.||+++|++...
T Consensus 547 ~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~ip~~~~--~~L~~L~Ls~N~l~~~ 602 (636)
T 4eco_A 547 RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDIKDNPNISI 602 (636)
T ss_dssp BCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--TTCCEEECCSCTTCEE
T ss_pred cccccCcccccChHHHhcCCCCCEEECCCCcC-CccCHhHh--CcCCEEECcCCCCccc
Confidence 56777778888888888888888888888 46777655 7888888888877643
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=553.87 Aligned_cols=498 Identities=22% Similarity=0.231 Sum_probs=367.0
Q ss_pred cCcccCCCCCCCEEEccCCCCcccC-CccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCC--C
Q 043720 99 LSPLVGGLSELRVLSLPFNGFSGEF-PPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFS--L 175 (1103)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~n~l~g~~-p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~--l 175 (1103)
.+..++++++|++|+|++|.+.+.+ |..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++.+|.. +
T Consensus 40 ~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 119 (844)
T 3j0a_A 40 TASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYF 119 (844)
T ss_dssp CSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSCSCSSCCCEECTTCCCSSCCSTTCCC
T ss_pred ChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHccCCcccCEeeCcCCCCCcccccCccc
Confidence 3455666677777777766555555 556666777777777777776666666777777777777777776655544 6
Q ss_pred CCCCCCCEEEccCCcCCCCCC-hhcccCCCCcEeecccccCCCCCChhHHhhc-CcCcEEECcCCccccccCccccCCCC
Q 043720 176 RNFESLEVLNLAGNQVKGVIP-GFLGSFLKLRVLFLSYNELNGSIPSELGKYC-RYLEHLDLSGNSLVGRIPSSLGKCQQ 253 (1103)
Q Consensus 176 ~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~-~~L~~L~L~~N~l~~~~p~~l~~l~~ 253 (1103)
+++++|++|+|++|.+++..+ ..|+++++|++|+|++|.+++..|..+.... ++|+.|++++|.+++..|..++.+++
T Consensus 120 ~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 199 (844)
T 3j0a_A 120 RNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199 (844)
T ss_dssp SSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHCSSCCCEECCSBSCCCCCCCCCSSSC
T ss_pred cccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCCccceEECCCCccccccccchhhcCC
Confidence 667777777777777665544 4566677777777777776655565554421 45677777777776666666555554
Q ss_pred ------CCEEeCCCccCCccccccccCC---CCCCEEEccC---------CcCCCcCCccccCC--CCCCeEecccCcCc
Q 043720 254 ------LRTLLLFSNMLNDVIPRELGWL---RKLEVLDVSR---------NRLNGLIPTELGNC--VELSVLVLSNLFDP 313 (1103)
Q Consensus 254 ------L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~Ls~---------N~l~~~~p~~l~~l--~~L~~L~l~~~~~~ 313 (1103)
|+.|++++|.+++..+..+... .+++.|+++. |.+.+..+..+..+ ++|+.|++++
T Consensus 200 ~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~---- 275 (844)
T 3j0a_A 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSH---- 275 (844)
T ss_dssp TTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSSTTGGGTTTTTTTTSCCCEEECTT----
T ss_pred ccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccccccccccCCCChhhhhccccCCccEEECCC----
Confidence 6777777776666655555432 4556666552 22333333334433 5677777774
Q ss_pred cccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccch
Q 043720 314 LLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIG 393 (1103)
Q Consensus 314 ~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 393 (1103)
|.+.+..|..+..+++|+.|++++|.+.+..|..|.++++|++|+|++|++++..+.
T Consensus 276 -----------------------n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 332 (844)
T 3j0a_A 276 -----------------------GFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332 (844)
T ss_dssp -----------------------CCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred -----------------------CcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence 566667788889999999999999999999999999999999999999999999999
Q ss_pred hhhccCCceEeecCCccccccccc-cccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHh
Q 043720 394 VFDRCKKLHFIDLSSNELSGELDV-KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMS 472 (1103)
Q Consensus 394 ~~~~l~~L~~LdLs~N~l~~~~~~-~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (1103)
.|.++++|+.|+|++|++++..+. +..+++|+.|++++|++++ ++.
T Consensus 333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~-i~~-------------------------------- 379 (844)
T 3j0a_A 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTT-IHF-------------------------------- 379 (844)
T ss_dssp SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCC-CSS--------------------------------
T ss_pred HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCc-ccC--------------------------------
Confidence 999999999999999999876654 4578999999999998873 111
Q ss_pred hhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCC
Q 043720 473 KARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNN 552 (1103)
Q Consensus 473 ~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n 552 (1103)
+..+ ..+++++|
T Consensus 380 ------------~~~L--------------------------------------------------------~~L~l~~N 391 (844)
T 3j0a_A 380 ------------IPSI--------------------------------------------------------PDIFLSGN 391 (844)
T ss_dssp ------------CCSC--------------------------------------------------------SEEEEESC
T ss_pred ------------CCCc--------------------------------------------------------chhccCCC
Confidence 0011 23556666
Q ss_pred cccccCCchhhhcCCCccEEECcCCcCCCCC-cccccCCCCCCEEEccCCcCCCCCCc-ccccCccCcEEeccCcccC--
Q 043720 553 NIIGHIPLDIGVMCKSLRVLDASHNQISGIV-PQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLT-- 628 (1103)
Q Consensus 553 ~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~-- 628 (1103)
++. .+|.. ..+++.|++++|++++.. +..+.++++|+.|+|++|++++..+. .+..+++|+.|+|++|.++
T Consensus 392 ~l~-~l~~~----~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~ 466 (844)
T 3j0a_A 392 KLV-TLPKI----NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLA 466 (844)
T ss_dssp CCC-CCCCC----CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSS
T ss_pred Ccc-ccccc----ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccc
Confidence 665 45543 256888999999998642 23456889999999999999865433 4566889999999999987
Q ss_pred ---CCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCC
Q 043720 629 ---GGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPW 705 (1103)
Q Consensus 629 ---~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~ 705 (1103)
+..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..+. ++|+.||+++|+|++.+|.
T Consensus 467 ~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~ 544 (844)
T 3j0a_A 467 WETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPD 544 (844)
T ss_dssp CCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSC
T ss_pred cccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChh
Confidence 44556788899999999999999988888899999999999999999977776665 8899999999999999999
Q ss_pred CccccccccccCCCCCCCCCCCCCCC
Q 043720 706 NVTTMNCSGVIGNPFLDPCQMYKDIS 731 (1103)
Q Consensus 706 ~~~~~~~~~l~~Np~~c~C~~~~~~~ 731 (1103)
.+..+..+.+.+|||.|+|++..+..
T Consensus 545 ~~~~L~~l~l~~Np~~C~c~~~~f~~ 570 (844)
T 3j0a_A 545 VFVSLSVLDITHNKFICECELSTFIN 570 (844)
T ss_dssp CCSSCCEEEEEEECCCCSSSCCSHHH
T ss_pred HhCCcCEEEecCCCcccccccHHHHH
Confidence 88888999999999999999865443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-55 Score=544.57 Aligned_cols=482 Identities=18% Similarity=0.207 Sum_probs=314.7
Q ss_pred ChhhHHHHHHHHhhccCCCCcccCcCCCC----CCC--Cce------------eeeEecCCCCeEEEEecCCCCCCCCCC
Q 043720 4 VLPEKTILLEFKNSVSDPSGILSSWQTNT----SSH--CSW------------FGVSCDSESRVVALNITGGDVSEGNSK 65 (1103)
Q Consensus 4 ~~~~~~aLl~~k~~~~d~~~~l~sW~~~~----~~~--C~W------------~GV~C~~~~~v~~l~l~~~~~~~~~~~ 65 (1103)
..+|++||++||+++.|| +|+.++ .+| |+| .||+|+..+||++|++++.
T Consensus 267 ~~~d~~ALl~~k~~l~~~-----~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~-------- 333 (876)
T 4ecn_A 267 YIKDYKALKAIWEALDGK-----NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF-------- 333 (876)
T ss_dssp HHHHHHHHHHHHHHTTGG-----GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTT--------
T ss_pred chHHHHHHHHHHHHcCCC-----CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccC--------
Confidence 457999999999999887 886554 345 999 9999998899999999764
Q ss_pred ccccccccccccccccccccceeccCCCccccccCcccCCCCCCCEEEc-cCCCCcccCCcccc----------------
Q 043720 66 PFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSL-PFNGFSGEFPPEIW---------------- 128 (1103)
Q Consensus 66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L-~~n~l~g~~p~~l~---------------- 128 (1103)
.+.|.+|+.+++|++|++|+| ++|.++|..|-...
T Consensus 334 ----------------------------~L~G~ip~~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~ 385 (876)
T 4ecn_A 334 ----------------------------GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRM 385 (876)
T ss_dssp ----------------------------CCEEEECGGGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHT
T ss_pred ----------------------------CCCCcCchHHhccccceEeeecccccccccccccccccccccchhHHHHHHH
Confidence 456899999999999999999 88988887553211
Q ss_pred -----------------------------------CCCCCCEEEee--cCCCCCCccccccCCCCCCEEEccccccCC--
Q 043720 129 -----------------------------------SLEKLEVLDVE--GNFLSGRLPNEFVGLRNLRVLNLAFNRIDG-- 169 (1103)
Q Consensus 129 -----------------------------------~l~~L~~L~Ls--~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-- 169 (1103)
....++.+.+. .|+++| +|..|+++++|++|+|++|+|+|
T Consensus 386 ~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~l~l~~l~l~~~~N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~ 464 (876)
T 4ecn_A 386 HYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDN 464 (876)
T ss_dssp HHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGG
T ss_pred hhhhhhhccCcchhhhHHHHHHhhhCccccccccccccchhhceeccccCcccc-hhHHHhcCCCCCEEECcCCcCCCCc
Confidence 11122333333 377776 88888888888888888888887
Q ss_pred ---------------CCCCCCC--CCCCCCEEEccCCcCCCCCChhcccCCCCcEeeccccc-CCC-CCChhHHhhc---
Q 043720 170 ---------------DIPFSLR--NFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE-LNG-SIPSELGKYC--- 227 (1103)
Q Consensus 170 ---------------~~p~~l~--~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~g-~ip~~~~~~~--- 227 (1103)
.+|..++ ++++|++|+|++|.+.+.+|..|+++++|++|+|++|+ ++| .+|..++.+.
T Consensus 465 i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~ 544 (876)
T 4ecn_A 465 IAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544 (876)
T ss_dssp BSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCT
T ss_pred ccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcc
Confidence 3788877 88888888888888888888888888888888888887 877 7887776642
Q ss_pred ---CcCcEEECcCCccccccCc--cccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCC-
Q 043720 228 ---RYLEHLDLSGNSLVGRIPS--SLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVE- 301 (1103)
Q Consensus 228 ---~~L~~L~L~~N~l~~~~p~--~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~- 301 (1103)
++|++|+|++|+++ .+|. .++++++|+.|+|++|.++ .+| .|+.+++|+.|+|++|+++ .+|..+.++++
T Consensus 545 ~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~ 620 (876)
T 4ecn_A 545 DTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQ 620 (876)
T ss_dssp TTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTT
T ss_pred cccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhcccc
Confidence 36777777777777 6776 7777777777777777777 466 6777777777777777777 66766777776
Q ss_pred CCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhcccc--ccccccCCccccccCCccc---c--cc
Q 043720 302 LSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSK--LRIIWAPRLNLEGKLPSSW---G--AC 374 (1103)
Q Consensus 302 L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~--L~~L~l~~n~l~~~~p~~~---~--~l 374 (1103)
|+.|++++ |.+. .+|..+..++. |+.|++++|.+.+.+|... . .+
T Consensus 621 L~~L~Ls~---------------------------N~L~-~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~ 672 (876)
T 4ecn_A 621 VEGLGFSH---------------------------NKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKG 672 (876)
T ss_dssp CCEEECCS---------------------------SCCC-SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCC
T ss_pred CCEEECcC---------------------------CCCC-cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccC
Confidence 77777764 2222 34444444332 5555555555555443211 1 12
Q ss_pred ccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEecCCccccccCCCCcccccccccccc
Q 043720 375 ESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSS 454 (1103)
Q Consensus 375 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~ 454 (1103)
++|+.|+|++|+++..+...+..+++ |+.|++++|+++ .+|......
T Consensus 673 ~~L~~L~Ls~N~L~~lp~~~~~~l~~-----------------------L~~L~Ls~N~L~-~ip~~~~~~--------- 719 (876)
T 4ecn_A 673 INASTVTLSYNEIQKFPTELFATGSP-----------------------ISTIILSNNLMT-SIPENSLKP--------- 719 (876)
T ss_dssp CCEEEEECCSSCCCSCCHHHHHTTCC-----------------------CSEEECCSCCCS-CCCTTSSSC---------
T ss_pred CCcCEEEccCCcCCccCHHHHccCCC-----------------------CCEEECCCCcCC-ccChHHhcc---------
Confidence 24445555555554333333344444 445555555444 333211000
Q ss_pred cccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcc
Q 043720 455 DLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGS 534 (1103)
Q Consensus 455 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~ 534 (1103)
. + .
T Consensus 720 ----------------------------------------------~------------------------------~-~ 722 (876)
T 4ecn_A 720 ----------------------------------------------K------------------------------D-G 722 (876)
T ss_dssp ----------------------------------------------T------------------------------T-S
T ss_pred ----------------------------------------------c------------------------------c-c
Confidence 0 0 0
Q ss_pred hhhhcccccccEEecCCCcccccCCchhh-hcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccC------CcCCCCC
Q 043720 535 LFQACNEFHGMVANLSNNNIIGHIPLDIG-VMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNG------NKLQGEI 607 (1103)
Q Consensus 535 ~~~~~~~~~~~~l~ls~n~~~~~ip~~~~-~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~------N~l~~~~ 607 (1103)
.+.+|. .+..|+|++|+++ .+|..++ ..+++|+.|+|++|+|++ +|..+.++++|+.|+|++ |++.+.+
T Consensus 723 ~l~nl~--~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~i 798 (876)
T 4ecn_A 723 NYKNTY--LLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQW 798 (876)
T ss_dssp CCTTGG--GCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCC
T ss_pred cccccC--CccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccC
Confidence 000000 1234566666665 5666655 223677777777777775 566677777777777765 5566666
Q ss_pred CcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCc
Q 043720 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676 (1103)
Q Consensus 608 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 676 (1103)
|..|..+++|+.|+|++|++ +.+|..+. ++|+.|||++|++....+..+.....+..+.|.+|++.
T Consensus 799 p~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~~~~L~~n~~~ 864 (876)
T 4ecn_A 799 PTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864 (876)
T ss_dssp CTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTTCCEEECCTTS
T ss_pred hHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccchheeecCCCcc
Confidence 66666666666666666666 35665554 46666666666666555555555555566666666554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-54 Score=530.05 Aligned_cols=526 Identities=18% Similarity=0.150 Sum_probs=421.0
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 78999999999999888889999999999999999999888889999999999999999999888999999999999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCC-CCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC----EEeCCC
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR----TLLLFS 261 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g-~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L~~ 261 (1103)
++|++++..+..++++++|++|++++|++++ .+|..+.. +++|++|++++|++++..+..++.+++|+ +|++++
T Consensus 112 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~-l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~ 190 (606)
T 3vq2_A 112 VETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN-LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190 (606)
T ss_dssp TTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGT-CTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTT
T ss_pred cCCccccccccccCCCCCCCEEeCCCCcccceechHhHhh-cCCCCEEEccCCcceecChhhhhhhhccccccceeeccC
Confidence 9999998887889999999999999999985 57888876 48899999999999988888888877665 899999
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCC-CcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCccc
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLN-GLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFI 340 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~ 340 (1103)
|.+++..+..+... +|+.|++++|.++ +.+|..+.++++|+.+++..+...... . ...+.
T Consensus 191 n~l~~~~~~~~~~~-~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~--------~----------l~~~~ 251 (606)
T 3vq2_A 191 NPIDFIQDQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER--------N----------LEIFE 251 (606)
T ss_dssp CCCCEECTTTTTTC-EEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSC--------C----------CSCCC
T ss_pred CCcceeCcccccCc-eeeeeeccCCccchhHHHHHhccccccccccccccccccCC--------c----------ccccC
Confidence 99998666665554 8999999999997 467888999999999888632111000 0 01111
Q ss_pred ccCchhhhcccccccccc-CCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccc
Q 043720 341 GSIPMEITTLSKLRIIWA-PRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL 419 (1103)
Q Consensus 341 ~~ip~~~~~L~~L~~L~l-~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~ 419 (1103)
...+..+..+ +++.+++ ..+.+.+.+|. +..+++|+.|++++|.+.... .+..+++|+.|++++|++ +.+|..
T Consensus 252 ~~~~~~l~~l-~l~~l~l~~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~l~--~l~~~~~L~~L~l~~n~l-~~lp~~- 325 (606)
T 3vq2_A 252 PSIMEGLCDV-TIDEFRLTYTNDFSDDIVK-FHCLANVSAMSLAGVSIKYLE--DVPKHFKWQSLSIIRCQL-KQFPTL- 325 (606)
T ss_dssp GGGGTTGGGS-EEEEEEECCCTTCCGGGGS-CGGGTTCSEEEEESCCCCCCC--CCCTTCCCSEEEEESCCC-SSCCCC-
T ss_pred hHHhhhhhhc-cHhheeccccccccccccc-cccCCCCCEEEecCccchhhh--hccccccCCEEEcccccC-cccccC-
Confidence 2223333333 3555555 56667777766 777888888888888876543 677777888888888887 556655
Q ss_pred cccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccc
Q 043720 420 QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFT 499 (1103)
Q Consensus 420 ~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~ 499 (1103)
.+++|+.|++++|+..+.++ +..++.|..+++++|+++
T Consensus 326 ~l~~L~~L~l~~n~~~~~~~------------------------------------------~~~l~~L~~L~ls~n~l~ 363 (606)
T 3vq2_A 326 DLPFLKSLTLTMNKGSISFK------------------------------------------KVALPSLSYLDLSRNALS 363 (606)
T ss_dssp CCSSCCEEEEESCSSCEECC------------------------------------------CCCCTTCCEEECCSSCEE
T ss_pred CCCccceeeccCCcCccchh------------------------------------------hccCCCCCEEECcCCccC
Confidence 77778888888876554332 112345667777777776
Q ss_pred cccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcC
Q 043720 500 GPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQI 579 (1103)
Q Consensus 500 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l 579 (1103)
+..+ +|. .+..+. ....+++++|.+. .+|..+..+ ++|++|++++|++
T Consensus 364 ~~~~---------------------------~~~-~~~~~~--~L~~L~L~~n~l~-~~~~~~~~l-~~L~~L~l~~n~l 411 (606)
T 3vq2_A 364 FSGC---------------------------CSY-SDLGTN--SLRHLDLSFNGAI-IMSANFMGL-EELQHLDFQHSTL 411 (606)
T ss_dssp EEEE---------------------------CCH-HHHCCS--CCCEEECCSCSEE-EECCCCTTC-TTCCEEECTTSEE
T ss_pred CCcc---------------------------hhh-hhccCC--cccEeECCCCccc-cchhhccCC-CCCCeeECCCCcc
Confidence 5210 011 112222 2457899999987 477666654 8999999999999
Q ss_pred CCCCc-ccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCC-CCCCcccCCCCCcEEeccCccccCcChh
Q 043720 580 SGIVP-QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG-GIPSSIGELRSLEVLELSSNSLSGEVPE 657 (1103)
Q Consensus 580 ~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 657 (1103)
++..| ..|.++++|++|++++|.+++..|..+..+++|++|+|++|++++ .+|..|+.+++|++|+|++|++++..|.
T Consensus 412 ~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 491 (606)
T 3vq2_A 412 KRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491 (606)
T ss_dssp ESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred CCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChh
Confidence 98877 789999999999999999998899999999999999999999997 4788999999999999999999988899
Q ss_pred hhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCC--Ccc-ccccccccCCCCCCCCCCCCCCCC
Q 043720 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPW--NVT-TMNCSGVIGNPFLDPCQMYKDISS 732 (1103)
Q Consensus 658 ~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~--~~~-~~~~~~l~~Np~~c~C~~~~~~~~ 732 (1103)
.+..+++|+.|+|++|++++.+|..+..+++|+.|++++|+++..++. .+. .+..+.+.+|||.|+|++..+..|
T Consensus 492 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~c~~~~~~~~ 569 (606)
T 3vq2_A 492 VFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACICEHQKFLQW 569 (606)
T ss_dssp TTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCSSTTHHHHTT
T ss_pred hhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccCCccHHHHHH
Confidence 999999999999999999988899999999999999999999965544 222 367778999999999998665544
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=529.97 Aligned_cols=528 Identities=17% Similarity=0.138 Sum_probs=429.1
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
.+++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..++++++|++|+++
T Consensus 34 ~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~ 113 (606)
T 3t6q_A 34 STECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFI 113 (606)
T ss_dssp TCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECT
T ss_pred cCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeecc
Confidence 68999999999998889999999999999999999998889999999999999999999998889999999999999999
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC--EEeCCCccCC
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR--TLLLFSNMLN 265 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~--~L~L~~N~l~ 265 (1103)
+|++++..+..++++++|++|++++|++++..++.+.. +++|++|++++|++++..|..++.+++|+ .|++++|.++
T Consensus 114 ~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~l~L~l~~n~l~ 192 (606)
T 3t6q_A 114 QTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFP-TEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192 (606)
T ss_dssp TSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCC-CTTCCEEECCSSCCCEECHHHHHTTTTCCSEEEECTTCCCC
T ss_pred ccCcccCCcchhccCCcccEEECCCCcccccCcccccC-CcccCEEEcccCcccccChhhhhhhcccceeEEecCCCccC
Confidence 99999877888999999999999999999532233333 68899999999999988888899999999 8999999999
Q ss_pred ccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCch
Q 043720 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM 345 (1103)
Q Consensus 266 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~ 345 (1103)
+..|..+.. .+|+.|++++|. .++..+..+.++....+.-..... .....+....+.
T Consensus 193 ~~~~~~~~~-~~L~~L~l~~~~---~~~~~~~~l~~~~l~~l~~~~~~~-------------------~~~~~i~~~~~~ 249 (606)
T 3t6q_A 193 GIEPGAFDS-AVFQSLNFGGTQ---NLLVIFKGLKNSTIQSLWLGTFED-------------------MDDEDISPAVFE 249 (606)
T ss_dssp EECTTTTTT-CEEEEEECTTCS---CHHHHHHHTTTCEEEEEECCCCTT-------------------SCCCCCCGGGGG
T ss_pred ccChhHhhh-ccccccccCCch---hHHHHhhhccccchhheechhhcc-------------------ccccccChhHhc
Confidence 977766654 689999999987 345566666665544443111000 001112222222
Q ss_pred hhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCcccccccc-ccccccce
Q 043720 346 EITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELD-VKLQVPCM 424 (1103)
Q Consensus 346 ~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~-~~~~~~~L 424 (1103)
.+..+ +|+.|++++|.+.+..+..|..+++|++|+|++|+++ .+|..+.++++|++|+|++|++++..+ .+..+++|
T Consensus 250 ~l~~~-~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L 327 (606)
T 3t6q_A 250 GLCEM-SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSL 327 (606)
T ss_dssp GGGGS-EEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTC
T ss_pred hhhcC-ceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcC
Confidence 22222 6888899999998888888999999999999999988 566678888999999999999887765 44578889
Q ss_pred eEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCcccccccc
Q 043720 425 ALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICW 504 (1103)
Q Consensus 425 ~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~ 504 (1103)
+.|++++|++.+.+|.. .+..++.|..+++++|++++..+.
T Consensus 328 ~~L~l~~n~~~~~~~~~---------------------------------------~~~~l~~L~~L~l~~n~l~~~~~~ 368 (606)
T 3t6q_A 328 THLSIKGNTKRLELGTG---------------------------------------CLENLENLRELDLSHDDIETSDCC 368 (606)
T ss_dssp SEEECCSCSSCCBCCSS---------------------------------------TTTTCTTCCEEECCSSCCCEEEES
T ss_pred CEEECCCCCcccccchh---------------------------------------hhhccCcCCEEECCCCccccccCc
Confidence 99999999888776642 123455677888888888753210
Q ss_pred CCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCc
Q 043720 505 LPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584 (1103)
Q Consensus 505 ~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p 584 (1103)
|. .+..+. ....+++++|++.+..|..+... ++|++|++++|++++..+
T Consensus 369 ---------------------------~~-~~~~l~--~L~~L~l~~n~l~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~ 417 (606)
T 3t6q_A 369 ---------------------------NL-QLRNLS--HLQSLNLSYNEPLSLKTEAFKEC-PQLELLDLAFTRLKVKDA 417 (606)
T ss_dssp ---------------------------TT-TTTTCT--TCCEEECCSCSCEEECTTTTTTC-TTCSEEECTTCCEECCTT
T ss_pred ---------------------------ch-hcccCC--CCCEEECCCCcCCcCCHHHhcCC-ccCCeEECCCCcCCCccc
Confidence 00 011122 34578999999997777777655 899999999999997765
Q ss_pred c-cccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCC---CCCcccCCCCCcEEeccCccccCcChhhhh
Q 043720 585 Q-SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGG---IPSSIGELRSLEVLELSSNSLSGEVPEGVV 660 (1103)
Q Consensus 585 ~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~---~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 660 (1103)
. .|..+++|++|++++|.+++..|..+..+++|++|+|++|++++. .+..+..+++|++|+|++|++++..|..+.
T Consensus 418 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~ 497 (606)
T 3t6q_A 418 QSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497 (606)
T ss_dssp CCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTT
T ss_pred chhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhc
Confidence 4 489999999999999999988899999999999999999999862 346789999999999999999988899999
Q ss_pred hcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCC---ccccccccccCCCCCCCCCCCCCCCC
Q 043720 661 NLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWN---VTTMNCSGVIGNPFLDPCQMYKDISS 732 (1103)
Q Consensus 661 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~---~~~~~~~~l~~Np~~c~C~~~~~~~~ 732 (1103)
.+++|+.|+|++|++++..|..+..++.| .|++++|++++.+|.. +..+..+++.+|||.|+|++..+..|
T Consensus 498 ~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~w 571 (606)
T 3t6q_A 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEW 571 (606)
T ss_dssp TCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTTCCEECSGGGHHHHHH
T ss_pred cccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCCCCccccCCcHHHHHH
Confidence 99999999999999999999999999999 9999999999988864 44667788999999999997654443
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-52 Score=518.17 Aligned_cols=549 Identities=19% Similarity=0.144 Sum_probs=440.4
Q ss_pred cccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCC
Q 043720 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLR 176 (1103)
Q Consensus 97 g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 176 (1103)
..+|..+. +++++|+|++|.+++..|..++++++|++|||++|.+++..|..|+++++|++|+|++|++++..+..|+
T Consensus 17 ~~ip~~~~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~ 94 (680)
T 1ziw_A 17 TQVPDDLP--TNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFA 94 (680)
T ss_dssp SSCCSCSC--TTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccccccC--CCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhc
Confidence 45776654 7899999999999877777889999999999999999988888899999999999999999854445788
Q ss_pred CCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCcccc--CCCCC
Q 043720 177 NFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLG--KCQQL 254 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~--~l~~L 254 (1103)
++++|++|+|++|++++..|..|+++++|++|++++|.+++..|..+.. +++|++|++++|++++..+..++ .+++|
T Consensus 95 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L 173 (680)
T 1ziw_A 95 FCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQ-LENLQELLLSNNKIQALKSEELDIFANSSL 173 (680)
T ss_dssp TCTTCSEEECCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSC-CTTCCEEECCSSCCCCBCHHHHGGGTTCEE
T ss_pred cCCCCCEEECCCCccCccChhHccccCCCCEEECCCCcccccCchhhcc-cccCCEEEccCCcccccCHHHhhccccccc
Confidence 9999999999999998777788899999999999999998666665554 57899999999999876666554 45889
Q ss_pred CEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCcccc---CCCCCCeEecccCcCccccCccccCcccccccCC
Q 043720 255 RTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELG---NCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDA 331 (1103)
Q Consensus 255 ~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~---~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~ 331 (1103)
+.|++++|.+++..|..+..+.+|+.|++++|.+.+.....+. ..++|+.|++++
T Consensus 174 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~---------------------- 231 (680)
T 1ziw_A 174 KKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSN---------------------- 231 (680)
T ss_dssp SEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTT----------------------
T ss_pred cEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccC----------------------
Confidence 9999999999988888888899999999998887643322221 347888888875
Q ss_pred CCCCCCcccccCchhhhcccc--ccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCc
Q 043720 332 SNGEKNSFIGSIPMEITTLSK--LRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSN 409 (1103)
Q Consensus 332 ~~~~~n~~~~~ip~~~~~L~~--L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N 409 (1103)
|.+.+..|..+..++. |+.|++++|.+.+..|..|+.+++|++|+|++|++.+..+..|.++++|+.|+|++|
T Consensus 232 -----n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~ 306 (680)
T 1ziw_A 232 -----SQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS 306 (680)
T ss_dssp -----SCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTC
T ss_pred -----CcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccch
Confidence 6677777888888865 999999999999999999999999999999999999999999999999999999988
Q ss_pred ccccc-----cc-----ccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCch
Q 043720 410 ELSGE-----LD-----VKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMP 479 (1103)
Q Consensus 410 ~l~~~-----~~-----~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (1103)
...+. +| .+..+++|+.|++++|++++..|..
T Consensus 307 ~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~-------------------------------------- 348 (680)
T 1ziw_A 307 FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNM-------------------------------------- 348 (680)
T ss_dssp BCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTT--------------------------------------
T ss_pred hhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhH--------------------------------------
Confidence 76542 23 3446789999999999998754431
Q ss_pred hhhhcccceEEEecCCCccccccccCCCCccccccccceeeeec-cccccccCCcchhhhcccccccEEecCCCcccccC
Q 043720 480 LLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAG-ANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHI 558 (1103)
Q Consensus 480 ~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~i 558 (1103)
+..+..|+.+++++|.+++....-... ..+ .......+.. .|++.+..| ..|..+.. ...|++++|.+.+.+
T Consensus 349 --~~~l~~L~~L~Ls~n~~~~~~l~~~~f-~~~-~~~~L~~L~L~~n~l~~~~~-~~~~~l~~--L~~L~L~~N~l~~~~ 421 (680)
T 1ziw_A 349 --FTGLINLKYLSLSNSFTSLRTLTNETF-VSL-AHSPLHILNLTKNKISKIES-DAFSWLGH--LEVLDLGLNEIGQEL 421 (680)
T ss_dssp --TTTCTTCCEEECTTCBSCCCEECTTTT-GGG-TTSCCCEEECTTSCCCEECT-TTTTTCTT--CCEEECCSSCCEEEC
T ss_pred --hccccCCcEEECCCCchhhhhcchhhh-ccc-ccCcCceEECCCCCCCeECh-hhhhCCCC--CCEEeCCCCcCcccc
Confidence 334566788899998865422110000 000 0112333333 344444444 44554544 458999999999989
Q ss_pred CchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCC--CCCCcccccCccCcEEeccCcccCCCCCCccc
Q 043720 559 PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ--GEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG 636 (1103)
Q Consensus 559 p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 636 (1103)
|...+..+++|++|++++|++++..+..|..+++|+.|++++|.++ +.+|..|..+++|+.|+|++|++++..+..|.
T Consensus 422 ~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~ 501 (680)
T 1ziw_A 422 TGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLE 501 (680)
T ss_dssp CSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred CcccccCcccccEEecCCCCcceeChhhhhcCcccccchhccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhc
Confidence 8766666699999999999999888999999999999999999987 56899999999999999999999988888899
Q ss_pred CCCCCcEEeccCccccCcCh--------hhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCc-
Q 043720 637 ELRSLEVLELSSNSLSGEVP--------EGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV- 707 (1103)
Q Consensus 637 ~l~~L~~L~Ls~N~l~~~~~--------~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~- 707 (1103)
++++|++|+|++|++++..+ ..+..+++|+.|+|++|+|+...+..|.++++|+.|++++|++++.++..+
T Consensus 502 ~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~ 581 (680)
T 1ziw_A 502 GLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFN 581 (680)
T ss_dssp TCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred cccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhC
Confidence 99999999999999986432 237889999999999999995555679999999999999999998877644
Q ss_pred --cccccccccCCCC
Q 043720 708 --TTMNCSGVIGNPF 720 (1103)
Q Consensus 708 --~~~~~~~l~~Np~ 720 (1103)
..+..+.+.+|..
T Consensus 582 ~l~~L~~L~L~~N~l 596 (680)
T 1ziw_A 582 NQVSLKSLNLQKNLI 596 (680)
T ss_dssp TCTTCCEEECTTSCC
T ss_pred CCCCCCEEECCCCcC
Confidence 5667777888855
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=498.17 Aligned_cols=483 Identities=20% Similarity=0.175 Sum_probs=407.9
Q ss_pred ccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCC
Q 043720 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPF 173 (1103)
Q Consensus 94 ~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 173 (1103)
.+.+..|..++++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..|.
T Consensus 44 ~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~ 123 (606)
T 3t6q_A 44 VLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFI 123 (606)
T ss_dssp CCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGS
T ss_pred ccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcc
Confidence 34444566899999999999999999999999999999999999999999988899999999999999999999976688
Q ss_pred CCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCc--EEECcCCccccccCccccCC
Q 043720 174 SLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLE--HLDLSGNSLVGRIPSSLGKC 251 (1103)
Q Consensus 174 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~--~L~L~~N~l~~~~p~~l~~l 251 (1103)
.++++++|++|++++|++++..+..+..+++|++|++++|++++..|..+.. +++|+ .|++++|++++..|..+..
T Consensus 124 ~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~-l~~L~~l~L~l~~n~l~~~~~~~~~~- 201 (606)
T 3t6q_A 124 PLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS-LQQATNLSLNLNGNDIAGIEPGAFDS- 201 (606)
T ss_dssp CCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHHHHHT-TTTCCSEEEECTTCCCCEECTTTTTT-
T ss_pred hhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChhhhhh-hcccceeEEecCCCccCccChhHhhh-
Confidence 8999999999999999999854444555999999999999999555655555 57799 8999999999877766554
Q ss_pred CCCCEEeCCCccCC--------------------------ccccccccCCC--CCCEEEccCCcCCCcCCccccCCCCCC
Q 043720 252 QQLRTLLLFSNMLN--------------------------DVIPRELGWLR--KLEVLDVSRNRLNGLIPTELGNCVELS 303 (1103)
Q Consensus 252 ~~L~~L~L~~N~l~--------------------------~~~p~~l~~l~--~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 303 (1103)
.+|+.|++++|... ...+..+..+. +|+.|++++|.+++..+..|+.+++|+
T Consensus 202 ~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 281 (606)
T 3t6q_A 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ 281 (606)
T ss_dssp CEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCS
T ss_pred ccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCC
Confidence 68999999887510 11122233332 789999999999998888899999999
Q ss_pred eEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcC
Q 043720 304 VLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLA 383 (1103)
Q Consensus 304 ~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls 383 (1103)
.|++++ |.+. .+|..+..+++|+.|++++|.+.+..|..+..+++|++|+++
T Consensus 282 ~L~l~~---------------------------n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 333 (606)
T 3t6q_A 282 ELDLTA---------------------------THLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIK 333 (606)
T ss_dssp EEECTT---------------------------SCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEEECC
T ss_pred EEeccC---------------------------CccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEEECC
Confidence 999985 3333 688889999999999999999999999999999999999999
Q ss_pred Ccccccccc-hhhhccCCceEeecCCccccccc---cccccccceeEEEecCCccccccCCCCccccccccccccccccc
Q 043720 384 QNVLRGDLI-GVFDRCKKLHFIDLSSNELSGEL---DVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQG 459 (1103)
Q Consensus 384 ~N~l~~~~~-~~~~~l~~L~~LdLs~N~l~~~~---~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~ 459 (1103)
+|.+.+..+ ..|..+++|++|++++|++++.. ..+..+++|+.|++++|++++..|..
T Consensus 334 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~------------------ 395 (606)
T 3t6q_A 334 GNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA------------------ 395 (606)
T ss_dssp SCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTT------------------
T ss_pred CCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHH------------------
Confidence 999986554 56999999999999999998764 34568899999999999988654431
Q ss_pred ccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhc
Q 043720 460 YDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQAC 539 (1103)
Q Consensus 460 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~ 539 (1103)
+..++.
T Consensus 396 ----------------------~~~l~~---------------------------------------------------- 401 (606)
T 3t6q_A 396 ----------------------FKECPQ---------------------------------------------------- 401 (606)
T ss_dssp ----------------------TTTCTT----------------------------------------------------
T ss_pred ----------------------hcCCcc----------------------------------------------------
Confidence 111111
Q ss_pred ccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCC---CCcccccCcc
Q 043720 540 NEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGE---IPSSLHRLKY 616 (1103)
Q Consensus 540 ~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~~~~l~~ 616 (1103)
.+.+++++|++.+..|......+++|++|++++|.+++..|..|..+++|++|+|++|++++. .+..+..+++
T Consensus 402 ----L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l~~ 477 (606)
T 3t6q_A 402 ----LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGR 477 (606)
T ss_dssp ----CSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGCTT
T ss_pred ----CCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccCCC
Confidence 235677777777776666444558999999999999988899999999999999999999862 3467899999
Q ss_pred CcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCC
Q 043720 617 LRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASF 696 (1103)
Q Consensus 617 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~ 696 (1103)
|+.|+|++|++++..|..|+.+++|++|+|++|++++..|..+..+++| .|+|++|++++.+|..+..+++|+.+++++
T Consensus 478 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 556 (606)
T 3t6q_A 478 LEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINLRQ 556 (606)
T ss_dssp CCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEECTT
T ss_pred ccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeCCC
Confidence 9999999999998889999999999999999999999899999999999 999999999988888889999999999999
Q ss_pred CCCCCCC
Q 043720 697 NNLSGPF 703 (1103)
Q Consensus 697 N~l~~~~ 703 (1103)
|++...-
T Consensus 557 N~~~c~c 563 (606)
T 3t6q_A 557 NPLDCTC 563 (606)
T ss_dssp CCEECSG
T ss_pred CCccccC
Confidence 9998643
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=491.10 Aligned_cols=503 Identities=19% Similarity=0.155 Sum_probs=416.6
Q ss_pred cccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCC
Q 043720 95 LVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFS 174 (1103)
Q Consensus 95 ~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 174 (1103)
+.+..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..|..
T Consensus 44 l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~ 123 (606)
T 3vq2_A 44 LKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFP 123 (606)
T ss_dssp CCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSC
T ss_pred cCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccc
Confidence 44444557999999999999999999888999999999999999999999888999999999999999999999777789
Q ss_pred CCCCCCCCEEEccCCcCCC-CCChhcccCCCCcEeecccccCCCCCChhHHhhcCcC----cEEECcCCccccccCcccc
Q 043720 175 LRNFESLEVLNLAGNQVKG-VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYL----EHLDLSGNSLVGRIPSSLG 249 (1103)
Q Consensus 175 l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L----~~L~L~~N~l~~~~p~~l~ 249 (1103)
++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..+... .+| .+|++++|.+++..+..+.
T Consensus 124 ~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l-~~L~~~l~~L~l~~n~l~~~~~~~~~ 202 (606)
T 3vq2_A 124 IGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL-RENPQVNLSLDMSLNPIDFIQDQAFQ 202 (606)
T ss_dssp CTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHH-HHCTTCCCEEECTTCCCCEECTTTTT
T ss_pred cCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhh-hccccccceeeccCCCcceeCccccc
Confidence 9999999999999999986 679999999999999999999997666666554 445 4899999999966555554
Q ss_pred CCCCCCEEeCCCccCCc-cccccccCCCCCCEEEccCCcCCCc------CCccccCCCC--CCeEecccCcCccccCccc
Q 043720 250 KCQQLRTLLLFSNMLND-VIPRELGWLRKLEVLDVSRNRLNGL------IPTELGNCVE--LSVLVLSNLFDPLLSGRNI 320 (1103)
Q Consensus 250 ~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~~------~p~~l~~l~~--L~~L~l~~~~~~~l~~~~~ 320 (1103)
. .+|+.|++++|.+++ ..|..+..+++|+.+++..+.+.+. .+..+..+.. ++.+++.
T Consensus 203 ~-~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~------------ 269 (606)
T 3vq2_A 203 G-IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT------------ 269 (606)
T ss_dssp T-CEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC------------
T ss_pred C-ceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc------------
Confidence 4 499999999999984 6788899999999999876655431 1122222222 2333332
Q ss_pred cCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCC
Q 043720 321 RGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKK 400 (1103)
Q Consensus 321 ~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 400 (1103)
..+.+.+.+|. +..+++|+.|++++|.+.. +| .+..+++|+.|++++|.+ +.+| .+ .+++
T Consensus 270 --------------~~~~~~~~~~~-~~~l~~L~~L~l~~~~~~~-l~-~l~~~~~L~~L~l~~n~l-~~lp-~~-~l~~ 329 (606)
T 3vq2_A 270 --------------YTNDFSDDIVK-FHCLANVSAMSLAGVSIKY-LE-DVPKHFKWQSLSIIRCQL-KQFP-TL-DLPF 329 (606)
T ss_dssp --------------CCTTCCGGGGS-CGGGTTCSEEEEESCCCCC-CC-CCCTTCCCSEEEEESCCC-SSCC-CC-CCSS
T ss_pred --------------ccccccccccc-cccCCCCCEEEecCccchh-hh-hccccccCCEEEcccccC-cccc-cC-CCCc
Confidence 14667777777 8999999999999999864 55 889999999999999999 4555 45 8999
Q ss_pred ceEeecCCccccccccccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchh
Q 043720 401 LHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPL 480 (1103)
Q Consensus 401 L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (1103)
|+.|++++|+..+.+ ....+++|+.|++++|++++..+ .+.
T Consensus 330 L~~L~l~~n~~~~~~-~~~~l~~L~~L~ls~n~l~~~~~--------------------------------------~~~ 370 (606)
T 3vq2_A 330 LKSLTLTMNKGSISF-KKVALPSLSYLDLSRNALSFSGC--------------------------------------CSY 370 (606)
T ss_dssp CCEEEEESCSSCEEC-CCCCCTTCCEEECCSSCEEEEEE--------------------------------------CCH
T ss_pred cceeeccCCcCccch-hhccCCCCCEEECcCCccCCCcc--------------------------------------hhh
Confidence 999999999766555 45578999999999999885321 123
Q ss_pred hhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCc
Q 043720 481 LVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPL 560 (1103)
Q Consensus 481 ~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~ 560 (1103)
.+..++.|..+++++|.+++.+.. |..+. ....|++++|++.+..|.
T Consensus 371 ~~~~~~~L~~L~L~~n~l~~~~~~-------------------------------~~~l~--~L~~L~l~~n~l~~~~~~ 417 (606)
T 3vq2_A 371 SDLGTNSLRHLDLSFNGAIIMSAN-------------------------------FMGLE--ELQHLDFQHSTLKRVTEF 417 (606)
T ss_dssp HHHCCSCCCEEECCSCSEEEECCC-------------------------------CTTCT--TCCEEECTTSEEESTTTT
T ss_pred hhccCCcccEeECCCCccccchhh-------------------------------ccCCC--CCCeeECCCCccCCccCh
Confidence 345667788899999988752211 11122 245799999999988884
Q ss_pred hhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCC-CCCcccccCccCcEEeccCcccCCCCCCcccCCC
Q 043720 561 DIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG-EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELR 639 (1103)
Q Consensus 561 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 639 (1103)
.....+++|++|++++|.+++..|..|.++++|++|+|++|++++ .+|..|..+++|+.|+|++|++++..|..|.+++
T Consensus 418 ~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 497 (606)
T 3vq2_A 418 SAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497 (606)
T ss_dssp TTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred hhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccc
Confidence 444455999999999999999999999999999999999999997 4799999999999999999999999999999999
Q ss_pred CCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCC-CCceEeCCCCCCCCCCC
Q 043720 640 SLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVT-SLSIFNASFNNLSGPFP 704 (1103)
Q Consensus 640 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~l~l~~N~l~~~~p 704 (1103)
+|++|+|++|++++..|..+..+++|+.|+|++|+|+ .+|..+..++ +|+.|++++|++...-+
T Consensus 498 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 498 RLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred cCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 9999999999999988999999999999999999999 6777798887 59999999999987443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=450.31 Aligned_cols=260 Identities=23% Similarity=0.400 Sum_probs=212.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|.+.+.||+|+||+||+|++. +++.||||+++... ....++|.+|++++++++|||||+++|+|.+.+..|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 35777889999999999999865 47889999997543 445688999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhc-------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC
Q 043720 895 LIYNYLPGGNLENFIKART-------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 961 (1103)
+|||||++|+|.++++... ...+++.++.+|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCc
Confidence 9999999999999997642 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHH
Q 043720 962 AYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIIS 1039 (1103)
Q Consensus 962 ~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1103)
+||+|||+|+........ ......||++|||||++.+..|+.++|||||||++|||+| |+.||.... ..+
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~--------~~~ 268 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLS--------NTE 268 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSC--------HHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCC--------HHH
Confidence 999999999876443332 3345679999999999999999999999999999999999 899987321 112
Q ss_pred HHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
....... + .....+..+++++.+++.+||+.||++||||+||+++|+.+.++|
T Consensus 269 ~~~~i~~-g---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p 321 (329)
T 4aoj_A 269 AIDCITQ-G---------RELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP 321 (329)
T ss_dssp HHHHHHH-T---------CCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred HHHHHHc-C---------CCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence 2222211 1 123345677889999999999999999999999999999998887
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=447.64 Aligned_cols=257 Identities=25% Similarity=0.363 Sum_probs=216.3
Q ss_pred CCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++++.+.||+|+||+||+|.+. +++.||||+++........++|.+|+.++++++|||||+++|+|.+.+..++
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 4667889999999999999863 4688999999876666667889999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC
Q 043720 896 IYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN 961 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~ 961 (1103)
|||||++|+|.++++... ...+++.++.+|+.|||+||+|||++ +||||||||+|||+++++.
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCC
Confidence 999999999999997542 23589999999999999999999999 9999999999999999999
Q ss_pred EEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHH
Q 043720 962 AYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIIS 1039 (1103)
Q Consensus 962 ~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~ 1039 (1103)
+||+|||+|+........ ......||++|||||++.+..|+.++|||||||++|||+| |+.||.... ..+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~--------~~~ 255 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS--------NQD 255 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC--------HHH
T ss_pred EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC--------HHH
Confidence 999999999876443332 3445689999999999999999999999999999999999 888986321 112
Q ss_pred HHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1040 WASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1040 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
....+ .. ....+.+..++..+.+++.+||+.||++||||+||+++|+.+.
T Consensus 256 ~~~~i-~~---------~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~ 305 (308)
T 4gt4_A 256 VVEMI-RN---------RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG 305 (308)
T ss_dssp HHHHH-HT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred HHHHH-Hc---------CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence 22221 11 1223446678889999999999999999999999999999763
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=445.10 Aligned_cols=258 Identities=24% Similarity=0.419 Sum_probs=216.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|.+.+.||+|+||+||+|++. +++.||||+++... ....++|.+|++++++++|||||+++|+|.+++..|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 46888899999999999999764 47889999997643 345678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhc-----------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEE
Q 043720 895 LIYNYLPGGNLENFIKART-----------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY 963 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 963 (1103)
+|||||++|+|.++++... ...+++.++.+|+.|||+||+|||++ +|+||||||+|||+++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997642 24699999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCcc-ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHH
Q 043720 964 LSDFGLSRLLGTSETHA-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~~~-~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
|+|||+|+......... .....||++|||||++.+..|+.++|||||||++|||+| |+.||.... ..+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~--------~~~~~ 240 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS--------NNEVI 240 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC--------HHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC--------HHHHH
Confidence 99999998765443332 334568999999999999999999999999999999999 899987321 11222
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.... .+ .....+..++.++.+++.+||+.||++||||+||.+.|+++.+
T Consensus 241 ~~i~-~~---------~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 241 ECIT-QG---------RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHH-HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-cC---------CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 2221 11 1223456678899999999999999999999999999999854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-49 Score=434.86 Aligned_cols=262 Identities=27% Similarity=0.436 Sum_probs=209.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.+++++.+.||+|+||+||+|++++ .||||+++... ..+..+.|.+|+.++++++|||||+++|++.+ +.+|+|||
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 3578889999999999999998763 59999997543 34456789999999999999999999999865 56899999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC-
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE- 977 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~- 977 (1103)
||++|+|.++++... ..+++.++.+|+.|||+||+|||++ +||||||||+|||+++++.+||+|||+|+......
T Consensus 112 y~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 112 WCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred cCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999998653 4599999999999999999999999 99999999999999999999999999998764332
Q ss_pred CccccCCcccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 978 THATTGVAGTFGYVAPEYALT---CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.......+||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ..........+..
T Consensus 188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~--------~~~~~~~~~~~~~---- 255 (307)
T 3omv_A 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN--------RDQIIFMVGRGYA---- 255 (307)
T ss_dssp ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHTTCC----
T ss_pred ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCC----
Confidence 233455689999999999863 4689999999999999999999999973221 1122222222211
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.+. ....+..++..+.++|.+||+.||++||||+||+++|+.++.+
T Consensus 256 ~p~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~ 301 (307)
T 3omv_A 256 SPD-LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS 301 (307)
T ss_dssp CCC-STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred CCC-cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence 111 1223456778899999999999999999999999999988754
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=479.37 Aligned_cols=311 Identities=15% Similarity=0.127 Sum_probs=239.0
Q ss_pred ccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCC
Q 043720 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRN 177 (1103)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 177 (1103)
.+|+.+. ++|++|+|++|.+++..|..+.++++|++|+|++|++++..|..|+.+++|++|+|++|++++..|..+++
T Consensus 19 ~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~ 96 (549)
T 2z81_A 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGP 96 (549)
T ss_dssp SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTT
T ss_pred cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhcc
Confidence 3555443 78999999999999988999999999999999999999888899999999999999999999777777999
Q ss_pred CCCCCEEEccCCcCCC-CCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCE
Q 043720 178 FESLEVLNLAGNQVKG-VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRT 256 (1103)
Q Consensus 178 l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 256 (1103)
+++|++|+|++|.+++ ..|..++++++|++|++++|++.+.+|...+..+++|++|++++|++++.+|..++.+++|++
T Consensus 97 l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~ 176 (549)
T 2z81_A 97 LSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHH 176 (549)
T ss_dssp CTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred CCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccccCce
Confidence 9999999999999997 367789999999999999999666787654455688999999999999999999999999999
Q ss_pred EeCCCccCCccccccccCCCCCCEEEccCCcCCCcC--C-ccccCCCCCCeEecccCcCccccCccccCcccccccCCCC
Q 043720 257 LLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLI--P-TELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASN 333 (1103)
Q Consensus 257 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~--p-~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~ 333 (1103)
|+++.|.++......+..+++|++|++++|++++.. | .....+++|+.|++++
T Consensus 177 L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~------------------------ 232 (549)
T 2z81_A 177 LTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG------------------------ 232 (549)
T ss_dssp EEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEES------------------------
T ss_pred EecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccc------------------------
Confidence 999999987643333467999999999999999742 2 2335678899999985
Q ss_pred CCCCccccc----CchhhhccccccccccCCccccccC------CccccccccCcEEEcCCccccccc-----chhhhcc
Q 043720 334 GEKNSFIGS----IPMEITTLSKLRIIWAPRLNLEGKL------PSSWGACESLEMLNLAQNVLRGDL-----IGVFDRC 398 (1103)
Q Consensus 334 ~~~n~~~~~----ip~~~~~L~~L~~L~l~~n~l~~~~------p~~~~~l~~L~~L~Ls~N~l~~~~-----~~~~~~l 398 (1103)
+.+.+. ++..+..+++|+.+++++|.+.+.. ...+..+.+|+.|++.++.+.... +..+..+
T Consensus 233 ---n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~ 309 (549)
T 2z81_A 233 ---SVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLL 309 (549)
T ss_dssp ---CEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHS
T ss_pred ---cccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhc
Confidence 334443 3334456677888888888776632 123456677777777777665421 2233445
Q ss_pred CCceEeecCCccccccccccc-cccceeEEEecCCccccc
Q 043720 399 KKLHFIDLSSNELSGELDVKL-QVPCMALFDVSGNHMSGS 437 (1103)
Q Consensus 399 ~~L~~LdLs~N~l~~~~~~~~-~~~~L~~l~ls~N~l~g~ 437 (1103)
++|+.|++++|+++..+.... .+++|+.|++++|++++.
T Consensus 310 ~~L~~L~l~~n~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~ 349 (549)
T 2z81_A 310 EKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEE 349 (549)
T ss_dssp TTCCEEEEESSCCCCCCHHHHHHCTTCCEEECCSSCCCHH
T ss_pred ccceEEEeccCccccCCHHHHhcCccccEEEccCCccccc
Confidence 667777777776653222221 456666666666665543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=472.20 Aligned_cols=505 Identities=19% Similarity=0.183 Sum_probs=374.3
Q ss_pred cccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCC
Q 043720 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLR 176 (1103)
Q Consensus 97 g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 176 (1103)
..+|..+. +.+++|+|++|.+++..+..|.++++|++|||++|++++..|..|+++++|++|+|++|++++..|..|+
T Consensus 20 ~~ip~~l~--~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 97 (570)
T 2z63_A 20 YKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFS 97 (570)
T ss_dssp SSCCSSSC--SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTT
T ss_pred cccCCCcc--ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhc
Confidence 35665443 5789999999999988888899999999999999999977778899999999999999999877778899
Q ss_pred CCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCC-CCChhHHhhcCcCcEEECcCCccccccCccccCCCCC-
Q 043720 177 NFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQL- 254 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g-~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L- 254 (1103)
++++|++|++++|++++..+..++++++|++|++++|.+++ .+|..+.. +++|++|++++|++++..+..++.+++|
T Consensus 98 ~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 176 (570)
T 2z63_A 98 GLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN-LTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176 (570)
T ss_dssp TCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGG-CTTCCEEECTTSCCCEECGGGGHHHHTCT
T ss_pred CccccccccccccccccCCCccccccccccEEecCCCccceecChhhhcc-cCCCCEEeCcCCccceecHHHccchhccc
Confidence 99999999999999987666678899999999999999985 47887776 4789999999999988777888888888
Q ss_pred ---CEEeCCCccCCccccccccCCCCCCEEEccCCcCCC-cCCccccCCCCCCeEecccCcCccccCccccCcccccccC
Q 043720 255 ---RTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG-LIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSD 330 (1103)
Q Consensus 255 ---~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~ 330 (1103)
+.|++++|.+++..|..+..+ +|+.|++++|.... .++..+..+++++.+.+...... .
T Consensus 177 ~~~~~L~l~~n~l~~~~~~~~~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~--------~-------- 239 (570)
T 2z63_A 177 LLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFR--------N-------- 239 (570)
T ss_dssp TCCCEEECTTCCCCEECTTTTTTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECC--------C--------
T ss_pred hhhhhcccCCCCceecCHHHhccC-cceeEecccccccccchhhhhcCccccceeeecccccc--------C--------
Confidence 889999999998877777765 79999999886543 45667778888877666421000 0
Q ss_pred CCCCCCCcccccCchhhhccc--cccccccCCc-cccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecC
Q 043720 331 ASNGEKNSFIGSIPMEITTLS--KLRIIWAPRL-NLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLS 407 (1103)
Q Consensus 331 ~~~~~~n~~~~~ip~~~~~L~--~L~~L~l~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs 407 (1103)
...+...-...+..+. .++.+++.++ .+.+..|..+..+++|+.|++++|.+.+ +|..+..+ +|+.|+++
T Consensus 240 -----~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~-l~~~~~~~-~L~~L~l~ 312 (570)
T 2z63_A 240 -----EGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNF-GWQHLELV 312 (570)
T ss_dssp -----CSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEESCEECS-CCBCCSCC-CCSEEEEE
T ss_pred -----chhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEecCccchh-hhhhhccC-CccEEeec
Confidence 0011111111222222 2556666666 6777888888888889999998888884 56667777 88888888
Q ss_pred CccccccccccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccc
Q 043720 408 SNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARF 487 (1103)
Q Consensus 408 ~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 487 (1103)
+|++. .+|. ..+++|+.|++++|.+.+.++.. .++.
T Consensus 313 ~n~~~-~l~~-~~l~~L~~L~l~~n~~~~~~~~~------------------------------------------~~~~ 348 (570)
T 2z63_A 313 NCKFG-QFPT-LKLKSLKRLTFTSNKGGNAFSEV------------------------------------------DLPS 348 (570)
T ss_dssp SCBCS-SCCB-CBCSSCCEEEEESCBSCCBCCCC------------------------------------------BCTT
T ss_pred cCccc-ccCc-ccccccCEEeCcCCccccccccc------------------------------------------cCCC
Confidence 88887 4443 46788888888888876544320 1112
Q ss_pred eEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccC--Cchhhhc
Q 043720 488 MVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHI--PLDIGVM 565 (1103)
Q Consensus 488 l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~i--p~~~~~~ 565 (1103)
|. .+++++|++.+.. |..+...
T Consensus 349 L~--------------------------------------------------------~L~l~~n~l~~~~~~~~~~~~~ 372 (570)
T 2z63_A 349 LE--------------------------------------------------------FLDLSRNGLSFKGCCSQSDFGT 372 (570)
T ss_dssp CC--------------------------------------------------------EEECCSSCCBEEEEEEHHHHTC
T ss_pred CC--------------------------------------------------------EEeCcCCccCcccccccccccc
Confidence 22 4555555555332 3444433
Q ss_pred CCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCC-cccccCccCcEEeccCcccCCCCCCcccCCCCCcEE
Q 043720 566 CKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP-SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVL 644 (1103)
Q Consensus 566 ~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 644 (1103)
++|++|++++|.+++..+. +..+++|++|++++|.+.+..| ..+..+++|++|+|++|++++..|..|.++++|++|
T Consensus 373 -~~L~~L~l~~n~l~~~~~~-~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 450 (570)
T 2z63_A 373 -TSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450 (570)
T ss_dssp -SCCCEEECCSCSEEEEEEE-EETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred -CccCEEECCCCcccccccc-ccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEE
Confidence 7788888888887754443 7777888888888887776554 467777888888888888877777777778888888
Q ss_pred eccCcccc-CcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCc---cccccccccCCCC
Q 043720 645 ELSSNSLS-GEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV---TTMNCSGVIGNPF 720 (1103)
Q Consensus 645 ~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~~~l~~Np~ 720 (1103)
+|++|+++ +.+|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++++.+|..+ ..+..+++.+|||
T Consensus 451 ~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~ 530 (570)
T 2z63_A 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530 (570)
T ss_dssp ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCB
T ss_pred ECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcc
Confidence 88888876 4577777778888888888888877777777778888888888888877766543 4556667889999
Q ss_pred CCCCCCCCCC
Q 043720 721 LDPCQMYKDI 730 (1103)
Q Consensus 721 ~c~C~~~~~~ 730 (1103)
.|+|+...+.
T Consensus 531 ~~~~~~~~~~ 540 (570)
T 2z63_A 531 DCSCPRIDYL 540 (570)
T ss_dssp CCCTTTTHHH
T ss_pred cCCCcchHHH
Confidence 9999876544
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=442.99 Aligned_cols=271 Identities=24% Similarity=0.354 Sum_probs=224.2
Q ss_pred CCCHHHHHHHhcCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCC-CceeE
Q 043720 810 PLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVT 882 (1103)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~ 882 (1103)
|+...+++...++|++.+.||+|+||+||+|.+.. ++.||||++.........+.|.+|+.+++++.| ||||+
T Consensus 53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~ 132 (353)
T 4ase_A 53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 132 (353)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence 34444455556789999999999999999997653 367999999877766677889999999999965 99999
Q ss_pred EEeEEec-CCeEEEEEeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccC
Q 043720 883 LIGYRAS-GNEMFLIYNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947 (1103)
Q Consensus 883 l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~ 947 (1103)
++|+|.+ ++.+|+|||||++|+|.++++.... ..+++.++..++.|||+||+|||++ +||||
T Consensus 133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHR 209 (353)
T 4ase_A 133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 209 (353)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecC
Confidence 9999966 4678999999999999999986432 3489999999999999999999999 99999
Q ss_pred CCCCCcEEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 043720 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALD 1025 (1103)
Q Consensus 948 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~ 1025 (1103)
||||+|||+++++.+||+|||+|+........ ......||++|||||++.+..|+.++|||||||++|||+| |+.||.
T Consensus 210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 289 (353)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence 99999999999999999999999876544333 3445678999999999999999999999999999999998 899986
Q ss_pred CCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1026 PSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.... .......+..+ .+...+..+++++.++|.+||+.||++||||+||+++|+++.+
T Consensus 290 ~~~~--------~~~~~~~i~~g---------~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq 347 (353)
T 4ase_A 290 GVKI--------DEEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 347 (353)
T ss_dssp TCCC--------SHHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCH--------HHHHHHHHHcC---------CCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHH
Confidence 3221 11122222222 2234456677889999999999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=435.14 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=208.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|+.. +|+.||||++..... ....+.+.+|+.++++++|||||++++++.+.+.+|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 58999999999999999999764 689999999976543 3456789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
||++|+|.++++......+++.+++.|+.||+.||+|||++ +||||||||+|||+++++.+||+|||+|+..... .
T Consensus 104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-V 179 (350)
T ss_dssp CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH-H
T ss_pred CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC-c
Confidence 99999999999877666789999999999999999999999 9999999999999999999999999999876422 1
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+.... .
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~-~-------- 242 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS--------MKNLVLKIISGS-F-------- 242 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC-C--------
T ss_pred ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHHcCC-C--------
Confidence 22345679999999999999999999999999999999999999997321 222222222221 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+.++.++|.+||+.||++|||++|++++
T Consensus 243 -~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 243 -PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12234566789999999999999999999999874
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=480.03 Aligned_cols=498 Identities=21% Similarity=0.166 Sum_probs=408.7
Q ss_pred ccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCc-cccccCCCCCCEEEccccccCCCCCCCCC
Q 043720 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRL-PNEFVGLRNLRVLNLAFNRIDGDIPFSLR 176 (1103)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 176 (1103)
.+|. ..++|++|+|++|.+++..|..|.++++|++|||++|.+.+.+ |..|+++++|++|+|++|++++..|..|+
T Consensus 18 ~vP~---lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~~~ 94 (844)
T 3j0a_A 18 QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQ 94 (844)
T ss_dssp CCCS---SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTSSC
T ss_pred CCCC---CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhHcc
Confidence 3555 4579999999999999999999999999999999999777777 78899999999999999999988899999
Q ss_pred CCCCCCEEEccCCcCCCCCChh--cccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCC--C
Q 043720 177 NFESLEVLNLAGNQVKGVIPGF--LGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKC--Q 252 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l--~ 252 (1103)
++++|++|+|++|.+++.+|.. |+++++|++|+|++|.+++..+...+..+++|++|+|++|.+++..+..++.+ +
T Consensus 95 ~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~~~ 174 (844)
T 3j0a_A 95 GLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGK 174 (844)
T ss_dssp SCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHHHC
T ss_pred CCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHcccccCC
Confidence 9999999999999999877765 99999999999999999966554444456889999999999999889999888 8
Q ss_pred CCCEEeCCCccCCccccccccCCCC------CCEEEccCCcCCCcCCccccCC---CCCCeEecccCcCccccCccccCc
Q 043720 253 QLRTLLLFSNMLNDVIPRELGWLRK------LEVLDVSRNRLNGLIPTELGNC---VELSVLVLSNLFDPLLSGRNIRGE 323 (1103)
Q Consensus 253 ~L~~L~L~~N~l~~~~p~~l~~l~~------L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~l~~~~~~~l~~~~~~~~ 323 (1103)
+|+.|++++|.+++..|..++.+.+ |+.|++++|.+++.+|..+... .++..|.++++....
T Consensus 175 ~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~--------- 245 (844)
T 3j0a_A 175 TLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGA--------- 245 (844)
T ss_dssp SSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBC---------
T ss_pred ccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceecccccccc---------
Confidence 9999999999999988887777665 9999999999999888887654 567777776322110
Q ss_pred ccccccCCCCCCCCcccccCchhhhcc--ccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCc
Q 043720 324 LSVGQSDASNGEKNSFIGSIPMEITTL--SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKL 401 (1103)
Q Consensus 324 ~~~~~~~~~~~~~n~~~~~ip~~~~~L--~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 401 (1103)
....+++.+..+..+..+ ++|+.|++++|.+.+..|..|..+++|+.|+|++|++++..+..|.++++|
T Consensus 246 ---------~~~~~~l~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L 316 (844)
T 3j0a_A 246 ---------GFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNL 316 (844)
T ss_dssp ---------SSSCSSSTTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSC
T ss_pred ---------cccccccCCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCC
Confidence 001122333333444443 789999999999999999999999999999999999999999999999999
Q ss_pred eEeecCCcccccccc-ccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchh
Q 043720 402 HFIDLSSNELSGELD-VKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPL 480 (1103)
Q Consensus 402 ~~LdLs~N~l~~~~~-~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 480 (1103)
++|+|++|++++..+ .+..+++|+.|++++|++++..+..
T Consensus 317 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~--------------------------------------- 357 (844)
T 3j0a_A 317 QVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQT--------------------------------------- 357 (844)
T ss_dssp CEEEEESCCCSCCCSCSCSSCTTCCEEECCSCCCCCCCSSC---------------------------------------
T ss_pred CEEECCCCCCCccCHHHhcCCCCCCEEECCCCCCCccChhh---------------------------------------
Confidence 999999999987755 4457889999999999886433321
Q ss_pred hhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCc
Q 043720 481 LVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPL 560 (1103)
Q Consensus 481 ~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~ 560 (1103)
+..++. +..|++++|.+. .++.
T Consensus 358 -~~~l~~--------------------------------------------------------L~~L~Ls~N~l~-~i~~ 379 (844)
T 3j0a_A 358 -FKFLEK--------------------------------------------------------LQTLDLRDNALT-TIHF 379 (844)
T ss_dssp -SCSCCC--------------------------------------------------------CCEEEEETCCSC-CCSS
T ss_pred -hcCCCC--------------------------------------------------------CCEEECCCCCCC-cccC
Confidence 011111 235677777776 3333
Q ss_pred hhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCC-CcccccCccCcEEeccCcccCCCCCC-cccCC
Q 043720 561 DIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI-PSSLHRLKYLRHLSLADNNLTGGIPS-SIGEL 638 (1103)
Q Consensus 561 ~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l 638 (1103)
+++|+.|++++|+++ .+|.. ..+++.|++++|++++.. +..+..+++|+.|+|++|++++..+. .+..+
T Consensus 380 -----~~~L~~L~l~~N~l~-~l~~~---~~~l~~L~ls~N~l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~ 450 (844)
T 3j0a_A 380 -----IPSIPDIFLSGNKLV-TLPKI---NLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSEN 450 (844)
T ss_dssp -----CCSCSEEEEESCCCC-CCCCC---CTTCCEEECCSCCCCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSC
T ss_pred -----CCCcchhccCCCCcc-ccccc---ccccceeecccCccccCchhhhhhcCCccceeeCCCCcccccccccccccC
Confidence 488999999999999 44543 568999999999999532 22456899999999999999965543 46678
Q ss_pred CCCcEEeccCcccc-----CcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCc-ccccc
Q 043720 639 RSLEVLELSSNSLS-----GEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV-TTMNC 712 (1103)
Q Consensus 639 ~~L~~L~Ls~N~l~-----~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~-~~~~~ 712 (1103)
++|++|+|++|.++ +..+..|..+++|+.|+|++|+|++.+|..|..+++|+.|++++|+|++.+|..+ ..+..
T Consensus 451 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~~L~~ 530 (844)
T 3j0a_A 451 PSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEI 530 (844)
T ss_dssp TTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCCSCCCE
T ss_pred CccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhhhheeECCCCCCCccChhhhhccccE
Confidence 99999999999997 3445678899999999999999999999999999999999999999999887654 46777
Q ss_pred ccccCCCCCC
Q 043720 713 SGVIGNPFLD 722 (1103)
Q Consensus 713 ~~l~~Np~~c 722 (1103)
+++.+|....
T Consensus 531 L~Ls~N~l~~ 540 (844)
T 3j0a_A 531 LDISRNQLLA 540 (844)
T ss_dssp EEEEEECCCC
T ss_pred EECCCCcCCC
Confidence 8888887754
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=427.83 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=210.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
..|+..+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+.+.+|+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS-SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 46888999999999999999765 6899999999765433 346688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
|++|+|.++++.. .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.+... ..
T Consensus 153 ~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 225 (346)
T 4fih_A 153 LEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 225 (346)
T ss_dssp CTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSS-SC
T ss_pred CCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCC-CC
Confidence 9999999999764 399999999999999999999999 9999999999999999999999999999876433 23
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+. .... ..
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~-~~~~-------~~ 289 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIR-DNLP-------PR 289 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHH-HSSC-------CC
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHH-cCCC-------CC
Confidence 3456789999999999999999999999999999999999999997321 111122211 1110 11
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+.++.++|.+||+.||++|||++|++++
T Consensus 290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H 324 (346)
T 4fih_A 290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 324 (346)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12234566789999999999999999999999875
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=468.20 Aligned_cols=525 Identities=18% Similarity=0.157 Sum_probs=368.8
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
+.+++|+|++|.|++..|.+|.++++|++|||++|+|++..|..|.++++|++|+|++|+|++..+..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 47899999999999777788999999999999999999777778999999999999999999666677999999999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCC-CChhHHhhcCcCcEEECcCCccccccCccccCCCCCC----EEeCCC
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS-IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR----TLLLFS 261 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~-ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L~~ 261 (1103)
++|++++..+..|+++++|++|+|++|++++. +|..+.. +++|++|+|++|++++..+..+..+.+++ .++++.
T Consensus 132 s~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~-l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~ 210 (635)
T 4g8a_A 132 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN-LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 210 (635)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGG-CTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTT
T ss_pred CCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhcc-chhhhhhcccCccccccccccccchhhhhhhhhhhhccc
Confidence 99999987778899999999999999999753 5555554 57899999999999988888887665544 688999
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCc-CCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCccc
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGL-IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFI 340 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~ 340 (1103)
|.++...+..+ ....++.+++++|..... .+..+..+..++...+..+.... ...+.
T Consensus 211 n~l~~i~~~~~-~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~---------------------~~~l~ 268 (635)
T 4g8a_A 211 NPMNFIQPGAF-KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRN---------------------EGNLE 268 (635)
T ss_dssp CCCCEECTTTT-TTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTT---------------------SCCCS
T ss_pred CcccccCcccc-cchhhhhhhhhcccccccccchhhcCCccccccccccccccc---------------------ccccc
Confidence 99988555444 445678899998876643 34556777777776664211100 01111
Q ss_pred ccCchhhhccccccccccCCcc---ccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccc
Q 043720 341 GSIPMEITTLSKLRIIWAPRLN---LEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDV 417 (1103)
Q Consensus 341 ~~ip~~~~~L~~L~~L~l~~n~---l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~ 417 (1103)
...+..+..+..+....+..+. .....+..+..+.+++.+++.+|.+.... .+....+|+.|++++|.+.+..+
T Consensus 269 ~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~--~~~~~~~L~~L~l~~~~~~~~~~- 345 (635)
T 4g8a_A 269 KFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVK--DFSYNFGWQHLELVNCKFGQFPT- 345 (635)
T ss_dssp CCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEECG--GGGSCCCCSEEEEESCEESSCCC-
T ss_pred cccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccccccccccc--ccccchhhhhhhcccccccCcCc-
Confidence 1112222333333333332221 11223344555666666666666655433 24445566666666666654322
Q ss_pred cccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCc
Q 043720 418 KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNN 497 (1103)
Q Consensus 418 ~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~ 497 (1103)
..+..|+.+++++|...+..+. ..+..+..+++++|.
T Consensus 346 -~~l~~L~~l~l~~n~~~~~~~~------------------------------------------~~l~~L~~L~ls~n~ 382 (635)
T 4g8a_A 346 -LKLKSLKRLTFTSNKGGNAFSE------------------------------------------VDLPSLEFLDLSRNG 382 (635)
T ss_dssp -CBCTTCCEEEEESCCSCCBCCC------------------------------------------CBCTTCCEEECCSSC
T ss_pred -ccchhhhhcccccccCCCCccc------------------------------------------ccccccccchhhccc
Confidence 2345566666666655432211 012234455556555
Q ss_pred cccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCC
Q 043720 498 FTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHN 577 (1103)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N 577 (1103)
+.... ..|... ........++++.|.+.+ ++..+.. +++|+.++++.|
T Consensus 383 l~~~~---------------------------~~~~~~---~~~~~L~~L~~~~~~~~~-~~~~~~~-l~~L~~l~l~~~ 430 (635)
T 4g8a_A 383 LSFKG---------------------------CCSQSD---FGTISLKYLDLSFNGVIT-MSSNFLG-LEQLEHLDFQHS 430 (635)
T ss_dssp CBEEE---------------------------ECCHHH---HSCSCCCEEECCSCSEEE-ECSCCTT-CTTCCEEECTTS
T ss_pred ccccc---------------------------ccccch---hhhhhhhhhhcccccccc-ccccccc-cccccchhhhhc
Confidence 54211 001111 111223456777777663 3344443 378888888888
Q ss_pred cCCCCCc-ccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccC-CCCCCcccCCCCCcEEeccCccccCcC
Q 043720 578 QISGIVP-QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLT-GGIPSSIGELRSLEVLELSSNSLSGEV 655 (1103)
Q Consensus 578 ~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 655 (1103)
++....+ ..|..+++++.+++++|.+.+..+..+..++.|+.|+|++|++. +.+|..|..+++|++|+|++|+|++..
T Consensus 431 ~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~ 510 (635)
T 4g8a_A 431 NLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 510 (635)
T ss_dssp EEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEEC
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcC
Confidence 7765443 56778888888888888888777888888888888888888754 457788888888888888888888888
Q ss_pred hhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCcc----ccccccccCCCCCCCCCCCCCCC
Q 043720 656 PEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVT----TMNCSGVIGNPFLDPCQMYKDIS 731 (1103)
Q Consensus 656 ~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~----~~~~~~l~~Np~~c~C~~~~~~~ 731 (1103)
|..|..+++|++|+|++|+|++..|..|..+++|++||+++|+|++.+|..+. .+..+++.+|||.|||++..+..
T Consensus 511 ~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~~~~~~~ 590 (635)
T 4g8a_A 511 PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQ 590 (635)
T ss_dssp TTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGGGHHHHH
T ss_pred hHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCCcHHHHH
Confidence 88888888888888888888877788888888888888888888888876543 45667899999999999876655
Q ss_pred C
Q 043720 732 S 732 (1103)
Q Consensus 732 ~ 732 (1103)
|
T Consensus 591 w 591 (635)
T 4g8a_A 591 W 591 (635)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=423.72 Aligned_cols=273 Identities=23% Similarity=0.298 Sum_probs=206.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC----eEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----EMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 896 (1103)
.+|.+.+.||+|+||+||+|++. |+.||||++...... ...++.|+..+.+++|||||+++|++.+.+ .+|+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 35778899999999999999885 899999998654322 233456777778899999999999997653 68999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC-----CCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC-----APRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
||||++|+|.++++... ++++.+.+++.|+++||+|||+++ .++|+||||||+|||++.++.+||+|||+|+
T Consensus 80 ~Ey~~~gsL~~~l~~~~---l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred ecCCCCCcHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 99999999999998653 899999999999999999999762 4589999999999999999999999999998
Q ss_pred ccCCCCCc---cccCCcccccccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC------cc
Q 043720 972 LLGTSETH---ATTGVAGTFGYVAPEYALTC------RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDG------FN 1036 (1103)
Q Consensus 972 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~------~~ 1036 (1103)
........ .....+||++|||||++.+. .++.++|||||||++|||+||+.||.......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 76443322 23346799999999998754 46779999999999999999998875432211110 01
Q ss_pred hHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1037 IISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
.................+... ....+++..+.+++.+||+.||++||||+||++.|++|.++.
T Consensus 237 ~~~~~~~~~~~~~~rp~~p~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~~ 299 (303)
T 3hmm_A 237 SVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGG---GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred hHHHHHHHHhcccCCCCCCcc---ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHHc
Confidence 111111111111111111111 113356778999999999999999999999999999997653
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=474.10 Aligned_cols=400 Identities=17% Similarity=0.235 Sum_probs=303.7
Q ss_pred CcCCCCCChhcccCCCCcEeecccccCCC-CCChhHHhhcCcCcEEECcCCccccccCcccc--CCCCCCEEeCCCccCC
Q 043720 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLG--KCQQLRTLLLFSNMLN 265 (1103)
Q Consensus 189 n~l~~~~p~~l~~l~~L~~L~L~~N~l~g-~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~L~~N~l~ 265 (1103)
|++++ +|..|+++++|++|+|++|+++| .+|..+ +.++.|.++|.+|..++ ++++|++|+|++|.+.
T Consensus 435 N~L~~-IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~---------~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~ 504 (876)
T 4ecn_A 435 NRITF-ISKAIQRLTKLQIIYFANSPFTYDNIAVDW---------EDANSDYAKQYENEELSWSNLKDLTDVELYNCPNM 504 (876)
T ss_dssp CEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSC---------SCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTC
T ss_pred Ccccc-hhHHHhcCCCCCEEECcCCcCCCCcccccc---------cccccccccccCChhhhhccCCCCCEEECcCCCCC
Confidence 55555 56566666666666666666664 122111 01122334446788877 8888888888888888
Q ss_pred ccccccccCCCCCCEEEccCCc-CCC-cCCccccCCC-------CCCeEecccCcCccccCccccCcccccccCCCCCCC
Q 043720 266 DVIPRELGWLRKLEVLDVSRNR-LNG-LIPTELGNCV-------ELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEK 336 (1103)
Q Consensus 266 ~~~p~~l~~l~~L~~L~Ls~N~-l~~-~~p~~l~~l~-------~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 336 (1103)
+.+|..|+++++|+.|+|++|+ ++| .+|..+++++ +|+.|++++
T Consensus 505 ~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~--------------------------- 557 (876)
T 4ecn_A 505 TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGY--------------------------- 557 (876)
T ss_dssp CSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCS---------------------------
T ss_pred ccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeC---------------------------
Confidence 8888888888888888888887 777 7777666665 888888874
Q ss_pred CcccccCch--hhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCC-ceEeecCCccccc
Q 043720 337 NSFIGSIPM--EITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKK-LHFIDLSSNELSG 413 (1103)
Q Consensus 337 n~~~~~ip~--~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~-L~~LdLs~N~l~~ 413 (1103)
|.+. .+|. .++++++|+.|++++|.+. .+| .|+.+++|+.|+|++|+++ .+|..+.++++ |+.|+|++|+++
T Consensus 558 N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~Ls~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~- 632 (876)
T 4ecn_A 558 NNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK- 632 (876)
T ss_dssp SCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEECCSSCCS-CCCTTSCEECTTCCEEECCSSCCC-
T ss_pred CcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEECcCCccc-cchHHHhhccccCCEEECcCCCCC-
Confidence 4445 6777 7888888888888888888 777 8889999999999999998 67778888988 999999999988
Q ss_pred cccccc-cc--cceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEE
Q 043720 414 ELDVKL-QV--PCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVI 490 (1103)
Q Consensus 414 ~~~~~~-~~--~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 490 (1103)
.+|... .. ++|+.|++++|+++|.+|.+....
T Consensus 633 ~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l--------------------------------------------- 667 (876)
T 4ecn_A 633 YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM--------------------------------------------- 667 (876)
T ss_dssp SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCT---------------------------------------------
T ss_pred cCchhhhccccCCCCEEECcCCcCCCccccchhhh---------------------------------------------
Confidence 455443 33 349999999999998777542000
Q ss_pred EecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCcc
Q 043720 491 HNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLR 570 (1103)
Q Consensus 491 ~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~ 570 (1103)
.......+..|+|++|++. .+|..++..+++|+
T Consensus 668 ----------------------------------------------~~~~~~~L~~L~Ls~N~L~-~lp~~~~~~l~~L~ 700 (876)
T 4ecn_A 668 ----------------------------------------------DDYKGINASTVTLSYNEIQ-KFPTELFATGSPIS 700 (876)
T ss_dssp ----------------------------------------------TTCCCCCEEEEECCSSCCC-SCCHHHHHTTCCCS
T ss_pred ----------------------------------------------ccccCCCcCEEEccCCcCC-ccCHHHHccCCCCC
Confidence 0000012346788888888 78888887678999
Q ss_pred EEECcCCcCCCCCcccccC-C-------CCCCEEEccCCcCCCCCCcccc--cCccCcEEeccCcccCCCCCCcccCCCC
Q 043720 571 VLDASHNQISGIVPQSLEN-L-------TSLVFLDLNGNKLQGEIPSSLH--RLKYLRHLSLADNNLTGGIPSSIGELRS 640 (1103)
Q Consensus 571 ~L~L~~N~l~~~~p~~~~~-l-------~~L~~L~Ls~N~l~~~~p~~~~--~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 640 (1103)
+|+|++|+|+ .+|..+.. . ++|+.|+|++|+|+ .+|..+. .+++|+.|+|++|+|++ +|..+..+++
T Consensus 701 ~L~Ls~N~L~-~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~-~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~ 777 (876)
T 4ecn_A 701 TIILSNNLMT-SIPENSLKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQ 777 (876)
T ss_dssp EEECCSCCCS-CCCTTSSSCTTSCCTTGGGCCEEECCSSCCC-CCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTT
T ss_pred EEECCCCcCC-ccChHHhccccccccccCCccEEECCCCCCc-cchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCC
Confidence 9999999999 44544333 2 38999999999999 7888887 99999999999999996 7889999999
Q ss_pred CcEEeccC------ccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCcc---ccc
Q 043720 641 LEVLELSS------NSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVT---TMN 711 (1103)
Q Consensus 641 L~~L~Ls~------N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~---~~~ 711 (1103)
|+.|+|++ |++.+.+|..+..+++|+.|+|++|+| +.+|..+. ++|+.||+++|++....+..+. ...
T Consensus 778 L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~Ip~~l~--~~L~~LdLs~N~l~~i~~~~~~~~~~~~ 854 (876)
T 4ecn_A 778 LKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAG 854 (876)
T ss_dssp CCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBCCSCCC--SSSCEEECCSCTTCEEECGGGHHHHHTT
T ss_pred CCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-CccCHhhc--CCCCEEECCCCCCCccChHHccccccch
Confidence 99999976 888889999999999999999999999 58888765 6999999999999876554332 234
Q ss_pred cccccCCCCCC--CCCCCC
Q 043720 712 CSGVIGNPFLD--PCQMYK 728 (1103)
Q Consensus 712 ~~~l~~Np~~c--~C~~~~ 728 (1103)
...+.+|++.| .|+..+
T Consensus 855 ~~~L~~n~~~~I~gC~~L~ 873 (876)
T 4ecn_A 855 MYVLLYDKTQDIRGCDALG 873 (876)
T ss_dssp CCEEECCTTSEEESCGGGC
T ss_pred heeecCCCccccCCCCCcc
Confidence 45688999987 887644
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=459.71 Aligned_cols=482 Identities=21% Similarity=0.211 Sum_probs=396.9
Q ss_pred ccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCC
Q 043720 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPF 173 (1103)
Q Consensus 94 ~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 173 (1103)
.+.+..+..++++++|++|+|++|.+++..|..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+.
T Consensus 39 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~ 118 (570)
T 2z63_A 39 PLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118 (570)
T ss_dssp CCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTC
T ss_pred ccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCc
Confidence 34444455799999999999999999988888999999999999999999987889999999999999999999965556
Q ss_pred CCCCCCCCCEEEccCCcCCC-CCChhcccCCCCcEeecccccCCCCCChhHHhhcCcC----cEEECcCCccccccCccc
Q 043720 174 SLRNFESLEVLNLAGNQVKG-VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYL----EHLDLSGNSLVGRIPSSL 248 (1103)
Q Consensus 174 ~l~~l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L----~~L~L~~N~l~~~~p~~l 248 (1103)
.++++++|++|++++|.+++ .+|..|+++++|++|++++|++++..|..+.. +++| ++|++++|.+++..|..+
T Consensus 119 ~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~~~~~L~l~~n~l~~~~~~~~ 197 (570)
T 2z63_A 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV-LHQMPLLNLSLDLSLNPMNFIQPGAF 197 (570)
T ss_dssp SCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHH-HHTCTTCCCEEECTTCCCCEECTTTT
T ss_pred cccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccc-hhccchhhhhcccCCCCceecCHHHh
Confidence 89999999999999999997 47999999999999999999999655666655 4667 899999999998888777
Q ss_pred cCCCCCCEEeCCCccCCc-cccccccCCCCCCEEEccCCcCCC------cCCccccCCCCC--CeEecccCcCccccCcc
Q 043720 249 GKCQQLRTLLLFSNMLND-VIPRELGWLRKLEVLDVSRNRLNG------LIPTELGNCVEL--SVLVLSNLFDPLLSGRN 319 (1103)
Q Consensus 249 ~~l~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~Ls~N~l~~------~~p~~l~~l~~L--~~L~l~~~~~~~l~~~~ 319 (1103)
..+ +|+.|++++|.... .++..+..+++++.+.+..+.+.. .....+..+.++ +.+++++
T Consensus 198 ~~~-~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~---------- 266 (570)
T 2z63_A 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY---------- 266 (570)
T ss_dssp TTC-EEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEE----------
T ss_pred ccC-cceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhc----------
Confidence 766 89999999986543 356778888888887765443321 222233333333 3344432
Q ss_pred ccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccC
Q 043720 320 IRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCK 399 (1103)
Q Consensus 320 ~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 399 (1103)
...+.+.+|..+..+++|+.|++++|.+. .+|..+..+ +|++|++++|.+...+. ..++
T Consensus 267 ----------------~~~~~~~~~~~~~~l~~L~~L~l~~~~l~-~l~~~~~~~-~L~~L~l~~n~~~~l~~---~~l~ 325 (570)
T 2z63_A 267 ----------------LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNF-GWQHLELVNCKFGQFPT---LKLK 325 (570)
T ss_dssp ----------------TTEEESCSTTTTGGGTTCSEEEEESCEEC-SCCBCCSCC-CCSEEEEESCBCSSCCB---CBCS
T ss_pred ----------------chhhhhhchhhhcCcCcccEEEecCccch-hhhhhhccC-CccEEeeccCcccccCc---cccc
Confidence 12567788999999999999999999998 588889888 99999999999995443 4789
Q ss_pred CceEeecCCccccccccccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCch
Q 043720 400 KLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMP 479 (1103)
Q Consensus 400 ~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 479 (1103)
+|+.|++++|.+.+..+. ..+++|+.|++++|++++... .+
T Consensus 326 ~L~~L~l~~n~~~~~~~~-~~~~~L~~L~l~~n~l~~~~~--------------------------------------~~ 366 (570)
T 2z63_A 326 SLKRLTFTSNKGGNAFSE-VDLPSLEFLDLSRNGLSFKGC--------------------------------------CS 366 (570)
T ss_dssp SCCEEEEESCBSCCBCCC-CBCTTCCEEECCSSCCBEEEE--------------------------------------EE
T ss_pred ccCEEeCcCCcccccccc-ccCCCCCEEeCcCCccCcccc--------------------------------------cc
Confidence 999999999999887666 788999999999999874310 01
Q ss_pred hhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCC
Q 043720 480 LLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIP 559 (1103)
Q Consensus 480 ~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip 559 (1103)
..+..++.| +.+++++|++.+ +|
T Consensus 367 ~~~~~~~~L--------------------------------------------------------~~L~l~~n~l~~-~~ 389 (570)
T 2z63_A 367 QSDFGTTSL--------------------------------------------------------KYLDLSFNGVIT-MS 389 (570)
T ss_dssp HHHHTCSCC--------------------------------------------------------CEEECCSCSEEE-EE
T ss_pred ccccccCcc--------------------------------------------------------CEEECCCCcccc-cc
Confidence 111122222 356666776663 34
Q ss_pred chhhhcCCCccEEECcCCcCCCCCc-ccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccC-CCCCCcccC
Q 043720 560 LDIGVMCKSLRVLDASHNQISGIVP-QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLT-GGIPSSIGE 637 (1103)
Q Consensus 560 ~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~ 637 (1103)
..+.. +++|++|++++|.+++..| ..+.++++|++|++++|.+.+..|..|..+++|+.|+|++|+++ +.+|..|..
T Consensus 390 ~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~ 468 (570)
T 2z63_A 390 SNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTE 468 (570)
T ss_dssp EEEET-CTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTT
T ss_pred ccccc-cCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhc
Confidence 44443 4899999999999997766 57899999999999999999888999999999999999999998 578999999
Q ss_pred CCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCC
Q 043720 638 LRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPW 705 (1103)
Q Consensus 638 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~ 705 (1103)
+++|++|+|++|++++..|..+..+++|+.|+|++|++++.+|..+..+++|+.|++++|++++..|.
T Consensus 469 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~~ 536 (570)
T 2z63_A 469 LRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536 (570)
T ss_dssp CTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTT
T ss_pred ccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCCCcc
Confidence 99999999999999988899999999999999999999988888899999999999999999987764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=421.51 Aligned_cols=248 Identities=22% Similarity=0.346 Sum_probs=211.3
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|+.. +++.||||++.+... ....+.+.+|++++++++|||||++++++.+.+.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999664 689999999976532 334678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++++.. .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 112 Ey~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~ 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 186 (311)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence 9999999999998754 499999999999999999999999 99999999999999999999999999999875433
Q ss_pred C-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 T-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
. ......+||+.|||||++.+..|+.++||||+||++|||++|+.||.... .......+....
T Consensus 187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~~~~-------- 250 (311)
T 4aw0_A 187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EGLIFAKIIKLE-------- 250 (311)
T ss_dssp TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTC--------
T ss_pred CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC--------
Confidence 2 33456789999999999999999999999999999999999999997321 122222222211
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVV 1092 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl 1092 (1103)
...+...+.++.++|.+||+.||++|||++|+.
T Consensus 251 ---~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 251 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp ---CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred ---CCCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence 122345567899999999999999999999864
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=471.96 Aligned_cols=453 Identities=20% Similarity=0.202 Sum_probs=327.1
Q ss_pred CCCCEEEeecCCCCCCccccccCCCCCCEEEccccccC------C------CCCCCCCCCCCCCEEEccCCcCCCCCChh
Q 043720 131 EKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRID------G------DIPFSLRNFESLEVLNLAGNQVKGVIPGF 198 (1103)
Q Consensus 131 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~------~------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~ 198 (1103)
.+++.|+|++|.++|.+|++++.|++|++|+|++|.+. | .+|... +..|+ +++++|.+.+.+|..
T Consensus 81 ~~V~~L~L~~~~l~g~lp~~l~~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~--~~~l~-l~l~~~~l~~~~~~~ 157 (636)
T 4eco_A 81 GRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQ--KQKMR-MHYQKTFVDYDPRED 157 (636)
T ss_dssp CCEEEEECTTSCCEEEECGGGGGCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHH--HHHHH-THHHHHHTCCCGGGG
T ss_pred CCEEEEEecCcccCCcCChHHhcCccceEEECcCCccccCCccccccccccCchHHH--HHHHH-hhHHHhhhccCchhh
Confidence 46889999999999999999999999999999999773 1 122211 22333 444444444444443
Q ss_pred ccc-CCCCcEeecccccCCCCCChhHHhhcCcCcEEEC--cCCccccccCccccCCCCCCEEeCCCccCCcc--------
Q 043720 199 LGS-FLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDL--SGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV-------- 267 (1103)
Q Consensus 199 l~~-l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L--~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-------- 267 (1103)
++. +..+..+++....+... ....++.+.+ .+|+++| +|..++++++|++|+|++|.+++.
T Consensus 158 ~~~~~~~l~~~~l~~~~~~~~-------~~~~l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~ 229 (636)
T 4eco_A 158 FSDLIKDCINSDPQQKSIKKS-------SRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWEN 229 (636)
T ss_dssp SCHHHHHHHHHCTTSCCCCCC-------CCCCCCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSC
T ss_pred HHHHHHHHhhcCccccccccc-------cccchhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccc
Confidence 331 11111222221111100 0001122222 2577777 777788888888888888887775
Q ss_pred ---------cccccc--CCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCC
Q 043720 268 ---------IPRELG--WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEK 336 (1103)
Q Consensus 268 ---------~p~~l~--~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 336 (1103)
+|..++ ++++|++|+|++|++.+.+|..++++++|+.|++++
T Consensus 230 ~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~--------------------------- 282 (636)
T 4eco_A 230 ENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVAC--------------------------- 282 (636)
T ss_dssp TTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTT---------------------------
T ss_pred cccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcC---------------------------
Confidence 777777 788888888888888778888888888888888874
Q ss_pred Cc-ccc-cCchhhhcc------ccccccccCCccccccCCc--cccccccCcEEEcCCcccccccchhhhccCCceEeec
Q 043720 337 NS-FIG-SIPMEITTL------SKLRIIWAPRLNLEGKLPS--SWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDL 406 (1103)
Q Consensus 337 n~-~~~-~ip~~~~~L------~~L~~L~l~~n~l~~~~p~--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdL 406 (1103)
|. +.| .+|..++.+ ++|+.|++++|++. .+|. .++++++|++|+|++|+++|.+| .|..+++|++|+|
T Consensus 283 n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L 360 (636)
T 4eco_A 283 NRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNL 360 (636)
T ss_dssp CTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEEC
T ss_pred CCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEEC
Confidence 44 666 677777776 77888888888777 6777 77788888888888888877666 7777788888888
Q ss_pred CCccccccccccccccc-eeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcc
Q 043720 407 SSNELSGELDVKLQVPC-MALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAA 485 (1103)
Q Consensus 407 s~N~l~~~~~~~~~~~~-L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 485 (1103)
++|+++..+..+..+++ |+.|++++|+++ .+|.... .
T Consensus 361 ~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~----------------------------------------~- 398 (636)
T 4eco_A 361 AYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFD----------------------------------------A- 398 (636)
T ss_dssp CSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCC----------------------------------------T-
T ss_pred CCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhh----------------------------------------h-
Confidence 88887743344556777 777777777776 4553210 0
Q ss_pred cceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhh--
Q 043720 486 RFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIG-- 563 (1103)
Q Consensus 486 ~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~-- 563 (1103)
........+++++|++.+.+|..+.
T Consensus 399 -----------------------------------------------------~~l~~L~~L~Ls~N~l~~~~p~~l~~~ 425 (636)
T 4eco_A 399 -----------------------------------------------------KSVSVMSAIDFSYNEIGSVDGKNFDPL 425 (636)
T ss_dssp -----------------------------------------------------TCSSCEEEEECCSSCTTTTTTCSSCTT
T ss_pred -----------------------------------------------------cccCccCEEECcCCcCCCcchhhhccc
Confidence 0000123456666666666665554
Q ss_pred -----hcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCccccc-C-------ccCcEEeccCcccCCC
Q 043720 564 -----VMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHR-L-------KYLRHLSLADNNLTGG 630 (1103)
Q Consensus 564 -----~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l-------~~L~~L~L~~N~l~~~ 630 (1103)
.. ++|++|+|++|+|+++.+..+..+++|++|+|++|+++ .+|..+.. . ++|+.|+|++|+++ .
T Consensus 426 ~~~~~~~-~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~ 502 (636)
T 4eco_A 426 DPTPFKG-INVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSLKDENENFKNTYLLTSIDLRFNKLT-K 502 (636)
T ss_dssp CSSCCCC-CCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCS-BCCSSSSEETTEECTTGGGCCEEECCSSCCC-B
T ss_pred ccccccC-CCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCC-CcCHHHhccccccccccCCccEEECcCCcCC-c
Confidence 33 68999999999999665666778999999999999999 67664433 2 39999999999999 7
Q ss_pred CCCccc--CCCCCcEEeccCccccCcChhhhhhccccccccc------ccccCcCCCCccccCCCCCceEeCCCCCCCCC
Q 043720 631 IPSSIG--ELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLL------DNNKLSGHLPSGLANVTSLSIFNASFNNLSGP 702 (1103)
Q Consensus 631 ~p~~~~--~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L------~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~ 702 (1103)
+|..+. .+++|++|+|++|+|++ +|..+..+++|+.|+| ++|++.+.+|..+..+++|+.|++++|++...
T Consensus 503 lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~i 581 (636)
T 4eco_A 503 LSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV 581 (636)
T ss_dssp CCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCCCBC
T ss_pred cChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcCCcc
Confidence 888887 99999999999999997 8999999999999999 56888899999999999999999999999555
Q ss_pred CCCCccccccccccCCCCCC
Q 043720 703 FPWNVTTMNCSGVIGNPFLD 722 (1103)
Q Consensus 703 ~p~~~~~~~~~~l~~Np~~c 722 (1103)
+......+..+++.+||+.|
T Consensus 582 p~~~~~~L~~L~Ls~N~l~~ 601 (636)
T 4eco_A 582 NEKITPNISVLDIKDNPNIS 601 (636)
T ss_dssp CSCCCTTCCEEECCSCTTCE
T ss_pred CHhHhCcCCEEECcCCCCcc
Confidence 44455678888999999987
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=425.71 Aligned_cols=252 Identities=21% Similarity=0.263 Sum_probs=207.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.|+..++||+|+||+||+|.+. +|+.||||+++..... .+|+.++++++|||||++++++.+++.+|+||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 45778889999999999999765 5899999999765332 3699999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccCCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~~~~ 978 (1103)
|++|+|.+++++.. .+++.++..++.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+.......
T Consensus 132 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred cCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 99999999998754 499999999999999999999999 999999999999999987 699999999987754322
Q ss_pred c----cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 979 H----ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 979 ~----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
. .....+||+.|||||++.+..|+.++||||+||++|||++|+.||...... ... ..+.....
T Consensus 207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~---~~i~~~~~----- 273 (336)
T 4g3f_A 207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG-----PLC---LKIASEPP----- 273 (336)
T ss_dssp -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS-----CCH---HHHHHSCC-----
T ss_pred ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-----HHH---HHHHcCCC-----
Confidence 1 223457999999999999999999999999999999999999999743221 111 11111110
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
.....+..++..+.++|.+||+.||++|||++|++++|.+..
T Consensus 274 ---~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l 315 (336)
T 4g3f_A 274 ---PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKAL 315 (336)
T ss_dssp ---GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ---CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHH
Confidence 011234566788999999999999999999999999988754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=410.19 Aligned_cols=248 Identities=23% Similarity=0.381 Sum_probs=199.5
Q ss_pred CCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec----CCeEEEEE
Q 043720 824 NTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS----GNEMFLIY 897 (1103)
Q Consensus 824 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 897 (1103)
++.+.||+|+||+||+|.+. +++.||||++..... ....+.|.+|+.++++++|||||++++++.+ .+.+|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 56678999999999999765 588999999976543 3456789999999999999999999999865 35689999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecccccccCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~ 976 (1103)
|||++|+|.+++++.. .+++..+..++.||+.||+|||++ .++|+||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999998754 489999999999999999999998 122999999999999984 78999999999986432
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..... ....... +..+... .
T Consensus 185 --~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~-------~~~~~~~-i~~~~~~----~ 249 (290)
T 3fpq_A 185 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR-VTSGVKP----A 249 (290)
T ss_dssp --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH-HTTTCCC----G
T ss_pred --CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCc-------HHHHHHH-HHcCCCC----C
Confidence 23345689999999998865 699999999999999999999999963211 1111111 1111110 0
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+...++++.++|.+||+.||++|||++|++++
T Consensus 250 ----~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1122344678999999999999999999999874
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=456.53 Aligned_cols=458 Identities=20% Similarity=0.242 Sum_probs=293.0
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 189 (1103)
++|++++|+++ .+|..+. ++|++|||++|.+++..|..|..+++|++|+|++|++++..|..|+++++|++|+|++|
T Consensus 3 ~~l~ls~n~l~-~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 79 (520)
T 2z7x_B 3 FLVDRSKNGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHN 79 (520)
T ss_dssp CEEECTTSCCS-SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSS
T ss_pred ceEecCCCCcc-ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCC
Confidence 46777777777 5776665 67777777777777666677777777777777777777666777777777777777777
Q ss_pred cCCCCCChhcccCCCCcEeecccccCCC-CCChhHHhhcCcCcEEECcCCccccccCccccCCCCC--CEEeCCCccC--
Q 043720 190 QVKGVIPGFLGSFLKLRVLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQL--RTLLLFSNML-- 264 (1103)
Q Consensus 190 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g-~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~l-- 264 (1103)
+++ .+|.. .+++|++|+|++|++++ .+|..++. +++|++|++++|++++ ..++.+++| +.|++++|.+
T Consensus 80 ~l~-~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~-l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~ 152 (520)
T 2z7x_B 80 KLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGN-MSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYG 152 (520)
T ss_dssp CCC-EEECC--CCCCCSEEECCSSCCSSCCCCGGGGG-CTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTT
T ss_pred cee-ecCcc--ccCCccEEeccCCccccccchhhhcc-CCcceEEEecCcccch---hhccccccceeeEEEeecccccc
Confidence 777 34544 56677777777777664 35555554 3556666666666654 234555555 6666666666
Q ss_pred CccccccccCCC-CCCEEEccCCcCCCcCCc-cccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCccccc
Q 043720 265 NDVIPRELGWLR-KLEVLDVSRNRLNGLIPT-ELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGS 342 (1103)
Q Consensus 265 ~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ 342 (1103)
++..|..+..+. +...+++++|++.+.++. .+.++++|+.|+++
T Consensus 153 ~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~---------------------------------- 198 (520)
T 2z7x_B 153 EKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK---------------------------------- 198 (520)
T ss_dssp SSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEE----------------------------------
T ss_pred cccccccccccccceEEEEeccCcchhhhhhhhhhcccceeecccc----------------------------------
Confidence 555555555443 223445555555544332 34445555555544
Q ss_pred CchhhhccccccccccCCcc-------ccccCCccccccccCcEEEcCCcccccccchhhh---ccCCceEeecCCcccc
Q 043720 343 IPMEITTLSKLRIIWAPRLN-------LEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFD---RCKKLHFIDLSSNELS 412 (1103)
Q Consensus 343 ip~~~~~L~~L~~L~l~~n~-------l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~---~l~~L~~LdLs~N~l~ 412 (1103)
+|. +.+.+| .++.+++|+.|+|++|.+.+..+..+. .+++|++|++++|+++
T Consensus 199 -----------------~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~ 260 (520)
T 2z7x_B 199 -----------------CVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQ 260 (520)
T ss_dssp -----------------ECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEE
T ss_pred -----------------ccccccccceeecchh-hhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeeccccc
Confidence 333 333333 455566666666666665543322211 1346666666666666
Q ss_pred cccccc------ccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhccc
Q 043720 413 GELDVK------LQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAAR 486 (1103)
Q Consensus 413 ~~~~~~------~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 486 (1103)
+.+|.. ..++.|+.+++++|.+ .+|..
T Consensus 261 ~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~--------------------------------------------- 293 (520)
T 2z7x_B 261 GQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQS--------------------------------------------- 293 (520)
T ss_dssp SCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTH---------------------------------------------
T ss_pred CccccchhhcccccCceeEeccccccce--ecchh---------------------------------------------
Confidence 554433 3455666666666655 33310
Q ss_pred ceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcC
Q 043720 487 FMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMC 566 (1103)
Q Consensus 487 ~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~ 566 (1103)
.++..........+++++|++.+.. +...+
T Consensus 294 -----------------------------------------------~~~~~~~~~~L~~L~l~~n~l~~~~---~~~~l 323 (520)
T 2z7x_B 294 -----------------------------------------------YIYEIFSNMNIKNFTVSGTRMVHML---CPSKI 323 (520)
T ss_dssp -----------------------------------------------HHHHHHHTCCCSEEEEESSCCCCCC---CCSSC
T ss_pred -----------------------------------------------hhhcccccCceeEEEcCCCcccccc---chhhC
Confidence 0000001111234555555554221 11234
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCC--CCCcccccCccCcEEeccCcccCCCCCC-cccCCCCCcE
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG--EIPSSLHRLKYLRHLSLADNNLTGGIPS-SIGELRSLEV 643 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~ 643 (1103)
++|++|+|++|++++..|..+..+++|++|+|++|++++ .+|..+..+++|++|+|++|++++.+|. .+..+++|++
T Consensus 324 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~ 403 (520)
T 2z7x_B 324 SPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLS 403 (520)
T ss_dssp CCCCEEECCSSCCCTTTTTTCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCE
T ss_pred CcccEEEeECCccChhhhhhhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCE
Confidence 778888888888887778888888888888888888875 4556778888888888888888864554 4777888888
Q ss_pred EeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCC---CccccccccccCCCC
Q 043720 644 LELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPW---NVTTMNCSGVIGNPF 720 (1103)
Q Consensus 644 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~---~~~~~~~~~l~~Np~ 720 (1103)
|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+|++.++. .+..+..+++.+|||
T Consensus 404 L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l~~N~~ 480 (520)
T 2z7x_B 404 LNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480 (520)
T ss_dssp EECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred EECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEEECcCCCC
Confidence 88888888776666553 67888888888888 6777777888888888888888865554 234566677999999
Q ss_pred CCCCCCCCC
Q 043720 721 LDPCQMYKD 729 (1103)
Q Consensus 721 ~c~C~~~~~ 729 (1103)
.|+|++..+
T Consensus 481 ~c~c~~~~~ 489 (520)
T 2z7x_B 481 DCSCPRIDY 489 (520)
T ss_dssp CCCHHHHHH
T ss_pred cccCCchHH
Confidence 999998554
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=408.52 Aligned_cols=247 Identities=25% Similarity=0.402 Sum_probs=194.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+.++++++|||||++++++.+.+.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999764 689999999976533 234567999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+ +|+|.+++.+.. .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG- 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred eCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCC-
Confidence 999 689999998654 499999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
......+||+.|||||++.+..| +.++||||+||++|||++|+.||... ........... +.
T Consensus 166 -~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~--------~~~~~~~~i~~-~~------- 228 (275)
T 3hyh_A 166 -NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE--------SIPVLFKNISN-GV------- 228 (275)
T ss_dssp ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS--------SHHHHHHHHHH-TC-------
T ss_pred -CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC--------CHHHHHHHHHc-CC-------
Confidence 23345689999999999998876 57999999999999999999999732 11222222221 11
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...++++.+++.+||+.||++|||++|++++
T Consensus 229 ---~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 229 ---YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred ---CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 12234456789999999999999999999999875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=429.49 Aligned_cols=250 Identities=24% Similarity=0.365 Sum_probs=210.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.|+..+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+.+|++++|||||++++++.+.+.+|+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS-SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46999999999999999999765 5899999999765433 346688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
|++|+|.++++... +++.++..|+.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+... ..
T Consensus 230 ~~gG~L~~~i~~~~---l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~ 302 (423)
T 4fie_A 230 LEGGALTDIVTHTR---MNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP 302 (423)
T ss_dssp CTTEEHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CC
T ss_pred CCCCcHHHHHhccC---CCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCC-Cc
Confidence 99999999997643 99999999999999999999999 9999999999999999999999999999876433 23
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.... .......+. .... . .
T Consensus 303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~--------~~~~~~~i~-~~~~-----~--~ 366 (423)
T 4fie_A 303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP--------PLKAMKMIR-DNLP-----P--R 366 (423)
T ss_dssp CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHH-HSCC-----C--C
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC--------HHHHHHHHH-cCCC-----C--C
Confidence 3456789999999999999999999999999999999999999997321 111122211 1110 0 1
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+.++.+||.+||+.||++|||++|++++
T Consensus 367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H 401 (423)
T 4fie_A 367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH 401 (423)
T ss_dssp CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 12234556789999999999999999999999875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=414.41 Aligned_cols=248 Identities=24% Similarity=0.325 Sum_probs=201.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|++.+.||+|+||+||+|+.. .++.||||++..... ......+.+|+.++++++|||||++++++.+.+.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999753 468899999976532 2234568899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|||||+||+|.+++++.. .+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+|+....
T Consensus 104 vmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 999999999999998754 499999999999999999999999 999999999999999999999999999986533
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.. ......+||+.|||||++.+..|+.++||||+||++|||+||+.||.... .......+....
T Consensus 179 ~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~--------~~~~~~~i~~~~------- 242 (304)
T 3ubd_A 179 HE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD--------RKETMTMILKAK------- 242 (304)
T ss_dssp ---CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-------
T ss_pred CC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC--------HHHHHHHHHcCC-------
Confidence 22 23445789999999999999999999999999999999999999997321 122222222111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTM-----KQVVQ 1093 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1093 (1103)
...+...++++.+++.+||+.||++|||+ +|+++
T Consensus 243 ----~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~ 281 (304)
T 3ubd_A 243 ----LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR 281 (304)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred ----CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence 12344567789999999999999999984 57764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=404.16 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=192.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC--------
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-------- 891 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-------- 891 (1103)
++|++.+.||+|+||+||+|... +|+.||||++.....+...+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 35889999999999999999765 689999999987766666778999999999999999999999886543
Q ss_pred ----eEEEEEeecCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 892 ----EMFLIYNYLPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 892 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
..|+|||||++|+|.++++.... ...++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence 47999999999999999986543 2345677889999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCC-----------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc
Q 043720 967 FGLSRLLGTSET-----------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF 1035 (1103)
Q Consensus 967 fgla~~~~~~~~-----------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~ 1035 (1103)
||+|+....... ......+||+.|||||++.+..|+.++|||||||++|||++ ||... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~-------~ 231 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ-------M 231 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH-------H
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc-------c
Confidence 999987643322 12234679999999999999999999999999999999996 66421 0
Q ss_pred chHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1036 NIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........ ....... +......+.+.+++.+||+.||++|||+.|++++
T Consensus 232 ~~~~~~~~-~~~~~~p---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 232 ERVRTLTD-VRNLKFP---------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHHH-HHTTCCC---------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHH-HhcCCCC---------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111111 1111110 0112334557789999999999999999999873
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=438.88 Aligned_cols=442 Identities=20% Similarity=0.203 Sum_probs=345.5
Q ss_pred ccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCC
Q 043720 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRN 177 (1103)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 177 (1103)
.+|+.+. ++|++|+|++|.+++..|..+.++++|++|+|++|++++..|..|+.+++|++|+|++|+++ .+|.. .
T Consensus 14 ~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~ 88 (520)
T 2z7x_B 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--P 88 (520)
T ss_dssp SCCCSCC--TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--C
T ss_pred ccccccc--ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--c
Confidence 4776665 89999999999999888889999999999999999999888999999999999999999999 78877 8
Q ss_pred CCCCCEEEccCCcCCC-CCChhcccCCCCcEeecccccCCCCCChhHHhhcCcC--cEEECcCCcc--ccccCccccCCC
Q 043720 178 FESLEVLNLAGNQVKG-VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYL--EHLDLSGNSL--VGRIPSSLGKCQ 252 (1103)
Q Consensus 178 l~~L~~L~L~~n~l~~-~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L--~~L~L~~N~l--~~~~p~~l~~l~ 252 (1103)
+++|++|+|++|++++ .+|..|+++++|++|++++|++++ ..+.. +++| ++|++++|.+ ++..|..+..+.
T Consensus 89 l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~-l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~ 164 (520)
T 2z7x_B 89 TVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEK---SSVLP-IAHLNISKVLLVLGETYGEKEDPEGLQDFN 164 (520)
T ss_dssp CCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCG---GGGGG-GTTSCEEEEEEEECTTTTSSCCTTTTTTCC
T ss_pred cCCccEEeccCCccccccchhhhccCCcceEEEecCcccch---hhccc-cccceeeEEEeecccccccccccccccccc
Confidence 9999999999999997 578999999999999999999985 23333 4668 9999999999 888888888776
Q ss_pred -CCCEEeCCCccCCcccc-ccccCCCCCCEEEccCCc-------CCCcCCccccCCCCCCeEecccCcCccccCccccCc
Q 043720 253 -QLRTLLLFSNMLNDVIP-RELGWLRKLEVLDVSRNR-------LNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGE 323 (1103)
Q Consensus 253 -~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~-------l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~ 323 (1103)
+...+++++|.+.+.++ ..+..+++|+.|++++|. +.+.+| .++.+++|+.|++++|
T Consensus 165 ~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~-~l~~l~~L~~L~l~~~------------- 230 (520)
T 2z7x_B 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILA-KLQTNPKLSNLTLNNI------------- 230 (520)
T ss_dssp EEEEEEECCSSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHH-GGGGCTTCCEEEEEEE-------------
T ss_pred cceEEEEeccCcchhhhhhhhhhcccceeeccccccccccccceeecchh-hhccccchhhcccccc-------------
Confidence 45577899999888655 467889999999999998 776666 7888888999888753
Q ss_pred ccccccCCCCCCCCcccccCchhhh---ccccccccccCCccccccCCccc-----cccccCcEEEcCCcccccccchhh
Q 043720 324 LSVGQSDASNGEKNSFIGSIPMEIT---TLSKLRIIWAPRLNLEGKLPSSW-----GACESLEMLNLAQNVLRGDLIGVF 395 (1103)
Q Consensus 324 ~~~~~~~~~~~~~n~~~~~ip~~~~---~L~~L~~L~l~~n~l~~~~p~~~-----~~l~~L~~L~Ls~N~l~~~~~~~~ 395 (1103)
.+.+..+..+. ..++|+.|++++|.+.|.+|..+ +.+++|+.+++++|.+ ..+...+
T Consensus 231 --------------~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~-~~p~~~~ 295 (520)
T 2z7x_B 231 --------------ETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF-GFPQSYI 295 (520)
T ss_dssp --------------EEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC-CSCTHHH
T ss_pred --------------ccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCceeEeccccccce-ecchhhh
Confidence 22222221111 13467777777777777777766 6677777777777766 2222444
Q ss_pred hcc---CCceEeecCCccccccccccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHh
Q 043720 396 DRC---KKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMS 472 (1103)
Q Consensus 396 ~~l---~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 472 (1103)
..+ .+|+.|++++|.+.... ....+++|+
T Consensus 296 ~~~~~~~~L~~L~l~~n~l~~~~-~~~~l~~L~----------------------------------------------- 327 (520)
T 2z7x_B 296 YEIFSNMNIKNFTVSGTRMVHML-CPSKISPFL----------------------------------------------- 327 (520)
T ss_dssp HHHHHTCCCSEEEEESSCCCCCC-CCSSCCCCC-----------------------------------------------
T ss_pred hcccccCceeEEEcCCCcccccc-chhhCCccc-----------------------------------------------
Confidence 443 45666666666654211 001223333
Q ss_pred hhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCC
Q 043720 473 KARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNN 552 (1103)
Q Consensus 473 ~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n 552 (1103)
.|++++|
T Consensus 328 -------------------------------------------------------------------------~L~Ls~n 334 (520)
T 2z7x_B 328 -------------------------------------------------------------------------HLDFSNN 334 (520)
T ss_dssp -------------------------------------------------------------------------EEECCSS
T ss_pred -------------------------------------------------------------------------EEEeECC
Confidence 4555555
Q ss_pred cccccCCchhhhcCCCccEEECcCCcCCC--CCcccccCCCCCCEEEccCCcCCCCCCc-ccccCccCcEEeccCcccCC
Q 043720 553 NIIGHIPLDIGVMCKSLRVLDASHNQISG--IVPQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTG 629 (1103)
Q Consensus 553 ~~~~~ip~~~~~~~~~L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~ 629 (1103)
++.+.+|..+..+ ++|++|+|++|+|++ .+|..+..+++|++|+|++|++++.+|. .+..+++|++|+|++|++++
T Consensus 335 ~l~~~~~~~~~~l-~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~L~~L~Ls~N~l~~ 413 (520)
T 2z7x_B 335 LLTDTVFENCGHL-TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTD 413 (520)
T ss_dssp CCCTTTTTTCCCC-SSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTTCCEEECCSSCCCG
T ss_pred ccChhhhhhhccC-CCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCccCCEEECcCCCCCc
Confidence 5555555555544 789999999999986 4567788999999999999999975665 47888999999999999988
Q ss_pred CCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCc-cccCCCCCceEeCCCCCCCCCC
Q 043720 630 GIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPS-GLANVTSLSIFNASFNNLSGPF 703 (1103)
Q Consensus 630 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-~l~~l~~L~~l~l~~N~l~~~~ 703 (1103)
.+|..+. ++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++ +|. .+..+++|+.|++++|++++..
T Consensus 414 ~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~-l~~~~~~~l~~L~~L~l~~N~~~c~c 484 (520)
T 2z7x_B 414 TIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPWDCSC 484 (520)
T ss_dssp GGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CCTTTTTTCTTCCEEECCSSCBCCCH
T ss_pred chhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc-cCHHHhccCCcccEEECcCCCCcccC
Confidence 7777665 78999999999998 678777799999999999999994 555 4888999999999999998743
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=436.41 Aligned_cols=182 Identities=22% Similarity=0.235 Sum_probs=150.3
Q ss_pred ccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCC--CCcccccCccCcE
Q 043720 542 FHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGE--IPSSLHRLKYLRH 619 (1103)
Q Consensus 542 ~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~--~p~~~~~l~~L~~ 619 (1103)
.....+++++|++.... +...+++|++|+|++|++++.+|..+.++++|++|+|++|++++. +|..|..+++|++
T Consensus 331 ~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~ 407 (562)
T 3a79_B 331 MNIKMLSISDTPFIHMV---CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLET 407 (562)
T ss_dssp CCCSEEEEESSCCCCCC---CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCE
T ss_pred CcceEEEccCCCccccc---CccCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCE
Confidence 34557888888875322 113448899999999999998999999999999999999999952 3467899999999
Q ss_pred EeccCcccCCCCCC-cccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCC
Q 043720 620 LSLADNNLTGGIPS-SIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNN 698 (1103)
Q Consensus 620 L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~ 698 (1103)
|+|++|++++.+|. .+..+++|++|+|++|++++..|..+. ++|+.|+|++|+|+ .+|..+..+++|+.|++++|+
T Consensus 408 L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~ 484 (562)
T 3a79_B 408 LDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQ 484 (562)
T ss_dssp EECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSC
T ss_pred EECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCC
Confidence 99999999984554 588999999999999999877766543 79999999999999 677777799999999999999
Q ss_pred CCCCCCC---CccccccccccCCCCCCCCCCCCC
Q 043720 699 LSGPFPW---NVTTMNCSGVIGNPFLDPCQMYKD 729 (1103)
Q Consensus 699 l~~~~p~---~~~~~~~~~l~~Np~~c~C~~~~~ 729 (1103)
|++.++. .+..+..+++.+|||.|+|++..+
T Consensus 485 l~~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~ 518 (562)
T 3a79_B 485 LKSVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRY 518 (562)
T ss_dssp CCCCCTTSTTTCTTCCCEECCSCCBCCCHHHHHH
T ss_pred CCCCCHHHHhcCCCCCEEEecCCCcCCCcchHHH
Confidence 9976664 344667778999999999998654
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=433.86 Aligned_cols=460 Identities=22% Similarity=0.183 Sum_probs=360.2
Q ss_pred ccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCC-CCC
Q 043720 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDG-DIP 172 (1103)
Q Consensus 94 ~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~-~~p 172 (1103)
.+.+..|..++++++|++|+|++|.+++..|..|+++++|++|||++|.+++..|..|+.+++|++|+|++|++++ .+|
T Consensus 37 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~ 116 (549)
T 2z81_A 37 KITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVT 116 (549)
T ss_dssp CCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSS
T ss_pred ccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchh
Confidence 3455556789999999999999999999888999999999999999999998888889999999999999999996 467
Q ss_pred CCCCCCCCCCEEEccCCcCCCCCC-hhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCcc-ccC
Q 043720 173 FSLRNFESLEVLNLAGNQVKGVIP-GFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSS-LGK 250 (1103)
Q Consensus 173 ~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~-l~~ 250 (1103)
..++++++|++|++++|.+.+.+| ..|+++++|++|++++|++++.+|..+.. +++|++|++++|.+.. +|.. +..
T Consensus 117 ~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~-l~~L~~L~l~~n~~~~-~~~~~~~~ 194 (549)
T 2z81_A 117 SLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKS-IRDIHHLTLHLSESAF-LLEIFADI 194 (549)
T ss_dssp CSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT-CSEEEEEEEECSBSTT-HHHHHHHS
T ss_pred hhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhc-cccCceEecccCcccc-cchhhHhh
Confidence 889999999999999999555555 68999999999999999999888988876 4789999999999874 4444 467
Q ss_pred CCCCCEEeCCCccCCccc--cc-cccCCCCCCEEEccCCcCCCcCC----ccccCCCCCCeEecccCcCccccCccccCc
Q 043720 251 CQQLRTLLLFSNMLNDVI--PR-ELGWLRKLEVLDVSRNRLNGLIP----TELGNCVELSVLVLSNLFDPLLSGRNIRGE 323 (1103)
Q Consensus 251 l~~L~~L~L~~N~l~~~~--p~-~l~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~ 323 (1103)
+++|++|++++|++++.. |. ....+++|+.|++++|.+++..+ ..+..+++|+.+++++|....+..
T Consensus 195 l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~------ 268 (549)
T 2z81_A 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGD------ 268 (549)
T ss_dssp TTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSC------
T ss_pred cccccEEEccCCccccccccccchhhhhhcccceeccccccchhHHHHHHHHhhhhcccccccccccccccccc------
Confidence 999999999999999842 22 23457899999999999987544 445678999999998754322110
Q ss_pred ccccccCCCCCCCCcccccCchhhhccccccccccCCcccccc-----CCccccccccCcEEEcCCcccccccchhhhcc
Q 043720 324 LSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGK-----LPSSWGACESLEMLNLAQNVLRGDLIGVFDRC 398 (1103)
Q Consensus 324 ~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~-----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 398 (1103)
+.......+..+.+|+.|.+.++.+... ++..+....+|+.|++++|++...+...+.++
T Consensus 269 ---------------~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n~l~~ip~~~~~~l 333 (549)
T 2z81_A 269 ---------------FNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHL 333 (549)
T ss_dssp ---------------CCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESSCCCCCCHHHHHHC
T ss_pred ---------------ccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccCccccCCHHHHhcC
Confidence 0001112345567788888887765532 22334456789999999999986665666789
Q ss_pred CCceEeecCCccccccccc----cccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhh
Q 043720 399 KKLHFIDLSSNELSGELDV----KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKA 474 (1103)
Q Consensus 399 ~~L~~LdLs~N~l~~~~~~----~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 474 (1103)
++|++|+|++|++++.++. ...+++|+.|++++|++++..+.
T Consensus 334 ~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~---------------------------------- 379 (549)
T 2z81_A 334 KSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKT---------------------------------- 379 (549)
T ss_dssp TTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHH----------------------------------
T ss_pred ccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccc----------------------------------
Confidence 9999999999999986542 34677788888888877531000
Q ss_pred hcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcc
Q 043720 475 RLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNI 554 (1103)
Q Consensus 475 ~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~ 554 (1103)
T Consensus 380 -------------------------------------------------------------------------------- 379 (549)
T 2z81_A 380 -------------------------------------------------------------------------------- 379 (549)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred cccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCc
Q 043720 555 IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSS 634 (1103)
Q Consensus 555 ~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 634 (1103)
......+++|++|+|++|+|+ .+|..+..+++|++|+|++|+|+ .+|..+ .++|+.|+|++|++++.+
T Consensus 380 -----~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~~~~L~~L~Ls~N~l~-~l~~~~--~~~L~~L~Ls~N~l~~~~--- 447 (549)
T 2z81_A 380 -----GEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVSNNNLDSFS--- 447 (549)
T ss_dssp -----HHHGGGCTTCCEEECTTCCCC-CCCSCCCCCTTCCEEECTTSCCS-CCCTTS--CTTCSEEECCSSCCSCCC---
T ss_pred -----hhhhhcCCCCCEEECCCCCCc-cCChhhcccccccEEECCCCCcc-cccchh--cCCceEEECCCCChhhhc---
Confidence 001112367889999999998 56788888899999999999988 455544 258899999999988642
Q ss_pred ccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCcccccccc
Q 043720 635 IGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSG 714 (1103)
Q Consensus 635 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~ 714 (1103)
..+++|++|+|++|+|+ .+|. ...+++|+.|+|++|+|++.+|..+..+++|+.|+
T Consensus 448 -~~l~~L~~L~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~--------------------- 503 (549)
T 2z81_A 448 -LFLPRLQELYISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIW--------------------- 503 (549)
T ss_dssp -CCCTTCCEEECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEE---------------------
T ss_pred -ccCChhcEEECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEE---------------------
Confidence 57888999999999998 5665 46788899999999999888888888888888775
Q ss_pred ccCCCCCCCCCC
Q 043720 715 VIGNPFLDPCQM 726 (1103)
Q Consensus 715 l~~Np~~c~C~~ 726 (1103)
+.+|||.|+|+.
T Consensus 504 l~~N~~~~~~~~ 515 (549)
T 2z81_A 504 LHTNPWDCSCPR 515 (549)
T ss_dssp CCSSCBCCCHHH
T ss_pred ecCCCccCCCcc
Confidence 456688899874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=386.35 Aligned_cols=268 Identities=29% Similarity=0.498 Sum_probs=214.4
Q ss_pred CCCChhhHHHHHHHHhhccCCCCcccCcCCCCCCCCc--eeeeEecCC---CCeEEEEecCCCCCCCCCCcccccccccc
Q 043720 1 SGKVLPEKTILLEFKNSVSDPSGILSSWQTNTSSHCS--WFGVSCDSE---SRVVALNITGGDVSEGNSKPFFSCLMTAQ 75 (1103)
Q Consensus 1 ~~~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~C~--W~GV~C~~~---~~v~~l~l~~~~~~~~~~~~~~~~~~~~~ 75 (1103)
++|.+.|++||++||+++.||. .+++|+.+ .|||. |.||+|+.. ++|+.+++.+..
T Consensus 1 ~~c~~~~~~aL~~~k~~~~~~~-~l~~W~~~-~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~----------------- 61 (313)
T 1ogq_A 1 ELCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN----------------- 61 (313)
T ss_dssp CCSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCC-----------------
T ss_pred CCCCHHHHHHHHHHHHhcCCcc-cccCCCCC-CCCCcCCCcceEeCCCCCCceEEEEECCCCC-----------------
Confidence 4799999999999999999987 79999764 48998 999999864 688888876542
Q ss_pred ccccccccccceeccCCCcccc--ccCcccCCCCCCCEEEccC-CCCcccCCccccCCCCCCEEEeecCCCCCCcccccc
Q 043720 76 FPFYGFGMRRRTCLHGRGKLVG--KLSPLVGGLSELRVLSLPF-NGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFV 152 (1103)
Q Consensus 76 ~~~~~~~~~~~~~~~~~~~~~g--~~~~~l~~l~~L~~L~L~~-n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~ 152 (1103)
+.| .+|+.++++++|++|+|++ |.+.+.+|..++++++|++|+|++|.+++.+|..|+
T Consensus 62 -------------------l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 122 (313)
T 1ogq_A 62 -------------------LPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122 (313)
T ss_dssp -------------------CSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGG
T ss_pred -------------------ccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHh
Confidence 234 5777788888888888884 888888888888888888888888888888888888
Q ss_pred CCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCC-CCcEeecccccCCCCCChhHHhhcCcCc
Q 043720 153 GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFL-KLRVLFLSYNELNGSIPSELGKYCRYLE 231 (1103)
Q Consensus 153 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~-~L~~L~L~~N~l~g~ip~~~~~~~~~L~ 231 (1103)
.+++|++|+|++|++++.+|..+.++++|++|+|++|++++.+|..++.++ +|++|++++|++++.+|..+... + |+
T Consensus 123 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l-~-L~ 200 (313)
T 1ogq_A 123 QIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-N-LA 200 (313)
T ss_dssp GCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC-C-CS
T ss_pred CCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCC-c-cc
Confidence 888888888888888888888888888888888888888878888888777 78888888888887777777654 4 88
Q ss_pred EEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEeccc
Q 043720 232 HLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309 (1103)
Q Consensus 232 ~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 309 (1103)
+|+|++|++++..|..++.+++|+.|+|++|.+++.+|. +..+++|++|+|++|++++.+|..+.++++|+.|++++
T Consensus 201 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~ 277 (313)
T 1ogq_A 201 FVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF 277 (313)
T ss_dssp EEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS
T ss_pred EEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcC
Confidence 888888888777777777788888888888887775554 66777777777777777777777777777777777763
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-43 Score=394.98 Aligned_cols=291 Identities=37% Similarity=0.694 Sum_probs=253.0
Q ss_pred CCCCHHHHHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe
Q 043720 809 VPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA 888 (1103)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 888 (1103)
..+++.++..+.++|++.+.||+|+||+||+|...+++.||||++...........+.+|+.+++.++||||+++++++.
T Consensus 18 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 18 KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp EECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred ceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 45788999999999999999999999999999888899999999987655444457899999999999999999999999
Q ss_pred cCCeEEEEEeecCCCChHHHHHhhcC--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 889 SGNEMFLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 889 ~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
..+..++||||+++|+|.++++.... ..+++..+..++.|++.||+|||+++.++|+||||||+||+++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 99999999999999999999987543 3489999999999999999999998777999999999999999999999999
Q ss_pred cccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+..............|......
T Consensus 178 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 257 (326)
T 3uim_A 178 FGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257 (326)
T ss_dssp CSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTS
T ss_pred CccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhh
Confidence 99998876555555566679999999999988889999999999999999999999997544444455566677766666
Q ss_pred cCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
........+.......+...+..+.+++.+||+.||++|||++||+++|++..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~ 310 (326)
T 3uim_A 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG 310 (326)
T ss_dssp SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence 66677777777777778889999999999999999999999999999998753
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=396.72 Aligned_cols=262 Identities=21% Similarity=0.328 Sum_probs=202.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec------CCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS------GNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 892 (1103)
++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+.+|+.+|+.++|||||++++++.. .+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999764 699999999976543 3345778899999999999999999998754 367
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+|||||+ |+|.+++.... .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+.
T Consensus 134 ~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~ 207 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARG 207 (398)
T ss_dssp EEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeee
Confidence 899999995 68999997643 599999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCC---CccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 973 LGTSE---THATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 973 ~~~~~---~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||..... ......+.......
T Consensus 208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~-----~~~l~~I~~~~g~p 282 (398)
T 4b99_A 208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNY-----VHQLQLIMMVLGTP 282 (398)
T ss_dssp C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSH-----HHHHHHHHHHHCCC
T ss_pred cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhcCCC
Confidence 64332 2234567899999999998775 468999999999999999999999974321 11111111110000
Q ss_pred ccccccc-----------ccc--cCC-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1049 QVKDVFN-----------AEL--WAS-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1049 ~~~~~~~-----------~~~--~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ..... ... ... .......++.+|+.+||..||++|||++|++++
T Consensus 283 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 345 (398)
T 4b99_A 283 S-PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH 345 (398)
T ss_dssp C-GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred C-hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 0 00000 000 000 011235678999999999999999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=390.99 Aligned_cols=199 Identities=25% Similarity=0.404 Sum_probs=171.0
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCe
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 892 (1103)
...++|++.+.||+|+||+||+|+.+ +++.||||++.... ....+.+|+++++.+ .|||||++++++.+.+.
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~---~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS---CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc---CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 45678999999999999999999653 46889999986543 335678999999998 69999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-CCEEEeeccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-FNAYLSDFGLSR 971 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla~ 971 (1103)
+|+||||+++|+|.++++ .+++.++..++.|++.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+
T Consensus 95 ~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~ 166 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQ 166 (361)
T ss_dssp EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence 999999999999999984 288999999999999999999999 99999999999999876 799999999998
Q ss_pred ccCCCCC---------------------------ccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCC
Q 043720 972 LLGTSET---------------------------HATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKA 1023 (1103)
Q Consensus 972 ~~~~~~~---------------------------~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p 1023 (1103)
....... ......+||+.|+|||++.+. .|+.++||||+||++|||++|+.|
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P 246 (361)
T 4f9c_A 167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP 246 (361)
T ss_dssp ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence 6543211 112345799999999999775 589999999999999999999999
Q ss_pred CCCC
Q 043720 1024 LDPS 1027 (1103)
Q Consensus 1024 ~~~~ 1027 (1103)
|...
T Consensus 247 f~~~ 250 (361)
T 4f9c_A 247 FYKA 250 (361)
T ss_dssp SSCC
T ss_pred CCCC
Confidence 9743
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=418.66 Aligned_cols=485 Identities=19% Similarity=0.197 Sum_probs=332.1
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
...+++++++|+++ .+|..+. ++|++|+|++|.+++..|..|..+++|++|+|++|++++..|..|.++++|++|+|
T Consensus 31 ~~~~~l~ls~~~L~-~ip~~~~--~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 107 (562)
T 3a79_B 31 ELESMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDV 107 (562)
T ss_dssp --CCEEECTTSCCC-SCCTTSC--TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCCcEEEcCCCCCc-cCCCCCC--CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEEC
Confidence 34478899998888 4887665 78889999999888777788888888999999988888777888888888888888
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCC-CCChhHHhhcCcCcEEECcCCccccccCccccCCCCC--CEEeCCCcc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQL--RTLLLFSNM 263 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g-~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L--~~L~L~~N~ 263 (1103)
++|+++ .+|.. .+++|++|+|++|++++ .+|..+.. +++|++|+|++|++++. .+..+++| ++|++++|.
T Consensus 108 s~N~l~-~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~-l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~ 180 (562)
T 3a79_B 108 SHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGN-LTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVS 180 (562)
T ss_dssp TTSCCC-EECSC--CCTTCSEEECCSSCCSBCCCCGGGGG-CTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESS
T ss_pred CCCcCC-ccCcc--ccccCCEEECCCCCccccCchHhhcc-cCcccEEecCCCccccC---chhhhhhceeeEEEeeccc
Confidence 888888 55655 78888888888888874 33456655 47788888888888753 34445555 888888888
Q ss_pred C--CccccccccCCC--CCCEEEccCCcCCCcCCc-cccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCc
Q 043720 264 L--NDVIPRELGWLR--KLEVLDVSRNRLNGLIPT-ELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNS 338 (1103)
Q Consensus 264 l--~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~ 338 (1103)
+ ++..|.++..+. .+ .+++++|.+.+.++. .+.++++|+.|++++|... ...
T Consensus 181 l~~~~~~~~~l~~l~~~~l-~l~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~----------------------~~~ 237 (562)
T 3a79_B 181 YHIKGGETESLQIPNTTVL-HLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN----------------------CQR 237 (562)
T ss_dssp CCCCSSSCCEEEECCEEEE-EEEECSSSCCCCCCEEEESSEEEEEEEEEECCSTT----------------------HHH
T ss_pred ccccccCcccccccCcceE-EEEecCccchhhhhhhcccccceEEEecccccccc----------------------cch
Confidence 8 777777777654 33 557778887765554 3556777777777643100 000
Q ss_pred ccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchh---hhccCCceEeecCCccccccc
Q 043720 339 FIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGV---FDRCKKLHFIDLSSNELSGEL 415 (1103)
Q Consensus 339 ~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~---~~~l~~L~~LdLs~N~l~~~~ 415 (1103)
+.+ .+..+. .+++|+.|+|+++.+.+..... ....++|++|++++|++++.+
T Consensus 238 l~~-~~~~l~------------------------~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~i 292 (562)
T 3a79_B 238 LMT-FLSELT------------------------RGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERI 292 (562)
T ss_dssp HHH-HHHHHH------------------------SCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCC
T ss_pred HHH-HHHHHh------------------------ccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccc
Confidence 111 112233 3444444444444443321110 112235666666666666554
Q ss_pred ccc------ccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceE
Q 043720 416 DVK------LQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMV 489 (1103)
Q Consensus 416 ~~~------~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 489 (1103)
|.. ..+..|+.++++.|.+ .+|... +. .......+.
T Consensus 293 p~~~~~~~~~~L~~L~~~~~~~~~~--~~p~~~------------------------~~------------~~~~~~~L~ 334 (562)
T 3a79_B 293 DREEFTYSETALKSLMIEHVKNQVF--LFSKEA------------------------LY------------SVFAEMNIK 334 (562)
T ss_dssp CCCCCCCCSCSCCEEEEEEEEECCC--SSCHHH------------------------HH------------HHHHTCCCS
T ss_pred cchhhhcccccchheehhhccccee--ecChhh------------------------hh------------hhhccCcce
Confidence 432 2344455555555544 222100 00 000012344
Q ss_pred EEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCc
Q 043720 490 IHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSL 569 (1103)
Q Consensus 490 ~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L 569 (1103)
.+++++|++....+ + . .......+++++|++.+.+|..+..+ ++|
T Consensus 335 ~L~l~~n~~~~~~~--~------------------------------~--~l~~L~~L~l~~n~l~~~~~~~~~~l-~~L 379 (562)
T 3a79_B 335 MLSISDTPFIHMVC--P------------------------------P--SPSSFTFLNFTQNVFTDSVFQGCSTL-KRL 379 (562)
T ss_dssp EEEEESSCCCCCCC--C------------------------------S--SCCCCCEEECCSSCCCTTTTTTCCSC-SSC
T ss_pred EEEccCCCcccccC--c------------------------------c--CCCCceEEECCCCccccchhhhhccc-CCC
Confidence 55566665543110 0 0 01123478999999998888888765 899
Q ss_pred cEEECcCCcCCCCC--cccccCCCCCCEEEccCCcCCCCCCc-ccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 570 RVLDASHNQISGIV--PQSLENLTSLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 570 ~~L~L~~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|+|++|+|+++. |..|.++++|++|+|++|++++.+|. .+..+++|++|+|++|++++.+|..+. ++|++|+|
T Consensus 380 ~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L 457 (562)
T 3a79_B 380 QTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP--PKVKVLDL 457 (562)
T ss_dssp CEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCGGGGSSCC--TTCSEEEC
T ss_pred CEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCcchhhhhc--CcCCEEEC
Confidence 99999999999743 56799999999999999999975665 588999999999999999988777665 79999999
Q ss_pred cCccccCcChhhhhhcccccccccccccCcCCCCcc-ccCCCCCceEeCCCCCCCCCCCC-C----cccccccccc----
Q 043720 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLSGPFPW-N----VTTMNCSGVI---- 716 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~l~l~~N~l~~~~p~-~----~~~~~~~~l~---- 716 (1103)
++|+|+ .+|..+..+++|+.|+|++|+|+ .+|.. +..+++|+.|++++|++.+..+. . +.......+.
T Consensus 458 ~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~~~~~~~~~~~~~~~~~~~~~~ 535 (562)
T 3a79_B 458 HNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCTCPGIRYLSEWINKHSGVVRNSAG 535 (562)
T ss_dssp CSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCCEECCSCCBCCCHHHHHHHHHHHHHTTTTEECSSS
T ss_pred CCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCEEEecCCCcCCCcchHHHHHHHHHhcCCccccccc
Confidence 999999 67777779999999999999999 45554 89999999999999999875432 1 1111112233
Q ss_pred -CCCCCCCCCC
Q 043720 717 -GNPFLDPCQM 726 (1103)
Q Consensus 717 -~Np~~c~C~~ 726 (1103)
+.|+.+.|..
T Consensus 536 ~~~~~~~~C~~ 546 (562)
T 3a79_B 536 SVAPDSAKCSG 546 (562)
T ss_dssp SBCSSSSCBSS
T ss_pred CCCCCCCccCC
Confidence 7788888876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-41 Score=381.17 Aligned_cols=283 Identities=34% Similarity=0.602 Sum_probs=241.5
Q ss_pred HHHHHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 813 YESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 813 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
+.++..++++|+..+.||+|+||+||+|...+++.||||++..... ...+.+.+|+.+++.++||||+++++++...+.
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 109 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS-QGIEEFETEIETLSFCRHPHLVSLIGFCDERNE 109 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCS-SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCe
Confidence 3444556789999999999999999999988899999999876543 356789999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcC--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
.++||||+++|+|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~ 186 (321)
T 2qkw_B 110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGIS 186 (321)
T ss_dssp CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 9999999999999999875432 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 971 RLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 971 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
+....... .......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......|.......+.
T Consensus 187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 264 (321)
T 2qkw_B 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPR--EMVNLAEWAVESHNNGQ 264 (321)
T ss_dssp EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSS--SCCCHHHHTHHHHTTTC
T ss_pred cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcH--HHHHHHHHhhhcccccc
Confidence 86543222 2234456899999999999889999999999999999999999999754432 23345566655566666
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+++......+...+..+.+++.+||+.||++||+++|++++|+.+.+.
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 6677777766667788899999999999999999999999999999988654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=403.03 Aligned_cols=250 Identities=23% Similarity=0.339 Sum_probs=203.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHH---HHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQ---FHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~---~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||+||+|+.. +|+.||||++.+... ...... ...++.+++.++|||||++++++.+.+.+|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 46999999999999999999765 589999999975432 112222 334567788889999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+|||||+||+|.+++++.. .+++..+..++.||+.||+|||++ +||||||||+|||++.+|.+||+|||+|+.+.
T Consensus 269 lVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp EEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 9999999999999998754 499999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.. .....+||+.|||||++.. ..|+.++||||+||++|||++|+.||...... .............
T Consensus 344 ~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~-----~~~~i~~~i~~~~----- 410 (689)
T 3v5w_A 344 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDRMTLTMA----- 410 (689)
T ss_dssp SC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC-----CHHHHHHHHHHCC-----
T ss_pred CC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHhhcCCC-----
Confidence 32 2345689999999999964 57999999999999999999999999743221 1111111111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+...+.++.++|.+||+.||++|++ ++||++|
T Consensus 411 ------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H 450 (689)
T 3v5w_A 411 ------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 450 (689)
T ss_dssp ------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred ------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence 1234456678999999999999999998 6787653
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-41 Score=395.84 Aligned_cols=273 Identities=22% Similarity=0.198 Sum_probs=167.2
Q ss_pred cccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCC-------------CEEEcccccc
Q 043720 101 PLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL-------------RVLNLAFNRI 167 (1103)
Q Consensus 101 ~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L-------------~~L~Ls~N~l 167 (1103)
|.-.+.++|++|++++|.+ |.+|++++++++|++|++++|.++|.+|..++.+++| ++|++++|.+
T Consensus 5 p~~~~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l 83 (454)
T 1jl5_A 5 PRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL 83 (454)
T ss_dssp ------------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCC
T ss_pred ccccccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcc
Confidence 3334568999999999999 7999999999999999999999999999999998875 8888888888
Q ss_pred CCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCcc
Q 043720 168 DGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSS 247 (1103)
Q Consensus 168 ~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~ 247 (1103)
++ +|.. .++|++|++++|.+++ +|.. +++|++|++++|+++ .+|.. .++|++|++++|++++ +| .
T Consensus 84 ~~-lp~~---~~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~-~l~~~----~~~L~~L~L~~n~l~~-lp-~ 148 (454)
T 1jl5_A 84 SS-LPEL---PPHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLK-ALSDL----PPLLEYLGVSNNQLEK-LP-E 148 (454)
T ss_dssp SC-CCSC---CTTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCS-CCCSC----CTTCCEEECCSSCCSS-CC-C
T ss_pred cc-CCCC---cCCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccC-cccCC----CCCCCEEECcCCCCCC-Cc-c
Confidence 84 5542 3678888888888886 5643 378888888888888 45432 2568888888888885 66 5
Q ss_pred ccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCccccc
Q 043720 248 LGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVG 327 (1103)
Q Consensus 248 l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~ 327 (1103)
++++++|++|++++|++++ +|..+ .+|++|++++|++++ +| .++++++|+.|++++|.
T Consensus 149 ~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l~~N~---------------- 206 (454)
T 1jl5_A 149 LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYADNNS---------------- 206 (454)
T ss_dssp CTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSC----------------
T ss_pred cCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEECCCCc----------------
Confidence 8888888888888888887 55443 588888888888886 45 57888888888887532
Q ss_pred ccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecC
Q 043720 328 QSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLS 407 (1103)
Q Consensus 328 ~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs 407 (1103)
+.+ +|... ++|+.|++++|.+. .+| .++.+++|++|++++|++++.+ . .+++|+.|+++
T Consensus 207 -----------l~~-l~~~~---~~L~~L~l~~n~l~-~lp-~~~~l~~L~~L~l~~N~l~~l~-~---~~~~L~~L~l~ 265 (454)
T 1jl5_A 207 -----------LKK-LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKTLP-D---LPPSLEALNVR 265 (454)
T ss_dssp -----------CSS-CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSSCC-S---CCTTCCEEECC
T ss_pred -----------CCc-CCCCc---CcccEEECcCCcCC-ccc-ccCCCCCCCEEECCCCcCCccc-c---cccccCEEECC
Confidence 221 22211 35666666666665 444 3566666666666666665422 1 12555666666
Q ss_pred CccccccccccccccceeEEEecCCccc
Q 043720 408 SNELSGELDVKLQVPCMALFDVSGNHMS 435 (1103)
Q Consensus 408 ~N~l~~~~~~~~~~~~L~~l~ls~N~l~ 435 (1103)
+|++++. |.. .++|+.|++++|+++
T Consensus 266 ~N~l~~l-~~~--~~~L~~L~ls~N~l~ 290 (454)
T 1jl5_A 266 DNYLTDL-PEL--PQSLTFLDVSENIFS 290 (454)
T ss_dssp SSCCSCC-CCC--CTTCCEEECCSSCCS
T ss_pred CCccccc-Ccc--cCcCCEEECcCCccC
Confidence 6665542 211 244555555555444
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-40 Score=388.68 Aligned_cols=377 Identities=23% Similarity=0.251 Sum_probs=262.0
Q ss_pred CCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCC-ChhcccCCCCcEeecc
Q 043720 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVI-PGFLGSFLKLRVLFLS 211 (1103)
Q Consensus 133 L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-p~~l~~l~~L~~L~L~ 211 (1103)
-+.++.+++.++ .+|. + .++|++|+|++|++++..|..++++++|++|+|++|.+.+.+ +..|+++++|++|+|+
T Consensus 12 ~~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls 87 (455)
T 3v47_A 12 GYNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD 87 (455)
T ss_dssp TTEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred ccccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence 346777777777 6665 3 277888888888888777778888888888888888877555 4567777788888888
Q ss_pred cccCCCCCChhHHhhcCcCcEEECcCCccccccCcc--ccCCCCCCEEeCCCccCCcccccc-ccCCCCCCEEEccCCcC
Q 043720 212 YNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSS--LGKCQQLRTLLLFSNMLNDVIPRE-LGWLRKLEVLDVSRNRL 288 (1103)
Q Consensus 212 ~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~--l~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~L~Ls~N~l 288 (1103)
+|++++..|..+.. +++|++|+|++|++++.++.. ++.+++|++|+|++|.+++..|.. +..+++|++|++++|++
T Consensus 88 ~n~l~~~~~~~~~~-l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 166 (455)
T 3v47_A 88 YNQFLQLETGAFNG-LANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166 (455)
T ss_dssp TCTTCEECTTTTTT-CTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred CCccCccChhhccC-cccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence 88777555655554 466777777777777644443 677777777777777777766655 66777777777777777
Q ss_pred CCcCCccccCC--CCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCcccccc
Q 043720 289 NGLIPTELGNC--VELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGK 366 (1103)
Q Consensus 289 ~~~~p~~l~~l--~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~ 366 (1103)
++..|..+..+ .+|+.|+++ +|.+.+.
T Consensus 167 ~~~~~~~l~~l~~~~L~~L~l~---------------------------------------------------~n~l~~~ 195 (455)
T 3v47_A 167 KSICEEDLLNFQGKHFTLLRLS---------------------------------------------------SITLQDM 195 (455)
T ss_dssp SCCCTTTSGGGTTCEEEEEECT---------------------------------------------------TCBCTTC
T ss_pred cccChhhhhccccccccccccc---------------------------------------------------cCccccc
Confidence 76666665554 344444444 3333322
Q ss_pred CCc--------cccccccCcEEEcCCcccccccchhhhcc---CCceEeecCCccccccccccccccceeEEEecCCccc
Q 043720 367 LPS--------SWGACESLEMLNLAQNVLRGDLIGVFDRC---KKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMS 435 (1103)
Q Consensus 367 ~p~--------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l---~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~ 435 (1103)
.+. .+..+++|++|+|++|++++..+..+..+ ++|+.|++++|.+.
T Consensus 196 ~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~~~~----------------------- 252 (455)
T 3v47_A 196 NEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM----------------------- 252 (455)
T ss_dssp STTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTCTTT-----------------------
T ss_pred chhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeecccccc-----------------------
Confidence 221 12344566666666666666665555443 45555555555433
Q ss_pred cccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccc
Q 043720 436 GSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRR 515 (1103)
Q Consensus 436 g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~ 515 (1103)
+.... .+++.+.
T Consensus 253 ~~~~~------------------------------------------------------~~~~~~~-------------- 264 (455)
T 3v47_A 253 GSSFG------------------------------------------------------HTNFKDP-------------- 264 (455)
T ss_dssp SCCTT------------------------------------------------------CCSSCCC--------------
T ss_pred ccccc------------------------------------------------------hhhhccC--------------
Confidence 21100 0000000
Q ss_pred cceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCE
Q 043720 516 TDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVF 595 (1103)
Q Consensus 516 ~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 595 (1103)
....+.+ ...++|++|++++|++++..|..|..+++|++
T Consensus 265 ----------------------------------~~~~~~~-------~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~ 303 (455)
T 3v47_A 265 ----------------------------------DNFTFKG-------LEASGVKTCDLSKSKIFALLKSVFSHFTDLEQ 303 (455)
T ss_dssp ----------------------------------CTTTTGG-------GTTSCCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred ----------------------------------ccccccc-------ccccCceEEEecCccccccchhhcccCCCCCE
Confidence 0000000 01267899999999999888889999999999
Q ss_pred EEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccC
Q 043720 596 LDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKL 675 (1103)
Q Consensus 596 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 675 (1103)
|+|++|++++..|..|..+++|++|+|++|++++..|..|..+++|++|+|++|++++..|..+..+++|++|+|++|+|
T Consensus 304 L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 383 (455)
T 3v47_A 304 LTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQL 383 (455)
T ss_dssp EECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCcc
Confidence 99999999987788899999999999999999888888899999999999999999888788899999999999999999
Q ss_pred cCCCCccccCCCCCceEeCCCC
Q 043720 676 SGHLPSGLANVTSLSIFNASFN 697 (1103)
Q Consensus 676 ~~~~p~~l~~l~~L~~l~l~~N 697 (1103)
++..+..+..+++|+.|++++|
T Consensus 384 ~~~~~~~~~~l~~L~~L~l~~N 405 (455)
T 3v47_A 384 KSVPDGIFDRLTSLQKIWLHTN 405 (455)
T ss_dssp SCCCTTTTTTCTTCCEEECCSS
T ss_pred ccCCHhHhccCCcccEEEccCC
Confidence 8766677788888888765544
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=403.32 Aligned_cols=499 Identities=21% Similarity=0.187 Sum_probs=384.3
Q ss_pred EEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcC
Q 043720 112 LSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQV 191 (1103)
Q Consensus 112 L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l 191 (1103)
.+-++-+++ .+|+.+. +++++|||++|+|++..|..|.++++|++|||++|+|++..|.+|.++++|++|+|++|+|
T Consensus 36 ~~c~~~~l~-~vP~~lp--~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l 112 (635)
T 4g8a_A 36 YQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 112 (635)
T ss_dssp EECTTSCCS-SCCSSSC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred EECCCCCcC-ccCCCCC--cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcC
Confidence 344445565 6787663 5799999999999977778999999999999999999977777899999999999999999
Q ss_pred CCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcccc-ccCccccCCCCCCEEeCCCccCCccccc
Q 043720 192 KGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG-RIPSSLGKCQQLRTLLLFSNMLNDVIPR 270 (1103)
Q Consensus 192 ~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~ 270 (1103)
++..+..|+++++|++|+|++|+++ .+|...+..+++|++|+|++|++++ .+|..++.+++|++|+|++|++++..+.
T Consensus 113 ~~l~~~~f~~L~~L~~L~Ls~N~l~-~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 191 (635)
T 4g8a_A 113 QSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCT 191 (635)
T ss_dssp CEECGGGGTTCTTCCEEECTTSCCC-CSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGG
T ss_pred CCCCHHHhcCCCCCCEEECCCCcCC-CCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccc
Confidence 9887888999999999999999999 5666544556889999999999975 4688899999999999999999998888
Q ss_pred cccCCCCC----CEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 271 ELGWLRKL----EVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 271 ~l~~l~~L----~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
.+..+.++ ..++++.|.++...+..+ ....+..+++.+|.. .....+..
T Consensus 192 ~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~-~~~~~~~l~l~~n~~--------------------------~~~~~~~~ 244 (635)
T 4g8a_A 192 DLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRNNFD--------------------------SLNVMKTC 244 (635)
T ss_dssp GGHHHHTCTTCCCEEECTTCCCCEECTTTT-TTCEEEEEEEESCCS--------------------------SHHHHHHH
T ss_pred cccchhhhhhhhhhhhcccCcccccCcccc-cchhhhhhhhhcccc--------------------------cccccchh
Confidence 88776554 478999999986555444 444566777764311 11223344
Q ss_pred hhccccccccccCCc------cccccCCccccccccCcEEEcCCccccc---ccchhhhccCCceEeecCCccccccccc
Q 043720 347 ITTLSKLRIIWAPRL------NLEGKLPSSWGACESLEMLNLAQNVLRG---DLIGVFDRCKKLHFIDLSSNELSGELDV 417 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n------~l~~~~p~~~~~l~~L~~L~Ls~N~l~~---~~~~~~~~l~~L~~LdLs~N~l~~~~~~ 417 (1103)
+..+..++...+..+ .+.......+..+..+..+++..+.... .....+..+.+++.+++.+|.+... +.
T Consensus 245 ~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~-~~ 323 (635)
T 4g8a_A 245 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLVSVTIERV-KD 323 (635)
T ss_dssp HHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEESCEEEEC-GG
T ss_pred hcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhcccccccccccccccc-cc
Confidence 556666665554322 2333445566777778777776665443 3345677788999999999988753 33
Q ss_pred cccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCc
Q 043720 418 KLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNN 497 (1103)
Q Consensus 418 ~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~ 497 (1103)
......++.|++++|++.+..+. ....+..+.+.+|.
T Consensus 324 ~~~~~~L~~L~l~~~~~~~~~~~-------------------------------------------~l~~L~~l~l~~n~ 360 (635)
T 4g8a_A 324 FSYNFGWQHLELVNCKFGQFPTL-------------------------------------------KLKSLKRLTFTSNK 360 (635)
T ss_dssp GGSCCCCSEEEEESCEESSCCCC-------------------------------------------BCTTCCEEEEESCC
T ss_pred cccchhhhhhhcccccccCcCcc-------------------------------------------cchhhhhccccccc
Confidence 44566789999999988643221 11223344555555
Q ss_pred cccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccc--cCCchhhhcCCCccEEECc
Q 043720 498 FTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIG--HIPLDIGVMCKSLRVLDAS 575 (1103)
Q Consensus 498 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~--~ip~~~~~~~~~L~~L~L~ 575 (1103)
..+++... .......+++++|.+.. ..|...... .+|++|+++
T Consensus 361 ~~~~~~~~----------------------------------~l~~L~~L~ls~n~l~~~~~~~~~~~~~-~~L~~L~~~ 405 (635)
T 4g8a_A 361 GGNAFSEV----------------------------------DLPSLEFLDLSRNGLSFKGCCSQSDFGT-ISLKYLDLS 405 (635)
T ss_dssp SCCBCCCC----------------------------------BCTTCCEEECCSSCCBEEEECCHHHHSC-SCCCEEECC
T ss_pred CCCCcccc----------------------------------cccccccchhhccccccccccccchhhh-hhhhhhhcc
Confidence 54422111 11124578999998853 455555544 899999999
Q ss_pred CCcCCCCCcccccCCCCCCEEEccCCcCCCCCC-cccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccc-cC
Q 043720 576 HNQISGIVPQSLENLTSLVFLDLNGNKLQGEIP-SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL-SG 653 (1103)
Q Consensus 576 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l-~~ 653 (1103)
.|.+.. .+..+..+++|+.+++++|.+....+ ..|..+.+++.+++++|.+++..+..+..++.|++|+|++|.+ .+
T Consensus 406 ~~~~~~-~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L~Ls~N~~~~~ 484 (635)
T 4g8a_A 406 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 484 (635)
T ss_dssp SCSEEE-ECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGG
T ss_pred cccccc-ccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhhhhhhcccccc
Confidence 999984 56678899999999999988775544 5688999999999999999999999999999999999999985 44
Q ss_pred cChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCc---cccccccccCCCCC
Q 043720 654 EVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV---TTMNCSGVIGNPFL 721 (1103)
Q Consensus 654 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~---~~~~~~~l~~Np~~ 721 (1103)
..|..|..+++|+.|+|++|+|++.+|..|.++++|+.|++++|+|++.+|..+ ..++.+++.+|...
T Consensus 485 ~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~ 555 (635)
T 4g8a_A 485 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 555 (635)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCC
T ss_pred cCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCC
Confidence 578889999999999999999999999999999999999999999999888644 46677789998764
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-40 Score=389.96 Aligned_cols=204 Identities=22% Similarity=0.233 Sum_probs=176.4
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCc-cccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEE
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRL-PNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (1103)
++|++|+|++|.+++..|..++++++|++|+|++|.+.+.+ |..|.++++|++|+|++|++++..|..++++++|++|+
T Consensus 30 ~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 109 (455)
T 3v47_A 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLT 109 (455)
T ss_dssp TTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTTCTTCEECTTTTTTCTTCCEEE
T ss_pred CccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCCCccCccChhhccCcccCCEEe
Confidence 78999999999999888999999999999999999998776 56799999999999999999988899999999999999
Q ss_pred ccCCcCCCCCChh--cccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCC--CCCCEEeCCC
Q 043720 186 LAGNQVKGVIPGF--LGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKC--QQLRTLLLFS 261 (1103)
Q Consensus 186 L~~n~l~~~~p~~--l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l--~~L~~L~L~~ 261 (1103)
|++|++++.++.. ++.+++|++|+|++|++++..|..++..+++|++|++++|++++..+..+..+ .+|+.|++++
T Consensus 110 L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~~~L~~L~l~~ 189 (455)
T 3v47_A 110 LTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSS 189 (455)
T ss_dssp CTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBSCCCTTTSGGGTTCEEEEEECTT
T ss_pred CCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcccccChhhhhcccccccccccccc
Confidence 9999999866554 89999999999999999977787755567889999999999998888888876 6899999999
Q ss_pred ccCCcccccc--------ccCCCCCCEEEccCCcCCCcCCccccCC---CCCCeEecccC
Q 043720 262 NMLNDVIPRE--------LGWLRKLEVLDVSRNRLNGLIPTELGNC---VELSVLVLSNL 310 (1103)
Q Consensus 262 N~l~~~~p~~--------l~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~l~~~ 310 (1103)
|.+++..+.. +..+++|+.|++++|++++.+|..+..+ ++|+.|++++|
T Consensus 190 n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~l~~~ 249 (455)
T 3v47_A 190 ITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNS 249 (455)
T ss_dssp CBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEECTTC
T ss_pred CcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEeeccc
Confidence 9998865443 3356789999999999988877777654 67777777753
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=402.09 Aligned_cols=252 Identities=23% Similarity=0.300 Sum_probs=209.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|..+ +|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+.+.+|+||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 57999999999999999999665 6899999998765433 457789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC--CCEEEeecccccccCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD--FNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~ki~Dfgla~~~~~~~ 977 (1103)
|++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 236 ~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 236 MSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred cCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999996543 3599999999999999999999999 99999999999999854 899999999999875332
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....+||+.|||||++.+..|+.++||||+||++|||++|+.||..... ......+.... . .+...
T Consensus 312 --~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~--------~~~~~~i~~~~-~--~~~~~ 378 (573)
T 3uto_A 312 --SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND--------DETLRNVKSCD-W--NMDDS 378 (573)
T ss_dssp --EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTC-C--CCCSG
T ss_pred --ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH--------HHHHHHHHhCC-C--CCCcc
Confidence 33455899999999999999999999999999999999999999973221 11122221111 0 01111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+..+.+||.+||+.||++||++.|+++|
T Consensus 379 ----~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H 411 (573)
T 3uto_A 379 ----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 411 (573)
T ss_dssp ----GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ----cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 123445778999999999999999999999875
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=379.25 Aligned_cols=259 Identities=24% Similarity=0.413 Sum_probs=217.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 890 (1103)
.++|++.+.||+|+||+||+|... ++..||||+++........+.+.+|+.+++++ +||||+++++++...
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 357899999999999999999753 35679999998776666778899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
+..|+||||+++|+|.++++.... ..+++.++..++.||+.||+|||++ +|+||||||+||++
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999987532 3478999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1103)
+.++.+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~----- 311 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 311 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH-----
Confidence 99999999999999876543322 2334567889999999999999999999999999999999 8888863211
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
. ..... ... ......+..++..+.+++.+||+.||++||+++|+++.|+++.
T Consensus 312 ~---~~~~~-~~~---------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il 363 (370)
T 2psq_A 312 E---ELFKL-LKE---------GHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363 (370)
T ss_dssp G---GHHHH-HHT---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H---HHHHH-Hhc---------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 11111 111 1122334566788999999999999999999999999999975
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=385.03 Aligned_cols=404 Identities=24% Similarity=0.275 Sum_probs=220.2
Q ss_pred CCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCC-------------CEEEccCCcCCCCC
Q 043720 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESL-------------EVLNLAGNQVKGVI 195 (1103)
Q Consensus 129 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-------------~~L~L~~n~l~~~~ 195 (1103)
+.++|++|++++|.+ |.+|++++++++|++|++++|+++|.+|.+++++++| ++|++++|.+++ +
T Consensus 9 ~~~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~-l 86 (454)
T 1jl5_A 9 SNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSS-L 86 (454)
T ss_dssp --------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSC-C
T ss_pred ccccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCcccc-C
Confidence 468999999999999 7999999999999999999999999999999998875 777777777775 3
Q ss_pred ChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCC
Q 043720 196 PGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWL 275 (1103)
Q Consensus 196 p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 275 (1103)
|.. .++|++|++++|++++ +|.. .++|++|++++|++++ +|.. .++|++|++++|++++ +| +++.+
T Consensus 87 p~~---~~~L~~L~l~~n~l~~-lp~~----~~~L~~L~l~~n~l~~-l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l 152 (454)
T 1jl5_A 87 PEL---PPHLESLVASCNSLTE-LPEL----PQSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNNQLEK-LP-ELQNS 152 (454)
T ss_dssp CSC---CTTCSEEECCSSCCSS-CCCC----CTTCCEEECCSSCCSC-CCSC---CTTCCEEECCSSCCSS-CC-CCTTC
T ss_pred CCC---cCCCCEEEccCCcCCc-cccc----cCCCcEEECCCCccCc-ccCC---CCCCCEEECcCCCCCC-Cc-ccCCC
Confidence 332 2577777777777774 6643 2567777777777764 3321 1567777777777776 55 47777
Q ss_pred CCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccc
Q 043720 276 RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRI 355 (1103)
Q Consensus 276 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~ 355 (1103)
++|++|++++|++++ +|..+ .+|++|++++ |.+.+ +| .++.+++|+.
T Consensus 153 ~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~---------------------------n~l~~-l~-~~~~l~~L~~ 199 (454)
T 1jl5_A 153 SFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGN---------------------------NQLEE-LP-ELQNLPFLTA 199 (454)
T ss_dssp TTCCEEECCSSCCSC-CCCCC---TTCCEEECCS---------------------------SCCSS-CC-CCTTCTTCCE
T ss_pred CCCCEEECCCCcCcc-cCCCc---ccccEEECcC---------------------------CcCCc-Cc-cccCCCCCCE
Confidence 777777777777774 45433 3666666664 22222 34 3556666666
Q ss_pred cccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEecCCccc
Q 043720 356 IWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMS 435 (1103)
Q Consensus 356 L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~ 435 (1103)
|++++|.+.+ +|... ++|++|++++|+++. +| .|..+++|++|++++|++++. |. .+++|+.|++++|+++
T Consensus 200 L~l~~N~l~~-l~~~~---~~L~~L~l~~n~l~~-lp-~~~~l~~L~~L~l~~N~l~~l-~~--~~~~L~~L~l~~N~l~ 270 (454)
T 1jl5_A 200 IYADNNSLKK-LPDLP---LSLESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLKTL-PD--LPPSLEALNVRDNYLT 270 (454)
T ss_dssp EECCSSCCSS-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCSSC-CS--CCTTCCEEECCSSCCS
T ss_pred EECCCCcCCc-CCCCc---CcccEEECcCCcCCc-cc-ccCCCCCCCEEECCCCcCCcc-cc--cccccCEEECCCCccc
Confidence 6666666654 33222 356666666666653 23 255666666666666666542 21 1245555555555554
Q ss_pred cccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccc
Q 043720 436 GSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRR 515 (1103)
Q Consensus 436 g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~ 515 (1103)
+ +|.. +
T Consensus 271 ~-l~~~---------------------------------------------------------------~---------- 276 (454)
T 1jl5_A 271 D-LPEL---------------------------------------------------------------P---------- 276 (454)
T ss_dssp C-CCCC---------------------------------------------------------------C----------
T ss_pred c-cCcc---------------------------------------------------------------c----------
Confidence 3 2210 0
Q ss_pred cceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCC-CCCC
Q 043720 516 TDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENL-TSLV 594 (1103)
Q Consensus 516 ~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l-~~L~ 594 (1103)
.....+++++|++++ +|. ..++|++|++++|+++++ + .+ ++|+
T Consensus 277 --------------------------~~L~~L~ls~N~l~~-l~~----~~~~L~~L~l~~N~l~~i-~----~~~~~L~ 320 (454)
T 1jl5_A 277 --------------------------QSLTFLDVSENIFSG-LSE----LPPNLYYLNASSNEIRSL-C----DLPPSLE 320 (454)
T ss_dssp --------------------------TTCCEEECCSSCCSE-ESC----CCTTCCEEECCSSCCSEE-C----CCCTTCC
T ss_pred --------------------------CcCCEEECcCCccCc-ccC----cCCcCCEEECcCCcCCcc-c----CCcCcCC
Confidence 012356777777765 221 115788999999998853 2 23 5899
Q ss_pred EEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccC--cChhhhhhccccccccccc
Q 043720 595 FLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSG--EVPEGVVNLRNLTALLLDN 672 (1103)
Q Consensus 595 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~L~~ 672 (1103)
+|++++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|++|++++|++++ .+|..+..+ +.
T Consensus 321 ~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ip~~l~~L--------~~ 384 (454)
T 1jl5_A 321 ELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPDIPESVEDL--------RM 384 (454)
T ss_dssp EEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCCCCTTCCEE--------EC
T ss_pred EEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCCChHHHHhh--------hh
Confidence 99999999985 6654 578999999999998 4665 47889999999999987 566655433 34
Q ss_pred ccCcCCCCccccCCCCCceEeCCCCCCCC--CCCCCccccccccccCCCCCC
Q 043720 673 NKLSGHLPSGLANVTSLSIFNASFNNLSG--PFPWNVTTMNCSGVIGNPFLD 722 (1103)
Q Consensus 673 N~l~~~~p~~l~~l~~L~~l~l~~N~l~~--~~p~~~~~~~~~~l~~Np~~c 722 (1103)
|.+.+.+|.. +++|+.|++++|++++ .+|.. +..+.+.+|.+.|
T Consensus 385 n~~~~~i~~~---~~~L~~L~ls~N~l~~~~~iP~s---l~~L~~~~~~~~~ 430 (454)
T 1jl5_A 385 NSHLAEVPEL---PQNLKQLHVETNPLREFPDIPES---VEDLRMNSERVVD 430 (454)
T ss_dssp CC--------------------------------------------------
T ss_pred cccccccccc---cCcCCEEECCCCcCCccccchhh---HhheeCcCcccCC
Confidence 6666666653 4678888888888887 44433 3444555555544
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=373.58 Aligned_cols=261 Identities=26% Similarity=0.427 Sum_probs=216.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|... .+..||||++.........+.+.+|+.++++++||||+++++++.+++..|+|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 56888999999999999999774 35569999998776666678899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.++++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.....
T Consensus 129 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 204 (325)
T 3kul_A 129 TEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDD 204 (325)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred eeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccC
Confidence 99999999999997653 3589999999999999999999999 9999999999999999999999999999876543
Q ss_pred CCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ........
T Consensus 205 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~--------~~~~~~~~-------- 268 (325)
T 3kul_A 205 PDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN--------RDVISSVE-------- 268 (325)
T ss_dssp --CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH--------HHHHHHHH--------
T ss_pred ccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHH--------
Confidence 222 2233456788999999998899999999999999999999 9999863211 11111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
.......+..++..+.+++.+||+.||++||+++||++.|+++.++|+
T Consensus 269 --~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~ 316 (325)
T 3kul_A 269 --EGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE 316 (325)
T ss_dssp --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred --cCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence 111223345667889999999999999999999999999999987764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=360.50 Aligned_cols=283 Identities=33% Similarity=0.582 Sum_probs=230.4
Q ss_pred CCCCHHHHHHHhcCCCCc------ceeccCCcccEEEEEEcCCcEEEEEEccccc---chhhHHHHHHHHHHHhcCCCCc
Q 043720 809 VPLTYESIIRATGDFNTS------NCIGSGGFGTTYKAEISPGILVAVKKLAVGR---FQHGVQQFHAEIKTLGNVRHPN 879 (1103)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~------~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~n 879 (1103)
..+++.++..++++|... +.||+|+||+||+|.. +++.||||++.... .....+.+.+|+.++++++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 457899999999998887 8999999999999986 48899999987542 2345678999999999999999
Q ss_pred eeEEEeEEecCCeEEEEEeecCCCChHHHHHhhc-CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC
Q 043720 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKART-SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD 958 (1103)
Q Consensus 880 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~ 958 (1103)
|+++++++.+.+..++||||+++++|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDE 168 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECT
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcC
Confidence 9999999999999999999999999999997543 34589999999999999999999999 9999999999999999
Q ss_pred CCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcch
Q 043720 959 DFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNI 1037 (1103)
Q Consensus 959 ~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~ 1037 (1103)
++.+||+|||++......... ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||...... ...
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~ 243 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP----QLL 243 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS----SBT
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch----HHH
Confidence 999999999999876443222 2334578999999998865 4789999999999999999999999754321 122
Q ss_pred HHHHHHHHhcC-cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1038 ISWASMLLRQG-QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1038 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
..+........ .....++... ...+...+..+.+++.+||+.||++||++++++++|+++.+|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s 307 (307)
T 2nru_A 244 LDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307 (307)
T ss_dssp THHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred HHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence 22322222211 1222223222 334667788999999999999999999999999999999864
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=360.67 Aligned_cols=257 Identities=24% Similarity=0.389 Sum_probs=217.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|...+++.||||++...... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 468899999999999999999988999999999765433 467899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.++++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 88 ~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 163 (269)
T 4hcu_A 88 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 163 (269)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccccc
Confidence 9999999997644 4589999999999999999999999 99999999999999999999999999998765444344
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+++.|+|||.+.+..++.++||||+|+++|||++ |+.||.... .......... ...
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~--------~~~~~~~~~~----------~~~ 225 (269)
T 4hcu_A 164 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDIST----------GFR 225 (269)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHT----------TCC
T ss_pred ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCC--------HHHHHHHHhc----------Ccc
Confidence 455667889999999998999999999999999999999 888886321 1111111111 111
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
...+...+..+.+++.+||+.||++||+++|++++|+++..+
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~ 267 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 267 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence 222344567899999999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=365.64 Aligned_cols=259 Identities=27% Similarity=0.423 Sum_probs=213.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|.+.+.||+|+||+||+|... +++.||+|++... .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 56889999999999999999765 5899999988553 344567899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 89 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 89 IKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp CTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccccc
Confidence 99999999998743 4589999999999999999999999 9999999999999999999999999999876433221
Q ss_pred c-------------ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 980 A-------------TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 980 ~-------------~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
. .....||+.|+|||++.+..++.++||||||+++|||++|..|+..............
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~-------- 236 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-------- 236 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCH--------
T ss_pred ccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhh--------
Confidence 1 1245799999999999999999999999999999999999999875433221111100
Q ss_pred cCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
........+..++..+.+++.+||+.||++|||++|+++.|+++++
T Consensus 237 --------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~ 282 (310)
T 3s95_A 237 --------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRM 282 (310)
T ss_dssp --------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 0001111234455678999999999999999999999999999864
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=367.40 Aligned_cols=262 Identities=28% Similarity=0.434 Sum_probs=208.4
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
...++|++.+.||+|+||+||+|... ++.||||++..... ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 34 i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 3p86_A 34 IPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIV 112 (309)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEE
T ss_pred CChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEE
Confidence 34567999999999999999999874 88999999876543 34467899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCC--cccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 897 YNYLPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPR--VLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|||+++|+|.++++.... ..+++..++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|||+++..
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 113 TEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 999999999999986432 3489999999999999999999999 8 999999999999999999999999999754
Q ss_pred CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||..... ..........
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~--------~~~~~~~~~~------ 254 (309)
T 3p86_A 190 AST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP--------AQVVAAVGFK------ 254 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHHHS------
T ss_pred ccc-ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhc------
Confidence 322 2233456789999999999999999999999999999999999999973211 1111111101
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
......+...+..+.+++.+||+.||++|||++|+++.|+.+.++
T Consensus 255 ---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 255 ---CKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp ---CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ---CCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 111233455667899999999999999999999999999998654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=377.43 Aligned_cols=260 Identities=25% Similarity=0.459 Sum_probs=206.3
Q ss_pred cCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|... .+..||||+++........+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 47999999999999999999765 57789999998766666678899999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 125 ~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 125 TEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp EECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 99999999999998643 4589999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ......
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~--------~~~~~~---------- 262 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN--------QDVIKA---------- 262 (373)
T ss_dssp -------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH--------HHHHHH----------
T ss_pred CccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHH----------
Confidence 221 1222345778999999999999999999999999999998 9999863211 111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
+........+..++..+.+++.+||+.||++||+++||++.|+++.+.|
T Consensus 263 i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~ 311 (373)
T 2qol_A 263 VDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP 311 (373)
T ss_dssp HHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred HHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence 1112223344566788999999999999999999999999999987654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=381.36 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=215.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|.+. +++.||||++.........+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 356888999999999999999876 6899999999866555556778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~ 268 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY 268 (377)
T ss_dssp CCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred cCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence 999999999998653 3489999999999999999999999 999999999999999999999999999986543222
Q ss_pred ccc-cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 979 HAT-TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 979 ~~~-~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
... ....+++.|+|||.+....++.++||||||+++|||++ |..||..... .. ...... .
T Consensus 269 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~--------~~-~~~~~~---------~ 330 (377)
T 3cbl_A 269 AASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN--------QQ-TREFVE---------K 330 (377)
T ss_dssp ECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH--------HH-HHHHHH---------T
T ss_pred eecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH--------HH-HHHHHH---------c
Confidence 211 12345778999999998889999999999999999998 8888863211 11 111111 1
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......+..++..+.+++.+||+.||++|||++++++.|+++++
T Consensus 331 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~ 374 (377)
T 3cbl_A 331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRK 374 (377)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHh
Confidence 12223455667889999999999999999999999999999875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.77 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=217.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||+||+|+..++..||||++...... .+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 3578999999999999999999998889999999765433 46789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 160 (268)
T 3sxs_A 85 ISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV 160 (268)
T ss_dssp CTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred cCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence 99999999998753 3589999999999999999999999 9999999999999999999999999999877555444
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......+++.|+|||.+.+..++.++||||+|+++|||++ |+.||..... ........ .. .
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~~~~-~~---------~ 222 (268)
T 3sxs_A 161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN--------SEVVLKVS-QG---------H 222 (268)
T ss_dssp ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHH-TT---------C
T ss_pred cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh--------HHHHHHHH-cC---------C
Confidence 4455667889999999998889999999999999999999 9999863211 11111111 11 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+...+..+.+++.+||+.||++|||++|++++|++++..
T Consensus 223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (268)
T 3sxs_A 223 RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265 (268)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence 1122334567799999999999999999999999999999764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=362.92 Aligned_cols=249 Identities=27% Similarity=0.410 Sum_probs=210.4
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 45799999999999999999976 5799999999976543 345677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp CCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred ECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 9999999999998754 389999999999999999999999 9999999999999999999999999999876433
Q ss_pred CccccCCcccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVS-DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
......+||+.|+|||++.+..++ .++||||+||++|||++|+.||.... ............
T Consensus 168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~-------- 230 (328)
T 3fe3_A 168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN--------LKELRERVLRGK-------- 230 (328)
T ss_dssp -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC--------
T ss_pred -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC--------
Confidence 234556899999999999888765 78999999999999999999997321 122222222111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++|||++|++++
T Consensus 231 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 265 (328)
T 3fe3_A 231 ---YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD 265 (328)
T ss_dssp ---CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred ---CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 12234456778999999999999999999999875
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=358.92 Aligned_cols=251 Identities=24% Similarity=0.393 Sum_probs=210.4
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|+.++++++||||+++++++...+..|+|||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc-HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 35799999999999999999975 56899999998765433 35678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.++++... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (297)
T ss_dssp CCTTCBHHHHHHHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCCCHHHHHhhcC---CCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc-
Confidence 999999999998653 89999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.......||+.|+|||++.+..++.++||||+|+++|||++|+.||..... ............ .
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~--------~ 234 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRALYLIATNGT--------P 234 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHHHHCS--------C
T ss_pred cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC--------C
Confidence 234456799999999999999999999999999999999999999973211 111111111111 0
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+...+..+.+++.+||+.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 270 (297)
T 3fxz_A 235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 270 (297)
T ss_dssp CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 112244566789999999999999999999999874
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=364.95 Aligned_cols=272 Identities=27% Similarity=0.410 Sum_probs=212.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC----eEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----EMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~l 895 (1103)
.++|++.+.||+|+||+||+|+.. ++.||||++..... ....+.+|+.++++++||||+++++++.... .+++
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 457999999999999999999877 89999999875432 3455667999999999999999999987743 4799
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC-------CCCcccCCCCCCcEEECCCCCEEEeecc
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC-------APRVLHRDVKPSNILLDDDFNAYLSDFG 968 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 968 (1103)
||||+++|+|.++++... +++..+..++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|||
T Consensus 100 v~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKANV---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEecCCCCCHHHHHHhcC---CCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999997643 999999999999999999999752 3389999999999999999999999999
Q ss_pred cccccCCCCCc-cccCCcccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc-------
Q 043720 969 LSRLLGTSETH-ATTGVAGTFGYVAPEYALT-----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF------- 1035 (1103)
Q Consensus 969 la~~~~~~~~~-~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~------- 1035 (1103)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 99876543322 2344679999999999976 3556688999999999999999999975443222111
Q ss_pred -chHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1036 -NIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1036 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+.... ............. .....+..+.+++.+||+.||++|||++||++.|++|++.
T Consensus 257 ~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 257 PSLEDMQEVV-VHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp CCHHHHHHHH-TTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred Cchhhhhhhh-hcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 111111111 1111111111111 1235667799999999999999999999999999998753
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=356.94 Aligned_cols=262 Identities=24% Similarity=0.433 Sum_probs=210.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 57999999999999999999754 689999999865432 344678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 91 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 165 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS 165 (294)
T ss_dssp ECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccccccc
Confidence 9999999999998764 489999999999999999999999 99999999999999999999999999998765444
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
........||+.|+|||.+.+..++.++||||+|+++|||++|+.||..... ........... .. .
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~-~~-----~ 231 (294)
T 4eqm_A 166 LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--------VSIAIKHIQDS-VP-----N 231 (294)
T ss_dssp ---------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--------HHHHHHHHSSC-CC-----C
T ss_pred ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhhcc-CC-----C
Confidence 4444556799999999999999999999999999999999999999974321 11111111111 10 1
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhcC
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRP-TMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~ 1101 (1103)
.........+..+.+++.+|++.||++|| +++++.+.|+++.+.
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11112344567899999999999999999 999999999987654
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=385.60 Aligned_cols=257 Identities=23% Similarity=0.415 Sum_probs=216.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||+||+|.+.++..||||+++.... ..+.+.+|+.++++++||||+++++++. .+..|+||||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~ 263 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEF 263 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEee
Confidence 346888999999999999999998899999999976542 4678999999999999999999999986 5678999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.++++......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 264 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~ 340 (454)
T 1qcf_A 264 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 340 (454)
T ss_dssp CTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCcee
Confidence 9999999999876544588999999999999999999999 9999999999999999999999999999876443333
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......+++.|+|||++....++.++|||||||++|||++ |+.||.... ......... ...
T Consensus 341 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~--------~~~~~~~i~----------~~~ 402 (454)
T 1qcf_A 341 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS--------NPEVIRALE----------RGY 402 (454)
T ss_dssp TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHHH----------HTC
T ss_pred ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCC--------HHHHHHHHH----------cCC
Confidence 3344556889999999998899999999999999999999 999986321 111111111 112
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
....+..++..+.++|.+||+.||++|||+++|++.|+++..
T Consensus 403 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 403 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 223455677889999999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=376.39 Aligned_cols=271 Identities=23% Similarity=0.358 Sum_probs=221.4
Q ss_pred CCCHHHHHHHhcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeE
Q 043720 810 PLTYESIIRATGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVT 882 (1103)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 882 (1103)
|+...+++...++|++.+.||+|+||+||+|.+ .+++.||||++.........+.+.+|+.+++++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 455566666778999999999999999999964 245889999998776666678899999999999 7999999
Q ss_pred EEeEEecCC-eEEEEEeecCCCChHHHHHhhcC-----------------------------------------------
Q 043720 883 LIGYRASGN-EMFLIYNYLPGGNLENFIKARTS----------------------------------------------- 914 (1103)
Q Consensus 883 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~----------------------------------------------- 914 (1103)
+++++.+.+ ..++||||+++|+|.++++....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999988754 58999999999999999986542
Q ss_pred -----------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 915 -----------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 915 -----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1288999999999999999999999 99999999999999999999999999998664333
Q ss_pred C-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 978 T-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 978 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...... ..........
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--------~~~~~~~~~~------- 312 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--------EEFCRRLKEG------- 312 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS--------HHHHHHHHHT-------
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh--------HHHHHHHHcC-------
Confidence 2 23345678899999999999999999999999999999998 99998633211 1111111111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+...+..+.+++.+||+.||++||+++|++++|+++.+
T Consensus 313 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 355 (359)
T 3vhe_A 313 --TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 355 (359)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1122344556789999999999999999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=374.62 Aligned_cols=261 Identities=21% Similarity=0.340 Sum_probs=215.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||+||+|.+. +++.||||++...........+.+|+.++++++||||+++++++...+..+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 56889999999999999999753 467899999987666666778999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcC-----CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEEEee
Q 043720 895 LIYNYLPGGNLENFIKARTS-----RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAYLSD 966 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~D 966 (1103)
+||||+++|+|.++++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECC
Confidence 99999999999999987542 3589999999999999999999999 999999999999999555 599999
Q ss_pred cccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 967 FGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 967 fgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.... ........
T Consensus 228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~--------~~~~~~~i 299 (367)
T 3l9p_A 228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEFV 299 (367)
T ss_dssp CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHHH
T ss_pred CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH
Confidence 999976532222 22334567899999999999999999999999999999998 888886321 11112111
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
... .....+..++..+.+++.+||+.||++||+++||+++|+.+.+.|
T Consensus 300 ~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~ 347 (367)
T 3l9p_A 300 TSG----------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 347 (367)
T ss_dssp HTT----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred HcC----------CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence 111 112234456678999999999999999999999999999987654
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=358.36 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=214.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||+||+|.+.++..||||++...... .+++.+|+.++++++||||+++++++.+.+..++||||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 4578899999999999999999998899999999765433 46789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 101 ~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 176 (283)
T 3gen_A 101 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 176 (283)
T ss_dssp CTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred cCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence 99999999998643 3489999999999999999999999 9999999999999999999999999999876544333
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......+++.|+|||++.+..++.++||||+|+++|||++ |+.||..... ........ . ..
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~--------~~~~~~~~-~---------~~ 238 (283)
T 3gen_A 177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN--------SETAEHIA-Q---------GL 238 (283)
T ss_dssp STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH--------HHHHHHHH-T---------TC
T ss_pred cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh--------hHHHHHHh-c---------cc
Confidence 4445567889999999998899999999999999999998 9999873211 11111111 1 11
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+...+..+.+++.+||+.||++||+++|++++|+++...
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 239 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 1222344567899999999999999999999999999998643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-39 Score=386.11 Aligned_cols=258 Identities=24% Similarity=0.428 Sum_probs=218.7
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.+|++.+.||+|+||+||+|.+.. +..||||+++.... ..+.|.+|+.++++++||||+++++++...+..|+||||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~ 297 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 297 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc--chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence 468889999999999999998775 88999999976533 357899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.++++......+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++........
T Consensus 298 ~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 374 (495)
T 1opk_A 298 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT 374 (495)
T ss_dssp CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEE
T ss_pred cCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCcee
Confidence 9999999999876666699999999999999999999999 9999999999999999999999999999876544333
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......+++.|+|||++....++.++|||||||++|||++ |+.||..... .... . .+....
T Consensus 375 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~-----~~~~---~----------~~~~~~ 436 (495)
T 1opk_A 375 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQVY---E----------LLEKDY 436 (495)
T ss_dssp CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GGHH---H----------HHHTTC
T ss_pred ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH-----HHHH---H----------HHHcCC
Confidence 3445567789999999998899999999999999999999 8888863221 1111 1 111122
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+..++..+.++|.+||+.||++||++++|++.|+++.+.
T Consensus 437 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~ 479 (495)
T 1opk_A 437 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 479 (495)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence 2334566778899999999999999999999999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=372.27 Aligned_cols=260 Identities=25% Similarity=0.414 Sum_probs=218.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 890 (1103)
.++|.+.+.||+|+||+||+|... .+..||||++.........+.+.+|+++++++ +||||+++++++...
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 357889999999999999999753 24679999998776666778899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
+..++||||+++|+|.++++.... ..+++.++++++.|++.||+|||++ +|+||||||+||++
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 224 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 224 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEE
Confidence 999999999999999999987542 3589999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1103)
++++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 225 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~------ 298 (382)
T 3tt0_A 225 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------ 298 (382)
T ss_dssp CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC------
Confidence 9999999999999987654332 23344567889999999999999999999999999999999 998886321
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
........ ..+ .....+..++.++.+++.+||+.||++||+++||+++|+++.+
T Consensus 299 --~~~~~~~~-~~~---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 352 (382)
T 3tt0_A 299 --VEELFKLL-KEG---------HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 352 (382)
T ss_dssp --HHHHHHHH-HTT---------CCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHH-HcC---------CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11122111 111 1222344567789999999999999999999999999999854
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=367.75 Aligned_cols=262 Identities=26% Similarity=0.422 Sum_probs=217.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
..++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++||||+++++++...+.
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 124 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 124 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence 3568999999999999999999775 3488999999876666667889999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcC----------------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCC
Q 043720 893 MFLIYNYLPGGNLENFIKARTS----------------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVK 950 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk 950 (1103)
.++||||+++|+|.++++.... ..+++.+++.++.||++||+|||++ +|+|||||
T Consensus 125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlk 201 (343)
T 1luf_A 125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 201 (343)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCC
Confidence 9999999999999999987421 4589999999999999999999999 99999999
Q ss_pred CCcEEECCCCCEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 043720 951 PSNILLDDDFNAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSF 1028 (1103)
Q Consensus 951 ~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~ 1028 (1103)
|+||+++.++.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 281 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence 9999999999999999999987643322 22334567899999999998899999999999999999999 888986321
Q ss_pred CCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1029 SSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....... ...+. ....+..++..+.+++.+||+.||++||+++|+++.|+++...
T Consensus 282 --------~~~~~~~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~ 336 (343)
T 1luf_A 282 --------HEEVIYY-VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336 (343)
T ss_dssp --------HHHHHHH-HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred --------hHHHHHH-HhCCC---------cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhh
Confidence 1111111 11111 1123445667899999999999999999999999999998754
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=363.55 Aligned_cols=261 Identities=25% Similarity=0.393 Sum_probs=218.1
Q ss_pred hcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|.+.+.||+|+||+||+|.. .+++.||||++.........+.+.+|+.++++++||||+++++++.+.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 45789999999999999999975 235889999998766666678899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC----------------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCC
Q 043720 894 FLIYNYLPGGNLENFIKARTS----------------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKP 951 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~ 951 (1103)
++||||+++++|.++++.... ..+++.+++.++.|++.||+|||++ +|+||||||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp 178 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAA 178 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSG
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccch
Confidence 999999999999999987532 3489999999999999999999999 999999999
Q ss_pred CcEEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCC
Q 043720 952 SNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFS 1029 (1103)
Q Consensus 952 ~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~ 1029 (1103)
+||+++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 258 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999999999999999876443322 2334467889999999998889999999999999999999 9999863321
Q ss_pred CCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1030 SHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1030 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
... . ...... .....+..++..+.+++.+||+.||++||+++|++++|+++...
T Consensus 259 -----~~~---~-~~~~~~---------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 259 -----ERL---F-NLLKTG---------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp -----GGH---H-HHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----HHH---H-HHhhcC---------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 111 1 111111 11223445678899999999999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=358.05 Aligned_cols=249 Identities=23% Similarity=0.291 Sum_probs=209.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|+.. +++.||||++.... .....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57899999999999999999765 58999999997653 2334677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 85 E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 158 (337)
T 1o6l_A 85 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccC-
Confidence 9999999999998654 489999999999999999999999 9999999999999999999999999999864322
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............
T Consensus 159 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~--------- 221 (337)
T 1o6l_A 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HERLFELILMEE--------- 221 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---------
T ss_pred CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCC--------HHHHHHHHHcCC---------
Confidence 223445689999999999999999999999999999999999999997321 111222221111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h 261 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence 123445667899999999999999999 89999865
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=356.02 Aligned_cols=263 Identities=23% Similarity=0.322 Sum_probs=216.1
Q ss_pred CCCCCHHHHHHHhcC----------CCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC
Q 043720 808 GVPLTYESIIRATGD----------FNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876 (1103)
Q Consensus 808 ~~~~~~~~~~~~~~~----------~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 876 (1103)
..+++++++..+++. |+..+.||+|+||+||+|... +|+.||||++..... ...+.+.+|+.++++++
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~ 100 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ-QRRELLFNEVVIMRDYQ 100 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CSHHHHHHHHHHHTTCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch-hHHHHHHHHHHHHHhCC
Confidence 356788888887764 666789999999999999876 699999999875543 34677889999999999
Q ss_pred CCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 877 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
||||+++++++...+..++||||+++++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||++
T Consensus 101 h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll 174 (321)
T 2c30_A 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL 174 (321)
T ss_dssp CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence 999999999999999999999999999999998753 489999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFN 1036 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1103)
+.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~-------- 245 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS-------- 245 (321)
T ss_dssp CTTCCEEECCCTTCEECCSSS-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------
T ss_pred CCCCcEEEeeeeeeeecccCc-cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--------
Confidence 999999999999998764332 23345679999999999999999999999999999999999999997321
Q ss_pred hHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1037 IISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......... .... . .......+..+.+++.+||+.||++||+++|++++
T Consensus 246 ~~~~~~~~~~-~~~~-----~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 295 (321)
T 2c30_A 246 PVQAMKRLRD-SPPP-----K--LKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH 295 (321)
T ss_dssp HHHHHHHHHH-SSCC-----C--CTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHhc-CCCC-----C--cCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111 1100 0 11223456779999999999999999999999975
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=355.72 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=202.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|++.+.||+|+||+||+|.... +..||+|++.........+.+.+|+..+++++||||+++++++. .+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 3578999999999999999997643 46799999887666666788999999999999999999999985 457899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++++|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 93 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 168 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 168 (281)
T ss_dssp EEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCc
Confidence 999999999999998653 3589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
..........+++.|+|||++....++.++||||||+++|||++ |..||..... .. ...... ..
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-----~~---~~~~i~-~~------ 233 (281)
T 1mp8_A 169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----ND---VIGRIE-NG------ 233 (281)
T ss_dssp ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG---HHHHHH-TT------
T ss_pred ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-----HH---HHHHHH-cC------
Confidence 44333444567889999999998899999999999999999997 8888874321 11 111111 11
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 234 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 276 (281)
T 1mp8_A 234 ---ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 276 (281)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 1122345667889999999999999999999999999999854
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=364.43 Aligned_cols=259 Identities=25% Similarity=0.445 Sum_probs=206.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCc----EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGI----LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|++.+.||+|+||+||+|.+. +++ .||+|++.........+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 46899999999999999999754 343 468888876655556788999999999999999999999998765 789
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~ 169 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence 999999999999998754 4589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||..... ... ...
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~----~~~--------- 231 (327)
T 3poz_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEI----SSI--------- 231 (327)
T ss_dssp TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH----HHH---------
T ss_pred CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH-----HHH----HHH---------
Confidence 3332 2334456889999999999999999999999999999999 9999874321 111 111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
+........+..++..+.+++.+||+.||++||+++|++++|+++.+.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~~ 280 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhhh
Confidence 1111122334556778999999999999999999999999999987643
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=377.22 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=211.7
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-eEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN-EMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|.+. ++.||||+++... ..+.+.+|+.++++++||||+++++++.... ..|+||||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred HHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 46888999999999999999887 7899999997654 3577999999999999999999999987654 79999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.++++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 269 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--- 342 (450)
T 1k9a_A 269 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 342 (450)
T ss_dssp CTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc---
Confidence 9999999999987655679999999999999999999999 9999999999999999999999999999854321
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.....+++.|+|||++.+..++.++||||||+++|||++ |+.||...... . .... +. ...
T Consensus 343 -~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-----~---~~~~-i~---------~~~ 403 (450)
T 1k9a_A 343 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-----D---VVPR-VE---------KGY 403 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-----T---HHHH-HH---------TTC
T ss_pred -ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-----H---HHHH-HH---------cCC
Confidence 122356889999999999999999999999999999998 99998643211 1 1111 11 112
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+..++..+.++|.+||+.||++||+++++++.|++|...
T Consensus 404 ~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~ 446 (450)
T 1k9a_A 404 KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446 (450)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence 2334566788999999999999999999999999999998754
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=357.23 Aligned_cols=267 Identities=24% Similarity=0.428 Sum_probs=210.4
Q ss_pred cCCCCcceeccCCcccEEEEEE-----cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 893 (1103)
++|++.+.||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 5789999999999999999974 358899999987543 34567899999999999999999999998553 568
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++|+|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 99999999999999998754 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC---
Q 043720 974 GTSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG--- 1048 (1103)
Q Consensus 974 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 1048 (1103)
..... .......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~---------~~~~~~~~~~~~~ 235 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA---------EFMRMIGNDKQGQ 235 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH---------HHHHHHCTTCCTH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH---------HHHhhhcCccccc
Confidence 43322 122344577889999999999999999999999999999999998863211 0000000000
Q ss_pred ----cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1049 ----QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1049 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
...+.+........+..++..+.+++.+||+.||++|||++|+++.|++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 236 MIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 00011111222334566778899999999999999999999999999998754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=380.95 Aligned_cols=257 Identities=26% Similarity=0.432 Sum_probs=209.6
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|.+..+..||||+++.... ..+.+.+|+.++++++||||+++++++.+ +..++||||+
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~ 260 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred hHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhh
Confidence 46888999999999999999999888999999976543 34679999999999999999999999876 6789999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++|+|.++++...+..+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 261 ~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 337 (452)
T 1fmk_A 261 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 337 (452)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred cCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceec
Confidence 999999999875555689999999999999999999999 99999999999999999999999999998765433333
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+++.|+|||.+....++.++||||||+++|||++ |+.||..... ....... .. ...
T Consensus 338 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~--------~~~~~~i-~~---------~~~ 399 (452)
T 1fmk_A 338 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--------REVLDQV-ER---------GYR 399 (452)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHHHH-HT---------TCC
T ss_pred ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH-Hc---------CCC
Confidence 445567889999999998899999999999999999999 8888863211 1111111 11 122
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
...+..++..+.++|.+||+.||++|||++++++.|+++..+
T Consensus 400 ~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 400 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 234556778899999999999999999999999999998643
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=353.94 Aligned_cols=262 Identities=23% Similarity=0.381 Sum_probs=202.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhc--CCCCceeEEEeEEec----CCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGN--VRHPNLVTLIGYRAS----GNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~ 893 (1103)
.++|++.+.||+|+||+||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ....
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 45799999999999999999987 5899999998654 23445555555555 799999999998644 3568
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHH--------hCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH--------DQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
++||||+++|+|.++++.. .+++..+.+++.|++.||+||| +. +|+||||||+||+++.++.+||+
T Consensus 82 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEEC
T ss_pred EEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999999653 4999999999999999999999 77 99999999999999999999999
Q ss_pred ecccccccCCCCCcc---ccCCcccccccCccccccC------CCCCcchhHHHHHHHHHHHhC----------CCCCCC
Q 043720 966 DFGLSRLLGTSETHA---TTGVAGTFGYVAPEYALTC------RVSDKADVYSYGVVLLELISD----------KKALDP 1026 (1103)
Q Consensus 966 Dfgla~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg----------~~p~~~ 1026 (1103)
|||+++......... .....||+.|+|||++.+. .++.++||||||+++|||++| +.||..
T Consensus 156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~ 235 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235 (301)
T ss_dssp CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence 999997664333221 2345799999999999876 455789999999999999999 777754
Q ss_pred CCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1027 SFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
...... .... ................. ......+..+.+++.+||+.||++|||++||++.|++|.
T Consensus 236 ~~~~~~---~~~~-~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~ 301 (301)
T 3q4u_A 236 VVPNDP---SFED-MRKVVCVDQQRPNIPNR---WFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301 (301)
T ss_dssp TSCSSC---CHHH-HHHHHTTSCCCCCCCGG---GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred cCCCCc---chhh-hhHHHhccCCCCCCChh---hccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence 332211 1111 11111111111111111 123457788999999999999999999999999999873
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=350.86 Aligned_cols=253 Identities=23% Similarity=0.323 Sum_probs=211.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... ++.||||++..... ....+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46999999999999999999886 89999999986543 34567799999999999999999999999887 7889999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCC--cccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR--VLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||+++|+|.++++......+++.++..++.|++.||+|||++ + |+||||||+||+++.++.++|+|||++....
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~- 164 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ- 164 (271)
T ss_dssp ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-
T ss_pred cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec-
Confidence 999999999999876655689999999999999999999998 7 9999999999999999999999999875432
Q ss_pred CCCccccCCcccccccCccccccCCCCC---cchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSD---KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~---~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
.....||+.|+|||.+.+..++. ++||||||+++|||++|+.||.... ...........
T Consensus 165 -----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--------~~~~~~~~~~~----- 226 (271)
T 3kmu_A 165 -----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS--------NMEIGMKVALE----- 226 (271)
T ss_dssp -----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC--------HHHHHHHHHHS-----
T ss_pred -----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC--------hHHHHHHHHhc-----
Confidence 22346799999999998765544 7999999999999999999997321 11111111111
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......+...+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 227 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 227 ----GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp ----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11223345567789999999999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-38 Score=353.51 Aligned_cols=269 Identities=19% Similarity=0.225 Sum_probs=216.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC--eEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN--EMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|.... ++.||||++.........+.+.+|+.++++++||||+++++++.... ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 468999999999999999997664 89999999987665556788899999999999999999999987755 789999
Q ss_pred eecCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE----CCCCCEEEeecccccc
Q 043720 898 NYLPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgla~~ 972 (1103)
||+++++|.++++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999987543 3389999999999999999999999 99999999999999 7888899999999987
Q ss_pred cCCCCCccccCCcccccccCccccc--------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYAL--------TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~--------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
..... ......||+.|+|||++. +..++.++|||||||++|||++|+.||.+..... .........
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~ 239 (319)
T 4euu_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR----RNKEVMYKI 239 (319)
T ss_dssp CCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGG----GCHHHHHHH
T ss_pred cCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccc----hhHHHHHHH
Confidence 64332 233457899999999986 5678899999999999999999999997443221 112222222
Q ss_pred HhcCcccc---c---c--------cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1045 LRQGQVKD---V---F--------NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1045 ~~~~~~~~---~---~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
........ . . +.......+...+..+.+++.+||+.||++||+++|++++..+.
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 22111000 0 0 00111123467788899999999999999999999999998865
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-38 Score=363.84 Aligned_cols=258 Identities=19% Similarity=0.291 Sum_probs=207.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|++.+.||+|+||+||+|+.+ +++.||||+++.... ....+.+.+|..++.++ +||||+++++++.+.+..|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357999999999999999999766 478999999976543 22345678899999887 89999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 131 V~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999998754 499999999999999999999999 999999999999999999999999999985322
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.........................
T Consensus 206 -~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~------ 278 (396)
T 4dc2_A 206 -PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------ 278 (396)
T ss_dssp -TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC------
T ss_pred -CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc------
Confidence 2233456789999999999999999999999999999999999999997443222211112222222221111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTM------KQVVQ 1093 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1093 (1103)
...+...+..+.+++.+||+.||++||++ +||++
T Consensus 279 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~ 318 (396)
T 4dc2_A 279 ----IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 318 (396)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred ----cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence 12344566789999999999999999985 56654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-39 Score=351.02 Aligned_cols=257 Identities=25% Similarity=0.390 Sum_probs=215.9
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|...+++.||+|++...... .+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 468889999999999999999988999999999765433 367899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++++|.++++... ..+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++..........
T Consensus 86 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 161 (267)
T 3t9t_A 86 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 161 (267)
T ss_dssp TTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHS
T ss_pred CCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccc
Confidence 9999999998653 4589999999999999999999999 99999999999999999999999999998764433333
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+++.|+|||++.+..++.++||||+|+++|||++ |+.||.... ......... .+ ..
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~i~-~~---------~~ 223 (267)
T 3t9t_A 162 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS--------NSEVVEDIS-TG---------FR 223 (267)
T ss_dssp TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHH-TT---------CC
T ss_pred cccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCC--------HHHHHHHHh-cC---------Cc
Confidence 345567889999999998889999999999999999999 888886321 111111111 11 11
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
...+...+..+.+++.+||+.||++||+++|++++|+++.++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~ 265 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES 265 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 122344567899999999999999999999999999998754
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-39 Score=356.88 Aligned_cols=259 Identities=25% Similarity=0.418 Sum_probs=219.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
..++|++.+.||+|+||+||+|.... +..||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS--THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 45679999999999999999997764 8899999987543 34678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 165 (288)
T 3kfa_A 89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 165 (288)
T ss_dssp ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSS
T ss_pred EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCc
Confidence 999999999999886666799999999999999999999999 99999999999999999999999999998776554
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
........+++.|+|||++.+..++.++||||+|+++|+|++ |..||..... .. .... +..
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~-----~~---~~~~----------~~~ 227 (288)
T 3kfa_A 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-----SQ---VYEL----------LEK 227 (288)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GG---HHHH----------HHT
T ss_pred cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HH---HHHH----------Hhc
Confidence 444555667889999999998899999999999999999999 8888863221 11 1111 111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......+..++..+.+++.+|++.||++||+++|+++.|+++.+
T Consensus 228 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~ 271 (288)
T 3kfa_A 228 DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271 (288)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHH
Confidence 12223345667889999999999999999999999999998753
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-39 Score=360.37 Aligned_cols=261 Identities=26% Similarity=0.406 Sum_probs=217.3
Q ss_pred hcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 892 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++.........+.+.+|+.+++++ +||||+++++++...+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 45799999999999999999975 346889999998766655678899999999999 89999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcC----------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 893 MFLIYNYLPGGNLENFIKARTS----------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
.++||||+++|+|.+++..... ..+++.+++.++.|++.||+|||++ +|+||||||+||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~ 178 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEE
Confidence 9999999999999999987543 2489999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1103)
+.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .
T Consensus 179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~----~ 254 (313)
T 1t46_A 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV----D 254 (313)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS----S
T ss_pred cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc----h
Confidence 99999999999999876544332 2334567889999999999899999999999999999999 9988864321 1
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......... ......+...+..+.+++.+||+.||++||+++|++++|+++..
T Consensus 255 ----~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 307 (313)
T 1t46_A 255 ----SKFYKMIKE---------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (313)
T ss_dssp ----HHHHHHHHH---------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----hHHHHHhcc---------CCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence 111111111 11122234566789999999999999999999999999998754
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=367.48 Aligned_cols=263 Identities=22% Similarity=0.348 Sum_probs=212.8
Q ss_pred HhcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCC
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGN 891 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 891 (1103)
..++|++.+.||+|+||+||+|.. ..+..||||++.........+.+.+|+.+++++ +||||+++++++...+
T Consensus 43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 456799999999999999999975 246789999998665555567899999999999 8999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcC---------------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCC
Q 043720 892 EMFLIYNYLPGGNLENFIKARTS---------------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVK 950 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk 950 (1103)
..++||||+++|+|.+++..... ..+++..++.++.|++.||+|||++ +|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCC
Confidence 99999999999999999986542 2378999999999999999999999 99999999
Q ss_pred CCcEEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCC
Q 043720 951 PSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSF 1028 (1103)
Q Consensus 951 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~ 1028 (1103)
|+||+++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||+| |..||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999999999999999999876433322 2334567889999999998899999999999999999998 999986432
Q ss_pred CCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1029 SSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
. . ......... ......+...+..+.+++.+||+.||++||++.|++++|+.+.+.
T Consensus 280 ~----~----~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 280 V----D----ANFYKLIQN---------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp C----S----HHHHHHHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred c----H----HHHHHHHhc---------CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1 1 111111111 112223445678899999999999999999999999999998664
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=358.44 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=208.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-----hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-----GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|++.+.||+|+||+||+|... +|+.||||++....... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 457999999999999999999765 58999999997654321 357899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC----CEEEeeccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF----NAYLSDFGL 969 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgl 969 (1103)
|+||||+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~ 165 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred EEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence 99999999999999997643 499999999999999999999999 999999999999998877 799999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
+...... .......||+.|+|||++.+..++.++||||+||++|+|++|..||.... .......+....
T Consensus 166 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~--------~~~~~~~i~~~~- 234 (361)
T 2yab_A 166 AHEIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT--------KQETLANITAVS- 234 (361)
T ss_dssp CEECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHTTC-
T ss_pred ceEcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhcC-
Confidence 9876432 22345679999999999999999999999999999999999999997321 111222211111
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .++... ....+..+.++|.+||..||++|||+.|++++
T Consensus 235 ~--~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h 273 (361)
T 2yab_A 235 Y--DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (361)
T ss_dssp C--CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred C--CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 111111 12345678999999999999999999999863
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=362.05 Aligned_cols=253 Identities=26% Similarity=0.377 Sum_probs=204.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++.+++..|+||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 57999999999999999999766 68999999997665554557789999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC-
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET- 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 978 (1103)
+++|+|.++++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..+.....
T Consensus 87 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 161 (323)
T 3tki_A 87 CSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161 (323)
T ss_dssp CTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence 99999999987543 489999999999999999999999 999999999999999999999999999986543222
Q ss_pred ccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... ......+ ... .
T Consensus 162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~~~~~~----~~~---------~ 225 (323)
T 3tki_A 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----KEK---------K 225 (323)
T ss_dssp CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTT---SHHHHHH----HTT---------C
T ss_pred cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHH----hcc---------c
Confidence 22345679999999999987765 77899999999999999999999743221 1111111 111 1
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+..+.+++.+||+.||++|||++|++++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h 262 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111123456778999999999999999999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-38 Score=355.80 Aligned_cols=257 Identities=20% Similarity=0.295 Sum_probs=207.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+.++.++ +||||+++++++.+.+..|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 46899999999999999999775 588999999976543 33456788999999988 899999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.++++... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 163 (345)
T ss_dssp ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence 99999999999998754 489999999999999999999999 9999999999999999999999999999854222
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.........................
T Consensus 164 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------- 235 (345)
T 3a8x_A 164 -GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------- 235 (345)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC-------
T ss_pred -CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC-------
Confidence 223445689999999999999999999999999999999999999997432221111111111111111111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTM------KQVVQ 1093 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1093 (1103)
...+...+..+.+++.+||+.||++||++ +|+++
T Consensus 236 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~ 275 (345)
T 3a8x_A 236 ---IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG 275 (345)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred ---CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence 12344566789999999999999999996 56654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=355.14 Aligned_cols=264 Identities=23% Similarity=0.365 Sum_probs=204.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|...+++.||||++...... ...+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 3679999999999999999999888999999999765433 235678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|++ ++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 173 (311)
T 3niz_A 100 FME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPV- 173 (311)
T ss_dssp CCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC-
T ss_pred CCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCc-
Confidence 997 58888887643 4589999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc------
Q 043720 979 HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK------ 1051 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1051 (1103)
.......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ................
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~~~~~~~~~~~ 248 (311)
T 3niz_A 174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD-----DQLPKIFSILGTPNPREWPQVQ 248 (311)
T ss_dssp C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT-----THHHHHHHHHCCCCTTTSGGGT
T ss_pred ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH-----HHHHHHHHHHCCCChHHhhhhh
Confidence 23344578999999999876 56899999999999999999999999743221 1111111111111000
Q ss_pred ----------ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 ----------DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ----------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..++...+.........++.+++.+|++.||++|||++|++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 301 (311)
T 3niz_A 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH 301 (311)
T ss_dssp TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0000000011112345678999999999999999999999974
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-39 Score=364.48 Aligned_cols=266 Identities=24% Similarity=0.398 Sum_probs=217.8
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEE
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYR 887 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 887 (1103)
+++...++|++.+.||+|+||+||+|.... ...||+|++.........+.+.+|+.+++++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999997653 2479999998776666678899999999999 899999999999
Q ss_pred ecCCeEEEEEeecCCCChHHHHHhhc------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEE
Q 043720 888 ASGNEMFLIYNYLPGGNLENFIKART------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955 (1103)
Q Consensus 888 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIl 955 (1103)
...+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+||+
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence 99999999999999999999997643 23478999999999999999999999 9999999999999
Q ss_pred ECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCC
Q 043720 956 LDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGD 1033 (1103)
Q Consensus 956 l~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~ 1033 (1103)
++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||.....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---- 272 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV---- 272 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS----
T ss_pred ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch----
Confidence 999999999999999866433222 2334567889999999998899999999999999999999 8888863221
Q ss_pred CcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1034 GFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
. .......... .....+...+..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 273 ~----~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~ 326 (333)
T 2i1m_A 273 N----SKFYKLVKDG---------YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ 326 (333)
T ss_dssp S----HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred h----HHHHHHHhcC---------CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence 1 1111111111 1122234456789999999999999999999999999998754
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=349.95 Aligned_cols=258 Identities=24% Similarity=0.355 Sum_probs=209.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|++.+.||+|+||+||+|.... +..||||++.........+.+.+|+.++++++||||+++++++.++ ..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEE
Confidence 4578999999999999999997543 3469999998776666678899999999999999999999998754 5689
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++++|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 90 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp EEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred EEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 999999999999997653 4589999999999999999999999 999999999999999999999999999987655
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ... ..... ..
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~-----~~~---~~~~~-~~------ 230 (281)
T 3cc6_A 166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN-----KDV---IGVLE-KG------ 230 (281)
T ss_dssp -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG-----GGH---HHHHH-HT------
T ss_pred ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh-----HHH---HHHHh-cC------
Confidence 44444445567889999999998899999999999999999998 9999863221 111 11111 11
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+..++..+.+++.+||+.||++||+++|++++|+++.+
T Consensus 231 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 231 ---DRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1122334456789999999999999999999999999998764
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=350.15 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=198.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc---hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|... ++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 357899999999999999999876 89999999876533 22357789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC--------CCCEEEeecc
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD--------DFNAYLSDFG 968 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~--------~~~~ki~Dfg 968 (1103)
|||+++++|.++++.. .+++..+..++.|++.|++|||++...+|+||||||+||+++. ++.+||+|||
T Consensus 85 ~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp EECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999998643 4899999999999999999999991112999999999999986 6789999999
Q ss_pred cccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
++....... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ ..
T Consensus 162 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-~~ 229 (271)
T 3dtc_A 162 LAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG--------LAVAYGVA-MN 229 (271)
T ss_dssp C----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH--------HHHHHHHH-TS
T ss_pred ccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHhhh-cC
Confidence 998654322 2245689999999999998999999999999999999999999973211 11111111 11
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
......+..++..+.+++.+||+.||++|||++|++++|++|
T Consensus 230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 230 --------KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --------CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 112223455678899999999999999999999999999875
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=359.68 Aligned_cols=249 Identities=24% Similarity=0.337 Sum_probs=203.6
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|..+++.+ +||||+++++++.+.+..|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999765 589999999976532 33456788999999988 69999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++|+|.++++... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 102 v~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~ 176 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176 (353)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeeccc
Confidence 999999999999998764 399999999999999999999999 999999999999999999999999999975422
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 177 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~------- 240 (353)
T 3txo_A 177 -NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAEN--------EDDLFEAILNDE------- 240 (353)
T ss_dssp ----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-------
T ss_pred -CCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCC--------HHHHHHHHHcCC-------
Confidence 2233445689999999999999999999999999999999999999997321 112222222111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCH------HHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTM------KQVVQ 1093 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~------~evl~ 1093 (1103)
...+...+..+.+++.+|++.||++||++ .|+++
T Consensus 241 ----~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 241 ----VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 12334456779999999999999999998 77765
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=351.71 Aligned_cols=272 Identities=24% Similarity=0.366 Sum_probs=207.2
Q ss_pred HHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcC--CCCceeEEEeEEecC----
Q 043720 817 IRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV--RHPNLVTLIGYRASG---- 890 (1103)
Q Consensus 817 ~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~---- 890 (1103)
....++|++.+.||+|+||+||+|+.. ++.||||++.... ...+.+|.+++... +||||+++++++...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred cccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 344568999999999999999999876 8999999986432 23444555555554 899999999999877
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC-----CCCcccCCCCCCcEEECCCCCEEEe
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC-----APRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
...++||||+++|+|.++++.. .+++..++.++.|++.||+|||+++ .++|+||||||+||+++.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999764 3899999999999999999999752 3489999999999999999999999
Q ss_pred ecccccccCCCCCc---cccCCcccccccCccccccCCCCCc------chhHHHHHHHHHHHhCC----------CCCCC
Q 043720 966 DFGLSRLLGTSETH---ATTGVAGTFGYVAPEYALTCRVSDK------ADVYSYGVVLLELISDK----------KALDP 1026 (1103)
Q Consensus 966 Dfgla~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~------sDvwslGvil~elltg~----------~p~~~ 1026 (1103)
|||+++........ ......||+.|+|||++.+..++.+ +|||||||++|||++|. .||..
T Consensus 185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~ 264 (337)
T 3mdy_A 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD 264 (337)
T ss_dssp CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence 99999776433322 1234579999999999987776665 99999999999999994 44432
Q ss_pred CCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1027 SFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
..... ..................+.... ....++..+.+++.+||+.||++||+++||+++|+++.++.+
T Consensus 265 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~ 334 (337)
T 3mdy_A 265 LVPSD----PSYEDMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQD 334 (337)
T ss_dssp TSCSS----CCHHHHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTTT
T ss_pred hcCCC----CchhhhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhcc
Confidence 22111 11111222221121111111111 123678889999999999999999999999999999987753
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=357.31 Aligned_cols=263 Identities=21% Similarity=0.360 Sum_probs=199.0
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcCCc----EEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISPGI----LVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
..++|++.+.||+|+||+||+|...... .||||++.... .....+.+.+|+.++++++||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 100 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK 100 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence 3467999999999999999999765432 79999997653 234567899999999999999999999999877655
Q ss_pred ------EEEEeecCCCChHHHHHhhcC----CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEE
Q 043720 894 ------FLIYNYLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY 963 (1103)
Q Consensus 894 ------~lV~E~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~k 963 (1103)
++||||+++|+|.+++..... ..+++.++..++.|++.||+|||++ +|+||||||+||++++++.+|
T Consensus 101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~k 177 (323)
T 3qup_A 101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVC 177 (323)
T ss_dssp ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEE
T ss_pred cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEE
Confidence 999999999999999976432 2489999999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHH
Q 043720 964 LSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
|+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... . ...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~---~~~ 249 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-----A---EIY 249 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----G---GHH
T ss_pred EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-----H---HHH
Confidence 9999999876443322 2234456789999999999999999999999999999999 8888873321 1 111
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
...... .....+...+..+.+++.+||+.||++|||+.|+++.|+++...|
T Consensus 250 ~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 250 NYLIGG----------NRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp HHHHTT----------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred HHHhcC----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 111111 112234456678999999999999999999999999999987654
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=366.58 Aligned_cols=174 Identities=20% Similarity=0.178 Sum_probs=112.0
Q ss_pred cccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCC
Q 043720 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLR 176 (1103)
Q Consensus 97 g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 176 (1103)
+..+..++++++|++|+|++|.+++ +| .++.+++|++|+|++|.+++ +| ++.+++|++|+|++|++++ +| ++
T Consensus 32 ~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~-~~--~~ 103 (457)
T 3bz5_A 32 ATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTN-LD--VT 103 (457)
T ss_dssp TTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSC-CC--CT
T ss_pred cccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCce-ee--cC
Confidence 3344566777777777777777775 34 57777777777777777775 33 6777777777777777774 33 66
Q ss_pred CCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCE
Q 043720 177 NFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRT 256 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 256 (1103)
++++|++|++++|++++ +| ++.+++|++|++++|++++ ++ +.. +++|++|++++|+..+.+ .++.+++|++
T Consensus 104 ~l~~L~~L~L~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~-l~--l~~-l~~L~~L~l~~n~~~~~~--~~~~l~~L~~ 174 (457)
T 3bz5_A 104 PLTKLTYLNCDTNKLTK-LD--VSQNPLLTYLNCARNTLTE-ID--VSH-NTQLTELDCHLNKKITKL--DVTPQTQLTT 174 (457)
T ss_dssp TCTTCCEEECCSSCCSC-CC--CTTCTTCCEEECTTSCCSC-CC--CTT-CTTCCEEECTTCSCCCCC--CCTTCTTCCE
T ss_pred CCCcCCEEECCCCcCCe-ec--CCCCCcCCEEECCCCccce-ec--ccc-CCcCCEEECCCCCccccc--ccccCCcCCE
Confidence 77777777777777775 33 6667777777777777763 33 222 355666666666544444 3555666666
Q ss_pred EeCCCccCCccccccccCCCCCCEEEccCCcCCC
Q 043720 257 LLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG 290 (1103)
Q Consensus 257 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 290 (1103)
|++++|++++ +| ++.+++|+.|++++|++++
T Consensus 175 L~ls~n~l~~-l~--l~~l~~L~~L~l~~N~l~~ 205 (457)
T 3bz5_A 175 LDCSFNKITE-LD--VSQNKLLNRLNCDTNNITK 205 (457)
T ss_dssp EECCSSCCCC-CC--CTTCTTCCEEECCSSCCSC
T ss_pred EECCCCccce-ec--cccCCCCCEEECcCCcCCe
Confidence 6666666655 23 5555666666666666554
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=359.38 Aligned_cols=260 Identities=24% Similarity=0.425 Sum_probs=215.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASG 890 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 890 (1103)
.++|++.+.||+|+||+||+|... ++..||||++.........+.+.+|+.+++++ +||||+++++++...
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467999999999999999999763 46789999998776666678899999999999 899999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
+..++||||+++|+|.++++.... ..+++.+++.++.|++.||+|||+. +|+||||||+||++
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEE
Confidence 999999999999999999986542 3488999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~ 1034 (1103)
+.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~------ 264 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 264 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC------
T ss_pred cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC------
Confidence 99999999999999876543322 2334457889999999998889999999999999999999 998886321
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......... .. .....+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 265 --~~~~~~~~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~ 318 (334)
T 2pvf_A 265 --VEELFKLLK-EG---------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILT 318 (334)
T ss_dssp --HHHHHHHHH-HT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHHHh-cC---------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111111111 11 1122344566789999999999999999999999999999853
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=356.93 Aligned_cols=260 Identities=24% Similarity=0.435 Sum_probs=208.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.+|+..+.||+|+||+||+|.... +..||||++...........+.+|+.++++++||||+++++++...+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 457778999999999999997653 246999999876656567789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++|+|.++++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 124 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 124 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 999999999999998643 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 976 SETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 976 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ........ .
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~--------~~~~~~~~-~----- 265 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--------HEVMKAIN-D----- 265 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHH-T-----
T ss_pred ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHHH-C-----
Confidence 3221 2223346789999999998899999999999999999999 9999863211 11111111 1
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
......+..++..+.+++.+||+.||++||+++|+++.|+++.+.+
T Consensus 266 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~ 311 (333)
T 1mqb_A 266 ----GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 311 (333)
T ss_dssp ----TCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred ----CCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1112234456788999999999999999999999999999986554
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=359.08 Aligned_cols=252 Identities=23% Similarity=0.383 Sum_probs=202.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC-------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------- 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 891 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 356899999999999999999876 789999999987666666788999999999999999999999885543
Q ss_pred --------------------------------------------------eEEEEEeecCCCChHHHHHhhcC-CcccHH
Q 043720 892 --------------------------------------------------EMFLIYNYLPGGNLENFIKARTS-RAVDWK 920 (1103)
Q Consensus 892 --------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~ 920 (1103)
..++||||+++++|.++++.... ...++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 38999999999999999987543 335666
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC-----------ccccCCccccc
Q 043720 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET-----------HATTGVAGTFG 989 (1103)
Q Consensus 921 ~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-----------~~~~~~~g~~~ 989 (1103)
.++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 7899999999999999999 999999999999999999999999999987754321 22344579999
Q ss_pred ccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHH
Q 043720 990 YVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLED 1069 (1103)
Q Consensus 990 y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1069 (1103)
|+|||++.+..++.++||||||+++|||++|..|+.. ..... ........ ..........
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~----------~~~~~-~~~~~~~~---------~~~~~~~~~~ 301 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME----------RVRII-TDVRNLKF---------PLLFTQKYPQ 301 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH----------HHHHH-HHHHTTCC---------CHHHHHHCHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH----------HHHHH-HHhhccCC---------CcccccCChh
Confidence 9999999999999999999999999999998765320 00011 11111100 0012334567
Q ss_pred HHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1070 MLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1070 l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+.+++.+||+.||++||+++|++++
T Consensus 302 ~~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 302 EHMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHHccCCCCcCCCHHHHhhc
Confidence 7999999999999999999999874
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=349.56 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=207.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56899999999999999999765 689999999976532 234577889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 86 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 158 (318)
T ss_dssp CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC--
Confidence 9999999999998754 489999999999999999999999 999999999999999999999999999986532
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--------~~~~~~~i~~~~--------- 219 (318)
T 1fot_A 159 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE--------- 219 (318)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC---------
T ss_pred --ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC---------
Confidence 2335679999999999999999999999999999999999999997321 112222222111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+.++.+++.+|++.||++|| +++|++++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h 259 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 259 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence 122344567899999999999999999 88888854
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=358.12 Aligned_cols=271 Identities=23% Similarity=0.370 Sum_probs=220.9
Q ss_pred CCCHHHHHHHhcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeE
Q 043720 810 PLTYESIIRATGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVT 882 (1103)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 882 (1103)
+....+.....++|++.+.||+|+||+||+|.. .+++.||||++.........+.+.+|+.+++++ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 445555556678899999999999999999964 346889999998776666677899999999999 7999999
Q ss_pred EEeEEecCC-eEEEEEeecCCCChHHHHHhhcCC--------------cccHHHHHHHHHHHHHHHHHHHhCCCCCcccC
Q 043720 883 LIGYRASGN-EMFLIYNYLPGGNLENFIKARTSR--------------AVDWKILHKIALDVASALAYLHDQCAPRVLHR 947 (1103)
Q Consensus 883 l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~--------------~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~ 947 (1103)
+++++...+ ..++||||+++|+|.+++...... .+++..+..++.|++.||+|||++ +|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Ccccc
Confidence 999987654 589999999999999999875432 288999999999999999999999 99999
Q ss_pred CCCCCcEEECCCCCEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCC
Q 043720 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALD 1025 (1103)
Q Consensus 948 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~ 1025 (1103)
||||+||+++.++.+||+|||+++....... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987644332 22334567889999999999999999999999999999998 999886
Q ss_pred CCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1026 PSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1026 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.... . .... .....+. ....+...+..+.+++.+||+.||++||+++|++++|+++.+
T Consensus 253 ~~~~----~---~~~~-~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 310 (316)
T 2xir_A 253 GVKI----D---EEFC-RRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310 (316)
T ss_dssp TCCC----S---HHHH-HHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccch----h---HHHH-HHhccCc---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 3221 1 1111 1111111 112234456789999999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-38 Score=355.61 Aligned_cols=248 Identities=24% Similarity=0.377 Sum_probs=206.4
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|.+.+.||+|+||+||+|.. .+++.||||++..... ......+.+|+.+++.++||||+++++++...+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 35799999999999999999976 5689999999875432 22346788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+ +|+|.+++.... .+++.++..++.|++.|++|||++ +|+||||||+||++++++.+||+|||++......
T Consensus 88 ~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp ECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred EECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 9999 789999987654 399999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
......+||+.|+|||++.+..+ +.++||||+||++|+|++|+.||....... ....+.
T Consensus 162 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~------------------~~~~i~ 221 (336)
T 3h4j_B 162 --NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN------------------LFKKVN 221 (336)
T ss_dssp --BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT------------------CBCCCC
T ss_pred --cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH------------------HHHHHH
Confidence 22345579999999999988776 679999999999999999999997433211 000011
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ....+...+..+.+++.+||+.||++|||++|++++
T Consensus 222 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 222 SC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp SS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred cC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 11 112344566789999999999999999999999865
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=360.34 Aligned_cols=259 Identities=22% Similarity=0.389 Sum_probs=207.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcE----EEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGIL----VAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|++.+.||+|+||+||+|.+. +++. ||+|++.........+.+.+|+.++++++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 46889999999999999999765 3443 78888765544444566788999999999999999999986 456899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+.+|+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 92 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 167 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPP 167 (325)
T ss_dssp EEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred EEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence 999999999999998653 3589999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... . ..... ...
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~---~~~~~-~~~------ 232 (325)
T 3kex_A 168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL-----A---EVPDL-LEK------ 232 (325)
T ss_dssp CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT-----T---HHHHH-HHT------
T ss_pred ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH-----H---HHHHH-HHc------
Confidence 4332 2344567889999999999999999999999999999999 9999874321 1 11111 111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
......+..++..+.+++.+||+.||++||+++|++++|+++.+.|
T Consensus 233 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~ 278 (325)
T 3kex_A 233 ---GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP 278 (325)
T ss_dssp ---TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred ---CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence 1112223345567899999999999999999999999999987653
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=360.34 Aligned_cols=269 Identities=23% Similarity=0.380 Sum_probs=214.5
Q ss_pred CCCcceeccCCcccEEEEEEc-----CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeEEE
Q 043720 823 FNTSNCIGSGGFGTTYKAEIS-----PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEMFL 895 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 895 (1103)
|++.+.||+|+||+||++.+. +++.||||++.........+.+.+|+.++++++||||+++++++.+ ....++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488999999999999988653 5889999999877666667889999999999999999999999987 467899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++|+|.++++... +++.+++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186 (318)
T ss_dssp EECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred EEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccc
Confidence 999999999999997653 89999999999999999999999 999999999999999999999999999987754
Q ss_pred CCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......+++.|+|||++.+..++.++||||||+++|||++|+.||....... .....+...........+.
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 263 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF---LELIGIAQGQMTVLRLTEL 263 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHHCSCCHHHHHHHHHHH
T ss_pred cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh---hhhhcccccchhHHHHHHH
Confidence 3321 2334567889999999998889999999999999999999999986321100 0000000000000111122
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
+........+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~ 310 (318)
T 3lxp_A 264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHE 310 (318)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 22233334456677889999999999999999999999999998853
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=358.88 Aligned_cols=266 Identities=20% Similarity=0.351 Sum_probs=218.5
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEE
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 887 (1103)
++.....++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.++++++||||+++++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV 97 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE
Confidence 334445678999999999999999999654 36889999998766666677899999999999999999999999
Q ss_pred ecCCeEEEEEeecCCCChHHHHHhhcC--------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC
Q 043720 888 ASGNEMFLIYNYLPGGNLENFIKARTS--------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD 959 (1103)
Q Consensus 888 ~~~~~~~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~ 959 (1103)
.+.+..++||||+++|+|.++++.... ..+++..+++++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~ 174 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174 (322)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTT
T ss_pred ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCC
Confidence 999999999999999999999976432 3468899999999999999999999 99999999999999999
Q ss_pred CCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcch
Q 043720 960 FNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNI 1037 (1103)
Q Consensus 960 ~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~ 1037 (1103)
+.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .
T Consensus 175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~ 246 (322)
T 1p4o_A 175 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--------N 246 (322)
T ss_dssp CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC--------H
T ss_pred CeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC--------H
Confidence 99999999999865433222 2234457889999999998899999999999999999999 788876321 1
Q ss_pred HHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1038 ISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
........ .+. ....+..++..+.+++.+||+.||++||++.|++++|+++..
T Consensus 247 ~~~~~~~~-~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 247 EQVLRFVM-EGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp HHHHHHHH-TTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HHHHHHHH-cCC---------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11222111 111 112344566789999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=372.57 Aligned_cols=263 Identities=21% Similarity=0.285 Sum_probs=212.0
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG 890 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 890 (1103)
.++....++|++.+.||+|+||+||+|+... ++.||||++..... ....+.+.+|+.++..++||||+++++++.+.
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 3444456889999999999999999998764 78999999975432 12234488999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
+..|+||||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla 222 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSC 222 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhh
Confidence 99999999999999999998742 3499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||.... .......+.
T Consensus 223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~--------~~~~~~~i~ 294 (437)
T 4aw2_A 223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES--------LVETYGKIM 294 (437)
T ss_dssp EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH
T ss_pred hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC--------hhHHHHhhh
Confidence 876554444455678999999999987 5678999999999999999999999997321 111111111
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLST--RPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1094 (1103)
..... . .........+..+.++|.+|+..+|++ ||+++|++++
T Consensus 295 ~~~~~--~----~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H 339 (437)
T 4aw2_A 295 NHKER--F----QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH 339 (437)
T ss_dssp THHHH--C----CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred hcccc--c----cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence 11000 0 001111235678999999999888888 9999999864
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=371.46 Aligned_cols=259 Identities=22% Similarity=0.310 Sum_probs=210.8
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 891 (1103)
++....++|++.+.||+|+||+||+|+.. +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 63 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 142 (410)
T 3v8s_A 63 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 142 (410)
T ss_dssp HHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECC
Confidence 34445678999999999999999999776 488999999875322 122345789999999999999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
..|+||||+++|+|.++++.. .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 143 ~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 143 YLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 999999999999999999764 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCccccccCC----CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTCR----VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.... .......+...
T Consensus 217 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~ 288 (410)
T 3v8s_A 217 KMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS--------LVGTYSKIMNH 288 (410)
T ss_dssp ECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHTH
T ss_pred eeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC--------hhhHHHHHHhc
Confidence 77544433445678999999999997655 7889999999999999999999997321 11112221111
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCC--CCCHHHHHHH
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLST--RPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~evl~~ 1094 (1103)
.. ....+.....+..+.++|.+|+..+|++ ||+++||+++
T Consensus 289 ~~-------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H 330 (410)
T 3v8s_A 289 KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 330 (410)
T ss_dssp HH-------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred cc-------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence 10 0111112245678999999999999998 9999999875
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.34 Aligned_cols=257 Identities=25% Similarity=0.422 Sum_probs=214.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||+||+|...++..||||++..... ..+.+.+|+.++++++||||+++++++.. +..++||||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~ 88 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc--cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEec
Confidence 357889999999999999999988888999999875432 35778999999999999999999999874 468999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++...+..+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++.........
T Consensus 89 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 165 (279)
T 1qpc_A 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (279)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence 9999999999765444589999999999999999999999 9999999999999999999999999999877544433
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......+++.|+|||.+.+..++.++||||||+++|||++ |+.||.... ......... .+ .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~--------~~~~~~~~~-~~---------~ 227 (279)
T 1qpc_A 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--------NPEVIQNLE-RG---------Y 227 (279)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHHHHH-TT---------C
T ss_pred cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccC--------HHHHHHHHh-cc---------c
Confidence 4445567889999999998889999999999999999999 888886321 111111111 11 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
....+...+..+.+++.+|++.||++||+++++++.|+++..
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 269 (279)
T 1qpc_A 228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (279)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 122344566789999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-38 Score=356.49 Aligned_cols=259 Identities=25% Similarity=0.432 Sum_probs=206.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcE----EEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGIL----VAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|++.+.||+|+||+||+|.+. +++. ||+|.+.........+.+.+|+.++++++||||+++++++.... .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57999999999999999999754 3443 57777766555556788999999999999999999999998765 789
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+||+.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 94 v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~ 169 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169 (327)
T ss_dssp EECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC------
T ss_pred EEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccC
Confidence 999999999999998754 3589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... .. ... .
T Consensus 170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-----~~---~~~-~--------- 231 (327)
T 3lzb_A 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SE---ISS-I--------- 231 (327)
T ss_dssp ----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GG---HHH-H---------
T ss_pred ccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-----HH---HHH-H---------
Confidence 322 22334456889999999999999999999999999999999 9999874321 11 111 1
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
+........+..++..+.+++.+||+.||++||+++|+++.|+++.+.|
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 280 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP 280 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence 1111122334556778999999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=357.03 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=206.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46999999999999999999765 488999999875432 334678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+.+|+|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~- 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE- 168 (384)
T ss_dssp CCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred ecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCC-
Confidence 9999999999998653 499999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccCCcccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 978 THATTGVAGTFGYVAPEYALT---CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.......||+.|+|||++.. ..++.++|||||||++|||++|+.||...... ........... .
T Consensus 169 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----~~~~~~~~~~~-~------ 235 (384)
T 4fr4_A 169 -TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSST-----SSKEIVHTFET-T------ 235 (384)
T ss_dssp -CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTS-----CHHHHHHHHHH-C------
T ss_pred -CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCc-----cHHHHHHHHhh-c------
Confidence 33455689999999999864 45889999999999999999999999743221 11111111111 1
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCC-HHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPT-MKQVVQ 1093 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~evl~ 1093 (1103)
....+...+..+.+++.+||+.||++||+ ++++.+
T Consensus 236 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 236 ----VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred ----ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 12234456678999999999999999998 666654
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=345.87 Aligned_cols=253 Identities=26% Similarity=0.497 Sum_probs=206.7
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhh------HHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHG------VQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++........ .+.+.+|+.++++++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 5799999999999999999976 4689999999876543221 267899999999999999999999997765
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCC--cccCCCCCCcEEECCCCC-----EEEee
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR--VLHRDVKPSNILLDDDFN-----AYLSD 966 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlk~~NIll~~~~~-----~ki~D 966 (1103)
++||||+++|+|.+++.... ..+++..+..++.|++.|++|||++ + |+||||||+||+++.++. +||+|
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 69999999999999987643 4589999999999999999999999 8 999999999999988776 99999
Q ss_pred cccccccCCCCCccccCCcccccccCcccc--ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYA--LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~--~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
||+++.... ......|++.|+|||++ ....++.++||||+|+++|||++|+.||..... ....+....
T Consensus 173 fg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~------~~~~~~~~~ 242 (287)
T 4f0f_A 173 FGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY------GKIKFINMI 242 (287)
T ss_dssp CTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCC------CHHHHHHHH
T ss_pred CCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccc------cHHHHHHHH
Confidence 999975432 33456789999999998 455678899999999999999999999974321 111111111
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
... ......+..++..+.+++.+||+.||++||+++|+++.|+++
T Consensus 243 ~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 243 REE---------GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHS---------CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred hcc---------CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 112233456678899999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=383.66 Aligned_cols=258 Identities=26% Similarity=0.425 Sum_probs=216.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||+||+|.+..+..||||+++.... ..+.|.+|+.++++++||||+++++++.+ +..|+||||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~ 342 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 342 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC--CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeeh
Confidence 456888999999999999999999888999999976543 34679999999999999999999999876 678999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.++++......+++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++........
T Consensus 343 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 419 (535)
T 2h8h_A 343 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 419 (535)
T ss_dssp CTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHH
T ss_pred hcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCcee
Confidence 9999999999875555689999999999999999999999 9999999999999999999999999999876433222
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
......++..|+|||++....++.++|||||||++|||++ |+.||.... ........ .. ..
T Consensus 420 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~--------~~~~~~~i-~~---------~~ 481 (535)
T 2h8h_A 420 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--------NREVLDQV-ER---------GY 481 (535)
T ss_dssp TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCC--------HHHHHHHH-HT---------TC
T ss_pred cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC--------HHHHHHHH-Hc---------CC
Confidence 3344567889999999998899999999999999999999 888886321 11111111 11 11
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+..++..+.++|.+||+.||++||++++|++.|+++..+
T Consensus 482 ~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 482 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 2233456778899999999999999999999999999998543
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=362.78 Aligned_cols=255 Identities=17% Similarity=0.121 Sum_probs=214.7
Q ss_pred CCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCC
Q 043720 116 FNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVI 195 (1103)
Q Consensus 116 ~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 195 (1103)
.....+..+..++++++|++|||++|.+++ +| .++.+++|++|+|++|++++ +| ++++++|++|++++|++++.
T Consensus 27 ~~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~-~~-~l~~l~~L~~L~Ls~n~l~~-~~--~~~l~~L~~L~Ls~N~l~~~- 100 (457)
T 3bz5_A 27 AFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNITT-LD--LSQNTNLTYLACDSNKLTNL- 100 (457)
T ss_dssp HTTCCTTSEEEHHHHTTCCEEECCSSCCCC-CT-TGGGCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCC-
T ss_pred hcCcCcccccChhHcCCCCEEEccCCCccc-Ch-hhcccCCCCEEEccCCcCCe-Ec--cccCCCCCEEECcCCCCcee-
Confidence 345566677789999999999999999996 46 79999999999999999996 45 89999999999999999975
Q ss_pred ChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCC
Q 043720 196 PGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWL 275 (1103)
Q Consensus 196 p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l 275 (1103)
+ ++++++|++|++++|++++ +| +. .+++|++|++++|++++. + ++.+++|++|++++|...+.+ .+..+
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~-l~--~~-~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~--~~~~l 169 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTK-LD--VS-QNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKL--DVTPQ 169 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSC-CC--CT-TCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCC--CCTTC
T ss_pred e--cCCCCcCCEEECCCCcCCe-ec--CC-CCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCccccc--ccccC
Confidence 4 8999999999999999995 66 44 458899999999999974 3 889999999999999766655 48899
Q ss_pred CCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccc
Q 043720 276 RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRI 355 (1103)
Q Consensus 276 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~ 355 (1103)
++|+.|++++|++++ +| ++.+++|+.|++++| .+.+. .++.+++|+.
T Consensus 170 ~~L~~L~ls~n~l~~-l~--l~~l~~L~~L~l~~N---------------------------~l~~~---~l~~l~~L~~ 216 (457)
T 3bz5_A 170 TQLTTLDCSFNKITE-LD--VSQNKLLNRLNCDTN---------------------------NITKL---DLNQNIQLTF 216 (457)
T ss_dssp TTCCEEECCSSCCCC-CC--CTTCTTCCEEECCSS---------------------------CCSCC---CCTTCTTCSE
T ss_pred CcCCEEECCCCccce-ec--cccCCCCCEEECcCC---------------------------cCCee---ccccCCCCCE
Confidence 999999999999997 45 899999999999863 33332 3778899999
Q ss_pred cccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEecCCccc
Q 043720 356 IWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMS 435 (1103)
Q Consensus 356 L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~ 435 (1103)
|++++|++.+ +| ++.+++|+.|+|++|++++.+ +..+++|+.|++++|+++ .|++++|++.
T Consensus 217 L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~---~~~l~~L~~L~l~~n~L~-------------~L~l~~n~~~ 277 (457)
T 3bz5_A 217 LDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELD---VSTLSKLTTLHCIQTDLL-------------EIDLTHNTQL 277 (457)
T ss_dssp EECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECTTCCCS-------------CCCCTTCTTC
T ss_pred EECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcC---HHHCCCCCEEeccCCCCC-------------EEECCCCccC
Confidence 9999999998 55 889999999999999999875 456778888998887653 4566666655
Q ss_pred cccC
Q 043720 436 GSIP 439 (1103)
Q Consensus 436 g~ip 439 (1103)
|.+|
T Consensus 278 ~~~~ 281 (457)
T 3bz5_A 278 IYFQ 281 (457)
T ss_dssp CEEE
T ss_pred Cccc
Confidence 5443
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=363.18 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=207.9
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
..++|++.+.||+|+||+||+|.. .+|+.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 346799999999999999999965 4689999999976543 33456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC---CCCCEEEeeccccccc
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD---DDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~ 973 (1103)
|||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++ .++.+||+|||++...
T Consensus 89 ~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 89 FDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp ECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 99999999999998754 489999999999999999999999 999999999999998 5678999999999876
Q ss_pred CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ........||+.|+|||++.+..++.++||||+||++|+|++|..||.... ........ ..+...
T Consensus 164 ~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~--------~~~~~~~i-~~~~~~-- 231 (444)
T 3soa_A 164 EGE-QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDED--------QHRLYQQI-KAGAYD-- 231 (444)
T ss_dssp CTT-CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHH-HHTCCC--
T ss_pred cCC-CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCcc--------HHHHHHHH-HhCCCC--
Confidence 432 223345689999999999999999999999999999999999999996321 11111111 111110
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+..+.+++.+||+.||++|||++|++++
T Consensus 232 ----~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h 268 (444)
T 3soa_A 232 ----FPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH 268 (444)
T ss_dssp ----CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred ----CCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 0011123456789999999999999999999999874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=353.27 Aligned_cols=246 Identities=20% Similarity=0.295 Sum_probs=208.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 47999999999999999999765 689999999976532 234677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 121 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999998754 389999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....
T Consensus 195 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~--------- 254 (350)
T 1rdq_E 195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK--------- 254 (350)
T ss_dssp ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---------
T ss_pred ---cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC--------HHHHHHHHHcCC---------
Confidence 334678999999999999999999999999999999999999997321 112222222111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++||+ ++||+++
T Consensus 255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h 294 (350)
T 1rdq_E 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence 1233455678999999999999999998 8888754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=351.96 Aligned_cols=265 Identities=21% Similarity=0.377 Sum_probs=211.8
Q ss_pred cCCCCcceeccCCcccEEEEEE-----cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC--CeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG--NEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 893 (1103)
.+|++.+.||+|+||+||+|.+ .+++.||||++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 3588899999999999999984 358999999998766555678899999999999999999999999876 678
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++++|.++++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 101 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAI 176 (302)
T ss_dssp EEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccc
Confidence 99999999999999997654 3489999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------CCCCCcchHHHHHHH
Q 043720 974 GTSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFS-------SHGDGFNIISWASML 1044 (1103)
Q Consensus 974 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~ 1044 (1103)
..... .......+|..|+|||++.+..++.++||||+|+++|||++|+.|+..... ............
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 253 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV--- 253 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH---
T ss_pred cCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH---
Confidence 54432 223445678899999999998899999999999999999999988642210 000000000011
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
..+........+..++..+.+++.+||+.||++|||++|+++.|+++.
T Consensus 254 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 254 -------NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -------HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 111111223345566788999999999999999999999999999875
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=350.49 Aligned_cols=265 Identities=22% Similarity=0.381 Sum_probs=194.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457999999999999999999765 5899999999876555455778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcC----CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 899 YLPGGNLENFIKARTS----RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
|++ |+|.+++..... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 699999976532 3589999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc---c
Q 043720 975 TSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ---V 1050 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 1050 (1103)
... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ............... .
T Consensus 160 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~ 233 (317)
T 2pmi_A 160 IPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-----EEQLKLIFDIMGTPNESLW 233 (317)
T ss_dssp SCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCTTTC
T ss_pred CCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhCCCChhHh
Confidence 322 22334578999999999876 4689999999999999999999999973321 111111111100000 0
Q ss_pred ccc-----cccc------------ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDV-----FNAE------------LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~-----~~~~------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... .... .........+..+.+++.+||+.||++|||++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h 294 (317)
T 2pmi_A 234 PSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH 294 (317)
T ss_dssp GGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence 000 0000 0001112345679999999999999999999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=345.74 Aligned_cols=263 Identities=23% Similarity=0.353 Sum_probs=202.7
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|...+++.||||++...... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 478899999999999999998888999999999765432 2346788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++ +|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...... .
T Consensus 82 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 155 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (288)
T ss_dssp CSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred cCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc-c
Confidence 975 9999987643 4589999999999999999999999 99999999999999999999999999998764322 2
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc---ccc---
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ---VKD--- 1052 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--- 1052 (1103)
......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ............... ...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 230 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE-----ADQLMRIFRILGTPNSKNWPNVTE 230 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHHCCCChhhchhhhc
Confidence 2334568999999999876 4589999999999999999999999973211 111111111100000 000
Q ss_pred --cccccc-------cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 --VFNAEL-------WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 --~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..++.. +.......+..+.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 281 (288)
T 1ob3_A 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (288)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 000000 111123456788999999999999999999999874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-38 Score=348.55 Aligned_cols=257 Identities=24% Similarity=0.402 Sum_probs=212.6
Q ss_pred cCCCCcc-eeccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSN-CIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|.+.+ .||+|+||+||+|... ++..||||++.........+.+.+|+.++++++||||+++++++ ..+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 3455665 8999999999999753 57889999998776666778899999999999999999999999 45678999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.+++... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 88 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~ 163 (287)
T 1u59_A 88 MEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163 (287)
T ss_dssp EECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence 9999999999999754 34589999999999999999999999 9999999999999999999999999999877543
Q ss_pred CCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||..... ....... ..+
T Consensus 164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~--------~~~~~~i-~~~----- 229 (287)
T 1u59_A 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAFI-EQG----- 229 (287)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHHH-HTT-----
T ss_pred cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH--------HHHHHHH-hcC-----
Confidence 322 2233456889999999988889999999999999999998 9999863321 1111111 111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+..++..+.+++.+||+.||++||++.|++++|+++..
T Consensus 230 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 272 (287)
T 1u59_A 230 ----KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 272 (287)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1123345667889999999999999999999999999999854
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-38 Score=361.41 Aligned_cols=258 Identities=28% Similarity=0.437 Sum_probs=199.6
Q ss_pred CCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec-CCeEEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNEMFLI 896 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV 896 (1103)
.|++.+.||+|+||+||+|...+ +..||||++.........+.+.+|+.++++++||||+++++++.. .+..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 46677899999999999997542 246899998776666677889999999999999999999998754 5678999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.++++... ..+++.++..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 170 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccccc
Confidence 99999999999997643 4588999999999999999999999 9999999999999999999999999999866433
Q ss_pred CCc---cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 977 ETH---ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 977 ~~~---~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
... ......+++.|+|||++.+..++.++||||||+++|||++ |..||..... ..... ... .+
T Consensus 246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~-----~~~~~---~~~-~~---- 312 (373)
T 3c1x_A 246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-----FDITV---YLL-QG---- 312 (373)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS-----SCHHH---HHH-TT----
T ss_pred ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH-----HHHHH---HHH-cC----
Confidence 221 2234567889999999999999999999999999999999 5555542211 11111 111 11
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.....+..++..+.+++.+||+.||++||+++|+++.|+++..+
T Consensus 313 -----~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~ 356 (373)
T 3c1x_A 313 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356 (373)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11123445677899999999999999999999999999998653
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-38 Score=355.16 Aligned_cols=251 Identities=24% Similarity=0.342 Sum_probs=207.2
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeE
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 893 (1103)
...++|++.+.||+|+||+||+|+.+ +++.||||+++.... ....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999775 589999999976532 33456788899999876 899999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+||||+++|+|.++++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 94 ~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 168 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN 168 (345)
T ss_dssp EEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence 99999999999999998754 389999999999999999999999 9999999999999999999999999999754
Q ss_pred CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+....
T Consensus 169 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~----- 234 (345)
T 1xjd_A 169 MLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD--------EEELFHSIRMDN----- 234 (345)
T ss_dssp CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-----
T ss_pred ccC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCC--------HHHHHHHHHhCC-----
Confidence 322 223445689999999999999999999999999999999999999997321 111111111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMK-QVVQ 1093 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1093 (1103)
...+...+..+.+++.+||+.||++||++. |+++
T Consensus 235 ------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~ 269 (345)
T 1xjd_A 235 ------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 269 (345)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence 122344567899999999999999999997 6653
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=348.40 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=208.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec---------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--------- 889 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 889 (1103)
.++|++.+.||+|+||.||+|... +++.||||++.... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 356999999999999999999776 68999999987543 346789999999999999999998754
Q ss_pred -------CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCE
Q 043720 890 -------GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNA 962 (1103)
Q Consensus 890 -------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 962 (1103)
....++||||+++++|.++++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 161 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQV 161 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCE
Confidence 44689999999999999999876666799999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHH
Q 043720 963 YLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWAS 1042 (1103)
Q Consensus 963 ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1103)
||+|||++....... ......|++.|+|||.+.+..++.++||||||+++|||++|..|+... ..+..
T Consensus 162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~----------~~~~~ 229 (284)
T 2a19_B 162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET----------SKFFT 229 (284)
T ss_dssp EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH----------HHHHH
T ss_pred EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH----------HHHHH
Confidence 999999998764332 233456899999999999999999999999999999999999876410 11111
Q ss_pred HHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1043 MLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
. .... ..+...+..+.+++.+||+.||++||++.|++++|+.++++++
T Consensus 230 ~-~~~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~ 277 (284)
T 2a19_B 230 D-LRDG------------IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE 277 (284)
T ss_dssp H-HHTT------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred H-hhcc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence 1 1111 1123345678999999999999999999999999999988764
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=352.41 Aligned_cols=252 Identities=23% Similarity=0.325 Sum_probs=207.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-----hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-----HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46889999999999999999765 5899999999765432 13678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC----CEEEeecccc
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF----NAYLSDFGLS 970 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgla 970 (1103)
+||||+++++|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 999999999999999764 3489999999999999999999999 999999999999999887 7999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .
T Consensus 166 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~~~~~~-~ 234 (326)
T 2y0a_A 166 HKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVN-Y 234 (326)
T ss_dssp EECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHHTC-C
T ss_pred eECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH--------HHHHHHHHhcC-C
Confidence 8764322 23345789999999999999999999999999999999999999963211 11111111111 0
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+.... ....+..+.+++.+||+.||++|||++|++++
T Consensus 235 --~~~~~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 272 (326)
T 2y0a_A 235 --EFEDEY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272 (326)
T ss_dssp --CCCHHH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred --CcCccc----cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 001111 12345678999999999999999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=352.10 Aligned_cols=251 Identities=20% Similarity=0.284 Sum_probs=208.2
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccc--hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 894 (1103)
..++|++.+.||+|+||+||+|+... ++.||||++..... ....+.+.+|..++..+ +||+|+++++++.+.+..|
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 34689999999999999999997764 78999999976532 23467788999999988 7999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+++|+|.++++... .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 172 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 172 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence 9999999999999998754 389999999999999999999999 99999999999999999999999999998542
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....
T Consensus 173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~------ 237 (353)
T 2i0e_A 173 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEHN------ 237 (353)
T ss_dssp CT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC------
T ss_pred cC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhCC------
Confidence 22 223445689999999999999999999999999999999999999997321 112222222111
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++||+ ++|++++
T Consensus 238 -----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h 277 (353)
T 2i0e_A 238 -----VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 277 (353)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 1234456678999999999999999995 5777654
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=355.75 Aligned_cols=253 Identities=22% Similarity=0.328 Sum_probs=208.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 457999999999999999999765 589999999976543 335677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~~ 974 (1103)
||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|||++....
T Consensus 108 e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~ 182 (362)
T 2bdw_A 108 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 182 (362)
T ss_dssp CCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred ecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence 9999999999997643 489999999999999999999999 999999999999998654 59999999998764
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... .+... +
T Consensus 183 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~--------~~~~~~~i~-~~~~~--~ 249 (362)
T 2bdw_A 183 DS--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED--------QHRLYAQIK-AGAYD--Y 249 (362)
T ss_dssp TC--CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTCCC--C
T ss_pred CC--cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-hCCCC--C
Confidence 32 22345679999999999999999999999999999999999999997321 111122111 11110 0
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ......+..+.+++.+||+.||++||++.|++++
T Consensus 250 ~~----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 250 PS----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CT----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred Cc----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00 1113456789999999999999999999999865
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=351.55 Aligned_cols=251 Identities=23% Similarity=0.344 Sum_probs=199.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-------------------------hhHHHHHHHHHHHh
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-------------------------HGVQQFHAEIKTLG 873 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~ 873 (1103)
.++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 357999999999999999999764 5889999998754321 12356889999999
Q ss_pred cCCCCceeEEEeEEec--CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCC
Q 043720 874 NVRHPNLVTLIGYRAS--GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKP 951 (1103)
Q Consensus 874 ~l~h~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~ 951 (1103)
+++||||+++++++.+ .+..|+||||+++++|.+++.. ..+++.++..++.|++.||+|||++ +|+||||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp 165 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKP 165 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCG
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCH
Confidence 9999999999999986 5689999999999999887543 3589999999999999999999999 999999999
Q ss_pred CcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCC
Q 043720 952 SNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR---VSDKADVYSYGVVLLELISDKKALDPSF 1028 (1103)
Q Consensus 952 ~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~ 1028 (1103)
+||+++.++.+||+|||+++...... .......||+.|+|||.+.+.. ++.++||||||+++|||++|+.||....
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999998764332 2234567999999999997655 3678999999999999999999997321
Q ss_pred CCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1029 SSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...... .. ...+.....+..+.+++.+||+.||++||+++|++++
T Consensus 245 --------~~~~~~~~~~-~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 245 --------IMCLHSKIKS-QA--------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp --------HHHHHHHHHH-CC--------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred --------HHHHHHHHhc-cc--------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 1112221111 11 1111123456789999999999999999999999864
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=351.17 Aligned_cols=259 Identities=18% Similarity=0.235 Sum_probs=209.2
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++...... +.+.+|+.+++++ +||||+++++++..++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA---PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS---CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch---HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 5799999999999999999975 56899999998755332 4578899999999 89999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC-----EEEeeccccccc
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN-----AYLSDFGLSRLL 973 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki~Dfgla~~~ 973 (1103)
|+ +++|.++++.. ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++. +||+|||+++.+
T Consensus 86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99 99999999865 34599999999999999999999999 9999999999999998887 999999999876
Q ss_pred CCCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 974 GTSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 974 ~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~~~ 235 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA-----DTLKERYQKIGDT 235 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC-----SSHHHHHHHHHHH
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc-----ccHHHHHHHHHhh
Confidence 443321 12456799999999999999999999999999999999999999974321 1111111111110
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
.. ...... .....+ .+.+++.+||+.||++||++++|.+.|+++.
T Consensus 236 ~~---~~~~~~---~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~ 280 (330)
T 2izr_A 236 KR---ATPIEV---LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLF 280 (330)
T ss_dssp HH---HSCHHH---HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred hc---cCCHHH---HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 00 000000 011234 8999999999999999999999999998874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=357.30 Aligned_cols=253 Identities=25% Similarity=0.293 Sum_probs=197.5
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||||++...... .+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 467999999999999999999776 6899999999764432 3568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC--EEEeecccccccCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN--AYLSDFGLSRLLGTS 976 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~~~~~ 976 (1103)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~- 170 (361)
T 3uc3_A 97 YASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 170 (361)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc-
Confidence 999999999997654 389999999999999999999999 9999999999999987765 99999999974322
Q ss_pred CCccccCCcccccccCccccccCCCCCc-chhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDK-ADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~-sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
........||+.|+|||++.+..++.+ +||||+||++|||++|+.||...... .............
T Consensus 171 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~----~~~~~~~~~~~~~-------- 237 (361)
T 3uc3_A 171 -HSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----RDYRKTIQRILSV-------- 237 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----C----CCHHHHHHHHHTT--------
T ss_pred -cCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccH----HHHHHHHHHHhcC--------
Confidence 222344578999999999988887665 89999999999999999999743221 1122222221111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.....+..+.+++.+||+.||++|||+.|++++
T Consensus 238 -~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 -KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp -CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred -CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111222345778999999999999999999999976
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=366.31 Aligned_cols=262 Identities=20% Similarity=0.230 Sum_probs=209.9
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG 890 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 890 (1103)
.+.....++|++.+.||+|+||+||+|+.+ +++.||||++..... ....+.+.+|..++..++||||+++++++.+.
T Consensus 54 ~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 133 (412)
T 2vd5_A 54 KEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDE 133 (412)
T ss_dssp HHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 344445678999999999999999999775 689999999975432 22345588999999999999999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
+..|+||||+++|+|.+++++.. ..+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla 209 (412)
T 2vd5_A 134 NYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSC 209 (412)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred CEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhh
Confidence 99999999999999999998653 3589999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccc-------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYAL-------TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~-------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
+.............+||+.|+|||++. ...++.++|||||||++|||++|+.||..... ......
T Consensus 210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~--------~~~~~~ 281 (412)
T 2vd5_A 210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADST--------AETYGK 281 (412)
T ss_dssp EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHH
T ss_pred eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCH--------HHHHHH
Confidence 877544443445568999999999987 45789999999999999999999999973211 111111
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCC---CCHHHHHHH
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTR---PTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~evl~~ 1094 (1103)
+...... ..........+.++.++|.+|+. +|++| |+++|++++
T Consensus 282 i~~~~~~------~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H 328 (412)
T 2vd5_A 282 IVHYKEH------LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH 328 (412)
T ss_dssp HHTHHHH------CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred HHhcccC------cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence 1111000 00011123456789999999999 99998 689998764
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=352.06 Aligned_cols=252 Identities=20% Similarity=0.258 Sum_probs=207.6
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||+|++.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 467999999999999999999765 58899999987543 345678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC--CCCEEEeecccccccCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD--DFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~ 976 (1103)
|+++|+|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++......
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 82 FISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred eCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999997543 3589999999999999999999999 9999999999999987 789999999999876433
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
. ......|++.|+|||++.+..++.++||||+|+++|||++|..||.... .............. ++.
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~~~~~~---~~~ 224 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET--------NQQIIENIMNAEYT---FDE 224 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---CCH
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC--------HHHHHHHHHcCCCC---CCh
Confidence 2 2334578999999999999889999999999999999999999997321 11222222211110 011
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ....+.++.+++.+|++.||++|||+.|++++
T Consensus 225 ~~----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h 258 (321)
T 1tki_A 225 EA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----hccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11 12345778999999999999999999999975
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=343.51 Aligned_cols=264 Identities=21% Similarity=0.300 Sum_probs=204.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 47899999999999999999765 5899999999765443 345778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++ ++.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... .
T Consensus 82 ~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-V 155 (292)
T ss_dssp CCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC-C
T ss_pred cCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc-c
Confidence 9965 6766665532 4599999999999999999999999 9999999999999999999999999999876432 2
Q ss_pred ccccCCcccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc---ccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK---DVF 1054 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 1054 (1103)
.......||+.|+|||++.+.. ++.++||||+||++|||++|+.||..... .................. ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS----HHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCC----HHHHHHHHHHHhCCCChhhhhhhc
Confidence 2334557899999999997765 79999999999999999999988753321 111111111111000000 000
Q ss_pred ------------cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 ------------NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
............+..+.+++.+|++.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 283 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000111123456788999999999999999999999874
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=348.69 Aligned_cols=260 Identities=29% Similarity=0.445 Sum_probs=208.1
Q ss_pred cCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe-cCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA-SGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l 895 (1103)
.+|++.+.||+|+||+||+|.... ...||||++.........+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468888999999999999997543 23689999887666667788999999999999999999999864 4567899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++|+|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 105 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp EEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred EEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccc
Confidence 999999999999997643 4589999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC---ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 976 SET---HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 976 ~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
... .......+++.|+|||.+.+..++.++||||+|+++|||++|+.|+...... .. ....... .
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~----~~---~~~~~~~-~---- 248 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FD---ITVYLLQ-G---- 248 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT----TT---HHHHHHT-T----
T ss_pred cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH----HH---HHHHHhc-C----
Confidence 322 2234456788999999999999999999999999999999965554322111 11 1111111 1
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.....+..++..+.+++.+||+.||++||+++|+++.|+++..+
T Consensus 249 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~ 292 (298)
T 3f66_A 249 -----RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 292 (298)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -----CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 11122344567899999999999999999999999999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=344.35 Aligned_cols=262 Identities=21% Similarity=0.288 Sum_probs=204.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999765 688999999976543 23357789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.++++... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred EEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999998754 489999999999999999999999 9999999999999999999999999999876544
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.........|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ............. .
T Consensus 188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---------~~~~~~~~~~~~~----~- 253 (309)
T 2h34_A 188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---------LSVMGAHINQAIP----R- 253 (309)
T ss_dssp ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---------HHHHHHHHHSCCC----C-
T ss_pred ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---------HHHHHHHhccCCC----C-
Confidence 3334445678999999999999999999999999999999999999987321 1111111111110 0
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhhcCC
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRP-TMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~~~~ 1102 (1103)
....+...+..+.+++.+||+.||++|| +++++++.|++..+.+
T Consensus 254 --~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 254 --PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp --GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred --ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 0112345567799999999999999999 9999999999876543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=346.96 Aligned_cols=258 Identities=28% Similarity=0.415 Sum_probs=209.7
Q ss_pred CCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE-EEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM-FLI 896 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lV 896 (1103)
.|...+.||+|+||+||+|.+.+ +..||+|++.........+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 45567899999999999997543 2379999998766666778899999999999999999999999776655 999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+.+|+|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 102 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 177 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177 (298)
T ss_dssp ECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred EecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence 99999999999997643 4589999999999999999999999 9999999999999999999999999999865433
Q ss_pred CC---ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ET---HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~---~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.. .......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..... ... ...... .
T Consensus 178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~----~~~---~~~~~~-~------ 243 (298)
T 3pls_A 178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID----PFD---LTHFLA-Q------ 243 (298)
T ss_dssp GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC----GGG---HHHHHH-T------
T ss_pred cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC----HHH---HHHHhh-c------
Confidence 21 223345678999999999999999999999999999999997766543221 111 111111 1
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......+...+..+.+++.+||+.||++|||++++++.|+++..
T Consensus 244 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~ 287 (298)
T 3pls_A 244 ---GRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVS 287 (298)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---CCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11122344566789999999999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=356.14 Aligned_cols=254 Identities=24% Similarity=0.361 Sum_probs=206.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch----hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ----HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 46999999999999999999765 6899999998654321 236789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC---EEEeecccc
Q 043720 896 IYNYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN---AYLSDFGLS 970 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfgla 970 (1103)
||||+++++|.+++.... +..+++..+..++.||+.||+|||++ +|+||||||+||+++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999998886543 23589999999999999999999999 9999999999999986654 999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ........... .
T Consensus 181 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---------~~~~~~i~~~~-~ 249 (351)
T 3c0i_A 181 IQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---------ERLFEGIIKGK-Y 249 (351)
T ss_dssp EECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---------HHHHHHHHHTC-C
T ss_pred eEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---------HHHHHHHHcCC-C
Confidence 8765432 22345679999999999999999999999999999999999999997321 11111111111 1
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ..+..+ ...+..+.+++.+||+.||++||++.|++++
T Consensus 250 ~--~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 250 K--MNPRQW----SHISESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp C--CCHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred C--CCcccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0 111111 2345778999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=349.16 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=197.5
Q ss_pred cCCCCcceeccCCcccEEEEEE----cCCcEEEEEEcccccc---hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
++|++.+.||+|+||+||+|+. .+++.||||++..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5799999999999999999976 4689999999976532 23456688999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+||||+++++|.++++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred EEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999998654 388999999999999999999999 9999999999999999999999999998754
Q ss_pred CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ........||+.|+|||++.+..++.++||||||+++|||++|+.||.... ............
T Consensus 172 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~--------~~~~~~~i~~~~----- 237 (327)
T 3a62_A 172 IHD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGEN--------RKKTIDKILKCK----- 237 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHTC-----
T ss_pred ccC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCC-----
Confidence 322 222345678999999999999999999999999999999999999997321 111222221111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++|| ++.|++++
T Consensus 238 ------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h 277 (327)
T 3a62_A 238 ------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH 277 (327)
T ss_dssp ------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred ------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence 122345567899999999999999999 77788764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=344.04 Aligned_cols=261 Identities=26% Similarity=0.447 Sum_probs=200.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|.... .||||+++.... ....+.+.+|+.++++++||||+++++++. .+..++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCccEEEEE
Confidence 4679999999999999999997653 599999976543 345678999999999999999999999764 556899999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC-
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE- 977 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~- 977 (1103)
|+++++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++......
T Consensus 100 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 175 (289)
T 3og7_A 100 WCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG 175 (289)
T ss_dssp CCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred ecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccc
Confidence 999999999996543 4589999999999999999999999 99999999999999999999999999997654322
Q ss_pred CccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 978 THATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
........|++.|+|||++. ...++.++||||||+++|||++|+.||..... ... ............
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------~~~-~~~~~~~~~~~~-- 245 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN-------RDQ-IIEMVGRGSLSP-- 245 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC-------HHH-HHHHHHHTSCCC--
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch-------HHH-HHHHhcccccCc--
Confidence 22234457899999999986 56788899999999999999999999973221 111 112222221111
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
. .......++..+.+++.+||+.||++||+++|+++.|+++.+
T Consensus 246 --~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 --D-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp --C-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred --c-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 0 111234566889999999999999999999999999999875
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=357.75 Aligned_cols=268 Identities=19% Similarity=0.264 Sum_probs=207.3
Q ss_pred hcCCCCcceeccC--CcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 820 TGDFNTSNCIGSG--GFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G--~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.++|++.+.||+| +||+||+|... +++.||||++..... ....+.+.+|+.+++.++|||||++++++.+.+..|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 4579999999999 99999999776 689999999976543 3345678899999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||.+.....
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999887556699999999999999999999999 999999999999999999999999998865421
Q ss_pred CC------CccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH--
Q 043720 976 SE------THATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL-- 1045 (1103)
Q Consensus 976 ~~------~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-- 1045 (1103)
.. ........||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ..........
T Consensus 181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~----~~~~~~~~~~~~ 256 (389)
T 3gni_B 181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ----MLLEKLNGTVPC 256 (389)
T ss_dssp TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT----HHHHC-------
T ss_pred ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHhcCCCCc
Confidence 11 112223478999999999987 678999999999999999999999997432211 0000000000
Q ss_pred --h------------------cCcccccc---------cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 --R------------------QGQVKDVF---------NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 --~------------------~~~~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .....+.. ........+...+..+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h 334 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH 334 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence 0 00000000 0000011233456779999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=343.31 Aligned_cols=262 Identities=17% Similarity=0.219 Sum_probs=211.3
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++..... .+.+.+|+..++.+ +|++++++++++......++||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 35799999999999999999975 5689999999865433 24577899999999 7999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC-----EEEeecccccc
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN-----AYLSDFGLSRL 972 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~-----~ki~Dfgla~~ 972 (1103)
||+ +++|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||+++.
T Consensus 86 e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 999 999999998653 4589999999999999999999999 9999999999999987776 99999999987
Q ss_pred cCCCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 973 LGTSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 973 ~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~ 235 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIGE 235 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHHHH
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccc-----cHHHHHHHHh
Confidence 6543321 2345679999999999999999999999999999999999999997432211 1111111111
Q ss_pred cCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1047 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
..... .... ....++..+.+++.+||+.||++||++++|++.|+++.+
T Consensus 236 ~~~~~--~~~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~ 283 (298)
T 1csn_A 236 KKQST--PLRE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 283 (298)
T ss_dssp HHHHS--CHHH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred hccCc--cHHH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence 10000 0000 112456789999999999999999999999999999754
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=345.06 Aligned_cols=252 Identities=25% Similarity=0.407 Sum_probs=203.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-CeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-NEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|+.. ++.||||++.... ..+.+.+|+.++++++||||+++++++... +..++|||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e 95 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 95 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEe
Confidence 357999999999999999999876 8899999987543 457789999999999999999999987554 47899999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.+++.......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-- 170 (278)
T 1byg_A 96 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 170 (278)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc--
Confidence 99999999999876544578999999999999999999999 9999999999999999999999999998765322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ....... ...
T Consensus 171 --~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~--------~~~~~~~----------~~~ 230 (278)
T 1byg_A 171 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--------KDVVPRV----------EKG 230 (278)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--------GGHHHHH----------TTT
T ss_pred --ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHHHH----------hcC
Confidence 223356889999999998899999999999999999998 9998863211 1111111 111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+...+..+.+++.+||+.||++||+++|+++.|++++.
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~ 273 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 273 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHh
Confidence 1223345567889999999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-38 Score=353.87 Aligned_cols=262 Identities=21% Similarity=0.351 Sum_probs=211.1
Q ss_pred hcCCCCcceeccCCcccEEEEEE------cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++...........+.+|+.++++++||||+++++++...+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 35799999999999999999974 346789999997665566677899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC-----CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEe
Q 043720 894 FLIYNYLPGGNLENFIKARTS-----RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLS 965 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~ 965 (1103)
|+||||+++++|.++++.... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999987542 3488999999999999999999999 9999999999999984 4469999
Q ss_pred ecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHH
Q 043720 966 DFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 966 Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
|||++........ .......+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .......
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~--------~~~~~~~ 257 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKS--------NQEVLEF 257 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC--------HHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcC--------HHHHHHH
Confidence 9999976533322 22234467889999999998899999999999999999998 888886321 1111111
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
.. .. .....+..++..+.+++.+||+.||++||+++|++++|+.+.+.+
T Consensus 258 ~~-~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~ 306 (327)
T 2yfx_A 258 VT-SG---------GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP 306 (327)
T ss_dssp HH-TT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred Hh-cC---------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence 11 11 111233456678999999999999999999999999999987654
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.76 Aligned_cols=254 Identities=26% Similarity=0.415 Sum_probs=200.9
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|.+. ++.||||++... ...+.+.+|+.++++++||||+++++++.+ ..++||||+
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~ 81 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE---SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA 81 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST---THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh---hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence 46888999999999999999876 788999998643 345788999999999999999999998874 478999999
Q ss_pred CCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC-EEEeecccccccCCCCC
Q 043720 901 PGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN-AYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~-~ki~Dfgla~~~~~~~~ 978 (1103)
++|+|.++++.... ..+++..++.++.|+++||+|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999986543 24788999999999999999999932229999999999999998887 799999999765322
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||..... .......... .. .
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~------~~~~~~~~~~-~~---------~ 221 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGG------PAFRIMWAVH-NG---------T 221 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCS------SHHHHHHHHH-TT---------C
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCc------cHHHHHHHHh-cC---------C
Confidence 2234689999999999999999999999999999999999999973221 1111111111 11 1
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
........+..+.+++.+||+.||++|||++|+++.|+++.+
T Consensus 222 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 263 (307)
T 2eva_A 222 RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263 (307)
T ss_dssp CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 112234556789999999999999999999999999998864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-37 Score=357.41 Aligned_cols=268 Identities=16% Similarity=0.262 Sum_probs=208.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC------CcEEEEEEcccccchh----------hHHHHHHHHHHHhcCCCCceeEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP------GILVAVKKLAVGRFQH----------GVQQFHAEIKTLGNVRHPNLVTL 883 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~------~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l 883 (1103)
.++|++.+.||+|+||+||+|.+.. ++.||||++....... ....+..|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4579999999999999999997765 4789999987653211 01234557778888999999999
Q ss_pred EeEEecC----CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC--
Q 043720 884 IGYRASG----NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-- 957 (1103)
Q Consensus 884 ~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~-- 957 (1103)
++++... ...|+||||+ +++|.++++.. ...+++.++..++.||+.||+|||++ +|+||||||+||+++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~ 188 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYK 188 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESS
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecC
Confidence 9998764 4589999999 99999999874 34599999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccccccCCCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043720 958 DDFNAYLSDFGLSRLLGTSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSH 1031 (1103)
Q Consensus 958 ~~~~~ki~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 1031 (1103)
.++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~-- 266 (364)
T 3op5_A 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK-- 266 (364)
T ss_dssp CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT--
T ss_pred CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc--
Confidence 8899999999999876433221 12344599999999999999999999999999999999999999974221
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
............ .......++..+. ...++..+.+++..||+.||++||++++|++.|+++..
T Consensus 267 --~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~ 329 (364)
T 3op5_A 267 --DPKYVRDSKIRY-RENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK 329 (364)
T ss_dssp --CHHHHHHHHHHH-HHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred --CHHHHHHHHHHh-hhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence 111111111111 1122222222221 23456789999999999999999999999999998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=379.57 Aligned_cols=254 Identities=23% Similarity=0.388 Sum_probs=206.3
Q ss_pred CCCcc-eeccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 823 FNTSN-CIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 823 ~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
+.+.+ .||+|+||+||+|.+. ++..||||+++........+.+.+|+.++++++|||||++++++.. +..++|||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E 415 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME 415 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence 34444 7999999999999764 4677999999877666677899999999999999999999999976 56899999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.+++... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++.......
T Consensus 416 ~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 416 MAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp CCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred eCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999754 34589999999999999999999999 999999999999999999999999999987643332
Q ss_pred cc--ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 979 HA--TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 979 ~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.. .....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ...... +..
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~~-i~~-------- 554 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAF-IEQ-------- 554 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS--------HHHHHH-HHT--------
T ss_pred eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH--------HHHHHH-HHc--------
Confidence 21 223345689999999999999999999999999999998 9999874321 111111 111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
......+..++..+.++|.+||+.||++||++++|++.|+.+.
T Consensus 555 -~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~ 597 (613)
T 2ozo_A 555 -GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 597 (613)
T ss_dssp -TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHH
T ss_pred -CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 1123345567789999999999999999999999999999864
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=354.98 Aligned_cols=253 Identities=19% Similarity=0.316 Sum_probs=201.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCC--CceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRH--PNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|...+++.||||++..... ....+.+.+|+.++++++| +||+++++++...+..|+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 356899999999999999999888899999999876543 3445788999999999976 9999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
||+ .+++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++.....
T Consensus 88 ~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp ECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 995 5889999998754 489999999999999999999999 999999999999997 578999999999876433
Q ss_pred CCc-cccCCcccccccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 977 ETH-ATTGVAGTFGYVAPEYALT-----------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 977 ~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... .......
T Consensus 161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~- 232 (343)
T 3dbq_A 161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHA- 232 (343)
T ss_dssp ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHH-
T ss_pred cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhh-------HHHHHHH-
Confidence 322 2345679999999999864 6788899999999999999999999963211 1111111
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
.++.......+...+..+.+++.+||+.||++|||++|++++-
T Consensus 233 --------~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp 275 (343)
T 3dbq_A 233 --------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP 275 (343)
T ss_dssp --------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred --------HhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence 1122222233444456789999999999999999999998763
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-37 Score=351.33 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=207.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcE--EEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGIL--VAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~--vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|... ++.. ||||++.........+.+.+|+.+++++ +||||+++++++.+.+..|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 57999999999999999999654 4554 4999987655555667899999999999 899999999999999999999
Q ss_pred EeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCE
Q 043720 897 YNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNA 962 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 962 (1103)
|||+++|+|.++++... ...+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999998653 24589999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHH
Q 043720 963 YLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 963 ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
||+|||+++.... ........+++.|+|||++.+..++.++||||||+++|||++ |+.||.... .....
T Consensus 182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~--------~~~~~ 251 (327)
T 1fvr_A 182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--------CAELY 251 (327)
T ss_dssp EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHH
T ss_pred EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc--------HHHHH
Confidence 9999999974321 122233456889999999998889999999999999999998 999986321 11111
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.. . ........+...+..+.+++.+||+.||++||+++|++++|+++...
T Consensus 252 ~~-~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 301 (327)
T 1fvr_A 252 EK-L---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 301 (327)
T ss_dssp HH-G---------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HH-h---------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 1 11112233445678899999999999999999999999999987543
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-37 Score=358.62 Aligned_cols=271 Identities=18% Similarity=0.233 Sum_probs=217.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC--eEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN--EMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lV~ 897 (1103)
++|.+.+.||+|+||+||+|.... ++.||||++.........+.+.+|++++++++||||+++++++...+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 468999999999999999997664 89999999987665556788899999999999999999999987755 789999
Q ss_pred eecCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE----CCCCCEEEeecccccc
Q 043720 898 NYLPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL----DDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki~Dfgla~~ 972 (1103)
||+++|+|.++++.... ..+++..++.++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999986543 3389999999999999999999999 99999999999999 7778899999999987
Q ss_pred cCCCCCccccCCcccccccCcccccc--------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALT--------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~--------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....... .......
T Consensus 166 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~----~~~~~~~ 239 (396)
T 4eut_A 166 LEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN----KEVMYKI 239 (396)
T ss_dssp CCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC----HHHHHHH
T ss_pred ccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch----HHHHHHH
Confidence 64332 2334678999999999865 56778999999999999999999999754332221 2222222
Q ss_pred HhcCccccc------c--------cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1045 LRQGQVKDV------F--------NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1045 ~~~~~~~~~------~--------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......... . +.......+...+..+.+++.+||+.||++||+++|+++.++++..
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 222111000 0 0011112346778889999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=348.47 Aligned_cols=246 Identities=27% Similarity=0.325 Sum_probs=196.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ......+..|+..+.++ +||||+++++++.+++..|+||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999776 689999998765432 23344555666665555 8999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+ +++|.+++.... ..+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~- 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA- 210 (311)
T ss_dssp ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence 999 679999987754 4599999999999999999999999 9999999999999999999999999999876432
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......||++|+|||++.+ .++.++|||||||++|||++|+.|+... ..| ....... ....
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~----------~~~--~~~~~~~----~~~~ 272 (311)
T 3p1a_A 211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG----------EGW--QQLRQGY----LPPE 272 (311)
T ss_dssp -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH----------HHH--HHHTTTC----CCHH
T ss_pred -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc----------cHH--HHHhccC----CCcc
Confidence 22344568999999999876 7899999999999999999998776521 111 1111111 1111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+...+..+.+++.+||+.||++|||++|++++
T Consensus 273 ----~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 305 (311)
T 3p1a_A 273 ----FTAGLSSELRSVLVMMLEPDPKLRATAEALLAL 305 (311)
T ss_dssp ----HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred ----cccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence 122345789999999999999999999999874
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=339.21 Aligned_cols=248 Identities=27% Similarity=0.423 Sum_probs=204.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|... +++.||||++...... .....+.+|+.++++++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 457999999999999999999665 4678999998654322 2356788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 88 ~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~- 161 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS- 161 (279)
T ss_dssp ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred EecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCc-
Confidence 99999999999998754 389999999999999999999999 999999999999999999999999999865432
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.... ..........
T Consensus 162 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~---------- 221 (279)
T 3fdn_A 162 --SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRISR---------- 221 (279)
T ss_dssp --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH----------
T ss_pred --ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCc--------HHHHHHHHHh----------
Confidence 22334578999999999999999999999999999999999999987321 1111111111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+..+.+++.+||+.||++||+++|++++
T Consensus 222 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 222 -VEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp -TCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred -CCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1112344456788999999999999999999999975
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=346.81 Aligned_cols=271 Identities=23% Similarity=0.334 Sum_probs=212.3
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhc--CCCCceeEEEeEEecCC
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGN--VRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~ 891 (1103)
.......++|++.+.||+|+||+||+|... ++.||||++... ..+.+.+|++++.. ++||||+++++++....
T Consensus 35 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 35 LVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 333445678999999999999999999875 899999998643 34567788888877 78999999999998876
Q ss_pred ----eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHH--------hCCCCCcccCCCCCCcEEECCC
Q 043720 892 ----EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH--------DQCAPRVLHRDVKPSNILLDDD 959 (1103)
Q Consensus 892 ----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH--------~~~~~~ivH~Dlk~~NIll~~~ 959 (1103)
..++||||+++|+|.++++.. .+++.+++.++.|++.||+||| +. +|+||||||+||+++.+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~ 183 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKN 183 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTT
T ss_pred CccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCC
Confidence 899999999999999999764 3899999999999999999999 77 99999999999999999
Q ss_pred CCEEEeecccccccCCCCCc---cccCCcccccccCccccccCC------CCCcchhHHHHHHHHHHHhC----------
Q 043720 960 FNAYLSDFGLSRLLGTSETH---ATTGVAGTFGYVAPEYALTCR------VSDKADVYSYGVVLLELISD---------- 1020 (1103)
Q Consensus 960 ~~~ki~Dfgla~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~------~~~~sDvwslGvil~elltg---------- 1020 (1103)
+.+||+|||++......... ......|++.|+|||++.+.. ++.++||||||+++|||++|
T Consensus 184 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~ 263 (342)
T 1b6c_B 184 GTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDY 263 (342)
T ss_dssp SCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccccc
Confidence 99999999999876443322 234557899999999987652 33689999999999999999
Q ss_pred CCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1021 KKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1021 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
..||....... .....+.... ........+.... ....++..+.+++.+||+.||++||++.||+++|+++.+
T Consensus 264 ~~p~~~~~~~~---~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~ 336 (342)
T 1b6c_B 264 QLPYYDLVPSD---PSVEEMRKVV-CEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336 (342)
T ss_dssp CCTTTTTSCSS---CCHHHHHHHH-TTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccCccccCcCc---ccHHHHHHHH-HHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHH
Confidence 56665332211 1112222221 1111111111111 134677889999999999999999999999999999976
Q ss_pred CC
Q 043720 1101 SP 1102 (1103)
Q Consensus 1101 ~~ 1102 (1103)
+.
T Consensus 337 ~~ 338 (342)
T 1b6c_B 337 QE 338 (342)
T ss_dssp TT
T ss_pred Hh
Confidence 53
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=348.69 Aligned_cols=263 Identities=21% Similarity=0.306 Sum_probs=207.9
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe----cCCeEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA----SGNEMF 894 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~ 894 (1103)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++. .....+
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 35799999999999999999976 568999999986543 345678899999999999999999999986 345789
Q ss_pred EEEeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 895 LIYNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
+||||+++|+|.+++... ....+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 999999999999999864 235589999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCCc--------cccCCcccccccCccccccCC---CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHH
Q 043720 973 LGTSETH--------ATTGVAGTFGYVAPEYALTCR---VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 973 ~~~~~~~--------~~~~~~g~~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
....... ......|++.|+|||++.... ++.++||||||+++|||++|+.||........ . .
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~----~ 256 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD---S----V 256 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS---C----H
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc---h----h
Confidence 5321111 112335789999999987543 68899999999999999999999863111100 0 0
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
.... ......+.....+..+.+++.+||+.||++||+++|++++|+++...+
T Consensus 257 ~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~ 308 (317)
T 2buj_A 257 ALAV---------QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPA 308 (317)
T ss_dssp HHHH---------HCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCC
T ss_pred hHHh---------hccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCC
Confidence 0000 111112223455678999999999999999999999999999987543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=356.51 Aligned_cols=266 Identities=23% Similarity=0.358 Sum_probs=213.7
Q ss_pred cCCCCcceeccCCcccEEEEEE-----cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe--cCCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA--SGNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~ 893 (1103)
++|++.+.||+|+||+||+|.+ .+++.||||++.... ....+.+.+|+.++++++||||+++++++. +....
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG-PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC-HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 4789999999999999999984 358899999987653 334677999999999999999999999886 45678
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++++|.++++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceec
Confidence 99999999999999998743 3489999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCC------CCCCcchHHHHHHHH
Q 043720 974 GTSETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSS------HGDGFNIISWASMLL 1045 (1103)
Q Consensus 974 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~------~~~~~~~~~~~~~~~ 1045 (1103)
...... ......+++.|+|||++.+..++.++||||||+++|||++|+.||...... .........
T Consensus 178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~------ 251 (327)
T 3lxl_A 178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS------ 251 (327)
T ss_dssp CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH------
T ss_pred ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH------
Confidence 543322 233456788999999999888999999999999999999999998632110 000000000
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...+.+........+..++..+.+++.+||+.||++||+++|++++|+++..
T Consensus 252 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~ 303 (327)
T 3lxl_A 252 ---RLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS 303 (327)
T ss_dssp ---HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred ---HHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0111112222334456677889999999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-37 Score=361.67 Aligned_cols=248 Identities=27% Similarity=0.421 Sum_probs=207.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|.+.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+..|+||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999776 689999999976532 234567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 96 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~ 170 (476)
T 2y94_A 96 EYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 170 (476)
T ss_dssp ECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence 999999999999754 3489999999999999999999999 99999999999999999999999999998764322
Q ss_pred CccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.....+||+.|+|||++.+..+ +.++||||+||++|||++|+.||+.... ......... +.
T Consensus 171 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~--------~~~~~~i~~-~~------- 232 (476)
T 2y94_A 171 --FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHV--------PTLFKKICD-GI------- 232 (476)
T ss_dssp --CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSS--------HHHHHHHHT-TC-------
T ss_pred --cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCH--------HHHHHHHhc-CC-------
Confidence 2345579999999999988765 6799999999999999999999973221 112222211 11
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++|||++|++++
T Consensus 233 ---~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 233 ---FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp ---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred ---cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 11233455779999999999999999999999974
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=350.25 Aligned_cols=251 Identities=23% Similarity=0.298 Sum_probs=191.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV---DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch---hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 457999999999999999999776 47889999987543 34568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeecccccccCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~~ 975 (1103)
|+++|+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++. ++.+||+|||+++....
T Consensus 129 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 129 LVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp CCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred eCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999997643 489999999999999999999999 9999999999999975 88999999999986543
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......... .....
T Consensus 204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-------~~~~~~~i~-~~~~~---- 269 (349)
T 2w4o_A 204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG-------DQFMFRRIL-NCEYY---- 269 (349)
T ss_dssp -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC-------HHHHHHHHH-TTCCC----
T ss_pred c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc-------cHHHHHHHH-hCCCc----
Confidence 2 223345789999999999999999999999999999999999999973321 011111111 11110
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+..+.+++.+||+.||++||++.|++++
T Consensus 270 --~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 306 (349)
T 2w4o_A 270 --FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH 306 (349)
T ss_dssp --CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred --cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0011123456789999999999999999999999874
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-37 Score=366.96 Aligned_cols=255 Identities=23% Similarity=0.318 Sum_probs=211.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|... +|+.||||++..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356889999999999999999775 689999999976532 23456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.+++.......+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 9999999999999876656699999999999999999999999 9999999999999999999999999999876433
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
. .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............ .
T Consensus 340 ~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~----~~~~~i~~~i~~-~-------- 404 (576)
T 2acx_A 340 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKK----IKREEVERLVKE-V-------- 404 (576)
T ss_dssp C--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSC----CCHHHHHHHHHH-C--------
T ss_pred c--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccc----hhHHHHHHHhhc-c--------
Confidence 2 234458999999999999989999999999999999999999999743221 111111111111 1
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
....+...+..+.+++.+||+.||++|| +++||+++
T Consensus 405 --~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H 445 (576)
T 2acx_A 405 --PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH 445 (576)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred --cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence 1123345667899999999999999999 78888764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=364.18 Aligned_cols=250 Identities=23% Similarity=0.277 Sum_probs=198.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++...+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357999999999999999999754 58999999997642 233456788999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|||+++|+|.+++.... .+++..+..++.|++.||+|||+ . +|+||||||+|||++.++.+||+|||+++....
T Consensus 227 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 227 MEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp ECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 99999999999997754 48999999999999999999998 8 999999999999999999999999999975432
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||.... ............
T Consensus 302 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~--------~~~~~~~i~~~~------- 365 (446)
T 4ejn_A 302 D-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD--------HEKLFELILMEE------- 365 (446)
T ss_dssp ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC-------
T ss_pred C-CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCC-------
Confidence 2 223445689999999999999999999999999999999999999997321 111222221111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++|| +++|++++
T Consensus 366 ----~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h 405 (446)
T 4ejn_A 366 ----IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH 405 (446)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred ----CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence 123345567899999999999999999 99999863
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-37 Score=357.84 Aligned_cols=251 Identities=19% Similarity=0.317 Sum_probs=200.8
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCC--CCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVR--HPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.+|++.+.||+|+||+||+|....++.||||++..... ....+.+.+|+.++++++ ||||+++++++...+..|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 45999999999999999999888899999999976543 345678999999999996 599999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
| +.+++|.++++... .+++.++..++.||+.||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 136 E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 136 E-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp E-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred e-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 9 55889999998754 488899999999999999999999 999999999999996 5799999999998764332
Q ss_pred Cc-cccCCcccccccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 978 TH-ATTGVAGTFGYVAPEYALT-----------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 978 ~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ........
T Consensus 209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~~~~- 280 (390)
T 2zmd_A 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHAI- 280 (390)
T ss_dssp -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCC-------HHHHHHHH-
T ss_pred ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhH-------HHHHHHHH-
Confidence 22 2345679999999999865 4688899999999999999999999963211 11111111
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
++.......+...+..+.+++.+||+.||++||+++|++++
T Consensus 281 --------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 281 --------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp --------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred --------hCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 11122222233345678999999999999999999999865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=348.31 Aligned_cols=267 Identities=21% Similarity=0.386 Sum_probs=204.3
Q ss_pred HHHHHHHhcCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEE
Q 043720 813 YESIIRATGDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887 (1103)
Q Consensus 813 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~ 887 (1103)
..++....++|.+.+.||+|+||+||+|... .++.||||++..... ....+.+.+|+.++++++||||+++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 105 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC 105 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence 3344445577999999999999999999654 345899999976543 34567799999999999999999999998
Q ss_pred ecCC-----eEEEEEeecCCCChHHHHHhh----cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC
Q 043720 888 ASGN-----EMFLIYNYLPGGNLENFIKAR----TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD 958 (1103)
Q Consensus 888 ~~~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~ 958 (1103)
...+ ..++||||+++|+|.+++... ....+++..++.++.|++.||+|||++ +|+||||||+||+++.
T Consensus 106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~ 182 (313)
T 3brb_A 106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD 182 (313)
T ss_dssp EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence 7755 359999999999999999642 235689999999999999999999999 9999999999999999
Q ss_pred CCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcc
Q 043720 959 DFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFN 1036 (1103)
Q Consensus 959 ~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~ 1036 (1103)
++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|||++ |..||..... ..
T Consensus 183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-----~~ 257 (313)
T 3brb_A 183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQN-----HE 257 (313)
T ss_dssp TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG-----GG
T ss_pred CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCH-----HH
Confidence 999999999999876433322 2234457889999999999999999999999999999999 8888763221 11
Q ss_pred hHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1037 IISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
........ .....+..++..+.+++.+||+.||++||++++++++|+++.+
T Consensus 258 ---~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~ 308 (313)
T 3brb_A 258 ---MYDYLLHG----------HRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLE 308 (313)
T ss_dssp ---HHHHHHTT----------CCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---HHHHHHcC----------CCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 11111111 1122345566789999999999999999999999999999754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=351.77 Aligned_cols=245 Identities=26% Similarity=0.336 Sum_probs=195.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHH-HhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKT-LGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|+.+ +++.||||++..... ....+.+.+|..+ ++.++||||+++++++.+.+..|+|
T Consensus 38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv 117 (373)
T 2r5t_A 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117 (373)
T ss_dssp GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence 46999999999999999999776 478899999976543 2234556777776 5778999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.+++++.. .+++..++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 118 ~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 118 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999998754 488999999999999999999999 9999999999999999999999999999864322
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.... .......+....
T Consensus 193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~--------~~~~~~~i~~~~-------- 255 (373)
T 2r5t_A 193 -NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN--------TAEMYDNILNKP-------- 255 (373)
T ss_dssp -CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSB--------HHHHHHHHHHSC--------
T ss_pred -CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhcc--------
Confidence 223445689999999999999999999999999999999999999997321 112222222111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQ 1090 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e 1090 (1103)
...+...+..+.+++.+||+.||++||++.+
T Consensus 256 ---~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~ 286 (373)
T 2r5t_A 256 ---LQLKPNITNSARHLLEGLLQKDRTKRLGAKD 286 (373)
T ss_dssp ---CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred ---cCCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence 1123345678999999999999999999854
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-37 Score=353.80 Aligned_cols=271 Identities=24% Similarity=0.368 Sum_probs=202.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHH--HHHHHHhcCCCCceeEEEeEEec-----CCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFH--AEIKTLGNVRHPNLVTLIGYRAS-----GNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~-----~~~ 892 (1103)
.++|++.+.||+|+||+||+|+. +++.||||++.... ...+. .|+..+..++||||+++++++.. ...
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 35799999999999999999976 48999999987543 23333 44444556899999999985532 336
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC------CCCcccCCCCCCcEEECCCCCEEEee
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC------APRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
+++||||+++|+|.++++... .++..+.+++.|++.||+|||+.+ .++|+||||||+||+++.++.+||+|
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D 163 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred EEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence 799999999999999997654 688999999999999999999863 33899999999999999999999999
Q ss_pred cccccccCCCC-------CccccCCcccccccCcccccc-------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043720 967 FGLSRLLGTSE-------THATTGVAGTFGYVAPEYALT-------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032 (1103)
Q Consensus 967 fgla~~~~~~~-------~~~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 1032 (1103)
||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......
T Consensus 164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~ 243 (336)
T 3g2f_A 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243 (336)
T ss_dssp CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence 99998764322 122334579999999999976 4566789999999999999999888765443221
Q ss_pred CCcchH---------HHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1033 DGFNII---------SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1033 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...... ...............+... ......++..+.+++.+||+.||++|||++|+++.|+++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA--WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT--CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHhhhcccCCCchHHHHHhhhcccccCCCCCcc--cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 111110 0111111111111111111 11233467789999999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-37 Score=344.98 Aligned_cols=265 Identities=24% Similarity=0.311 Sum_probs=202.1
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch----hhHHHHHHHHHHHhcCC---CCceeEEEeEEecC
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ----HGVQQFHAEIKTLGNVR---HPNLVTLIGYRASG 890 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~ 890 (1103)
..++|++.+.||+|+||+||+|.. .+++.||||++...... .....+.+|+.++++++ ||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 356899999999999999999975 46899999998754321 12345667777777664 99999999999775
Q ss_pred C-----eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 891 N-----EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 891 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
. ..++||||+. ++|.++++......+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~ 162 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLA 162 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEEC
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEe
Confidence 5 5899999996 6999999887666699999999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 966 DFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 966 Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...........
T Consensus 163 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~ 235 (308)
T 3g33_A 163 DFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE-----ADQLGKIFDLI 235 (308)
T ss_dssp SCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSH-----HHHHHHHHHHH
T ss_pred eCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHh
Confidence 99999865432 223456789999999999999999999999999999999999999974221 11111111111
Q ss_pred hcCccccc---c---ccccc-------CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDV---F---NAELW-------ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~---~---~~~~~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........ . ..... .......+..+.+++.+|++.||++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 297 (308)
T 3g33_A 236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH 297 (308)
T ss_dssp CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence 00000000 0 00000 00012345778999999999999999999999875
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=338.81 Aligned_cols=252 Identities=26% Similarity=0.364 Sum_probs=201.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|.+.+.||+|+||+||+|... ++..||+|++.........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 46999999999999999999764 58899999998776666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE---CCCCCEEEeecccccccC
Q 043720 900 LPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 900 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~ 974 (1103)
+++|+|.+++... ....+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++....
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 9999999998654 235699999999999999999999999 99999999999999 456789999999998654
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.. .......|++.|+|||++. ..++.++||||+|+++|||++|+.||.... ..............
T Consensus 179 ~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~--------~~~~~~~~~~~~~~---- 243 (285)
T 3is5_A 179 SD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS--------LEEVQQKATYKEPN---- 243 (285)
T ss_dssp ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCCCC----
T ss_pred Cc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC--------HHHHHhhhccCCcc----
Confidence 32 2234457899999999886 468899999999999999999999997321 11111111111100
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .......+..+.+++.+||+.||++||+++|++++
T Consensus 244 ---~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 244 ---Y-AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp ---C-CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred ---c-ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 00112245678999999999999999999999864
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=340.99 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=208.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357899999999999999999765 6899999999776655567889999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.++++.. ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+........
T Consensus 86 ~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred ecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 99999999998654 3489999999999999999999999 999999999999999999999999999986543221
Q ss_pred -ccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 979 -HATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 979 -~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ......| . ...
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~-~~~------- 225 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---CQEYSDW----K-EKK------- 225 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTT---SHHHHHH----H-TTC-------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchH---HHHHHHh----h-hcc-------
Confidence 22345678999999999987665 67899999999999999999999743221 1111111 1 110
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+..+.+++.+||+.||++|||++|++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (276)
T 2yex_A 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262 (276)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence 0011123456778999999999999999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=344.30 Aligned_cols=257 Identities=25% Similarity=0.332 Sum_probs=206.9
Q ss_pred hcCCCCcc-eeccCCcccEEEEEEc---CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 820 TGDFNTSN-CIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 820 ~~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
.++|++.+ .||+|+||+||+|... .++.||||++...... ...+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 34677777 8999999999999543 3688999999765432 3467899999999999999999999999 566789
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+++++|.++++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 94 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168 (291)
T ss_dssp EEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence 9999999999999998753 489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCcc--ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 975 TSETHA--TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 975 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||..... ..... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~--------~~~~~-~~~~~--- 236 (291)
T 1xbb_A 169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTA-MLEKG--- 236 (291)
T ss_dssp TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHH-HHHTT---
T ss_pred cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH--------HHHHH-HHHcC---
Confidence 443322 223346789999999988888999999999999999999 9999873211 11111 11111
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+..++..+.+++.+||+.||++||+++|+++.|+++..
T Consensus 237 ------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 279 (291)
T 1xbb_A 237 ------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 279 (291)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1122345667889999999999999999999999999998743
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-37 Score=352.57 Aligned_cols=253 Identities=20% Similarity=0.243 Sum_probs=207.6
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP-LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch-hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 357999999999999999999765 588999999876533 245678999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC--CCCEEEeecccccccCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD--DFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~ 976 (1103)
|+++|+|.+++.... ..+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||+++.....
T Consensus 129 ~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 129 FLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999987543 3589999999999999999999999 9999999999999974 567999999999876533
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............
T Consensus 205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~--------~~~~~~~i~~~~~------- 267 (387)
T 1kob_A 205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCDW------- 267 (387)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCCC-------
T ss_pred cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-------
Confidence 22 233478999999999999999999999999999999999999997321 1111222111110
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..........+..+.+++.+||+.||++||++.|++++
T Consensus 268 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 305 (387)
T 1kob_A 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 305 (387)
T ss_dssp CCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence 01111223456789999999999999999999999875
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=347.49 Aligned_cols=259 Identities=23% Similarity=0.347 Sum_probs=198.8
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC----e
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----E 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 892 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ......+.+|+.++++++||||+++++++.... .
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 35799999999999999999975 5689999999976533 334567899999999999999999999886643 3
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+||||+++++|.++++... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 91 ~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~ 165 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 165 (311)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred cEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence 499999999999999998654 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 973 LGTSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 973 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
...... .......|++.|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--------~~~~~~~~~~~~~ 237 (311)
T 3ork_A 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP--------VSVAYQHVREDPI 237 (311)
T ss_dssp ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHCCCC
T ss_pred ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHhcCCCC
Confidence 643322 223345789999999999999999999999999999999999999973221 1111111111110
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHH-HHHHhh
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVV-QCLKQI 1098 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl-~~L~~i 1098 (1103)
. .. ......+.++.+++.+||+.||++||++.+++ +.+.++
T Consensus 238 ~----~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 P----PS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp C----HH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred C----cc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 0 00 01223567799999999999999999666554 555554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=344.58 Aligned_cols=262 Identities=25% Similarity=0.378 Sum_probs=203.1
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 35799999999999999999976 468999999987532 234567789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 897 YNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
|||+++++|.++++.. ....+++..++.++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 9999999999999753 235589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
... .......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ........... .....
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~-~~~~~--- 256 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK------MNLYSLCKKIE-QCDYP--- 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---------CCHHHHHHHHH-TTCSC---
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc------hhHHHHHHHhh-cccCC---
Confidence 322 22334568999999999999999999999999999999999999986321 11122222211 11111
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.......+..+.+++.+||+.||++||++++|++.|+++++
T Consensus 257 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~ 297 (310)
T 2wqm_A 257 -----PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297 (310)
T ss_dssp -----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -----CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence 11123456789999999999999999999999999999865
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=351.19 Aligned_cols=262 Identities=23% Similarity=0.284 Sum_probs=205.2
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc----chhhHHHHHHHHHHHhcCCCCceeEEEeEEec
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR----FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS 889 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 889 (1103)
++....++|++.+.||+|+||+||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556778999999999999999999764 57899999987543 23456789999999999999999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhhc--------------------------------------CCcccHHHHHHHHHHHHH
Q 043720 890 GNEMFLIYNYLPGGNLENFIKART--------------------------------------SRAVDWKILHKIALDVAS 931 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------~~~l~~~~~~~i~~~ia~ 931 (1103)
.+..++||||+++|+|.++++... ...+++..++.++.|++.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 999999999999999999985210 122467888999999999
Q ss_pred HHHHHHhCCCCCcccCCCCCCcEEECCCC--CEEEeecccccccCCCC---CccccCCcccccccCcccccc--CCCCCc
Q 043720 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDF--NAYLSDFGLSRLLGTSE---THATTGVAGTFGYVAPEYALT--CRVSDK 1004 (1103)
Q Consensus 932 gL~~LH~~~~~~ivH~Dlk~~NIll~~~~--~~ki~Dfgla~~~~~~~---~~~~~~~~g~~~y~aPE~~~~--~~~~~~ 1004 (1103)
||+|||++ +|+||||||+||+++.++ .+||+|||+++.+.... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 89999999998653322 223345678999999999865 678899
Q ss_pred chhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCC
Q 043720 1005 ADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLST 1084 (1103)
Q Consensus 1005 sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~ 1084 (1103)
+||||||+++|||++|+.||..... ............. .........+..+.+++.+||+.||++
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~ 321 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVND--------ADTISQVLNKKLC-------FENPNYNVLSPLARDLLSNLLNRNVDE 321 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHCCCC-------TTSGGGGGSCHHHHHHHHHHSCSCTTT
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcccc-------cCCcccccCCHHHHHHHHHHcCCChhH
Confidence 9999999999999999999973221 1122222211110 000111235678999999999999999
Q ss_pred CCCHHHHHHH
Q 043720 1085 RPTMKQVVQC 1094 (1103)
Q Consensus 1085 RPs~~evl~~ 1094 (1103)
||++.|++++
T Consensus 322 Rps~~~~l~h 331 (345)
T 3hko_A 322 RFDAMRALQH 331 (345)
T ss_dssp SCCHHHHHHS
T ss_pred CCCHHHHhcC
Confidence 9999999874
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-37 Score=341.56 Aligned_cols=251 Identities=20% Similarity=0.307 Sum_probs=204.1
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-C-------cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-G-------ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
++|++.+.||+|+||+||+|.... + ..||+|++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH-RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG-GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 468899999999999999996553 3 579999986543 3356789999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC--------EEE
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN--------AYL 964 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~--------~ki 964 (1103)
.++||||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeee
Confidence 999999999999999998753 3489999999999999999999999 9999999999999998887 999
Q ss_pred eecccccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 965 SDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
+|||++...... ....+++.|+|||++.+ ..++.++||||||+++|||++|+.|+..... .......
T Consensus 163 ~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~-------~~~~~~~ 230 (289)
T 4fvq_A 163 SDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALD-------SQRKLQF 230 (289)
T ss_dssp CCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSC-------HHHHHHH
T ss_pred ccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccc-------hHHHHHH
Confidence 999998754321 23457889999999987 7789999999999999999997666542211 1111111
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.... ...+...+..+.+++.+||+.||++|||++|++++|+++..
T Consensus 231 ~~~~------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~ 275 (289)
T 4fvq_A 231 YEDR------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT 275 (289)
T ss_dssp HHTT------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred hhcc------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 1110 11122334568999999999999999999999999999864
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=335.92 Aligned_cols=253 Identities=23% Similarity=0.330 Sum_probs=208.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 467999999999999999999765 588999999976543 344677889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC---EEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN---AYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfgla~~~~ 974 (1103)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++. +||+|||++....
T Consensus 85 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 85 DLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 9999999999987754 489999999999999999999999 9999999999999986655 9999999998764
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
... ......|++.|+|||++.+..++.++||||+|+++|+|++|+.||..... ....... ..+...
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--------~~~~~~~-~~~~~~--- 225 (284)
T 3kk8_A 160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ--------HRLYAQI-KAGAYD--- 225 (284)
T ss_dssp SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH-HHTCCC---
T ss_pred cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch--------hHHHHHH-Hhcccc---
Confidence 322 23446789999999999999999999999999999999999999963211 1111111 111110
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+..+.+++.+|++.||++||+++|++++
T Consensus 226 ---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (284)
T 3kk8_A 226 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV 262 (284)
T ss_dssp ---CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 0011123456779999999999999999999999874
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=351.97 Aligned_cols=208 Identities=25% Similarity=0.342 Sum_probs=182.1
Q ss_pred CCCCHHHHHHHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-----CCceeE
Q 043720 809 VPLTYESIIRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-----HPNLVT 882 (1103)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~ 882 (1103)
..+++.+.....++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+..|+.+++.++ ||||++
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~~iv~ 100 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNNNIVK 100 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence 3455555555678999999999999999999976 46889999998743 234566788999999886 999999
Q ss_pred EEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC----
Q 043720 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---- 958 (1103)
Q Consensus 883 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---- 958 (1103)
+++++...+..++||||+ +++|.+++.......+++.++..++.||+.||+|||++ +|+||||||+||+++.
T Consensus 101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 999999999999999999 89999999887666799999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHH
Q 043720 959 ---------------------DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLEL 1017 (1103)
Q Consensus 959 ---------------------~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~el 1017 (1103)
++.+||+|||+++.... ......||+.|+|||++.+..++.++|||||||++|||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 78899999999986432 22345789999999999999999999999999999999
Q ss_pred HhCCCCCCC
Q 043720 1018 ISDKKALDP 1026 (1103)
Q Consensus 1018 ltg~~p~~~ 1026 (1103)
++|+.||..
T Consensus 253 l~g~~pf~~ 261 (360)
T 3llt_A 253 YTGSLLFRT 261 (360)
T ss_dssp HHSSCSCCC
T ss_pred HHCCCCCCC
Confidence 999999974
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-37 Score=350.83 Aligned_cols=243 Identities=23% Similarity=0.336 Sum_probs=204.4
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch-------hhHHHHHHHHHHHhcCCCCceeEEEeEEecCC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ-------HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 891 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++...... ...+.+.+|+.++++++||||+++++++.+.+
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 45799999999999999999965 46899999999765421 13345778999999999999999999999999
Q ss_pred eEEEEEeecCCC-ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 892 EMFLIYNYLPGG-NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 892 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
..++||||+.+| +|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a 177 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSA 177 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccc
Confidence 999999999777 9999998654 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
....... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||.....
T Consensus 178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------------------- 235 (335)
T 3dls_A 178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE-------------------- 235 (335)
T ss_dssp EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG--------------------
T ss_pred eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH--------------------
Confidence 8764332 2334578999999999988776 7789999999999999999999963111
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..... ...+...+..+.+++.+||+.||++||+++|++++
T Consensus 236 ---~~~~~--~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 236 ---TVEAA--IHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp ---GTTTC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred ---HHhhc--cCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00111 11233356779999999999999999999999986
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=344.66 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=208.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh-----hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH-----GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|++.+.||+|+||+||+|... +++.||||++....... ..+.+.+|+.++++++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356999999999999999999765 58999999997654322 367899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC----CEEEeeccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF----NAYLSDFGL 969 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgl 969 (1103)
++||||+++++|.+++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++ .+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~ 165 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGL 165 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence 9999999999999999764 3489999999999999999999999 999999999999999888 799999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
+....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ...........
T Consensus 166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~i~~~~- 234 (321)
T 2a2a_A 166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANITSVS- 234 (321)
T ss_dssp CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH--------HHHHHHHHTTC-
T ss_pred ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHhcc-
Confidence 98764332 23445789999999999999999999999999999999999999963211 11111111111
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+... ....+..+.+++.+|++.||++|||++|++++
T Consensus 235 --~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h 273 (321)
T 2a2a_A 235 --YDFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273 (321)
T ss_dssp --CCCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred --cccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0011111 12345678999999999999999999999874
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=352.35 Aligned_cols=255 Identities=24% Similarity=0.343 Sum_probs=208.0
Q ss_pred cCCCCcceeccCCcccEEEEEE----cCCcEEEEEEcccccc---hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~----~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 892 (1103)
++|++.+.||+|+||+||+|+. .+++.||||+++.... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5799999999999999999977 3689999999875432 22345677899999999 69999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.++||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~ 208 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 208 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence 999999999999999998754 489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
.............||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .............
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~----~~~~~~~~~~~~~--- 281 (355)
T 1vzo_A 209 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK----NSQAEISRRILKS--- 281 (355)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC----CCHHHHHHHHHHC---
T ss_pred cccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCcc----chHHHHHHHHhcc---
Confidence 65444444455679999999999985 45788999999999999999999999743221 1112222222111
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQCL 1095 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~L 1095 (1103)
....+...+..+.+++.+||+.||++|| +++|++++.
T Consensus 282 --------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~ 323 (355)
T 1vzo_A 282 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL 323 (355)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred --------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence 1123445667899999999999999999 999998764
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-37 Score=350.28 Aligned_cols=249 Identities=25% Similarity=0.351 Sum_probs=204.2
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+.|+..+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 3488889999999999999975 5689999999875432 334567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+. |++.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~-- 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-- 206 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence 9996 68988886543 4589999999999999999999999 999999999999999999999999999976532
Q ss_pred CccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 978 THATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.....||+.|+|||++. ...++.++|||||||++|||++|+.||.... .............
T Consensus 207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~--------~~~~~~~~~~~~~----- 270 (348)
T 1u5q_A 207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES----- 270 (348)
T ss_dssp ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC-----
T ss_pred ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC--------hHHHHHHHHhcCC-----
Confidence 23457899999999984 5678999999999999999999999986321 1111222221111
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLK 1096 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~ 1096 (1103)
....+...+..+.+++.+||+.||++|||+++++++-.
T Consensus 271 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~ 308 (348)
T 1u5q_A 271 ----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 308 (348)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred ----CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence 01112345677899999999999999999999987644
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=337.99 Aligned_cols=251 Identities=24% Similarity=0.416 Sum_probs=187.3
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35689999999999999999976 4689999999865432 22357789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.++++... ..+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 165 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP 165 (278)
T ss_dssp EECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence 99999999999998643 4589999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .......
T Consensus 166 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----------------~~~~~~~ 227 (278)
T 3cok_A 166 HE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-----------------LNKVVLA 227 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------------------CCSS
T ss_pred CC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-----------------HHHHhhc
Confidence 22 22345789999999999998899999999999999999999999974322110 0000001
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ...+...+..+.+++.+||+.||++||+++|++++
T Consensus 228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 263 (278)
T 3cok_A 228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH 263 (278)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence 1 11234456789999999999999999999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=349.80 Aligned_cols=248 Identities=23% Similarity=0.285 Sum_probs=198.3
Q ss_pred CcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 825 TSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
..+.||+|+||+||+|... +|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++||||++++
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM-KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 3567999999999999764 689999999876543 34678999999999999999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE--CCCCCEEEeecccccccCCCCCccc
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL--DDDFNAYLSDFGLSRLLGTSETHAT 981 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll--~~~~~~ki~Dfgla~~~~~~~~~~~ 981 (1103)
+|.+++.... ..+++.++..++.||+.||+|||+. +|+||||||+||++ +.++.+||+|||+++...... ..
T Consensus 172 ~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~ 245 (373)
T 2x4f_A 172 ELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL 245 (373)
T ss_dssp EEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence 9999987643 3489999999999999999999999 99999999999999 667889999999998764332 23
Q ss_pred cCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCC
Q 043720 982 TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061 (1103)
Q Consensus 982 ~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1061 (1103)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.... .............. +...
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~--------~~~~~~~i~~~~~~---~~~~---- 310 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN--------DAETLNNILACRWD---LEDE---- 310 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHTCCC---SCSG----
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhccCC---CChh----
Confidence 34578999999999999999999999999999999999999997321 11122222211110 0011
Q ss_pred CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1062 ~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+..+.+++.+||+.||++||+++|++++
T Consensus 311 ~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h 343 (373)
T 2x4f_A 311 EFQDISEEAKEFISKLLIKEKSWRISASEALKH 343 (373)
T ss_dssp GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 112446789999999999999999999999973
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-36 Score=361.74 Aligned_cols=254 Identities=26% Similarity=0.343 Sum_probs=210.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+.++++++||||+++++++...+..|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888999999999999999775 589999999976533 234577899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||+++|+|.+++.... ...+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999997644 34599999999999999999999999 999999999999999999999999999987643
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ...............
T Consensus 342 ~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~----~~~~~~~~~~i~~~~------- 409 (543)
T 3c4z_A 342 GQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE----KVENKELKQRVLEQA------- 409 (543)
T ss_dssp TC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTC----CCCHHHHHHHHHHCC-------
T ss_pred CC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCcc----chhHHHHHHHHhhcc-------
Confidence 32 223446899999999999999999999999999999999999999974321 111122222222111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTM-----KQVVQ 1093 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1093 (1103)
...+...+..+.+++.+||+.||++||++ ++|++
T Consensus 410 ----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~ 448 (543)
T 3c4z_A 410 ----VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT 448 (543)
T ss_dssp ----CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred ----cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence 12344567889999999999999999965 66664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-37 Score=350.65 Aligned_cols=265 Identities=17% Similarity=0.221 Sum_probs=202.5
Q ss_pred cCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccchh----------hHHHHHHHHHHHhcCCCCceeEEEeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRFQH----------GVQQFHAEIKTLGNVRHPNLVTLIGY 886 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~h~niv~l~~~ 886 (1103)
++|++.+.||+|+||+||+|... .+..||||++....... ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999775 57889999987653211 12346788999999999999999999
Q ss_pred Eec----CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC--
Q 043720 887 RAS----GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-- 960 (1103)
Q Consensus 887 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-- 960 (1103)
+.. ....|+||||+ +++|.++++... .+++.+++.++.|++.||+|||++ +|+||||||+||+++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~ 190 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPD 190 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTT
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCC
Confidence 887 77899999999 999999997654 599999999999999999999999 999999999999998877
Q ss_pred CEEEeecccccccCCCCC------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043720 961 NAYLSDFGLSRLLGTSET------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDG 1034 (1103)
Q Consensus 961 ~~ki~Dfgla~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~ 1034 (1103)
.+||+|||+++.+..... .......|++.|+|||++.+..++.++|||||||++|||++|+.||..... .
T Consensus 191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~ 266 (345)
T 2v62_A 191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLK----D 266 (345)
T ss_dssp SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT----C
T ss_pred cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccc----c
Confidence 999999999987643221 112456789999999999999999999999999999999999999963211 1
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
.............. ........ ......+..+.+++.+||+.||++||++++|++.|+++.
T Consensus 267 ~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 PVAVQTAKTNLLDE-LPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHHHHHHHHHHHHT-TTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cHHHHHHHHhhccc-ccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 11111111111111 11111000 011245678999999999999999999999999999864
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=353.57 Aligned_cols=265 Identities=25% Similarity=0.370 Sum_probs=193.9
Q ss_pred HHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEccccc-chhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCC--e
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGN--E 892 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~ 892 (1103)
...++|++.+.||+|+||+||+|.. .+++.||||++.... .....+.+.+|+.+++++. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3457899999999999999999965 468999999986542 2345677889999999997 999999999997543 7
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+||||++ ++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 158 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRS 158 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccccc
Confidence 899999996 6999999764 389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCC--------------------CccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043720 973 LGTSE--------------------THATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSH 1031 (1103)
Q Consensus 973 ~~~~~--------------------~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 1031 (1103)
..... .......+||+.|+|||++.+ ..++.++||||+||++|||++|+.||.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~-- 236 (388)
T 3oz6_A 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST-- 236 (388)
T ss_dssp SSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--
T ss_pred ccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH--
Confidence 53211 112344679999999999876 6789999999999999999999999974321
Q ss_pred CCCcchHHHHHHHHhcCc-----------------------------cccccc----ccccCCCChhHHHHHHHHHHHcc
Q 043720 1032 GDGFNIISWASMLLRQGQ-----------------------------VKDVFN----AELWASGPHDDLEDMLHLALRCT 1078 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~----~~~~~~~~~~~~~~l~~li~~cl 1078 (1103)
.....-+........ ....+. ..........++..+.+++.+||
T Consensus 237 ---~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 237 ---MNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp ---HHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred ---HHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 100000000000000 000000 00000011134567899999999
Q ss_pred ccCCCCCCCHHHHHHH
Q 043720 1079 VETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1079 ~~dP~~RPs~~evl~~ 1094 (1103)
+.||++|||++|++++
T Consensus 314 ~~dP~~R~t~~e~l~H 329 (388)
T 3oz6_A 314 QFNPNKRISANDALKH 329 (388)
T ss_dssp CSSGGGSCCHHHHTTS
T ss_pred ccCcccCCCHHHHhCC
Confidence 9999999999999987
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=352.93 Aligned_cols=253 Identities=21% Similarity=0.265 Sum_probs=193.7
Q ss_pred cCCCCc-ceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHh-cCCCCceeEEEeEEec----CCeE
Q 043720 821 GDFNTS-NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLG-NVRHPNLVTLIGYRAS----GNEM 893 (1103)
Q Consensus 821 ~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~----~~~~ 893 (1103)
++|.+. +.||+|+||+||+|... +++.||||++... ..+.+|+.++. ..+||||+++++++.. .+..
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 456665 68999999999999765 5889999998632 34667888774 4589999999998865 5678
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeecccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLS 970 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla 970 (1103)
|+||||+++|+|.+++.......+++.++..++.||+.||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccc
Confidence 9999999999999999876556699999999999999999999999 9999999999999997 788999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
+..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........... . .. .+..+..
T Consensus 212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~---~~-~i~~~~~ 284 (400)
T 1nxk_A 212 KETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-M---KT-RIRMGQY 284 (400)
T ss_dssp EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS-H---HH-HHHHTCC
T ss_pred cccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH-H---HH-HHHcCcc
Confidence 865422 223456789999999999999999999999999999999999999975433221111 1 11 1111111
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
. .........+.++.++|.+||+.||++|||++|++++-
T Consensus 285 ~------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 285 E------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c------CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 00011134567899999999999999999999999863
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-37 Score=346.19 Aligned_cols=266 Identities=24% Similarity=0.421 Sum_probs=212.1
Q ss_pred cCCCCcceeccCCcccEEEEEE-----cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC--eE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN--EM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~ 893 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++...+ ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST-EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC-SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 4688999999999999999974 368999999987643 345678999999999999999999999986644 78
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||+++++|.++++... ..+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 99999999999999998753 3589999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC-------CCCCCcchHHHHHHH
Q 043720 974 GTSETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFS-------SHGDGFNIISWASML 1044 (1103)
Q Consensus 974 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~-------~~~~~~~~~~~~~~~ 1044 (1103)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..|+..... .............
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 273 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI-- 273 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH--
T ss_pred cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH--
Confidence 543322 12334567889999999988899999999999999999999988763210 0000000000000
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
+.+........+..++..+.+++.+||+.||++||+++|+++.|+++++
T Consensus 274 -------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~ 322 (326)
T 2w1i_A 274 -------ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD 322 (326)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 1111111223345677889999999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=340.01 Aligned_cols=246 Identities=22% Similarity=0.312 Sum_probs=201.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|++.+.||+|+||+||+|... +++.||||++..... ......+.+|+..+..+ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 457999999999999999999776 689999999876533 33467788999999999 899999999999999999999
Q ss_pred EeecCCCChHHHHHhhcC--CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC---------------
Q 043720 897 YNYLPGGNLENFIKARTS--RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD--------------- 959 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~--------------- 959 (1103)
|||+++++|.++++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999986532 4589999999999999999999999 99999999999999844
Q ss_pred ----CCEEEeecccccccCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043720 960 ----FNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDG 1034 (1103)
Q Consensus 960 ----~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~ 1034 (1103)
..+||+|||.+...... ....|++.|+|||.+.+. .++.++||||||+++|||++|.+++...
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~------- 234 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG------- 234 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS-------
T ss_pred cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch-------
Confidence 47999999999876432 223589999999999765 5667999999999999999998765421
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+. ....+. ....+...+..+.+++.+||+.||++||+++|++++
T Consensus 235 ---~~~~--~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 235 ---DQWH--EIRQGR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp ---HHHH--HHHTTC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred ---hHHH--HHHcCC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 0111 111111 122334556789999999999999999999999875
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-37 Score=342.78 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=210.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.|+..+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 46889999999999999999654 68999999998776666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++....... .
T Consensus 102 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~ 174 (303)
T 3a7i_A 102 LGGGSALDLLEPG---PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I 174 (303)
T ss_dssp CTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred CCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence 9999999999753 489999999999999999999999 99999999999999999999999999998764332 2
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......|++.|+|||++.+..++.++||||||+++|||++|+.||.... ......... ... .
T Consensus 175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~-~~~---------~ 236 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH--------PMKVLFLIP-KNN---------P 236 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHH-HSC---------C
T ss_pred ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC--------HHHHHHHhh-cCC---------C
Confidence 3345678999999999999999999999999999999999999986321 111111111 111 1
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL 1095 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L 1095 (1103)
...+...+..+.+++.+||+.||++||++.|++++.
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 112334567799999999999999999999998764
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=343.32 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=188.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 568999999999999999999654 6889999999776555566788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhh------cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 899 YLPGGNLENFIKAR------TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
|+++++|.++++.. ....+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 170 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAF 170 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHH
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchhe
Confidence 99999999999752 234589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC----ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 973 LGTSET----HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 973 ~~~~~~----~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
...... .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||...... . .......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~---~~~~~~~- 241 (303)
T 2vwi_A 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPM-----K---VLMLTLQ- 241 (303)
T ss_dssp CC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGG-----G---HHHHHHT-
T ss_pred eccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchh-----h---HHHHHhc-
Confidence 643221 12234578999999999876 56899999999999999999999999743211 1 1111111
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...................+..+.+++.+||+.||++||+++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp SSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred cCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence 11111100001111223455779999999999999999999999874
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=340.36 Aligned_cols=263 Identities=24% Similarity=0.315 Sum_probs=200.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999775 4899999998665443 335678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.++++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 156 (311)
T 4agu_A 83 YCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS- 156 (311)
T ss_dssp CCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred eCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-
Confidence 999999999887543 489999999999999999999999 99999999999999999999999999998764322
Q ss_pred ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH-----------h
Q 043720 979 HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL-----------R 1046 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----------~ 1046 (1103)
.......|++.|+|||++.+ ..++.++||||+|+++|||++|+.||..... ........... .
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~ 231 (311)
T 4agu_A 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-----VDQLYLIRKTLGDLIPRHQQVFS 231 (311)
T ss_dssp ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCHHHHHHHH
T ss_pred cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhcccccccccccc
Confidence 22334578999999999875 6789999999999999999999999974321 11111111100 0
Q ss_pred cCcccc---cccccccC---CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKD---VFNAELWA---SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~---~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...... ..++.... ......+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp TCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred cccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00000000 0012356678999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-37 Score=342.11 Aligned_cols=259 Identities=25% Similarity=0.426 Sum_probs=208.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEe--cCCeEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRA--SGNEMFL 895 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 895 (1103)
.++|++.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.++++++||||+++++++. ..+..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357899999999999999999765 689999999976543 345677999999999999999999999874 4678999
Q ss_pred EEeecCCCChHHHHHhhc--CCcccHHHHHHHHHHHHHHHHHHHhCCCCC-----cccCCCCCCcEEECCCCCEEEeecc
Q 043720 896 IYNYLPGGNLENFIKART--SRAVDWKILHKIALDVASALAYLHDQCAPR-----VLHRDVKPSNILLDDDFNAYLSDFG 968 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~-----ivH~Dlk~~NIll~~~~~~ki~Dfg 968 (1103)
||||+++++|.+++.... ...+++..++.++.|++.||+|||+. + |+||||||+||+++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 999999999999997643 24489999999999999999999998 7 9999999999999999999999999
Q ss_pred cccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.... ....... ...+
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~-i~~~ 231 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGK-IREG 231 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH-HHHT
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccC--------HHHHHHH-Hhhc
Confidence 9987643221 2233468999999999999899999999999999999999999987321 1111111 1111
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.. ...+...+..+.+++.+||+.||++||+++|+++++..-..
T Consensus 232 ~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 232 KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred cc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 11 12234566789999999999999999999999998765543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=344.39 Aligned_cols=262 Identities=22% Similarity=0.274 Sum_probs=198.7
Q ss_pred cCCCCc-ceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTS-NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
+.|++. +.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++.++ .||||+++++++.+.+..|+||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP-GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS-SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc-chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 467774 78999999999999754 68999999997653 33467889999999885 7999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC---EEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN---AYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfgla~~~~ 974 (1103)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||++....
T Consensus 91 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred EcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999998754 489999999999999999999999 9999999999999998776 9999999987653
Q ss_pred CCCC------ccccCCcccccccCcccccc-----CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc---ch---
Q 043720 975 TSET------HATTGVAGTFGYVAPEYALT-----CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF---NI--- 1037 (1103)
Q Consensus 975 ~~~~------~~~~~~~g~~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~---~~--- 1037 (1103)
.... .......||+.|+|||++.. ..++.++|||||||++|||++|+.||........... ..
T Consensus 166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 245 (316)
T 2ac3_A 166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC 245 (316)
T ss_dssp ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence 2211 12224468999999999875 5688999999999999999999999975432211100 00
Q ss_pred HHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1038 ISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1038 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+...... +.... ....+..+.+++.+||+.||++|||++|++++
T Consensus 246 ~~~~~~~i~~~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 296 (316)
T 2ac3_A 246 QNMLFESIQEGKYE--FPDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH 296 (316)
T ss_dssp HHHHHHHHHHCCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHHHHhccCcc--cCchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00011111111100 00000 01345679999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=353.85 Aligned_cols=262 Identities=15% Similarity=0.233 Sum_probs=207.4
Q ss_pred cCCCCcceeccCCcccEEEEEEcC---------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeE---------
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP---------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVT--------- 882 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~--------- 882 (1103)
++|++.+.||+|+||+||+|.... ++.||||++... +.+.+|+.++++++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 579999999999999999997764 789999998754 35778999999999999987
Q ss_pred ------EEeEEec-CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEE
Q 043720 883 ------LIGYRAS-GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNIL 955 (1103)
Q Consensus 883 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIl 955 (1103)
+++++.. .+..|+||||+ +++|.++++......+++.++..++.|++.||+|||++ +|+||||||+||+
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl 191 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIF 191 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEE
Confidence 6777765 77899999999 99999999876455699999999999999999999999 9999999999999
Q ss_pred ECCCC--CEEEeecccccccCCCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Q 043720 956 LDDDF--NAYLSDFGLSRLLGTSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPS 1027 (1103)
Q Consensus 956 l~~~~--~~ki~Dfgla~~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~ 1027 (1103)
++.++ .+||+|||+++........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 271 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC 271 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 99998 8999999999876433221 123457899999999999999999999999999999999999999743
Q ss_pred CCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1028 FSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1028 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.. ............. . ......+.. ......+..+.+++.+||+.||++||+++++++.|+++.+
T Consensus 272 ~~---~~~~~~~~~~~~~-~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 336 (352)
T 2jii_A 272 LP---NTEDIMKQKQKFV-D-KPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQ 336 (352)
T ss_dssp TT---CHHHHHHHHHHHH-H-SCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred Cc---CHHHHHHHHHhcc-C-Chhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHH
Confidence 21 1111111111111 1 111111111 0112345789999999999999999999999999999864
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=336.82 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=204.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|.... +..||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE-DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc-hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4579999999999999999997654 678999998765433 46789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE---CCCCCEEEeecccccccCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+++++|.+++.... .+++.++..++.|++.|++|||++ +|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 87 LCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred ccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999999998754 389999999999999999999999 99999999999999 7888999999999987643
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.. ......|++.|+|||.+.+. ++.++||||+|+++|||++|+.||..... ........ .+... ..
T Consensus 162 ~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~~--~~ 227 (277)
T 3f3z_A 162 GK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD--------SEVMLKIR-EGTFT--FP 227 (277)
T ss_dssp TS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCCCC--CC
T ss_pred cc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHH-hCCCC--CC
Confidence 32 23445789999999998764 89999999999999999999999973221 11111111 11100 00
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... ....+..+.+++.+|++.||++||++.|++++
T Consensus 228 ~~~----~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 228 EKD----WLNVSPQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp HHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred chh----hhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 01345779999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-36 Score=338.01 Aligned_cols=263 Identities=22% Similarity=0.291 Sum_probs=204.2
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEE-ecCCeEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR-ASGNEMFLI 896 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lV 896 (1103)
..++|++.+.||+|+||+||+|.. .+++.||||++...... +.+.+|+.+++.++|++++..++++ ...+..++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 356899999999999999999975 56899999987654332 3577899999999887776665554 677888999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE---CCCCCEEEeeccccccc
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~ 973 (1103)
|||+ +++|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||+++..
T Consensus 84 ~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp EECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 9999 999999998543 3599999999999999999999999 99999999999999 78899999999999876
Q ss_pred CCCCC------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 974 GTSET------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 974 ~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
..... .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... ............
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~ 237 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ-KYERISEKKMST 237 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS-HHHHHHHHHHHS
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh-hhhhhhcccccc
Confidence 54332 12335678999999999999999999999999999999999999997543322111 111111111000
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
. ... .....+..+.+++.+||+.||++||+++++++.|+++.+
T Consensus 238 ~------~~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~ 280 (296)
T 4hgt_A 238 P------IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp C------HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred h------hhh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence 0 000 012345789999999999999999999999999998754
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=348.03 Aligned_cols=251 Identities=14% Similarity=0.140 Sum_probs=204.4
Q ss_pred HhcCCCCcceeccCCcccEEEE------EEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC---CCceeEEEeEEec
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKA------EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR---HPNLVTLIGYRAS 889 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 889 (1103)
..++|.+.+.||+|+||+||+| ....++.||||++... ...++.+|+.+++.++ |+||+++++++..
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 3467999999999999999999 3556899999998754 2456777888887776 9999999999999
Q ss_pred CCeEEEEEeecCCCChHHHHHhh---cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC--------
Q 043720 890 GNEMFLIYNYLPGGNLENFIKAR---TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-------- 958 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-------- 958 (1103)
.+..|+||||+++|+|.++++.. ....+++..++.++.|++.||+|||++ +|+||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999753 235699999999999999999999999 9999999999999998
Q ss_pred ---CCCEEEeecccccccCC-CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043720 959 ---DFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDG 1034 (1103)
Q Consensus 959 ---~~~~ki~Dfgla~~~~~-~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~ 1034 (1103)
++.+||+|||+++.... ..........||++|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999976532 22334456689999999999999999999999999999999999999986332210
Q ss_pred cchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCC-CCHHHHHHHHHhhh
Q 043720 1035 FNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTR-PTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R-Ps~~evl~~L~~i~ 1099 (1103)
........ .......+.+++..|++.+|.+| |+++++.+.|+++.
T Consensus 293 -----------------~~~~~~~~---~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l 338 (365)
T 3e7e_A 293 -----------------CKPEGLFR---RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVF 338 (365)
T ss_dssp -----------------EEECSCCT---TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHH
T ss_pred -----------------eeechhcc---ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHH
Confidence 00011110 11235678899999999999999 57888888888753
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-37 Score=373.89 Aligned_cols=250 Identities=26% Similarity=0.340 Sum_probs=202.8
Q ss_pred ceeccCCcccEEEEEEc---CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEIS---PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|.+. .++.||||+++.... ....+++.+|+.++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999553 467899999976543 3346789999999999999999999999965 568999999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc--c
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH--A 980 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~--~ 980 (1103)
|+|.++++... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ .
T Consensus 454 g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~ 528 (635)
T 4fl3_A 454 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 528 (635)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred CCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence 99999997643 489999999999999999999999 9999999999999999999999999999877543322 2
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+++.|+|||++.+..++.++|||||||++|||++ |+.||..... ..... .+.. ...
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~--------~~~~~-~i~~---------~~~ 590 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG--------SEVTA-MLEK---------GER 590 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--------HHHHH-HHHT---------TCC
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH--------HHHHH-HHHc---------CCC
Confidence 233456789999999999999999999999999999998 9999873221 11111 1111 122
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...+..++..+.++|.+||+.||++||++++|++.|+++..
T Consensus 591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~ 631 (635)
T 4fl3_A 591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 631 (635)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 23455677889999999999999999999999999998753
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-35 Score=349.38 Aligned_cols=256 Identities=24% Similarity=0.306 Sum_probs=182.1
Q ss_pred CCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCE
Q 043720 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183 (1103)
Q Consensus 104 ~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (1103)
..+++|+.|+++++.+. .+| .+..+++|++|||++|.+++..| +..+++|++|+|++|++++..| ++++++|++
T Consensus 43 ~~l~~l~~L~l~~~~i~-~l~-~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~ 116 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTG 116 (466)
T ss_dssp HHHHTCCEEECCSSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred hHhccccEEecCCCCCc-cCc-chhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCccccChh--hcCCCCCCE
Confidence 34678899999999887 466 47888999999999999985544 8899999999999999985444 888999999
Q ss_pred EEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCcc
Q 043720 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM 263 (1103)
Q Consensus 184 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 263 (1103)
|++++|.+++..+ ++.+++|++|++++|.++ .++. +. .+++|++|+++ |.+.+.. .++++++|++|++++|.
T Consensus 117 L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~-~~~~-~~-~l~~L~~L~l~-~~~~~~~--~~~~l~~L~~L~l~~n~ 188 (466)
T 1o6v_A 117 LTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DISA-LS-GLTSLQQLSFG-NQVTDLK--PLANLTTLERLDISSNK 188 (466)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEEC-CCGG-GT-TCTTCSEEEEE-ESCCCCG--GGTTCTTCCEEECCSSC
T ss_pred EECCCCCCCCChH--HcCCCCCCEEECCCCccC-CChh-hc-cCCcccEeecC-CcccCch--hhccCCCCCEEECcCCc
Confidence 9999999886543 888899999999999888 4553 43 35778888886 4555332 37788888888888888
Q ss_pred CCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccC
Q 043720 264 LNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSI 343 (1103)
Q Consensus 264 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~i 343 (1103)
+++. ..+..+++|+.|++++|.+++..| ++.+++|+.|++++
T Consensus 189 l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~---------------------------------- 230 (466)
T 1o6v_A 189 VSDI--SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNG---------------------------------- 230 (466)
T ss_dssp CCCC--GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCS----------------------------------
T ss_pred CCCC--hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCC----------------------------------
Confidence 8764 347778888888888888876544 56666777776664
Q ss_pred chhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccc
Q 043720 344 PMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPC 423 (1103)
Q Consensus 344 p~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~ 423 (1103)
|.+.+. ..+..+++|+.|++++|.+.+..+ +..+++|+.|++++|++++..+ ...+++
T Consensus 231 -----------------n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~-~~~l~~ 288 (466)
T 1o6v_A 231 -----------------NQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP-LAGLTA 288 (466)
T ss_dssp -----------------SCCCCC--GGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG-GTTCTT
T ss_pred -----------------CCcccc--hhhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc-ccCCCc
Confidence 333321 245566677777777777776554 6677777777777777654322 223333
Q ss_pred eeEEEecCCc
Q 043720 424 MALFDVSGNH 433 (1103)
Q Consensus 424 L~~l~ls~N~ 433 (1103)
|+.|++++|+
T Consensus 289 L~~L~L~~n~ 298 (466)
T 1o6v_A 289 LTNLELNENQ 298 (466)
T ss_dssp CSEEECCSSC
T ss_pred cCeEEcCCCc
Confidence 3334433333
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-37 Score=341.54 Aligned_cols=259 Identities=25% Similarity=0.375 Sum_probs=201.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc--CC--cEEEEEEccccc--chhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS--PG--ILVAVKKLAVGR--FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~--~~--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||+||+|.+. ++ ..||||++.... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 47999999999999999999753 23 368999987653 2345678999999999999999999999998765 88
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+|+||+++++|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++....
T Consensus 97 ~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 9999999999999998753 3489999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 975 TSETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 975 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
..... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||.... ............
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~--------~~~~~~~~~~~~--- 241 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKEG--- 241 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTSC---
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCC--------HHHHHHHHHccC---
Confidence 43322 2234457889999999988888999999999999999999 999986321 112222221111
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.....+...+..+.+++.+||+.||++||+++++++.|+++.+.
T Consensus 242 ------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 285 (291)
T 1u46_A 242 ------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285 (291)
T ss_dssp ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence 11223445678899999999999999999999999999998764
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=335.15 Aligned_cols=257 Identities=24% Similarity=0.350 Sum_probs=206.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-----hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-----HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++...+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46889999999999999999776 6899999998765432 23678999999999999999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC----CEEEeecccc
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF----NAYLSDFGLS 970 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgla 970 (1103)
+||||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||++
T Consensus 85 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~ 159 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159 (283)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence 9999999999999997654 489999999999999999999999 999999999999998877 7999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
....... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ........ ....
T Consensus 160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~ 228 (283)
T 3bhy_A 160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK--------QETLTNIS-AVNY 228 (283)
T ss_dssp EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTCC
T ss_pred eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch--------HHHHHHhH-hccc
Confidence 8764322 22345689999999999999999999999999999999999999873211 11111111 1100
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhh
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQIQ 1099 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 1099 (1103)
...... ....+..+.+++.+||+.||++||+++|++++ +++++
T Consensus 229 --~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 --DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp --CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred --CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 001111 12345678999999999999999999999973 44443
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=351.34 Aligned_cols=356 Identities=24% Similarity=0.356 Sum_probs=249.0
Q ss_pred CCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCC
Q 043720 117 NGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIP 196 (1103)
Q Consensus 117 n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p 196 (1103)
+.+.+.++. ..+++|+.|++++|.+. .+|. +..+++|++|+|++|.+++. |. +.++++|++|++++|++++..+
T Consensus 34 ~~~~~~i~~--~~l~~l~~L~l~~~~i~-~l~~-~~~l~~L~~L~Ls~n~l~~~-~~-~~~l~~L~~L~l~~n~l~~~~~ 107 (466)
T 1o6v_A 34 TNVTDTVSQ--TDLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIADITP 107 (466)
T ss_dssp SSTTSEECH--HHHHTCCEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGG
T ss_pred cccccccCh--hHhccccEEecCCCCCc-cCcc-hhhhcCCCEEECCCCccCCc-hh-hhccccCCEEECCCCccccChh
Confidence 344444442 34678999999999998 5664 88899999999999999854 44 8999999999999999996655
Q ss_pred hhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCC
Q 043720 197 GFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR 276 (1103)
Q Consensus 197 ~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 276 (1103)
++++++|++|++++|+++ .++. +. .+++|++|++++|.+++ ++ .++.+++|++|+++ |.+.+..+ +..++
T Consensus 108 --~~~l~~L~~L~L~~n~l~-~~~~-~~-~l~~L~~L~l~~n~l~~-~~-~~~~l~~L~~L~l~-~~~~~~~~--~~~l~ 177 (466)
T 1o6v_A 108 --LANLTNLTGLTLFNNQIT-DIDP-LK-NLTNLNRLELSSNTISD-IS-ALSGLTSLQQLSFG-NQVTDLKP--LANLT 177 (466)
T ss_dssp --GTTCTTCCEEECCSSCCC-CCGG-GT-TCTTCSEEEEEEEEECC-CG-GGTTCTTCSEEEEE-ESCCCCGG--GTTCT
T ss_pred --hcCCCCCCEEECCCCCCC-CChH-Hc-CCCCCCEEECCCCccCC-Ch-hhccCCcccEeecC-CcccCchh--hccCC
Confidence 889999999999999988 4554 43 45788899998888875 33 47888888888886 55555332 77888
Q ss_pred CCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhcccccccc
Q 043720 277 KLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRII 356 (1103)
Q Consensus 277 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L 356 (1103)
+|+.|++++|++++. ..+..+++|+.|++
T Consensus 178 ~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l------------------------------------------------- 206 (466)
T 1o6v_A 178 TLERLDISSNKVSDI--SVLAKLTNLESLIA------------------------------------------------- 206 (466)
T ss_dssp TCCEEECCSSCCCCC--GGGGGCTTCSEEEC-------------------------------------------------
T ss_pred CCCEEECcCCcCCCC--hhhccCCCCCEEEe-------------------------------------------------
Confidence 888888888887643 23455555555555
Q ss_pred ccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEecCCcccc
Q 043720 357 WAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSG 436 (1103)
Q Consensus 357 ~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g 436 (1103)
++|.+.+..| ++.+++|+.|+|++|++++. +.+..+++|+.|++++|++++..+ ...+++|+.|++++|++++
T Consensus 207 --~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~ 279 (466)
T 1o6v_A 207 --TNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP-LSGLTKLTELKLGANQISN 279 (466)
T ss_dssp --CSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCCC
T ss_pred --cCCccccccc--ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchh-hhcCCCCCEEECCCCccCc
Confidence 4555555444 67789999999999999975 468899999999999999876543 4445555555555554442
Q ss_pred ccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCcccccccc
Q 043720 437 SIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRT 516 (1103)
Q Consensus 437 ~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~ 516 (1103)
.
T Consensus 280 ~------------------------------------------------------------------------------- 280 (466)
T 1o6v_A 280 I------------------------------------------------------------------------------- 280 (466)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 1
Q ss_pred ceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEE
Q 043720 517 DYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFL 596 (1103)
Q Consensus 517 ~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 596 (1103)
|. +. .+++|++|+|++|++++..+ +..+++|+.|
T Consensus 281 ------------------------------------------~~-~~-~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L 314 (466)
T 1o6v_A 281 ------------------------------------------SP-LA-GLTALTNLELNENQLEDISP--ISNLKNLTYL 314 (466)
T ss_dssp ------------------------------------------GG-GT-TCTTCSEEECCSSCCSCCGG--GGGCTTCSEE
T ss_pred ------------------------------------------cc-cc-CCCccCeEEcCCCcccCchh--hcCCCCCCEE
Confidence 11 11 12556666666666665433 5666666667
Q ss_pred EccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCc
Q 043720 597 DLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676 (1103)
Q Consensus 597 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 676 (1103)
+|++|++++..| +..+++|+.|++++|++++. ..+..+++|++|++++|++++..| +..+++|+.|++++|+++
T Consensus 315 ~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~~~ 388 (466)
T 1o6v_A 315 TLYFNNISDISP--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWT 388 (466)
T ss_dssp ECCSSCCSCCGG--GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG--GTTCTTCCEEECCCEEEE
T ss_pred ECcCCcCCCchh--hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch--hhcCCCCCEEeccCCccc
Confidence 776666665433 56666666666666666643 356666667777777776665554 566666666666666666
Q ss_pred C
Q 043720 677 G 677 (1103)
Q Consensus 677 ~ 677 (1103)
+
T Consensus 389 ~ 389 (466)
T 1o6v_A 389 N 389 (466)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-36 Score=346.20 Aligned_cols=267 Identities=23% Similarity=0.350 Sum_probs=206.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... +++.||+|++.........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 56899999999999999999766 68999999998776666678899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++++|.++++... .+++..+..++.+++.|++|||+.. +|+||||||+||+++.++.+||+|||++......
T Consensus 113 ~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 185 (360)
T 3eqc_A 113 MDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 185 (360)
T ss_dssp CTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH---
T ss_pred CCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc---
Confidence 99999999998754 3899999999999999999999831 7999999999999999999999999998755321
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC----------CCc-----------chH
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG----------DGF-----------NII 1038 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~----------~~~-----------~~~ 1038 (1103)
......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ... ...
T Consensus 186 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3eqc_A 186 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLN 265 (360)
T ss_dssp C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------
T ss_pred cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccc
Confidence 22345789999999999999999999999999999999999999974321000 000 000
Q ss_pred HHHHHHHhcCccccccc----ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1039 SWASMLLRQGQVKDVFN----AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1039 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+...........+..+ ...........+..+.+++.+||+.||++|||++|++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 325 (360)
T 3eqc_A 266 KFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 325 (360)
T ss_dssp --------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 00000000000000000 000011122346679999999999999999999999864
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-37 Score=348.10 Aligned_cols=263 Identities=21% Similarity=0.319 Sum_probs=196.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... +++.||||++...........+.+|+.++++++||||+++++++...+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999776 68999999997654433333456799999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
++ |+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~ 155 (324)
T 3mtl_A 82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP-TK 155 (324)
T ss_dssp CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCC-cc
Confidence 96 59999987653 4589999999999999999999999 9999999999999999999999999999865432 22
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc---cccccc
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ---VKDVFN 1055 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~ 1055 (1103)
......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||..... ............... ......
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~~~~~~~~~~~~ 230 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-----EEQLHFIFRILGTPTEETWPGILS 230 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCChHhchhhhc
Confidence 2334578999999999876 5689999999999999999999999974321 111111111111000 000000
Q ss_pred c---------cc----cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 A---------EL----WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~---------~~----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .. ........+..+.+++.+|++.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 282 (324)
T 3mtl_A 231 NEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH 282 (324)
T ss_dssp CHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred chhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0 00 000112345678999999999999999999999873
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-37 Score=347.78 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=190.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEe--------c
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRA--------S 889 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------~ 889 (1103)
..+|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.+++++. ||||+++++++. .
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE-EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc-hHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 347899999999999999999764 68999999986543 335677899999999996 999999999983 3
Q ss_pred CCeEEEEEeecCCCChHHHHHhhc-CCcccHHHHHHHHHHHHHHHHHHHhCCCCC--cccCCCCCCcEEECCCCCEEEee
Q 043720 890 GNEMFLIYNYLPGGNLENFIKART-SRAVDWKILHKIALDVASALAYLHDQCAPR--VLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
...+++||||+. |+|.++++... ...+++.+++.++.|++.||+|||++ + |+||||||+||+++.++.+||+|
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~D 181 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCD 181 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCC
T ss_pred CceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEec
Confidence 446899999995 79999987632 34599999999999999999999999 8 99999999999999999999999
Q ss_pred cccccccCCCCCc-----------cccCCcccccccCcccc---ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043720 967 FGLSRLLGTSETH-----------ATTGVAGTFGYVAPEYA---LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032 (1103)
Q Consensus 967 fgla~~~~~~~~~-----------~~~~~~g~~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 1032 (1103)
||+++........ ......|++.|+|||++ .+..++.++||||||+++|||++|+.||......
T Consensus 182 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-- 259 (337)
T 3ll6_A 182 FGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-- 259 (337)
T ss_dssp CTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred CccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH--
Confidence 9999876433221 11244689999999998 5667888999999999999999999998632110
Q ss_pred CCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1033 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...............+..+.+++.+||+.||++||+++|++++|+++.+
T Consensus 260 -------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~ 308 (337)
T 3ll6_A 260 -------------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAA 308 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 0111111112223334558899999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-37 Score=345.16 Aligned_cols=251 Identities=24% Similarity=0.305 Sum_probs=181.5
Q ss_pred cceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 826 SNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
.+.||+|+||+||+|... +++.||||++... ....+.+|+.+++.+. ||||+++++++.+.+..|+||||+++|
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 478999999999999765 5899999998643 3466788999999997 999999999999999999999999999
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEEEeecccccccCCCCCcc
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~Dfgla~~~~~~~~~~ 980 (1103)
+|.++++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++..... ...
T Consensus 92 ~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~ 165 (325)
T 3kn6_A 92 ELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQP 165 (325)
T ss_dssp BHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred cHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCc
Confidence 9999998753 499999999999999999999999 999999999999998765 7999999999865432 223
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....||+.|+|||++.+..++.++||||+|+++|||++|+.||......... ......... +..+... +....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~~~~~-i~~~~~~--~~~~~-- 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC-TSAVEIMKK-IKKGDFS--FEGEA-- 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------C-CCHHHHHHH-HTTTCCC--CCSHH--
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccc-ccHHHHHHH-HHcCCCC--CCccc--
Confidence 34557899999999999999999999999999999999999999754321111 111111111 1111110 00000
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.++.+++.+||+.||++||+++|++++
T Consensus 240 --~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h 271 (325)
T 3kn6_A 240 --WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN 271 (325)
T ss_dssp --HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred --ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence 12346789999999999999999999998754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=333.75 Aligned_cols=247 Identities=23% Similarity=0.357 Sum_probs=206.9
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56999999999999999999765 578899999865432 223567899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 94 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 94 EFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999998754 389999999999999999999999 9999999999999999999999999998765322
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......... .
T Consensus 168 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------~~~~~~~~~-~--------- 227 (284)
T 2vgo_A 168 --RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH--------TETHRRIVN-V--------- 227 (284)
T ss_dssp --CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHT-T---------
T ss_pred --ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH--------hHHHHHHhc-c---------
Confidence 23345789999999999999999999999999999999999999973211 111111111 1
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+...+..+.+++.+|++.||++||+++|++++
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 228 -DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred -ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 012234456789999999999999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=336.91 Aligned_cols=262 Identities=22% Similarity=0.298 Sum_probs=207.7
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeE-EecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY-RASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++...... +.+.+|+.+++.++|++++..+++ ....+..++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 46799999999999999999976 57899999998765433 458899999999998776665554 46677889999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC---CCCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD---DDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~ 974 (1103)
||+ +++|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||++....
T Consensus 85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred Eec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 999 899999997543 4599999999999999999999999 999999999999994 88899999999998765
Q ss_pred CCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 975 TSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 975 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
..... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||......... ..............
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTP 238 (296)
T ss_dssp CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSS-SHHHHHHHHHHHSC
T ss_pred ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhh-hhhhhhcccccCCc
Confidence 43321 234567899999999999999999999999999999999999999754322111 11111111111000
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
... .....+..+.+++.+||+.||++||+++++++.|+++..
T Consensus 239 ------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 280 (296)
T 3uzp_A 239 ------IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 280 (296)
T ss_dssp ------HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred ------hHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence 000 013345779999999999999999999999999998754
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-36 Score=330.99 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=199.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|.+.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 357999999999999999999776 689999999875432 23456789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 164 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 164 (276)
T ss_dssp EECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred EeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence 99999999999998754 389999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.||.... ........ ....
T Consensus 165 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~-~~~~------ 227 (276)
T 2h6d_A 165 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH--------VPTLFKKI-RGGV------ 227 (276)
T ss_dssp --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHH-HHCC------
T ss_pred c--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc--------HHHHHHHh-hcCc------
Confidence 2 2234568999999999987765 579999999999999999999987321 11111111 1111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+|++.||++||+++|++++
T Consensus 228 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h 262 (276)
T 2h6d_A 228 ----FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH 262 (276)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 11233456779999999999999999999999985
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-36 Score=335.44 Aligned_cols=250 Identities=21% Similarity=0.311 Sum_probs=208.6
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|.+.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357889999999999999999766 478899999876532 34567789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.++++... .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 94 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 168 (294)
T 2rku_A 94 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 168 (294)
T ss_dssp EECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence 99999999999987654 489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
. .......|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ........ ...
T Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--------~~~~~~~~-~~~------- 231 (294)
T 2rku_A 169 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL--------KETYLRIK-KNE------- 231 (294)
T ss_dssp T-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHH-TTC-------
T ss_pred c-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHh-hcc-------
Confidence 2 223445789999999999998899999999999999999999999973211 11111111 111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++||+++|++++
T Consensus 232 ---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 232 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 12233456779999999999999999999999875
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=345.81 Aligned_cols=252 Identities=22% Similarity=0.290 Sum_probs=202.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|... +++.||||++...... ..+|++++.++ +||||+++++++.+++..|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 457999999999999999999765 5889999999765322 34678888887 7999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC----CCEEEeeccccccc
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD----FNAYLSDFGLSRLL 973 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~~~ 973 (1103)
||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||++.++ +.+||+|||++...
T Consensus 96 E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999997653 489999999999999999999999 99999999999998543 34999999999876
Q ss_pred CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... ........... .+...
T Consensus 171 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~~~~i~-~~~~~-- 241 (342)
T 2qr7_A 171 RAEN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-----DTPEEILARIG-SGKFS-- 241 (342)
T ss_dssp BCTT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTT-----SCHHHHHHHHH-HCCCC--
T ss_pred cCCC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCc-----CCHHHHHHHHc-cCCcc--
Confidence 4332 233456789999999999888889999999999999999999999974321 11122222221 11110
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+..+.+++.+||+.||++||+++|++++
T Consensus 242 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h 278 (342)
T 2qr7_A 242 ----LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH 278 (342)
T ss_dssp ----CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred ----cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 1111223456789999999999999999999999875
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-36 Score=342.02 Aligned_cols=250 Identities=21% Similarity=0.319 Sum_probs=208.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
.++|.+.+.||+|+||+||+|... +++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357889999999999999999765 478899999876532 34567789999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.++++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 120 ~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 194 (335)
T 2owb_A 120 LELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD 194 (335)
T ss_dssp ECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence 99999999999988654 489999999999999999999999 9999999999999999999999999999876432
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
. .......|++.|+|||++.+..++.++||||||+++|||++|+.||.... .......... ..
T Consensus 195 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~~~~-~~------- 257 (335)
T 2owb_A 195 G-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC--------LKETYLRIKK-NE------- 257 (335)
T ss_dssp T-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHH-TC-------
T ss_pred c-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC--------HHHHHHHHhc-CC-------
Confidence 2 22344578999999999999889999999999999999999999997321 1111111111 11
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++||+++|++++
T Consensus 258 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~ 292 (335)
T 2owb_A 258 ---YSIPKHINPVAASLIQKMLQTDPTARPTINELLND 292 (335)
T ss_dssp ---CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred ---CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11233455778999999999999999999999874
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.54 Aligned_cols=248 Identities=23% Similarity=0.368 Sum_probs=200.0
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec----CCeEEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS----GNEMFL 895 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l 895 (1103)
.|.+.+.||+|+||+||+|... ++..||+|++..... ....+.+.+|+.++++++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4777889999999999999664 578899999876543 3456789999999999999999999998865 456899
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCC--cccCCCCCCcEEEC-CCCCEEEeecccccc
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR--VLHRDVKPSNILLD-DDFNAYLSDFGLSRL 972 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~ 972 (1103)
||||+++++|.++++... .+++..+..++.|++.||+|||+. + |+||||||+||+++ .++.+||+|||++..
T Consensus 107 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~ 181 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence 999999999999998754 389999999999999999999999 7 99999999999998 788999999999975
Q ss_pred cCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
.... ......|++.|+|||++.+ .++.++||||+|+++|+|++|+.||..... ......... .+...
T Consensus 182 ~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~-------~~~~~~~~~-~~~~~- 248 (290)
T 1t4h_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRRVT-SGVKP- 248 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHHHT-TTCCC-
T ss_pred cccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCc-------HHHHHHHHh-ccCCc-
Confidence 4322 2334568999999998864 589999999999999999999999963221 111211111 11100
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++|||++|++++
T Consensus 249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 283 (290)
T 1t4h_A 249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01122334679999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-36 Score=344.45 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=194.5
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
..++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 4568999999999999999999654 6899999999765433 2345678999999999999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE-----CCCCCEEEeeccccc
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL-----DDDFNAYLSDFGLSR 971 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll-----~~~~~~ki~Dfgla~ 971 (1103)
|||++ |+|.+++..... +++..+..++.|++.||+|||++ +|+||||||+||++ ++++.+||+|||+++
T Consensus 112 ~e~~~-~~L~~~~~~~~~--~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~ 185 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185 (329)
T ss_dssp EECCS-EEHHHHHHHCTT--CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred EecCC-CCHHHHHhhcCC--CCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence 99997 599999987543 89999999999999999999999 99999999999999 455569999999998
Q ss_pred ccCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc-Cc
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ-GQ 1049 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~ 1049 (1103)
...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .......... +.
T Consensus 186 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~~~~~~~~~~ 256 (329)
T 3gbz_A 186 AFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE--------IDQLFKIFEVLGL 256 (329)
T ss_dssp HHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCC
T ss_pred ccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH--------HHHHHHHHHHhCC
Confidence 764332 223445679999999999874 489999999999999999999999973221 1111111110 00
Q ss_pred ccc-----cc-------------cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKD-----VF-------------NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~-----~~-------------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... .. ............+..+.+++.+||+.||++|||++|++++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 319 (329)
T 3gbz_A 257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH 319 (329)
T ss_dssp CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence 000 00 0000000011245778999999999999999999999873
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-36 Score=344.37 Aligned_cols=256 Identities=23% Similarity=0.370 Sum_probs=197.3
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------ 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 891 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 35799999999999999999976 4689999999865432 334577899999999999999999999997653
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+|+||||+ +++|.++++.. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 176 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 176 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccc
Confidence 569999999 88999999863 389999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh-cCc
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR-QGQ 1049 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1049 (1103)
.... ......+|+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ......+.. .+.
T Consensus 177 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~l~~i~~~~g~ 244 (367)
T 1cm8_A 177 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH--------LDQLKEIMKVTGT 244 (367)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCC
T ss_pred cccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHhcCC
Confidence 7542 2345678999999999877 6799999999999999999999999974321 111111110 000
Q ss_pred cc-cc------------------ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VK-DV------------------FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~-~~------------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. +. .............+..+.+++.+|++.||++|||++|++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h 308 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 308 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence 00 00 00000111223456789999999999999999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-36 Score=356.25 Aligned_cols=194 Identities=24% Similarity=0.400 Sum_probs=155.3
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec-----CCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-----GNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~ 893 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++.. ....
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 57999999999999999999655 689999999865432 3356788999999999999999999999843 3579
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+||||+ +++|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 133 ~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~ 206 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206 (458)
T ss_dssp EEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred EEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhc
Confidence 9999998 57999999764 3499999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCC--------------------------ccccCCcccccccCcccc-ccCCCCCcchhHHHHHHHHHHHhC
Q 043720 974 GTSET--------------------------HATTGVAGTFGYVAPEYA-LTCRVSDKADVYSYGVVLLELISD 1020 (1103)
Q Consensus 974 ~~~~~--------------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg 1020 (1103)
..... ......+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg 280 (458)
T 3rp9_A 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM 280 (458)
T ss_dssp TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence 43221 123456789999999976 566799999999999999999994
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-36 Score=372.93 Aligned_cols=259 Identities=25% Similarity=0.366 Sum_probs=210.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
..++|++.+.||+|+||+||+|.+.. +..||||++.........+.+.+|+.++++++||||+++++++.+ +..|
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~ 466 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVW 466 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CceE
Confidence 34678899999999999999997643 567999998876666667889999999999999999999999854 5689
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+++|+|.++++... ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 467 lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 467 IIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp EEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred EEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 9999999999999998653 3589999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
...........+++.|+|||++.+..++.++||||||+++|||++ |..||..... ..........
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~--------~~~~~~i~~~------ 608 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN--------NDVIGRIENG------ 608 (656)
T ss_dssp C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--------HHHHHHHHHT------
T ss_pred CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH--------HHHHHHHHcC------
Confidence 444434444567889999999998899999999999999999997 8888863211 1111111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.....+..++..+.+++.+||+.||++||++.|+++.|+++..
T Consensus 609 ----~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 609 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1122345667889999999999999999999999999998853
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-36 Score=356.58 Aligned_cols=258 Identities=24% Similarity=0.339 Sum_probs=195.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------C
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------N 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 891 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999654 58999999997653 234467788999999999999999999998654 4
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
..|+||||+++ ++.+.+.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 141 ~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~ 212 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 212 (464)
T ss_dssp EEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-
T ss_pred eEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeee
Confidence 67999999965 57776643 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc--
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ-- 1049 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-- 1049 (1103)
..... ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ..++.......+.
T Consensus 213 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~-------~~~~~~i~~~lg~p~ 283 (464)
T 3ttj_A 213 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY-------IDQWNKVIEQLGTPC 283 (464)
T ss_dssp ----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHHHHCSCC
T ss_pred ecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHhcCCCC
Confidence 76432 234456899999999999999999999999999999999999999974321 1111111100000
Q ss_pred --------------------cc-----ccccccccCCC---ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 --------------------VK-----DVFNAELWASG---PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 --------------------~~-----~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ..+........ .......+.+++.+||+.||++|||++|++++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 356 (464)
T 3ttj_A 284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 356 (464)
T ss_dssp HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00000000000 01125678999999999999999999999875
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-36 Score=341.93 Aligned_cols=264 Identities=20% Similarity=0.261 Sum_probs=210.4
Q ss_pred CCHHHHHHHhcCCCCc-ceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCC-CCceeEEEeE
Q 043720 811 LTYESIIRATGDFNTS-NCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVR-HPNLVTLIGY 886 (1103)
Q Consensus 811 ~~~~~~~~~~~~~~~~-~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~ 886 (1103)
..++..+...++|.+. +.||+|+||+||+|... +++.||||++...... .....+.+|+.+++.+. ||||++++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~ 97 (327)
T 3lm5_A 18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97 (327)
T ss_dssp CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence 3444555566778877 88999999999999765 5899999999765432 34678899999999994 6999999999
Q ss_pred EecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEE
Q 043720 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAY 963 (1103)
Q Consensus 887 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~k 963 (1103)
+...+..++||||+++|+|.+++.......+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+|
T Consensus 98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 99999999999999999999998765556799999999999999999999999 9999999999999998 78999
Q ss_pred EeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 964 LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
|+|||+++...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||..... ......
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~ 244 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN--------QETYLN 244 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--------hHHHHH
Confidence 99999998764322 23345789999999999999999999999999999999999999963211 111111
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..... ...........+..+.+++.+||+.||++||+++|++++
T Consensus 245 i~~~~-------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h 288 (327)
T 3lm5_A 245 ISQVN-------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH 288 (327)
T ss_dssp HHHTC-------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred HHhcc-------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence 11110 011112233556789999999999999999999999875
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-36 Score=352.76 Aligned_cols=200 Identities=23% Similarity=0.365 Sum_probs=168.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----Ce
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 892 (1103)
.++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 457999999999999999999665 588999999975432 33567889999999999999999999998765 57
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+||||++ ++|.++++.. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~ 178 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLART 178 (432)
T ss_dssp EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence 999999995 6999999764 3489999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCC---------------------ccccCCcccccccCcccc-ccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 043720 973 LGTSET---------------------HATTGVAGTFGYVAPEYA-LTCRVSDKADVYSYGVVLLELISDKKALD 1025 (1103)
Q Consensus 973 ~~~~~~---------------------~~~~~~~g~~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~~ 1025 (1103)
...... ......+||+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus 179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~ 253 (432)
T 3n9x_A 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI 253 (432)
T ss_dssp C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence 643321 123566899999999986 56679999999999999999998766654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=342.50 Aligned_cols=265 Identities=21% Similarity=0.337 Sum_probs=201.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357999999999999999999765 4899999998665433 34566889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++..... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++......
T Consensus 104 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 178 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 178 (331)
T ss_dssp ECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred ecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence 9999999988876543 489999999999999999999999 99999999999999999999999999998654322
Q ss_pred CccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHH-----------HHHH
Q 043720 978 THATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWA-----------SMLL 1045 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~ 1045 (1103)
.......|++.|+|||++.+. .++.++||||+|+++|||++|+.||...... ....... ....
T Consensus 179 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 179 -EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDI----DQLYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH----HHHHHHHHHHCSCCHHHHHHHH
T ss_pred -cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCChhhhhHhh
Confidence 223345789999999998775 7899999999999999999999998743210 0000000 0000
Q ss_pred hcCcccccccccccCC-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWAS-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..........+..... .....+..+.+++.+||+.||++||+++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 307 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH 307 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0111111111111111 112456789999999999999999999999864
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=356.10 Aligned_cols=242 Identities=15% Similarity=0.181 Sum_probs=193.0
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEccccc--chhhHHHHHHHH---HHHhcCCCCceeEEE-------eE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGR--FQHGVQQFHAEI---KTLGNVRHPNLVTLI-------GY 886 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 886 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+ ..+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 35688899999999999999975 568999999997542 233567899999 555666899999998 66
Q ss_pred EecCC-----------------eEEEEEeecCCCChHHHHHhhcC-----CcccHHHHHHHHHHHHHHHHHHHhCCCCCc
Q 043720 887 RASGN-----------------EMFLIYNYLPGGNLENFIKARTS-----RAVDWKILHKIALDVASALAYLHDQCAPRV 944 (1103)
Q Consensus 887 ~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~gL~~LH~~~~~~i 944 (1103)
+...+ ..|+||||+ +|+|.++++.... ..+++..+..|+.||+.||+|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 289999999 6899999986432 2244688899999999999999999 99
Q ss_pred ccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCccccccC-----------CCCCcchhHHHHHH
Q 043720 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC-----------RVSDKADVYSYGVV 1013 (1103)
Q Consensus 945 vH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-----------~~~~~sDvwslGvi 1013 (1103)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 3345567 999999999887 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1014 LLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1014 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
+|||++|+.||....... ...... ......+..+.+++.+||+.||++||++.|+++
T Consensus 303 l~elltg~~Pf~~~~~~~-----------------~~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 359 (377)
T 3byv_A 303 IYWIWCADLPITKDAALG-----------------GSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 359 (377)
T ss_dssp HHHHHHSSCCC------C-----------------CSGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred HHHHHHCCCCCccccccc-----------------chhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence 999999999996432211 001111 111344578999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-36 Score=334.64 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=204.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|.+.+.||+|+||+||+|... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF-RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 357899999999999999999765 6899999999754332 34678899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE---CCCCCEEEeecccccccCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++ +.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 87 LVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161 (304)
T ss_dssp CCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred cCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence 999999999997654 489999999999999999999999 99999999999999 7888999999999875432
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. ......|++.|+|||++.+..++.++||||+|+++|||++|+.||.... ......... .+..
T Consensus 162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~~~~i~-~~~~----- 224 (304)
T 2jam_A 162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET--------ESKLFEKIK-EGYY----- 224 (304)
T ss_dssp B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHH-HCCC-----
T ss_pred C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCC-----
Confidence 2 2233468999999999999999999999999999999999999987321 111112111 1111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..........+..+.+++.+|++.||++||+++|++++
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h 262 (304)
T 2jam_A 225 -EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH 262 (304)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred -CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 01111223456789999999999999999999999874
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-36 Score=349.01 Aligned_cols=253 Identities=11% Similarity=0.069 Sum_probs=185.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHH---HHHhcCCCCceeEEE-------eEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEI---KTLGNVRHPNLVTLI-------GYR 887 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~~ 887 (1103)
.+|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+ ..++. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 35888999999999999999765 689999999987653 33456677784 55555 799988855 444
Q ss_pred ecC-----------------CeEEEEEeecCCCChHHHHHhhcCCcccHHHH------HHHHHHHHHHHHHHHhCCCCCc
Q 043720 888 ASG-----------------NEMFLIYNYLPGGNLENFIKARTSRAVDWKIL------HKIALDVASALAYLHDQCAPRV 944 (1103)
Q Consensus 888 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~gL~~LH~~~~~~i 944 (1103)
... ...|+||||++ |+|.++++.... .+++..+ ..++.||+.||+|||++ +|
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~i 215 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSK---GL 215 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHC---CC
Confidence 332 34899999998 899999987532 2455556 77889999999999999 99
Q ss_pred ccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCC
Q 043720 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKK 1022 (1103)
Q Consensus 945 vH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~ 1022 (1103)
+||||||+|||++.++.+||+|||+++..... .....+++.|+|||++.+ ..++.++|||||||++|||++|+.
T Consensus 216 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~ 291 (371)
T 3q60_A 216 VHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL 291 (371)
T ss_dssp EETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC
T ss_pred ccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC
Confidence 99999999999999999999999999865422 113456799999999987 789999999999999999999999
Q ss_pred CCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1023 ALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1023 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
||............ ....................+..+.+++.+||+.||++||+++|+++
T Consensus 292 Pf~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 292 PFGLVTPGIKGSWK----------RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp STTBCCTTCTTCCC----------BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCcCcccccchh----------hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99855332111100 00001111112222223456788999999999999999999999975
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=345.08 Aligned_cols=257 Identities=23% Similarity=0.379 Sum_probs=201.3
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEec---
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRAS--- 889 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~--- 889 (1103)
++....++|++.+.||+|+||+||+|... +++.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS--TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc--cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 34445678999999999999999999764 689999999875433 346788999999999 79999999999876
Q ss_pred ---CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 890 ---GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 890 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
.+..++||||+++++|.++++......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 46899999999999999999876556689999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHH
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 1041 (1103)
||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.||..... ....
T Consensus 173 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~ 243 (326)
T 2x7f_A 173 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP--------MRAL 243 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHH
T ss_pred CcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH--------HHHH
Confidence 99998654322 2233457899999999986 56788999999999999999999999863211 1111
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....... .. .......+..+.+++.+||+.||++||+++|++++
T Consensus 244 ~~~~~~~-~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 287 (326)
T 2x7f_A 244 FLIPRNP-AP--------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH 287 (326)
T ss_dssp HHHHHSC-CC--------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHhhcCc-cc--------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 1111111 10 11123445789999999999999999999999874
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=341.69 Aligned_cols=257 Identities=28% Similarity=0.397 Sum_probs=207.2
Q ss_pred HHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-------hhhHHHHHHHHHHHhcC-CCCceeEEEeE
Q 043720 816 IIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-------QHGVQQFHAEIKTLGNV-RHPNLVTLIGY 886 (1103)
Q Consensus 816 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l-~h~niv~l~~~ 886 (1103)
.....++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|+.+++++ .||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3445577999999999999999999875 699999999875432 12245688999999999 79999999999
Q ss_pred EecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 887 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
+...+..|+||||+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~D 243 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSD 243 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEe
Confidence 999999999999999999999998653 489999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCCccccCCcccccccCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYALT------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.... ....
T Consensus 244 fG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~--------~~~~ 313 (365)
T 2y7j_A 244 FGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR--------QILM 313 (365)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS--------HHHH
T ss_pred cCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC--------HHHH
Confidence 99998764332 2345678999999999863 357889999999999999999999996321 1111
Q ss_pred HHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1041 ASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1041 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..... .+... ..... ....+..+.+++.+||+.||++||+++|++++
T Consensus 314 ~~~i~-~~~~~--~~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 360 (365)
T 2y7j_A 314 LRMIM-EGQYQ--FSSPE----WDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360 (365)
T ss_dssp HHHHH-HTCCC--CCHHH----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHH-hCCCC--CCCcc----cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 11111 11110 00000 01234678999999999999999999999874
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=355.62 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=204.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357999999999999999999765 689999999865432 334678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC---CCCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD---DDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~ 974 (1103)
||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++...
T Consensus 101 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 175 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (486)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred EcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence 9999999999987654 489999999999999999999999 999999999999995 45679999999998664
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.. .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ......... .+... +
T Consensus 176 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~-~~~~~--~ 241 (486)
T 3mwu_A 176 QN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVE-TGKYA--F 241 (486)
T ss_dssp CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HTCCC--S
T ss_pred CC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-hCCCC--C
Confidence 32 23345679999999999876 58999999999999999999999997321 111222221 11111 0
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+ .+.....+..+.+++.+||+.||++|||+.|++++
T Consensus 242 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 242 D----LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp C----SGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred C----CcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0 01123456789999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=353.80 Aligned_cols=255 Identities=22% Similarity=0.355 Sum_probs=194.0
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-------hhhHHHHHHHHHHHhcCCCCceeEEEeEEec
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-------QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS 889 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 889 (1103)
...++|.+.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++..
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 211 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 34678999999999999999999655 579999999876432 1123358899999999999999999999754
Q ss_pred CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEEEee
Q 043720 890 GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAYLSD 966 (1103)
Q Consensus 890 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~ki~D 966 (1103)
+..|+||||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 212 -~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~D 285 (419)
T 3i6u_A 212 -EDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITD 285 (419)
T ss_dssp -SEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECC
T ss_pred -CceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEee
Confidence 56899999999999999887543 489999999999999999999999 999999999999997544 599999
Q ss_pred cccccccCCCCCccccCCcccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPEYALT---CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
||+++..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ... ..
T Consensus 286 FG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~----~~ 355 (419)
T 3i6u_A 286 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSL----KD 355 (419)
T ss_dssp SSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS----CCH----HH
T ss_pred cccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch----HHH----HH
Confidence 9999876432 23345678999999999853 56788999999999999999999999743221 111 11
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.... .+.. ....+..+.+++.+||+.||++||+++|++++
T Consensus 356 ~i~~~~~~~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h 400 (419)
T 3i6u_A 356 QITSGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 400 (419)
T ss_dssp HHHTTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHhcCCCCC--Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence 111111110 0111 12345778999999999999999999999874
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=341.39 Aligned_cols=153 Identities=22% Similarity=0.232 Sum_probs=102.8
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|++|+|++|++++. ..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++ +|..+..+++|++|+|
T Consensus 226 ~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~L 302 (390)
T 3o6n_A 226 VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302 (390)
T ss_dssp SSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCE-EECSSSCCTTCCEEEC
T ss_pred ccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCcc-cCcccCCCCCCCEEEC
Confidence 3466666666666643 456666777777777777776666677777777777777777763 4556667778888888
Q ss_pred cCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCC-CCccccccccccCCCCCCCCC
Q 043720 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP-WNVTTMNCSGVIGNPFLDPCQ 725 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p-~~~~~~~~~~l~~Np~~c~C~ 725 (1103)
++|+++ .+|..+..+++|+.|+|++|+|+.. | +..+++|+.|++++|++..... ..+..+....+.+++..|.|.
T Consensus 303 ~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~c~~~ 378 (390)
T 3o6n_A 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKID 378 (390)
T ss_dssp CSSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCSCCCTT
T ss_pred CCCcce-ecCccccccCcCCEEECCCCcccee-C--chhhccCCEEEcCCCCccchhHHHHHHHHHhhcccccCceeccc
Confidence 888887 4666677788888888888888743 3 5567778888777777754211 123334444567778777765
Q ss_pred C
Q 043720 726 M 726 (1103)
Q Consensus 726 ~ 726 (1103)
.
T Consensus 379 ~ 379 (390)
T 3o6n_A 379 Y 379 (390)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-35 Score=331.46 Aligned_cols=252 Identities=21% Similarity=0.311 Sum_probs=203.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc---hhhHHHHHHHHHHHhcCCCCceeEEEeEE--ecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNVRHPNLVTLIGYR--ASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~--~~~~~~ 893 (1103)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999764 588999999976532 23567899999999999999999999998 445688
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||++++ +.+++.......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~ 159 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEAL 159 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeecccccccc
Confidence 9999999765 88888876666799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-CccccCCcccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 974 GTSE-THATTGVAGTFGYVAPEYALTCR--VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 974 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
.... ........|++.|+|||++.+.. ++.++||||||+++|||++|+.||.... ......... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~i~-~~~- 229 (305)
T 2wtk_C 160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKLFENIG-KGS- 229 (305)
T ss_dssp CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHH-HCC-
T ss_pred CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch--------HHHHHHHHh-cCC-
Confidence 4322 22234556899999999987644 3779999999999999999999997321 111222111 111
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+..++..+.+++.+||+.||++||+++|++++
T Consensus 230 ---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 230 ---------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp ---------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred ---------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 12234556789999999999999999999999975
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-36 Score=340.22 Aligned_cols=263 Identities=25% Similarity=0.363 Sum_probs=198.2
Q ss_pred HHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh----hHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH----GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
...++|++.+.||+|+||+||+|... +|+.||||++....... ..+.+.+|+.++++++||||+++++++...+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34568999999999999999999765 58999999997643322 12467899999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.++||||+++ +|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKS 161 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred eEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence 9999999975 8999887643 4588899999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc-Cc-
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ-GQ- 1049 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~- 1049 (1103)
..... .......||+.|+|||++.+. .++.++|||||||++|||++|..||..... .......... +.
T Consensus 162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~--------~~~~~~i~~~~~~~ 232 (346)
T 1ua2_A 162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD--------LDQLTRIFETLGTP 232 (346)
T ss_dssp TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHHHHCCC
T ss_pred ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH--------HHHHHHHHHHcCCC
Confidence 64322 233456789999999998754 588899999999999999999988863211 1111111110 00
Q ss_pred -cccc---------ccccccCCC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 -VKDV---------FNAELWASG-----PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 -~~~~---------~~~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.... +........ ....+.++.+++.+|++.||++|||++|++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 0000 000000000 13345789999999999999999999999875
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=355.16 Aligned_cols=319 Identities=21% Similarity=0.219 Sum_probs=212.1
Q ss_pred cEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccC
Q 043720 206 RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285 (1103)
Q Consensus 206 ~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 285 (1103)
+.++.++++++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|.+++..|..|.++++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~ip~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~ 89 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP---TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRS 89 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC---TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-cCCCCCC---CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCC
Confidence 45667777776 6776543 4577788888887776677777788888888888888777777788888888888888
Q ss_pred CcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccc
Q 043720 286 NRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEG 365 (1103)
Q Consensus 286 N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~ 365 (1103)
|++++..+..|.++++|+.|++++ |.+.+..|..+..+++|+.|++++|.+.+
T Consensus 90 n~l~~~~~~~~~~l~~L~~L~Ls~---------------------------n~i~~~~~~~~~~l~~L~~L~l~~n~l~~ 142 (477)
T 2id5_A 90 NRLKLIPLGVFTGLSNLTKLDISE---------------------------NKIVILLDYMFQDLYNLKSLEVGDNDLVY 142 (477)
T ss_dssp SCCCSCCTTSSTTCTTCCEEECTT---------------------------SCCCEECTTTTTTCTTCCEEEECCTTCCE
T ss_pred CcCCccCcccccCCCCCCEEECCC---------------------------CccccCChhHccccccCCEEECCCCccce
Confidence 887766555677777777777764 44444455556666666666666777777
Q ss_pred cCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccc-cccccceeEEEecCCccccccCCCCcc
Q 043720 366 KLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDV-KLQVPCMALFDVSGNHMSGSIPRFDYN 444 (1103)
Q Consensus 366 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~-~~~~~~L~~l~ls~N~l~g~ip~~~~~ 444 (1103)
..+..|.++++|+.|+|++|++++..+..|.++++|+.|+|++|++++..+. +..+++|+.|++++|++
T Consensus 143 ~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~---------- 212 (477)
T 2id5_A 143 ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY---------- 212 (477)
T ss_dssp ECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTT----------
T ss_pred eChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcc----------
Confidence 7777777777777777777777777777777777777777777776643321 22333344444433332
Q ss_pred cccccccccccccccccCCCchhhHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeecc
Q 043720 445 VCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGA 524 (1103)
Q Consensus 445 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (1103)
T Consensus 213 -------------------------------------------------------------------------------- 212 (477)
T 2id5_A 213 -------------------------------------------------------------------------------- 212 (477)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCCcchhhhcccccccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCC
Q 043720 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604 (1103)
Q Consensus 525 ~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 604 (1103)
.+.+|...... .+|++|+|++|+|+++.+..|..+++|+.|+|++|.++
T Consensus 213 ------------------------------~~~~~~~~~~~-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~ 261 (477)
T 2id5_A 213 ------------------------------LDTMTPNCLYG-LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS 261 (477)
T ss_dssp ------------------------------CCEECTTTTTT-CCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCC
T ss_pred ------------------------------ccccCcccccC-ccccEEECcCCcccccCHHHhcCccccCeeECCCCcCC
Confidence 22333333222 35777777777777555556677777777777777777
Q ss_pred CCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCc
Q 043720 605 GEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676 (1103)
Q Consensus 605 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 676 (1103)
+..+..|..+++|+.|+|++|++++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++.
T Consensus 262 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~ 333 (477)
T 2id5_A 262 TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333 (477)
T ss_dssp EECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEE
T ss_pred ccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCcc
Confidence 555566666777777777777777666666666777777777777766555555566666666666666665
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=367.42 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=208.7
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 894 (1103)
..++|++.+.||+|+||+||+|... +++.||||+++... .....+.+..|..++..+ +||+|+++++++.+.+..|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 3568999999999999999999765 57889999997643 233456788899999988 7999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+++|+|.++++... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 419 lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred EEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 9999999999999998754 399999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.. .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.... .......+...
T Consensus 494 ~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~------- 557 (674)
T 3pfq_A 494 WD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED--------EDELFQSIMEH------- 557 (674)
T ss_dssp CT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHSS-------
T ss_pred cC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCC--------HHHHHHHHHhC-------
Confidence 22 233456789999999999999999999999999999999999999997321 11222222211
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCH-----HHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTM-----KQVVQ 1093 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~evl~ 1093 (1103)
. ..++...+.++.++|.+||+.||++||++ +||++
T Consensus 558 --~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~ 597 (674)
T 3pfq_A 558 --N--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 597 (674)
T ss_dssp --C--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred --C--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence 1 12345567889999999999999999997 67764
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-35 Score=332.01 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=202.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
..++|++.+.||+|+||+||+|... +|+.||||++.... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES---DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS---CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH---HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 3567999999999999999999765 48999999987643 3467889999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++.. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 104 e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 104 EYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp ECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred ecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 999999999999753 24589999999999999999999999 99999999999999999999999999998764322
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......|++.|+|||.+.+..++.++||||||+++|||++|+.||..... ........ ....
T Consensus 180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--------~~~~~~~~-~~~~------- 242 (314)
T 3com_A 180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--------MRAIFMIP-TNPP------- 242 (314)
T ss_dssp -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--------HHHHHHHH-HSCC-------
T ss_pred -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHh-cCCC-------
Confidence 233455789999999999998999999999999999999999999873211 11111111 1110
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+..+.+++.+||+.||++||++.+++++
T Consensus 243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~ 279 (314)
T 3com_A 243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH 279 (314)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 0011233456789999999999999999999999864
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-35 Score=338.86 Aligned_cols=264 Identities=22% Similarity=0.304 Sum_probs=200.7
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEec--------C
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--------G 890 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 890 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++...... .....+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 5799999999999999999977 56899999998665432 234577899999999999999999999877 4
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
+..|+||||++ +++.+.+.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 171 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 171 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence 56899999996 48888876543 3489999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCC---CccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 971 RLLGTSE---THATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 971 ~~~~~~~---~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
+...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ............
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~ 246 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQLCG 246 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHC
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCCh-----HHHHHHHHHHhC
Confidence 8764322 223345678999999998876 5589999999999999999999999874321 111111111110
Q ss_pred cCc---cccccccccc------C--CCC-h------hHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQ---VKDVFNAELW------A--SGP-H------DDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~---~~~~~~~~~~------~--~~~-~------~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... .......... . ... . .....+.+++.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 312 (351)
T 3mi9_A 247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312 (351)
T ss_dssp CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence 000 0000000000 0 000 0 013568899999999999999999999875
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=357.44 Aligned_cols=251 Identities=24% Similarity=0.351 Sum_probs=206.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+..|+||
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 46999999999999999999765 689999999865532 335678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE---CCCCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~ 974 (1103)
||+.+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+++...
T Consensus 106 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~ 180 (484)
T 3nyv_A 106 EVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE 180 (484)
T ss_dssp CCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred ecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence 9999999999997654 489999999999999999999999 99999999999999 567899999999998764
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... ......... .+....
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~i~-~~~~~~-- 246 (484)
T 3nyv_A 181 ASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGAN--------EYDILKKVE-KGKYTF-- 246 (484)
T ss_dssp CCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCCCC--
T ss_pred ccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCC--------HHHHHHHHH-cCCCCC--
Confidence 332 2334578999999999876 68999999999999999999999997321 111222221 111110
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .+.....+..+.+++.+||+.||++|||++|++++
T Consensus 247 ~----~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 282 (484)
T 3nyv_A 247 E----LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH 282 (484)
T ss_dssp C----SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C----CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence 0 01123456789999999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=332.53 Aligned_cols=252 Identities=21% Similarity=0.342 Sum_probs=200.7
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
+|.....||+|+||+||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD-SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC-C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc-hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 456667899999999999975 458899999987653 334677899999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecccccccCCCCC
Q 043720 901 PGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla~~~~~~~~ 978 (1103)
++++|.++++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~- 177 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN- 177 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence 99999999987533 3467889999999999999999999 9999999999999987 8999999999998764322
Q ss_pred ccccCCcccccccCccccccCC--CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCR--VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......|++.|+|||++.+.. ++.++||||||+++|||++|+.||..... .. ........ .
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~-~~~~~~~~-~--------- 241 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE-----PQ-AAMFKVGM-F--------- 241 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS-----HH-HHHHHHHH-H---------
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc-----hh-HHHHhhcc-c---------
Confidence 2233457899999999987643 78899999999999999999999863211 00 00000000 0
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......+...+..+.+++.+||+.||++||+++|++++
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~ 279 (295)
T 2clq_A 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD 279 (295)
T ss_dssp CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11122344566789999999999999999999999864
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-36 Score=345.57 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=197.2
Q ss_pred HHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec-------
Q 043720 818 RATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS------- 889 (1103)
Q Consensus 818 ~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 889 (1103)
...++|++.+.||+|+||+||+|.. .+++.||||++...... ..+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4567899999999999999999965 56899999998654322 2379999999999999999998843
Q ss_pred -------------------------------CCeEEEEEeecCCCChHHHHHh--hcCCcccHHHHHHHHHHHHHHHHHH
Q 043720 890 -------------------------------GNEMFLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYL 936 (1103)
Q Consensus 890 -------------------------------~~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~L 936 (1103)
....++||||++ |+|.+.++. .....+++..+..++.|++.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 334899999997 588888764 2335699999999999999999999
Q ss_pred HhCCCCCcccCCCCCCcEEEC-CCCCEEEeecccccccCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHH
Q 043720 937 HDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVL 1014 (1103)
Q Consensus 937 H~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil 1014 (1103)
|++ +|+||||||+||+++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 999 999999999999997 68899999999998764332 23445789999999998765 489999999999999
Q ss_pred HHHHhCCCCCCCCCCCCCCCcchHHHHHHHH--h----------cCcccc-----cccccccCCCChhHHHHHHHHHHHc
Q 043720 1015 LELISDKKALDPSFSSHGDGFNIISWASMLL--R----------QGQVKD-----VFNAELWASGPHDDLEDMLHLALRC 1077 (1103)
Q Consensus 1015 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~----------~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~c 1077 (1103)
|||++|+.||..... ......... . .....+ .....+....+...+..+.+++.+|
T Consensus 233 ~ell~g~~pf~~~~~-------~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 305 (383)
T 3eb0_A 233 GELILGKPLFSGETS-------IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQI 305 (383)
T ss_dssp HHHHHSSCSSCCSSH-------HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCh-------HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHH
Confidence 999999999974321 111111100 0 000000 0011111112344667899999999
Q ss_pred cccCCCCCCCHHHHHHH
Q 043720 1078 TVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1078 l~~dP~~RPs~~evl~~ 1094 (1103)
|+.||++|||+.|++++
T Consensus 306 L~~dP~~R~t~~e~l~h 322 (383)
T 3eb0_A 306 LRYEPDLRINPYEAMAH 322 (383)
T ss_dssp CCSSGGGSCCHHHHHTS
T ss_pred ccCChhhCCCHHHHhcC
Confidence 99999999999999853
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-36 Score=347.60 Aligned_cols=264 Identities=21% Similarity=0.315 Sum_probs=204.9
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC--------CCceeEEEeEEe--
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR--------HPNLVTLIGYRA-- 888 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~-- 888 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.++++++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 36799999999999999999965 45889999998754 334577889999999985 788999999987
Q ss_pred --cCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC------
Q 043720 889 --SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF------ 960 (1103)
Q Consensus 889 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~------ 960 (1103)
.....++||||+ ++++.+++.......+++..++.++.||+.||+|||+++ +|+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHH
T ss_pred CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhh
Confidence 566899999999 667877777655566999999999999999999999864 899999999999999775
Q ss_pred -------------------------------------------CEEEeecccccccCCCCCccccCCcccccccCccccc
Q 043720 961 -------------------------------------------NAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997 (1103)
Q Consensus 961 -------------------------------------------~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~ 997 (1103)
.+||+|||+++..... .....||+.|+|||++.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~ 266 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI 266 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence 7999999999876432 33457899999999999
Q ss_pred cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh-cCc-----------cccccccc--------
Q 043720 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR-QGQ-----------VKDVFNAE-------- 1057 (1103)
Q Consensus 998 ~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~-----------~~~~~~~~-------- 1057 (1103)
+..++.++|||||||++|||++|+.||......... ........... .+. ....+...
T Consensus 267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYT--RDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSC--HHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccC--chHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 999999999999999999999999999754332111 01111111100 000 00000000
Q ss_pred -----------ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 -----------LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 -----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+..+.+++.+||+.||++|||++|++++
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0112345677889999999999999999999999874
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=357.26 Aligned_cols=252 Identities=23% Similarity=0.343 Sum_probs=202.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch------------hhHHHHHHHHHHHhcCCCCceeEEEeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ------------HGVQQFHAEIKTLGNVRHPNLVTLIGY 886 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~h~niv~l~~~ 886 (1103)
.++|.+.+.||+|+||+||+|... +++.||||++...... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 467999999999999999999765 5789999999765322 335778999999999999999999999
Q ss_pred EecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC---CEE
Q 043720 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF---NAY 963 (1103)
Q Consensus 887 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~---~~k 963 (1103)
+.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~k 189 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIK 189 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEE
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEE
Confidence 999999999999999999999997754 499999999999999999999999 999999999999998776 699
Q ss_pred EeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 964 LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
|+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.... .......
T Consensus 190 l~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~--------~~~~~~~ 258 (504)
T 3q5i_A 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQN--------DQDIIKK 258 (504)
T ss_dssp ECCCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHH
T ss_pred EEECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCC--------HHHHHHH
Confidence 9999999876433 23345679999999999874 68999999999999999999999997322 1122222
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... +... ++... ....+..+.+++.+|++.||++|||++|++++
T Consensus 259 i~~-~~~~--~~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h 302 (504)
T 3q5i_A 259 VEK-GKYY--FDFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS 302 (504)
T ss_dssp HHH-CCCC--CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHc-CCCC--CCccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence 221 1110 01111 12345779999999999999999999999864
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=354.80 Aligned_cols=251 Identities=23% Similarity=0.327 Sum_probs=200.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|... ++..||||++..... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46999999999999999999765 688999999976542 2345778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC---CCEEEeecccccccCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD---FNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~Dfgla~~~~~ 975 (1103)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.. +.+||+|||++.....
T Consensus 117 ~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 117 CYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp CCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999987654 389999999999999999999999 99999999999999764 4599999999987643
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. .......||+.|+|||++. ..++.++||||+||++|+|++|+.||..... ........ .+... +.
T Consensus 192 ~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~~~~~i~-~~~~~--~~ 257 (494)
T 3lij_A 192 Q--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD--------QEILRKVE-KGKYT--FD 257 (494)
T ss_dssp T--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HTCCC--CC
T ss_pred C--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHH-hCCCC--CC
Confidence 3 2334567999999999886 4689999999999999999999999973221 11222221 11110 11
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... ....+..+.+++.+||+.||++|||+.|++++
T Consensus 258 ~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 258 SPE----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp SGG----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred chh----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence 111 12345778999999999999999999999864
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-36 Score=333.01 Aligned_cols=253 Identities=24% Similarity=0.326 Sum_probs=189.5
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhH-HHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++......... +.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 45799999999999999999976 46899999999766444333 34455556688889999999999999999999999
Q ss_pred eecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 898 NYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||++ |+|.++++.. ....+++..+..++.|++.|++|||+++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 162 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence 9996 5998887652 3356999999999999999999999843 899999999999999999999999999986643
Q ss_pred CCCccccCCcccccccCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 976 SETHATTGVAGTFGYVAPEYA----LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.. ......|++.|+|||++ .+..++.++||||+|+++|||++|+.||..... ............
T Consensus 163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-------~~~~~~~~~~~~--- 230 (290)
T 3fme_A 163 DV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-------PFQQLKQVVEEP--- 230 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-------HHHHHHHHHHSC---
T ss_pred cc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-------hHHHHHHHhccC---
Confidence 22 22334689999999996 566788999999999999999999999973211 111111111111
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
.........+..+.+++.+|++.||++|||++|+++
T Consensus 231 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 231 ------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp ------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111112345678999999999999999999999987
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=343.56 Aligned_cols=263 Identities=23% Similarity=0.341 Sum_probs=204.6
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----CeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 893 (1103)
.++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 457999999999999999999655 68899999998665555668899999999999999999999998654 478
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+||||++ |+|.++++... +++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 106 ~iv~e~~~-~~L~~~l~~~~---~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~ 178 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKTQH---LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178 (364)
T ss_dssp EEEEECCS-EEHHHHHHHCC---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEcccC-cCHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence 99999996 59999997643 89999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc--cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 974 GTSETH--ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 974 ~~~~~~--~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ................
T Consensus 179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~~~ 253 (364)
T 3qyz_A 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGILGSPSQ 253 (364)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSG-----GGHHHHHHHHHCSCCH
T ss_pred CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCCh-----HHHHHHHHHHhCCCCH
Confidence 533222 1345579999999998754 4589999999999999999999999974321 1111111111000000
Q ss_pred cc-----------c---cccc---ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KD-----------V---FNAE---LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~-----------~---~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. . .... .+.......+..+.+++.+||+.||++|||++|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 314 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 314 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 0 0000 0000112345678999999999999999999999874
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=333.08 Aligned_cols=253 Identities=22% Similarity=0.358 Sum_probs=200.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH-HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 457999999999999999999776 488999999875533 356788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++...... .
T Consensus 97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 171 (302)
T 2j7t_A 97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-L 171 (302)
T ss_dssp CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-H
T ss_pred eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc-c
Confidence 999999999987643 4589999999999999999999999 9999999999999999999999999987643211 1
Q ss_pred ccccCCcccccccCcccc-----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 979 HATTGVAGTFGYVAPEYA-----LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~-----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.......|++.|+|||++ ....++.++||||||+++|||++|+.||.... ............. .
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--------~~~~~~~~~~~~~-~-- 240 (302)
T 2j7t_A 172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVLLKIAKSDP-P-- 240 (302)
T ss_dssp HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC-C--
T ss_pred cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC--------HHHHHHHHhccCC-c--
Confidence 122345689999999998 46678899999999999999999999987321 1111111111111 0
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+...+..+.+++.+||+.||++|||++|++++
T Consensus 241 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 276 (302)
T 2j7t_A 241 -----TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH 276 (302)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred -----ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 011234456789999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-36 Score=343.64 Aligned_cols=260 Identities=20% Similarity=0.352 Sum_probs=207.2
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchh----------------hHHHHHHHHHHHhcCCCCceeEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQH----------------GVQQFHAEIKTLGNVRHPNLVTL 883 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~h~niv~l 883 (1103)
.++|++.+.||+|+||+||+|.. +++.||||++....... ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 35799999999999999999988 89999999987553221 12789999999999999999999
Q ss_pred EeEEecCCeEEEEEeecCCCChHHH------HHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEE
Q 043720 884 IGYRASGNEMFLIYNYLPGGNLENF------IKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 884 ~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll 956 (1103)
++++.+.+..++||||+++++|.++ ++......+++..++.++.|++.||+|||+ . +|+||||||+||++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~ 185 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILM 185 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEE
Confidence 9999999999999999999999999 665445669999999999999999999999 8 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCccccCCcccccccCccccccC-CCCC-cchhHHHHHHHHHHHhCCCCCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC-RVSD-KADVYSYGVVLLELISDKKALDPSFSSHGDG 1034 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~-~sDvwslGvil~elltg~~p~~~~~~~~~~~ 1034 (1103)
+.++.+||+|||.+...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||......
T Consensus 186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---- 258 (348)
T 2pml_X 186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISL---- 258 (348)
T ss_dssp CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCS----
T ss_pred cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcH----
Confidence 99999999999999875432 33456789999999999877 5666 999999999999999999999743221
Q ss_pred cchHHHHHHHHhcCcccccccc---------cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1035 FNIISWASMLLRQGQVKDVFNA---------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1035 ~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....... .........+. ..........+..+.+++.+||+.||++||+++|++++
T Consensus 259 ---~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 259 ---VELFNNI-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp ---HHHHHHH-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred ---HHHHHHH-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 11111000000 00000114456789999999999999999999999873
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-36 Score=343.72 Aligned_cols=270 Identities=21% Similarity=0.297 Sum_probs=201.7
Q ss_pred HHHHHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch----------hhHHHHHHHHHHHhcCCCCceeE
Q 043720 813 YESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ----------HGVQQFHAEIKTLGNVRHPNLVT 882 (1103)
Q Consensus 813 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~ 882 (1103)
..++....++|++.+.||+|+||+||+|...+++.||||++...... ...+.+.+|+.++++++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677788999999999999999999998888999999998654321 22478999999999999999999
Q ss_pred EEeEEec-----CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC
Q 043720 883 LIGYRAS-----GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957 (1103)
Q Consensus 883 l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~ 957 (1103)
+++++.. ....|+||||++ |+|.+++.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~ 168 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLA 168 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEc
Confidence 9999843 347899999997 69999887543 4589999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccccccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 043720 958 DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFN 1036 (1103)
Q Consensus 958 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1103)
.++.+||+|||++...... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||..... ..
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~ 241 (362)
T 3pg1_A 169 DNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF-----YN 241 (362)
T ss_dssp TTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HH
T ss_pred CCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH-----HH
Confidence 9999999999999754322 22344578999999999876 6789999999999999999999999974321 11
Q ss_pred hHHHHHHHHhcCccc-----------cc-------ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1037 IISWASMLLRQGQVK-----------DV-------FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~-----------~~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
............... +. .....+.......+..+.+++.+||+.||++|||++|++++
T Consensus 242 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 111111000000000 00 00000111123345678999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=339.21 Aligned_cols=263 Identities=24% Similarity=0.332 Sum_probs=202.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----CeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~ 893 (1103)
.++|++.+.||+|+||+||+|... +|+.||||++...........+.+|+.++++++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 457999999999999999999765 58999999997655555667888999999999999999999988654 678
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
++||||++ ++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARII 162 (353)
T ss_dssp EEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence 99999996 6999998764 389999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCCc---------cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 974 GTSETH---------ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 974 ~~~~~~---------~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
...... ......||+.|+|||++.. ..++.++||||||+++|||++|+.||..... .........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~ 237 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDY-----RHQLLLIFG 237 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHH
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCc-----HHHHHHHHH
Confidence 432211 1223578999999998754 6789999999999999999999999974321 000000000
Q ss_pred HHhcCcccc------------ccc------ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 LLRQGQVKD------------VFN------AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~------------~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......... .+. ...........+.++.+++.+||+.||++|||++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (353)
T 2b9h_A 238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306 (353)
T ss_dssp HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000000 000 000000112456778999999999999999999999874
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-36 Score=338.12 Aligned_cols=257 Identities=19% Similarity=0.282 Sum_probs=200.9
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEec--CCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRAS--GNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++... ..+.+.+|+.++++++ ||||+++++++.. ....++|
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 5799999999999999999965 56899999998643 3467889999999997 9999999999987 6788999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLGT 975 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~ 975 (1103)
|||+++++|.++++. +++.++..++.|++.||+|||++ +|+||||||+||+++.++ .+||+|||+++....
T Consensus 112 ~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred EeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 999999999998753 78899999999999999999999 999999999999999776 899999999987643
Q ss_pred CCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH--------HHh
Q 043720 976 SETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM--------LLR 1046 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------~~~ 1046 (1103)
.. ......|++.|+|||++.+ ..++.++|||||||++|||++|+.||...... .......... ...
T Consensus 184 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~---~~~l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 184 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN---YDQLVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH---HHHHHHHHHHHCHHHHHHHHH
T ss_pred CC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch---HHHHHHHHHhcCCchhhhHHH
Confidence 32 2334578999999999877 67899999999999999999999999643221 0000000000 000
Q ss_pred cCc--------------ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQ--------------VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~--------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... .................+..+.+++.+||+.||++|||++|++++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h 320 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 000 000001111111223357889999999999999999999999974
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=348.04 Aligned_cols=197 Identities=26% Similarity=0.335 Sum_probs=172.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcC------CCCceeEEEeEEecCCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV------RHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~ 892 (1103)
..+|++.+.||+|+||+||+|... +++.||||++.... ...+.+.+|+.+++.+ .|+||+++++++...+.
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 357999999999999999999655 58999999987542 2345667787777776 57899999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC--EEEeecccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN--AYLSDFGLS 970 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla 970 (1103)
.++||||+. ++|.+++.......+++..+..++.||+.||+|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999995 6999999887666699999999999999999999999 9999999999999999887 999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDP 1026 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 1026 (1103)
+.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 250 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~ 301 (429)
T 3kvw_A 250 CYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPG 301 (429)
T ss_dssp EETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCC
Confidence 76432 23345789999999999999999999999999999999999999874
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=340.26 Aligned_cols=257 Identities=24% Similarity=0.338 Sum_probs=193.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC------e
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------E 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 892 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 57999999999999999999654 589999999976432 334577889999999999999999999997654 7
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+||||++ ++|.++++. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 105 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 105 VYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp EEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred eEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 899999996 588888853 388999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH--------
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML-------- 1044 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------- 1044 (1103)
.... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...+....
T Consensus 177 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~-------~~~~~~i~~~~~~~~~ 247 (371)
T 2xrw_A 177 AGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH-------IDQWNKVIEQLGTPCP 247 (371)
T ss_dssp ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH-------HHHHHHHHC-CCCCCH
T ss_pred cccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH-------HHHHHHHHHHhCCCCH
Confidence 5432 223446789999999999999999999999999999999999999974321 11111100
Q ss_pred -------------HhcC-ccc-----ccccccccCCC---ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 -------------LRQG-QVK-----DVFNAELWASG---PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 -------------~~~~-~~~-----~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.... ... ..+........ ....+..+.+++.+||+.||++|||++|++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 319 (371)
T 2xrw_A 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 319 (371)
T ss_dssp HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence 0000 000 00000000000 12236789999999999999999999999975
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-34 Score=346.13 Aligned_cols=178 Identities=22% Similarity=0.234 Sum_probs=99.4
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 189 (1103)
+.++.++++++ .+|..+. +++++|||++|++++..|..|..+++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus 14 ~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n 90 (477)
T 2id5_A 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90 (477)
T ss_dssp TEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred CEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence 45666666666 5665543 46667777777766555666666666666666666666555666666666666666666
Q ss_pred cCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccc
Q 043720 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269 (1103)
Q Consensus 190 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 269 (1103)
++++..+..|+++++|++|+|++|++++..|..+.. +++|++|+|++|.+++..+..+..+++|++|+|++|.+++..+
T Consensus 91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 169 (477)
T 2id5_A 91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQD-LYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPT 169 (477)
T ss_dssp CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTT-CTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCH
T ss_pred cCCccCcccccCCCCCCEEECCCCccccCChhHccc-cccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcccCh
Confidence 666544445555666666666666555333333322 3445555555555544444444444444444444444444433
Q ss_pred ccccCCCCCCEEEccCCcCCCc
Q 043720 270 RELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 270 ~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
..+..+++|+.|+|++|.+.+.
T Consensus 170 ~~l~~l~~L~~L~l~~n~i~~~ 191 (477)
T 2id5_A 170 EALSHLHGLIVLRLRHLNINAI 191 (477)
T ss_dssp HHHTTCTTCCEEEEESCCCCEE
T ss_pred hHhcccCCCcEEeCCCCcCcEe
Confidence 4444444444444444444433
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-35 Score=328.11 Aligned_cols=254 Identities=24% Similarity=0.333 Sum_probs=206.5
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--------hhhHHHHHHHHHHHhcCC-CCceeEEEeEEe
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--------QHGVQQFHAEIKTLGNVR-HPNLVTLIGYRA 888 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 888 (1103)
..++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999775 589999999865431 223567889999999996 999999999999
Q ss_pred cCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecc
Q 043720 889 SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFG 968 (1103)
Q Consensus 889 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 968 (1103)
..+..++||||+++++|.++++... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg 169 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 169 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEeccc
Confidence 9999999999999999999998753 489999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccCCcccccccCccccc------cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHH
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYAL------TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWAS 1042 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 1042 (1103)
++....... ......|++.|+|||++. ...++.++||||||+++|||++|+.||.... ......
T Consensus 170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~ 239 (298)
T 1phk_A 170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK--------QMLMLR 239 (298)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHH
T ss_pred chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc--------HHHHHH
Confidence 998764332 234457899999999885 4567889999999999999999999986321 111111
Q ss_pred HHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1043 MLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1043 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...... .. .........+..+.+++.+||+.||++||+++|++++
T Consensus 240 ~~~~~~-~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (298)
T 1phk_A 240 MIMSGN-YQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 284 (298)
T ss_dssp HHHHTC-CC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HHhcCC-cc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence 111111 10 0011123456789999999999999999999999863
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-35 Score=347.22 Aligned_cols=261 Identities=21% Similarity=0.311 Sum_probs=207.6
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCC-CceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|.. .+++.||||++...... +.+.+|+++++.++| +++..+..++...+..++||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 36799999999999999999975 56899999987655433 357789999999976 66667777778888999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE---CCCCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll---~~~~~~ki~Dfgla~~~~ 974 (1103)
||+ +++|.++++... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 83 e~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 999 999999998543 4599999999999999999999999 99999999999999 588899999999998765
Q ss_pred CCCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 975 TSETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 975 ~~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ............
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~-----~~~~~~~~i~~~- 231 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAG-----TKKQKYEKISEK- 231 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCS-----SHHHHHHHHHHH-
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccch-----hHHHHHHHHhhc-
Confidence 43321 223567999999999999999999999999999999999999999743221 111111111111
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
.....++ .. ...++.++.+++.+||+.+|++||++++|++.|+++.
T Consensus 232 ~~~~~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~ 277 (483)
T 3sv0_A 232 KVATSIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLF 277 (483)
T ss_dssp HHHSCHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred cccccHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 0000000 00 1234578999999999999999999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=334.76 Aligned_cols=265 Identities=24% Similarity=0.348 Sum_probs=204.2
Q ss_pred HhcCCCCcceeccCCcccEEEEEE--cCCcEEEEEEcccccchh-hHHHHHHHHHHHhcC---CCCceeEEEeEEe----
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI--SPGILVAVKKLAVGRFQH-GVQQFHAEIKTLGNV---RHPNLVTLIGYRA---- 888 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 888 (1103)
+.++|++.+.||+|+||+||+|.. .+++.||||++....... ....+.+|+.+++.+ .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 456899999999999999999987 458899999987654321 223456677776665 8999999999987
Q ss_pred -cCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeec
Q 043720 889 -SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDF 967 (1103)
Q Consensus 889 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Df 967 (1103)
.....++||||++ |+|.+++.......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Df 164 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 164 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecC
Confidence 5568899999997 6999999887666699999999999999999999999 9999999999999999999999999
Q ss_pred ccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 968 GLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 968 gla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
|+++..... .......|++.|+|||++.+..++.++||||||+++|||++|+.||..... .............
T Consensus 165 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~ 237 (326)
T 1blx_A 165 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGL 237 (326)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCC
T ss_pred cccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHHHcCC
Confidence 999865422 233456789999999999999999999999999999999999999974321 1111111111000
Q ss_pred C---cccc-------ccc---ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 G---QVKD-------VFN---AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~---~~~~-------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .... .+. ...........+..+.+++.+||+.||++||+++|++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 297 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0000 000 000011223456788999999999999999999999964
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-35 Score=333.22 Aligned_cols=264 Identities=20% Similarity=0.310 Sum_probs=207.0
Q ss_pred cCCCCcceeccCCcccEEEEEE--cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCC------ceeEEEeEEecCCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI--SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP------NLVTLIGYRASGNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~~~~~~ 892 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.+++.++|+ +++++++++...+.
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 5799999999999999999976 35889999998653 23456788899999888655 49999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC--------------
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-------------- 958 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-------------- 958 (1103)
.++||||+ +++|.+++.......+++..+..++.|++.||+|||++ +|+||||||+||+++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccc
Confidence 99999999 88999999887656789999999999999999999999 9999999999999987
Q ss_pred -----CCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC
Q 043720 959 -----DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD 1033 (1103)
Q Consensus 959 -----~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~ 1033 (1103)
++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---- 239 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDS---- 239 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCH----
T ss_pred cccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCh----
Confidence 66899999999986432 22345789999999999999999999999999999999999999974321
Q ss_pred CcchHHHHHHHHhcCccc---------ccc---------------------c-ccccCCCChhHHHHHHHHHHHccccCC
Q 043720 1034 GFNIISWASMLLRQGQVK---------DVF---------------------N-AELWASGPHDDLEDMLHLALRCTVETL 1082 (1103)
Q Consensus 1034 ~~~~~~~~~~~~~~~~~~---------~~~---------------------~-~~~~~~~~~~~~~~l~~li~~cl~~dP 1082 (1103)
........... ..... ..+ . ...........+..+.+++.+||+.||
T Consensus 240 -~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 317 (339)
T 1z57_A 240 -KEHLAMMERIL-GPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDP 317 (339)
T ss_dssp -HHHHHHHHHHH-CSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred -HHHHHHHHHHh-CCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCc
Confidence 11111111100 00000 000 0 000011234567889999999999999
Q ss_pred CCCCCHHHHHHH--HHhhhc
Q 043720 1083 STRPTMKQVVQC--LKQIQH 1100 (1103)
Q Consensus 1083 ~~RPs~~evl~~--L~~i~~ 1100 (1103)
++|||++|++++ ++++++
T Consensus 318 ~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 318 AKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp TTSCCHHHHTTSGGGGGGGC
T ss_pred ccccCHHHHhcCHHHHHHhc
Confidence 999999999965 555443
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=333.91 Aligned_cols=253 Identities=19% Similarity=0.315 Sum_probs=199.9
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCC--CCceeEEEeEEecCCeEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVR--HPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 895 (1103)
..++|++.+.||+|+||+||+|...+++.||||++..... ....+.+.+|+.++++++ |+||+++++++...+..++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 4567999999999999999999888899999999976543 345678899999999997 5999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||| +.+++|.++++... .+++.++..++.|++.||+|||++ +|+||||||+||++++ +.+||+|||++.....
T Consensus 106 v~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~ 178 (313)
T 3cek_A 106 VME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQP 178 (313)
T ss_dssp EEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC---
T ss_pred EEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccC
Confidence 999 55889999998754 489999999999999999999999 9999999999999965 7999999999987643
Q ss_pred CCCc-cccCCcccccccCcccccc-----------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 976 SETH-ATTGVAGTFGYVAPEYALT-----------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 976 ~~~~-~~~~~~g~~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
.... ......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... .......
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-------~~~~~~~ 251 (313)
T 3cek_A 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-------QISKLHA 251 (313)
T ss_dssp -----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHH
T ss_pred ccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH-------HHHHHHH
Confidence 3221 2234578999999999865 4678899999999999999999999963211 1111111
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .+.......+...+..+.+++.+||+.||++||+++|++++
T Consensus 252 ~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 252 I---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp H---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred H---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 1 11122222333445779999999999999999999999975
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-36 Score=341.77 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=184.0
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------C
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------N 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 891 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 36799999999999999999965 468999999986543 233567788999999999999999999998654 5
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
..|+|+||+ +++|.++++.. .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~ 180 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR 180 (367)
T ss_dssp CCEEEEECC-CEECC-----C---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-----
T ss_pred eEEEEeccc-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeeccccc
Confidence 689999999 78999998763 499999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc-
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ- 1049 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 1049 (1103)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... ...............
T Consensus 181 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~l~~i~~~~g~p~~ 251 (367)
T 2fst_X 181 HTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLVGTPGA 251 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCSCCH
T ss_pred cccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhCCCCH
Confidence 6532 2344678999999999876 6789999999999999999999999974321 111111111100000
Q ss_pred --ccc--------cccc------cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 --VKD--------VFNA------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 --~~~--------~~~~------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... .+.. ..........+..+.+++.+||+.||++|||++|++++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h 312 (367)
T 2fst_X 252 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312 (367)
T ss_dssp HHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence 000 0000 00000012335678999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-35 Score=347.44 Aligned_cols=266 Identities=22% Similarity=0.352 Sum_probs=184.5
Q ss_pred CCCC-cceeccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe--cCCeEEE
Q 043720 822 DFNT-SNCIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA--SGNEMFL 895 (1103)
Q Consensus 822 ~~~~-~~~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l 895 (1103)
.|++ .++||+|+||+||+|... +++.||||++...... ..+.+|+.++++++||||+++++++. .....|+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l 97 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS---MSACREIALLRELKHPNVISLQKVFLSHADRKVWL 97 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC---HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC---HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence 4555 457999999999999865 4789999999755433 46789999999999999999999984 4678999
Q ss_pred EEeecCCCChHHHHHhhcC-------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE----CCCCCEEE
Q 043720 896 IYNYLPGGNLENFIKARTS-------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL----DDDFNAYL 964 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll----~~~~~~ki 964 (1103)
||||++ ++|.+++..... ..+++..++.++.||+.||+|||++ +|+||||||+||++ +.++.+||
T Consensus 98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 999996 588888864321 2489999999999999999999999 99999999999999 67789999
Q ss_pred eecccccccCCCCC--ccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC--CCCcchHH
Q 043720 965 SDFGLSRLLGTSET--HATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSH--GDGFNIIS 1039 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~ 1039 (1103)
+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ........
T Consensus 174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 253 (405)
T 3rgf_A 174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253 (405)
T ss_dssp CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence 99999987643322 233456789999999999874 58999999999999999999999997443211 00111111
Q ss_pred HHHHHHhcCcc-----ccc------------cccccc---------CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1040 WASMLLRQGQV-----KDV------------FNAELW---------ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1040 ~~~~~~~~~~~-----~~~------------~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
........+.. ... +..... ..........+.+++.+||+.||++|||++|+++
T Consensus 254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~ 333 (405)
T 3rgf_A 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ 333 (405)
T ss_dssp HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 11110000000 000 000000 0001112456889999999999999999999987
Q ss_pred H
Q 043720 1094 C 1094 (1103)
Q Consensus 1094 ~ 1094 (1103)
+
T Consensus 334 h 334 (405)
T 3rgf_A 334 D 334 (405)
T ss_dssp S
T ss_pred C
Confidence 5
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=336.21 Aligned_cols=253 Identities=23% Similarity=0.381 Sum_probs=197.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-------hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-------QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 891 (1103)
.++|++.+.||+|+||+||+|... +++.||||++..... ......+.+|+.++++++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457999999999999999999765 578999999865432 122345889999999999999999999987665
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC---EEEeecc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN---AYLSDFG 968 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfg 968 (1103)
.|+||||+++++|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++. +||+|||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg 162 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFG 162 (322)
T ss_dssp -EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred -eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence 899999999999999997643 489999999999999999999999 9999999999999987654 9999999
Q ss_pred cccccCCCCCccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHH
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 1045 (1103)
++...... .......|++.|+|||++. ...++.++||||||+++|||++|+.||...... ..... ..
T Consensus 163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~----~~~~~----~~ 232 (322)
T 2ycf_A 163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ----VSLKD----QI 232 (322)
T ss_dssp TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS----SCHHH----HH
T ss_pred cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH----HHHHH----HH
Confidence 99876432 1223446899999999974 567889999999999999999999999743221 11111 11
Q ss_pred hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1046 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..+... ..+.. ....+..+.+++.+||+.||++||+++|++++
T Consensus 233 ~~~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h 275 (322)
T 2ycf_A 233 TSGKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275 (322)
T ss_dssp HHTCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HhCccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence 111110 00111 12345778999999999999999999999853
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-35 Score=343.01 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=194.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC------eEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------EMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~ 894 (1103)
.+|++.+.||+|+||+||+|+...+..||+|++...... ..+|+.+++.++||||+++++++...+ ..+
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 468999999999999999999887878999988654322 236999999999999999999985533 388
Q ss_pred EEEeecCCCChHHHHHh--hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC-CCCCEEEeeccccc
Q 043720 895 LIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSR 971 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfgla~ 971 (1103)
+||||+++ ++.+.+.. .....+++..+..++.|++.||+|||++ +|+||||||+||+++ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999976 44444432 1235589999999999999999999999 999999999999998 79999999999998
Q ss_pred ccCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH------
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML------ 1044 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1044 (1103)
...... ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...... ..........
T Consensus 191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~----~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI----DQLVEIIKVLGTPSRE 264 (394)
T ss_dssp ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHH
T ss_pred cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHHhCCCCHH
Confidence 764332 23355789999999998764 5899999999999999999999999743210 0011111000
Q ss_pred ---HhcCcccc-----cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 ---LRQGQVKD-----VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 ---~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........ .....+....+...+.++.+++.+||+.||++|||+.|++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h 322 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH 322 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence 00000000 000000011123356789999999999999999999999975
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-36 Score=340.32 Aligned_cols=259 Identities=21% Similarity=0.346 Sum_probs=202.2
Q ss_pred HhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
..++|++.+.||+|+||+||+|.... .||+|++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 35689999999999999999998764 499999876533 223456788999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++ ++.+||+|||+++......
T Consensus 109 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp BCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred ecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 9999999999997643 4589999999999999999999999 999999999999998 6799999999987653211
Q ss_pred ----CccccCCcccccccCcccccc---------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 978 ----THATTGVAGTFGYVAPEYALT---------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 978 ----~~~~~~~~g~~~y~aPE~~~~---------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
........|++.|+|||++.. ..++.++||||||+++|||++|+.||..... ......
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--------~~~~~~- 254 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA--------EAIIWQ- 254 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH--------HHHHHH-
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHH-
Confidence 122334468999999999864 4578899999999999999999999873211 111111
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
...+... . ......+..+.+++.+||+.||++||+++++++.|+++.+.
T Consensus 255 ~~~~~~~-----~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~ 303 (319)
T 2y4i_B 255 MGTGMKP-----N---LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR 303 (319)
T ss_dssp HHTTCCC-----C---CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred hccCCCC-----C---CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence 1111111 0 11123456689999999999999999999999999998653
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-35 Score=328.05 Aligned_cols=252 Identities=23% Similarity=0.368 Sum_probs=195.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec---------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--------- 889 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------- 889 (1103)
.++|++.+.||+|+||+||+|... +++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 457899999999999999999764 6899999998643 3446788999999999999999999998754
Q ss_pred ----CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 890 ----GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 890 ----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
.+..|+||||+++|+|.++++... ..+++.+++.++.|++.||+|||++ +|+||||||+||+++.++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEEC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEe
Confidence 457899999999999999998643 4578899999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCC-------------CccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCC
Q 043720 966 DFGLSRLLGTSE-------------THATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSH 1031 (1103)
Q Consensus 966 Dfgla~~~~~~~-------------~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~ 1031 (1103)
|||++....... ........|++.|+|||++.+. .++.++||||||+++|||++ ||...
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~---- 231 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG---- 231 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH----
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc----
Confidence 999998654221 1122345689999999999764 68999999999999999998 44311
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........... .. ........+...+..+.+++.+||+.||++|||++|++++
T Consensus 232 ---~~~~~~~~~~~-~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 284 (303)
T 1zy4_A 232 ---MERVNILKKLR-SV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284 (303)
T ss_dssp ---HHHHHHHHHHH-ST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ---hhHHHHHHhcc-cc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence 01111111111 11 1111122344566778999999999999999999999874
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=354.96 Aligned_cols=150 Identities=23% Similarity=0.241 Sum_probs=101.3
Q ss_pred CccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEecc
Q 043720 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELS 647 (1103)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 647 (1103)
+|+.|+|++|.+++ +..+..+++|+.|+|++|.+++..|..|..+++|+.|+|++|++++ +|..+..+++|++|+|+
T Consensus 233 ~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls 309 (597)
T 3oja_B 233 ELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLS 309 (597)
T ss_dssp CCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECC
T ss_pred CCCEEECCCCCCCC--ChhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECC
Confidence 46666666666664 2556667777777777777776667777777777777777777774 46666777888888888
Q ss_pred CccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCC-CCccccccccccCCCCCCCC
Q 043720 648 SNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP-WNVTTMNCSGVIGNPFLDPC 724 (1103)
Q Consensus 648 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p-~~~~~~~~~~l~~Np~~c~C 724 (1103)
+|.++ .+|..+..+++|+.|+|++|+|++. | +..+++|+.|++++|++.+... ..+..+....+.+++..|.+
T Consensus 310 ~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~~~~~~~~~~~~~~~~~~~~C~~ 383 (597)
T 3oja_B 310 HNHLL-HVERNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383 (597)
T ss_dssp SSCCC-CCGGGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHHHHHHTTTCCTTTBCCCCCCCCT
T ss_pred CCCCC-ccCcccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChhHHHHHHHHhhhccccccccCCc
Confidence 88887 5677777888888888888888744 2 5566777777777776654211 12233333345666666654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-35 Score=323.61 Aligned_cols=252 Identities=24% Similarity=0.325 Sum_probs=204.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 467999999999999999999775 689999999876543 335678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC---CCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD---FNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~---~~~ki~Dfgla~~~~ 974 (1103)
||+++++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.+ +.+||+|||++....
T Consensus 101 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 101 ELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp CCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999987654 489999999999999999999999 99999999999999754 469999999998664
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
... ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||.... ......... .+....
T Consensus 176 ~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~--------~~~~~~~~~-~~~~~~-- 241 (287)
T 2wei_A 176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN--------EYDILKRVE-TGKYAF-- 241 (287)
T ss_dssp CCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHH-HCCCCC--
T ss_pred CCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC--------HHHHHHHHH-cCCCCC--
Confidence 322 2233458899999998876 48899999999999999999999987321 112222221 111100
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+. +.....+..+.+++.+|++.||++||+++|++++
T Consensus 242 ~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 242 DL----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp CS----GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred Cc----hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 00 0112445779999999999999999999999984
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-35 Score=332.11 Aligned_cols=256 Identities=27% Similarity=0.364 Sum_probs=183.3
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHH-HHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIK-TLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|... +++.||||++...........+..|+. +++.++||||+++++++...+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 57999999999999999999775 689999999987655555566666666 7778899999999999999999999999
Q ss_pred ecCCCChHHHHHhh---cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 899 YLPGGNLENFIKAR---TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
|+++ +|.+++... ....+++..+..++.|++.|+.|||+.. +|+||||||+||+++.++.+||+|||+++....
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 178 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence 9974 888887642 2356899999999999999999999842 899999999999999999999999999986643
Q ss_pred CCCccccCCcccccccCcccc----ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 976 SETHATTGVAGTFGYVAPEYA----LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.. ......|++.|+|||++ .+..++.++||||||+++|||++|+.||........ .. ....
T Consensus 179 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----------~~--~~~~ 243 (327)
T 3aln_A 179 SI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----------QL--TQVV 243 (327)
T ss_dssp -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------------------CCCC
T ss_pred cc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----------HH--HHHh
Confidence 22 22334689999999998 466789999999999999999999999974321100 00 0000
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+..........+..+.+++.+||+.||++||+++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 0001111111223456789999999999999999999999863
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=330.44 Aligned_cols=259 Identities=19% Similarity=0.310 Sum_probs=193.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEe----------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRA---------- 888 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~---------- 888 (1103)
.++|++.+.||+|+||+||+|.... ++.||||++.... ....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3579999999999999999997764 8999999987553 345678899999999999999999999873
Q ss_pred ----cCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC-CCCCEE
Q 043720 889 ----SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAY 963 (1103)
Q Consensus 889 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~k 963 (1103)
+....|+||||++ |+|.++++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++ +++.+|
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEE
Confidence 3468899999997 6999999653 489999999999999999999999 999999999999997 567999
Q ss_pred EeecccccccCCCCC--ccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH
Q 043720 964 LSDFGLSRLLGTSET--HATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW 1040 (1103)
Q Consensus 964 i~Dfgla~~~~~~~~--~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~ 1040 (1103)
|+|||+++....... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||..... ...
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~ 233 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE--------LEQ 233 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH--------HHH
Confidence 999999987643221 12233457889999998865 6789999999999999999999999974321 111
Q ss_pred HHHHHhcCc-------------ccccccccccC------CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1041 ASMLLRQGQ-------------VKDVFNAELWA------SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1041 ~~~~~~~~~-------------~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......... ........... ......+..+.+++.+||+.||++||+++|++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 306 (320)
T 2i6l_A 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306 (320)
T ss_dssp HHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence 111111000 00000000000 0112356789999999999999999999999874
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-35 Score=342.54 Aligned_cols=259 Identities=24% Similarity=0.331 Sum_probs=194.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------CeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------NEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 893 (1103)
.+|++.+.||+|+||+||+|... +++.||||++..... ...+|++++++++||||+++++++... ...
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 35888999999999999999875 589999999865432 234799999999999999999987432 236
Q ss_pred EEEEeecCCCChHHHHHh--hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-CCEEEeecccc
Q 043720 894 FLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-FNAYLSDFGLS 970 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-~~~ki~Dfgla 970 (1103)
++||||+++ ++.+.++. .....+++..+..++.||++||+|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999975 77776654 2235689999999999999999999999 99999999999999965 56899999999
Q ss_pred cccCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH-----
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML----- 1044 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----- 1044 (1103)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... ...+.......
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~----~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG----VDQLVEIIKVLGTPTR 278 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCSCCH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHHHhCCCCH
Confidence 8764332 23345789999999998764 789999999999999999999999974321 01111111100
Q ss_pred --Hh--cCccccccccccc-----CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 --LR--QGQVKDVFNAELW-----ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 --~~--~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+. .....+...+... ...+...+.++.+++.+||+.||++||++.|++++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h 337 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 337 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence 00 0001111000000 00123456789999999999999999999999864
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-34 Score=326.54 Aligned_cols=268 Identities=21% Similarity=0.302 Sum_probs=244.9
Q ss_pred CCCChhhHHHHHHHHhhc-cCCCCcccCcC---CCCCCCCceeeeEecC---------CCCeEEEEecCCCCCCCCCCcc
Q 043720 1 SGKVLPEKTILLEFKNSV-SDPSGILSSWQ---TNTSSHCSWFGVSCDS---------ESRVVALNITGGDVSEGNSKPF 67 (1103)
Q Consensus 1 ~~~~~~~~~aLl~~k~~~-~d~~~~l~sW~---~~~~~~C~W~GV~C~~---------~~~v~~l~l~~~~~~~~~~~~~ 67 (1103)
++++..|++||++||+++ .|+.+++++|. ....++|.|.||.|+. ..+|+.+++++..+
T Consensus 22 ~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l-------- 93 (328)
T 4fcg_A 22 STALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPL-------- 93 (328)
T ss_dssp -CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCC--------
T ss_pred cccCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCc--------
Confidence 467889999999999999 58888999994 3345799999999962 36888898876432
Q ss_pred ccccccccccccccccccceeccCCCccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCc
Q 043720 68 FSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRL 147 (1103)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~ 147 (1103)
..+|+.++++++|++|+|++|.++ .+|..++++++|++|+|++|.++ .+
T Consensus 94 -----------------------------~~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~l 142 (328)
T 4fcg_A 94 -----------------------------PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-AL 142 (328)
T ss_dssp -----------------------------SSCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CC
T ss_pred -----------------------------hhcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cC
Confidence 257888899999999999999999 99999999999999999999999 89
Q ss_pred cccccCCCCCCEEEccccccCCCCCCCCCC---------CCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCC
Q 043720 148 PNEFVGLRNLRVLNLAFNRIDGDIPFSLRN---------FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS 218 (1103)
Q Consensus 148 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~---------l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ 218 (1103)
|..++.+++|++|+|++|++.+.+|..+.. +++|++|+|++|+++ .+|..++++++|++|+|++|+++ .
T Consensus 143 p~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~-~ 220 (328)
T 4fcg_A 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-A 220 (328)
T ss_dssp CGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCC-C
T ss_pred cHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCC-c
Confidence 999999999999999999999999998875 999999999999999 88999999999999999999999 6
Q ss_pred CChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccC
Q 043720 219 IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGN 298 (1103)
Q Consensus 219 ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 298 (1103)
+|..+.. +++|++|+|++|++.+.+|..++.+++|++|+|++|.+.+.+|..+..+++|+.|+|++|++.+.+|..+++
T Consensus 221 l~~~l~~-l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~ 299 (328)
T 4fcg_A 221 LGPAIHH-LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQ 299 (328)
T ss_dssp CCGGGGG-CTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGG
T ss_pred Cchhhcc-CCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhh
Confidence 8887765 588999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCeEecccC
Q 043720 299 CVELSVLVLSNL 310 (1103)
Q Consensus 299 l~~L~~L~l~~~ 310 (1103)
+++|+.+++..+
T Consensus 300 L~~L~~l~l~~~ 311 (328)
T 4fcg_A 300 LPANCIILVPPH 311 (328)
T ss_dssp SCTTCEEECCGG
T ss_pred ccCceEEeCCHH
Confidence 999999999754
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=331.82 Aligned_cols=269 Identities=22% Similarity=0.304 Sum_probs=191.7
Q ss_pred HHHHHHHhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC
Q 043720 813 YESIIRATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN 891 (1103)
Q Consensus 813 ~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 891 (1103)
.++.....++|++.+.||+|+||+||+|... +++.||||++...... ...+.+|+..++.++||||+++++++...+
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 3556677889999999999999999999775 5899999988654322 245667888888889999999999986533
Q ss_pred e-------EEEEEeecCCCChHHHHHh--hcCCcccHHHHHHHHHHHHHHHHHHH--hCCCCCcccCCCCCCcEEECC-C
Q 043720 892 E-------MFLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAYLH--DQCAPRVLHRDVKPSNILLDD-D 959 (1103)
Q Consensus 892 ~-------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~gL~~LH--~~~~~~ivH~Dlk~~NIll~~-~ 959 (1103)
. .++||||+++ ++.+.+.. .....+++..+..++.|++.|+.||| +. +|+||||||+||+++. +
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~ 168 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEAD 168 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCC
Confidence 2 8899999975 66655543 22345889999999999999999999 88 9999999999999996 8
Q ss_pred CCEEEeecccccccCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchH
Q 043720 960 FNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 960 ~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1103)
+.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..... .....
T Consensus 169 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~~~~~ 242 (360)
T 3e3p_A 169 GTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS----AGQLH 242 (360)
T ss_dssp TEEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHH
T ss_pred CcEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh----HHHHH
Confidence 999999999998764332 23345789999999998654 489999999999999999999999974321 00111
Q ss_pred HHHHHHHhcC------------ccccccc------ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1039 SWASMLLRQG------------QVKDVFN------AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1039 ~~~~~~~~~~------------~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.... ..... ......+ ...........+..+.+++.+||+.||++|||++|++++
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 315 (360)
T 3e3p_A 243 EIVR-VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315 (360)
T ss_dssp HHHH-HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHH-HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1110 00000 0000000 001112223357789999999999999999999999875
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-35 Score=332.81 Aligned_cols=253 Identities=23% Similarity=0.260 Sum_probs=175.8
Q ss_pred hcCCCCcc-eeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec----CCeE
Q 043720 820 TGDFNTSN-CIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS----GNEM 893 (1103)
Q Consensus 820 ~~~~~~~~-~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 893 (1103)
.++|.+.+ .||+|+||+||+|... +++.||||++.... ....+....++.+.||||+++++++.. ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 45788855 6999999999999776 68999999986432 112223334556689999999999876 4568
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeecccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLS 970 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla 970 (1103)
++||||+++|+|.+++.......+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 9999999999999999987666799999999999999999999999 9999999999999986 455999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
+..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........... ........
T Consensus 179 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~~~~-- 248 (336)
T 3fhr_A 179 KETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG-----MKRRIRLG-- 248 (336)
T ss_dssp EEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred eecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh-----HHHhhhcc--
Confidence 865422 22345679999999999888899999999999999999999999974432111000 00000000
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
............+..+.+++.+||+.||++|||++|++++
T Consensus 249 ----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 288 (336)
T 3fhr_A 249 ----QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH 288 (336)
T ss_dssp ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ----ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0011111123456789999999999999999999999974
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-35 Score=337.16 Aligned_cols=263 Identities=20% Similarity=0.298 Sum_probs=201.8
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-----------CCceeEEEeEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-----------HPNLVTLIGYRA 888 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 888 (1103)
++|++.+.||+|+||+||+|.. .+++.||||++.... ...+.+.+|+.+++++. |+||+++++++.
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 5799999999999999999976 568999999987532 23567888999998886 899999999987
Q ss_pred cCC----eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC------C
Q 043720 889 SGN----EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD------D 958 (1103)
Q Consensus 889 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~------~ 958 (1103)
..+ ..++||||+ +++|.+++.......+++..+..++.||+.||+|||+++ +|+||||||+||+++ .
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~ 173 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPEN 173 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcC
Confidence 644 789999999 899999998866666999999999999999999999953 899999999999994 4
Q ss_pred CCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchH
Q 043720 959 DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 959 ~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1103)
.+.+||+|||++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.......... . .
T Consensus 174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-~-~ 247 (373)
T 1q8y_A 174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK-D-D 247 (373)
T ss_dssp EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C-H-H
T ss_pred cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC-h-H
Confidence 457999999999876432 234578999999999999999999999999999999999999997543211110 0 0
Q ss_pred HHHHHHHh-cCcccc-----------cccc-------------------cccCCCChhHHHHHHHHHHHccccCCCCCCC
Q 043720 1039 SWASMLLR-QGQVKD-----------VFNA-------------------ELWASGPHDDLEDMLHLALRCTVETLSTRPT 1087 (1103)
Q Consensus 1039 ~~~~~~~~-~~~~~~-----------~~~~-------------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs 1087 (1103)
........ .+.... .+.. ......+...+..+.+++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 11111100 000000 0000 0012345677889999999999999999999
Q ss_pred HHHHHHH
Q 043720 1088 MKQVVQC 1094 (1103)
Q Consensus 1088 ~~evl~~ 1094 (1103)
++|++++
T Consensus 328 ~~ell~h 334 (373)
T 1q8y_A 328 AGGLVNH 334 (373)
T ss_dssp HHHHHTC
T ss_pred HHHHhhC
Confidence 9999874
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-34 Score=332.38 Aligned_cols=200 Identities=26% Similarity=0.335 Sum_probs=171.6
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CC-----ceeEEEeEEecCC
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HP-----NLVTLIGYRASGN 891 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~ 891 (1103)
..++|++.+.||+|+||+||+|... +++.||||++... ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 3568999999999999999999765 5889999998743 233566778888888774 44 5999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC--CCCCEEEeeccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD--DDFNAYLSDFGL 969 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgl 969 (1103)
..|+||||++ ++|.+++.......+++..+..++.|++.||+|||++ ..+|+||||||+||+++ .++.+||+|||+
T Consensus 130 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~ 207 (382)
T 2vx3_A 130 HLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGS 207 (382)
T ss_dssp EEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred ceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence 9999999995 5999999887656699999999999999999999952 22999999999999995 577899999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCC
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDP 1026 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~ 1026 (1103)
++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 208 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~ 260 (382)
T 2vx3_A 208 SCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260 (382)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred ceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9876432 3346789999999999999999999999999999999999999974
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-35 Score=335.29 Aligned_cols=254 Identities=21% Similarity=0.335 Sum_probs=196.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE-----
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM----- 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----- 893 (1103)
++|.+.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 57999999999999999999655 589999999976533 33467788999999999999999999999877654
Q ss_pred -EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 894 -FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 894 -~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
|+||||+. ++|.+++. ..+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 193 (371)
T 4exu_A 122 FYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 193 (371)
T ss_dssp CEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred EEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence 99999996 68888773 2389999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc-Ccc
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ-GQV 1050 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1050 (1103)
... ......||+.|+|||++.+ ..++.++||||||+++|||++|+.||..... .......... +..
T Consensus 194 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 194 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGVP 261 (371)
T ss_dssp ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH--------HHHHHHHHHHHCCC
T ss_pred ccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCh--------HHHHHHHHHHhCCC
Confidence 532 2345578999999999877 7789999999999999999999999974321 1111111110 000
Q ss_pred -ccc---------------ccccc---cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 -KDV---------------FNAEL---WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 -~~~---------------~~~~~---~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.+. +.... ........+..+.+++.+||+.||++|||++|++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 324 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 324 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence 000 00000 000112346789999999999999999999999875
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-35 Score=333.13 Aligned_cols=243 Identities=26% Similarity=0.381 Sum_probs=201.1
Q ss_pred HhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchh-----hHHHHHHHHHHHhcCC--CCceeEEEeEEecC
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQH-----GVQQFHAEIKTLGNVR--HPNLVTLIGYRASG 890 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~ 890 (1103)
..++|++.+.||+|+||+||+|.. .+++.||||++....... ..+.+.+|+.++++++ |+||+++++++...
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~ 120 (320)
T 3a99_A 41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 120 (320)
T ss_dssp CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence 356799999999999999999965 468999999997654321 2345678999999996 59999999999999
Q ss_pred CeEEEEEeecCC-CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC-CCCCEEEeecc
Q 043720 891 NEMFLIYNYLPG-GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFG 968 (1103)
Q Consensus 891 ~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki~Dfg 968 (1103)
+..++|+|++.+ ++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++ +++.+||+|||
T Consensus 121 ~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 121 DSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp SEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred CcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 999999999976 89999998754 489999999999999999999999 999999999999999 78899999999
Q ss_pred cccccCCCCCccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
+++..... ......|++.|+|||++.+..+ +.++||||||+++|||++|+.||.... .....
T Consensus 196 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------------~~~~~ 258 (320)
T 3a99_A 196 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------------EIIRG 258 (320)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------------HHHHC
T ss_pred cccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------------hhhcc
Confidence 99876432 2234568999999999877665 678999999999999999999986210 11111
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ...+...+..+.+++.+||+.||++||+++|++++
T Consensus 259 ~-----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 294 (320)
T 3a99_A 259 Q-----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 294 (320)
T ss_dssp C-----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred c-----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 11233456789999999999999999999999874
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=323.87 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=183.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhH-HHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.++|++.+.||+|+||+||+|... +++.||||++......... +.+.++..+++.++||||+++++++...+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 356889999999999999999775 6899999999776544333 34445556788889999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
||+ ++.+..+... ....+++..+..++.|++.||+|||+ . +|+||||||+||+++.++.+||+|||++......
T Consensus 104 e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp CCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999 5555555443 34568999999999999999999998 6 8999999999999999999999999999765432
Q ss_pred CCccccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 977 ETHATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
. ......|++.|+|||++. ...++.++||||||+++|||++|+.||..... ............. .
T Consensus 179 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~-~ 248 (318)
T 2dyl_A 179 K--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------DFEVLTKVLQEEP-P 248 (318)
T ss_dssp ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCS-------HHHHHHHHHHSCC-C
T ss_pred c--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCc-------cHHHHHHHhccCC-C
Confidence 2 233456899999999984 56788999999999999999999999873211 1112222221110 0
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
........+..+.+++.+||+.||++||+++|++++
T Consensus 249 -------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 249 -------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp -------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred -------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 011122456789999999999999999999999864
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-34 Score=328.46 Aligned_cols=260 Identities=19% Similarity=0.277 Sum_probs=201.9
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CC-cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCc------eeEEEeEEecCC
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PG-ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN------LVTLIGYRASGN 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~ 891 (1103)
.++|++.+.||+|+||+||+|... ++ +.||||++... ....+.+.+|+.++++++|++ ++.+++++...+
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 357999999999999999999764 34 78999998753 234567888999999987655 999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE---------------
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL--------------- 956 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll--------------- 956 (1103)
..++||||+ ++++.+++.......+++.++..++.||+.||+|||++ +|+||||||+||++
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccc
Confidence 999999999 67888888776556699999999999999999999999 99999999999999
Q ss_pred ----CCCCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCC
Q 043720 957 ----DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032 (1103)
Q Consensus 957 ----~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~ 1032 (1103)
+.++.+||+|||+++.... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--- 244 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN--- 244 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---
T ss_pred cccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH---
Confidence 5678999999999986432 22345789999999999999999999999999999999999999974321
Q ss_pred CCcchHHHHHHHHhc--------Ccccc-cccc---------------------cccCCCChhHHHHHHHHHHHccccCC
Q 043720 1033 DGFNIISWASMLLRQ--------GQVKD-VFNA---------------------ELWASGPHDDLEDMLHLALRCTVETL 1082 (1103)
Q Consensus 1033 ~~~~~~~~~~~~~~~--------~~~~~-~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~dP 1082 (1103)
............. ..... .... ..........+..+.+++.+||+.||
T Consensus 245 --~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP 322 (355)
T 2eu9_A 245 --REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP 322 (355)
T ss_dssp --HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred --HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence 1111111111000 00000 0000 00011223446789999999999999
Q ss_pred CCCCCHHHHHHH
Q 043720 1083 STRPTMKQVVQC 1094 (1103)
Q Consensus 1083 ~~RPs~~evl~~ 1094 (1103)
++|||++|++++
T Consensus 323 ~~Rpt~~e~l~h 334 (355)
T 2eu9_A 323 AQRITLAEALLH 334 (355)
T ss_dssp TTSCCHHHHTTS
T ss_pred hhCcCHHHHhcC
Confidence 999999999854
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=340.07 Aligned_cols=250 Identities=24% Similarity=0.336 Sum_probs=188.1
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEeec
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.+++++ +||||+++++++.+.+..|+||||+
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 34556789999999998877778999999998653 235678899999876 8999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCc-----ccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC-------------CCE
Q 043720 901 PGGNLENFIKARTSRA-----VDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD-------------FNA 962 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~-------------~~~ 962 (1103)
. |+|.++++...... .++..++.++.||+.||+|||++ +|+||||||+||+++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999998654311 12334678999999999999999 99999999999999754 479
Q ss_pred EEeecccccccCCCCCc---cccCCcccccccCcccccc-------CCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043720 963 YLSDFGLSRLLGTSETH---ATTGVAGTFGYVAPEYALT-------CRVSDKADVYSYGVVLLELIS-DKKALDPSFSSH 1031 (1103)
Q Consensus 963 ki~Dfgla~~~~~~~~~---~~~~~~g~~~y~aPE~~~~-------~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~ 1031 (1103)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~- 246 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR- 246 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH-
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh-
Confidence 99999999877543221 2234579999999999865 678999999999999999999 89998633210
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
.......... .+..........+.++.+++.+||+.||++||++.|+++
T Consensus 247 ---------~~~i~~~~~~----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 247 ---------ESNIIRGIFS----LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp ---------HHHHHHTCCC----CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------HHHHhcCCCC----cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 0111111100 011111224466788999999999999999999999986
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-35 Score=350.38 Aligned_cols=268 Identities=24% Similarity=0.360 Sum_probs=206.4
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec------CCe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS------GNE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 892 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||++.........+.+.+|+.++++++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 36899999999999999999966 45899999999876666667889999999999999999999998765 677
Q ss_pred EEEEEeecCCCChHHHHHhhcC-CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCC---EEEeecc
Q 043720 893 MFLIYNYLPGGNLENFIKARTS-RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN---AYLSDFG 968 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~---~ki~Dfg 968 (1103)
.++||||+++|+|.++++.... ..+++..++.++.+++.||+|||+. +|+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999987442 3588999999999999999999999 9999999999999997765 9999999
Q ss_pred cccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
++....... ......|++.|+|||++.+..++.++||||+|+++|||++|+.||.+... ...|........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-------~~~~~~~i~~~~ 240 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-------PVQWHGKVREKS 240 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-------HHHSSTTCC---
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-------hhhhhhhhhccc
Confidence 998764332 23456789999999999999999999999999999999999999975321 011100000000
Q ss_pred ----cccccccc--------cccCCCChhHHHHHHHHHHHccccCCCCCCCHHH-----HHHHHHhhh
Q 043720 1049 ----QVKDVFNA--------ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQ-----VVQCLKQIQ 1099 (1103)
Q Consensus 1049 ----~~~~~~~~--------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~e-----vl~~L~~i~ 1099 (1103)
...+.... ..........+..+.+++.+|++.||++||+++| +.+.++++.
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000000 0011234557889999999999999999999988 445555553
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-35 Score=329.41 Aligned_cols=245 Identities=24% Similarity=0.375 Sum_probs=193.6
Q ss_pred HHHhcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchh-----hHHHHHHHHHHHhcC----CCCceeEEEeE
Q 043720 817 IRATGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQH-----GVQQFHAEIKTLGNV----RHPNLVTLIGY 886 (1103)
Q Consensus 817 ~~~~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l----~h~niv~l~~~ 886 (1103)
....++|++.+.||+|+||+||+|.. .+++.||||++....... ....+.+|+.+++++ +||||++++++
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~ 106 (312)
T 2iwi_A 27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW 106 (312)
T ss_dssp ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence 34457899999999999999999966 468899999997654321 233456788888888 89999999999
Q ss_pred EecCCeEEEEEee-cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC-CCCCEEE
Q 043720 887 RASGNEMFLIYNY-LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYL 964 (1103)
Q Consensus 887 ~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~-~~~~~ki 964 (1103)
+...+..++|+|| +.+++|.+++.... .+++..++.++.|++.||+|||++ +|+||||||+||+++ .++.+||
T Consensus 107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl 181 (312)
T 2iwi_A 107 FETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKL 181 (312)
T ss_dssp C-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEE
T ss_pred EecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEE
Confidence 9999999999999 78999999998754 489999999999999999999999 999999999999999 8899999
Q ss_pred eecccccccCCCCCccccCCcccccccCccccccCCCC-CcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHH
Q 043720 965 SDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVS-DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043 (1103)
Q Consensus 965 ~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 1043 (1103)
+|||++...... ......|++.|+|||++.+..+. .++||||||+++|||++|+.||... ..
T Consensus 182 ~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--------------~~ 244 (312)
T 2iwi_A 182 IDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--------------QE 244 (312)
T ss_dssp CCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------------HH
T ss_pred EEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh--------------HH
Confidence 999999876432 23345689999999998776654 5899999999999999999998621 00
Q ss_pred HHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1044 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
... . ....+...+..+.+++.+||+.||++||+++|++++
T Consensus 245 ~~~-~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 284 (312)
T 2iwi_A 245 ILE-A----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD 284 (312)
T ss_dssp HHH-T----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred Hhh-h----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 110 0 012234456789999999999999999999999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-34 Score=329.28 Aligned_cols=254 Identities=21% Similarity=0.328 Sum_probs=197.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe------
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE------ 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------ 892 (1103)
++|.+.+.||+|+||+||+|... +|+.||||++..... ....+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57899999999999999999764 689999999876433 3345778999999999999999999999987653
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+||||++ ++|.+++.. .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~ 175 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARH 175 (353)
T ss_dssp CEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred EEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccC
Confidence 599999996 688887742 389999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc-Ccc
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ-GQV 1050 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1050 (1103)
... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||..... .......... +..
T Consensus 176 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 176 ADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY--------LDQLTQILKVTGVP 243 (353)
T ss_dssp ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCH--------HHHHHHHHHHHCBC
T ss_pred CCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHHHhCCC
Confidence 532 2334578999999999876 6789999999999999999999999974321 1111111110 000
Q ss_pred -c----c-----------ccc---ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 -K----D-----------VFN---AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 -~----~-----------~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. . .+. ...........+..+.+++.+|++.||++||+++|++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 306 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0 0 000 000111223557889999999999999999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-34 Score=335.90 Aligned_cols=248 Identities=25% Similarity=0.334 Sum_probs=188.1
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.+|...+.||+|+||+||.....+++.||||++...... .+.+|+.+++++ +|||||++++++.+.+..|+||||
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 468888999999999977666677999999998654322 356799999999 799999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-----CCCEEEeecccccccC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-----DFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~Dfgla~~~~ 974 (1103)
+. |+|.+++..... ...+..+..++.||+.||+|||++ +|+||||||+||+++. ...+||+|||+++...
T Consensus 100 ~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~ 174 (432)
T 3p23_A 100 CA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA 174 (432)
T ss_dssp CS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred CC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence 95 699999986542 344556778999999999999999 9999999999999953 3358899999998764
Q ss_pred CCCC--ccccCCcccccccCccccc---cCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 975 TSET--HATTGVAGTFGYVAPEYAL---TCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 975 ~~~~--~~~~~~~g~~~y~aPE~~~---~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
.... .......||+.|+|||++. ...++.++||||+||++|||++ |..||..... ....... ..
T Consensus 175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~---------~~~~~~~-~~ 244 (432)
T 3p23_A 175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ---------RQANILL-GA 244 (432)
T ss_dssp -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT---------HHHHHHT-TC
T ss_pred CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH---------HHHHHHh-cc
Confidence 3321 2334567999999999997 4567889999999999999999 8888853211 0011111 11
Q ss_pred cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1049 QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1049 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
.... ...........+.+++.+||+.||++||+++|+++
T Consensus 245 ~~~~------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 245 CSLD------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CCCT------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCcc------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 0000 01122345666899999999999999999999985
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-33 Score=325.37 Aligned_cols=154 Identities=21% Similarity=0.155 Sum_probs=136.3
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|++|++++|.++.. |.. ..++|+.|+|++|++++. ..+..+++|++|+|++|++++..|..|..+++|++|+|
T Consensus 205 ~~L~~L~l~~n~l~~~-~~~--~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 279 (390)
T 3o6n_A 205 IAVEELDASHNSINVV-RGP--VNVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYI 279 (390)
T ss_dssp SSCSEEECCSSCCCEE-ECC--CCSSCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEEC
T ss_pred CcceEEECCCCeeeec-ccc--ccccccEEECCCCCCccc--HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEEC
Confidence 4578888888888854 332 347999999999999953 57999999999999999999888999999999999999
Q ss_pred cCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCccccccccccCCCCCCCCCC
Q 043720 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQM 726 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~l~~Np~~c~C~~ 726 (1103)
++|++++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++......+..+..+.+.+|||.|+|..
T Consensus 280 ~~n~l~~-~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~~~~~ 357 (390)
T 3o6n_A 280 SNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCNSLR 357 (390)
T ss_dssp CSSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHHHHH
T ss_pred CCCcCcc-cCcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccchhHH
Confidence 9999995 6777788999999999999999 6777788999999999999999998878888999999999999999865
Q ss_pred C
Q 043720 727 Y 727 (1103)
Q Consensus 727 ~ 727 (1103)
.
T Consensus 358 ~ 358 (390)
T 3o6n_A 358 A 358 (390)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.38 Aligned_cols=231 Identities=13% Similarity=0.080 Sum_probs=186.6
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-CcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|.... ++.||||++..... .+..+.+.+|+..+++++||||+++++++...+..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 579999999999999999997754 89999999976543 334578999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++++|.++++.. ....++.+++.|++.||+|||++ +|+||||||+||+++.++.+||++++
T Consensus 111 e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp ECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999542 34557888999999999999999 99999999999999999999998443
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
|++| ++.++||||||+++|||++|+.||........-.. ........
T Consensus 175 ------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--------------~~~~~~~~ 221 (286)
T 3uqc_A 175 ------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--------------AERDTAGQ 221 (286)
T ss_dssp ------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--------------CCBCTTSC
T ss_pred ------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--------------HHHHhccC
Confidence 3333 57899999999999999999999985433210000 00000000
Q ss_pred c--cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1058 L--WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1058 ~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
. ........+..+.+++.+||+.||++| |+.|+++.|+++...
T Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 0 001123456779999999999999999 999999999998654
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=351.04 Aligned_cols=239 Identities=23% Similarity=0.316 Sum_probs=195.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc--CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe-----E
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS--PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE-----M 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----~ 893 (1103)
++|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++||||+++++++...+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999775 5899999999766555567789999999999999999999999987654 7
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|+||||+++++|.+++.. .+++.+++.++.||+.||+|||++ +|+||||||+||+++.+ .+||+|||+++..
T Consensus 160 ~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp EEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred EEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 999999999999998754 489999999999999999999999 99999999999999986 9999999999876
Q ss_pred CCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 974 GTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 974 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ....||++|+|||++.+.. +.++|||||||++|||++|..||....... .
T Consensus 232 ~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~---------------------~ 284 (681)
T 2pzi_A 232 NSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG---------------------L 284 (681)
T ss_dssp TCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS---------------------C
T ss_pred ccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc---------------------c
Confidence 432 3457899999999987654 889999999999999999988876321100 0
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhh
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRP-TMKQVVQCLKQI 1098 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i 1098 (1103)
. ........+..+.+++.+||+.||++|| +++++.+.+..+
T Consensus 285 ~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 P----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp C----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred c----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 0 0001122346789999999999999999 566666666654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-33 Score=342.36 Aligned_cols=313 Identities=20% Similarity=0.174 Sum_probs=240.6
Q ss_pred CcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEec
Q 043720 228 RYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL 307 (1103)
Q Consensus 228 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 307 (1103)
.+++.|++++|.++...+..++.+++|++|+|++|.+++..|..|+.+++|++|+|++|.+++..|..|+++++|+.|+|
T Consensus 51 ~~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 130 (597)
T 3oja_B 51 NNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVL 130 (597)
T ss_dssp CCCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEe
Confidence 56788888888887555555677888888888888888877778888888888888888888776766777777777666
Q ss_pred ccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCccc
Q 043720 308 SNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVL 387 (1103)
Q Consensus 308 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l 387 (1103)
++ |.+.+..+..|+++++|++|+|++|.+
T Consensus 131 ~~---------------------------------------------------n~l~~l~~~~~~~l~~L~~L~Ls~N~l 159 (597)
T 3oja_B 131 ER---------------------------------------------------NDLSSLPRGIFHNTPKLTTLSMSNNNL 159 (597)
T ss_dssp CS---------------------------------------------------SCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred eC---------------------------------------------------CCCCCCCHHHhccCCCCCEEEeeCCcC
Confidence 64 334433334456666677777777777
Q ss_pred ccccchhhhccCCceEeecCCccccccccccccccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchh
Q 043720 388 RGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYM 467 (1103)
Q Consensus 388 ~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 467 (1103)
++.++..|.++++|++|+|++|++++.. ...++.|+.|++++|.+++
T Consensus 160 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~--~~~l~~L~~L~l~~n~l~~------------------------------- 206 (597)
T 3oja_B 160 ERIEDDTFQATTSLQNLQLSSNRLTHVD--LSLIPSLFHANVSYNLLST------------------------------- 206 (597)
T ss_dssp CBCCTTTTTTCTTCCEEECTTSCCSBCC--GGGCTTCSEEECCSSCCSE-------------------------------
T ss_pred CCCChhhhhcCCcCcEEECcCCCCCCcC--hhhhhhhhhhhcccCcccc-------------------------------
Confidence 6666666667777777777776665421 1223344444444443321
Q ss_pred hHHHhhhhcCchhhhhcccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEE
Q 043720 468 QYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA 547 (1103)
Q Consensus 468 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l 547 (1103)
T Consensus 207 -------------------------------------------------------------------------------- 206 (597)
T 3oja_B 207 -------------------------------------------------------------------------------- 206 (597)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCccc
Q 043720 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNL 627 (1103)
Q Consensus 548 ~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 627 (1103)
. + ...+|++|++++|.++.. +..+ .++|+.|+|++|.+++ +..+..+++|+.|+|++|.+
T Consensus 207 ---------l-~-----~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~--~~~l~~l~~L~~L~Ls~N~l 266 (597)
T 3oja_B 207 ---------L-A-----IPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTD--TAWLLNYPGLVEVDLSYNEL 266 (597)
T ss_dssp ---------E-E-----CCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCC
T ss_pred ---------c-c-----CCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCC--ChhhccCCCCCEEECCCCcc
Confidence 0 0 014688899999998844 3322 3689999999999995 47899999999999999999
Q ss_pred CCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCc
Q 043720 628 TGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNV 707 (1103)
Q Consensus 628 ~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~ 707 (1103)
++.+|..|+.+++|++|+|++|.+++ +|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|++++..+..+
T Consensus 267 ~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 344 (597)
T 3oja_B 267 EKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTH 344 (597)
T ss_dssp CEEESGGGTTCSSCCEEECTTSCCCE-EECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTT
T ss_pred CCCCHHHhcCccCCCEEECCCCCCCC-CCcccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhc
Confidence 99999999999999999999999995 6777788999999999999999 688888999999999999999999888888
Q ss_pred cccccccccCCCCCCCCCC
Q 043720 708 TTMNCSGVIGNPFLDPCQM 726 (1103)
Q Consensus 708 ~~~~~~~l~~Np~~c~C~~ 726 (1103)
..+..+.+.+|||.|+|..
T Consensus 345 ~~L~~L~l~~N~~~~~~~~ 363 (597)
T 3oja_B 345 HTLKNLTLSHNDWDCNSLR 363 (597)
T ss_dssp CCCSEEECCSSCEEHHHHH
T ss_pred CCCCEEEeeCCCCCChhHH
Confidence 8999999999999999954
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=329.04 Aligned_cols=241 Identities=17% Similarity=0.188 Sum_probs=182.4
Q ss_pred CCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch--hhHHHHHHHHHHHhcCCC-Cce----------e-----E
Q 043720 822 DFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRH-PNL----------V-----T 882 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h-~ni----------v-----~ 882 (1103)
.|...+.||+|+||+||+|.+ .+|+.||||++...... ...+.+.+|+.+++.++| ++. + .
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 477788999999999999974 46899999998744332 235779999999999987 211 1 1
Q ss_pred ------EEeEEec-----CCeEEEEEeecCCCChHHHHHh-----hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCccc
Q 043720 883 ------LIGYRAS-----GNEMFLIYNYLPGGNLENFIKA-----RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLH 946 (1103)
Q Consensus 883 ------l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~-----~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH 946 (1103)
+..++.. ....+++|+++ +++|.++++. .....+++..+..++.|+++||+|||++ +|+|
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiH 234 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVH 234 (413)
T ss_dssp CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cccc
Confidence 1111111 22467777776 6899999852 2234588899999999999999999999 9999
Q ss_pred CCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCcccc----------ccCCCCCcchhHHHHHHHHH
Q 043720 947 RDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA----------LTCRVSDKADVYSYGVVLLE 1016 (1103)
Q Consensus 947 ~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~----------~~~~~~~~sDvwslGvil~e 1016 (1103)
|||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++||
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYW 309 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHH
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHH
Confidence 999999999999999999999998865432 344567 999999999 56668889999999999999
Q ss_pred HHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1017 LISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1017 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
|++|+.||....... .....+. .....+..+.+++.+||+.||++||++.|++++
T Consensus 310 lltg~~Pf~~~~~~~-----------------~~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 310 IWCADLPNTDDAALG-----------------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHSSCCCCTTGGGS-----------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHCCCCCCCcchhh-----------------hHHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999997432211 1111111 112345779999999999999999998877543
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-33 Score=311.47 Aligned_cols=250 Identities=23% Similarity=0.354 Sum_probs=206.0
Q ss_pred CCCCEEEccCCCCcc--cCCccccCCCCCCEEEeec-CCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCE
Q 043720 107 SELRVLSLPFNGFSG--EFPPEIWSLEKLEVLDVEG-NFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g--~~p~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (1103)
.+++.|+|++|.++| .+|..++++++|++|+|++ |.+.+.+|..|+.+++|++|+|++|++++.+|..+.++++|++
T Consensus 50 ~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~ 129 (313)
T 1ogq_A 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred ceEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCE
Confidence 578899999999999 8999999999999999995 9999999999999999999999999999899999999999999
Q ss_pred EEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCcc
Q 043720 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM 263 (1103)
Q Consensus 184 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 263 (1103)
|+|++|.+++.+|..++.+++|++|++++|+++|.+|..++...++|++|++++|++++.+|..++.++ |++|++++|.
T Consensus 130 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N~l~~~~~~~~~~l~-L~~L~Ls~N~ 208 (313)
T 1ogq_A 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCC-CSEEECCSSE
T ss_pred EeCCCCccCCcCChHHhcCCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCCeeeccCChHHhCCc-ccEEECcCCc
Confidence 999999999999999999999999999999999889988887654799999999999988898888887 9999999999
Q ss_pred CCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccC
Q 043720 264 LNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSI 343 (1103)
Q Consensus 264 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~i 343 (1103)
+++..|..+..+++|+.|+|++|++++.+|. +..+++|+.|+++
T Consensus 209 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls----------------------------------- 252 (313)
T 1ogq_A 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLR----------------------------------- 252 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECC-----------------------------------
T ss_pred ccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECc-----------------------------------
Confidence 9888888888889999999999888866554 5666666666665
Q ss_pred chhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCcc
Q 043720 344 PMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNE 410 (1103)
Q Consensus 344 p~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~ 410 (1103)
+|.+.+.+|..+..+++|++|+|++|++++.+|.. ..+++|+.|++++|+
T Consensus 253 ----------------~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~-~~l~~L~~l~l~~N~ 302 (313)
T 1ogq_A 253 ----------------NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDVSAYANNK 302 (313)
T ss_dssp ----------------SSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS-TTGGGSCGGGTCSSS
T ss_pred ----------------CCcccCcCChHHhcCcCCCEEECcCCcccccCCCC-ccccccChHHhcCCC
Confidence 44455555555555566666666666666555554 556666666666665
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-33 Score=309.25 Aligned_cols=227 Identities=20% Similarity=0.282 Sum_probs=180.4
Q ss_pred cCCCCc-ceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHH-hcCCCCceeEEEeEEec----CCeE
Q 043720 821 GDFNTS-NCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTL-GNVRHPNLVTLIGYRAS----GNEM 893 (1103)
Q Consensus 821 ~~~~~~-~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~ 893 (1103)
++|.+. +.||+|+||+||+|.. .+++.||||++... ..+.+|+.++ +..+||||+++++++.. ....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 467776 7799999999999976 46899999998642 4566788887 55689999999999876 6788
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeecccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLS 970 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla 970 (1103)
++||||+++|+|.++++......+++..+..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 9999999999999999987666799999999999999999999999 9999999999999998 788999999998
Q ss_pred cccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
.... +..++.++||||+|+++|||++|+.||......... . ..
T Consensus 168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------------~-~~ 210 (299)
T 3m2w_A 168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------------P-GM 210 (299)
T ss_dssp EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------------C-CS
T ss_pred cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------------H-HH
Confidence 6542 133567899999999999999999999743221100 0 00
Q ss_pred cccccccccCCCC----hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1051 KDVFNAELWASGP----HDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+.... ...+ ...+..+.+++.+||+.||++||+++|++++
T Consensus 211 ~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h 257 (299)
T 3m2w_A 211 KTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 257 (299)
T ss_dssp CCSSCTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HHHHhhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence 00000000 0111 2356789999999999999999999999974
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-31 Score=300.13 Aligned_cols=129 Identities=27% Similarity=0.343 Sum_probs=70.9
Q ss_pred ccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCc
Q 043720 127 IWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLR 206 (1103)
Q Consensus 127 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~ 206 (1103)
+..+++|++|++++|.+. .+|. +..+++|++|+|++|+++ .+|. +.++++|++|++++|.++. ++ .++.+++|+
T Consensus 40 ~~~l~~L~~L~l~~~~i~-~~~~-~~~~~~L~~L~l~~n~i~-~~~~-~~~l~~L~~L~L~~n~i~~-~~-~~~~l~~L~ 113 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQIT-DISP-LSNLVKLTNLYIGTNKITD-IS-ALQNLTNLR 113 (347)
T ss_dssp HHHHTTCSEEECCSSCCC-CCTT-GGGCTTCCEEECCSSCCC-CCGG-GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCS
T ss_pred chhcccccEEEEeCCccc-cchh-hhhcCCccEEEccCCccc-cchh-hhcCCcCCEEEccCCcccC-ch-HHcCCCcCC
Confidence 445677777777777776 3443 666777777777777776 3343 6666777777777776664 22 455666666
Q ss_pred EeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCC
Q 043720 207 VLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265 (1103)
Q Consensus 207 ~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 265 (1103)
+|++++|+++ .++. + ..+++|++|++++|.....+ ..+..+++|++|++++|.++
T Consensus 114 ~L~l~~n~i~-~~~~-~-~~l~~L~~L~l~~n~~~~~~-~~~~~l~~L~~L~l~~~~~~ 168 (347)
T 4fmz_A 114 ELYLNEDNIS-DISP-L-ANLTKMYSLNLGANHNLSDL-SPLSNMTGLNYLTVTESKVK 168 (347)
T ss_dssp EEECTTSCCC-CCGG-G-TTCTTCCEEECTTCTTCCCC-GGGTTCTTCCEEECCSSCCC
T ss_pred EEECcCCccc-Cchh-h-ccCCceeEEECCCCCCcccc-cchhhCCCCcEEEecCCCcC
Confidence 6666666655 3333 2 22344444444444332221 12334444444444444433
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-31 Score=299.09 Aligned_cols=126 Identities=28% Similarity=0.447 Sum_probs=89.9
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|++|++++|++++..+ +..+++|++|++++|.+++ + +.+..+++|++|++++|++++. ..+..+++|++|++
T Consensus 221 ~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L 294 (347)
T 4fmz_A 221 TRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFL 294 (347)
T ss_dssp TTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEEC
T ss_pred CcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEEC
Confidence 567777777777775433 6777777777777777774 3 3577777777777777777743 35677778888888
Q ss_pred cCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCC
Q 043720 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~ 700 (1103)
++|++++..|..+..+++|+.|+|++|++++..| +..+++|+.|++++|+|+
T Consensus 295 ~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 295 NNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp CSSCCCGGGHHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred cCCcCCCcChhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 8888777777777777888888888888775555 677778888888877764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-33 Score=320.61 Aligned_cols=245 Identities=16% Similarity=0.173 Sum_probs=186.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-------hhhHHHHHHHHHHHhcCC---------CCceeEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-------QHGVQQFHAEIKTLGNVR---------HPNLVTL 883 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---------h~niv~l 883 (1103)
.++|++.+.||+|+||+||+|.. +|+.||||++..... ....+.+.+|+.++++++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35689999999999999999987 589999999976532 234577888999888885 8888888
Q ss_pred EeEEe------------------------------cCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHH
Q 043720 884 IGYRA------------------------------SGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASAL 933 (1103)
Q Consensus 884 ~~~~~------------------------------~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL 933 (1103)
.+++. ..+..|+||||+++|++.+.+.+ ..+++.+++.++.||+.||
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHHH
Confidence 77642 26789999999999977666643 3489999999999999999
Q ss_pred HHHH-hCCCCCcccCCCCCCcEEECCCC--------------------CEEEeecccccccCCCCCccccCCcccccccC
Q 043720 934 AYLH-DQCAPRVLHRDVKPSNILLDDDF--------------------NAYLSDFGLSRLLGTSETHATTGVAGTFGYVA 992 (1103)
Q Consensus 934 ~~LH-~~~~~~ivH~Dlk~~NIll~~~~--------------------~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~a 992 (1103)
+||| ++ +|+||||||+|||++.++ .+||+|||+|+..... ...||+.|+|
T Consensus 175 ~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~a 245 (336)
T 2vuw_A 175 AVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMD 245 (336)
T ss_dssp HHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTC
T ss_pred HHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccC
Confidence 9999 89 999999999999999887 8999999999876422 3478999999
Q ss_pred ccccccCCCCCcchhHHHHHH-HHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHH
Q 043720 993 PEYALTCRVSDKADVYSYGVV-LLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDML 1071 (1103)
Q Consensus 993 PE~~~~~~~~~~sDvwslGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1071 (1103)
||++.+.. +.++||||+|++ .+++++|..||.. ..|.......-..................+.++.
T Consensus 246 PE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 246 EDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN-----------VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp SGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH-----------HHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHH
T ss_pred hhhhcCCC-ccceehhhhhCCCCcccccccCCCcc-----------hhhhhHHHHhhhhhhccCcccchhhhhhcCHHHH
Confidence 99998766 889999998777 7778888888741 1221111110000000001111112345788899
Q ss_pred HHHHHccccCCCCCCCHHHHH-HH
Q 043720 1072 HLALRCTVETLSTRPTMKQVV-QC 1094 (1103)
Q Consensus 1072 ~li~~cl~~dP~~RPs~~evl-~~ 1094 (1103)
+++.+||+.| |++|++ ++
T Consensus 314 dli~~~L~~d-----sa~e~l~~H 332 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLLCQH 332 (336)
T ss_dssp HHHHHGGGSS-----SHHHHHHHC
T ss_pred HHHHHHhccC-----CHHHHHhcC
Confidence 9999999976 999988 53
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=6e-31 Score=298.51 Aligned_cols=131 Identities=24% Similarity=0.283 Sum_probs=85.4
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|++|+|++|++++..+..|..+++|+.|+|++|++++..+..|..+++|++|+|++|+++ .+|..+..+++|++|++
T Consensus 193 ~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l 271 (332)
T 2ft3_A 193 ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYL 271 (332)
T ss_dssp SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEEC
T ss_pred CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEEC
Confidence 45666677777776666666777777777777777777655556677777777777777776 56666677777777777
Q ss_pred cCccccCcChhhhhh------cccccccccccccCc--CCCCccccCCCCCceEeCCCCC
Q 043720 647 SSNSLSGEVPEGVVN------LRNLTALLLDNNKLS--GHLPSGLANVTSLSIFNASFNN 698 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~------l~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~l~l~~N~ 698 (1103)
++|+|++..+..|.. ...|+.|++++|++. +..|..|..++.|+.+++++|+
T Consensus 272 ~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 272 HTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred CCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 777776555555543 245677777777765 4556666777777777776663
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.7e-30 Score=289.71 Aligned_cols=269 Identities=19% Similarity=0.227 Sum_probs=216.1
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
+.|++|+|++|.+++..+..++++++|++|+|++|.+++..|..|+.+++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 52 ~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~--~~L~~L~l 128 (330)
T 1xku_A 52 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP--KTLQELRV 128 (330)
T ss_dssp TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCcCC-ccChhhc--ccccEEEC
Confidence 57889999999999877778999999999999999999888999999999999999999998 7787765 78999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCC--CCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccC
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNG--SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g--~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 264 (1103)
++|++++..+..++++++|++|++++|.++. ..+..+.. +++|++|++++|+++ .+|..+. ++|++|++++|.+
T Consensus 129 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-l~~L~~L~l~~n~l~-~l~~~~~--~~L~~L~l~~n~l 204 (330)
T 1xku_A 129 HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQG-MKKLSYIRIADTNIT-TIPQGLP--PSLTELHLDGNKI 204 (330)
T ss_dssp CSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGG-CTTCCEEECCSSCCC-SCCSSCC--TTCSEEECTTSCC
T ss_pred CCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccC-CCCcCEEECCCCccc-cCCcccc--ccCCEEECCCCcC
Confidence 9999998877889999999999999999863 44545544 578999999999998 4666554 7899999999999
Q ss_pred CccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCc
Q 043720 265 NDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIP 344 (1103)
Q Consensus 265 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip 344 (1103)
++..|..+..+++|+.|+|++|++++..+..+..+++|+.|++++| .+. .+|
T Consensus 205 ~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N---------------------------~l~-~lp 256 (330)
T 1xku_A 205 TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN---------------------------KLV-KVP 256 (330)
T ss_dssp CEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSS---------------------------CCS-SCC
T ss_pred CccCHHHhcCCCCCCEEECCCCcCceeChhhccCCCCCCEEECCCC---------------------------cCc-cCC
Confidence 9888888999999999999999998887778888888888888753 222 566
Q ss_pred hhhhccccccccccCCccccccCCcccccc------ccCcEEEcCCccccc--ccchhhhccCCceEeecCCcc
Q 043720 345 MEITTLSKLRIIWAPRLNLEGKLPSSWGAC------ESLEMLNLAQNVLRG--DLIGVFDRCKKLHFIDLSSNE 410 (1103)
Q Consensus 345 ~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l------~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~LdLs~N~ 410 (1103)
..+..+++|+.|++++|.+++..+..|+.. .+|+.|+|++|.+.. ..+..|..+.+|+.++|++|+
T Consensus 257 ~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 257 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred hhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 677777777777777777777666666433 667777777777653 556677777777777777764
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-30 Score=292.98 Aligned_cols=268 Identities=22% Similarity=0.250 Sum_probs=217.6
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
++|++|+|++|.+++..|..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|+++ .+|..+. ++|++|++
T Consensus 54 ~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~--~~L~~L~l 130 (332)
T 2ft3_A 54 PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNLP--SSLVELRI 130 (332)
T ss_dssp TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSSCCC-SCCSSCC--TTCCEEEC
T ss_pred CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCCcCC-ccCcccc--ccCCEEEC
Confidence 68899999999999877888999999999999999999878899999999999999999998 7787766 79999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCC--CCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccC
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNG--SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g--~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 264 (1103)
++|++++..+..|+.+++|++|++++|.++. ..|..+.. + +|++|++++|++++ +|..+. ++|++|++++|.+
T Consensus 131 ~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~-l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i 205 (332)
T 2ft3_A 131 HDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG-L-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKI 205 (332)
T ss_dssp CSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS-C-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCC
T ss_pred CCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC-C-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcC
Confidence 9999997777788999999999999999862 44444443 3 69999999999984 666554 6899999999999
Q ss_pred CccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCc
Q 043720 265 NDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIP 344 (1103)
Q Consensus 265 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip 344 (1103)
++..+..+..+++|+.|+|++|++++..+..+..+++|+.|++++ |.+. .+|
T Consensus 206 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~---------------------------N~l~-~lp 257 (332)
T 2ft3_A 206 QAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDN---------------------------NKLS-RVP 257 (332)
T ss_dssp CCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCS---------------------------SCCC-BCC
T ss_pred CccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCC---------------------------CcCe-ecC
Confidence 988778889999999999999999888777888888999998875 3333 577
Q ss_pred hhhhccccccccccCCccccccCCcccccc------ccCcEEEcCCcccc--cccchhhhccCCceEeecCCcc
Q 043720 345 MEITTLSKLRIIWAPRLNLEGKLPSSWGAC------ESLEMLNLAQNVLR--GDLIGVFDRCKKLHFIDLSSNE 410 (1103)
Q Consensus 345 ~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l------~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~LdLs~N~ 410 (1103)
..+..+++|+.|++++|.+++..+..|+.. .+|+.|++++|.+. +..+..|..+++|+.|+|++|+
T Consensus 258 ~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 258 AGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp TTGGGCTTCCEEECCSSCCCBCCTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred hhhhcCccCCEEECCCCCCCccChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 777788888888888888887766666553 56778888888776 5667777778888888887774
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-29 Score=288.19 Aligned_cols=290 Identities=21% Similarity=0.202 Sum_probs=248.0
Q ss_pred CCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEE
Q 043720 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185 (1103)
Q Consensus 106 l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (1103)
..+++.++++++.++ .+|..+. +.|++|+|++|.+++..+..|+.+++|++|+|++|++++..|..++++++|++|+
T Consensus 30 ~c~l~~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 106 (330)
T 1xku_A 30 QCHLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLY 106 (330)
T ss_dssp EEETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred cCCCeEEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEE
Confidence 347899999999998 7887665 6899999999999977777899999999999999999988899999999999999
Q ss_pred ccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccc--cccCccccCCCCCCEEeCCCcc
Q 043720 186 LAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLV--GRIPSSLGKCQQLRTLLLFSNM 263 (1103)
Q Consensus 186 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~ 263 (1103)
+++|+++ .+|..+. ++|++|++++|+++ .++...+..+++|++|++++|.++ +..+..+..+++|++|++++|.
T Consensus 107 Ls~n~l~-~l~~~~~--~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~ 182 (330)
T 1xku_A 107 LSKNQLK-ELPEKMP--KTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182 (330)
T ss_dssp CCSSCCS-BCCSSCC--TTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSC
T ss_pred CCCCcCC-ccChhhc--ccccEEECCCCccc-ccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCc
Confidence 9999999 5665554 79999999999999 566555555789999999999996 3678889999999999999999
Q ss_pred CCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccC
Q 043720 264 LNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSI 343 (1103)
Q Consensus 264 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~i 343 (1103)
++. +|..+. ++|+.|++++|++++..|..+..+++|+.|++++ |.+.+..
T Consensus 183 l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~---------------------------n~l~~~~ 232 (330)
T 1xku_A 183 ITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF---------------------------NSISAVD 232 (330)
T ss_dssp CCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS---------------------------SCCCEEC
T ss_pred ccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCC---------------------------CcCceeC
Confidence 987 565554 8999999999999998899999999999999985 5566666
Q ss_pred chhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhcc------CCceEeecCCccccc--cc
Q 043720 344 PMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRC------KKLHFIDLSSNELSG--EL 415 (1103)
Q Consensus 344 p~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l------~~L~~LdLs~N~l~~--~~ 415 (1103)
+..+..+++|+.|++++|.+. .+|..+..+++|++|+|++|+|++..+..|... ..|+.|++++|++.. ..
T Consensus 233 ~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~ 311 (330)
T 1xku_A 233 NGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 311 (330)
T ss_dssp TTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSC
T ss_pred hhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCccChhhcCCcccccccccccceEeecCcccccccC
Confidence 678889999999999999998 788899999999999999999999888888654 789999999999874 22
Q ss_pred -cccccccceeEEEecCCc
Q 043720 416 -DVKLQVPCMALFDVSGNH 433 (1103)
Q Consensus 416 -~~~~~~~~L~~l~ls~N~ 433 (1103)
..+..+..++.+++++|+
T Consensus 312 ~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 312 PSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp GGGGTTCCCGGGEEC----
T ss_pred ccccccccceeEEEecccC
Confidence 234467888999999885
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-33 Score=335.89 Aligned_cols=63 Identities=27% Similarity=0.260 Sum_probs=36.1
Q ss_pred CCCCEEEeecCCCCCCcccc-ccCCCCCCEEEccccccCC----CCCCCCCCCCCCCEEEccCCcCCC
Q 043720 131 EKLEVLDVEGNFLSGRLPNE-FVGLRNLRVLNLAFNRIDG----DIPFSLRNFESLEVLNLAGNQVKG 193 (1103)
Q Consensus 131 ~~L~~L~Ls~n~l~~~~p~~-l~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~n~l~~ 193 (1103)
++|++|||++|+++...... +..+++|++|+|++|++++ .++..+..+++|++|+|++|.++.
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~ 70 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGD 70 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHH
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCCh
Confidence 35667777777766333222 5566666666666666653 234445555556666666555543
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-33 Score=336.18 Aligned_cols=256 Identities=21% Similarity=0.180 Sum_probs=189.2
Q ss_pred CCCCEEEccCCCCcccCCcc-ccCCCCCCEEEeecCCCCC----CccccccCCCCCCEEEccccccCCCCCCCC-CCCC-
Q 043720 107 SELRVLSLPFNGFSGEFPPE-IWSLEKLEVLDVEGNFLSG----RLPNEFVGLRNLRVLNLAFNRIDGDIPFSL-RNFE- 179 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~-l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~- 179 (1103)
++|++|+|++|.++...... +..+++|++|+|++|.+++ .++..+..+++|++|+|++|++++..+..+ ..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 56889999999998654444 6789999999999999984 467788889999999999999985444333 2344
Q ss_pred ---CCCEEEccCCcCCC----CCChhcccCCCCcEeecccccCCCCCChhHHhh----cCcCcEEECcCCccccc----c
Q 043720 180 ---SLEVLNLAGNQVKG----VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY----CRYLEHLDLSGNSLVGR----I 244 (1103)
Q Consensus 180 ---~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~----~~~L~~L~L~~N~l~~~----~ 244 (1103)
+|++|+|++|+++. .++..+..+++|++|++++|.+++..+..+... .++|++|+|++|++++. +
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 79999999999984 568889999999999999999986555555543 24699999999998863 3
Q ss_pred CccccCCCCCCEEeCCCccCCcccccccc-----CCCCCCEEEccCCcCCCc----CCccccCCCCCCeEecccCcCccc
Q 043720 245 PSSLGKCQQLRTLLLFSNMLNDVIPRELG-----WLRKLEVLDVSRNRLNGL----IPTELGNCVELSVLVLSNLFDPLL 315 (1103)
Q Consensus 245 p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~l~~~~~~~l 315 (1103)
+..+..+++|++|++++|.+++..+..+. ..++|+.|+|++|.+++. ++..+..+++|+.|++++
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~------ 236 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGS------ 236 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCS------
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccC------
Confidence 55667778899999999888775444443 256888888888888763 455566666666666664
Q ss_pred cCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccC-----CccccccccCcEEEcCCcccccc
Q 043720 316 SGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKL-----PSSWGACESLEMLNLAQNVLRGD 390 (1103)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~ 390 (1103)
|.+.+.. +..+..+++|++|+|++|++++.
T Consensus 237 ---------------------------------------------n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~ 271 (461)
T 1z7x_W 237 ---------------------------------------------NKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAK 271 (461)
T ss_dssp ---------------------------------------------SBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHH
T ss_pred ---------------------------------------------CcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHH
Confidence 3332211 11223467778888888877764
Q ss_pred ----cchhhhccCCceEeecCCccccc
Q 043720 391 ----LIGVFDRCKKLHFIDLSSNELSG 413 (1103)
Q Consensus 391 ----~~~~~~~l~~L~~LdLs~N~l~~ 413 (1103)
++..+..+++|++|+|++|++++
T Consensus 272 ~~~~l~~~l~~~~~L~~L~Ls~n~i~~ 298 (461)
T 1z7x_W 272 GCGDLCRVLRAKESLKELSLAGNELGD 298 (461)
T ss_dssp HHHHHHHHHHHCTTCCEEECTTCCCHH
T ss_pred HHHHHHHHHhhCCCcceEECCCCCCch
Confidence 45666677888888888887753
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=292.04 Aligned_cols=198 Identities=20% Similarity=0.279 Sum_probs=151.7
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEE
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
..+.++.|+|++|.++ .+|+.++++++|++|+|++|.++ .+|..++.+++|++|+|++|+++ .+|..++++++|++|
T Consensus 79 ~~~~l~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L 155 (328)
T 4fcg_A 79 TQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLREL 155 (328)
T ss_dssp TSTTCCEEEEESSCCS-SCCSCGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEE
T ss_pred cccceeEEEccCCCch-hcChhhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEE
Confidence 3578899999999998 88999999999999999999999 89999999999999999999999 889999999999999
Q ss_pred EccCCcCCCCCChhccc---------CCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC
Q 043720 185 NLAGNQVKGVIPGFLGS---------FLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR 255 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~---------l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 255 (1103)
+|++|++.+.+|..++. +++|++|+|++|+++ .+|..+.. +++|++|+|++|++++ +|..++.+++|+
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~-l~~L~~L~L~~N~l~~-l~~~l~~l~~L~ 232 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIAN-LQNLKSLKIRNSPLSA-LGPAIHHLPKLE 232 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGG-CTTCCEEEEESSCCCC-CCGGGGGCTTCC
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcC-CCCCCEEEccCCCCCc-CchhhccCCCCC
Confidence 99999888888887654 677777777777776 66666554 3556666666666663 455566666666
Q ss_pred EEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecc
Q 043720 256 TLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS 308 (1103)
Q Consensus 256 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 308 (1103)
+|+|++|.+.+.+|..++.+++|+.|+|++|++.+.+|..++++++|+.|+++
T Consensus 233 ~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~ 285 (328)
T 4fcg_A 233 ELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285 (328)
T ss_dssp EEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECT
T ss_pred EEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCC
Confidence 66666666666666666666666666666666666666656555555555555
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-29 Score=288.93 Aligned_cols=267 Identities=20% Similarity=0.221 Sum_probs=195.2
Q ss_pred cCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCC
Q 043720 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNF 178 (1103)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (1103)
+|..+. ++|++|+|++|.+++..+..+.++++|++|+|++|.+++..|..|+.+++|++|+|++|++++..+..+.++
T Consensus 46 iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l 123 (353)
T 2z80_A 46 IPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPL 123 (353)
T ss_dssp CCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTC
T ss_pred cccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCC
Confidence 444443 589999999999997666689999999999999999998778889999999999999999995444448899
Q ss_pred CCCCEEEccCCcCCCCCC-hhcccCCCCcEeeccccc-CCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCE
Q 043720 179 ESLEVLNLAGNQVKGVIP-GFLGSFLKLRVLFLSYNE-LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRT 256 (1103)
Q Consensus 179 ~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~-l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 256 (1103)
++|++|++++|++++..+ ..++.+++|++|++++|+ ++ .++...+..+++|++|++++|++++..|..++.+++|++
T Consensus 124 ~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 202 (353)
T 2z80_A 124 SSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFT-KIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202 (353)
T ss_dssp TTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCC-EECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEE
T ss_pred ccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCcccc-ccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCe
Confidence 999999999999995444 478899999999999995 55 554443444688999999999999888999999999999
Q ss_pred EeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccC---CCCCCeEecccCcCccccCccccCcccccccCCCC
Q 043720 257 LLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGN---CVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASN 333 (1103)
Q Consensus 257 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~---l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~ 333 (1103)
|++++|.++...+..+..+++|+.|++++|++++..+..+.. ...++.+++++
T Consensus 203 L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~------------------------ 258 (353)
T 2z80_A 203 LILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN------------------------ 258 (353)
T ss_dssp EEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEES------------------------
T ss_pred ecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhcccccc------------------------
Confidence 999999997644444566899999999999998765443332 22333333322
Q ss_pred CCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccc
Q 043720 334 GEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSG 413 (1103)
Q Consensus 334 ~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~ 413 (1103)
+.++++.+. .+|..+..+++|++|+|++|+|+..+...|..+++|++|+|++|++++
T Consensus 259 ----------------------~~l~~~~l~-~l~~~l~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~~~~ 315 (353)
T 2z80_A 259 ----------------------VKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTNPWDC 315 (353)
T ss_dssp ----------------------CBCCHHHHH-HHHHHHHTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCC
T ss_pred ----------------------ccccCcchh-hhHHHHhcccCCCEEECCCCCCCccCHHHHhcCCCCCEEEeeCCCccC
Confidence 111122211 244555666666666666666665555555666666666666666665
Q ss_pred cc
Q 043720 414 EL 415 (1103)
Q Consensus 414 ~~ 415 (1103)
.+
T Consensus 316 ~~ 317 (353)
T 2z80_A 316 SC 317 (353)
T ss_dssp CH
T ss_pred cC
Confidence 43
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=319.68 Aligned_cols=148 Identities=16% Similarity=0.077 Sum_probs=93.3
Q ss_pred EecCCCcccccCCchhhhcCCCccEEECc----CCcCCCC-----CcccccCCCCCCEEEccCC--cCCCCCCcccc-cC
Q 043720 547 ANLSNNNIIGHIPLDIGVMCKSLRVLDAS----HNQISGI-----VPQSLENLTSLVFLDLNGN--KLQGEIPSSLH-RL 614 (1103)
Q Consensus 547 l~ls~n~~~~~ip~~~~~~~~~L~~L~L~----~N~l~~~-----~p~~~~~l~~L~~L~Ls~N--~l~~~~p~~~~-~l 614 (1103)
|+++.|++++..+..+...+++|++|+|+ .|++++. ++..+.++++|+.|+|+++ .+++..+..+. .+
T Consensus 383 L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~~~~~~~ 462 (592)
T 3ogk_B 383 MAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYS 462 (592)
T ss_dssp EEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHHHHHHSC
T ss_pred EEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHHHHHHhC
Confidence 44445555555555555545778888885 6677653 3334566788888888643 35544444443 37
Q ss_pred ccCcEEeccCcccCC-CCCCcccCCCCCcEEeccCccccCc-ChhhhhhcccccccccccccCcCCCCccc-cCCCCCce
Q 043720 615 KYLRHLSLADNNLTG-GIPSSIGELRSLEVLELSSNSLSGE-VPEGVVNLRNLTALLLDNNKLSGHLPSGL-ANVTSLSI 691 (1103)
Q Consensus 615 ~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~ 691 (1103)
++|++|+|++|++++ .++..+.++++|++|+|++|.|++. ++..+..+++|+.|+|++|+++..-...+ ..++.+..
T Consensus 463 ~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~ 542 (592)
T 3ogk_B 463 PNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNI 542 (592)
T ss_dssp TTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEE
T ss_pred ccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEE
Confidence 778888888888875 3444556778888888888887644 33444577888888888888775433333 34555554
Q ss_pred EeC
Q 043720 692 FNA 694 (1103)
Q Consensus 692 l~l 694 (1103)
..+
T Consensus 543 ~~~ 545 (592)
T 3ogk_B 543 ELI 545 (592)
T ss_dssp EEE
T ss_pred EEe
Confidence 433
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-28 Score=270.75 Aligned_cols=258 Identities=22% Similarity=0.221 Sum_probs=192.7
Q ss_pred CCCCEEEccCCCCcccCCc-cccCCCCCCEEEeecCCCC--CCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCE
Q 043720 107 SELRVLSLPFNGFSGEFPP-EIWSLEKLEVLDVEGNFLS--GRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~-~l~~l~~L~~L~Ls~n~l~--~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (1103)
++|++|+|++|.++ .+|. .+.++++|++|+|++|.++ +.+|..+..+++|++|+|++|.++ .+|..+.++++|++
T Consensus 28 ~~l~~L~L~~n~l~-~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~-~l~~~~~~l~~L~~ 105 (306)
T 2z66_A 28 SSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105 (306)
T ss_dssp TTCCEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEE-EEEEEEETCTTCCE
T ss_pred CCCCEEECCCCccC-ccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccc-cChhhcCCCCCCCE
Confidence 57899999999998 4554 4789999999999999988 334777888999999999999998 67778888999999
Q ss_pred EEccCCcCCCCCC-hhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcccc-ccCccccCCCCCCEEeCCC
Q 043720 184 LNLAGNQVKGVIP-GFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG-RIPSSLGKCQQLRTLLLFS 261 (1103)
Q Consensus 184 L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~-~~p~~l~~l~~L~~L~L~~ 261 (1103)
|++++|++++..+ ..+..+++|++|++++|.+++..|..+.. +++|++|++++|.+++ .+|..+..+++|++|++++
T Consensus 106 L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~ 184 (306)
T 2z66_A 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG-LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQ 184 (306)
T ss_dssp EECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTT-CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTT
T ss_pred EECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhccc-CcCCCEEECCCCccccccchhHHhhCcCCCEEECCC
Confidence 9999999886655 57888888888888888888555554443 4678888888888876 5677788888888888888
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccc
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~ 341 (1103)
|.+++..|..+..+++|+.|+|++|++++..+..+..+++|+.|+++
T Consensus 185 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~--------------------------------- 231 (306)
T 2z66_A 185 CQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYS--------------------------------- 231 (306)
T ss_dssp SCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECT---------------------------------
T ss_pred CCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECC---------------------------------
Confidence 88887777777788888888888888776555555555555555554
Q ss_pred cCchhhhccccccccccCCccccccCCccccccc-cCcEEEcCCcccccccc--hhhhccCCceEeecCCcccccccccc
Q 043720 342 SIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACE-SLEMLNLAQNVLRGDLI--GVFDRCKKLHFIDLSSNELSGELDVK 418 (1103)
Q Consensus 342 ~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~LdLs~N~l~~~~~~~ 418 (1103)
+|.+.+..|..+..++ +|++|+|++|.+.+... ....-+..++.+.+..+.+.+..|..
T Consensus 232 ------------------~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~~~~~~~~~~~~~~C~~p~~ 293 (306)
T 2z66_A 232 ------------------LNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSD 293 (306)
T ss_dssp ------------------TSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHHHTGGGBSCGGGCBEEESGG
T ss_pred ------------------CCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHHhhhhhhccccccccCCchh
Confidence 5566666666777774 78888888888876432 22233445555666677777655543
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.2e-29 Score=312.07 Aligned_cols=139 Identities=20% Similarity=0.133 Sum_probs=110.1
Q ss_pred hcCCCccEEECcCCcCCCCCcccccC-CCCCCEEEcc----CCcCCCC-----CCcccccCccCcEEeccCc--ccCCCC
Q 043720 564 VMCKSLRVLDASHNQISGIVPQSLEN-LTSLVFLDLN----GNKLQGE-----IPSSLHRLKYLRHLSLADN--NLTGGI 631 (1103)
Q Consensus 564 ~~~~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~Ls----~N~l~~~-----~p~~~~~l~~L~~L~L~~N--~l~~~~ 631 (1103)
..+++|++|+++.|++++..+..+.. +++|+.|+|+ .|.+++. ++..+..+++|++|+|++| .+++..
T Consensus 375 ~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~ 454 (592)
T 3ogk_B 375 QGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLG 454 (592)
T ss_dssp HHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHH
T ss_pred hhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHH
Confidence 34589999999999999776666765 8999999996 7888853 3334677999999999854 477555
Q ss_pred CCccc-CCCCCcEEeccCccccCc-ChhhhhhcccccccccccccCcCC-CCccccCCCCCceEeCCCCCCCCC
Q 043720 632 PSSIG-ELRSLEVLELSSNSLSGE-VPEGVVNLRNLTALLLDNNKLSGH-LPSGLANVTSLSIFNASFNNLSGP 702 (1103)
Q Consensus 632 p~~~~-~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~l~l~~N~l~~~ 702 (1103)
+..++ .+++|++|+|++|++++. ++..+..+++|+.|+|++|++++. ++..+..+++|+.|++++|+++..
T Consensus 455 ~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~ 528 (592)
T 3ogk_B 455 LSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMT 528 (592)
T ss_dssp HHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTT
T ss_pred HHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHH
Confidence 55554 489999999999999863 455567899999999999998754 344456789999999999998764
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=272.29 Aligned_cols=281 Identities=16% Similarity=0.130 Sum_probs=170.7
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEE
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
.++.....++++++++ .+|..+. ++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..+.++++|++|
T Consensus 29 ~C~~~~~c~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (353)
T 2z80_A 29 SCDRNGICKGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHL 105 (353)
T ss_dssp EECTTSEEECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred CCCCCeEeeCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEE
Confidence 3444455666666666 5565544 366666666666664444456666666666666666665555566666666666
Q ss_pred EccCCcCCCCCChhcccCCCCcEeecccccCCCCCCh-hHHhhcCcCcEEECcCC-ccccccCccccCCCCCCEEeCCCc
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPS-ELGKYCRYLEHLDLSGN-SLVGRIPSSLGKCQQLRTLLLFSN 262 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~-~~~~~~~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N 262 (1103)
+|++|++++..+..|+++++|++|++++|+++ .+|. ..+..+++|++|++++| .+++..+..++.+++|++|++++|
T Consensus 106 ~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n 184 (353)
T 2z80_A 106 DLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDAS 184 (353)
T ss_dssp ECCSSCCSSCCHHHHTTCTTCSEEECTTCCCS-SSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEET
T ss_pred ECCCCcCCcCCHhHhCCCccCCEEECCCCCCc-ccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCC
Confidence 66666666444444566666666666666665 4444 22233455555555555 244333445555555555555555
Q ss_pred cCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCccccc
Q 043720 263 MLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGS 342 (1103)
Q Consensus 263 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ 342 (1103)
.+++..|..+..+++|+.|++++|+++...+..+.
T Consensus 185 ~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~--------------------------------------------- 219 (353)
T 2z80_A 185 DLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVD--------------------------------------------- 219 (353)
T ss_dssp TCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHH---------------------------------------------
T ss_pred CcCccCHHHHhccccCCeecCCCCccccchhhhhh---------------------------------------------
Confidence 55554455555555555555555555422222222
Q ss_pred CchhhhccccccccccCCccccccCCccc---cccccCcEEEcCCccccc----ccchhhhccCCceEeecCCccccccc
Q 043720 343 IPMEITTLSKLRIIWAPRLNLEGKLPSSW---GACESLEMLNLAQNVLRG----DLIGVFDRCKKLHFIDLSSNELSGEL 415 (1103)
Q Consensus 343 ip~~~~~L~~L~~L~l~~n~l~~~~p~~~---~~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~LdLs~N~l~~~~ 415 (1103)
.+++|+.|++++|.+.+..+..+ .....++.++|++|.+.+ .+|..+..+++|++|||++|+++...
T Consensus 220 ------~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~~i~ 293 (353)
T 2z80_A 220 ------VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLKSVP 293 (353)
T ss_dssp ------HTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCCCCC
T ss_pred ------hcccccEEECCCCccccccccccccccccchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCCccC
Confidence 34555555555555555433332 235678888888888876 46778999999999999999999655
Q ss_pred ccc-ccccceeEEEecCCccccccCC
Q 043720 416 DVK-LQVPCMALFDVSGNHMSGSIPR 440 (1103)
Q Consensus 416 ~~~-~~~~~L~~l~ls~N~l~g~ip~ 440 (1103)
+.. ..+++|+.|++++|++.+..|.
T Consensus 294 ~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 294 DGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred HHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 444 5789999999999999986653
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=266.66 Aligned_cols=276 Identities=20% Similarity=0.178 Sum_probs=181.1
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCC--CCCCCCCCCCCCCEEEcc
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDG--DIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~ 187 (1103)
+.+++++++++ .+|..+. ++|++|+|++|.++...+..|..+++|++|+|++|+++. .+|..+..+++|++|+|+
T Consensus 10 ~~l~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls 86 (306)
T 2z66_A 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLS 86 (306)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECC
T ss_pred CEEEcCCCCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECC
Confidence 35677777776 5665443 567777777777773333346777777777777777762 225555666777777777
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc-
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND- 266 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~- 266 (1103)
+|.++ .+|..+..+++|++|++++|++++..+...+..+++|++|++++|.+++..+..+..+++|++|++++|.+++
T Consensus 87 ~n~i~-~l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 165 (306)
T 2z66_A 87 FNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQEN 165 (306)
T ss_dssp SCSEE-EEEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGG
T ss_pred CCccc-cChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccc
Confidence 77776 3555566677777777777776632221222334556666666666665556666666666666666666655
Q ss_pred cccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
.+|..+..+++|+.|+|++|++++..|..+..+++|+
T Consensus 166 ~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~------------------------------------------- 202 (306)
T 2z66_A 166 FLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQ------------------------------------------- 202 (306)
T ss_dssp EECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCC-------------------------------------------
T ss_pred cchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCC-------------------------------------------
Confidence 4555666666666666666666655555555555554
Q ss_pred hhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccC-CceEeecCCccccccccccc---ccc
Q 043720 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCK-KLHFIDLSSNELSGELDVKL---QVP 422 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~LdLs~N~l~~~~~~~~---~~~ 422 (1103)
.|++++|.+.+..+..+..+++|+.|+|++|++++..+..+..++ +|++|+|++|++++.....+ -+.
T Consensus 203 --------~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c~~~~~~~~l~ 274 (306)
T 2z66_A 203 --------VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIK 274 (306)
T ss_dssp --------EEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSGGGHHHHHHHH
T ss_pred --------EEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeecccChHHHHHHHH
Confidence 455555666666666788899999999999999999999999984 99999999999997654321 122
Q ss_pred ceeEEEecCCccccccCC
Q 043720 423 CMALFDVSGNHMSGSIPR 440 (1103)
Q Consensus 423 ~L~~l~ls~N~l~g~ip~ 440 (1103)
..+.+.+..+.+....|.
T Consensus 275 ~~~~~~~~~~~~~C~~p~ 292 (306)
T 2z66_A 275 DQRQLLVEVERMECATPS 292 (306)
T ss_dssp HTGGGBSCGGGCBEEESG
T ss_pred hhhhhhccccccccCCch
Confidence 333445566777766665
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=3.9e-27 Score=285.87 Aligned_cols=261 Identities=25% Similarity=0.268 Sum_probs=141.4
Q ss_pred CCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccC
Q 043720 109 LRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188 (1103)
Q Consensus 109 L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (1103)
++.|++++|+++ .+|..+. ++|++|+|++|.++ .+|. .+++|++|+|++|+|+ .+|. .+++|++|+|++
T Consensus 42 l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~-~lp~---~l~~L~~L~Ls~ 110 (622)
T 3g06_A 42 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLT-SLPV---LPPGLLELSIFS 110 (622)
T ss_dssp CCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCS-CCCC---CCTTCCEEEECS
T ss_pred CcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCC-cCCC---CCCCCCEEECcC
Confidence 445555555555 4554443 45555555555555 3443 3455555555555555 3443 345555555555
Q ss_pred CcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccc
Q 043720 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268 (1103)
Q Consensus 189 n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 268 (1103)
|.+++ +|. .+++|+.|++++|+++ .+|.. +++|++|+|++|++++ +|. .+++|+.|++++|.+++ +
T Consensus 111 N~l~~-l~~---~l~~L~~L~L~~N~l~-~lp~~----l~~L~~L~Ls~N~l~~-l~~---~~~~L~~L~L~~N~l~~-l 176 (622)
T 3g06_A 111 NPLTH-LPA---LPSGLCKLWIFGNQLT-SLPVL----PPGLQELSVSDNQLAS-LPA---LPSELCKLWAYNNQLTS-L 176 (622)
T ss_dssp CCCCC-CCC---CCTTCCEEECCSSCCS-CCCCC----CTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-C
T ss_pred CcCCC-CCC---CCCCcCEEECCCCCCC-cCCCC----CCCCCEEECcCCcCCC-cCC---ccCCCCEEECCCCCCCC-C
Confidence 55553 222 3445555555555555 34432 2445555555555552 232 22445555555555554 3
Q ss_pred cccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhh
Q 043720 269 PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEIT 348 (1103)
Q Consensus 269 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~ 348 (1103)
| ..+++|+.|++++|++++ +|.. +++|+.|++++|.+. .+|.
T Consensus 177 ~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~L~~L~L~~N~l~----------------------------~l~~--- 218 (622)
T 3g06_A 177 P---MLPSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLT----------------------------SLPA--- 218 (622)
T ss_dssp C---CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS----------------------------SCCC---
T ss_pred c---ccCCCCcEEECCCCCCCC-CCCc---cchhhEEECcCCccc----------------------------ccCC---
Confidence 3 234555555555555553 2322 245555555532211 1221
Q ss_pred ccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEE
Q 043720 349 TLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFD 428 (1103)
Q Consensus 349 ~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ 428 (1103)
.+++|+.|++++|.+++ +| ..+++|+.|+|++|+|+..+. .+++|+.|+|++|+|+..++.+..+++|+.|+
T Consensus 219 ~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~~lp~----~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~ 290 (622)
T 3g06_A 219 LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLTSLPM----LPSGLLSLSVYRNQLTRLPESLIHLSSETTVN 290 (622)
T ss_dssp CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEE
T ss_pred CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCCcCCc----ccccCcEEeCCCCCCCcCCHHHhhccccCEEE
Confidence 12456666666666664 34 345677777777777775443 56777778888887774444455677778888
Q ss_pred ecCCccccccCC
Q 043720 429 VSGNHMSGSIPR 440 (1103)
Q Consensus 429 ls~N~l~g~ip~ 440 (1103)
+++|+++|.+|.
T Consensus 291 L~~N~l~~~~~~ 302 (622)
T 3g06_A 291 LEGNPLSERTLQ 302 (622)
T ss_dssp CCSCCCCHHHHH
T ss_pred ecCCCCCCcCHH
Confidence 888887765553
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=272.63 Aligned_cols=250 Identities=25% Similarity=0.219 Sum_probs=171.8
Q ss_pred CCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccC
Q 043720 109 LRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188 (1103)
Q Consensus 109 L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (1103)
.+.++.++++++ .+|..+. ++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|.++++|++|+|++
T Consensus 56 ~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~ 132 (452)
T 3zyi_A 56 FSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFD 132 (452)
T ss_dssp SCEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CcEEEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCC
Confidence 456777777776 5666554 5777777777777766677777777777777777777766667777777777777777
Q ss_pred CcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCC-ccccccCccccCCCCCCEEeCCCccCCcc
Q 043720 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGN-SLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267 (1103)
Q Consensus 189 n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 267 (1103)
|++++..+..|+.+++|++|+|++|+++ .+|...+..+++|++|++++| .++...+..+..+++|++|+|++|.+++.
T Consensus 133 n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~ 211 (452)
T 3zyi_A 133 NWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM 211 (452)
T ss_dssp SCCSBCCTTTSSSCTTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred CcCCccChhhhcccCCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence 7777666666777777777777777776 555544444566777777663 33333333466666666666666666653
Q ss_pred ccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhh
Q 043720 268 IPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI 347 (1103)
Q Consensus 268 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~ 347 (1103)
| .+..+++|+.|+|++|++++..|..|.++++|+.|++
T Consensus 212 -~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L---------------------------------------- 249 (452)
T 3zyi_A 212 -P-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWV---------------------------------------- 249 (452)
T ss_dssp -C-CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEEC----------------------------------------
T ss_pred -c-cccccccccEEECcCCcCcccCcccccCccCCCEEEe----------------------------------------
Confidence 3 3556666666666666666555555555554444444
Q ss_pred hccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccc
Q 043720 348 TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGEL 415 (1103)
Q Consensus 348 ~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~ 415 (1103)
++|.+.+..|..|.++++|+.|+|++|+|++.++..|..+++|+.|+|++|++....
T Consensus 250 -----------~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 250 -----------MNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp -----------TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred -----------CCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 455666666777788888888888888888888888888888888888888877543
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=254.64 Aligned_cols=252 Identities=21% Similarity=0.222 Sum_probs=148.3
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 189 (1103)
+.++.++++++ .+|..+ .++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..+.++++|++|++++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 45666666665 455433 346666666666666544455666666666666666666555566666666666666666
Q ss_pred c-CCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccc
Q 043720 190 Q-VKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268 (1103)
Q Consensus 190 ~-l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 268 (1103)
. ++...|..+..+++|++|++++|+++ +..|..+.++++|++|++++|.+++..
T Consensus 91 ~~l~~~~~~~~~~l~~L~~L~l~~n~l~-------------------------~~~~~~~~~l~~L~~L~l~~n~l~~~~ 145 (285)
T 1ozn_A 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-------------------------ELGPGLFRGLAALQYLYLQDNALQALP 145 (285)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCC-------------------------CCCTTTTTTCTTCCEEECCSSCCCCCC
T ss_pred CCccccCHHHhcCCcCCCEEECCCCcCC-------------------------EECHhHhhCCcCCCEEECCCCcccccC
Confidence 5 55444555555555555555555554 333334444444444444444444443
Q ss_pred cccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhh
Q 043720 269 PRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEIT 348 (1103)
Q Consensus 269 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~ 348 (1103)
+..|..+++|+.|+|++|++++..+..+..+++|+.|+++
T Consensus 146 ~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~---------------------------------------- 185 (285)
T 1ozn_A 146 DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH---------------------------------------- 185 (285)
T ss_dssp TTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC----------------------------------------
T ss_pred HhHhccCCCccEEECCCCcccccCHHHhcCccccCEEECC----------------------------------------
Confidence 4444455555555555555543333333333333333333
Q ss_pred ccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEE
Q 043720 349 TLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFD 428 (1103)
Q Consensus 349 ~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ 428 (1103)
+|.+.+..|..|..+++|+.|+|++|++++.++..|..+++|++|+|++|++.+..+..+....++.+.
T Consensus 186 -----------~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~~~~~~~~~~l~~~~ 254 (285)
T 1ozn_A 186 -----------QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFR 254 (285)
T ss_dssp -----------SSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCC
T ss_pred -----------CCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCCCCcHHHHHHHHhcc
Confidence 334444455566667777788888888887777778888888888888888887665544445566666
Q ss_pred ecCCccccccCC
Q 043720 429 VSGNHMSGSIPR 440 (1103)
Q Consensus 429 ls~N~l~g~ip~ 440 (1103)
.+.+.+.+..|.
T Consensus 255 ~~~~~~~c~~p~ 266 (285)
T 1ozn_A 255 GSSSEVPCSLPQ 266 (285)
T ss_dssp SEECCCBEEESG
T ss_pred cccCccccCCch
Confidence 777777777665
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=6.6e-26 Score=268.46 Aligned_cols=237 Identities=20% Similarity=0.129 Sum_probs=207.3
Q ss_pred ccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCC
Q 043720 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRN 177 (1103)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~ 177 (1103)
.+|..+. ++|++|+|++|++++..|..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..+.+
T Consensus 68 ~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~ 145 (452)
T 3zyi_A 68 EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEY 145 (452)
T ss_dssp SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSBCCTTTSSS
T ss_pred ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcCCccChhhhcc
Confidence 4555443 68999999999999999999999999999999999999888899999999999999999999666677999
Q ss_pred CCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEE
Q 043720 178 FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTL 257 (1103)
Q Consensus 178 l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 257 (1103)
+++|++|+|++|+++...+..|.++++|++|++++|+..+.++...+..+++|++|+|++|++++ +| .+..+++|+.|
T Consensus 146 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~~L 223 (452)
T 3zyi_A 146 LSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLVGLEEL 223 (452)
T ss_dssp CTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSS-CC-CCTTCTTCCEE
T ss_pred cCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCcccc-cc-cccccccccEE
Confidence 99999999999999987778899999999999999655558888766777899999999999995 44 58899999999
Q ss_pred eCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCC
Q 043720 258 LLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337 (1103)
Q Consensus 258 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n 337 (1103)
+|++|.+++..|..|..+++|+.|+|++|++++..|..|..+++|+.|+|++
T Consensus 224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~---------------------------- 275 (452)
T 3zyi_A 224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAH---------------------------- 275 (452)
T ss_dssp ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCS----------------------------
T ss_pred ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCC----------------------------
Confidence 9999999999999999999999999999999988888888877777777764
Q ss_pred cccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCccccc
Q 043720 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG 389 (1103)
Q Consensus 338 ~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 389 (1103)
|++++..+..|..+++|+.|+|++|.+..
T Consensus 276 -----------------------N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 304 (452)
T 3zyi_A 276 -----------------------NNLSSLPHDLFTPLRYLVELHLHHNPWNC 304 (452)
T ss_dssp -----------------------SCCSCCCTTSSTTCTTCCEEECCSSCEEC
T ss_pred -----------------------CcCCccChHHhccccCCCEEEccCCCcCC
Confidence 44454555667778888889999888764
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=6.2e-26 Score=267.72 Aligned_cols=250 Identities=26% Similarity=0.274 Sum_probs=168.8
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
..+.++.++++++ .+|..+. ++++.|+|++|++++..+..|.++++|++|+|++|++++..+..|.++++|++|+|+
T Consensus 44 ~~~~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELF 120 (440)
T ss_dssp TSCEEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECC
T ss_pred CCCEEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECC
Confidence 3456777777776 6776654 567777777777776666777777777777777777776556677777777777777
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCc-cccccCccccCCCCCCEEeCCCccCCc
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNS-LVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~-l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
+|++++..+..|..+++|++|+|++|+++ .+|...+..+++|++|+|++|+ ++...+..+.++++|++|+|++|.++.
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~ 199 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE 199 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence 77777655566777777777777777776 4554444445666666666633 333333356666666666666666654
Q ss_pred cccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
+| .+..+++|+.|+|++|++++..|..|.++++|+
T Consensus 200 -~~-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~------------------------------------------- 234 (440)
T 3zyj_A 200 -IP-NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ------------------------------------------- 234 (440)
T ss_dssp -CC-CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCC-------------------------------------------
T ss_pred -cc-ccCCCcccCEEECCCCccCccChhhhccCccCC-------------------------------------------
Confidence 23 355566666666666666555455554444444
Q ss_pred hhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCcccccc
Q 043720 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGE 414 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ 414 (1103)
.|++++|.+.+..+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 235 --------~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 235 --------KLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp --------EEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred --------EEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 444445666666777788888888888888888888888888888888888888887653
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-26 Score=254.34 Aligned_cols=211 Identities=23% Similarity=0.260 Sum_probs=188.6
Q ss_pred cccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccc-cCCCCCCCC
Q 043720 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR-IDGDIPFSL 175 (1103)
Q Consensus 97 g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l 175 (1103)
..+|..+ .++|++|+|++|.+++..+..+.++++|++|+|++|.+++..|..|..+++|++|+|++|+ +++..|..+
T Consensus 24 ~~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~ 101 (285)
T 1ozn_A 24 QAVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATF 101 (285)
T ss_dssp SSCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTT
T ss_pred ccCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHh
Confidence 4556543 5799999999999998877889999999999999999998889999999999999999997 886668899
Q ss_pred CCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC
Q 043720 176 RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR 255 (1103)
Q Consensus 176 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 255 (1103)
.++++|++|++++|.+++..|..+.++++|++|++++|+++ .+|...+..+++|++|+|++|++++..+..+..+++|+
T Consensus 102 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~ 180 (285)
T 1ozn_A 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLD 180 (285)
T ss_dssp TTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred cCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCccc-ccCHhHhccCCCccEEECCCCcccccCHHHhcCccccC
Confidence 99999999999999999988999999999999999999999 56655444568899999999999976667799999999
Q ss_pred EEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccC
Q 043720 256 TLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 256 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
+|++++|.+++..|..+..+++|+.|++++|++++..+..+..+++|+.|++++|
T Consensus 181 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N 235 (285)
T 1ozn_A 181 RLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235 (285)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred EEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCC
Confidence 9999999999988999999999999999999999877777889999999999863
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-25 Score=269.26 Aligned_cols=116 Identities=26% Similarity=0.291 Sum_probs=82.9
Q ss_pred CCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeec
Q 043720 131 EKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFL 210 (1103)
Q Consensus 131 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 210 (1103)
.++++|++++|.++ .+|..+. ++|++|+|++|+|+ .+|. .+++|++|+|++|++++ +|. .+++|++|+|
T Consensus 40 ~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~L 108 (622)
T 3g06_A 40 NGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA---LPPELRTLEVSGNQLTS-LPV---LPPGLLELSI 108 (622)
T ss_dssp HCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCS-CCCC---CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEE
T ss_pred CCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCC-CCCC---cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEEC
Confidence 35889999999999 8888776 89999999999998 6776 56788888888888884 554 5677888888
Q ss_pred ccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc
Q 043720 211 SYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 211 ~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
++|+++ .+|. .+++|+.|++++|++++ +|.. +++|++|+|++|.+++
T Consensus 109 s~N~l~-~l~~----~l~~L~~L~L~~N~l~~-lp~~---l~~L~~L~Ls~N~l~~ 155 (622)
T 3g06_A 109 FSNPLT-HLPA----LPSGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS 155 (622)
T ss_dssp CSCCCC-CCCC----CCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSC
T ss_pred cCCcCC-CCCC----CCCCcCEEECCCCCCCc-CCCC---CCCCCEEECcCCcCCC
Confidence 888777 4554 23556677776666663 4432 2455555555555544
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.6e-28 Score=269.72 Aligned_cols=182 Identities=23% Similarity=0.237 Sum_probs=95.7
Q ss_pred CCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCC-CCCcccccc-------CCCCCCEEEccccccCCCCCCCC
Q 043720 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFL-SGRLPNEFV-------GLRNLRVLNLAFNRIDGDIPFSL 175 (1103)
Q Consensus 104 ~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l-~~~~p~~l~-------~l~~L~~L~Ls~N~l~~~~p~~l 175 (1103)
+..++|+.|++++|.+ .+|..+... |++|+|++|.+ .+.+|..+. ++++|++|+|++|++++.+|..+
T Consensus 40 ~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 115 (312)
T 1wwl_A 40 GGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115 (312)
T ss_dssp EEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCS
T ss_pred ccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHH
Confidence 4455666666666666 566655543 66666666666 344555554 56666666666666666666654
Q ss_pred --CCCCCCCEEEccCCcCCCCCChhcccC-----CCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccc--cCc
Q 043720 176 --RNFESLEVLNLAGNQVKGVIPGFLGSF-----LKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGR--IPS 246 (1103)
Q Consensus 176 --~~l~~L~~L~L~~n~l~~~~p~~l~~l-----~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~--~p~ 246 (1103)
..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..+.. +++|++|+|++|++++. ++.
T Consensus 116 ~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 116 LEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV-FPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC-CSSCCEEECCSCTTCHHHHHHH
T ss_pred HHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc-CCCCCEEECCCCCcCcchHHHH
Confidence 5666666666666666655 5555544 55555555555555333233332 34455555555554433 122
Q ss_pred cc--cCCCCCCEEeCCCccCCcc--cc-ccccCCCCCCEEEccCCcCCCc
Q 043720 247 SL--GKCQQLRTLLLFSNMLNDV--IP-RELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 247 ~l--~~l~~L~~L~L~~N~l~~~--~p-~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
.+ +.+++|++|+|++|++++. ++ ..+..+++|+.|+|++|++++.
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~ 243 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSS
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcc
Confidence 22 4444555555555555421 11 2223444455555555544443
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.6e-28 Score=269.36 Aligned_cols=250 Identities=20% Similarity=0.134 Sum_probs=180.8
Q ss_pred ccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccC-CCCCCCCC-------CCCCCCEEEccCCcCCCCCChh
Q 043720 127 IWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRID-GDIPFSLR-------NFESLEVLNLAGNQVKGVIPGF 198 (1103)
Q Consensus 127 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~-~~~p~~l~-------~l~~L~~L~L~~n~l~~~~p~~ 198 (1103)
++..++|++|++++|.+ .+|..+... |++|+|++|+++ +.+|..+. ++++|++|+|++|++++.+|..
T Consensus 39 ~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 114 (312)
T 1wwl_A 39 YGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPP 114 (312)
T ss_dssp EEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCC
T ss_pred EccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHH
Confidence 45566777888888887 667666544 777788888773 45666555 6778888888888888777776
Q ss_pred c--ccCCCCcEeecccccCCCCCChhHHhhc----CcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcc--ccc
Q 043720 199 L--GSFLKLRVLFLSYNELNGSIPSELGKYC----RYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV--IPR 270 (1103)
Q Consensus 199 l--~~l~~L~~L~L~~N~l~g~ip~~~~~~~----~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~p~ 270 (1103)
+ +.+++|++|+|++|++++. |..+.... ++|++|+|++|++++..|..++.+++|++|+|++|++.+. .|.
T Consensus 115 ~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 193 (312)
T 1wwl_A 115 LLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193 (312)
T ss_dssp SSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHH
T ss_pred HHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHH
Confidence 5 7788888888888888754 66665542 6688888888888776667788888888888888887664 233
Q ss_pred cc--cCCCCCCEEEccCCcCCC--cCC-ccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCc-
Q 043720 271 EL--GWLRKLEVLDVSRNRLNG--LIP-TELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIP- 344 (1103)
Q Consensus 271 ~l--~~l~~L~~L~Ls~N~l~~--~~p-~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip- 344 (1103)
.+ ..+++|++|+|++|++++ .++ ..+.++++|+.|++++ |.+.+.+|
T Consensus 194 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~---------------------------N~l~~~~~~ 246 (312)
T 1wwl_A 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSH---------------------------NSLRDAAGA 246 (312)
T ss_dssp HSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTT---------------------------SCCCSSCCC
T ss_pred HHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCC---------------------------CcCCcccch
Confidence 44 677888888888888773 222 3345677888888875 44444443
Q ss_pred hhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccc
Q 043720 345 MEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSG 413 (1103)
Q Consensus 345 ~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~ 413 (1103)
..+..+++|+.|++++|.++ .+|..+. ++|++|+|++|+|++. |. +..+++|++|+|++|++++
T Consensus 247 ~~~~~l~~L~~L~Ls~N~l~-~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~ 310 (312)
T 1wwl_A 247 PSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLD 310 (312)
T ss_dssp SCCCCCTTCCEEECTTSCCS-SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTC
T ss_pred hhhhhcCCCCEEECCCCccC-hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCC
Confidence 33455677888888888877 6666665 7888999999999877 44 8888999999999998875
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=264.95 Aligned_cols=239 Identities=22% Similarity=0.168 Sum_probs=209.4
Q ss_pred ccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCC
Q 043720 96 VGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSL 175 (1103)
Q Consensus 96 ~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 175 (1103)
...+|..+. +.++.|+|++|.+++..+..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..+..+
T Consensus 55 l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~ 132 (440)
T 3zyj_A 55 LREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAF 132 (440)
T ss_dssp CSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSCCSSCCTTTS
T ss_pred cCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCcCCeeCHhHh
Confidence 346777654 789999999999998888999999999999999999998888999999999999999999996666689
Q ss_pred CCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC
Q 043720 176 RNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR 255 (1103)
Q Consensus 176 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 255 (1103)
.++++|++|+|++|.++...+..|..+++|++|+|++|+..+.++...+..+++|++|+|++|+++ .+| .+..+++|+
T Consensus 133 ~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~ 210 (440)
T 3zyj_A 133 VYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLD 210 (440)
T ss_dssp CSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCC
T ss_pred hccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccC
Confidence 999999999999999998878899999999999999966555888877777899999999999999 556 588999999
Q ss_pred EEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCC
Q 043720 256 TLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGE 335 (1103)
Q Consensus 256 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~ 335 (1103)
.|+|++|.+++..|..|..+++|+.|+|++|++++..+..|.++++|+.|+|++
T Consensus 211 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~-------------------------- 264 (440)
T 3zyj_A 211 ELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAH-------------------------- 264 (440)
T ss_dssp EEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTT--------------------------
T ss_pred EEECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCC--------------------------
Confidence 999999999998899999999999999999999988888888877777777764
Q ss_pred CCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCccccc
Q 043720 336 KNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRG 389 (1103)
Q Consensus 336 ~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 389 (1103)
|++++..+..|..+++|+.|+|++|.+..
T Consensus 265 -------------------------N~l~~~~~~~~~~l~~L~~L~L~~Np~~C 293 (440)
T 3zyj_A 265 -------------------------NNLTLLPHDLFTPLHHLERIHLHHNPWNC 293 (440)
T ss_dssp -------------------------SCCCCCCTTTTSSCTTCCEEECCSSCEEC
T ss_pred -------------------------CCCCccChhHhccccCCCEEEcCCCCccC
Confidence 44555555667788888888998888763
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-27 Score=265.00 Aligned_cols=266 Identities=19% Similarity=0.199 Sum_probs=175.8
Q ss_pred CCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccC
Q 043720 109 LRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188 (1103)
Q Consensus 109 L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (1103)
++.++++.+.+...++..+..+++|++|+|++|.+++..|..|..+++|++|+|++|++++..| +..+++|++|++++
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls~ 89 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNN 89 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECCS
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECcC
Confidence 3445555555553333444455667777777777776666667777777777777777764433 66667777777777
Q ss_pred CcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccc
Q 043720 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVI 268 (1103)
Q Consensus 189 n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~ 268 (1103)
|++++.. ..++|++|++++|++++. +... +++|++|++++|++++..+..++.+++|++|+|++|.+++..
T Consensus 90 n~l~~l~-----~~~~L~~L~l~~n~l~~~-~~~~---~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 160 (317)
T 3o53_A 90 NYVQELL-----VGPSIETLHAANNNISRV-SCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVN 160 (317)
T ss_dssp SEEEEEE-----ECTTCCEEECCSSCCSEE-EECC---CSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEE
T ss_pred Ccccccc-----CCCCcCEEECCCCccCCc-Cccc---cCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCccc
Confidence 7666322 236777777777777633 3221 355777777777777666666777777777777777777766
Q ss_pred ccccc-CCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhh
Q 043720 269 PRELG-WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI 347 (1103)
Q Consensus 269 p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~ 347 (1103)
+..+. .+++|++|+|++|++++. + ....+++|+.|++++ |.+. .+|..+
T Consensus 161 ~~~~~~~l~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~---------------------------N~l~-~l~~~~ 210 (317)
T 3o53_A 161 FAELAASSDTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSS---------------------------NKLA-FMGPEF 210 (317)
T ss_dssp GGGGGGGTTTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCS---------------------------SCCC-EECGGG
T ss_pred HHHHhhccCcCCEEECCCCcCccc-c-cccccccCCEEECCC---------------------------CcCC-cchhhh
Confidence 66553 577777777777777654 2 233467777777764 2232 234456
Q ss_pred hccccccccccCCccccccCCccccccccCcEEEcCCcccc-cccchhhhccCCceEeecCCcc-cccccc
Q 043720 348 TTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLR-GDLIGVFDRCKKLHFIDLSSNE-LSGELD 416 (1103)
Q Consensus 348 ~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~LdLs~N~-l~~~~~ 416 (1103)
..+++|+.|++++|.+. .+|..+..+++|+.|+|++|.+. +..+..+..+++|+.|++++|+ +++..+
T Consensus 211 ~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~ 280 (317)
T 3o53_A 211 QSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280 (317)
T ss_dssp GGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSS
T ss_pred cccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcCHHHHHhccccceEEECCCchhccCCch
Confidence 67777777777777777 45777888888999999999888 7778888888888888888443 555443
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.9e-27 Score=284.20 Aligned_cols=184 Identities=22% Similarity=0.150 Sum_probs=130.7
Q ss_pred eccCCcccEEEE-EEcCCcEEEEEEcccccc---------hhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEEE
Q 043720 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRF---------QHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 829 lg~G~fg~V~~~-~~~~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
.+.|++|.+..+ +..-|+.||||++.+... +...++|.+|+++|+++ .|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 566667666655 333488899999976521 23456799999999999 6999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||++|++|.+++++... ++.. +|+.||+.||+|+|++ +||||||||+|||++++|.+||+|||+|+......
T Consensus 322 Eyv~G~~L~d~i~~~~~--l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~ 393 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEE--IDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC 393 (569)
T ss_dssp ECCCSEEHHHHHHTTCC--CCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred ecCCCCcHHHHHHhCCC--CCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence 99999999999987543 5543 5889999999999999 99999999999999999999999999998764332
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKK 1022 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~ 1022 (1103)
......+||++|||||++.+ .+..++|+||+|++.+++.++..
T Consensus 394 -~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 394 -SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -CCSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred -ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 23445679999999999876 45678999999999887765543
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-26 Score=258.68 Aligned_cols=112 Identities=21% Similarity=0.258 Sum_probs=94.4
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|++|+|++|+|++. + ....+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|
T Consensus 169 ~~L~~L~L~~N~l~~~-~-~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l 244 (317)
T 3o53_A 169 DTLEHLNLQYNFIYDV-K-GQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDL 244 (317)
T ss_dssp TTCCEEECTTSCCCEE-E-CCCCCTTCCEEECCSSCCC-EECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEEC
T ss_pred CcCCEEECCCCcCccc-c-cccccccCCEEECCCCcCC-cchhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEc
Confidence 6788999999998865 3 3345899999999999998 46666999999999999999999 57888999999999999
Q ss_pred cCcccc-CcChhhhhhcccccccccc-cccCcCCCCcc
Q 043720 647 SSNSLS-GEVPEGVVNLRNLTALLLD-NNKLSGHLPSG 682 (1103)
Q Consensus 647 s~N~l~-~~~~~~~~~l~~L~~L~L~-~N~l~~~~p~~ 682 (1103)
++|+++ +.+|..+..+++|+.|+++ .+.+++..|..
T Consensus 245 ~~N~~~~~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~ 282 (317)
T 3o53_A 245 RGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEE 282 (317)
T ss_dssp TTCCCBHHHHHHHHHTCHHHHHHHHHHHHHHHSSSSCC
T ss_pred cCCCccCcCHHHHHhccccceEEECCCchhccCCchhc
Confidence 999998 7788899999999999999 44667665544
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.93 E-value=7.6e-25 Score=240.31 Aligned_cols=217 Identities=25% Similarity=0.293 Sum_probs=161.4
Q ss_pred CCCceeeeEecCCCCeEEEEecCCCCCCCCCCccccccccccccccccccccceeccCCCccccccCcccCCCCCCCEEE
Q 043720 34 SHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLS 113 (1103)
Q Consensus 34 ~~C~W~GV~C~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~ 113 (1103)
++|.|.|+.|+-.+.++.+++++..+ ..+|..+. +.|++|+
T Consensus 3 ~~C~~~~~~C~c~~~~~~l~~~~~~l-------------------------------------~~ip~~~~--~~l~~L~ 43 (270)
T 2o6q_A 3 ALCKKDGGVCSCNNNKNSVDCSSKKL-------------------------------------TAIPSNIP--ADTKKLD 43 (270)
T ss_dssp CCBGGGTCSBEEETTTTEEECTTSCC-------------------------------------SSCCSCCC--TTCSEEE
T ss_pred ccCCCCCCCCEeCCCCCEEEccCCCC-------------------------------------CccCCCCC--CCCCEEE
Confidence 68999999997555555566554322 12343332 5688888
Q ss_pred ccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCC
Q 043720 114 LPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKG 193 (1103)
Q Consensus 114 L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~ 193 (1103)
|++|.+++..+..+.++++|++|+|++|.++...+..|..+++|++|+|++|++++..+..+.++++|++|+|++|++++
T Consensus 44 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 123 (270)
T 2o6q_A 44 LQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKS 123 (270)
T ss_dssp CCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCC
T ss_pred CcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCe
Confidence 88888886666678888888888888888885555556788888888888888886555667888888888888888887
Q ss_pred CCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccccccc
Q 043720 194 VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELG 273 (1103)
Q Consensus 194 ~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~ 273 (1103)
..+..|+.+++|++|+|++|+++ .+|...+..+++|++|+|++|++++..+..+..+++|++|+|++|.+++..+..+.
T Consensus 124 ~~~~~~~~l~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 202 (270)
T 2o6q_A 124 LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFD 202 (270)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred eCHHHhCcCcCCCEEECCCCcCC-ccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhc
Confidence 77777888888888888888887 56655444457788888888888766566677778888888888888776666677
Q ss_pred CCCCCCEEEccCCcCCC
Q 043720 274 WLRKLEVLDVSRNRLNG 290 (1103)
Q Consensus 274 ~l~~L~~L~Ls~N~l~~ 290 (1103)
.+++|+.|+|++|.+..
T Consensus 203 ~l~~L~~L~l~~N~~~c 219 (270)
T 2o6q_A 203 SLEKLKMLQLQENPWDC 219 (270)
T ss_dssp TCTTCCEEECCSSCBCC
T ss_pred cccCCCEEEecCCCeeC
Confidence 77888888888887764
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=269.40 Aligned_cols=234 Identities=22% Similarity=0.206 Sum_probs=125.0
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
+|++|+|++|.+++..|..|+.+++|++|+|++|.+++..| ++.+++|++|+|++|.|++ +| ..++|++|+++
T Consensus 35 ~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~----~~~~L~~L~L~ 107 (487)
T 3oja_A 35 NVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE-LL----VGPSIETLHAA 107 (487)
T ss_dssp GCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE-EE----ECTTCCEEECC
T ss_pred CccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC-CC----CCCCcCEEECc
Confidence 55566666665555555555555555555555555554443 5555555555555555552 22 12455555555
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcc
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 267 (1103)
+|.+++..+. .+++|++|+|++|.++ +..|..++.+++|+.|+|++|.+++.
T Consensus 108 ~N~l~~~~~~---~l~~L~~L~L~~N~l~-------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~ 159 (487)
T 3oja_A 108 NNNISRVSCS---RGQGKKNIYLANNKIT-------------------------MLRDLDEGCRSRVQYLDLKLNEIDTV 159 (487)
T ss_dssp SSCCCCEEEC---CCSSCEEEECCSSCCC-------------------------SGGGBCGGGGSSEEEEECTTSCCCEE
T ss_pred CCcCCCCCcc---ccCCCCEEECCCCCCC-------------------------CCCchhhcCCCCCCEEECCCCCCCCc
Confidence 5555543332 2344455555555544 44444444444444444444444444
Q ss_pred cccccc-CCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 268 IPRELG-WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 268 ~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
.|..+. .+++|+.|+|++|.+++.. .+..+++|+.|+|++ |.+.+ +|..
T Consensus 160 ~~~~l~~~l~~L~~L~Ls~N~l~~~~--~~~~l~~L~~L~Ls~---------------------------N~l~~-~~~~ 209 (487)
T 3oja_A 160 NFAELAASSDTLEHLNLQYNFIYDVK--GQVVFAKLKTLDLSS---------------------------NKLAF-MGPE 209 (487)
T ss_dssp EGGGGGGGTTTCCEEECTTSCCCEEE--CCCCCTTCCEEECCS---------------------------SCCCE-ECGG
T ss_pred ChHHHhhhCCcccEEecCCCcccccc--ccccCCCCCEEECCC---------------------------CCCCC-CCHh
Confidence 444443 3444555555555444331 122344444444442 22222 2223
Q ss_pred hhccccccccccCCccccccCCccccccccCcEEEcCCcccc-cccchhhhccCCceEeecC
Q 043720 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLR-GDLIGVFDRCKKLHFIDLS 407 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~LdLs 407 (1103)
+..+++|+.|++++|.+.+ +|..+..+++|+.|+|++|.+. +.++..+..++.|+.++++
T Consensus 210 ~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 210 FQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp GGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHH
T ss_pred HcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEecc
Confidence 4445555555555666664 5666777788888888888887 5666777777788777775
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.92 E-value=9.3e-26 Score=268.61 Aligned_cols=156 Identities=21% Similarity=0.132 Sum_probs=105.3
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccc-cCccCcEEeccCcccCCCCCCcccCCCCCcEEe
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLH-RLKYLRHLSLADNNLTGGIPSSIGELRSLEVLE 645 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 645 (1103)
++|++|+|++|.|++..|..|..+++|++|+|++|.|++..|..+. .+++|+.|+|++|.|++..+ +..+++|++|+
T Consensus 120 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~ 197 (487)
T 3oja_A 120 QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLD 197 (487)
T ss_dssp SSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEE
T ss_pred CCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEE
Confidence 5677777777777776677777777777777777777766666665 67777777777777775422 33577777777
Q ss_pred ccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCC-CCCCCCcc---ccccccc------
Q 043720 646 LSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS-GPFPWNVT---TMNCSGV------ 715 (1103)
Q Consensus 646 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~-~~~p~~~~---~~~~~~l------ 715 (1103)
|++|.|++..| .+..+++|+.|+|++|.|++ +|..+..+++|+.|++++|++. +.+|..+. .+..+.+
T Consensus 198 Ls~N~l~~~~~-~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c~~~~~~~~~l~~L~~l~~~~~~~~ 275 (487)
T 3oja_A 198 LSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275 (487)
T ss_dssp CCSSCCCEECG-GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCHHHHHHHHTTCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCH-hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcCcchHHHHHhCCCCcEEeccccccc
Confidence 77777775433 47777777777777777773 5666777777777777777776 33332222 2222233
Q ss_pred -cCCCCCCCCCC
Q 043720 716 -IGNPFLDPCQM 726 (1103)
Q Consensus 716 -~~Np~~c~C~~ 726 (1103)
.+||+.|.|..
T Consensus 276 ~~~~~~~c~~~~ 287 (487)
T 3oja_A 276 TGQNEEECTVPT 287 (487)
T ss_dssp TSSSSCCCSSTT
T ss_pred cCCCcccccCCc
Confidence 38999999853
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-27 Score=292.15 Aligned_cols=258 Identities=18% Similarity=0.208 Sum_probs=149.3
Q ss_pred cCCCCCCCEEEccCCCCcc---cCCcc------------ccCCCCCCEEEeecCCCCCCcccccc-CCCCCCEEEcccc-
Q 043720 103 VGGLSELRVLSLPFNGFSG---EFPPE------------IWSLEKLEVLDVEGNFLSGRLPNEFV-GLRNLRVLNLAFN- 165 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g---~~p~~------------l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~N- 165 (1103)
+..+++|+.|+|+++.... ..|.. ...+++|++|+|++|.+++..+..+. .+++|++|+|++|
T Consensus 62 ~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~ 141 (594)
T 2p1m_B 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCE 141 (594)
T ss_dssp HHHCTTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCE
T ss_pred HhhCCCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcC
Confidence 4567889999999875321 12211 23577888888888888877776665 6788888888888
Q ss_pred ccCCC-CCCCCCCCCCCCEEEccCCcCCCCCChhcc----cCCCCcEeeccccc--CCCCCChhHHhhcCcCcEEECcCC
Q 043720 166 RIDGD-IPFSLRNFESLEVLNLAGNQVKGVIPGFLG----SFLKLRVLFLSYNE--LNGSIPSELGKYCRYLEHLDLSGN 238 (1103)
Q Consensus 166 ~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~----~l~~L~~L~L~~N~--l~g~ip~~~~~~~~~L~~L~L~~N 238 (1103)
.++.. ++..+.++++|++|+|++|.+++..+..+. .+++|++|++++|. ++......+...+++|++|++++|
T Consensus 142 ~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~ 221 (594)
T 2p1m_B 142 GFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRA 221 (594)
T ss_dssp EEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTT
T ss_pred CCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCC
Confidence 55432 344445778888888888887765544443 55678888888776 221111222223466777777766
Q ss_pred -ccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeE-ecccCcCcccc
Q 043720 239 -SLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVL-VLSNLFDPLLS 316 (1103)
Q Consensus 239 -~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L-~l~~~~~~~l~ 316 (1103)
.+++ ++..+..+++|++|+++.+... ++.|.+.+ ++..+.++++|+.| .+.+
T Consensus 222 ~~~~~-l~~~~~~~~~L~~L~l~~~~~~-----------------~~~~~~~~-l~~~l~~~~~L~~Ls~~~~------- 275 (594)
T 2p1m_B 222 VPLEK-LATLLQRAPQLEELGTGGYTAE-----------------VRPDVYSG-LSVALSGCKELRCLSGFWD------- 275 (594)
T ss_dssp SCHHH-HHHHHHHCTTCSEEECSBCCCC-----------------CCHHHHHH-HHHHHHTCTTCCEEECCBT-------
T ss_pred CcHHH-HHHHHhcCCcceEcccccccCc-----------------cchhhHHH-HHHHHhcCCCcccccCCcc-------
Confidence 3333 5566666666776665443210 11222222 22344455555554 2211
Q ss_pred CccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCC-ccccccccCcEEEcCCcccccccc-hh
Q 043720 317 GRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLP-SSWGACESLEMLNLAQNVLRGDLI-GV 394 (1103)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~~-~~ 394 (1103)
...+.+|..+..+++|+.|++++|.+.+... ..+..+++|+.|++++| +.+... ..
T Consensus 276 ---------------------~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l 333 (594)
T 2p1m_B 276 ---------------------AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVL 333 (594)
T ss_dssp ---------------------CCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHH
T ss_pred ---------------------cchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHH
Confidence 1112334444455666666666666544322 22456777888888777 443322 23
Q ss_pred hhccCCceEeecCC
Q 043720 395 FDRCKKLHFIDLSS 408 (1103)
Q Consensus 395 ~~~l~~L~~LdLs~ 408 (1103)
...+++|+.|+|++
T Consensus 334 ~~~~~~L~~L~L~~ 347 (594)
T 2p1m_B 334 ASTCKDLRELRVFP 347 (594)
T ss_dssp HHHCTTCCEEEEEC
T ss_pred HHhCCCCCEEEEec
Confidence 34577888887744
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-26 Score=284.21 Aligned_cols=409 Identities=16% Similarity=0.122 Sum_probs=240.6
Q ss_pred CCCCCCEEEccCCcCCCCCChhcc-cCCCCcEeecccc-cCCCCCChhHHhhcCcCcEEECcCCccccccCcccc----C
Q 043720 177 NFESLEVLNLAGNQVKGVIPGFLG-SFLKLRVLFLSYN-ELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLG----K 250 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~l~~~~p~~l~-~l~~L~~L~L~~N-~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~----~ 250 (1103)
.+++|++|+|++|.+++..+..+. .+++|++|+|++| .++......+...+++|++|+|++|.+++..+..+. .
T Consensus 103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~ 182 (594)
T 2p1m_B 103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT 182 (594)
T ss_dssp HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence 456777777777776665555554 5677777777777 444322334444467788888888877654443333 5
Q ss_pred CCCCCEEeCCCcc--CCcc-ccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCccccc
Q 043720 251 CQQLRTLLLFSNM--LNDV-IPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVG 327 (1103)
Q Consensus 251 l~~L~~L~L~~N~--l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~ 327 (1103)
+++|+.|++++|. ++.. ++..+..+++|+.|+|++|...+.+|..+.++++|+.|+++.+...
T Consensus 183 ~~~L~~L~l~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~l~~~~~~~~~L~~L~l~~~~~~-------------- 248 (594)
T 2p1m_B 183 YTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAE-------------- 248 (594)
T ss_dssp CCCCCEEECTTCCSCCCHHHHHHHHHHCTTCCEEECCTTSCHHHHHHHHHHCTTCSEEECSBCCCC--------------
T ss_pred CCcCcEEEecccCCcCCHHHHHHHHHhCCCCcEEecCCCCcHHHHHHHHhcCCcceEcccccccCc--------------
Confidence 6788889888886 3221 2222345689999999988333337888888999999988643110
Q ss_pred ccCCCCCCCCcccccCchhhhcccccccc-ccCCccccccCCccccccccCcEEEcCCcccccccch-hhhccCCceEee
Q 043720 328 QSDASNGEKNSFIGSIPMEITTLSKLRII-WAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIG-VFDRCKKLHFID 405 (1103)
Q Consensus 328 ~~~~~~~~~n~~~~~ip~~~~~L~~L~~L-~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~Ld 405 (1103)
...+.+ ..++..+.++++|+.| .+.... .+.++..+..+++|++|+|++|.+++.... .+..+++|+.|+
T Consensus 249 ------~~~~~~-~~l~~~l~~~~~L~~Ls~~~~~~-~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~ 320 (594)
T 2p1m_B 249 ------VRPDVY-SGLSVALSGCKELRCLSGFWDAV-PAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLW 320 (594)
T ss_dssp ------CCHHHH-HHHHHHHHTCTTCCEEECCBTCC-GGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEE
T ss_pred ------cchhhH-HHHHHHHhcCCCcccccCCcccc-hhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEe
Confidence 011223 3355678888888888 444332 234555566788999999999987764433 456888999999
Q ss_pred cCCccccc-cccccc-cccceeEEEecCCccccccCCCCcccccccccccccccccccCCCchhhHHHhhhhcCchhhhh
Q 043720 406 LSSNELSG-ELDVKL-QVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVS 483 (1103)
Q Consensus 406 Ls~N~l~~-~~~~~~-~~~~L~~l~ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 483 (1103)
+++| ++. .++... .+++|+.|+++++.-.|..
T Consensus 321 l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~--------------------------------------------- 354 (594)
T 2p1m_B 321 VLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVME--------------------------------------------- 354 (594)
T ss_dssp EEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSS---------------------------------------------
T ss_pred CcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccc---------------------------------------------
Confidence 9988 442 222222 4677888887543211100
Q ss_pred cccceEEEecCCCccccccccCCCCccccccccceeeeeccccccccCCcchhhhcccccccEEecCCCcccccCCchhh
Q 043720 484 AARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIG 563 (1103)
Q Consensus 484 ~~~~l~~~~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~~~~~l~ls~n~~~~~ip~~~~ 563 (1103)
..+.+++ .-...+...|.. ...|+++.|++++..+..+.
T Consensus 355 ----------~~~~l~~-----------------------------~~l~~l~~~~~~--L~~L~~~~~~l~~~~~~~l~ 393 (594)
T 2p1m_B 355 ----------PNVALTE-----------------------------QGLVSVSMGCPK--LESVLYFCRQMTNAALITIA 393 (594)
T ss_dssp ----------CSSCCCH-----------------------------HHHHHHHHHCTT--CCEEEEEESCCCHHHHHHHH
T ss_pred ----------cCCCCCH-----------------------------HHHHHHHHhchh--HHHHHHhcCCcCHHHHHHHH
Confidence 0000000 000000011111 12345556666655555565
Q ss_pred hcCCCccEEECc--C----CcCCCCC-----cccccCCCCCCEEEccCCcCCCCCCccccc-CccCcEEeccCcccCCCC
Q 043720 564 VMCKSLRVLDAS--H----NQISGIV-----PQSLENLTSLVFLDLNGNKLQGEIPSSLHR-LKYLRHLSLADNNLTGGI 631 (1103)
Q Consensus 564 ~~~~~L~~L~L~--~----N~l~~~~-----p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~-l~~L~~L~L~~N~l~~~~ 631 (1103)
..+++|++|+|+ + |.+++.. +..+..+++|+.|+|++ .+++..+..+.. +++|+.|+|++|.+++..
T Consensus 394 ~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~~l~~~~~~L~~L~L~~~~i~~~~ 472 (594)
T 2p1m_B 394 RNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472 (594)
T ss_dssp HHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHHHHHHHCTTCCEEEEESCCSSHHH
T ss_pred hhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHHHHHHhchhccEeeccCCCCcHHH
Confidence 555778888887 3 5555221 12255667788888866 555444444444 677777888777776544
Q ss_pred CCcc-cCCCCCcEEeccCccccCcChh-hhhhcccccccccccccCcCCCCccc-cCCCCCceEeCC
Q 043720 632 PSSI-GELRSLEVLELSSNSLSGEVPE-GVVNLRNLTALLLDNNKLSGHLPSGL-ANVTSLSIFNAS 695 (1103)
Q Consensus 632 p~~~-~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~l~l~ 695 (1103)
+..+ ..+++|++|+|++|.+++.... .+..+++|+.|++++|+++......+ ..++.|+...+.
T Consensus 473 ~~~l~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~l~~~lp~l~i~~~~ 539 (594)
T 2p1m_B 473 MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVSFGACKLLGQKMPKLNVEVID 539 (594)
T ss_dssp HHHHHHHCTTCCEEEEESCSCCHHHHHHTGGGGGGSSEEEEESSCCBHHHHHHHHHHCTTEEEEEEC
T ss_pred HHHHHhcCCCcCEEECcCCCCcHHHHHHHHHhCCCCCEEeeeCCCCCHHHHHHHHHhCCCCEEEEec
Confidence 4333 4577777778877777543333 33457777777777777743222223 345555554443
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.3e-24 Score=236.35 Aligned_cols=140 Identities=31% Similarity=0.382 Sum_probs=108.6
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|++|+|++|+|+ .+|..+..+++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 77 ~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L 155 (290)
T 1p9a_G 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (290)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEEC
Confidence 56788888888887 56777788888888888888888666677888888888888888888776777788888888888
Q ss_pred cCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCccccccccccCCCCCCCCCC
Q 043720 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQM 726 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~l~~Np~~c~C~~ 726 (1103)
++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.+ .+.+|||.|+|++
T Consensus 156 ~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l---------------------~L~~Np~~C~c~~ 213 (290)
T 1p9a_G 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA---------------------FLHGNPWLCNCEI 213 (290)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE---------------------ECCSCCBCCSGGG
T ss_pred CCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeE---------------------EeCCCCccCcCcc
Confidence 888888665566777888888888888887 666666655566554 5678899999987
Q ss_pred CCC
Q 043720 727 YKD 729 (1103)
Q Consensus 727 ~~~ 729 (1103)
...
T Consensus 214 ~~l 216 (290)
T 1p9a_G 214 LYF 216 (290)
T ss_dssp HHH
T ss_pred HHH
Confidence 543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-23 Score=226.43 Aligned_cols=228 Identities=22% Similarity=0.281 Sum_probs=127.3
Q ss_pred EEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeeccccc
Q 043720 135 VLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214 (1103)
Q Consensus 135 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 214 (1103)
.++.++..++ .+|..+. ++|++|+|++|++++..+..+.++++|++|++++|++++..+..|+.+++|++|+|++|+
T Consensus 11 ~~~c~~~~l~-~ip~~l~--~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 87 (276)
T 2z62_A 11 TYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87 (276)
T ss_dssp EEECTTSCCS-SCCSSSC--TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred eEEecCCCcc-ccCCCCC--CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCc
Confidence 3445555555 5565443 467777777777765555566667777777777777765555566666666666666666
Q ss_pred CCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcc-ccccccCCCCCCEEEccCCcCCCcCC
Q 043720 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV-IPRELGWLRKLEVLDVSRNRLNGLIP 293 (1103)
Q Consensus 215 l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p 293 (1103)
+++..+..+.. +++|++|++++|++++..+..++.+++|++|++++|.+++. +|..+..+++|+.|+|++|++++..+
T Consensus 88 l~~~~~~~~~~-l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~ 166 (276)
T 2z62_A 88 IQSLALGAFSG-LSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYC 166 (276)
T ss_dssp CCEECTTTTTT-CTTCCEEECTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECG
T ss_pred cCccChhhhcC-CccccEEECCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCH
Confidence 66333333332 35566666666666544444555556666666666655552 35555555555555555555554433
Q ss_pred ccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccc
Q 043720 294 TELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGA 373 (1103)
Q Consensus 294 ~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~ 373 (1103)
..+..+++|+.+.+ .|++++|.+.+..+..+..
T Consensus 167 ~~~~~l~~L~~l~l-----------------------------------------------~L~ls~n~l~~~~~~~~~~ 199 (276)
T 2z62_A 167 TDLRVLHQMPLLNL-----------------------------------------------SLDLSLNPMNFIQPGAFKE 199 (276)
T ss_dssp GGGHHHHTCTTCCE-----------------------------------------------EEECCSSCCCEECTTSSCS
T ss_pred HHhhhhhhccccce-----------------------------------------------eeecCCCcccccCccccCC
Confidence 33333333221100 3444455555444333332
Q ss_pred cccCcEEEcCCcccccccchhhhccCCceEeecCCcccccc
Q 043720 374 CESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGE 414 (1103)
Q Consensus 374 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~ 414 (1103)
.+|+.|+|++|++++.++..|..+++|+.|+|++|++++.
T Consensus 200 -~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 239 (276)
T 2z62_A 200 -IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 239 (276)
T ss_dssp -CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCC
T ss_pred -CcccEEECCCCceeecCHhHhcccccccEEEccCCccccc
Confidence 3566666666666666555666666666666666666543
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.8e-23 Score=225.16 Aligned_cols=202 Identities=22% Similarity=0.218 Sum_probs=177.5
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
+.|++|+|++|.+++..+..+.++++|++|+|++|.+++..+..|..+++|++|+|++|++++..|..+.++++|++|++
T Consensus 28 ~~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 107 (276)
T 2z62_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (276)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred CCccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEEC
Confidence 57999999999999877778999999999999999999777778999999999999999999777788999999999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCC-CCChhHHhhcCcCcEEECcCCccccccCccccCCCCCC----EEeCCC
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNG-SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR----TLLLFS 261 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g-~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~----~L~L~~ 261 (1103)
++|.+++..+..++.+++|++|++++|++++ .+|..+.. +++|++|+|++|++++..+..+..+++|+ .|++++
T Consensus 108 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~-l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~ 186 (276)
T 2z62_A 108 VETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN-LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186 (276)
T ss_dssp TTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGG-CTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCS
T ss_pred CCCCccccCchhcccCCCCCEEECcCCccceecCchhhcc-CCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCC
Confidence 9999998777789999999999999999985 36777766 47899999999999987777888777777 899999
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccC
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
|.+++..+..+. ..+|+.|+|++|++++..+..+.++++|+.|++++|
T Consensus 187 n~l~~~~~~~~~-~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N 234 (276)
T 2z62_A 187 NPMNFIQPGAFK-EIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234 (276)
T ss_dssp SCCCEECTTSSC-SCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSS
T ss_pred CcccccCccccC-CCcccEEECCCCceeecCHhHhcccccccEEEccCC
Confidence 999986555554 458999999999999877777899999999999864
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.89 E-value=9.1e-23 Score=221.12 Aligned_cols=159 Identities=28% Similarity=0.338 Sum_probs=95.7
Q ss_pred CCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecc
Q 043720 132 KLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLS 211 (1103)
Q Consensus 132 ~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 211 (1103)
+|++|+|++|.+++..+..|..+++|++|+|++|++++..|..+.++++|++|+|++|++++..+..|+.+++|++|+|+
T Consensus 36 ~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 115 (251)
T 3m19_A 36 DTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLG 115 (251)
T ss_dssp TCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcC
Confidence 45555555555554444455555555555555555554444455555555555555555555444555555556666666
Q ss_pred cccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCc
Q 043720 212 YNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 212 ~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
+|+++ .+|...+..+++|++|+|++|++++..+..++.+++|++|+|++|++++..+..+..+++|+.|+|++|++++.
T Consensus 116 ~N~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 116 GNQLK-SLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp SSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred CCcCC-CcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 66555 44444333345566666666666655455666777777777777777776666777777777777777777654
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.2e-23 Score=225.87 Aligned_cols=212 Identities=23% Similarity=0.242 Sum_probs=183.2
Q ss_pred ccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCC
Q 043720 102 LVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESL 181 (1103)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (1103)
.+..+++|+.|++++|.++ .++ .+..+++|++|+|++|.+++ + ..++.+++|++|+|++|++++..+..+.++++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L 111 (272)
T 3rfs_A 36 TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLILTGNQLQSLPNGVFDKLTNL 111 (272)
T ss_dssp CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEECTTSCCCCCCTTTTTTCTTC
T ss_pred ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEECCCCccCccChhHhcCCcCC
Confidence 3567899999999999987 343 58899999999999999986 3 478999999999999999997777778999999
Q ss_pred CEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCC
Q 043720 182 EVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS 261 (1103)
Q Consensus 182 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 261 (1103)
++|+|++|++++..+..|+.+++|++|++++|+++ .+|...+..+++|++|++++|++++..+..++.+++|++|++++
T Consensus 112 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 190 (272)
T 3rfs_A 112 KELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQ 190 (272)
T ss_dssp CEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEECCCCcCCccCHHHhccCCCCCEEECCCCccC-ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCC
Confidence 99999999999888888999999999999999999 56655555568899999999999987777789999999999999
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccc
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~ 341 (1103)
|.+++..+..+..+++|+.|+|++|.+.+. +++|+.|++++ |.+.|
T Consensus 191 N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~---------------------------n~~~g 236 (272)
T 3rfs_A 191 NQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWI---------------------------NKHSG 236 (272)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHH---------------------------HHTGG
T ss_pred CcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHH---------------------------HhCCC
Confidence 999998888899999999999999998854 45678888774 67788
Q ss_pred cCchhhhcccc
Q 043720 342 SIPMEITTLSK 352 (1103)
Q Consensus 342 ~ip~~~~~L~~ 352 (1103)
.+|.+++.++.
T Consensus 237 ~ip~~~~~~~~ 247 (272)
T 3rfs_A 237 VVRNSAGSVAP 247 (272)
T ss_dssp GBBCTTSCBCG
T ss_pred cccCcccccCC
Confidence 88888776654
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.89 E-value=4e-22 Score=218.59 Aligned_cols=200 Identities=23% Similarity=0.279 Sum_probs=178.8
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
..+.+++++++++ .+|..+. ++|++|+|++|++++..+..|..+++|++|+|++|+++...+..+.++++|++|+|+
T Consensus 17 ~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~ 93 (270)
T 2o6q_A 17 NKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93 (270)
T ss_dssp TTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECC
T ss_pred CCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECC
Confidence 5679999999999 6887765 689999999999997777799999999999999999995555567899999999999
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcc
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 267 (1103)
+|++++..+..|..+++|++|++++|+++ .++...+..+++|++|+|++|++++..+..++.+++|++|+|++|.+++.
T Consensus 94 ~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 172 (270)
T 2o6q_A 94 DNKLQALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRV 172 (270)
T ss_dssp SSCCCCCCTTTTTTCSSCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred CCcCCcCCHhHcccccCCCEEECCCCccC-eeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCcEe
Confidence 99999887888999999999999999999 55555555568899999999999976666789999999999999999998
Q ss_pred ccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCc
Q 043720 268 IPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311 (1103)
Q Consensus 268 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~ 311 (1103)
.+..|..+++|+.|+|++|++++..+..+..+++|+.|++++|.
T Consensus 173 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~ 216 (270)
T 2o6q_A 173 PEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENP 216 (270)
T ss_dssp CTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSC
T ss_pred ChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEecCCC
Confidence 78889999999999999999998777789999999999999753
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=6.4e-23 Score=225.13 Aligned_cols=228 Identities=21% Similarity=0.232 Sum_probs=185.7
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
..+..+++..+.+.+.. .+..+++|+.|++++|.++ .++ .+..+++|++|+|++|++++ + ..+.++++|++|++
T Consensus 19 ~~l~~l~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~-~~~-~l~~l~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~L 92 (272)
T 3rfs_A 19 AETIKANLKKKSVTDAV--TQNELNSIDQIIANNSDIK-SVQ-GIQYLPNVRYLALGGNKLHD-I-SALKELTNLTYLIL 92 (272)
T ss_dssp HHHHHHHHTCSCTTSEE--CHHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECTTSCCCC-C-GGGTTCTTCCEEEC
T ss_pred HHHHHHHhcCccccccc--ccccccceeeeeeCCCCcc-ccc-ccccCCCCcEEECCCCCCCC-c-hhhcCCCCCCEEEC
Confidence 44556677777776543 3667899999999999988 444 58899999999999999985 3 47899999999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
++|.+++..+..|+.+++|++|++++|+++ .+|...+..+++|++|+|++|++++..+..++.+++|++|++++|++++
T Consensus 93 ~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 171 (272)
T 3rfs_A 93 TGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS 171 (272)
T ss_dssp TTSCCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCccCccChhHhcCCcCCCEEECCCCcCC-ccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCEEECCCCCcCc
Confidence 999999888888999999999999999999 5555544456889999999999997777778999999999999999999
Q ss_pred cccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchh
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~ 346 (1103)
..+..+..+++|+.|+|++|++++..|..+..+++|+.|++++ |.+.+.
T Consensus 172 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~---------------------------N~~~~~---- 220 (272)
T 3rfs_A 172 LPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHD---------------------------NPWDCT---- 220 (272)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCS---------------------------SCBCCC----
T ss_pred cCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccC---------------------------CCcccc----
Confidence 8787889999999999999999988888889999999999985 333322
Q ss_pred hhccccccccccCCccccccCCccccccc
Q 043720 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACE 375 (1103)
Q Consensus 347 ~~~L~~L~~L~l~~n~l~~~~p~~~~~l~ 375 (1103)
+++|+.++++.|.+.|.+|..++.+.
T Consensus 221 ---~~~l~~l~~~~n~~~g~ip~~~~~~~ 246 (272)
T 3rfs_A 221 ---CPGIRYLSEWINKHSGVVRNSAGSVA 246 (272)
T ss_dssp ---TTTTHHHHHHHHHTGGGBBCTTSCBC
T ss_pred ---CcHHHHHHHHHHhCCCcccCcccccC
Confidence 33566666666666666666665544
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=3.1e-24 Score=246.17 Aligned_cols=180 Identities=23% Similarity=0.172 Sum_probs=107.4
Q ss_pred EEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCcc----ccccCCC-CCCEEEccccccCCCCCCCCCCC-----CC
Q 043720 111 VLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLP----NEFVGLR-NLRVLNLAFNRIDGDIPFSLRNF-----ES 180 (1103)
Q Consensus 111 ~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l-----~~ 180 (1103)
+++|+.|+++|.+|..+...++|++|||++|.+++..+ ..+..++ +|++|+|++|++++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 35667777777777666666667777777777775555 5566666 67777777777776555555553 67
Q ss_pred CCEEEccCCcCCCCCChhccc----C-CCCcEeecccccCCCCCChhHHhh----cCcCcEEECcCCcccccc----Ccc
Q 043720 181 LEVLNLAGNQVKGVIPGFLGS----F-LKLRVLFLSYNELNGSIPSELGKY----CRYLEHLDLSGNSLVGRI----PSS 247 (1103)
Q Consensus 181 L~~L~L~~n~l~~~~p~~l~~----l-~~L~~L~L~~N~l~g~ip~~~~~~----~~~L~~L~L~~N~l~~~~----p~~ 247 (1103)
|++|+|++|++++..+..++. + ++|++|+|++|++++..+..+... +++|++|+|++|++++.. +..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 777777777776655554333 2 667777777777764444444332 245666666666665322 223
Q ss_pred ccCCC-CCCEEeCCCccCCcccccccc----CC-CCCCEEEccCCcCCC
Q 043720 248 LGKCQ-QLRTLLLFSNMLNDVIPRELG----WL-RKLEVLDVSRNRLNG 290 (1103)
Q Consensus 248 l~~l~-~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~ 290 (1103)
+..++ +|++|+|++|++++..+..++ .+ ++|+.|+|++|++++
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~ 210 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL 210 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGG
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCCh
Confidence 33343 566666666666554443332 22 356666666665553
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=3e-24 Score=257.67 Aligned_cols=186 Identities=18% Similarity=0.223 Sum_probs=146.2
Q ss_pred CCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-------hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 824 NTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-------QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 824 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
...+.||+|+||+||+|... ++.+++|+...... ....+.+.+|++++++++||||+++..++...+..|+|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 44678999999999999544 78899998644322 11245689999999999999999655555566777999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++++|.++++. +..++.|+++||+|||++ +|+||||||+|||++. .+||+|||+++.....
T Consensus 418 mE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 418 MSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp EECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred EECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 999999999999865 557999999999999999 9999999999999999 9999999999987543
Q ss_pred CCcc------ccCCcccccccCcccccc--CCCCCcchhHHHHHHHHHHHhCCCCCC
Q 043720 977 ETHA------TTGVAGTFGYVAPEYALT--CRVSDKADVYSYGVVLLELISDKKALD 1025 (1103)
Q Consensus 977 ~~~~------~~~~~g~~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~ 1025 (1103)
.... .....||+.|+|||++.. ..|+.++|+|+..+-..+.+.++.+|.
T Consensus 483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 2221 235679999999999986 567788999999999999888876653
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.88 E-value=3.3e-22 Score=221.23 Aligned_cols=202 Identities=23% Similarity=0.255 Sum_probs=179.2
Q ss_pred ccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCC
Q 043720 102 LVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESL 181 (1103)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (1103)
.++++++++.+++++++++ .+|..+. +++++|+|++|.+++..|..|..+++|++|+|++|++++ ++.. +.+++|
T Consensus 5 ~~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~-~~l~~L 79 (290)
T 1p9a_G 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD-GTLPVL 79 (290)
T ss_dssp EEECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC-SCCTTC
T ss_pred cccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC-CCCCcC
Confidence 3678899999999999998 7887775 789999999999998888999999999999999999994 4443 789999
Q ss_pred CEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCC
Q 043720 182 EVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS 261 (1103)
Q Consensus 182 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 261 (1103)
++|+|++|+++ .+|..+..+++|++|+|++|+++ .+|...+..+++|++|+|++|++++..+..+..+++|+.|+|++
T Consensus 80 ~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 157 (290)
T 1p9a_G 80 GTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLAN 157 (290)
T ss_dssp CEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred CEEECCCCcCC-cCchhhccCCCCCEEECCCCcCc-ccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCC
Confidence 99999999999 67888899999999999999999 66655455568899999999999977777789999999999999
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCc
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~ 311 (1103)
|++++..+..|..+++|+.|+|++|+++ .+|..+..+.+|+.|++++|.
T Consensus 158 N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np 206 (290)
T 1p9a_G 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNP 206 (290)
T ss_dssp SCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCC
T ss_pred CcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCC
Confidence 9999877777889999999999999999 778888899999999998753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-24 Score=252.25 Aligned_cols=243 Identities=19% Similarity=0.280 Sum_probs=131.1
Q ss_pred cCCccccCCCCCCEEEeecCCCCCCc----cccccCCCCCCEEEcccc---ccCCCCCCCC-------CCCCCCCEEEcc
Q 043720 122 EFPPEIWSLEKLEVLDVEGNFLSGRL----PNEFVGLRNLRVLNLAFN---RIDGDIPFSL-------RNFESLEVLNLA 187 (1103)
Q Consensus 122 ~~p~~l~~l~~L~~L~Ls~n~l~~~~----p~~l~~l~~L~~L~Ls~N---~l~~~~p~~l-------~~l~~L~~L~L~ 187 (1103)
.++..+..+++|++|+|++|.+++.. +..+..+++|++|+|++| ++++.+|..+ .++++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 34444555555555555555555432 223445556666666553 3333444433 455666666666
Q ss_pred CCcCCC----CCChhcccCCCCcEeecccccCCCCCChhHHhhc------------CcCcEEECcCCccc-cccC---cc
Q 043720 188 GNQVKG----VIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYC------------RYLEHLDLSGNSLV-GRIP---SS 247 (1103)
Q Consensus 188 ~n~l~~----~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~------------~~L~~L~L~~N~l~-~~~p---~~ 247 (1103)
+|.+++ .+|..+..+++|++|+|++|.+++..+..+...+ ++|++|+|++|+++ +.++ ..
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~ 182 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHHH
Confidence 666665 3455556666666666666666533333333221 45666666666654 2233 24
Q ss_pred ccCCCCCCEEeCCCccCCc-----cccccccCCCCCCEEEccCCcCC----CcCCccccCCCCCCeEecccCcCccccCc
Q 043720 248 LGKCQQLRTLLLFSNMLND-----VIPRELGWLRKLEVLDVSRNRLN----GLIPTELGNCVELSVLVLSNLFDPLLSGR 318 (1103)
Q Consensus 248 l~~l~~L~~L~L~~N~l~~-----~~p~~l~~l~~L~~L~Ls~N~l~----~~~p~~l~~l~~L~~L~l~~~~~~~l~~~ 318 (1103)
+..+++|++|+|++|.++. ..|..+..+++|+.|+|++|.++ +.+|..+..+++|+.|+|+
T Consensus 183 l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~---------- 252 (386)
T 2ca6_A 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLN---------- 252 (386)
T ss_dssp HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECT----------
T ss_pred HHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECC----------
Confidence 4455566666666666552 22335555566666666666654 3344444444444444444
Q ss_pred cccCcccccccCCCCCCCCcccccCchhhhccccccccccCCcccccc----CCccc--cccccCcEEEcCCccccc---
Q 043720 319 NIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGK----LPSSW--GACESLEMLNLAQNVLRG--- 389 (1103)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~----~p~~~--~~l~~L~~L~Ls~N~l~~--- 389 (1103)
+|.+.+. ++..+ +.+++|+.|+|++|.|++
T Consensus 253 -----------------------------------------~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~ 291 (386)
T 2ca6_A 253 -----------------------------------------DCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291 (386)
T ss_dssp -----------------------------------------TCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHH
T ss_pred -----------------------------------------CCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHH
Confidence 3333332 23334 236677777777777776
Q ss_pred -ccchhh-hccCCceEeecCCccccccc
Q 043720 390 -DLIGVF-DRCKKLHFIDLSSNELSGEL 415 (1103)
Q Consensus 390 -~~~~~~-~~l~~L~~LdLs~N~l~~~~ 415 (1103)
.++..+ .++++|++|+|++|++++..
T Consensus 292 ~~l~~~l~~~l~~L~~L~l~~N~l~~~~ 319 (386)
T 2ca6_A 292 RTLKTVIDEKMPDLLFLELNGNRFSEED 319 (386)
T ss_dssp HHHHHHHHHHCTTCCEEECTTSBSCTTS
T ss_pred HHHHHHHHhcCCCceEEEccCCcCCcch
Confidence 355544 55677777777777777655
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=9.2e-22 Score=213.17 Aligned_cols=182 Identities=22% Similarity=0.256 Sum_probs=164.8
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccC
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 624 (1103)
..++++++++. .+|..+. ++++.|+|++|+|++..+..|.++++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 17 ~~l~~~~~~l~-~~p~~~~---~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 92 (251)
T 3m19_A 17 KEVDCQGKSLD-SVPSGIP---ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLAN 92 (251)
T ss_dssp TEEECTTCCCS-SCCSCCC---TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred eEEecCCCCcc-ccCCCCC---CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCC
Confidence 46899999998 8888776 6899999999999999899999999999999999999988888899999999999999
Q ss_pred cccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCC
Q 043720 625 NNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704 (1103)
Q Consensus 625 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 704 (1103)
|++++..+..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|++++|++++.++
T Consensus 93 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 172 (251)
T 3m19_A 93 NQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPH 172 (251)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCT
T ss_pred CcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCH
Confidence 99998888889999999999999999998777778999999999999999997777789999999999999999999887
Q ss_pred CCc---cccccccccCCCCCCC-CCCCCCC
Q 043720 705 WNV---TTMNCSGVIGNPFLDP-CQMYKDI 730 (1103)
Q Consensus 705 ~~~---~~~~~~~l~~Np~~c~-C~~~~~~ 730 (1103)
..+ ..+..+.+.+|||.|+ |++....
T Consensus 173 ~~~~~l~~L~~L~l~~N~~~c~~~~~~~l~ 202 (251)
T 3m19_A 173 GAFDRLGKLQTITLFGNQFDCSRCEILYLS 202 (251)
T ss_dssp TTTTTCTTCCEEECCSCCBCTTSTTHHHHH
T ss_pred HHHhCCCCCCEEEeeCCceeCCccccHHHH
Confidence 544 4667778999999999 8875533
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.3e-23 Score=236.59 Aligned_cols=201 Identities=21% Similarity=0.242 Sum_probs=155.4
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCC-ccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEE
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGR-LPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (1103)
+.++.|++++|.+.+..|. +..+++|++|+|++|.+++. +|..+..+++|++|+|++|++++..|..++.+++|++|+
T Consensus 70 ~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~ 148 (336)
T 2ast_B 70 QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 148 (336)
T ss_dssp TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEE
T ss_pred ccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEE
Confidence 6888999999998877665 66789999999999988865 888888899999999999988877888888889999999
Q ss_pred ccCC-cCCCC-CChhcccCCCCcEeecccc-cCCCC-CChhHHhhcC-cCcEEECcCC--ccc-cccCccccCCCCCCEE
Q 043720 186 LAGN-QVKGV-IPGFLGSFLKLRVLFLSYN-ELNGS-IPSELGKYCR-YLEHLDLSGN--SLV-GRIPSSLGKCQQLRTL 257 (1103)
Q Consensus 186 L~~n-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~g~-ip~~~~~~~~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L 257 (1103)
|++| .+++. ++..+.++++|++|++++| .+++. ++..+.. ++ +|++|++++| .++ +.++..+..+++|++|
T Consensus 149 L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~-l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L 227 (336)
T 2ast_B 149 LSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAH-VSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 227 (336)
T ss_dssp CTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHH-SCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEE
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHHHHHh-cccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEE
Confidence 9988 67753 6666788888889998888 88754 4544544 46 7888888888 455 4566677778888888
Q ss_pred eCCCcc-CCccccccccCCCCCCEEEccCCc-CCCcCCccccCCCCCCeEeccc
Q 043720 258 LLFSNM-LNDVIPRELGWLRKLEVLDVSRNR-LNGLIPTELGNCVELSVLVLSN 309 (1103)
Q Consensus 258 ~L~~N~-l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~l~~ 309 (1103)
++++|. +++..+..+..+++|+.|++++|. +.......++++++|+.|++++
T Consensus 228 ~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~l~~ 281 (336)
T 2ast_B 228 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281 (336)
T ss_dssp ECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred eCCCCCcCCHHHHHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEeccC
Confidence 888888 676667778888888888888884 3322223566777777777764
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.1e-22 Score=221.90 Aligned_cols=202 Identities=26% Similarity=0.235 Sum_probs=173.9
Q ss_pred CCCCCCEEEccCCCCcccCCccc--cCCCCCCEEEeecCCCCCCcc----ccccCCCCCCEEEccccccCCCCCCCCCCC
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEI--WSLEKLEVLDVEGNFLSGRLP----NEFVGLRNLRVLNLAFNRIDGDIPFSLRNF 178 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l--~~l~~L~~L~Ls~n~l~~~~p----~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (1103)
.+++|++|+|++|.+++.+|..+ ..+++|++|+|++|.+++..+ ..+..+++|++|+|++|++++..|..++++
T Consensus 89 ~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l 168 (310)
T 4glp_A 89 AYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAF 168 (310)
T ss_dssp HHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCC
T ss_pred ccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccC
Confidence 34679999999999999999998 899999999999999997655 455689999999999999998888999999
Q ss_pred CCCCEEEccCCcCCCC--C--ChhcccCCCCcEeecccccCCCCCChh---HHhhcCcCcEEECcCCccccccCccccCC
Q 043720 179 ESLEVLNLAGNQVKGV--I--PGFLGSFLKLRVLFLSYNELNGSIPSE---LGKYCRYLEHLDLSGNSLVGRIPSSLGKC 251 (1103)
Q Consensus 179 ~~L~~L~L~~n~l~~~--~--p~~l~~l~~L~~L~L~~N~l~g~ip~~---~~~~~~~L~~L~L~~N~l~~~~p~~l~~l 251 (1103)
++|++|+|++|++.+. + +..++.+++|++|+|++|+++ .++.. ++..+++|++|+|++|++++..|..++.+
T Consensus 169 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~ 247 (310)
T 4glp_A 169 PALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRC 247 (310)
T ss_dssp TTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSC
T ss_pred CCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhc
Confidence 9999999999998753 2 233578999999999999997 55543 44456889999999999998888888877
Q ss_pred ---CCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcC
Q 043720 252 ---QQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFD 312 (1103)
Q Consensus 252 ---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~ 312 (1103)
++|++|+|++|+++. +|..+. ++|+.|+|++|++++. |. +..+++|+.|++++|..
T Consensus 248 ~~~~~L~~L~Ls~N~l~~-lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l 306 (310)
T 4glp_A 248 MWSSALNSLNLSFAGLEQ-VPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPF 306 (310)
T ss_dssp CCCTTCCCEECCSSCCCS-CCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTT
T ss_pred cCcCcCCEEECCCCCCCc-hhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCC
Confidence 699999999999995 677764 8999999999999975 43 68889999999997643
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-21 Score=211.15 Aligned_cols=197 Identities=18% Similarity=0.184 Sum_probs=169.4
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCC-CCCCccccccCCCCCCEEEccc-cccCCCCCCCCCCCCCCCEE
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNF-LSGRLPNEFVGLRNLRVLNLAF-NRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~-l~~~~p~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L 184 (1103)
+.|++|+|++|++++..+..+.++++|++|+|++|. +++..+..|..+++|++|+|++ |++++..+..+.++++|++|
T Consensus 31 ~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L 110 (239)
T 2xwt_C 31 PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFL 110 (239)
T ss_dssp TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEE
T ss_pred CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEE
Confidence 379999999999997777789999999999999997 8865666899999999999999 99996666789999999999
Q ss_pred EccCCcCCCCCChhcccCCCCc---Eeecccc-cCCCCCChhHHhhcCcCc-EEECcCCccccccCccccCCCCCCEEeC
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLR---VLFLSYN-ELNGSIPSELGKYCRYLE-HLDLSGNSLVGRIPSSLGKCQQLRTLLL 259 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~---~L~L~~N-~l~g~ip~~~~~~~~~L~-~L~L~~N~l~~~~p~~l~~l~~L~~L~L 259 (1103)
++++|++++ +|. ++.+++|+ +|++++| +++ .+|...+..+++|+ +|++++|+++ .+|......++|+.|++
T Consensus 111 ~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~-~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L 186 (239)
T 2xwt_C 111 GIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMT-SIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186 (239)
T ss_dssp EEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCC-EECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEEC
T ss_pred eCCCCCCcc-ccc-cccccccccccEEECCCCcchh-hcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEc
Confidence 999999996 666 88888888 9999999 998 66766555578899 9999999999 56655444489999999
Q ss_pred CCcc-CCccccccccCC-CCCCEEEccCCcCCCcCCccccCCCCCCeEecccC
Q 043720 260 FSNM-LNDVIPRELGWL-RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 260 ~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
++|+ +++..+..|..+ ++|+.|++++|++++. |.. .+++|+.|+++++
T Consensus 187 ~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l-~~~--~~~~L~~L~l~~~ 236 (239)
T 2xwt_C 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL-PSK--GLEHLKELIARNT 236 (239)
T ss_dssp TTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCC-CCT--TCTTCSEEECTTC
T ss_pred CCCCCcccCCHHHhhccccCCcEEECCCCccccC-Chh--HhccCceeeccCc
Confidence 9995 998777889999 9999999999999954 444 6788999999864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.87 E-value=6.5e-23 Score=235.10 Aligned_cols=175 Identities=22% Similarity=0.126 Sum_probs=135.7
Q ss_pred EEEeecCCCCCCccccccCCCCCCEEEccccccCCCCC----CCCCCCC-CCCEEEccCCcCCCCCChhcccC-----CC
Q 043720 135 VLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIP----FSLRNFE-SLEVLNLAGNQVKGVIPGFLGSF-----LK 204 (1103)
Q Consensus 135 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p----~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l-----~~ 204 (1103)
.++|+.|.++|.+|..+...++|++|+|++|++++..+ ..+.+++ +|++|+|++|.+++..+..+..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46889999999999888888889999999999996655 6777888 89999999999998877777765 89
Q ss_pred CcEeecccccCCCCCChhHHhhc----CcCcEEECcCCccccccCcccc----C-CCCCCEEeCCCccCCcc----cccc
Q 043720 205 LRVLFLSYNELNGSIPSELGKYC----RYLEHLDLSGNSLVGRIPSSLG----K-CQQLRTLLLFSNMLNDV----IPRE 271 (1103)
Q Consensus 205 L~~L~L~~N~l~g~ip~~~~~~~----~~L~~L~L~~N~l~~~~p~~l~----~-l~~L~~L~L~~N~l~~~----~p~~ 271 (1103)
|++|+|++|++++..+..++..+ ++|++|+|++|++++..+..++ . .++|++|+|++|.+++. ++..
T Consensus 82 L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~ 161 (362)
T 3goz_A 82 VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQI 161 (362)
T ss_dssp CCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred ccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHH
Confidence 99999999999877776665542 6799999999999866554443 3 35899999999988864 3444
Q ss_pred ccCCC-CCCEEEccCCcCCCcCCccccC----C-CCCCeEeccc
Q 043720 272 LGWLR-KLEVLDVSRNRLNGLIPTELGN----C-VELSVLVLSN 309 (1103)
Q Consensus 272 l~~l~-~L~~L~Ls~N~l~~~~p~~l~~----l-~~L~~L~l~~ 309 (1103)
+..++ +|+.|+|++|++++..+..+.. + ++|+.|+|++
T Consensus 162 l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~ 205 (362)
T 3goz_A 162 LAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSA 205 (362)
T ss_dssp HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTT
T ss_pred HhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCC
Confidence 55555 8888999888888766554443 3 4677777764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.86 E-value=2.1e-23 Score=241.71 Aligned_cols=247 Identities=19% Similarity=0.237 Sum_probs=168.3
Q ss_pred CccccccCCCCCCEEEccccccCCC----CCCCCCCCCCCCEEEccCC---cCCCCCChhc-------ccCCCCcEeecc
Q 043720 146 RLPNEFVGLRNLRVLNLAFNRIDGD----IPFSLRNFESLEVLNLAGN---QVKGVIPGFL-------GSFLKLRVLFLS 211 (1103)
Q Consensus 146 ~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~n---~l~~~~p~~l-------~~l~~L~~L~L~ 211 (1103)
.++..+..+++|++|+|++|++++. ++..+.++++|++|+|++| ++++.+|..+ ..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 4666777788888888888888755 3345777888888888885 4445555544 567778888888
Q ss_pred cccCCC----CCChhHHhhcCcCcEEECcCCccccccCcccc----CC---------CCCCEEeCCCccCC-cccc---c
Q 043720 212 YNELNG----SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLG----KC---------QQLRTLLLFSNMLN-DVIP---R 270 (1103)
Q Consensus 212 ~N~l~g----~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~----~l---------~~L~~L~L~~N~l~-~~~p---~ 270 (1103)
+|.+++ .+|..+.. +++|++|+|++|.+++..+..+. .+ ++|++|+|++|+++ +.++ .
T Consensus 103 ~n~l~~~~~~~l~~~l~~-~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~ 181 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSK-HTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAK 181 (386)
T ss_dssp SCCCCTTTHHHHHHHHHH-CTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHH
T ss_pred CCcCCHHHHHHHHHHHHh-CCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHHHHH
Confidence 887775 25555544 46677777777777643333333 23 66777777777766 2233 3
Q ss_pred cccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhcc
Q 043720 271 ELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTL 350 (1103)
Q Consensus 271 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L 350 (1103)
.+..+++|+.|+|++|+++.. .....+|..+..+
T Consensus 182 ~l~~~~~L~~L~L~~n~l~~~----------------------------------------------g~~~l~~~~l~~~ 215 (386)
T 2ca6_A 182 TFQSHRLLHTVKMVQNGIRPE----------------------------------------------GIEHLLLEGLAYC 215 (386)
T ss_dssp HHHHCTTCCEEECCSSCCCHH----------------------------------------------HHHHHHHTTGGGC
T ss_pred HHHhCCCcCEEECcCCCCCHh----------------------------------------------HHHHHHHHHhhcC
Confidence 455666677777766666521 0000122234445
Q ss_pred ccccccccCCcccc----ccCCccccccccCcEEEcCCcccccc----cchhhhc--cCCceEeecCCccccc----ccc
Q 043720 351 SKLRIIWAPRLNLE----GKLPSSWGACESLEMLNLAQNVLRGD----LIGVFDR--CKKLHFIDLSSNELSG----ELD 416 (1103)
Q Consensus 351 ~~L~~L~l~~n~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~--l~~L~~LdLs~N~l~~----~~~ 416 (1103)
++|+.|++++|.++ +.+|..+..+++|+.|+|++|.|++. ++..+.. +++|+.|+|++|++++ .++
T Consensus 216 ~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~ 295 (386)
T 2ca6_A 216 QELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLK 295 (386)
T ss_dssp TTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHH
T ss_pred CCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEECCCCCCchhhHHHHHHHHhhccCCCeEEEECcCCcCCHHHHHHHH
Confidence 55555555566664 45667788899999999999999986 4566643 8999999999999998 355
Q ss_pred ccc--cccceeEEEecCCccccccC
Q 043720 417 VKL--QVPCMALFDVSGNHMSGSIP 439 (1103)
Q Consensus 417 ~~~--~~~~L~~l~ls~N~l~g~ip 439 (1103)
... ++++|+.|++++|++++..+
T Consensus 296 ~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 296 TVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHhcCCCceEEEccCCcCCcchh
Confidence 443 47999999999999998764
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.86 E-value=6.8e-23 Score=232.66 Aligned_cols=198 Identities=19% Similarity=0.167 Sum_probs=151.6
Q ss_pred CCCEEEccCCCCcccCCccccCC--CCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCC-CCCCCCCCCCCCEE
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSL--EKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGD-IPFSLRNFESLEVL 184 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l--~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L 184 (1103)
.++.|+++++.+. |..+..+ ++++.|++++|.+++..+. +..+++|++|+|++|.+++. +|..+.++++|++|
T Consensus 48 ~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEE
T ss_pred hheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEE
Confidence 3678888888776 5566666 8888899988888866555 55788888888888888755 77778888888888
Q ss_pred EccCCcCCCCCChhcccCCCCcEeecccc-cCCCC-CChhHHhhcCcCcEEECcCC-ccccc-cCccccCCC-CCCEEeC
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYN-ELNGS-IPSELGKYCRYLEHLDLSGN-SLVGR-IPSSLGKCQ-QLRTLLL 259 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~g~-ip~~~~~~~~~L~~L~L~~N-~l~~~-~p~~l~~l~-~L~~L~L 259 (1103)
+|++|.+++..+..++.+++|++|++++| .+++. ++..+. .+++|++|++++| .+++. ++..+..++ +|++|++
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~-~~~~L~~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l 202 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLS-SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNL 202 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHH-HCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEEC
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHh-cCCCCCEEcCCCCCCcChHHHHHHHHhcccCCCEEEe
Confidence 88888888777888888888888888888 67653 444343 4577888888888 88754 566677788 8888888
Q ss_pred CCc--cCC-ccccccccCCCCCCEEEccCCc-CCCcCCccccCCCCCCeEecccC
Q 043720 260 FSN--MLN-DVIPRELGWLRKLEVLDVSRNR-LNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 260 ~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
++| .++ +.+|..+..+++|+.|++++|. +++..+..+.++++|+.|++++|
T Consensus 203 ~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~~l~~L~~L~l~~~ 257 (336)
T 2ast_B 203 SGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRC 257 (336)
T ss_dssp CSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTC
T ss_pred CCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHhCCCCCCEeeCCCC
Confidence 888 555 3466677778888888888888 66666777777777777777753
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.86 E-value=4.6e-22 Score=222.90 Aligned_cols=180 Identities=19% Similarity=0.134 Sum_probs=102.6
Q ss_pred CCCEEEccCCCCcccCCcc---ccCCCCCCEEEeecCCCCCCccccc--cCCCCCCEEEccccccCCCCC----CCCCCC
Q 043720 108 ELRVLSLPFNGFSGEFPPE---IWSLEKLEVLDVEGNFLSGRLPNEF--VGLRNLRVLNLAFNRIDGDIP----FSLRNF 178 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~---l~~l~~L~~L~Ls~n~l~~~~p~~l--~~l~~L~~L~Ls~N~l~~~~p----~~l~~l 178 (1103)
.++.|.+.++.++...-.. ...+++|++|+|++|.+++..|..+ ..+++|++|+|++|++++..| ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 4666677666654221111 1124557777777777776666666 667777777777777765444 233456
Q ss_pred CCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEe
Q 043720 179 ESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLL 258 (1103)
Q Consensus 179 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 258 (1103)
++|++|+|++|++++..+..|+.+++|++|+|++|++.+... + ..+..++.+++|++|+
T Consensus 145 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~-------------------~~~~~~~~l~~L~~L~ 203 (310)
T 4glp_A 145 PGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERG--L-------------------MAALCPHKFPAIQNLA 203 (310)
T ss_dssp SCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHH--H-------------------HTTSCTTSSCCCCSCB
T ss_pred cCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchh--h-------------------hHHHhhhcCCCCCEEE
Confidence 666666666666666555666666666666666666542100 0 0112234566666666
Q ss_pred CCCccCCcc--ccc-cccCCCCCCEEEccCCcCCCcCCccccCC---CCCCeEecc
Q 043720 259 LFSNMLNDV--IPR-ELGWLRKLEVLDVSRNRLNGLIPTELGNC---VELSVLVLS 308 (1103)
Q Consensus 259 L~~N~l~~~--~p~-~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l---~~L~~L~l~ 308 (1103)
|++|+++.. .+. .+..+++|++|+|++|++++..|..+..+ ++|+.|+++
T Consensus 204 Ls~N~l~~l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls 259 (310)
T 4glp_A 204 LRNTGMETPTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLS 259 (310)
T ss_dssp CCSSCCCCHHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECC
T ss_pred CCCCCCCchHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECC
Confidence 766666532 111 24566777777777777776666665554 344444444
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.85 E-value=5.1e-22 Score=227.39 Aligned_cols=180 Identities=23% Similarity=0.262 Sum_probs=158.5
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCccccc-CCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLE-NLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
..+++++|++. .+|..+. +.++.|+|++|+|+++.+..|. ++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 21 ~~l~c~~~~l~-~iP~~~~---~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 96 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLS 96 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC---TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEEEeCCCCcC-ccCccCC---CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECC
Confidence 47899999998 6898776 5689999999999988888888 99999999999999997777889999999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccc---cCCCCCceEeCCCCCCC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGL---ANVTSLSIFNASFNNLS 700 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l---~~l~~L~~l~l~~N~l~ 700 (1103)
+|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..| ..+++|+.|++++|+|+
T Consensus 97 ~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~ 176 (361)
T 2xot_A 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK 176 (361)
T ss_dssp SSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCSSCCC
T ss_pred CCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCC
Confidence 999998888889999999999999999998889999999999999999999996555555 57999999999999999
Q ss_pred CCCCCCcccc-----ccccccCCCCCCCCCCCC
Q 043720 701 GPFPWNVTTM-----NCSGVIGNPFLDPCQMYK 728 (1103)
Q Consensus 701 ~~~p~~~~~~-----~~~~l~~Np~~c~C~~~~ 728 (1103)
+.++..+..+ ..+.+.+|||.|||++..
T Consensus 177 ~l~~~~~~~l~~~~l~~l~l~~N~~~C~C~l~~ 209 (361)
T 2xot_A 177 KLPLTDLQKLPAWVKNGLYLHNNPLECDCKLYQ 209 (361)
T ss_dssp CCCHHHHHHSCHHHHTTEECCSSCEECCHHHHH
T ss_pred ccCHHHhhhccHhhcceEEecCCCccCCcCcHH
Confidence 8776544433 557899999999999754
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=6.4e-22 Score=237.05 Aligned_cols=215 Identities=24% Similarity=0.265 Sum_probs=177.4
Q ss_pred CCCCcccCcCCCCCCCC-----ceeee-EecCCCCeEEEEecCCCCCCCCCCccccccccccccccccccccceeccCCC
Q 043720 20 DPSGILSSWQTNTSSHC-----SWFGV-SCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQFPFYGFGMRRRTCLHGRG 93 (1103)
Q Consensus 20 d~~~~l~sW~~~~~~~C-----~W~GV-~C~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (1103)
+....+.+|..+ .++| .|.|+ .|. .++++.+++++..+
T Consensus 28 ~~~~~l~~W~~~-~~~~~~~~~~~~~l~~C~-~~~L~~L~Ls~n~L---------------------------------- 71 (571)
T 3cvr_A 28 DYFSAWDKWEKQ-ALPGENRNEAVSLLKECL-INQFSELQLNRLNL---------------------------------- 71 (571)
T ss_dssp HHHHHHHHHHTT-CCTTCCHHHHHHHHHHHH-HTTCSEEECCSSCC----------------------------------
T ss_pred hHHHHHHHHhcc-CCccccccchhhhccccc-cCCccEEEeCCCCC----------------------------------
Confidence 334457889754 4678 79999 786 35788888876432
Q ss_pred ccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCC
Q 043720 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPF 173 (1103)
Q Consensus 94 ~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 173 (1103)
.+ +|+.+ +++|++|+|++|.|+ .+| ..+++|++|+|++|.|++ +|. +.. +|++|+|++|+|++ +|.
T Consensus 72 --~~-lp~~l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~ 137 (571)
T 3cvr_A 72 --SS-LPDNL--PPQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE 137 (571)
T ss_dssp --SC-CCSCC--CTTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC
T ss_pred --Cc-cCHhH--cCCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC
Confidence 22 55555 378999999999999 788 557999999999999996 887 765 99999999999996 777
Q ss_pred CCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCC
Q 043720 174 SLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQ 253 (1103)
Q Consensus 174 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~ 253 (1103)
.+++|++|+|++|++++ +|. .+++|++|+|++|++++ +|. +. ++|++|+|++|+|+ .+|. +.. +
T Consensus 138 ---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l~---~~L~~L~Ls~N~L~-~lp~-~~~--~ 201 (571)
T 3cvr_A 138 ---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-LP---ESLEALDVSTNLLE-SLPA-VPV--R 201 (571)
T ss_dssp ---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-CC---TTCCEEECCSSCCS-SCCC-CC----
T ss_pred ---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-hh---CCCCEEECcCCCCC-chhh-HHH--h
Confidence 68999999999999996 665 57899999999999994 887 44 78999999999999 6777 655 7
Q ss_pred C-------CEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCC
Q 043720 254 L-------RTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVE 301 (1103)
Q Consensus 254 L-------~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 301 (1103)
| +.|+|++|+|+. +|..+..+++|+.|+|++|++++.+|..+..++.
T Consensus 202 L~~~~~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~ 255 (571)
T 3cvr_A 202 NHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTA 255 (571)
T ss_dssp ------CCEEEECCSSCCCC-CCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHHH
T ss_pred hhcccccceEEecCCCccee-cCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhhc
Confidence 7 999999999986 7888888999999999999999999998887654
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.84 E-value=4.6e-21 Score=202.87 Aligned_cols=159 Identities=23% Similarity=0.344 Sum_probs=137.6
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccC
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 624 (1103)
..+++++|++. .+|..+. ++|++|+|++|+|+++.+..|..+++|++|+|++|+|++..|..|..+++|++|+|++
T Consensus 14 ~~v~c~~~~l~-~iP~~l~---~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~ 89 (220)
T 2v9t_B 14 NIVDCRGKGLT-EIPTNLP---ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYG 89 (220)
T ss_dssp TEEECTTSCCS-SCCSSCC---TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCS
T ss_pred CEEEcCCCCcC-cCCCccC---cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCC
Confidence 46889999887 7888766 6799999999999988888899999999999999999977788999999999999999
Q ss_pred cccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCC
Q 043720 625 NNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP 704 (1103)
Q Consensus 625 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p 704 (1103)
|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 90 N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~----------- 158 (220)
T 2v9t_B 90 NKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMH----------- 158 (220)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEE-----------
T ss_pred CcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEE-----------
Confidence 999976666788899999999999999988888899999999999999999877777788888877764
Q ss_pred CCccccccccccCCCCCCCCCCCC
Q 043720 705 WNVTTMNCSGVIGNPFLDPCQMYK 728 (1103)
Q Consensus 705 ~~~~~~~~~~l~~Np~~c~C~~~~ 728 (1103)
+.+|||.|||++..
T Consensus 159 ----------L~~N~~~c~c~l~~ 172 (220)
T 2v9t_B 159 ----------LAQNPFICDCHLKW 172 (220)
T ss_dssp ----------CCSSCEECSGGGHH
T ss_pred ----------eCCCCcCCCCccHH
Confidence 56789999999754
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.84 E-value=1.5e-20 Score=210.04 Aligned_cols=193 Identities=22% Similarity=0.330 Sum_probs=168.3
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
.+++++|++|++++|.++ .+| .+..+++|++|+|++|.+++. +. +..+++|++|+|++|++++ ++ .+.++++|+
T Consensus 37 ~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~~-~~-~~~l~~L~~L~L~~n~l~~-~~-~~~~l~~L~ 110 (308)
T 1h6u_A 37 QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDL-AP-LKNLTKITELELSGNPLKN-VS-AIAGLQSIK 110 (308)
T ss_dssp HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCC
T ss_pred HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCCC-hh-HccCCCCCEEEccCCcCCC-ch-hhcCCCCCC
Confidence 457889999999999998 466 689999999999999999954 44 9999999999999999995 44 789999999
Q ss_pred EEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCc
Q 043720 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262 (1103)
Q Consensus 183 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 262 (1103)
+|++++|++++. +. ++.+++|++|++++|+++ .++. +. .+++|++|+|++|++++. +. +..+++|+.|++++|
T Consensus 111 ~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~-~~~~-l~-~l~~L~~L~l~~n~l~~~-~~-l~~l~~L~~L~l~~n 183 (308)
T 1h6u_A 111 TLDLTSTQITDV-TP-LAGLSNLQVLYLDLNQIT-NISP-LA-GLTNLQYLSIGNAQVSDL-TP-LANLSKLTTLKADDN 183 (308)
T ss_dssp EEECTTSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG-GG-GCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSS
T ss_pred EEECCCCCCCCc-hh-hcCCCCCCEEECCCCccC-cCcc-cc-CCCCccEEEccCCcCCCC-hh-hcCCCCCCEEECCCC
Confidence 999999999964 43 899999999999999998 5554 44 468899999999999964 43 899999999999999
Q ss_pred cCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcC
Q 043720 263 MLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFD 312 (1103)
Q Consensus 263 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~ 312 (1103)
.+++..+ +..+++|+.|+|++|++++.. .+..+++|+.|++++|..
T Consensus 184 ~l~~~~~--l~~l~~L~~L~L~~N~l~~~~--~l~~l~~L~~L~l~~N~i 229 (308)
T 1h6u_A 184 KISDISP--LASLPNLIEVHLKNNQISDVS--PLANTSNLFIVTLTNQTI 229 (308)
T ss_dssp CCCCCGG--GGGCTTCCEEECTTSCCCBCG--GGTTCTTCCEEEEEEEEE
T ss_pred ccCcChh--hcCCCCCCEEEccCCccCccc--cccCCCCCCEEEccCCee
Confidence 9998544 899999999999999999765 389999999999997543
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=197.87 Aligned_cols=164 Identities=23% Similarity=0.226 Sum_probs=125.5
Q ss_pred CCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEE
Q 043720 106 LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185 (1103)
Q Consensus 106 l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (1103)
.++|++|+|++|.+++..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+.++++|++|+
T Consensus 27 ~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 106 (208)
T 2o6s_A 27 PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELA 106 (208)
T ss_dssp CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEE
Confidence 35788999999999866666678889999999999999866666678889999999999988865556678888888888
Q ss_pred ccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCC
Q 043720 186 LAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN 265 (1103)
Q Consensus 186 L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~ 265 (1103)
+++|++++..+..|..+++|++|++++|+++ .+|...+..+++|++|++++|.+.+. +++|++|+++.|+++
T Consensus 107 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~L~~~~n~~~ 178 (208)
T 2o6s_A 107 LNTNQLQSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHS 178 (208)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCS-CCCTTTTTTCTTCCEEECCSCCBCCC-------TTTTHHHHHHHHHCT
T ss_pred cCCCcCcccCHhHhccCCcCCEEECCCCccc-eeCHHHhccCCCccEEEecCCCeecC-------CCCHHHHHHHHHhCC
Confidence 8888888777777788888888888888887 45555444456777777777766532 446677777777777
Q ss_pred ccccccccCCCC
Q 043720 266 DVIPRELGWLRK 277 (1103)
Q Consensus 266 ~~~p~~l~~l~~ 277 (1103)
|.+|.+++.++.
T Consensus 179 g~ip~~~~~l~~ 190 (208)
T 2o6s_A 179 GVVRNSAGSVAP 190 (208)
T ss_dssp TTBBCTTSSBCT
T ss_pred ceeeccCccccC
Confidence 777766665544
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.83 E-value=9.5e-21 Score=203.58 Aligned_cols=183 Identities=16% Similarity=0.207 Sum_probs=150.8
Q ss_pred CcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccc-cCCCCCCCCCCCCCCCEEEccC-CcCCCCCC
Q 043720 119 FSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR-IDGDIPFSLRNFESLEVLNLAG-NQVKGVIP 196 (1103)
Q Consensus 119 l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l~~L~~L~L~~-n~l~~~~p 196 (1103)
++ .+|. +. ++|++|+|++|++++..+..|..+++|++|+|++|+ +++..+..+.++++|++|++++ |++++..+
T Consensus 23 l~-~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~i~~ 98 (239)
T 2xwt_C 23 IQ-RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98 (239)
T ss_dssp CS-SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCEECT
T ss_pred cc-ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeEcCH
Confidence 44 6776 44 489999999999997667789999999999999997 8855566899999999999998 99998777
Q ss_pred hhcccCCCCcEeecccccCCCCCChhHHhhcCcCc---EEECcCC-ccccccCccccCCCCCC-EEeCCCccCCcccccc
Q 043720 197 GFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLE---HLDLSGN-SLVGRIPSSLGKCQQLR-TLLLFSNMLNDVIPRE 271 (1103)
Q Consensus 197 ~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~---~L~L~~N-~l~~~~p~~l~~l~~L~-~L~L~~N~l~~~~p~~ 271 (1103)
..|.++++|++|++++|+++ .+|. +. .+++|+ +|++++| ++++..+..+..+++|+ +|++++|+++...+..
T Consensus 99 ~~f~~l~~L~~L~l~~n~l~-~lp~-~~-~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~~~ 175 (239)
T 2xwt_C 99 DALKELPLLKFLGIFNTGLK-MFPD-LT-KVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYA 175 (239)
T ss_dssp TSEECCTTCCEEEEEEECCC-SCCC-CT-TCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCCEECTTT
T ss_pred HHhCCCCCCCEEeCCCCCCc-cccc-cc-cccccccccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCcccCHhh
Confidence 88999999999999999998 5886 43 457788 9999999 89876667788999999 9999999998544444
Q ss_pred ccCCCCCCEEEccCCc-CCCcCCccccCC-CCCCeEeccc
Q 043720 272 LGWLRKLEVLDVSRNR-LNGLIPTELGNC-VELSVLVLSN 309 (1103)
Q Consensus 272 l~~l~~L~~L~Ls~N~-l~~~~p~~l~~l-~~L~~L~l~~ 309 (1103)
+.. ++|+.|+|++|+ +++..+..|..+ ++|+.|++++
T Consensus 176 ~~~-~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~ 214 (239)
T 2xwt_C 176 FNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQ 214 (239)
T ss_dssp TTT-CEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTT
T ss_pred cCC-CCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCC
Confidence 444 889999999995 886666777777 7777777764
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.83 E-value=2.5e-20 Score=208.23 Aligned_cols=164 Identities=23% Similarity=0.305 Sum_probs=105.6
Q ss_pred EEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcC
Q 043720 112 LSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQV 191 (1103)
Q Consensus 112 L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l 191 (1103)
+.+..+.+++.++ +.++++|++|++++|.++ .+| .+..+++|++|+|++|++++ ++. +.++++|++|+|++|++
T Consensus 24 ~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~l~-~~~~l~~L~~L~L~~n~i~~-~~~-~~~l~~L~~L~L~~n~l 97 (308)
T 1h6u_A 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITD-LAP-LKNLTKITELELSGNPL 97 (308)
T ss_dssp HHTTCSSTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCCSCCEEECCSCCC
T ss_pred HHhCCCCcCceec--HHHcCCcCEEEeeCCCcc-Cch-hhhccCCCCEEEccCCcCCC-Chh-HccCCCCCEEEccCCcC
Confidence 3445555554332 456778888888888887 455 57778888888888888874 444 77888888888888887
Q ss_pred CCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccccc
Q 043720 192 KGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRE 271 (1103)
Q Consensus 192 ~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~ 271 (1103)
++. + .++.+++|++|++++|+++ .++. +. .+++|++|++++|++++..+ ++.+++|++|++++|.+++..+
T Consensus 98 ~~~-~-~~~~l~~L~~L~l~~n~l~-~~~~-l~-~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-- 168 (308)
T 1h6u_A 98 KNV-S-AIAGLQSIKTLDLTSTQIT-DVTP-LA-GLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (308)
T ss_dssp SCC-G-GGTTCTTCCEEECTTSCCC-CCGG-GT-TCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred CCc-h-hhcCCCCCCEEECCCCCCC-Cchh-hc-CCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--
Confidence 753 3 5677777777777777776 3443 32 34556666666666664322 5556666666666666655322
Q ss_pred ccCCCCCCEEEccCCcCCC
Q 043720 272 LGWLRKLEVLDVSRNRLNG 290 (1103)
Q Consensus 272 l~~l~~L~~L~Ls~N~l~~ 290 (1103)
+..+++|+.|++++|++++
T Consensus 169 l~~l~~L~~L~l~~n~l~~ 187 (308)
T 1h6u_A 169 LANLSKLTTLKADDNKISD 187 (308)
T ss_dssp GTTCTTCCEEECCSSCCCC
T ss_pred hcCCCCCCEEECCCCccCc
Confidence 5555666666666655553
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.83 E-value=8.5e-21 Score=200.79 Aligned_cols=160 Identities=21% Similarity=0.284 Sum_probs=132.9
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCc-ccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP-QSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
..+++++|++. .+|..+. ..+++|+|++|+|+++.+ ..|..+++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 14 ~~l~~s~n~l~-~iP~~~~---~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls 89 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP---QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLT 89 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECC
T ss_pred CEeEeCCCCcc-cCccCCC---CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECC
Confidence 47889998887 6887765 457899999999987744 457888999999999999987777788889999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPF 703 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~ 703 (1103)
+|++++..+..|..+++|++|+|++|+|++..|..|..+++|+.|+|++|+|++..|..|..+++|+.|+
T Consensus 90 ~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~---------- 159 (220)
T 2v70_A 90 SNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLN---------- 159 (220)
T ss_dssp SSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEE----------
T ss_pred CCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEE----------
Confidence 9999877777788889999999999999887788888888899999999988877788888888887764
Q ss_pred CCCccccccccccCCCCCCCCCCCCC
Q 043720 704 PWNVTTMNCSGVIGNPFLDPCQMYKD 729 (1103)
Q Consensus 704 p~~~~~~~~~~l~~Np~~c~C~~~~~ 729 (1103)
+.+|||.|+|++...
T Consensus 160 -----------L~~N~l~c~c~l~~l 174 (220)
T 2v70_A 160 -----------LLANPFNCNCYLAWL 174 (220)
T ss_dssp -----------CCSCCEECSGGGHHH
T ss_pred -----------ecCcCCcCCCchHHH
Confidence 557789999987553
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.82 E-value=3.3e-20 Score=211.40 Aligned_cols=196 Identities=18% Similarity=0.086 Sum_probs=156.1
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccc-cccCCCCCCE-EEccccccCCCCCCCCCCCCCCCEE
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPN-EFVGLRNLRV-LNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~-~l~~l~~L~~-L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
+++++|+|++|+|+..-+.+|.++++|++|+|++|.+.+.+|. .|.++++|++ +.++.|++++..|..|.++++|++|
T Consensus 30 ~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L 109 (350)
T 4ay9_X 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 109 (350)
T ss_dssp TTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEEETTCCEECTTSBCCCTTCCEE
T ss_pred CCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhcccCCcccccCchhhhhccccccc
Confidence 5789999999999954445789999999999999999877764 6788988875 6677899997778889999999999
Q ss_pred EccCCcCCCCCChhcccCCCCcEeeccc-ccCCCCCChhHHh-hcCcCcEEECcCCccccccCccccCCCCCCEEeCCC-
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSY-NELNGSIPSELGK-YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS- 261 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~-N~l~g~ip~~~~~-~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~- 261 (1103)
++++|++++..+..+....++..|++.+ |++. .+|...+. ....++.|+|++|+++ .+|.......+|+.|++.+
T Consensus 110 ~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~ 187 (350)
T 4ay9_X 110 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDN 187 (350)
T ss_dssp EEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTC
T ss_pred cccccccccCCchhhcccchhhhhhhccccccc-cccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccC
Confidence 9999999987777777788899999976 5666 66655433 3346899999999999 5666666678899999975
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEec
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL 307 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 307 (1103)
|.++.+.++.|..+++|++|||++|+|+...+..+. +|+.|.+
T Consensus 188 n~l~~i~~~~f~~l~~L~~LdLs~N~l~~lp~~~~~---~L~~L~~ 230 (350)
T 4ay9_X 188 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLE---NLKKLRA 230 (350)
T ss_dssp TTCCCCCTTTTTTEECCSEEECTTSCCCCCCSSSCT---TCCEEEC
T ss_pred CcccCCCHHHhccCcccchhhcCCCCcCccChhhhc---cchHhhh
Confidence 677765556789999999999999999955444444 4444444
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.82 E-value=8.3e-21 Score=208.52 Aligned_cols=152 Identities=13% Similarity=0.113 Sum_probs=120.9
Q ss_pred HHHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch-----------------hhHHHHHHHHHHHhcCCC
Q 043720 815 SIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-----------------HGVQQFHAEIKTLGNVRH 877 (1103)
Q Consensus 815 ~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~h 877 (1103)
.+......|.+.+.||+|+||.||+|...+|+.||||+++..... .....+.+|+.++++++|
T Consensus 84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~ 163 (282)
T 1zar_A 84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG 163 (282)
T ss_dssp HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence 344445567788999999999999998877999999999654321 135678999999999984
Q ss_pred CceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC
Q 043720 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957 (1103)
Q Consensus 878 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~ 957 (1103)
+++.+++.. +..|+||||+++++|.+ +.. .....++.|++.||+|||+. +|+||||||+||+++
T Consensus 164 ---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~ 227 (282)
T 1zar_A 164 ---LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS 227 (282)
T ss_dssp ---SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred ---CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE
Confidence 555554433 45699999999999988 421 23446999999999999999 999999999999999
Q ss_pred CCCCEEEeecccccccCCCCCccccCCcccccccCccccc
Q 043720 958 DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997 (1103)
Q Consensus 958 ~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~ 997 (1103)
++.+||+|||+++. +..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999863 33578899874
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=193.71 Aligned_cols=156 Identities=28% Similarity=0.379 Sum_probs=134.1
Q ss_pred ccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 544 GMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 544 ~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
...++++++++. .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|+...+..|..+++|+.|+|+
T Consensus 21 ~~~v~c~~~~l~-~ip~~~~---~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls 96 (229)
T 3e6j_A 21 GTTVDCRSKRHA-SVPAGIP---TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLG 96 (229)
T ss_dssp TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEeEccCCCcC-ccCCCCC---CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECC
Confidence 346889888886 8888776 789999999999998889999999999999999999986556678899999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPF 703 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~ 703 (1103)
+|+|++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|+|++..+..+..+++|+.|+
T Consensus 97 ~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~---------- 165 (229)
T 3e6j_A 97 TNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAY---------- 165 (229)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE----------
T ss_pred CCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEE----------
Confidence 99999777777889999999999999998 6788889999999999999999876667788888888774
Q ss_pred CCCccccccccccCCCCCCCCC
Q 043720 704 PWNVTTMNCSGVIGNPFLDPCQ 725 (1103)
Q Consensus 704 p~~~~~~~~~~l~~Np~~c~C~ 725 (1103)
+.+|||.|+|.
T Consensus 166 -----------l~~N~~~c~c~ 176 (229)
T 3e6j_A 166 -----------LFGNPWDCECR 176 (229)
T ss_dssp -----------CTTSCBCTTBG
T ss_pred -----------eeCCCccCCcc
Confidence 55778889996
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.6e-19 Score=216.27 Aligned_cols=189 Identities=24% Similarity=0.331 Sum_probs=164.6
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
+|+.|+|++|++++ +|..+. ++|++|+|++|.|+ .+| ..+++|++|+|++|+|++ +|. +.+ +|++|+|+
T Consensus 60 ~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~-~ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls 128 (571)
T 3cvr_A 60 QFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVD 128 (571)
T ss_dssp TCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCS-CCC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECC
T ss_pred CccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCc-ccc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECC
Confidence 89999999999996 888774 89999999999999 788 558999999999999996 888 766 99999999
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcc
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 267 (1103)
+|++++ +|. .+++|++|+|++|+++ .+|. .+++|++|+|++|++++ +|. +. ++|+.|+|++|.|+.
T Consensus 129 ~N~l~~-lp~---~l~~L~~L~Ls~N~l~-~lp~----~l~~L~~L~Ls~N~L~~-lp~-l~--~~L~~L~Ls~N~L~~- 194 (571)
T 3cvr_A 129 NNQLTM-LPE---LPALLEYINADNNQLT-MLPE----LPTSLEVLSVRNNQLTF-LPE-LP--ESLEALDVSTNLLES- 194 (571)
T ss_dssp SSCCSC-CCC---CCTTCCEEECCSSCCS-CCCC----CCTTCCEEECCSSCCSC-CCC-CC--TTCCEEECCSSCCSS-
T ss_pred CCcCCC-CCC---cCccccEEeCCCCccC-cCCC----cCCCcCEEECCCCCCCC-cch-hh--CCCCEEECcCCCCCc-
Confidence 999997 666 6899999999999999 4887 35789999999999996 777 66 899999999999995
Q ss_pred ccccccCCCCC-------CEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCccc
Q 043720 268 IPRELGWLRKL-------EVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFI 340 (1103)
Q Consensus 268 ~p~~l~~l~~L-------~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~ 340 (1103)
+|. +.. +| +.|+|++|+|+ .+|..+.++++|+.|+|++ |.+.
T Consensus 195 lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~---------------------------N~l~ 243 (571)
T 3cvr_A 195 LPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILED---------------------------NPLS 243 (571)
T ss_dssp CCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCS---------------------------SSCC
T ss_pred hhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeC---------------------------CcCC
Confidence 666 654 77 99999999999 5799899999999999985 7788
Q ss_pred ccCchhhhcccc
Q 043720 341 GSIPMEITTLSK 352 (1103)
Q Consensus 341 ~~ip~~~~~L~~ 352 (1103)
+.+|..+..++.
T Consensus 244 ~~~p~~l~~l~~ 255 (571)
T 3cvr_A 244 SRIRESLSQQTA 255 (571)
T ss_dssp HHHHHHHHHHHH
T ss_pred CcCHHHHHHhhc
Confidence 888888877654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.81 E-value=4.7e-20 Score=210.15 Aligned_cols=241 Identities=15% Similarity=0.092 Sum_probs=153.8
Q ss_pred CEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCC-hhcccCCCCcE-eecc
Q 043720 134 EVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIP-GFLGSFLKLRV-LFLS 211 (1103)
Q Consensus 134 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~-L~L~ 211 (1103)
++++.++++++ .+|..+ .+++++|+|++|+|+...+..|.++++|++|+|++|++.+.+| ..|.++++|++ +.++
T Consensus 12 ~~v~C~~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~ 88 (350)
T 4ay9_X 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88 (350)
T ss_dssp TEEEEESTTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred CEEEecCCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence 67888888888 777766 3678888888888883333467888888888888888766555 45677777664 4555
Q ss_pred cccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCC-ccCCccccccccCCC-CCCEEEccCCcCC
Q 043720 212 YNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS-NMLNDVIPRELGWLR-KLEVLDVSRNRLN 289 (1103)
Q Consensus 212 ~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~-N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~ 289 (1103)
.|+++ .+++..+..+++|++|++++|++++..+..+....++..|++.+ |.++...+..|..+. .++.|+|++|+|+
T Consensus 89 ~N~l~-~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~ 167 (350)
T 4ay9_X 89 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 167 (350)
T ss_dssp ETTCC-EECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred CCccc-ccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence 67776 55544444456677777777777655455555556666666644 455554445555543 4666667666666
Q ss_pred CcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCC-
Q 043720 290 GLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLP- 368 (1103)
Q Consensus 290 ~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p- 368 (1103)
. +|...... .+|+.+++.+++..+.+|
T Consensus 168 ~-i~~~~f~~---------------------------------------------------~~L~~l~l~~~n~l~~i~~ 195 (350)
T 4ay9_X 168 E-IHNSAFNG---------------------------------------------------TQLDELNLSDNNNLEELPN 195 (350)
T ss_dssp E-ECTTSSTT---------------------------------------------------EEEEEEECTTCTTCCCCCT
T ss_pred C-CChhhccc---------------------------------------------------cchhHHhhccCCcccCCCH
Confidence 3 33332233 344445554433333343
Q ss_pred ccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEecCCc
Q 043720 369 SSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNH 433 (1103)
Q Consensus 369 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~ls~N~ 433 (1103)
..|.++++|++|||++|+|+..++..|.++++|+.+++ .--..+|....+++|+.++++++.
T Consensus 196 ~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~---~~l~~lP~l~~l~~L~~l~l~~~~ 257 (350)
T 4ay9_X 196 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST---YNLKKLPTLEKLVALMEASLTYPS 257 (350)
T ss_dssp TTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC---TTCCCCCCTTTCCSCCEEECSCHH
T ss_pred HHhccCcccchhhcCCCCcCccChhhhccchHhhhccC---CCcCcCCCchhCcChhhCcCCCCc
Confidence 46788888888888888888777766666655555444 223355666778888888887654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=190.51 Aligned_cols=181 Identities=23% Similarity=0.253 Sum_probs=158.1
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 189 (1103)
+.+++++++++ .+|..+ .++|++|+|++|++++..+..|+.+++|++|+|++|++++..+..+.++++|++|+|++|
T Consensus 10 ~~v~c~~~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 10 TTVECYSQGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp TEEECCSSCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEecCCCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEECCCC
Confidence 46788888887 677655 468999999999999777777899999999999999999666667899999999999999
Q ss_pred cCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccc
Q 043720 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269 (1103)
Q Consensus 190 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 269 (1103)
++++..+..|+.+++|++|++++|+++ .+|...+..+++|++|+|++|++++..+..+..+++|++|++++|.+.+.
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-- 163 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-- 163 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCC--
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCc-ccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeecC--
Confidence 999877778899999999999999999 56666555568899999999999977677789999999999999988753
Q ss_pred ccccCCCCCCEEEccCCcCCCcCCccccCCCC
Q 043720 270 RELGWLRKLEVLDVSRNRLNGLIPTELGNCVE 301 (1103)
Q Consensus 270 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~ 301 (1103)
+++|++|+++.|+++|.+|.++++++.
T Consensus 164 -----~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 164 -----CPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp -----TTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred -----CCCHHHHHHHHHhCCceeeccCccccC
Confidence 568999999999999999999988765
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.5e-18 Score=184.72 Aligned_cols=133 Identities=26% Similarity=0.214 Sum_probs=81.7
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
++|++|+|++|.+++..|..+..+++|++|+|++|++++..+..|..+++|++|+|++|+|++..+..+..+++|++|+|
T Consensus 40 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L 119 (229)
T 3e6j_A 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFM 119 (229)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEECCCCcCCccChhHhCcchhhCeEec
Confidence 66777777777777666777777777777777777776444455666777777777777776544445566666666666
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLV 241 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~ 241 (1103)
++|+++ .+|..+..+++|++|+|++|+++ .+|...+..+++|++|+|++|.++
T Consensus 120 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~N~~~ 172 (229)
T 3e6j_A 120 CCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIPHGAFDRLSSLTHAYLFGNPWD 172 (229)
T ss_dssp CSSCCC-SCCTTGGGCTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECTTSCBC
T ss_pred cCCccc-ccCcccccCCCCCEEECCCCcCC-ccCHHHHhCCCCCCEEEeeCCCcc
Confidence 666666 45555556666666666666555 333332233344444444444444
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.78 E-value=3.7e-20 Score=230.32 Aligned_cols=229 Identities=18% Similarity=0.157 Sum_probs=105.6
Q ss_pred ChhhHHHHHHHHhhcc-CCCCcccCcCCCCCCCCceeeeEecCCCCeEEEEecCCCCCCCCCCccccccccccccccccc
Q 043720 4 VLPEKTILLEFKNSVS-DPSGILSSWQTNTSSHCSWFGVSCDSESRVVALNITGGDVSEGNSKPFFSCLMTAQFPFYGFG 82 (1103)
Q Consensus 4 ~~~~~~aLl~~k~~~~-d~~~~l~sW~~~~~~~C~W~GV~C~~~~~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 82 (1103)
...+++||+++..++. +....-++|.......+.|.|++++. .+++.+++.+..+..... .. +....+.
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~~~~-~~--------l~~l~Ls 199 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST-PLTPKIELFANGKDEANQ-AL--------LQHKKLS 199 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC-CccceEEeeCCCCCcchh-hH--------hhcCccC
Confidence 4678999999998884 33444567865444567899999985 578888776543322100 00 0000000
Q ss_pred cccceeccCCCccccccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEc
Q 043720 83 MRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162 (1103)
Q Consensus 83 ~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~L 162 (1103)
......++...+.....+..+..++.|+.|+|++|.+. .+|..+.++++|++|+|++|.|+ .+|..|+.|++|++|+|
T Consensus 200 ~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L 277 (727)
T 4b8c_D 200 QYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDL 277 (727)
T ss_dssp ----------------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEEC
T ss_pred cccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeC
Confidence 00000000001111123445666677777777777766 66666666777777777777776 66666777777777777
Q ss_pred cccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcccc
Q 043720 163 AFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG 242 (1103)
Q Consensus 163 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~ 242 (1103)
++|+|+ .+|..|++|++|++|+|++|.|+ .+|..|+++++|++|+|++|.|+|.+|..++.....+..|+|++|.+++
T Consensus 278 s~N~l~-~lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~ 355 (727)
T 4b8c_D 278 SHNRLT-SLPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEI 355 (727)
T ss_dssp TTSCCS-SCCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred cCCcCC-ccChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccC
Confidence 777776 66766777777777777777665 5566666777777777777777666665554432223345666666666
Q ss_pred ccCc
Q 043720 243 RIPS 246 (1103)
Q Consensus 243 ~~p~ 246 (1103)
.+|.
T Consensus 356 ~~p~ 359 (727)
T 4b8c_D 356 PLPH 359 (727)
T ss_dssp CCCC
T ss_pred cCcc
Confidence 6554
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.76 E-value=2.2e-18 Score=208.95 Aligned_cols=174 Identities=26% Similarity=0.374 Sum_probs=130.0
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
+..|++|+.|+|++|.+. .+| .+..+++|++|+|++|.+++..| +..+++|++|+|++|+|++ +| .+..+++|+
T Consensus 39 ~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~-l~-~l~~l~~L~ 112 (605)
T 1m9s_A 39 QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIKD-LS-SLKDLKKLK 112 (605)
T ss_dssp HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCCC-CT-TSTTCTTCC
T ss_pred hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCCC-Ch-hhccCCCCC
Confidence 456788888888888887 344 57788888888888888885544 7888888888888888874 44 678888888
Q ss_pred EEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCc
Q 043720 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262 (1103)
Q Consensus 183 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 262 (1103)
+|+|++|.+++. ..+..+++|+.|+|++|++++ + ..+.. +++|+.|+|++|++++..| +..+++|+.|+|++|
T Consensus 113 ~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l-~~l~~-l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N 185 (605)
T 1m9s_A 113 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-I-TVLSR-LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 185 (605)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCC-C-GGGGS-CTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEEecCCCCCCC--ccccCCCccCEEECCCCccCC-c-hhhcc-cCCCCEEECcCCcCCCchh--hccCCCCCEEECcCC
Confidence 888888888853 347778888888888888873 4 33433 4678888888888876544 777788888888888
Q ss_pred cCCccccccccCCCCCCEEEccCCcCCCc
Q 043720 263 MLNDVIPRELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 263 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
.|++. ..+..+++|+.|+|++|++.+.
T Consensus 186 ~i~~l--~~l~~l~~L~~L~L~~N~l~~~ 212 (605)
T 1m9s_A 186 HISDL--RALAGLKNLDVLELFSQECLNK 212 (605)
T ss_dssp CCCBC--GGGTTCTTCSEEECCSEEEECC
T ss_pred CCCCC--hHHccCCCCCEEEccCCcCcCC
Confidence 87764 3577777888888888877654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.9e-18 Score=191.19 Aligned_cols=174 Identities=25% Similarity=0.363 Sum_probs=135.8
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
++.+++|++|++++|.+.+ +| .+..+++|++|+|++|++++..+ +..+++|++|+|++|++++ +| .+.++++|+
T Consensus 42 ~~~l~~L~~L~l~~~~i~~-~~-~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~-~l~~l~~L~ 115 (291)
T 1h6t_A 42 QNELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLK 115 (291)
T ss_dssp HHHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCC
T ss_pred hhhcCcccEEEccCCCccc-Ch-hHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC-Ch-hhccCCCCC
Confidence 4567888889998888873 44 47888888999999888885444 8888889999998888884 44 488888888
Q ss_pred EEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCc
Q 043720 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262 (1103)
Q Consensus 183 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 262 (1103)
+|++++|++++. ..++.+++|++|++++|+++ .+ ..+.. +++|++|++++|++++..+ +..+++|+.|++++|
T Consensus 116 ~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~-~~-~~l~~-l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~L~~N 188 (291)
T 1h6t_A 116 SLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT-DI-TVLSR-LTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188 (291)
T ss_dssp EEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC-CC-GGGGG-CTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSS
T ss_pred EEECCCCcCCCC--hhhcCCCCCCEEEccCCcCC-cc-hhhcc-CCCCCEEEccCCccccchh--hcCCCccCEEECCCC
Confidence 888888888863 45778888888888888888 44 34443 5778888888888886544 788888888888888
Q ss_pred cCCccccccccCCCCCCEEEccCCcCCCc
Q 043720 263 MLNDVIPRELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 263 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
.+++. + .+..+++|+.|++++|+++..
T Consensus 189 ~i~~l-~-~l~~l~~L~~L~l~~n~i~~~ 215 (291)
T 1h6t_A 189 HISDL-R-ALAGLKNLDVLELFSQECLNK 215 (291)
T ss_dssp CCCBC-G-GGTTCTTCSEEEEEEEEEECC
T ss_pred cCCCC-h-hhccCCCCCEEECcCCcccCC
Confidence 88774 3 478888888888888888753
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.76 E-value=4.4e-18 Score=179.85 Aligned_cols=152 Identities=20% Similarity=0.304 Sum_probs=93.9
Q ss_pred EEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeeccccc
Q 043720 135 VLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214 (1103)
Q Consensus 135 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~ 214 (1103)
.++++++.++ .+|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|++++..|..|..+++|++|+|++|+
T Consensus 15 ~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~ 91 (220)
T 2v9t_B 15 IVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNK 91 (220)
T ss_dssp EEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEEECCSSC
T ss_pred EEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEEECCCCc
Confidence 3444444444 3443332 445555555555554444455555555555555555555555555556666666666666
Q ss_pred CCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCC
Q 043720 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG 290 (1103)
Q Consensus 215 l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 290 (1103)
++ .+|...+..+++|++|+|++|++++..|..+..+++|++|+|++|++++..+..|..+++|+.|+|++|.+..
T Consensus 92 l~-~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 92 IT-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp CC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CC-ccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcCC
Confidence 65 5555554445666666666676666666677777778888888888877666677778888888888887763
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.75 E-value=8.3e-18 Score=177.74 Aligned_cols=133 Identities=20% Similarity=0.227 Sum_probs=74.2
Q ss_pred CEEEccccccCCCCC-CCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECc
Q 043720 158 RVLNLAFNRIDGDIP-FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLS 236 (1103)
Q Consensus 158 ~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~ 236 (1103)
++|+|++|+|++..| ..+.++++|++|+|++|++++..+..|+.+++|++|+|++|+++ .++...+..+++|++|+|+
T Consensus 35 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls 113 (220)
T 2v70_A 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKTLMLR 113 (220)
T ss_dssp SEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-CCCGGGGTTCSSCCEEECT
T ss_pred CEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCCccC-ccCHhHhcCCcCCCEEECC
Confidence 444444444443322 22344444444444444444444444444555555555555554 2333322334555666666
Q ss_pred CCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCc
Q 043720 237 GNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 237 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
+|++++..|..+..+++|++|+|++|++++..|..|..+++|+.|+|++|.+++.
T Consensus 114 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 114 SNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCN 168 (220)
T ss_dssp TSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECS
T ss_pred CCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCC
Confidence 6666655566666777777777777777776677777777777777777777654
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.74 E-value=7.1e-18 Score=204.42 Aligned_cols=188 Identities=27% Similarity=0.295 Sum_probs=158.0
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
..+..+.|..+.+.+.++ +..+++|+.|+|++|.+. .+| .+..+++|++|+|++|+|++..| +.++++|+.|+|
T Consensus 21 ~~l~~l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~L 94 (605)
T 1m9s_A 21 AETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFL 94 (605)
T ss_dssp HHHHHHHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCC-CCT-TGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEEC
T ss_pred HHHHHHhccCCCcccccc--hhcCCCCCEEECcCCCCC-CCh-HHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEEC
Confidence 345556777777775544 567899999999999998 455 58999999999999999996444 899999999999
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
++|.+++ +| .++.+++|++|+|++|+++ .++ .+.. +++|+.|+|++|++++. ..+..+++|+.|+|++|.+++
T Consensus 95 s~N~l~~-l~-~l~~l~~L~~L~Ls~N~l~-~l~-~l~~-l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~ 167 (605)
T 1m9s_A 95 DENKIKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD 167 (605)
T ss_dssp CSSCCCC-CT-TSTTCTTCCEEECTTSCCC-CCG-GGGG-CTTCSEEECCSSCCCCC--GGGGSCTTCSEEECCSSCCCC
T ss_pred cCCCCCC-Ch-hhccCCCCCEEEecCCCCC-CCc-cccC-CCccCEEECCCCccCCc--hhhcccCCCCEEECcCCcCCC
Confidence 9999996 33 6899999999999999998 454 4444 58899999999999964 678999999999999999998
Q ss_pred cccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCc
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~ 311 (1103)
..| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|.
T Consensus 168 ~~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~ 208 (605)
T 1m9s_A 168 IVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQE 208 (605)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEE
T ss_pred chh--hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCc
Confidence 766 89999999999999999864 468889999999998643
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.74 E-value=9.7e-18 Score=185.45 Aligned_cols=187 Identities=27% Similarity=0.276 Sum_probs=158.2
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
.+..+.+..+.+++..+ +..+++|++|++++|.++ .++ .+..+++|++|+|++|++++. +. +.++++|++|+++
T Consensus 25 ~~~~~~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~-~~~-~~~~l~~L~~L~L~~n~l~~~-~~-l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 25 ETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQ-GIQYLPNVTKLFLNGNKLTDI-KP-LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHHTTCSCTTSEEC--HHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECC
T ss_pred HHHHHHhcCCCcccccc--hhhcCcccEEEccCCCcc-cCh-hHhcCCCCCEEEccCCccCCC-cc-cccCCCCCEEECC
Confidence 34445566677765433 467899999999999998 445 489999999999999999954 44 9999999999999
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcc
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV 267 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~ 267 (1103)
+|.+++ ++ .++.+++|++|++++|+++ .++ .+.. +++|++|++++|++++. ..++.+++|++|++++|++++.
T Consensus 99 ~n~l~~-~~-~l~~l~~L~~L~L~~n~i~-~~~-~l~~-l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~ 171 (291)
T 1h6t_A 99 ENKVKD-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVH-LPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDI 171 (291)
T ss_dssp SSCCCC-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGG-CTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCC
T ss_pred CCcCCC-Ch-hhccCCCCCEEECCCCcCC-CCh-hhcC-CCCCCEEEccCCcCCcc--hhhccCCCCCEEEccCCccccc
Confidence 999996 33 4899999999999999998 454 4544 58899999999999964 6899999999999999999996
Q ss_pred ccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCc
Q 043720 268 IPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLF 311 (1103)
Q Consensus 268 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~ 311 (1103)
.+ +..+++|+.|+|++|++++. + .+..+++|+.|++++|.
T Consensus 172 ~~--l~~l~~L~~L~L~~N~i~~l-~-~l~~l~~L~~L~l~~n~ 211 (291)
T 1h6t_A 172 VP--LAGLTKLQNLYLSKNHISDL-R-ALAGLKNLDVLELFSQE 211 (291)
T ss_dssp GG--GTTCTTCCEEECCSSCCCBC-G-GGTTCTTCSEEEEEEEE
T ss_pred hh--hcCCCccCEEECCCCcCCCC-h-hhccCCCCCEEECcCCc
Confidence 55 99999999999999999964 4 59999999999999754
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.73 E-value=5.7e-18 Score=193.68 Aligned_cols=175 Identities=23% Similarity=0.201 Sum_probs=116.2
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCcccccc-CCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFV-GLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (1103)
+.+++++++++ .+|..+. ..+++|+|++|+|++..+..+. .+++|++|+|++|+|++..|..|.++++|++|+|++
T Consensus 21 ~~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~ 97 (361)
T 2xot_A 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97 (361)
T ss_dssp TEEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CEEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCC
Confidence 46777777776 5666554 3467777777777765565665 777777777777777755556677777777777777
Q ss_pred CcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCcc-c---cCCCCCCEEeCCCccC
Q 043720 189 NQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSS-L---GKCQQLRTLLLFSNML 264 (1103)
Q Consensus 189 n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~-l---~~l~~L~~L~L~~N~l 264 (1103)
|+|++..+..|..+++|++|+|++|++++..|..+. .+++|++|+|++|++++ +|.. + ..+++|+.|+|++|+|
T Consensus 98 N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~-~l~~L~~L~L~~N~l~~-l~~~~~~~~~~l~~L~~L~L~~N~l 175 (361)
T 2xot_A 98 NHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE-DMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKL 175 (361)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTT-TCTTCCEEECCSSCCCS-CCGGGTC----CTTCCEEECCSSCC
T ss_pred CcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhC-CcccCCEEECCCCcCCe-eCHHHhcCcccCCcCCEEECCCCCC
Confidence 777766666677777777777777777633333333 34667777777777764 3333 3 4567777777777777
Q ss_pred CccccccccCCCC--CCEEEccCCcCC
Q 043720 265 NDVIPRELGWLRK--LEVLDVSRNRLN 289 (1103)
Q Consensus 265 ~~~~p~~l~~l~~--L~~L~Ls~N~l~ 289 (1103)
++..+..+..++. |+.|+|++|.+.
T Consensus 176 ~~l~~~~~~~l~~~~l~~l~l~~N~~~ 202 (361)
T 2xot_A 176 KKLPLTDLQKLPAWVKNGLYLHNNPLE 202 (361)
T ss_dssp CCCCHHHHHHSCHHHHTTEECCSSCEE
T ss_pred CccCHHHhhhccHhhcceEEecCCCcc
Confidence 7655566666665 366777777765
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.73 E-value=7.1e-20 Score=220.74 Aligned_cols=122 Identities=28% Similarity=0.377 Sum_probs=102.2
Q ss_pred CccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEecc
Q 043720 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELS 647 (1103)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 647 (1103)
.|++|+|++|+|++ +|. |..+++|+.|+|++|+|+ .+|..|+.+++|+.|+|++|+|++ +| .|+.+++|++|+|+
T Consensus 442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls 516 (567)
T 1dce_A 442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC 516 (567)
T ss_dssp TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence 47889999999986 465 888999999999999998 788899999999999999999985 66 88899999999999
Q ss_pred CccccCcC-hhhhhhcccccccccccccCcCCCCcc---ccCCCCCceEeC
Q 043720 648 SNSLSGEV-PEGVVNLRNLTALLLDNNKLSGHLPSG---LANVTSLSIFNA 694 (1103)
Q Consensus 648 ~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~---l~~l~~L~~l~l 694 (1103)
+|+|++.. |..+..+++|+.|+|++|+|++.+|.. +..+++|+.||+
T Consensus 517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 99998776 888999999999999999998665532 234788888764
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.73 E-value=1e-17 Score=172.99 Aligned_cols=137 Identities=24% Similarity=0.344 Sum_probs=98.9
Q ss_pred cEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCc
Q 043720 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSN 649 (1103)
Q Consensus 570 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 649 (1103)
+++++++|+|+ .+|..+. ++|++|+|++|+|+ .+|..|..+++|+.|+|++|+|++..+..|.++++|++|+|++|
T Consensus 13 ~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N 88 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN 88 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred CEEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence 45666666666 3344332 46777777777776 56677777777777777777777666677777888888888888
Q ss_pred cccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCccccccccccCCCCCCCCCCCCC
Q 043720 650 SLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQMYKD 729 (1103)
Q Consensus 650 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~l~~Np~~c~C~~~~~ 729 (1103)
+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+ +.+|||.|||++..+
T Consensus 89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~---------------------L~~N~~~C~c~l~~l 147 (193)
T 2wfh_A 89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLA---------------------IGANPLYCDCNMQWL 147 (193)
T ss_dssp CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEE---------------------CCSSCEECSGGGHHH
T ss_pred ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEE---------------------eCCCCeecCCcCHHH
Confidence 88777777777788888888888888765556677777777764 567899999998654
Q ss_pred CC
Q 043720 730 IS 731 (1103)
Q Consensus 730 ~~ 731 (1103)
..
T Consensus 148 ~~ 149 (193)
T 2wfh_A 148 SD 149 (193)
T ss_dssp HH
T ss_pred HH
Confidence 33
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.72 E-value=3.9e-20 Score=223.00 Aligned_cols=147 Identities=22% Similarity=0.117 Sum_probs=71.9
Q ss_pred CCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEe
Q 043720 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208 (1103)
Q Consensus 129 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 208 (1103)
.+++|+.|+|++|+++ .+|.+++.+++|+.|++++|.....+|.. +..+.+.+.+|..++.+++|+.|
T Consensus 347 ~~~~L~~L~Ls~n~L~-~Lp~~i~~l~~L~~L~l~~n~~l~~l~~l-----------l~~~~~~~~~~~~l~~l~~L~~L 414 (567)
T 1dce_A 347 TDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILL-----------MRALDPLLYEKETLQYFSTLKAV 414 (567)
T ss_dssp TTTTSSSCCCCHHHHH-HHHHHHHHHHHHHHHCTTCHHHHHHHHHH-----------HHHHCTGGGHHHHHHHHHHHHHH
T ss_pred cCccceeccCChhhHH-hhHHHHHHHHHHHHhccccchhhhhHHHH-----------HHhcccccCCHHHHHHHHhcccC
Confidence 3445555555555554 45555555555555555443311011100 00112445666677777777777
Q ss_pred e-cccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCc
Q 043720 209 F-LSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNR 287 (1103)
Q Consensus 209 ~-L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 287 (1103)
+ ++.|.+. .|+.+.+++|.++...+ ..|+.|+|++|.|++ +|. ++.+++|+.|+|++|+
T Consensus 415 ~~l~~n~~~------------~L~~l~l~~n~i~~l~~------~~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~ 474 (567)
T 1dce_A 415 DPMRAAYLD------------DLRSKFLLENSVLKMEY------ADVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNR 474 (567)
T ss_dssp CGGGHHHHH------------HHHHHHHHHHHHHHHHH------TTCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSC
T ss_pred cchhhcccc------------hhhhhhhhcccccccCc------cCceEEEecCCCCCC-CcC-ccccccCcEeecCccc
Confidence 7 5655443 13333444444442211 135555555555555 343 5555555555555555
Q ss_pred CCCcCCccccCCCCCCeEecc
Q 043720 288 LNGLIPTELGNCVELSVLVLS 308 (1103)
Q Consensus 288 l~~~~p~~l~~l~~L~~L~l~ 308 (1103)
|+ .+|..++++++|+.|+|+
T Consensus 475 l~-~lp~~~~~l~~L~~L~Ls 494 (567)
T 1dce_A 475 LR-ALPPALAALRCLEVLQAS 494 (567)
T ss_dssp CC-CCCGGGGGCTTCCEEECC
T ss_pred cc-ccchhhhcCCCCCEEECC
Confidence 55 445555555555555554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.9e-17 Score=171.08 Aligned_cols=103 Identities=27% Similarity=0.326 Sum_probs=54.9
Q ss_pred CCCEEEccCCcCCCCCCc-ccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhccccccccc
Q 043720 592 SLVFLDLNGNKLQGEIPS-SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLL 670 (1103)
Q Consensus 592 ~L~~L~Ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 670 (1103)
+|++|+|++|+|++..+. .|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|
T Consensus 30 ~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 109 (192)
T 1w8a_A 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNL 109 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCCcCCccCHHHhcCCCCCCEEEC
Confidence 445555555555433322 2455555555555555555544555555555555555555555544445555555555555
Q ss_pred ccccCcCCCCccccCCCCCceEeC
Q 043720 671 DNNKLSGHLPSGLANVTSLSIFNA 694 (1103)
Q Consensus 671 ~~N~l~~~~p~~l~~l~~L~~l~l 694 (1103)
++|+|++.+|..+..+++|+.|++
T Consensus 110 ~~N~l~~~~~~~~~~l~~L~~L~L 133 (192)
T 1w8a_A 110 YDNQISCVMPGSFEHLNSLTSLNL 133 (192)
T ss_dssp CSSCCCEECTTSSTTCTTCCEEEC
T ss_pred CCCcCCeeCHHHhhcCCCCCEEEe
Confidence 555555555555655666665543
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=2.9e-17 Score=170.56 Aligned_cols=153 Identities=19% Similarity=0.227 Sum_probs=79.1
Q ss_pred CCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCE
Q 043720 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183 (1103)
Q Consensus 104 ~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (1103)
+.+++|++|++++|.++ .+| .+..+++|++|++++|.++ .+..+..+++|++|+|++|++++..|..++.+++|++
T Consensus 41 ~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~ 116 (197)
T 4ezg_A 41 AQMNSLTYITLANINVT-DLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL 116 (197)
T ss_dssp HHHHTCCEEEEESSCCS-CCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCE
T ss_pred hhcCCccEEeccCCCcc-ChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCE
Confidence 44555555666555555 444 4555555555555555443 2224555555555555555555445555555555555
Q ss_pred EEccCCcCCCCCChhcccCCCCcEeeccccc-CCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCc
Q 043720 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE-LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262 (1103)
Q Consensus 184 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 262 (1103)
|++++|++++..|..++.+++|++|++++|+ ++ .+| .+..+++|++|++++|
T Consensus 117 L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~--------------------------~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 117 LDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM--------------------------PLKTLPELKSLNIQFD 169 (197)
T ss_dssp EECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG--------------------------GGGGCSSCCEEECTTB
T ss_pred EEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH--------------------------hhcCCCCCCEEECCCC
Confidence 5555555555445555555555555555554 32 333 3444555555555555
Q ss_pred cCCccccccccCCCCCCEEEccCCcCC
Q 043720 263 MLNDVIPRELGWLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 263 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 289 (1103)
.+++. + .+..+++|+.|++++|++.
T Consensus 170 ~i~~~-~-~l~~l~~L~~L~l~~N~i~ 194 (197)
T 4ezg_A 170 GVHDY-R-GIEDFPKLNQLYAFSQTIG 194 (197)
T ss_dssp CCCCC-T-TGGGCSSCCEEEECBC---
T ss_pred CCcCh-H-HhccCCCCCEEEeeCcccC
Confidence 55542 2 4555555555555555554
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=171.54 Aligned_cols=173 Identities=21% Similarity=0.235 Sum_probs=141.1
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcc-cccCCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQ-SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
..+++++|++. .+|..+. .++++|+|++|+|+++.+. .|..+++|++|+|++|+|++..|..|..+++|++|+|+
T Consensus 11 ~~l~~s~~~l~-~ip~~~~---~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcC-cCccCCC---CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECC
Confidence 57899999995 8998776 5899999999999977765 58999999999999999998889999999999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCcc-ccCCCCCceEeCCCCCCCCC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSG-LANVTSLSIFNASFNNLSGP 702 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~-l~~l~~L~~l~l~~N~l~~~ 702 (1103)
+|+|++..+..|.++++|++|+|++|+|++..|..+..+++|+.|+|++|++++..+.. +. ..++...+..+.....
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l~~~~--~~l~~~~~~~~~~~C~ 164 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFA--EWLRKKSLNGGAARCG 164 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHH--HHHHHHCCSGGGCBBC
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcchHHH--HHHHHcCCCCCCCCCC
Confidence 99999988888999999999999999999988999999999999999999998654421 11 1122223344444444
Q ss_pred CCCCccccccccccCCCCCCC
Q 043720 703 FPWNVTTMNCSGVIGNPFLDP 723 (1103)
Q Consensus 703 ~p~~~~~~~~~~l~~Np~~c~ 723 (1103)
.|..+....-..+..+.+.|+
T Consensus 165 ~P~~l~~~~l~~l~~~~~~C~ 185 (192)
T 1w8a_A 165 APSKVRDVQIKDLPHSEFKCS 185 (192)
T ss_dssp SSTTTTTSBGGGSCTTTCCCC
T ss_pred CChHHcCCChhhCcHhhcCcC
Confidence 555555555556667777775
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.71 E-value=3.2e-17 Score=170.14 Aligned_cols=138 Identities=17% Similarity=0.216 Sum_probs=116.0
Q ss_pred cccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCC
Q 043720 97 GKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLR 176 (1103)
Q Consensus 97 g~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~ 176 (1103)
..+| .+..+++|++|++++|.++ .++.+..+++|++|+|++|.+++..|..++.+++|++|+|++|++++..|..++
T Consensus 57 ~~l~-~l~~l~~L~~L~l~~n~~~--~~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~ 133 (197)
T 4ezg_A 57 TDLT-GIEYAHNIKDLTINNIHAT--NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKIN 133 (197)
T ss_dssp SCCT-TGGGCTTCSEEEEESCCCS--CCGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHT
T ss_pred cChH-HHhcCCCCCEEEccCCCCC--cchhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHh
Confidence 3566 6899999999999999765 445899999999999999999988999999999999999999999988899999
Q ss_pred CCCCCCEEEccCCc-CCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcccc
Q 043720 177 NFESLEVLNLAGNQ-VKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG 242 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~-l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~ 242 (1103)
.+++|++|++++|. ++ .+| .+..+++|++|++++|+++ .++ .+.. +++|++|++++|++.+
T Consensus 134 ~l~~L~~L~L~~n~~i~-~~~-~l~~l~~L~~L~l~~n~i~-~~~-~l~~-l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 134 TLPKVNSIDLSYNGAIT-DIM-PLKTLPELKSLNIQFDGVH-DYR-GIED-FPKLNQLYAFSQTIGG 195 (197)
T ss_dssp TCSSCCEEECCSCTBCC-CCG-GGGGCSSCCEEECTTBCCC-CCT-TGGG-CSSCCEEEECBC----
T ss_pred hCCCCCEEEccCCCCcc-ccH-hhcCCCCCCEEECCCCCCc-ChH-Hhcc-CCCCCEEEeeCcccCC
Confidence 99999999999998 55 555 6889999999999999998 455 3443 4678888888887653
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.70 E-value=1.1e-17 Score=181.90 Aligned_cols=171 Identities=25% Similarity=0.316 Sum_probs=108.7
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEE
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
++.++..++++.|.+++ ++ .+..+++|++|++++|.++ .+| .+..+++|++|+|++|++++ +|. +.++++|++|
T Consensus 17 ~l~~l~~l~l~~~~i~~-~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~-~~~-l~~l~~L~~L 90 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTD-LV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISD-LSP-LKDLTKLEEL 90 (263)
T ss_dssp HHHHHHHHHHTCSCTTS-EE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCSSCCEE
T ss_pred HHHHHHHHHhcCCCccc-cc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCC-Chh-hccCCCCCEE
Confidence 45566677777777763 33 4667777777777777777 455 57777777777777777774 333 7777777777
Q ss_pred EccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccC
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 264 (1103)
+|++|++++ +|.. .. ++|++|+|++|+++ .++ .+.. +++|++|+|++|++++. + .++.+++|+.|+|++|++
T Consensus 91 ~L~~N~l~~-l~~~-~~-~~L~~L~L~~N~l~-~~~-~l~~-l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i 162 (263)
T 1xeu_A 91 SVNRNRLKN-LNGI-PS-ACLSRLFLDNNELR-DTD-SLIH-LKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEI 162 (263)
T ss_dssp ECCSSCCSC-CTTC-CC-SSCCEEECCSSCCS-BSG-GGTT-CTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCC
T ss_pred ECCCCccCC-cCcc-cc-CcccEEEccCCccC-CCh-hhcC-cccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcC
Confidence 777777775 3332 22 66777777777766 333 2332 45566666666666643 2 466666666666666666
Q ss_pred CccccccccCCCCCCEEEccCCcCCCc
Q 043720 265 NDVIPRELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 265 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
++. ..+..+++|+.|++++|++++.
T Consensus 163 ~~~--~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 163 TNT--GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp CBC--TTSTTCCCCCEEEEEEEEEECC
T ss_pred cch--HHhccCCCCCEEeCCCCcccCC
Confidence 654 4556666666666666666543
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.69 E-value=1.1e-17 Score=181.92 Aligned_cols=164 Identities=24% Similarity=0.304 Sum_probs=73.4
Q ss_pred CCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeec
Q 043720 131 EKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFL 210 (1103)
Q Consensus 131 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 210 (1103)
.++..+++++|.++ .++ .+..+++|++|++++|+++ .+| .+..+++|++|+|++|++++..+ ++.+++|++|+|
T Consensus 19 ~~l~~l~l~~~~i~-~~~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L 92 (263)
T 1xeu_A 19 ANAVKQNLGKQSVT-DLV-SQKELSGVQNFNGDNSNIQ-SLA-GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSV 92 (263)
T ss_dssp HHHHHHHHTCSCTT-SEE-CHHHHTTCSEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEEC
T ss_pred HHHHHHHhcCCCcc-ccc-chhhcCcCcEEECcCCCcc-cch-HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEEC
Confidence 33444444444444 222 3444444445555444444 333 34444445555555444443322 444444455555
Q ss_pred ccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCC
Q 043720 211 SYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG 290 (1103)
Q Consensus 211 ~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 290 (1103)
++|+++ .+|.... ++|++|+|++|++++. +.++.+++|+.|+|++|++++. + .+..+++|+.|+|++|++++
T Consensus 93 ~~N~l~-~l~~~~~---~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~ 164 (263)
T 1xeu_A 93 NRNRLK-NLNGIPS---ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSI-V-MLGFLSKLEVLDLHGNEITN 164 (263)
T ss_dssp CSSCCS-CCTTCCC---SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCBC-G-GGGGCTTCCEEECTTSCCCB
T ss_pred CCCccC-CcCcccc---CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCCC-h-HHccCCCCCEEECCCCcCcc
Confidence 544444 2332211 3344455555444431 2344444445555555444442 2 34444445555555544443
Q ss_pred cCCccccCCCCCCeEecccC
Q 043720 291 LIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 291 ~~p~~l~~l~~L~~L~l~~~ 310 (1103)
. ..+..+++|+.|++++|
T Consensus 165 ~--~~l~~l~~L~~L~l~~N 182 (263)
T 1xeu_A 165 T--GGLTRLKKVNWIDLTGQ 182 (263)
T ss_dssp C--TTSTTCCCCCEEEEEEE
T ss_pred h--HHhccCCCCCEEeCCCC
Confidence 3 34444444444444444
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.67 E-value=4.8e-17 Score=176.39 Aligned_cols=137 Identities=18% Similarity=0.222 Sum_probs=106.8
Q ss_pred CCCcceeccCCcccEEEEEE-cCCcE--EEEEEcccccch-----------------------hhHHHHHHHHHHHhcCC
Q 043720 823 FNTSNCIGSGGFGTTYKAEI-SPGIL--VAVKKLAVGRFQ-----------------------HGVQQFHAEIKTLGNVR 876 (1103)
Q Consensus 823 ~~~~~~lg~G~fg~V~~~~~-~~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~ 876 (1103)
|++.+.||+|+||.||+|.. .+|+. ||||+++..... .....+.+|+..++++.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56788999999999999987 67888 999987543211 11236788999999998
Q ss_pred CCce--eEEEeEEecCCeEEEEEeecCC-C----ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHH-hCCCCCcccCC
Q 043720 877 HPNL--VTLIGYRASGNEMFLIYNYLPG-G----NLENFIKARTSRAVDWKILHKIALDVASALAYLH-DQCAPRVLHRD 948 (1103)
Q Consensus 877 h~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH-~~~~~~ivH~D 948 (1103)
|+++ ..++++ +..++||||+.+ | +|.++... .++..+..++.|++.|+.||| +. +|+|||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~---givHrD 196 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEA---ELVHAD 196 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTS---CEECSS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHC---CEEeCC
Confidence 7754 344443 346899999942 4 66665432 234567889999999999999 88 999999
Q ss_pred CCCCcEEECCCCCEEEeeccccccc
Q 043720 949 VKPSNILLDDDFNAYLSDFGLSRLL 973 (1103)
Q Consensus 949 lk~~NIll~~~~~~ki~Dfgla~~~ 973 (1103)
|||+|||++. .++|+|||+|...
T Consensus 197 lkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 197 LSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp CSTTSEEESS--SEEECCCTTCEET
T ss_pred CCHHHEEEcC--cEEEEECcccccC
Confidence 9999999998 9999999999754
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.66 E-value=5.5e-17 Score=201.84 Aligned_cols=153 Identities=27% Similarity=0.333 Sum_probs=54.0
Q ss_pred CCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCC---------CCCCCCCCCCCCCEEEccCCcCCCCCChhccc
Q 043720 131 EKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDG---------DIPFSLRNFESLEVLNLAGNQVKGVIPGFLGS 201 (1103)
Q Consensus 131 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~---------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 201 (1103)
+.++.|+|++|.+.. +|..+ |+.++|+.|.|++ ..|..+..+++|+.|+|++|.+. .+|..+..
T Consensus 173 ~~~~~l~L~~n~~~~-~~~~~-----l~~l~Ls~~~i~~~~~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~ 245 (727)
T 4b8c_D 173 PLTPKIELFANGKDE-ANQAL-----LQHKKLSQYSIDEDDDIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFK 245 (727)
T ss_dssp -------------------------------------------------------CCCCCCEEECTTSCCS-CCCGGGGG
T ss_pred CccceEEeeCCCCCc-chhhH-----hhcCccCcccccCccccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcC
Confidence 557888888888874 44433 4444455544432 23444455555555555555554 34444444
Q ss_pred CCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEE
Q 043720 202 FLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVL 281 (1103)
Q Consensus 202 l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 281 (1103)
+++|++|+|++|+|+ .+|..++. +++|++|+|++|+|+ .+|..++++++|++|+|++|.|+. +|..|+.+++|+.|
T Consensus 246 l~~L~~L~Ls~N~l~-~lp~~~~~-l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~-lp~~~~~l~~L~~L 321 (727)
T 4b8c_D 246 YDFLTRLYLNGNSLT-ELPAEIKN-LSNLRVLDLSHNRLT-SLPAELGSCFQLKYFYFFDNMVTT-LPWEFGNLCNLQFL 321 (727)
T ss_dssp CCSCSCCBCTTSCCS-CCCGGGGG-GTTCCEEECTTSCCS-SCCSSGGGGTTCSEEECCSSCCCC-CCSSTTSCTTCCCE
T ss_pred CCCCCEEEeeCCcCc-ccChhhhC-CCCCCEEeCcCCcCC-ccChhhcCCCCCCEEECCCCCCCc-cChhhhcCCCccEE
Confidence 555555555555554 44444433 244555555555544 344444444444444444444432 34444444444444
Q ss_pred EccCCcCCCcCCc
Q 043720 282 DVSRNRLNGLIPT 294 (1103)
Q Consensus 282 ~Ls~N~l~~~~p~ 294 (1103)
+|++|.|++.+|.
T Consensus 322 ~L~~N~l~~~~p~ 334 (727)
T 4b8c_D 322 GVEGNPLEKQFLK 334 (727)
T ss_dssp ECTTSCCCSHHHH
T ss_pred eCCCCccCCCChH
Confidence 4444444444333
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.64 E-value=1.5e-16 Score=179.59 Aligned_cols=103 Identities=16% Similarity=0.044 Sum_probs=72.9
Q ss_pred cCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCc-EEeccCcccCCCCCCcccCCCCCcE
Q 043720 565 MCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLR-HLSLADNNLTGGIPSSIGELRSLEV 643 (1103)
Q Consensus 565 ~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~ 643 (1103)
.+++|+.|+|++|+++.+.+.+|.++++|+.|+|++| ++..-+.+|.++.+|+ .++|.+ +++...+..|.++++|+.
T Consensus 224 ~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~ 301 (329)
T 3sb4_A 224 YMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRY 301 (329)
T ss_dssp HCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEE
T ss_pred hcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCE
Confidence 3577778888877777666677777777777777777 6645556677777777 777776 666555667777777777
Q ss_pred EeccCccccCcChhhhhhcccccccc
Q 043720 644 LELSSNSLSGEVPEGVVNLRNLTALL 669 (1103)
Q Consensus 644 L~Ls~N~l~~~~~~~~~~l~~L~~L~ 669 (1103)
|++++|+++.+.+.+|.++++|+.|+
T Consensus 302 l~l~~n~i~~I~~~aF~~~~~L~~ly 327 (329)
T 3sb4_A 302 VLATGDKITTLGDELFGNGVPSKLIY 327 (329)
T ss_dssp EEECSSCCCEECTTTTCTTCCCCEEE
T ss_pred EEeCCCccCccchhhhcCCcchhhhc
Confidence 77777777655556677777776665
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.8e-16 Score=178.77 Aligned_cols=264 Identities=11% Similarity=0.078 Sum_probs=140.9
Q ss_pred CCCCCEEEccCCCCcccCCccccC-CCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCC-------
Q 043720 106 LSELRVLSLPFNGFSGEFPPEIWS-LEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRN------- 177 (1103)
Q Consensus 106 l~~L~~L~L~~n~l~g~~p~~l~~-l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~------- 177 (1103)
+.+++.|.++++ +.+.--..+.. +++|++|||++|++. .....-+.++.++.+.+..|.+. +..|.+
T Consensus 24 ~~~l~~L~l~g~-i~~~~~~~l~~~l~~L~~LdLs~n~i~-~~~~~~~~~~~~~~~~~~~~~I~---~~aF~~~~~~~~~ 98 (329)
T 3sb4_A 24 ANSITHLTLTGK-LNAEDFRHLRDEFPSLKVLDISNAEIK-MYSGKAGTYPNGKFYIYMANFVP---AYAFSNVVNGVTK 98 (329)
T ss_dssp HHHCSEEEEEEE-ECHHHHHHHHHSCTTCCEEEEEEEEEC-CEEESSSSSGGGCCEEECTTEEC---TTTTEEEETTEEE
T ss_pred hCceeEEEEecc-ccHHHHHHHHHhhccCeEEecCcceeE-EecCccccccccccccccccccC---HHHhccccccccc
Confidence 566777777653 11111112333 677788888887776 11111112222344444444332 233444
Q ss_pred -CCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCcc----ccccCccc----
Q 043720 178 -FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL----VGRIPSSL---- 248 (1103)
Q Consensus 178 -l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l----~~~~p~~l---- 248 (1103)
+++|+.|+|.+ .++...+.+|.++++|+.|++++|.+. .+++..+..+.++..+.+..+.. .......+
T Consensus 99 g~~~L~~l~L~~-~i~~I~~~aF~~~~~L~~l~l~~n~i~-~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~ 176 (329)
T 3sb4_A 99 GKQTLEKVILSE-KIKNIEDAAFKGCDNLKICQIRKKTAP-NLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGE 176 (329)
T ss_dssp ECTTCCC-CBCT-TCCEECTTTTTTCTTCCEEEBCCSSCC-EECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESC
T ss_pred ccCCCcEEECCc-cccchhHHHhhcCcccceEEcCCCCcc-ccchhhhcCCCceEEecCcchhhhhcccccccccccccc
Confidence 56666666655 555444455556666666666666555 45554444444444444333111 00000011
Q ss_pred ----------------------cCCCCCCEEeCCCccCCccccccc-cCCCCCCEEEccCCcCCCcCCccccCCCCCCeE
Q 043720 249 ----------------------GKCQQLRTLLLFSNMLNDVIPREL-GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVL 305 (1103)
Q Consensus 249 ----------------------~~l~~L~~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 305 (1103)
....+++.+.+.++-. ......+ ..+++|+.|+|++|+++...+..|.+|++|+.+
T Consensus 177 ~L~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~-~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l 255 (329)
T 3sb4_A 177 PLETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLD-NADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKI 255 (329)
T ss_dssp CCEEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCC-HHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEE
T ss_pred ccceeEEecCCCcHHHHHhhcccCccccceEEEeeeec-HHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEE
Confidence 1233445555544321 1111112 126677777777777775555667777777777
Q ss_pred ecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhcccccc-ccccCCccccccCCccccccccCcEEEcCC
Q 043720 306 VLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLR-IIWAPRLNLEGKLPSSWGACESLEMLNLAQ 384 (1103)
Q Consensus 306 ~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~-~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~ 384 (1103)
++.+| +...-+..|.++++|+ .+.++. ++....+.+|.++++|+.|+|++
T Consensus 256 ~l~~n----------------------------i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~ 306 (329)
T 3sb4_A 256 KLPHN----------------------------LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATG 306 (329)
T ss_dssp ECCTT----------------------------CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECS
T ss_pred ECCcc----------------------------cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCC
Confidence 77531 1111223345556666 666665 56666677888888888888888
Q ss_pred cccccccchhhhccCCceEeec
Q 043720 385 NVLRGDLIGVFDRCKKLHFIDL 406 (1103)
Q Consensus 385 N~l~~~~~~~~~~l~~L~~LdL 406 (1103)
|.++.+...+|.++++|+.++.
T Consensus 307 n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 307 DKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp SCCCEECTTTTCTTCCCCEEEC
T ss_pred CccCccchhhhcCCcchhhhcc
Confidence 8888888888888888887763
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.62 E-value=1.3e-15 Score=157.21 Aligned_cols=128 Identities=27% Similarity=0.356 Sum_probs=118.2
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccC
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 624 (1103)
..+++++|++. .+|..+. ++|++|+|++|+|+ .+|..|.++++|+.|+|++|+|++..+..|..+++|++|+|++
T Consensus 13 ~~l~~~~~~l~-~ip~~~~---~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~ 87 (193)
T 2wfh_A 13 TVVRCSNKGLK-VLPKGIP---RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSY 87 (193)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEcCCCCCC-cCCCCCC---CCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCC
Confidence 57899999988 8898765 68999999999999 6678999999999999999999988888999999999999999
Q ss_pred cccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcC
Q 043720 625 NNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSG 677 (1103)
Q Consensus 625 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 677 (1103)
|+|++..|..|..+++|++|+|++|+|++..+..|..+++|+.|+|++|++..
T Consensus 88 N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C 140 (193)
T 2wfh_A 88 NRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYC 140 (193)
T ss_dssp SCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEEC
T ss_pred CccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeec
Confidence 99998888899999999999999999997777789999999999999999973
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.62 E-value=1.5e-15 Score=153.23 Aligned_cols=133 Identities=24% Similarity=0.190 Sum_probs=88.6
Q ss_pred CCCCCEEEccCCCCc-ccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEE
Q 043720 106 LSELRVLSLPFNGFS-GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 106 l~~L~~L~L~~n~l~-g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
.++|++|+|++|.++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+.++++|++|
T Consensus 23 ~~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 100 (168)
T 2ell_A 23 PAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL 100 (168)
T ss_dssp TTSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred cccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence 467778888888777 67777777777777777777777754 667777777777777777776566666667777777
Q ss_pred EccCCcCCCCC-ChhcccCCCCcEeecccccCCCCCCh---hHHhhcCcCcEEECcCCccc
Q 043720 185 NLAGNQVKGVI-PGFLGSFLKLRVLFLSYNELNGSIPS---ELGKYCRYLEHLDLSGNSLV 241 (1103)
Q Consensus 185 ~L~~n~l~~~~-p~~l~~l~~L~~L~L~~N~l~g~ip~---~~~~~~~~L~~L~L~~N~l~ 241 (1103)
+|++|.+++.. +..++.+++|++|++++|.++ .+|. ..+..+++|++|++++|.+.
T Consensus 101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~-~~~~~~~~~~~~l~~L~~L~l~~n~~~ 160 (168)
T 2ell_A 101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT-NLNDYRESVFKLLPQLTYLDGYDREDQ 160 (168)
T ss_dssp ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGG-TSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred eccCCccCcchhHHHHhcCCCCCEEEeeCCcCc-chHHHHHHHHHhCccCcEecCCCCChh
Confidence 77777776532 255666666666666666666 3333 22233455555555555554
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.61 E-value=6.4e-16 Score=155.86 Aligned_cols=134 Identities=24% Similarity=0.258 Sum_probs=93.2
Q ss_pred CCccEEECcCCcCC-CCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEe
Q 043720 567 KSLRVLDASHNQIS-GIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLE 645 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 645 (1103)
++|++|+|++|+++ +.+|..+..+++|++|+|++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 101 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLN 101 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEE
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEe
Confidence 56777777777776 55666677777777777777777743 5677777777777777777765666666677777777
Q ss_pred ccCccccCcCh-hhhhhcccccccccccccCcCCCC---ccccCCCCCceEeCCCCCCCCC
Q 043720 646 LSSNSLSGEVP-EGVVNLRNLTALLLDNNKLSGHLP---SGLANVTSLSIFNASFNNLSGP 702 (1103)
Q Consensus 646 Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~l~l~~N~l~~~ 702 (1103)
|++|+|++... ..+..+++|+.|++++|++++..+ ..+..+++|+.|++++|.+...
T Consensus 102 Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~ 162 (168)
T 2ell_A 102 LSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQEA 162 (168)
T ss_dssp CBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSCBC
T ss_pred ccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChhhc
Confidence 77777774322 566777777777777777774444 3667777777777777766543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.59 E-value=3.6e-15 Score=151.72 Aligned_cols=130 Identities=22% Similarity=0.254 Sum_probs=87.5
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccC
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 624 (1103)
..+++++|++. .+|..+. ++|++|++++|+++++.+..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 10 ~~l~~~~~~l~-~~p~~~~---~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 85 (177)
T 2o6r_A 10 TEIRCNSKGLT-SVPTGIP---SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHE 85 (177)
T ss_dssp TEEECCSSCCS-SCCTTCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CEEEecCCCCc-cCCCCCC---CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECCC
Confidence 45677777766 5665544 5677777777777766666667777777777777777755555566777777777777
Q ss_pred cccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCC
Q 043720 625 NNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGH 678 (1103)
Q Consensus 625 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 678 (1103)
|++++..+..|..+++|++|+|++|+|++..+..+..+++|+.|+|++|++.+.
T Consensus 86 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 139 (177)
T 2o6r_A 86 NKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 139 (177)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred CCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence 777765555666777777777777777655554556666667777776666643
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.59 E-value=1e-15 Score=150.96 Aligned_cols=127 Identities=22% Similarity=0.288 Sum_probs=100.6
Q ss_pred CCccEEECcCCcCC-CCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEe
Q 043720 567 KSLRVLDASHNQIS-GIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLE 645 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 645 (1103)
++|++|++++|.++ +.+|..+..+++|++|++++|.+++. ..+..+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 56888888888887 67777788888888888888888854 6778888888888888888876777777788888888
Q ss_pred ccCccccCc-ChhhhhhcccccccccccccCcCCCC---ccccCCCCCceEeCC
Q 043720 646 LSSNSLSGE-VPEGVVNLRNLTALLLDNNKLSGHLP---SGLANVTSLSIFNAS 695 (1103)
Q Consensus 646 Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~p---~~l~~l~~L~~l~l~ 695 (1103)
+++|++++. .+..+..+++|+.|++++|++++..+ ..+..+++|+.||++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCC
Confidence 888888853 23678888888888888888886555 467788888888775
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.58 E-value=2.1e-15 Score=148.76 Aligned_cols=127 Identities=25% Similarity=0.258 Sum_probs=73.1
Q ss_pred CCCCEEEccCCCCc-ccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEE
Q 043720 107 SELRVLSLPFNGFS-GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~-g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 185 (1103)
++|+.|++++|.++ +.+|..+..+++|++|+|++|.+++. ..++.+++|++|+|++|++++.+|..+.++++|++|+
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~ 94 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLN 94 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEE
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEE
Confidence 55666677666666 56666666666666666666666643 5556666666666666666654555555566666666
Q ss_pred ccCCcCCCC-CChhcccCCCCcEeecccccCCCCCCh---hHHhhcCcCcEEECc
Q 043720 186 LAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPS---ELGKYCRYLEHLDLS 236 (1103)
Q Consensus 186 L~~n~l~~~-~p~~l~~l~~L~~L~L~~N~l~g~ip~---~~~~~~~~L~~L~L~ 236 (1103)
+++|.+++. .+..++.+++|++|++++|.+++ +|. .....+++|++|+++
T Consensus 95 ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~~~~~~~l~~L~~L~l~ 148 (149)
T 2je0_A 95 LSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN-LNDYRENVFKLLPQLTYLDGY 148 (149)
T ss_dssp CTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG-STTHHHHHHHHCTTCCEETTB
T ss_pred CCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc-hHHHHHHHHHHCCCcccccCC
Confidence 666666542 22455555556666666665552 232 222333445555543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.58 E-value=8e-15 Score=149.16 Aligned_cols=130 Identities=25% Similarity=0.262 Sum_probs=107.9
Q ss_pred CccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEecc
Q 043720 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELS 647 (1103)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 647 (1103)
+.+.+++++|+++. +|..+ .++|+.|++++|++++..+..|..+++|++|+|++|++++..+..|..+++|++|+|+
T Consensus 8 ~~~~l~~~~~~l~~-~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 8 SGTEIRCNSKGLTS-VPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp ETTEEECCSSCCSS-CCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCCEEEecCCCCcc-CCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEECC
Confidence 35789999999984 45443 3789999999999997666778999999999999999997777778999999999999
Q ss_pred CccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCC
Q 043720 648 SNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLS 700 (1103)
Q Consensus 648 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~ 700 (1103)
+|+|++..+..+..+++|+.|+|++|+|++..+..+..+++|+.|++++|++.
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~ 137 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 137 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBC
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCee
Confidence 99999777777888999999999999999666666788888888866655443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.52 E-value=6.6e-15 Score=165.08 Aligned_cols=139 Identities=12% Similarity=0.125 Sum_probs=102.5
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccch-------------hh--------HHHHHHHHHHHhcCCCCc
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQ-------------HG--------VQQFHAEIKTLGNVRHPN 879 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~-------------~~--------~~~~~~E~~~l~~l~h~n 879 (1103)
.=|.+.++||+|+||.||+|...+|+.||||+++..... .. .....+|...+.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 348899999999999999999889999999987543110 00 011245677777775444
Q ss_pred ee--EEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC
Q 043720 880 LV--TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957 (1103)
Q Consensus 880 iv--~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~ 957 (1103)
+. ..+++. ..++||||+++++|.++.. ......++.|++.+|.|||+. +||||||||.|||++
T Consensus 175 v~vp~p~~~~----~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~ 239 (397)
T 4gyi_A 175 FPVPEPIAQS----RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKH---GLIHGDFNEFNILIR 239 (397)
T ss_dssp CSCCCEEEEE----TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE
T ss_pred CCCCeeeecc----CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEe
Confidence 32 223321 2379999999988866432 123456889999999999999 999999999999998
Q ss_pred CCC----------CEEEeecccccccC
Q 043720 958 DDF----------NAYLSDFGLSRLLG 974 (1103)
Q Consensus 958 ~~~----------~~ki~Dfgla~~~~ 974 (1103)
+++ .+.|+||+-+....
T Consensus 240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 240 EEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CCCCcccccccccceEEEEeCCcccCC
Confidence 776 38999999876543
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.51 E-value=3e-14 Score=143.69 Aligned_cols=104 Identities=29% Similarity=0.336 Sum_probs=50.7
Q ss_pred ccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccC
Q 043720 569 LRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSS 648 (1103)
Q Consensus 569 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 648 (1103)
.++|++++|+++. +|..+. ++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++
T Consensus 11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~ 87 (170)
T 3g39_A 11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND 87 (170)
T ss_dssp TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence 3456666666653 343332 4555555555555544454555555555555555555544444444555555555555
Q ss_pred ccccCcChhhhhhcccccccccccccC
Q 043720 649 NSLSGEVPEGVVNLRNLTALLLDNNKL 675 (1103)
Q Consensus 649 N~l~~~~~~~~~~l~~L~~L~L~~N~l 675 (1103)
|+|++..+..|..+++|+.|+|++|++
T Consensus 88 N~l~~~~~~~~~~l~~L~~L~L~~N~~ 114 (170)
T 3g39_A 88 NQLKSIPRGAFDNLKSLTHIWLLNNPW 114 (170)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCB
T ss_pred CccCEeCHHHhcCCCCCCEEEeCCCCC
Confidence 555443333344444444444444433
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.51 E-value=1.9e-16 Score=164.51 Aligned_cols=161 Identities=25% Similarity=0.322 Sum_probs=83.0
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
+.....++.++++.+.++|.+|. ++ .+|..+..+++|++|+|++|++++ +| .+.++++|+
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~-----------------l~-~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~ 73 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPP-----------------IE-KMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLR 73 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTT-----------------CC-CCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCC
T ss_pred HHhcccccCcchheeEeccccCc-----------------Hh-hhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCC
Confidence 34455666677777777766664 00 122244444444444444444442 34 444444555
Q ss_pred EEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccC-ccccCCCCCCEEeCCC
Q 043720 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP-SSLGKCQQLRTLLLFS 261 (1103)
Q Consensus 183 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~ 261 (1103)
+|++++|.++ .+|..+..+++|++|++++|+++ .+| .+.. +++|++|++++|++++..+ ..+..+++|++|++++
T Consensus 74 ~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~-~l~-~~~~-l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~ 149 (198)
T 1ds9_A 74 ILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEK-LVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAG 149 (198)
T ss_dssp EEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECC-CHH-HHHH-HHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECS
T ss_pred EEECCCCCcc-cccchhhcCCcCCEEECcCCcCC-cCC-cccc-CCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecC
Confidence 5555555544 34444444455555555555555 233 2332 2445555555555553211 3455566666666666
Q ss_pred ccCCccccc----------cccCCCCCCEEEccCCcCC
Q 043720 262 NMLNDVIPR----------ELGWLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 262 N~l~~~~p~----------~l~~l~~L~~L~Ls~N~l~ 289 (1103)
|.+++.+|. .+..+++|+.|| +|.++
T Consensus 150 N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 150 NPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp CHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred CccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 666554443 266677777766 55554
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.49 E-value=2.2e-14 Score=145.66 Aligned_cols=128 Identities=21% Similarity=0.221 Sum_probs=83.6
Q ss_pred CCccEEECcCCcCCCCCcccccCC-CCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEe
Q 043720 567 KSLRVLDASHNQISGIVPQSLENL-TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLE 645 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 645 (1103)
.+|++|+|++|+|+.+ |. +..+ ++|++|+|++|.|++. ..|..+++|++|+|++|+|++..+..|..+++|++|+
T Consensus 19 ~~L~~L~l~~n~l~~i-~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 94 (176)
T 1a9n_A 19 VRDRELDLRGYKIPVI-EN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI 94 (176)
T ss_dssp TSCEEEECTTSCCCSC-CC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred CCceEEEeeCCCCchh-HH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEE
Confidence 5677777777777633 43 3333 3777777777777643 4566777777777777777754444456777777777
Q ss_pred ccCccccCcChh--hhhhcccccccccccccCcCCCCcc----ccCCCCCceEeCCCCCCC
Q 043720 646 LSSNSLSGEVPE--GVVNLRNLTALLLDNNKLSGHLPSG----LANVTSLSIFNASFNNLS 700 (1103)
Q Consensus 646 Ls~N~l~~~~~~--~~~~l~~L~~L~L~~N~l~~~~p~~----l~~l~~L~~l~l~~N~l~ 700 (1103)
|++|+|+ .+|. .+..+++|+.|++++|+++ .+|.. +..+++|+.||++.|.+.
T Consensus 95 L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 95 LTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCHH
Confidence 7777775 3444 5667777777777777776 44543 666777777777776653
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.49 E-value=4.4e-16 Score=161.71 Aligned_cols=150 Identities=24% Similarity=0.251 Sum_probs=120.2
Q ss_pred ccCCCCCCEEEccccccCCCCCC------CCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHH
Q 043720 151 FVGLRNLRVLNLAFNRIDGDIPF------SLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG 224 (1103)
Q Consensus 151 l~~l~~L~~L~Ls~N~l~~~~p~------~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~ 224 (1103)
+.....++.++++.+.++|.+|. .+.++++|++|+|++|.+++ +| .++.+++|++|++++|+++ .+|..+.
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~ 90 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA 90 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHH
T ss_pred HHhcccccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhh
Confidence 44456667777777777766666 78888999999999999986 66 7888899999999999998 7887655
Q ss_pred hhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccc-ccccCCCCCCEEEccCCcCCCcCCcc--------
Q 043720 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP-RELGWLRKLEVLDVSRNRLNGLIPTE-------- 295 (1103)
Q Consensus 225 ~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~-------- 295 (1103)
. +++|++|+|++|++++ +| .++.+++|++|++++|++++..+ ..+..+++|++|++++|.+++.+|..
T Consensus 91 ~-~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~ 167 (198)
T 1ds9_A 91 V-ADTLEELWISYNQIAS-LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRI 167 (198)
T ss_dssp H-HHHCSEEEEEEEECCC-HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHH
T ss_pred c-CCcCCEEECcCCcCCc-CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHH
Confidence 4 4679999999999985 44 68888899999999999987432 57888999999999999988776653
Q ss_pred --ccCCCCCCeEe
Q 043720 296 --LGNCVELSVLV 306 (1103)
Q Consensus 296 --l~~l~~L~~L~ 306 (1103)
+..+++|+.|+
T Consensus 168 ~~~~~l~~L~~Ld 180 (198)
T 1ds9_A 168 EVVKRLPNLKKLD 180 (198)
T ss_dssp HHHHHCSSCSEEC
T ss_pred HHHHhCCCcEEEC
Confidence 78888998887
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.48 E-value=7.8e-14 Score=141.09 Aligned_cols=79 Identities=27% Similarity=0.267 Sum_probs=36.8
Q ss_pred ccCcEEeccCcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEe
Q 043720 615 KYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFN 693 (1103)
Q Consensus 615 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~ 693 (1103)
++|+.|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++|+|++..+..|..+++|+.|+
T Consensus 33 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~ 111 (174)
T 2r9u_A 33 TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111 (174)
T ss_dssp TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCCCccceeCHHHhccccCCCEEE
Confidence 3444444444444444444444444444444444444443333344445555555555555433333455555555543
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.46 E-value=7.2e-14 Score=141.91 Aligned_cols=134 Identities=17% Similarity=0.201 Sum_probs=68.9
Q ss_pred ccCCCCCCEEEeecCCCCCCccccccCCC-CCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCC
Q 043720 127 IWSLEKLEVLDVEGNFLSGRLPNEFVGLR-NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKL 205 (1103)
Q Consensus 127 l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~-~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L 205 (1103)
+.++.+|++|+|++|.++ .+|. +..+. +|++|+|++|++++. ..+.++++|++|+|++|++++..+..++.+++|
T Consensus 15 ~~~~~~L~~L~l~~n~l~-~i~~-~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 90 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDL 90 (176)
T ss_dssp EECTTSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred cCCcCCceEEEeeCCCCc-hhHH-hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCC
Confidence 445566666666666666 3343 33333 666666666666532 455555556666666655554433334555555
Q ss_pred cEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccc----cccCCCCCCEE
Q 043720 206 RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPR----ELGWLRKLEVL 281 (1103)
Q Consensus 206 ~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~----~l~~l~~L~~L 281 (1103)
++|++++|+++ .+|.. ..++.+++|+.|++++|.++. +|. .+..+++|+.|
T Consensus 91 ~~L~L~~N~i~-~~~~~-----------------------~~l~~l~~L~~L~l~~N~i~~-~~~~~~~~~~~l~~L~~L 145 (176)
T 1a9n_A 91 TELILTNNSLV-ELGDL-----------------------DPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVRVL 145 (176)
T ss_dssp CEEECCSCCCC-CGGGG-----------------------GGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCSEE
T ss_pred CEEECCCCcCC-cchhh-----------------------HhhhcCCCCCEEEecCCCCCC-cHhHHHHHHHHCCcccee
Confidence 55555555553 34330 134444445555555555443 233 24555555555
Q ss_pred EccCCcCC
Q 043720 282 DVSRNRLN 289 (1103)
Q Consensus 282 ~Ls~N~l~ 289 (1103)
|+++|.+.
T Consensus 146 d~~~n~~~ 153 (176)
T 1a9n_A 146 DFQKVKLK 153 (176)
T ss_dssp TTEECCHH
T ss_pred CCCcCCHH
Confidence 55555543
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.44 E-value=1.3e-12 Score=150.29 Aligned_cols=246 Identities=11% Similarity=0.091 Sum_probs=123.5
Q ss_pred CCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEEC
Q 043720 156 NLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDL 235 (1103)
Q Consensus 156 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 235 (1103)
+|+.++|..| ++..-..+|.+ .+|+.+.+.+ .++..-+..|.++++|+.+++++|+++ .++...+. +.+|+.+.|
T Consensus 136 ~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~~n~l~-~I~~~aF~-~~~L~~l~l 210 (401)
T 4fdw_A 136 QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLSKTKIT-KLPASTFV-YAGIEEVLL 210 (401)
T ss_dssp CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECTTSCCS-EECTTTTT-TCCCSEEEC
T ss_pred CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecCCCcce-EechhhEe-ecccCEEEe
Confidence 3444444433 33222233333 2355555443 333333344445555555555555554 44444444 244555555
Q ss_pred cCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccc
Q 043720 236 SGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLL 315 (1103)
Q Consensus 236 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l 315 (1103)
..+ ++..-...|.++++|+.+++..| ++.+...+|.. .+|+.+.+ .|.++..-..+|.+|++|+.+.+.++...
T Consensus 211 p~~-l~~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~-- 284 (401)
T 4fdw_A 211 PVT-LKEIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN-- 284 (401)
T ss_dssp CTT-CCEECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC--
T ss_pred CCc-hheehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc--
Confidence 422 44333444555555555555543 33333444444 45555555 23344344445555555555555432110
Q ss_pred cCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhh
Q 043720 316 SGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVF 395 (1103)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 395 (1103)
.+.....-+..|..+++|+.+.+. +++...-..+|.++++|+.++|..| ++.+...+|
T Consensus 285 --------------------~~~~~~I~~~aF~~c~~L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF 342 (401)
T 4fdw_A 285 --------------------DDPEAMIHPYCLEGCPKLARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAF 342 (401)
T ss_dssp --------------------CCTTCEECTTTTTTCTTCCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSS
T ss_pred --------------------CCcccEECHHHhhCCccCCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhC
Confidence 000001112334555566666666 3455555667777777777777544 666677777
Q ss_pred hccCCceEeecCCcccccccccc-ccc-cceeEEEecCCccc
Q 043720 396 DRCKKLHFIDLSSNELSGELDVK-LQV-PCMALFDVSGNHMS 435 (1103)
Q Consensus 396 ~~l~~L~~LdLs~N~l~~~~~~~-~~~-~~L~~l~ls~N~l~ 435 (1103)
.++ +|+.+++++|.+....+.. ..+ ..+..+++..|.+.
T Consensus 343 ~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 343 NNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp SSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred CCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 777 7888888777765433322 234 35667777666544
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=5.3e-13 Score=134.47 Aligned_cols=108 Identities=29% Similarity=0.371 Sum_probs=98.7
Q ss_pred ccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 544 GMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 544 ~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
...+++++|++. .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|++|+|+
T Consensus 11 ~~~l~~s~n~l~-~ip~~~~---~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~ 86 (170)
T 3g39_A 11 GTTVDCSGKSLA-SVPTGIP---TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86 (170)
T ss_dssp TTEEECTTSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CCEEEeCCCCcC-ccCccCC---CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECC
Confidence 457999999998 6998775 789999999999999989999999999999999999997777778999999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEV 655 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 655 (1103)
+|+|++..+..|..+++|++|+|++|+++...
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c 118 (170)
T 3g39_A 87 DNQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC 118 (170)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred CCccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence 99999877778999999999999999998643
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.42 E-value=5.6e-13 Score=134.76 Aligned_cols=105 Identities=27% Similarity=0.332 Sum_probs=87.3
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccC
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 624 (1103)
..+++++|++. .+|..+. ++|++|+|++|+|+++.|..|.++++|++|+|++|+|++..+..|..+++|+.|+|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~---~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~ 90 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP---TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND 90 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC---TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred cEEEeCCCCCC-ccCCCcC---CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence 46888888885 7888775 6788999999999888888888899999999999998865555678888899999999
Q ss_pred cccCCCCCCcccCCCCCcEEeccCccccC
Q 043720 625 NNLTGGIPSSIGELRSLEVLELSSNSLSG 653 (1103)
Q Consensus 625 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 653 (1103)
|+|++..+..|..+++|++|+|++|++..
T Consensus 91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred CccceeCHHHhccccCCCEEEeCCCCccc
Confidence 98886666668888888888888888874
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.38 E-value=7.4e-12 Score=144.11 Aligned_cols=266 Identities=11% Similarity=0.092 Sum_probs=179.4
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEc
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNL 186 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L 186 (1103)
..++.+.+.+ .++..-..+|.++ +|+.++|..+ ++..-..+|.+ .+|+.+.|.. .++..-+.+|.++++|+.+++
T Consensus 113 ~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l 187 (401)
T 4fdw_A 113 KGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADL 187 (401)
T ss_dssp SSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEEC
T ss_pred CCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeec
Confidence 5566666654 3443334455554 6777777655 55344445555 3577777775 555444566777777777777
Q ss_pred cCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCc
Q 043720 187 AGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 187 ~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
++|+++......|. .++|+.+.+..+ ++ .|+...+..+++|+.+++..| ++..-..+|.+ .+|+.+.+ .+.++.
T Consensus 188 ~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~aF~~~~~L~~l~l~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~ 261 (401)
T 4fdw_A 188 SKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQAFLKTSQLKTIEIPEN-VSTIGQEAFRE-SGITTVKL-PNGVTN 261 (401)
T ss_dssp TTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTTTTTTCTTCCCEECCTT-CCEECTTTTTT-CCCSEEEE-ETTCCE
T ss_pred CCCcceEechhhEe-ecccCEEEeCCc-hh-eehhhHhhCCCCCCEEecCCC-ccCcccccccc-CCccEEEe-CCCccE
Confidence 77777755555555 467777777643 55 677777766777777777764 44344455555 67777777 445666
Q ss_pred cccccccCCCCCCEEEccCCcCC-----CcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccc
Q 043720 267 VIPRELGWLRKLEVLDVSRNRLN-----GLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIG 341 (1103)
Q Consensus 267 ~~p~~l~~l~~L~~L~Ls~N~l~-----~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~ 341 (1103)
+...+|..+++|+.+++.+|.+. ...+..|.+|++|+.+.+.+ ++..
T Consensus 262 I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~----------------------------~i~~ 313 (401)
T 4fdw_A 262 IASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE----------------------------SIRI 313 (401)
T ss_dssp ECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT----------------------------TCCE
T ss_pred EChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC----------------------------ceEE
Confidence 56677777778888887777664 34456677788888877752 1111
Q ss_pred cCchhhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccC-CceEeecCCccccc
Q 043720 342 SIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCK-KLHFIDLSSNELSG 413 (1103)
Q Consensus 342 ~ip~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~LdLs~N~l~~ 413 (1103)
.-...|.++++|+.+.+..+ +...-..+|.++ +|+.|++++|.+.......|.+++ +++.|++..+.+..
T Consensus 314 I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~~ 384 (401)
T 4fdw_A 314 LGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVEK 384 (401)
T ss_dssp ECTTTTTTCCSCCEEEECTT-CCEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHHH
T ss_pred EhhhhhcCCCCccEEEECcc-ccEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHHH
Confidence 22334566677888888554 666777899999 999999999999988889999885 78999999887653
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.37 E-value=1.5e-11 Score=142.14 Aligned_cols=101 Identities=18% Similarity=0.122 Sum_probs=60.6
Q ss_pred hhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCc
Q 043720 563 GVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLE 642 (1103)
Q Consensus 563 ~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 642 (1103)
+..+.+|+.+.+..+ ++.+...+|.++++|+.++|.++ ++..-..+|.++.+|+.+.|..| ++..-...|.++++|+
T Consensus 293 F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~ 369 (394)
T 4fs7_A 293 FYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLK 369 (394)
T ss_dssp TTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCC
T ss_pred ccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCC
Confidence 334456666666544 54455666777777777777644 55344556677777777777655 5544556677777777
Q ss_pred EEeccCccccCcChhhhhhccccccc
Q 043720 643 VLELSSNSLSGEVPEGVVNLRNLTAL 668 (1103)
Q Consensus 643 ~L~Ls~N~l~~~~~~~~~~l~~L~~L 668 (1103)
.+++..| ++ .+..+|.++++|+.+
T Consensus 370 ~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 370 KVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp EEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred EEEECCC-CE-EhhheecCCCCCcEE
Confidence 7777654 33 234456666666543
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.33 E-value=1.3e-12 Score=148.50 Aligned_cols=103 Identities=25% Similarity=0.256 Sum_probs=53.3
Q ss_pred EEECcCC-cCCCCCcccccCCCCCCEEEccC-CcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccC
Q 043720 571 VLDASHN-QISGIVPQSLENLTSLVFLDLNG-NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSS 648 (1103)
Q Consensus 571 ~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~ 648 (1103)
.++++++ +|++ +|. +..+++|+.|+|++ |+|++..+..|..+++|+.|+|++|+|++..|..|.+|++|++|+|++
T Consensus 12 ~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~ 89 (347)
T 2ifg_A 12 GLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (347)
T ss_dssp CEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred EEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCCC
Confidence 3455555 5553 344 55555566666654 555544445555555555555555555555555555555555555555
Q ss_pred ccccCcChhhhhhcccccccccccccCc
Q 043720 649 NSLSGEVPEGVVNLRNLTALLLDNNKLS 676 (1103)
Q Consensus 649 N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 676 (1103)
|+|++..+..+..++ |+.|+|++|++.
T Consensus 90 N~l~~~~~~~~~~~~-L~~l~l~~N~~~ 116 (347)
T 2ifg_A 90 NALESLSWKTVQGLS-LQELVLSGNPLH 116 (347)
T ss_dssp SCCSCCCSTTTCSCC-CCEEECCSSCCC
T ss_pred CccceeCHHHcccCC-ceEEEeeCCCcc
Confidence 555543333333332 444444444443
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.32 E-value=2.6e-11 Score=140.17 Aligned_cols=126 Identities=13% Similarity=0.053 Sum_probs=87.4
Q ss_pred CchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCC
Q 043720 559 PLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGEL 638 (1103)
Q Consensus 559 p~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 638 (1103)
+...+..+..++.+.+..+.+. ...|..+.+|+.+.+.++ ++..-..+|.++.+|+.++|.++ ++..-...|.++
T Consensus 268 ~~~~F~~~~~l~~~~~~~~~i~---~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c 342 (394)
T 4fs7_A 268 GGSLFYNCSGLKKVIYGSVIVP---EKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGC 342 (394)
T ss_dssp CSCTTTTCTTCCEEEECSSEEC---TTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTC
T ss_pred eccccccccccceeccCceeec---cccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCC
Confidence 3334444566677766665443 456778888888888765 55445667888888888888754 665556788888
Q ss_pred CCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceE
Q 043720 639 RSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIF 692 (1103)
Q Consensus 639 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l 692 (1103)
.+|+.+++..| ++.+-..+|.+|.+|+.+++..+ ++ .+...|.++++|+.+
T Consensus 343 ~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~-~~-~~~~~F~~c~~L~~I 393 (394)
T 4fs7_A 343 TSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR-LE-QYRYDFEDTTKFKWI 393 (394)
T ss_dssp TTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG-GG-GGGGGBCTTCEEEEE
T ss_pred CCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC-CE-EhhheecCCCCCcEE
Confidence 88888888777 66556678888888888888755 33 334567777777654
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.26 E-value=4.5e-13 Score=152.73 Aligned_cols=87 Identities=22% Similarity=0.080 Sum_probs=42.3
Q ss_pred CCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccc-----cCCCCCCEEeCCCccCCcc----cccccc
Q 043720 203 LKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSL-----GKCQQLRTLLLFSNMLNDV----IPRELG 273 (1103)
Q Consensus 203 ~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~L~~N~l~~~----~p~~l~ 273 (1103)
++|++|+|++|.++......+...+++|++|+|++|.++......+ ...++|++|+|++|.|++. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 3555555555555433233333333445555555555543322222 1234566666666655442 333345
Q ss_pred CCCCCCEEEccCCcCC
Q 043720 274 WLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 274 ~l~~L~~L~Ls~N~l~ 289 (1103)
.+++|++|+|++|.|+
T Consensus 181 ~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 181 GNTSVTHLSLLHTGLG 196 (372)
T ss_dssp TCSSCCEEECTTSSCH
T ss_pred cCCCcCEEeCCCCCCC
Confidence 5556666666666654
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.20 E-value=4.7e-11 Score=135.50 Aligned_cols=128 Identities=18% Similarity=0.123 Sum_probs=102.7
Q ss_pred cEEecCCC-cccccCCchhhhcCCCccEEECcC-CcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEec
Q 043720 545 MVANLSNN-NIIGHIPLDIGVMCKSLRVLDASH-NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSL 622 (1103)
Q Consensus 545 ~~l~ls~n-~~~~~ip~~~~~~~~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 622 (1103)
..++++++ ++. .||. +... ++|++|+|++ |+|+++.+..|.++++|+.|+|++|+|++..|..|..+++|+.|+|
T Consensus 11 ~~v~~~~~n~l~-~ip~-l~~~-~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALD-SLHH-LPGA-ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCT-TTTT-SCSC-SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCC-ccCC-CCCC-CCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeC
Confidence 45789998 777 6998 6655 8899999996 9999888899999999999999999999988899999999999999
Q ss_pred cCcccCCCCCCcccCCCCCcEEeccCccccCcCh-hhhhhcccccccccccccCc
Q 043720 623 ADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVP-EGVVNLRNLTALLLDNNKLS 676 (1103)
Q Consensus 623 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 676 (1103)
++|+|++..+..|..++ |+.|+|++|.+...-. ..|....+.....+..+.++
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~l~~~~~~~~~~~~~l~~~~~~ 141 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQ 141 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCC
T ss_pred CCCccceeCHHHcccCC-ceEEEeeCCCccCCCccHHHHHHHHhCcccccccCCC
Confidence 99999977767777776 9999999999985332 22333333333344444444
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=4.4e-13 Score=152.81 Aligned_cols=143 Identities=24% Similarity=0.167 Sum_probs=73.9
Q ss_pred CCCCEEEccccccCCCCCCCC-CCCCCCCEEEccCCcCCCCCChhc-----ccCCCCcEeecccccCCCC----CChhHH
Q 043720 155 RNLRVLNLAFNRIDGDIPFSL-RNFESLEVLNLAGNQVKGVIPGFL-----GSFLKLRVLFLSYNELNGS----IPSELG 224 (1103)
Q Consensus 155 ~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~~L~L~~n~l~~~~p~~l-----~~l~~L~~L~L~~N~l~g~----ip~~~~ 224 (1103)
++|++|+|++|.++......+ ..+++|++|+|++|.++......+ ...++|++|+|++|.++.. ++..+.
T Consensus 101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~ 180 (372)
T 3un9_A 101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA 180 (372)
T ss_dssp SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence 345555555554442211111 123345555555555543322222 1234566666666655421 111112
Q ss_pred hhcCcCcEEECcCCccccc----cCccccCCCCCCEEeCCCccCCcc----ccccccCCCCCCEEEccCCcCCCcCCccc
Q 043720 225 KYCRYLEHLDLSGNSLVGR----IPSSLGKCQQLRTLLLFSNMLNDV----IPRELGWLRKLEVLDVSRNRLNGLIPTEL 296 (1103)
Q Consensus 225 ~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l 296 (1103)
..++|++|+|++|.++.. ++..+...++|++|+|++|.|++. ++..+...++|++|+|++|.|++.....+
T Consensus 181 -~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L 259 (372)
T 3un9_A 181 -GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVL 259 (372)
T ss_dssp -TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHH
T ss_pred -cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHH
Confidence 234566666666666532 244555666777777777777653 33445556778888888888775544444
Q ss_pred cC
Q 043720 297 GN 298 (1103)
Q Consensus 297 ~~ 298 (1103)
..
T Consensus 260 ~~ 261 (372)
T 3un9_A 260 RD 261 (372)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.11 E-value=2.6e-09 Score=123.28 Aligned_cols=154 Identities=14% Similarity=0.182 Sum_probs=65.9
Q ss_pred cccCCC-CCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCC
Q 043720 126 EIWSLE-KLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLK 204 (1103)
Q Consensus 126 ~l~~l~-~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~ 204 (1103)
+|.++. .|+.+.+..+ ++..-..+|.++++|+.+.++.|.-. .++..-..+|..+.+
T Consensus 58 aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~---------------------~l~~Ig~~aF~~c~~ 115 (394)
T 4gt6_A 58 VFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPS---------------------CVKKIGRQAFMFCSE 115 (394)
T ss_dssp TTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCC---------------------CCCEECTTTTTTCTT
T ss_pred hccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCC---------------------eeeEechhhchhccc
Confidence 344443 3666666432 44233445555555555555544311 122222233444444
Q ss_pred CcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEcc
Q 043720 205 LRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284 (1103)
Q Consensus 205 L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 284 (1103)
|+.+.+..+ ++ .++...+..+.+|+.+.+..+ ++......+..+..|+.+.+..+ ++.+-..+|.. .+|+.+.+.
T Consensus 116 L~~i~~~~~-~~-~I~~~aF~~c~~L~~i~lp~~-~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~-~~l~~i~ip 190 (394)
T 4gt6_A 116 LTDIPILDS-VT-EIDSEAFHHCEELDTVTIPEG-VTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTG-TALTQIHIP 190 (394)
T ss_dssp CCBCGGGTT-CS-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT-CCCSEEEEC
T ss_pred ceeeccCCc-cc-eehhhhhhhhcccccccccce-eeeecccceecccccccccccce-eeEeccccccc-cceeEEEEC
Confidence 444444332 22 334444444444555555332 22123334455555555555433 33322233332 445555554
Q ss_pred CCcCCCcCCccccCCCCCCeEec
Q 043720 285 RNRLNGLIPTELGNCVELSVLVL 307 (1103)
Q Consensus 285 ~N~l~~~~p~~l~~l~~L~~L~l 307 (1103)
.+-.. .....+.++.++.....
T Consensus 191 ~~~~~-i~~~af~~c~~l~~~~~ 212 (394)
T 4gt6_A 191 AKVTR-IGTNAFSECFALSTITS 212 (394)
T ss_dssp TTCCE-ECTTTTTTCTTCCEEEE
T ss_pred Ccccc-cccchhhhccccceecc
Confidence 43221 23344555555555544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.03 E-value=3.9e-10 Score=122.33 Aligned_cols=147 Identities=14% Similarity=0.029 Sum_probs=113.9
Q ss_pred HHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEE
Q 043720 816 IIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 816 ~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 894 (1103)
+......|.+...++.|+.+.||++... ++.+++|+...... .....+.+|+.+++.+. +..+.++++++...+..|
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~-~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYK-GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGT-TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccC-CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 3344567888888998999999999755 68899999865321 12345788999998884 677888999998888999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC---------------------------------- 940 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~---------------------------------- 940 (1103)
+||||++|.++.+... +......++.++++++..||+..
T Consensus 87 lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWE 159 (263)
T ss_dssp EEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGS
T ss_pred EEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccc
Confidence 9999999999877531 11223468889999999999820
Q ss_pred ----------------------CCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 941 ----------------------APRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 941 ----------------------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+.++|+|+++.||+++++..+.|+||+.+.
T Consensus 160 ~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 160 EDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp TTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1358999999999999876556799998775
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=99.01 E-value=9.8e-09 Score=118.40 Aligned_cols=134 Identities=12% Similarity=0.149 Sum_probs=86.9
Q ss_pred CCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccC
Q 043720 558 IPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGE 637 (1103)
Q Consensus 558 ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 637 (1103)
+....+..|..|+.+.+.++..+ +...+|.++++|+.+.+. +.++..-..+|.++.+|+.+.|..+ ++..-...|.+
T Consensus 256 i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~ 332 (394)
T 4gt6_A 256 IETHAFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAG 332 (394)
T ss_dssp ECTTTTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTT
T ss_pred cccceeeecccccEEecccccce-ecCcccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhC
Confidence 33444555677788887766554 666778888888888886 4455445567888888888888754 55455677888
Q ss_pred CCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCC
Q 043720 638 LRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNN 698 (1103)
Q Consensus 638 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~ 698 (1103)
+.+|+.+.|..+ ++.+-..+|.+|.+|+.+++.+|.... ..+.....|+.+.+..|.
T Consensus 333 C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~~---~~~~~~~~L~~i~i~~~~ 389 (394)
T 4gt6_A 333 CEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQW---NAISTDSGLQNLPVAPGS 389 (394)
T ss_dssp CTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHHH---HTCBCCCCC---------
T ss_pred CCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceeeh---hhhhccCCCCEEEeCCCC
Confidence 888888888655 664556788888888888888776542 345556677776665553
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.91 E-value=3.4e-10 Score=127.78 Aligned_cols=165 Identities=16% Similarity=0.151 Sum_probs=85.8
Q ss_pred cCcccCCCCCCCEEEccCCCCc---------ccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCC
Q 043720 99 LSPLVGGLSELRVLSLPFNGFS---------GEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDG 169 (1103)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~n~l~---------g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 169 (1103)
+..++.++++|+.|.+.++... +.++..+..+++|+.|+|++|.-. .++. + .+++|++|+|..|.++.
T Consensus 131 L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~ 207 (362)
T 2ra8_A 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPD 207 (362)
T ss_dssp HHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCH
T ss_pred HHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCCh
Confidence 3445667788888888665331 224444556777888888776311 2333 3 26777777777766653
Q ss_pred CCCCCCC--CCCCCCEEEccC--CcCCCC-----CChhc--ccCCCCcEeecccccCCCCCChhHHh--hcCcCcEEECc
Q 043720 170 DIPFSLR--NFESLEVLNLAG--NQVKGV-----IPGFL--GSFLKLRVLFLSYNELNGSIPSELGK--YCRYLEHLDLS 236 (1103)
Q Consensus 170 ~~p~~l~--~l~~L~~L~L~~--n~l~~~-----~p~~l--~~l~~L~~L~L~~N~l~g~ip~~~~~--~~~~L~~L~L~ 236 (1103)
.....+. .+++|++|+|+. |...+. +...+ ..+++|++|+|++|.+++..+..++. .+++|++|+|+
T Consensus 208 ~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs 287 (362)
T 2ra8_A 208 SVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDIS 287 (362)
T ss_dssp HHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECC
T ss_pred HHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECC
Confidence 3222332 567777777642 221111 01111 23566666666666665333333332 23445555555
Q ss_pred CCccccc----cCccccCCCCCCEEeCCCccCCc
Q 043720 237 GNSLVGR----IPSSLGKCQQLRTLLLFSNMLND 266 (1103)
Q Consensus 237 ~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~ 266 (1103)
.|.+++. ++..+.++++|+.|+|++|.+++
T Consensus 288 ~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 288 AGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp SSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred CCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 5555432 22233344555555555555544
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.90 E-value=1e-09 Score=118.79 Aligned_cols=137 Identities=15% Similarity=0.134 Sum_probs=100.1
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCc--eeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN--LVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~E 898 (1103)
..+.+....+.|..+.||++...+|..+++|+.... ....+.+|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 345443333466679999998777888999987643 1245678888888885444 4568888888888999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC--------------------------------------
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC-------------------------------------- 940 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------------- 940 (1103)
|++|.++. ... .+ ...++.++++.+..||+..
T Consensus 96 ~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (264)
T 1nd4_A 96 EVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL 165 (264)
T ss_dssp CCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred ecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence 99998884 111 11 2256777888888888651
Q ss_pred -----------------CCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 941 -----------------APRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 941 -----------------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+.++|+|++|.||++++++.+.|+||+.+.
T Consensus 166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1139999999999999877667799999875
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.84 E-value=7.5e-09 Score=117.82 Aligned_cols=143 Identities=13% Similarity=0.182 Sum_probs=106.8
Q ss_pred CcceeccCCcccEEEEEEcCCcEEEEEEcc--cccchhhHHHHHHHHHHHhcCC--CCceeEEEeEEecC---CeEEEEE
Q 043720 825 TSNCIGSGGFGTTYKAEISPGILVAVKKLA--VGRFQHGVQQFHAEIKTLGNVR--HPNLVTLIGYRASG---NEMFLIY 897 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~ 897 (1103)
..+.++.|.++.||++... +..+++|+.. ..........+.+|+.+++.+. +..+.++++++.+. +..|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 4567899999999999876 4678888876 4332223456788999999886 45678889988776 4589999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC------------------------------------- 940 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~------------------------------------- 940 (1103)
||++|..+.+.. -..++..+...++.++++.|+.||+..
T Consensus 121 e~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 121 EFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp ECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999988775411 123677888899999999999999731
Q ss_pred ------------------CCCcccCCCCCCcEEECCCCC--EEEeecccccc
Q 043720 941 ------------------APRVLHRDVKPSNILLDDDFN--AYLSDFGLSRL 972 (1103)
Q Consensus 941 ------------------~~~ivH~Dlk~~NIll~~~~~--~ki~Dfgla~~ 972 (1103)
.+.++|||+++.||+++.++. +.|.||+.+..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997753 68999998864
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.81 E-value=1.6e-09 Score=122.27 Aligned_cols=182 Identities=13% Similarity=0.089 Sum_probs=109.8
Q ss_pred CCCCEEEccCCCCcc-c-------CCccccCCCCCCEEEeecCCCC---------CCccccccCCCCCCEEEccccccCC
Q 043720 107 SELRVLSLPFNGFSG-E-------FPPEIWSLEKLEVLDVEGNFLS---------GRLPNEFVGLRNLRVLNLAFNRIDG 169 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g-~-------~p~~l~~l~~L~~L~Ls~n~l~---------~~~p~~l~~l~~L~~L~Ls~N~l~~ 169 (1103)
..++.|.+....+.| . +.+++.++++|+.|.+..+... +.+...+..+++|+.|+|++|.-.
T Consensus 107 ~~v~~L~lg~~~~~~~~~~~~~~~L~~s~~~l~~L~~L~l~~~~~e~~~is~~~~~~L~~ll~~~P~L~~L~L~g~~~l- 185 (362)
T 2ra8_A 107 PSLKQITIGXWGYEGEDCSDIADGIVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNL- 185 (362)
T ss_dssp GGCSEEEECCCCSSSCCSHHHHHHHHTTHHHHTTCSEEEECCCCTTTCCGGGCBCCBCHHHHHTCTTCCEEEEECCBTC-
T ss_pred hhcceEEEcccccCCCcHHHHHHHHHHhhhhcchhhheeecCcchhhcccccccccCHHHHHhcCCCCcEEEEeCCCCc-
Confidence 456677777665553 2 1334556889999999765432 234555667788999999887311
Q ss_pred CCCCCCCCCCCCCEEEccCCcCCCCCChhcc--cCCCCcEeeccc--ccCCCCC-----ChhHH-hhcCcCcEEECcCCc
Q 043720 170 DIPFSLRNFESLEVLNLAGNQVKGVIPGFLG--SFLKLRVLFLSY--NELNGSI-----PSELG-KYCRYLEHLDLSGNS 239 (1103)
Q Consensus 170 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~--~l~~L~~L~L~~--N~l~g~i-----p~~~~-~~~~~L~~L~L~~N~ 239 (1103)
.++. +. +++|++|+|..|.++......++ .+++|++|+|+. |...|.. ...+. ..+++|++|+|++|.
T Consensus 186 ~l~~-~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~ 263 (362)
T 2ra8_A 186 SIGK-KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAE 263 (362)
T ss_dssp BCCS-CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCT
T ss_pred eecc-cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCC
Confidence 2333 33 78888888888887644333443 678888888753 2221111 11111 124567777777777
Q ss_pred cccccCcccc---CCCCCCEEeCCCccCCcc----ccccccCCCCCCEEEccCCcCCCc
Q 043720 240 LVGRIPSSLG---KCQQLRTLLLFSNMLNDV----IPRELGWLRKLEVLDVSRNRLNGL 291 (1103)
Q Consensus 240 l~~~~p~~l~---~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~ 291 (1103)
+++..+..+. .+++|++|+|+.|.+++. ++..+..+++|+.|+|++|.++..
T Consensus 264 i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d~ 322 (362)
T 2ra8_A 264 EQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDE 322 (362)
T ss_dssp THHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCHH
T ss_pred CchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCHH
Confidence 7643332332 466777777777777663 233344567777777777776643
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.74 E-value=1.1e-10 Score=124.78 Aligned_cols=66 Identities=32% Similarity=0.421 Sum_probs=32.5
Q ss_pred CCCCCCEEEccccccCC--CCCCCCCCCCCCCEEEccCCcCCCCCChhcccCC--CCcEeecccccCCCCCC
Q 043720 153 GLRNLRVLNLAFNRIDG--DIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFL--KLRVLFLSYNELNGSIP 220 (1103)
Q Consensus 153 ~l~~L~~L~Ls~N~l~~--~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~--~L~~L~L~~N~l~g~ip 220 (1103)
.+++|++|+|++|+|++ .+|..+..+++|+.|+|++|++++. ..+..+. +|++|+|++|.+.+.+|
T Consensus 168 ~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 168 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 45555666666665554 3334444555555555555555543 1222222 45555555555544333
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.70 E-value=6.6e-07 Score=102.45 Aligned_cols=40 Identities=15% Similarity=0.164 Sum_probs=26.4
Q ss_pred CccccccccCcEEEcCCcccccccchhhhccCCceEeecCC
Q 043720 368 PSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSS 408 (1103)
Q Consensus 368 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~ 408 (1103)
...+..+.+|+.+.+..+ +..+....|.++..|+.+.+..
T Consensus 210 ~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~ 249 (379)
T 4h09_A 210 AYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPK 249 (379)
T ss_dssp TTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECT
T ss_pred ecccccccccceeeeccc-eeEEccccccCCccceEEEcCC
Confidence 445666777777777544 5556666777777777776644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.67 E-value=9.7e-09 Score=113.89 Aligned_cols=186 Identities=16% Similarity=0.170 Sum_probs=121.8
Q ss_pred cceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCc--eeEEEeEEecCC---eEEEEEee
Q 043720 826 SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPN--LVTLIGYRASGN---EMFLIYNY 899 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~E~ 899 (1103)
.+.++.|....||++. ..+++|+.... .....+.+|+..++.+. +.. +.+++......+ ..|+|||+
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~ 97 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK 97 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence 4568999999999873 56889886533 34567889999998873 322 344555543333 34889999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC--------------------------------------- 940 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~--------------------------------------- 940 (1103)
++|.++.+.... .++..+...++.++++.+..||+..
T Consensus 98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 999888754321 2667777888888888888888621
Q ss_pred ----------------CCCcccCCCCCCcEEECC--CCCEEEeecccccccCCCCCccccCC----cc---------ccc
Q 043720 941 ----------------APRVLHRDVKPSNILLDD--DFNAYLSDFGLSRLLGTSETHATTGV----AG---------TFG 989 (1103)
Q Consensus 941 ----------------~~~ivH~Dlk~~NIll~~--~~~~ki~Dfgla~~~~~~~~~~~~~~----~g---------~~~ 989 (1103)
.+.++|+|+++.||++++ ...+.|+||+.+........-..... .+ ..+
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~ 253 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYK 253 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHT
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcC
Confidence 145899999999999998 45688999998875322111000000 00 001
Q ss_pred ccC-ccccccCCCCCcchhHHHHHHHHHHHhCCCCC
Q 043720 990 YVA-PEYALTCRVSDKADVYSYGVVLLELISDKKAL 1024 (1103)
Q Consensus 990 y~a-PE~~~~~~~~~~sDvwslGvil~elltg~~p~ 1024 (1103)
+.. |+..... ....+.|++|.++|++.+|..+|
T Consensus 254 ~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 254 HKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp CSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHHH
T ss_pred CCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 2222111 12368999999999999998664
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.60 E-value=2.1e-06 Score=98.16 Aligned_cols=121 Identities=13% Similarity=0.083 Sum_probs=72.8
Q ss_pred hhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCC
Q 043720 562 IGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSL 641 (1103)
Q Consensus 562 ~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 641 (1103)
.+..+..|+.+.+..+ ++.+-..+|.++.+|+.+.+..+ ++......|..+.+|+.+.+.++.++..-...|.++.+|
T Consensus 235 ~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~~c~~L 312 (379)
T 4h09_A 235 AFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFMDCVKL 312 (379)
T ss_dssp TTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTTTCTTC
T ss_pred cccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhcCCCCC
Confidence 3334456666666654 44455566777777777777544 443344566677777777777776665555667777777
Q ss_pred cEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCC
Q 043720 642 EVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANV 686 (1103)
Q Consensus 642 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 686 (1103)
+.++|..+ ++.+-..+|.++.+|+.+.+..+ ++..-..+|.+.
T Consensus 313 ~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~-v~~I~~~aF~~c 355 (379)
T 4h09_A 313 SSVTLPTA-LKTIQVYAFKNCKALSTISYPKS-ITLIESGAFEGS 355 (379)
T ss_dssp CEEECCTT-CCEECTTTTTTCTTCCCCCCCTT-CCEECTTTTTTS
T ss_pred CEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc-cCEEchhHhhCC
Confidence 77777654 54344556777777777766544 442333444443
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.35 E-value=4e-08 Score=99.94 Aligned_cols=119 Identities=14% Similarity=0.131 Sum_probs=70.1
Q ss_pred ccCcccCCCCCCCEEEccCC-CCccc----CCccccCCCCCCEEEeecCCCCCC----ccccccCCCCCCEEEccccccC
Q 043720 98 KLSPLVGGLSELRVLSLPFN-GFSGE----FPPEIWSLEKLEVLDVEGNFLSGR----LPNEFVGLRNLRVLNLAFNRID 168 (1103)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~n-~l~g~----~p~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 168 (1103)
.+...+...+.|++|+|++| .+... +...+...++|++|+|++|.++.. +...+...+.|++|+|++|.|+
T Consensus 27 ~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~ 106 (185)
T 1io0_A 27 TLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFIS 106 (185)
T ss_dssp HHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCC
T ss_pred HHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCC
Confidence 34455667788888888888 77643 334455567777788877777632 3344445566777777777766
Q ss_pred CC----CCCCCCCCCCCCEEEc--cCCcCCCCC----ChhcccCCCCcEeecccccCC
Q 043720 169 GD----IPFSLRNFESLEVLNL--AGNQVKGVI----PGFLGSFLKLRVLFLSYNELN 216 (1103)
Q Consensus 169 ~~----~p~~l~~l~~L~~L~L--~~n~l~~~~----p~~l~~l~~L~~L~L~~N~l~ 216 (1103)
.. +...+...++|++|+| ++|.++... ...+...++|++|+|++|.+.
T Consensus 107 ~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 107 GSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp HHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred HHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 32 3444555566666666 556665321 222333345555555555543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.34 E-value=4.4e-08 Score=104.58 Aligned_cols=67 Identities=30% Similarity=0.467 Sum_probs=39.3
Q ss_pred cCCCCCCEEEccCCcCCC--CCCcccccCccCcEEeccCcccCCCCCCcccCCC--CCcEEeccCccccCcCh
Q 043720 588 ENLTSLVFLDLNGNKLQG--EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELR--SLEVLELSSNSLSGEVP 656 (1103)
Q Consensus 588 ~~l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~--~L~~L~Ls~N~l~~~~~ 656 (1103)
.++++|+.|+|++|+|++ .+|..+..+++|+.|+|++|+|++. ..+..+. +|++|+|++|.+++.+|
T Consensus 167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~ 237 (267)
T 3rw6_A 167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFR 237 (267)
T ss_dssp HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCS
T ss_pred hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccC
Confidence 356677777777777765 2345555666666666666666643 2233333 66666666666654433
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.30 E-value=2.6e-07 Score=93.85 Aligned_cols=61 Identities=20% Similarity=0.167 Sum_probs=35.7
Q ss_pred cCcEEECcCCccccc----cCccccCCCCCCEEeC--CCccCCcc----ccccccCCCCCCEEEccCCcCC
Q 043720 229 YLEHLDLSGNSLVGR----IPSSLGKCQQLRTLLL--FSNMLNDV----IPRELGWLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 229 ~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L--~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 289 (1103)
+|++|+|++|.++.. +...+...++|++|+| ++|.++.. +...+...++|+.|+|++|.+.
T Consensus 94 ~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 94 TLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp SCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 455555555555422 2344555566777777 66777653 3344555577777777777764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=2.2e-05 Score=86.70 Aligned_cols=136 Identities=20% Similarity=0.208 Sum_probs=93.5
Q ss_pred cceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCC---ceeEEEeEEe-cCCeEEEEEeecC
Q 043720 826 SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP---NLVTLIGYRA-SGNEMFLIYNYLP 901 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~E~~~ 901 (1103)
.+.++.|....||+. +..+++|+... ......+.+|+.+++.+.+. .+.+.+.++. ..+..++||||++
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 456888999999998 56788887532 23456788999999998642 3556666664 4556789999999
Q ss_pred CCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 043720 902 GGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ------------------------------------------ 939 (1103)
Q Consensus 902 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~------------------------------------------ 939 (1103)
|..+.+..-. .++..+...++.++++.+..||+.
T Consensus 97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 9888663211 133344444555555555555532
Q ss_pred ---------------CCCCcccCCCCCCcEEECC---CCC-EEEeecccccc
Q 043720 940 ---------------CAPRVLHRDVKPSNILLDD---DFN-AYLSDFGLSRL 972 (1103)
Q Consensus 940 ---------------~~~~ivH~Dlk~~NIll~~---~~~-~ki~Dfgla~~ 972 (1103)
..+.++|+|+++.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2335799999999999987 455 48999998764
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.07 E-value=1.6e-05 Score=86.05 Aligned_cols=135 Identities=19% Similarity=0.164 Sum_probs=97.9
Q ss_pred eeccCCcc-cEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEEEeecCCCC
Q 043720 828 CIGSGGFG-TTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLIYNYLPGGN 904 (1103)
Q Consensus 828 ~lg~G~fg-~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV~E~~~~gs 904 (1103)
.+..|..| .||+..... +..+++|+-... ....+.+|...++.+. +--+.++++++.+.+..++|||+++|.+
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 45556666 589886654 567889976533 3456788999888774 3336678889988899999999999988
Q ss_pred hHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 043720 905 LENFIKARTSRAVDWKILHKIALDVASALAYLHDQC-------------------------------------------- 940 (1103)
Q Consensus 905 L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------------------- 940 (1103)
+.+...... .....++.+++..+..||+..
T Consensus 107 ~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 107 AFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 877654321 223456667777777777421
Q ss_pred -----------CCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 941 -----------APRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 941 -----------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.+.++|+|+.+.||+++.++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12479999999999999877778999998753
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.1e-06 Score=79.23 Aligned_cols=67 Identities=19% Similarity=0.296 Sum_probs=41.2
Q ss_pred EEeccCcccc-CcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCccccccccccCCCCC
Q 043720 643 VLELSSNSLS-GEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFL 721 (1103)
Q Consensus 643 ~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~l~~Np~~ 721 (1103)
.++.+++.++ ..+|..+ -++|+.|+|++|+|+...+..|..+++|+.| .|.+|||.
T Consensus 12 ~v~Cs~~~L~~~~vP~~l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L---------------------~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAF--PVDTTELVLTGNNLTALPPGLLDALPALRTA---------------------HLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCC--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEE---------------------ECCSSCCB
T ss_pred EEEeCCCCCccccCCCCC--CcCCCEEECCCCcCCccChhhhhhccccCEE---------------------EecCCCee
Confidence 4556666654 1233222 1346666666666665555556666666655 56789999
Q ss_pred CCCCCCCCCCC
Q 043720 722 DPCQMYKDISS 732 (1103)
Q Consensus 722 c~C~~~~~~~~ 732 (1103)
|||++..+..|
T Consensus 69 CdC~l~~l~~w 79 (130)
T 3rfe_A 69 CDCRLVPLRAW 79 (130)
T ss_dssp CSGGGHHHHHH
T ss_pred ccCccHHHHHH
Confidence 99998665544
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.77 E-value=1.9e-05 Score=89.45 Aligned_cols=81 Identities=9% Similarity=0.062 Sum_probs=54.8
Q ss_pred ccee-ccCCcccEEEEEEc-------CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCC-C--CceeEEEeEEecC--
Q 043720 826 SNCI-GSGGFGTTYKAEIS-------PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVR-H--PNLVTLIGYRASG-- 890 (1103)
Q Consensus 826 ~~~l-g~G~fg~V~~~~~~-------~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 890 (1103)
.+.| +.|....+|+.... +++.+++|+...... ......+.+|+.+++.+. + -.+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998654 266788998654330 001234667888887774 2 3466788887665
Q ss_pred -CeEEEEEeecCCCChH
Q 043720 891 -NEMFLIYNYLPGGNLE 906 (1103)
Q Consensus 891 -~~~~lV~E~~~~gsL~ 906 (1103)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3568999999886654
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.52 E-value=2.1e-05 Score=77.67 Aligned_cols=34 Identities=6% Similarity=-0.051 Sum_probs=17.5
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecC
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGN 141 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n 141 (1103)
.|+.|||+++.++..--..+..+++|++|+|++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C 95 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKC 95 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCC
Confidence 4555555555555443344445555555555555
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.45 E-value=4.1e-05 Score=75.60 Aligned_cols=83 Identities=7% Similarity=0.117 Sum_probs=39.0
Q ss_pred CCCEEEccCCcCCCCCChhcccCCCCcEeeccccc-CCCCCChhHHh---hcCcCcEEECcCCc-cccccCccccCCCCC
Q 043720 180 SLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE-LNGSIPSELGK---YCRYLEHLDLSGNS-LVGRIPSSLGKCQQL 254 (1103)
Q Consensus 180 ~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~-l~g~ip~~~~~---~~~~L~~L~L~~N~-l~~~~p~~l~~l~~L 254 (1103)
.|++||++++.++..--..+..+++|++|+|++|. ++..--..+.. .+++|++|+|+++. +|..--..+..+++|
T Consensus 62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L 141 (176)
T 3e4g_A 62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL 141 (176)
T ss_dssp CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence 34444554444443323334455555555555553 44222222222 12346666666653 554333345555666
Q ss_pred CEEeCCCc
Q 043720 255 RTLLLFSN 262 (1103)
Q Consensus 255 ~~L~L~~N 262 (1103)
++|+|+++
T Consensus 142 ~~L~L~~c 149 (176)
T 3e4g_A 142 KYLFLSDL 149 (176)
T ss_dssp CEEEEESC
T ss_pred CEEECCCC
Confidence 66666655
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00061 Score=74.78 Aligned_cols=138 Identities=17% Similarity=0.173 Sum_probs=91.8
Q ss_pred CcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC---CCceeEEEeEEecCCeEEEEEeecC
Q 043720 825 TSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR---HPNLVTLIGYRASGNEMFLIYNYLP 901 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lV~E~~~ 901 (1103)
..+.|+.|....+|+.... ++.+++|+.... ....+.+|+..++.+. ...+.++++++...+..++||||++
T Consensus 40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~ 114 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN 114 (312)
T ss_dssp EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence 3467999999999999864 678889986543 2466788988888874 3667788888888889999999999
Q ss_pred CCChH--------H---HHHhhcC-C-------------------cccHHHHH---HHH----------------HHHHH
Q 043720 902 GGNLE--------N---FIKARTS-R-------------------AVDWKILH---KIA----------------LDVAS 931 (1103)
Q Consensus 902 ~gsL~--------~---~l~~~~~-~-------------------~l~~~~~~---~i~----------------~~ia~ 931 (1103)
+..+. + .++.... . .-+|.... ++. ..++.
T Consensus 115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~ 194 (312)
T 3jr1_A 115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ 194 (312)
T ss_dssp CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence 87642 1 1222111 0 01343221 111 11111
Q ss_pred H-HHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecc
Q 043720 932 A-LAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFG 968 (1103)
Q Consensus 932 g-L~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 968 (1103)
. ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 223432 2357899999999999999887 8899974
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00024 Score=81.50 Aligned_cols=76 Identities=11% Similarity=0.024 Sum_probs=48.0
Q ss_pred cceeccCCcccEEEEEEc-CCcEEEEEEcccccc------hhhHHHHHHHHHHHhcCCC--C-ceeEEEeEEecCCeEEE
Q 043720 826 SNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF------QHGVQQFHAEIKTLGNVRH--P-NLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~~~~~~l 895 (1103)
.+.+|.|.++.||++... +++.|+||....... ......+..|.++++.+.. + .+.+++.+. .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence 457899999999999654 467899997643211 1123456678888877632 3 344566553 334589
Q ss_pred EEeecCCC
Q 043720 896 IYNYLPGG 903 (1103)
Q Consensus 896 V~E~~~~g 903 (1103)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00066 Score=76.00 Aligned_cols=139 Identities=17% Similarity=0.318 Sum_probs=78.7
Q ss_pred ceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcC-----CCCceeEEE-e--EEecCCeEEEEEe
Q 043720 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-----RHPNLVTLI-G--YRASGNEMFLIYN 898 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lV~E 898 (1103)
+.|+.|..+.||++...+| .+++|+..... ..+..|+.+++.+ ..|.++... | +....+..++|||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~~-----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRPE-----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSCH-----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCCH-----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 3466678899999987655 58899886521 2233344444433 234444311 1 1234667899999
Q ss_pred ecCCCChH-----------H---HHHhhcC-C--c---------ccHHH-------------------------------
Q 043720 899 YLPGGNLE-----------N---FIKARTS-R--A---------VDWKI------------------------------- 921 (1103)
Q Consensus 899 ~~~~gsL~-----------~---~l~~~~~-~--~---------l~~~~------------------------------- 921 (1103)
|++|..+. + .++.... . + -.|..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986542 1 1111110 0 0 11211
Q ss_pred HHHHHHHHHHHHHHHHh----------CCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 922 LHKIALDVASALAYLHD----------QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 922 ~~~i~~~ia~gL~~LH~----------~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
+..+...+.+++++|++ ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122234456666763 023589999999999999888899999999775
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00027 Score=81.68 Aligned_cols=78 Identities=14% Similarity=0.106 Sum_probs=48.7
Q ss_pred CCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcc--cccccCccccccCC---CCCcchhHHHHHHHH
Q 043720 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG--TFGYVAPEYALTCR---VSDKADVYSYGVVLL 1015 (1103)
Q Consensus 941 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g--~~~y~aPE~~~~~~---~~~~sDvwslGvil~ 1015 (1103)
.+.++|||+++.||+++.++ ++++||+.+..-..... ...... ...|.+|+...... .....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--la~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--IGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--HHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--HHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 34899999999999998876 99999998875321100 000010 13466666553211 112355668888888
Q ss_pred HHHhCC
Q 043720 1016 ELISDK 1021 (1103)
Q Consensus 1016 elltg~ 1021 (1103)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887653
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.00083 Score=73.16 Aligned_cols=79 Identities=16% Similarity=0.134 Sum_probs=56.0
Q ss_pred CCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-C--CceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-H--PNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lV~E 898 (1103)
++.-.+.+|.|..+.||+.+..+|+.|+||+....... ....|.+|+..|+.+. . --+.+++++. .-++|||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~-~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e 90 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPA-LDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME 90 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCC-CTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcc-hhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence 45556789999999999999999999999987544322 2345678888888773 2 2344555553 2378999
Q ss_pred ecCCCCh
Q 043720 899 YLPGGNL 905 (1103)
Q Consensus 899 ~~~~gsL 905 (1103)
|++++..
T Consensus 91 ~l~~~~~ 97 (288)
T 3f7w_A 91 WVDERPP 97 (288)
T ss_dssp CCCCCCC
T ss_pred eecccCC
Confidence 9987643
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.96 E-value=0.00016 Score=72.84 Aligned_cols=117 Identities=15% Similarity=0.110 Sum_probs=66.9
Q ss_pred cCcccCCCCCCCEEEccCC-CCccc----CCccccCCCCCCEEEeecCCCCCC----ccccccCCCCCCEEEccccccCC
Q 043720 99 LSPLVGGLSELRVLSLPFN-GFSGE----FPPEIWSLEKLEVLDVEGNFLSGR----LPNEFVGLRNLRVLNLAFNRIDG 169 (1103)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~n-~l~g~----~p~~l~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 169 (1103)
+...+.+-+.|++|+|++| .|... +-+.+..-+.|++|+|++|.|... +...+..-+.|++|+|++|.|+.
T Consensus 33 l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~ 112 (197)
T 1pgv_A 33 INRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTP 112 (197)
T ss_dssp HHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCH
T ss_pred HHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCH
Confidence 3344566678888888875 66532 233445556778888888877632 33444455777777777777763
Q ss_pred C----CCCCCCCCCCCCEEEccCCc---CCC----CCChhcccCCCCcEeecccccC
Q 043720 170 D----IPFSLRNFESLEVLNLAGNQ---VKG----VIPGFLGSFLKLRVLFLSYNEL 215 (1103)
Q Consensus 170 ~----~p~~l~~l~~L~~L~L~~n~---l~~----~~p~~l~~l~~L~~L~L~~N~l 215 (1103)
. +-..+..-+.|++|+|++|. +.. .+...+..-+.|+.|+++.|.+
T Consensus 113 ~Ga~ala~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 113 ELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHHHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 2 23344444567777776542 221 1223334445556666555543
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.00041 Score=69.80 Aligned_cols=118 Identities=15% Similarity=0.111 Sum_probs=55.1
Q ss_pred cccCCCCCCEEEcccc-ccCCC----CCCCCCCCCCCCEEEccCCcCCCC----CChhcccCCCCcEeecccccCCCCCC
Q 043720 150 EFVGLRNLRVLNLAFN-RIDGD----IPFSLRNFESLEVLNLAGNQVKGV----IPGFLGSFLKLRVLFLSYNELNGSIP 220 (1103)
Q Consensus 150 ~l~~l~~L~~L~Ls~N-~l~~~----~p~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~g~ip 220 (1103)
.+..-+.|++|+|++| +|... +...+..-+.|+.|+|++|++... +...+..-+.|++|+|+.|.|+..--
T Consensus 36 ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga 115 (197)
T 1pgv_A 36 LREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELL 115 (197)
T ss_dssp HHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHH
T ss_pred HHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHH
Confidence 3344566777777664 55421 233344445566666666665522 11222233344444444444432111
Q ss_pred hhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCc---cCCcc----ccccccCCCCCCEEEccCCcC
Q 043720 221 SELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN---MLNDV----IPRELGWLRKLEVLDVSRNRL 288 (1103)
Q Consensus 221 ~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N---~l~~~----~p~~l~~l~~L~~L~Ls~N~l 288 (1103)
.. +-..+..-+.|++|+|++| .+... +...+..-+.|+.|+++.|.+
T Consensus 116 ~a---------------------la~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 116 AR---------------------LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp HH---------------------HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HH---------------------HHHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 11 1223333445666666543 23321 334455556667777666554
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.80 E-value=0.0042 Score=69.09 Aligned_cols=140 Identities=11% Similarity=0.095 Sum_probs=72.1
Q ss_pred ceeccCCccc-EEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC--CCceeEEEeEEecCCeEEEEEeecCCC
Q 043720 827 NCIGSGGFGT-TYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR--HPNLVTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 827 ~~lg~G~fg~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
+.|+.|.... +|+....++..+++|....... ..+..|+.+++.+. .-.+.+++.+....+ +++||++.+.
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 3465565554 7777654466777776543210 22334555555543 123455666654444 6899999776
Q ss_pred ChHHHHHhhcC------------------------CcccHHHHH-------H-H------------HHHHHHHHHHHHh-
Q 043720 904 NLENFIKARTS------------------------RAVDWKILH-------K-I------------ALDVASALAYLHD- 938 (1103)
Q Consensus 904 sL~~~l~~~~~------------------------~~l~~~~~~-------~-i------------~~~ia~gL~~LH~- 938 (1103)
.+.+++..... ..++..... . + ...+...++.+.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 77655432110 001111100 0 0 0111122233311
Q ss_pred --CCCCCcccCCCCCCcEEECCC----CCEEEeecccccc
Q 043720 939 --QCAPRVLHRDVKPSNILLDDD----FNAYLSDFGLSRL 972 (1103)
Q Consensus 939 --~~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~~ 972 (1103)
...+.++|||+.+.||+++.+ +.+.|+||+.+..
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123489999999999999874 6799999998864
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.76 E-value=0.0016 Score=61.30 Aligned_cols=56 Identities=16% Similarity=0.266 Sum_probs=34.8
Q ss_pred EEecCCCccc-ccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCC
Q 043720 546 VANLSNNNII-GHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604 (1103)
Q Consensus 546 ~l~ls~n~~~-~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 604 (1103)
.++.++++++ ..+|..+. ++|++|+|++|+|+.+.+..|..+++|+.|+|++|.+.
T Consensus 12 ~v~Cs~~~L~~~~vP~~lp---~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 12 LVDCGRRGLTWASLPTAFP---VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp EEECCSSCCCTTTSCSCCC---TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred EEEeCCCCCccccCCCCCC---cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 5677777775 46665544 45666666666666555555666666666666666543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.59 E-value=0.016 Score=58.46 Aligned_cols=102 Identities=14% Similarity=0.147 Sum_probs=67.8
Q ss_pred ChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCccccC
Q 043720 904 NLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983 (1103)
Q Consensus 904 sL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~ 983 (1103)
+|.+.|+... .+++++++|.++.|.+.+|.-.-.+. .-..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 34 SL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------ 97 (229)
T 2yle_A 34 SLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD------------ 97 (229)
T ss_dssp EHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred cHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc------------
Confidence 8999998764 67999999999999999988773221 111233457999999999998864 1110
Q ss_pred CcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCC
Q 043720 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKA 1023 (1103)
Q Consensus 984 ~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p 1023 (1103)
.....+.|||... ...+.+.=|||+|+++|.-+--+.|
T Consensus 98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 0122456888763 3456788999999999999865443
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.41 E-value=0.012 Score=64.87 Aligned_cols=158 Identities=13% Similarity=0.195 Sum_probs=87.7
Q ss_pred CCCHHHHHHHhcCCCC-----cceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-----CCc
Q 043720 810 PLTYESIIRATGDFNT-----SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-----HPN 879 (1103)
Q Consensus 810 ~~~~~~~~~~~~~~~~-----~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~n 879 (1103)
+++.+++.....+|.. .+.|+.|....+|+....+| .+++|+....... +.+..|+.+++.+. -|.
T Consensus 6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~~~---~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCCCH---HHHHHHHHHHHHHHHCCCCCCc
Confidence 4556666666666655 24577788899999987755 6888987653211 23445666655543 233
Q ss_pred eeEEE-e--EEecCCeEEEEEeecCCCChHH-----------H---HHhhc-C---C------cccHHHHHH--------
Q 043720 880 LVTLI-G--YRASGNEMFLIYNYLPGGNLEN-----------F---IKART-S---R------AVDWKILHK-------- 924 (1103)
Q Consensus 880 iv~l~-~--~~~~~~~~~lV~E~~~~gsL~~-----------~---l~~~~-~---~------~l~~~~~~~-------- 924 (1103)
++... | +....+..+++++|++|..+.. . ++... . . ...|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 33211 1 1122456799999998865311 1 11110 0 0 011222110
Q ss_pred ----HHHHHHHHHHHHHhC----CCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 925 ----IALDVASALAYLHDQ----CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 925 ----i~~~ia~gL~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
+...+.+.++++++. ....++|+|+.+.||+++++..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011244455566532 13479999999999999887666899998775
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.38 E-value=0.022 Score=62.91 Aligned_cols=158 Identities=15% Similarity=0.165 Sum_probs=87.6
Q ss_pred CCCHHHHHHHhcCCCC-----cceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCc--eeE
Q 043720 810 PLTYESIIRATGDFNT-----SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN--LVT 882 (1103)
Q Consensus 810 ~~~~~~~~~~~~~~~~-----~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 882 (1103)
.++.+.+......|.+ ...++ |....||+....+|+.+++|....... ....+..|..+++.+.... +.+
T Consensus 10 ~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~~vp~ 86 (328)
T 1zyl_A 10 TLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAA 86 (328)
T ss_dssp CCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCC
T ss_pred CCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCCeecc
Confidence 3455555555444432 23566 888899999877777899999863321 2345556777666653211 333
Q ss_pred EEeE-----EecCCeEEEEEeecCCCChH-----H------H---HHhhc-------CCcccHHHH----HHH-------
Q 043720 883 LIGY-----RASGNEMFLIYNYLPGGNLE-----N------F---IKART-------SRAVDWKIL----HKI------- 925 (1103)
Q Consensus 883 l~~~-----~~~~~~~~lV~E~~~~gsL~-----~------~---l~~~~-------~~~l~~~~~----~~i------- 925 (1103)
++.. ....+..++||||++|..+. . . ++... ....++... ..+
T Consensus 87 ~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 166 (328)
T 1zyl_A 87 PVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLI 166 (328)
T ss_dssp CCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSS
T ss_pred eeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcC
Confidence 3332 22355678999999875431 1 1 11110 001121111 001
Q ss_pred --------HHHHHHHHHHHHhC----CCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 926 --------ALDVASALAYLHDQ----CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 926 --------~~~ia~gL~~LH~~----~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
...+...++.+.+. ....++|||+++.||+++ + .+.|+||+.+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 167 PSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred CHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 11111223333221 234789999999999999 4 899999987753
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0049 Score=67.44 Aligned_cols=71 Identities=7% Similarity=0.024 Sum_probs=43.3
Q ss_pred cceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCce-eEEEeEEecCCeEEEEEeec-CCC
Q 043720 826 SNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL-VTLIGYRASGNEMFLIYNYL-PGG 903 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~-~~g 903 (1103)
.+.|+.|....+|+. +.+++|+....... .....+|+..++.+....+ .++++++.+ .-++|+||+ ++.
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence 677999999999999 56888887653211 1123457766666542222 345555432 346899999 654
Q ss_pred Ch
Q 043720 904 NL 905 (1103)
Q Consensus 904 sL 905 (1103)
++
T Consensus 94 ~l 95 (301)
T 3dxq_A 94 TM 95 (301)
T ss_dssp EC
T ss_pred cC
Confidence 44
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.24 E-value=0.0084 Score=67.51 Aligned_cols=141 Identities=15% Similarity=0.170 Sum_probs=83.3
Q ss_pred cceeccCCcccEEEEEEc--------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEE
Q 043720 826 SNCIGSGGFGTTYKAEIS--------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 896 (1103)
.+.+..|-...+|++... +++.|++|+.... ......+.+|..+++.+. +.-..++++++.+ .+|
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~--~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI--LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc--cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 345777888999999765 2478999986432 123456668999888774 3223566776654 289
Q ss_pred EeecCCCChHH--------------HHHh---hc---CCcc--cHHHHHHHHHHHHH-------------------HHHH
Q 043720 897 YNYLPGGNLEN--------------FIKA---RT---SRAV--DWKILHKIALDVAS-------------------ALAY 935 (1103)
Q Consensus 897 ~E~~~~gsL~~--------------~l~~---~~---~~~l--~~~~~~~i~~~ia~-------------------gL~~ 935 (1103)
|||++|..+.. .+.+ .. ++.. -+.++.++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99998765421 1111 10 0111 23455555544322 2333
Q ss_pred HH----hC-CCCCcccCCCCCCcEEECCC----CCEEEeecccccc
Q 043720 936 LH----DQ-CAPRVLHRDVKPSNILLDDD----FNAYLSDFGLSRL 972 (1103)
Q Consensus 936 LH----~~-~~~~ivH~Dlk~~NIll~~~----~~~ki~Dfgla~~ 972 (1103)
|. .. ....++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 32 22 23479999999999999876 7899999998763
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.15 E-value=0.0048 Score=71.16 Aligned_cols=72 Identities=15% Similarity=0.093 Sum_probs=48.2
Q ss_pred cceeccCCcccEEEEEEcC--------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCce-eEEEeEEecCCeEEEE
Q 043720 826 SNCIGSGGFGTTYKAEISP--------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL-VTLIGYRASGNEMFLI 896 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV 896 (1103)
.+.|+.|....||++...+ +..+++|+...... ...+.+|..+++.+...++ .++++.+.. .+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v 150 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 150 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence 3458888899999998653 47899998843211 1344578888887743333 566776543 389
Q ss_pred EeecCCCC
Q 043720 897 YNYLPGGN 904 (1103)
Q Consensus 897 ~E~~~~gs 904 (1103)
+||++|.+
T Consensus 151 ~e~l~G~~ 158 (429)
T 1nw1_A 151 EEYIPSRP 158 (429)
T ss_dssp ECCCCEEE
T ss_pred EEEeCCcc
Confidence 99998643
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=95.49 E-value=0.0096 Score=67.22 Aligned_cols=73 Identities=14% Similarity=0.049 Sum_probs=42.9
Q ss_pred ceeccCCcccEEEEEEcC---------CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCc-eeEEEeEEecCCeEEEE
Q 043720 827 NCIGSGGFGTTYKAEISP---------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN-LVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV 896 (1103)
+.++.|....+|+....+ ++.+++|+....... ..+...|..+++.+...+ +.++++... + ++|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~~~~E~~~l~~L~~~g~~P~~~~~~~--~--~~v 112 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--LYNTISEFEVYKTMSKYKIAPQLLNTFN--G--GRI 112 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--TSCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--eecHHHHHHHHHHHHhcCCCCceEEecC--C--cEE
Confidence 457788888999997654 268888887543211 112356777777764223 345665542 2 689
Q ss_pred EeecCCCCh
Q 043720 897 YNYLPGGNL 905 (1103)
Q Consensus 897 ~E~~~~gsL 905 (1103)
|||++|..+
T Consensus 113 ~e~i~G~~l 121 (369)
T 3c5i_A 113 EEWLYGDPL 121 (369)
T ss_dssp EECCCSEEC
T ss_pred EEEecCCcC
Confidence 999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.41 E-value=0.02 Score=66.30 Aligned_cols=74 Identities=12% Similarity=0.002 Sum_probs=47.4
Q ss_pred cceeccCCcccEEEEEEcC-CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCce-eEEEeEEecCCeEEEEEeecCCC
Q 043720 826 SNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL-VTLIGYRASGNEMFLIYNYLPGG 903 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~E~~~~g 903 (1103)
.+.|+.|-...+|++...+ +..+++|+...... ...+..+|..+++.+...++ .++++++. + .+|+||++|.
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~--~~idR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~ 186 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD--EIINREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGY 186 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CC--SCSCHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChh--hhcCHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCc
Confidence 4568889999999998775 47888998754321 11122578888888864444 46777763 2 2599999875
Q ss_pred Ch
Q 043720 904 NL 905 (1103)
Q Consensus 904 sL 905 (1103)
++
T Consensus 187 ~l 188 (458)
T 2qg7_A 187 AL 188 (458)
T ss_dssp EC
T ss_pred cC
Confidence 43
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.36 E-value=0.041 Score=61.16 Aligned_cols=31 Identities=23% Similarity=0.443 Sum_probs=27.7
Q ss_pred CCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 942 ~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4799999999999999888899999987764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.70 E-value=0.15 Score=58.00 Aligned_cols=140 Identities=13% Similarity=0.090 Sum_probs=82.3
Q ss_pred cceeccCCcccEEEEEEcC--------CcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEE
Q 043720 826 SNCIGSGGFGTTYKAEISP--------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 896 (1103)
.+.+..|-...+|+....+ ++.|++|+...... ..-+..+|..+++.+. +.-..++++.+. + ++|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~--~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG--KFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC---CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc--hhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEE
Confidence 3457778889999997763 57899998754321 1123456777777764 222345555432 2 689
Q ss_pred EeecCCCChHH--------------HHH---h--h---------cCCcccHHHHHHHHHHH-------------------
Q 043720 897 YNYLPGGNLEN--------------FIK---A--R---------TSRAVDWKILHKIALDV------------------- 929 (1103)
Q Consensus 897 ~E~~~~gsL~~--------------~l~---~--~---------~~~~l~~~~~~~i~~~i------------------- 929 (1103)
+||++|..+.. .+. . . ...+.-+.++.++..++
T Consensus 149 ~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l 228 (424)
T 3mes_A 149 EEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKI 228 (424)
T ss_dssp EECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHH
T ss_pred EEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHH
Confidence 99998865311 111 0 0 00111234443333222
Q ss_pred HHHHHHHHhC---------------------CCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 930 ASALAYLHDQ---------------------CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 930 a~gL~~LH~~---------------------~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
...+++|.+. ....++|+|+.+.||+ +.++.+.++||..+..
T Consensus 229 ~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 229 LEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 2233333211 1246899999999999 7788999999998864
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=87.48 E-value=1.2 Score=50.31 Aligned_cols=30 Identities=33% Similarity=0.450 Sum_probs=25.3
Q ss_pred CcccCCCCCCcEEE------CCCCCEEEeecccccc
Q 043720 943 RVLHRDVKPSNILL------DDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 943 ~ivH~Dlk~~NIll------~~~~~~ki~Dfgla~~ 972 (1103)
.++|+|+.+.||++ +++..++++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 46799999999999 4567799999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.15 E-value=0.9 Score=32.77 Aligned_cols=29 Identities=24% Similarity=0.395 Sum_probs=14.1
Q ss_pred eeeeehhHHHHHHHHHHHHHhhhhcccCC
Q 043720 760 QIASIVSASAIVLILLTLVILFFYVRKGF 788 (1103)
Q Consensus 760 ~i~~iv~~~~ivl~l~~~~~~~~~~~~~~ 788 (1103)
.|++.|++.+++++++++..+++++||+.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 35555554444444444555555555543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=81.70 E-value=1.3 Score=44.64 Aligned_cols=123 Identities=13% Similarity=0.178 Sum_probs=82.1
Q ss_pred HHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccC
Q 043720 868 EIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947 (1103)
Q Consensus 868 E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~ 947 (1103)
|+..+.. .||+.+.. .+..+.+.+.+.++.-+ +...|-.- +..+...+++++.+|+....+++.. +|-
T Consensus 36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf 103 (215)
T 4ann_A 36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNRTR-----YTF 103 (215)
T ss_dssp GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGGSS-----EEC
T ss_pred HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhcCc-----eEE
Confidence 3444433 68888876 56666676666666543 33333222 2277889999999999988777654 788
Q ss_pred CCCCCcEEECCCCCEEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCC
Q 043720 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALD 1025 (1103)
Q Consensus 948 Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~ 1025 (1103)
-+.|+|++++.++.+++.-.|+...+ +|.. .++..=.-.+=+++..+++++..|+
T Consensus 104 ~L~P~NL~f~~~~~p~i~~RGik~~l------------------~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 104 VLAPDELFFTRDGLPIAKTRGLQNVV------------------DPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp CCSGGGEEECTTSCEEESCCEETTTB------------------SCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEecceEEEcCCCCEEEEEccCccCC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 89999999999999999877764322 2221 1122223456678888999887775
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1103 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-62 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-60 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-59 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-57 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-57 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-57 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-56 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-55 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-55 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-55 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 7e-55 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 2e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 9e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-52 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-52 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-52 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 8e-52 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-51 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-48 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-47 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-46 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 8e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-45 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-44 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-43 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-42 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-42 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-40 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-40 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-39 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-39 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-39 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-39 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-39 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-37 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-36 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-36 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-31 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-30 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-29 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 8e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-26 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-14 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-12 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-20 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-18 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-12 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-14 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-18 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-17 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-14 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-06 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-13 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-10 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-09 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-12 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-11 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-10 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 8e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-09 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-09 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 7e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 0.001 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-07 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 6e-05 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-07 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 6e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 8e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 7e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.002 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-06 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 8e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 0.001 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-04 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 4e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (546), Expect = 2e-63
Identities = 70/286 (24%), Positives = 126/286 (44%), Gaps = 25/286 (8%)
Query: 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPN 879
G IGSG FGT YK + VAVK L V +Q F E+ L RH N
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
++ +GY ++ ++ ++ + G +L + + ++ + L IA A + YLH +
Sbjct: 66 ILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLHAK 123
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT-SETHATTGVAGTFGYVAPEYALT 998
++HRD+K +NI L +D + DFGL+ + S +H ++G+ ++APE
Sbjct: 124 S---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 999 ---CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055
S ++DVY++G+VL EL++ + N ++ +G +
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPY--------SNINNRDQIIFMVGRGYLSPDL- 231
Query: 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
+ + + M L C + RP Q++ ++ + S
Sbjct: 232 ----SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 2e-62
Identities = 65/277 (23%), Positives = 120/277 (43%), Gaps = 23/277 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+G+G FG + + VAVK L G F AE + ++H LV
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP--DAFLAEANLMKQLQHQRLV 71
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L + +++I Y+ G+L +F+K + + L +A +A +A++ ++
Sbjct: 72 RLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN- 129
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+HRD++ +NIL+ D + ++DFGL+RL+ +E A G + APE
Sbjct: 130 --YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187
Query: 1002 SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061
+ K+DV+S+G++L E+++ + P ++ N+ M+
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR---------------- 231
Query: 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
P + E++ L C E RPT + L+
Sbjct: 232 -PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 212 bits (540), Expect = 3e-62
Identities = 76/318 (23%), Positives = 130/318 (40%), Gaps = 41/318 (12%)
Query: 803 LFIDIGVPLTYESIIRATGDFNTS---------NCIGSGGFGTTYKAEI----SPGILVA 849
+FID P T+E A +F IG+G FG + I VA
Sbjct: 2 IFID---PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVA 58
Query: 850 VKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFI 909
+K L G + + F +E +G HPN++ L G + +I ++ G+L++F+
Sbjct: 59 IKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 118
Query: 910 KARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGL 969
+ + L + +A+ + YL D +HRD+ NIL++ + +SDFGL
Sbjct: 119 RQNDGQ-FTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 970 SRLLGTSETHATT----GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALD 1025
SR L + T G + APE + + +DV+SYG+V+ E++S +
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 1026 PSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTR 1085
++ V + + P D + L L C + + R
Sbjct: 235 WDMTNQ-----------------DVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
Query: 1086 PTMKQVVQCLKQIQHSPN 1103
P Q+V L ++ +PN
Sbjct: 278 PKFGQIVNTLDKMIRNPN 295
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (524), Expect = 1e-60
Identities = 67/280 (23%), Positives = 121/280 (43%), Gaps = 23/280 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+ IGSG FG + VA+K + G + F E + + + HP LV
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE--EDFIEEAEVMMKLSHPKLV 63
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L G + L++ ++ G L ++++ + + L + LDV +AYL + C
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGMAYLEEAC- 121
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
V+HRD+ N L+ ++ +SDFG++R + + ++TG + +PE R
Sbjct: 122 --VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 1002 SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061
S K+DV+S+GV++ E+ S+ K + S+ + IS L +
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYEN-RSNSEVVEDISTGFRLYK--------------- 223
Query: 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
P + + C E RP ++++ L +I S
Sbjct: 224 -PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 6e-60
Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 23/277 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
D +G+G FG + VA+K + G +F E K + N+ H LV
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE--DEFIEEAKVMMNLSHEKLV 62
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L G +F+I Y+ G L N+++ R + L ++ DV A+ YL +
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLESKQ- 120
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
LHRD+ N L++D +SDFGLSR + E ++ G + PE + +
Sbjct: 121 --FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 1002 SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061
S K+D++++GV++ E+ S K F++ +I +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---------------- 222
Query: 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
PH E + + C E RPT K ++ + +
Sbjct: 223 -PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 6e-59
Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 23/281 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+G G FG + + VA+K L G + F E + + +RH LV
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP--EAFLQEAQVMKKLRHEKLV 75
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L S ++++ Y+ G+L +F+K T + + L +A +AS +AY+
Sbjct: 76 QLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN- 133
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+HRD++ +NIL+ ++ ++DFGL+RL+ +E A G + APE AL R
Sbjct: 134 --YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191
Query: 1002 SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061
+ K+DV+S+G++L EL + + P + + M
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---------------- 235
Query: 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102
P + E + L +C + RPT + + L+ S
Sbjct: 236 -PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 198 bits (503), Expect = 2e-57
Identities = 67/283 (23%), Positives = 121/283 (42%), Gaps = 23/283 (8%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
D + +G G +G Y+ + VAVK L + V++F E + ++HPNL
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNL 75
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V L+G ++I ++ GNL ++++ + V +L +A ++SA+ YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK-- 133
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+HRD+ N L+ ++ ++DFGLSRL+ A G + APE +
Sbjct: 134 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 1001 VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060
S K+DV+++GV+L E+ + + P QV ++ +
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYELLEKDYRM 235
Query: 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
P E + L C S RP+ ++ Q + + +
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 3e-57
Identities = 67/279 (24%), Positives = 118/279 (42%), Gaps = 29/279 (10%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLV 881
+ IG G FG + G VAVK + + Q F AE + +RH NLV
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 882 TLIGY-RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
L+G ++++ Y+ G+L +++++R + L K +LDV A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN- 122
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+HRD+ N+L+ +D A +SDFGL++ +++ + APE +
Sbjct: 123 --NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREKK 176
Query: 1001 VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060
S K+DV+S+G++L E+ S + P + +G D
Sbjct: 177 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--------DVVPRVEKGYKMDA------- 221
Query: 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
P + + C + RP+ Q+ + L+ I+
Sbjct: 222 --PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 5e-57
Identities = 64/293 (21%), Positives = 116/293 (39%), Gaps = 27/293 (9%)
Query: 828 CIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGY- 886
IG G FG ++ + G VAVK + + AEI +RH N++ I
Sbjct: 10 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS--WFREAEIYQTVMLRHENILGFIAAD 66
Query: 887 ---RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA-- 941
+ +++L+ +Y G+L +++ T V + + K+AL AS LA+LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 942 ---PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH---ATTGVAGTFGYVAPEY 995
P + HRD+K NIL+ + ++D GL+ ++ A GT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 996 ALTC------RVSDKADVYSYGVVLLELISDKK--ALDPSFSSHGDGFNIISWASMLLRQ 1047
+AD+Y+ G+V E+ + + + +R+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 1048 GQVKDVFNAELWASG-PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
+ + + L M + C + R T ++ + L Q+
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 296
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (494), Expect = 4e-56
Identities = 68/306 (22%), Positives = 123/306 (40%), Gaps = 49/306 (16%)
Query: 822 DFNTSNCIGSGGFGTTYKAE------ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV 875
+ IG G FG ++A P +VAVK L F E +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 73
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV------------------ 917
+PN+V L+G A G M L++ Y+ G+L F+++ + V
Sbjct: 74 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133
Query: 918 ----DWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973
IA VA+ +AYL ++ + +HRD+ N L+ ++ ++DFGLSR +
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 974 GTSE-THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032
+++ A A ++ PE R + ++DV++YGVVL E+ S +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE- 249
Query: 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVV 1092
+R G + P + ++ +L C + + RP+ +
Sbjct: 250 -------EVIYYVRDGNILAC---------PENCPLELYNLMRLCWSKLPADRPSFCSIH 293
Query: 1093 QCLKQI 1098
+ L+++
Sbjct: 294 RILQRM 299
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 5e-56
Identities = 66/298 (22%), Positives = 120/298 (40%), Gaps = 33/298 (11%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP-GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
DF + +G+G G +K P G+++A K + + Q E++ L P +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYI 66
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V G S E+ + ++ GG+L+ +K + +IL K+++ V L YL ++
Sbjct: 67 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
+++HRDVKPSNIL++ L DFG+S L S GT Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTH 179
Query: 1001 VSDKADVYSYGVVLLELISDKKALDPSFSSH----------GDGFNIISWASMLLRQG-- 1048
S ++D++S G+ L+E+ + + P + GD R
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 1049 -------------QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ + N + +C ++ + R +KQ++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (490), Expect = 9e-56
Identities = 62/278 (22%), Positives = 115/278 (41%), Gaps = 27/278 (9%)
Query: 829 IGSGGFGTTYKAEI---SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIG 885
+G G FG+ + I VA+K L G + ++ E + + + +P +V LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 886 YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVL 945
+ L+ GG L F+ + + + ++ V+ + YL ++ +
Sbjct: 77 V-CQAEALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEK---NFV 131
Query: 946 HRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH--ATTGVAGTFGYVAPEYALTCRVSD 1003
HRD+ N+LL + A +SDFGLS+ LG +++ A + + APE + S
Sbjct: 132 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 191
Query: 1004 KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGP 1063
++DV+SYGV + E +S + + + QG+ + P
Sbjct: 192 RSDVWSYGVTMWEALSYGQ---KPYKKMKG-----PEVMAFIEQGKRMEC---------P 234
Query: 1064 HDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
+ ++ L C + RP V Q ++ +S
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 1e-55
Identities = 76/307 (24%), Positives = 119/307 (38%), Gaps = 44/307 (14%)
Query: 822 DFNTSNCIGSGGFGTTYKAEI------SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV 875
+ +G+G FG +A + VAVK L + +E+K L +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 876 -RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR----------------TSRAVD 918
H N+V L+G G +I Y G+L NF++ + A+D
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143
Query: 919 WKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978
+ L + VA +A+L + +HRD+ NILL + DFGL+R +
Sbjct: 144 LEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN 200
Query: 979 HATTG-VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNI 1037
+ G ++APE C + ++DV+SYG+ L EL S + P + +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 1038 ISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCL-K 1096
I +L P +M + C RPT KQ+VQ + K
Sbjct: 261 IKEGFRMLS----------------PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 1097 QIQHSPN 1103
QI S N
Sbjct: 305 QISESTN 311
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 68/289 (23%), Positives = 121/289 (41%), Gaps = 28/289 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876
IG+G FG YK + + VA+K L G + F E +G
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYL 936
H N++ L G + M +I Y+ G L+ F++ + L + +A+ + YL
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYL 126
Query: 937 HDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL--GTSETHATTGVAGTFGYVAPE 994
+ +HRD+ NIL++ + +SDFGLSR+L T+ T+G + APE
Sbjct: 127 ANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 995 YALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054
+ + +DV+S+G+V+ E+++ + S+H +V
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----------------EVMKAI 226
Query: 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
N P D + L ++C + + RP +V L ++ +P+
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 4e-55
Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 29/286 (10%)
Query: 824 NTSNCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN 879
+ + IG G FG Y + I AVK L V QF E + + HPN
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 880 LVTLIGY-RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
+++L+G S ++ Y+ G+L NFI+ T K L L VA +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKG---MKF 145
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE---THATTGVAGTFGYVAPEY 995
+ + +HRD+ N +LD+ F ++DFGL+R + E H TG ++A E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 996 ALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055
T + + K+DV+S+GV+L EL++ P + N LL+ ++
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGA---PPY----PDVNTFDITVYLLQGRRLLQ--- 255
Query: 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
P + + + L+C RP+ ++V + I +
Sbjct: 256 -------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 7e-55
Identities = 60/304 (19%), Positives = 113/304 (37%), Gaps = 48/304 (15%)
Query: 822 DFNTSNCIGSGGFGTTYKA------EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV 875
+ +GSG FG A + I VAVK L + +E+K + +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 876 -RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSR------------------- 915
H N+V L+G ++LI+ Y G+L N+++++ +
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 916 --AVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLL 973
+ ++ L A VA + +L + +HRD+ N+L+ + DFGL+R +
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 974 GTSETHAT-TGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHG 1032
+ + ++APE + K+DV+SYG++L E+ S P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 1033 DGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVV 1092
+ + +I + + P E++ + C RP+ +
Sbjct: 275 NFYKLIQNGFKMDQ----------------PFYATEEIYIIMQSCWAFDSRKRPSFPNLT 318
Query: 1093 QCLK 1096
L
Sbjct: 319 SFLG 322
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 2e-54
Identities = 68/280 (24%), Positives = 129/280 (46%), Gaps = 27/280 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPN 879
D+ IG+G +G K S G ++ K+L G + Q +E+ L ++HPN
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 880 LVTLIGY--RASGNEMFLIYNYLPGGNLENFIKA--RTSRAVDWKILHKIALDVASALAY 935
+V + ++++ Y GG+L + I + + +D + + ++ + AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 936 LHDQ--CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
H + VLHRD+KP+N+ LD N L DFGL+R+L + A GT Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSP 183
Query: 994 EYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053
E ++K+D++S G +L EL + P F F+ A +R+G+ + +
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALM----PPF----TAFSQKELAGK-IREGKFRRI 234
Query: 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
P+ +++ + R RP+++++++
Sbjct: 235 ---------PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-53
Identities = 68/293 (23%), Positives = 132/293 (45%), Gaps = 29/293 (9%)
Query: 816 IIRATGDFNTSNCIGSGGFGTTYKAEISP-----GILVAVKKLAVGRFQHGVQQFHAEIK 870
I++ T +F +GSG FGT YK P I VA+K+L ++ E
Sbjct: 5 ILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 871 TLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVA 930
+ +V +P++ L+G + + LI +P G L ++++ + + L + +A
Sbjct: 64 VMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIA 121
Query: 931 SALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA-TTGVAGTFG 989
+ YL D+ R++HRD+ N+L+ + ++DFGL++LLG E G
Sbjct: 122 KGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIK 178
Query: 990 YVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049
++A E L + ++DV+SYGV + EL++ + DG +S+L + +
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGS---KPY----DGIPASEISSILEKGER 231
Query: 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102
+ P D+ + ++C + +RP ++++ ++ P
Sbjct: 232 LPQ----------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 7e-53
Identities = 69/300 (23%), Positives = 123/300 (41%), Gaps = 40/300 (13%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPG---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RH 877
D + IG G FG KA I + A+K++ + + F E++ L + H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDWKILH 923
PN++ L+G ++L Y P GNL +F++ T+ + + L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 924 KIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTG 983
A DVA + YL + +HRD+ NIL+ +++ A ++DFGLSR T
Sbjct: 131 HFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KTM 185
Query: 984 VAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043
++A E + +DV+SYGV+L E++S + G
Sbjct: 186 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG---TPY----CGMTCAELYEK 238
Query: 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
L + +++ P + +++ L +C E RP+ Q++ L ++
Sbjct: 239 LPQGYRLEK----------PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (467), Expect = 9e-53
Identities = 66/276 (23%), Positives = 105/276 (38%), Gaps = 24/276 (8%)
Query: 821 GDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN 879
D++ +G G +G A VAVK + + R + EI + H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V G+R GN +L Y GG L + I+ + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG-TSETHATTGVAGTFGYVAPEYALT 998
+ HRD+KP N+LLD+ N +SDFGL+ + + + GT YVAPE
Sbjct: 123 G---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 179
Query: 999 CRVSD-KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057
DV+S G+VL +++ + + D S +
Sbjct: 180 REFHAEPVDVWSCGIVLTAMLAGE----LPWDQPSD--------SCQEYSDWKEKKTYLN 227
Query: 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
W L L + VE S R T+ + +
Sbjct: 228 PWKKID----SAPLALLHKILVENPSARITIPDIKK 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 3e-52
Identities = 59/272 (21%), Positives = 111/272 (40%), Gaps = 30/272 (11%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
IG G F T YK + VA +L + + Q+F E + L ++HPN+V
Sbjct: 17 IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDS 76
Query: 887 RAS----GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
S + L+ + G L+ ++K + + K+L + L +LH + P
Sbjct: 77 WESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRT-P 133
Query: 943 RVLHRDVKPSNILLDD-DFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
++HRD+K NI + + + D GL+ L V GT ++APE +
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIGTPEFMAPEM-YEEKY 189
Query: 1002 SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWAS 1061
+ DVY++G+ +LE+ + + +S + I + V + AS
Sbjct: 190 DESVDVYAFGMCMLEMATSE----YPYSECQNAAQIY------------RRVTSGVKPAS 233
Query: 1062 GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ ++ + C + R ++K ++
Sbjct: 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 6e-52
Identities = 66/279 (23%), Positives = 105/279 (37%), Gaps = 29/279 (10%)
Query: 829 IGSGGFGTTYKAEI---SPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLI 884
+GSG FGT K VAVK L + AE + + +P +V +I
Sbjct: 15 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMI 74
Query: 885 GYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRV 944
G L+ G L +++ R V K + ++ V+ + YL +
Sbjct: 75 GI-CEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NF 128
Query: 945 LHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH--ATTGVAGTFGYVAPEYALTCRVS 1002
+HRD+ N+LL A +SDFGLS+ L E + A T + APE + S
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 1003 DKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASG 1062
K+DV+S+GV++ E S + + +L +G+
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGS--------EVTAMLEKGERMGC--------- 231
Query: 1063 PHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101
P +M L C + RP V L+ +
Sbjct: 232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 8e-52
Identities = 67/290 (23%), Positives = 120/290 (41%), Gaps = 31/290 (10%)
Query: 813 YESIIRATG---DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAE 868
YE + R + +G G FG YKA+ +L A K + + + ++ + E
Sbjct: 1 YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDT-KSEEELEDYMVE 59
Query: 869 IKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALD 928
I L + HPN+V L+ N ++++ + GG ++ + R + + +
Sbjct: 60 IDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQ 118
Query: 929 VASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTF 988
AL YLHD +++HRD+K NIL D + L+DFG+S + + GT
Sbjct: 119 TLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTP 174
Query: 989 GYVAPEYALTCRVSD-----KADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASM 1043
++APE + D KADV+S G+ L+E+ + P N +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE----PPH----HELNPMRVLLK 226
Query: 1044 LLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ + + + +D L +C + + R T Q++Q
Sbjct: 227 IAKSEPPTLAQPSRW-----SSNFKDFL---KKCLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 8e-52
Identities = 64/286 (22%), Positives = 110/286 (38%), Gaps = 29/286 (10%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQH--GVQQFHAEIKTLGNV 875
D +G G FG + E + VAVK L + F E+ + ++
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
H NL+ L G + M ++ P G+L + ++ L + A+ VA + Y
Sbjct: 69 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEGMGY 126
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH--ATTGVAGTFGYVAP 993
L + +HRD+ N+LL + DFGL R L ++ H F + AP
Sbjct: 127 LESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 994 EYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053
E T S +D + +GV L E+ + + + G N + ++G+
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQ---EPW----IGLNGSQILHKIDKEGERLPR 236
Query: 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099
P D +D+ ++ ++C RPT + L + Q
Sbjct: 237 ---------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 182 bits (462), Expect = 1e-51
Identities = 66/277 (23%), Positives = 111/277 (40%), Gaps = 33/277 (11%)
Query: 823 FNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQ--HGVQQFHAEIKTLGNVRHPN 879
F+ IG G FG Y A + +VA+KK++ Q Q E++ L +RHPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+ G + +L+ Y G + + + + + + LAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
++HRDVK NILL + L DFG + ++ + + GT ++APE L
Sbjct: 135 ---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAM 186
Query: 1000 ---RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056
+ K DV+S G+ +EL K L + ++ ++I S L+ G
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPPL-FNMNAMSALYHIAQNESPALQSGHWS----- 240
Query: 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
E + C + RPT + +++
Sbjct: 241 -----------EYFRNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 4e-51
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 26/281 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAEI----SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH 877
CIG G FG ++ +P + VA+K ++F E T+ H
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
P++V LIG + N +++I G L +F++ R +D L A +++ALAYL
Sbjct: 68 PHIVKLIGV-ITENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAYLE 125
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ R +HRD+ N+L+ + L DFGLSR + S + + ++APE
Sbjct: 126 SK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 182
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057
R + +DV+ +GV + E++ ++ I + + +
Sbjct: 183 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM------------ 230
Query: 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
P + + L +C S RP ++ L I
Sbjct: 231 -----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 2e-50
Identities = 71/275 (25%), Positives = 118/275 (42%), Gaps = 30/275 (10%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHP 878
DF +G G FG Y A ++A+K L + + Q E++ ++RHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
N++ L GY ++LI Y P G + ++ D + ++A+AL+Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS 124
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ RV+HRD+KP N+LL ++DFG S +S + GT Y+ PE
Sbjct: 125 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEG 178
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058
+K D++S GV+ E + K P F ++ ++ R +V+ F
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGK----PPFEAN-------TYQETYKRISRVEFTF---- 223
Query: 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
P E L R S RP +++V++
Sbjct: 224 ----PDFVTEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 4e-48
Identities = 64/266 (24%), Positives = 120/266 (45%), Gaps = 25/266 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G GT Y A +++ G VA++++ + + Q + EI + ++PN+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
G+E++++ YL GG+L + + +D + + + AL +LH +V+HR
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVT---ETCMDEGQIAAVCRECLQALEFLHSN---QVIHR 140
Query: 948 DVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADV 1007
D+K NILL D + L+DFG + ++ +T V GT ++APE K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 1008 YSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDL 1067
+S G++ +E+I + P + N + ++ G + P
Sbjct: 200 WSLGIMAIEMIEGE----PPY----LNENPLRALYLIATNGTPELQN--------PEKLS 243
Query: 1068 EDMLHLALRCTVETLSTRPTMKQVVQ 1093
RC + R + K+++Q
Sbjct: 244 AIFRDFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 9e-48
Identities = 68/301 (22%), Positives = 122/301 (40%), Gaps = 44/301 (14%)
Query: 822 DFNTSNCIGSGGFGTTYKAE--------ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLG 873
+G G FG AE + VAVK L + + +E++ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 874 NV-RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAV--------------D 918
+ +H N++ L+G +++I Y GNL +++AR +
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 919 WKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978
K L A VA + YL + +HRD+ N+L+ +D ++DFGL+R + +
Sbjct: 134 SKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 979 HATT-GVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNI 1037
+ T ++APE + ++DV+S+GV+L E+ + + P
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------- 242
Query: 1038 ISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097
+ LL++G D P + ++ + C S RPT KQ+V+ L +
Sbjct: 243 VEELFKLLKEGHRMDK---------PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293
Query: 1098 I 1098
I
Sbjct: 294 I 294
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-47
Identities = 54/294 (18%), Positives = 113/294 (38%), Gaps = 35/294 (11%)
Query: 822 DFNTSNCIGSGGFGTTYKAE------ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV 875
S +G G FG Y+ P VA+K + +F E +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKAR--------TSRAVDWKILHKIAL 927
++V L+G + G +I + G+L++++++ + ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG-TSETHATTGVAG 986
++A +AYL+ + +HRD+ N ++ +DF + DFG++R + T
Sbjct: 141 EIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL 197
Query: 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046
+++PE + +DV+S+GVVL E+ + + S+ +
Sbjct: 198 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--------QVLRFVM 249
Query: 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100
+G + D P + + + L C RP+ +++ +K+
Sbjct: 250 EGGLLDK---------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 1e-46
Identities = 66/300 (22%), Positives = 114/300 (38%), Gaps = 42/300 (14%)
Query: 822 DFNTSNCIGSGGFGTTYKA------EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLG-N 874
+G G FG +A + + VAVK L G + +E+K L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 875 VRHPNLVTLIGY-RASGNEMFLIYNYLPGGNLENFIKAR--------------TSRAVDW 919
H N+V L+G G + +I + GNL +++++ +
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 920 KILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979
+ L + VA + +L + + +HRD+ NILL + + DFGL+R + +
Sbjct: 134 EHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 980 A-TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNII 1038
++APE + ++DV+S+GV+L E+ S + P G I
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-------GVKID 243
Query: 1039 SWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098
L++G P +M L C S RPT ++V+ L +
Sbjct: 244 EEFCRRLKEGTRMRA---------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 166 bits (422), Expect = 8e-46
Identities = 64/288 (22%), Positives = 114/288 (39%), Gaps = 28/288 (9%)
Query: 809 VPLTYESIIRATGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHA 867
V + ++ ++ ++ +G+G FG ++ E + G A K + + +
Sbjct: 17 VEIKHDHVL---DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMT-PHESDKETVRK 72
Query: 868 EIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIAL 927
EI+T+ +RHP LV L NEM +IY ++ GG L + ++ + +
Sbjct: 73 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMR 131
Query: 928 DVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAY--LSDFGLSRLLGTSETHATTGVA 985
V L ++H+ +H D+KP NI+ + L DFGL+ L ++ T
Sbjct: 132 QVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-- 186
Query: 986 GTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045
GT + APE A V D++S GV+ L+S F D L
Sbjct: 187 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL----SPFGGEND-------DETLR 235
Query: 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ ++ ED + + +TR T+ Q ++
Sbjct: 236 NVKSCDWNMDDSAFSGIS----EDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 1e-45
Identities = 60/283 (21%), Positives = 113/283 (39%), Gaps = 28/283 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHP 878
DF +G G F T A E++ A+K L ++ V E + + HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
V L +++ +Y G L +I R + D ++ SAL YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSALEYLHG 126
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG-TSETHATTGVAGTFGYVAPEYAL 997
+ ++HRD+KP NILL++D + ++DFG +++L S+ GT YV+PE
Sbjct: 127 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057
+D+++ G ++ +L++ P F + + + + +++ F +
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGL----PPFRAG-------NEYLIFQKIIKLEYDFPEK 232
Query: 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100
+ L + V + R +++ H
Sbjct: 233 FF--------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (407), Expect = 2e-44
Identities = 70/276 (25%), Positives = 113/276 (40%), Gaps = 26/276 (9%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
++ + +G+G F AE LVA+K +A + EI L ++HPN+
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 69
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V L SG ++LI + GG L + I + + ++ V A+ YLHD
Sbjct: 70 VALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 941 APRVLHRDVKPSNILL---DDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
++HRD+KP N+L D+D +SDFGLS++ + GT GYVAPE
Sbjct: 128 ---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTACGTPGYVAPEVLA 182
Query: 998 TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057
S D +S GV+ L+ P F + A + + + + F++
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGY----PPFYDE-------NDAKLFEQILKAEYEFDSP 231
Query: 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
W + + R T +Q +Q
Sbjct: 232 YWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 160 bits (405), Expect = 1e-43
Identities = 55/268 (20%), Positives = 97/268 (36%), Gaps = 25/268 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+GSG FG ++ E + G + K + + EI + + HP L+ L
Sbjct: 37 LGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
EM LI +L GG L + I A + + + L ++H+ ++H
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDYK-MSEAEVINYMRQACEGLKHMHEH---SIVHL 151
Query: 948 DVKPSNILLD--DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
D+KP NI+ + + + DFGL+ L E T T + APE V
Sbjct: 152 DIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAEFAAPEIVDREPVGFYT 209
Query: 1006 DVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065
D+++ GV+ L+S F L + F+ + ++S
Sbjct: 210 DMWAIGVLGYVLLSGLSP-----------FAGEDDLETLQNVKRCDWEFDEDAFSSVS-- 256
Query: 1066 DLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ + R T+ ++
Sbjct: 257 --PEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 4e-43
Identities = 65/297 (21%), Positives = 104/297 (35%), Gaps = 28/297 (9%)
Query: 817 IRATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV 875
+R + IGSG FG Y I+ G VA+K V Q H E K +
Sbjct: 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMM 59
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
+ + I + + + ++ L G +LE+ SR K + +A + S + Y
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFN-FCSRKFSLKTVLLLADQMISRIEY 118
Query: 936 LHDQCAPRVLHRDVKPSNIL---LDDDFNAYLSDFGLSRLLGTSETHA------TTGVAG 986
+H + +HRDVKP N L Y+ DFGL++ + TH + G
Sbjct: 119 IHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046
T Y + L S + D+ S G VL+ G + R
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGS--------LPWQGLKAATKRQKYER 227
Query: 1047 QGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
+ K E+ G + L+ C +P + Q + + H
Sbjct: 228 ISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQG 281
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 154 bits (390), Expect = 2e-42
Identities = 61/291 (20%), Positives = 114/291 (39%), Gaps = 30/291 (10%)
Query: 820 TGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVR 876
+ + +G GG + A + VAVK L + +F E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 877 HPNLVTLIGY----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASA 932
HP +V + +G +++ Y+ G L + + + K ++ D A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQA 123
Query: 933 LAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA--TTGVAGTFGY 990
L + H ++HRDVKP+NI++ + DFG++R + S T V GT Y
Sbjct: 124 LNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180
Query: 991 VAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050
++PE A V ++DVYS G VL E+++ + F S S+ + +
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP-----------FTGDSPVSVAYQHVRE 229
Query: 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRP-TMKQVVQCLKQIQH 1100
+ + D+ + L+ + R T ++ L ++ +
Sbjct: 230 DPIPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (389), Expect = 2e-42
Identities = 65/288 (22%), Positives = 105/288 (36%), Gaps = 38/288 (13%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKL--------AVGRFQHGVQQFHAEIKTL 872
++ +G G + AVK + + Q + E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 873 GNVR-HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVAS 931
V HPN++ L + FL+++ + G L +++ + + K KI +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYV 991
+ LH ++HRD+KP NILLDDD N L+DFG S L E V GT Y+
Sbjct: 122 VICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPSYL 176
Query: 992 APEYALTCRV------SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLL 1045
APE + D++S GV++ L++ P F ML
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS----PPFWHR-------KQMLMLR 225
Query: 1046 RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
F + W + + L R V R T ++ +
Sbjct: 226 MIMSGNYQFGSPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-41
Identities = 53/268 (19%), Positives = 99/268 (36%), Gaps = 26/268 (9%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G FG ++ E S K + V EI L RH N++ L
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ--VLVKKEISILNIARHRNILHLHESF 70
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
S E+ +I+ ++ G ++ I ++ + + V AL +LH + H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHSH---NIGHF 126
Query: 948 DVKPSNILLDDDFNAY--LSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKA 1005
D++P NI+ ++ + +FG +R L + Y APE VS
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVSTAT 184
Query: 1006 DVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHD 1065
D++S G ++ L+S F + + ++ + F+ E +
Sbjct: 185 DMWSLGTLVYVLLSGI----NPFLAETN-------QQIIENIMNAEYTFDEEAFKEIS-- 231
Query: 1066 DLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ + R V+ +R T + +Q
Sbjct: 232 --IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 3e-40
Identities = 64/284 (22%), Positives = 115/284 (40%), Gaps = 16/284 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPN 879
+F IG G +G YKA G +VA+KK+ + GV EI L + HPN
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V L+ + N+++L++ +L +L+ F+ A + ++ + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
VLHRD+KP N+L++ + L+DFGL+R G T V +
Sbjct: 122 R---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 1000 RVSDKADVYSYGVVLLELI---------SDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050
S D++S G + E++ S+ L F + G ++ + +
Sbjct: 179 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 1051 KDV-FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ + ++ ED L + + R + K +
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 3e-40
Identities = 66/296 (22%), Positives = 114/296 (38%), Gaps = 35/296 (11%)
Query: 808 GVPLTYESIIRATGDFN-TSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQF 865
G+ + +II D+ TS +G G G + A+K L +
Sbjct: 1 GLQIKKNAII---DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML------QDCPKA 51
Query: 866 HAEIKTLGNV-RHPNLVTLIGY----RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWK 920
E++ + P++V ++ A + ++ L GG L + I+ R +A +
Sbjct: 52 RREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER 111
Query: 921 ILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFN---AYLSDFGLSRLLGTSE 977
+I + A+ YLH + HRDVKP N+L L+DFG ++ +
Sbjct: 112 EASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNI 1037
+ T T YVAPE + D++S GV++ L+ P F S+ G I
Sbjct: 169 SLTTPCY--TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY----PPFYSN-HGLAI 221
Query: 1038 ISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+R GQ + F W+ E++ L + R T+ + +
Sbjct: 222 SPGMKTRIRMGQYE--FPNPEWSEVS----EEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 5e-40
Identities = 71/282 (25%), Positives = 113/282 (40%), Gaps = 21/282 (7%)
Query: 827 NCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG----VQQFHAEIKTLGNVRHPNLV 881
+ +G G F T YKA + +VA+KK+ +G + EIK L + HPN++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 882 TLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
L+ + + L+++++ I S + + L L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW- 120
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRV 1001
+LHRD+KP+N+LLD++ L+DFGL++ G S A T T Y APE R+
Sbjct: 121 --ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVVTRWYRAPELLFGARM 177
Query: 1002 SD-KADVYSYGVVLLELI---------SDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051
D+++ G +L EL+ SD L F + G L
Sbjct: 178 YGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTF 237
Query: 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
F +D+L L + R T Q ++
Sbjct: 238 KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 9e-40
Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 10/204 (4%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLG-NVRH 877
DF +G G FG + AE A+K L V+ E + L H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
P L + + +F + YL GG+L I++ D A ++ L +LH
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLH 120
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL 997
+ +++RD+K NILLD D + ++DFG+ + + T GT Y+APE L
Sbjct: 121 SK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILL 176
Query: 998 TCRVSDKADVYSYGVVLLELISDK 1021
+ + D +S+GV+L E++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 146 bits (370), Expect = 1e-39
Identities = 64/284 (22%), Positives = 117/284 (41%), Gaps = 18/284 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPNL 880
++ IG G +G YKA+ + G A+KK+ + + G+ EI L ++H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 881 VTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
V L + + L++ +L + ++ L + + +AY HD+
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
RVLHRD+KP N+L++ + ++DFGL+R G T + + + +
Sbjct: 120 --RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177
Query: 1001 VSDKADVYSYGVVLLELI---------SDKKALDPSFSSHGDGFNIISWASM--LLRQGQ 1049
S D++S G + E++ S+ L F G N +W ++ L +
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGT-PNSKNWPNVTELPKYDP 236
Query: 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
V+ W S E + L + + R T KQ ++
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 148 bits (375), Expect = 2e-39
Identities = 53/207 (25%), Positives = 91/207 (43%), Gaps = 15/207 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRF-----QHGVQQFHAEIKTLGNV 875
DF+ IG GGFG Y G + A+K L R + + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 876 RHPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAY 935
P +V + + +++ I + + GG+L + + A ++ L +
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEH 122
Query: 936 LHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEY 995
+H++ V++RD+KP+NILLD+ + +SD GL+ + HA+ GT GY+APE
Sbjct: 123 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEV 176
Query: 996 ALTCRVSD-KADVYSYGVVLLELISDK 1021
D AD +S G +L +L+
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 4e-39
Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 27/296 (9%)
Query: 818 RATGDFNTSNCIGSGGFGTTYKAE--ISPGILVAVKKLAVGRFQHGVQQFH----AEIKT 871
RA + IG G +G +KA + G VA+K++ V + G+ A ++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 872 LGNVRHPNLVTLIGYRASG-----NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIA 926
L HPN+V L ++ L++ ++ ++ V + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMM 122
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAG 986
+ L +LH V+HRD+KP NIL+ L+DFGL+R+ S A T V
Sbjct: 123 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI--YSFQMALTSVVV 177
Query: 987 TFGYVAPEYALTCRVSDKADVYSYGVVLLELI---------SDKKALDPSFSSHGDGFNI 1037
T Y APE L + D++S G + E+ SD L G
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL-PGE 236
Query: 1038 ISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
W + Q +A+ D E L L+C + R + +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 145 bits (367), Expect = 6e-39
Identities = 53/204 (25%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHP 878
DF +G+G FG + G A+K L V+ + E L V HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
++ + G ++F+I +Y+ GG L + ++ + A +V AL YLH
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF--PNPVAKFYAAEVCLALEYLHS 122
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ +++RD+KP NILLD + + ++DFG ++ + + GT Y+APE T
Sbjct: 123 KD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----LCGTPDYIAPEVVST 175
Query: 999 CRVSDKADVYSYGVVLLELISDKK 1022
+ D +S+G+++ E+++
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 7e-39
Identities = 67/298 (22%), Positives = 115/298 (38%), Gaps = 34/298 (11%)
Query: 820 TGDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHP 878
+ + IG G +G A + + VA+KK++ Q Q+ EIK L RH
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 879 NLVTLIGYRASGN----EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALA 934
N++ + + + + +L G +L +K ++ + + + L
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK---TQHLSNDHICYFLYQILRGLK 123
Query: 935 YLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHAT--TGVAGTFGYVA 992
Y+H VLHRD+KPSN+LL+ + + DFGL+R+ H T T Y A
Sbjct: 124 YIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 180
Query: 993 PEYALTCRVSD-KADVYSYGVVLLELISDKKALDPSF--SSHGDGFNIISWASMLLRQGQ 1049
PE L + D++S G +L E++S++ P F + D N I Q
Sbjct: 181 PEIMLNSKGYTKSIDIWSVGCILAEMLSNR----PIFPGKHYLDQLNHILGILGSPSQED 236
Query: 1050 VKDVFNAEL--------------WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ + N + W + L L + R ++Q +
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 143 bits (360), Expect = 2e-38
Identities = 47/287 (16%), Positives = 95/287 (33%), Gaps = 30/287 (10%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
IG G FG ++ + VA+K + Q E +T + + + Y
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 888 ASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHR 947
++ L G +LE+ + R K + A + + + +H++ +++R
Sbjct: 70 GQEGLHNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYR 125
Query: 948 DVKPSNILLDDDFN-----AYLSDFGLSRLLGTSETHA------TTGVAGTFGYVAPEYA 996
D+KP N L+ + Y+ DFG+ + T ++GT Y++
Sbjct: 126 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 185
Query: 997 LTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056
L S + D+ + G V + + G + R G+ K
Sbjct: 186 LGREQSRRDDLEALGHVFMYFLRGSL--------PWQGLKAATNKQKYERIGEKKQSTPL 237
Query: 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103
+G ++ +H P + ++ N
Sbjct: 238 RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 62/275 (22%), Positives = 109/275 (39%), Gaps = 32/275 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQH-----GVQQFHAEIKTLGNVRHPNLVT 882
+GSG F K E S G+ A K + R + + E+ L ++HPN++T
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 883 LIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAP 942
L + ++ LI + GG L +F+ + ++ + + + + + YLH
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ-- 133
Query: 943 RVLHRDVKPSNILLDDD----FNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ H D+KP NI+L D + DFGL+ + + + GT +VAPE
Sbjct: 134 -IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNY 190
Query: 999 CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058
+ +AD++S GV+ L+S F + L V F E
Sbjct: 191 EPLGLEADMWSIGVITYILLSGASP-----------FLGDTKQETLANVSAVNYEFEDEY 239
Query: 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+++ R V+ R T++ +Q
Sbjct: 240 FSNTS----ALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 20/286 (6%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGV-QQFHAEIKTLGNVRHPN 879
+ IG G +GT +KA+ +VA+K++ + GV EI L ++H N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 880 LVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQ 939
+V L S ++ L++ + + F +D +I+ + L + H +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 940 CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTC 999
VLHRD+KP N+L++ + L++FGL+R G + V +
Sbjct: 121 N---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 1000 RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059
S D++S G + EL + + L P + D I + Q + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236
Query: 1060 ASGPHDDL------------EDMLHLALRCTVETLSTRPTMKQVVQ 1093
P L R + ++ +Q
Sbjct: 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 5e-36
Identities = 66/292 (22%), Positives = 107/292 (36%), Gaps = 30/292 (10%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNL 880
+ + IG+G FG Y+A+ G LVA+KK+ + + E++ + + H N+
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNI 75
Query: 881 VTLIGYRASGNE------MFLIYNYLPGGNLENFIK-ARTSRAVDWKILHKIALDVASAL 933
V L + S E + L+ +Y+P +R + + + + +L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAY-LSDFGLSRLLGTSETHATTGVAGTFGYVA 992
AY+H + HRD+KP N+LLD D L DFG ++ L E + + + Y A
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYIC--SRYYRA 190
Query: 993 PEYAL-TCRVSDKADVYSYGVVLLELI---------SDKKALDPSFSSHGDGFNIISWAS 1042
PE + DV+S G VL EL+ S L G
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 1043 MLLRQGQVKDVFNAELWASGPHDDL-EDMLHLALRCTVETLSTRPTMKQVVQ 1093
A W + + L R T + R T +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 67/284 (23%), Positives = 107/284 (37%), Gaps = 44/284 (15%)
Query: 821 GDFNTSNCIGSGGFGTTYKA-EISPGILVAVKKLAVGRFQ-----HGVQQFHAEIKTLGN 874
+ +GSGGFG+ Y +S + VA+K + R + E+ L
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 875 VR--HPNLVTLIGYRASGNEMFLIYNYL-PGGNLENFIKARTSRAVDWKILHKIALDVAS 931
V ++ L+ + + LI P +L +FI R A+ ++ V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLE 121
Query: 932 ALAYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGY 990
A+ + H+ VLHRD+K NIL+D + L DFG LL + T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVY 175
Query: 991 VAPEYALTCRVSDK-ADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049
PE+ R + A V+S G++L +++ F + I + RQ
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD----IPF----EHDEEIIRGQVFFRQ-- 225
Query: 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
S + HL C S RPT +++
Sbjct: 226 ---------RVS------SECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 3e-35
Identities = 52/201 (25%), Positives = 81/201 (40%), Gaps = 9/201 (4%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHP 878
DF+ +G G FG + G A+K L V E + L N RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
L L + + + + Y GG L + + ++ SAL YLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS 123
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+ V++RD+K N++LD D + ++DFGL + + GT Y+APE
Sbjct: 124 R---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179
Query: 999 CRVSDKADVYSYGVVLLELIS 1019
D + GVV+ E++
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMC 200
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 4e-34
Identities = 61/306 (19%), Positives = 107/306 (34%), Gaps = 36/306 (11%)
Query: 817 IRATGDFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGN 874
+ IG G FG +KA G VA+KK+ + + G EIK L
Sbjct: 6 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQL 65
Query: 875 VRHPNLVTLIG--------YRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIA 926
++H N+V LI Y ++L++++ + I
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE-----IK 120
Query: 927 LDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET---HATTG 983
+ L L+ ++LHRD+K +N+L+ D L+DFGL+R ++ + T
Sbjct: 121 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 180
Query: 984 VAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWAS 1042
T Y PE L R D++ G ++ E+ + + ++ +IS
Sbjct: 181 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG--NTEQHQLALISQLC 238
Query: 1043 MLLRQGQVKDVFNAELWAS---------------GPHDDLEDMLHLALRCTVETLSTRPT 1087
+ +V N EL+ + L L + V + R
Sbjct: 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 1088 MKQVVQ 1093
+
Sbjct: 299 SDDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 127 bits (319), Expect = 3e-32
Identities = 44/203 (21%), Positives = 84/203 (41%), Gaps = 12/203 (5%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQH--GVQQFHAEIKTLGNVRHP 878
F+ +G+G FG + G A+K L + ++ E + L V P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 879 NLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD 938
LV L + ++++ Y+ GG + + ++ A + YLH
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHS 159
Query: 939 QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALT 998
+++RD+KP N+L+D ++DFG ++ T + GT +APE L+
Sbjct: 160 L---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILS 212
Query: 999 CRVSDKADVYSYGVVLLELISDK 1021
+ D ++ GV++ E+ +
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY 235
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 122 bits (306), Expect = 9e-31
Identities = 53/297 (17%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 822 DFNTSNCIGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPN 879
D+ +G G + ++A I+ V VK L + ++ EIK L N+R PN
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPN 91
Query: 880 LVTLIGY--RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
++TL L++ ++ + + + T + ++ AL Y H
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT-----DYDIRFYMYEILKALDYCH 146
Query: 938 DQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYA 996
++HRDVKP N+++D + L D+GL+ + + + + PE
Sbjct: 147 SMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELL 201
Query: 997 LTCRVSD-KADVYSYGVVLLELISDKKALDPSFSSHGDGFNII--------------SWA 1041
+ ++ D D++S G +L +I K+ ++ I
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 1042 SMLLRQGQVKDVFNAELWASGPHDDL-----EDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ R + + + W H + + L + +R T ++ ++
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 2e-30
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 15/210 (7%)
Query: 822 DFNTSNCIGSGGFGTTYKAE----ISPGILVAVKKL---AVGRFQHGVQQFHAEIKTLGN 874
+F +G+G +G + G L A+K L + + + E + L +
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 875 VRH-PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASAL 933
+R P LVTL + ++ LI +Y+ GG L + R + ++ AL
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLAL 142
Query: 934 AYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAP 993
+LH +++RD+K NILLD + + L+DFGLS+ ET GT Y+AP
Sbjct: 143 EHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAP 199
Query: 994 EYALTCRVSD--KADVYSYGVVLLELISDK 1021
+ D +S GV++ EL++
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 3e-29
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 32/286 (11%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGY 886
+GSG +G A + G VA+KKL ++ + E++ L ++RH N++ L+
Sbjct: 26 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 85
Query: 887 ------RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
+ +L+ ++ G +L +K + + + + L Y+H
Sbjct: 86 FTPDETLDDFTDFYLVMPFM-GTDLGKLMK---HEKLGEDRIQFLVYQMLKGLRYIHAAG 141
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL-TC 999
HRD+KP N+ +++D + DFGL+R + TG T Y APE L
Sbjct: 142 II---HRDLKPGNLAVNEDCELKILDFGLARQADSE----MTGYVVTRWYRAPEVILNWM 194
Query: 1000 RVSDKADVYSYGVVLLELISDK---KALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN- 1055
R + D++S G ++ E+I+ K K D + + +++ Q + N
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 254
Query: 1056 --------AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093
+ +AS + ++L + V R T + +
Sbjct: 255 MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 8e-29
Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 18/201 (8%)
Query: 829 IGSGGFGTTYKA-EISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886
IGSG G A + VA+KKL+ Q ++ + E+ + V H N+++L+
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV 84
Query: 887 ------RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC 940
+++L+ + + D + + + + + +LH
Sbjct: 85 FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCGIKHLHSAG 139
Query: 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCR 1000
++HRD+KPSNI++ D + DFGL+R GTS T T Y APE L
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM--MTPYVVTRYYRAPEVILGMG 194
Query: 1001 VSDKADVYSYGVVLLELISDK 1021
+ D++S G ++ E++ K
Sbjct: 195 YKENVDIWSVGCIMGEMVRHK 215
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 5e-26
Identities = 51/201 (25%), Positives = 92/201 (45%), Gaps = 18/201 (8%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHG-VQQFHAEIKTLGNVRHPNLVTLIGY 886
+GSG +G+ A G+ VAVKKL+ ++ + E++ L +++H N++ L+
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 887 RASGN-----EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCA 941
+ +L G +L N +K + + + + + L Y+H
Sbjct: 86 FTPARSLEEFNDVYLVTHLMGADLNNIVK---CQKLTDDHVQFLIYQILRGLKYIHSADI 142
Query: 942 PRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYAL-TCR 1000
HRD+KPSN+ +++D + DFGL+R TG T Y APE L
Sbjct: 143 I---HRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWMH 195
Query: 1001 VSDKADVYSYGVVLLELISDK 1021
+ D++S G ++ EL++ +
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 8e-25
Identities = 51/261 (19%), Positives = 93/261 (35%), Gaps = 22/261 (8%)
Query: 829 IGSGGFGTTYKAE-ISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYR 887
+G G F T + A+ + VA+K + + + EIK L V +
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT--EAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 888 ASG--------------NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASAL 933
A+ ++ + G NL IK R + + +I+ + L
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 934 AYLHDQCAPRVLHRDVKPSNILLD-DDFNAYLSDFGLSRLLGTSETHAT-TGVAGTFGYV 991
Y+H +C ++H D+KP N+L++ D L ++ L T T Y
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 992 APEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051
+PE L AD++S ++ ELI+ L H + A ++ G++
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELIT-GDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 1052 DVFNAELWASGPHDDLEDMLH 1072
+ + +L
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLR 276
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 97.5 bits (241), Expect = 2e-22
Identities = 78/315 (24%), Positives = 126/315 (40%), Gaps = 19/315 (6%)
Query: 7 EKTILLEFKNSVSDPSGILSSWQTNTSS-HCSWFGVSCDSES---RVVALNITGGDVSEG 62
+K LL+ K + +P+ LSSW T + +W GV CD+++ RV L+++G ++ +
Sbjct: 7 DKQALLQIKKDLGNPT-TLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 63 NSKPFFSCLMTAQFPFYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPFNGFSGE 122
P + + G LVG + P + L++L L + SG
Sbjct: 66 YPIPSSLANLP---------YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGA 116
Query: 123 FPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182
P + ++ L LD N LSG LP L NL + NRI G IP S +F L
Sbjct: 117 IPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVG 242
+ +F L + F+ + + + + +
Sbjct: 177 TSMTISRN--RLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLA 234
Query: 243 RIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVEL 302
+G + L L L +N + +P+ L L+ L L+VS N L G IP + GN
Sbjct: 235 FDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRF 293
Query: 303 SVLVLSNLFDPLLSG 317
V +N + L G
Sbjct: 294 DVSAYAN--NKCLCG 306
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 72.1 bits (175), Expect = 5e-14
Identities = 47/259 (18%), Positives = 80/259 (30%), Gaps = 35/259 (13%)
Query: 404 IDLSSNELSGELDV--------KLQVP----CMALFDVSGNHMSGSIPRFDYNVCHQMPL 451
+DLS L + L L ++ + H
Sbjct: 55 LDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 452 QSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPER 511
+ + + + + +P +S+ +V F GN +G I + +
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 512 LRRRTDYAFLAGANKLTGSFPGSLFQACNEFH------------------GMVANLSNNN 553
L + N+LTG P + F +
Sbjct: 175 LFTSMTISR----NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230
Query: 554 IIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHR 613
L + K+L LD +N+I G +PQ L L L L+++ N L GEIP +
Sbjct: 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN- 289
Query: 614 LKYLRHLSLADNNLTGGIP 632
L+ + A+N G P
Sbjct: 290 LQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 65.5 bits (158), Expect = 6e-12
Identities = 40/263 (15%), Positives = 77/263 (29%), Gaps = 16/263 (6%)
Query: 428 DVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARF 487
D+SG ++ P ++ + L + + +L +
Sbjct: 56 DLSGLNLPKPYP-IPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVS 114
Query: 488 MVIHNFSGNNFTGPICWL------PVAPERLRRRTDY-AFLAGANKLTGSFPGSLFQACN 540
I +F T P + + N+++G+ P S
Sbjct: 115 GAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSK 174
Query: 541 EFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNG 600
F M + N + V + + + +
Sbjct: 175 LFTSMT---ISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 601 NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVV 660
+ L + L +N + G +P + +L+ L L +S N+L GE+P+G
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-G 288
Query: 661 NLRNLTALLLDNNKL--SGHLPS 681
NL+ NNK LP+
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 57.5 bits (137), Expect = 3e-09
Identities = 64/255 (25%), Positives = 96/255 (37%), Gaps = 31/255 (12%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSN 551
+ SG N P +P + L ++ G N L G P ++ + + +
Sbjct: 56 DLSGLNLPKPYP-IPSSLANLPYLNFL-YIGGINNLVGPIPPAIAKLTQLHYLYI----T 109
Query: 552 NNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL 611
+ + D K+L LD S+N +SG +P S+ +L +LV + +GN++ G IP S
Sbjct: 110 HTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 612 HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSL-------------------- 651
L N G +L ++LS N L
Sbjct: 170 GSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLA 229
Query: 652 ---SGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFP--WN 706
V +NL L L NN++ G LP GL + L N SFNNL G P N
Sbjct: 230 KNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 707 VTTMNCSGVIGNPFL 721
+ + S N L
Sbjct: 290 LQRFDVSAYANNKCL 304
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.1 bits (131), Expect = 2e-08
Identities = 56/285 (19%), Positives = 95/285 (33%), Gaps = 33/285 (11%)
Query: 104 GGLSELRVLSLPFNGFSGEF--PPEIWSLEKLEVLDVEGN-FLSGRLPNEFVGLRNLRVL 160
+ L L + P + +L L L + G L G +P L L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 161 NLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIP 220
+ + G IP L ++L L+ + N + G +P + S L + N ++G+IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 221 SELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEV 280
G + + + +S N L G+IP + S + + L K
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVD--LSRNMLEGDASVLFGSDKNTQ 224
Query: 281 LDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFI 340
++G L+ L L N N
Sbjct: 225 KIHLAKNSLAFDLGKVGLSKNLNGLDLRN---------------------------NRIY 257
Query: 341 GSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQN 385
G++P +T L L + NL G++P G + ++ A N
Sbjct: 258 GTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.8 bits (125), Expect = 1e-07
Identities = 18/67 (26%), Positives = 28/67 (41%), Gaps = 4/67 (5%)
Query: 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRI 244
+L N++ G +P L L L +S+N L G IP G + + + N +
Sbjct: 250 DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYANNKCLCGS 307
Query: 245 PSSLGKC 251
P L C
Sbjct: 308 P--LPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.1 bits (123), Expect = 2e-07
Identities = 50/261 (19%), Positives = 89/261 (34%), Gaps = 6/261 (2%)
Query: 181 LEVLNLAGNQVKGV--IPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGN 238
+ L+L+G + IP L + L L++ L +L ++
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 239 SLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGN 298
++ G IP L + + L TL N L+ +P + L L + NR++G IP G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 299 CVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWA 358
+L + + L++ D S +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKN----TQKIH 227
Query: 359 PRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVK 418
N G ++L L+L N + G L + K LH +++S N L GE+
Sbjct: 228 LAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 419 LQVPCMALFDVSGNHMSGSIP 439
+ + + N P
Sbjct: 288 GNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 4e-07
Identities = 57/261 (21%), Positives = 100/261 (38%), Gaps = 11/261 (4%)
Query: 153 GLRNLRVLNLAFNRIDGD--IPFSLRNFESLEVLNLAGN-QVKGVIPGFLGSFLKLRVLF 209
+ L+L+ + IP SL N L L + G + G IP + +L L+
Sbjct: 48 QTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLY 107
Query: 210 LSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269
+++ ++G+IP + L LD S N+L G +P S+ L + N ++ IP
Sbjct: 108 ITHTNVSGAIPDF-LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 270 RELGWLRKLEV-LDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQ 328
G KL + +SRNRL G IP N V + N+ + + +
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEG-----DASVLFGSDK 221
Query: 329 SDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLR 388
+ + + ++ L + + G LP + L LN++ N L
Sbjct: 222 NTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281
Query: 389 GDLIGVFDRCKKLHFIDLSSN 409
G I ++ ++N
Sbjct: 282 G-EIPQGGNLQRFDVSAYANN 301
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 4e-07
Identities = 55/256 (21%), Positives = 91/256 (35%), Gaps = 13/256 (5%)
Query: 192 KGVIPGFLGSFLKLRVLFLSYNELNG--SIPSELGKYCRYLEHLDLSGN-SLVGRIPSSL 248
GV+ ++ L LS L IPS L YL L + G +LVG IP ++
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLAN-LPYLNFLYIGGINNLVGPIPPAI 97
Query: 249 GKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS 308
K QL L + ++ IP L ++ L LD S N L+G +P + + L +
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFD 157
Query: 309 N--LFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGK 366
+ + +L + + N + N+
Sbjct: 158 GNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN------LAFVDLSRNMLEG 211
Query: 367 LPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL-QVPCMA 425
S + +G K L+ +DL +N + G L L Q+ +
Sbjct: 212 DASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLH 271
Query: 426 LFDVSGNHMSGSIPRF 441
+VS N++ G IP+
Sbjct: 272 SLNVSFNNLCGEIPQG 287
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 50.9 bits (120), Expect = 4e-07
Identities = 21/66 (31%), Positives = 32/66 (48%), Gaps = 1/66 (1%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
+NL L+L NRI G +P L + L LN++ N + G IP G+ + V + N+
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302
Query: 215 LNGSIP 220
P
Sbjct: 303 CLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 45.9 bits (107), Expect = 2e-05
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 3/143 (2%)
Query: 573 DASHNQISGIVPQSLENLTSLVFLDLNGNKLQG--EIPSSLHRLKYLRHLSLADN-NLTG 629
D + G++ + + LDL+G L IPSSL L YL L + NL G
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 630 GIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSL 689
IP +I +L L L ++ ++SG +P+ + ++ L L N LSG LP ++++ +L
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 690 SIFNASFNNLSGPFPWNVTTMNC 712
N +SG P + + +
Sbjct: 152 VGITFDGNRISGAIPDSYGSFSK 174
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 98.5 bits (244), Expect = 2e-22
Identities = 50/206 (24%), Positives = 76/206 (36%), Gaps = 17/206 (8%)
Query: 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA 163
L+ L L N S P I + L+ L + GN L L NL L+LA
Sbjct: 194 AKLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLA 249
Query: 164 FNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSEL 223
N+I P S L L L NQ+ + P L L N
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISP-----LAGLTALTNLELNENQLEDISP 302
Query: 224 GKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDV 283
+ L +L L N++ P + +L+ L +N ++D L L + L
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 284 SRNRLNGLIPTELGNCVELSVLVLSN 309
N+++ L P L N ++ L L++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLND 382
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 93.1 bits (230), Expect = 1e-20
Identities = 72/375 (19%), Positives = 129/375 (34%), Gaps = 47/375 (12%)
Query: 350 LSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSN 409
L++ + N+ + + + + L + ++ + G + L I+ S+N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSNN 76
Query: 410 ELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQY 469
+L+ +K L D+ N+ + N+ + L + +
Sbjct: 77 QLTDITPLK---NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 470 FMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTG 529
+ +A + + P+A R D +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISS--------- 184
Query: 530 SFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLEN 589
+ + + +NN I PL I +L L + NQ+ I +L +
Sbjct: 185 NKVSDISVLAKLTNLESLIATNNQISDITPLGI---LTNLDELSLNGNQLKDI--GTLAS 239
Query: 590 LTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIP----------------- 632
LT+L LDL N++ P L L L L L N ++ P
Sbjct: 240 LTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQL 297
Query: 633 ---SSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSL 689
S I L++L L L N++S P +L L L NNK+S S LAN+T++
Sbjct: 298 EDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLANLTNI 353
Query: 690 SIFNASFNNLSGPFP 704
+ +A N +S P
Sbjct: 354 NWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 84.3 bits (207), Expect = 9e-18
Identities = 65/380 (17%), Positives = 122/380 (32%), Gaps = 59/380 (15%)
Query: 331 ASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGD 390
+ K + ++ T L ++ + A RL + K +L +N + N L
Sbjct: 26 KTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQINFSNNQLTD- 80
Query: 391 LIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMP 450
I KL I +++N+++ + L + + N+
Sbjct: 81 -ITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 451 LQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPE 510
++ T +Q ++ ++ + + S N + +
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKL--- 196
Query: 511 RLRRRTDYAFLAGANKLTGSFPG-------SLFQACNEFHG----------MVANLSNNN 553
+ +A N+++ P L N+ +L+NN
Sbjct: 197 ----TNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQ 252
Query: 554 IIGHIPLDIGVMCKSLRVLDASHNQISGIVP--------------------QSLENLTSL 593
I PL L L NQIS I P + NL +L
Sbjct: 253 ISNLAPLS---GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNL 309
Query: 594 VFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSG 653
+L L N + P + L L+ L A+N ++ SS+ L ++ L N +S
Sbjct: 310 TYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 654 EVPEGVVNLRNLTALLLDNN 673
P + NL +T L L++
Sbjct: 366 LTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 77.0 bits (188), Expect = 3e-15
Identities = 57/395 (14%), Positives = 116/395 (29%), Gaps = 40/395 (10%)
Query: 233 LDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLI 292
L ++ + + Q+ TL + + + +L L ++ S N+L +
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 82
Query: 293 PTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSK 352
P L N L+ L D L++ I + G ++
Sbjct: 83 P--LKN--------LTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 353 LRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELS 412
N + + G ++ Q L + + + S+
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDI-- 190
Query: 413 GELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQ-GYDPSFTYMQYF- 470
V ++ + + N +S P ++ L + L G S T +
Sbjct: 191 ---SVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLD 247
Query: 471 MSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGS 530
++ ++ +S + N + + +
Sbjct: 248 LANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNEN------------ 295
Query: 531 FPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENL 590
+ N + L NNI P+ L+ L ++N++S SL NL
Sbjct: 296 QLEDISPISNLKNLTYLTLYFNNISDISPVS---SLTKLQRLFFANNKVSD--VSSLANL 350
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADN 625
T++ +L N++ P L L + L L D
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 9e-13
Identities = 36/158 (22%), Positives = 54/158 (34%), Gaps = 29/158 (18%)
Query: 101 PLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLP------------ 148
+ L+ L L L N S P + L KL L + N +S P
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL 292
Query: 149 --------NEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLG 200
+ L+NL L L FN I P S + L+ L A N+V L
Sbjct: 293 NENQLEDISPISNLKNLTYLTLYFNNISDISPVS--SLTKLQRLFFANNKVSD--VSSLA 348
Query: 201 SFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGN 238
+ + L +N+++ P L + L L+
Sbjct: 349 NLTNINWLSAGHNQISDLTP--LAN-LTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 66.9 bits (162), Expect = 4e-12
Identities = 69/455 (15%), Positives = 123/455 (27%), Gaps = 87/455 (19%)
Query: 162 LAFNRIDGDIP----FSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
L I D P F+ L V + ++ L +
Sbjct: 1 LGSATITQDTPINQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK- 57
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
SI + Y L ++ S N L P L +L +L+ +N + D+ P
Sbjct: 58 SIDG-VE-YLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLT 113
Query: 278 LEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337
L ++ + SN + + + + + K
Sbjct: 114 GLTLFNNQITDIDPLKNLTNLNRLELS---SNTISDISALSGLTSLQQLSFGNQVTDLKP 170
Query: 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKL-----------PSSWGACESLEMLNLAQNV 386
+ + S + L + G +L+ L+L N
Sbjct: 171 LANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQ 230
Query: 387 LRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVC 446
L+ IG L +DL++N++S L +SG + +
Sbjct: 231 LKD--IGTLASLTNLTDLDLANNQISN------------LAPLSGLTKLTELKLGANQIS 276
Query: 447 HQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLP 506
+ PL + + ++ + L + NN +
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPISNLKN---------LTYLTLYFNNISDIS---- 323
Query: 507 VAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMC 566
++ KL +NN + L
Sbjct: 324 -------------PVSSLTKLQ-----------------RLFFANNKVSDVSSLA---NL 350
Query: 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGN 601
++ L A HNQIS + P L NLT + L LN
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 1e-06
Identities = 55/367 (14%), Positives = 105/367 (28%), Gaps = 50/367 (13%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
L+E L + L+++ L + + + L NL +N +
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 75
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG 224
N++ P N L + + NQ+ + P + L LF + + +
Sbjct: 76 NQLTDITPLK--NLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTL------------LLFSNMLNDVIPREL 272
L +S S + + S + L + L
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332
L LE L + N+++ + P L L +L L L+
Sbjct: 194 AKLTNLESLIATNNQISDITPLG--ILTNLDEL---SLNGNQLKDIGTLASLT--NLTDL 246
Query: 333 NGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLP--------------------SSWG 372
+ N P ++ L+KL + + P S
Sbjct: 247 DLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS 304
Query: 373 ACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGN 432
++L L L N + I KL + ++N++S + + + N
Sbjct: 305 NLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSD-VSSLANLTNINWLSAGHN 361
Query: 433 HMSGSIP 439
+S P
Sbjct: 362 QISDLTP 368
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.2 bits (210), Expect = 2e-19
Identities = 25/157 (15%), Positives = 48/157 (30%), Gaps = 18/157 (11%)
Query: 827 NCIGSGGFGTTYKAEISPGILVAVKKLAVGR---------FQHGVQQFHAEIKTLGNVRH 877
+G G + VK VG +G F
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 878 PNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLH 937
L L G + +Y + L I A+ V + ++ + +A +
Sbjct: 66 RALQKLQGLA-----VPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY 120
Query: 938 DQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974
+ ++H D+ N+L+ + ++ DF S +G
Sbjct: 121 HRG---IVHGDLSQYNVLV-SEEGIWIIDFPQSVEVG 153
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 47/293 (16%), Positives = 103/293 (35%), Gaps = 19/293 (6%)
Query: 122 EFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESL 181
+ P ++ +LD++ N ++ +F L+NL L L N+I P + L
Sbjct: 24 KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 182 EVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLV 241
E L L+ NQ+K + + +LRV ++ S+ + L + L +
Sbjct: 82 ERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLN--QMIVVELGTNPLKSS 139
Query: 242 GRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVE 301
G + ++L + + + + G L L + N++ + L
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNN 196
Query: 302 LSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRL 361
L+ L LS + ++ + + + N+ + +P + +++++
Sbjct: 197 LAKLGLSFNSISAVDNGSLANTPHLRELHLN----NNKLVKVPGGLADHKYIQVVYLHNN 252
Query: 362 NLEG------KLPSSWGACESLEMLNLAQNVLRGDLI--GVFDRCKKLHFIDL 406
N+ P S ++L N ++ I F + L
Sbjct: 253 NISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.8 bits (177), Expect = 2e-14
Identities = 39/178 (21%), Positives = 64/178 (35%), Gaps = 5/178 (2%)
Query: 543 HGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNK 602
H V S+ + +P D+ +LD +N+I+ I +NL +L L L NK
Sbjct: 11 HLRVVQCSDLGLE-KVPKDLP---PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNK 66
Query: 603 LQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNL 662
+ P + L L L L+ N L L+ L V E + V +N
Sbjct: 67 ISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVF-NGLNQ 125
Query: 663 RNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPF 720
+ L + K SG + LS + N++ ++ + GN
Sbjct: 126 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKI 183
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 72.4 bits (176), Expect = 4e-14
Identities = 44/241 (18%), Positives = 77/241 (31%), Gaps = 17/241 (7%)
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRK 277
+P +L LDL N + + L TL+L +N ++ + P L K
Sbjct: 24 KVPKDLPPD---TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVK 80
Query: 278 LEVLDVSRNRLNGLIPTELGNCVEL--SVLVLSNLFDPLLSGRNIRGELSVGQSDASNGE 335
LE L +S+N+L L EL ++ + + +G N + +
Sbjct: 81 LERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL------GTN 134
Query: 336 KNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVF 395
G + KL I N+ +P G SL L+L N +
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAASL 191
Query: 396 DRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSD 455
L + LS N +S + + + + + + +Q
Sbjct: 192 KGLNNLAKLGLSFNSISAVDN---GSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVY 248
Query: 456 L 456
L
Sbjct: 249 L 249
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.2 bits (173), Expect = 8e-14
Identities = 42/203 (20%), Positives = 76/203 (37%), Gaps = 5/203 (2%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNR 166
+ +L L N + + +L+ L L + N +S P F L L L L+ N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY 226
+ + + L V +V+ + L + + L + + +G
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGIENGAFQG- 148
Query: 227 CRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRN 286
+ L ++ ++ ++ IP L L L L N + V L L L L +S N
Sbjct: 149 MKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 287 RLNGLIPTELGNCVELSVLVLSN 309
++ + L N L L L+N
Sbjct: 206 SISAVDNGSLANTPHLRELHLNN 228
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 61.6 bits (148), Expect = 1e-10
Identities = 49/313 (15%), Positives = 89/313 (28%), Gaps = 39/313 (12%)
Query: 342 SIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKL 401
+P ++ ++ + + ++L L L N + G F KL
Sbjct: 24 KVPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 81
Query: 402 HFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYD 461
+ LS N+L EL K+ L F+ +
Sbjct: 82 ERLYLSKNQLK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV------------ 128
Query: 462 PSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFL 521
+ K+ + + + N T LP + L
Sbjct: 129 ---VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH-------- 177
Query: 522 AGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISG 581
NK+T SL + LS N+I LR L ++N++
Sbjct: 178 LDGNKITKVDAASL---KGLNNLAKLGLSFNSISAVDN-GSLANTPHLRELHLNNNKLV- 232
Query: 582 IVPQSLENLTSLVFLDLNGNKLQG------EIPSSLHRLKYLRHLSLADNNLTGG--IPS 633
VP L + + + L+ N + P + +SL N + PS
Sbjct: 233 KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPS 292
Query: 634 SIGELRSLEVLEL 646
+ + ++L
Sbjct: 293 TFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 58.1 bits (139), Expect = 2e-09
Identities = 52/308 (16%), Positives = 104/308 (33%), Gaps = 61/308 (19%)
Query: 376 SLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKL-QVPCMALFDVSGNHM 434
+L+L N + G F K LH + L +N++S + + +S N +
Sbjct: 32 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 91
Query: 435 SGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFS 494
+P ++ + +++ + F + + PL
Sbjct: 92 K-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPL-------------- 136
Query: 495 GNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNI 554
K +G G+ + +++ NI
Sbjct: 137 -------------------------------KSSGIENGAFQGMKKLSYI---RIADTNI 162
Query: 555 IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRL 614
IP + SL L N+I+ + SL+ L +L L L+ N + SL
Sbjct: 163 -TTIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 218
Query: 615 KYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSG------EVPEGVVNLRNLTAL 668
+LR L L +N L +P + + + ++V+ L +N++S P + + +
Sbjct: 219 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 277
Query: 669 LLDNNKLS 676
L +N +
Sbjct: 278 SLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 5e-09
Identities = 38/163 (23%), Positives = 64/163 (39%), Gaps = 8/163 (4%)
Query: 551 NNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ--GEIP 608
+ N + +P + + LRV N+I+ + L ++ ++L N L+ G
Sbjct: 87 SKNQLKELPEKMPKTLQELRV---HENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 609 SSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTAL 668
+ +K L ++ +AD N+T IP + SL L L N ++ + L NL L
Sbjct: 144 GAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200
Query: 669 LLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMN 711
L N +S LAN L + + N L
Sbjct: 201 GLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKY 243
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 6e-09
Identities = 50/249 (20%), Positives = 77/249 (30%), Gaps = 58/249 (23%)
Query: 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFL---------- 143
K+ L L L L N S P L KLE L + N L
Sbjct: 42 KITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKT 101
Query: 144 -------------------------------------SGRLPNEFVGLRNLRVLNLAFNR 166
SG F G++ L + +A
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
Query: 167 IDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKY 226
I IP L SL L+L GN++ V L L L LS+N ++
Sbjct: 162 IT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGS-LAN 217
Query: 227 CRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDV------IPRELGWLRKLEV 280
+L L L+ N LV ++P L + ++ + L +N ++ + P
Sbjct: 218 TPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 276
Query: 281 LDVSRNRLN 289
+ + N +
Sbjct: 277 VSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 53.9 bits (128), Expect = 4e-08
Identities = 28/152 (18%), Positives = 47/152 (30%), Gaps = 3/152 (1%)
Query: 596 LDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEV 655
+ + L+ ++P L L L +N +T L++L L L +N +S
Sbjct: 15 VQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71
Query: 656 PEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGV 715
P L L L L N+L + L + + + M +
Sbjct: 72 PGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVEL 131
Query: 716 IGNPFLDPCQMYKDISSSELTSSNANSQHNIT 747
NP + S + NIT
Sbjct: 132 GTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.8 bits (210), Expect = 6e-18
Identities = 59/466 (12%), Positives = 119/466 (25%), Gaps = 32/466 (6%)
Query: 203 LKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL----VGRIPSSLGKCQQLRTLL 258
L ++ L + EL+ + +EL + + + L L I S+L L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 259 LFSNMLNDVIPRELGWL-----RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDP 313
L SN L DV + K++ L + L L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNC--CLTGAGCGVLSSTLRTLPTLQELHL 119
Query: 314 LLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGA 373
+ G + + + + ++ S + R + K +
Sbjct: 120 SDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN 179
Query: 374 CESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNH 433
+ + + L+ + + + + + +
Sbjct: 180 DINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLG 239
Query: 434 MSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNF 493
G + L++ + + + +S A +
Sbjct: 240 DVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEG 299
Query: 494 SGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNN 553
+ + + + S S+ + + +
Sbjct: 300 ARLLCETLLEPGCQLESLWVKSCSF------TAACCSHFSSVLAQNRFLLELQISNNRLE 353
Query: 554 IIGHIPLDIGVM--CKSLRVLDASHNQISGI----VPQSLENLTSLVFLDLNGNKLQGEI 607
G L G+ LRVL + +S + +L SL LDL+ N L
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 608 PSSL-----HRLKYLRHLSLADNNLTGGIPSSIGELR----SLEVL 644
L L L L D + + + L SL V+
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.1 bits (203), Expect = 4e-17
Identities = 54/462 (11%), Positives = 104/462 (22%), Gaps = 23/462 (4%)
Query: 230 LEHLDLSGNSLV-GRIPSSLGKCQQLRTLLLFSNMLNDV----IPRELGWLRKLEVLDVS 284
++ LD+ L R L QQ + + L L + I L L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 285 RNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIP 344
N L + + ++ + L L + V S +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLS--LQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 121
Query: 345 MEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFI 404
+ + C + + + I
Sbjct: 122 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 181
Query: 405 DLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSF 464
+ + + + AL S S + V + L+ L
Sbjct: 182 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 241
Query: 465 TYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGA 524
+ L I + + E +
Sbjct: 242 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGAR 301
Query: 525 NKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVP 584
+ + + + + + + +
Sbjct: 302 LLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELC 361
Query: 585 QS-LENLTSLVFLDLNGNKLQGE----IPSSLHRLKYLRHLSLADNNLTGGIPSSIGE-- 637
Q + + L L L + + ++L LR L L++N L + E
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 638 ---LRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676
LE L L S E+ + L AL D L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.1 bits (177), Expect = 7e-14
Identities = 66/465 (14%), Positives = 132/465 (28%), Gaps = 30/465 (6%)
Query: 180 SLEVLNLAGNQVKGV-IPGFLGSFLKLRVLFLSYNELNGSIPSELG---KYCRYLEHLDL 235
++ L++ ++ L + +V+ L L + ++ + L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 236 SGNSLVGRIPSSLGK-----CQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG 290
N L + + +++ L L + L L + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLR------TLPTLQE 116
Query: 291 LIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTL 350
L ++ L+ L DP ++ E + + + + T+
Sbjct: 117 LHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTV 176
Query: 351 SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNE 410
S I A L L S E+L++ + + K +
Sbjct: 177 SNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSN 236
Query: 411 LSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYF 470
G++ + P + + C + + S +
Sbjct: 237 KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 296
Query: 471 MSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGS 530
ARL L+ + +FT C + + R N+L +
Sbjct: 297 DEGARLLCETLLEPGCQLESLWVKSCSFT-AACCSHFSSVLAQNRFLLELQISNNRLEDA 355
Query: 531 FPGSLFQACNEFHGM--VANLSNNNIIGHIPLDIGVM---CKSLRVLDASHNQISGIVPQ 585
L Q + + V L++ ++ + SLR LD S+N +
Sbjct: 356 GVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 415
Query: 586 SL-----ENLTSLVFLDLNGNKLQGEIPSSLHRLK----YLRHLS 621
L + L L L E+ L L+ LR +S
Sbjct: 416 QLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 1e-08
Identities = 58/468 (12%), Positives = 118/468 (25%), Gaps = 32/468 (6%)
Query: 133 LEVLDVEGNFLS-GRLPNEFVGLRNLRVLNLAFNRIDGD----IPFSLRNFESLEVLNLA 187
++ LD++ LS R L+ +V+ L + I +LR +L LNL
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSS 247
N++ V + L+ ++ L L L G
Sbjct: 64 SNELGDVGVHCVLQGLQ--------------------TPSCKIQKLSLQNCCLTGAGCGV 103
Query: 248 LGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL 307
L + L ++ ++++ L +LD + + L
Sbjct: 104 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 163
Query: 308 SNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKL 367
P + + + S R
Sbjct: 164 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 223
Query: 368 PSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALF 427
+ +L L + G+ +L + + ++ + L A
Sbjct: 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 283
Query: 428 DVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARF 487
+ ++ D CQ + + +L
Sbjct: 284 SLKELSLA-GNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFL 342
Query: 488 MVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVA 547
+ + + + L + +LA ++ S SL H +
Sbjct: 343 LELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLAD-CDVSDSSCSSLAATLLANHSLRE 401
Query: 548 -NLSNNNIIGHIPLDIGVMCKS----LRVLDASHNQISGIVPQSLENL 590
+LSNN + L + + L L S + L+ L
Sbjct: 402 LDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.1 bits (133), Expect = 1e-08
Identities = 17/91 (18%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 568 SLRVLDASHNQISGI-VPQSLENLTSLVFLDLNGNKLQGE----IPSSLHRLKYLRHLSL 622
++ LD ++S + L L + L+ L I S+L L L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 623 ADNNLTGGIPSSIGELRSLEVLELSSNSLSG 653
N L + + ++ SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 1e-07
Identities = 27/149 (18%), Positives = 45/149 (30%), Gaps = 13/149 (8%)
Query: 589 NLTSLVFLDLNGNKLQGE-IPSSLHRLKYLRHLSLADNNLTG----GIPSSIGELRSLEV 643
++ SL D+ +L L L+ + + L D LT I S++ +L
Sbjct: 3 DIQSL---DIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 644 LELSSNSLSGEVPEGV-----VNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNN 698
L L SN L V + L L N L+G L++ +
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119
Query: 699 LSGPFPWNVTTMNCSGVIGNPFLDPCQMY 727
+ C G++
Sbjct: 120 SDNLLGDAGLQLLCEGLLDPQCRLEKLQL 148
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 23/92 (25%), Positives = 32/92 (34%), Gaps = 8/92 (8%)
Query: 175 LRNFESLEVLNLAGNQVKGVIPGFLGSFLK----LRVLFLSYNELNGSIPSELGKYCR-- 228
+ L VL LA V L + L LR L LS N L + +L + R
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 229 --YLEHLDLSGNSLVGRIPSSLGKCQQLRTLL 258
LE L L + L ++ + L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQALEKDKPSL 456
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 3e-06
Identities = 21/105 (20%), Positives = 32/105 (30%), Gaps = 13/105 (12%)
Query: 117 NGFSGEFPPEIWSLEKLEVLDVEGNFLSGR----LPNEFVGLRNLRVLNLAFNRIDGDIP 172
G L VL + +S L + +LR L+L+ N +
Sbjct: 355 AGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGI 414
Query: 173 FSL-----RNFESLEVLNLAGNQVKGVIPGFLGSFLK----LRVL 208
L + LE L L + L + K LRV+
Sbjct: 415 LQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 3e-13
Identities = 54/282 (19%), Positives = 80/282 (28%), Gaps = 30/282 (10%)
Query: 155 RNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNE 214
+ + L NRI S R +L +L L N + + L L LS N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 215 LNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGW 274
S+ L L L L P L+ L L N L +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 275 LRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNG 334
L L L + NR++ + L L+L
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ------------------------- 186
Query: 335 EKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGV 394
N P L +L ++ NL + +L+ L L N D
Sbjct: 187 --NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD-CRA 243
Query: 395 FDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSG 436
L SS+E+ L +L L ++ N + G
Sbjct: 244 RPLWAWLQKFRGSSSEVPCSLPQRLA--GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (159), Expect = 4e-12
Identities = 53/258 (20%), Positives = 84/258 (32%), Gaps = 33/258 (12%)
Query: 133 LEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDI--------------------- 171
+ + + GN +S F RNL +L L N +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 172 ----PFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYC 227
P + L L+L ++ + PG L+ L+L N L +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF-RDL 152
Query: 228 RYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNR 287
L HL L GN + + L LLL N + V P L +L L + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 288 LNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEI 347
L+ L L L L L++ +P + R + Q G + S+P
Sbjct: 213 LSALPTEALAPLRALQYLRLND--NPWVCDCRARPLWAWLQK--FRGSSSEVPCSLPQR- 267
Query: 348 TTLSKLRIIWAPRLNLEG 365
L+ + +L+G
Sbjct: 268 --LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (157), Expect = 8e-12
Identities = 43/269 (15%), Positives = 79/269 (29%), Gaps = 29/269 (10%)
Query: 171 IPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYL 230
+P + + + + L GN++ V + L +L+L N L +
Sbjct: 26 VPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 231 EHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNG 290
+ L P++ +L TL L L ++ P L L+ L + N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 291 LIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTL 350
L + L+ L L N L
Sbjct: 144 LPDDTFRDLGNLTHLFLHG---------------------------NRISSVPERAFRGL 176
Query: 351 SKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNE 410
L + + + P ++ L L L N L + L ++ L+ N
Sbjct: 177 HSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNP 236
Query: 411 LSGELDVKLQVPCMALFDVSGNHMSGSIP 439
+ + + F S + + S+P
Sbjct: 237 WVCDCRARPLWAWLQKFRGSSSEVPCSLP 265
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (144), Expect = 3e-10
Identities = 46/225 (20%), Positives = 81/225 (36%), Gaps = 7/225 (3%)
Query: 505 LPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGV 564
L P + + FL G N+++ S N + +N +
Sbjct: 23 LQAVPVGIPAASQRIFLHG-NRISHVPAASFRACRNLTILWL---HSNVLARIDAAAFTG 78
Query: 565 MCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624
+ ++ + + Q+ + P + L L L L+ LQ P L L++L L D
Sbjct: 79 LALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD 138
Query: 625 NNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLA 684
N L + +L +L L L N +S L +L LLL N+++ P
Sbjct: 139 NALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFR 198
Query: 685 NVTSLSIFNASFNNLSGPFPWNVTTMNCSGVI---GNPFLDPCQM 726
++ L NNLS + + + NP++ C+
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (138), Expect = 2e-09
Identities = 42/259 (16%), Positives = 74/259 (28%), Gaps = 22/259 (8%)
Query: 428 DVSGNHMSGSIP---------RFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGM 478
+ GN +S + + + + G ++ R
Sbjct: 38 FLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD 97
Query: 479 PLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQA 538
P + + L L+ N L +
Sbjct: 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQD-----NALQALPDDTFRDL 152
Query: 539 CNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDL 598
N H + + N I +P SL L N+++ + P + +L L+ L L
Sbjct: 153 GNLTHLFL----HGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 599 NGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEG 658
N L +L L+ L++L L DN + L+ SS+ + +P+
Sbjct: 209 FANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQ- 266
Query: 659 VVNLRNLTALLLDNNKLSG 677
L L N L G
Sbjct: 267 --RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.7 bits (135), Expect = 5e-09
Identities = 44/209 (21%), Positives = 71/209 (33%), Gaps = 26/209 (12%)
Query: 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGN------------------------- 141
+ + + L N S + L +L + N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 142 FLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGS 201
L P F GL L L+L + P R +L+ L L N ++ +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 202 FLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS 261
L LFL N ++ +P + L+ L L N + P + +L TL LF+
Sbjct: 152 LGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNG 290
N L+ + L LR L+ L ++ N
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (133), Expect = 7e-09
Identities = 34/145 (23%), Positives = 50/145 (34%), Gaps = 2/145 (1%)
Query: 94 KLVGKLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVG 153
L L L L L N S L L+ L + N ++ P+ F
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRD 199
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN 213
L L L L N + +L +L+ L L N + L+ S +
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSS 258
Query: 214 ELNGSIPSEL-GKYCRYLEHLDLSG 237
E+ S+P L G+ + L DL G
Sbjct: 259 EVPCSLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.8 bits (130), Expect = 2e-08
Identities = 41/210 (19%), Positives = 63/210 (30%), Gaps = 8/210 (3%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSN 551
GN + A L ++ +LS+
Sbjct: 38 FLHGNRISHVPAASFRACRNLTILWLHSN--------VLARIDAAAFTGLALLEQLDLSD 89
Query: 552 NNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSL 611
N + + L L + + P L +L +L L N LQ +
Sbjct: 90 NAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTF 149
Query: 612 HRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLD 671
L L HL L N ++ + L SL+ L L N ++ P +L L L L
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLF 209
Query: 672 NNKLSGHLPSGLANVTSLSIFNASFNNLSG 701
N LS LA + +L + N
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVC 239
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 67.9 bits (164), Expect = 2e-12
Identities = 54/370 (14%), Positives = 93/370 (25%), Gaps = 54/370 (14%)
Query: 274 WLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASN 333
R+ L+++ L+ L P + L LV S
Sbjct: 36 LDRQAHELELNNLGLSSL-PELPPH---LESLVASC------------------------ 67
Query: 334 GEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIG 393
NS + +P +L L + L P S L
Sbjct: 68 ---NS-LTELPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPE-------- 115
Query: 394 VFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQS 453
L ID+ +N L D+ + +A + + +
Sbjct: 116 -LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSL 174
Query: 454 SDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLR 513
L + + L + + N L R
Sbjct: 175 KKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDN 234
Query: 514 RRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLD 573
TD L + + +++N I + + SL L+
Sbjct: 235 YLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLC----DLPPSLEELN 290
Query: 574 ASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPS 633
S+N++ + P L L + N L E+P LK L + N L P
Sbjct: 291 VSNNKLIEL-PALPPRLER---LIASFNHLA-EVPELPQNLK---QLHVEYNPLR-EFPD 341
Query: 634 SIGELRSLEV 643
+ L +
Sbjct: 342 IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 64.8 bits (156), Expect = 2e-11
Identities = 46/329 (13%), Positives = 97/329 (29%), Gaps = 26/329 (7%)
Query: 337 NSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFD 396
N + S+P L L N +LP SL+ L + N +L + D
Sbjct: 47 NLGLSSLPELPPHLESLVASC----NSLTELPELPQ---SLKSLLVDNN----NLKALSD 95
Query: 397 RCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDL 456
L ++ +S+N ++ + + + + ++ + ++
Sbjct: 96 LPPLLEYLGVSNN------QLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGN 149
Query: 457 CQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRT 516
Q + F++ L + +
Sbjct: 150 NQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTI 209
Query: 517 DYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASH 576
+ + + L + + +I L
Sbjct: 210 YADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYL 269
Query: 577 NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIG 636
N S + + SL L+++ NKL E+P+ RL+ L + N+L +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLAE-VPELPQ 324
Query: 637 ELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
+L+ L + N L E P+ ++ +L
Sbjct: 325 ---NLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 57.1 bits (136), Expect = 5e-09
Identities = 58/372 (15%), Positives = 97/372 (26%), Gaps = 45/372 (12%)
Query: 335 EKNSFIGSIPMEITTLSKLRIIW---APRLNLEG----KLPSSWGACESLEMLNLAQNVL 387
E+N+ G+ +S+LR A L L LP LE L + N L
Sbjct: 14 ERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPELPP---HLESLVASCNSL 70
Query: 388 RGDLIGVFDRCKKLHFIDLSSNELSG------ELDVKLQVPCMALFDVSGNHMSGSIPRF 441
+ + + L + + +N L L+ + S
Sbjct: 71 TE----LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIID 126
Query: 442 DYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGP 501
N + + ++ L + A +
Sbjct: 127 VDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLES 186
Query: 502 ICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLD 561
I E L + FL + V + ++
Sbjct: 187 IVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSL 246
Query: 562 IGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLS 621
+ S N EI S L L+
Sbjct: 247 TFLDVSENIFSGLSELP----------------PNLYYLNASSNEIRSLCDLPPSLEELN 290
Query: 622 LADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPS 681
+++N L +P+ LE L S N L+ EVPE +NL L ++ N L P
Sbjct: 291 VSNNKLIE-LPALPP---RLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLRE-FPD 341
Query: 682 GLANVTSLSIFN 693
+V L + +
Sbjct: 342 IPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 55.2 bits (131), Expect = 2e-08
Identities = 22/95 (23%), Positives = 33/95 (34%), Gaps = 10/95 (10%)
Query: 161 NLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIP 220
N +I SLE LN++ N++ +P L L S+N L +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLA-EVP 320
Query: 221 SELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLR 255
L+ L + N L P + LR
Sbjct: 321 ELPQN----LKQLHVEYNPLRE-FPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 1e-07
Identities = 24/94 (25%), Positives = 36/94 (38%), Gaps = 9/94 (9%)
Query: 114 LPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPF 173
N S E LE L+V N L LP L L +FN + ++P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL---PPRLERLIASFNHL-AEVPE 321
Query: 174 SLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRV 207
+N L+ L++ N ++ P S LR+
Sbjct: 322 LPQN---LKQLHVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 5e-07
Identities = 20/96 (20%), Positives = 38/96 (39%), Gaps = 13/96 (13%)
Query: 141 NFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLG 200
N S + + +L LN++ N++ ++P LE L + N + +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELPQ 324
Query: 201 SFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLS 236
+ L+ L + YN L P +E L ++
Sbjct: 325 N---LKQLHVEYNPLR-EFPDIPES----VEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.7 bits (109), Expect = 1e-05
Identities = 51/366 (13%), Positives = 98/366 (26%), Gaps = 55/366 (15%)
Query: 227 CRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRN 286
R L+L+ L +P L +L+ N L + +P L+ L V + +
Sbjct: 37 DRQAHELELNNLGL-SSLPELPP---HLESLVASCNSLTE-LPELPQSLKSLLVDNNNLK 91
Query: 287 RLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPME 346
L+ L P V + L + I + + + FI + +
Sbjct: 92 ALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQ 151
Query: 347 ITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDL 406
+ L +L+ + L + ++ + + L I
Sbjct: 152 LEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYA 211
Query: 407 SSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTY 466
+N L D+ + + + D + + +
Sbjct: 212 DNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNA 271
Query: 467 MQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANK 526
+ P L N S N LP P RL R
Sbjct: 272 SSNEIRSLCDLPPSLEEL-------NVSNNKLIE----LPALPPRLER------------ 308
Query: 527 LTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI--VP 584
S N+ + +P +L+ L +N + +P
Sbjct: 309 --------------------LIASFNH-LAEVPELPQ----NLKQLHVEYNPLREFPDIP 343
Query: 585 QSLENL 590
+S+E+L
Sbjct: 344 ESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 17/66 (25%), Positives = 25/66 (37%), Gaps = 6/66 (9%)
Query: 204 KLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM 263
+ L L+ L+ S+P LE L S NSL +P + L
Sbjct: 39 QAHELELNNLGLS-SLPELPPH----LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 264 LNDVIP 269
L+D+ P
Sbjct: 93 LSDLPP 98
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 57.8 bits (139), Expect = 1e-10
Identities = 28/125 (22%), Positives = 47/125 (37%), Gaps = 27/125 (21%)
Query: 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS-------------------- 609
RVL +H ++ + LE L + LDL+ N+L+ P+
Sbjct: 1 RVLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENV 58
Query: 610 -SLHRLKYLRHLSLADNNLTGG-IPSSIGELRSLEVLELSSNSLSGE---VPEGVVNLRN 664
+ L L+ L L +N L + L +L L NSL E L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 665 LTALL 669
++++L
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 8e-08
Identities = 31/127 (24%), Positives = 49/127 (38%), Gaps = 8/127 (6%)
Query: 135 VLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGV 194
VL + L+ L + L+L+ NR+ P +L LEVL + N ++ V
Sbjct: 2 VLHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENV 58
Query: 195 IPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGR---IPSSLGKC 251
+ +L+ L L N L S + C L L+L GNSL
Sbjct: 59 DGVA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 252 QQLRTLL 258
+ ++L
Sbjct: 117 PSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 49.7 bits (118), Expect = 1e-07
Identities = 27/122 (22%), Positives = 44/122 (36%), Gaps = 8/122 (6%)
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
RVL+LA + + L + L+L+ N+++ + P + LR L + N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNA 54
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVG-RIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLR 276
+ L+ L L N L L C +L L L N L L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLA 113
Query: 277 KL 278
++
Sbjct: 114 EM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.0 bits (111), Expect = 7e-07
Identities = 34/107 (31%), Positives = 48/107 (44%), Gaps = 6/107 (5%)
Query: 596 LDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEV 655
L L L + L +L + HL L+ N L P+ + LR LEVL ++ + E
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNALEN 57
Query: 656 PEGVVNLRNLTALLLDNNKL-SGHLPSGLANVTSLSIFNASFNNLSG 701
+GV NL L LLL NN+L L + L + N N+L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 2e-06
Identities = 25/108 (23%), Positives = 42/108 (38%), Gaps = 25/108 (23%)
Query: 206 RVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPS------------------- 246
RVL L++ +L ++ L + + HLDLS N L P+
Sbjct: 1 RVLHLAHKDL--TVLCHLEQ-LLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN 57
Query: 247 --SLGKCQQLRTLLLFSNMLNDV-IPRELGWLRKLEVLDVSRNRLNGL 291
+ +L+ LLL +N L + L +L +L++ N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 18/89 (20%), Positives = 30/89 (33%), Gaps = 3/89 (3%)
Query: 536 FQACNEFHGMVANL--SNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI-VPQSLENLTS 592
+A + L + +D L+ L +N++ Q L +
Sbjct: 32 LRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPR 91
Query: 593 LVFLDLNGNKLQGEIPSSLHRLKYLRHLS 621
LV L+L GN L E + L +S
Sbjct: 92 LVLLNLQGNSLCQEEGIQERLAEMLPSVS 120
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.5 bits (134), Expect = 3e-09
Identities = 33/235 (14%), Positives = 62/235 (26%), Gaps = 23/235 (9%)
Query: 375 ESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHM 434
+ L LR G F L I++ + +V +
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEI---------------SQNDVLEVIEADV 73
Query: 435 SGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFS 494
++P+ + + + +S + V +
Sbjct: 74 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLD 133
Query: 495 GNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNI 554
+ + L + +L A N NLS+NN
Sbjct: 134 IQDNINIHTIERNSFVGLSFESVILWLNKNG-----IQEIHNCAFNGTQLDELNLSDNNN 188
Query: 555 IGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPS 609
+ +P D+ +LD S +I + LENL L K ++P+
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 3e-06
Identities = 25/209 (11%), Positives = 50/209 (23%), Gaps = 6/209 (2%)
Query: 428 DVSGNHMSGSIPR-FDYNVCHQMPL--QSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSA 484
+ F + Q+ L F+ + L+
Sbjct: 35 RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI 94
Query: 485 ARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHG 544
+ + + P+ + + L
Sbjct: 95 NPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFE 154
Query: 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604
V N N I I + + + +N + + + V LD++ ++
Sbjct: 155 SVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH 214
Query: 605 GEIPSSLHRLKYLRHLSLADNNLTGGIPS 633
L LK LR S NL +P+
Sbjct: 215 SLPSYGLENLKKLRARST--YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 18/85 (21%), Positives = 29/85 (34%)
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L L+ N + + Q L +N L ++ +LD+SR
Sbjct: 151 LSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISR 210
Query: 286 NRLNGLIPTELGNCVELSVLVLSNL 310
R++ L L N +L NL
Sbjct: 211 TRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 7/47 (14%), Positives = 17/47 (36%)
Query: 216 NGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262
+P+++ LD+S + L ++LR ++
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 15/75 (20%), Positives = 26/75 (34%)
Query: 112 LSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDI 171
L L NG + E+ + N L + F G +L+++ RI
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLP 217
Query: 172 PFSLRNFESLEVLNL 186
+ L N + L +
Sbjct: 218 SYGLENLKKLRARST 232
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 19/87 (21%), Positives = 31/87 (35%), Gaps = 3/87 (3%)
Query: 595 FLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGE 654
L LN N +Q + + + +NNL +L++S +
Sbjct: 157 ILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSL 216
Query: 655 VPEGVVNLRNLTALLLDNNKLSGHLPS 681
G+ NL+ L A N K LP+
Sbjct: 217 PSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 56.0 bits (133), Expect = 9e-09
Identities = 34/327 (10%), Positives = 76/327 (23%), Gaps = 46/327 (14%)
Query: 360 RLNLEGK--------------LPSSWGACESLEMLNLAQNVLRGD----LIGVFDRCKKL 401
R ++EGK + + +S++ + L+ N + + L K L
Sbjct: 2 RFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61
Query: 402 HFIDLSSNELSGELDV----------------KLQVPCMALFDVSGNHMSGSIPRFDYNV 445
+ S D KL ++ I +
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHT 121
Query: 446 CHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWL 505
+ ++ + + N N
Sbjct: 122 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 181
Query: 506 PVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVM 565
+ L + L + + + ++
Sbjct: 182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 241
Query: 566 CKSLRVLDASHNQISGIVPQSL------ENLTSLVFLDLNGNKLQGEIPSSL-----HRL 614
+LR L + +S ++ L L L N+++ + +L ++
Sbjct: 242 WPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKM 301
Query: 615 KYLRHLSLADNNLTGGIPSSIGELRSL 641
L L L N + E+R +
Sbjct: 302 PDLLFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 33/364 (9%), Positives = 84/364 (23%), Gaps = 73/364 (20%)
Query: 268 IPRELGWLRKLEVLDVSRNRLNG----LIPTELGNCVELSVLVLSNLFDPLLSGRNIRGE 323
+ L ++ + +S N + + + + +L + S++F +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRV-------- 74
Query: 324 LSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLA 383
E + + + KL + S
Sbjct: 75 ---------KDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125
Query: 384 QNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDY 443
+ L +L+ N P + N + +
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVN------KKAKNAPPLRSIICGRNRLENGSMKEWA 179
Query: 444 NVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPIC 503
L + +++ + + L G++
Sbjct: 180 KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIAL 239
Query: 504 WLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIG 563
+ + L++ + +
Sbjct: 240 K-----------------------------------SWPNLRELGLNDCLLSARGAAAVV 264
Query: 564 VMCK-----SLRVLDASHNQISGIVPQSL-----ENLTSLVFLDLNGNKLQGEIPSSLHR 613
L+ L +N+I ++L E + L+FL+LNGN+ E +
Sbjct: 265 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDE 323
Query: 614 LKYL 617
++ +
Sbjct: 324 IREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 6/94 (6%)
Query: 586 SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG----GIPSSIGELRSL 641
S+E SL + + + + L ++ + L+ N + + +I + L
Sbjct: 4 SIEGK-SLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDL 61
Query: 642 EVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKL 675
E+ E S E LR L LL KL
Sbjct: 62 EIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKL 95
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.6 bits (98), Expect = 2e-04
Identities = 14/117 (11%), Positives = 35/117 (29%), Gaps = 5/117 (4%)
Query: 615 KYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGE----VPEGVVNLRNLTALLL 670
K L+ ++ + + + + E S++ + LS N++ E + E + + ++L
Sbjct: 8 KSLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 671 DNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQMY 727
+ + L L + + FL
Sbjct: 67 SDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPL 123
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 0.001
Identities = 13/83 (15%), Positives = 31/83 (37%), Gaps = 9/83 (10%)
Query: 203 LKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSL----VGRIPSSLGKCQQLRTLL 258
L++ ++ + S+ + L ++ + LSGN++ + ++ + L
Sbjct: 8 KSLKLDAITTEDEK-SVFAVL-LEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAE 65
Query: 259 LFSNM---LNDVIPRELGWLRKL 278
+ D IP L L +
Sbjct: 66 FSDIFTGRVKDEIPEALRLLLQA 88
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 13/64 (20%), Positives = 21/64 (32%), Gaps = 7/64 (10%)
Query: 150 EFVGLRNLRVLNLAFNRIDGDIPFSL-----RNFESLEVLNLAGNQVK--GVIPGFLGSF 202
+ L+ L L +N I+ D +L L L L GN+ + +
Sbjct: 268 SKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREV 327
Query: 203 LKLR 206
R
Sbjct: 328 FSTR 331
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 1e-08
Identities = 38/267 (14%), Positives = 82/267 (30%), Gaps = 20/267 (7%)
Query: 158 RVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
+ L+L + D+ L + + + + + + S +++ + LS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEV 60
Query: 218 SIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLF--SNMLNDVIPRELGWL 275
S + C L++L L G L I ++L K L L L S + L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 276 RKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGE 335
+L+ N TE V ++ + + L R + +
Sbjct: 121 SRLDE----LNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176
Query: 336 KNSFIGSIPMEITTLSKLRIIWAPRL---------NLEGKLPSSWGACESLEMLNLAQNV 386
S + + L ++ + G +L+ L + V
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236
Query: 387 LRGDLIGVFDRCKKLHFIDLSSNELSG 413
G L + + L ++ + +
Sbjct: 237 PDGTLQLLKEALPHL---QINCSHFTT 260
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.7 bits (117), Expect = 7e-07
Identities = 38/229 (16%), Positives = 72/229 (31%), Gaps = 14/229 (6%)
Query: 98 KLSPLVGG---LSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGR-LPNEFVG 153
L P V G + P + E +S +++ +D+ + + L
Sbjct: 11 NLHPDVTGRLLSQGVIAFRCPRSFMDQP-LAEHFSPFRVQHMDLSNSVIEVSTLHGILSQ 69
Query: 154 LRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSF----LKLRVLF 209
L+ L+L R+ I +L +L LNL+G L L
Sbjct: 70 CSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLS 129
Query: 210 LSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLN---- 265
++ + + + L+LSG + ++ L+ +
Sbjct: 130 WCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLK 189
Query: 266 DVIPRELGWLRKLEVLDVSR-NRLNGLIPTELGNCVELSVLVLSNLFDP 313
+ +E L L+ L +SR + ELG L L + +
Sbjct: 190 NDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.2 bits (113), Expect = 3e-06
Identities = 35/274 (12%), Positives = 74/274 (27%), Gaps = 23/274 (8%)
Query: 376 SLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMAL--FDVSGNH 433
+ ++ + L F ++ +DLS++ + + C L + G
Sbjct: 24 GVIAFRCPRSFMDQPLAEHF-SPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82
Query: 434 MSGSIPRFDYNVCHQMPLQSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNF 493
+S I + + L S + + + +
Sbjct: 83 LSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC---------------SRLDELN 127
Query: 494 SGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNN 553
F + VA + L+G K S + +
Sbjct: 128 LSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 187
Query: 554 IIGHIPLDIGVMCKSLRVLDASH-NQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLH 612
+ + L+ L S I L + +L L + G G +
Sbjct: 188 LKNDCFQEFF-QLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKE 246
Query: 613 RLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646
L HL + ++ T +IG ++ E+ +
Sbjct: 247 ALP---HLQINCSHFTTIARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.1 bits (92), Expect = 0.001
Identities = 22/106 (20%), Positives = 39/106 (36%), Gaps = 10/106 (9%)
Query: 492 NFSGNNFTGPICWLPVAPERLRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSN 551
+ +G N P RL + AF + + L + + F +LSN
Sbjct: 6 DLTGKNL------HPDVTGRLLSQGVIAFRCPRSFMDQP----LAEHFSPFRVQHMDLSN 55
Query: 552 NNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
+ I I C L+ L ++S + +L ++LV L+
Sbjct: 56 SVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.7 bits (91), Expect = 0.001
Identities = 35/291 (12%), Positives = 86/291 (29%), Gaps = 20/291 (6%)
Query: 404 IDLSSNELSGELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPLQSSDLCQGYDPS 463
+DL+ L ++ +L + F + M + +Q DL
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEH----FSPFRVQHMDLS------ 54
Query: 464 FTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPERLRRRTDYAFLAG 523
+ ++S + + G + PI L R
Sbjct: 55 ------NSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGF 108
Query: 524 ANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIV 583
+ + S + + + ++ + + + + Q S +
Sbjct: 109 SEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLS 168
Query: 584 PQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLAD-NNLTGGIPSSIGELRSLE 642
+ + L+ + +L YL+HLSL+ ++ +GE+ +L+
Sbjct: 169 TLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLK 228
Query: 643 VLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFN 693
L++ G + L +L ++ + + + N + I+
Sbjct: 229 TLQVFGIVPDGTLQLLKEALPHLQ---INCSHFTTIARPTIGNKKNQEIWG 276
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.9 bits (120), Expect = 3e-07
Identities = 42/214 (19%), Positives = 63/214 (29%), Gaps = 57/214 (26%)
Query: 539 CNEFHGMV-ANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLD 597
++ + N N+ +P D+ K +L S N + +L T L L+
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP---KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 598 LNGNK---------------------------------------------LQGEIPSSLH 612
L+ + L +L
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 613 RLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDN 672
L L+ L L N L P + LE L L++N+L+ + L NL LLL
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 673 NKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWN 706
N L +P G L N PW
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGN------PWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.8 bits (112), Expect = 3e-06
Identities = 18/97 (18%), Positives = 28/97 (28%), Gaps = 1/97 (1%)
Query: 531 FPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENL 590
A + N + +P + L L ++N ++ + L L
Sbjct: 112 LTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGL 171
Query: 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNL 627
+L L L N L IP L L N
Sbjct: 172 ENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 39/204 (19%), Positives = 68/204 (33%), Gaps = 24/204 (11%)
Query: 126 EIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLN 185
E+ + ++ + L+ LP + ++ +L+L+ N + +L + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 186 LAGNQVKGVIPGFLGSFLKLRVLFLSYNELN--------------------GSIPSELGK 225
L ++ + L L + + S+P +
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSR 285
L+ L L GN L P L +L L L +N L ++ L L L+ L +
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 286 NRLNGLIPTELGNCVELSVLVLSN 309
N L IP L L
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHG 204
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.6 bits (109), Expect = 7e-06
Identities = 12/65 (18%), Positives = 24/65 (36%), Gaps = 3/65 (4%)
Query: 586 SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLE 645
+ + S + ++ + L +P L K L L++N L +++ L L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 646 LSSNS 650
L
Sbjct: 62 LDRAE 66
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.9 bits (102), Expect = 5e-05
Identities = 42/208 (20%), Positives = 60/208 (28%), Gaps = 50/208 (24%)
Query: 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNL 162
V ++ ++ + PP++ +L + N L + L LNL
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 163 A---------------------------------------------FNRIDGDIPFSLRN 177
FNR+ +LR
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 178 FESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSG 237
L+ L L GN++K + PG L KL L L+ N L L L+ L L
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNG-LENLDTLLLQE 181
Query: 238 NSLVGRIPSSLGKCQQLRTLLLFSNMLN 265
NSL IP L L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 23/213 (10%), Positives = 48/213 (22%), Gaps = 13/213 (6%)
Query: 395 FDRCKKLHFIDLSSNELS---GELDVKLQVPCMALFDVSGNHMSGSIPRFDYNVCHQMPL 451
+ ++ L+ +L + +S N + L
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLPKDTTI-----LHLSENLLYTFSLATLMPYTRLTQL 60
Query: 452 QSSDLCQGYDPSFTYMQYFMSKARLGMPLLVSAARFMVIHNFSGNNFTGPICWLPVAPER 511
+ + L + + + +
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 512 LRRRTDYAFLAGANKLTGSFPGSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRV 571
N+L PG L + +NNN+ + ++L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL---ANNNLTELPAGLLN-GLENLDT 176
Query: 572 LDASHNQISGIVPQSLENLTSLVFLDLNGNKLQ 604
L N + +P+ L F L+GN
Sbjct: 177 LLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.6 bits (96), Expect = 3e-04
Identities = 14/65 (21%), Positives = 26/65 (40%), Gaps = 3/65 (4%)
Query: 610 SLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALL 669
+ ++ ++ NLT +P + + +L LS N L ++ LT L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 670 LDNNK 674
LD +
Sbjct: 62 LDRAE 66
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (115), Expect = 5e-07
Identities = 23/136 (16%), Positives = 46/136 (33%), Gaps = 6/136 (4%)
Query: 125 PEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184
+ + + LD+ G + + N L ++ + N I F L+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTL 68
Query: 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSG---NSLV 241
+ N++ + G + L L L+ N L + + L +L + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 242 GRIPSSLGKCQQLRTL 257
+ K Q+R L
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.8 bits (97), Expect = 9e-05
Identities = 21/143 (14%), Positives = 46/143 (32%), Gaps = 8/143 (5%)
Query: 598 LNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPE 657
L ++ + + ++ R L L + I + L + ++ S N + +
Sbjct: 3 LTAELIE-QAAQYTNAVR-DRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI--RKLD 57
Query: 658 GVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNAS---FNNLSGPFPWNVTTMNCSG 714
G LR L LL++NN++ + L+ + L P
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYL 117
Query: 715 VIGNPFLDPCQMYKDISSSELTS 737
I + + Y+ ++
Sbjct: 118 CILRNPVTNKKHYRLYVIYKVPQ 140
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 6e-04
Identities = 23/91 (25%), Positives = 35/91 (38%), Gaps = 3/91 (3%)
Query: 586 SLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLE 645
N LDL G K+ I + L + +DN + LR L+ L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLL 69
Query: 646 LSSNSLSGEVPEGVVNLRNLTALLLDNNKLS 676
+++N + L +LT L+L NN L
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 6e-04
Identities = 19/87 (21%), Positives = 32/87 (36%), Gaps = 3/87 (3%)
Query: 566 CKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADN 625
R LD +I I L +D + N+++ L+ L+ L + +N
Sbjct: 17 AVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVNNN 73
Query: 626 NLTGGIPSSIGELRSLEVLELSSNSLS 652
+ L L L L++NSL
Sbjct: 74 RICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (86), Expect = 0.002
Identities = 27/133 (20%), Positives = 47/133 (35%), Gaps = 10/133 (7%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+L I I ++G +D S N+I + L L L +N N++
Sbjct: 24 DLRGYKI-PVIE-NLGATLDQFDAIDFSDNEIRKLDGFP--LLRRLKTLLVNNNRICRIG 79
Query: 608 PSSLHRLKYLRHLSLADNNLTG-GIPSSIGELRSLEVLELSS---NSLSGEVPEGVVNLR 663
L L L L +N+L G + L+SL L + + + +
Sbjct: 80 EGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVP 139
Query: 664 NLTALLLDNNKLS 676
+ +LD K+
Sbjct: 140 QVR--VLDFQKVK 150
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 3e-06
Identities = 18/90 (20%), Positives = 30/90 (33%), Gaps = 4/90 (4%)
Query: 535 LFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLV 594
+ + L L L A N+IS I P L +L +L+
Sbjct: 141 ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLI 198
Query: 595 FLDLNGNKLQGEIPSSLHRLKYLRHLSLAD 624
+ L N++ P L L ++L +
Sbjct: 199 EVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.6 bits (109), Expect = 6e-06
Identities = 17/62 (27%), Positives = 30/62 (48%), Gaps = 4/62 (6%)
Query: 248 LGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL 307
L +L TL N ++D+ P L L L + + N+++ + P L N L ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 308 SN 309
+N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 8e-05
Identities = 17/73 (23%), Positives = 29/73 (39%), Gaps = 4/73 (5%)
Query: 575 SHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSS 634
S L NL+ L L + NK+ P L L L + L +N ++ P
Sbjct: 157 SIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP-- 212
Query: 635 IGELRSLEVLELS 647
+ +L ++ L+
Sbjct: 213 LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 2e-04
Identities = 19/68 (27%), Positives = 30/68 (44%), Gaps = 5/68 (7%)
Query: 123 FPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182
+ +L KL L + N +S P L NL ++L N+I P + N +L
Sbjct: 165 DLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLA--NTSNLF 220
Query: 183 VLNLAGNQ 190
++ L NQ
Sbjct: 221 IVTLT-NQ 227
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 14/73 (19%), Positives = 27/73 (36%), Gaps = 6/73 (8%)
Query: 579 ISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGEL 638
I+ I P L + + + + + + + L + LS +T + L
Sbjct: 9 INVIFP--DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTT--IEGVQYL 62
Query: 639 RSLEVLELSSNSL 651
+L LEL N +
Sbjct: 63 NNLIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 7e-04
Identities = 15/61 (24%), Positives = 26/61 (42%), Gaps = 4/61 (6%)
Query: 151 FVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFL 210
L L L N+I P + + +L ++L NQ+ V P L + L ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 211 S 211
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.2 bits (90), Expect = 0.001
Identities = 18/62 (29%), Positives = 27/62 (43%), Gaps = 4/62 (6%)
Query: 611 LHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLL 670
L L L L DN ++ P + L +L + L +N +S P + N NL + L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 671 DN 672
N
Sbjct: 225 TN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.002
Identities = 15/62 (24%), Positives = 24/62 (38%), Gaps = 5/62 (8%)
Query: 175 LRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLD 234
L N L L N++ + P L S L + L N+++ P L L +
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LAN-TSNLFIVT 223
Query: 235 LS 236
L+
Sbjct: 224 LT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 13/59 (22%), Positives = 22/59 (37%), Gaps = 4/59 (6%)
Query: 226 YCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
L L N + P L L + L +N ++DV P L L ++ ++
Sbjct: 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 14/65 (21%), Positives = 28/65 (43%), Gaps = 4/65 (6%)
Query: 614 LKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNN 673
L ++ +N+T + + +L + L ++ EGV L NL L L +N
Sbjct: 18 LANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 674 KLSGH 678
+++
Sbjct: 74 QITDL 78
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.3 bits (109), Expect = 3e-06
Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 11/145 (7%)
Query: 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNL 157
+L ++ + +L G P++ + VL+ + + L + L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 158 RVLNLAFNRIDG--DIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNEL 215
LNL+ NR+ D+ ++ +L++LNL+GN++K LKL L+L N L
Sbjct: 68 LSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSL 127
Query: 216 NGSIPSELG------KYCRYLEHLD 234
+ + + + L LD
Sbjct: 128 SDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.7 bits (102), Expect = 2e-05
Identities = 31/129 (24%), Positives = 46/129 (35%), Gaps = 8/129 (6%)
Query: 132 KLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQV 191
+ LD++G R + V VLN + + N L LNL+ N++
Sbjct: 23 SQQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRL 77
Query: 192 KGV--IPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLG 249
+ + + L++L LS NEL S LE L L GNSL
Sbjct: 78 YRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIKGLKLEELWLDGNSLSDTFRDQST 136
Query: 250 KCQQLRTLL 258
+R
Sbjct: 137 YISAIRERF 145
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 8e-05
Identities = 28/136 (20%), Positives = 52/136 (38%), Gaps = 13/136 (9%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQG-- 605
+L + V VL+ + + + EN+ L+ L+L+ N+L
Sbjct: 28 DLKGLRSDPDL-----VAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLD 81
Query: 606 EIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNL 665
++ S + + L+ L+L+ N L + LE L L NSLS + + +
Sbjct: 82 DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAI 141
Query: 666 TALL-----LDNNKLS 676
LD ++L
Sbjct: 142 RERFPKLLRLDGHELP 157
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 1e-04
Identities = 23/119 (19%), Positives = 43/119 (36%), Gaps = 3/119 (2%)
Query: 101 PLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGR--LPNEFVGLRNLR 158
P + + VL+ + + ++ +L L++ N L + + NL+
Sbjct: 36 PDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLK 94
Query: 159 VLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNG 217
+LNL+ N + + LE L L GN + +R F L+G
Sbjct: 95 ILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLDG 153
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (96), Expect = 2e-04
Identities = 18/93 (19%), Positives = 38/93 (40%), Gaps = 2/93 (2%)
Query: 543 HGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGI--VPQSLENLTSLVFLDLNG 600
+ L+ + + I L L+ S+N++ + + ++ +L L+L+G
Sbjct: 41 QNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSG 100
Query: 601 NKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPS 633
N+L+ E + L L L N+L+
Sbjct: 101 NELKSERELDKIKGLKLEELWLDGNSLSDTFRD 133
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.6 bits (89), Expect = 0.001
Identities = 23/134 (17%), Positives = 40/134 (29%), Gaps = 6/134 (4%)
Query: 573 DASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIP 632
+ Q+ + + L+ L+ L L+ +++ +
Sbjct: 3 ELKPEQVEQL-KLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNR-RSSMAATLR 58
Query: 633 SSIGELRSLEVLELSSNSLSG--EVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLS 690
+ L L LS+N L ++ V NL L L N+L L
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 691 IFNASFNNLSGPFP 704
N+LS F
Sbjct: 119 ELWLDGNSLSDTFR 132
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 36/205 (17%), Positives = 71/205 (34%), Gaps = 17/205 (8%)
Query: 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAF 164
+E +L + L ++ + + + ++ L N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQY--LPNVTKLFLNG 77
Query: 165 NRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELG 224
N++ P + +L+ L V LK + I +
Sbjct: 78 NKLTDIKPLA-----NLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 225 KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVS 284
+L + + + + + +L TL L N ++D++P L L KL+ L +S
Sbjct: 133 LPQLESLYLGNNKITDITVLS----RLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLS 186
Query: 285 RNRLNGLIPTELGNCVELSVLVLSN 309
+N ++ L L L VL L +
Sbjct: 187 KNHISDL--RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 14/65 (21%), Positives = 31/65 (47%), Gaps = 4/65 (6%)
Query: 614 LKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNN 673
+L ++T + + EL S++ + +++ + +G+ L N+T L L+ N
Sbjct: 23 FAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLNGN 78
Query: 674 KLSGH 678
KL+
Sbjct: 79 KLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 4e-04
Identities = 19/101 (18%), Positives = 39/101 (38%), Gaps = 6/101 (5%)
Query: 522 AGANKLTGSFP-GSLFQACNEFHGMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQIS 580
G+ +T P +F + NL ++ + + S+ + A+++ I
Sbjct: 3 LGSETITVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN---ELNSIDQIIANNSDIK 59
Query: 581 GIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLS 621
+ ++ L ++ L LNGNKL P + + L
Sbjct: 60 SVQG--IQYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLD 98
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.003
Identities = 11/55 (20%), Positives = 21/55 (38%), Gaps = 4/55 (7%)
Query: 575 SHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTG 629
++ V Q+ L S+ + N + ++ + L + L L N LT
Sbjct: 32 KKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD 82
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 25/144 (17%), Positives = 48/144 (33%), Gaps = 3/144 (2%)
Query: 548 NLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEI 607
+ + + + + + + + + L L L L + + L+
Sbjct: 14 RCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72
Query: 608 PSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSNSLS-GEVPEGVVNLRNLT 666
P + H L L+L+ N L + + SL+ L LS N L +
Sbjct: 73 PDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 667 ALLLDNNKLSGHLPSGLANVTSLS 690
+ KL H LA++ + S
Sbjct: 132 LGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 3e-04
Identities = 19/100 (19%), Positives = 35/100 (35%), Gaps = 4/100 (4%)
Query: 576 HNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSI 635
N+I I + L L L+L N++ +P S L L L+ +N
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLN-LASNPFNCNCHLA 145
Query: 636 GELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKL 675
L L+ + P +R++ L +++
Sbjct: 146 WFAEWLRKKSLNGGAARCGAPS---KVRDVQIKDLPHSEF 182
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 8/66 (12%)
Query: 585 QSLENLTSLVFLDLNGNKLQGEIP------SSLHRLKYLRHLSLADNNLTGGIPSSIGEL 638
+ E S+V + +L G IP ++L LK +HL+L+ NN+ SS+ +
Sbjct: 12 RIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEK--ISSLSGM 69
Query: 639 RSLEVL 644
+L +L
Sbjct: 70 ENLRIL 75
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1103 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.95 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.89 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.86 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.8 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.78 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.72 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.69 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.68 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.67 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.66 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.66 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.64 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.52 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.5 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.49 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.45 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.45 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.39 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.29 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.25 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.5 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.16 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.12 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.51 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.49 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.41 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 96.89 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.67 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.56 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 94.81 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-49 Score=424.90 Aligned_cols=258 Identities=24% Similarity=0.384 Sum_probs=206.9
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|.+.+++.||||++..... ..++|.+|++++++++|||||+++|++...+..++||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC--cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence 46888999999999999999998899999999976543 3478999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++|+|.+++.... ..+++..+.+++.|||.||+|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 83 EHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999987653 4588999999999999999999999 99999999999999999999999999998775554444
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....||+.|+|||++.+..++.++|||||||++|||+|++.|+.... ...+....... ....
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~-------~~~~~~~~i~~----------~~~~ 221 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR-------SNSEVVEDIST----------GFRL 221 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC-------CHHHHHHHHHH----------TCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC-------CHHHHHHHHHh----------cCCC
Confidence 555678999999999999999999999999999999999766654221 11222222211 1122
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
..+..++.++.+++.+||+.||++|||++||+++|++|+.+
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 33455667899999999999999999999999999999754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-48 Score=432.11 Aligned_cols=272 Identities=26% Similarity=0.458 Sum_probs=214.3
Q ss_pred CCCHHHHHHHh---------cCCCCcceeccCCcccEEEEEEcC-C---cEEEEEEcccccchhhHHHHHHHHHHHhcCC
Q 043720 810 PLTYESIIRAT---------GDFNTSNCIGSGGFGTTYKAEISP-G---ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR 876 (1103)
Q Consensus 810 ~~~~~~~~~~~---------~~~~~~~~lg~G~fg~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 876 (1103)
|+++++...++ ++|++.+.||+|+||+||+|.++. + ..||||++.........+.|.+|+.++++++
T Consensus 6 ~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~ 85 (299)
T d1jpaa_ 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85 (299)
T ss_dssp GGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC
T ss_pred CCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC
Confidence 44555555544 345667899999999999997753 2 3689999887766767788999999999999
Q ss_pred CCceeEEEeEEecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEE
Q 043720 877 HPNLVTLIGYRASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILL 956 (1103)
Q Consensus 877 h~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll 956 (1103)
|||||+++|++...+..++||||+++|+|.++++... ..+++.++.+++.|||+||+|||++ +|+||||||+|||+
T Consensus 86 HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl 161 (299)
T d1jpaa_ 86 HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILV 161 (299)
T ss_dssp CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CCCCccEEEEEeeCCEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEE
Confidence 9999999999999999999999999999999988643 3589999999999999999999999 99999999999999
Q ss_pred CCCCCEEEeecccccccCCCCCc----cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCC
Q 043720 957 DDDFNAYLSDFGLSRLLGTSETH----ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSH 1031 (1103)
Q Consensus 957 ~~~~~~ki~Dfgla~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~ 1031 (1103)
+.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~--- 238 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT--- 238 (299)
T ss_dssp CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC---
T ss_pred CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC---
Confidence 99999999999999876433221 2223467899999999999999999999999999999998 788886321
Q ss_pred CCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1032 GDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1032 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
..+...... ...+.+.+..++..+.+++.+||+.||++|||++||++.|+++.++|+
T Consensus 239 -----~~~~~~~i~----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p~ 295 (299)
T d1jpaa_ 239 -----NQDVINAIE----------QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPN 295 (299)
T ss_dssp -----HHHHHHHHH----------TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred -----HHHHHHHHH----------cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcChh
Confidence 111111111 122234456678889999999999999999999999999999998885
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-48 Score=427.74 Aligned_cols=260 Identities=26% Similarity=0.437 Sum_probs=222.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|.+. +++.||||+++.... ..++|.+|+.++++++|||||+++|++.+++..|+|||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS--CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc--hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 457888999999999999999775 588999999875543 35789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.+++.......+++..+..++.|||.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~ 170 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 170 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCc
Confidence 99999999999887667799999999999999999999999 999999999999999999999999999988765555
Q ss_pred ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.......|++.|+|||++.+..|+.++|||||||++|||++|+.||..... ..... ... ....
T Consensus 171 ~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~-------~~~~~-~~i---------~~~~ 233 (287)
T d1opja_ 171 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-------LSQVY-ELL---------EKDY 233 (287)
T ss_dssp EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC-------HHHHH-HHH---------HTTC
T ss_pred eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcch-------HHHHH-HHH---------hcCC
Confidence 555566789999999999999999999999999999999998887753221 11111 111 1222
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
....+..++.++.+++.+||+.||++|||++||++.|+.+.+.
T Consensus 234 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 234 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 3344566778899999999999999999999999999988654
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-47 Score=414.80 Aligned_cols=262 Identities=26% Similarity=0.445 Sum_probs=209.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|+++. .||||+++.... ....+.|.+|+.++++++|||||+++|++.+ +..++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 4579999999999999999998653 599999976543 4467889999999999999999999999765 56899999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+++|+|.++++... ..+++.++..|+.|||+||+|||++ +||||||||+|||++.++.+||+|||+|+.......
T Consensus 84 y~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~ 159 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159 (276)
T ss_dssp CCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred cCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence 999999999997653 4599999999999999999999999 999999999999999999999999999987643332
Q ss_pred -ccccCCcccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 979 -HATTGVAGTFGYVAPEYALT---CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 979 -~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
.......||+.|||||++.+ ..|+.++|||||||++|||+||+.||..... ..........+...
T Consensus 160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~--------~~~~~~~~~~~~~~--- 228 (276)
T d1uwha_ 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN--------RDQIIFMVGRGYLS--- 228 (276)
T ss_dssp ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC--------HHHHHHHHHHTSCC---
T ss_pred cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh--------HHHHHHHHhcCCCC---
Confidence 23445679999999999864 3588999999999999999999999973221 11111222222111
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
+. ....+..+++.+.+++.+||+.||++||||+||+++|+.++++
T Consensus 229 -p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 -PD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp -CC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred -Cc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence 11 1122445678899999999999999999999999999999876
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-48 Score=422.76 Aligned_cols=257 Identities=25% Similarity=0.426 Sum_probs=216.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
.++|++.+.||+|+||+||+|.+++++.||||++..... ..+.|.+|+.++++++|||||+++|++.+ +..++||||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM--SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC--CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEe
Confidence 356888999999999999999999889999999976443 35679999999999999999999998865 567899999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.+++.......+++.++.+|+.||++||+|||++ +|+||||||+|||+++++.+||+|||+|+........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccc
Confidence 9999999988766555699999999999999999999999 9999999999999999999999999999987655555
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
......||+.|+|||++.+..++.++|||||||++|||+||+.|+..... ......... ....
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~-------~~~~~~~i~----------~~~~ 228 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT-------NPEVIQNLE----------RGYR 228 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHH----------TTCC
T ss_pred cccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCC-------HHHHHHHHH----------hcCC
Confidence 55667889999999999999999999999999999999998777653221 111111111 1122
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
...+..++.++.+++.+||+.||++|||++||++.|+.+-
T Consensus 229 ~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 2334566788999999999999999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-47 Score=410.20 Aligned_cols=254 Identities=27% Similarity=0.417 Sum_probs=218.8
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|++++++.||||+++..... .++|.+|+.++++++||||++++|++.+.+..++||||+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence 579999999999999999999998899999999865443 468999999999999999999999999999999999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++|++.+++.... ..+++..+.+++.|+++||+|||++ +|+||||||+||++++++.+||+|||+++.........
T Consensus 82 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 82 ANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999987654 3488999999999999999999999 99999999999999999999999999998776655555
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+...... . ..+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~--------~~~~~~~i~-~---------~~~ 219 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT--------NSETAEHIA-Q---------GLR 219 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC--------HHHHHHHHH-T---------TCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCC--------HHHHHHHHH-h---------CCC
Confidence 566789999999999999999999999999999999998 788886321 112222211 1 122
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
...+..++..+.++|.+||+.||++|||++||+++|.+|
T Consensus 220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 334556678899999999999999999999999999865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=418.23 Aligned_cols=262 Identities=25% Similarity=0.431 Sum_probs=213.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcCC-----cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPG-----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
++|+..+.||+|+||+||+|.++.. ..||||++.....+....+|.+|+.++++++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4688899999999999999976642 47999999877666667789999999999999999999999999999999
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
||||+.++++.+++.... ..+++.++.+++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 87 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 162 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 162 (283)
T ss_dssp EEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred EEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccC
Confidence 999999999999887653 4599999999999999999999999 999999999999999999999999999987643
Q ss_pred CCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.|+..... ..+....
T Consensus 163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~-------~~~~~~~---------- 225 (283)
T d1mqba_ 163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS-------NHEVMKA---------- 225 (283)
T ss_dssp -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-------HHHHHHH----------
T ss_pred CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC-------HHHHHHH----------
Confidence 322 233455789999999999999999999999999999999998777653221 1111111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSPN 1103 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~~ 1103 (1103)
+....+.+.+..++..+.++|.+||+.||++||+|+||++.|+++.++|+
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCcc
Confidence 12223334556677889999999999999999999999999999988774
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=414.85 Aligned_cols=253 Identities=26% Similarity=0.348 Sum_probs=205.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|... +|+.||||++......+..+.+.+|+.++++++|||||++++++.+.+..|+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 46999999999999999999765 68999999998766555567799999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC-
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET- 978 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~- 978 (1103)
+++|+|.++++.. ..+++.++..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 9999999999754 3499999999999999999999999 999999999999999999999999999987643322
Q ss_pred ccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||...... . ..........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~---~----~~~~~~~~~~--------- 223 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS---C----QEYSDWKEKK--------- 223 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT---S----HHHHHHHTTC---------
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH---H----HHHHHHhcCC---------
Confidence 23456789999999999988775 57899999999999999999999743211 0 1111111111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+.++.+++.+||+.||++|||++|++++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111223456778999999999999999999999864
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-46 Score=407.66 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=211.0
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+.+.+|+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP-KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS-CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh-HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 4799999999999999999975 46999999998765433 457799999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.+++.+. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...... .
T Consensus 99 ~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~-~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (293)
T ss_dssp CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-C
T ss_pred cCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc-c
Confidence 9999999988764 399999999999999999999999 99999999999999999999999999998764332 3
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... .............. .
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~~~~~~~~--------~ 235 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN--------PLRALYLIATNGTP--------E 235 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHHCSC--------C
T ss_pred cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCC--------HHHHHHHHHhCCCC--------C
Confidence 3455689999999999999999999999999999999999999996321 11112222222111 1
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+..+.+++.+||+.||++|||++|++++
T Consensus 236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 12234566789999999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=402.99 Aligned_cols=247 Identities=27% Similarity=0.423 Sum_probs=209.4
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|..+ +++.||||++..... ....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999775 588999999875432 234677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.++++... .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|......
T Consensus 86 Ey~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred eecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence 9999999999998754 399999999999999999999999 9999999999999999999999999999765422
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.... ......... ...
T Consensus 160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~-~~~-------- 220 (263)
T d2j4za1 160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT--------YQETYKRIS-RVE-------- 220 (263)
T ss_dssp --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHH-TTC--------
T ss_pred --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC--------HHHHHHHHH-cCC--------
Confidence 2345679999999999999999999999999999999999999996321 111111111 111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...++++.+++.+||+.||++|||++|++++
T Consensus 221 --~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 --FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred --CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 12344566789999999999999999999999874
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-46 Score=410.46 Aligned_cols=255 Identities=24% Similarity=0.401 Sum_probs=212.4
Q ss_pred cCCCCcc-eeccCCcccEEEEEEc---CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSN-CIGSGGFGTTYKAEIS---PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~-~lg~G~fg~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|.+.+ .||+|+||+||+|.++ ++..||||+++........++|.+|++++++++|||||+++|++.+ +..|+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 3455666 4999999999999664 3567999999877666677889999999999999999999999875 468999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.+++.... ..+++.++.+++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 87 mE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhccccc
Confidence 99999999999986543 4589999999999999999999999 9999999999999999999999999999887544
Q ss_pred CCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 977 ETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 977 ~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .+.... +..
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~--------~~~~~~-i~~------ 227 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------PEVMAF-IEQ------ 227 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT--------HHHHHH-HHT------
T ss_pred ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH--------HHHHHH-HHc------
Confidence 332 2334568999999999999999999999999999999998 8999873211 111111 111
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
..+...+..++.++.++|.+||+.||++||||.+|.+.|+.+
T Consensus 228 ---~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 228 ---GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 122344566778999999999999999999999999999875
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-47 Score=409.37 Aligned_cols=255 Identities=25% Similarity=0.421 Sum_probs=198.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec--CCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--GNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|... +|+.||||++..... +...+.+.+|++++++++|||||++++++.+ .+.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 57999999999999999999764 689999999976643 3456779999999999999999999998865 4568999
Q ss_pred EeecCCCChHHHHHhh--cCCcccHHHHHHHHHHHHHHHHHHHhCC--CCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 897 YNYLPGGNLENFIKAR--TSRAVDWKILHKIALDVASALAYLHDQC--APRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~gL~~LH~~~--~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
|||+++|+|.+++++. ....+++..++.++.|++.||+|||++. ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999753 2356999999999999999999999871 12499999999999999999999999999987
Q ss_pred cCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccc
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKD 1052 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1052 (1103)
..... .......||+.|+|||++.+..|+.++|||||||++|||+||+.||.... ..+..... ..+..
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~--------~~~~~~~i-~~~~~-- 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFS--------QKELAGKI-REGKF-- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHH-HHTCC--
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCC--------HHHHHHHH-HcCCC--
Confidence 65332 23345689999999999999999999999999999999999999996321 11222221 11111
Q ss_pred cccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1053 VFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1053 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...++++.+++.+||+.||++|||++|++++
T Consensus 232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 12234566789999999999999999999999864
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-46 Score=409.12 Aligned_cols=257 Identities=26% Similarity=0.434 Sum_probs=209.8
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeec
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYL 900 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~ 900 (1103)
++|++.+.||+|+||+||+|.+++++.||||++..... ..+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~--~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM--SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS--CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC--CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence 57999999999999999999999888999999975543 34789999999999999999999999865 5678999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCcc
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETHA 980 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~~ 980 (1103)
++|+|.+++.......+++.+++.++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.........
T Consensus 94 ~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 170 (285)
T d1fmka3 94 SKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA 170 (285)
T ss_dssp TTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCcee
Confidence 999999999876656699999999999999999999999 99999999999999999999999999998775555555
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccccC
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELWA 1060 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1060 (1103)
.....||+.|+|||++.+..++.++|||||||++|||++|+.|+..... .......... ....
T Consensus 171 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~-------~~~~~~~i~~----------~~~~ 233 (285)
T d1fmka3 171 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-------NREVLDQVER----------GYRM 233 (285)
T ss_dssp -----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC-------HHHHHHHHHT----------TCCC
T ss_pred eccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCC-------HHHHHHHHHh----------cCCC
Confidence 5566789999999999999999999999999999999998877653221 1222222111 1122
Q ss_pred CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1061 SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1061 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
+.+..++.++.++|.+||+.||++||++++|++.|+.+..
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 3455667889999999999999999999999999998654
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-46 Score=417.36 Aligned_cols=257 Identities=23% Similarity=0.346 Sum_probs=210.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcCC------cEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPG------ILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 893 (1103)
++|++.+.||+|+||+||+|.+... ..||||++...........+.+|+.++.++ +|||||++++++.+.+..
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence 5789999999999999999976532 369999987766555667899999999998 899999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC---------------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCC
Q 043720 894 FLIYNYLPGGNLENFIKARTS---------------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPS 952 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~ 952 (1103)
|+||||+++|+|.++++.... ..+++..++.++.||++||+|||++ +||||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGG
T ss_pred EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchh
Confidence 999999999999999976532 3488999999999999999999999 9999999999
Q ss_pred cEEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCC
Q 043720 953 NILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSS 1030 (1103)
Q Consensus 953 NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~ 1030 (1103)
||+++.++.+||+|||+|+........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~- 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV- 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC-
T ss_pred ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCH-
Confidence 999999999999999999876443332 2345678999999999999999999999999999999998 8889863221
Q ss_pred CCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHh
Q 043720 1031 HGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQ 1097 (1103)
Q Consensus 1031 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~ 1097 (1103)
.. ....... .....+.+..++.++.++|.+||+.||++|||++||+++|..
T Consensus 273 ---~~----~~~~~~~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 ---DA----NFYKLIQ---------NGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp ---SH----HHHHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---HH----HHHHHHh---------cCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence 11 1111121 122334456677889999999999999999999999999964
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=402.70 Aligned_cols=248 Identities=26% Similarity=0.341 Sum_probs=202.4
Q ss_pred ceeccCCcccEEEEEEcC---CcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEeecCC
Q 043720 827 NCIGSGGFGTTYKAEISP---GILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNYLPG 902 (1103)
Q Consensus 827 ~~lg~G~fg~V~~~~~~~---~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~~~~ 902 (1103)
+.||+|+||+||+|.++. ++.||||+++.... ....+.|.+|+.++++++|||||+++|++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 469999999999997653 46899999976543 3346789999999999999999999999965 457899999999
Q ss_pred CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc--c
Q 043720 903 GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH--A 980 (1103)
Q Consensus 903 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~--~ 980 (1103)
|+|.++++... .+++.++.+++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++........ .
T Consensus 92 g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~ 166 (277)
T d1xbba_ 92 GPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 166 (277)
T ss_dssp EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred CcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence 99999998654 499999999999999999999999 9999999999999999999999999999876544332 2
Q ss_pred ccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccccc
Q 043720 981 TTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAELW 1059 (1103)
Q Consensus 981 ~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1059 (1103)
.....||++|+|||.+.+..++.++|||||||++|||+| |+.||.... ..+... .+.. ..+
T Consensus 167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~--------~~~~~~-~i~~---------~~~ 228 (277)
T d1xbba_ 167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK--------GSEVTA-MLEK---------GER 228 (277)
T ss_dssp ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC--------HHHHHH-HHHT---------TCC
T ss_pred ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC--------HHHHHH-HHHc---------CCC
Confidence 334578999999999999999999999999999999998 899986321 111111 1111 122
Q ss_pred CCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1060 ASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1060 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
.+.+..++.++.++|.+||+.||++|||++||.+.|+.+
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 344566778899999999999999999999999988865
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-46 Score=415.14 Aligned_cols=271 Identities=23% Similarity=0.352 Sum_probs=210.1
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +|+.||||+++........+.+.+|+.++++++|||||++++++.+.+.+|+|||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999764 6899999999876666667889999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
|+++|+|.+++++.. .+++..+..++.|++.||+|||+ + +|+||||||+|||+++++.+||+|||+|+....
T Consensus 85 y~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp CCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred cCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 999999999998754 39999999999999999999997 5 899999999999999999999999999986632
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCC----------Ccch---HHHH---
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGD----------GFNI---ISWA--- 1041 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~----------~~~~---~~~~--- 1041 (1103)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||......... .... ..+.
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 2234568999999999999999999999999999999999999999754321000 0000 0000
Q ss_pred -HHHH-hcCc---cccccccccc---CC-CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 043720 1042 -SMLL-RQGQ---VKDVFNAELW---AS-GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQI 1098 (1103)
Q Consensus 1042 -~~~~-~~~~---~~~~~~~~~~---~~-~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1098 (1103)
.... .... ..+..+.... .. .....+.++.+++.+||+.||++|||++|++++ +++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000 0000 0000000000 00 011234678999999999999999999999985 5443
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-45 Score=407.85 Aligned_cols=253 Identities=26% Similarity=0.360 Sum_probs=193.8
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.+.|++.+.||+|+||+||+|... +++.||||++.........+.+.+|+.++++++|||||++++++.+++.+|+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 456999999999999999999765 5899999999876655556778899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC---CCCCEEEeecccccccCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD---DDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~---~~~~~ki~Dfgla~~~~~ 975 (1103)
|+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++ +++.+||+|||+|+....
T Consensus 88 ~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 88 LVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP 162 (307)
T ss_dssp CCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence 999999999997643 499999999999999999999999 999999999999995 578999999999986543
Q ss_pred CCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ............ .
T Consensus 163 ~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~~~-~----- 226 (307)
T d1a06a_ 163 G--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN--------DAKLFEQILKAE-Y----- 226 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHTTC-C-----
T ss_pred C--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHhccC-C-----
Confidence 2 22345679999999999999999999999999999999999999997321 111112222111 0
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....+.....++++.+++.+||+.||++|||++|++++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11112234566789999999999999999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-44 Score=392.07 Aligned_cols=246 Identities=23% Similarity=0.367 Sum_probs=198.8
Q ss_pred CCcceeccCCcccEEEEEEc-CCcEEEEEEccccc-chhhHHHHHHHHHHHhcCCCCceeEEEeEEec----CCeEEEEE
Q 043720 824 NTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR-FQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS----GNEMFLIY 897 (1103)
Q Consensus 824 ~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lV~ 897 (1103)
++.+.||+|+||+||+|... +++.||+|++.... .....+.+.+|++++++++|||||++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55668999999999999765 58899999987654 34456789999999999999999999999864 45689999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCC--cccCCCCCCcEEEC-CCCCEEEeecccccccC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPR--VLHRDVKPSNILLD-DDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~--ivH~Dlk~~NIll~-~~~~~ki~Dfgla~~~~ 974 (1103)
||+++|+|.+++++.. .+++..+..++.||++||+|||++ + |+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred eCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 9999999999998754 489999999999999999999998 6 99999999999997 57899999999998643
Q ss_pred CCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
. ......+||+.|+|||++.+ .++.++||||+||++|||++|+.||..... ....... +..+...
T Consensus 167 ~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~-------~~~~~~~-i~~~~~~--- 231 (270)
T d1t4ha_ 167 A---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN-------AAQIYRR-VTSGVKP--- 231 (270)
T ss_dssp T---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS-------HHHHHHH-HTTTCCC---
T ss_pred C---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCccc-------HHHHHHH-HHcCCCC---
Confidence 2 23345689999999999875 599999999999999999999999963211 1111111 1111111
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ..+...++++.+++.+||+.||++|||++|++++
T Consensus 232 -~----~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 232 -A----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -G----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -c----ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence 1 1122345678999999999999999999999874
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-45 Score=402.86 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=208.0
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
+.|++.+.||+|+||+||+|... +++.||||++.... ....+.+.+|++++++++|||||++++++.+.+..|+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS-SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence 35889999999999999999765 68999999987653 33467889999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.+++.+.. ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 91 ~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~ 165 (288)
T d2jfla1 91 CAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQ 165 (288)
T ss_dssp CTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HH
T ss_pred CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC-cc
Confidence 99999999987643 4599999999999999999999999 9999999999999999999999999999765321 12
Q ss_pred cccCCcccccccCccccc-----cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccc
Q 043720 980 ATTGVAGTFGYVAPEYAL-----TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVF 1054 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1054 (1103)
......||+.|+|||++. ...|+.++||||+||++|||++|+.||..... .+......... .
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~--------~~~~~~i~~~~-~---- 232 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP--------MRVLLKIAKSE-P---- 232 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG--------GGHHHHHHHSC-C----
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH--------HHHHHHHHcCC-C----
Confidence 334568999999999983 55688999999999999999999999974321 11111221111 1
Q ss_pred cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1055 NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1055 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+...+.++.+++.+||+.||++|||++|++++
T Consensus 233 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 ---PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp ---CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred ---CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112344567889999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-45 Score=402.05 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=206.7
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|... +++.||||++..... ....+.+.+|++++++++|||||++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46999999999999999999764 689999999875432 334677999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+|+.+....
T Consensus 88 Ey~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCC
Confidence 9999999999988764 399999999999999999999999 99999999999999999999999999998775433
Q ss_pred C-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 978 T-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 978 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
. ......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... .......+.. ..
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~--------~~~~~~~i~~-~~------- 226 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN--------EYLIFQKIIK-LE------- 226 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHT-TC-------
T ss_pred cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcC--------HHHHHHHHHc-CC-------
Confidence 2 23445689999999999999999999999999999999999999997321 1111222111 11
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQ 1093 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~ 1093 (1103)
...+...+.++.++|.+||+.||++|||++|+++
T Consensus 227 ---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 227 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp ---CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred ---CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence 1234456678999999999999999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-45 Score=401.03 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=203.2
Q ss_pred cCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|.+.. +..||||+++........+.+.+|+.++++++|||||+++|++.+ +..|+|
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~~iv 85 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWII 85 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CeEEEE
Confidence 578999999999999999997653 456999998776666667889999999999999999999999964 678999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|++.+++.... ..+++..++.++.||++||+|||++ +|+||||||+||++++++.+||+|||+|+.....
T Consensus 86 ~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCC
Confidence 99999999999887643 4589999999999999999999999 9999999999999999999999999999877555
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.........||+.|+|||++.+..++.++|||||||++|||++ |..||..... ... .... ..+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~-----~~~---~~~i-~~~------- 225 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-----NDV---IGRI-ENG------- 225 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-----GGH---HHHH-HTT-------
T ss_pred cceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH-----HHH---HHHH-HcC-------
Confidence 4445556678999999999999999999999999999999998 7878763321 111 1111 111
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...+.+..++..+.++|.+||+.||++|||++||+++|++|.+
T Consensus 226 --~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 226 --ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 1123455677889999999999999999999999999998854
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=396.79 Aligned_cols=251 Identities=25% Similarity=0.421 Sum_probs=203.3
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec-CCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|.++ |+.||||+++... ..+.+.+|++++++++||||++++|++.+ .+.+|+||||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 46888999999999999999986 8899999997543 44678999999999999999999999865 4568999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+++|+|.+++.......+++..+++|+.||+.||+|||+. +|+||||||+||+++.++.+|++|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--- 156 (262)
T ss_dssp CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC---
Confidence 9999999999876555689999999999999999999999 9999999999999999999999999999865322
Q ss_pred cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccccc
Q 043720 980 ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAEL 1058 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1058 (1103)
.....+++.|+|||++.+..++.++||||||+++|||+| |+.||..... .... ... ....
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~-----~~~~---~~i----------~~~~ 217 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-----KDVV---PRV----------EKGY 217 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-----GGHH---HHH----------TTTC
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCH-----HHHH---HHH----------HcCC
Confidence 223457889999999999999999999999999999998 5666652211 1111 111 1122
Q ss_pred cCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1059 WASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1059 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
+.+.+..+++++.+++.+||+.||++||||+|++++|++|+.
T Consensus 218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 334455667889999999999999999999999999999874
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.2e-45 Score=404.69 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=215.9
Q ss_pred HhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCe
Q 043720 819 ATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNE 892 (1103)
Q Consensus 819 ~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 892 (1103)
..++|++.+.||+|+||+||+|+++ +++.||||++......+..++|.+|++++++++||||+++++++...+.
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 90 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP 90 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence 3567999999999999999999764 3578999999877666667889999999999999999999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhc----------------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCC
Q 043720 893 MFLIYNYLPGGNLENFIKART----------------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVK 950 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk 950 (1103)
.++||||+++|+|.++++... ...+++.+++.|+.|++.||+|||++ +|||||||
T Consensus 91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlK 167 (301)
T d1lufa_ 91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLA 167 (301)
T ss_dssp CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEc
Confidence 999999999999999997532 13478999999999999999999999 99999999
Q ss_pred CCcEEECCCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC-CCCCCC
Q 043720 951 PSNILLDDDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKK-ALDPSF 1028 (1103)
Q Consensus 951 ~~NIll~~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~-p~~~~~ 1028 (1103)
|+|||++.++.+||+|||+|+........ ......|++.|+|||.+.+..|+.++|||||||++|||++|+. ||...
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~- 246 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 246 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCC-
Confidence 99999999999999999999866433322 2345678899999999999999999999999999999999975 55421
Q ss_pred CCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1029 SSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1029 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
...+.... +..+. ....+..++.++.+++.+||+.||++||||.||++.|++|.
T Consensus 247 -------~~~e~~~~-v~~~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 247 -------AHEEVIYY-VRDGN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp -------CHHHHHHH-HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred -------CHHHHHHH-HHcCC---------CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 11112221 11221 12335566788999999999999999999999999999985
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-45 Score=403.82 Aligned_cols=246 Identities=26% Similarity=0.354 Sum_probs=203.5
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.|+..+.||+|+||+||+|... +++.||||++..... ....+.+.+|+.++++++|||||++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4889999999999999999754 688999999976543 3345679999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
||++|++..++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (309)
T ss_dssp CCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred ecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC---
Confidence 99999998776554 3499999999999999999999999 999999999999999999999999999986532
Q ss_pred ccccCCcccccccCcccccc---CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALT---CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFN 1055 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1055 (1103)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.... ............. .
T Consensus 168 --~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~--------~~~~~~~i~~~~~-~---- 232 (309)
T d1u5ra_ 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSALYHIAQNES-P---- 232 (309)
T ss_dssp --BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC--------HHHHHHHHHHSCC-C----
T ss_pred --CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCC--------HHHHHHHHHhCCC-C----
Confidence 234579999999999853 468999999999999999999999986321 1111222221111 0
Q ss_pred ccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 AELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...++.+.+++.+||+.||++|||++|++++
T Consensus 233 ----~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 233 ----ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ----CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ----CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11123456789999999999999999999999863
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=404.55 Aligned_cols=271 Identities=23% Similarity=0.338 Sum_probs=209.3
Q ss_pred CCHHHHHHHhcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEE
Q 043720 811 LTYESIIRATGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTL 883 (1103)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l 883 (1103)
+...+++...++|++.+.||+|+||+||+|.+. +++.||||+++........+.+.+|...+.++ +|+||+.+
T Consensus 3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~ 82 (299)
T d1ywna1 3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 82 (299)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence 333444344568999999999999999999754 24689999998776666677888888888877 68999999
Q ss_pred EeEEecC-CeEEEEEeecCCCChHHHHHhhcC--------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCC
Q 043720 884 IGYRASG-NEMFLIYNYLPGGNLENFIKARTS--------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRD 948 (1103)
Q Consensus 884 ~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~D 948 (1103)
++++... ...++||||+++|+|.++++.... ..+++.++..++.||++||+|||++ +|+|||
T Consensus 83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD 159 (299)
T d1ywna1 83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD 159 (299)
T ss_dssp EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence 9988664 568999999999999999976432 3488999999999999999999999 999999
Q ss_pred CCCCcEEECCCCCEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCC-CCCC
Q 043720 949 VKPSNILLDDDFNAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKK-ALDP 1026 (1103)
Q Consensus 949 lk~~NIll~~~~~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~-p~~~ 1026 (1103)
|||+|||+++++.+||+|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||+. ||..
T Consensus 160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~ 239 (299)
T d1ywna1 160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239 (299)
T ss_dssp CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999987644333 23445679999999999999999999999999999999999765 5542
Q ss_pred CCCCCCCCcchHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1027 SFSSHGDGFNIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1027 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
... . .........+ .....+..+++++.+++.+||+.||++|||++||+++|++|.++
T Consensus 240 ~~~----~----~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 240 VKI----D----EEFCRRLKEG---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCC----S----HHHHHHHHHT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCH----H----HHHHHHHhcC---------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 211 1 1122222222 12233455677899999999999999999999999999998654
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-45 Score=405.51 Aligned_cols=259 Identities=25% Similarity=0.453 Sum_probs=208.6
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-Cc----EEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GI----LVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 895 (1103)
.+|++.+.||+|+||+||+|.+.. |+ .||||++......+..+.|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 469999999999999999997653 43 68999887666666678899999999999999999999999875 5678
Q ss_pred EEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCC
Q 043720 896 IYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 896 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~ 975 (1103)
++||+.+|+|.+++.... ..+++..+++++.|||.||+|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 88 v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 889999999999887653 5599999999999999999999999 999999999999999999999999999988754
Q ss_pred CCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 976 SETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 976 ~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||..... .. ... .+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~-----~~---~~~-~i-------- 226 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SE---ISS-IL-------- 226 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCG-----GG---HHH-HH--------
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCH-----HH---HHH-HH--------
Confidence 4333 2334568999999999999999999999999999999999 6777653211 11 111 11
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcCC
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHSP 1102 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~~ 1102 (1103)
....+.+.+..++..+.+++.+||+.||++|||++||+++|+++.++|
T Consensus 227 -~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~ 274 (317)
T d1xkka_ 227 -EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274 (317)
T ss_dssp -HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSH
T ss_pred -HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhCh
Confidence 112223445667788999999999999999999999999999986654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-44 Score=393.74 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=208.7
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-----hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-----QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+.++++++|||||++++++.+.+.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 35799999999999999999976 4689999999875433 22467899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC----CEEEeeccc
Q 043720 894 FLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF----NAYLSDFGL 969 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~----~~ki~Dfgl 969 (1103)
|+||||+++|+|.++++... .+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999998764 499999999999999999999999 999999999999998776 499999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
|...... .......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...........
T Consensus 164 a~~~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------~~~~~~i~~~~- 232 (293)
T d1jksa_ 164 AHKIDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--------QETLANVSAVN- 232 (293)
T ss_dssp CEECTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHHTTC-
T ss_pred hhhcCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCH--------HHHHHHHHhcC-
Confidence 9876433 233456789999999999999999999999999999999999999973211 11111111111
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ..... .+...+..+.++|.+||+.||++|||++|++++
T Consensus 233 ~--~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 Y--EFEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C--CCCHH----HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C--CCCch----hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 00011 112345678999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-44 Score=400.02 Aligned_cols=258 Identities=27% Similarity=0.422 Sum_probs=208.6
Q ss_pred cCCCCcceeccCCcccEEEEEEcC-Cc--EEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP-GI--LVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|.+++ +. .||||++......+..+.+.+|+++++++ +|||||+++|++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 578999999999999999997654 43 57888887665555677899999999999 799999999999999999999
Q ss_pred EeecCCCChHHHHHhh--------------cCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCE
Q 043720 897 YNYLPGGNLENFIKAR--------------TSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNA 962 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ 962 (1103)
|||+++|+|.++++.. ....+++.++.+++.|||.||.|+|++ +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 9999999999999754 235689999999999999999999999 99999999999999999999
Q ss_pred EEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCC-CCCCCCCCCCCcchHHHH
Q 043720 963 YLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKA-LDPSFSSHGDGFNIISWA 1041 (1103)
Q Consensus 963 ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p-~~~~~~~~~~~~~~~~~~ 1041 (1103)
||+|||+++..... .......||..|+|||.+.+..++.++|||||||++|||++|+.| |... ...+..
T Consensus 167 kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~--------~~~~~~ 236 (309)
T d1fvra_ 167 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--------TCAELY 236 (309)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC--------CHHHHH
T ss_pred EEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC--------CHHHHH
Confidence 99999999865322 223345689999999999999999999999999999999998764 4321 111111
Q ss_pred HHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1042 SMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1042 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.. +. ...+...+..++.++.++|.+||+.||++||||+||+++|+++.+.
T Consensus 237 ~~-i~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 237 EK-LP---------QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HH-GG---------GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HH-HH---------hcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 11 11 1122344566778999999999999999999999999999998644
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-43 Score=394.79 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=210.9
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... ....+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999976 4689999999976532 335678899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|+|.+++++... +++..++.++.||+.||+|||++ +|+||||||+|||++++|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~~--~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~- 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD- 158 (337)
T ss_dssp ECCTTCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-
T ss_pred eccCCCchhhhhhcccC--CcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccC-
Confidence 99999999999987653 89999999999999999999999 9999999999999999999999999999865432
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......+||+.|+|||++.+..|+.++||||+||++|||++|+.||..... ........ .+.
T Consensus 159 ~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~--------~~~~~~i~-~~~-------- 221 (337)
T d1o6la_ 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--------ERLFELIL-MEE-------- 221 (337)
T ss_dssp TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHHH-HCC--------
T ss_pred CcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH--------HHHHHHHh-cCC--------
Confidence 2334567899999999999999999999999999999999999999974321 11122211 111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
...+...+.++.++|.+||+.||++||+ +.|++++
T Consensus 222 --~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred --CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1234556678899999999999999995 7888764
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-43 Score=393.50 Aligned_cols=255 Identities=28% Similarity=0.454 Sum_probs=209.6
Q ss_pred cceeccCCcccEEEEEEcCC----cEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEec-CCeEEEEEeec
Q 043720 826 SNCIGSGGFGTTYKAEISPG----ILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS-GNEMFLIYNYL 900 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lV~E~~ 900 (1103)
.++||+|+||+||+|.+..+ ..||||+++........++|.+|++++++++|||||+++|++.. ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 56799999999999976542 36899999866666677889999999999999999999999865 56899999999
Q ss_pred CCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc-
Q 043720 901 PGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH- 979 (1103)
Q Consensus 901 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~- 979 (1103)
++|+|.++++... ...++..+.+++.|+++||.|+|+. +|+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp TTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred ecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 9999999987654 4578889999999999999999999 9999999999999999999999999999876443322
Q ss_pred --cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 980 --ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 980 --~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......||+.|+|||.+.+..++.++||||||+++|||+||+.||...... .. +...... +
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~----~~---~~~~i~~-g--------- 250 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT----FD---ITVYLLQ-G--------- 250 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------------CHHHHHT-T---------
T ss_pred ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH----HH---HHHHHHc-C---------
Confidence 233457899999999999999999999999999999999998887643221 11 1111111 1
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhcC
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQHS 1101 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 1101 (1103)
.+...+..++..+.++|.+||+.||++||++.||+++|+++.++
T Consensus 251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~ 294 (311)
T d1r0pa_ 251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294 (311)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence 12233455677899999999999999999999999999998654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=8.4e-44 Score=400.31 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=209.3
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +|+.||||++...... ..+.+.+|+.++++++|||||++++++.+.+.+|+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 357999999999999999999764 6899999999765433 46788999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC--CCCCEEEeecccccccCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD--DDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgla~~~~~~ 976 (1103)
||++|+|.+++.... ..+++..+..|+.||+.||+|||++ +||||||||+|||++ .++.+||+|||+++.....
T Consensus 104 ~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 104 FMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred cCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999996543 3499999999999999999999999 999999999999996 4678999999999876433
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.... .......+..... . ..
T Consensus 180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~--------~~~~~~~i~~~~~-~--~~- 245 (350)
T d1koaa2 180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEN--------DDETLRNVKSCDW-N--MD- 245 (350)
T ss_dssp --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHTCC-C--SC-
T ss_pred --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCCC-C--CC-
Confidence 23345678999999999999999999999999999999999999996321 1122222221111 0 00
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.......+..+.++|.+||+.||++|||++|++++
T Consensus 246 ---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 246 ---DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp ---CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred ---cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11123456778999999999999999999999985
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-44 Score=390.85 Aligned_cols=256 Identities=24% Similarity=0.362 Sum_probs=200.8
Q ss_pred cCCCCcceeccCCcccEEEEEEcC----CcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP----GILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~----~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||+||+|.+.. ...||||++..... .+..++|.+|+.++++++|||||+++|++.+. ..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-chh
Confidence 468999999999999999997542 24789999876533 34467899999999999999999999999764 678
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+++|++.+++.... ..+++..+++++.|||+||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 87 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred eeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 9999999999999887654 3599999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCCc--cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 975 TSETH--ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 975 ~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
..... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||.... ...........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~--------~~~~~~~i~~~---- 230 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN--------GSQILHKIDKE---- 230 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC--------HHHHHHHHHTS----
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcC--------HHHHHHHHHhC----
Confidence 44332 2334567889999999999999999999999999999998 899886321 11222222221
Q ss_pred ccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1052 DVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1052 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
....+.+..++..+.+++.+||+.||++||||+||.+.|++.
T Consensus 231 -----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 231 -----GERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 222234456678899999999999999999999999999875
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-44 Score=397.24 Aligned_cols=261 Identities=26% Similarity=0.409 Sum_probs=217.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCCeE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 893 (1103)
++|++.+.||+|+||+||+|++. +++.||||+++..........+.+|+.+++++ +|||||+++|++.+.+..
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~ 102 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPT 102 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEE
Confidence 57889999999999999999753 45789999998777666777899999999999 699999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC----------------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC
Q 043720 894 FLIYNYLPGGNLENFIKARTS----------------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~ 957 (1103)
++||||+++|+|.++++.... ..+++..+.+++.||++|++|||++ +||||||||+||+++
T Consensus 103 ~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 103 LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLT 179 (311)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEE
T ss_pred EEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccccccc
Confidence 999999999999999986432 3588999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccccccCCCCC-ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcc
Q 043720 958 DDFNAYLSDFGLSRLLGTSET-HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFN 1036 (1103)
Q Consensus 958 ~~~~~ki~Dfgla~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~ 1036 (1103)
.++.+|++|||.++....... .......||+.|+|||++.+..++.++|||||||++|||+|++.|+...... .
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~---~-- 254 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV---D-- 254 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS---S--
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH---H--
Confidence 999999999999987754433 3344568899999999999999999999999999999999966665422211 0
Q ss_pred hHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1037 IISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
......+ ........+...+..+.++|.+||+.||++||||+||++.|+++..
T Consensus 255 --~~~~~~i---------~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 255 --SKFYKMI---------KEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp --HHHHHHH---------HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHHHH---------hcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111111 1222333445567889999999999999999999999999987543
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-44 Score=393.52 Aligned_cols=259 Identities=25% Similarity=0.398 Sum_probs=211.9
Q ss_pred cCCCCcceeccCCcccEEEEEEcC--------CcEEEEEEcccccchhhHHHHHHHHHHHhcC-CCCceeEEEeEEecCC
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISP--------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNV-RHPNLVTLIGYRASGN 891 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 891 (1103)
++|++.+.||+|+||+||+|+... +..||||+++.+.......++.+|+..+.++ +|||||++++++.+.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence 478899999999999999996532 3579999998877766778899999999888 7999999999999999
Q ss_pred eEEEEEeecCCCChHHHHHhhc--------------CCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC
Q 043720 892 EMFLIYNYLPGGNLENFIKART--------------SRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD 957 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~ 957 (1103)
..++||||+++|+|.++++... ...+++.++++++.||+.||+|||++ +||||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEC
T ss_pred eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeec
Confidence 9999999999999999997653 24589999999999999999999999 999999999999999
Q ss_pred CCCCEEEeecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHh-CCCCCCCCCCCCCCCc
Q 043720 958 DDFNAYLSDFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELIS-DKKALDPSFSSHGDGF 1035 (1103)
Q Consensus 958 ~~~~~ki~Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~ 1035 (1103)
.++.+||+|||+++........ ......+++.|+|||.+.+..|+.++|||||||++|||++ |..||....
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~------- 242 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP------- 242 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-------
T ss_pred CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC-------
Confidence 9999999999999877543332 3445678999999999999999999999999999999998 566665211
Q ss_pred chHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1036 NIISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1036 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
..+ ....+. .......+..++.++.++|.+||+.||++|||++||++.|++|.+
T Consensus 243 -~~~-~~~~i~---------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 243 -VEE-LFKLLK---------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHH-HHHHHH---------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHH-HHHHHH---------cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 111 111221 122233455667889999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2e-43 Score=397.47 Aligned_cols=252 Identities=20% Similarity=0.249 Sum_probs=209.4
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+.++++++|||||++++++.+++.+|+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL-DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 5799999999999999999976 46999999998765433 456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEEC--CCCCEEEeecccccccCCCC
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLD--DDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~--~~~~~ki~Dfgla~~~~~~~ 977 (1103)
+++|+|.+++.... ..+++.+++.|+.||+.||+|||++ +|+||||||+|||++ .++.+||+|||+|+......
T Consensus 108 ~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 108 LSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999999876543 4599999999999999999999999 999999999999998 67899999999998875432
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.... ............ . .
T Consensus 184 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~i~~~~-~------~ 246 (352)
T d1koba_ 184 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED--------DLETLQNVKRCD-W------E 246 (352)
T ss_dssp --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS--------HHHHHHHHHHCC-C------C
T ss_pred --ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC--------HHHHHHHHHhCC-C------C
Confidence 2344578999999999999999999999999999999999999997321 111122211111 1 1
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.........+.++.++|.+||+.||++|||++|++++
T Consensus 247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1112234566789999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4e-43 Score=389.65 Aligned_cols=246 Identities=26% Similarity=0.389 Sum_probs=208.6
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|+.+ +|+.||||++..... ....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46999999999999999999764 589999999975432 334678999999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+++|++..++..... +++..+..++.||+.|++|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~~--~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQR--FPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTSS--CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS--
T ss_pred eecCCcccccccccccc--ccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc--
Confidence 99999999999887654 78889999999999999999999 999999999999999999999999999987643
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.... ............
T Consensus 157 --~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~--------- 217 (316)
T d1fota_ 157 --VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN--------TMKTYEKILNAE--------- 217 (316)
T ss_dssp --CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS--------HHHHHHHHHHCC---------
T ss_pred --ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC--------HHHHHHHHHcCC---------
Confidence 2335689999999999999999999999999999999999999997321 111222222111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+.++.+++.+|++.||++|| +++|++++
T Consensus 218 --~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 123345567899999999999999996 89999864
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-43 Score=387.99 Aligned_cols=271 Identities=24% Similarity=0.312 Sum_probs=204.1
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC----eEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----EMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lV 896 (1103)
.+|.+.+.||+|+||+||+|++. |+.||||++...... ...++.|+..++.++|||||+++|++.+.+ .+|+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence 35778889999999999999875 899999998654322 233445666677889999999999997643 68999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC-----CCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC-----APRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-----~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
|||+++|+|.+++++.. +++.++.+++.|+|.||+|+|+.+ .++|+||||||+|||+++++.+||+|||+++
T Consensus 80 ~Ey~~~g~L~~~l~~~~---l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EECCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EecccCCCHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 99999999999998653 999999999999999999999731 2499999999999999999999999999998
Q ss_pred ccCCCCCc---cccCCcccccccCccccccC------CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCc------c
Q 043720 972 LLGTSETH---ATTGVAGTFGYVAPEYALTC------RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGF------N 1036 (1103)
Q Consensus 972 ~~~~~~~~---~~~~~~g~~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~------~ 1036 (1103)
........ ......||++|+|||++.+. .++.++|||||||++|||+||..||........... .
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence 76433321 23456799999999998754 356789999999999999999988754332211111 1
Q ss_pred hHHHHHHHHhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1037 IISWASMLLRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1037 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
...........+....-+... .........+.+++.+||+.||++|||+.||++.|++|.+
T Consensus 237 ~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 237 SVEEMRKVVCEQKLRPNIPNR---WQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp CHHHHHHHHTTSCCCCCCCGG---GGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHhccccCCCCCcc---cCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 112222222222111111111 1133466779999999999999999999999999999865
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.4e-43 Score=383.89 Aligned_cols=260 Identities=23% Similarity=0.348 Sum_probs=206.5
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC----e
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----E 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 892 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||+++.... ....+.+.+|+.++++++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 35799999999999999999975 5699999999976543 334567999999999999999999999887643 4
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+||||+++++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhh
Confidence 899999999999999987764 499999999999999999999999 999999999999999999999999999876
Q ss_pred cCCCCC--ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 973 LGTSET--HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 973 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
...... .......||+.|+|||++.+..++.++||||+||++|||+||+.||.... ..............
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~--------~~~~~~~~~~~~~~ 232 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS--------PVSVAYQHVREDPI 232 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS--------HHHHHHHHHHCCCC
T ss_pred hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcC--------HHHHHHHHHhcCCC
Confidence 533322 23445679999999999999999999999999999999999999997321 11222222222211
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCC-CHHHHHHHHHhhh
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRP-TMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 1099 (1103)
. + .......+.++.+++.+||+.||++|| |++++++.|.+++
T Consensus 233 ~----~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 P----P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp C----G---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C----C---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 0 0 112234567899999999999999999 8999999999876
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=392.71 Aligned_cols=261 Identities=20% Similarity=0.350 Sum_probs=216.4
Q ss_pred hcCCCCcceeccCCcccEEEEEEc------CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS------PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEM 893 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 893 (1103)
.++|++.+.||+|+||+||+|.+. +++.||||+++..........|.+|+.++++++|||||+++|++...+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 357899999999999999999764 25789999998766666677899999999999999999999999999999
Q ss_pred EEEEeecCCCChHHHHHhhcC--------CcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEe
Q 043720 894 FLIYNYLPGGNLENFIKARTS--------RAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLS 965 (1103)
Q Consensus 894 ~lV~E~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~ 965 (1103)
++||||+++|+|.+++..... ..+++..+.+++.|+|+||.|||++ +|+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEe
Confidence 999999999999999875421 3368899999999999999999999 99999999999999999999999
Q ss_pred ecccccccCCCCCc-cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 966 DFGLSRLLGTSETH-ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 966 Dfgla~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||+||+.|+... ....++....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~-------~~~~~~~~~i 248 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG-------LSNEQVLRFV 248 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT-------SCHHHHHHHH
T ss_pred ecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC-------CCHHHHHHHH
Confidence 99999876443332 234456899999999999999999999999999999999996443311 1222222222
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhhc
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQH 1100 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 1100 (1103)
.. + ...+.+..++..+.++|.+||+.+|++|||++||+++|++..+
T Consensus 249 ~~-~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 249 ME-G---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HT-T---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred Hh-C---------CCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence 21 1 1223345667889999999999999999999999999998754
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.4e-42 Score=377.65 Aligned_cols=252 Identities=25% Similarity=0.351 Sum_probs=207.7
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc--------hhhHHHHHHHHHHHhcCC-CCceeEEEeEEecC
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF--------QHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASG 890 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~ 890 (1103)
++|++.+.||+|+||+||+|+. .+++.||||++..... +...+.+.+|+.++++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 5799999999999999999976 4689999999876432 223456889999999997 99999999999999
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
+..|+||||+++|+|.++++... .+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred cceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchhe
Confidence 99999999999999999998754 499999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCccccCCcccccccCcccccc------CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALT------CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML 1044 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 1044 (1103)
+..... .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||..... .......
T Consensus 158 ~~~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~--------~~~~~~i 227 (277)
T d1phka_ 158 CQLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ--------MLMLRMI 227 (277)
T ss_dssp EECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHHH
T ss_pred eEccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH--------HHHHHHH
Confidence 876543 23445689999999999853 3568899999999999999999999973211 1111111
Q ss_pred HhcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1045 LRQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1045 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. .+... .........++++.+++.+||+.||++|||++||+++
T Consensus 228 ~-~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 M-SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp H-HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred H-hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1 11111 1112234566789999999999999999999999875
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-42 Score=389.93 Aligned_cols=246 Identities=20% Similarity=0.294 Sum_probs=209.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIY 897 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~ 897 (1103)
++|++.+.||+|+||+||+|..+ +|+.||||++..... ....+.+.+|+.+++.++|||||++++++...+..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999764 699999999875432 234677899999999999999999999999999999999
Q ss_pred eecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCC
Q 043720 898 NYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSE 977 (1103)
Q Consensus 898 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~ 977 (1103)
||+.+|+|.+++.+.. .+++.++..++.||+.||+|||++ +||||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~-- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc--
Confidence 9999999999998764 499999999999999999999999 999999999999999999999999999987643
Q ss_pred CccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 978 THATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 978 ~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
......||+.|||||++.+..++.++||||+||++|||+||+.||.... .......+....
T Consensus 194 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~--------~~~~~~~i~~~~--------- 254 (350)
T d1rdqe_ 194 --RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ--------PIQIYEKIVSGK--------- 254 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS--------HHHHHHHHHHCC---------
T ss_pred --ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcC--------HHHHHHHHhcCC---------
Confidence 2335679999999999999999999999999999999999999997321 112222222111
Q ss_pred ccCCCChhHHHHHHHHHHHccccCCCCCC-----CHHHHHHH
Q 043720 1058 LWASGPHDDLEDMLHLALRCTVETLSTRP-----TMKQVVQC 1094 (1103)
Q Consensus 1058 ~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~evl~~ 1094 (1103)
...+...+.++.+++.+||+.||++|+ +++|++++
T Consensus 255 --~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred --CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 122445667899999999999999994 89999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-42 Score=386.85 Aligned_cols=248 Identities=25% Similarity=0.366 Sum_probs=206.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEccccc--chhhHHHHHHHHHHHh-cCCCCceeEEEeEEecCCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGR--FQHGVQQFHAEIKTLG-NVRHPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|... +++.||||+++... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57999999999999999999765 68999999997643 2334566777777665 68999999999999999999999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~ 976 (1103)
|||+++|+|.++++.... +++.++..++.||+.||+|||++ +|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~~--~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHSS--CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EeecCCCcHHHHhhccCC--CCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccc
Confidence 999999999999987654 89999999999999999999999 9999999999999999999999999999865433
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
........||+.|+|||++.+..++.++||||+||++|||++|+.||..... ...... +..+.
T Consensus 157 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~--------~~~~~~-i~~~~------- 219 (320)
T d1xjda_ 157 -DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE--------EELFHS-IRMDN------- 219 (320)
T ss_dssp -TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH--------HHHHHH-HHHCC-------
T ss_pred -cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH--------HHHHHH-HHcCC-------
Confidence 2334456899999999999999999999999999999999999999973211 111111 11111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHH-HHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMK-QVVQ 1093 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-evl~ 1093 (1103)
...+...+.++.+++.+||+.||++||++. |+++
T Consensus 220 ---~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 123445667899999999999999999995 6754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.3e-42 Score=389.86 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=202.3
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc--hhhHHHH---HHHHHHHhcCCCCceeEEEeEEecCCeEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF--QHGVQQF---HAEIKTLGNVRHPNLVTLIGYRASGNEMF 894 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 894 (1103)
++|++.+.||+|+||+||+|... +|+.||||++..... ......+ ..|+.+++.++|||||++++++.+.+.+|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 57999999999999999999765 589999999865432 1122233 34577888889999999999999999999
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
+||||+++|+|.+++++.. .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence 9999999999999998764 388999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccc
Q 043720 975 TSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDV 1053 (1103)
Q Consensus 975 ~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1053 (1103)
.. ......||+.|+|||++.. ..|+.++||||+||++|||+||+.||...... ....... ...
T Consensus 159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-----~~~~~~~----~~~---- 222 (364)
T d1omwa3 159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-----DKHEIDR----MTL---- 222 (364)
T ss_dssp SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-----CHHHHHH----HSS----
T ss_pred CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHH----hcc----
Confidence 33 2345679999999999864 56899999999999999999999999743221 1111111 000
Q ss_pred ccccccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1054 FNAELWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1054 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
......+...++++.++|.+||+.||++||+ ++|++++
T Consensus 223 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 ---TMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp ---SCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred ---cCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 0011223456678999999999999999999 6888754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-42 Score=387.83 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=200.3
Q ss_pred hcCCCCcc-eeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhc-CCCCceeEEEeEEec----CCe
Q 043720 820 TGDFNTSN-CIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGN-VRHPNLVTLIGYRAS----GNE 892 (1103)
Q Consensus 820 ~~~~~~~~-~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~ 892 (1103)
.++|++.. .||+|+||+||+|.. .+++.||||+++.. ..+.+|+.++.+ .+|||||++++++.+ ...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence 35788765 599999999999976 56899999998632 456789988655 489999999998865 467
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeeccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGL 969 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgl 969 (1103)
+|+|||||++|+|.++++......+++.+++.|+.||+.||+|||++ +|+||||||+|||++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccce
Confidence 89999999999999999876556799999999999999999999999 9999999999999985 55799999999
Q ss_pred ccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 970 SRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 970 a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
|+...... ......||+.|+|||++.+..|+.++||||+||++|||+||+.||......... ....
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~-----~~~~------- 226 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----PGMK------- 226 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-------------------
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH-----HHHH-------
Confidence 98765332 334567999999999999999999999999999999999999999743321100 0000
Q ss_pred ccccccccccCC--CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWAS--GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
..........+ .....+.++.+++.+||+.||++|||+.|++++
T Consensus 227 -~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 227 -TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 00000111111 112456789999999999999999999999885
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.1e-41 Score=380.94 Aligned_cols=293 Identities=29% Similarity=0.485 Sum_probs=249.7
Q ss_pred CChhhHHHHHHHHhhccCCCCcccCcCCCCCCCC--ceeeeEecCCC---CeEEEEecCCCCCCCCCCcccccccccccc
Q 043720 3 KVLPEKTILLEFKNSVSDPSGILSSWQTNTSSHC--SWFGVSCDSES---RVVALNITGGDVSEGNSKPFFSCLMTAQFP 77 (1103)
Q Consensus 3 ~~~~~~~aLl~~k~~~~d~~~~l~sW~~~~~~~C--~W~GV~C~~~~---~v~~l~l~~~~~~~~~~~~~~~~~~~~~~~ 77 (1103)
|+++||+|||+||++++||. .++||..+ .||| .|+||+|+..+ ||+.+++.+..+.
T Consensus 3 c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~----------------- 63 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP----------------- 63 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCS-----------------
T ss_pred CCHHHHHHHHHHHHHCCCCC-cCCCCCCC-CCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCC-----------------
Confidence 99999999999999999985 69999865 4899 59999998653 8999999875321
Q ss_pred ccccccccceeccCCCccccccCcccCCCCCCCEEEccC-CCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCC
Q 043720 78 FYGFGMRRRTCLHGRGKLVGKLSPLVGGLSELRVLSLPF-NGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRN 156 (1103)
Q Consensus 78 ~~~~~~~~~~~~~~~~~~~g~~~~~l~~l~~L~~L~L~~-n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~ 156 (1103)
..+.+|+++++|++|++|+|++ |+++|.+|++|+++++|++|+|++|++.+..|..+..+.+
T Consensus 64 -----------------g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~ 126 (313)
T d1ogqa_ 64 -----------------KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKT 126 (313)
T ss_dssp -----------------SCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTT
T ss_pred -----------------CCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhh
Confidence 1236889999999999999986 8999999999999999999999999999988999999999
Q ss_pred CCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCC-cEeecccccCCCCCChhHHhhcCcCcEEEC
Q 043720 157 LRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKL-RVLFLSYNELNGSIPSELGKYCRYLEHLDL 235 (1103)
Q Consensus 157 L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L-~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L 235 (1103)
|+++++++|++.+.+|..+.+++.|+++++++|.+++.+|..++.+.++ +.+++++|+++|..|..+... .+..+++
T Consensus 127 L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l--~~~~l~l 204 (313)
T d1ogqa_ 127 LVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL--NLAFVDL 204 (313)
T ss_dssp CCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGC--CCSEEEC
T ss_pred hcccccccccccccCchhhccCcccceeecccccccccccccccccccccccccccccccccccccccccc--ccccccc
Confidence 9999999999999999999999999999999999999999988888886 889999999998888777653 3568999
Q ss_pred cCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccc
Q 043720 236 SGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLL 315 (1103)
Q Consensus 236 ~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l 315 (1103)
+++.+.+.+|..++.+++|+.+++++|.+++.+| .+..+++|+.|+|++|+++|.+|..|+++++|++|+|++
T Consensus 205 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~------ 277 (313)
T d1ogqa_ 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSF------ 277 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCS------
T ss_pred cccccccccccccccccccccccccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcC------
Confidence 9999998889888999999999999999988654 678888999999999999988888888888888888874
Q ss_pred cCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCcc
Q 043720 316 SGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLN 362 (1103)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~ 362 (1103)
|+++|.+|. ++++++|+.+++++|+
T Consensus 278 ---------------------N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 278 ---------------------NNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp ---------------------SEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred ---------------------CcccccCCC-cccCCCCCHHHhCCCc
Confidence 566666663 4556666666666654
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-42 Score=384.20 Aligned_cols=252 Identities=20% Similarity=0.257 Sum_probs=207.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
.++|++.+.||+|+||+||+|... +++.||||+++.... ....+.+|+++++.++|||||++++++.+.+.+|+|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~--~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT--DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH--HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc--cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 467999999999999999999765 688999999976543 34568899999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCC--CCEEEeecccccccCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDD--FNAYLSDFGLSRLLGTS 976 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~--~~~ki~Dfgla~~~~~~ 976 (1103)
||++|+|.++++... ..+++.++..++.||+.||+|||++ +|+||||||+|||++.+ ..+||+|||+++.....
T Consensus 82 ~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 82 FISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred cCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999997643 3589999999999999999999999 99999999999999854 47999999999876432
Q ss_pred CCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcccccccc
Q 043720 977 ETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNA 1056 (1103)
Q Consensus 977 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1056 (1103)
.......+++.|+|||...+..|+.++||||+||++|||++|+.||..... ......+..... .++.
T Consensus 158 --~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~--------~~~~~~i~~~~~---~~~~ 224 (321)
T d1tkia_ 158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN--------QQIIENIMNAEY---TFDE 224 (321)
T ss_dssp --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH--------HHHHHHHHHTCC---CCCH
T ss_pred --CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCH--------HHHHHHHHhCCC---CCCh
Confidence 223445789999999999999999999999999999999999999974321 122222221110 0111
Q ss_pred cccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1057 ELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1057 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ....+.++.+++.+|++.||++|||++|++++
T Consensus 225 ~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 EA----FKEISIEAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp HH----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred hh----ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11 11345678999999999999999999999974
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-42 Score=377.29 Aligned_cols=267 Identities=25% Similarity=0.403 Sum_probs=205.9
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccch-hhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQ-HGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|.. .+|+.||||+++..... ...+.+.+|++++++++|||||++++++.+++..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5799999999999999999976 56899999999765432 235778999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
|+. +++.+++.......+++.++..++.|++.||+|||++ +||||||||+|||++.++.+||+|||.|+......
T Consensus 82 ~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~- 156 (298)
T d1gz8a_ 82 FLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 156 (298)
T ss_dssp CCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred ecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence 995 5666666665556799999999999999999999999 99999999999999999999999999998764332
Q ss_pred ccccCCcccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccccccccc
Q 043720 979 HATTGVAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVKDVFNAE 1057 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1057 (1103)
.......||+.|+|||.+.... ++.++||||+||++|||++|+.||..... ...+.......+...+.....
T Consensus 157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~-------~~~~~~i~~~~~~~~~~~~~~ 229 (298)
T d1gz8a_ 157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE-------IDQLFRIFRTLGTPDEVVWPG 229 (298)
T ss_dssp BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-------HHHHHHHHHHHCCCCTTTSTT
T ss_pred ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH-------HHHHHHHHHhcCCCchhhccc
Confidence 3344567999999999877655 57899999999999999999999973321 111111111001100000000
Q ss_pred ------ccC------C-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhh
Q 043720 1058 ------LWA------S-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQIQ 1099 (1103)
Q Consensus 1058 ------~~~------~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 1099 (1103)
... . .......++.+++.+|++.||++|||++|++++ ++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 230 VTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVT 290 (298)
T ss_dssp GGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCC
Confidence 000 0 012334678999999999999999999999986 65553
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-42 Score=378.79 Aligned_cols=259 Identities=25% Similarity=0.321 Sum_probs=194.5
Q ss_pred CcceeccCCcccEEEEEEc-CCcEEEEEEcccccchh----hHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 825 TSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQH----GVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 825 ~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
..+.||+|+||+||+|... +|+.||||+++...... ..+.+.+|+.++++++|||||++++++.+.+..|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 3578999999999999764 58999999997654322 134688999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+.++++..+... ...+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...... .
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~ 155 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-R 155 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-C
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc-c
Confidence 988776665543 34589999999999999999999999 99999999999999999999999999998764332 2
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc---cccc
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK---DVFN 1055 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~ 1055 (1103)
.....+||+.|+|||++.. ..|+.++||||+||++|||++|+.||..... ......+.......... ....
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-----~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-----LDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-----HHHHHHHHHhcCCCChhhccchhc
Confidence 3345679999999999865 4579999999999999999999999863221 11111111111000000 0000
Q ss_pred ------ccccCCC-----ChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1056 ------AELWASG-----PHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1056 ------~~~~~~~-----~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
....... ......++.+++.+||+.||++|||++|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000 12345679999999999999999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-42 Score=375.66 Aligned_cols=241 Identities=25% Similarity=0.376 Sum_probs=199.1
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccch-----hhHHHHHHHHHHHhcCC--CCceeEEEeEEecCCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQ-----HGVQQFHAEIKTLGNVR--HPNLVTLIGYRASGNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~ 892 (1103)
++|++.+.||+|+||+||+|... +|+.||||++...... .....+.+|+.++++++ |||||++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999764 6899999998754321 12234678999999986 8999999999999999
Q ss_pred EEEEEeecCC-CChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-CCCEEEeecccc
Q 043720 893 MFLIYNYLPG-GNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-DFNAYLSDFGLS 970 (1103)
Q Consensus 893 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-~~~~ki~Dfgla 970 (1103)
.|+||||+.+ +++.++++... .+++.+++.++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccc
Confidence 9999999976 58888887654 499999999999999999999999 9999999999999985 478999999999
Q ss_pred cccCCCCCccccCCcccccccCccccccCCC-CCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 971 RLLGTSETHATTGVAGTFGYVAPEYALTCRV-SDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 971 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
+..... ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... .......
T Consensus 159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~--------------~~i~~~~- 220 (273)
T d1xwsa_ 159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD--------------EEIIRGQ- 220 (273)
T ss_dssp EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH--------------HHHHHCC-
T ss_pred eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc--------------hHHhhcc-
Confidence 865322 3345679999999999987665 56789999999999999999999631 0111111
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
...+...+.++.+++.+||+.||++|||++|++++
T Consensus 221 ----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 221 ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp ----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 11233456789999999999999999999999874
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.7e-41 Score=370.78 Aligned_cols=264 Identities=23% Similarity=0.324 Sum_probs=202.0
Q ss_pred cCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEee
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYNY 899 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E~ 899 (1103)
++|++.+.||+|+||+||+|+.++|+.||||++..... +...+.+.+|+.++++++|||||++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 57999999999999999999999999999999976543 23357899999999999999999999999999999999999
Q ss_pred cCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCCc
Q 043720 900 LPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSETH 979 (1103)
Q Consensus 900 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~~ 979 (1103)
+.++.+..+.+.. ..+++..+..++.||+.||+|||++ +||||||||+|||++.++.+|++|||.+....... .
T Consensus 82 ~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-R 155 (286)
T ss_dssp CSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred ehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc-c
Confidence 9876666665443 4599999999999999999999999 99999999999999999999999999998765432 2
Q ss_pred cccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh--cCccccc---
Q 043720 980 ATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR--QGQVKDV--- 1053 (1103)
Q Consensus 980 ~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--- 1053 (1103)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||..... ............. .......
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~ 231 (286)
T d1ob3a_ 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWPNVTEL 231 (286)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGS
T ss_pred ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH----HHHHHHHHHhhCCCChhhccchhhh
Confidence 3344568999999999865 4568999999999999999999999974321 0000000000000 0000000
Q ss_pred ---------ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1054 ---------FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1054 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.............+..+.+++.+||+.||++|||++|++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000111223445788999999999999999999999864
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-40 Score=370.79 Aligned_cols=270 Identities=23% Similarity=0.325 Sum_probs=201.7
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-C-CcEEEEEEcccccchh-hHHHHHHHHHHHhcC---CCCceeEEEeEEec----
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-P-GILVAVKKLAVGRFQH-GVQQFHAEIKTLGNV---RHPNLVTLIGYRAS---- 889 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~-~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 889 (1103)
.++|++.+.||+|+||+||+|... + ++.||||+++.....+ ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999763 4 5679999997654322 233456777776655 79999999998853
Q ss_pred -CCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecc
Q 043720 890 -GNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFG 968 (1103)
Q Consensus 890 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfg 968 (1103)
....+++|||+.++++.... ......+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg 161 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFG 161 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred cCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchh
Confidence 35789999999876655443 33445689999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcC
Q 043720 969 LSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQG 1048 (1103)
Q Consensus 969 la~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 1048 (1103)
+++.... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||..... .....-........
T Consensus 162 ~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 162 LARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD-----VDQLGKILDVIGLP 234 (305)
T ss_dssp SCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHHCCC
T ss_pred hhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH-----HHHHHHHHHhhCCC
Confidence 9876432 2344567899999999999999999999999999999999999999974321 11000010100000
Q ss_pred cccc----------cc---cccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhhc
Q 043720 1049 QVKD----------VF---NAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQIQH 1100 (1103)
Q Consensus 1049 ~~~~----------~~---~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~~ 1100 (1103)
.... .. ............++.+.+|+.+||+.||++|||++|++++ ++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 0000 00 0000011223455778999999999999999999999986 666644
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-39 Score=367.80 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=198.7
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC----eEE
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN----EMF 894 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 894 (1103)
..+|++.+.||+|+||+||+|.. .+|+.||||++.........+.+++|+.++++++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 45799999999999999999965 5799999999987665666778999999999999999999999986643 234
Q ss_pred EEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccC
Q 043720 895 LIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLG 974 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~ 974 (1103)
++++|+.+|+|.++++.. .+++..++.++.|++.||+|||++ +||||||||+|||++.++.+||+|||++....
T Consensus 87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 445566699999999764 399999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCC--ccccCCcccccccCccccc-cCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 975 TSET--HATTGVAGTFGYVAPEYAL-TCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 975 ~~~~--~~~~~~~g~~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.... .......||+.|+|||++. ...++.++||||+||++|||++|+.||..... ........... .....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~-----~~~~~~~~~~~-~~~~~ 234 (345)
T d1pmea_ 161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY-----LDQLNHILGIL-GSPSQ 234 (345)
T ss_dssp GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH-CSCCH
T ss_pred CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH-----HHHHHHHhhhc-cCCCh
Confidence 3322 2234567999999999985 45678899999999999999999999974321 00110000000 00000
Q ss_pred cc-------------ccccccCC-----CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DV-------------FNAELWAS-----GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~-------------~~~~~~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ........ .......++.+++.+|++.||++|||++|++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00000000 011234578999999999999999999999976
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-39 Score=359.59 Aligned_cols=263 Identities=21% Similarity=0.269 Sum_probs=194.7
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec--------C
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS--------G 890 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 890 (1103)
++|++.+.||+|+||+||+|.. .+|+.||||++..... +...+.+.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6799999999999999999976 4799999999866543 3345678899999999999999999998755 3
Q ss_pred CeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccc
Q 043720 891 NEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLS 970 (1103)
Q Consensus 891 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla 970 (1103)
+..|+||||++++.+..+... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~ 164 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLA 164 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred ceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeeccee
Confidence 468999999987666554433 24588999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCCCC---ccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh
Q 043720 971 RLLGTSET---HATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR 1046 (1103)
Q Consensus 971 ~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 1046 (1103)
........ .......||+.|+|||++.+. .++.++||||+||++|||++|+.||..... .....-.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-----~~~~~~i~~~~- 238 (318)
T d3blha1 165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-----QHQLALISQLC- 238 (318)
T ss_dssp EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH-
T ss_pred eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-----HHHHHHHHHhc-
Confidence 87653322 223345799999999998754 689999999999999999999999973211 11111111111
Q ss_pred cCccccc------------ccccccCCCC-------hhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1047 QGQVKDV------------FNAELWASGP-------HDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1047 ~~~~~~~------------~~~~~~~~~~-------~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.....+. .......... ......+.+++.+||+.||++|||++|++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence 0000000 0000000000 0113456789999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=364.76 Aligned_cols=264 Identities=22% Similarity=0.348 Sum_probs=198.0
Q ss_pred hcCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCC------
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGN------ 891 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 891 (1103)
.++|++.+.||+|+||+||+|... +|+.||||+++.... +...+.+.+|+.++++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 357999999999999999999764 699999999976433 344677899999999999999999999997654
Q ss_pred eEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 892 EMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 892 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+|+||||+ +.+|..+.+.. .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+|++|||+|+
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~ 169 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 169 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccccee
Confidence 579999999 66888877653 399999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHH------
Q 043720 972 LLGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASML------ 1044 (1103)
Q Consensus 972 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------ 1044 (1103)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||...... ..........
T Consensus 170 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL----DQLKEIMKVTGTPPAE 241 (346)
T ss_dssp ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHHHCCCCHH
T ss_pred ccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChH----HHHHHHHhccCCCcHH
Confidence 6543 2345678999999999876 45688999999999999999999999743210 0000000000
Q ss_pred -HhcC----------cccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhhh
Q 043720 1045 -LRQG----------QVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQIQ 1099 (1103)
Q Consensus 1045 -~~~~----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i~ 1099 (1103)
.... ...+. ...............+.+|+.+||..||++|||++|++++ ++++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPEL-EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCC-CCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHhhhcchhhhhhhccCCcc-cccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 0000 00000 0000011123445678999999999999999999999986 55543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-39 Score=361.61 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=206.8
Q ss_pred cCCCCcceeccCCcccEEEEEEc----CCcEEEEEEcccccc---hhhHHHHHHHHHHHhcCCC-CceeEEEeEEecCCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS----PGILVAVKKLAVGRF---QHGVQQFHAEIKTLGNVRH-PNLVTLIGYRASGNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 892 (1103)
++|++.+.||+|+||+||+|... +|+.||||+++.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999652 478999999875432 2235668899999999966 899999999999999
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.++||||+.+|+|.++++.... +.+..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred eeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhh
Confidence 9999999999999999987654 77889999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCccccCCcccccccCccccccC--CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCcc
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTC--RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQV 1050 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1050 (1103)
+............|++.|+|||.+.+. .++.++||||+||++|||++|+.||....... ............
T Consensus 179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~----~~~~i~~~~~~~--- 251 (322)
T d1vzoa_ 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN----SQAEISRRILKS--- 251 (322)
T ss_dssp CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC----CHHHHHHHHHHC---
T ss_pred hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHHhcccC---
Confidence 755555555567899999999998654 46789999999999999999999997443211 111111111111
Q ss_pred cccccccccCCCChhHHHHHHHHHHHccccCCCCCCC-----HHHHHHH
Q 043720 1051 KDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPT-----MKQVVQC 1094 (1103)
Q Consensus 1051 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~evl~~ 1094 (1103)
....+...+.++.+++.+||++||++||| ++|++++
T Consensus 252 --------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 --------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp --------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 11234566788999999999999999995 7888863
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-39 Score=356.15 Aligned_cols=259 Identities=22% Similarity=0.286 Sum_probs=200.0
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCc-eeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN-LVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|.. .+|+.||||++...... +.+.+|+++++.++|++ |+.+.++..+++..++|||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 5799999999999999999976 46899999988765432 45778999999998666 5555666788889999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC---CCCEEEeecccccccCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD---DFNAYLSDFGLSRLLGT 975 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~---~~~~ki~Dfgla~~~~~ 975 (1103)
|+ ++++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+||+++. +..+|++|||+|+....
T Consensus 84 ~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred Ec-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 99 567777665433 4599999999999999999999999 9999999999999864 45799999999988754
Q ss_pred CCCc------cccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCc
Q 043720 976 SETH------ATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQ 1049 (1103)
Q Consensus 976 ~~~~------~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1049 (1103)
.... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......... .....+........
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~-~~~~~~~~~~~~~~- 236 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR-QKYERISEKKMSTP- 236 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHHSC-
T ss_pred cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH-HHHHHhhcccCCCC-
Confidence 3321 234567999999999999999999999999999999999999999754322111 11111111100000
Q ss_pred ccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhh
Q 043720 1050 VKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQI 1098 (1103)
Q Consensus 1050 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i 1098 (1103)
.+. ....++.++.+++.+||+.+|++||+++++.+.|+++
T Consensus 237 -----~~~----~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~ 276 (299)
T d1ckia_ 237 -----IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276 (299)
T ss_dssp -----HHH----HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHH
T ss_pred -----hhH----hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 000 1234567899999999999999999999999888875
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-39 Score=353.12 Aligned_cols=261 Identities=21% Similarity=0.295 Sum_probs=206.5
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|+. .+++.||||+++.... +...+.+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999976 4688999999976543 3356789999999999999999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccccCCCCC
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRLLGTSET 978 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~~~~~~~ 978 (1103)
++.++++..+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.++.......
T Consensus 82 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR 156 (292)
T ss_dssp CCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred ecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence 999988888876543 488999999999999999999999 999999999999999999999999999987654332
Q ss_pred ccccCCcccccccCccccccCC-CCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHh-cCc-----cc
Q 043720 979 HATTGVAGTFGYVAPEYALTCR-VSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLR-QGQ-----VK 1051 (1103)
Q Consensus 979 ~~~~~~~g~~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~-----~~ 1051 (1103)
......+++.|+|||++.... ++.++||||+||++|||++|+.||..... ..+....... ... ..
T Consensus 157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND-------VDDQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSS-------HHHHHHHHHHHHCCCCTTTCT
T ss_pred -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCC-------HHHHHHHHHhhcCCCChhhhh
Confidence 333456788999999987655 68999999999999999999999753221 1111111111 000 00
Q ss_pred cc------------ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DV------------FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
.. ................+.+++.+|++.||++|||++|++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00 00001111223445678999999999999999999999874
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-39 Score=362.73 Aligned_cols=263 Identities=23% Similarity=0.301 Sum_probs=195.3
Q ss_pred CCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCceeEEEeEEecC------CeEE
Q 043720 822 DFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG------NEMF 894 (1103)
Q Consensus 822 ~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 894 (1103)
+|+..++||+|+||+||+|+.. +|+.||||++...... +.+|++++++++||||+++++++... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~ 95 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 95 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence 5888999999999999999765 6899999999765322 34799999999999999999988542 3579
Q ss_pred EEEeecCCCChHHHHHh-hcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccc
Q 043720 895 LIYNYLPGGNLENFIKA-RTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRL 972 (1103)
Q Consensus 895 lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~ 972 (1103)
+||||++++.+..+... .....+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 96 lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 96 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999976543333322 2335699999999999999999999999 999999999999999775 899999999987
Q ss_pred cCCCCCccccCCcccccccCcccccc-CCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHH---------
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALT-CRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWAS--------- 1042 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------- 1042 (1103)
..... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...... ........
T Consensus 173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~----~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV----DQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH----HHHHHHHHHHCCCCHHH
T ss_pred ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH----HHHHHHHHHhCCChHHh
Confidence 64332 2334578999999998764 57899999999999999999999999633210 00000000
Q ss_pred --HHH---hcCcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH--HHhh
Q 043720 1043 --MLL---RQGQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC--LKQI 1098 (1103)
Q Consensus 1043 --~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~--L~~i 1098 (1103)
... .....................++++.+++.+||..||++|||++|++++ ++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence 000 0000000000111111223456779999999999999999999999975 5554
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-38 Score=349.52 Aligned_cols=260 Identities=17% Similarity=0.228 Sum_probs=206.3
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccchhhHHHHHHHHHHHhcCCC-CceeEEEeEEecCCeEEEEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRH-PNLVTLIGYRASGNEMFLIYN 898 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lV~E 898 (1103)
++|++.+.||+|+||+||+|... +|+.||||++...... +.+.+|++.++.++| +|++.+++++..+...++|||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57999999999999999999765 6899999988654432 346678888888865 999999999999999999999
Q ss_pred ecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECC-----CCCEEEeeccccccc
Q 043720 899 YLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDD-----DFNAYLSDFGLSRLL 973 (1103)
Q Consensus 899 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~-----~~~~ki~Dfgla~~~ 973 (1103)
|+ +++|.++++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++. ++.+||+|||+|+.+
T Consensus 82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99 789999987643 4589999999999999999999999 9999999999999974 568999999999876
Q ss_pred CCCCC------ccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhc
Q 043720 974 GTSET------HATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQ 1047 (1103)
Q Consensus 974 ~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1047 (1103)
..... .......||+.|||||.+.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~-----~~~~~~~i~~~ 231 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT-----NKQKYERIGEK 231 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCC-----HHHHHHHHHHH
T ss_pred ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchh-----HHHHHHHHHhc
Confidence 43322 12345679999999999999999999999999999999999999997433211 11111111111
Q ss_pred CcccccccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHHHHhhh
Q 043720 1048 GQVKDVFNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQCLKQIQ 1099 (1103)
Q Consensus 1048 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~L~~i~ 1099 (1103)
... ...... ...+++++.+++..|+..+|++||+++.+.+.|+++.
T Consensus 232 ~~~--~~~~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 232 KQS--TPLREL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp HHH--SCHHHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred cCC--CChHHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 000 000011 2235578999999999999999999999999888763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=6.3e-39 Score=360.23 Aligned_cols=260 Identities=18% Similarity=0.269 Sum_probs=197.7
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEec--CCeEEEE
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRAS--GNEMFLI 896 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lV 896 (1103)
++|++.+.||+|+||+||+|+. .+++.||||+++.. ..+.+.+|++++++++ ||||+++++++.. ....++|
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v 110 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 110 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence 4799999999999999999976 46899999998653 2467889999999995 9999999999874 4569999
Q ss_pred EeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCC-CEEEeecccccccCC
Q 043720 897 YNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDF-NAYLSDFGLSRLLGT 975 (1103)
Q Consensus 897 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~-~~ki~Dfgla~~~~~ 975 (1103)
|||+.+++|.++. +.+++.+++.++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+|+....
T Consensus 111 ~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 111 FEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999998764 2389999999999999999999999 999999999999998655 599999999987643
Q ss_pred CCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH-----HHHHHhcCc
Q 043720 976 SETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW-----ASMLLRQGQ 1049 (1103)
Q Consensus 976 ~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 1049 (1103)
.. ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||................ .........
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence 32 33456789999999998765 47999999999999999999999997443210000000000 000000000
Q ss_pred c--ccc------------ccccccCCCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1050 V--KDV------------FNAELWASGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1050 ~--~~~------------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
. ... ...............++.+|+.+||+.||++|||++|++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000 00001111223456778999999999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-37 Score=351.40 Aligned_cols=260 Identities=22% Similarity=0.280 Sum_probs=190.2
Q ss_pred cCCCCcceeccCCcccEEEEEEc-CCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEec------CCe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEIS-PGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRAS------GNE 892 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 892 (1103)
++|++.+.||+|+||+||+|... +|+.||||++..... +...+.+.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999765 699999999976543 3345678999999999999999999999854 468
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.|+||||+.+ ++.+.+. ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|++|||+++.
T Consensus 97 ~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~ 168 (355)
T d2b1pa1 97 VYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART 168 (355)
T ss_dssp EEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred eEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhc
Confidence 8999999965 4544443 2389999999999999999999999 999999999999999999999999999886
Q ss_pred cCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHH------------
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISW------------ 1040 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~------------ 1040 (1103)
... ........+|+.|+|||++.+..++.++||||+||++|||++|+.||..... .......
T Consensus 169 ~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~----~~~~~~i~~~~~~~~~~~~ 242 (355)
T d2b1pa1 169 AGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY----IDQWNKVIEQLGTPCPEFM 242 (355)
T ss_dssp --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH----HHHHHHHHHHHCCCCHHHH
T ss_pred ccc--ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH----HHHHHHHHHhccCCCHHHH
Confidence 543 2334455789999999999999999999999999999999999999863221 0000000
Q ss_pred ------HHHHHhcCc-cc-----ccccccccCC---CChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1041 ------ASMLLRQGQ-VK-----DVFNAELWAS---GPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1041 ------~~~~~~~~~-~~-----~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
......... .. ..+....... ........+.+++.+|++.||++|||++|++++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000000000 00 0000011010 112346778999999999999999999999865
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-37 Score=353.27 Aligned_cols=259 Identities=22% Similarity=0.312 Sum_probs=195.6
Q ss_pred hcCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccc-hhhHHHHHHHHHHHhcCCCCceeEEEeEEecC-----Ce
Q 043720 820 TGDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRF-QHGVQQFHAEIKTLGNVRHPNLVTLIGYRASG-----NE 892 (1103)
Q Consensus 820 ~~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 892 (1103)
.++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+.+.+|+.++++++|||+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 45799999999999999999975 5699999999976543 33456789999999999999999999998643 34
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
.+++++|+.+|+|.++++.. .+++.++..++.||+.||+|||++ +|+||||||+|||++.++.+|++|||++..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcc
Confidence 46667788899999999654 399999999999999999999999 999999999999999999999999999975
Q ss_pred cCCCCCccccCCcccccccCccccccC-CCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchHHHHHHHHhcCccc
Q 043720 973 LGTSETHATTGVAGTFGYVAPEYALTC-RVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNIISWASMLLRQGQVK 1051 (1103)
Q Consensus 973 ~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1051 (1103)
.. .......|++.|+|||...+. .++.++||||+||++|+|++|+.||..... ........... .....
T Consensus 171 ~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~-----~~~~~~i~~~~-~~~~~ 240 (348)
T d2gfsa1 171 TD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH-----IDQLKLILRLV-GTPGA 240 (348)
T ss_dssp CT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHHH-CCCCH
T ss_pred cC----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHHhc-CCCCh
Confidence 43 334456789999999987665 468899999999999999999999973321 10010000000 00000
Q ss_pred cc------------ccccccC------CCChhHHHHHHHHHHHccccCCCCCCCHHHHHHH
Q 043720 1052 DV------------FNAELWA------SGPHDDLEDMLHLALRCTVETLSTRPTMKQVVQC 1094 (1103)
Q Consensus 1052 ~~------------~~~~~~~------~~~~~~~~~l~~li~~cl~~dP~~RPs~~evl~~ 1094 (1103)
+. ....... .........+.+++.+|++.||++|||++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence 00 0000000 0012345678999999999999999999999974
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=7.9e-34 Score=323.69 Aligned_cols=264 Identities=20% Similarity=0.227 Sum_probs=191.7
Q ss_pred cCCCCcceeccCCcccEEEEEE-cCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-----------CCceeEEEeEEe
Q 043720 821 GDFNTSNCIGSGGFGTTYKAEI-SPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-----------HPNLVTLIGYRA 888 (1103)
Q Consensus 821 ~~~~~~~~lg~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~ 888 (1103)
++|++++.||+|+||+||+|+. .+|+.||||+++.... ..+.+.+|+.+++.++ |+||+++++++.
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~--~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV--YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH--HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc--chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence 3599999999999999999976 4699999999976532 2456778888888775 578999998875
Q ss_pred c--CCeEEEEEeecCCCC-hHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHh-CCCCCcccCCCCCCcEEECCCCC---
Q 043720 889 S--GNEMFLIYNYLPGGN-LENFIKARTSRAVDWKILHKIALDVASALAYLHD-QCAPRVLHRDVKPSNILLDDDFN--- 961 (1103)
Q Consensus 889 ~--~~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~-~~~~~ivH~Dlk~~NIll~~~~~--- 961 (1103)
. ....+++++++..+. ............+++..+..++.||+.|++|||+ . +|+||||||+|||++.++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred eccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence 4 345666666665543 4444444445678999999999999999999998 6 9999999999999986653
Q ss_pred ---EEEeecccccccCCCCCccccCCcccccccCccccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCCCCCCcchH
Q 043720 962 ---AYLSDFGLSRLLGTSETHATTGVAGTFGYVAPEYALTCRVSDKADVYSYGVVLLELISDKKALDPSFSSHGDGFNII 1038 (1103)
Q Consensus 962 ---~ki~Dfgla~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~ 1038 (1103)
++++|||.+..... ......||+.|+|||++....++.++||||+||+++||++|+.||.+......... ..
T Consensus 168 ~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~-~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD-DD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH-HH
T ss_pred cceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccch-hH
Confidence 99999999976532 23456789999999999999999999999999999999999999975433221111 00
Q ss_pred HHHHHHHhcCc-----------cccccc---------c----------cccCCCChhHHHHHHHHHHHccccCCCCCCCH
Q 043720 1039 SWASMLLRQGQ-----------VKDVFN---------A----------ELWASGPHDDLEDMLHLALRCTVETLSTRPTM 1088 (1103)
Q Consensus 1039 ~~~~~~~~~~~-----------~~~~~~---------~----------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1088 (1103)
........-+. ....++ . ............++.+++.+|++.||++|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11100000000 000000 0 01122345677889999999999999999999
Q ss_pred HHHHHH
Q 043720 1089 KQVVQC 1094 (1103)
Q Consensus 1089 ~evl~~ 1094 (1103)
+|++++
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHhcC
Confidence 999875
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=2.7e-30 Score=287.89 Aligned_cols=250 Identities=24% Similarity=0.374 Sum_probs=197.1
Q ss_pred CCCCEEEccCCCCcc--cCCccccCCCCCCEEEeec-CCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCE
Q 043720 107 SELRVLSLPFNGFSG--EFPPEIWSLEKLEVLDVEG-NFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g--~~p~~l~~l~~L~~L~Ls~-n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (1103)
.+++.|+|++|+++| .+|+++++|++|++|||++ |+++|.+|.+|++|++|++|+|++|++.+..|..+.++.+|++
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~ 129 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129 (313)
T ss_dssp CCEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCE
T ss_pred EEEEEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccchhhhcc
Confidence 367889999999988 5889999999999999986 8999999999999999999999999999888888999999999
Q ss_pred EEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCcc
Q 043720 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM 263 (1103)
Q Consensus 184 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 263 (1103)
+++++|.+.+.+|..++++++|+++++++|.++|.+|..++.....++.+++++|++++..|..++.+..+ .++++.|.
T Consensus 130 l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~ 208 (313)
T d1ogqa_ 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNM 208 (313)
T ss_dssp EECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSE
T ss_pred cccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccccccccccccccc-cccccccc
Confidence 99999999999999999999999999999999999998888775656889999999998888888877544 68888888
Q ss_pred CCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccC
Q 043720 264 LNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSI 343 (1103)
Q Consensus 264 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~i 343 (1103)
+.+.+|..+..+++|+.+++++|.+.+.+| .++.+++|+.|+|++ |++.|.+
T Consensus 209 ~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~---------------------------N~l~g~i 260 (313)
T d1ogqa_ 209 LEGDASVLFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRN---------------------------NRIYGTL 260 (313)
T ss_dssp EEECCGGGCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCS---------------------------SCCEECC
T ss_pred cccccccccccccccccccccccccccccc-ccccccccccccCcc---------------------------CeecccC
Confidence 888888888888888888888888887654 566667777777663 4455555
Q ss_pred chhhhccccccccccCCccccccCCccccccccCcEEEcCCcc
Q 043720 344 PMEITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNV 386 (1103)
Q Consensus 344 p~~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~ 386 (1103)
|.+++++++|+.|+|++|+++|.+|. ++++++|+.+++++|+
T Consensus 261 P~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 261 PQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNK 302 (313)
T ss_dssp CGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGGGTCSSS
T ss_pred ChHHhCCCCCCEEECcCCcccccCCC-cccCCCCCHHHhCCCc
Confidence 55555555555555555554444442 3444444444444443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.95 E-value=2.4e-26 Score=263.51 Aligned_cols=104 Identities=25% Similarity=0.328 Sum_probs=49.9
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEE
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
.+.+|++|++++++|+. + +.+..+++|++|||++|+|++ +| .++++++|++|++++|++++ ++ .++++++|+.|
T Consensus 42 ~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~~-i~-~l~~l~~L~~L 115 (384)
T d2omza2 42 DLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGL 115 (384)
T ss_dssp HHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCCC-CG-GGTTCTTCCEE
T ss_pred HhCCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCC-Cc-cccCCccccccccccccccc-cc-ccccccccccc
Confidence 34455555555555542 2 234555555555555555553 22 15555555555555555552 22 24455555555
Q ss_pred EccCCcCCCCCChhcccCCCCcEeecccccCC
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELN 216 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 216 (1103)
++++|.+++..+ ......+..+....|.+.
T Consensus 116 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~ 145 (384)
T d2omza2 116 TLFNNQITDIDP--LKNLTNLNRLELSSNTIS 145 (384)
T ss_dssp ECCSSCCCCCGG--GTTCTTCSEEEEEEEEEC
T ss_pred cccccccccccc--cccccccccccccccccc
Confidence 555555543322 222334444444444443
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=5.5e-26 Score=260.52 Aligned_cols=118 Identities=22% Similarity=0.305 Sum_probs=79.9
Q ss_pred EccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCC
Q 043720 113 SLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192 (1103)
Q Consensus 113 ~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~ 192 (1103)
.+..+.+++.+. ...+.+|++|++++|.++ .+ +.+..+++|++|+|++|+|++ +| .++++++|++|++++|+++
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~-~l-~gl~~L~nL~~L~Ls~N~l~~-l~-~l~~L~~L~~L~L~~n~i~ 101 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSNNQLTD-IT-PLKNLTKLVDILMNNNQIA 101 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCC-CC-TTGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCC-Cc-cccccCCCCCEEeCcCCcCCC-Cc-cccCCcccccccccccccc
Confidence 455666766554 346778888888888887 34 457788888888888888884 44 3778888888888888887
Q ss_pred CCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccc
Q 043720 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLV 241 (1103)
Q Consensus 193 ~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~ 241 (1103)
+..+ ++.+++|+.|++++|.+++ ++... ....+..+....|.+.
T Consensus 102 ~i~~--l~~l~~L~~L~~~~~~~~~-~~~~~--~~~~~~~~~~~~~~l~ 145 (384)
T d2omza2 102 DITP--LANLTNLTGLTLFNNQITD-IDPLK--NLTNLNRLELSSNTIS 145 (384)
T ss_dssp CCGG--GTTCTTCCEEECCSSCCCC-CGGGT--TCTTCSEEEEEEEEEC
T ss_pred cccc--ccccccccccccccccccc-ccccc--cccccccccccccccc
Confidence 5432 6777778888777777763 33221 1234555555555554
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=3e-23 Score=229.41 Aligned_cols=267 Identities=22% Similarity=0.244 Sum_probs=178.7
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
.++.++-++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|.++...|..|.++++|++|+++
T Consensus 11 ~~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~ 87 (305)
T d1xkua_ 11 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLS 87 (305)
T ss_dssp ETTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred cCCEEEecCCCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEeccc
Confidence 4566777777777 7777664 578888888888884444568888888888888888886667778888888888888
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccc--cccCccccCCCCCCEEeCCCccCC
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLV--GRIPSSLGKCQQLRTLLLFSNMLN 265 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~--~~~p~~l~~l~~L~~L~L~~N~l~ 265 (1103)
+|+++. +|..+ ...++.|++++|.+. .++...+.....+..++...|... ...+..+..+++|+.+++++|.++
T Consensus 88 ~n~l~~-l~~~~--~~~l~~L~~~~n~l~-~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~ 163 (305)
T d1xkua_ 88 KNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 163 (305)
T ss_dssp SSCCSB-CCSSC--CTTCCEEECCSSCCC-BBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred CCccCc-Cccch--hhhhhhhhccccchh-hhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence 888874 44433 357788888888887 566666555566777887777543 344556777778888888888776
Q ss_pred ccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCch
Q 043720 266 DVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPM 345 (1103)
Q Consensus 266 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~ 345 (1103)
. +|..+ +++|+.|++++|.+++..+..+.+++.++.|++++ |.+.+..+.
T Consensus 164 ~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~---------------------------n~l~~~~~~ 213 (305)
T d1xkua_ 164 T-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSF---------------------------NSISAVDNG 213 (305)
T ss_dssp S-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCS---------------------------SCCCEECTT
T ss_pred c-cCccc--CCccCEEECCCCcCCCCChhHhhcccccccccccc---------------------------ccccccccc
Confidence 5 34332 56778888888887777777777777777777764 333344444
Q ss_pred hhhccccccccccCCccccccCCccccccccCcEEEcCCcccccccchhh------hccCCceEeecCCcccc
Q 043720 346 EITTLSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVF------DRCKKLHFIDLSSNELS 412 (1103)
Q Consensus 346 ~~~~L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~------~~l~~L~~LdLs~N~l~ 412 (1103)
.+..+++|+.|+|++|.++ .+|.+|.++++|++|+|++|+|+.+....| ..+.+|+.|+|++|+++
T Consensus 214 ~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 214 SLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cccccccceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 5555566666666666555 335566666666666666666665443333 23444555555555543
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=3.5e-23 Score=228.83 Aligned_cols=271 Identities=20% Similarity=0.213 Sum_probs=222.9
Q ss_pred cCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCC
Q 043720 99 LSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNF 178 (1103)
Q Consensus 99 ~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l 178 (1103)
+|+.+. +.+++|+|++|+|+...+.+|.++++|++|++++|.+....|..|..+++|++|++++|+++ .+|..+.
T Consensus 25 lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~-~l~~~~~-- 99 (305)
T d1xkua_ 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMP-- 99 (305)
T ss_dssp CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCS-BCCSSCC--
T ss_pred cCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccccchhhhhCCCccCEecccCCccC-cCccchh--
Confidence 454442 67999999999999544557999999999999999999777889999999999999999999 6776543
Q ss_pred CCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCC-CChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEE
Q 043720 179 ESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGS-IPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTL 257 (1103)
Q Consensus 179 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~-ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 257 (1103)
..|+.|++++|.+.+..+..+.....++.++...|..... .....+..+++|+.+++++|.++ .+|..+ +++|+.|
T Consensus 100 ~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~-~l~~~~--~~~L~~L 176 (305)
T d1xkua_ 100 KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTEL 176 (305)
T ss_dssp TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC-SCCSSC--CTTCSEE
T ss_pred hhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc-ccCccc--CCccCEE
Confidence 5899999999999987777788888999999988865421 22233444678999999999998 456543 6799999
Q ss_pred eCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCC
Q 043720 258 LLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKN 337 (1103)
Q Consensus 258 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n 337 (1103)
++++|..++..+..|..++.++.|++++|.+++..+..+.++++|++|+|++ |
T Consensus 177 ~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~---------------------------N 229 (305)
T d1xkua_ 177 HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNN---------------------------N 229 (305)
T ss_dssp ECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCS---------------------------S
T ss_pred ECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccc---------------------------c
Confidence 9999999999999999999999999999999998899999999999999985 3
Q ss_pred cccccCchhhhccccccccccCCccccccCCcc------ccccccCcEEEcCCcccc--cccchhhhccCCceEee
Q 043720 338 SFIGSIPMEITTLSKLRIIWAPRLNLEGKLPSS------WGACESLEMLNLAQNVLR--GDLIGVFDRCKKLHFID 405 (1103)
Q Consensus 338 ~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~~------~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~Ld 405 (1103)
.+ ..+|.++..+++|+.|++++|+|+...... +..+.+|+.|+|++|.++ ...|.+|.-+.....++
T Consensus 230 ~L-~~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~~~~~~~f~~~~~~~~~~ 304 (305)
T d1xkua_ 230 KL-VKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304 (305)
T ss_dssp CC-SSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEE
T ss_pred cc-cccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccCcCCHhHhcccccCcccc
Confidence 33 357888999999999999999998754433 456789999999999986 46677777665544443
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.4e-24 Score=232.91 Aligned_cols=143 Identities=31% Similarity=0.360 Sum_probs=116.5
Q ss_pred CCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEec
Q 043720 567 KSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLEL 646 (1103)
Q Consensus 567 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 646 (1103)
++|++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.++++|++++|.+++..+..+..+++|+.|++
T Consensus 77 ~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 77 PVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSL 155 (266)
T ss_dssp TTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEEC
T ss_pred cccccccccccccc-ccccccccccccccccccccccceeeccccccccccccccccccccceeccccccccccchhccc
Confidence 56788888888887 44667888888888888888888777777888888888888888888777777888888999999
Q ss_pred cCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCccccccccccCCCCCCCCCC
Q 043720 647 SSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQM 726 (1103)
Q Consensus 647 s~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~l~~Np~~c~C~~ 726 (1103)
++|+|++..+..|..+++|++|+|++|+|+ .+|+.+..+++|+.| .|.||||.|||++
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L---------------------~L~~Np~~CdC~~ 213 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA---------------------FLHGNPWLCNCEI 213 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEE---------------------ECCSCCBCCSGGG
T ss_pred ccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEE---------------------EecCCCCCCCcch
Confidence 999998777778888889999999999988 777777777777766 4668899999998
Q ss_pred CCCCCC
Q 043720 727 YKDISS 732 (1103)
Q Consensus 727 ~~~~~~ 732 (1103)
..+..|
T Consensus 214 ~~l~~w 219 (266)
T d1p9ag_ 214 LYFRRW 219 (266)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 654433
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=6.1e-24 Score=232.34 Aligned_cols=251 Identities=22% Similarity=0.243 Sum_probs=141.6
Q ss_pred EEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc-CC
Q 043720 111 VLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA-GN 189 (1103)
Q Consensus 111 ~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~-~n 189 (1103)
.++.++++++ .+|..+. +.+++|+|++|+|+...+..|.++++|++|++++|++.+..+..+.+++.++.++.. .|
T Consensus 15 ~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~ 91 (284)
T d1ozna_ 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91 (284)
T ss_dssp EEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCT
T ss_pred EEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhcccccccccccccccccccccccccccccccccccccc
Confidence 3455666666 5665543 456666666666664334456666666666666666665555555566666665543 44
Q ss_pred cCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccc
Q 043720 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269 (1103)
Q Consensus 190 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 269 (1103)
.++...+..|+++++|++|++++|.+. .++...+....+|+.+++++|++++..+..+..+++|+.|++++|++++..+
T Consensus 92 ~~~~l~~~~~~~l~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 92 QLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TCCCCCTTTTTTCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred ccccccchhhcccccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccch
Confidence 455444555555666666666655554 3333333333444444554444443333334444444444444444444333
Q ss_pred ccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhc
Q 043720 270 RELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITT 349 (1103)
Q Consensus 270 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~ 349 (1103)
.+|.++++|+.+++++|+
T Consensus 171 ~~f~~l~~L~~l~l~~N~-------------------------------------------------------------- 188 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNR-------------------------------------------------------------- 188 (284)
T ss_dssp TTTTTCTTCCEEECCSSC--------------------------------------------------------------
T ss_pred hhhccccccchhhhhhcc--------------------------------------------------------------
Confidence 444444444444444444
Q ss_pred cccccccccCCccccccCCccccccccCcEEEcCCcccccccchhhhccCCceEeecCCccccccccccccccceeEEEe
Q 043720 350 LSKLRIIWAPRLNLEGKLPSSWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSSNELSGELDVKLQVPCMALFDV 429 (1103)
Q Consensus 350 L~~L~~L~l~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~N~l~~~~~~~~~~~~L~~l~l 429 (1103)
+.+..|..|.++++|++|++++|++.+..+..|..+++|++|+|++|++.+..+..+-...++.+..
T Consensus 189 -------------l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~~l~~~l~~~~~ 255 (284)
T d1ozna_ 189 -------------VAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRG 255 (284)
T ss_dssp -------------CCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGHHHHHHHHHCCS
T ss_pred -------------ccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCCccchHHHHHHHhCcC
Confidence 4444455566667777777777888877777888888888888888888776554444444555555
Q ss_pred cCCccccccCC
Q 043720 430 SGNHMSGSIPR 440 (1103)
Q Consensus 430 s~N~l~g~ip~ 440 (1103)
..+++..+.|.
T Consensus 256 ~~~~~~C~~p~ 266 (284)
T d1ozna_ 256 SSSEVPCSLPQ 266 (284)
T ss_dssp EECCCBEEESG
T ss_pred CCCceEeCCch
Confidence 56666655443
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.89 E-value=3e-23 Score=226.72 Aligned_cols=210 Identities=23% Similarity=0.263 Sum_probs=189.7
Q ss_pred ccCcccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEcc-ccccCCCCCCCCC
Q 043720 98 KLSPLVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLA-FNRIDGDIPFSLR 176 (1103)
Q Consensus 98 ~~~~~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls-~N~l~~~~p~~l~ 176 (1103)
.+|..+. +.+++|+|++|+|++.-+..|.++++|++||+++|.+.+..+..+..+..+++++.+ .|.++...|..+.
T Consensus 25 ~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 102 (284)
T d1ozna_ 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFH 102 (284)
T ss_dssp SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTT
T ss_pred ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhc
Confidence 6666553 678999999999996666779999999999999999998888888999999999875 5677766688899
Q ss_pred CCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCE
Q 043720 177 NFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRT 256 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 256 (1103)
++++|++|++++|.+....+..+...++|+.+++++|+++ .+|+..+...++|++|++++|++++..+..+.++++|+.
T Consensus 103 ~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~ 181 (284)
T d1ozna_ 103 GLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181 (284)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred ccccCCEEecCCcccccccccccchhcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhhhccccccch
Confidence 9999999999999999888888999999999999999999 777776666788999999999999888889999999999
Q ss_pred EeCCCccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccC
Q 043720 257 LLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 257 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
+++++|++++..|..|..+++|++|++++|++.+..+..|+++++|+.|++++|
T Consensus 182 l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N 235 (284)
T d1ozna_ 182 LLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235 (284)
T ss_dssp EECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSS
T ss_pred hhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCC
Confidence 999999999999999999999999999999999988889999999999999863
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.86 E-value=1.8e-21 Score=210.06 Aligned_cols=198 Identities=23% Similarity=0.261 Sum_probs=156.9
Q ss_pred CCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEE
Q 043720 105 GLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 105 ~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 184 (1103)
+...+..++.++++++ .+|+.+. ++|++|||++|+|++..+..|.++++|++|+|++|+|+ .+| .++.+++|++|
T Consensus 8 ~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L 82 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTL 82 (266)
T ss_dssp CSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEE
T ss_pred ccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-ccc-ccccccccccc
Confidence 4455666788888888 6787664 57888888888888655567888888888888888887 455 35678888888
Q ss_pred EccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccC
Q 043720 185 NLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNML 264 (1103)
Q Consensus 185 ~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l 264 (1103)
+|++|++++ .+..+..+++|++|++++|.+. .++...+..+.++++|++++|.++...+..+..+++|+.|++++|++
T Consensus 83 ~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~-~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l 160 (266)
T d1p9ag_ 83 DLSHNQLQS-LPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNL 160 (266)
T ss_dssp ECCSSCCSS-CCCCTTTCTTCCEEECCSSCCC-CCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCC
T ss_pred ccccccccc-cccccccccccccccccccccc-eeeccccccccccccccccccccceeccccccccccchhcccccccc
Confidence 888888884 4666788888888888888887 56655556667888888888888866667777888888888888888
Q ss_pred CccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecccC
Q 043720 265 NDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSNL 310 (1103)
Q Consensus 265 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~~ 310 (1103)
++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|
T Consensus 161 ~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~N 205 (266)
T d1p9ag_ 161 TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205 (266)
T ss_dssp SCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSC
T ss_pred cccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCC
Confidence 8877778888888888888888888 67888888888888888864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=4.8e-21 Score=195.37 Aligned_cols=165 Identities=13% Similarity=0.156 Sum_probs=122.3
Q ss_pred CCcceeccCCcccEEEEEEcCCcEEEEEEcccccc-----------------hhhHHHHHHHHHHHhcCCCCceeEEEeE
Q 043720 824 NTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRF-----------------QHGVQQFHAEIKTLGNVRHPNLVTLIGY 886 (1103)
Q Consensus 824 ~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 886 (1103)
.+.++||+|+||+||+|...+|+.||||+++.... ......+.+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45788999999999999888899999998753211 1112345678999999999999988876
Q ss_pred EecCCeEEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCCCCCcccCCCCCCcEEECCCCCEEEee
Q 043720 887 RASGNEMFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQCAPRVLHRDVKPSNILLDDDFNAYLSD 966 (1103)
Q Consensus 887 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~~~~ivH~Dlk~~NIll~~~~~~ki~D 966 (1103)
.. .+++|||+++..+.+ ++.....+++.|++++++|||++ +|+||||||+|||++++ .++++|
T Consensus 83 ~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp ET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECC
T ss_pred cC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEEEEE
Confidence 43 279999998755433 44455678999999999999999 99999999999999965 589999
Q ss_pred cccccccCCCCCccccCCcccccccCcc-----ccccCCCCCcchhHHHHHHH
Q 043720 967 FGLSRLLGTSETHATTGVAGTFGYVAPE-----YALTCRVSDKADVYSYGVVL 1014 (1103)
Q Consensus 967 fgla~~~~~~~~~~~~~~~g~~~y~aPE-----~~~~~~~~~~sDvwslGvil 1014 (1103)
||.|+....+... .|.... .+....|..++|+||..--+
T Consensus 146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred CCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 9999765432211 111110 01235678899999976543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=2.6e-18 Score=193.12 Aligned_cols=95 Identities=26% Similarity=0.297 Sum_probs=58.6
Q ss_pred CCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEcc
Q 043720 108 ELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLA 187 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~ 187 (1103)
+|++|+|++++++ .+|+. +++|++|+|++|+|+ .+|+.+ .+|+.|++++|+++ .++.- .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---cccccccccc
Confidence 5677777777776 56643 356777777777777 566543 46677777777766 33321 1346666666
Q ss_pred CCcCCCCCChhcccCCCCcEeecccccCC
Q 043720 188 GNQVKGVIPGFLGSFLKLRVLFLSYNELN 216 (1103)
Q Consensus 188 ~n~l~~~~p~~l~~l~~L~~L~L~~N~l~ 216 (1103)
+|.++ .+|. ++.+++|++|++++|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~ 133 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLK 133 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCS
T ss_pred ccccc-cccc-hhhhccceeecccccccc
Confidence 66666 3343 455666666666666655
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.80 E-value=1.1e-17 Score=188.07 Aligned_cols=138 Identities=26% Similarity=0.298 Sum_probs=80.6
Q ss_pred CCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeec
Q 043720 131 EKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFL 210 (1103)
Q Consensus 131 ~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 210 (1103)
.++++|||++|.++ .+|+. .++|++|+|++|+|+ .+|..+ .+|++|++++|+++ .++.. .+.|++|++
T Consensus 38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L 105 (353)
T d1jl5a_ 38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGV 105 (353)
T ss_dssp HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEEC
T ss_pred cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhh---ccccccccc
Confidence 36778888888887 67753 467888888888888 677654 46777888887776 23321 134666666
Q ss_pred ccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccccCCCCCCEEEccCCcCC
Q 043720 211 SYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPRELGWLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 211 ~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 289 (1103)
++|.++ .+|. .+ .+++|++|++++|.++.. +.. ...+..+.+..+.... +..+..++.++.|++++|.+.
T Consensus 106 ~~n~l~-~lp~-~~-~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 106 SNNQLE-KLPE-LQ-NSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CSSCCS-SCCC-CT-TCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCS
T ss_pred cccccc-cccc-hh-hhccceeecccccccccc-ccc---cccccchhhccccccc--cccccccccceeccccccccc
Confidence 666665 5553 22 235566666666665522 221 2344455554444432 233445555555555555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.78 E-value=1.5e-19 Score=184.24 Aligned_cols=176 Identities=20% Similarity=0.197 Sum_probs=151.9
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCCcCCC-CCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISG-IVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
..+++++++++ .||.++. +++++|+|++|+|++ +.+..|.++++|+.|+|++|++.+..+..|..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcC-ccCCCCC---CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeec
Confidence 46899999998 8999876 689999999999986 456778999999999999999998889999999999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCCCC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPF 703 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~ 703 (1103)
+|+|++..|..|.++++|++|+|++|+|+++.+++|..+++|++|+|++|++....+.. .-...++.+.+..|.++...
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~-~~~~~l~~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA-WFAEWLRKKSLNGGAARCGA 165 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGH-HHHHHHHHHCCSGGGCBBCS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccchH-HHhhhhhhhcccCCCeEeCC
Confidence 99999888899999999999999999999888889999999999999999997433211 11233566677888888777
Q ss_pred CCCccccccccccCCCCCCCCC
Q 043720 704 PWNVTTMNCSGVIGNPFLDPCQ 725 (1103)
Q Consensus 704 p~~~~~~~~~~l~~Np~~c~C~ 725 (1103)
|..+..+...++..|.+.|+++
T Consensus 166 p~~l~~~~l~~L~~n~l~C~~~ 187 (192)
T d1w8aa_ 166 PSKVRDVQIKDLPHSEFKCSSE 187 (192)
T ss_dssp STTTTTSBGGGSCTTTCCCCCC
T ss_pred ChhhcCCEeeecCHhhCcCCCC
Confidence 8777777777899999999876
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.73 E-value=1.3e-20 Score=220.54 Aligned_cols=85 Identities=26% Similarity=0.207 Sum_probs=47.9
Q ss_pred CCCEEEeecCCCCCC-ccccccCCCCCCEEEccccccCC----CCCCCCCCCCCCCEEEccCCcCCCCC----Chhcc-c
Q 043720 132 KLEVLDVEGNFLSGR-LPNEFVGLRNLRVLNLAFNRIDG----DIPFSLRNFESLEVLNLAGNQVKGVI----PGFLG-S 201 (1103)
Q Consensus 132 ~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~----~~p~~l~~l~~L~~L~L~~n~l~~~~----p~~l~-~ 201 (1103)
+|++||+++|++++. +.+.+..+++|++|+|++|.++. .++..+..+++|++|||++|.++... ...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 467777777777743 23345556777777777777662 23344556666777777776664211 11111 1
Q ss_pred CCCCcEeecccccCC
Q 043720 202 FLKLRVLFLSYNELN 216 (1103)
Q Consensus 202 l~~L~~L~L~~N~l~ 216 (1103)
..+|++|+|++|+++
T Consensus 83 ~~~L~~L~L~~n~it 97 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLT 97 (460)
T ss_dssp TCCCCEEECTTSCCB
T ss_pred CCCCCEEECCCCCcc
Confidence 234555555555554
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=3.3e-17 Score=171.70 Aligned_cols=191 Identities=23% Similarity=0.349 Sum_probs=161.6
Q ss_pred ccCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCC
Q 043720 102 LVGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESL 181 (1103)
Q Consensus 102 ~l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L 181 (1103)
.++.|.+|+.|++.+|+|+ .++ .+.++++|++|+|++|.+++..| +..+++|+++++++|.++ .++ .+.++++|
T Consensus 36 ~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~-~i~-~l~~l~~L 109 (227)
T d1h6ua2 36 TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK-NVS-AIAGLQSI 109 (227)
T ss_dssp CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS-CCG-GGTTCTTC
T ss_pred CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--cccccccccccccccccc-ccc-cccccccc
Confidence 3567889999999999998 454 69999999999999999996544 899999999999999998 454 58899999
Q ss_pred CEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCC
Q 043720 182 EVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFS 261 (1103)
Q Consensus 182 ~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~ 261 (1103)
+.++++++...+.. .+...+.++.+.++.+.+....+ +. .+++|++|++++|.+++. ..++++++|+.|+|++
T Consensus 110 ~~l~l~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~--~~-~~~~L~~L~l~~n~~~~~--~~l~~l~~L~~L~Ls~ 182 (227)
T d1h6ua2 110 KTLDLTSTQITDVT--PLAGLSNLQVLYLDLNQITNISP--LA-GLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADD 182 (227)
T ss_dssp CEEECTTSCCCCCG--GGTTCTTCCEEECCSSCCCCCGG--GG-GCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCS
T ss_pred cccccccccccccc--hhccccchhhhhchhhhhchhhh--hc-cccccccccccccccccc--hhhcccccceecccCC
Confidence 99999999988543 36678899999999999874332 33 357899999999999843 3488999999999999
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEeccc
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLSN 309 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~~ 309 (1103)
|++++. + .++.+++|++|+|++|++++. + .++++++|+.|++++
T Consensus 183 n~l~~l-~-~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 183 NKISDI-S-PLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLTN 226 (227)
T ss_dssp SCCCCC-G-GGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEEE
T ss_pred CccCCC-h-hhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEeeC
Confidence 999984 3 489999999999999999965 3 489999999999973
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=1.3e-19 Score=211.92 Aligned_cols=110 Identities=19% Similarity=0.205 Sum_probs=86.4
Q ss_pred CCCEEEccCCCCcccC-CccccCCCCCCEEEeecCCCCC----CccccccCCCCCCEEEccccccCCC----CCCCCC-C
Q 043720 108 ELRVLSLPFNGFSGEF-PPEIWSLEKLEVLDVEGNFLSG----RLPNEFVGLRNLRVLNLAFNRIDGD----IPFSLR-N 177 (1103)
Q Consensus 108 ~L~~L~L~~n~l~g~~-p~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~-~ 177 (1103)
+|+.||+++|++++.. .+-+..++++++|+|++|+++. .+...+..+++|++|||++|+|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5789999999998643 3345668999999999999982 4566778899999999999998621 233333 2
Q ss_pred CCCCCEEEccCCcCCCC----CChhcccCCCCcEeecccccCCC
Q 043720 178 FESLEVLNLAGNQVKGV----IPGFLGSFLKLRVLFLSYNELNG 217 (1103)
Q Consensus 178 l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~L~~N~l~g 217 (1103)
..+|++|+|++|+++.. ++..+..+++|++|+|++|.++.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~ 126 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 126 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence 35899999999999854 34567788999999999999873
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.69 E-value=7.5e-17 Score=168.95 Aligned_cols=165 Identities=22% Similarity=0.277 Sum_probs=103.2
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 189 (1103)
..++++.+.+++.+ .+..+.+|++|++++|.++ .++ .+..+++|++|+|++|++++..| +..+++|++|++++|
T Consensus 22 ~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l~-~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n 95 (227)
T d1h6ua2 22 IKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGN 95 (227)
T ss_dssp HHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSC
T ss_pred HHHHhCCCCcCCcC--CHHHcCCcCEEECCCCCCC-cch-hHhcCCCCcEeecCCceeecccc--ccccccccccccccc
Confidence 34566667776544 3566778888888888887 453 57788888888888888874333 777788888888888
Q ss_pred cCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCcccc
Q 043720 190 QVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIP 269 (1103)
Q Consensus 190 ~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p 269 (1103)
.++. ++ .+..+++|+.++++++...+ ++. +. ..+.++.+.++++.+... ..+..+++|+.|++++|.+++..
T Consensus 96 ~~~~-i~-~l~~l~~L~~l~l~~~~~~~-~~~-~~-~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~- 167 (227)
T d1h6ua2 96 PLKN-VS-AIAGLQSIKTLDLTSTQITD-VTP-LA-GLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT- 167 (227)
T ss_dssp CCSC-CG-GGTTCTTCCEEECTTSCCCC-CGG-GT-TCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-
T ss_pred cccc-cc-cccccccccccccccccccc-cch-hc-cccchhhhhchhhhhchh--hhhccccccccccccccccccch-
Confidence 7763 33 46677777777777777653 221 11 234566666666665532 23445555666666665555422
Q ss_pred ccccCCCCCCEEEccCCcCC
Q 043720 270 RELGWLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 270 ~~l~~l~~L~~L~Ls~N~l~ 289 (1103)
.++++++|+.|+|++|+++
T Consensus 168 -~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 168 -PLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp -GGTTCTTCCEEECCSSCCC
T ss_pred -hhcccccceecccCCCccC
Confidence 2455555555555555554
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.6e-16 Score=163.92 Aligned_cols=179 Identities=27% Similarity=0.316 Sum_probs=110.8
Q ss_pred EccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCC
Q 043720 113 SLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192 (1103)
Q Consensus 113 ~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~ 192 (1103)
.+..+.+++.++. ..+.+|++|++++|.++. ++ .+..+++|++|+|++|+|++ ++ .++++++|++|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC
T ss_pred HhCcCccCCccCH--HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc
Confidence 3444455444432 234566666666666653 22 25566666666666666663 33 2456666666666666666
Q ss_pred CCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccc
Q 043720 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL 272 (1103)
Q Consensus 193 ~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l 272 (1103)
+ +| .+..+++|+.|++++|.+. .++ .+.. ++.++.+++++|.+++ +..+..+++|+.+++++|++++.. .+
T Consensus 104 ~-l~-~l~~l~~L~~L~l~~~~~~-~~~-~l~~-l~~l~~l~~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 104 D-LS-SLKDLKKLKSLSLEHNGIS-DIN-GLVH-LPQLESLYLGNNKITD--ITVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp C-GG-GGTTCTTCCEEECTTSCCC-CCG-GGGG-CTTCCEEECCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred c-cc-ccccccccccccccccccc-ccc-cccc-cccccccccccccccc--cccccccccccccccccccccccc--cc
Confidence 3 33 3566666777777766665 333 2332 3567777777777663 234566777777777777777632 27
Q ss_pred cCCCCCCEEEccCCcCCCcCCccccCCCCCCeEecc
Q 043720 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVLS 308 (1103)
Q Consensus 273 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l~ 308 (1103)
+++++|+.|+|++|+++. +| .+.++++|+.|+|+
T Consensus 175 ~~l~~L~~L~Ls~N~i~~-l~-~l~~l~~L~~L~Ls 208 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELF 208 (210)
T ss_dssp TTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEE
T ss_pred cCCCCCCEEECCCCCCCC-Ch-hhcCCCCCCEEEcc
Confidence 777788888888887774 34 57778888888775
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.68 E-value=6.7e-17 Score=171.25 Aligned_cols=220 Identities=15% Similarity=0.127 Sum_probs=130.8
Q ss_pred CEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCC-hhcccCCCCcEeeccc
Q 043720 134 EVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIP-GFLGSFLKLRVLFLSY 212 (1103)
Q Consensus 134 ~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p-~~l~~l~~L~~L~L~~ 212 (1103)
++++.+++.++ .+|+.+. +++++|+|++|+|+...+..|.++++|++|++++|.+...++ ..|..++++++|.+..
T Consensus 11 ~~i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~ 87 (242)
T d1xwdc1 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 87 (242)
T ss_dssp SEEEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEEC
T ss_pred CEEEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccc
Confidence 67788887777 6776553 577888888888874334467778888888888887765443 4567777777777653
Q ss_pred -ccCCCCCChhHHhhcCcCcEEECcCCccccccC-ccccCCCCCCEEeCCCccCCccccccccCCC-CCCEEEccCCcCC
Q 043720 213 -NELNGSIPSELGKYCRYLEHLDLSGNSLVGRIP-SSLGKCQQLRTLLLFSNMLNDVIPRELGWLR-KLEVLDVSRNRLN 289 (1103)
Q Consensus 213 -N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~-~L~~L~Ls~N~l~ 289 (1103)
|++. .++...+..+++|++|++++|+++...+ ..+..+..+..+..+++.+....+..|..++ .++.|++++|+++
T Consensus 88 ~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~ 166 (242)
T d1xwdc1 88 ANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ 166 (242)
T ss_dssp CTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred ccccc-ccccccccccccccccccchhhhcccccccccccccccccccccccccccccccccccccccceeeeccccccc
Confidence 4555 3443433445666677776666653211 1223344444555555555554444444443 4555666666555
Q ss_pred CcCCccccCCCCCCeEecccCcCccccCccccCcccccccCCCCCCCCcccccCchhhhccccccccccCCccccccCCc
Q 043720 290 GLIPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDASNGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGKLPS 369 (1103)
Q Consensus 290 ~~~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~~p~ 369 (1103)
.. +....+..++.. .+++.+|+++...+.
T Consensus 167 ~i-~~~~~~~~~l~~--------------------------------------------------~~~l~~n~l~~l~~~ 195 (242)
T d1xwdc1 167 EI-HNCAFNGTQLDE--------------------------------------------------LNLSDNNNLEELPND 195 (242)
T ss_dssp EE-CTTTTTTCCEEE--------------------------------------------------EECTTCTTCCCCCTT
T ss_pred cc-ccccccchhhhc--------------------------------------------------cccccccccccccHH
Confidence 32 221112222211 223344555544445
Q ss_pred cccccccCcEEEcCCcccccccchhhhccCCceEeecCC
Q 043720 370 SWGACESLEMLNLAQNVLRGDLIGVFDRCKKLHFIDLSS 408 (1103)
Q Consensus 370 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~LdLs~ 408 (1103)
.|.++++|++|+|++|+|+..++..|.++++|+.+++++
T Consensus 196 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred HhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcCCC
Confidence 677788888888888888877777777777777777654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.67 E-value=1.8e-16 Score=167.81 Aligned_cols=199 Identities=18% Similarity=0.115 Sum_probs=97.5
Q ss_pred CCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCcc-ccccCCCCCCEEEccc-cccCCCCCCCCCCCCCCCEE
Q 043720 107 SELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLP-NEFVGLRNLRVLNLAF-NRIDGDIPFSLRNFESLEVL 184 (1103)
Q Consensus 107 ~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p-~~l~~l~~L~~L~Ls~-N~l~~~~p~~l~~l~~L~~L 184 (1103)
+++++|+|++|.|+...+..|.++++|++|+|++|.+...+| ..|..++++++|++.. |++....+..+.++++|++|
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccccccccccccccccccccccc
Confidence 355666666666653333345556666666666665554332 2455566666665543 45554445555666666666
Q ss_pred EccCCcCCCCCC-hhcccCCCCcEeecccccCCCCCChhHH-hhcCcCcEEECcCCccccccCccccCCCCCCEE-eCCC
Q 043720 185 NLAGNQVKGVIP-GFLGSFLKLRVLFLSYNELNGSIPSELG-KYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTL-LLFS 261 (1103)
Q Consensus 185 ~L~~n~l~~~~p-~~l~~l~~L~~L~L~~N~l~g~ip~~~~-~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L-~L~~ 261 (1103)
++++|.++...+ ..+..+..+..+..+++++. .++...+ .....++.|++++|+++. ++....+.++++.+ ++++
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~-~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~ 186 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDN 186 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCC-EECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTC
T ss_pred ccchhhhcccccccccccccccccccccccccc-cccccccccccccceeeecccccccc-cccccccchhhhccccccc
Confidence 666665553222 12333444444444454554 3332222 222345556666666553 33333333343333 3455
Q ss_pred ccCCccccccccCCCCCCEEEccCCcCCCcCCccccCCCCCCeEec
Q 043720 262 NMLNDVIPRELGWLRKLEVLDVSRNRLNGLIPTELGNCVELSVLVL 307 (1103)
Q Consensus 262 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~l 307 (1103)
|+++...+..|.++++|++|+|++|+|+...+..|.++++|+.+++
T Consensus 187 n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred cccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCcccccCcC
Confidence 5555543444555566666666666555333333444444444333
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.66 E-value=2.9e-16 Score=159.54 Aligned_cols=154 Identities=22% Similarity=0.219 Sum_probs=132.8
Q ss_pred ccEEecCCCcccccCCchhhhcCCCccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 544 GMVANLSNNNIIGHIPLDIGVMCKSLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 544 ~~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
.+.|+|++|+|++.++...+..+++|++|+|++|++..+.+..|..+++|++|+|++|+|+...|.+|.++++|++|+|+
T Consensus 31 l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~ 110 (192)
T d1w8aa_ 31 TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110 (192)
T ss_dssp CSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECC
T ss_pred CCEEEeCCCCCcccccccccCCCceEeeeeccccccccccccccccccccceeeeccccccccCHHHHhCCCcccccccC
Confidence 35799999999988888777767999999999999999999999999999999999999998778899999999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccccccccCcCCCCccccCCCCCceEeCCCCCCCC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPSGLANVTSLSIFNASFNNLSG 701 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~ 701 (1103)
+|+|++..|+.|..+++|++|+|++|.+..... ...-...++.+.+..|.++...|..+ ..++.++++.|.+.-
T Consensus 111 ~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~-~~~~~~~l~~~~l~~~~~~c~~p~~l---~~~~l~~L~~n~l~C 184 (192)
T d1w8aa_ 111 DNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKC 184 (192)
T ss_dssp SSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG-GHHHHHHHHHHCCSGGGCBBCSSTTT---TTSBGGGSCTTTCCC
T ss_pred CccccccCHHHhcCCcccccccccccccccccc-hHHHhhhhhhhcccCCCeEeCCChhh---cCCEeeecCHhhCcC
Confidence 999998888999999999999999999985433 22233457888899999987777654 556778899898864
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=4.2e-16 Score=160.79 Aligned_cols=167 Identities=25% Similarity=0.352 Sum_probs=142.1
Q ss_pred CCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCE
Q 043720 104 GGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEV 183 (1103)
Q Consensus 104 ~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 183 (1103)
..+..|++|++++|.++. ++ .+..+++|++|+|++|.+++ ++ .++.+++|++|++++|+++ .+| .+.++++|+.
T Consensus 43 ~~L~~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~L~~n~i~~-l~-~~~~l~~L~~L~l~~n~i~-~l~-~l~~l~~L~~ 116 (210)
T d1h6ta2 43 NELNSIDQIIANNSDIKS-VQ-GIQYLPNVTKLFLNGNKLTD-IK-PLANLKNLGWLFLDENKVK-DLS-SLKDLKKLKS 116 (210)
T ss_dssp HHHHTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCC-CG-GGTTCTTCCEEECCSSCCC-CGG-GGTTCTTCCE
T ss_pred HHhcCccEEECcCCCCCC-ch-hHhhCCCCCEEeCCCccccC-cc-ccccCcccccccccccccc-ccc-cccccccccc
Confidence 357899999999999984 33 48889999999999999995 44 3789999999999999998 455 5889999999
Q ss_pred EEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCcc
Q 043720 184 LNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNM 263 (1103)
Q Consensus 184 L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~ 263 (1103)
|++++|.+.. ...+..+++|+.+++++|.++ ..+ ... .+++|+++++++|++++. + .++++++|+.|+|++|+
T Consensus 117 L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~-~~~-~~~-~l~~L~~l~l~~n~l~~i-~-~l~~l~~L~~L~Ls~N~ 189 (210)
T d1h6ta2 117 LSLEHNGISD--INGLVHLPQLESLYLGNNKIT-DIT-VLS-RLTKLDTLSLEDNQISDI-V-PLAGLTKLQNLYLSKNH 189 (210)
T ss_dssp EECTTSCCCC--CGGGGGCTTCCEEECCSSCCC-CCG-GGG-GCTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSSC
T ss_pred cccccccccc--ccccccccccccccccccccc-ccc-ccc-cccccccccccccccccc-c-cccCCCCCCEEECCCCC
Confidence 9999999874 345889999999999999998 333 333 358899999999999853 3 48999999999999999
Q ss_pred CCccccccccCCCCCCEEEccC
Q 043720 264 LNDVIPRELGWLRKLEVLDVSR 285 (1103)
Q Consensus 264 l~~~~p~~l~~l~~L~~L~Ls~ 285 (1103)
+++ +| .+..+++|++|+|++
T Consensus 190 i~~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 190 ISD-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CCB-CG-GGTTCTTCSEEEEEE
T ss_pred CCC-Ch-hhcCCCCCCEEEccC
Confidence 987 44 699999999999974
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.66 E-value=5.6e-16 Score=158.41 Aligned_cols=176 Identities=27% Similarity=0.331 Sum_probs=102.7
Q ss_pred EccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCC
Q 043720 113 SLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVK 192 (1103)
Q Consensus 113 ~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~ 192 (1103)
.++.+.+++.++ ...+.+|++|++++|.++ .++ .+..+++|++|+|++|++++ ++. ++++++|++|++++|.+.
T Consensus 24 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~-~~~-l~~l~~L~~L~l~~n~~~ 97 (199)
T d2omxa2 24 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTD-ITP-LKNLTKLVDILMNNNQIA 97 (199)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCC-CGG-GTTCTTCCEEECCSSCCC
T ss_pred HhCCCCCCCccC--HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccC-ccc-ccCCcccccccccccccc
Confidence 344445544332 234555666666666665 232 35556666666666666663 222 566666666666666655
Q ss_pred CCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCccCCccccccc
Q 043720 193 GVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSNMLNDVIPREL 272 (1103)
Q Consensus 193 ~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l 272 (1103)
. ++ .++++++|+.|++++|.+. .++ .+.. +++|+.|++++|++.. + +.+..+++|+.|++++|++++.. .+
T Consensus 98 ~-~~-~l~~l~~L~~L~l~~~~~~-~~~-~~~~-l~~L~~L~l~~n~l~~-~-~~l~~~~~L~~L~l~~n~l~~l~--~l 168 (199)
T d2omxa2 98 D-IT-PLANLTNLTGLTLFNNQIT-DID-PLKN-LTNLNRLELSSNTISD-I-SALSGLTSLQQLNFSSNQVTDLK--PL 168 (199)
T ss_dssp C-CG-GGTTCTTCSEEECCSSCCC-CCG-GGTT-CTTCSEEECCSSCCCC-C-GGGTTCTTCSEEECCSSCCCCCG--GG
T ss_pred c-cc-ccccccccccccccccccc-ccc-ccch-hhhhHHhhhhhhhhcc-c-ccccccccccccccccccccCCc--cc
Confidence 3 22 2556666666666666655 222 2222 4557777777776652 2 34666777777777777776632 36
Q ss_pred cCCCCCCEEEccCCcCCCcCCccccCCCCCCeE
Q 043720 273 GWLRKLEVLDVSRNRLNGLIPTELGNCVELSVL 305 (1103)
Q Consensus 273 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 305 (1103)
+++++|+.|++++|++++ ++ .++++++|+.|
T Consensus 169 ~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 169 ANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp TTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 777777777777777764 22 46677777654
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.64 E-value=1e-15 Score=156.43 Aligned_cols=164 Identities=27% Similarity=0.329 Sum_probs=139.7
Q ss_pred cCCCCCCCEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCC
Q 043720 103 VGGLSELRVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLE 182 (1103)
Q Consensus 103 l~~l~~L~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 182 (1103)
...++++++|++++|+++ .++ .+..+++|++|+|++|++++..| ++++++|++|++++|.+. .++ .+.++++|+
T Consensus 36 ~~~l~~l~~L~l~~~~i~-~l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~ 109 (199)
T d2omxa2 36 QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLT 109 (199)
T ss_dssp HHHHTTCCEEECTTSCCC-CCT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCS
T ss_pred HHHhcCCCEEECCCCCCC-Ccc-ccccCCCcCcCccccccccCccc--ccCCcccccccccccccc-ccc-ccccccccc
Confidence 356789999999999998 443 58899999999999999996443 999999999999999998 455 488999999
Q ss_pred EEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCCCCCCEEeCCCc
Q 043720 183 VLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKCQQLRTLLLFSN 262 (1103)
Q Consensus 183 ~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N 262 (1103)
.|++++|.+... ..+..+++|+.|++++|++. .++ .+.. +++|++|++++|++++. + .++++++|++|++++|
T Consensus 110 ~L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~l~~-~~~L~~L~l~~n~l~~l-~-~l~~l~~L~~L~ls~N 182 (199)
T d2omxa2 110 GLTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-ALSG-LTSLQQLNFSSNQVTDL-K-PLANLTTLERLDISSN 182 (199)
T ss_dssp EEECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-GGTT-CTTCSEEECCSSCCCCC-G-GGTTCTTCCEEECCSS
T ss_pred cccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-cccc-cccccccccccccccCC-c-cccCCCCCCEEECCCC
Confidence 999999999853 34788999999999999997 565 3443 57899999999999853 3 4899999999999999
Q ss_pred cCCccccccccCCCCCCEE
Q 043720 263 MLNDVIPRELGWLRKLEVL 281 (1103)
Q Consensus 263 ~l~~~~p~~l~~l~~L~~L 281 (1103)
++++. + .++.+++|+.|
T Consensus 183 ~i~~i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 183 KVSDI-S-VLAKLTNLESL 199 (199)
T ss_dssp CCCCC-G-GGGGCTTCSEE
T ss_pred CCCCC-c-cccCCCCCCcC
Confidence 99984 3 58899999876
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.52 E-value=1.7e-15 Score=163.94 Aligned_cols=156 Identities=21% Similarity=0.153 Sum_probs=70.7
Q ss_pred CCCCCEEEccccccCCC-CCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccc-cCCCCCChhHHhhcCcCc
Q 043720 154 LRNLRVLNLAFNRIDGD-IPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYN-ELNGSIPSELGKYCRYLE 231 (1103)
Q Consensus 154 l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N-~l~g~ip~~~~~~~~~L~ 231 (1103)
..+|++|||+++.++.. ++..+.++++|++|+|++|.+++..+..++.+++|++|+++++ .++...-..+...+++|+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~ 124 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD 124 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred CCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcc
Confidence 34555555555555422 2233445555555555555555444455555555555555553 333211122233345555
Q ss_pred EEECcCC-ccccc-cCccccC-CCCCCEEeCCCc--cCCcc-ccccccCCCCCCEEEccCC-cCCCcCCccccCCCCCCe
Q 043720 232 HLDLSGN-SLVGR-IPSSLGK-CQQLRTLLLFSN--MLNDV-IPRELGWLRKLEVLDVSRN-RLNGLIPTELGNCVELSV 304 (1103)
Q Consensus 232 ~L~L~~N-~l~~~-~p~~l~~-l~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~ 304 (1103)
+|+++++ .++.. +...+.. .++|+.|+++++ .+++. +......+++|+.|++++| .+++..+..+.++++|++
T Consensus 125 ~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~ 204 (284)
T d2astb2 125 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204 (284)
T ss_dssp EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCE
T ss_pred ccccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCE
Confidence 5555553 23211 1111222 245555555543 23321 1222234555555555553 244444444555555555
Q ss_pred Eeccc
Q 043720 305 LVLSN 309 (1103)
Q Consensus 305 L~l~~ 309 (1103)
|++++
T Consensus 205 L~L~~ 209 (284)
T d2astb2 205 LSLSR 209 (284)
T ss_dssp EECTT
T ss_pred EECCC
Confidence 55543
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.50 E-value=5.7e-14 Score=130.56 Aligned_cols=119 Identities=26% Similarity=0.303 Sum_probs=84.2
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGN 189 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 189 (1103)
|+|+|++|+++ .+| .+.++++|++|||++|.|+ .+|+.++.+++|++|++++|+|+ .+| .++++++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhccccccccccccc-ccC-ccccccccCeEECCCC
Confidence 46788888887 444 4777888888888888887 66777788888888888888887 444 4777888888888888
Q ss_pred cCCCCC-ChhcccCCCCcEeecccccCCCC--CChhHHhhcCcCcEE
Q 043720 190 QVKGVI-PGFLGSFLKLRVLFLSYNELNGS--IPSELGKYCRYLEHL 233 (1103)
Q Consensus 190 ~l~~~~-p~~l~~l~~L~~L~L~~N~l~g~--ip~~~~~~~~~L~~L 233 (1103)
+++... ...++.+++|++|++++|.+++. .+..+...+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 877443 24567777788888887777622 344555555656554
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.49 E-value=3.2e-14 Score=132.31 Aligned_cols=102 Identities=31% Similarity=0.458 Sum_probs=71.3
Q ss_pred cEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCCCCcccCCCCCcEEeccCc
Q 043720 570 RVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGIPSSIGELRSLEVLELSSN 649 (1103)
Q Consensus 570 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 649 (1103)
++|+|++|+|+. ++ .+..+++|++|++++|+|+ .+|+.|+.+++|+.|++++|+|++ +| .++.+++|++|++++|
T Consensus 1 R~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred CEEEcCCCCCCC-Cc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence 467777777773 33 3677777777777777777 566677777777777777777773 33 4777777777777777
Q ss_pred cccCcC-hhhhhhcccccccccccccCc
Q 043720 650 SLSGEV-PEGVVNLRNLTALLLDNNKLS 676 (1103)
Q Consensus 650 ~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 676 (1103)
+|+... ...+..+++|+.|++++|+++
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred ccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 776432 245667777777777777776
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.48 E-value=4.3e-15 Score=166.02 Aligned_cols=40 Identities=25% Similarity=0.333 Sum_probs=19.4
Q ss_pred CCCCCCEEEccCCcCCCCC----ChhcccCCCCcEeecccccCC
Q 043720 177 NFESLEVLNLAGNQVKGVI----PGFLGSFLKLRVLFLSYNELN 216 (1103)
Q Consensus 177 ~l~~L~~L~L~~n~l~~~~----p~~l~~l~~L~~L~L~~N~l~ 216 (1103)
.+++|++|+|++|.++... ...+...++|++|++++|.++
T Consensus 91 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~ 134 (344)
T d2ca6a1 91 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLG 134 (344)
T ss_dssp TCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCH
T ss_pred hCCCcccccccccccccccccchhhhhcccccchheeccccccc
Confidence 3445555555555554321 222334455555555555543
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.4e-14 Score=139.09 Aligned_cols=85 Identities=19% Similarity=0.235 Sum_probs=35.5
Q ss_pred CCCCCCEEEeecCCCCCCccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEe
Q 043720 129 SLEKLEVLDVEGNFLSGRLPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVL 208 (1103)
Q Consensus 129 ~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L 208 (1103)
++.+|++|||++|+|+ .+|..+..+++|++|+|++|+|+ .++ .+..+++|++|++++|+++...+..+..+++|++|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCccccccccccccc
Confidence 3334444444444444 33333344444444444444444 222 23444444444444444443333333334444444
Q ss_pred ecccccCC
Q 043720 209 FLSYNELN 216 (1103)
Q Consensus 209 ~L~~N~l~ 216 (1103)
++++|+++
T Consensus 93 ~L~~N~i~ 100 (162)
T d1a9na_ 93 ILTNNSLV 100 (162)
T ss_dssp ECCSCCCC
T ss_pred eecccccc
Confidence 44444443
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=2.8e-14 Score=154.18 Aligned_cols=199 Identities=22% Similarity=0.253 Sum_probs=127.2
Q ss_pred CEEEccCCCCcccCCccccCCCCCCEEEeecCCCCCC-ccccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccC
Q 043720 110 RVLSLPFNGFSGEFPPEIWSLEKLEVLDVEGNFLSGR-LPNEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAG 188 (1103)
Q Consensus 110 ~~L~L~~n~l~g~~p~~l~~l~~L~~L~Ls~n~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~ 188 (1103)
..+.++...+...+. ......+|++|||++|.++.. ++..+..+++|++|+|+++.+++..+..++.+++|++|++++
T Consensus 26 ~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 26 IAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp SEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTT
T ss_pred eEeeccccccccchh-hhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccc
Confidence 344444444332222 233445677777777776633 444566777777777777777766666677777777777777
Q ss_pred C-cCCCC-CChhcccCCCCcEeecccc-cCCCC-CChhHHhhcCcCcEEECcCC--ccccc-cCccccCCCCCCEEeCCC
Q 043720 189 N-QVKGV-IPGFLGSFLKLRVLFLSYN-ELNGS-IPSELGKYCRYLEHLDLSGN--SLVGR-IPSSLGKCQQLRTLLLFS 261 (1103)
Q Consensus 189 n-~l~~~-~p~~l~~l~~L~~L~L~~N-~l~g~-ip~~~~~~~~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~L~~ 261 (1103)
+ .++.. +...+.++++|++|+++++ .++.. +...+...+++|+.|++++. .++.. +.....++++|++|++++
T Consensus 105 c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~ 184 (284)
T d2astb2 105 CSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSD 184 (284)
T ss_dssp CBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTT
T ss_pred cccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccccccccccccccccccccccccccc
Confidence 4 44421 1222356778888888775 34321 23334444567888888764 34422 223345678888888887
Q ss_pred c-cCCccccccccCCCCCCEEEccCC-cCCCcCCccccCCCCCCeEeccc
Q 043720 262 N-MLNDVIPRELGWLRKLEVLDVSRN-RLNGLIPTELGNCVELSVLVLSN 309 (1103)
Q Consensus 262 N-~l~~~~p~~l~~l~~L~~L~Ls~N-~l~~~~p~~l~~l~~L~~L~l~~ 309 (1103)
| .+++.....+..+++|++|+|+++ .+++.....++++++|+.|++++
T Consensus 185 ~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~ 234 (284)
T d2astb2 185 SVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 234 (284)
T ss_dssp CTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTT
T ss_pred ccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeC
Confidence 5 477667777888888888888884 67766667788888888888875
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=7.7e-14 Score=135.53 Aligned_cols=119 Identities=18% Similarity=0.087 Sum_probs=80.6
Q ss_pred CCCCEEEccCCcCCCCCCcccccCccCcEEeccCc-ccCCCCCCcccCCCCCcEEeccCccccCcChhhhhhcccccccc
Q 043720 591 TSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADN-NLTGGIPSSIGELRSLEVLELSSNSLSGEVPEGVVNLRNLTALL 669 (1103)
Q Consensus 591 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 669 (1103)
...+.++.+++.+. ..|..+..+++|++|+|++| .|+...+..|.++++|+.|+|++|+|+.+.+.+|..+++|+.|+
T Consensus 8 ~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~ 86 (156)
T d2ifga3 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLN 86 (156)
T ss_dssp SSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEE
T ss_pred CCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCccccccccccccccee
Confidence 34455677777776 56666777777777777655 47655556677777788888888877766677777777777777
Q ss_pred cccccCcCCCCccccCCCCCceEeCCCCCCCCCCCCCccccccccccCCCCCCCCCCCCCCCC
Q 043720 670 LDNNKLSGHLPSGLANVTSLSIFNASFNNLSGPFPWNVTTMNCSGVIGNPFLDPCQMYKDISS 732 (1103)
Q Consensus 670 L~~N~l~~~~p~~l~~l~~L~~l~l~~N~l~~~~p~~~~~~~~~~l~~Np~~c~C~~~~~~~~ 732 (1103)
|++|+|+...+..+.. .+|+. +.+.+|||.|||++.....|
T Consensus 87 Ls~N~l~~l~~~~~~~-~~l~~---------------------L~L~~Np~~C~C~~~~l~~~ 127 (156)
T d2ifga3 87 LSFNALESLSWKTVQG-LSLQE---------------------LVLSGNPLHCSCALRWLQRW 127 (156)
T ss_dssp CCSSCCSCCCSTTTCS-CCCCE---------------------EECCSSCCCCCGGGHHHHHH
T ss_pred ccCCCCcccChhhhcc-ccccc---------------------cccCCCcccCCchHHHHHHH
Confidence 7777777333333332 23444 46778899999998654443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=6.4e-14 Score=137.04 Aligned_cols=129 Identities=19% Similarity=0.220 Sum_probs=91.3
Q ss_pred cccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCc
Q 043720 150 EFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRY 229 (1103)
Q Consensus 150 ~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~ 229 (1103)
.+.+..+|++|||++|+|+ .++..+..+++|++|+|++|+++. ++ .|..+++|++|++++|+++ .+|+.++..+++
T Consensus 13 ~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~-l~-~~~~l~~L~~L~ls~N~i~-~l~~~~~~~l~~ 88 (162)
T d1a9na_ 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-LD-GFPLLRRLKTLLVNNNRIC-RIGEGLDQALPD 88 (162)
T ss_dssp EEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCE-EC-CCCCCSSCCEEECCSSCCC-EECSCHHHHCTT
T ss_pred hccCcCcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCc-cC-CcccCcchhhhhccccccc-CCCccccccccc
Confidence 3567778899999999998 667766788899999999998884 33 4778888888888888887 677666666677
Q ss_pred CcEEECcCCcccccc-CccccCCCCCCEEeCCCccCCccc---cccccCCCCCCEEE
Q 043720 230 LEHLDLSGNSLVGRI-PSSLGKCQQLRTLLLFSNMLNDVI---PRELGWLRKLEVLD 282 (1103)
Q Consensus 230 L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~~---p~~l~~l~~L~~L~ 282 (1103)
|++|++++|+++... ...+..+++|++|++++|.++... +..+..+++|++||
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred cccceeccccccccccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeC
Confidence 888888888876321 134566666777777766665421 12345555555554
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.39 E-value=6.7e-14 Score=156.15 Aligned_cols=187 Identities=22% Similarity=0.254 Sum_probs=114.4
Q ss_pred hcccCCCCcEeecccccCCCCCChhHH---hhcCcCcEEECcCCccccccCcc-------------ccCCCCCCEEeCCC
Q 043720 198 FLGSFLKLRVLFLSYNELNGSIPSELG---KYCRYLEHLDLSGNSLVGRIPSS-------------LGKCQQLRTLLLFS 261 (1103)
Q Consensus 198 ~l~~l~~L~~L~L~~N~l~g~ip~~~~---~~~~~L~~L~L~~N~l~~~~p~~-------------l~~l~~L~~L~L~~ 261 (1103)
.+...++|++|+|++|.++..-...+. ..+++|++|++++|.++...... ....+.|+.+++++
T Consensus 88 ~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~ 167 (344)
T d2ca6a1 88 ALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 167 (344)
T ss_dssp HHTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred HHhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccccccccccccccccCcccceeeccc
Confidence 355678899999999998754333332 23567999999999875321111 13456788888888
Q ss_pred ccCCcc----ccccccCCCCCCEEEccCCcCCCc-----CCccccCCCCCCeEecccCcCccccCccccCcccccccCCC
Q 043720 262 NMLNDV----IPRELGWLRKLEVLDVSRNRLNGL-----IPTELGNCVELSVLVLSNLFDPLLSGRNIRGELSVGQSDAS 332 (1103)
Q Consensus 262 N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~~l~~l~~L~~L~l~~~~~~~l~~~~~~~~~~~~~~~~~ 332 (1103)
|.++.. +...+...+.|+.|+|++|+++.. +...+..+++|+.|++++
T Consensus 168 n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~----------------------- 224 (344)
T d2ca6a1 168 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQD----------------------- 224 (344)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCS-----------------------
T ss_pred ccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccc-----------------------
Confidence 887643 334456677888888888887632 233455556666666654
Q ss_pred CCCCCcccccCchhhhccccccccccCCcccccc----CCccccccccCcEEEcCCcccccccchhh----hc--cCCce
Q 043720 333 NGEKNSFIGSIPMEITTLSKLRIIWAPRLNLEGK----LPSSWGACESLEMLNLAQNVLRGDLIGVF----DR--CKKLH 402 (1103)
Q Consensus 333 ~~~~n~~~~~ip~~~~~L~~L~~L~l~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~----~~--l~~L~ 402 (1103)
|.+... +...+..+++|++|+|++|.|++.....+ .. .+.|+
T Consensus 225 ----------------------------N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~ 276 (344)
T d2ca6a1 225 ----------------------------NTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQ 276 (344)
T ss_dssp ----------------------------SCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHHHHHHTCSSCCCC
T ss_pred ----------------------------ccccccccccccccccccccchhhhhhcCccCchhhHHHHHHhhhccCCCCC
Confidence 333221 22344556667777777777765433333 22 34577
Q ss_pred EeecCCcccccc----ccccc--cccceeEEEecCCccc
Q 043720 403 FIDLSSNELSGE----LDVKL--QVPCMALFDVSGNHMS 435 (1103)
Q Consensus 403 ~LdLs~N~l~~~----~~~~~--~~~~L~~l~ls~N~l~ 435 (1103)
+|||++|+++.. +.... +.+.|+.|++++|+++
T Consensus 277 ~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 277 TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315 (344)
T ss_dssp EEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred EEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence 777777776642 11111 3566777777777775
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=6.7e-14 Score=141.98 Aligned_cols=128 Identities=29% Similarity=0.363 Sum_probs=58.3
Q ss_pred ccccCCCCCCEEEccccccCCCCCCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcC
Q 043720 149 NEFVGLRNLRVLNLAFNRIDGDIPFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCR 228 (1103)
Q Consensus 149 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~ 228 (1103)
..+..+++|++|+|++|+|+ .++ .+.++++|++|+|++|+++ .+|..+..+++|++|++++|+++ .++ .+.. ++
T Consensus 42 ~sl~~L~~L~~L~Ls~n~I~-~i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~-~l~-~~~~-l~ 115 (198)
T d1m9la_ 42 ATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SLS-GIEK-LV 115 (198)
T ss_dssp HHHHHTTTCCEEECSEEEES-CCC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECC-CHH-HHHH-HH
T ss_pred hHHhcccccceeECcccCCC-Ccc-cccCCccccChhhcccccc-ccccccccccccccccccccccc-ccc-cccc-cc
Confidence 33444444444444444444 232 2444444444444444444 23333333344555555555554 232 2222 24
Q ss_pred cCcEEECcCCccccccC-ccccCCCCCCEEeCCCccCCccccc----------cccCCCCCCEEE
Q 043720 229 YLEHLDLSGNSLVGRIP-SSLGKCQQLRTLLLFSNMLNDVIPR----------ELGWLRKLEVLD 282 (1103)
Q Consensus 229 ~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~L~~N~l~~~~p~----------~l~~l~~L~~L~ 282 (1103)
+|++|++++|+++.... ..+..+++|+.|+|++|.++...+. .+..+++|+.||
T Consensus 116 ~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp~L~~LD 180 (198)
T d1m9la_ 116 NLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180 (198)
T ss_dssp HSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCSSCCEES
T ss_pred cccccccccchhccccccccccCCCccceeecCCCccccCcccccchhhHHHHHHHHCCCcCEeC
Confidence 45555555555542211 2345555555555555555443221 145677777776
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.29 E-value=8.3e-14 Score=141.27 Aligned_cols=112 Identities=28% Similarity=0.299 Sum_probs=51.2
Q ss_pred CCCCCCCCCCCEEEccCCcCCCCCChhcccCCCCcEeecccccCCCCCChhHHhhcCcCcEEECcCCccccccCccccCC
Q 043720 172 PFSLRNFESLEVLNLAGNQVKGVIPGFLGSFLKLRVLFLSYNELNGSIPSELGKYCRYLEHLDLSGNSLVGRIPSSLGKC 251 (1103)
Q Consensus 172 p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~g~ip~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l 251 (1103)
|.++..+++|++|+|++|+++. ++ .+..+++|++|+|++|+++ .+|.... .+++|++|++++|+++. + +.+..+
T Consensus 41 ~~sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~-~~~~L~~L~l~~N~i~~-l-~~~~~l 114 (198)
T d1m9la_ 41 DATLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDA-VADTLEELWISYNQIAS-L-SGIEKL 114 (198)
T ss_dssp HHHHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHH-HHHHCCEEECSEEECCC-H-HHHHHH
T ss_pred hhHHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-ccccccc-ccccccccccccccccc-c-cccccc
Confidence 3344445555555555555542 22 2444555555555555554 4443222 22345555555555542 1 224444
Q ss_pred CCCCEEeCCCccCCcccc-ccccCCCCCCEEEccCCcCC
Q 043720 252 QQLRTLLLFSNMLNDVIP-RELGWLRKLEVLDVSRNRLN 289 (1103)
Q Consensus 252 ~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~ 289 (1103)
++|+.|++++|+++.... ..+..+++|+.|+|++|++.
T Consensus 115 ~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 115 VNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHH
T ss_pred ccccccccccchhccccccccccCCCccceeecCCCccc
Confidence 555555555555544211 23444555555555555443
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.25 E-value=1.5e-11 Score=119.01 Aligned_cols=139 Identities=19% Similarity=0.113 Sum_probs=95.6
Q ss_pred cEEecCCCcccccCCchhhhcCCCccEEECcCC-cCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEecc
Q 043720 545 MVANLSNNNIIGHIPLDIGVMCKSLRVLDASHN-QISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLA 623 (1103)
Q Consensus 545 ~~l~ls~n~~~~~ip~~~~~~~~~L~~L~L~~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 623 (1103)
..++++++++. .+|..+... ++|++|++++| .|+.+.+.+|.++++|+.|+|++|+|+...|.+|..+++|++|+|+
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l-~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls 88 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGA-ENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS 88 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSC-SCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred CeEEecCCCCc-cCcccccCc-cccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceecc
Confidence 35778888887 677777655 78899999766 4887777888899999999999999987667888899999999999
Q ss_pred CcccCCCCCCcccCCCCCcEEeccCccccCcC-hhhhhhcccccccccccccCcCCCCccccCC
Q 043720 624 DNNLTGGIPSSIGELRSLEVLELSSNSLSGEV-PEGVVNLRNLTALLLDNNKLSGHLPSGLANV 686 (1103)
Q Consensus 624 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l 686 (1103)
+|+|+...+..|.. .+|+.|+|++|.+.-.- -..+..........+..++++-..|..+.++
T Consensus 89 ~N~l~~l~~~~~~~-~~l~~L~L~~Np~~C~C~~~~l~~~~~~~~~~~~~~~~~C~~p~~l~~~ 151 (156)
T d2ifga3 89 FNALESLSWKTVQG-LSLQELVLSGNPLHCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHM 151 (156)
T ss_dssp SSCCSCCCSTTTCS-CCCCEEECCSSCCCCCGGGHHHHHHHHTTCSSCGGGCCCCSSSSCSSCC
T ss_pred CCCCcccChhhhcc-ccccccccCCCcccCCchHHHHHHHHHhccCccCcCCcEECcChHHCcC
Confidence 99998544445544 46889999999885211 1123222223333444455554444444433
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.50 E-value=3.4e-09 Score=102.83 Aligned_cols=121 Identities=22% Similarity=0.181 Sum_probs=78.9
Q ss_pred CccEEECcCCcCCCCCcccccCCCCCCEEEccCCcCCCCCCcccccCccCcEEeccCcccCCCC--CCcccCCCCCcEEe
Q 043720 568 SLRVLDASHNQISGIVPQSLENLTSLVFLDLNGNKLQGEIPSSLHRLKYLRHLSLADNNLTGGI--PSSIGELRSLEVLE 645 (1103)
Q Consensus 568 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~~~l~~L~~L~ 645 (1103)
..+.|+++++... ..+..+..+..++..+|... .++..+..+++|++|+|++|+|+... +..+..+++|+.|+
T Consensus 23 ~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~ 97 (162)
T d1koha1 23 SQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILN 97 (162)
T ss_dssp SSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCC
T ss_pred hhCeeecccCCCC----chhhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccc
Confidence 3455666655432 12344444555555555443 34445567888888888888888532 34566788899999
Q ss_pred ccCccccCcChhhhhhcccccccccccccCcCCCCc-------cccCCCCCceEe
Q 043720 646 LSSNSLSGEVPEGVVNLRNLTALLLDNNKLSGHLPS-------GLANVTSLSIFN 693 (1103)
Q Consensus 646 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~-------~l~~l~~L~~l~ 693 (1103)
|++|.|+...+-.+....+|+.|++++|+++..... .+..+|+|+.||
T Consensus 98 Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 98 LSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccCccccchhhhhhhccccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 999998854443444556788999999998755442 256788888875
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.16 E-value=1.1e-07 Score=91.75 Aligned_cols=13 Identities=46% Similarity=0.350 Sum_probs=4.9
Q ss_pred CCCcEeecccccC
Q 043720 203 LKLRVLFLSYNEL 215 (1103)
Q Consensus 203 ~~L~~L~L~~N~l 215 (1103)
++|++|+|++|++
T Consensus 65 ~~L~~L~Ls~N~i 77 (162)
T d1koha1 65 PELLSLNLSNNRL 77 (162)
T ss_dssp TTCCCCCCCSSCC
T ss_pred CCCCEeeCCCccc
Confidence 3333333333333
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.12 E-value=3e-06 Score=88.82 Aligned_cols=149 Identities=13% Similarity=0.028 Sum_probs=100.8
Q ss_pred HHHHHHhcCCCCcceeccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCe
Q 043720 814 ESIIRATGDFNTSNCIGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNE 892 (1103)
Q Consensus 814 ~~~~~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 892 (1103)
.++.+....|+..+..+.++.+.||+...+ ++.+++|+....... ....+.+|...+..+. +--+.+++.+...++.
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~-~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKG-TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTT-STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCccc-chhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence 455666677877776655666789998754 566778877544322 2334667877776653 3335677788888889
Q ss_pred EEEEEeecCCCChHHHHHhhcCCcccHHHHHHHHHHHHHHHHHHHhCC--------------------------------
Q 043720 893 MFLIYNYLPGGNLENFIKARTSRAVDWKILHKIALDVASALAYLHDQC-------------------------------- 940 (1103)
Q Consensus 893 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~gL~~LH~~~-------------------------------- 940 (1103)
.++||++++|.++.+..... .....++.++++.++.||+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred eEEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988776543211 112334555666666666421
Q ss_pred ------------------------CCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 941 ------------------------APRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 941 ------------------------~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
.+.++|+|+.|.||++++++.+.|.||+.+.
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1247899999999999987667799999875
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.51 E-value=7.6e-05 Score=77.22 Aligned_cols=74 Identities=14% Similarity=0.187 Sum_probs=52.4
Q ss_pred eeccCCc-ccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC--CCceeEEEeEEecCCeEEEEEeecCCCC
Q 043720 828 CIGSGGF-GTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR--HPNLVTLIGYRASGNEMFLIYNYLPGGN 904 (1103)
Q Consensus 828 ~lg~G~f-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lV~E~~~~gs 904 (1103)
.+..|.. +.||+...+++..+++|....... ..+.+|+..++.+. .-.+.+++++..+++..++||||++|.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence 3455554 678999888888889997654432 23556666666653 3335677888888889999999998765
Q ss_pred h
Q 043720 905 L 905 (1103)
Q Consensus 905 L 905 (1103)
+
T Consensus 93 ~ 93 (255)
T d1nd4a_ 93 L 93 (255)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.49 E-value=1.5e-05 Score=76.72 Aligned_cols=89 Identities=16% Similarity=0.124 Sum_probs=49.2
Q ss_pred CCCCCCCEEEccCC-CCccc----CCccccCCCCCCEEEeecCCCCC----CccccccCCCCCCEEEccccccCCC----
Q 043720 104 GGLSELRVLSLPFN-GFSGE----FPPEIWSLEKLEVLDVEGNFLSG----RLPNEFVGLRNLRVLNLAFNRIDGD---- 170 (1103)
Q Consensus 104 ~~l~~L~~L~L~~n-~l~g~----~p~~l~~l~~L~~L~Ls~n~l~~----~~p~~l~~l~~L~~L~Ls~N~l~~~---- 170 (1103)
.+.+.|+.|+|+++ .++.. +-..+...+.|++|+|++|.++. .+...+...+.|++|+|++|.++..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence 34567777777763 45432 22334455667777777776652 2223344456666666666666532
Q ss_pred CCCCCCCCCCCCEEEccCCcCC
Q 043720 171 IPFSLRNFESLEVLNLAGNQVK 192 (1103)
Q Consensus 171 ~p~~l~~l~~L~~L~L~~n~l~ 192 (1103)
+-..+...++|++|++++|.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~ 113 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQS 113 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSC
T ss_pred HHHHHHhCCcCCEEECCCCcCC
Confidence 2223444555666666665543
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.41 E-value=5e-05 Score=72.96 Aligned_cols=59 Identities=14% Similarity=-0.003 Sum_probs=27.1
Q ss_pred CcCcEEECcCCccccc----cCccccCCCCCCEEeCCCccCCcc-------ccccccCCCCCCEEEccCC
Q 043720 228 RYLEHLDLSGNSLVGR----IPSSLGKCQQLRTLLLFSNMLNDV-------IPRELGWLRKLEVLDVSRN 286 (1103)
Q Consensus 228 ~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~-------~p~~l~~l~~L~~L~Ls~N 286 (1103)
+.|++|+|++|.++.. +-..+...+.|++|++++|.+... +...+...++|+.|+++.+
T Consensus 72 ~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~ 141 (167)
T d1pgva_ 72 PSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFA 141 (167)
T ss_dssp SSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCC
T ss_pred ccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCC
Confidence 3455555555544321 112334445566666655544321 2333444555566655544
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=96.89 E-value=0.00074 Score=74.31 Aligned_cols=77 Identities=9% Similarity=0.022 Sum_probs=47.1
Q ss_pred cceeccCCcccEEEEEEcC-CcEEEEEEcccc------cchhhHHHHHHHHHHHhcCC---CCceeEEEeEEecCCeEEE
Q 043720 826 SNCIGSGGFGTTYKAEISP-GILVAVKKLAVG------RFQHGVQQFHAEIKTLGNVR---HPNLVTLIGYRASGNEMFL 895 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~-~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l 895 (1103)
.+.||.|....||++...+ ++.|+||.-... .......+...|+..++.+. ...+.+++.+..+ ..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~--~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTE--MAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETT--TTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCC--CCEE
Confidence 3458999999999997654 678888854211 11112334556777776552 2445667766543 4578
Q ss_pred EEeecCCCC
Q 043720 896 IYNYLPGGN 904 (1103)
Q Consensus 896 V~E~~~~gs 904 (1103)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.67 E-value=0.00045 Score=65.93 Aligned_cols=87 Identities=16% Similarity=0.129 Sum_probs=38.9
Q ss_pred cCCCCcEeecccccCCCCCChhHHh---hcCcCcEEECcCCccccc----cCccccCCCCCCEEeC--CCccCCcc----
Q 043720 201 SFLKLRVLFLSYNELNGSIPSELGK---YCRYLEHLDLSGNSLVGR----IPSSLGKCQQLRTLLL--FSNMLNDV---- 267 (1103)
Q Consensus 201 ~l~~L~~L~L~~N~l~g~ip~~~~~---~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~L--~~N~l~~~---- 267 (1103)
..++|++|++++|.++...-..++. ..++++.+++++|.++.. +...+...++|+.++| ++|.+...
T Consensus 44 ~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~ 123 (166)
T d1io0a_ 44 TNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEME 123 (166)
T ss_dssp TCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHH
T ss_pred cCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHHHHHhCccccEEeeccCCCcCcHHHHHH
Confidence 4445555555555444221111111 123455555555554321 2234444555655433 34555431
Q ss_pred ccccccCCCCCCEEEccCCc
Q 043720 268 IPRELGWLRKLEVLDVSRNR 287 (1103)
Q Consensus 268 ~p~~l~~l~~L~~L~Ls~N~ 287 (1103)
+.+.+...++|+.|+++.+.
T Consensus 124 La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 124 IANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHhCCCcCEEeCcCCC
Confidence 33344455666666665543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.56 E-value=0.00015 Score=69.39 Aligned_cols=108 Identities=15% Similarity=0.193 Sum_probs=61.2
Q ss_pred CCccEEECcC-CcCCCC----CcccccCCCCCCEEEccCCcCCCC----CCcccccCccCcEEeccCcccCCC----CCC
Q 043720 567 KSLRVLDASH-NQISGI----VPQSLENLTSLVFLDLNGNKLQGE----IPSSLHRLKYLRHLSLADNNLTGG----IPS 633 (1103)
Q Consensus 567 ~~L~~L~L~~-N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~ 633 (1103)
++|++|+|++ +.|+.. +..++...++|++|+|++|.++.. +-..+...+.++.|++++|.++.. +..
T Consensus 17 ~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~~ 96 (166)
T d1io0a_ 17 PDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALVE 96 (166)
T ss_dssp TTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHHH
T ss_pred CCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHHH
Confidence 6778888876 456521 233455677788888888877632 222344556777777777776532 224
Q ss_pred cccCCCCCcEEec--cCccccCc----Chhhhhhccccccccccccc
Q 043720 634 SIGELRSLEVLEL--SSNSLSGE----VPEGVVNLRNLTALLLDNNK 674 (1103)
Q Consensus 634 ~~~~l~~L~~L~L--s~N~l~~~----~~~~~~~l~~L~~L~L~~N~ 674 (1103)
.+...++|+.++| ++|.+... +...+...++|+.|+++.+.
T Consensus 97 ~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 97 ALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp GGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCC
Confidence 4455566665444 45555421 22334445556666655443
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.10 E-value=0.0044 Score=65.97 Aligned_cols=137 Identities=15% Similarity=0.133 Sum_probs=77.4
Q ss_pred CCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCCCCc-----eeEEE--eEEecCCeEEEEEeecCCCC
Q 043720 832 GGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVRHPN-----LVTLI--GYRASGNEMFLIYNYLPGGN 904 (1103)
Q Consensus 832 G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l~--~~~~~~~~~~lV~E~~~~gs 904 (1103)
+..-.||++...+|+.|++|+...... ..+++..|...+..+.... .+..- .....++..+.++++++|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~~--s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cccceeEEEEcCCCCEEEEEEeCCCCC--CHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 334579999999999999999865432 2355667777776664221 12211 12344667899999997642
Q ss_pred h-----HHH------H---Hhh-c------CCcc-------------------cHH---HHHHHHHHHHHHHHHHH-hCC
Q 043720 905 L-----ENF------I---KAR-T------SRAV-------------------DWK---ILHKIALDVASALAYLH-DQC 940 (1103)
Q Consensus 905 L-----~~~------l---~~~-~------~~~l-------------------~~~---~~~~i~~~ia~gL~~LH-~~~ 940 (1103)
+ ..+ + +.. . .... +.. .....+..+...+.-.- +..
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccC
Confidence 2 111 1 100 0 0011 111 12222333333332221 222
Q ss_pred CCCcccCCCCCCcEEECCCCCEEEeecccccc
Q 043720 941 APRVLHRDVKPSNILLDDDFNAYLSDFGLSRL 972 (1103)
Q Consensus 941 ~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~~ 972 (1103)
..+++|+|+.+.|||++++ ..+.||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4579999999999999754 45899997753
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.42 E-value=0.052 Score=56.91 Aligned_cols=158 Identities=12% Similarity=0.061 Sum_probs=86.2
Q ss_pred CCCHHHHHHHhcCCCCcce-----eccCCcccEEEEEEcCCcEEEEEEcccccchhhHHHHHHHHHHHhcCC-----CCc
Q 043720 810 PLTYESIIRATGDFNTSNC-----IGSGGFGTTYKAEISPGILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-----HPN 879 (1103)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~-----lg~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----h~n 879 (1103)
+++.+++.....+|.+.+. |..|.--+.|+.+..+|+ +++|++...... +++..|...+..+. -|.
T Consensus 2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~---~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVEK---NDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC---C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCCH---HHHHHHHHHHHhhhhccccccc
Confidence 4567788888888887654 446666788999888665 889987654322 33444555555543 222
Q ss_pred eeEEEe---EEecCCeEEEEEeecCCCChHH-----------HH---Hhh-------------------------cCCcc
Q 043720 880 LVTLIG---YRASGNEMFLIYNYLPGGNLEN-----------FI---KAR-------------------------TSRAV 917 (1103)
Q Consensus 880 iv~l~~---~~~~~~~~~lV~E~~~~gsL~~-----------~l---~~~-------------------------~~~~l 917 (1103)
.+...+ +....+..+.++.++.+..... .+ +.. .....
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 222111 2233456677777776542211 00 000 00000
Q ss_pred cHHHHHHHHHHHHHHHHHHHhC-CCCCcccCCCCCCcEEECCCCCEEEeeccccc
Q 043720 918 DWKILHKIALDVASALAYLHDQ-CAPRVLHRDVKPSNILLDDDFNAYLSDFGLSR 971 (1103)
Q Consensus 918 ~~~~~~~i~~~ia~gL~~LH~~-~~~~ivH~Dlk~~NIll~~~~~~ki~Dfgla~ 971 (1103)
........+......+...+.. .+.++||+|+.+.||+++.+...-|.||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 1111222233333333333321 23489999999999999988777899999875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=94.81 E-value=0.036 Score=60.32 Aligned_cols=73 Identities=15% Similarity=0.058 Sum_probs=49.1
Q ss_pred cceeccCCcccEEEEEEcC--------CcEEEEEEcccccchhhHHHHHHHHHHHhcCC-CCceeEEEeEEecCCeEEEE
Q 043720 826 SNCIGSGGFGTTYKAEISP--------GILVAVKKLAVGRFQHGVQQFHAEIKTLGNVR-HPNLVTLIGYRASGNEMFLI 896 (1103)
Q Consensus 826 ~~~lg~G~fg~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lV 896 (1103)
++.|+.|-.=.+|++...+ ...|.+++..... ......+|..+++.+. +.-..++++++.. .+|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~---~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE---TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC---CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc---hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence 3568888889999997654 3457777665221 2345667888888875 4334477887754 589
Q ss_pred EeecCCCCh
Q 043720 897 YNYLPGGNL 905 (1103)
Q Consensus 897 ~E~~~~gsL 905 (1103)
+||+++..+
T Consensus 120 ~efi~g~~l 128 (395)
T d1nw1a_ 120 EEYIPSRPL 128 (395)
T ss_dssp ECCCCEEEC
T ss_pred EEEeccccC
Confidence 999987543
|